Citrus Sinensis ID: 008898
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 549 | 2.2.26 [Sep-21-2011] | |||||||
| Q8H1D6 | 467 | Receptor-like cytosolic s | no | no | 0.520 | 0.612 | 0.391 | 3e-54 | |
| Q9FX99 | 663 | Probable receptor-like pr | no | no | 0.581 | 0.481 | 0.390 | 1e-53 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.506 | 0.373 | 0.405 | 5e-53 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.506 | 0.426 | 0.404 | 2e-52 | |
| Q8VYY5 | 565 | Receptor-like serine/thre | no | no | 0.535 | 0.520 | 0.395 | 3e-52 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.499 | 0.402 | 0.408 | 5e-52 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.626 | 0.485 | 0.373 | 6e-52 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.537 | 0.387 | 0.393 | 9e-52 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.491 | 0.375 | 0.405 | 1e-51 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.500 | 0.540 | 0.378 | 2e-51 |
| >sp|Q8H1D6|RBK1_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK1 OS=Arabidopsis thaliana GN=RBK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 213 bits (542), Expect = 3e-54, Method: Compositional matrix adjust.
Identities = 119/304 (39%), Positives = 184/304 (60%), Gaps = 18/304 (5%)
Query: 231 AVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS 290
A A+ S R FT +EL T F+P+ +IG+GG+++VY+ ++G+ A+K L
Sbjct: 130 AFFMAKPSWRNFTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKE 189
Query: 291 EEE----VLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL----KQLKW 342
EEE L E+ +++ + H N R+ G+ + ++ ++ GSL L + L+W
Sbjct: 190 EEERVSDFLSELGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFGSEECLEW 249
Query: 343 NERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQS 400
R VA+G+A L YLH+ C IIHRD+K+SNILL+ ++ Q+SDFG A + +
Sbjct: 250 KIRYKVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYE-AQISDFGLAKWLPENWP 308
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
H V V P+ GTFGYLAPEY M+G VDEKIDV+++GV+LLE+IT + A+ T A+R+
Sbjct: 309 HHV---VFPIE--GTFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDT--ASRQ 361
Query: 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520
S+V WA+ L E ++DP+L +N E++ VM A +C+ H ++ RP M L++L
Sbjct: 362 SIVAWAKPFLEKNSMEDIVDPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLL 421
Query: 521 QEPD 524
+ D
Sbjct: 422 RGED 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 136/348 (39%), Positives = 206/348 (59%), Gaps = 29/348 (8%)
Query: 213 QETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTN 272
+ T VP S+ +F K+ ++ + R+F+ +E+ + T++F+ +IGQGG VY+
Sbjct: 291 KSTKSVPSSLP--VF-KIHEDDSSSAFRKFSYKEMTNATNDFN--TVIGQGGFGTVYKAE 345
Query: 273 HVDGQVAAVKVL-KCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330
DG +AAVK + K + +E++ RE+ LL+ + H N+V + G+C +K+ +VY+ + N
Sbjct: 346 FNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKN 405
Query: 331 GSLKQYLKQL-----KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385
GSLK +L + W RM +AI VA ALEYLH CDPP+ HRD+KSSNILL ENF
Sbjct: 406 GSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-V 464
Query: 386 PQLSDFGAAMVHHQSHQVSENVKPVN--VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLL 443
+LSDFG A H S S +PVN + GT GY+ PEY++ ++ EK DVYSYGVVLL
Sbjct: 465 AKLSDFGLA---HSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLL 521
Query: 444 ELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNR---EEIEIVMCAAR 500
ELITG+ A+ R + + R LL+ L+DP++ + N ++++ V+ R
Sbjct: 522 ELITGRRAVD---EGRNLVEMSQRFLLAKSKHLELVDPRIKDSINDAGGKQLDAVVTVVR 578
Query: 501 LCLLHSSSRRPTMKTLLKLFQE---PDYWLKMKREKEELL--NERRSN 543
LC RP++K +L+L E P + K +EE+ + +RSN
Sbjct: 579 LCTEKEGRSRPSIKQVLRLLCESCDPVHSAFAKAVEEEIGWDSRKRSN 626
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (531), Expect = 5e-53, Method: Compositional matrix adjust.
Identities = 118/291 (40%), Positives = 183/291 (62%), Gaps = 13/291 (4%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEE-EVLR 296
S + FT EL T FS K ++G+GG +VY+ + DG AVK+L N + + E +
Sbjct: 333 SVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIA 392
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVA 353
EVE+LS + H N+V++IG C ++Y L+ NGS++ +L + L W+ R+ +A+G A
Sbjct: 393 EVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGTLDWDARLKIALGAA 452
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV 413
+ L YLH +P +IHRD K+SN+LL ++F P++SDFG A ++ + S+++ V+
Sbjct: 453 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFT-PKVSDFGLA---REATEGSQHIS-TRVM 507
Query: 414 GTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK-ANRESLVLWARSLLSS 472
GTFGY+APEY M G + K DVYSYGVVLLEL+TG+ + ++ + E+LV WAR LL++
Sbjct: 508 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLAN 567
Query: 473 --GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
GL E+L+DP L YN +++ V A +C+ S RP M +++ +
Sbjct: 568 REGL-EQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALK 617
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (527), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 120/297 (40%), Positives = 175/297 (58%), Gaps = 19/297 (6%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKC-TNWSEEEVLR 296
S FT +EL T+ FS L+GQGG V++ G+ AVK LK + E E
Sbjct: 264 SKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQA 323
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL-----KQLKWNERMDVAI 350
EVE++S + H ++V +IGYC + +VY + N +L+ +L ++W+ R+ +A+
Sbjct: 324 EVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIAL 383
Query: 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH-QVSENVKP 409
G AK L YLH C+P IIHRD+K+SNIL+ F +++DFG A + ++ VS
Sbjct: 384 GSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEA-KVADFGLAKIASDTNTHVS----- 437
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN-RESLVLWARS 468
V+GTFGYLAPEY GK+ EK DV+S+GVVLLELITG+ + N +SLV WAR
Sbjct: 438 TRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARP 497
Query: 469 LLS----SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
LL+ G E L D ++ EY+REE+ ++ A C+ HS+ RRP M +++ +
Sbjct: 498 LLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYY5|NCRK_ARATH Receptor-like serine/threonine-protein kinase NCRK OS=Arabidopsis thaliana GN=NCRK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (525), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 130/329 (39%), Positives = 184/329 (55%), Gaps = 35/329 (10%)
Query: 216 VQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVD 275
V PE+I IF+ F+ EL T+ FS +IG GG+S VYR D
Sbjct: 185 VSKPETIHGAIFQ-------------FSYTELEQATNKFSSNSVIGHGGSSCVYRGQLKD 231
Query: 276 GQVAAVKVLKCTNWSEEEVL--REVELLSSIKHENIVRIIGYC------HSKEMYAIVYN 327
G+ AA+K L + + L EVELLS + H ++V +IGYC H++ + Y
Sbjct: 232 GKTAAIKRLNTPKGDDTDTLFSTEVELLSRLHHYHVVPLIGYCSEFHGKHAERLLVFEY- 290
Query: 328 LLNGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382
+ GSL+ L +++ WN R+ VA+G A+ LEYLH P I+HRDVKS+NILL EN
Sbjct: 291 MSYGSLRDCLDGELGEKMTWNIRISVALGAARGLEYLHEAAAPRILHRDVKSTNILLDEN 350
Query: 383 FHHPQLSDFGAAMVHHQSHQVSENVKP-VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVV 441
+ H +++D G A S + P + GTFGY APEY + G + DV+S+GVV
Sbjct: 351 W-HAKITDLGMAKCLSSDGLQSGSSSPTTGLQGTFGYFAPEYAIAGCASQMSDVFSFGVV 409
Query: 442 LLELITGKEAIQ--TNKANRESLVLWARSLL--SSGLCERLIDPQLNEEYNREEIEIVMC 497
LLELITG++ IQ +N ESLV+WA L S + E L DP+LN ++ EE++I+
Sbjct: 410 LLELITGRKPIQKPSNNKGEESLVIWAVPRLQDSKRVIEELPDPRLNGKFAEEEMQIMAY 469
Query: 498 AARLCLLHSSSRRPTMKTLLKLFQ--EPD 524
A+ CLL RPTM+ ++++ PD
Sbjct: 470 LAKECLLLDPESRPTMREVVQILSTITPD 498
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (523), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 118/289 (40%), Positives = 176/289 (60%), Gaps = 15/289 (5%)
Query: 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCT-NWSEEEVLREVEL 300
F+ EL +T FS K L+G+GG VY+ DG+ AVK LK + E E EVE+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAK 354
+S + H ++V ++GYC S++ +VY+ + N +L +L + W R+ VA G A+
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAAR 446
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
+ YLH C P IIHRD+KSSNILL +F ++DFG A + Q ++ +V V+G
Sbjct: 447 GIAYLHEDCHPRIIHRDIKSSNILLDNSFEA-LVADFGLAKIA-QELDLNTHVS-TRVMG 503
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWARSLLSSG 473
TFGY+APEY GK+ EK DVYSYGV+LLELITG++ + T++ ESLV WAR LL
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563
Query: 474 L----CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ + L+DP+L + + E+ ++ AA C+ HS+++RP M +++
Sbjct: 564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVR 612
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 205 bits (522), Expect = 6e-52, Method: Compositional matrix adjust.
Identities = 141/378 (37%), Positives = 208/378 (55%), Gaps = 34/378 (8%)
Query: 184 RQLQKSLTAPS------SSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEG 237
R+ +K L+A S S SST R SD Q + V S + ++ + G
Sbjct: 304 RKREKRLSAVSGGDVTPSPMSSTAR--SDSAFFRMQSSAPVGASKRSGSYQSQS--GGLG 359
Query: 238 SSRR-FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-SEEEVL 295
+S+ F+ +EL T+ FS + L+G+GG VY+ DG+V AVK LK + E
Sbjct: 360 NSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFK 419
Query: 296 REVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAI 350
EVE LS I H ++V I+G+C S + ++Y+ + N L +L L W R+ +A
Sbjct: 420 AEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSVLDWATRVKIAA 479
Query: 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK 408
G A+ L YLH C P IIHRD+KSSNILL +NF ++SDFG A + +H +
Sbjct: 480 GAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDA-RVSDFGLARLALDCNTHITTR--- 535
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWAR 467
V+GTFGY+APEY GK+ EK DV+S+GVVLLELITG++ + T++ ESLV WAR
Sbjct: 536 ---VIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWAR 592
Query: 468 SLLSSGL----CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE- 522
L+S + + L DP+L Y E+ ++ AA C+ H +++RP M +++ F+
Sbjct: 593 PLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESL 652
Query: 523 --PDYWLKMKREKEELLN 538
D M+ + E+ N
Sbjct: 653 AAEDLTNGMRLGESEVFN 670
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 205 bits (521), Expect = 9e-52, Method: Compositional matrix adjust.
Identities = 126/320 (39%), Positives = 184/320 (57%), Gaps = 25/320 (7%)
Query: 237 GSSRR-FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-SEEEV 294
G SR F+ +EL T+ FS + L+G+GG +VY+ D +V AVK LK + E
Sbjct: 412 GQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREF 471
Query: 295 LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL-----KQLKWNERMDV 348
EV+ +S + H N++ ++GYC S+ ++Y+ + N +L +L L W R+ +
Sbjct: 472 KAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKI 531
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSEN 406
A G A+ L YLH C P IIHRD+KSSNILL NFH +SDFG A + +H +
Sbjct: 532 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHA-LVSDFGLAKLALDCNTHITTR- 589
Query: 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLW 465
V+GTFGY+APEY GK+ EK DV+S+GVVLLELITG++ + ++ ESLV W
Sbjct: 590 -----VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 644
Query: 466 ARSLLSSGL----CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
AR LLS+ L DP+L Y E+ ++ AA C+ HS+++RP M +++ F
Sbjct: 645 ARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFD 704
Query: 522 ---EPDYWLKMKREKEELLN 538
E D M+ + E++N
Sbjct: 705 SLAEEDLTNGMRLGESEIIN 724
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 118/291 (40%), Positives = 178/291 (61%), Gaps = 21/291 (7%)
Query: 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKC-TNWSEEEVLREVEL 300
F+ +EL +T F+ K ++G+GG VY+ DG+V AVK LK + + E EVE+
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAK 354
+S + H ++V ++GYC S + ++Y + N +L+ +L L+W++R+ +AIG AK
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAK 478
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH--QSHQVSENVKPVNV 412
L YLH C P IIHRD+KS+NILL + + Q++DFG A ++ Q+H VS V
Sbjct: 479 GLAYLHEDCHPKIIHRDIKSANILLDDEYEA-QVADFGLARLNDTTQTH-VS-----TRV 531
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI-QTNKANRESLVLWARSLL- 470
+GTFGYLAPEY GK+ ++ DV+S+GVVLLEL+TG++ + QT ESLV WAR LL
Sbjct: 532 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLL 591
Query: 471 ---SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+G LID +L + Y E+ ++ A C+ HS +RP M +++
Sbjct: 592 KAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVR 642
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (518), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 111/293 (37%), Positives = 179/293 (61%), Gaps = 18/293 (6%)
Query: 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKC-TNWSEEEVLREVEL 300
FT ++L T NFS L+GQGG V+R VDG + A+K LK + E E E++
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQT 190
Query: 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAK 354
+S + H ++V ++GYC + +VY + N +L+ +L + ++W++RM +A+G AK
Sbjct: 191 ISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALGAAK 250
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
L YLH C+P IHRDVK++NIL+ +++ +L+DFG A +S ++ ++G
Sbjct: 251 GLAYLHEDCNPKTIHRDVKAANILIDDSYEA-KLADFGLA----RSSLDTDTHVSTRIMG 305
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK--ANRESLVLWARSL--- 469
TFGYLAPEY GK+ EK DV+S GVVLLELITG+ + ++ A+ +S+V WA+ L
Sbjct: 306 TFGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQ 365
Query: 470 -LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
L+ G + L+DP+L +++ E+ ++ A + HS+ RRP M +++ F+
Sbjct: 366 ALNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFE 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 549 | ||||||
| 225428253 | 566 | PREDICTED: proline-rich receptor-like pr | 0.974 | 0.945 | 0.644 | 0.0 | |
| 297744499 | 529 | unnamed protein product [Vitis vinifera] | 0.907 | 0.941 | 0.605 | 0.0 | |
| 255575035 | 531 | serine-threonine protein kinase, plant-t | 0.921 | 0.952 | 0.597 | 1e-173 | |
| 147785221 | 932 | hypothetical protein VITISV_042429 [Viti | 0.883 | 0.520 | 0.567 | 1e-172 | |
| 449454370 | 601 | PREDICTED: probable LRR receptor-like se | 0.941 | 0.860 | 0.517 | 1e-143 | |
| 224105105 | 284 | predicted protein [Populus trichocarpa] | 0.502 | 0.971 | 0.718 | 1e-111 | |
| 351727927 | 649 | protein kinase family protein [Glycine m | 0.928 | 0.785 | 0.346 | 3e-75 | |
| 255550554 | 674 | ATP binding protein, putative [Ricinus c | 0.890 | 0.725 | 0.350 | 1e-73 | |
| 356515943 | 743 | PREDICTED: probable receptor-like serine | 0.570 | 0.421 | 0.445 | 3e-66 | |
| 356507630 | 750 | PREDICTED: probable receptor-like serine | 0.624 | 0.457 | 0.414 | 4e-66 |
| >gi|225428253|ref|XP_002279474.1| PREDICTED: proline-rich receptor-like protein kinase PERK9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/540 (64%), Positives = 446/540 (82%), Gaps = 5/540 (0%)
Query: 1 MVGKLSIEKNFFSVLRTRTLKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEE 60
M+G+ E+ F + R+RT KKRT++FGLKS + SR +LL+LL+ + GD VLAVHV+E
Sbjct: 1 MLGRTRTERRIFGLRRSRTSKKRTIVFGLKSSNGSRGVLLKLLSSVVVTGDEVLAVHVQE 60
Query: 61 Q--NDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSG 118
+DT DLNTFHIHEDLCKSK+VDF VKVC+G+SYI+EL++QVR+S+ATILALGCS S
Sbjct: 61 PEPDDTFDLNTFHIHEDLCKSKQVDFHVKVCVGESYISELTHQVRVSFATILALGCS-SS 119
Query: 119 LKDSEVLTRCLRALPPACTILVMDNLGRILVQRQGTSQQGSTNVLLKSSLSSSSKYPAFG 178
D ++ CL+ LPP CT+LV DN GRIL+QR GTSQQGS + +S++SSS+ +
Sbjct: 120 RPDDSIVANCLKKLPPTCTLLVTDNGGRILIQRPGTSQQGSKTEVFQSTVSSSTTHMYLN 179
Query: 179 QPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGS 238
+ T +KSLT PS STS+TTR+ + G I++ T+Q+P+ ++ K+F++LA+LEA+G
Sbjct: 180 RTGTPHHFRKSLTMPSPSTSTTTREADNNGQKISKMTMQLPDFMEEKLFQRLALLEAKGL 239
Query: 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREV 298
+RFTS EL T +FSP+M+IG+GG+SKVYR N DG++AAVKVLK T W E++L+EV
Sbjct: 240 GKRFTSSELKLATRDFSPEMVIGEGGHSKVYRANLGDGRLAAVKVLKPTRWYAEDLLQEV 299
Query: 299 ELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEY 358
E+LS + HENIV+IIGYC ++EM+A+VY+LL GSLKQ L+QL+W ERM VAIGVAKALEY
Sbjct: 300 EILSDVNHENIVQIIGYCSNREMHAVVYDLLKGSLKQKLRQLRWKERMGVAIGVAKALEY 359
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LHH+CDPPIIHRDVKSSN+LLSEN HPQLSDFG+AMV++++ QVS VKP+ VVGTFGY
Sbjct: 360 LHHSCDPPIIHRDVKSSNVLLSENC-HPQLSDFGSAMVYNRAQQVSAKVKPLRVVGTFGY 418
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWARSLLSSGLCER 477
LAPEYMMYGKVDEK+DVYSYGVVLLELI+GKEAIQTN+A N ESLVLWARSLLS GLC+R
Sbjct: 419 LAPEYMMYGKVDEKVDVYSYGVVLLELISGKEAIQTNQASNHESLVLWARSLLSCGLCDR 478
Query: 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELL 537
LIDP L ++YN+EE++ ++ AARLCL+HSSSRRPTMK +L+LF+EP+YWLKM+R++EELL
Sbjct: 479 LIDPNLKDDYNKEEMKTMVVAARLCLMHSSSRRPTMKMILQLFEEPEYWLKMQRDREELL 538
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297744499|emb|CBI37761.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1723), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/540 (60%), Positives = 418/540 (77%), Gaps = 42/540 (7%)
Query: 1 MVGKLSIEKNFFSVLRTRTLKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEE 60
M+G+ E+ F + R+RT KKRT++FGLKS + SR +LL+LL+ + GD VLAVHV+E
Sbjct: 1 MLGRTRTERRIFGLRRSRTSKKRTIVFGLKSSNGSRGVLLKLLSSVVVTGDEVLAVHVQE 60
Query: 61 Q--NDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSG 118
+DT DLNTFHIHEDLCKSK+VDF VKVC+G+SYI+EL++QVR+S+ATILALGCS S
Sbjct: 61 PEPDDTFDLNTFHIHEDLCKSKQVDFHVKVCVGESYISELTHQVRVSFATILALGCS-SS 119
Query: 119 LKDSEVLTRCLRALPPACTILVMDNLGRILVQRQGTSQQGSTNVLLKSSLSSSSKYPAFG 178
D ++ CL+ LPP CT+LV DN GRIL+QR GTSQQGS + +S++SSS+ +
Sbjct: 120 RPDDSIVANCLKKLPPTCTLLVTDNGGRILIQRPGTSQQGSKTEVFQSTVSSSTTHMYLN 179
Query: 179 QPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGS 238
+ T +KSLT PS STS+TTR+ + G I++ T+Q+P+ ++ K+F++LA+LEA+G
Sbjct: 180 RTGTPHHFRKSLTMPSPSTSTTTREADNNGQKISKMTMQLPDFMEEKLFQRLALLEAKGL 239
Query: 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREV 298
+RFTS EL T +FSP+M+IG+GG+SKVYR
Sbjct: 240 GKRFTSSELKLATRDFSPEMVIGEGGHSKVYR---------------------------- 271
Query: 299 ELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEY 358
NIV+IIGYC ++EM+A+VY+LL GSLKQ L+QL+W ERM VAIGVAKALEY
Sbjct: 272 ---------NIVQIIGYCSNREMHAVVYDLLKGSLKQKLRQLRWKERMGVAIGVAKALEY 322
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LHH+CDPPIIHRDVKSSN+LLSEN HPQLSDFG+AMV++++ QVS VKP+ VVGTFGY
Sbjct: 323 LHHSCDPPIIHRDVKSSNVLLSENC-HPQLSDFGSAMVYNRAQQVSAKVKPLRVVGTFGY 381
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWARSLLSSGLCER 477
LAPEYMMYGKVDEK+DVYSYGVVLLELI+GKEAIQTN+A N ESLVLWARSLLS GLC+R
Sbjct: 382 LAPEYMMYGKVDEKVDVYSYGVVLLELISGKEAIQTNQASNHESLVLWARSLLSCGLCDR 441
Query: 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELL 537
LIDP L ++YN+EE++ ++ AARLCL+HSSSRRPTMK +L+LF+EP+YWLKM+R++EELL
Sbjct: 442 LIDPNLKDDYNKEEMKTMVVAARLCLMHSSSRRPTMKMILQLFEEPEYWLKMQRDREELL 501
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575035|ref|XP_002528423.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223532159|gb|EEF33965.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1581), Expect = e-173, Method: Compositional matrix adjust.
Identities = 316/529 (59%), Positives = 405/529 (76%), Gaps = 23/529 (4%)
Query: 1 MVGKLSIEKNFFSVLRTRTLKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEE 60
M G+LS+E+ +S+LRTR++KKRT+I GLKSD++SRE+LL+LL V+ KPGDNV+A+HV+E
Sbjct: 1 MAGRLSLERQIYSLLRTRSVKKRTIIVGLKSDNHSREMLLRLLNVVVKPGDNVIAIHVQE 60
Query: 61 QNDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLK 120
+ DLNTFH HEDLCKSK+VDFL+K+C G+SYI ELS QVRI+YATILA+GCS S K
Sbjct: 61 PFGSFDLNTFHTHEDLCKSKQVDFLIKICTGNSYIFELSQQVRINYATILAIGCSFSRPK 120
Query: 121 DSEVLTRCLRALPPACTILVMDNLGRILVQRQGTSQQGSTNVL---------LKSSLSSS 171
S V++ CL+ LPP C +L++DN+GRI++Q QGTSQQGS +VL SS S+
Sbjct: 121 QS-VISSCLKGLPPTCGLLIIDNVGRIILQMQGTSQQGSFHVLPGSSISSSSSSSSSSTE 179
Query: 172 SKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLA 231
Y PA +LQ S+ S ST + + ++VP+ + + IF+KL
Sbjct: 180 KGYVRQNIPA---ELQNSVGETSLLAQSTKGRHG------LKRAIEVPD-LAKSIFQKLV 229
Query: 232 VLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE 291
+LE +G R FT Q+L T NFSP+M+IG+GGNSKVYR N DG+ AAVKV+K +
Sbjct: 230 LLEPDGFIRLFTLQDLYSATDNFSPQMVIGEGGNSKVYRANFQDGRTAAVKVVKPAHCLA 289
Query: 292 EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG 351
E++ +EVE+LSSI+H+NIV+IIGYC+ K+++A+VYNL+ GSLKQ L QLKW+ERM+VAIG
Sbjct: 290 EDLFQEVEILSSIRHDNIVQIIGYCNCKDLHAVVYNLMKGSLKQNLTQLKWSERMEVAIG 349
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
VAKAL+YL H+ +PPIIH VKSSNILLSEN PQLSDFG AMV+++S ++ ++P +
Sbjct: 350 VAKALDYL-HSFNPPIIHGHVKSSNILLSENC-QPQLSDFGGAMVYNKSEEIPAKIRPFD 407
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL- 470
VVGTFGY+APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ N+A +ESLVL ARSLL
Sbjct: 408 VVGTFGYIAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQANQAKQESLVLLARSLLR 467
Query: 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519
SS E LIDP+LNE+Y EE+E +M AARLCL+HSSSRRPTMK ++
Sbjct: 468 SSRRPECLIDPRLNEDYVEEEMEAMMFAARLCLMHSSSRRPTMKMVISF 516
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147785221|emb|CAN75128.1| hypothetical protein VITISV_042429 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1577), Expect = e-172, Method: Compositional matrix adjust.
Identities = 306/539 (56%), Positives = 394/539 (73%), Gaps = 54/539 (10%)
Query: 1 MVGKLSIEKNFFSVLRTRTLKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEE 60
M+G+ E+ F + R+RT KKRT++FGLKS + SR +LL+LL+ + GD VLAVHV+E
Sbjct: 418 MLGRTRTERRIFGLRRSRTSKKRTIVFGLKSSNGSRGVLLKLLSSVVVTGDEVLAVHVQE 477
Query: 61 Q--NDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSG 118
+DT DLNTFHIHEDLCKSK+VDF VKVC+G+SYI+EL++QVR+S+ATILALGCS S
Sbjct: 478 PEPDDTFDLNTFHIHEDLCKSKQVDFQVKVCVGESYISELTHQVRVSFATILALGCS-SS 536
Query: 119 LKDSEVLTRCLRALPPACTILVMDNLGRILVQRQGTSQQGSTNVLLKSSLSSSSKYPAFG 178
D ++ CL+ LPP CT+LV DN GRIL+QR GTSQQGS + +S++SSS+ +
Sbjct: 537 RPDBSIVANCLKKLPPTCTLLVTDNGGRILIQRPGTSQQGSKTEVFQSTVSSSTTHMYLN 596
Query: 179 QPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGS 238
+P T +KSLT PS S S+TTR+ + G IA+ T+Q+P+ ++ K+F++LA+LEA+G
Sbjct: 597 RPGTPHHXRKSLTMPSPSXSTTTREADNNGQKIAKMTMQLPDFMEEKLFQRLALLEAKGL 656
Query: 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREV 298
+RFTS EL T +FSP+M+IG+GG+SKVYR N DG++AAVKVLK T W E++L
Sbjct: 657 GKRFTSSELKLATRDFSPEMVIGEGGHSKVYRANLGDGRLAAVKVLKPTRWYAEDLL--- 713
Query: 299 ELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEY 358
+ +I KEM+A+VY+LL GSLKQ L+QL+W ER VAIGVAKALEY
Sbjct: 714 -----PRSRDI---------KEMHAVVYDLLKGSLKQKLRQLRWKERXGVAIGVAKALEY 759
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LHH+CDPPIIHRDVKSSN+LLSEN HPQLSDFG+AMV++ + QVS VKP+ VVGTFGY
Sbjct: 760 LHHSCDPPIIHRDVKSSNVLLSEN-RHPQLSDFGSAMVYNGAQQVSAKVKPLRVVGTFGY 818
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478
LAPEYMMYGKVDEK ARSLLS GLC+RL
Sbjct: 819 LAPEYMMYGKVDEK---------------------------------ARSLLSCGLCDRL 845
Query: 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELL 537
IDP L +YN+EE++ ++ AARLCL+HSSSRRPTMK +L+LF+EP+YWLKM+R++EELL
Sbjct: 846 IDPNLKGDYNKEEMKTMVVAARLCLMHSSSRRPTMKMILQLFEEPEYWLKMQRDREELL 904
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454370|ref|XP_004144928.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Cucumis sativus] gi|449470503|ref|XP_004152956.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Cucumis sativus] gi|449526776|ref|XP_004170389.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1324), Expect = e-143, Method: Compositional matrix adjust.
Identities = 288/557 (51%), Positives = 378/557 (67%), Gaps = 40/557 (7%)
Query: 9 KNFFSVLRTRTL------KKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQN 62
K FS++RT++ KKRT+I GL +++ RE LL++L VI K GDNV+AV V E N
Sbjct: 19 KEMFSLVRTKSAAAAAGRKKRTIIVGLNAENSGRETLLRMLVVIVKTGDNVVAVRVSEPN 78
Query: 63 DTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLKDS 122
D D NTFHIHEDLCKSK+VDF V++C G+SYI+EL+ QVR+++AT+L LG + SG KDS
Sbjct: 79 DNFDPNTFHIHEDLCKSKQVDFQVRICEGESYISELTRQVRLNFATVLVLGTTNSGPKDS 138
Query: 123 EVLTRCLRALPPACTILVMDNLGRILVQRQGTSQQGSTNVLLKSS-LSSSSKYPAFG--- 178
V T CL+ LPP CT+LV+DN G I +Q +GTSQ+GS + K LSS + P
Sbjct: 139 VVKT-CLKGLPPTCTLLVIDNKGNIQIQMKGTSQEGSKRPISKPPPLSSPTNDPNNIINE 197
Query: 179 ------QPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAV 232
P+ + S ++ SSS S+ +ES +++ VQ+P + EKL
Sbjct: 198 SSSSSIHPSLNPLTESSSSSSSSSPLSSQPEESHTPTHVSK-AVQIPTFVS----EKLRR 252
Query: 233 LEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEE 292
++ + S R FT QE+ T NFSP MLI +G K+Y DGQ AVKV + +S E
Sbjct: 253 VDLKHSIRLFTPQEIASATKNFSPLMLIEEGVCFKMYSAKLEDGQFVAVKV-QTKQFSSE 311
Query: 293 EVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN-LLNGSLKQYLKQLKWNERMDVAIG 351
++LRE+E+L +KHENIV+I+G C+ +E+ A+VYN L G+L Q LK+LKW +R+ VAIG
Sbjct: 312 DLLREIEMLCGLKHENIVKILGCCNREEIRAVVYNHRLKGNLMQNLKKLKWTDRVKVAIG 371
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
VAKAL+YLHH+C P IIHR+VKSSNILLS++ PQLS+FG AMV + S V
Sbjct: 372 VAKALKYLHHSCSPSIIHRNVKSSNILLSDH-SQPQLSNFGEAMVRPAVQEDSTQVD--- 427
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS 471
+G F YLAPEY+M+GKV+EK+DVYSYGV+LLELITGK A+QT NR SLV WARSLLS
Sbjct: 428 -IGKFSYLAPEYLMFGKVNEKVDVYSYGVMLLELITGKLAVQTEPTNRRSLVFWARSLLS 486
Query: 472 SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKT-----------LLKLF 520
L E LIDP L E+YN + +E++M ARLCLLHSSSRRPTM+T ++KLF
Sbjct: 487 CNLAEHLIDPYLKEDYNHDVMEMMMIIARLCLLHSSSRRPTMETVRSFFPCTEISIVKLF 546
Query: 521 QEPDYWLKMKREKEELL 537
+EP+Y KM+R KE+LL
Sbjct: 547 EEPEYLKKMQRGKEDLL 563
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224105105|ref|XP_002313688.1| predicted protein [Populus trichocarpa] gi|222850096|gb|EEE87643.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 410 bits (1053), Expect = e-111, Method: Compositional matrix adjust.
Identities = 202/281 (71%), Positives = 236/281 (83%), Gaps = 5/281 (1%)
Query: 240 RRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVE 299
+ F QEL T+NFSP+M+IG GG+SKVYR N VDGQ AVK+LK T++ E++L EV
Sbjct: 1 KHFKFQELNLATNNFSPEMVIGVGGHSKVYRANLVDGQAVAVKILKETHFPAEDLLHEVR 60
Query: 300 LLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYL 359
+LS +KHENI++IIGYC+SKEM+AIVYNLL GSLKQ L+QLKWNERM VA+GVA+ALEYL
Sbjct: 61 ILSDVKHENIIQIIGYCYSKEMHAIVYNLLIGSLKQNLRQLKWNERMGVAVGVAQALEYL 120
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
HH+ +PPIIHRDVKSSNILLS PQLSDFGAAMV+ S Q S + KP VVGTFGYL
Sbjct: 121 HHSFNPPIIHRDVKSSNILLSGTC-QPQLSDFGAAMVNQPSKQNSASTKPFKVVGTFGYL 179
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW----ARSLLSSGLC 475
APEYMMYGKVDEK+DVYSYGVVLLELITG+EAIQTN+AN ESLVLW ARSLL+SGLC
Sbjct: 180 APEYMMYGKVDEKVDVYSYGVVLLELITGQEAIQTNEANHESLVLWVREEARSLLNSGLC 239
Query: 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTL 516
ERLIDP L+ +Y REE+EI++ ARLCL+HSSSRRPTMK +
Sbjct: 240 ERLIDPHLSGDYKREEMEIMISVARLCLVHSSSRRPTMKMV 280
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727927|ref|NP_001238713.1| protein kinase family protein [Glycine max] gi|223452363|gb|ACM89509.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 289 bits (740), Expect = 3e-75, Method: Compositional matrix adjust.
Identities = 204/589 (34%), Positives = 310/589 (52%), Gaps = 79/589 (13%)
Query: 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL--------------N 68
R V+ G+K D +S E+L L +A+PGD VLA+HV ++ ++ +
Sbjct: 18 RIVVVGMKMDSHSTELLTWALFKVAQPGDVVLALHVLGNDEIVNREGKSSLFSLVKAFDS 77
Query: 69 TFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLKDSE----V 124
++E C K+VD K+C G S L + AT + +G S GL + V
Sbjct: 78 ILAVYEGFCNLKQVDLKFKICRGSSVTRILVREANAYSATHIIVGSS-QGLHITRPCISV 136
Query: 125 LTRCLRALPPACTILVMDNLGRILVQRQGTSQQGST------------------------ 160
C + LP C + +DN G+I+ +R+G++ S
Sbjct: 137 ARYCAKKLPKDCWVFAVDN-GKIVFKREGSAATRSDLKEFIEKKRCSTSASEEEESCADA 195
Query: 161 ----NVLLKSSLSSSSKYPAFGQPATTRQL-------QKSLTAPSSSTSSTTRQESDVGV 209
N L + ++ G P + + Q+SL S +S V
Sbjct: 196 CDEMNPLAIVPVQTNDAASKPGWPLLRKTIVSDRKCSQRSLLC-QISVVQWAMHKSGALV 254
Query: 210 CIAQETVQVP--ESIKRKIFEKLAVLEAEGSS--RRFTSQELCHLTHNFSPKMLIGQGGN 265
+ E P E R I ++L L + SS R F QEL T NF P+ LIG+GG+
Sbjct: 255 PVDAEIGTAPSTEHNSRSIPKELEGLHEKYSSTCRLFKYQELVLATSNFLPENLIGKGGS 314
Query: 266 SKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325
S+VYR DG+ AVK+LK ++ +E + E+E+++++ H++++ ++G+C +V
Sbjct: 315 SQVYRGCLPDGKELAVKILKPSDDVLKEFVLEIEIITTLNHKSLISLLGFCFEDGNLLLV 374
Query: 326 YNLLN-GSLKQYLKQLK-------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNI 377
Y+ L+ GSL++ L K W ER VAIGVA+ALEYLH+ +IHRDVKSSN+
Sbjct: 375 YDFLSRGSLEENLHGNKKNPLMFGWTERYKVAIGVAEALEYLHNNDGQSVIHRDVKSSNV 434
Query: 378 LLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYS 437
LLSE+F PQLSDFG A + S ++ +V GTFGY+APEY MYGKV++KIDVY+
Sbjct: 435 LLSEDF-EPQLSDFGLA---KWASTTSSHIICTDVAGTFGYMAPEYFMYGKVNDKIDVYA 490
Query: 438 YGVVLLELITGKEAIQTN-KANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVM 496
+GVVLLEL++G++ I + +ESLV+WA +L+SG +L+DP L + YN EE+E ++
Sbjct: 491 FGVVLLELLSGRKPISGDYPKGQESLVMWASPILNSGKVLQLLDPSLGDNYNHEEMERMV 550
Query: 497 CAARLCLLHSSSRRPTMKTLLKLF-QEPDY--WLKMK---REKEELLNE 539
AA LC + RP M + KL +PD W +++ E E+L++
Sbjct: 551 LAATLCTRRAPRARPQMSLISKLLGGDPDVIKWARLEVNALEAPEMLDD 599
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550554|ref|XP_002516327.1| ATP binding protein, putative [Ricinus communis] gi|223544557|gb|EEF46074.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 284 bits (726), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 202/577 (35%), Positives = 298/577 (51%), Gaps = 88/577 (15%)
Query: 30 KSDHYSREILLQLLTVIAKPGDNVLAVHVEE--------QNDTLDL-NTFH----IHEDL 76
K D SRE+L L +AKPGD V+A+HV + + L L TF ++E
Sbjct: 31 KLDGDSRELLTWTLMKLAKPGDRVIALHVLDSLTEFVGGRTSLLSLVKTFDCFLAVYEGF 90
Query: 77 CKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLK---DSEVLTRCLRALP 133
C K+VD +KVC G S L + + S A +L G S K + V C R L
Sbjct: 91 CNLKQVDLKLKVCRGSSVRKTLVREAKSSGAAMLITGTSKKRHKIRSSTSVAKYCARNLS 150
Query: 134 PACTILVMDNLGRILVQRQGT--SQQGSTNVLLKSSLSSSSKYPAFGQP--------ATT 183
+ ++ + N G+I+ QR+ T S + L + S +SS + P + T
Sbjct: 151 KSFSVFAVSN-GKIMFQREATPASVNHFQDKLNQESQNSSQNNDSLDSPSLLSIAHNSET 209
Query: 184 RQLQKSLT----------APSSSTSSTTRQESDV---------GVCIAQETVQVPE---- 220
L++SL P + + T S V G I + V +P+
Sbjct: 210 NSLEESLDDGEVDNSLALVPVQTNEAVTNFNSSVVERSPEYKHGWSILRR-VFLPKRRHR 268
Query: 221 --------SIKRKIF--------------EKLAVLEAEGSS--RRFTSQELCHLTHNFSP 256
S+ + +F E+L L SS R F+ +ELC T NF P
Sbjct: 269 EESHGKRTSVVKWVFKVPSRNSSSVVGLPEELKGLHERYSSSCRLFSYEELCSATSNFMP 328
Query: 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
+ L+G+GG+S VY+ DG+ AVK+LK + +E + E+++++++ H NI+ + G+C
Sbjct: 329 ENLVGKGGSSHVYKGCLPDGKELAVKILKPSEDVLKEFIAEIDIITTLHHNNIISLFGFC 388
Query: 317 HSKEMYAIVYNLLN-GSLKQYL-------KQLKWNERMDVAIGVAKALEYLHHTCDPPII 368
+VY+ L+ GSL++ L W R VA+GVA+AL+YLH CD P+I
Sbjct: 389 FEHNNLLLVYDFLSRGSLEENLHGNKKDGNSFGWQGRFKVAVGVAEALDYLHSFCDQPVI 448
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRDVKSSNILLS++F PQLSDFG A S S ++ +V GTFGYLAPEY ++GK
Sbjct: 449 HRDVKSSNILLSDDF-EPQLSDFGLASWVSTS---SSHMACTDVAGTFGYLAPEYFLHGK 504
Query: 429 VDEKIDVYSYGVVLLELITGKEAIQT-NKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487
V +K+DV+++GVVLLEL++G+ I N +ESLV+WA+ +L G L+DP + Y
Sbjct: 505 VSDKVDVFAFGVVLLELLSGRMPINGENPKGQESLVMWAKPILDGGKVSELLDPHIGTNY 564
Query: 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524
N ++IE ++ AA LC+ S RP + +LKL Q D
Sbjct: 565 NDDQIERMVLAATLCIRRSPRSRPQISLVLKLLQGDD 601
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515943|ref|XP_003526656.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 259 bits (661), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 146/328 (44%), Positives = 209/328 (63%), Gaps = 15/328 (4%)
Query: 215 TVQVPESIKRKIFEKLAVLEAEGSS--RRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTN 272
T PE+ I ++L L + SS R F QEL T NF + LIG+GG+S+VYR
Sbjct: 356 TASSPENNSGNIPKELEGLHEKYSSTCRLFEYQELVSATSNFLHENLIGKGGSSQVYRGC 415
Query: 273 HVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN-G 331
DG+ AVK+L ++ E L E+E+++++ H+NI+ ++G+C +VY+ L+ G
Sbjct: 416 LPDGKELAVKILNPSDDVLSEFLLEIEIITTLHHKNIISLLGFCFENGKLLLVYDFLSRG 475
Query: 332 SLKQYLKQLK-------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384
SL++ L K W+ER VA+GVA+AL+YLH D P+IHRDVKSSN+LLSENF
Sbjct: 476 SLEENLHGNKKNSLVFGWSERYKVAVGVAEALDYLHSKDDQPVIHRDVKSSNVLLSENFE 535
Query: 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLE 444
PQLSDFG A + +S ++ +V GTFGYLAPEY MYGKV++KIDVY++GVVLLE
Sbjct: 536 -PQLSDFGLA---KWASTLSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 591
Query: 445 LITGKEAIQTN-KANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCL 503
L++G++ I + +ESLV+WA +L+SG +L+DP L + Y+ EE+E ++ AA LC+
Sbjct: 592 LLSGRKPISRDYPKGQESLVMWASPILNSGKVLQLLDPSLGDNYDHEEMEKIVLAATLCI 651
Query: 504 LHSSSRRPTMKTLLKLFQEPDYWLKMKR 531
+ RP M + KL Q +K R
Sbjct: 652 KRAPRARPQMNLISKLLQGDAEAIKWAR 679
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507630|ref|XP_003522567.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 258 bits (660), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 151/364 (41%), Positives = 221/364 (60%), Gaps = 21/364 (5%)
Query: 179 QPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGS 238
+P Q Q A S + + ++++G T +PE I ++L L + S
Sbjct: 333 KPNICDQGQDQHAALDSESGALVPVDAELG------TASLPEHNSGNIPKELEGLHEKYS 386
Query: 239 S--RRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLR 296
S R F QEL T NF P LIG+GG+S+VYR DG+ AVK+LK ++ E L
Sbjct: 387 STCRLFEYQELVLATSNFLPGNLIGKGGSSQVYRGCLPDGKELAVKILKPSDNVLSEFLL 446
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLK-------WNERMDV 348
E+E+++++ H+NI+ ++G+C +VY+ L+ GSL++ L K W+ER V
Sbjct: 447 EIEIITTLHHKNIISLLGFCFENGKLLLVYDFLSRGSLEENLHGNKKISLVFGWSERYKV 506
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408
A+G+A+AL+YLH D P+IHRDVKSSN+LLSE+F PQL DFG A + +S ++
Sbjct: 507 AVGIAEALDYLHSKDDQPVIHRDVKSSNVLLSEDF-EPQLCDFGLA---KWASTLSSHIT 562
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN-KANRESLVLWAR 467
+V GTFGYLAPEY MYGKV++KIDVY++GVVLLEL++G++ I + +ESLV+WA
Sbjct: 563 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISPDYPKGQESLVMWAT 622
Query: 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527
+L+SG +L+DP L E Y+ E+E ++ AA LC+ + RP M + KL Q +
Sbjct: 623 PILNSGKVLQLLDPSLGENYDHGEMEKMVLAATLCIKRAPRARPQMSLISKLLQGDAEAI 682
Query: 528 KMKR 531
K R
Sbjct: 683 KRAR 686
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 549 | ||||||
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.546 | 0.377 | 0.435 | 5.3e-73 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.566 | 0.441 | 0.427 | 3.3e-71 | |
| TAIR|locus:2026957 | 756 | AT1G21590 [Arabidopsis thalian | 0.510 | 0.370 | 0.426 | 3.3e-69 | |
| TAIR|locus:2059919 | 617 | AT2G16750 [Arabidopsis thalian | 0.511 | 0.455 | 0.419 | 1.4e-62 | |
| TAIR|locus:2155700 | 456 | AT5G65530 [Arabidopsis thalian | 0.519 | 0.625 | 0.392 | 5.6e-52 | |
| TAIR|locus:2144970 | 511 | AT5G18910 [Arabidopsis thalian | 0.500 | 0.538 | 0.376 | 1.4e-48 | |
| TAIR|locus:2142514 | 467 | RBK1 "ROP binding protein kina | 0.520 | 0.612 | 0.378 | 3.7e-48 | |
| TAIR|locus:2012191 | 693 | AT1G49730 [Arabidopsis thalian | 0.542 | 0.430 | 0.385 | 9.8e-48 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.533 | 0.759 | 0.385 | 3.3e-47 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.491 | 0.362 | 0.395 | 9.5e-47 |
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 5.3e-73, Sum P(2) = 5.3e-73
Identities = 138/317 (43%), Positives = 197/317 (62%)
Query: 218 VPESIKRKIFEKLAVLEAEGSS--RRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVD 275
+P++ RK+ E+L L SS R F +EL +T NFS IG+GG+S+V+R +
Sbjct: 407 IPDNSPRKLPEELEGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSN 466
Query: 276 GQVAAVKVLKCTNWXXXXXXXXXXXXXXIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLK 334
G+V AVK+LK T + H+NI+ ++G+C +VYN L+ GSL+
Sbjct: 467 GRVVAVKILKQTEDVLNDFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLE 526
Query: 335 QYLKQLK-------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387
+ L K W+ER VA+GVA+AL+YLH+T P+IHRDVKSSNILLS++F PQ
Sbjct: 527 ENLHGNKKDPLAFCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFE-PQ 585
Query: 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
LSDFG A S + ++ +V GTFGYLAPEY MYGKV++KIDVY++GVVLLEL++
Sbjct: 586 LSDFGLARWASIS---TTHIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLS 642
Query: 448 GKEAIQTN-KANRESLVLWARSLLSSGLCERLIDPQL--NEEYNREEIEIVMCAARLCLL 504
G++ I + +ESLV+WA+ +L G +L+DP L N N ++++ + AA LC+
Sbjct: 643 GRKPISSGCPKGQESLVMWAKPILDDGKYSQLLDPSLRDNNNNNDDQMQRMALAATLCIR 702
Query: 505 HSSSRRPTMKTLLKLFQ 521
S RP M +LKL +
Sbjct: 703 RSPQARPKMSIVLKLLK 719
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 605 (218.0 bits), Expect = 3.3e-71, Sum P(2) = 3.3e-71
Identities = 142/332 (42%), Positives = 205/332 (61%)
Query: 206 DVGVC-IAQETVQVPESI---KRKIFEKLAVLEAEGSS--RRFTSQELCHLTHNFSPKML 259
DV + E +Q P S I E+L L + SS R FT +E+ +T NF+ + L
Sbjct: 308 DVSISRFGSELMQSPLSPFIGSNNIPEELEGLHEKYSSTCRLFTYEEVLSITSNFASENL 367
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLK-CTNWXXXXXXXXXXXXXXIKHENIVRIIGYCHS 318
+G+GGNS VYR + DG+ AVK+LK C + + H+NIV + G+C
Sbjct: 368 VGEGGNSYVYRGDLPDGRELAVKILKPCLD-VLKEFILEIEVITSVHHKNIVSLFGFCFE 426
Query: 319 KEMYAIVYNLL-NGSLKQYL-------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
+VY+ L GSL++ L K+ W ER VA+GVA+AL+YLH+T DP +IHR
Sbjct: 427 NNNLMLVYDYLPRGSLEENLHGNRKDAKKFGWMERYKVAVGVAEALDYLHNTHDPEVIHR 486
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
DVKSSN+LL+++F PQLSDFG A + + S++V ++ GTFGYLAPEY M+GKV
Sbjct: 487 DVKSSNVLLADDFE-PQLSDFGFASL---ASSTSQHVAGGDIAGTFGYLAPEYFMHGKVT 542
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKAN-RESLVLWARSLLSSGLCERLIDPQLNEEYNR 489
+KIDVY++GVVLLELI+G++ I +++ +ESLVLWA +L SG +L+DP L + +
Sbjct: 543 DKIDVYAFGVVLLELISGRKPICVDQSKGQESLVLWANPILDSGKFAQLLDPSLENDNSN 602
Query: 490 EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
+ IE ++ AA LC+ + RP + +LK+ Q
Sbjct: 603 DLIEKLLLAATLCIKRTPHDRPQIGLVLKILQ 634
|
|
| TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 587 (211.7 bits), Expect = 3.3e-69, Sum P(2) = 3.3e-69
Identities = 125/293 (42%), Positives = 185/293 (63%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWXXXXXXXX 297
S + FT +EL +T NF IG+GG+S+V+R +G+ AVK+LK T
Sbjct: 393 SCQFFTYKELVSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKRTECVLKDFVAE 452
Query: 298 XXXXXXIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYL----KQL---KWNERMDVA 349
+ H+N++ ++GYC +VYN L+ GSL++ L K L +WNER VA
Sbjct: 453 IDIITTLHHKNVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNERYKVA 512
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+G+A+AL+YLH+ P+IHRDVKSSNILLS++F PQLSDFG A +S + +
Sbjct: 513 VGIAEALDYLHNDAPQPVIHRDVKSSNILLSDDFE-PQLSDFGLAKWASES---TTQIIC 568
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN-RESLVLWARS 468
+V GTFGYLAPEY MYGK++ KIDVY+YGVVLLEL++G++ + + ++SLV+WA+
Sbjct: 569 SDVAGTFGYLAPEYFMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVMWAKP 628
Query: 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
+L +L+D L ++ N +++E + AA LC+ H+ RPTM +L+L +
Sbjct: 629 ILDDKEYSQLLDSSLQDDNNSDQMEKMALAATLCIRHNPQTRPTMGMVLELLK 681
|
|
| TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 1.4e-62, Sum P(2) = 1.4e-62
Identities = 123/293 (41%), Positives = 188/293 (64%)
Query: 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLK-CTNWXXXXXXXX 297
+R F+ L T +FS + LIG+GG ++VY+ DG+ AVK+LK
Sbjct: 262 NRWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKILKPSVKEAVKEFVHE 321
Query: 298 XXXXXXIKHENIVRIIGYC-HSKEMYAIVYNLLN-GSLKQYLKQ---LKWNERMDVAIGV 352
+ H NI +IG C H ++ + VYNL + GSL++ L+ L+W ER+ +AIG+
Sbjct: 322 VSIVSSLSHSNISPLIGVCVHYNDLIS-VYNLSSKGSLEETLQGKHVLRWEERLKIAIGL 380
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
+AL+YLH+ C P+IHRDVKSSN+LLS+ F PQLSDFG +M +S + + ++ +V
Sbjct: 381 GEALDYLHNQCSNPVIHRDVKSSNVLLSDEFE-PQLSDFGLSMWGSKSCRYT--IQR-DV 436
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN-RESLVLWARSLLS 471
VGTFGYLAPEY MYGKV +K+DVY++GVVLLELI+G+ +I ++ +ESLV+WA+ ++
Sbjct: 437 VGTFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSPRGQESLVMWAKPMIE 496
Query: 472 SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524
G + L+DP + ++ ++ ++ AA CL +++ RP +K +LKL + D
Sbjct: 497 KGNAKELLDPNIAGTFDEDQFHKMVLAATHCLTRAATYRPNIKEILKLLRGED 549
|
|
| TAIR|locus:2155700 AT5G65530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 5.6e-52, P = 5.6e-52
Identities = 119/303 (39%), Positives = 181/303 (59%)
Query: 232 VLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVL----KCT 287
+L A+ S R FT EL T NF+P+ +IG+GG+++VY+ DG+ A+K L K
Sbjct: 122 ILVAKPSWRNFTFDELVAATDNFNPENMIGKGGHAEVYKGVLPDGETVAIKKLTRHAKEV 181
Query: 288 NWXXXXXXXXXXXXXXIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL----KQLKWN 343
+ H N R+ G+ + ++ ++ +GSL L + L W
Sbjct: 182 EERVSDFLSELGIIAHVNHPNAARLRGFSCDRGLHFVLEYSSHGSLASLLFGSEECLDWK 241
Query: 344 ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSH 401
+R VA+G+A L YLH+ C IIHRD+K+SNILLS+++ Q+SDFG A + H H
Sbjct: 242 KRYKVAMGIADGLSYLHNDCPRRIIHRDIKASNILLSQDYE-AQISDFGLAKWLPEHWPH 300
Query: 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461
+ V P+ GTFGYLAPEY M+G VDEK DV+++GV+LLE+ITG+ A+ T+ +R+S
Sbjct: 301 HI---VFPIE--GTFGYLAPEYFMHGIVDEKTDVFAFGVLLLEIITGRRAVDTD--SRQS 353
Query: 462 LVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
+V+WA+ LL E ++DPQL +++ E++ VM A +C+ H S+ RP M L++L +
Sbjct: 354 IVMWAKPLLEKNNMEEIVDPQLGNDFDETEMKRVMQTASMCIHHVSTMRPDMNRLVQLLR 413
Query: 522 EPD 524
D
Sbjct: 414 GDD 416
|
|
| TAIR|locus:2144970 AT5G18910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 507 (183.5 bits), Expect = 1.4e-48, P = 1.4e-48
Identities = 110/292 (37%), Positives = 175/292 (59%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLK--CTNWXXXXXX 295
S R F+ +++ T+++S + LIG+GG ++VY+ DGQ+ A+K L
Sbjct: 176 SWRNFSLRDIQTATNDYSRENLIGEGGYAEVYKGQMADGQIVAIKKLTRGSAEEMTMDYL 235
Query: 296 XXXXXXXXIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL----KQLKWNERMDVAIG 351
+ H NI ++IGYC M+ ++ NGSL L ++L W+ R VA+G
Sbjct: 236 SELGIIVHVDHPNIAKLIGYCVEGGMHLVLELSPNGSLASLLYEAKEKLNWSMRYKVAMG 295
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKP 409
A+ L YLH C IIH+D+K+SNILL++NF Q+SDFG A + +H V+
Sbjct: 296 TAEGLYYLHEGCQRRIIHKDIKASNILLTQNFE-AQISDFGLAKWLPDQWTHHTVSKVE- 353
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL 469
GTFGYL PE+ M+G VDEK DVY+YGV+LLELITG++A+ +++ S+V+WA+ L
Sbjct: 354 ----GTFGYLPPEFFMHGIVDEKTDVYAYGVLLLELITGRQALDSSQ---HSIVMWAKPL 406
Query: 470 LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
+ ++L+DP L ++Y+ EE++ ++ A LC+ +S RP M ++++ +
Sbjct: 407 IKENKIKQLVDPILEDDYDVEELDRLVFIASLCIHQTSMNRPQMSQVVEILR 458
|
|
| TAIR|locus:2142514 RBK1 "ROP binding protein kinases 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 3.7e-48, P = 3.7e-48
Identities = 115/304 (37%), Positives = 176/304 (57%)
Query: 231 AVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVL----KC 286
A A+ S R FT +EL T F+P+ +IG+GG+++VY+ ++G+ A+K L K
Sbjct: 130 AFFMAKPSWRNFTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKE 189
Query: 287 TNWXXXXXXXXXXXXXXIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL----KQLKW 342
+ H N R+ G+ + ++ ++ GSL L + L+W
Sbjct: 190 EEERVSDFLSELGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFGSEECLEW 249
Query: 343 NERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQS 400
R VA+G+A L YLH+ C IIHRD+K+SNILL+ ++ Q+SDFG A + +
Sbjct: 250 KIRYKVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYE-AQISDFGLAKWLPENWP 308
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
H V V P+ GTFGYLAPEY M+G VDEKIDV+++GV+LLE+IT + A+ T A+R+
Sbjct: 309 HHV---VFPIE--GTFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDT--ASRQ 361
Query: 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520
S+V WA+ L E ++DP+L +N E++ VM A +C+ H ++ RP M L++L
Sbjct: 362 SIVAWAKPFLEKNSMEDIVDPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLL 421
Query: 521 QEPD 524
+ D
Sbjct: 422 RGED 425
|
|
| TAIR|locus:2012191 AT1G49730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 9.8e-48, P = 9.8e-48
Identities = 124/322 (38%), Positives = 184/322 (57%)
Query: 213 QETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTN 272
+ T VP S+ +F K+ ++ + R+F+ +E+ + T++F+ +IGQGG VY+
Sbjct: 321 KSTKSVPSSLP--VF-KIHEDDSSSAFRKFSYKEMTNATNDFNT--VIGQGGFGTVYKAE 375
Query: 273 HVDGQVAAVKVL-KCTNWXXXXXXXXXXXXXXIKHENIVRIIGYCHSKEMYAIVYNLL-N 330
DG +AAVK + K + + H N+V + G+C +K+ +VY+ + N
Sbjct: 376 FNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKN 435
Query: 331 GSLKQYLKQL-----KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385
GSLK +L + W RM +AI VA ALEYLH CDPP+ HRD+KSSNILL ENF
Sbjct: 436 GSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV- 494
Query: 386 PQLSDFGAAMVHHQSHQVSENVKPVN--VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLL 443
+LSDFG A H S S +PVN + GT GY+ PEY++ ++ EK DVYSYGVVLL
Sbjct: 495 AKLSDFGLA---HSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLL 551
Query: 444 ELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNR---EEIEIVMCAAR 500
ELITG+ A+ R + + R LL+ L+DP++ + N ++++ V+ R
Sbjct: 552 ELITGRRAVDEG---RNLVEMSQRFLLAKSKHLELVDPRIKDSINDAGGKQLDAVVTVVR 608
Query: 501 LCLLHSSSRRPTMKTLLKLFQE 522
LC RP++K +L+L E
Sbjct: 609 LCTEKEGRSRPSIKQVLRLLCE 630
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
Identities = 120/311 (38%), Positives = 171/311 (54%)
Query: 221 SIKRKIFEKLAVL-EAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTN-HVDGQV 278
S +R I E++A L + S+ FT +ELC T NF+P +G+GG +VY+ QV
Sbjct: 48 SRRRYISEEIAKLGKGNISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQV 107
Query: 279 AAVKVLKCTNWXXXXXXXXXXXXXXI-KHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQY 336
AVK L + + H+N+V ++GYC + +VY + NGSL+ +
Sbjct: 108 VAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDH 167
Query: 337 L--------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388
L K L W+ RM VA G A+ LEYLH T DPP+I+RD K+SNILL E F+ P+L
Sbjct: 168 LLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFN-PKL 226
Query: 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
SDFG A V + + + V+GT+GY APEY + G++ K DVYS+GVV LE+ITG
Sbjct: 227 SDFGLAKVGPTGGETHVSTR---VMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITG 283
Query: 449 KEAIQTNKANRE-SLVLWARSLLSSGLCERLI-DPQLNEEYNREEIEIVMCAARLCLLHS 506
+ I T K E +LV WA L L+ DP L +Y + + + A +CL
Sbjct: 284 RRVIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEE 343
Query: 507 SSRRPTMKTLL 517
++ RP M ++
Sbjct: 344 AATRPMMSDVV 354
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 9.5e-47, P = 9.5e-47
Identities = 112/283 (39%), Positives = 169/283 (59%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWXXXXXXXX 297
S + FT EL T FS K ++G+GG +VY+ + DG AVK+L N
Sbjct: 333 SVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIA 392
Query: 298 XXXXXX-IKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVA 353
+ H N+V++IG C ++Y L+ NGS++ +L + L W+ R+ +A+G A
Sbjct: 393 EVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGTLDWDARLKIALGAA 452
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV 413
+ L YLH +P +IHRD K+SN+LL ++F P++SDFG A ++ + S+++ V+
Sbjct: 453 RGLAYLHEDSNPRVIHRDFKASNVLLEDDFT-PKVSDFGLA---REATEGSQHIS-TRVM 507
Query: 414 GTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK-ANRESLVLWARSLLSS 472
GTFGY+APEY M G + K DVYSYGVVLLEL+TG+ + ++ + E+LV WAR LL++
Sbjct: 508 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLAN 567
Query: 473 --GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM 513
GL E+L+DP L YN +++ V A +C+ S RP M
Sbjct: 568 REGL-EQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFM 609
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00036249001 | SubName- Full=Chromosome chr3 scaffold_8, whole genome shotgun sequence; (352 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| CIPK19 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (392 aa) | • | 0.467 | ||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 549 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-48
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC 316
+G+GG VY + G+ A+K++K + S EE+LRE+E+L + H NIV++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 317 HSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
+ +V GSLK LK+ L +E + + + + + LEYLH IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE-YMMYGKVD 430
+K NILL + +L+DFG + + +VGT Y+APE + G
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKS-----LLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 431 EKIDVYSYGVVLLELITGKEAIQ 453
EK D++S GV+L EL K+ I+
Sbjct: 173 EKSDIWSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 82/274 (29%), Positives = 127/274 (46%), Gaps = 27/274 (9%)
Query: 254 FSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENI 309
+ +G G VY+ + G++ AVK+LK + ++ RE+ +L + H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDP 365
VR+I K+ +V G L YL + L +E +A+ + + LEYLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
IIHRD+K NILL EN +++DFG A +S + VGT Y+APE ++
Sbjct: 118 GIIHRDLKPENILLDEN-GVVKIADFGLAKKLLKS-----SSSLTTFVGTPWYMAPEVLL 171
Query: 426 YGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484
G K+DV+S GV+L EL+TGK + L+ L L +
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ------LQLIRRILGPPLEFDEPK 225
Query: 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
EE + ++ CL S+RPT + +L+
Sbjct: 226 WSSGSEEAKDLIKK---CLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 8e-39
Identities = 68/198 (34%), Positives = 102/198 (51%), Gaps = 17/198 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G KVY + G++ A+KV+K E +LRE+++L +KH NIVR+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 316 CHSKEMYAIVYNLLN-GSLKQYLKQLK-WNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
++ +V G L LK+ +E + ALEYLH I+HRD
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVHRD 122
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
+K NILL E+ H +L+DFG A Q+ K VGT Y+APE ++ +
Sbjct: 123 LKPENILLDED-GHVKLADFGLA------RQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 432 KIDVYSYGVVLLELITGK 449
+D++S GV+L EL+TGK
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 74/274 (27%), Positives = 118/274 (43%), Gaps = 35/274 (12%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G +VY+ AVK LK + EE LRE ++ + H NIV++
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPP 366
+G C +E IV + G L YL++ L ++ + A+ +A+ +EYL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
IHRD+ + N L+ EN ++SDFG + + + + ++APE +
Sbjct: 124 FIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYKVKGGKLPI----RWMAPESLKE 178
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486
GK K DV+S+GV+L E+ T E +N E L G RL P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-----VLEYLKKG--YRLPKP----P 227
Query: 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520
E+ +M C RPT L+++
Sbjct: 228 NCPPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G +VY+ AVK LK + EE LRE ++ + H N+V++
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 313 IGYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPI 367
+G C +E IV + G L YL+ +L ++ + A+ +A+ +EYL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
IHRD+ + N L+ EN ++SDFG + + + + + ++APE + G
Sbjct: 124 IHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYRKRGGKLPI----RWMAPESLKEG 178
Query: 428 KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487
K K DV+S+GV+L E+ T E +N E L +G RL PQ
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----VLEYLKNG--YRL--PQ--PPN 227
Query: 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520
E+ +M C RPT L+++
Sbjct: 228 CPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 7e-36
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV---LREVELLSSIKHENIVRIIG 314
L+G+G VY + G++ AVK ++ + SEEE+ RE+ +LSS++H NIVR G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 315 YCHSKEMYAIVYNLL-----NGSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHTCDPP 366
+E N+ GSL LK+ K E + + + L YLH
Sbjct: 67 SERDEE--KNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNG 121
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
I+HRD+K +NIL+ + +L+DFG A V GT ++APE +
Sbjct: 122 IVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGEGTGS---VRGTPYWMAPEVIRG 177
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
+ D++S G ++E+ TGK
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 78/276 (28%), Positives = 123/276 (44%), Gaps = 39/276 (14%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRI 312
+G+G +VY+ AVK LK E EE L E ++ + H NIVR+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPI 367
+G C E IV + G L +L++ L + + +A+ +AK +EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK-PVNVVGTFGYLAPEYM 424
+HRD+ + N L++EN ++SDFG + + ++ K P+ ++APE +
Sbjct: 124 VHRDLAARNCLVTEN-LVVKISDFGLSRDIYEDDYYRKRGGGKLPIK------WMAPESL 176
Query: 425 MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484
GK K DV+S+GV+L E+ T E +N E LL G RL P
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----VLELLEDG--YRLPRP--- 226
Query: 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520
E +E+ +M C + RPT L++
Sbjct: 227 -ENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 253 NFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEE---EVLREVELLSSIKHEN 308
N+ LIG+G VY+ N G A+K + EE +++E++LL ++KH N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 309 IVRIIGYCHSKEMYAIVYNL-LNGSLKQYLKQL-KWNERMDVAIGVA---KALEYLHHTC 363
IV+ IG + + I+ NGSL+Q +K+ + E + VA+ V + L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-VAVYVYQVLQGLAYLH--- 116
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPE 422
+ +IHRD+K++NIL +++ +L+DFG A ++++ K VVGT ++APE
Sbjct: 117 EQGVIHRDIKAANILTTKD-GVVKLADFGVAT------KLNDVSKDDASVVGTPYWMAPE 169
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGK 449
+ D++S G ++EL+TG
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 72/206 (34%), Positives = 109/206 (52%), Gaps = 23/206 (11%)
Query: 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVR 311
F IG+GG +VY+ H G+ A+KV+K + + E+++ E+++L KH NIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 312 IIG-YCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTC 363
G Y E++ IV + GSLK LK N+ + V + K LEYLH
Sbjct: 62 YYGSYLKKDELW-IVMEFCSGGSLKDLLKS--TNQTLTESQIAYVCKELLKGLEYLH--- 115
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
IIHRD+K++NILL+ + +L DFG S Q+S+ +VGT ++APE
Sbjct: 116 SNGIIHRDIKAANILLTSDGE-VKLIDFGL------SAQLSDTKARNTMVGTPYWMAPEV 168
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGK 449
+ D K D++S G+ +EL GK
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 260 IGQGGNSKVYR----TNHVDGQVAAVKVLKC--TNWSEEEVLREVELLSSIKHENIVRII 313
+G+G +VY+ AVK LK + ++ L+E ++ + H N+VR++
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLKQ------------LKWNERMDVAIGVAKALEYLH 360
G C +E +V + G L YL++ L + + AI +AK +EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK-PVNVVGTFG 417
+HRD+ + N L+ E+ ++SDFG + + ++ K P+
Sbjct: 123 S---KKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDDDYYRKKTGGKLPIR------ 172
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCE 476
++APE + G K DV+S+GV+L E+ T G +N E L G
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEE-----VLEYLRKG--Y 224
Query: 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
RL P EY +E+ +M C RPT L++ +
Sbjct: 225 RLPKP----EYCPDELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 48/279 (17%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHENIVRIIG 314
IG+G KVY DG++ +K + +N SE+E L EV++L + H NI++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--- 63
Query: 315 YCHS---KEMYAIVYNLLN-GSLKQYLKQLKW-------NERMDVAIGVAKALEYLHHTC 363
Y S K IV + G L Q +K+ K + +D + + AL+YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--- 120
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
I+HRD+K NI L+ N +L DFG + V + +++ VVGT YL+PE
Sbjct: 121 SRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAK-----TVVGTPYYLSPEL 174
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID--- 480
+ K D++S G VL EL T K + +LL L +++
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFE------------GENLLE--LALKILKGQY 220
Query: 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519
P + +Y+ E +V L RP++ +L+
Sbjct: 221 PPIPSQYSSELRNLV----SSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (282), Expect = 3e-27
Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 26/283 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKC----TNWSEEEVLREVELLSSIKHE- 307
++ +G+G +VY D ++ A+KVL + E LRE+++L+S+ H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 308 NIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMD------VAIGVAKALEYLH 360
NIV++ + + +V ++G SL+ LK++ + + + ALEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPVNVVGTFGYL 419
IIHRD+K NILL + +L DFG A ++ S P VGT GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 420 APEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR-SLLSSGLC 475
APE ++ D++S G+ L EL+TG + K + + L +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ P E ++ +++ L R + + L
Sbjct: 236 ASPLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 61/197 (30%), Positives = 106/197 (53%), Gaps = 19/197 (9%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIG-YCH 317
IG+G + +VY+ G+ A+K ++ ++E ++ E+ ++ KH NIV Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 318 SKEMYAIVYNLLN-GSLKQYLKQ--LKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDV 372
E++ +V ++ GSL + Q ++ NE + V + LEYLH +IHRD+
Sbjct: 87 GDELW-VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDI 142
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDE 431
KS NILLS++ +L+DFG A Q+++ K +VVGT ++APE +
Sbjct: 143 KSDNILLSKD-GSVKLADFGFAA------QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 432 KIDVYSYGVVLLELITG 448
K+D++S G++ +E+ G
Sbjct: 196 KVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 73/270 (27%), Positives = 123/270 (45%), Gaps = 36/270 (13%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC 316
+GQG + VY+ H G++ A+K + E +++LRE++ L S + +V+ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 317 HSKEMYAIVYNLLN-GSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHTCDPPIIHRDV 372
+ + +IV ++ GSL LK++ K E + +A + K L+YLH IIHRD+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDI 126
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN--VKPVNVVGTFGYLAPEY---MMYG 427
K SN+L++ +++DFG + +V EN + VGT Y++PE Y
Sbjct: 127 KPSNLLINSK-GEVKIADFGIS-------KVLENTLDQCNTFVGTVTYMSPERIQGESYS 178
Query: 428 KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487
D++S G+ LLE GK + L +C+ EE+
Sbjct: 179 Y---AADIWSLGLTLLECALGKFPFL----PPGQPSFFE---LMQAICDGPPPSLPAEEF 228
Query: 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLL 517
+ E + + CL +RP+ LL
Sbjct: 229 SPEFRDFISA----CLQKDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 67/247 (27%), Positives = 112/247 (45%), Gaps = 31/247 (12%)
Query: 280 AVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK 338
A+K+++ SE++ + E +++ + H N+V++ G C + IV + NG L YL+
Sbjct: 32 AIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR 91
Query: 339 QLKWNERM----DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394
+ K D+ V +A+EYL IHRD+ + N L+ E+ ++SDFG A
Sbjct: 92 ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNV-VKVSDFGLA 147
Query: 395 -MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452
V + S+ K PV + PE Y + K DV+S+GV++ E+ + +
Sbjct: 148 RYVLDDQYTSSQGTKFPVK------WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
Query: 453 QTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT 512
+N E + +S+G RL P+L E+ +M C RP
Sbjct: 202 YERFSNSEVV-----ESVSAGY--RLYRPKLAP----TEVYTIMY---SCWHEKPEDRPA 247
Query: 513 MKTLLKL 519
K LL
Sbjct: 248 FKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 41/229 (17%)
Query: 252 HNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL---------KCTNWSEEEVLREVELL 301
+F +IG+G S V + A+K+L K + V E E+L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-----VKYVKIEKEVL 55
Query: 302 SSIK-HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLK-WNERMDVAIG--VAKAL 356
+ + H I+++ +E V NG L QY+++ +E+ + AL
Sbjct: 56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLAL 115
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV------ 410
EYLH IIHRD+K NILL ++ H +++DFG A V + E+ K
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLD-PNSSPESNKGDATNIDS 170
Query: 411 ----------NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+ VGT Y++PE + + D+++ G ++ +++TGK
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 30/271 (11%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC 316
IG+G VY+ AVK + T + + L+E E+L H NIV++IG C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 317 HSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
K+ IV L+ GSL +L+ +L + + +++ A +EYL IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQS-HQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
+ + N L+ EN + ++SDFG + + VS+ +K + + T APE + YG+
Sbjct: 119 LAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYGRYT 173
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490
+ DV+SYG++L E + + +N++ R + SG R+ PQL E
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRERIESGY--RMPAPQLCP----E 222
Query: 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
EI +M C + RP+ + Q
Sbjct: 223 EIYRLM---LQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G+G VY+ H + GQV A+KV+ +E+++E+ +L IV+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 318 SKEMYAIVYNLLN-GSLKQYLK--QLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDV 372
IV GS+ +K E AI K LEYLH IHRD+
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDI 125
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
K+ NILL+E +L+DFG + K V+GT ++APE + + K
Sbjct: 126 KAGNILLNEE-GQAKLADFGVS-----GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179
Query: 433 IDVYSYGVVLLELITGK 449
D++S G+ +E+ GK
Sbjct: 180 ADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 19/200 (9%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE--EVLREVELLSSIKH---ENIVRI 312
LIG+G VYR HV G+V A+K++ ++ ++ REV LLS ++ NI +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 313 IG-YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIH 369
G Y ++ I+ GS++ +K E+ I V AL+Y+H +IH
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIH 124
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
RD+K++NIL++ N + +L DFG A + +Q+ + K VGT ++APE + GK
Sbjct: 125 RDIKAANILVT-NTGNVKLCDFGVAALLNQN-----SSKRSTFVGTPYWMAPEVITEGKY 178
Query: 430 -DEKIDVYSYGVVLLELITG 448
D K D++S G+ + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 37/276 (13%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHENIVRIIGY 315
IG+G V + DG++ K + N +E+E ++ EV +L +KH NIVR
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 316 CHSKE---MYAIVYNLLNGSLKQYLKQLKWNERM---DVAIGV----AKALEYLHHTCDP 365
+ +Y ++ G L Q +++ K + + + AL H+ DP
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 366 P--IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
++HRD+K +NI L N ++ +L DFG A + ++ VGT Y++PE
Sbjct: 128 GNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTY-----VGTPYYMSPEQ 181
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483
+ + DEK D++S G ++ EL N+ L S + G R I +
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFT--ARNQLQL----ASKIKEGKFRR-IPYRY 234
Query: 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519
+ E N E++ + L +RP+ + LL+L
Sbjct: 235 SSELN----EVI----KSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 49/278 (17%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIGYC 316
+G G + V + H G++ AVK ++ ++LRE+++L IV G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 317 HSKEMYAIVYNLLN-GSLKQYLKQLK--WNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
++ +I ++ GSL + LK+++ ER+ +A+ V K L YLH IIHRD
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 372 VKSSNILLSENFHHPQ--LSDFGAAMVHHQSHQVSENVKPVN-----VVGTFGYLAPEYM 424
VK SNIL++ Q L DFG VS + VN VGT Y+APE +
Sbjct: 127 VKPSNILVN---SRGQIKLCDFG----------VSGQL--VNSLAKTFVGTSSYMAPERI 171
Query: 425 MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID---P 481
K D++S G+ L+EL TG+ + + LL +++ P
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF----ELLQ-----YIVNEPPP 222
Query: 482 QL-NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+L + +++ + + V LCL+ RP+ K LL+
Sbjct: 223 RLPSGKFSPDFQDFV----NLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 53/218 (24%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
IG+G +VY+ N G++ A+K ++ +E+E +RE++LL ++H NIVR+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 314 GYCHSKEMYAI--VY----NLLNGSL------------KQYLKQLKWNERMDVAIGVAKA 355
SK +I V+ + L G L K Y+KQL +
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------------LEG 112
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L+YLH I+HRD+K SNIL++ + +L+DFG A + + + N V T
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDG-VLKLADFGLA----RPYTKRNSADYTNRVIT 164
Query: 416 FGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y PE ++ YG ++D++S G +L EL GK
Sbjct: 165 LWYRPPELLLGATRYG---PEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 16/240 (6%)
Query: 283 VLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLK 341
V+K N E+ + ++H NIV++IG C S++ +++ + G +L + L+ L
Sbjct: 719 VVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS 778
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDFGAAMVHHQS 400
W R +AIG+AKAL +LH C P ++ ++ I++ ++ H +LS G +
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKC 838
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
S Y+APE + EK D+Y +G++L+EL+TGK
Sbjct: 839 FISS------------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886
Query: 461 SLVLWARSLLSSGLCERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
S+V WAR S + IDP + + N+ EI VM A C + RP +LK
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 80/276 (28%), Positives = 123/276 (44%), Gaps = 38/276 (13%)
Query: 260 IGQGGNSKVYRTNHVDGQ-VAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
IG G + VY + A+K + KC S +E+ +EV+ +S H N+V+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 316 CHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAI------GVAKALEYLHHTCDPPII 368
+ +V L+ GSL +K +D AI V K LEYLH I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+K+ NILL E+ +++DFG + + V+ VGT ++APE M
Sbjct: 125 HRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRK-TFVGTPCWMAPEVMEQVH 182
Query: 429 -VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE- 486
D K D++S+G+ +EL TG A + + L+L L + P L
Sbjct: 183 GYDFKADIWSFGITAIELATGA-APYSKYPPMKVLML----TLQND------PPSLETGA 231
Query: 487 ----YNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
Y++ +++ LCL S+RPT + LLK
Sbjct: 232 DYKKYSKSFRKMI----SLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIG- 314
IG+G +VY+ + QV A+KV+ + E++ +E++ LS + I + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI---GVAKALEYLHHTCDPPIIHRD 371
+ +++ I+ GS LK K +E +A V LEYLH + IHRD
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY-IAFILREVLLGLEYLH---EEGKIHRD 123
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV-VGTFGYLAPEYMMYGKVD 430
+K++NILLSE +L+DFG S Q++ + N VGT ++APE + D
Sbjct: 124 IKAANILLSEE-GDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 431 EKIDVYSYGVVLLELITGK 449
EK D++S G+ +EL G+
Sbjct: 177 EKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 4e-21
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 254 FSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIKHEN 308
+ +G+G VY+ + G++ A+K ++ N EE + LRE+ LL +KH N
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPN 59
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK--------ALEYLH 360
IV+++ H++ +V+ + LK+YL ++ + K L Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDMDLKKYLD----KRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQL--SDFG-AAMVHHQSHQVSENVKPVNVVGTFG 417
I+HRD+K NIL++ + L +DFG A + V T
Sbjct: 116 SHR---ILHRDLKPQNILINRD---GVLKLADFGLARAFGIPLRTYTHEVV------TLW 163
Query: 418 YLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y APE ++ Y +D++S G + E+ITGK
Sbjct: 164 YRAPEILLGSKHYST---AVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 4e-21
Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 28/204 (13%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRIIG 314
+G+G KV D G++ A+KVLK E L E +LS I H IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 315 YCHSKE-MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK--------ALEYLHHTCDP 365
++E +Y ++ G L +L + R A+ ALEYLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSE--ERARFYAAEIVLALEYLH-SLG- 113
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
II+RD+K NILL + H +L+DFG A SE + GT YLAPE ++
Sbjct: 114 -IIYRDLKPENILLDAD-GHIKLTDFGLAK-----ELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 426 YGKVDEKIDVYSYGVVLLELITGK 449
+ +D +S GV+L E++TGK
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 55/176 (31%), Positives = 94/176 (53%), Gaps = 18/176 (10%)
Query: 280 AVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK 338
AVK LK S E L+E +++ ++H+ +V++ C +E IV + GSL +LK
Sbjct: 34 AVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK 93
Query: 339 -----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG- 392
+L+ + +D+A +A+ + YL IHRD+ + NIL+ EN +++DFG
Sbjct: 94 SGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGEN-LVCKIADFGL 149
Query: 393 AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
A ++ + E K P+ + APE YG+ K DV+S+G++L E++T
Sbjct: 150 ARLIEDDEYTAREGAKFPIK------WTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVL---KCTNWSE-EEVLREVELLSSIKHENIVRI-I 313
IG+G KV D ++ A+K + KC VL E +L + H +V +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYL-KQLKWNE---RMDVAIGVAKALEYLHHTCDPPIIH 369
+ + MY +V LL G L+ +L +++K++E + + + ALEYLH IIH
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLH---SKGIIH 123
Query: 370 RDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
RD+K NILL E H ++DF A V + S GT GY+APE +
Sbjct: 124 RDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTTS-------TSGTPGYMAPEVLCRQG 175
Query: 429 VDEKIDVYSYGVVLLELITGK 449
+D +S GV E + GK
Sbjct: 176 YSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 57/195 (29%), Positives = 101/195 (51%), Gaps = 17/195 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ + A+K LK + S E L E L+ ++H +VR+ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 320 EMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y I + NGSL +LK +L N+ +D+A +A+ + ++ IHRD+++
Sbjct: 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRA 130
Query: 375 SNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+SE +++DFG A ++ + E K P+ + APE + YG K
Sbjct: 131 ANILVSETL-CCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPEAINYGTFTIK 183
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G++L E++T
Sbjct: 184 SDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKC---TNWSEEEVLREVELLSSIKHENIVRIIGY 315
IG G KVY ++D G++ AVK ++ + +E+ E+++L +KH N+V+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 316 -CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV----AIGVAKALEYLHHTCDPPIIHR 370
H +++Y + G+L++ L+ V + + + L YLH I+HR
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHR 123
Query: 371 DVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
D+K +NI L N +L DFG A + + + + E V+ ++ GT Y+APE + GK
Sbjct: 124 DIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQ--SLAGTPAYMAPEVITGGKG 180
Query: 430 DEK---IDVYSYGVVLLELITGK 449
D++S G V+LE+ TGK
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 52/223 (23%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIG-- 314
+IG+G KVY+ H GQ+ A+K++ EEE+ E +L H NI G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 315 -----YCHSKEMYAI--------VYNLLNGSLKQYLKQLKWNERMDVAI------GVAKA 355
+ +++ + V +L+ G K+ +R+ +
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-------GKRLKEEWIAYILRETLRG 125
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV-SENVKPVNVVG 414
L YLH + +IHRD+K NILL++N +L DFG S Q+ S + +G
Sbjct: 126 LAYLH---ENKVIHRDIKGQNILLTKNA-EVKLVDFG------VSAQLDSTLGRRNTFIG 175
Query: 415 TFGYLAPEYMM--------YGKVDEKIDVYSYGVVLLELITGK 449
T ++APE + Y D + DV+S G+ +EL GK
Sbjct: 176 TPYWMAPEVIACDEQPDASY---DARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 260 IGQGGNSKVYR---TNHVDGQ--VAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV D AVK L + RE+E+L ++ HENIV+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 313 IGYC---HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV------AIGVAKALEYLHHTC 363
G C + + I+ L +GSL+ YL++ + +++++ + + K ++YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLG--- 126
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
IHRD+ + NIL+ E+ ++SDFG A V + VK F Y APE
Sbjct: 127 SQRYIHRDLAARNILV-ESEDLVKISDFGLAKVLPEDKDYYY-VKEPGESPIFWY-APEC 183
Query: 424 MMYGKVDEKIDVYSYGVVLLELIT 447
+ K DV+S+GV L EL T
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE------EEVLREVELLSSIKHENIVR 311
L+G G VY N DG AVK + + + +++ +E+ LLS ++H NIV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 312 IIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAIG-----VAKALEYLHHTCDP 365
+G ++ I L+ GSL + LK K+ + I + LEYLH D
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLK--KYGSFPEPVIRLYTRQILLGLEYLH---DR 121
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
+HRD+K +NIL+ N +L+DFG A QV E + G+ ++APE +
Sbjct: 122 NTVHRDIKGANILVDTN-GVVKLADFGMA------KQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 426 -YGKVDEKIDVYSYGVVLLELITGK 449
G D++S G +LE+ TGK
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 260 IGQGGNSKVY-RTNHVDGQVAAVKVLKCTNWSEE----EVLREVELLSSIKHENIVRII- 313
I +G +V+ G + A+KV+K + + +VL E ++LS + +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQL-KWNERMDVAI--GVAKALEYLHHTCDPPIIHR 370
+ K +Y ++ L G L L+ + +E + + ALEYLH IIHR
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHR 117
Query: 371 DVKSSNILLSENFHHPQLSDFG---AAMVHHQSHQVSENVKPVNVVGTFGYLAPEY---M 424
D+K NIL+ N H +L+DFG +V Q + + + +VGT Y+APE
Sbjct: 118 DLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 425 MYGKVDEKIDVYSYGVVLLELITG 448
+ K +D +S G +L E + G
Sbjct: 177 GHSK---TVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 45/219 (20%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVR 311
+G+G KVY+ + A+K LK ++E +E EL+S ++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYL-------------------KQLKWNERMDVAIG 351
++G C ++ +++ L +G L ++L L ++ + +AI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 352 VAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS---HQVSEN 406
+A +EYL HH +HRD+ + N L+ E ++SDFG + + + S++
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEG-LTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
+ PV ++ PE ++YGK + D++S+GVVL E+
Sbjct: 187 LLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 29/200 (14%)
Query: 260 IGQGGNSKVY-RTNHVDGQVAAVKVL----KCTNWSEEEVLREVELLSSIKHENIVRIIG 314
IG G VY + +V A+K + K +N +++++EV L ++H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 315 YCHSKEMYA-IVYNLLNGS----LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
C+ +E A +V GS L+ + K L+ E + G + L YLH IH
Sbjct: 83 -CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIH 138
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEY---MM 425
RD+K+ NILL+E +L+DFG+A + V P N VGT ++APE M
Sbjct: 139 RDIKAGNILLTEP-GTVKLADFGSASL----------VSPANSFVGTPYWMAPEVILAMD 187
Query: 426 YGKVDEKIDVYSYGVVLLEL 445
G+ D K+DV+S G+ +EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ AVK LK S E L E +++ ++H+ +V++ +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y + + GSL +LK LK +D+A VA + Y+ IHRD++S
Sbjct: 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRS 130
Query: 375 SNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+ + +++DFG A ++ + + K P+ + APE +YG+ K
Sbjct: 131 ANILVGDGLV-CKIADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGRFTIK 183
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESL 462
DV+S+G++L EL+T NRE L
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+GQG +V+ A+K LK S E L+E +++ ++HE +V++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 320 EMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y + + GSL +LK L+ + +D+A +A + Y+ +HRD+++
Sbjct: 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRA 130
Query: 375 SNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+ EN +++DFG A ++ + + K P+ + APE +YG+ K
Sbjct: 131 ANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGRFTIK 183
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESL 462
DV+S+G++L EL T NRE L
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 67/281 (23%), Positives = 122/281 (43%), Gaps = 42/281 (14%)
Query: 253 NFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHEN 308
+F IG+G V++ D +V A+K + + + EE + E +L+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 309 IVRII-GYCHSKEMYAIVYNLLNGSLKQYLK---------QLKWNERMDVAIGVAKALEY 358
I+R + ++ ++ NG L + LK W + + +G L +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH I+HRD+KS N+ L + + ++ D G A + + +VGT Y
Sbjct: 117 LHSK---KILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDN-----TNFANTIVGTPYY 167
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478
L+PE +EK DV++ GVVL E TGK N N+ +L+ ++ R
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN--NQGALI---LKII------RG 216
Query: 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519
+ P +++ Y+++ +++ CL +RP LL+
Sbjct: 217 VFPPVSQMYSQQLAQLI----DQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 4e-18
Identities = 68/270 (25%), Positives = 122/270 (45%), Gaps = 31/270 (11%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+GQG +V+ A+K LK E L+E +++ ++H+ +V + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y + + GSL +LK+ LK + +D+A +A + Y+ IHRD+++
Sbjct: 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRA 130
Query: 375 SNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+ +N +++DFG A ++ + + K P+ + APE +YG+ K
Sbjct: 131 ANILVGDNLV-CKIADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGRFTIK 183
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEI 492
DV+S+G++L EL+T NRE L R R+ PQ E E +
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-------RMPCPQGCPESLHELM 236
Query: 493 EIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
+LC RPT + + ++
Sbjct: 237 -------KLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 54/178 (30%), Positives = 95/178 (53%), Gaps = 22/178 (12%)
Query: 280 AVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK 338
AVK LK ++ L E +++ ++H ++++ C +E IV L+ GSL +YL+
Sbjct: 34 AVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ 93
Query: 339 -----QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391
LK + +D+A VA + YL + IHRD+ + N+L+ EN + +++DF
Sbjct: 94 GGAGRALKLPQLIDMAAQVASGMAYLEAQN-----YIHRDLAARNVLVGEN-NICKVADF 147
Query: 392 GAAMVHHQS-HQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
G A V + ++ E K P+ + APE +Y + K DV+S+G++L E++T
Sbjct: 148 GLARVIKEDIYEAREGAKFPIK------WTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 53/196 (27%), Positives = 99/196 (50%), Gaps = 18/196 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHS 318
+G G +V+ + A+K+LK + +++ +EV+ L ++H++++ + C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 319 KEMYAIVYNLL-NGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
E I+ L+ GSL +L + L +D+A VA+ + YL + IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
+ NIL+ E+ +++DFG A + + +S + K P + APE +G
Sbjct: 131 AARNILVGEDLV-CKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAASHGTFST 183
Query: 432 KIDVYSYGVVLLELIT 447
K DV+S+G++L E+ T
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 19/195 (9%)
Query: 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
IG+G V ++ GQ AVK LK + + + L E ++++++H N+V+++G
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 317 -HSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
+Y + + GSL YL+ + +++ A+ V + +EYL + +HR
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+ + N+L+SE+ ++SDFG A Q + PV + APE + K
Sbjct: 127 DLAARNVLVSEDL-VAKVSDFGLAKEASQGQDSGK--LPVK------WTAPEALREKKFS 177
Query: 431 EKIDVYSYGVVLLEL 445
K DV+S+G++L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 70/207 (33%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 260 IGQGGNSKVY-RTNHVDGQVAAVKVL----KCTNWSEEEVLREVELLSSIKHENIVRIIG 314
IG G VY TN +V AVK + K TN +++++EV+ L +KH N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 315 YCHSKEMYA-IVYNLLNGS----LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
C+ KE A +V GS L+ + K L+ E + G + L YLH +IH
Sbjct: 89 -CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIH 144
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEYMMY-- 426
RD+K+ NILL+E +L+DFG+A P N VGT ++APE ++
Sbjct: 145 RDIKAGNILLTEP-GQVKLADFGSASK----------SSPANSFVGTPYWMAPEVILAMD 193
Query: 427 -GKVDEKIDVYSYGVVLLELITGKEAI 452
G+ D K+DV+S G+ +EL K +
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 56/180 (31%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 276 GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYNLLNGSLK 334
AVK LK EE L+E ++ IKH N+V+++G C Y I + G+L
Sbjct: 31 SLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90
Query: 335 QYLKQLKWNERMDV-----AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
YL++ E V A ++ A+EYL IHRD+ + N L+ EN H +++
Sbjct: 91 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN-HLVKVA 146
Query: 390 DFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
DFG + ++ ++ K P+ + APE + Y K K DV+++GV+L E+ T
Sbjct: 147 DFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 66/259 (25%), Positives = 119/259 (45%), Gaps = 47/259 (18%)
Query: 280 AVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
A+KVL+ + +E+L E +++S+ H ++VR++G C S ++ I + G L Y+
Sbjct: 40 AIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYV 99
Query: 338 KQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387
+ L W + +AK + YL + ++HRD+ + N+L+ + H +
Sbjct: 100 RNHKDNIGSQYLLNWCVQ------IAKGMSYLE---EKRLVHRDLAARNVLV-KTPQHVK 149
Query: 388 LSDFGAAM---VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLE 444
++DFG A V + + P+ ++A E +++ K DV+SYGV + E
Sbjct: 150 ITDFGLAKLLDVDEKEYHAEGGKVPIK------WMALESILHRIYTHKSDVWSYGVTVWE 203
Query: 445 LIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCL 503
L+T G + + E LL G ERL P + I++ M + C
Sbjct: 204 LMTFGAKPYE-GIPAVE-----IPDLLEKG--ERLPQPPIC------TIDVYMVLVK-CW 248
Query: 504 LHSSSRRPTMKTLLKLFQE 522
+ + RPT K L+ F +
Sbjct: 249 MIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 75/289 (25%), Positives = 119/289 (41%), Gaps = 40/289 (13%)
Query: 261 GQGGN-SKVYRTNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC- 316
G GG+ +K N G + A+K + + +++LRE+E+ S K IV+ G
Sbjct: 12 GAGGSVTKCRLKN--TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 317 --HSKEMYAIVYNLLNGSLKQYLKQLK-----WNERM--DVAIGVAKALEYLHHTCDPPI 367
S + + GSL K++K E++ +A V K L YLH I
Sbjct: 70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKI 126
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS-ENVKPV--NVVGTFGYLAPEYM 424
IHRD+K SNILL+ +L DFG VS E V + GT Y+APE +
Sbjct: 127 IHRDIKPSNILLTRK-GQVKLCDFG----------VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 425 MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484
DV+S G+ LLE+ + + +++ E +P
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235
Query: 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533
+++ E + + CL +RRPT +L E + ++K
Sbjct: 236 IKWSEEFKDFIKQ----CLEKDPTRRPTPWDML----EHPWIKAQMKKK 276
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 83/287 (28%), Positives = 137/287 (47%), Gaps = 42/287 (14%)
Query: 260 IGQGGNSKV--YR---TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV Y N G++ AVK LK C + +E+ +L ++ HENIV+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 313 IGYCHS---KEMYAIVYNLLNGSLKQYLKQLKWN--ERMDVAIGVAKALEYLHHTCDPPI 367
G C K + I+ + GSL+ YL + K N + + A + + + YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HY 128
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMV---HHQSHQVSEN-VKPVNVVGTFGYLAPEY 423
IHRD+ + N+LL +N ++ DFG A H+ ++V E+ PV F Y A E
Sbjct: 129 IHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-----FWY-AVEC 181
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483
+ K DV+S+GV L EL+T ++ Q+ E ++ + ++ RLI+ L
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV---VRLIE--L 236
Query: 484 NEEYNR--------EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
E R +E+ I+M + C + RPT ++L+ + +E
Sbjct: 237 LERGMRLPCPKNCPQEVYILM---KNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 52/227 (22%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G+G KV+ D ++ AVK LK +N + ++ RE ELL++ +HENIV+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYL-----------------KQLKWNERMDVAIGVA 353
G C + +V+ + +G L ++L +L ++ + +A+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 354 KALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ YL H +HRD+ + N L+ + ++ DFG +S +V +
Sbjct: 133 SGMVYLASQH-----FVHRDLATRNCLVGYDL-VVKIGDFG----------MSRDVYTTD 176
Query: 412 ---VVGT----FGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKE 450
V G ++ PE +MY K + DV+S+GVVL E+ T GK+
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVAAVK-VLKCTNWSE------EEVLREVELLSSIKHENIV 310
+G G S Y+ V G + AVK V N S E + +E+ L++ + H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 311 RIIG-YCHSKEMYAIVYNLLNGSLKQYLKQL-KWNERMDVA--IGVAKALEYLHHTCDPP 366
R++G C V + GS+ L + + E + + + + L YLH +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQ 123
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM- 425
IIHRDVK +N+L+ +++DFGAA + + ++GT ++APE +
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG-QLLGTIAFMAPEVLRG 182
Query: 426 --YGKVDEKIDVYSYGVVLLELITGK 449
YG+ DV+S G V++E+ T K
Sbjct: 183 EQYGR---SCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 37/205 (18%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIG--- 314
IG G VY+ G++ A+KV+K + E + +E+ +L +H NIV G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 315 ----------YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCD 364
YC + I Y + G L + V K L YLH T
Sbjct: 71 RRDKLWIVMEYCGGGSLQDI-YQVTRGPLSELQIAY-------VCRETLKGLAYLHET-- 120
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEY 423
IHRD+K +NILL+E+ +L+DFG S Q++ + +GT ++APE
Sbjct: 121 -GKIHRDIKGANILLTED-GDVKLADFGV------SAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 424 M---MYGKVDEKIDVYSYGVVLLEL 445
G D K D+++ G+ +EL
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 19/193 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG+G V + + GQ AVK +KC + + + L E +++ + H+N+VR++G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC-DVTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71
Query: 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y ++ + G+L +L+ + + + ++ VA+ +EYL ++HRD+ +
Sbjct: 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAA 128
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
NIL+SE+ ++SDFG A V S V + PV + APE + + K K D
Sbjct: 129 RNILVSED-GVAKVSDFGLARV--GSMGVDNSKLPVK------WTAPEALKHKKFSSKSD 179
Query: 435 VYSYGVVLLELIT 447
V+SYGV+L E+ +
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 29/209 (13%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH 317
IG+G KVY+ TN DG +AAVK+L + +EE+ E +L S+ H N+V+ G +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 318 SKEMYA-----IVYNLLNG-SLKQYLKQL-KWNERMDVAI------GVAKALEYLHHTCD 364
+ +V L NG S+ + +K L +R+D A+ G L++LH+
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-- 147
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
IIHRDVK +NILL+ +L DFG + + S ++ VGT ++APE +
Sbjct: 148 -RIIHRDVKGNNILLTTE-GGVKLVDFGVS-----AQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 425 MYGK-----VDEKIDVYSYGVVLLELITG 448
+ D + DV+S G+ +EL G
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 52/284 (18%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE--VLREVE-LLSSIKHENIVRIIG 314
IG+G V + H G + AVK ++ T +E+ +L +++ ++ S IV+ G
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 315 YCHSK---------------EMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALE 357
+ + Y VY +L + E + +A+ KAL
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVI---------PEEILGKIAVATVKALN 121
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
YL IIHRDVK SNILL N + +L DFG S Q+ +++ G
Sbjct: 122 YLKEELK--IIHRDVKPSNILLDRN-GNIKLCDFGI------SGQLVDSIAKTRDAGCRP 172
Query: 418 YLAPEYM---MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474
Y+APE + D + DV+S G+ L E+ TGK + + L + + G
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL-----TQVVKGD 227
Query: 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
L E++ + + LCL+ S+RP K LL+
Sbjct: 228 PPIL-SNSEEREFSPSFVNFI----NLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEV----LREVELLSSIKHENIVRII 313
++G+G V + + G++ A+K K + +E+V LREV++L ++HENIV +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFK-ESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI------GVAKALEYLHHTCDPPI 367
K +V+ + +L + L+ + + +A+ Y H I
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGG--LPPDAVRSYIWQLLQAIAYCHSH---NI 121
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV--NVVGTFGYLAPE--- 422
IHRD+K NIL+SE+ +L DFG A + + V T Y APE
Sbjct: 122 IHRDIKPENILVSES-GVLKLCDFGFA------RALRARPASPLTDYVATRWYRAPELLV 174
Query: 423 -YMMYGKVDEKIDVYSYGVVLLELITG 448
YGK +DV++ G ++ EL+ G
Sbjct: 175 GDTNYGK---PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 64/186 (34%), Positives = 98/186 (52%), Gaps = 26/186 (13%)
Query: 276 GQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIGYCHS---KEMYAIVYNLLNG 331
G+V AVK L+ + + RE+E+L S++H+NIV+ G C+S + + ++ L G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 332 SLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385
SL+ YL+ K ER+D A + K +EYL +HRD+ + NIL+ E+ +
Sbjct: 93 SLRDYLQ--KHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILV-ESENR 146
Query: 386 PQLSDFGAAMVHHQS---HQVSE-NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVV 441
++ DFG V Q ++V E P+ F Y APE + K DV+S+GVV
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPI-----FWY-APESLTESKFSVASDVWSFGVV 200
Query: 442 LLELIT 447
L EL T
Sbjct: 201 LYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 35/222 (15%)
Query: 260 IGQGGNSK-VYRTNHVDGQVAAVK---VLKCTNWSEEEVLREVELLSSIKHENIVR---- 311
IG+G K + + DG+ +K + K + EE +EV +LS++KH NIV+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 312 ---------IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHT 362
++ YC ++Y + N G L + L W + + AL+++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDW------FVQICLALKHVH-- 118
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
D I+HRD+KS NI L+++ +L DFG A V + + +++ +GT YL+PE
Sbjct: 119 -DRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELAR-----TCIGTPYYLSPE 171
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
+ K D+++ G VL E+ T K A + N ++LVL
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEA--GNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 46/281 (16%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHEN 308
+F +G+G VY+ + D Q A+K + + S+ E+ + E+ +L+S+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 309 IVR-----IIG--YCHSKEMYAIVYNLLN--GSLKQYLKQLKWNERMDVAIGVAKALEYL 359
I+ + G C E YA +L K+ K + E + I + + L+ L
Sbjct: 61 IISYKEAFLDGNKLCIVME-YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
H + I+HRD+KS+NILL N ++ D G + +V + +GT Y+
Sbjct: 120 H---EQKILHRDLKSANILLVANDLV-KIGDLGIS-------KVLKKNMAKTQIGTPHYM 168
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479
APE K D++S G +L E+ T + ARS+ L ++
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE------------ARSM--QDLRYKVQ 214
Query: 480 D---PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLL 517
P + Y+++ + R L RP +L
Sbjct: 215 RGKYPPIPPIYSQDLQNFI----RSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 75/294 (25%), Positives = 135/294 (45%), Gaps = 60/294 (20%)
Query: 259 LIGQGGNSKVYRT------NHVDGQVAAVKVLKCTNWSEEEV---LREVELLSSI-KHEN 308
+G+G +V + N + AVK+LK + +E+++ + E+E++ I KH+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 309 IVRIIGYCHSK-EMYAIVYNLLNGSLKQYLK-------------------QLKWNERMDV 348
I+ ++G C + +Y +V +G+L+ +L+ L + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-VHHQSH--QVSE 405
A VA+ +E+L IHRD+ + N+L++E+ H +++DFG A +HH + + +
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTED-HVMKIADFGLARDIHHIDYYRKTTN 193
Query: 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVL 464
PV ++APE + + DV+S+GV+L E+ T G E L
Sbjct: 194 GRLPVK------WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--EELF- 244
Query: 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
LL G R+ PQ +E+ +M C S+RPT K L++
Sbjct: 245 ---KLLKEG--YRMEKPQ----NCTQELYHLMRD---CWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 53/196 (27%), Positives = 102/196 (52%), Gaps = 18/196 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ + + AVK LK S + L E L+ +++H+ +VR+ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 320 E-MYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVK 373
E +Y I + GSL +LK ++ + +D + +A+ + Y+ IHRD++
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLR 130
Query: 374 SSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
++N+L+SE+ +++DFG A ++ + E K P+ + APE + +G
Sbjct: 131 AANVLVSESLM-CKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFGSFTI 183
Query: 432 KIDVYSYGVVLLELIT 447
K DV+S+G++L E++T
Sbjct: 184 KSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRII-GYC 316
IGQG + VY V GQ A+K + ++E ++ E+ ++ KH NIV + Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L GSL + + +E A+ +ALE+LH +IHRD+KS
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKS 143
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVS-ENVKPVNVVGTFGYLAPEYMMYGKVDEKI 433
NILL + +L+DFG Q++ E K +VGT ++APE + K+
Sbjct: 144 DNILLGMD-GSVKLTDFGFCA------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 434 DVYSYGVVLLELITGK 449
D++S G++ +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEE---EVLR---EVELLSSIKHENIVR 311
L+GQG +VY VD G+ AVK + S E EV E++LL +++HE IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPI 367
G E +I + GS+K LK L + + +EYLH I
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMI 125
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-- 425
+HRD+K +NIL + +L DFGA+ +K V GT +++PE +
Sbjct: 126 VHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWMSPEVISGE 182
Query: 426 -YGKVDEKIDVYSYGVVLLELITGK 449
YG+ K DV+S G ++E++T K
Sbjct: 183 GYGR---KADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCH 317
IG+G KV++ N +G AAVK+L + +EE+ E +L ++ H N+V+ G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 318 SKEMYA-----IVYNLLNG-SLKQYLKQ-LKWNERMD---VAIGVAKALEYLHHTCDPPI 367
K++ +V L NG S+ +K LK ERM+ +A + +AL L H
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKT 145
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM--- 424
IHRDVK +NILL+ +L DFG + + S ++ VGT ++APE +
Sbjct: 146 IHRDVKGNNILLTTE-GGVKLVDFGVS-----AQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 425 --MYGKVDEKIDVYSYGVVLLELITG 448
+ D + DV+S G+ +EL G
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 259 LIGQGGNSKVYRTNHVD-------GQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENI 309
+G G +VY D AVK L+ +E E L+E L+S+ H NI
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 310 VRIIGYCHSKE-MYAIVYNLLNGSLKQYLKQ----------LKWNERMDVAIGVAKALEY 358
V+++G C E Y I+ + G L YL+ L E +D+ + VAK Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHP----QLSDFGAAMVHHQS---HQVSENVKPVN 411
L IHRD+ + N L+SE + ++ DFG A ++S + E + PV
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++APE ++ GK + DV+S+GV++ E++T
Sbjct: 179 ------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 43/211 (20%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIG- 314
IG+G + V++ + G+ A+K + + + LRE++ L + +H +V+++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDP 365
+ H +V + L + L+ Q+K RM + K + Y+H
Sbjct: 68 FPHGSGFV-LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM-----LLKGVAYMH---AN 118
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMV------HHQSHQVSENVKPVNVVGTFGYL 419
I+HRD+K +N+L+S + +++DFG A + SHQ V T Y
Sbjct: 119 GIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSHQ----------VATRWYR 167
Query: 420 APEYMMYG--KVDEKIDVYSYGVVLLELITG 448
APE ++YG K D +D+++ G + EL+ G
Sbjct: 168 APE-LLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 59/178 (33%), Positives = 88/178 (49%), Gaps = 21/178 (11%)
Query: 280 AVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQY 336
AVK LK + ++E LRE +++ + H IVR+IG C E +V L G L +Y
Sbjct: 27 AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKY 85
Query: 337 LKQLKWNERMDV---AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG- 392
LK+ + D+ A VA + YL +HRD+ + N+LL N H ++SDFG
Sbjct: 86 LKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLL-VNRHQAKISDFGM 141
Query: 393 --AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
A ++ + + P+ + APE + YGK K DV+SYGV L E +
Sbjct: 142 SRALGAGSDYYRATTAGRWPLK------WYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKV-YRTNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIKHENIVRIIG-YC 316
IG+G V T+ G+ AVK + E+L EV ++ +H NIV + Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L G+L + + NE V + V KAL +LH +IHRD+KS
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKS 143
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKI 433
+ILL+ + +LSDFG QVS+ V + ++VGT ++APE + ++
Sbjct: 144 DSILLTSD-GRVKLSDFGFCA------QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 434 DVYSYGVVLLELITGK 449
D++S G++++E++ G+
Sbjct: 197 DIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEV--LREVELLSSIKHENIVRIIGYC 316
L+G+G +V++ D AVK K E ++ L E +L H NIV++IG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 317 HSKEMYAIVYNLLNGS-----LKQYLKQLKWNERMDVAIGVAKALEYLH-HTCDPPIIHR 370
++ IV L+ G L++ +LK + + A+ A + YL C IHR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC----IHR 117
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+ + N L+ EN + ++SDFG + S +K + + T APE + YG+
Sbjct: 118 DLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGRYS 172
Query: 431 EKIDVYSYGVVLLE 444
+ DV+SYG++L E
Sbjct: 173 SESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 27/201 (13%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRII-GYC 316
+G G KVY+ H + G AA K+++ + E E+ + E+++LS KH NIV + Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLK--WNERMDVAIG--VAKALEYLHHTCDPPIIHRDV 372
+ +++ ++ G+L + +L+ E + + +AL +LH +IHRD+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM------- 425
K+ NILL+ + +L+DFG + + S K +GT ++APE +
Sbjct: 130 KAGNILLTLD-GDVKLADFGVS-----AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 426 -YGKVDEKIDVYSYGVVLLEL 445
Y D K D++S G+ L+EL
Sbjct: 184 PY---DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 29/200 (14%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVL----KCTNWSEEEVLREVELLSSIKHENIVRIIG 314
IG G VY V + +V A+K + K +N +++++EV L ++H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 315 YCHSKEMYA-IVYNLLNGS----LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
C+ +E A +V GS L+ + K L+ E V G + L YLH +IH
Sbjct: 83 -CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEYMMY-- 426
RDVK+ NILLSE +L DFG+A + + P N VGT ++APE ++
Sbjct: 139 RDVKAGNILLSEP-GLVKLGDFGSASI----------MAPANXFVGTPYWMAPEVILAMD 187
Query: 427 -GKVDEKIDVYSYGVVLLEL 445
G+ D K+DV+S G+ +EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 47/276 (17%)
Query: 260 IGQGGNSKVY-RTNHVDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVR---- 311
IG+G K+Y D + +K + T +E +EV LL+ +KH NIV
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 312 ---------IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHT 362
++ YC ++ + N G L + L W + +++G L H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSW--FVQISLG-------LKHI 117
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
D I+HRD+KS NI LS+N +L DFG A + S +++ VGT YL+PE
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY-----TCVGTPYYLSPE 172
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482
+ K D++S G VL EL T K + N N LVL +C+ P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVL--------KICQGYFAP- 221
Query: 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
++ ++R+ ++ ++ S RP++ ++LK
Sbjct: 222 ISPNFSRDLRSLISQLFKV----SPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 38/277 (13%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYC 316
L+G G +VY+ HV GQ+AA+KV+ T EEE+ +E+ +L H NI G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 317 HSK-------EMYAIVYNLLNGSLKQYLKQLKWNERMD--VAIGVAKALEYLHHTCDPPI 367
K +++ ++ GS+ +K K N + +A + L L H +
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV 132
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV-VGTFGYLAPEYMMY 426
IHRD+K N+LL+EN +L DFG S Q+ V N +GT ++APE +
Sbjct: 133 IHRDIKGQNVLLTEN-AEVKLVDFGV------SAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 427 -----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481
D K D++S G+ +E+ G + R A L+ RL
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLIPRNPAPRLKSK 239
Query: 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ ++++ + IE CL+ + S+RPT + L+K
Sbjct: 240 KWSKKF-QSFIES-------CLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 49/195 (25%), Positives = 102/195 (52%), Gaps = 17/195 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ + AVK +K + S E L E ++ +++H+ +V++ +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 320 EMYAIVYNLLNGSLKQYLKQLKWNER-----MDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y I + GSL +LK + +++ +D + +A+ + ++ IHRD+++
Sbjct: 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRA 130
Query: 375 SNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+S + +++DFG A ++ + E K P+ + APE + +G K
Sbjct: 131 ANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFGSFTIK 183
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G++L+E++T
Sbjct: 184 SDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 76/266 (28%), Positives = 115/266 (43%), Gaps = 32/266 (12%)
Query: 260 IGQGGNSKVYR--TNHVDGQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIG- 314
IG+G +VY+ N +V A+K++ +E ++ +E+ +LS I R G
Sbjct: 12 IGKGSFGEVYKGIDNRTK-EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDV 372
Y +++ I+ L GS LK E I + K L+YLH IHRD+
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK---IHRDI 127
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
K++N+LLSE +L+DFG A +K VGT ++APE + D K
Sbjct: 128 KAANVLLSEQ-GDVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEI 492
D++S G+ +EL G+ R ++ S P L +Y++
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-----------PPTLEGQYSKPFK 230
Query: 493 EIVMCAARLCLLHSSSRRPTMKTLLK 518
E V CL RPT K LLK
Sbjct: 231 EFV----EACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 72/288 (25%), Positives = 118/288 (40%), Gaps = 51/288 (17%)
Query: 260 IGQGGNSKVYR--TNHVDG----QVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G G +VY DG AVK L C+ E + L E ++S H+NIVR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLK----------QLKWNERMDVAIGVAKALEYLH 360
+IG + I+ L+ G LK +L+ L + + A VAK +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQ----LSDFGAAMVHHQSHQVSENVK---PVNVV 413
+ IHRD+ + N LL+ P ++DFG A +++ + + P+
Sbjct: 134 ---ENHFIHRDIAARNCLLTCK--GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK-- 186
Query: 414 GTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG 473
++ PE + G K DV+S+GV+L E+ + + N+E + ++ G
Sbjct: 187 ----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-----EFVTGG 237
Query: 474 LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
RL + + V C H+ RP T+L+ Q
Sbjct: 238 --GRL-------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKV-YRTNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIKHENIVRII-GYC 316
IG+G V T G+ AVK + E+L EV ++ HEN+V + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L G+L + + NE V + V +AL YLH + +IHRD+KS
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKS 146
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKI 433
+ILL+ + +LSDFG QVS+ V K ++VGT ++APE + ++
Sbjct: 147 DSILLTSD-GRIKLSDFGFCA------QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 434 DVYSYGVVLLELITGK 449
D++S G++++E+I G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 55/285 (19%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVK--VLKCTNWSEEE-----VLREVELLSSIKHENIVR 311
++G+G VY GQ+ AVK L +N E + EV+LL S+KH NIV+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLKQL---------KWNERMDVAIGVAKALEYLHH 361
+G C +I + GS+ L + K+ ++ + GVA YLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ--ILDGVA----YLHN 120
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA----MVH-HQSHQVSENVKPVNVVGTF 416
C ++HRD+K +N++L N +L DFG A V H +H S +K ++ GT
Sbjct: 121 NC---VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTH--SNMLKSMH--GTP 172
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW---ARSLLSSG 473
++APE + K D++S G + E+ TGK + + +R + + + R L+
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS--MDRLAAMFYIGAHRGLM--- 227
Query: 474 LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
P+L + ++ I+ V CL RP+ LL+
Sbjct: 228 -------PRLPDSFSAAAIDFV----TSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 66/252 (26%), Positives = 107/252 (42%), Gaps = 50/252 (19%)
Query: 280 AVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
AVK LK S+ ++ L+E ++ S+ HEN++R+ G + + + GSL L
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRL 86
Query: 338 KQLKWNERM-----DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392
++ + D A+ +A + YL IHRD+ + NILL+ + ++ DFG
Sbjct: 87 RKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASD-DKVKIGDFG 142
Query: 393 ---AAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT- 447
A + + + E++K P F + APE + DV+ +GV L E+ T
Sbjct: 143 LMRALPQNEDHYVMEEHLKVP------FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTY 196
Query: 448 ------GKEAIQT-NKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAAR 500
G Q K ++E ERL P E ++I VM
Sbjct: 197 GEEPWAGLSGSQILKKIDKEG--------------ERLERP----EACPQDIYNVM---L 235
Query: 501 LCLLHSSSRRPT 512
C H+ + RPT
Sbjct: 236 QCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 34/267 (12%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE-----EEVLREVELLSSIKHENIVRIIG 314
IG+G +V++ +D + V +K + E E++ +E+ +LS + + G
Sbjct: 12 IGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 315 -YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRD 371
Y +++ I+ L GS L+ ++E + + K L+YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH---SEKKIHRD 126
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
+K++N+LLSE +L+DFG A +K VGT ++APE + D
Sbjct: 127 IKAANVLLSEQ-GDVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 432 KIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREE 491
K D++S G+ +EL G+ N VL+ L + P L E+++
Sbjct: 181 KADIWSLGITAIELAKGEPP---NSDMHPMRVLF--------LIPKNNPPTLTGEFSKPF 229
Query: 492 IEIVMCAARLCLLHSSSRRPTMKTLLK 518
E + CL S RPT K LLK
Sbjct: 230 KEFI----DACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIKHENIVRIIG 314
+G+G + VY+ + ++GQ+ A+KV+ +EE V +RE LL +KH NIV +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
H+KE V+ ++ L QY+ Q L + + L Y+H I+HR
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHR 127
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+K N+L+S +L+DFG A ++ + VV T Y P+ ++ G D
Sbjct: 128 DLKPQNLLIS-YLGELKLADFGLA----RAKSIPSQTYSSEVV-TLWYRPPDVLL-GATD 180
Query: 431 --EKIDVYSYGVVLLELITGKEA 451
+D++ G + +E++ G+ A
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKV-YRTNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIKHENIVRII-GYC 316
IG+G V T G++ AVK + E+L EV ++ +HEN+V + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L G+L + + NE V + V KAL LH +IHRD+KS
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKS 144
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKI 433
+ILL+ + +LSDFG QVS+ V + ++VGT ++APE + ++
Sbjct: 145 DSILLTHD-GRVKLSDFGFCA------QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 434 DVYSYGVVLLELITGK 449
D++S G++++E++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 57/231 (24%), Positives = 110/231 (47%), Gaps = 24/231 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG G V+ ++ + A+K ++ SEE+ + E +++ + H +V++ G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 320 EMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+V+ + +G L YL+ + + + + V + + YL + +IHRD+ +
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAA 128
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
N L+ EN ++SDFG V + S K PV + +PE + K K
Sbjct: 129 RNCLVGEN-QVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEVFSFSKYSSK 181
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483
DV+S+GV++ E+ + + N++N E + +++G RL P+L
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVV-----ETINAGF--RLYKPRL 225
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 28/202 (13%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEV--LREVELLSSIK-HENIVRIIGY 315
IG+G S+V + G+ A+K +K S E+V LRE++ L + H NI+R+I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 316 CHSKEM--YAIVYNLLNGSL-------KQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366
++ A+V+ L++ +L K+ L + + M + K+L+++H
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYM---YQLLKSLDHMHRN---G 120
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
I HRD+K NIL+ +L+DFG+ + +E + T Y APE ++
Sbjct: 121 IFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTE------YISTRWYRAPECLLT 172
Query: 427 -GKVDEKIDVYSYGVVLLELIT 447
G K+D+++ G V E+++
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 31/207 (14%)
Query: 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVL----KCTNWSEEEVLREVELLSSIKHEN 308
F+ IG G VY V +V A+K + K +N +++++EV+ L IKH N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 309 IVRIIGYCHSKEMYA-IVYNLLNGS----LKQYLKQLKWNERMDVAIGVAKALEYLH-HT 362
+ G C+ +E A +V GS L+ + K L+ E + G + L YLH H
Sbjct: 87 SIEYKG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAP 421
+IHRD+K+ NILL+E +L+DFG+A + P N VGT ++AP
Sbjct: 146 ----MIHRDIKAGNILLTEP-GQVKLADFGSASI----------ASPANSFVGTPYWMAP 190
Query: 422 EYMMY---GKVDEKIDVYSYGVVLLEL 445
E ++ G+ D K+DV+S G+ +EL
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 61/219 (27%), Positives = 112/219 (51%), Gaps = 31/219 (14%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEE----------EVLR-EVELLSSIKH 306
LIG+G +VY +V G++ AVK ++ + LR E+E L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 307 ENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHT 362
NIV+ +G+ ++E +I + GS+ L+ ++ E++ V + L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH-- 125
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
I+HRD+K+ N+L+ + ++SDFG + +S + +N + +++ G+ ++APE
Sbjct: 126 -SKGILHRDLKADNLLVDAD-GICKISDFG---ISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 423 YM-MYGK-VDEKIDVYSYGVVLLELITGK------EAIQ 453
+ Y + K+D++S G V+LE+ G+ EAI
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 44/213 (20%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVR-- 311
IG+G VYR + G++ A+K ++ N E + LRE+ LL +++H NIV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 312 -------------IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEY 358
++ YC +++ +++ N+ + +K L + + + L+Y
Sbjct: 73 EVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSESQVKCL--------MLQLLRGLQY 123
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFG 417
LH IIHRD+K SN+LL++ +++DFG A + ++ V T
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTPKVV------TLW 173
Query: 418 YLAPEYMMYGKV-DEKIDVYSYGVVLLELITGK 449
Y APE ++ ID+++ G +L EL+ K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 65/267 (24%), Positives = 126/267 (47%), Gaps = 43/267 (16%)
Query: 280 AVKVLKCTNWSEEEVLREVE----LLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQ 335
A+K ++ + S + +E+ + S+ H IVR++G C + + GSL
Sbjct: 40 AIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLD 97
Query: 336 YLKQLKWN----ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391
+++Q + + ++ + +AK + YL ++HR++ + NILL + Q++DF
Sbjct: 98 HVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDS-IVQIADF 153
Query: 392 GAAMVHH---QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT- 447
G A + + + + SE+ P+ ++A E +++G+ + DV+SYGV + E+++
Sbjct: 154 GVADLLYPDDKKYFYSEHKTPIK------WMALESILFGRYTHQSDVWSYGVTVWEMMSY 207
Query: 448 GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSS 507
G E + + LL G ERL PQ+ I++ M + C +
Sbjct: 208 GAEPYAGMRPHE------VPDLLEKG--ERLAQPQIC------TIDVYMVMVK-CWMIDE 252
Query: 508 SRRPTMKTLLKLF----QEPDYWLKMK 530
+ RPT K L F ++P +L +K
Sbjct: 253 NVRPTFKELANEFTRMARDPPRYLVIK 279
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/197 (31%), Positives = 106/197 (53%), Gaps = 18/197 (9%)
Query: 260 IGQGGNSKV--YRTNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIKHENIVRII-GY 315
IG+G V R H QVA VK++ E+L EV ++ +H+N+V + Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVA-VKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVK 373
+E++ ++ L G+L + Q + NE V V +AL YLH +IHRD+K
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIK 144
Query: 374 SSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEK 432
S +ILL+ + +LSDFG Q+S++V K ++VGT ++APE + +
Sbjct: 145 SDSILLTLD-GRVKLSDFGFCA------QISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 433 IDVYSYGVVLLELITGK 449
+D++S G++++E++ G+
Sbjct: 198 VDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRII-GYC 316
IGQG + V+ V GQ A+K + ++E ++ E+ ++ +K+ NIV + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L GSL + + +E A+ +ALE+LH +IHRD+KS
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKS 143
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
N+LL + +L+DFG + E K +VGT ++APE + K+D
Sbjct: 144 DNVLLGMD-GSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 435 VYSYGVVLLELITGK 449
++S G++ +E++ G+
Sbjct: 198 IWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 68/246 (27%), Positives = 109/246 (44%), Gaps = 31/246 (12%)
Query: 280 AVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQYLK 338
A+K + SEE+ + E +++ + H +V++ G C K +Y + + NG L YL+
Sbjct: 32 AIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR 91
Query: 339 QLKWNERMDVAIG----VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394
Q + D+ + V + +EYL IHRD+ + N L+S ++SDFG
Sbjct: 92 QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSST-GVVKVSDFGMT 147
Query: 395 -MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452
V + S K PV + PE + K K DV+S+GV++ E+ T +
Sbjct: 148 RYVLDDEYTSSSGAKFPVK------WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
Query: 453 QTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT 512
K+N E + ++S G RL P+L E VM + C RPT
Sbjct: 202 FEKKSNYEVV-----EMISRG--FRLYRPKLASMTVYE----VMYS---CWHEKPEGRPT 247
Query: 513 MKTLLK 518
LL+
Sbjct: 248 FAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 79/274 (28%), Positives = 124/274 (45%), Gaps = 37/274 (13%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEE--EVLREVE-LLSSIKHENIVRIIG 314
IG G +VY+ G V AVK ++ T EE +L +++ +L S IV+ G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLK--WNERM--DVAIGVAKALEYLHHTCDPPIIHR 370
Y + I L++ L + LK+++ E + + + + KAL YL +IHR
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHR 139
Query: 371 DVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPEYM---- 424
DVK SNILL + + +L DFG + +V ++ S G Y+APE +
Sbjct: 140 DVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRS--------AGCAAYMAPERIDPPD 190
Query: 425 MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484
K D + DV+S G+ L+EL TG+ + K E +L+ L E N
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--------VLTKILQEEPPSLPPN 242
Query: 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
E ++ + V LCL +RP + LL+
Sbjct: 243 EGFSPDFCSFV----DLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 67/247 (27%), Positives = 121/247 (48%), Gaps = 35/247 (14%)
Query: 280 AVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE--MYAIVYNLLNGSLKQYL 337
A+K++K + SE+E + E +++ + HE +V++ G C +K+ +Y + + NG L YL
Sbjct: 32 AIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-TKQRPIYIVTEYMSNGCLLNYL 90
Query: 338 ----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393
K+ + ++ +++ V + + YL IHRD+ + N L+ + ++SDFG
Sbjct: 91 REHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQG-CVKVSDFGL 146
Query: 394 A-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKE 450
+ V + S K PV + PE ++Y K K DV+++GV++ E+ + GK
Sbjct: 147 SRYVLDDEYTSSVGSKFPVR------WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200
Query: 451 AIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRR 510
+ + N V +S GL RL P L E++ +M + C + R
Sbjct: 201 PYE--RFNNSETVE----KVSQGL--RLYRPHLAS----EKVYAIMYS---CWHEKAEER 245
Query: 511 PTMKTLL 517
PT + LL
Sbjct: 246 PTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 40/278 (14%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYC 316
++G G +VY+ HV GQ+AA+KV+ T EEE+ E+ +L H NI G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 317 -------HSKEMYAIVYNLLNGSLKQYLKQLKWNERMD--VAIGVAKALEYLHHTCDPPI 367
H +++ ++ GS+ +K K N + +A + L L H +
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKV 142
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV-VGTFGYLAPEYMMY 426
IHRD+K N+LL+EN +L DFG S Q+ V N +GT ++APE +
Sbjct: 143 IHRDIKGQNVLLTEN-AEVKLVDFGV------SAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 427 -----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481
D + D++S G+ +E+ G + R +L L R+ P
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-ALFLIPRN----------PPP 244
Query: 482 QL-NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+L +++++++ I+ + CL+ + RP+ + LLK
Sbjct: 245 KLKSKKWSKKFIDFI----EGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEE---EVLREVELLSSIKHENIVRIIGY 315
IGQG +V++ H Q+ A+K + N E LRE+++L +KHEN+V +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 316 CHSKEMYAIVYNLLNGSL-------KQYLKQLKWNERMDVAIGVAKA--------LEYLH 360
C +K A YN GS + L L N+ + + K L Y+H
Sbjct: 80 CRTK---ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
I+HRD+K++NIL++++ +L+DFG A S N + N V T Y
Sbjct: 137 RN---KILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPN-RYTNRVVTLWYRP 191
Query: 421 PEYMM----YGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
PE ++ YG ID++ G ++ E+ T +Q N
Sbjct: 192 PELLLGERDYGP---PIDMWGAGCIMAEMWTRSPIMQGN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 54/181 (29%), Positives = 93/181 (51%), Gaps = 24/181 (13%)
Query: 280 AVKVLKCT-NWSEEEVL-REVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T + SE E L E++++S + HENIV ++G C + I G L
Sbjct: 69 AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN 128
Query: 336 YLKQ-----LKWNERMDVAIGVAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
+L++ L + + + VAK + +L C IHRD+ + N+LL+ ++
Sbjct: 129 FLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHG-KIVKIC 183
Query: 390 DFGAA--MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446
DFG A +++ ++ V N + PV ++APE + + DV+SYG++L E+
Sbjct: 184 DFGLARDIMNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 447 T 447
+
Sbjct: 238 S 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKC---TNWSEEEVLREVELLSSIKHENIVRIIGY 315
IG+G VY+ + + G++ A+K +K + + LRE++LL + H NI++++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLH-HTCDPPIIHR 370
K +V+ ++ L + +K L + + + L + H H I+HR
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG----ILHR 122
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQS-----HQVSENVKPVNVVGTFGYLAPEYMM 425
D+K N+L++ +L+DFG A H V T Y APE ++
Sbjct: 123 DLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVV----------TRWYRAPELLL 171
Query: 426 YGKV-DEKIDVYSYGVVLLELITGK 449
K +D++S G + EL++ +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 253 NFSPKMLIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHEN 308
NF IG+G VY+ N + G+V A+K ++ +E +RE+ LL + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVA----IGVAKALEYLHHT-- 362
IV+++ H++ +V+ L+ LK++ MD + I + YL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKF---------MDASPLSGIPLPLIKSYLFQLLQ 111
Query: 363 ----CDP-PIIHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNV 412
C ++HRD+K N+L++ +L+DFG A V +H+V
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVV-------- 162
Query: 413 VGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGK 449
T Y APE ++ K +D++S G + E++T +
Sbjct: 163 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 260 IGQGGNSKVY----RTNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
IG G +V + A+K LK ++ + L E ++ H NI+R+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPII 368
G I+ + NGSL ++L+ + + + + G+A ++YL +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YV 128
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG------YLAPE 422
HRD+ + NIL++ N ++SDFG + + E+ + T G + APE
Sbjct: 129 HRDLAARNILVNSNLV-CKVSDFGLS-------RRLEDSEAT--YTTKGGKIPIRWTAPE 178
Query: 423 YMMYGKVDEKIDVYSYGVVLLELIT 447
+ Y K DV+S+G+V+ E+++
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRII-GYC 316
IGQG + VY V GQ A++ + ++E ++ E+ ++ K+ NIV + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L GSL + + +E A+ +ALE+LH +IHRD+KS
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKS 144
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
NILL + +L+DFG + E K +VGT ++APE + K+D
Sbjct: 145 DNILLGMD-GSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 435 VYSYGVVLLELITGK 449
++S G++ +E+I G+
Sbjct: 199 IWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 260 IGQGGNSKVYRTN-HVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC 316
IG+G +V+ D AVK + T + + L+E +L H NIVR+IG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 317 HSKEMYAIVYNLLNGS-----LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
K+ IV L+ G L+ +LK E + + A +EYL IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQV---SENVKPVNVVGTFGYLAPEYMMYGK 428
+ + N L++E + ++SDFG M + V + +K + V T APE + YG+
Sbjct: 120 LAARNCLVTEK-NVLKISDFG--MSREEEDGVYASTGGMKQIPVKWT----APEALNYGR 172
Query: 429 VDEKIDVYSYGVVLLE---LITGKEAIQTNKANRESL 462
+ DV+S+G++L E L A +N+ RE++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 34/203 (16%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGY 315
IG+G V++ N ++ A+K ++ + E LRE+ LL +KH+NIVR+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI------GVAKALEYLH-HTCDPPII 368
HS + +V+ + LK+Y N +D I + K L + H H ++
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN----VL 121
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAPEY 423
HRD+K N+L+++N +L+DFG A V S +V T Y P+
Sbjct: 122 HRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVV----------TLWYRPPDV 170
Query: 424 MMYGKV-DEKIDVYSYGVVLLEL 445
+ K+ ID++S G + EL
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 57/185 (30%), Positives = 98/185 (52%), Gaps = 23/185 (12%)
Query: 276 GQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIGYCHS---KEMYAIVYNLLN 330
G+ AVK LK + ++ +E+E+L ++ HENIV+ G C + I+ L +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 331 GSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386
GSLK+YL ++ +++ A+ + K ++YL +HRD+ + N+L+ E+ H
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLV-ESEHQV 148
Query: 387 QLSDFG---AAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVL 442
++ DFG A + + V +++ PV F Y APE ++ K DV+S+GV L
Sbjct: 149 KIGDFGLTKAIETDKEYYTVKDDLDSPV-----FWY-APECLIQSKFYIASDVWSFGVTL 202
Query: 443 LELIT 447
EL+T
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 54/198 (27%), Positives = 107/198 (54%), Gaps = 21/198 (10%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIG-YC 316
+G G KVY+ N G +AA KV++ + E E+ + E+E+L++ H IV+++G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 317 HSKEMYAIVYNLLNGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+++ ++ G++ + + L + + + +AL+YLH IIHRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDL 136
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV--- 429
K+ N+LL+ + +L+DFG + + ++ Q + + +GT ++APE +M +
Sbjct: 137 KAGNVLLTLD-GDIKLADFGVSAKNVKTLQ-----RRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 430 --DEKIDVYSYGVVLLEL 445
D K D++S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 65/232 (28%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
+G+G +VY+ + G+V A+K K +E++ LRE+++L +KH N+V +I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 314 G--YCHSKEMY---AIVYNL-------LNGSL------------KQYLKQLKWNERMDVA 349
+ VY + L+G L K Y+ QL
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL--------- 124
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENV 407
+ + YLH + I+HRD+K++NIL+ + L +DFG A + +
Sbjct: 125 ---LEGINYLH---ENHILHRDIKAANILID---NQGILKIADFGLARPYDGPPPNPKGG 175
Query: 408 KPV------NVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
N+V T Y PE ++ Y +D++ G V E+ T +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTT---AVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 33/204 (16%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRIIG 314
+G G +V H G+ A+K+L E VL E +L SI+H +V + G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 315 -YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV------AIGVAKALEYLHHTCDPPI 367
+ +Y ++ + G L +L++ + R A V ALEYLH D I
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS-LD--I 122
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-- 425
++RD+K N+LL + + +++DFG A V + GT YLAPE ++
Sbjct: 123 VYRDLKPENLLLDSD-GYIKITDFGFAKR------VKGRTY--TLCGTPEYLAPEIILSK 173
Query: 426 -YGKVDEKIDVYSYGVVLLELITG 448
YGK +D ++ G+++ E++ G
Sbjct: 174 GYGK---AVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 75/276 (27%), Positives = 128/276 (46%), Gaps = 47/276 (17%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHENIVRIIGY 315
+G+G +V H DG+ +K L N S E +E +LLS +KH NIV Y
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV---AY 64
Query: 316 CHSKE-----MYAIVYNLLNGSLKQYLKQLKW-----NERMDVAIGVAKALEYLHHTCDP 365
S E +Y ++ G L LK+ K N+ ++ + +A AL+YLH +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EK 121
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+HRD+K+ N+ L+ + ++ D G A V ++ + +GT Y++PE
Sbjct: 122 HILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTL-----IGTPYYMSPELFS 175
Query: 426 YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID---PQ 482
+ K DV++ G + E+ T K A N + SLV R+I+ P
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAF--NAKDMNSLVY------------RIIEGKLPP 221
Query: 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ ++Y+ E E++ L +RP++K++L+
Sbjct: 222 MPKDYSPELGELI----ATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 69/228 (30%), Positives = 115/228 (50%), Gaps = 29/228 (12%)
Query: 259 LIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWSEEEVLR---EVELLSSIKHENIVR 311
++GQG KV+ + GQ+ A+KVLK + +R E ++L+ + H IV+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 312 IIGYCHSKE--MYAIVYNLLNGSLKQYL-KQLKWNERMDVAIGVAK---ALEYLHHTCDP 365
+ Y E +Y I+ L G L L K++ + E DV +A+ AL++LH
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-DVKFYLAELALALDHLHSL--- 117
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
II+RD+K NILL E H +L+DFG + + H+ K + GT Y+APE
Sbjct: 118 GIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK-------KAYSFCGTVEYMAPEV 169
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS 471
+ + D +S+GV++ E++TG Q K +E++ + ++ L
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQ-GKDRKETMTMILKAKLG 216
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 30/205 (14%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE------VLREVELLSSIKHENIVR 311
L+G+G V + H + GQ+ A+K SE++ +RE+ +L ++HEN+V
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFL---ESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 312 IIGYCHSKEMYAIVYNLLNGS----LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
+I K+ +V+ ++ + L++Y L + + + +E+ H I
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NI 121
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-- 425
IHRD+K NIL+S++ +L DFG A +V + V T Y APE ++
Sbjct: 122 IHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVY-----TDYVATRWYRAPELLVGD 175
Query: 426 --YGKVDEKIDVYSYGVVLLELITG 448
YG+ +D+++ G ++ E++TG
Sbjct: 176 TKYGR---AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
IG+G VY+ + GQ+ A+K ++ SEEE +RE+ LL ++H NIV +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI------GVAKALEYLHHTCDPPI 367
+ +++ L+ LK+YL L + MD + + + + + H +
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
+HRD+K N+L+ +L+DFG A ++ + V VV T Y APE ++
Sbjct: 123 LHRDLKPQNLLIDNK-GVIKLADFGLA----RAFGIPVRVYTHEVV-TLWYRAPEVLLGS 176
Query: 428 -KVDEKIDVYSYGVVLLELITGK 449
+ +D++S G + E+ T K
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRII-GYC 316
IGQG + VY + GQ A+K + ++E ++ E+ ++ K+ NIV + Y
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L GSL + + +E A+ +AL++LH +IHRD+KS
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKS 143
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
NILL + +L+DFG + E K +VGT ++APE + K+D
Sbjct: 144 DNILLGMD-GSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 435 VYSYGVVLLELITGK 449
++S G++ +E++ G+
Sbjct: 198 IWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 44/219 (20%)
Query: 259 LIGQGGNSKVY-RTNHVDGQVAAVKVLKCTNWSE----------EEVLREVELLSSIKHE 307
LIG G VY N G++ AVK ++ + S + + RE+ LL ++HE
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 308 NIVRIIGYCHSKEMYAI---------VYNLLN--GSL-----KQYLKQLKWNERMDVAIG 351
NIV+ +G + I V LLN G+ + +++Q
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------------ 114
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPV 410
+ K L YLH+ IIHRD+K +NIL+ +N ++SDFG + + S N
Sbjct: 115 ILKGLNYLHNR---GIIHRDIKGANILV-DNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
++ G+ ++APE + K D++S G +++E++TGK
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 53/219 (24%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV------LREVELLSSIKHENIVR 311
+G+G + VY+ + G++ A+K +K E + LRE++LL +KH NI+
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 312 IIG-YCHSKEMYAIVYNLLNGSL----------------KQYLKQLKWNERMDVAIGVAK 354
++ + H + +V+ + L K Y+ +
Sbjct: 67 LLDVFGHKSNIN-LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMT------------LR 113
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
LEYLH I+HRD+K +N+L++ + +L+DFG A S N K + V
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASD-GVLKLADFGLARSF-----GSPNRKMTHQVV 164
Query: 415 TFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
T Y APE + YG +D++S G + EL+
Sbjct: 165 TRWYRAPELLFGARHYGV---GVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 34/267 (12%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE-----EEVLREVELLSSIKHENIVRIIG 314
IG+G +V++ +D + V +K + E E++ +E+ +LS + + G
Sbjct: 12 IGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 315 -YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRD 371
Y +++ I+ L GS L+ +E I + K L+YLH IHRD
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRD 126
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
+K++N+LLSE+ +L+DFG A +K VGT ++APE + D
Sbjct: 127 IKAANVLLSEH-GEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 432 KIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREE 491
K D++S G+ +EL G E + + L L ++ P L Y++
Sbjct: 181 KADIWSLGITAIELAKG-EPPHSELHPMKVLFLIPKN----------NPPTLEGNYSKPL 229
Query: 492 IEIVMCAARLCLLHSSSRRPTMKTLLK 518
E V CL S RPT K LLK
Sbjct: 230 KEFV----EACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 91/329 (27%), Positives = 133/329 (40%), Gaps = 66/329 (20%)
Query: 257 KMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLR---EVELLSSIKHENIVRI 312
++G G V V DG+ AVKV+ SE + R EV L + +IV+
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK- 95
Query: 313 IGYCH------------SKEMYAIVYNLLN-GSLKQYLKQLKWNERM----DVAIGVAKA 355
CH + M A+V + N G L+Q +K R + + +
Sbjct: 96 ---CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L +HH +IHRD+KS+NILL N +L DFG + VS++V GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFG--FSKMYAATVSDDVGR-TFCGT 208
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475
Y+APE +K D++S GV+L EL+T K + E++ ++ L
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-----DGENM----EEVMHKTLA 259
Query: 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLL-----KLF---------- 520
R DP L + E EIV A L RRP+ LL KLF
Sbjct: 260 GRY-DP-LPPSISPEMQEIV--TALLS--SDPKRRPSSSKLLNMPICKLFISGLLEIVQT 313
Query: 521 -------QEPDYWLKMKREKEELLNERRS 542
++++ K+ L ERR
Sbjct: 314 QPGFSGPLRDTISRQIQQTKQLLQVERRR 342
|
Length = 496 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVL----REVELLSSIKHENIVRIIG 314
IG G VY+ H G++ A+KV+ + E+ V RE+E+L + H N+V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 315 -YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
+ H+ E+ ++ + GSL+ +E+ DVA + + YLH I+HRD
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE---GTHIADEQFLADVARQILSGIAYLHRR---HIVHRD 193
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEY----MMY 426
+K SN+L++ + +++DFG + + Q+ + P N VGT Y++PE + +
Sbjct: 194 IKPSNLLINSA-KNVKIADFGVSRILAQT------MDPCNSSVGTIAYMSPERINTDLNH 246
Query: 427 GKVDEKI-DVYSYGVVLLELITGK 449
G D D++S GV +LE G+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEE----EVLREVELLSSIKHENIVRIIG 314
+G+G + VY+ N G++ A+K + +EE +RE+ L+ +KHENIVR+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLK------QLKWNERMDVAIGVAKALEYLHHTCDPPII 368
H++ +V+ ++ LK+Y+ L N + K + + H + ++
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVL 122
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+K N+L+++ +L+DFG A ++ + N VV T Y AP+ ++ +
Sbjct: 123 HRDLKPQNLLINKR-GELKLADFGLA----RAFGIPVNTFSNEVV-TLWYRAPDVLLGSR 176
Query: 429 V-DEKIDVYSYGVVLLELITGK 449
ID++S G ++ E+ITG+
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 257 KMLIGQGGNSKVYRTNHVDGQVA-AVKVLKCTNWSEEEVL-REVELLSSIKHENIVRIIG 314
++++G+G VY + QV A+K + + + L E+ L S +KH NIV+ +G
Sbjct: 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 315 YCHSKEMYAI-VYNLLNGSLKQYLKQ----LKWNERMDVAIG--VAKALEYLHHTCDPPI 367
+ I + + GSL L+ LK NE+ + + + L+YLH D I
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQI 129
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
+HRD+K N+L++ ++SDFG + + +E GT Y+APE + G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-----GTLQYMAPEVIDKG 184
Query: 428 K--VDEKIDVYSYGVVLLELITGK 449
D++S G ++E+ TGK
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 35/213 (16%)
Query: 260 IGQGGNSKVYR-------TNHVDGQVAAVKVLKCTNWSEE-EVLREVELLSSIKHENIVR 311
+GQG VY + +VA V + + E E L E ++ ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 312 IIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNER-------------MDVAIGVAKALE 357
++G + + +V L+ G LK YL+ + + +A +A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK---PVNVVG 414
YL +HRD+ + N +++E+ ++ DFG +++ + K PV
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLT-VKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++APE + G K DV+S+GVVL E+ T
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 54/187 (28%), Positives = 94/187 (50%), Gaps = 21/187 (11%)
Query: 271 TNHVDGQVAAVKVLK---CTNWSEEEVLREVELLSSIKHENIVRI--IGYCHSKEMYAIV 325
+ + GQ A+K + T + RE++LL ++HENI+ + I +++Y V
Sbjct: 30 RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY-FV 88
Query: 326 YNLLNGSLKQYLKQLKWNERMD--VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383
LL L + L ++ + + L+Y+H ++HRD+K SNIL++EN
Sbjct: 89 TELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENC 145
Query: 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVL 442
++ DFG A + Q Q++ V T Y APE M+ + K D ++D++S G +
Sbjct: 146 DL-KICDFGLARI--QDPQMT------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIF 196
Query: 443 LELITGK 449
E++ GK
Sbjct: 197 AEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 22/225 (9%)
Query: 251 THNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIK 305
NF + IG+G S VY+ +DG+V A+K ++ + ++ L+E++LL +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 306 HENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM-------DVAIGVAKALE 357
H N+++ + IV L + G L + +K K +R+ + + ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
++H I+HRD+K +N+ ++ +L D G S+ ++VGT
Sbjct: 121 HMHSK---RIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-----SKTTAAHSLVGTPY 171
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
Y++PE + + K D++S G +L E+ + +K N SL
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 60/242 (24%), Positives = 106/242 (43%), Gaps = 41/242 (16%)
Query: 228 EKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVA--AVKVLK 285
+ L +E G +F LC Q + K + N AVKVL+
Sbjct: 5 QPLNFVEKLGE-GQFGEVHLCE---ADGL-----QDFSEKAFAENDNADAPVLVAVKVLR 55
Query: 286 CTNWSE--EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV-YNLLNGSLKQYL----- 337
E+ L+EV++LS + NI R++G C ++ + NG L Q+L
Sbjct: 56 PDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVA 115
Query: 338 ---------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388
K L ++ + +A +A + YL +HRD+ + N L+ +N+ ++
Sbjct: 116 ETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNY-TIKI 171
Query: 389 SDFGAAMVHHQS--HQVSEN-VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
+DFG + + S ++V P+ ++A E ++ GK K DV+++GV L E+
Sbjct: 172 ADFGMSRNLYSSDYYRVQGRAPLPIR------WMAWESVLLGKFTTKSDVWAFGVTLWEI 225
Query: 446 IT 447
+T
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 7e-13
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
+G+G + VY+ + V+G++ A+KV++ EEE +RE LL +KH NIV +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRL---QEEEGTPFTAIREASLLKGLKHANIVLLH 69
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD----VAIGVAKALEYLHHTCDPPIIH 369
H+KE +V+ ++ L QY+ + + + + L Y+H I+H
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILH 126
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHH-QSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
RD+K N+L+S+ +L+DFG A SH S N V T Y P+ ++ G
Sbjct: 127 RDLKPQNLLISDT-GELKLADFGLARAKSVPSHTYS------NEVVTLWYRPPDVLL-GS 178
Query: 429 VDEK--IDVYSYGVVLLELITGKEAIQTNKANRESL 462
+ +D++ G + +E+I G A K ++ L
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL 214
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 8e-13
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRI 312
IG G V + G+ A+K K +N ++ +LRE++LL ++HENI+ +
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 313 I------GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEYLH 360
+ ++Y IV L+ L + +K + + + + L+YLH
Sbjct: 65 LDILRPPSPEDFNDVY-IVTELMETDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLH 120
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLS--DFGAAMVHHQSHQVSENVKPVNV---VGT 415
+ + +IHRD+K SNIL++ N L DFG A + + + V T
Sbjct: 121 -SAN--VIHRDLKPSNILVNSNC---DLKICDFGLARG-----VDPDEDEKGFLTEYVVT 169
Query: 416 FGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
Y APE ++ + + ID++S G + EL+T K
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 37/228 (16%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE------VLREVELLSSIKHENIVRI 312
IG+G V++ + + GQ+ A+K K SE++ LRE+ +L +KH N+V +
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK--KFVE-SEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 313 IGYCHSKEMYAIV-----YNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLH-HTCDPP 366
I K +V + +LN L++ + + + + +A+ + H H C
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLN-ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
IHRDVK NIL+++ +L DFG A ++ ++ V T Y APE ++
Sbjct: 122 -IHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTD------YVATRWYRAPELLV 173
Query: 426 ----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL 469
YG +DV++ G V EL+TG + + K++ + L L ++L
Sbjct: 174 GDTQYGP---PVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 25/200 (12%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-----ENIVRII 313
I +G VY G A+KVLK ++ + + V+ +I + ++
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 314 GYCHSKEMYAIVYNLLNG----SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
SK+ +V LNG SL + L L + V +E LH IIH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIH 120
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGK 428
RD+K N+L+ + H +L+DFG +S N + VGT YLAPE ++
Sbjct: 121 RDIKPENLLIDQT-GHLKLTDFG----------LSRNGLENKKFVGTPDYLAPETILGVG 169
Query: 429 VDEKIDVYSYGVVLLELITG 448
D+ D +S G V+ E + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 254 FSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEE---EVLREVELLSSIK---H 306
+ P IG G VY+ G A+K ++ + +REV LL ++ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 307 ENIVRIIGYCHSKEM-----YAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKAL 356
NIVR++ C + +V+ ++ L+ YL + L D+ + L
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
++LH C I+HRD+K NIL++ +L+DFG A ++ S Q++ + PV V T
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSG-GQVKLADFGLARIY--SCQMA--LTPVVV--TL 171
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y APE ++ +D++S G + E+ K
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 259 LIGQGGNSKVYRTNHVDG----QVAAVKVL-KCTNWSE-EEVLREVELLSSIKHENIVRI 312
+IG+G VY +D AVK L + T+ E E+ L+E ++ H N++ +
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 313 IGYCHSKEMYAIVY--NLLNGSLKQYLKQLKWNERMDVAIG----VAKALEYLHHTCDPP 366
+G C E +V + +G L+ +++ N + IG VAK +EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKK 118
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA--------MVHHQSHQVSENVKPVNVVGTFGY 418
+HRD+ + N +L E+F +++DFG A H VK +
Sbjct: 119 FVHRDLAARNCMLDESFT-VKVADFGLARDIYDKEYYSVHNHTGAKLPVK---------W 168
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+A E + K K DV+S+GV+L EL+T
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 35/220 (15%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRI- 312
IG+G +VY+ + G++ A+K ++ N E+E +RE+++L + H NIV +
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDN--EKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 313 ---------IGYCHSKEMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHH 361
+ + K + +V+ ++ L L+ + ++E + + + LE L++
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-HIKSFMKQLLEGLNY 131
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP-VNVVGTFGYLA 420
+HRD+K SNILL+ N +L+DFG A +++ SE +P N V T Y
Sbjct: 132 CHKKNFLHRDIKCSNILLN-NKGQIKLADFGLARLYN-----SEESRPYTNKVITLWYRP 185
Query: 421 PEYM----MYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
PE + YG IDV+S G +L EL T K Q N+
Sbjct: 186 PELLLGEERYGPA---IDVWSCGCILGELFTKKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 39/210 (18%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIK---HENIV 310
IG+G VY+ + G+ A+K ++ SEE + LRE+ LL ++ H NIV
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 311 RIIGYCHSKEMY-----AIVYNLLNGSLKQYL----------KQLKWNERMDVAIGVAKA 355
R++ CH +V+ ++ L YL + +K D+ + +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK-----DLMRQLLRG 119
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
+++LH I+HRD+K NIL++ + +++DFG A ++ S + +VV T
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSD-GQVKIADFGLARIY------SFEMALTSVVVT 169
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
Y APE ++ +D++S G + EL
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEE----EVLREVELLSS 303
+ + IG+G V T+ G A+K K + + + LRE+++L
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KISPFEHQTFCQRTLREIKILRR 59
Query: 304 IKHENIVRI------IGYCHSKEMYAIVYNLLNGSLKQYLK-QLKWNERMDVAI-GVAKA 355
KHENI+ I + ++Y IV L+ L + +K Q N+ + + + +
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVY-IVQELMETDLYKLIKTQHLSNDHIQYFLYQILRG 118
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L+Y+ H+ + ++HRD+K SN+LL+ N ++ DFG A + H + + V T
Sbjct: 119 LKYI-HSAN--VLHRDLKPSNLLLNTNCDL-KICDFGLARIADPEHDHTGFL--TEYVAT 172
Query: 416 FGYLAPEYMMYGKVDEK-IDVYSYGVVLLELITGK 449
Y APE M+ K K ID++S G +L E+++ +
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 72/282 (25%), Positives = 120/282 (42%), Gaps = 46/282 (16%)
Query: 253 NFSPKMLIGQG--GNSKVYRTNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHE 307
++ P ++G+G G + +YR D + K + T SE+E L E+ +LS ++H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 308 NIVRIIGYCHSKEMYAIVYNLLNG-SLKQYL---KQLKWNERM--DVAIGVAKALEYLHH 361
NI+ + I NG +L + K + E M + A+ Y+H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 362 TCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
I+HRD+K+ NI L++ +L DFG + + + ++E V VGT Y++
Sbjct: 120 A---GILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMAETV-----VGTPYYMS 169
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ-TNKANRESLVLWARSLLSSGLCERLI 479
PE K + K D+++ G VL EL+T K TN N L +++
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---------------LVVKIV 214
Query: 480 D---PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ Y+ E I +V L +RPT +L
Sbjct: 215 QGNYTPVVSVYSSELISLV----HSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 38/227 (16%)
Query: 252 HNFSPKMLIGQGGNSKVYRTN------HVDGQVAAVKVLK-CTNWSEEEVLREVELLSSI 304
HN K +G+G KV+ D + AVK LK ++ + ++ RE ELL+++
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 305 KHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK----------------QLKWNERMD 347
+HE+IV+ G C + +V+ + +G L ++L+ +L ++ +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV---S 404
+A +A + YL +HRD+ + N L+ EN ++ DFG + + +
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLL-VKIGDFGMSRDVYSTDYYRVGG 180
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKE 450
+ P+ ++ PE +MY K + DV+S GVVL E+ T GK+
Sbjct: 181 HTMLPIR------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 253 NFSPKMLIGQGGNSKVYR----TNHVDGQVAAVKVLKCTNW-----SEEEVLREVELLSS 303
NF ++G G KV+ + H G++ A+KVLK + E E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 304 IKHENIVRIIGYCHSKE--MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK---ALEY 358
I+ + + Y + ++ I+ + G L +L Q + + +V I + ALE+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH II+RD+K NILL N H L+DFG + H+ E + + GT Y
Sbjct: 121 LHKL---GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHE----DEVERAYSFCGTIEY 172
Query: 419 LAPEYMMYGKV--DEKIDVYSYGVVLLELITG 448
+AP+ + G D+ +D +S GV++ EL+TG
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 30/191 (15%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T+ +++ E+E++ I KH+NI+ ++G C +Y +V G+L++
Sbjct: 48 AVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLRE 107
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
YL+ QL + + + A VA+ +EYL IHRD+ + N
Sbjct: 108 YLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARN 164
Query: 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVY 436
+L++E+ + +++DFG A H + K N ++APE + + DV+
Sbjct: 165 VLVTED-NVMKIADFGLA---RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 437 SYGVVLLELIT 447
S+GV+L E+ T
Sbjct: 221 SFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 255 SPKMLIGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHEN 308
+ IG+G VY+ + + ++A AVK K + E+ L+E ++ H +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGV------AKALEYLHHT 362
IV++IG ++ ++ G L+ YL+ K +D+A + + AL YL
Sbjct: 69 IVKLIGVITENPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK 126
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVK-PVNVVGTFGYLA 420
+HRD+ + N+L+S +L DFG + + +S+ + K P+ ++A
Sbjct: 127 ---RFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDESYYKASKGKLPIK------WMA 176
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLE-LITGKEAIQ 453
PE + + + DV+ +GV + E L+ G + Q
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEE--VLREVEL-LSSIKHENIVRIIGY 315
+G+G V + HV G + AVK ++ T S+E+ +L ++++ + S+ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQ-LKWNERM------DVAIGVAKALEYLHHTCDPPII 368
+ I +++ SL ++ K+ + +A+ + KALEYLH +I
Sbjct: 69 LFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VI 126
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY----M 424
HRDVK SN+L++ N +L DFG + + V K ++ G Y+APE +
Sbjct: 127 HRDVKPSNVLINRN-GQVKLCDFGIS-----GYLVDSVAKTID-AGCKPYMAPERINPEL 179
Query: 425 MYGKVDEKIDVYSYGVVLLELITGK 449
D K DV+S G+ ++EL TG+
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIG 314
+G+GG +V G++ A K L E+ L E ++L + IV +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 315 YCHSKEMYAIVYNLLNG-SLKQYLKQLKWNER-------MDVAIGVAKALEYLHHTCDPP 366
+K+ +V L+NG LK ++ + E + A + LE+LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---R 115
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
I++RD+K N+LL ++ + ++SD G A+ ++ K GT GY+APE +
Sbjct: 116 IVYRDLKPENVLLDDH-GNVRISDLGLAV------ELKGGKKIKGRAGTPGYMAPEVLQG 168
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
D +D ++ G L E+I G+ + K E
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 14/193 (7%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR-EVELLSSIKHENIVRIIG-YC 316
IG G VY+ +V+ G++AA+KV+K + V++ E+ ++ KH NIV G Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
+++ + GSL+ +A + L+ L++ +HRD+K +N
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGAN 136
Query: 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMY---GKVDEK 432
ILL++N H +L+DFG S Q++ + K + +GT ++APE G ++
Sbjct: 137 ILLTDN-GHVKLADFGV------SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189
Query: 433 IDVYSYGVVLLEL 445
D+++ G+ +EL
Sbjct: 190 CDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 40/224 (17%)
Query: 257 KMLIGQGGNSKVYRTN------HVDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENI 309
K +G+G KV+ D + AVK LK + S ++ RE ELL+ ++H++I
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLK------------------QLKWNERMDVAI 350
VR G C +V+ + +G L ++L+ QL + + +A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQV-SENV 407
+A + YL +HRD+ + N L+ + ++ DFG + + ++V +
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKE 450
P+ ++ PE ++Y K + D++S+GVVL E+ T GK+
Sbjct: 186 LPIR------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 21/195 (10%)
Query: 261 GQGGNSK--VYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGY 315
G G K +Y+ + + AVK+LK N +E+LRE ++ + + IVR+IG
Sbjct: 6 GNFGTVKKGMYKMKKSE-KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGI 64
Query: 316 CHSKEMYAIVYNLLN-GSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
C + E + +V L G L ++L K + ++ V+ ++YL T +HRD
Sbjct: 65 CEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRD 120
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF--GYLAPEYMMYGKV 429
+ + N+LL H+ ++SDFG + ++ EN G + + APE M Y K
Sbjct: 121 LAARNVLLVTQ-HYAKISDFGLS----KALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 430 DEKIDVYSYGVVLLE 444
K DV+S+GV++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 55/198 (27%), Positives = 105/198 (53%), Gaps = 21/198 (10%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRII-GYC 316
+G G KVY+ N G +AA KV+ + E E+ + E+++L+S H NIV+++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERM----DVAIGVAKALEYLHHTCDPPIIHRDV 372
+ ++ ++ G++ + +L ER + + + LE L++ + IIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK---- 428
K+ NIL + + +L+DFG + + ++ Q + + +GT ++APE +M
Sbjct: 130 KAGNILFTLD-GDIKLADFGVSAKNTRTIQRRD-----SFIGTPYWMAPEVVMCETSKDR 183
Query: 429 -VDEKIDVYSYGVVLLEL 445
D K DV+S G+ L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
+G+G + VY+ + + GQ+ A+K ++ EE +RE LL +KH NIV +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRL---EHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
H+K+ +V+ L+ LKQY+ L + + + L Y H ++H
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLH 126
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHH-QSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
RD+K N+L+SE +L+DFG A S S N V T Y P+ ++ G
Sbjct: 127 RDLKPQNLLISER-GELKLADFGLARAKSVPSKTYS------NEVVTLWYRPPDVLL-GS 178
Query: 429 VD--EKIDVYSYGVVLLELITG 448
+ +D++ G + E+ TG
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 50/237 (21%), Positives = 98/237 (41%), Gaps = 41/237 (17%)
Query: 253 NFSPKMLIGQGGNSKVYRTN------HVDGQVAAVKVLKCT--NWSEEEVLREVELLSSI 304
N +G+G +V+ + VK L+ T + E RE+++ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 305 KHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYL------------KQLKWNERMDVAIG 351
H+N+VR++G C E + ++ + G LKQ+L L +++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFH----HPQLSD--FGAAMVHHQSHQVSE 405
+A +++L + +HRD+ + N L+S LS + + ++ +
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-- 180
Query: 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
P+ +LAPE + K DV+S+GV++ E+ T E ++ E L
Sbjct: 181 ---PLR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 72/293 (24%), Positives = 133/293 (45%), Gaps = 44/293 (15%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVA----AVKVLKCTNWSEE--EVLREVELLSSIKHENIVR 311
++G G VY+ V +G+ A+K+L T + E + E +++S+ H ++VR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWN----ERMDVAIGVAKALEYLHHTCDPPI 367
++G C S + + + +G L Y+ + K N ++ + +AK + YL + +
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRL 130
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMV---HHQSHQVSENVKPVNVVGTFGYLAPEYM 424
+HRD+ + N+L+ ++ +H +++DFG A + + + P+ ++A E +
Sbjct: 131 VHRDLAARNVLV-KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------WMALECI 183
Query: 425 MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484
Y K + DV+SYGV + EL+T RE LL G ERL P +
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-----IPDLLEKG--ERLPQPPIC 236
Query: 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELL 537
I++ M + C + + RP K L F +M R+ + L
Sbjct: 237 ------TIDVYMVMVK-CWMIDADSRPKFKELAAEFS------RMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 36/194 (18%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T +++ E+E++ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 54 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 113
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
YL+ QL + + + A VA+ +EYL IHRD+ + N
Sbjct: 114 YLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 170
Query: 377 ILLSENFHHPQLSDFGAAM-VHHQSH--QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKI 433
+L++E+ + +++DFG A +HH + + + PV ++APE + +
Sbjct: 171 VLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQS 223
Query: 434 DVYSYGVVLLELIT 447
DV+S+GV+L E+ T
Sbjct: 224 DVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 44/205 (21%)
Query: 268 VYRTNHVD-GQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRIIGYCHSKEM 321
VYR G++ A+K LK E+E LRE+ +L ++H NIV + KE+
Sbjct: 21 VYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHPNIVTV------KEV 72
Query: 322 YA--------IVYNLLNGSLKQYLKQLKWN----ERMDVAIGVAKALEYLHHTCDPPIIH 369
+V + LK ++ +K E + + + + +LH D I+H
Sbjct: 73 VVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILH 129
Query: 370 RDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPV--NVVGTFGYLAPEYMM 425
RD+K+SN+LL+ + L DFG A + +KP VV T Y APE ++
Sbjct: 130 RDLKTSNLLLN---NRGILKICDFGLA------REYGSPLKPYTQLVV-TLWYRAPELLL 179
Query: 426 YGKV-DEKIDVYSYGVVLLELITGK 449
K ID++S G + EL+T K
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 9e-12
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 259 LIGQGGNSKVY----RTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRII- 313
++G+G V+ + + + + V + T E ++L + H NI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD---VAIGVAKALEYLHHTCDPPIIHR 370
+ K + ++ G+L +Y+++ + N +D + + L LHH I+HR
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+K+ NILL ++ ++ DFG S +S K VVGT Y++PE +
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGI------SKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
+K D+++ G VL EL + K A + AN +LVL
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEA--ANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 46/162 (28%), Positives = 71/162 (43%), Gaps = 26/162 (16%)
Query: 295 LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK 354
L E LL ++ H +++R+ S + +V + L YL + +D A+ + K
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 355 A----LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
L YLH IIHRDVK+ NI + + + D GAA PV
Sbjct: 165 QILEGLRYLHAQ---RIIHRDVKTENIFI-NDVDQVCIGDLGAAQF------------PV 208
Query: 411 N------VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446
+ GT APE + K + K D++S G+VL E++
Sbjct: 209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 259 LIGQGGNSKVYRTN-HVDGQ---VAAVKVLKC--TNWSEEEVLREVELLSSIKHENIVRI 312
+IG G +V+R + G+ A+K LK T ++ L E ++ H NI+R+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 313 IGYCHS-KEMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPI 367
G K I + NG+L +YL+ + + + + G+A ++YL D
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNY 128
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ----SHQVSENVKPVNVVGTFGYLAPEY 423
+HRD+ + NIL++ N ++SDFG + V ++ S P+ + APE
Sbjct: 129 VHRDLAARNILVNSNLE-CKVSDFGLSRVLEDDPEGTYTTSGGKIPIR------WTAPEA 181
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
+ Y K DV+S+G+V+ E+++ E + +N E
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 38/195 (19%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T+ +++ E+EL+ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 48 AVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLRE 107
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYLH-HTCDPPIIHRDVKSS 375
+L+ QL + + + A VA+ +EYL C IHRD+ +
Sbjct: 108 FLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAAR 163
Query: 376 NILLSENFHHPQLSDFGAAM-VHHQSH--QVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
N+L++E+ + +++DFG A VH + + S PV ++APE + +
Sbjct: 164 NVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVK------WMAPEALFDRVYTHQ 216
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G+++ E+ T
Sbjct: 217 SDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 52/191 (27%), Positives = 94/191 (49%), Gaps = 30/191 (15%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T +++ E+E++ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 51 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
YL+ Q+ + + + VA+ +EYL IHRD+ + N
Sbjct: 111 YLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARN 167
Query: 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVY 436
+L++EN + +++DFG A + + K N ++APE + + DV+
Sbjct: 168 VLVTEN-NVMKIADFGLA---RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223
Query: 437 SYGVVLLELIT 447
S+GV++ E+ T
Sbjct: 224 SFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 259 LIGQGGNSKVYRTNHVDG----QVAAVKVLK----CTNWSEEEVLR-EVELLSSIKHENI 309
++G+GG KV++ V G ++ A+KVLK N + + E +L ++KH I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 310 VRII-GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM---DVAI----GVAKALEYLHH 361
V +I + ++Y I+ L G L +L++ E + D A ++ ALE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ 118
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
II+RD+K NILL H +L+DFG + E GT Y+AP
Sbjct: 119 Q---GIIYRDLKPENILLDAQ-GHVKLTDFGLC-----KESIHEGTVTHTFCGTIEYMAP 169
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELITG 448
E +M + +D +S G ++ +++TG
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 260 IGQGGNSKVYRTN-HVDG----QVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRI 312
+G+ K+Y+ + ++ G Q+ A+K LK N ++ E +E L++ + H NIV +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 313 IGYCHSKEMYAIVYNLLN-GSLKQYL--------------------KQLKWNERMDVAIG 351
+G ++ +++ LN G L ++L L + + +AI
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+A +EYL +H+D+ + NIL+ E H ++SD G + + + V+P
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLH-VKISDLGLSREIYSADYY--RVQP-K 185
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ ++ PE +MYGK D++S+GVVL E+ +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 41/225 (18%)
Query: 257 KMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENI 309
K +G+G KV+ D + AVK LK + ++ RE ELL++++HE+I
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLK-------------------QLKWNERMDVA 349
V+ G C + +V+ + +G L ++L+ +L ++ + +A
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS--HQVS-EN 406
+A + YL +HRD+ + N L+ N ++ DFG + + + ++V
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLL-VKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKE 450
+ P+ ++ PE +MY K + DV+S+GV+L E+ T GK+
Sbjct: 186 MLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKC----TNWSEEEVLREVELLSSIKHEN---IV 310
+IG+GG +VY D G++ A+K L E L E +LS + + IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 311 RIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
+ H+ + + +L+NG L +L Q ++ + + L H + +++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
RD+K +NILL E+ H ++SD G A + KP VGT GY+APE + G
Sbjct: 121 RDLKPANILLDEH-GHVRISDLGLACDFSKK-------KPHASVGTHGYMAPEVLQKGTA 172
Query: 430 -DEKIDVYSYGVVLLELITGKEAIQTNK 456
D D +S G +L +L+ G + +K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 21/192 (10%)
Query: 280 AVKVLKC--TNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQY 336
A+K LK T + L E ++ H NI+ + G SK + + + NGSL +
Sbjct: 36 AIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF 95
Query: 337 LK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392
L+ Q + + + G+A ++YL D +HRD+ + NIL++ N ++SDFG
Sbjct: 96 LRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLV-CKVSDFG 151
Query: 393 AAMVHHQSHQVSENVK----PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
+ V + + + P+ + APE + Y K DV+SYG+V+ E+++
Sbjct: 152 LSRVLEDDPEAAYTTRGGKIPIR------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 205
Query: 449 KEAIQTNKANRE 460
E +N++
Sbjct: 206 GERPYWEMSNQD 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKC----TNWSEEEVLREVELLSSIKHEN---IV 310
+IG+GG +VY D G++ A+K L E L E +LS + + IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 311 RIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
+ H+ + + + +L+NG L +L Q ++ A+ + L H + +++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-K 428
RD+K +NILL E H ++SD G A + KP VGT GY+APE + G
Sbjct: 121 RDLKPANILLDE-HGHVRISDLGLACDFSKK-------KPHASVGTHGYMAPEVLQKGVA 172
Query: 429 VDEKIDVYSYGVVLLELITGKEAIQTNKA 457
D D +S G +L +L+ G + +K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHE 307
NF + IG+G S+VYR + DG A+K ++ + + + ++E++LL + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 308 NIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM-------DVAIGVAKALEYL 359
N+++ IV L + G L + +K K +R+ + + ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
H ++HRD+K +N+ ++ +L D G S+ ++VGT Y+
Sbjct: 123 HSR---RVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-----SKTTAAHSLVGTPYYM 173
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462
+PE + + K D++S G +L E+ + +K N SL
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 31/204 (15%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYC 316
+G G V + H+ G V A KV+ S +++LRE++++ + IV G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 317 HSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDV----AIGVAKALEYL---HHTCDPPII 368
++ + ++ GSL + K+ +++ A+ V + L YL H I+
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR-----IM 126
Query: 369 HRDVKSSNILLSENFH-HPQLSDFGAAMVHHQSHQVSENVKPV--NVVGTFGYLAPEYMM 425
HRD+K SNIL+ N +L DFG + E + + VGT Y++PE +
Sbjct: 127 HRDIKPSNILV--NSRGQIKLCDFGVS---------GELINSIADTFVGTSTYMSPERIQ 175
Query: 426 YGKVDEKIDVYSYGVVLLELITGK 449
GK K DV+S G+ ++EL GK
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
+G G VY+ H+ ++ AVKV L T +++++ E+E+L I+ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 317 HSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSS 375
+ +I ++G SL Y +++ + +A+ V K L YL I+HRDVK S
Sbjct: 69 FVENRISICTEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPS 124
Query: 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDV 435
N+L++ +L DFG S Q+ ++ VGT Y+APE + + DV
Sbjct: 125 NMLVNTR-GQVKLCDFGV------STQLVNSIAK-TYVGTNAYMAPERISGEQYGIHSDV 176
Query: 436 YSYGVVLLELITGKEAIQTNKANRESLV 463
+S G+ +EL G+ + N+ SL+
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSLM 204
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 260 IGQGGNSKVY--RTNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRI 312
+G+G + VY R+ D VA LK EE +REV LL +KH NIV +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVA----LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM-DVAIGVAKALEYLHHTCDPPIIHRD 371
H+++ +V+ L+ LKQYL + M +V + + + L L++ ++HRD
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD- 430
+K N+L++E +L+DFG A + N V T Y P+ ++ G D
Sbjct: 130 LKPQNLLINER-GELKLADFGLARAKSIPTKTYS-----NEVVTLWYRPPDILL-GSTDY 182
Query: 431 -EKIDVYSYGVVLLELITGK 449
+ID++ G + E+ TG+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 47/176 (26%), Positives = 86/176 (48%), Gaps = 22/176 (12%)
Query: 280 AVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
A+KVLK N +E++RE E++ + + IVR+IG C ++ + ++ G L ++L
Sbjct: 26 AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL 85
Query: 338 KQLKWNERMDVAIGVAKALEYLHHTC-------DPPIIHRDVKSSNILLSENFHHPQLSD 390
K I V+ +E +H +HRD+ + N+LL N H+ ++SD
Sbjct: 86 SGKK------DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV-NQHYAKISD 138
Query: 391 FGAAMVHHQSHQVSENVKPVNVVGTF--GYLAPEYMMYGKVDEKIDVYSYGVVLLE 444
FG + ++ ++ G + + APE + + K + DV+SYG+ + E
Sbjct: 139 FGLS----KALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 65/284 (22%), Positives = 128/284 (45%), Gaps = 42/284 (14%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHE 307
NF + IG+G S+VYR T +D + A+K ++ + ++ ++E++LL + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 308 NIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM-------DVAIGVAKALEYL 359
N+++ + IV L + G L Q +K K +R+ + + A+E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
H ++HRD+K +N+ ++ +L D G S+ ++VGT Y+
Sbjct: 123 HSR---RVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-----SKTTAAHSLVGTPYYM 173
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL- 478
+PE + + K D++S G +L E+ + +K N L S LC+++
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------LFS--LCQKIE 221
Query: 479 ---IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519
P E Y+ + E+V +C+ +RP + + ++
Sbjct: 222 QCDYPPLPTEHYSEKLRELV----SMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK---CTNWSEEE-VLREVELLSSIKHENIVRII- 313
+G GG +V + A+K +K ++E + E E+L H IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQL----KWNERMDVAIGVAKALEYLHHTCDPPIIH 369
+ K +Y ++ L G L L+ ++ R +A V A EYLH+ II+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHNR---GIIY 116
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
RD+K N+LL N + +L DFG A ++ K GT Y+APE ++
Sbjct: 117 RDLKPENLLLDSN-GYVKLVDFGFA------KKLKSGQKTWTFCGTPEYVAPEIILNKGY 169
Query: 430 DEKIDVYSYGVVLLELITGK 449
D +D +S G++L EL+TG+
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 37/209 (17%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
IG+G VY+ + G++ A+K ++ +E+E +RE+ LL + H NIVR++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE--TEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDP-------P 366
HS+ +V+ L+ LK+Y+ + YL+
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSP-----LTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAP 421
++HRD+K N+L+ +L+DFG A V +H+V T Y AP
Sbjct: 120 VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVV----------TLWYRAP 168
Query: 422 EYMMYGK-VDEKIDVYSYGVVLLELITGK 449
E ++ + +D++S G + E++ +
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 18/231 (7%)
Query: 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENI 309
+F +G G V + H G + A K+ L+ +++RE+++L I
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 310 VRIIGYCHSK-EMYAIVYNLLNGSLKQYLKQLK-WNERM--DVAIGVAKALEYLHHTCDP 365
V G +S E+ + ++ GSL Q LK+ K E + V+I V + L YL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ- 124
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+HRDVK SNIL++ +L DFG S Q+ +++ + VGT Y++PE +
Sbjct: 125 -IMHRDVKPSNILVNSR-GEIKLCDFGV------SGQLIDSMAN-SFVGTRSYMSPERLQ 175
Query: 426 YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476
+ D++S G+ L+EL G+ I A +E ++ R ++ E
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGE 225
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 47/225 (20%)
Query: 260 IGQGGNSKVYRTN------HVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
IGQG +V++ + + AVK+LK + + + RE L++ H NIV+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 312 IIGYCH-SKEMYAIVYNLLNGSLKQYLK-------------------------QLKWNER 345
++G C K M + + G L ++L+ L E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 346 MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQV 403
+ +A VA + YL + +HRD+ + N L+ EN +++DFG + + ++
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYYKA 188
Query: 404 SEN-VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
SEN P+ ++ PE + Y + + DV++YGVVL E+ +
Sbjct: 189 SENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 25/202 (12%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRII 313
+G G +V+ + A+KV+ E+ V E +L + H I+R+
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL- 66
Query: 314 GYCHSKE---MYAIVYNLLNGSLKQYLKQL-KWNERMDV--AIGVAKALEYLHHTCDPPI 367
+ + +Y ++ + G L YL+ +++ + A + ALEYLH I
Sbjct: 67 -FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EI 122
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
++RD+K NILL + H +L+DFG A + + GT YLAPE +
Sbjct: 123 VYRDLKPENILLDKE-GHIKLTDFGFAKKLRD--------RTWTLCGTPEYLAPEVIQSK 173
Query: 428 KVDEKIDVYSYGVVLLELITGK 449
++ +D ++ G+++ E++ G
Sbjct: 174 GHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 40/223 (17%)
Query: 260 IGQGGNSKVY---RTNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIKHENIVRI 312
IG+G +VY R N DG+ A+K K + RE+ LL +KHEN+V +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 313 IGYC---HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKAL--------EYLHH 361
+ K +Y ++++ L Q +K + +R+ + + K+L YLH
Sbjct: 68 VEVFLEHADKSVY-LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 362 TCDPPIIHRDVKSSNILL-SENFHHP--QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
++HRD+K +NIL+ E ++ D G A + + + ++ PV VV T Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV-VV-TIWY 181
Query: 419 LAPEYMM----YGKVDEKIDVYSYGVVLLELIT------GKEA 451
APE ++ Y K ID+++ G + EL+T G+EA
Sbjct: 182 RAPELLLGARHYTKA---IDIWAIGCIFAELLTLEPIFKGREA 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 35/213 (16%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLR---------EVELL 301
+F +G G +V H G+ A+K LK + E+L+ E +L
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK-----KREILKMKQVQHVAQEKSIL 72
Query: 302 SSIKHENIVRII-GYCHSKEMYAIVYNLLNGSLKQYLKQL-KWNERMDVA----IGVAKA 355
+ H IV ++ + +Y ++ ++ G L +L++ ++ DVA + A
Sbjct: 73 MELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN--DVAKFYHAELVLA 130
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
EYLH + D II+RD+K N+LL +N H +++DFG A +V + + + GT
Sbjct: 131 FEYLH-SKD--IIYRDLKPENLLL-DNKGHVKVTDFGFA------KKVPD--RTFTLCGT 178
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
YLAPE + + +D ++ GV+L E I G
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVE----------LLSSIKHEN 308
IG+G KV H DG+ AVKVL ++ +L++ E LL ++KH
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL-----QKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGS-----LKQYLKQLKWNERMDVAIGVAKALEYLHHTC 363
+V + + + V + +NG L++ + R A +A AL YLH
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHSL- 115
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF----GYL 419
II+RD+K NILL H L+DFG E ++ TF YL
Sbjct: 116 --NIIYRDLKPENILLDSQ-GHVVLTDFGLC---------KEGIEHSKTTSTFCGTPEYL 163
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITG 448
APE + D +D + G VL E++ G
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 33/170 (19%)
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL---KQLKWNERMDVAIGVA 353
E +L +I H +I+++ G + ++ L YL + + + + + V
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ---LSDFGAAMVHHQSHQVSENVKPV 410
+A++YLH IIHRD+K+ NI ++ HP L DFGAA PV
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFIN----HPGDVCLGDFGAACF------------PV 233
Query: 411 NV--------VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452
++ GT APE + +D++S G+VL E+ T +++
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 52/194 (26%), Positives = 100/194 (51%), Gaps = 23/194 (11%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG+G V ++ G AVK +K + + + L E +++ ++H N+V+++G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 320 E--MYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+ +Y + + GSL YL+ L + + ++ V +A+EYL +HRD+
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDL 128
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
+ N+L+SE+ + ++SDFG + ++ + K PV + APE + K
Sbjct: 129 AARNVLVSED-NVAKVSDFG---LTKEASSTQDTGKLPVK------WTAPEALREKKFST 178
Query: 432 KIDVYSYGVVLLEL 445
K DV+S+G++L E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 63/268 (23%), Positives = 126/268 (47%), Gaps = 41/268 (15%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
A+K L+ + + +E+L E +++S+ + ++ R++G C + + I + G L Y+
Sbjct: 40 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV 99
Query: 338 KQLKWN----ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393
++ K N ++ + +AK + YL + ++HRD+ + N+L+ + H +++DFG
Sbjct: 100 REHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLV-KTPQHVKITDFGL 155
Query: 394 AMV---HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GK 449
A + + + P+ ++A E +++ + DV+SYGV + EL+T G
Sbjct: 156 AKLLGADEKEYHAEGGKVPIK------WMALESILHRIYTHQSDVWSYGVTVWELMTFGS 209
Query: 450 EAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSR 509
+ A+ S S+L G ERL P + I++ M + C + +
Sbjct: 210 KPYDGIPASEIS------SILEKG--ERLPQPPIC------TIDVYMIMVK-CWMIDADS 254
Query: 510 RPTMKTLLKLFQEPDYWLKMKREKEELL 537
RP + L+ F KM R+ + L
Sbjct: 255 RPKFRELIIEFS------KMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 8/157 (5%)
Query: 295 LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM-DVAIGVA 353
+REV LL ++KH NIV + H++ +V+ L+ LKQYL M +V I +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMF 110
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV 413
+ L L + I+HRD+K N+L++E +L+DFG A + N V
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYS-----NEV 164
Query: 414 GTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
T Y P+ ++ + ID++ G +L E+ TG+
Sbjct: 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 14/190 (7%)
Query: 276 GQVAAVKVLKCTNWSEEEVL-----REVELLSSIKHENIVRII--GYCHSKEMYAIVYNL 328
G A+K+L+ T+ EEE RE L + + H NIV ++ G ++A V+
Sbjct: 3 GHEVAIKLLR-TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEY 60
Query: 329 LNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHH 385
+ G +L++ L + + + L+ L + I+HRD+K NI++S+ H
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 386 PQLSDFGAAMVHHQSHQVSEN--VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLL 443
++ DFG + + V+GT Y APE + V D+Y++G++ L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 444 ELITGKEAIQ 453
E +TG+ +Q
Sbjct: 181 ECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 295 LREVELLSSIKHENIVRIIGYC-----HSKEMYAIVYNLLNGSLKQ--YLKQLKWNERMD 347
LRE+++L KH+NI+ I K++Y +V +L+ L + Q E +
Sbjct: 52 LRELKILRHFKHDNIIAIRDILRPPGADFKDVY-VVMDLMESDLHHIIHSDQPLTEEHIR 110
Query: 348 VAIG-VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM------VHHQS 400
+ + + L+Y+H +IHRD+K SN+L++E+ ++ DFG A H+
Sbjct: 111 YFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCEL-RIGDFGMARGLSSSPTEHKY 166
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKE 450
V T Y APE ++ + ID++S G + E++ ++
Sbjct: 167 FMTEY-------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 70/277 (25%), Positives = 117/277 (42%), Gaps = 51/277 (18%)
Query: 259 LIGQGGNSKVYRTNHVDG-QVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGY 315
++G+G + HV+ Q A+K ++ S E+ +E LL+ +KH NIV +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV---AF 63
Query: 316 CHSKE----MYAIVYNLLNGSLKQYLKQ-----------LKWNERMDVAIGVAKALEYLH 360
S E +Y ++ G L Q +K L+W +M + +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV---------Q 114
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
H + ++HRD+KS NI L++N +L DFG+A + + + VGT Y+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARL--LTSPGA---YACTYVGTPYYVP 168
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480
PE + K D++S G +L EL T K Q N W +L +C+
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILK--VCQGSYK 218
Query: 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLL 517
P L Y+ E ++ + + RP+ T+L
Sbjct: 219 P-LPSHYSYELRSLIKQMFK----RNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 53/224 (23%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVD--GQVAAVKVLKCTNWSEEE-----VLREVELL--- 301
+ IG+G KV++ + G+ A+K ++ + EE +REV +L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHL 58
Query: 302 SSIKHENIVRIIGYC-----HSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIG 351
+ +H N+VR+ C + +V+ ++ L YL + + D+
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ + L++LH ++HRD+K NIL++ + +L+DFG A ++ S Q++
Sbjct: 119 LLRGLDFLH---SHRVVHRDLKPQNILVTSS-GQIKLADFGLARIY--SFQMALTS---- 168
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
VV T Y APE ++ +D++S G + E+ K + +
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
+G G V++ +H G + A K+ L+ +++RE+++L IV G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 317 HSK-EMYAIVYNLLNGSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHTCDPPIIHRDV 372
+S E+ + ++ GSL Q LK+ + E++ V+I V K L YL I+HRDV
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDV 130
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
K SNIL++ +L DFG S Q+ +++ + VGT Y++PE + +
Sbjct: 131 KPSNILVNSR-GEIKLCDFGV------SGQLIDSMAN-SFVGTRSYMSPERLQGTHYSVQ 182
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
D++S G+ L+E+ G+ I A L+
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 296 REVELLSSIKHENIVRIIGYCH---SKEMYAIVY---NLLNGSLKQYLKQLKWNERMDVA 349
RE+ LL + HEN++ ++ S E + VY +L+ L +K K ++
Sbjct: 63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF 122
Query: 350 I--GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+ + + L+Y+H + IIHRD+K SNI ++E+ L DFG A H +++
Sbjct: 123 LVYQILRGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKIL-DFGLA--RHTDDEMT--- 173
Query: 408 KPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE M+ + ++ +D++S G ++ EL+TGK
Sbjct: 174 ---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 51/172 (29%), Positives = 84/172 (48%), Gaps = 28/172 (16%)
Query: 290 SEEEVLREVELL-SSIKHENIVRII-GYCHSKEMYAIVYNLLNG-SLKQYLKQLK----- 341
S +++ EV ++ ++H NIVR + + +Y IV +L+ G L ++ LK
Sbjct: 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY-IVMDLIEGAPLGEHFNSLKEKKQR 109
Query: 342 ------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395
WN + + + AL YLH + I+HRD+ +NI+L E+ ++DFG A
Sbjct: 110 FTEERIWN----IFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGED-DKVTITDFGLA- 161
Query: 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
Q K +VVGT Y PE + EK DV+++G +L ++ T
Sbjct: 162 -----KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 64/210 (30%), Positives = 92/210 (43%), Gaps = 39/210 (18%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVE----------LLSSIKHE 307
+IG+G KV DG AVKVL+ ++ +L++ E LL ++KH
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQ-----KKTILKKKEQNHIMAERNVLLKNLKHP 56
Query: 308 NIVRIIGYCHSKEMYAIVYNLLNGS-----LKQYLKQLKWNERMDVAIGVAKALEYLHHT 362
+V + + E V + +NG L++ L+ R A VA A+ YLH
Sbjct: 57 FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSL 115
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF----GY 418
II+RD+K NILL H L+DFG E V+P TF Y
Sbjct: 116 ---NIIYRDLKPENILLDSQ-GHVVLTDFGLC---------KEGVEPEETTSTFCGTPEY 162
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
LAPE + D +D + G VL E++ G
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 28/169 (16%)
Query: 295 LREVELLSSIKHENIVRI------IGYCHSKEMYAIVYNLLNGSLKQYLK--QLKWNERM 346
LRE++LL + HEN++ I ++Y IVY L++ L Q ++ Q ++
Sbjct: 52 LREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY-IVYELMDTDLHQIIRSSQTLSDDHC 110
Query: 347 DVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ-VS 404
+ + + L+Y+H ++HRD+K SN+LL+ N ++ DFG A + ++
Sbjct: 111 QYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDL-KICDFGLARTTSEKGDFMT 166
Query: 405 ENVKPVNVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
E V T Y APE ++ Y IDV+S G + EL+ K
Sbjct: 167 E------YVVTRWYRAPELLLNCSEYTTA---IDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLK----CTNWSEEEVLREVE-LLSSIKHENIVRI 312
+IG+G KV H + + AVKVL+ E+ ++ E LL ++KH +V +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 313 -IGYCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPI 367
+ + ++Y ++ + G L +L++ L+ R A +A AL YLH I
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSL---NI 117
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF----GYLAPEY 423
++RD+K NILL H L+DFG EN++ TF YLAPE
Sbjct: 118 VYRDLKPENILLDSQ-GHIVLTDFGLC---------KENIEHNGTTSTFCGTPEYLAPEV 167
Query: 424 MMYGKVDEKIDVYSYGVVLLELITG 448
+ D +D + G VL E++ G
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 253 NFSPKMLIGQGGNSKVY----RTNHVDGQVAAVKVLKCTNW-----SEEEVLREVELLSS 303
NF ++G G KV+ H G++ A+KVLK + E E ++L +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 304 IKHENIVRIIGYCHSKE--MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK---ALEY 358
++ + + Y + ++ I+ + G L +L Q + +V + +A+ AL++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH II+RD+K NILL H L+DFG + + E + + GT Y
Sbjct: 121 LHQL---GIIYRDIKLENILLDSE-GHVVLTDFGLS----KEFLAEEEERAYSFCGTIEY 172
Query: 419 LAPEYMMYGKV--DEKIDVYSYGVVLLELITG 448
+APE + G D+ +D +S GV+ EL+TG
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGY 315
IG+G VY+ V + A+K ++ E +RE+ LL ++H NIVR+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQ---LKWNERM--DVAIGVAKALEYLHHTCDPPIIHR 370
HS++ +V+ L+ LK+++ N R+ + + + Y H ++HR
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHR 126
Query: 371 DVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
D+K N+L+ + +L+DFG A V +H+V T Y APE ++
Sbjct: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----------TLWYRAPEILL 176
Query: 426 YGK-VDEKIDVYSYGVVLLELITGK 449
+ +D++S G + E++ K
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 260 IGQGGNSKVY--RTNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRI 312
+G+G + V+ R+ + VA LK EE +REV LL +KH NIV +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVA----LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM-DVAIGVAKALEYLHHTCDPPIIHRD 371
H+ + +V+ L+ LKQY+ M +V I + + L L + ++HRD
Sbjct: 70 HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRD 129
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVD 430
+K N+L++E +L+DFG A + N V T Y P+ ++ +
Sbjct: 130 LKPQNLLINER-GELKLADFGLARAKSVPTKTYS-----NEVVTLWYRPPDVLLGSSEYS 183
Query: 431 EKIDVYSYGVVLLELITGK 449
+ID++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 40/210 (19%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIK-HENIVRIIGY 315
+G G VY N G++ A+K +K +W E LREV+ L + H NIV++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKL--- 63
Query: 316 CHSKEMYA------IVYNLLNGSLKQYLKQLKWNERMDVAIGVAK--------ALEYLHH 361
KE++ V+ + G+L Q +K + + V + L ++H
Sbjct: 64 ---KEVFRENDELYFVFEYMEGNLYQLMKD---RKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP-VNVVGTFGYLA 420
HRD+K N+L+S +++DFG A + + P + V T Y A
Sbjct: 118 H---GFFHRDLKPENLLVSGPE-VVKIADFGLA-------REIRSRPPYTDYVSTRWYRA 166
Query: 421 PEYMMY-GKVDEKIDVYSYGVVLLELITGK 449
PE ++ +D+++ G ++ EL T +
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 259 LIGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEEVL-----REVELLSSIKHENIVRI 312
LIG+GG +VY + V + A+K ++ + SE +L RE ++ + + H IV +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 313 IGYCHSKEM--YAIVYNLLNG-SLKQYLKQLKWNERM--DVAIG------------VAKA 355
C + Y + Y + G +LK LK + E + ++A +
Sbjct: 68 YSICSDGDPVYYTMPY--IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV------------ 403
+EY+H ++HRD+K NILL F + D+GAA+ +
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGL-FGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 404 -SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
S P +VGT Y+APE ++ E D+Y+ GV+L +++T
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 39/207 (18%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVL-KCTNWSEEE---VLREVELLSSIKHENIVRII- 313
+GQGG +V+ D G++ A+K + K + E VL E ++L++ K E +V+++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 314 GYCHSKEMY-AIVY-------NLLN--GSLKQYLKQLKWNERMDVAIGVAKALEYLHHTC 363
+ + +Y A+ Y LLN G L + + E M A+ L Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAE-MFEAVDALHELGY----- 122
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPE 422
IHRD+K N L+ + H +L+DFG + V N VVG+ Y+APE
Sbjct: 123 ----IHRDLKPENFLIDAS-GHIKLTDFGLS---------KGIVTYANSVVGSPDYMAPE 168
Query: 423 YMMYGK-VDEKIDVYSYGVVLLELITG 448
++ GK D +D +S G +L E + G
Sbjct: 169 -VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 38/210 (18%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR------- 311
IG+G +VY+ D ++ A+KVL S++E++ + E+ +I NI+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL-----SKKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 312 --IIGYCHS----KEMYAIVYNLLNGSLKQYL-KQLKWNE-RMDVAIG-VAKALEYLHHT 362
I+G S ++Y + + G L +L K+ +++E R I + ALE+LH
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
I++RD+K NILL H L DFG + + +++N GT YLAPE
Sbjct: 116 ---DIVYRDLKPENILLDAT-GHIALCDFGLSKAN-----LTDNKTTNTFCGTTEYLAPE 166
Query: 423 YMM----YGKVDEKIDVYSYGVVLLELITG 448
++ Y K +D +S GV++ E+ G
Sbjct: 167 VLLDEKGYTK---HVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 47/197 (23%), Positives = 95/197 (48%), Gaps = 38/197 (19%)
Query: 278 VAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334
+ AVK+L+ + + L+EV++LS +K NI+R++G C ++ ++ + NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 335 QYLKQLKWNER----------------------MDVAIGVAKALEYLHHTCDPPIIHRDV 372
Q+L +++ + VA+ +A ++YL +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL 164
Query: 373 KSSNILLSENFHHPQLSDFGAA--MVHHQSHQVS-ENVKPVNVVGTFGYLAPEYMMYGKV 429
+ N L+ EN +++DFG + + +++ V P+ ++A E ++ GK
Sbjct: 165 ATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIR------WMAWECILMGKF 217
Query: 430 DEKIDVYSYGVVLLELI 446
DV+++GV L E++
Sbjct: 218 TTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 293 EVLREVELLSSIKHENIVRIIG-YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM----- 346
+++RE+++L IV G + E+ + ++ GSL Q LK+ R+
Sbjct: 45 QIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENIL 101
Query: 347 -DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405
++I V + L YL I+HRDVK SNIL++ +L DFG V Q
Sbjct: 102 GKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFG---VSGQLIDSMA 155
Query: 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452
N + VGT Y++PE + + D++S G+ L+E+ G+ I
Sbjct: 156 N----SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 37/198 (18%)
Query: 280 AVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIGYCHSKE-MYAIVYNLLNGSLKQY 336
AVK+LK S E ++L E LL + H +++++ G C + IV GSL+ +
Sbjct: 34 AVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF 93
Query: 337 LKQLKWNERMDVAIGVAKALEYLHHTCDPPI------------------------IHRDV 372
L++ + + + YL + + + +HRD+
Sbjct: 94 LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL 153
Query: 373 KSSNILLSENFHHPQLSDFGAAM-VHHQSHQV--SENVKPVNVVGTFGYLAPEYMMYGKV 429
+ N+L++E ++SDFG + V+ + V S+ PV ++A E +
Sbjct: 154 AARNVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVK------WMAIESLFDHIY 206
Query: 430 DEKIDVYSYGVVLLELIT 447
+ DV+S+GV+L E++T
Sbjct: 207 TTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 29/187 (15%)
Query: 280 AVKVLKC--TNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQY 336
A+K LK T + L E ++ H NI+ + G I+ + NG+L +
Sbjct: 36 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSF 95
Query: 337 LKQLKWNERMDVAI-------GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
L+Q N+ I G+A ++YL + +HRD+ + NIL++ N ++S
Sbjct: 96 LRQ---NDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLV-CKVS 148
Query: 390 DFGAAMVHHQSHQVSENVKPVNVVGTFG------YLAPEYMMYGKVDEKIDVYSYGVVLL 443
DFG S + ++ + G + APE + Y K DV+SYG+V+
Sbjct: 149 DFGL------SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 202
Query: 444 ELITGKE 450
E+++ E
Sbjct: 203 EVMSYGE 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEE---EVLREVELLSSIKHENIVRIIG 314
++G+G V + H + ++ A+K K + +EE LRE+++L ++K ENIV +
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD-VAIGVAKALEYLHHTCDPPIIHRDVK 373
+ +V+ + ++ + L+++ + V + + ++ +H I+HRD+K
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127
Query: 374 SSNILLSENFHHPQLSDFGAAMVHHQSHQVSE--NVKPVNVVGTFGYLAPEYMMYGKVDE 431
N+L+S N +L DFG A +SE N V T Y +PE ++ +
Sbjct: 128 PENLLISHN-DVLKLCDFGFA------RNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 432 KIDVYSYGVVLLELITGK 449
+D++S G +L EL G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR------EVELLSSIKHENIVR 311
L+GQG +VY D G+ AVK ++ S E E++LL ++ HE IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 312 IIGYCH---SKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDP 365
G + + + ++ GS+K LK L N + + + YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM-- 126
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+HRD+K +NI L ++ + +L DFGA+ +K +V GT +++PE +
Sbjct: 127 -IVHRDIKGANI-LRDSVGNVKLGDFGASKRLQTICLSGTGMK--SVTGTPYWMSPEVIS 182
Query: 426 YGKVDEKIDVYSYGVVLLELITGK 449
K D++S G ++E++T K
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVL----KCTNWSEE--EVLREVELLSSIK 305
N+ L+G+G +VY D G+ AVK + S+E + E++LL +++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 306 HENIVRIIGYC----HSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEY 358
H+ IV+ G C K++ V + GS+K LK L N + + + Y
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH I+HRD+K +NI L ++ + +L DFGA+ +K +V GT +
Sbjct: 122 LHSNM---IVHRDIKGANI-LRDSAGNVKLGDFGASKRIQTICMSGTGIK--SVTGTPYW 175
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
++PE + K DV+S ++E++T K
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR-EVELLSSIKHENI 309
H++ +G G VY+ ++ G++AAVK++K + +++ E+ ++ KH NI
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 310 VRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPII 368
V G S+E I G SL+ + +A + L+ L + +
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-- 426
HRD+K +NILL++N +L+DFG A + + K + +GT ++APE
Sbjct: 129 HRDIKGANILLTDN-GDVKLADFGVA-----AKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 427 -GKVDEKIDVYSYGVVLLEL 445
G ++ D+++ G+ +EL
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 49/200 (24%), Positives = 96/200 (48%), Gaps = 33/200 (16%)
Query: 271 TNHVDGQ--VAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326
DGQ + AVK+L+ T + + L+E++++S +K+ NI+R++G C S + ++
Sbjct: 37 APEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMIT 96
Query: 327 NLL-NGSLKQYLKQ---------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
+ NG L Q+L Q + + +A+ +A ++YL +HR
Sbjct: 97 EYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHR 153
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV---SENVKPVNVVGTFGYLAPEYMMYG 427
D+ + N L+ ++ +++DFG + + V P+ ++A E ++ G
Sbjct: 154 DLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIR------WMAWESILLG 206
Query: 428 KVDEKIDVYSYGVVLLELIT 447
K DV+++GV L E+ T
Sbjct: 207 KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 62/277 (22%), Positives = 127/277 (45%), Gaps = 38/277 (13%)
Query: 258 MLIGQGGNSKVYRTNHV-DGQ----VAAVKVLK--CTNWSEEEVLREVELLSSIKHENIV 310
++G G VY+ + DG+ A+KVL+ + + +E+L E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 311 RIIGYCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPP 366
R++G C + + + + G L Y+++ + + ++ + +AK + YL +
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAM---VHHQSHQVSENVKPVNVVGTFGYLAPEY 423
++HRD+ + N+L+ ++ +H +++DFG A + + P+ ++A E
Sbjct: 130 LVHRDLAARNVLV-KSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------WMALES 182
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483
+++ + + DV+SYGV + EL+T RE LL G ERL P +
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-----IPDLLEKG--ERLPQPPI 235
Query: 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520
I++ M + C + S RP + L+ F
Sbjct: 236 C------TIDVYMIMVK-CWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLK---QYLKQLKWNERM 346
E L E ++L + +V + +K+ +V L+NG LK ++ + + E
Sbjct: 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGR 103
Query: 347 DV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
V A + LE LH I++RD+K NILL ++ H ++SD G A VH V
Sbjct: 104 AVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDH-GHIRISDLGLA-VH-----VP 153
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA--NRESL 462
E VGT GY+APE + + D ++ G +L E+I G+ Q K RE +
Sbjct: 154 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
Query: 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLC 502
ERL+ ++ EEY+ + A LC
Sbjct: 214 -------------ERLVK-EVQEEYSEKFSP---DARSLC 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEE---EVLR---EVELLSSIKHENIVR 311
L+GQG +VY VD G+ A K ++ S E EV E++LL +++HE IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 312 IIGYC---HSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCD 364
G C +++ I + GS+K LK L + + + + YLH
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM- 126
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
I+HRD+K +NIL ++ + +L DFGA+ ++ +V GT +++PE +
Sbjct: 127 --IVHRDIKGANIL-RDSAGNVKLGDFGASKRLQTICMSGTGIR--SVTGTPYWMSPEVI 181
Query: 425 MYGKVDEKIDVYSYGVVLLELITGK 449
K DV+S G ++E++T K
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 16/172 (9%)
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLK---WNERM 346
E L E ++L + +V + +K+ +V L+NG LK ++ + ++E
Sbjct: 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEER 103
Query: 347 DV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
V A + LE LH I++RD+K NILL +++ H ++SD G A+ ++
Sbjct: 104 AVFYAAEITCGLEDLHRE---RIVYRDLKPENILL-DDYGHIRISDLGLAV------EIP 153
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
E VGT GY+APE + + D + G ++ E+I GK + K
Sbjct: 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 48/163 (29%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 296 REVELLSSIKHENIVRIIGY---CHSKEMYAIVY---NLLNGSLKQYLK--QLKWNERMD 347
RE+ LL +KHEN++ ++ S E + VY +L+ L +K +L +
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+ + + L+Y+H IIHRD+K SN+ ++E+ L DFG A H +++
Sbjct: 125 LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL-DFGLA--RHTDDEMT--- 175
Query: 408 KPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE M+ + ++ +D++S G ++ EL+TG+
Sbjct: 176 ---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 50/257 (19%), Positives = 109/257 (42%), Gaps = 39/257 (15%)
Query: 275 DGQVAAVKVLKCTNWSEEEVLR----EVELLSSIKHENIVRIIGY----CHSKEMYAIVY 326
+ + ++ K + + ++ E++ L I NI++I G+ +++
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 327 N-LLNGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382
G L++ L K L + ++D+AI K L L+ + P ++++ S + L++EN
Sbjct: 102 EYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTEN 159
Query: 383 FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM--MYGKVDEKIDVYSYGV 440
+ ++ H ++ + P V Y + + + ++ + K D+YS GV
Sbjct: 160 YK--------LKIICHGLEKIL-SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210
Query: 441 VLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAAR 500
VL E+ TGK + +L + + + +I+ + + + + C
Sbjct: 211 VLWEIFTGKIPFE--------------NLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE 256
Query: 501 LCLLHSSSRRPTMKTLL 517
C H S +RP +K +L
Sbjct: 257 ACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 51/212 (24%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 253 NFSPKMLIGQGGNSKVYRTN-HVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+F+ M++G+G KV ++ A+K+LK ++ V+++ ++ ++ + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILK-----KDVVIQDDDVECTMVEKRVLA 55
Query: 312 I------IGYCHS-----KEMYAIVYNLLNGSLKQYLKQL-KWNERMDV--AIGVAKALE 357
+ + HS +Y ++ + G L +++Q+ K+ E V A ++ L
Sbjct: 56 LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
+LH II+RD+K N++L H +++DFG H + + V GT
Sbjct: 116 FLHRR---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKEH-----MVDGVTTRTFCGTPD 166
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + Y + +D ++YGV+L E++ G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 50/163 (30%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 296 REVELLSSIKHENIVRIIGY---CHSKEMYAIVY---NLLNGSLKQYLK-QLKWNERMDV 348
RE+ LL +KHEN++ ++ S E + VY NL+ L +K Q +E +
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122
Query: 349 AI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
I + + L+Y+H IIHRD+K SN+ ++E+ ++ DFG A Q + +
Sbjct: 123 LIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCEL-RILDFGLA------RQADDEM 172
Query: 408 KPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE M+ + ++ +D++S G ++ EL+ GK
Sbjct: 173 --TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHEN-IVRI 312
IG+G KVY+ + G++ A+K K +EE LRE+ LL + IVR+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 313 IGYCHSKE-----MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEY-----LHHT 362
+ H +E +V+ L+ LK+++ + K+ Y + H
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFG 417
++HRD+K N+L+ + +++D G V +H++ T
Sbjct: 127 HKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----------TLW 176
Query: 418 YLAPEYMMYGK-VDEKIDVYSYGVVLLELITG 448
Y APE ++ +D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 28/172 (16%)
Query: 294 VLREVELLSSIKHENIVRI--IGYCHS----KEMYAIVYNLLNGSLKQYLK---QLKWNE 344
+LRE++LL ++H +IV I I S K++Y +V+ L+ L Q +K L
Sbjct: 46 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY-VVFELMESDLHQVIKANDDLTPEH 104
Query: 345 RMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
+ +AL+Y+H + HRD+K NIL + + ++ DFG A V
Sbjct: 105 HQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKL-KICDFGLARVAF------ 154
Query: 405 ENVKPVNV-----VGTFGYLAPEYM--MYGKVDEKIDVYSYGVVLLELITGK 449
N P + V T Y APE + K ID++S G + E++TGK
Sbjct: 155 -NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLK---CTNWSEEEVL---REVELLSSIKHENIVR 311
+IG+G KV +DG+ AVKVL+ N E++ + R V LL ++KH +V
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 312 IIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNE-RMDVAIG-VAKALEYLHHTCDPPI 367
+ + E V + +NG ++ + E R +A AL YLH I
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NI 117
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
++RD+K NILL ++ H L+DFG ++++ GT YLAPE +
Sbjct: 118 VYRDLKPENILL-DSQGHVVLTDFGLC-----KEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 428 KVDEKIDVYSYGVVLLELITG 448
D +D + G VL E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 18/104 (17%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
V AL+ +H IHRDVK N+LL ++ H +L+DFG M + V +
Sbjct: 151 VVLALDAIHSM---GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCD----T 202
Query: 412 VVGTFGYLAPEYMM-------YGKVDEKIDVYSYGVVLLELITG 448
VGT Y++PE + YG+ + D +S GV L E++ G
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 260 IGQGGNSKVYRT-NHVDGQVAAVKVLKCTNWSEEE---------------VLREVELLSS 303
+G+G KV + + + G++ A+K +K S + LRE+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 304 IKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVA------IGVAKALE 357
IKHENI+ ++ + +V +++ LK K + R+ + + + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLK---KVVDRKIRLTESQVKCILLQILNGLN 133
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV----- 412
LH +HRD+ +NI ++ + +++DFG A + K +
Sbjct: 134 VLHKWY---FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 413 ----VGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE +M K +D++S G + EL+TGK
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 259 LIGQGGNSKVYRTNHVDG--QVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGY- 315
+IG G VY +D +VA KVL+ + RE+ ++ ++ H NI+ + Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN----RELLIMKNLNHINIIFLKDYY 128
Query: 316 ---CHSKEMYAIVYNLLNGSLKQYL-KQLKWNERMDVAI----------GVAKALEYLHH 361
C K I N++ + Q + K +K R + A+ + +AL Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
I HRD+K N+L+ N H +L DFG+A + + V+ + + Y AP
Sbjct: 189 KF---ICHRDLKPQNLLIDPNTHTLKLCDFGSA------KNLLAGQRSVSYICSRFYRAP 239
Query: 422 EYMMYGKVD--EKIDVYSYGVVLLELITG 448
E +M G + ID++S G ++ E+I G
Sbjct: 240 E-LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 31/118 (26%), Positives = 49/118 (41%), Gaps = 28/118 (23%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV----------- 403
AL+ +H IHRD+K NIL+ + H +L+DFG +++
Sbjct: 113 ALDSVH---KLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 404 ----------SENVKPVN---VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
+ V VGT Y+APE + + D +S GV+L E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 259 LIGQGGNSKVYRTN-HVDG--QVAAVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRI 312
+IG+G +V R DG AA+K+LK + + E+E+L + H NI+ +
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 313 IGYCHSK-EMYAIVYNLLNGSLKQYLKQ-------------------LKWNERMDVAIGV 352
+G C ++ +Y + G+L +L++ L + + A V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
A ++YL + IHRD+ + N+L+ EN +++DFG + + + PV
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENL-ASKIADFGLSRGEEVYVKKTMGRLPVR- 183
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++A E + Y K DV+S+GV+L E+++
Sbjct: 184 -----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 296 REVELLSSIKHENIVRIIGYCHSKEMYAIV--------YNLLNGSLKQYLKQLKWNERMD 347
RE+++L +I H I+ +I K +V + ++ S L+Q +R
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR-- 192
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+ +AL YLH IIHRDVK+ NI L E + L DFGAA + +
Sbjct: 193 ---RLLEALAYLH---GRGIIHRDVKTENIFLDEP-ENAVLGDFGAAC---KLDAHPDTP 242
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
+ GT +PE + K D++S G+VL E+
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 296 REVELLSSIKHENIVRIIGYC---HSKEMYAIVY---NLLNGSLKQYLKQLKWNERMDVA 349
RE+ LL + H+NI+ ++ S E + VY L++ +L Q + +ERM
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ + L + H IIHRD+K SNI++ + ++ DFG A N
Sbjct: 129 L--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLA------RTACTNFMM 179
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQ 453
V T Y APE ++ E +D++S G ++ EL+ G Q
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 258 MLIGQGGNSKV----YRTNHVDGQVAAVKVLK-----------CTNWSEEEVLREVELLS 302
++G+G KV + ++ AVKVLK CT +E+ VL
Sbjct: 1 KVLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECT-MTEKRVLALAG--- 53
Query: 303 SIKHENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERMDV--AIGVAKALEY 358
KH + ++ +K+ V +NG + + +++E A + L++
Sbjct: 54 --KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQF 111
Query: 359 LHHTCDPPIIHRDVKSSNILL-SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
LH + II+RD+K N+LL SE H +++DFG + V GT
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDSEG--HIKIADFGMC-----KEGILGGVTTSTFCGTPD 161
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + Y +D ++ GV+L E++ G+
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 58/260 (22%), Positives = 115/260 (44%), Gaps = 41/260 (15%)
Query: 281 VKVLKCTNWSEEEV--LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYL 337
VK L+ + +E++ L+EV+ + H N+++ +G C Y +V G LK YL
Sbjct: 27 VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL 86
Query: 338 KQLKWNERMD--------VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
+ + +A VA L +LH IH D+ N L+ + ++
Sbjct: 87 RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADL-SVKIG 142
Query: 390 DFGAAMVHH-QSHQVSENVKPVNVVGTFGYLAPEYM-------MYGKVDEKIDVYSYGVV 441
D+G A+ + + + ++++ V + +LAPE + + +K +++S GV
Sbjct: 143 DYGLALEQYPEDYYITKDCHAVPL----RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVT 198
Query: 442 LLELITGKEAIQTNKANRESL--VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAA 499
+ EL T + + ++ + L V+ + + +L PQL+ +Y+ E++
Sbjct: 199 MWELFTAADQPYPDLSDEQVLKQVVREQDI-------KLPKPQLDLKYSDRWYEVMQ--- 248
Query: 500 RLCLLHSSSRRPTMKTLLKL 519
C L RPT + + +L
Sbjct: 249 -FCWL-DPETRPTAEEVHEL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 260 IGQGGNSKVYRT--NHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI----- 312
+G G N V+ + D +VA K++ S + LRE++++ + H+NIV++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 313 ---------IGYCHSKEMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHH 361
+G IV + L L+Q L + + L+Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQ--VSENVKPVNVVGTFG 417
++HRD+K +N+ ++ ++ DFG A + H SH+ +SE + T
Sbjct: 133 A---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV------TKW 183
Query: 418 YLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y +P ++ Y K ID+++ G + E++TGK
Sbjct: 184 YRSPRLLLSPNNYTKA---IDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVA---AVKVLKCTNWSEEEVLREVELLSSIKHENIVRI--IG 314
+G+G VY+ DG+ A+K ++ T S RE+ LL +KH N++ + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS-ACREIALLRELKHPNVIALQKVF 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLK---QLKWNER-MDVAIGVAKALEY-----LHHTCDP 365
HS ++++ L +K K N++ M + + K+L Y +H+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 366 PIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
++HRD+K +NIL+ +++D G A + + + ++ PV V TF Y APE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPE 185
Query: 423 YMMYGK-VDEKIDVYSYGVVLLELITGK 449
++ + + ID+++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 253 NFSPKMLIGQGGNSKVYR----TNHVDGQVAAVKVL-KCT----NWSEEEVLREVELLSS 303
NF ++G G KV+ T H G++ A+KVL K + E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 304 IKHENIVRIIGYCHSKE--MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK---ALEY 358
++ + + Y E ++ I+ + G + +L Q +V + ALE+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH I++RD+K NILL H L+DFG + + E + + GT Y
Sbjct: 121 LHKL---GIVYRDIKLENILLDSE-GHVVLTDFGLS----KEFLSEEKERTYSFCGTIEY 172
Query: 419 LAPEYMM----YGKVDEKIDVYSYGVVLLELITG 448
+APE + +GK +D +S G+++ EL+TG
Sbjct: 173 MAPEIIRGKGGHGKA---VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 52/208 (25%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVA---AVKVLKCTNWSEEEVLREVELLSSIKHENIVRI--IG 314
+G+G VY+ DG+ A+K ++ T S RE+ LL +KH N++ + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS-ACREIALLRELKHPNVISLQKVF 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLK---QLKWNER-MDVAIGVAKALEY-----LHHTCDP 365
H+ ++++ L +K K N++ + + G+ K+L Y +H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 366 PIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
++HRD+K +NIL+ +++D G A + + + ++ PV V TF Y APE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPE 185
Query: 423 YMMYGK-VDEKIDVYSYGVVLLELITGK 449
++ + + ID+++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 257 KMLIGQGGNSKVYRTN-HVDGQVAAVKVLK----CTNWSEEEVLREVELLS-SIKHENIV 310
KML G+G KV+ Q A+K LK + E + E +LS + +H +
Sbjct: 1 KML-GKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 311 RIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV------AIGVAKALEYLHHTCD 364
+ +KE V LNG + ++ + D+ A + L++LH
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMF--HIQSCHKFDLPRATFYAAEIICGLQFLH---S 114
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
I++RD+K NILL + H +++DFG + + K GT Y+APE +
Sbjct: 115 KGIVYRDLKLDNILLDTD-GHIKIADFGMC-----KENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 425 MYGKVDEKIDVYSYGVVLLELITGK 449
+ K + +D +S+GV+L E++ G+
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 64/288 (22%), Positives = 121/288 (42%), Gaps = 49/288 (17%)
Query: 260 IGQGGNSKVYRTNHVD---GQVAAVKVLKCTNWSEE-----EVLREVELLSSIKHENIVR 311
+GQG VY N D G+ +K N S E L E ++ ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLKQLK-------------WNERMDVAIGVAKALE 357
++G + +V L+ +G LK YL+ L+ E + +A +A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK---PVNVVG 414
YL+ +HRD+ + N +++ +F ++ DFG +++ + K PV
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFT-VKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474
++APE + G D++S+GVVL E+ + E +N + L + ++ G
Sbjct: 187 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KFVMDGGY 239
Query: 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
++ + E + +M R+C + RPT ++ L ++
Sbjct: 240 LDQ-------PDNCPERVTDLM---RMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 258 MLIGQG--GNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR---EVELLSSIKHENIVR 311
LIG+ V+ H + AVK + + S+E++ E+ ++H NI+
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 312 IIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM-DVAI-----GVAKALEYLHHTCD 364
+ +V L+ GS + LK + E + ++AI V AL+Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKT-HFPEGLPELAIAFILKDVLNALDYIHSK-- 120
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPE 422
IHR VK+S+ILLS + LS + M+ H Q + P + V +L+PE
Sbjct: 121 -GFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 423 YM---MYGKVDEKIDVYSYGVVLLELITG 448
+ + G +EK D+YS G+ EL G
Sbjct: 179 VLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 39/243 (16%)
Query: 260 IGQGGNSKVYR-------TNHVDGQVAAVKVLKCTNWSEE-EVLREVELLSSIKHENIVR 311
+GQG VY + + +VA V + + E E L E ++ ++VR
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 312 IIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNER-------------MDVAIGVAKALE 357
++G + ++ L+ G LK YL+ L+ + +A +A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK---PVNVVG 414
YL+ +HRD+ + N +++E+F ++ DFG +++ + K PV
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474
+++PE + G DV+S+GVVL E+ T E +N + L R ++ GL
Sbjct: 187 ---WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL----RFVMEGGL 239
Query: 475 CER 477
++
Sbjct: 240 LDK 242
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 259 LIGQGGNSKVYRTN-HVDG--QVAAVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRI 312
+IG+G +V + DG AA+K +K + + E+E+L + H NI+ +
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 313 IGYC-HSKEMYAIVYNLLNGSLKQYLKQ-------------------LKWNERMDVAIGV 352
+G C H +Y + +G+L +L++ L + + A V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
A+ ++YL IHRD+ + NIL+ EN+ +++DFG + + + PV
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVR- 188
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++A E + Y DV+SYGV+L E+++
Sbjct: 189 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 253 NFSPKMLIGQG--GNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV 310
+F +IG+G G V + H + ++ A+K+L W E+L+ E + + E V
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTE-RIYAMKIL--NKW---EMLKRAET-ACFREERNV 54
Query: 311 RIIGYCH-----------SKEMYAIVYNLLNGSLKQYLKQLKWNERMDVA-IGVAKALEY 358
+ G C +Y ++ + G L L + + D+A +A+ +
Sbjct: 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
+H +HRD+K N+LL N H +L+DFG+ + +Q V +V VGT Y
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSV----AVGTPDY 169
Query: 419 LAPEYMM-----YGKVDEKIDVYSYGVVLLELITGK 449
++PE + GK + D +S GV + E++ G+
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 29/205 (14%)
Query: 259 LIGQGGNSKVYRTN-HVDGQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
++G+G KV G++ AVKVLK + E + E +LS ++ + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 314 GYC-HSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPP 366
C + + V +NG + ++ + R D A + AL +LH D
Sbjct: 62 YCCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKG 116
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY--- 423
II+RD+K N+LL H +L+DFG + GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHE-GHCKLADFGMC-----KEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 424 MMYGKVDEKIDVYSYGVVLLELITG 448
M+YG +D ++ GV+L E++ G
Sbjct: 171 MLYGPS---VDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 59/239 (24%), Positives = 94/239 (39%), Gaps = 53/239 (22%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE----VLREVELLSSIKH 306
+F L+G+G +V+ G++ A+KVL + VL E E+L+++ H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 307 -------------ENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA 353
+ ++ YC E++ LL +Q K L A V
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFR----LLQ---RQPGKCLSEEVARFYAAEVL 113
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF---------GAAMVHH-----Q 399
ALEYLH I++RD+K NILL E+ H LSDF + +
Sbjct: 114 LALEYLHLL---GIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 400 SHQVSENVKPVNV----------VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
V+ VGT Y+APE + +D ++ G++L E++ G
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 40/175 (22%)
Query: 296 REVELLSSIK-HENIVR---IIGYCHSKEMY------------AIVYNLLNGSLKQY-LK 338
RE+ L + H NIV+ +I + K++Y I N+L K+Y +
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY 114
Query: 339 QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398
QL KAL+Y+H +IHRD+K SNILL+ + +L+DFG A
Sbjct: 115 QL------------LKALKYIHSG---NVIHRDLKPSNILLNSDC-RVKLADFGLARSLS 158
Query: 399 QSHQVSENVKPVNVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
+ + EN + V T Y APE ++ Y K +D++S G +L E++ GK
Sbjct: 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTK---GVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 259 LIGQGGNSKVYRTN-HVDG--QVAAVKVLK--CTNWSEEEVLREVELLSSIKHE-NIVRI 312
+IG+G +V + DG AA+K +K + + E+E+L + H NI+ +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 313 IGYCHSK-EMYAIVYNLLNGSLKQYLKQ-------------------LKWNERMDVAIGV 352
+G C + +Y + +G+L +L++ L + + A V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
A+ ++YL IHRD+ + NIL+ EN+ +++DFG + + + PV
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYV-AKIADFGLSRGQEVYVKKTMGRLPVR- 176
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++A E + Y DV+SYGV+L E+++
Sbjct: 177 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 43/141 (30%), Positives = 65/141 (46%), Gaps = 23/141 (16%)
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
LE+LH II+RD+K N+LL +N + ++SD G A V + Q K GT
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLL-DNDGNVRISDLGLA-VELKDGQS----KTKGYAGT 160
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR-------- 467
G++APE + + D +D ++ GV L E+I + + E+ L R
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY 220
Query: 468 ----SLLSSGLCERLI--DPQ 482
S S CE L+ DP+
Sbjct: 221 PDKFSPASKSFCEALLAKDPE 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
L++LH II+RD+K N+LL ++ H +++DFG ++ K G
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKD-GHIKIADFGMC-----KENMNGEGKASTFCG 158
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
T Y+APE + K +E +D +S+GV+L E++ G+
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 35/122 (28%), Positives = 62/122 (50%), Gaps = 12/122 (9%)
Query: 331 GSLKQYLKQL-KWNERMDV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387
G L +++Q+ K+ E V A +A L +LH II+RD+K N++L H +
Sbjct: 86 GDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAE-GHIK 141
Query: 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
++DFG + + GT Y+APE + Y + +D +++GV+L E++
Sbjct: 142 IADFGMCKEN-----IFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
Query: 448 GK 449
G+
Sbjct: 197 GQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 39/118 (33%), Positives = 60/118 (50%), Gaps = 23/118 (19%)
Query: 345 RMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV-------- 396
RM A V ALEYLH+ I+HRD+K N+L++ + H +L+DFG + +
Sbjct: 104 RMYFAETVL-ALEYLHNY---GIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTN 158
Query: 397 ---HHQSHQVSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITG 448
H E + V GT Y+APE ++ YGK +D ++ G++L E + G
Sbjct: 159 LYEGHIEKDTREFLDK-QVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 16/172 (9%)
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLK---WNERM 346
E L E ++L + + +V + +K+ +V ++NG LK ++ + + E
Sbjct: 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER 103
Query: 347 DV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
+ A + LE LH ++RD+K NILL +++ H ++SD G A+ ++
Sbjct: 104 ALFYAAEILCGLEDLHRE---NTVYRDLKPENILL-DDYGHIRISDLGLAV------KIP 153
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
E VGT GY+APE + + D + G ++ E+I G+ + K
Sbjct: 154 EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 25/179 (13%)
Query: 290 SEEEVLREVELLSSIKHENIVRIIGYCHS------KEMYAIVYNLLNGSLKQYL--KQLK 341
S + V RE+++L KH+N++ + +E+Y +V L+ L + + Q
Sbjct: 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY-VVTELMQSDLHKIIVSPQPL 100
Query: 342 WNERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400
++ + V + + + L+YLH I+HRD+K N+L++ N ++ DFG A V
Sbjct: 101 SSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNC-VLKICDFGLARVEEP- 155
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
E+ V T Y APE +M Y +D++S G + EL+ + Q
Sbjct: 156 ---DESKHMTQEVVTQYYRAPEILMGSRHYT---SAVDIWSVGCIFAELLGRRILFQAQ 208
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 15/159 (9%)
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNL-----LNGSLKQYLKQLKWNERMDVAI- 350
E+ L++ H IV+ S + ++ LN +KQ LK+ + +V +
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 351 --GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408
+ AL+ +H ++HRD+KS+NI L +L DFG + + S VS +V
Sbjct: 175 FYQIVLALDEVHSRK---MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDS--VSLDVA 228
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ GT YLAPE + +K D++S GV+L EL+T
Sbjct: 229 S-SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 253 NFSPKMLIGQG--GNSKVYRTNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSSIKH 306
+F K L+G+G G +V R G + A+KV+K + +E E ++LS
Sbjct: 2 DFDVKSLVGRGHFGEVQVVR-EKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 307 ENIVRIIGYCHSKEMYAIVYNLLNGS-----LKQYLKQLKWNERMDVAIGVAKALEYLHH 361
I ++ K+ +V G L +Y Q +E M +A+ + +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF--DEDM-AQFYLAELVLAIHS 117
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
+HRD+K N+L+ + H +L+DFG+A ++ V VGT Y+AP
Sbjct: 118 VHQMGYVHRDIKPENVLI-DRTGHIKLADFGSA----ARLTANKMVNSKLPVGTPDYIAP 172
Query: 422 EYMM----YGK--VDEKIDVYSYGVVLLELITGK 449
E + GK + D +S GV+ E+I G+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 44/238 (18%)
Query: 260 IGQGGNSKVYRTNHVDGQV----AAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
IG G +V+ H Q A+ + +++ EV ++ +KH+NIVR I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 316 CHSK---EMYAIVYNLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDP 365
+K ++Y ++ G L + +++ ++ + +D+ + AL Y H+ D
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 366 P----IIHRDVKSSNILLSENFHH----------------PQLSDFGAAMVHHQSHQVSE 405
P ++HRD+K NI LS H ++ DFG S +
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL------SKNIGI 194
Query: 406 NVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461
+ VGT Y +PE +++ D+K D+++ G ++ EL +GK +KAN S
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF--HKANNFS 250
|
Length = 1021 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 297 EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG--------SLKQYLKQLKWNERMDV 348
E +LLS + H IV+ ++ + I+ G LK K L N+ +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408
I + + Y+H I+HRD+K+ NI L N ++ DFG + + S ++
Sbjct: 112 FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLA---- 162
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
GT Y++PE + + D K D++S G +L E+
Sbjct: 163 -TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 42/172 (24%), Positives = 80/172 (46%), Gaps = 16/172 (9%)
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYL-----KQLKWNE 344
E+ L E E+L + IV + SK +V +L+NG LK ++ + L+
Sbjct: 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER 96
Query: 345 RMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
+ + + + +LH I++RD+K N+LL + + +LSD G A+ ++
Sbjct: 97 VIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQ-GNCRLSDLGLAV------ELK 146
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
+ GT GY+APE + +D ++ G + E++ G+ + +K
Sbjct: 147 DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 50/219 (22%), Positives = 98/219 (44%), Gaps = 41/219 (18%)
Query: 260 IGQGGNSKVYRTNHVDG-------QVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIV 310
+G+ KVY+ H+ G Q A+K LK EE E + S ++H NIV
Sbjct: 13 LGEDRFGKVYK-GHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 311 RIIGYCHSKEMYAIVYNLLN-GSLKQYL-------------------KQLKWNERMDVAI 350
++G ++ +++++ + L ++L L+ + + +
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 351 GVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408
+A +E+L HH H+D+ + N+L+ + + ++SD G + + +
Sbjct: 132 QIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLN-VKISDLG---LFREVYAADYYKL 182
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
N + +++PE +MYGK D++SYGVVL E+ +
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQ-VAAVKVLKCTNW-SEEEV---LREVELLSSIKHENIVRIIG 314
IG+G KV + D Q + A+K ++ + S EV L E +L+ + IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG---VAKALEYLHHTCDPPIIHRD 371
S E +V +NG + L+ R D++ A+ L L + +I+RD
Sbjct: 61 SFQSPEKLYLVLAFINGG--ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
+K NILL H L DFG ++ + ++ K GT YLAPE ++ +
Sbjct: 119 LKPENILLDYQ-GHIALCDFGLCKLN-----MKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 432 KIDVYSYGVVLLELITG 448
+D ++ GV+L E++TG
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 42/213 (19%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLK-----------CTNWSEEEVLREVELL 301
+F ML G +VY A+KVLK CT + E +L
Sbjct: 7 SFGKVMLAELKGTDEVY----------AIKVLKKDVILQDDDVDCT-------MTEKRIL 49
Query: 302 S-SIKHENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERMD--VAIGVAKAL 356
+ + KH + + +K+ V +NG + Q + K++E A V AL
Sbjct: 50 ALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL 109
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
+LH +I+RD+K NILL H +L+DFG + V GT
Sbjct: 110 MFLHRH---GVIYRDLKLDNILLDAE-GHCKLADFGMC-----KEGILNGVTTTTFCGTP 160
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + + +D ++ GV++ E++ G+
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 296 REVELLSSIKHENIVRIIG-YCHSKEMYA-----IVYNLLNGSLKQYLKQLKWNERMDVA 349
RE+ L+ + H+NI+ ++ + K + IV L++ +L Q ++ +ERM
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ + L + H IIHRD+K SNI++ + ++ DFG A S ++ V
Sbjct: 132 L--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVV- 187
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
T Y APE ++ E +D++S G ++ E+I G
Sbjct: 188 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 16/172 (9%)
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLK---WNERM 346
E L E +L + +V + +K+ +V ++NG LK ++ + ++E+
Sbjct: 44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR 103
Query: 347 DV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
+ A + LE L I++RD+K NILL + H ++SD G A+ Q+
Sbjct: 104 AIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDR-GHIRISDLGLAV------QIP 153
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
E VGT GY+APE + K D + G ++ E+I G+ + K
Sbjct: 154 EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 296 REVELLSSIKHENIVRIIGYCHSKEM------YAIVYNLLNGSLKQYLKQLKWNE-RMDV 348
RE+ LL +KHEN++ ++ + +V + L + +K K +E R+
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF 122
Query: 349 AI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+ + K L+Y+H IIHRD+K N+ ++E+ L DFG A SE
Sbjct: 123 LVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL-DFGLA-----RQTDSEMT 173
Query: 408 KPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE ++ + + +D++S G ++ E++TGK
Sbjct: 174 ---GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 296 REVELLSSIKHENIVRIIG-------YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV 348
RE+ L+ + H+NI+ ++ +++Y +V L++ +L Q ++ +ERM
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY-LVMELMDANLCQVIQMDLDHERMSY 122
Query: 349 AI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
+ + +++LH IIHRD+K SNI++ + L DFG A S ++ V
Sbjct: 123 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL-DFGLARTAGTSFMMTPYV 178
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
T Y APE ++ E +D++S G ++ E+I G
Sbjct: 179 V------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 41/178 (23%), Positives = 81/178 (45%), Gaps = 15/178 (8%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGY-CHSKEMYAIVYNLLNGSLKQY 336
A+ L+ C++ L E L H NIVR+ G M + + NG+L +
Sbjct: 37 AIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSF 96
Query: 337 LK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392
L+ QL + M + G+A ++YL + +H+ + + +L++ + ++S F
Sbjct: 97 LRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLV-CKISGFR 152
Query: 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
+ +S + + + V + APE + Y DV+S+G+V+ E+++ E
Sbjct: 153 R-LQEDKSEAIYTTMSGKSPVL---WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 40/212 (18%)
Query: 259 LIGQGGNSKVYRTNHVDGQ-VAAVKVLKCTNWSEEEVLR---------EVELLSSIKHEN 308
+IG+G +V H Q V A+K+L S+ E+++ E ++++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLL-----SKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 309 IVRII-GYCHSKEMYAIVYNLLNGSLKQYLKQL----KWNERMDVAIGVAKALEYLHHTC 363
+V++ + K +Y ++ + G L + KW + V AL+ +H
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAE--VVLALDAIHSM- 161
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
+IHRDVK N+LL + H +L+DFG M ++ V + VGT Y++PE
Sbjct: 162 --GLIHRDVKPDNMLL-DKHGHLKLADFGTCMKMDETGMVRCD----TAVGTPDYISPEV 214
Query: 424 M-------MYGKVDEKIDVYSYGVVLLELITG 448
+ YG+ + D +S GV L E++ G
Sbjct: 215 LKSQGGDGYYGR---ECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ AL YLH +CD +++RD+K N++L + H +++DFG +S+
Sbjct: 104 IVSALGYLH-SCD--VVYRDLKLENLML-DKDGHIKITDFGLC-----KEGISDGATMKT 154
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
GT YLAPE + +D + GVV+ E++ G+
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 50/212 (23%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDG-QVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+F+ M++G+G KV ++ A+K+LK ++ V+++ ++ ++ + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILK-----KDVVIQDDDVECTMVEKRVLA 55
Query: 312 IIG------YCHS-----KEMYAIVYNLLNGSLKQYLKQL-KWNERMDV--AIGVAKALE 357
+ G HS +Y ++ + G L ++Q+ ++ E V A +A L
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
+LH II+RD+K N++L H +++DFG + + V GT
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDSE-GHIKIADFGMC-----KENMWDGVTTKTFCGTPD 166
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + Y + +D +++GV+L E++ G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKC-TNWSEEEV---LREVELLSSIKHENIVRII 313
L+G+G KV G+ A+K+LK +++EV L E +L + +H + +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 314 GYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERMDVAIG--VAKALEYLHHTCDPPIIH 369
+K+ V +NG ++ ++E G + AL+YLH I++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVY 118
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
RD+K N++L ++ H +++DFG +++ GT YLAPE +
Sbjct: 119 RDLKLENLMLDKD-GHIKITDFGLC-----KEGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 430 DEKIDVYSYGVVLLELITGK 449
+D + GVV+ E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 45/193 (23%), Positives = 79/193 (40%), Gaps = 38/193 (19%)
Query: 280 AVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC---HSKEMYAIVYNLL---- 329
AVK +K + EE L E + H N++++IG C S + +L
Sbjct: 31 AVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMK 90
Query: 330 NGSLKQYL---------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380
+G L +L ++L + + +A +EYL + IHRD+ + N +L
Sbjct: 91 HGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLR 147
Query: 381 ENFHHPQLSDFGAAM------VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
E+ ++DFG + + Q VK ++A E + K D
Sbjct: 148 EDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVK---------WIAIESLADRVYTSKSD 197
Query: 435 VYSYGVVLLELIT 447
V+++GV + E+ T
Sbjct: 198 VWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 33/117 (28%), Positives = 47/117 (40%), Gaps = 40/117 (34%)
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH-----QVSENVKPVN----------- 411
IHRD+K N+LL H +LSDFG +SH ++ + P N
Sbjct: 123 IHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 412 -----------------VVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITG 448
VGT Y+APE + Y K D +S GV++ E++ G
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE---CDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 29/188 (15%)
Query: 276 GQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN--LLN 330
G+ A+K L SE + RE+ LL ++HEN++ ++ S + L+
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 331 GSLKQYLKQLKWNERMDVAI-----GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385
++ L+++ + + + + L+Y+H IIHRD+K N+ ++E+
Sbjct: 100 PYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCEL 156
Query: 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE----YMMYGKVDEKIDVYSYGVV 441
L DFG A + + V T Y APE +M Y + +D++S G +
Sbjct: 157 KIL-DFGLAR--------HADAEMTGYVVTRWYRAPEVILNWMHYNQT---VDIWSVGCI 204
Query: 442 LLELITGK 449
+ E++TGK
Sbjct: 205 MAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 19/143 (13%)
Query: 315 YC--HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV------AIGVAKALEYLHHTCDPP 366
YC +KE V LNG + Q K R D+ A + L++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---G 116
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
II+RD+K N++L + H +++DFG + + +N + GT Y+APE +
Sbjct: 117 IIYRDLKLDNVMLDRD-GHIKIADFGMC----KENVFGDN-RASTFCGTPDYIAPEILQG 170
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
K +D +S+GV+L E++ G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 260 IGQGGNSKVYRTNH-------VDGQVAAV----KVLKCTNWSEEEVLREVELLSSIKHEN 308
+GQG + +Y+ + G V KVL + L+S + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 309 IVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNE----RMDVAIGVAKALEYLHHTC 363
+V++ G C E +V + G L +L + K N ++DVA +A AL YL
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118
Query: 364 DPPIIHRDVKSSNILL---SENFHHP---QLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
D ++H +V NIL+ N + +LSD G + E V+ +
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT---VLSREERVERIP------ 169
Query: 418 YLAPEYMMYG--KVDEKIDVYSYGVVLLELIT-GKEAIQT 454
++APE + G + D +S+G LLE+ + G+E + T
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 17/99 (17%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
AL +LH + II+RD+K N+LL H +L+D+G E ++P +
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAE-GHIKLTDYG---------MCKEGIRPGDTTS 154
Query: 415 TF----GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
TF Y+APE + +D ++ GV++ E++ G+
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 36/213 (16%)
Query: 260 IGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWSEEEVL-----REVELLSSIK-HENIV 310
+GQG V + + + A+K K TN +++L RE++LL + H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIK--KITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 311 RIIGYCHSKEMYAIVYNLLNGS-LKQYLKQLKWNE--RMDVAIGVAK----------ALE 357
+ +M + N L + L + ++ R + A L+
Sbjct: 66 CLY------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
Y+H ++HRD+K N+L++ + ++ DFG A ++ + V T
Sbjct: 120 YIHSA---NVLHRDLKPGNLLVNADCEL-KICDFGLARGFSENPGENAG-FMTEYVATRW 174
Query: 418 YLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
Y APE M+ + + IDV+S G +L EL+ K
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-- 425
+HRD+K N+LL +N H +L+DFG+ + V NV VGT Y++PE +
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNV----AVGTPDYISPEILQAM 178
Query: 426 ---YGKVDEKIDVYSYGVVLLELITGK 449
G+ + D +S GV + E++ G+
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 296 REVELLSSIKHENIVRIIGYCHSKEMYA------IVYNLLNGSLKQYLKQLKWNERMDVA 349
RE+ L+ + H+NI+ ++ ++ +V L++ +L Q ++ +ERM
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ + L + H IIHRD+K SNI++ + ++ DFG A S ++ V
Sbjct: 125 L--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVV- 180
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
T Y APE ++ E +D++S G ++ E++ K
Sbjct: 181 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 280 AVKVLK---CTNWSEEEVLREVELLSSIKHENIVRIIGYC---HSKEMY----AIVYNLL 329
AVK +K CT E+ L E + H N++R+IG C E Y I+ +
Sbjct: 30 AVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMK 89
Query: 330 NGSLKQYLKQLKWNER---------MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380
+G L +L + + + +A +EYL IHRD+ + N +L+
Sbjct: 90 HGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLN 146
Query: 381 ENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYG 439
EN + ++DFG + +++ + + + V ++A E + K DV+S+G
Sbjct: 147 ENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPV----KWIAIESLADRVYTTKSDVWSFG 201
Query: 440 VVLLELIT 447
V + E+ T
Sbjct: 202 VTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 45/188 (23%), Positives = 93/188 (49%), Gaps = 30/188 (15%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQY 336
AVK+L+ + + L+E++++S +K NI+R++ C S + I + NG L Q+
Sbjct: 50 AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109
Query: 337 LKQLKWNERMD--------------VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382
L + + E + +A +A ++YL +HRD+ + N L+ +N
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKN 166
Query: 383 FHHPQLSDFGAA--MVHHQSHQVS-ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYG 439
+ +++DFG + + +++ V P+ +++ E ++ GK DV+++G
Sbjct: 167 Y-TIKIADFGMSRNLYSGDYYRIQGRAVLPIR------WMSWESILLGKFTTASDVWAFG 219
Query: 440 VVLLELIT 447
V L E++T
Sbjct: 220 VTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 260 IGQGGN--SKVYRTNHV-DGQVAAVKVLKCTNWSEEEV---LREVELLSSIKHENIVRII 313
IG+G + VY H G + V++ N +EE + EV L +H NI+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 314 G-YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI------GVAKALEYLHHTCDPP 366
+ ++ I + GS LK + E M A+ G + L YLH
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQN---G 121
Query: 367 IIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
IHR++K+S+IL+S + LS + + + Q +V + P +L+PE +
Sbjct: 122 YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF-PQFSTSVLPWLSPELL 180
Query: 425 ---MYGKVDEKIDVYSYGVVLLELITGKEAIQ 453
+YG + K D+YS G+ EL TG+ Q
Sbjct: 181 RQDLYG-YNVKSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 62/299 (20%), Positives = 117/299 (39%), Gaps = 37/299 (12%)
Query: 161 NVLLKSSLSSSSKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPE 220
LL ++ A P+ S + + V +AQ ++ +
Sbjct: 90 GELLVPRSNADLFASAGDGPSGAEDSDASHLDFDEAPPD-----AAGPVPLAQAKLKHDD 144
Query: 221 SIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAA 280
F + L G+ F +C L + + +G NS + +A
Sbjct: 145 EFLAH-FRVIDDL-PAGA---FGKIFICAL-RASTEEAEARRGVNSTNQGKPKCERLIA- 197
Query: 281 VKVLKCTNWSEEEVLREVELLSSIKHENIVRI------------IGYCHSKEMYAIVYNL 328
K +K + + ++ E+ L + HENI++I I + ++Y+ +Y+
Sbjct: 198 -KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD- 255
Query: 329 LNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388
+ + L R + + A+EY+H D +IHRD+K NI L+ + L
Sbjct: 256 --EAFDWKDRPLLKQTRA-IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD-GKIVL 308
Query: 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
DFG AM + + + VGT +PE + E D++S G++LL++++
Sbjct: 309 GDFGTAMPFEKEREAFD----YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ ALEYLH +++RD+K N++L ++ H +++DFG +S+
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKD-GHIKITDFGLC-----KEGISDGATMKT 154
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
GT YLAPE + +D + GVV+ E++ G+
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 34/109 (31%), Positives = 53/109 (48%), Gaps = 19/109 (17%)
Query: 346 MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405
M +AI L Y +HRD+K NIL+ N H +L+DFG+ + + V
Sbjct: 111 MVIAIDSVHQLHY---------VHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQS 160
Query: 406 NVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGK 449
+V VGT Y++PE + GK + D +S GV + E++ G+
Sbjct: 161 SV----AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 18/104 (17%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
V AL+ +H IHRDVK N+LL ++ H +L+DFG M ++ V +
Sbjct: 151 VVLALDAIHSM---GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCD----T 202
Query: 412 VVGTFGYLAPEYM-------MYGKVDEKIDVYSYGVVLLELITG 448
VGT Y++PE + YG+ + D +S GV L E++ G
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 51/189 (26%), Positives = 89/189 (47%), Gaps = 36/189 (19%)
Query: 281 VKVLKCTNWSEEEV---LREVELLSSIKHENIVRIIGYC---HSKEMYAIVYNLLNGSLK 334
VK +K + SE +V L+E LL + H+NI+ I+ C Y G+LK
Sbjct: 40 VKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNW-GNLK 97
Query: 335 QYLKQLKWNER-----------MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383
+L+Q + E + +AI +A + YLH +IH+D+ + N ++ E
Sbjct: 98 LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEEL 154
Query: 384 HHPQLSDFGAA-----MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSY 438
+++D + M +H +EN +PV ++A E ++ + DV+S+
Sbjct: 155 -QVKITDNALSRDLFPMDYH-CLGDNEN-RPVK------WMALESLVNKEYSSASDVWSF 205
Query: 439 GVVLLELIT 447
GV+L EL+T
Sbjct: 206 GVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 51/288 (17%)
Query: 260 IGQGGNSKVYRTN-HVDGQVA--AVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIG 314
IG G KV + + D VA VK LK S+E E L++ + ++H NI++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 315 YCHSKEMYAIVYNLLN-GSLKQYLKQLKWN---------ERMDVAIGVAKALEYLHHTCD 364
C Y +V+ G LK YL Q +W+ +RM I + H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV--------NVVGTF 416
+H D+ N L+ + ++ D+G ++ + +VG F
Sbjct: 120 --FLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 417 --GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL--VLWARSLLSS 472
G + E +V++ GV L EL ++ ++RE L V+ + +
Sbjct: 177 HGGLITAEQTKPS------NVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV--- 227
Query: 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520
+L PQL Y+ E++ + C L S +R T + + +L
Sbjct: 228 ----KLFKPQLELPYSERWYEVL----QFCWL-SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 17/99 (17%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
AL +LH + II+RD+K N+LL + H +L+D+G E + P +
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAD-GHIKLTDYG---------MCKEGLGPGDTTS 154
Query: 415 TF----GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
TF Y+APE + + +D ++ GV++ E++ G+
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 28/171 (16%)
Query: 352 VAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
VA+ +E+L C IHRD+ + NILLSEN + ++ DFG A ++ + V+
Sbjct: 182 VARGMEFLASRKC----IHRDLAARNILLSEN-NVVKICDFGLA---RDIYKDPDYVRKG 233
Query: 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSL 469
+ ++APE + + DV+S+GV+L E+ + G + + E
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--------- 284
Query: 470 LSSGLCERLID--PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
C RL + EY EI +M C ++ RPT L++
Sbjct: 285 ----FCRRLKEGTRMRAPEYATPEIYSIMLD---CWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 27/98 (27%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ AL+YLH + +++RD+K N++L ++ H +++DFG + +
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKD-GHIKITDFGLC-----KEGIKDGATMKT 155
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
GT YLAPE + +D + GVV+ E++ G+
Sbjct: 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 8/105 (7%)
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQSHQVSE 405
+ GV KAL+Y+HH +HR VK+S+IL+S + + L + + H Q +V
Sbjct: 106 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162
Query: 406 NVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITG 448
+ P V +L+PE + D K D+YS G+ EL G
Sbjct: 163 DF-PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 30/102 (29%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
++ AL YLH + II+RD+K N+LL H +L+D+G E ++P +
Sbjct: 105 ISLALNYLH---ERGIIYRDLKLDNVLLDSE-GHIKLTDYG---------MCKEGLRPGD 151
Query: 412 VV----GTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
GT Y+APE + +D ++ GV++ E++ G+
Sbjct: 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 50/148 (33%), Positives = 75/148 (50%), Gaps = 17/148 (11%)
Query: 260 IGQGGNSKVY--RTNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRII 313
I +G KVY R + + ++ AVKV+K + +V E + L+ K IV +
Sbjct: 12 ISRGAFGKVYLGRKKN-NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 314 GYCHS-KEMYAIVYNLLNGSLKQYLKQLKW-NERMDVAI--GVAKALEYLH-HTCDPPII 368
S +Y ++ L+ G +K L + +E M V VA AL+YLH H II
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG----II 126
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMV 396
HRD+K N+L+S N H +L+DFG + V
Sbjct: 127 HRDLKPDNMLIS-NEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 39/233 (16%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE----VLREVELLSSIKHE 307
+F +IG+G +V D G V A+K+L+ + E+E + E ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 308 NIVRIIGYCHSK-EMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366
+V++ K +Y I+ L G + L + + +A+ + +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN--------------- 411
IHRD+K N+LL H +LSDFG ++H+ +E + +N
Sbjct: 122 FIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHR-TEFYRNLNHSLPSDFTFQNMNSK 179
Query: 412 ----------------VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
VGT Y+APE M ++ D +S GV++ E++ G
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 44/149 (29%), Positives = 60/149 (40%), Gaps = 38/149 (25%)
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV 413
AL+ LH T I+HRDVK NI+ SE ++ D GAA +V N P +
Sbjct: 266 FALDGLHST---GIVHRDVKPQNIIFSEGSGSFKIIDLGAA----ADLRVGINYIPKEFL 318
Query: 414 GTFGYLAPE-YMMYGKVDE---------------------KIDVYSYGVVLLE-----LI 446
Y APE Y+M + + D+YS G++ L+ L
Sbjct: 319 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLR 378
Query: 447 TGKEAIQTN---KANRESLVLWARSLLSS 472
+ IQ N K N LV W R L+
Sbjct: 379 SDSNLIQFNRQLKRNDYDLVAW-RKLVEP 406
|
Length = 566 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 43/235 (18%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE----VLREVELLSSIKHE 307
+F +IG+G +V D G + A+K+L+ + E+E + E ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 308 NIVRII-GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK---ALEYLHHTC 363
+V++ + + +Y I+ L G + L + +A+ A++ +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL- 120
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV-------------------- 403
IHRD+K N+LL H +LSDFG ++H+
Sbjct: 121 --GFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 404 ----SENVK------PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
+E K + VGT Y+APE M ++ D +S GV++ E++ G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 13/93 (13%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ---LSDFGAAMVHHQSHQVSENVKPVN 411
A++Y+H IIHRD+K+ N+L++ P+ L DFGAA S
Sbjct: 272 AIDYIHGE---GIIHRDIKTENVLVNG----PEDICLGDFGAACFARGSWSTP---FHYG 321
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLE 444
+ GT APE + +D++S G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENIVRIIG-- 314
+G+G VY+ H G A+K L+ +++ E+++L IV G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPPII 368
+ + Y + GSL + E + + V K L++L + II
Sbjct: 69 FIEGAVYMCMEY-MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRDVK +N+L++ N +L DFG S + ++ N +G Y+APE + G
Sbjct: 126 HRDVKPTNVLVNGN-GQVKLCDFGV------SGNLVASLAKTN-IGCQSYMAPERIKSGG 177
Query: 429 VDEKI------DVYSYGVVLLELITGK 449
++ DV+S G+ +LE+ G+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 43/185 (23%), Positives = 85/185 (45%), Gaps = 26/185 (14%)
Query: 292 EEVLREVELLSSIKHENIVRIIG-YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI 350
+ V E ++L+ I H V + G + +Y ++ ++ G +L++ N+R +
Sbjct: 76 DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR---NKRFPNDV 132
Query: 351 GVAKA------LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
G A EYL I++RD+K N+LL ++ +++DFG A V
Sbjct: 133 GCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKD-GFIKMTDFGFAKV-------- 180
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464
+ + + GT Y+APE ++ + D ++ G+ + E++ G N E L++
Sbjct: 181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN----EPLLI 236
Query: 465 WARSL 469
+ + L
Sbjct: 237 YQKIL 241
|
Length = 340 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 17/101 (16%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
V L+YLH + I++RD+K N+LL +++DFG E + +
Sbjct: 110 VVLGLQYLH---ENKIVYRDLKLDNLLLDTE-GFVKIADFGLC---------KEGMGFGD 156
Query: 412 VVGTF----GYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
TF +LAPE + +D + GV++ E++ G
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 28/173 (16%)
Query: 352 VAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
VA+ +E+L C IHRD+ + NILLSEN + ++ DFG A ++ + V+
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSEN-NVVKICDFGLA---RDIYKDPDYVRKG 234
Query: 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSL 469
+ ++APE + + DV+S+GV+L E+ + G + N E
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--------- 285
Query: 470 LSSGLCERLIDPQLNE--EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520
C+RL D E EI +M A C RPT L+++
Sbjct: 286 ----FCQRLKDGTRMRAPENATPEIYRIMLA---CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 15/100 (15%)
Query: 352 VAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK 408
VA+ +++L C IHRDV + N+LL+ + ++ DFG A +++ ++ V N +
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNAR 275
Query: 409 -PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
PV ++APE + + DV+SYG++L E+ +
Sbjct: 276 LPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 32/194 (16%)
Query: 276 GQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC-HSKEM------YAIV 325
Q AVK+LK +S EE LRE + H N++++IG S+ I+
Sbjct: 27 FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86
Query: 326 YNLLNGSLKQYLKQLKWNER---------MDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
+ +G L +L + E + I +A +EYL IHRD+ + N
Sbjct: 87 PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARN 143
Query: 377 ILLSENFHHPQLSDFGAAMVHHQS---HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKI 433
+L+EN ++DFG + + Q + PV +LA E +
Sbjct: 144 CMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVK------WLALESLADNVYTTHS 196
Query: 434 DVYSYGVVLLELIT 447
DV+++GV + E++T
Sbjct: 197 DVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 30/123 (24%), Positives = 45/123 (36%), Gaps = 43/123 (34%)
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH---------QVSENVKPVN------- 411
IHRD+K NIL+ H +LSDFG + H+ H Q N ++
Sbjct: 123 IHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 412 --------------------------VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
VGT Y+APE + ++ D +S G ++ E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241
Query: 446 ITG 448
+ G
Sbjct: 242 LIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 37/136 (27%), Positives = 58/136 (42%), Gaps = 42/136 (30%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM--------------VH 397
+ A+E +H IHRD+K NIL+ + H +L+DFG H
Sbjct: 110 LTCAIESVHKM---GFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 398 HQ------SHQVSEN----VKPVNV--------------VGTFGYLAPEYMMYGKVDEKI 433
H+ S + SE +KP+ VGT Y+APE ++ +
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 434 DVYSYGVVLLELITGK 449
D +S GV+L E++ G+
Sbjct: 226 DWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 24/126 (19%), Positives = 53/126 (42%), Gaps = 7/126 (5%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV--RIIGYC 316
L+ G ++VY + +K+ + + REV +L + + + +++
Sbjct: 5 LLKGGLTNRVYLL-GTKDEDYVLKINP-SREKGADREREVAILQLLARKGLPVPKVLASG 62
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376
S ++ + G + L ++ E+ D+A +A+ L LH + H D+ N
Sbjct: 63 ESDGWSYLLMEWIEG---ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGN 119
Query: 377 ILLSEN 382
IL+ +
Sbjct: 120 ILVDDG 125
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 35/146 (23%), Positives = 59/146 (40%), Gaps = 45/146 (30%)
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH-------------------------- 401
IHRD+K NIL+ + H +L+DFG +H
Sbjct: 123 IHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 402 --QVSENVKPV--------------NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLEL 445
+ + +KP+ ++VGT Y+APE ++ + D +S GV+L E+
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 446 ITGKEAI--QTNKANRESLVLWARSL 469
+ G+ QT + ++ W SL
Sbjct: 242 LVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 30/100 (30%), Positives = 43/100 (43%), Gaps = 16/100 (16%)
Query: 352 VAKALEYLH-HTCDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKP 409
+ +AL LH H IIH D+K N+L L D+G ++ S
Sbjct: 118 LVEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY------- 166
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
GT Y +PE + D D ++ GV+ EL+TGK
Sbjct: 167 ---DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 352 VAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
VAK +E+L C IHRD+ + NILLSEN + ++ DFG A ++ + V+
Sbjct: 188 VAKGMEFLASRKC----IHRDLAARNILLSEN-NVVKICDFGLA---RDIYKDPDYVRKG 239
Query: 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
+ ++APE + + DV+S+GV+L E+ +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 340 LKWNERMDVAIGVAKALEYL-HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-VH 397
L + + VA+ +E+L C +HRD+ + N+LL++ ++ DFG A +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQG-KIVKICDFGLARDIM 288
Query: 398 HQSHQVSENVK--PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
H S+ VS+ PV ++APE + DV+SYG++L E+ +
Sbjct: 289 HDSNYVSKGSTFLPVK------WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 260 IGQGGNSKVYRTNHVD----GQVAAVKVL------KCTNWSEEEVLREVELLSSIKHENI 309
+GQG +K+++ + G++ +VL N+SE ++S + H+++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSES-FFEAASMMSQLSHKHL 61
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEY-LHHTCDPPI 367
V G C + +V + GSL YLK+ K + + VAK L + LH D +
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGL 121
Query: 368 IHRDVKSSNILL 379
H +V + N+LL
Sbjct: 122 THGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 549 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.66 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.56 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 98.5 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 98.49 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 98.49 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 98.37 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 98.35 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.34 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.33 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.29 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.28 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 98.23 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 98.23 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.1 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.05 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.98 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.92 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.88 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.81 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 97.74 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.72 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.65 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.55 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.46 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.39 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 97.25 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.21 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.19 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.13 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 97.12 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.08 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 96.99 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.73 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.3 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.23 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 96.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.89 | |
| PLN02236 | 344 | choline kinase | 95.87 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.67 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.58 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.47 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=434.44 Aligned_cols=280 Identities=45% Similarity=0.775 Sum_probs=249.6
Q ss_pred CccccCHHHHHhhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEE
Q 008898 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYC 316 (549)
Q Consensus 238 ~~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~ 316 (549)
..+.|++.++..+|++|...++||+|+||.||+|...+|..+|||.+...... ..+|..|++++.+++|||+++|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999988999999988876554 66799999999999999999999999
Q ss_pred EcCC-eEEEEEecc-CCCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEe
Q 008898 317 HSKE-MYAIVYNLL-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389 (549)
Q Consensus 317 ~~~~-~~~lv~e~~-~gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~ 389 (549)
.+.+ ..+|||||+ +|+|.++|. .++|..+++||.++|+||+|||+.+...||||||||+|||||+++ ++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEcc
Confidence 9988 599999999 899999983 468999999999999999999999888899999999999999996 89999
Q ss_pred eeccccccccccccccCcccccc-ccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCccc-chhhHHHHHH
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNV-VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWAR 467 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~-~~~~l~~~~~ 467 (549)
|||+|+..... .....+. .||++|+|||++..+..+.|+|||||||+|+||+||+++.+...+ ....+..|+.
T Consensus 220 DFGLa~~~~~~-----~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 220 DFGLAKLGPEG-----DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred CccCcccCCcc-----ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999554320 1111122 799999999999999999999999999999999999999987653 4556999999
Q ss_pred HhhcccccccccCCccc-ccCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 468 SLLSSGLCERLIDPQLN-EEYNR-EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
+....+.+.+++|+.+. ..+.. ++...+..++..|++.+|..||+|.+|++.|+..
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999999999987 66665 6889999999999999999999999999988443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=384.96 Aligned_cols=257 Identities=28% Similarity=0.409 Sum_probs=211.1
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC--CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-eEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT--NWSEEEVLREVELLSSIKHENIVRIIGYCHSKE-MYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-~~~lv~e~ 328 (549)
+.+..+.||+|..|+||++.| .+++.+|+|++... ....+++.+|++|++..+|||||.+||.|..+. ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 445567799999999999998 57999999999433 334578999999999999999999999999888 59999999
Q ss_pred c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 329 ~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
| +|+|+++++. +++.....++.+|++||.|||+ . +||||||||+|||++.. |++||||||.+....++
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS--- 232 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccC-CCEEeccccccHHhhhh---
Confidence 9 7899999976 8888899999999999999996 5 99999999999999998 89999999998654432
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+................+.. -.-|.+
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~------~ppP~l 302 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD------EPPPRL 302 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc------CCCCCC
Confidence 5568899999999999999999999999999999999999999998753222211111111111 112333
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
+.. .+...+..++..||++||.+||++.++++ |+|++.....+
T Consensus 303 P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~-----Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 303 PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ-----HPFIKKFEDPN 345 (364)
T ss_pred Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc-----CHHHhhccccc
Confidence 332 35566777889999999999999999999 99998766543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=389.64 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=207.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--------SEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
.+.|.+.+.||+|+||.|-+|.. .+|+.||||++++... ....+.+|++||++|+|||||+++++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45688889999999999999965 7899999999975421 22346799999999999999999999999999
Q ss_pred EEEEEecc-CCCHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeecccc
Q 008898 322 YAIVYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAM 395 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla~ 395 (549)
.|+||||+ +|+|.+++- .+.+..-..+++|++.|+.|||+. ||+||||||+|||+..+ .-.+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999 789999983 366666678999999999999999 99999999999999765 1268999999998
Q ss_pred ccccccccccCccccccccCCccccccccccCCC---CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV---DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS 472 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 472 (549)
+... .....+.||||.|.|||++..+++ ..++|+||+||+||-+|+|.+||........... .+. .
T Consensus 328 ~~g~------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----QI~-~ 396 (475)
T KOG0615|consen 328 VSGE------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----QIL-K 396 (475)
T ss_pred cccc------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH----HHh-c
Confidence 7543 334568899999999999987653 4588999999999999999999987654432111 111 1
Q ss_pred cccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 473 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
|... ..+.+-....+...++|.+||..||++|||+.|+++ |+||+...
T Consensus 397 G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~-----hpW~~~~~ 444 (475)
T KOG0615|consen 397 GRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN-----HPWFKDAP 444 (475)
T ss_pred Cccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc-----Chhhhccc
Confidence 1110 111223455678889999999999999999999999 99998544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=397.30 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=211.7
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
..|...++||+|||++||.+.. .+|..||+|++.+. ....+.+.+|++|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3588999999999999999988 78999999999763 344577899999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+| +|+|.+++++ +++.++..+..||+.||.|||++ +|||||||..|+||++++ ++||+|||+|.....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~--- 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEY--- 170 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcC-cEEecccceeeeecC---
Confidence 999 8999999964 88999999999999999999999 999999999999999995 899999999976543
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
+..+..+.||||.|+|||++...+++..+||||+|||||-||.|++||+...-.. ....+ ...+..-
T Consensus 171 --~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-----ty~~I----k~~~Y~~-- 237 (592)
T KOG0575|consen 171 --DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-----TYNKI----KLNEYSM-- 237 (592)
T ss_pred --cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-----HHHHH----HhcCccc--
Confidence 3345568999999999999999999999999999999999999999998764321 11111 1112211
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+........+||..+|++||.+|||+++|+. |+||+.-
T Consensus 238 -----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~-----h~Ff~~g 275 (592)
T KOG0575|consen 238 -----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD-----HPFFKSG 275 (592)
T ss_pred -----ccccCHHHHHHHHHHhcCCcccCCCHHHHhc-----CHhhhCC
Confidence 1233445667889999999999999999998 8888443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=377.70 Aligned_cols=266 Identities=26% Similarity=0.332 Sum_probs=216.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|++.++||+|+||+||.++. .+++.||+|++++... ..+....|..||..++||+||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 35799999999999999999987 5699999999986543 235688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
++|+ +|.|.-+|++ +.+.....++..|+.||.|||++ +||||||||+|||||.+ |+++|+|||+|+..
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~---- 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQ-GHIKLTDFGLCKED---- 175 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCC-CcEEEeccccchhc----
Confidence 9999 6799999974 78888888999999999999999 99999999999999999 89999999999643
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
...+....++|||+.|||||++.+.+|+.++|+||||+++|||++|.+||...+.. .+.+.+.... +
T Consensus 176 -~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~~I~~~k----~--- 242 (357)
T KOG0598|consen 176 -LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYDKILKGK----L--- 242 (357)
T ss_pred -ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHHHHhcCc----C---
Confidence 33444556799999999999999999999999999999999999999999876532 2222222222 0
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHHhcCCchhhhhhhHHHHHHh-hccCCCC
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRP----TMKTLLKLFQEPDYWLKMKREKEELLN-ERRSNGP 545 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP----s~~evl~~L~~~~~w~~~~~~~~~~~~-~~~~~~~ 545 (549)
..++.-......+++...+..||++|. .+.+|-+ |+||+..++..-..+ ..+.+.|
T Consensus 243 ---~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~-----HpfF~~inW~~l~~k~l~PpF~P 303 (357)
T KOG0598|consen 243 ---PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR-----HPFFKGINWEKLLAKKLSPPFKP 303 (357)
T ss_pred ---CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc-----CcccccCCHHHHHhcCCCCCeec
Confidence 111112334567778999999999996 4555544 788888887776654 3334443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=378.09 Aligned_cols=248 Identities=30% Similarity=0.481 Sum_probs=203.4
Q ss_pred CCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-eEEEEEecc-
Q 008898 255 SPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKE-MYAIVYNLL- 329 (549)
Q Consensus 255 ~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-~~~lv~e~~- 329 (549)
...+.||.|+||+||+|.+.....+|||++...... .+.|.+|+.+|++++|||||+++|+|.+.. .+++||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 344459999999999999865555999999865433 347999999999999999999999999887 799999999
Q ss_pred CCCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCC-EEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPP-IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 ~gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~-iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+|+|.+++. .+++..++.++.|||.||.|||++ + ||||||||+|||++.++.++||+|||+++......
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 899999993 378888999999999999999999 7 99999999999999993389999999997755432
Q ss_pred ccCccccccccCCccccccccc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 404 SENVKPVNVVGTFGYLAPEYMM--YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~--~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||......+.. .... ..
T Consensus 199 ---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~-----~~v~---------~~ 261 (362)
T KOG0192|consen 199 ---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA-----SAVV---------VG 261 (362)
T ss_pred ---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH-----HHHH---------hc
Confidence 2222368999999999999 568999999999999999999999999887652211 1111 11
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.....++..+...+..++..||..||..||++.+++..|+...
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 1222223336667888889999999999999999999987654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=362.03 Aligned_cols=198 Identities=30% Similarity=0.492 Sum_probs=175.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
..+|...+.||+|+||+||+|.+ .++..||||.+.+.... .+-+..|+.||+.++|||||.+++++..++.+++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35788888899999999999988 56899999999766422 345789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC-----CceEEeeecccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF-----HHPQLSDFGAAMVH 397 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~~kL~DFGla~~~ 397 (549)
||| +|+|.+|+++ +++.....++.||+.||++||++ +||||||||+||||+... ..+||+|||+|+..
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999 6899999965 67788889999999999999999 999999999999998641 25899999999875
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~ 457 (549)
.. .....+.||+|-|||||+++.+.|+.|+|+||+|+|+|+|++|++||+....
T Consensus 166 ~~------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 166 QP------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred Cc------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 53 4455688999999999999999999999999999999999999999987654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=381.90 Aligned_cols=265 Identities=21% Similarity=0.295 Sum_probs=214.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l 324 (549)
.++|...++||+|.||+|+++.. .+++.||||+++++.. +.+..+.|..|+.... ||++++|++.|++.+.+|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 35799999999999999999987 5688999999998753 3456888999988775 9999999999999999999
Q ss_pred EEecc-CCCHHHHH--HHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 325 VYNLL-NGSLKQYL--KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 325 v~e~~-~gsL~~~l--~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
||||+ +|+|..+. ..+++..+..++..|+.||+|||++ +|||||||.+|||||.+ |++||+|||+++.
T Consensus 447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe----- 517 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTE-GHVKIADFGLCKE----- 517 (694)
T ss_pred EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEccc-CcEEecccccccc-----
Confidence 99999 56755544 3488888889999999999999999 99999999999999999 8999999999943
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
....+..+.++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+++++. .+ ..+. ..|+
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~F----dsI~-------~d~~ 585 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VF----DSIV-------NDEV 585 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HH----HHHh-------cCCC
Confidence 3445557789999999999999999999999999999999999999999998776432 11 1111 1122
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCchhhhhhhHHHHHHh-hccCCCC
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTM-----KTLLKLFQEPDYWLKMKREKEELLN-ERRSNGP 545 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~L~~~~~w~~~~~~~~~~~~-~~~~~~~ 545 (549)
.+ +.-+......+++.+|.++|++|..+ .+|.+ |++|+...+.+-..+ ..+++.|
T Consensus 586 ~y----P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~-----hpFFr~i~w~~L~~r~i~PPf~P 646 (694)
T KOG0694|consen 586 RY----PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK-----HPFFRSIDWDDLLNRRIKPPFVP 646 (694)
T ss_pred CC----CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh-----CCccccCCHHHHhhccCCCCCCc
Confidence 22 33334455667789999999999976 44554 788888887765554 4444444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=344.87 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=213.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|+..+.||.|+||+|.+++. .+|..||+|++++.... .+....|..+|+.+.||+++++++.|.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4799999999999999999987 56899999999866532 245778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||. +|.|..++++ +++.....+|.+|+.||+|||++ +|++|||||+|||+|.+ |++||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQN-GHIKITDFGFAKRVSG--- 196 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccC-CcEEEEeccceEEecC---
Confidence 999 7789999965 88899999999999999999999 99999999999999999 8999999999965432
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.+.+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||....+.+ . .+.+... ++ .
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----i-Y~KI~~~----~v---~ 259 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----I-YEKILEG----KV---K 259 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH----H-HHHHHhC----cc---c
Confidence 3568899999999999999999999999999999999999999998776521 1 1122111 11 1
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCC-----CCHHHHHHHhcCCchhhhhhhHHHHHHh-hccCCCC
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRR-----PTMKTLLKLFQEPDYWLKMKREKEELLN-ERRSNGP 545 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~R-----Ps~~evl~~L~~~~~w~~~~~~~~~~~~-~~~~~~~ 545 (549)
. +.-....+.+|++..++.|-.+| +...+|-. |+||+...+.+.+.. -+.+++|
T Consensus 260 f----P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~-----H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 260 F----PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKN-----HPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred C----CcccCHHHHHHHHHHHhhhhHhhhcCcCCCcccccc-----CcccccccHHHHhhccccCCCCC
Confidence 1 22223346677788899999888 33445554 799998887776655 3334444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=346.18 Aligned_cols=268 Identities=23% Similarity=0.341 Sum_probs=212.7
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+.|+...++|+|+||.||+|++ .+|+.||||.+..+..++ +-.++|+.+|++|+|+|+|.|+.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3577788899999999999988 459999999998665443 347899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
||..++.+-|+. .+......+++|++.|+.|+|++ ++|||||||+|||++.+ |.+||||||+|+....
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~---- 153 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQN-GVVKLCDFGFARTLSA---- 153 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecC-CcEEeccchhhHhhcC----
Confidence 999887777765 56677888999999999999999 99999999999999999 7999999999977542
Q ss_pred ccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc---------
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--------- 473 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--------- 473 (549)
.+...+..+.|..|.|||.+.+ ..|+..+||||+||++.||++|.+.|.+..+- +.+....+.+..--
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-DQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-DQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH-HHHHHHHHHHcccCHHHHHHhcc
Confidence 3344556788999999999987 57999999999999999999999999887642 33443333332111
Q ss_pred --cccccc--CCcccccC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 474 --LCERLI--DPQLNEEY---NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 474 --~~~~~~--d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.+..+. .+.-..+. .+....-+.++++.||..||.+|++-++++. |++|..-.+.+
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~-----H~yFd~~~er~ 294 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH-----HPYFDGFIERE 294 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc-----ChHHHHHHHHH
Confidence 111111 11111111 1233457889999999999999999999997 77775544443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=351.26 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=200.7
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEE-EE-EcCCeEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIG-YC-HSKEMYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~-~~-~~~~~~~lv~ 326 (549)
+|.++++||+|.||.||++.+ .+|..+|.|.+.....+ ..++..|+.+|++|+|||||++++ .+ +++..+.|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 578888999999999999976 78999999999755433 356889999999999999999998 34 4455599999
Q ss_pred ecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCC-CEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDP-PIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 327 e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~-~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
|+| .|+|.+.++. +++...++++.|++.||..+|+.-.+ -|+||||||.||+|+.+ |.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhHhHh
Confidence 999 7999999854 67788999999999999999994322 38999999999999999 79999999999876
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.... ......+|||.||+||.+.+.+|+.|+||||+||++|||+.-++||.+.. +....+.+... .
T Consensus 179 ~s~~-----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~L~~KI~qg-d--- 244 (375)
T KOG0591|consen 179 SSKT-----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLSLCKKIEQG-D--- 244 (375)
T ss_pred cchh-----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHHHHHHHHcC-C---
Confidence 5532 34457799999999999999999999999999999999999999998762 32333332221 1
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
-|.++ +.-....+.+++..|+..||+.||+.-.+++.+.
T Consensus 245 --~~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 245 --YPPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --CCCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 11111 2445567888899999999999998555544433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=368.80 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=215.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|..++.||+|+|++||+|.. .+++.||||++.+.... .+.+.+|-++|.+| .||.|++||..|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 46899999999999999999976 57999999999765332 24577899999999 79999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|+||+ +|+|.++|++ +.+.....++.+|+.||+|||++ |||||||||+|||||.| ++++|+|||.|+.+...
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~d-mhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKD-GHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCC-CcEEEeeccccccCChh
Confidence 99999 8999999976 56666778999999999999999 99999999999999999 69999999999887664
Q ss_pred ccc-----c---cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc
Q 008898 401 HQV-----S---ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS 472 (549)
Q Consensus 401 ~~~-----~---~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 472 (549)
... . .......++||..|.+||++..+..+..+|+|+||||||+|+.|.+||....+- ..+.+.+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----liFqkI~--- 300 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LIFQKIQ--- 300 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HHHHHHH---
Confidence 332 1 112235699999999999999999999999999999999999999999865431 1111111
Q ss_pred cccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 473 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
-++-.+ ++..++.+.+|+++.|..||.+|+|..+|-+ |+||....+++
T Consensus 301 -----~l~y~f----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~-----HpFF~~Vdw~n 348 (604)
T KOG0592|consen 301 -----ALDYEF----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKA-----HPFFEGVDWEN 348 (604)
T ss_pred -----HhcccC----CCCCCHHHHHHHHHHHccCccccccHHHHhh-----CcccccCChhh
Confidence 012222 3333467788889999999999999999998 89998888887
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=353.29 Aligned_cols=273 Identities=28% Similarity=0.412 Sum_probs=220.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|+....||.|..+.||+|.. ..+..||||++..+.. +.+.+.+|+..|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 5799999999999999999976 6689999999976543 346789999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
| .|++.+.++. +.+..+..|..++++||.|||.+ |.||||||+.||||+++ |.+||+|||.+.....+.
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~~~G- 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSD-GTVKLADFGVSASLFDSG- 180 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCC-CcEEEcCceeeeeecccC-
Confidence 9 7899999965 66777888999999999999999 99999999999999999 899999999876655433
Q ss_pred cccCccc-cccccCCccccccccc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 403 VSENVKP-VNVVGTFGYLAPEYMM--YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 403 ~~~~~~~-~~~~gt~~y~APE~~~--~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
...... .+++||++|||||+++ ..+|+.|+||||||+...||.+|..||....+.+..+.. + ++......
T Consensus 181 -~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t----L--qn~pp~~~ 253 (516)
T KOG0582|consen 181 -DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT----L--QNDPPTLL 253 (516)
T ss_pred -ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH----h--cCCCCCcc
Confidence 222222 6889999999999965 457999999999999999999999999887664432221 1 11111111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHhhcc
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLNERR 541 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~~~~ 541 (549)
-..+...........+.+++..||..||.+|||++++++ |.||+.....+.+.+..+
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk-----h~FFk~~k~~~~~~~~~l 310 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK-----HAFFKKAKSKEYLVKKLL 310 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc-----cHHHhhccchhhcchhhh
Confidence 111122222334457888999999999999999999999 899998887776665443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=368.72 Aligned_cols=246 Identities=29% Similarity=0.437 Sum_probs=205.8
Q ss_pred CCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCHH
Q 008898 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~ 334 (549)
..+.||+|-||.||.|.+.....+|+|.++......++|.+|+.+|++|+|+|||+|+++|..++.++|||||| .|+|.
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 34569999999999999987779999999988878889999999999999999999999999988999999999 89999
Q ss_pred HHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccc
Q 008898 335 QYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409 (549)
Q Consensus 335 ~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 409 (549)
+||+. +...+.+.++.|||+|++||+++ ++|||||...||||+++ ..+||+|||||+......+......
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~~Y~~~~~~- 364 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDED-LVVKISDFGLARLIGDDEYTASEGG- 364 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccC-ceEEEcccccccccCCCceeecCCC-
Confidence 99975 66788899999999999999999 99999999999999999 6899999999985443332222111
Q ss_pred cccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCC
Q 008898 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYN 488 (549)
Q Consensus 410 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 488 (549)
.-...|.|||.+..+.++.|+|||||||+||||+| |+.|+...... +.+ +.++....-+-+
T Consensus 365 ---kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-ev~--------------~~le~GyRlp~P 426 (468)
T KOG0197|consen 365 ---KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-EVL--------------ELLERGYRLPRP 426 (468)
T ss_pred ---CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-HHH--------------HHHhccCcCCCC
Confidence 22457999999999999999999999999999999 77777655432 211 122233333445
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 489 REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 489 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
..++..+.+++..||+.+|++|||++.+...|++..
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 667888999999999999999999999988776543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=359.46 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=211.2
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
..++|+.+++||+|+||.||+|+. .+|..||+|+++++... .+.+..|-.||....+|+||+||-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 357899999999999999999976 56999999999887532 3567889999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
+|||+ +|++..+|.. +++.....++.+++.|+..||+. |+|||||||+|+|||.. |++||+||||+.-....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCC-CCEeeccccccchhhhh
Confidence 99999 7899888854 78888899999999999999999 99999999999999999 89999999998532211
Q ss_pred ccc------------------ccCc------------------------cccccccCCccccccccccCCCCchhhHHHH
Q 008898 401 HQV------------------SENV------------------------KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSY 438 (549)
Q Consensus 401 ~~~------------------~~~~------------------------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSl 438 (549)
... .+.. .....+|||.|||||++++.+|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 0000 1124689999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCcccchh--hHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC---H
Q 008898 439 GVVLLELITGKEAIQTNKANRE--SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT---M 513 (549)
Q Consensus 439 Gvil~elltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~ 513 (549)
|||+||||.|.+||.+..+... .++.|...+.... .........++|.+|+. ||.+|.. +
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 9999999999999998876432 3444443332111 11122556778888888 9999975 6
Q ss_pred HHHHHHhcCCchhhhhhhHHH
Q 008898 514 KTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 514 ~evl~~L~~~~~w~~~~~~~~ 534 (549)
.||-+ |+||+...+..
T Consensus 440 ~EIK~-----HPfF~~v~W~~ 455 (550)
T KOG0605|consen 440 EEIKK-----HPFFKGVDWDH 455 (550)
T ss_pred HHHhc-----CCccccCCcch
Confidence 67766 89998887653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=357.12 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=207.1
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----C--cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----N--WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~--~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~ 321 (549)
....|...+.||+|+||+|+.|.+ .+|..+|+|+++.. . ...+.+.+|+.+++.+. ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 356899999999999999999976 67899999987653 1 12345678999999999 9999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+++||||+ +|+|.+++.. +.+.+...++.|++.|++|||++ ||+||||||+|||++.+.+++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999 6799999954 77788899999999999999999 99999999999999988458999999999664
Q ss_pred ccccccccCccccccccCCccccccccccCC-CC-chhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VD-EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~-~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... ....+...
T Consensus 172 ~-----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-----l~~ki~~~--- 238 (370)
T KOG0583|consen 172 P-----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-----LYRKIRKG--- 238 (370)
T ss_pred C-----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-----HHHHHhcC---
Confidence 2 2334556889999999999999987 85 78999999999999999999998743211 11111111
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.+ .++.... ...+..++.+|+..||..|+|+.+|++ |+||+..
T Consensus 239 -~~---~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~-----h~w~~~~ 281 (370)
T KOG0583|consen 239 -EF---KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE-----HPWFQKE 281 (370)
T ss_pred -Cc---cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh-----ChhhccC
Confidence 11 1111111 455777889999999999999999997 9999973
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=326.20 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=210.2
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.+|...+.||+|.||.||+|++ .+|+.||||.++..+.. .....+|++.|+.++|+||+.|+++|-..+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577888999999999999976 77999999999876543 3568899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+..+|+..++. +...+...++.++++||+|||.+ .|+||||||+|+|++++ |.+||+|||+|+........
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCC-CcEEeecccchhccCCCCcc
Confidence 999999999965 67778889999999999999999 99999999999999999 79999999999876553322
Q ss_pred ccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc---------
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--------- 473 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--------- 473 (549)
....+-|..|.|||.+.|. .|+..+||||.|||+.||+-|.+-|.+..+ -+++......+.-..
T Consensus 158 -----~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 158 -----QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred -----cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCcccCccccc
Confidence 2223678899999998875 599999999999999999999988877664 233333222221110
Q ss_pred -----ccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 474 -----LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 474 -----~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.+.....+.+.. +-..+.+...+++..|+..||.+|+|+++.++ |+||+.
T Consensus 232 lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~-----~~yf~~ 286 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALK-----HPYFKS 286 (318)
T ss_pred cccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhc-----chhhhc
Confidence 011111111111 22344556789999999999999999999999 888874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=360.10 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=217.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHH-HHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~-~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
..|.....||+|+.|.||.+.. .+++.||||++.......++ +++|+.+|+..+|+|||++++.|..++.+++||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 3566777899999999999966 67899999999877766554 689999999999999999999888889999999999
Q ss_pred -CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 -~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+.+.. +++.++..|+.++++||+|||.+ +|||||||.+|||++.+ |.+||+|||+|.... ...
T Consensus 353 ~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~-----~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMD-GSVKLTDFGFCAQIS-----EEQ 423 (550)
T ss_pred CCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccC-CcEEEeeeeeeeccc-----ccc
Confidence 7789999864 78888999999999999999999 99999999999999999 799999999985433 334
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
....+.+|||+|||||++....|++|+||||||++++||+-|.+||-...+-++. .++..+-...+-.
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl------yLIa~ng~P~lk~------ 491 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGTPKLKN------ 491 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH------HHHhhcCCCCcCC------
Confidence 4667889999999999999999999999999999999999999999875543321 1121211112211
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHhh
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLNE 539 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~~ 539 (549)
.......+.+++.+||..|+.+||+++|||+ |+|+++.....++...
T Consensus 492 -~~klS~~~kdFL~~cL~~dv~~RasA~eLL~-----HpFl~~a~p~ssL~pL 538 (550)
T KOG0578|consen 492 -PEKLSPELKDFLDRCLVVDVEQRASAKELLE-----HPFLKMAKPESSLNPL 538 (550)
T ss_pred -ccccCHHHHHHHHHHhhcchhcCCCHHHHhc-----ChhhhhcCCHHHhHHH
Confidence 2334456777889999999999999999999 9999888877777653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=355.58 Aligned_cols=242 Identities=28% Similarity=0.397 Sum_probs=206.0
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHH---HHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEE---EVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~---~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|...+.||+|+||+||||+. .+.+.||+|.+.+....++ .+.+|++|++.++||||+.++++|++...+++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4678888999999999999976 5689999999987665554 47789999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 328 LLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 328 ~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
|+-|+|..++.+ ++++....++.++..||.|||++ +|+|||+||.|||++.. +.+|+||||+|+.+.....
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~-- 155 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTS-- 155 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCC-CceeechhhhhhhcccCce--
Confidence 999999999965 88999999999999999999999 99999999999999999 7999999999987665332
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
....+.|||.|||||...++.|+..+|+||+|||+|||++|++||.... +....+.+..+ +.
T Consensus 156 ---vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~I~~d--------~v-- 217 (808)
T KOG0597|consen 156 ---VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVKSILKD--------PV-- 217 (808)
T ss_pred ---eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHHHHhcC--------CC--
Confidence 2345679999999999999999999999999999999999999996543 33333333222 21
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.++......+..+++-.+.+||.+|.|-.+++.
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 122345556677778999999999999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=346.70 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=201.5
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--eEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKE--MYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--~~~lv~e 327 (549)
.+|...+.||+|+||.||++.+. +|..+|||.+...+.. .+.+.+|+.+|++++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35777889999999999999874 5999999998765322 355889999999999999999999854444 6999999
Q ss_pred cc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec-CCCceEEeeecccccccccc
Q 008898 328 LL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 328 ~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~~kL~DFGla~~~~~~~ 401 (549)
|+ +|+|.+++.. +++.....+..||++||.|||++ |||||||||+|||++. + +.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~-~~~KlaDFG~a~~~~~-- 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSN-GDVKLADFGLAKKLES-- 170 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCC-CeEEeccCcccccccc--
Confidence 99 8899999975 57888899999999999999999 9999999999999999 5 6899999999865543
Q ss_pred ccccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCc-ccchhhHHHHHHHhhccccccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTN-KANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~-~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
..........+.||+.|||||++..+. ...++|||||||++.||+||.+||... ......+ .+.... .
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~-----~ig~~~-----~ 240 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL-----LIGRED-----S 240 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH-----HHhccC-----C
Confidence 111222334678999999999999643 345999999999999999999999864 2111111 111111 1
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
-|.+ +........+++..|+..||..|||+.++|+ |+|......
T Consensus 241 ~P~i----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~-----hpf~~~~~~ 284 (313)
T KOG0198|consen 241 LPEI----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLE-----HPFLKQNSI 284 (313)
T ss_pred CCCC----CcccCHHHHHHHHHHhhcCcccCcCHHHHhh-----Chhhhcccc
Confidence 2223 3334555667778999999999999999999 888876654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=360.15 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=207.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.-|..++-||+|+.|.|-+|++ .+|+.+|||++.+.. .....+.+|+.||+.+.|||+++||++++++..+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3477888899999999999988 789999999997542 22356889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|.|++++-. +.+.+..+++.||+.|+.|||.. +|+||||||+|+|||.. +.+||+|||+|....
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~---- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVK-NNIKIADFGMASLEV---- 163 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcc-cCEeeeccceeeccc----
Confidence 999 7899999943 78889999999999999999999 99999999999999998 469999999996533
Q ss_pred cccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.+....+-||.|.|.|||+++|.+| +.++||||.|||||.||+|+.||+++.-. .+..... .|.+
T Consensus 164 --~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-----~LLlKV~-~G~f------ 229 (786)
T KOG0588|consen 164 --PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-----VLLLKVQ-RGVF------ 229 (786)
T ss_pred --CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-----HHHHHHH-cCcc------
Confidence 3334457799999999999999999 57999999999999999999999854321 1111111 1111
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
..+........+|+++|+..||.+|.|+.||++ |+|+...-..
T Consensus 230 ----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k-----HP~l~g~~~~ 272 (786)
T KOG0588|consen 230 ----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK-----HPFLSGYTSL 272 (786)
T ss_pred ----cCCCcCCHHHHHHHHHHhccCccccccHHHHhh-----CchhhcCCCC
Confidence 112233345677889999999999999999999 9998766533
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=350.98 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=207.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~l 324 (549)
.+.|+.++.||+|.||.||++++ .+|+.||+|.+..+... ..-..+||.||++|+||||++|.+...+. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35688888999999999999976 77999999999876533 24567999999999999999999988765 68999
Q ss_pred EEeccCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|+|||..+|..++. +++..++..++.|+++||+|||.+ ||+|||||.+|||||.+ |.+||+|||||++....
T Consensus 196 VFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNN-GVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCC-CCEEeccccceeeccCC
Confidence 99999999999985 488899999999999999999999 99999999999999999 89999999999876543
Q ss_pred cccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc--c--
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL--C-- 475 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~-- 475 (549)
.. ...+..+-|..|.|||.++|. .|+.++|+||.||||.||++|++.|++..+ -+++....+....... .
T Consensus 272 ~~----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 272 GS----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred CC----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHhCCCChhcccc
Confidence 22 224456779999999999976 599999999999999999999999998765 2233332222221110 0
Q ss_pred ccccCCcc---cccCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 476 ERLIDPQL---NEEYNR-------EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 476 ~~~~d~~l---~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
..+..... ...|.. ......++|+..+|..||.+|.|+.+.|+ +.||
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~-----seyF 403 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ-----SEYF 403 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc-----Cccc
Confidence 01110000 011111 22356778889999999999999999998 5666
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=339.26 Aligned_cols=265 Identities=24% Similarity=0.299 Sum_probs=206.5
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
|+..+.||+|+||.||++.. .+|+.+|+|.+..... ....+.+|+.+++.++|+||+++++++.+++.++++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999976 6799999999875432 123567899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++++ +.++|+|||++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCC--
Confidence 9 6789887742 56778888999999999999999 99999999999999988 68999999998654321
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........ ..
T Consensus 156 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~-~~--------- 220 (285)
T cd05631 156 ----ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDRRVK-ED--------- 220 (285)
T ss_pred ----CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHHHhh-cc---------
Confidence 1123457999999999999999999999999999999999999999865432111 11111110 00
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHH-HHHHhhccCCCC
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREK-EELLNERRSNGP 545 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~-~~~~~~~~~~~~ 545 (549)
...++......+.+++..||..||.+||+ +.++++ |+||..-... .+....++++.|
T Consensus 221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~-----h~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05631 221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ-----HPIFKNINFKRLEANMLEPPFCP 283 (285)
T ss_pred -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc-----CHhhcCCCHHHHHhCcCCcCCCC
Confidence 01122233456778899999999999997 889998 8999876533 333334455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=349.92 Aligned_cols=267 Identities=22% Similarity=0.324 Sum_probs=211.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHH--HHHHHHHHhcCC-CCCeeeEEEEEEcCC-eEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE--VLREVELLSSIK-HENIVRIIGYCHSKE-MYAI 324 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~--~~~E~~il~~l~-h~nIv~l~~~~~~~~-~~~l 324 (549)
+.++|...+.||.|+||.||+|.. .+|..||||.++..-...++ -+||+..|++|+ ||||++|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346788888999999999999976 67999999999876555454 468999999999 999999999998877 9999
Q ss_pred EEeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|||||..+|++.++. +++..+..|+.||++||.|+|.+ |+.|||+||+|||+..++ .+||+|||+|+....
T Consensus 88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGND-VIKIADFGLAREVRS- 162 (538)
T ss_pred eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccc-eeEeccccccccccc-
Confidence 999999999999965 88899999999999999999999 999999999999999663 799999999976443
Q ss_pred cccccCccccccccCCccccccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc-----
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL----- 474 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----- 474 (549)
....+..+.|..|.|||++. .+-|+.++|+||+|||++|+.+-++.|.+..+-+. +......+...+.
T Consensus 163 -----kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 163 -----KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEVLGTPDKDSWPE 236 (538)
T ss_pred -----CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHHhCCCccccchh
Confidence 33455678899999999986 55689999999999999999999999988765332 3222222221110
Q ss_pred ---cc---cccCCcc----cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 475 ---CE---RLIDPQL----NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 475 ---~~---~~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
+. .+.-|.. ....-+.+.....+++..|++.||.+|||+.++++ |++|.....
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~-----~pffq~~~~ 299 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ-----HPFFQVGRA 299 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc-----Ccccccccc
Confidence 00 0111111 01111235667888899999999999999999999 777765543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=340.80 Aligned_cols=267 Identities=23% Similarity=0.350 Sum_probs=204.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|...+.||+|+||.||+|.. .+++.+|+|+++.... ....+.+|+.+++.++||||+++++++.+++.++++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46799999999999999999987 4689999999975432 23457789999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.++|.+++.. +....+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~--- 156 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDT-GELKLADFGLARAKSVP--- 156 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEECCCCcceeccCC---
Confidence 999999888854 56778888999999999999999 99999999999999988 68999999998543221
Q ss_pred ccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc--cc---c
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL--CE---R 477 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~~---~ 477 (549)
........||+.|+|||++.+. .++.++|||||||++|||++|..||.......+.+............ .. .
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred --CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 1122345689999999998754 58899999999999999999999998755433333222211110000 00 0
Q ss_pred --ccCCcccccCC-----H-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 478 --LIDPQLNEEYN-----R-----EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 478 --~~d~~l~~~~~-----~-----~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..++.....+. . .....+.+++..||..||.+|||+.++++ |+||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~-----h~~f~~~~ 295 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS-----HEYFSDLP 295 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc-----CcccccCC
Confidence 00000000000 0 01245678999999999999999999998 99997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=347.97 Aligned_cols=251 Identities=28% Similarity=0.367 Sum_probs=211.5
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
..|....+||+|.||.||+|.. .+++.||+|++..+.. ..+++.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3577778899999999999976 6799999999987653 346789999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+ +|++.+.++. +.+....-++.++..||.|||.. +.||||||+.|||+..+ |.+||+|||.+.....
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~----- 163 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSES-GDVKLADFGVAGQLTN----- 163 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEecc-CcEEEEecceeeeeec-----
Confidence 9 7789888865 35666677889999999999999 99999999999999999 7999999999855433
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
...+..+++|||.|||||++....|+.|+||||||++++||.+|.+|+...++.. +..++-...+
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vlflIpk~~P 228 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VLFLIPKSAP 228 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EEEeccCCCC
Confidence 2334468999999999999998899999999999999999999999998877632 2222333333
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..+...+...+.+++..||.+||+.||++.++++ |++++...
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK-----h~FIk~a~ 270 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK-----HKFIKRAK 270 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh-----hHHHHhcC
Confidence 3344455566788889999999999999999999 77877654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.14 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=194.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcC-C
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSK-E 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~-~ 320 (549)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++.... ....+.+|+.+++.+ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999964 2356899999975432 234688999999999 899999999988754 4
Q ss_pred eEEEEEecc-CCCHHHHHHH------------------------------------------------------------
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ------------------------------------------------------------ 339 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~------------------------------------------------------------ 339 (549)
.++++|||+ +|+|.+++..
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 688999999 7899998853
Q ss_pred -----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcccccccc
Q 008898 340 -----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414 (549)
Q Consensus 340 -----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~g 414 (549)
+.+.....++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||++........ ........+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~---~~~~~~~~~ 238 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPD---YVRKGSARL 238 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCC-CcEEEeecccccccccCcc---hhcccCCCC
Confidence 34456678899999999999999 99999999999999988 6899999999865432111 111123356
Q ss_pred CCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHH
Q 008898 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIE 493 (549)
Q Consensus 415 t~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 493 (549)
++.|+|||++.+..++.++|||||||++|||++ |..||........ + ...+. .+. .... +.....
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~---~~~~~-~~~-----~~~~----~~~~~~ 304 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-F---CQRLK-DGT-----RMRA----PENATP 304 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-H---HHHHh-cCC-----CCCC----CCCCCH
Confidence 788999999999999999999999999999997 9999976543221 1 11111 111 0111 122345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 494 IVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 494 ~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+.+++..||..||.+|||+.+|++.|+.
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 67889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=319.32 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=208.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
-++|++++.||+|-||.||.|+. .++..+|+|++.++.. ...++.+|++|.+.|+||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35799999999999999999976 5688999999976642 346788999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 326 YNLL-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 326 ~e~~-~gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+||. .|+|...|+ ++++.....+..|+|.||.|+|.+ +||||||||+|+|++.+ +.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSA-GELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCC-CCeeccCCCceeecC-
Confidence 9999 899999996 377778889999999999999999 99999999999999999 799999999986532
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
..+..+.|||..|++||+..+..++..+|+|++|++.||++.|.+||..... .+......+ .++.
T Consensus 176 ------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k--------~~~~ 240 (281)
T KOG0580|consen 176 ------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRK--------VDLK 240 (281)
T ss_pred ------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHH--------cccc
Confidence 3455688999999999999999999999999999999999999999987662 222211111 1122
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
+| ........++|..|+..+|.+|.+..++++ |+|+..
T Consensus 241 ~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~-----hpwI~a 278 (281)
T KOG0580|consen 241 FP-------STISGGAADLISRLLVKNPIERLALTEVMD-----HPWIVA 278 (281)
T ss_pred CC-------cccChhHHHHHHHHhccCccccccHHHHhh-----hHHHHh
Confidence 22 223345777889999999999999999999 899753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.98 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=203.7
Q ss_pred hhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
...+++.....||+|.||+||+|.+. ..||||+++.+.... +.|..|+..+++-+|.||+-++|+|..... .||
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred cCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 34456677888999999999999874 348999998776554 457899999999999999999999988776 899
Q ss_pred EeccCC-CHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLLNG-SLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~~g-sL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
..+|.| +|+.++. ++.....+.||.||++|+.|||.+ +|||||||..|||+.++ +.+||+|||++......
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRW 541 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccC-CcEEEecccceeeeeee
Confidence 999966 6999983 478888899999999999999999 99999999999999998 68999999999654432
Q ss_pred cccccCccccccccCCcccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
..........|...|||||+++. .+|++.+||||||+++|||+||..||.....++. ++.-|.-.-
T Consensus 542 ---~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--------ifmVGrG~l 610 (678)
T KOG0193|consen 542 ---SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--------IFMVGRGYL 610 (678)
T ss_pred ---ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--------EEEeccccc
Confidence 33334445678889999999874 4689999999999999999999999983332221 111111111
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
..|. .....++++.|.+|+..||..++++||++.+|+..|+...
T Consensus 611 ~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 611 MPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred Cccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 1111 2234567788899999999999999999999999666544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=346.22 Aligned_cols=249 Identities=20% Similarity=0.298 Sum_probs=200.3
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CC
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~g 331 (549)
++||+|+||.||++.+ .+|+.+|+|+++.... ....+.+|+.+++.++||||+++++++..++.++++|||+ +|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999977 5789999999975421 2245678999999999999999999999999999999999 67
Q ss_pred CHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 008898 332 SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (549)
Q Consensus 332 sL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (549)
+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~-----~~~~ 151 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIS-----DGAT 151 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCC-CCEEEeeCCCCccccc-----CCCc
Confidence 89888854 67788888999999999999999 99999999999999998 6899999999854221 1222
Q ss_pred ccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCC
Q 008898 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYN 488 (549)
Q Consensus 409 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 488 (549)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ...... +..++
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~---~~~~~~-------~~~~p---- 215 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF---ELILME-------EIRFP---- 215 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HH---HHHHcC-------CCCCC----
Confidence 335679999999999999999999999999999999999999997643221 11 111100 11112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 489 REEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 489 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
......+.+++..||..||.+|| ++.++++ |+||.........
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~-----h~~f~~~~~~~~~ 263 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME-----HRFFASINWQDVV 263 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc-----CCCcCCCCHHHHH
Confidence 22344577888999999999999 8999998 8999876655444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.60 Aligned_cols=241 Identities=25% Similarity=0.402 Sum_probs=202.3
Q ss_pred hcCCCCCceEcccCceEEEEEE-ecCCcEEEEEEeecCCcCH----HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTN-HVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~-~~~g~~~AvK~l~~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
..+|++.+.||+|.||+|-++. +..|+.||||.++++.... -.+.+|++||+.|+||||+.+|.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4567888889999999999995 4789999999998765433 3477899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||. +|.|++|+.. +++.+...++.||..|+.|+|.+ +++|||||.+|||+|.+ +++||+|||++.++.
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N-~NiKIADFGLSNly~--- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQN-NNIKIADFGLSNLYA--- 204 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCC-CCeeeeccchhhhhc---
Confidence 9999 8899999954 88888999999999999999999 99999999999999999 699999999986543
Q ss_pred ccccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
......++||+|-|.+||++.+.+| ++.+|-|||||+||-|+.|..||++.+... + +..+- ...+..
T Consensus 205 ---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--l---vrQIs----~GaYrE 272 (668)
T KOG0611|consen 205 ---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--L---VRQIS----RGAYRE 272 (668)
T ss_pred ---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--H---HHHhh----cccccC
Confidence 3445568999999999999999998 688999999999999999999998765321 1 11111 111222
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
|.. +....-+|++||..||++|.|+.+|..
T Consensus 273 P~~--------PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 273 PET--------PSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred CCC--------CchHHHHHHHHHhcCcccchhHHHHhh
Confidence 222 223455789999999999999999998
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.75 Aligned_cols=261 Identities=24% Similarity=0.365 Sum_probs=200.4
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|...+.||+|+||.||+|.. .+++.+|+|+++.... ....+.+|+.+++.++||||+++++++.+++.++++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4689999999999999999977 5689999999975432 234678999999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~---- 156 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEK-GELKLADFGLARAKSVP---- 156 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC-CCEEECcCcceeeccCC----
Confidence 99999998854 56777888999999999999999 99999999999999998 68999999998653321
Q ss_pred cCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc-----------c
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS-----------S 472 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~-----------~ 472 (549)
........||+.|+|||++.+ ..++.++|||||||++|||++|++||........ +......... .
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 -TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred -CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccc
Confidence 112234568999999998875 4689999999999999999999999976543222 1111111100 0
Q ss_pred cccccccCCccccc----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 473 GLCERLIDPQLNEE----YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 473 ~~~~~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
........+..... ..........++++.||..||.+|||++|+++ |+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~-----hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR-----HSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc-----CCCC
Confidence 00001111110000 00112345678999999999999999999998 8886
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=340.93 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=202.7
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...+.||+|+||.||++.. .+|+.+|+|++..... ..+.+.+|+.+++.++||||+++++++.+++.++++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3688899999999999999987 4689999999975431 2345788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~--- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRD--- 153 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCC-CCEEEEecCcchhccC---
Confidence 999 6799999854 67778888999999999999999 99999999999999988 6899999999865322
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... . ...+... . ..
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~---~~~i~~~-~------~~ 216 (291)
T cd05612 154 -----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--I---YEKILAG-K------LE 216 (291)
T ss_pred -----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H---HHHHHhC-C------cC
Confidence 1224579999999999999899999999999999999999999997654321 1 1111111 0 11
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~ 533 (549)
+.. .....+.++++.||..||.+||+ +.++++ |+|+......
T Consensus 217 ~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~-----h~~~~~~~~~ 263 (291)
T cd05612 217 FPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN-----HRWFKSVDWD 263 (291)
T ss_pred CCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc-----CccccCCCHH
Confidence 111 22345778999999999999995 999997 8999765544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.46 Aligned_cols=258 Identities=26% Similarity=0.356 Sum_probs=205.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---------------HHHHHHHHHHHhcCCCCCeeeEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---------------EEEVLREVELLSSIKHENIVRII 313 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---------------~~~~~~E~~il~~l~h~nIv~l~ 313 (549)
..++|.+.+.||+|.||+|-+|.. .+++.||||++.+.... .+.+.+|+.||++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 346899999999999999999977 67999999999654321 25688999999999999999999
Q ss_pred EEEEc--CCeEEEEEecc-CCCHHHHH--HH-hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceE
Q 008898 314 GYCHS--KEMYAIVYNLL-NGSLKQYL--KQ-LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (549)
Q Consensus 314 ~~~~~--~~~~~lv~e~~-~gsL~~~l--~~-~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~k 387 (549)
.+..+ .+.+|+|+||| .|.+...- +. +.+.+.+.++.++..||+|||.+ |||||||||+|+||+++ |++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~-g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD-GTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC-CcEE
Confidence 99965 46899999999 55543322 22 77889999999999999999999 99999999999999999 8999
Q ss_pred EeeeccccccccccccccCccccccccCCccccccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHH
Q 008898 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK----VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLV 463 (549)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~ 463 (549)
|+|||.+..+...............+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-....-
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~----- 325 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL----- 325 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-----
Confidence 99999997765442222233334578999999999988743 257899999999999999999999765421
Q ss_pred HHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 464 LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 464 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.. ...++...+.-+-.++..+.+.++|.++|.+||+.|.++.+|.. |+|....
T Consensus 326 ~l---------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~-----Hpwvt~~ 378 (576)
T KOG0585|consen 326 EL---------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL-----HPWVTRD 378 (576)
T ss_pred HH---------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee-----cceeccC
Confidence 11 12223333333333466788999999999999999999999987 8897544
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.74 Aligned_cols=272 Identities=19% Similarity=0.247 Sum_probs=200.5
Q ss_pred HHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCC------CCeeeEEEEEEc
Q 008898 246 ELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH------ENIVRIIGYCHS 318 (549)
Q Consensus 246 el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h------~nIv~l~~~~~~ 318 (549)
++...+++|.+.++||+|+||+||++.+ .+++.||||+++.......+...|+.+++.+.| .+++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3334567899999999999999999977 568899999997543333455667777776654 458899998865
Q ss_pred C-CeEEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCC---------
Q 008898 319 K-EMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFH--------- 384 (549)
Q Consensus 319 ~-~~~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~--------- 384 (549)
+ ..+++||++++++|.+++.+ +.+.....++.||+.||.|||+ . +||||||||+|||++.+..
T Consensus 203 ~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccc
Confidence 4 57899999999999998854 6788889999999999999997 6 9999999999999986521
Q ss_pred ------ceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc
Q 008898 385 ------HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (549)
Q Consensus 385 ------~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~ 458 (549)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~--------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER--------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cCCCCceEEECCCCccccCc--------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 48999999874321 1223568999999999999999999999999999999999999999765432
Q ss_pred hhhHHHHHHHhhc--------------------ccccccccCCccc------c-cCCHHHHHHHHHHHHHhcccCCCCCC
Q 008898 459 RESLVLWARSLLS--------------------SGLCERLIDPQLN------E-EYNREEIEIVMCAARLCLLHSSSRRP 511 (549)
Q Consensus 459 ~~~l~~~~~~~~~--------------------~~~~~~~~d~~l~------~-~~~~~~~~~l~~li~~Cl~~dP~~RP 511 (549)
+.+......+.. .+......++... . .........+.+++..||..||.+||
T Consensus 352 -~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 352 -EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred -HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 111111111000 0000000000000 0 00001124577999999999999999
Q ss_pred CHHHHHHHhcCCchhhhhhhHHH
Q 008898 512 TMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 512 s~~evl~~L~~~~~w~~~~~~~~ 534 (549)
|++|+++ |+||.......
T Consensus 431 ta~e~L~-----Hp~~~~~~~~~ 448 (467)
T PTZ00284 431 NARQMTT-----HPYVLKYYPEC 448 (467)
T ss_pred CHHHHhc-----CccccccCCcc
Confidence 9999998 99998765543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=332.78 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=200.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|.+.+.||+|+||.||++.+ .+++.+|+|+++.... ..+.+.+|+.+++.++||||+++++++..++.++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3688999999999999999987 4688999999975432 23567889999999999999999999999999999999
Q ss_pred ccCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.+++.+.+. .+++.....++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~-- 154 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGS-- 154 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CcEEEeeccCcccccccc--
Confidence 99766555553 267778889999999999999999 99999999999999988 689999999986643211
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHH-----------hhcc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARS-----------LLSS 472 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~-----------~~~~ 472 (549)
........||+.|+|||++.+..++.++|||||||++|||++|++||........ +...... ....
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 155 --NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred --cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhcc
Confidence 1122345789999999999998999999999999999999999999986543221 1111100 0000
Q ss_pred cccccccCCcccc------cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 473 GLCERLIDPQLNE------EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 473 ~~~~~~~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
........+.... .+.......+.++++.||+.||.+|||++++++ |+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~-----hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN-----HPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc-----CCCC
Confidence 0000110111100 011123456889999999999999999999998 8886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=345.60 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=203.0
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|.+.+.||+|+||.||+|.+ .+|+.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+++.++++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5788999999999999999987 4689999999975421 2345789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~--- 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPD--- 170 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCC-CCEEEeeccCceEcCC---
Confidence 998 6799999864 56777788999999999999999 99999999999999998 6899999999865432
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.. +. ..
T Consensus 171 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~~i~~-~~------~~ 233 (329)
T PTZ00263 171 -----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-----IYEKILA-GR------LK 233 (329)
T ss_pred -----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-----HHHHHhc-CC------cC
Confidence 1224579999999999999999999999999999999999999997654321 1111111 11 01
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~~ 534 (549)
++..+ ...+.+++..||..||.+||+ +.+++. |+||+......
T Consensus 234 ~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~-----hp~f~~~~~~~ 281 (329)
T PTZ00263 234 FPNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN-----HPYFHGANWDK 281 (329)
T ss_pred CCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc-----CCccCCCCHHH
Confidence 11122 245678899999999999997 799998 89998755443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.46 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=196.5
Q ss_pred CCCCCceEcccCceEEEEEEe-c-CCcEEEEEEeecCCcC---HHHHHHHHHHHhcC---CCCCeeeEEEEEE-----cC
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-V-DGQVAAVKVLKCTNWS---EEEVLREVELLSSI---KHENIVRIIGYCH-----SK 319 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~-~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l---~h~nIv~l~~~~~-----~~ 319 (549)
+|...+.||+|+||.||++.+ . +|+.+|+|.++..... ...+.+|+.+++.+ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 688899999999999999976 3 4688999998754322 24566788777765 6999999999885 34
Q ss_pred CeEEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 320 ~~~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
..++++||++.|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS-GQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCC-CCEEEccccce
Confidence 56899999999999999854 56778899999999999999999 99999999999999998 68999999998
Q ss_pred cccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc-
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG- 473 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~- 473 (549)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|++||....... .+...........
T Consensus 158 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~ 230 (290)
T cd07862 158 RIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE 230 (290)
T ss_pred EeccCC------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCCh
Confidence 654321 22234578999999999998899999999999999999999999998764322 1111111110000
Q ss_pred -cc-------ccccCCcc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 474 -LC-------ERLIDPQL---NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 474 -~~-------~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.. .....+.. ......+....+.+++.+||+.||++|||+.++++ |+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~-----hp~f 290 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS-----HPYF 290 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc-----CCCC
Confidence 00 00000000 00111223456778999999999999999999998 8886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.74 Aligned_cols=256 Identities=22% Similarity=0.296 Sum_probs=204.4
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|.+.+.||+|+||.||+|.+. +++.+|+|+++.... ....+..|+.++..++||||+++++++..++.++++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999874 589999999975421 2345788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCC-CCEEEEeCcCCccccc---
Confidence 999 7799999864 67778888999999999999999 99999999999999998 6899999999864332
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
......||+.|+|||++.+..++.++|||||||++|||++|..||........ ...... .... +..+.
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~---~~~~---~~~~~ 221 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKY---WKET---LQRPV 221 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHh---cccc---ccCCC
Confidence 22356799999999999999999999999999999999999999976543221 111000 0000 00111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
. ..........+.+++..||..+|.+||++.++++ |+||.....
T Consensus 222 ~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~-----h~~~~~~~~ 265 (333)
T cd05600 222 Y-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN-----HPFFKEVDW 265 (333)
T ss_pred C-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHh-----CcccCCCCH
Confidence 1 0001123456778889999999999999999999 899886543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=341.20 Aligned_cols=267 Identities=24% Similarity=0.330 Sum_probs=199.6
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----CeEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSK-----EMYA 323 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~~~~ 323 (549)
+|...+.||+|+||.||+|.. .+|+.||||.++... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999986 568999999987432 2234578999999999999999999988533 3589
Q ss_pred EEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 324 IVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 324 lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
++|||++++|.+++.. +++.....++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANAD-CKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC-CcEEEccCccccccccc
Confidence 9999999999998854 77888899999999999999999 99999999999999998 68999999998653221
Q ss_pred cccccCccccccccCCcccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHh---------
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL--------- 469 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~--------- 469 (549)
.. .........||+.|+|||++.+ ..++.++|||||||++|||++|++||....... .+.......
T Consensus 157 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 157 TP--TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTPSPETIS 233 (338)
T ss_pred cC--ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence 11 1112234579999999999875 678999999999999999999999997654311 110000000
Q ss_pred --hccc---ccccccCCcccccCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 470 --LSSG---LCERLIDPQLNEEYN---REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 470 --~~~~---~~~~~~d~~l~~~~~---~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.... ....+ .+.....+. ......+.+++..||..||.+|||++++++ |+||+....
T Consensus 234 ~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~-----hp~f~~~~~ 298 (338)
T cd07859 234 RVRNEKARRYLSSM-RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA-----DPYFKGLAK 298 (338)
T ss_pred HhhhhhHHHHHHhh-cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc-----CchhhhcCc
Confidence 0000 00000 000000000 112345678999999999999999999998 899976544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=354.37 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=198.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC--------Ce
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK--------EM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--------~~ 321 (549)
..+|...+.||+|+||.||+|.+ .+++.+|||.+.... ....+|+.+|+.++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 45799999999999999999987 568999999886443 2345799999999999999998876321 25
Q ss_pred EEEEEeccCCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
++++|||+.++|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+.+.+||+|||+|
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 778999999998887742 56677888999999999999999 99999999999999977457999999999
Q ss_pred cccccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG 473 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 473 (549)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||....... .+......+....
T Consensus 219 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~ 291 (440)
T PTZ00036 219 KNLLAG------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPT 291 (440)
T ss_pred hhccCC------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence 654321 122345789999999998764 68999999999999999999999997654322 2222111110000
Q ss_pred ---------ccccc-----cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 474 ---------LCERL-----IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 474 ---------~~~~~-----~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
....+ ....+...++...+..+.+++..||..||.+|||+.++++ |+||.....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~-----hp~f~~~~~ 359 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA-----DPFFDDLRD 359 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC-----ChhHHhhhc
Confidence 00000 0001111112223456888999999999999999999999 899976544
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=345.87 Aligned_cols=260 Identities=21% Similarity=0.268 Sum_probs=200.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEeccC
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 330 (549)
.+|...+.||+|+||.||++.. .+++.+|+|... ...+.+|+.+++.++||||+++++++..+...++++|++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 5799999999999999999976 568999999754 2357789999999999999999999999999999999999
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
++|..++.. +++...+.++.||+.||.|||++ +|+||||||+|||++.+ +.++|+|||+|...... ...
T Consensus 167 ~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~----~~~ 238 (391)
T PHA03212 167 TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDI----NAN 238 (391)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCC-CCEEEEeCCcccccccc----ccc
Confidence 999988854 67788899999999999999999 99999999999999988 68999999998543221 111
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCccc------chhhHHHHHHHhhcc---------
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA------NRESLVLWARSLLSS--------- 472 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~------~~~~l~~~~~~~~~~--------- 472 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..........
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 22356799999999999999999999999999999999999988754321 011111111100000
Q ss_pred ccccc---------ccCCcccccC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 473 GLCER---------LIDPQLNEEY--NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 473 ~~~~~---------~~d~~l~~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
..... ...+...... ....+..+.+++.+||..||.+|||++|+++ |+||..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~-----hp~f~~ 381 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD-----FAAFQD 381 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc-----Chhhcc
Confidence 00000 0000000000 1123456888999999999999999999998 899965
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=333.30 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=195.5
Q ss_pred cCCCCCceEcccCceEEEEEEecC-----------------CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD-----------------GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRI 312 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~-----------------g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l 312 (549)
++|.+.+.||+|+||.||++...+ +..+|+|++..... ...++.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999996432 34799999876432 23468899999999999999999
Q ss_pred EEEEEcCCeEEEEEecc-CCCHHHHHHH----------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEE
Q 008898 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQ----------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIH 369 (549)
Q Consensus 313 ~~~~~~~~~~~lv~e~~-~gsL~~~l~~----------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiH 369 (549)
++++.+.+..+++|||+ +|+|.+++.. +++...+.++.||+.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999 7799998853 34566788999999999999999 9999
Q ss_pred ecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc--
Q 008898 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-- 447 (549)
Q Consensus 370 rDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-- 447 (549)
|||||+|||++.+ +.+||+|||++......... .......+++.|+|||++.++.++.++|||||||++|||++
T Consensus 162 ~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEEcCC-ccEEECCCccceecccCcee---EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999998 68999999998654332111 11123356789999999998899999999999999999987
Q ss_pred CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 448 GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 448 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+..||..... .................. .. ..+..++..+.+++..||..||.+|||+.+|.+.|++
T Consensus 238 ~~~p~~~~~~--~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELTD--EQVIENAGEFFRDQGRQV--YL----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCCH--HHHHHHHHHHhhhccccc--cc----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5567765432 112222222111111000 00 0112234568889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=338.27 Aligned_cols=247 Identities=20% Similarity=0.282 Sum_probs=197.9
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CC
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~g 331 (549)
+.||+|+||.||++.. .+|+.||+|+++... .....+.+|+.+++.++||||+++++++..++.+++||||+ +|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999976 568999999997532 12245678999999999999999999999999999999999 67
Q ss_pred CHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 008898 332 SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (549)
Q Consensus 332 sL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (549)
+|..++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~-----~~~~ 151 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS-----DGAT 151 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCC-CCEEecccHHhccccC-----CCCc
Confidence 89888854 67788889999999999999999 99999999999999998 6899999999854221 1122
Q ss_pred ccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCC
Q 008898 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYN 488 (549)
Q Consensus 409 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 488 (549)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||........ .. ..... +..++.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~----~~~~~-------~~~~p~--- 216 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FE----LILME-------EIRFPR--- 216 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HH----HHhcC-------CCCCCC---
Confidence 2346799999999999999999999999999999999999999976543211 11 11000 011112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHH
Q 008898 489 REEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 489 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.....+.+++..||..||.+|| ++.++++ |+||.......
T Consensus 217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~-----h~~~~~~~~~~ 261 (323)
T cd05595 217 -TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME-----HRFFLSINWQD 261 (323)
T ss_pred -CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc-----CCCcCCCCHHH
Confidence 2334577888999999999998 8999998 88987655443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=336.99 Aligned_cols=244 Identities=24% Similarity=0.286 Sum_probs=195.4
Q ss_pred EcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCH
Q 008898 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (549)
Q Consensus 260 lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL 333 (549)
||+|+||.||++.+ .+++.+|+|+++... .....+.+|+.++++++||||+++++++.+.+.++++|||+ +|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999987 468899999997532 22345778999999999999999999999999999999999 7799
Q ss_pred HHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 008898 334 KQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (549)
Q Consensus 334 ~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (549)
.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++..... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~-----~~~~~~ 151 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMK-----DDDKTN 151 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCC-CcEEEEECcccccCcc-----CCCccc
Confidence 999854 67788888999999999999999 99999999999999998 6899999999864322 112233
Q ss_pred ccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHH
Q 008898 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490 (549)
Q Consensus 411 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 490 (549)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... ..+ +..
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-----~~~~~~~~~-------~~~----~~~ 215 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-----MYRKILQEP-------LRF----PDG 215 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-----HHHHHHcCC-------CCC----CCc
Confidence 5679999999999999999999999999999999999999997653321 111111110 111 122
Q ss_pred HHHHHHHHHHHhcccCCCCCCC---HHHHHHHhcCCchhhhhhhHH
Q 008898 491 EIEIVMCAARLCLLHSSSRRPT---MKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 491 ~~~~l~~li~~Cl~~dP~~RPs---~~evl~~L~~~~~w~~~~~~~ 533 (549)
....+.+++..||..||.+||+ +.+++. |+||......
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~-----hp~~~~~~~~ 256 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN-----HPFFSQLSWK 256 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc-----CCCcCCCCHH
Confidence 3345778889999999999975 677777 8998876443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=317.60 Aligned_cols=256 Identities=24% Similarity=0.356 Sum_probs=203.6
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC---CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT---NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
++++|++.+.||+|.|+.||++.+ .+|+.+|+|+++.. ..+.+++.+|+.|.+.|+||||++|.+...+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788888999999999999966 67999999998543 34567899999999999999999999999999999999
Q ss_pred Eecc-CCCHH-HHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeecccccccc
Q 008898 326 YNLL-NGSLK-QYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 326 ~e~~-~gsL~-~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla~~~~~ 399 (549)
+|++ +|+|. +..++ +++...-.++.||++||.|+|.+ +|||||+||+|+++.+. ..-+||+|||+|....
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 9999 55664 44454 44455567899999999999999 99999999999999532 2368999999996643
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.+.....++|||+|||||++...+|+..+|||+.|||||-||.|.+||.+....+ + .+.+.... --+
T Consensus 165 -----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--l---ye~I~~g~---yd~ 231 (355)
T KOG0033|consen 165 -----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--L---YEQIKAGA---YDY 231 (355)
T ss_pred -----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--H---HHHHhccc---cCC
Confidence 3445567899999999999999999999999999999999999999998754322 2 22222111 111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
++...+ ...+...+++++||..||.+|.|+.|.|+ |+|++...
T Consensus 232 ~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~-----HpWi~~r~ 274 (355)
T KOG0033|consen 232 PSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALK-----HPWICNRE 274 (355)
T ss_pred CCcccC----cCCHHHHHHHHHHhccChhhhccHHHHhC-----CchhcchH
Confidence 222222 23345677889999999999999999998 99986544
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=315.90 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=207.9
Q ss_pred hhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-----CH----HHHHHHHHHHhcCC-CCCeeeEEEEEE
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-----SE----EEVLREVELLSSIK-HENIVRIIGYCH 317 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-----~~----~~~~~E~~il~~l~-h~nIv~l~~~~~ 317 (549)
.+.+.|.+.+.||.|..+.|-++.+ .+|+.+|+|++..... .. +...+|+.||+++. ||||+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3456788999999999999999876 6789999999864321 11 34567999999985 999999999999
Q ss_pred cCCeEEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecc
Q 008898 318 SKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (549)
Q Consensus 318 ~~~~~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGl 393 (549)
.+..+++|+|+| .|.|+++|.. +++.+...++.|+.+|++|||.+ +|+||||||+|||++++ .+++|+|||+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn-~~i~isDFGF 169 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDN-MNIKISDFGF 169 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccc-cceEEeccce
Confidence 999999999999 8999999965 78888899999999999999999 99999999999999999 4899999999
Q ss_pred ccccccccccccCccccccccCCcccccccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHH
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY------GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~ 467 (549)
|.. ...+.+....||||+|+|||.+.. .+|+..+|+||+|||||-||.|.+||-.... +.+ -
T Consensus 170 a~~------l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----mlM--L 237 (411)
T KOG0599|consen 170 ACQ------LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----MLM--L 237 (411)
T ss_pred eec------cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----HHH--H
Confidence 865 344556678899999999999853 3588899999999999999999999964432 222 1
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
.++.+|..+ +-.| -=.+......+++++||+.||.+|.|.+|+|. |+||.+...+
T Consensus 238 R~ImeGkyq-F~sp-----eWadis~~~KdLIsrlLqVdp~~Ritake~La-----Hpff~q~~~~ 292 (411)
T KOG0599|consen 238 RMIMEGKYQ-FRSP-----EWADISATVKDLISRLLQVDPTKRITAKEALA-----HPFFIQIAQQ 292 (411)
T ss_pred HHHHhcccc-cCCc-----chhhccccHHHHHHHHHeeCchhcccHHHHhc-----ChHHHHHHHh
Confidence 222222211 1111 11233456788999999999999999999999 9999665543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=338.61 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=198.1
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CC
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~g 331 (549)
+.||+|+||.||++.. .+|+.+|+|+++... .....+.+|+.+++.++||||+++++++..++.+++||||+ +|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 568999999997542 12345778999999999999999999999999999999999 77
Q ss_pred CHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 008898 332 SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (549)
Q Consensus 332 sL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (549)
+|..++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~-----~~~~ 151 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKD-GHIKITDFGLCKEGIT-----DAAT 151 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCC-CcEEEecCcCCccCCC-----cccc
Confidence 89888853 67788889999999999999999 99999999999999988 6899999999854221 1112
Q ss_pred ccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCC
Q 008898 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYN 488 (549)
Q Consensus 409 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 488 (549)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...... .+..++..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~---~~~~~~-------~~~~~p~~-- 217 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--L---FELILM-------EDIKFPRT-- 217 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--H---HHHhcc-------CCccCCCC--
Confidence 234679999999999999999999999999999999999999997653321 1 111110 01112222
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHH
Q 008898 489 REEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 489 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~ 534 (549)
....+.+++..||..||.+|| ++.++++ |+||.......
T Consensus 218 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~-----h~~~~~~~~~~ 261 (328)
T cd05593 218 --LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR-----HSFFTGVNWQD 261 (328)
T ss_pred --CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc-----CCCcCCCCHHH
Confidence 234567788999999999997 8999998 88987765543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=330.41 Aligned_cols=243 Identities=20% Similarity=0.321 Sum_probs=194.2
Q ss_pred CCceEcccCceEEEEEEecCCcEEEEEEeecCCcCH----HHHHHHHHHHhcCCCCCeeeEEEEEEc----CCeEEEEEe
Q 008898 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHS----KEMYAIVYN 327 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~~~lv~e 327 (549)
....||+|++|.||+|.. +|+.+|||.++...... +.+.+|+.+|++++||||+++++++.+ ...++++||
T Consensus 24 ~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 24 TSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 336799999999999987 78899999997654433 456799999999999999999999866 457899999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+ +|+|.+++.. +++.....++.+++.||.|||+.. +++||||||+|||++.+ +.+||+|||++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSP--- 176 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC-CcEEEcccchHhhhccc---
Confidence 99 6789999954 678888999999999999999742 78899999999999998 68999999998653221
Q ss_pred ccCccccccccCCcccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... + .......+. .+
T Consensus 177 -----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~---~~~i~~~~~-----~~ 241 (283)
T PHA02988 177 -----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--I---YDLIINKNN-----SL 241 (283)
T ss_pred -----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--H---HHHHHhcCC-----CC
Confidence 123468899999999876 689999999999999999999999998654221 1 111111110 11
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
..+...+..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 242 ----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 ----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 112234567888999999999999999999999887653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=328.53 Aligned_cols=259 Identities=22% Similarity=0.279 Sum_probs=209.9
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
+.|+..+.||.|.-|+||+++.. ++..+|+|++.+.... ...+..|.+||+.+.||++..||..++.+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 45778889999999999999874 4689999999765433 234677999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 327 NLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 327 e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
||| +|+|...+++ ++...+..++..++.||+|||.+ |||+|||||+||||.++ |++.|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvred-GHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVRED-GHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecC-CcEEeeeccccccCCCC
Confidence 999 8899988854 77888889999999999999999 99999999999999999 89999999997432110
Q ss_pred c---------------------------------c------------------cccCccccccccCCccccccccccCCC
Q 008898 401 H---------------------------------Q------------------VSENVKPVNVVGTFGYLAPEYMMYGKV 429 (549)
Q Consensus 401 ~---------------------------------~------------------~~~~~~~~~~~gt~~y~APE~~~~~~~ 429 (549)
. . .....+...++||-.|+|||++.|.+.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 001123346899999999999999999
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCC
Q 008898 430 DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSR 509 (549)
Q Consensus 430 ~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~ 509 (549)
+.++|||+|||++||||.|..||.+...... +.. . +-..+.-.-.+.......+||+..|.+||.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~N---I----------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-LRN---I----------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh-HHH---H----------hcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 9999999999999999999999987764432 211 1 1111111111244567888999999999999
Q ss_pred CCC----HHHHHHHhcCCchhhhhhhHH
Q 008898 510 RPT----MKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 510 RPs----~~evl~~L~~~~~w~~~~~~~ 533 (549)
|.. +.||-+ |+||+..++.
T Consensus 379 Rlg~~rGA~eIK~-----HpFF~gVnWa 401 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR-----HPFFEGVNWA 401 (459)
T ss_pred hhccccchHHhhc-----CccccCCChh
Confidence 998 888888 8888888887
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=341.26 Aligned_cols=252 Identities=20% Similarity=0.314 Sum_probs=202.9
Q ss_pred cCCCCCceEcccCceEEEEEEec-C-CcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-D-GQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~-g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|...+.||+|+||.||+|.+. + +..+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++.++++
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46889999999999999999753 3 4689999986532 2234678899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCC-CCEEEecCCCCeecCC--
Confidence 9999 7799999854 67778889999999999999999 99999999999999988 6999999999865422
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
......||+.|+|||++.+..++.++|||||||++|||++|..||....... .+. .+.. +. .
T Consensus 184 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~-~i~~-~~------~ 245 (340)
T PTZ00426 184 ------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----IYQ-KILE-GI------I 245 (340)
T ss_pred ------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----HHH-HHhc-CC------C
Confidence 1235679999999999998889999999999999999999999997654311 111 1111 10 0
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
.++..++ ..+.+++++|++.||.+|+ +++++++ |+||.........
T Consensus 246 ~~p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~-----hp~f~~~~~~~~~ 296 (340)
T PTZ00426 246 YFPKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE-----HPWFGNIDWVSLL 296 (340)
T ss_pred CCCCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc-----CCCcCCCCHHHHH
Confidence 1112222 3467788999999999995 8999998 8999876554433
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.15 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=203.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|+..+.||+|+||.||++.+ .+|..+|+|++..... ....+.+|+++++.++||||+++++++..++.++++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 36899999999999999999987 4688999999875432 23568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+ +|+|.+++.. +++.....++.|++.||.|||+.+ +|+||||||+|||++.+ +.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCC-CcEEEccCccccccccc---
Confidence 99 6799999864 677788899999999999999852 69999999999999998 68999999998543221
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHH-Hhhcccc--------
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR-SLLSSGL-------- 474 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~-~~~~~~~-------- 474 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +..... .......
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCc
Confidence 1234579999999999999999999999999999999999999997543211 111100 0000000
Q ss_pred -------------------------cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 475 -------------------------CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 475 -------------------------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
...+................+.+++.+||..||++|||++++++ |+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~-----h~~~~~ 306 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN-----HTFIKR 306 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc-----ChHHhh
Confidence 00000000000001123456788999999999999999999998 899876
Q ss_pred hh
Q 008898 530 KR 531 (549)
Q Consensus 530 ~~ 531 (549)
..
T Consensus 307 ~~ 308 (331)
T cd06649 307 SE 308 (331)
T ss_pred cc
Confidence 54
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=343.60 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=199.3
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.|...+.||+|+||.||+|.+ .+++.+|+|+++.... ....+.+|+.+++.++||||+++++++.+.+.++++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588889999999999999976 5689999999975432 12457889999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+ +|+|.+++.+ +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCC-CCEEEeeCcCCccccccccc
Confidence 99 7799999855 56677788899999999999999 99999999999999988 79999999997532110000
Q ss_pred ------------------------------------------ccCccccccccCCccccccccccCCCCchhhHHHHHHH
Q 008898 404 ------------------------------------------SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVV 441 (549)
Q Consensus 404 ------------------------------------------~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvi 441 (549)
.........+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00001134679999999999999899999999999999
Q ss_pred HHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHH--hcccCCCCCCCHHHHHHH
Q 008898 442 LLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARL--CLLHSSSRRPTMKTLLKL 519 (549)
Q Consensus 442 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dP~~RPs~~evl~~ 519 (549)
+|||++|..||........... ....... ..-+ ....++.+.. +++.+ |+..+|..||++.++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~----i~~~~~~---~~~~-~~~~~s~~~~----dli~~ll~~~~~~~~R~~~~~~l~- 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLK----VINWENT---LHIP-PQVKLSPEAV----DLITKLCCSAEERLGRNGADDIKA- 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHH----HHccccc---cCCC-CCCCCCHHHH----HHHHHHccCcccccCCCCHHHHhc-
Confidence 9999999999976554222111 0000000 0000 1112344444 44444 66777778999999998
Q ss_pred hcCCchhhhhhhHHHH
Q 008898 520 FQEPDYWLKMKREKEE 535 (549)
Q Consensus 520 L~~~~~w~~~~~~~~~ 535 (549)
|+||........
T Consensus 305 ----hp~f~~~~~~~~ 316 (381)
T cd05626 305 ----HPFFSEVDFSSD 316 (381)
T ss_pred ----CcccCCCChhHH
Confidence 899987655443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=319.69 Aligned_cols=261 Identities=25% Similarity=0.289 Sum_probs=205.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEE--cCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCH--SKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~l 324 (549)
-++|+..+.|++|+||.||+|++ .+++.||+|.++.+.... -...+||.+|.+++|||||.+-.+.. +-+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 35688899999999999999976 678999999998665221 24689999999999999999988775 3467999
Q ss_pred EEeccCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
||||+..+|...+. .+...+...++.|++.|++|||.+ .|+||||||+|+|++.. |.+||+|||+|+....
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygs- 229 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHK-GILKIADFGLAREYGS- 229 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccC-CcEEecccchhhhhcC-
Confidence 99999998888884 466778889999999999999999 99999999999999999 7999999999965443
Q ss_pred cccccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.....+..+-|..|.|||.+.+.+ |+.++|+||+|||+.||+++++.|.+..+- +++......+. ...+-+
T Consensus 230 ----p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llG---tPte~i 301 (419)
T KOG0663|consen 230 ----PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLG---TPSEAI 301 (419)
T ss_pred ----CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhC---CCcccc
Confidence 233445667799999999998764 899999999999999999999999887652 23333222221 111111
Q ss_pred CCcc-------------------cccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 480 DPQL-------------------NEEYNRE-EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 480 d~~l-------------------~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.|.+ ...+... ..+.-++++...|..||.+|.|+++.|+ |.||..
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~-----h~~F~e 366 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK-----HEYFRE 366 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc-----cccccc
Confidence 1111 0111111 2356677889999999999999999998 889865
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=337.80 Aligned_cols=265 Identities=21% Similarity=0.336 Sum_probs=198.4
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|+..+.||+|+||.||++.+ .+++.+|+|+++.... ....+.+|+.++..++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4788999999999999999977 4689999999975421 1245778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.+ +++.....++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCC-CCEEEeeccCccccccccc
Confidence 999 6799999854 67788889999999999999999 99999999999999998 7999999999865432110
Q ss_pred c------------------------------ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008898 403 V------------------------------SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452 (549)
Q Consensus 403 ~------------------------------~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~ 452 (549)
. .........+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0001113468999999999999999999999999999999999999999
Q ss_pred CCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 453 QTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 453 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
........ . ..+.... ..+..+. ...++.+..+.+..+ .|...++..||++.+|++ |+||.....
T Consensus 237 ~~~~~~~~-~----~~i~~~~--~~~~~p~-~~~~s~~~~~li~~l--~~~~~~r~~r~~~~ei~~-----hp~f~~~~~ 301 (363)
T cd05628 237 CSETPQET-Y----KKVMNWK--ETLIFPP-EVPISEKAKDLILRF--CCEWEHRIGAPGVEEIKT-----NPFFEGVDW 301 (363)
T ss_pred CCCCHHHH-H----HHHHcCc--CcccCCC-cCCCCHHHHHHHHHH--cCChhhcCCCCCHHHHhC-----CCCCCCCCH
Confidence 76543211 1 1111100 0111111 012334333333222 133334456799999998 899987765
Q ss_pred HHH
Q 008898 533 KEE 535 (549)
Q Consensus 533 ~~~ 535 (549)
..-
T Consensus 302 ~~~ 304 (363)
T cd05628 302 EHI 304 (363)
T ss_pred HHH
Confidence 543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=361.13 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=205.3
Q ss_pred CCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
+....+.||+|+||+||+|+.. +...||||.++..... ..+|.+|++.|..|+|||||+|+|+|.+++.+++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 4445567999999999999542 2468999999876544 4689999999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH-----------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCce
Q 008898 325 VYNLL-NGSLKQYLKQ-----------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~-----------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~ 386 (549)
|+||| .|+|.+||+. ++..+.+.||.|||.|+.||-++ .++||||..+|+||.++. .+
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l-~V 642 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL-VV 642 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce-EE
Confidence 99999 8999999942 55678899999999999999999 999999999999999995 89
Q ss_pred EEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHH
Q 008898 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLW 465 (549)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~ 465 (549)
||+|||+++.....++...... ..-..+|||||.+++++|+.++|||||||+|||+++ |+.|+.....++ .+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~---t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-VI--- 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGN---TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-VI--- 715 (774)
T ss_pred EecccccchhhhhhhhhcccCC---ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-HH---
Confidence 9999999988777665543321 123568999999999999999999999999999998 888887765432 12
Q ss_pred HHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 466 ARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 466 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.....+.+ -+.+..++..++.++..||..+|.+||+++||-..|+
T Consensus 716 --e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 716 --ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred --HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 11222222 2335677889999999999999999999999998874
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=334.44 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=194.7
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+|+..+.||+|+||.||++.+ .+|+.||||++...... ...+.+|+++++.++|+||+++++++..++.++++|||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 466677899999999999987 56899999999654322 356889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 008898 330 -NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (549)
Q Consensus 330 -~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (549)
+|+|.+.. .........++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++....... ..
T Consensus 155 ~~~~L~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~-----~~ 224 (353)
T PLN00034 155 DGGSLEGTH-IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTM-----DP 224 (353)
T ss_pred CCCcccccc-cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCC-CCEEEcccccceeccccc-----cc
Confidence 56776542 244566778999999999999999 99999999999999998 689999999986543211 11
Q ss_pred ccccccCCcccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 409 PVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 409 ~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
.....||+.|+|||++.. ...+.++|||||||++|||++|+.||........ .......... ..+.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~------~~~~- 295 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--ASLMCAICMS------QPPE- 295 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhcc------CCCC-
Confidence 234579999999998743 2245689999999999999999999974332211 1111111000 0011
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
........+.+++..||..||.+|||+.|+++ |+|+.....
T Consensus 296 ---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~-----hp~~~~~~~ 336 (353)
T PLN00034 296 ---APATASREFRHFISCCLQREPAKRWSAMQLLQ-----HPFILRAQP 336 (353)
T ss_pred ---CCCccCHHHHHHHHHHccCChhhCcCHHHHhc-----CcccccCCc
Confidence 11223456788899999999999999999999 899987643
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.88 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=211.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l 324 (549)
...|...+.||+|.||.||++.. .+|+.+|+|++++... ..+.+.+|+.||+++. ||||+.++++|++.+.+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 45688889999999999999987 4599999999976543 3367899999999998 9999999999999999999
Q ss_pred EEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC---CceEEeeeccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF---HHPQLSDFGAAMVHH 398 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~~kL~DFGla~~~~ 398 (549)
|||++ +|.|.+.+.. +++.....++.|+++|+.|||+. ||+||||||+|+|+.... +.++++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999 6889999866 78888899999999999999999 999999999999996542 369999999997644
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
. .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.........+ .+.. +..
T Consensus 191 ~------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~~-~~~--- 255 (382)
T KOG0032|consen 191 P------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AILR-GDF--- 255 (382)
T ss_pred C------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHHc-CCC---
Confidence 3 334567899999999999999999999999999999999999999998876533322 1111 111
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.....+-....+.+.++++.|+..||..|+|+.++++ |+|+...
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~-----HpWi~~~ 299 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ-----HPWIKSI 299 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc-----CccccCC
Confidence 2222222334566778889999999999999999999 8998753
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.27 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=198.1
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHH---hcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELL---SSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il---~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
|.+.+.||+|+||.||++.+ .+|+.+|||+++... ...+.+.+|+.++ +.++||||+++++++..++.+++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999976 568999999997542 1224466666654 567899999999999999999999
Q ss_pred Eecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|||+ +|+|..++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~--- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMG--- 153 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCC-CcEEeCcccCCccCCC---
Confidence 9999 6789888754 78888899999999999999999 99999999999999998 6899999999854221
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...+.... ..
T Consensus 154 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~----~~~i~~~~-------~~ 219 (324)
T cd05589 154 --FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-V----FDSIVNDE-------VR 219 (324)
T ss_pred --CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-H----HHHHHhCC-------CC
Confidence 1122345679999999999999999999999999999999999999997654321 1 11111110 11
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
.+. .....+.+++.+||..||.+|| ++.++++ |+||+.......
T Consensus 220 ~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~-----~~~f~~~~~~~~ 268 (324)
T cd05589 220 YPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK-----QPFFRDINWDDL 268 (324)
T ss_pred CCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh-----CCCcCCCCHHHH
Confidence 112 2234567888999999999999 6788877 789877654443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.35 Aligned_cols=260 Identities=21% Similarity=0.311 Sum_probs=201.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|+..+.||+|+||.||++.. .+|+.+|||+++.... ....+.+|+.+++.++||||+++++++.+++.++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4788999999999999999987 4689999999975421 2245678999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCC-CCEEEeecccceecccccc
Confidence 999 7799999854 67788889999999999999999 99999999999999998 6899999999865432110
Q ss_pred cc---------------------------------cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCC
Q 008898 403 VS---------------------------------ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449 (549)
Q Consensus 403 ~~---------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~ 449 (549)
.. ........+||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 000112357999999999999999999999999999999999999
Q ss_pred CCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHhcCCchh
Q 008898 450 EAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT---MKTLLKLFQEPDYW 526 (549)
Q Consensus 450 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~~L~~~~~w 526 (549)
.||........ . ..+.... ..+..+ . .......+.+++..|+. +|.+|++ +.++++ |+|
T Consensus 237 ~Pf~~~~~~~~-~----~~i~~~~--~~~~~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~-----h~~ 298 (364)
T cd05599 237 PPFCSDNPQET-Y----RKIINWK--ETLQFP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS-----HPF 298 (364)
T ss_pred CCCCCCCHHHH-H----HHHHcCC--CccCCC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc-----CCC
Confidence 99976543221 1 1111100 000001 0 00123345667788886 9999998 999998 899
Q ss_pred hhhhhHH
Q 008898 527 LKMKREK 533 (549)
Q Consensus 527 ~~~~~~~ 533 (549)
|+.....
T Consensus 299 ~~~~~~~ 305 (364)
T cd05599 299 FKGVDWE 305 (364)
T ss_pred cCCCCHH
Confidence 9776543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.82 Aligned_cols=268 Identities=21% Similarity=0.263 Sum_probs=203.5
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcC------
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK------ 319 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 319 (549)
..++|...+.||+|+||.||++.. .+++.+|+|.+...... ...+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 356899999999999999999976 56899999999754322 34677899999999999999999988543
Q ss_pred CeEEEEEeccCCCHHHHHH-HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 320 EMYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 320 ~~~~lv~e~~~gsL~~~l~-~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
..++++|||+.++|.+++. .+++.....++.|+++||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~-~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 170 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCC-CCEEEeeCcccccCC
Confidence 3579999999999888774 367788888999999999999999 99999999999999998 689999999986533
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHh---------
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL--------- 469 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~--------- 469 (549)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .....+
T Consensus 171 ~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~ 243 (355)
T cd07874 171 TS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN-KVIEQLGTPCPEFMK 243 (355)
T ss_pred Cc------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCCHHHHH
Confidence 21 12234578999999999999999999999999999999999999997654321110 000000
Q ss_pred ---------hcc-cccccccCCc------c--cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 470 ---------LSS-GLCERLIDPQ------L--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 470 ---------~~~-~~~~~~~d~~------l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
... .....+..+. . ...........+.+++.+||..||++|||+.++++ |+|+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~-----hp~~~~~~ 318 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ-----HPYINVWY 318 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc-----Ccchhccc
Confidence 000 0000000000 0 00111122356788999999999999999999998 89997654
Q ss_pred HH
Q 008898 532 EK 533 (549)
Q Consensus 532 ~~ 533 (549)
..
T Consensus 319 ~~ 320 (355)
T cd07874 319 DP 320 (355)
T ss_pred Ch
Confidence 43
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=341.96 Aligned_cols=261 Identities=23% Similarity=0.295 Sum_probs=205.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|.+.+.||+|+||.||++.. .+|+.+|+|+++... .....+..|+.++..++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3688999999999999999987 469999999997543 22345788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc-
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH- 401 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~- 401 (549)
||+ +|+|.+++.. ++......++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC-CCEEeecCCCCccCcccCc
Confidence 999 7799999854 67788889999999999999998 99999999999999998 689999999986544321
Q ss_pred -----------------------ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc
Q 008898 402 -----------------------QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (549)
Q Consensus 402 -----------------------~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~ 458 (549)
............||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 000011233567999999999999999999999999999999999999999866532
Q ss_pred hhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhcCCchhhhhhhHHH
Q 008898 459 RESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT-MKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 459 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.. + ..+.... ..+.-+.. ......+.+++..|+. ||.+||+ +.++++ |+|++......
T Consensus 237 ~~----~-~~i~~~~--~~~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~-----hp~~~~~~~~~ 295 (350)
T cd05573 237 ET----Y-NKIINWK--ESLRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS-----HPFFKGIDWEN 295 (350)
T ss_pred HH----H-HHHhccC--CcccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc-----CCCcCCCCHHH
Confidence 11 1 1111100 00101110 1134557778889997 9999999 999998 89987655443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.02 Aligned_cols=273 Identities=23% Similarity=0.307 Sum_probs=210.5
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCC-eeeEEEEEEcCC------e
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHEN-IVRIIGYCHSKE------M 321 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~------~ 321 (549)
.|...+.||+|+||+||+|.. .+|+.||+|.+..+.. .+....+|+-+|+.|+|+| |+.|++++.+.+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 355566799999999999976 6799999999986644 3466899999999999999 999999998877 8
Q ss_pred EEEEEeccCCCHHHHHHHhc-------hhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 322 YAIVYNLLNGSLKQYLKQLK-------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~~~-------~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
+++|+||+.-+|..++...+ ...+..++.||+.||.|||++ +|+||||||.||||+++ |.+||+|||+|
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~-G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSS-GVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCC-CcEeeeccchH
Confidence 99999999999999997644 346788999999999999999 99999999999999998 89999999999
Q ss_pred cccccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG 473 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 473 (549)
+...- ........++|..|.|||++.+. .|+..+||||+|||++||+++++.|.+..+. +.+......+.-.+
T Consensus 168 ra~~i-----p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 168 RAFSI-----PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPN 241 (323)
T ss_pred HHhcC-----CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCC
Confidence 74331 22224566789999999999987 6899999999999999999999999887753 22322222222111
Q ss_pred ---cc--ccccCCc--cc-----ccCCHHHH---HHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 474 ---LC--ERLIDPQ--LN-----EEYNREEI---EIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 474 ---~~--~~~~d~~--l~-----~~~~~~~~---~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
+. ..+.+-. .. ..+..... ....+++.+|++.+|.+|.|++..++ |+||..-......+.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~-----h~yf~~~~~~~~~~~ 316 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT-----HPYFSELPEKSSQLL 316 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc-----Chhhcccccchhhhh
Confidence 10 0111111 11 11111112 36788999999999999999999999 788876655554444
Q ss_pred hc
Q 008898 539 ER 540 (549)
Q Consensus 539 ~~ 540 (549)
..
T Consensus 317 ~~ 318 (323)
T KOG0594|consen 317 LQ 318 (323)
T ss_pred cc
Confidence 33
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.13 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=195.0
Q ss_pred cCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 322 (549)
++|+..+.||+|+||.||+|.. .++..+|||+++.... ..+.+.+|+.+++.+ +||||++++++|..++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999853 2366899999975432 234678999999999 899999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH--------------------------------------------------------------
Q 008898 323 AIVYNLL-NGSLKQYLKQ-------------------------------------------------------------- 339 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~-------------------------------------------------------------- 339 (549)
+++|||+ +|+|.+++..
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999 7899988853
Q ss_pred ----------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 340 ----------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 340 ----------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECC-CcEEEecCccceeccCcccc
Confidence 34556778999999999999999 99999999999999988 68999999998654332111
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||........ +..+. ..+.. +.
T Consensus 271 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~----~~~~~-----~~ 337 (375)
T cd05104 271 ---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMI----KEGYR-----ML 337 (375)
T ss_pred ---cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHH----HhCcc-----CC
Confidence 11112345678999999999999999999999999999998 8888866543221 11111 11110 00
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. +...+..+.+++..||..||.+|||+.+|++.|++
T Consensus 338 ~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 S----PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0 11123467889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.87 Aligned_cols=256 Identities=22% Similarity=0.281 Sum_probs=199.9
Q ss_pred CCCCCceEcccCceEEEEEEe----cCCcEEEEEEeecCC-----cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~----~~g~~~AvK~l~~~~-----~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 322 (549)
+|++.+.||+|+||.||++.. .+++.+|+|+++... ...+.+..|+.+++.+ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999865 358899999997532 1224577899999999 599999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+++|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCC-CCEEEeeCcCCcccc
Confidence 9999999 6799998854 67788889999999999999999 99999999999999998 689999999986532
Q ss_pred cccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
... ........||+.|+|||++.+. .++.++|||||||++|||++|..||........ ...+......
T Consensus 157 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~------ 225 (332)
T cd05614 157 SEE----KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK------ 225 (332)
T ss_pred ccC----CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc------
Confidence 211 1122346799999999998865 478999999999999999999999975432111 1111111111
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHH
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~ 533 (549)
.++.+... ....+.+++..||..||.+|| +++++++ |+|++.....
T Consensus 226 -~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~-----h~~~~~~~~~ 276 (332)
T cd05614 226 -CDPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE-----HPFFKGLDWE 276 (332)
T ss_pred -CCCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc-----CCCcCCCCHH
Confidence 12222222 234567788999999999999 7889998 8998765433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=333.69 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=195.7
Q ss_pred ceEcccCceEEEEEEe----cCCcEEEEEEeecCC-----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 258 MLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~----~~g~~~AvK~l~~~~-----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+.||+|+||.||++.. .+++.+|+|+++... .....+..|+.+++.++||||+++++++..++.++++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999965 357899999997532 1224567899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+ +|+|.+++.. +.+.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~----- 152 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIH----- 152 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC-CCEEEeeCcCCeeccc-----
Confidence 9 6799999865 45667778899999999999999 99999999999999998 6899999999854322
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+... . ..++
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-----~~~~~~~-~------~~~~ 220 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-----IDKILKG-K------LNLP 220 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-----HHHHHcC-C------CCCC
Confidence 11222345799999999999988899999999999999999999999976543211 1111111 0 1111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHH
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~ 533 (549)
. .....+.+++..||..||.+|| ++.++++ |+|++.....
T Consensus 221 ~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~-----h~~~~~~~~~ 265 (323)
T cd05584 221 P----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS-----HPFFRHVNWD 265 (323)
T ss_pred C----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc-----CCCcCCCCHH
Confidence 1 2234577888999999999999 8999998 8898765443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.94 Aligned_cols=264 Identities=22% Similarity=0.290 Sum_probs=200.5
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKE----- 320 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 320 (549)
..++|...+.||+|+||.||++.+ .+|+.+|+|++..... ....+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 346899999999999999999977 5689999999965422 2356778999999999999999999886443
Q ss_pred -eEEEEEeccCCCHHHHHH-HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 321 -MYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 321 -~~~lv~e~~~gsL~~~l~-~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
.++++|||+.++|.+.+. .++......++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAC 174 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC-CCEEEecCCCccccc
Confidence 579999999988887764 467778888999999999999999 99999999999999998 689999999986432
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc-----
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG----- 473 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----- 473 (549)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+...........
T Consensus 175 ~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 175 T------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred c------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHH
Confidence 2 112234578999999999999999999999999999999999999998654311 1111000000000
Q ss_pred ----cccccc--CCccc----------------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 474 ----LCERLI--DPQLN----------------EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 474 ----~~~~~~--d~~l~----------------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
....+. .+... ..........+.+++.+||..||.+|||+.|+++ |+|+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~-----hp~~~~ 320 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR-----HPYITV 320 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc-----Cchhhh
Confidence 000000 00000 0001112355788999999999999999999998 899864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=336.01 Aligned_cols=246 Identities=20% Similarity=0.288 Sum_probs=196.6
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CC
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~g 331 (549)
+.||+|+||.||++.+ .+|+.+|+|+++... .....+..|+.+++.++||||+++++++..++.+++||||+ +|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 578999999997542 12245678999999999999999999999999999999999 67
Q ss_pred CHHHHHHH---hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 332 SLKQYLKQ---LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 332 sL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
+|..++.. +++.....++.||+.||.|||+ . +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~-----~~~ 151 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIK-----DGA 151 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCC-CCEEEecCCCCeecCC-----CCc
Confidence 89888854 6778888999999999999997 6 99999999999999998 6899999999854221 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ....... ...++..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~---~~~i~~~-------~~~~p~~~ 219 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--L---FELILME-------EIRFPRTL 219 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--H---HHHHhcC-------CCCCCCCC
Confidence 2234579999999999999999999999999999999999999997654321 1 1111100 11112222
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~ 533 (549)
...+.+++..||+.||.+|+ ++.++++ |+||......
T Consensus 220 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~-----h~~~~~~~~~ 261 (325)
T cd05594 220 ----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ-----HKFFAGIVWQ 261 (325)
T ss_pred ----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc-----CCCcCCCCHH
Confidence 34567788999999999997 8999998 8898865544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=336.37 Aligned_cols=245 Identities=26% Similarity=0.443 Sum_probs=199.2
Q ss_pred CCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCHH
Q 008898 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~ 334 (549)
.++-||.|+.|.||+|+.. ++.||||.++ +.-..+|+-|++|+||||+.+.|+|.....|+|+|||| .|-|.
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 3456999999999999874 6789999875 22235788899999999999999999999999999999 89999
Q ss_pred HHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccccc
Q 008898 335 QYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411 (549)
Q Consensus 335 ~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 411 (549)
+.|+. +.......+..+||.|+.|||.+ .|||||||.=||||+.+ ..+||+|||.++.... ......
T Consensus 201 ~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~------~STkMS 270 (904)
T KOG4721|consen 201 EVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYD-DVVKISDFGTSKELSD------KSTKMS 270 (904)
T ss_pred HHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeecc-ceEEeccccchHhhhh------hhhhhh
Confidence 99965 55566677889999999999999 99999999999999988 5899999998755332 234457
Q ss_pred cccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHH
Q 008898 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREE 491 (549)
Q Consensus 412 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 491 (549)
++||..|||||++...+.++|+|||||||+|||||||.-||..-.... . +..-| ...+--..+..+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---I-----IwGVG------sNsL~LpvPstc 336 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---I-----IWGVG------SNSLHLPVPSTC 336 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---e-----EEecc------CCcccccCcccC
Confidence 899999999999999999999999999999999999999986543211 1 11111 011222345667
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc---------hhhhhhh
Q 008898 492 IEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD---------YWLKMKR 531 (549)
Q Consensus 492 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~---------~w~~~~~ 531 (549)
++-+..|++.||+..|++||++++|+..|+=-. .||+.+.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf~sq~ 385 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYFKSQA 385 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHHHHHH
Confidence 788899999999999999999999998775322 6776655
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.40 Aligned_cols=262 Identities=21% Similarity=0.277 Sum_probs=197.3
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.|...+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+.+++.++||||+++++.+.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999977 5688999999975432 12457789999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc-
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ- 402 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~- 402 (549)
|+ +|+|.+++.+ ++......++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CCEEEeECCCCccccccccc
Confidence 99 6799999854 56677788899999999999999 99999999999999998 7999999999753211000
Q ss_pred -----------------------------------------cccCccccccccCCccccccccccCCCCchhhHHHHHHH
Q 008898 403 -----------------------------------------VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVV 441 (549)
Q Consensus 403 -----------------------------------------~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvi 441 (549)
..........+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000011124579999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 008898 442 LLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT---MKTLLK 518 (549)
Q Consensus 442 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 518 (549)
+|||++|++||.......... ...... .....+. ...++.+ ..+++.+|+ .+|.+|++ +.++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~-----~i~~~~--~~~~~p~-~~~~s~~----~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQM-----KVINWQ--TSLHIPP-QAKLSPE----ASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHH-----HHHccC--CCcCCCC-cccCCHH----HHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999998654322111 010000 0000010 1123333 344445554 49999997 888887
Q ss_pred HhcCCchhhhhhhHHHHH
Q 008898 519 LFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 519 ~L~~~~~w~~~~~~~~~~ 536 (549)
|+||+........
T Consensus 305 -----hp~f~~~~~~~~~ 317 (382)
T cd05625 305 -----HPFFKTIDFSSDL 317 (382)
T ss_pred -----CCCcCCcChHHHH
Confidence 8999876555443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=331.34 Aligned_cols=250 Identities=22% Similarity=0.388 Sum_probs=213.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.=|..++-||+|-|+.|-+++| .+|.+||||++.+.. .....++.|+..|+.++|||||+||.+..+...+|++.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3477778899999999999988 789999999997654 344679999999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 328 LL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 328 ~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+- +|+|++|+-+ +.+....+++.||..|+.|+|+. .++||||||+|+.+-+..|-+||+|||++..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNk------ 168 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNK------ 168 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccccc------
Confidence 99 6799999943 67777889999999999999999 8999999999999999889999999999743
Q ss_pred cccCccccccccCCccccccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVD-EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~-~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
...+....+.||...|-|||++.+..|+ +++||||||||||-|++|++||+...+.. . +..++|.
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-T-------------LTmImDC 234 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-T-------------LTMIMDC 234 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-h-------------hhhhhcc
Confidence 4455566788999999999999999996 68999999999999999999998765432 1 2334555
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.+. .+........++|..||.+||.+|.+.++|.. +.|++...
T Consensus 235 KYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s-----~~Wlq~~D 277 (864)
T KOG4717|consen 235 KYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS-----TSWLQAGD 277 (864)
T ss_pred ccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc-----cccccCCC
Confidence 542 24555667778889999999999999999998 78976543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.12 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=195.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 321 (549)
.++|...+.||+|+||.||++.. .++..||+|+++..... ...+.+|+.+++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34788999999999999999864 22458999999754322 34578999999999 89999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH-------------------------------------------------------------
Q 008898 322 YAIVYNLL-NGSLKQYLKQ------------------------------------------------------------- 339 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~------------------------------------------------------------- 339 (549)
++++|||+ +|+|.+++..
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999 7899998843
Q ss_pred ------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 340 ------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 340 ------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
+++.....++.||++||.|||++ +|+||||||+|||++++ +.++|+|||++........ ..
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~---~~ 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSN---YV 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcc---ee
Confidence 34556788999999999999999 99999999999999988 6899999999865432111 11
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
......+++.|+|||++.+..++.++|||||||++|||++ |+.||............ ...+ ..+.....
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~-----~~~~-----~~~~~~~~ 339 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-----VKRG-----YQMSRPDF 339 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH-----HHcc-----cCccCCCC
Confidence 1122345678999999998899999999999999999997 99999765433221111 1111 01111111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+..+.+++..||+.||.+|||+.+|++.|++
T Consensus 340 ----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 340 ----APPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred ----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 23467888899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=326.24 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=195.8
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcC---CCCCeeeEEEEEEc-----CC
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSI---KHENIVRIIGYCHS-----KE 320 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l---~h~nIv~l~~~~~~-----~~ 320 (549)
+|++.+.||+|+||.||++.+ .+|+.+|+|.++.... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478889999999999999987 4689999999875321 224566787777665 79999999998854 34
Q ss_pred eEEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 321 MYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
.++++||++.++|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~-~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG-GQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CCEEECccCccc
Confidence 6899999999999998864 67788899999999999999999 99999999999999988 689999999986
Q ss_pred ccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG-- 473 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-- 473 (549)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|++||....... .+...........
T Consensus 157 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~ 229 (288)
T cd07863 157 IYSCQ------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPED 229 (288)
T ss_pred cccCc------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChh
Confidence 54321 12234568999999999998899999999999999999999999997654322 1111111110000
Q ss_pred -ccc------cccCCccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 474 -LCE------RLIDPQLN---EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 474 -~~~------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
... ....+... ....+...+.+.+++..||..||.+|||+.+++. |+||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~-----hp~f 288 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ-----HPFF 288 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc-----CCCC
Confidence 000 00000000 0111233456788999999999999999999998 8886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=318.96 Aligned_cols=247 Identities=24% Similarity=0.378 Sum_probs=199.4
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|...+.||+|+||.||++...++..+|+|.++.......++.+|+.+++.++||||+++++++..++.++++|||+ +
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 357888899999999999998888889999998866666778999999999999999999999999999999999999 6
Q ss_pred CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 331 gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
|+|.+++.. +++.....++.|++.||.|||++ +|+|+||||+||+++.+ +.++|+|||++.........
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~--- 156 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYT--- 156 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCC-CeEEECCCCCccccCCCcee---
Confidence 899998853 57788899999999999999999 99999999999999988 68999999998654322111
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .+ ..+.... ....+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-~~----~~i~~~~---~~~~~~--- 224 (256)
T cd05114 157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-VV----EMISRGF---RLYRPK--- 224 (256)
T ss_pred -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HH----HHHHCCC---CCCCCC---
Confidence 1112245678999999998899999999999999999999 899997654321 11 1111111 111111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.....+.+++.+||..+|.+||++.++++.|.
T Consensus 225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12346788999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=330.52 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=197.1
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCeEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKH-ENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~lv~ 326 (549)
+|...+.||+|+||.||+|.. .+++.+|+|+++... ...+.+..|..++..+.| ++|+++++++.+.+.++++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478889999999999999977 457899999997532 223457789999999976 56888999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~--- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIF--- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCC-CCEEEeecCcceecCC---
Confidence 999 6799988854 67788889999999999999999 99999999999999998 6899999999853221
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+... ...
T Consensus 154 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~---~~i~~~-------~~~ 219 (324)
T cd05587 154 --GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LF---QSIMEH-------NVS 219 (324)
T ss_pred --CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HH---HHHHcC-------CCC
Confidence 1122335679999999999999999999999999999999999999997654321 11 111110 111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCchhhhhhhH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTM-----KTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~L~~~~~w~~~~~~ 532 (549)
++.. ....+.+++..||..||.+||+. .++++ |+||.....
T Consensus 220 ~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~-----hp~~~~~~~ 265 (324)
T cd05587 220 YPKS----LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE-----HAFFRRIDW 265 (324)
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc-----CCCcCCCCH
Confidence 1122 23456788899999999999986 67766 788766543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=331.88 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=202.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|+..+.||+|+||.||++.+ .++..+|+|++..... ....+.+|+++++.++||||++++++|.+++.++++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 46899999999999999999987 4688999999875432 23568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+ +|+|.+++.. +.+.....++.|++.||.|||+.+ +|+|+||||+|||++.+ +.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh---
Confidence 99 6799999864 566777889999999999999742 79999999999999988 68999999998543221
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc-------
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE------- 476 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~------- 476 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... ...+...
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL--ELMFGC-PVEGDPAESETSPR 230 (333)
T ss_pred ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH--HHHhcC-cccCCccccccCcc
Confidence 12245789999999999988899999999999999999999999976543211 100000 0000000
Q ss_pred --------------------------cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 477 --------------------------RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 477 --------------------------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
..................+.+++.+||..||.+|||+.++++ |+|++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~-----h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV-----HAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh-----CHHHhcC
Confidence 000000000000012345788999999999999999999998 8999776
Q ss_pred hH
Q 008898 531 RE 532 (549)
Q Consensus 531 ~~ 532 (549)
..
T Consensus 306 ~~ 307 (333)
T cd06650 306 EA 307 (333)
T ss_pred cc
Confidence 43
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.87 Aligned_cols=266 Identities=22% Similarity=0.271 Sum_probs=201.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSK------E 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------~ 320 (549)
.++|...+.||+|+||.||++.+ ..++.+|||++.... .....+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999976 568899999997542 2235678899999999999999999987543 3
Q ss_pred eEEEEEeccCCCHHHHHHH-hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 321 MYAIVYNLLNGSLKQYLKQ-LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~~-~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
.+++||||+.++|.+++.. +++.....++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGT 178 (364)
T ss_pred eEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCC-CcEEEEeCCCccccCC
Confidence 5799999999998887753 67778888999999999999999 99999999999999998 6899999999965432
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc--------
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS-------- 471 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~-------- 471 (549)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.........
T Consensus 179 ~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 179 S------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred C------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHh
Confidence 1 122345789999999999999999999999999999999999999976543211 1111110000
Q ss_pred ----------cc-cc-----ccccCCcc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 472 ----------SG-LC-----ERLIDPQL---NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 472 ----------~~-~~-----~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.. .. ..+..... ...........+.+++.+|+..||.+|||+.++++ |+|+.....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~-----hp~~~~~~~ 326 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ-----HPYINVWYD 326 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc-----CcccccccC
Confidence 00 00 00000000 00011112346788999999999999999999999 899865433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.21 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=199.3
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
..++|+..+.||+|+||.||++.+ .+++.+|+|++.... .....+.+|+.+++.++||||+++++++.+++.+++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 357899999999999999999987 468899999996422 122447789999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
||||+ +|+|.+++.. ++......++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|.......
T Consensus 121 v~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCC-CCEEEEecccceecccCC
Confidence 99999 7899999865 56667788999999999999999 99999999999999988 699999999986543211
Q ss_pred ccccCccccccccCCccccccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGK----VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .. ..+..... .
T Consensus 197 ----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~----~~i~~~~~--~ 265 (370)
T cd05621 197 ----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TY----SKIMDHKN--S 265 (370)
T ss_pred ----ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HH----HHHHhCCc--c
Confidence 11223567999999999987543 7889999999999999999999997654321 11 11111110 0
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCchhhhhhh
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSR--RPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~L~~~~~w~~~~~ 531 (549)
+ ..+. .......+.+++..|+..++.+ ||++.++++ |+||+...
T Consensus 266 ~---~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~-----hp~~~~~~ 311 (370)
T cd05621 266 L---NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ-----HPFFKNDQ 311 (370)
T ss_pred c---CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhc-----CcccCCCC
Confidence 0 0111 1122445667778888765544 899999999 89997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=322.63 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=196.0
Q ss_pred EcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCH
Q 008898 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (549)
Q Consensus 260 lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL 333 (549)
||+|+||+||++.+ .+|+.+|+|.+...... .+.+..|+.+++.++||||+++.+++..++.++++|||+ +|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999976 57899999998754322 245678999999999999999999999999999999999 6789
Q ss_pred HHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 334 KQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 334 ~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
..++.. +++.....++.||+.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~----- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQ----- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEeeCccceecCCCC-----
Confidence 887732 66778889999999999999999 99999999999999988 689999999986543321
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ....... ... ..
T Consensus 152 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~---------~~~--~~ 219 (280)
T cd05608 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQRIL---------NDS--VT 219 (280)
T ss_pred ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-HHHHhhc---------ccC--CC
Confidence 12234578999999999999999999999999999999999999997654321111 1111111 000 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHH
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~ 533 (549)
++......+.+++..||+.||.+|| +++++++ |+||+.....
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~-----h~~~~~~~~~ 266 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT-----HPLFRDLNWR 266 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc-----ChhhhcCCHh
Confidence 1223445677888999999999999 7788888 8999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=325.05 Aligned_cols=271 Identities=22% Similarity=0.318 Sum_probs=208.9
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC---C--eEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK---E--MYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~---~--~~~lv~ 326 (549)
.|...+++|.|+||.||.|.. .+++.+|||.+-.+. +.-.+|++||+.+.|||||+|.-+|... + .+.+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC---CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 477788999999999999976 557999999886543 2334799999999999999998877432 1 456799
Q ss_pred eccCCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 327 NLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 327 e~~~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
||+..+|.++++. ++...+.-+.+||.+||.|||+. +|+||||||.|+|+|.+.|.+||||||.|+....
T Consensus 102 eymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 102 EYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999999999974 44455667899999999999998 9999999999999999989999999999987544
Q ss_pred ccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc--c-
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL--C- 475 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~- 475 (549)
+........|..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+.. ..++++...+.+.-... +
T Consensus 179 ------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 179 ------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred ------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHh
Confidence 2233455678899999998875 59999999999999999999999998855 44455555554432211 0
Q ss_pred ----c--cccCCccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHhhcc
Q 008898 476 ----E--RLIDPQLN-----EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLNERR 541 (549)
Q Consensus 476 ----~--~~~d~~l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~~~~ 541 (549)
. +...|.+. .-+........++++.+++..+|.+|.++.+++. |++|......+..++-++
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~-----h~fFdelr~~~~~l~~g~ 323 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA-----HPFFDELRDPNTKLPNGR 323 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc-----chhhHHhhCcCccCcCCC
Confidence 0 11112111 1123344566788889999999999999999998 888877766655444433
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.30 Aligned_cols=257 Identities=22% Similarity=0.282 Sum_probs=201.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|...+.||+|+||.||++.+ .+++.+|+|+++... .....+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 46799999999999999999987 568999999997532 1223467899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|||+ +|+|.+++.. ++......++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~- 196 (370)
T cd05596 122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANG- 196 (370)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCC-CCEEEEeccceeeccCCC-
Confidence 9999 7899999865 55667778899999999999999 99999999999999998 699999999986543211
Q ss_pred cccCccccccccCCccccccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYG----KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.......+||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+..... .+
T Consensus 197 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~~--~~ 266 (370)
T cd05596 197 ---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMDHKN--SL 266 (370)
T ss_pred ---cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-----HHHHHcCCC--cC
Confidence 1122356799999999998653 478999999999999999999999976543211 111111100 00
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCchhhhhhhH
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSR--RPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
..+. .......+.+++..||..+|.+ ||++.++++ |+|++....
T Consensus 267 ---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~-----h~~~~~~~~ 312 (370)
T cd05596 267 ---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS-----HPFFKNDQW 312 (370)
T ss_pred ---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc-----CcccCCCCh
Confidence 0111 1122456677889999999988 999999998 899877543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=319.48 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=201.1
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|+..+.||+|+||.||+|...++..+|+|.+.......+.+.+|+.+++.++|+||+++++++.+.+..+++|||+ +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 568889999999999999998878889999998766655678899999999999999999999999999999999998 7
Q ss_pred CCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
|+|.+++.. +++.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.........
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~-- 159 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSES-LMCKIADFGLARVIEDNEYT-- 159 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCC-CcEEECCCccceecCCCcee--
Confidence 899999854 56677888999999999999999 99999999999999998 68999999999664332111
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
......++..|+|||++.++.++.++|||||||++|+|++ |..||....... .... +.. + ...+ .
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~---~~~-~----~~~~-~- 225 (261)
T cd05072 160 --AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSA---LQR-G----YRMP-R- 225 (261)
T ss_pred --ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHH---HHc-C----CCCC-C-
Confidence 1122345778999999998889999999999999999998 999997654322 1111 110 1 0001 1
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
....+..+.+++.+|+..+|++||+++++.+.|++
T Consensus 226 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 ---MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11233557888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=332.05 Aligned_cols=251 Identities=19% Similarity=0.252 Sum_probs=193.9
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++||+|+||.||++.. .+++.+|+|+++.... ....+.+|+.++.++ +||||+++++++..++.++++|||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 5688999999975421 224467888888776 7999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|..++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~-----~~~ 151 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLR-----PGD 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCC-CCEEEeeCCccccccC-----CCC
Confidence 789888753 67788889999999999999999 99999999999999998 6899999999854221 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc---hhhHHHHHHHhhcccccccccCCccc
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN---RESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+......... ..++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~~p 225 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IRIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------CCCC
Confidence 223567999999999999999999999999999999999999999632211 1111111111111111 1112
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHHhcCCchhhhhhhH
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPT------MKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl~~L~~~~~w~~~~~~ 532 (549)
......+.+++..||..||.+||+ +.++++ |+||+....
T Consensus 226 ----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~-----hp~f~~~~~ 270 (329)
T cd05618 226 ----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG-----HPFFRNVDW 270 (329)
T ss_pred ----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc-----CCCCCCCCH
Confidence 222345678889999999999998 578876 899876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=322.78 Aligned_cols=249 Identities=24% Similarity=0.411 Sum_probs=198.1
Q ss_pred cCCCCCceEcccCceEEEEEEecC-C-----cEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD-G-----QVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~-g-----~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
++|+..+.||+|+||.||+|.... + ..+|+|.++..... ...+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999997532 2 57999998754322 345789999999999999999999999889999
Q ss_pred EEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC
Q 008898 324 IVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~ 383 (549)
++|||+ +|+|.+++.. +++...+.++.|++.||.|||+. +++|+||||+||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~- 160 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG- 160 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC-
Confidence 999999 6899999854 45567788999999999999999 99999999999999998
Q ss_pred CceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhH
Q 008898 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESL 462 (549)
Q Consensus 384 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l 462 (549)
+.++|+|||++........ ........+++.|+|||.+.++.++.++|||||||++|||++ |..||......+ +
T Consensus 161 ~~~~L~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~ 235 (283)
T cd05048 161 LTVKISDFGLSRDIYSADY---YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--V 235 (283)
T ss_pred CcEEECCCcceeecccccc---ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 6899999999865432211 111223456889999999998899999999999999999998 999997654321 1
Q ss_pred HHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 463 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.. .+ ..+ .....+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 236 ~~---~i-~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IE---MI-RSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH---HH-HcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 11 111 1111233455778899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=330.85 Aligned_cols=252 Identities=21% Similarity=0.351 Sum_probs=198.2
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
+|...+.||+|+||.||++.+ .+++.+|+|+++.... ....+..|..++..+ +|++|+++++++.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 578889999999999999987 4578999999975421 223466788888777 5899999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~--- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMW--- 153 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCC-CcEEEccCCCceecCC---
Confidence 999 6899988854 67788899999999999999999 99999999999999999 6899999999854321
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ..+... ...
T Consensus 154 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~---~~i~~~-------~~~ 219 (323)
T cd05616 154 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LF---QSIMEH-------NVA 219 (323)
T ss_pred --CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HH---HHHHhC-------CCC
Confidence 1122335679999999999999999999999999999999999999997654321 11 111110 011
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCchhhhhhhHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTM-----KTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~L~~~~~w~~~~~~~~ 534 (549)
++......+.+++..|++.||.+|++. .++++ |+||+......
T Consensus 220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~-----h~~~~~~~~~~ 267 (323)
T cd05616 220 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE-----HAFFRYIDWEK 267 (323)
T ss_pred ----CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc-----CCCcCCCCHHH
Confidence 122234457788899999999999985 66655 78887655443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=323.94 Aligned_cols=270 Identities=24% Similarity=0.352 Sum_probs=206.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC---CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEc-----CCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT---NWSEEEVLREVELLSSIKHENIVRIIGYCHS-----KEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-----~~~ 321 (549)
...|...+.||+|+||.|+.+.. .+|+.||+|.+... ....+...+|+.+|+.++|+||+.+++++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 45566778899999999999976 67999999998622 2334678899999999999999999998854 458
Q ss_pred EEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
.|+|+|+|+.+|.+.++. ++......+++||+.||.|+|+. +|+||||||.|+|++.+ ..+||||||+|+...
T Consensus 101 vYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~-c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNAD-CDLKICDFGLARYLD 176 (359)
T ss_pred eEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccC-CCEEeccccceeecc
Confidence 999999999999999965 66777888999999999999999 99999999999999999 489999999998765
Q ss_pred cccccccCccccccccCCccccccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCccc-chhhHHHHHHHhhcccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~~ 476 (549)
.. ......+..+-|..|.|||++. ...|+.++||||.|||+.|||+|++.|.+.+. .+-.+....-.......+.
T Consensus 177 ~~---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 177 KF---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred cc---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 43 2233335667899999999876 55799999999999999999999999987654 2222221111111111111
Q ss_pred ccc--------C--Cc-----ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 477 RLI--------D--PQ-----LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 477 ~~~--------d--~~-----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
.+- . |. +...++ .......+++.+||..||.+|+|++|.|+ |+++......
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~-----hPYl~~~hdp 319 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA-----HPYLAPYHDP 319 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc-----ChhhhhhcCC
Confidence 111 0 00 001111 22345677889999999999999999999 7776655433
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.68 Aligned_cols=260 Identities=21% Similarity=0.290 Sum_probs=188.9
Q ss_pred CceEcccCceEEEEEEec---CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCeEEEEEeccCC
Q 008898 257 KMLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS--KEMYAIVYNLLNG 331 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~g 331 (549)
.+.||+|+||.||+|... +++.+|+|.++.... ...+.+|+.+++.++||||+++++++.. +..++++|||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 457999999999999764 467999999875432 3467889999999999999999998853 5678999999999
Q ss_pred CHHHHHH------------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec---CCCceEEeeeccccc
Q 008898 332 SLKQYLK------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---NFHHPQLSDFGAAMV 396 (549)
Q Consensus 332 sL~~~l~------------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~~kL~DFGla~~ 396 (549)
+|.+++. .++......++.||+.||.|||+. +|+||||||+|||++. ..+.+||+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9988874 256677888999999999999999 9999999999999942 225899999999976
Q ss_pred cccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccch--------hhHHHHHH
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANR--------ESLVLWAR 467 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~--------~~l~~~~~ 467 (549)
...... .........||+.|+|||++.+. .++.++||||+||++|||++|++||....... ..+.....
T Consensus 162 ~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 162 FNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred cCCCCc--cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 543211 11122356789999999998874 58999999999999999999999997543211 11111000
Q ss_pred Hhhccc---------------ccccccC-----Ccccc---cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 468 SLLSSG---------------LCERLID-----PQLNE---EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 468 ~~~~~~---------------~~~~~~d-----~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.+.... ....... ..+.. .........+.++++.||..||.+|||++|+++ |
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~-----h 314 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ-----D 314 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc-----C
Confidence 000000 0000000 00000 000001134678999999999999999999998 8
Q ss_pred hhh
Q 008898 525 YWL 527 (549)
Q Consensus 525 ~w~ 527 (549)
+||
T Consensus 315 p~f 317 (317)
T cd07868 315 PYF 317 (317)
T ss_pred CCC
Confidence 886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.96 Aligned_cols=259 Identities=21% Similarity=0.278 Sum_probs=197.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|++.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+++++.++||||+++++.+.+++.++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688999999999999999987 568999999996432 12345778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. ++......++.||+.||.|||++ +|+||||||+|||++.+ +.++|+|||+|........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccc
Confidence 999 7899999865 45667778899999999999999 99999999999999988 6899999999743210000
Q ss_pred --------------------------------------cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHH
Q 008898 403 --------------------------------------VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLE 444 (549)
Q Consensus 403 --------------------------------------~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~e 444 (549)
..........+||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000011124579999999999999999999999999999999
Q ss_pred HHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHHhc
Q 008898 445 LITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRP---TMKTLLKLFQ 521 (549)
Q Consensus 445 lltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP---s~~evl~~L~ 521 (549)
|++|+.||.......... .+.... .....+. ...++. .+.+++..|+ .+|.+|+ ++.++++
T Consensus 237 ll~G~~Pf~~~~~~~~~~-----~i~~~~--~~~~~~~-~~~~s~----~~~~li~~l~-~~p~~R~~~~t~~ell~--- 300 (376)
T cd05598 237 MLVGQPPFLADTPAETQL-----KVINWE--TTLHIPS-QAKLSR----EASDLILRLC-CGAEDRLGKNGADEIKA--- 300 (376)
T ss_pred hhhCCCCCCCCCHHHHHH-----HHhccC--ccccCCC-CCCCCH----HHHHHHHHHh-cCHhhcCCCCCHHHHhC---
Confidence 999999998765422111 111000 0000110 112233 3445556655 4999999 8999998
Q ss_pred CCchhhhhhhH
Q 008898 522 EPDYWLKMKRE 532 (549)
Q Consensus 522 ~~~~w~~~~~~ 532 (549)
|+||+....
T Consensus 301 --h~~~~~~~~ 309 (376)
T cd05598 301 --HPFFKGIDF 309 (376)
T ss_pred --CCCcCCCCH
Confidence 899876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=330.39 Aligned_cols=250 Identities=18% Similarity=0.256 Sum_probs=195.3
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++||+|+||.||++.+ .+++.+|+|+++.... ....+.+|..++..+ +||||+++++++.+++.++++|||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999987 5689999999986432 123477899999988 7999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~-----~~~ 151 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIR-----PGD 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCC-CCEEECcCcccccccc-----CCC
Confidence 789888843 77888899999999999999999 99999999999999998 6899999999853211 122
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc---hhhHHHHHHHhhcccccccccCCccc
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN---RESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+......... ..++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~p 225 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCCC
Confidence 234568999999999999999999999999999999999999999642211 1111111111111111 1112
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHHhcCCchhhhhhh
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPT------MKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl~~L~~~~~w~~~~~ 531 (549)
..+ ...+.+++..||..||.+||+ +.++++ |+||....
T Consensus 226 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~-----hp~~~~~~ 269 (329)
T cd05588 226 RSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS-----HPFFRNID 269 (329)
T ss_pred CCC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc-----CCCCCCCC
Confidence 222 345677889999999999997 788887 89987644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=329.83 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=195.2
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++||+|+||.||++.. .+++.+|+|+++... .....+..|..++..+ +||||+++++++...+.+++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 468999999997532 2234567888888876 6999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|.+++.. +++.....++.|++.||.|||++ +|+||||||+|||++.+ +.++|+|||++..... ...
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~-----~~~ 151 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIF-----NGK 151 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCc-----CCC
Confidence 799988854 67788888999999999999999 99999999999999998 6899999999854221 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ...+.... ...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~---~~~i~~~~-------~~~~~~- 218 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--L---FEAILNDE-------VVYPTW- 218 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--H---HHHHhcCC-------CCCCCC-
Confidence 2335679999999999998899999999999999999999999997654321 1 11111110 111112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhcCCchhhhhhhHH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTM------KTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~~L~~~~~w~~~~~~~ 533 (549)
....+.++++.||..||.+||++ +++++ |+||......
T Consensus 219 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~-----h~~f~~~~~~ 262 (320)
T cd05590 219 ---LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR-----HPFFKELDWE 262 (320)
T ss_pred ---CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc-----CCCcCCCCHH
Confidence 23456788899999999999998 77776 8998765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.14 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=202.5
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+|+..++||+|+||.||++.. .+++.+|+|++...... ...+.+|+.+++.++||||+++++.+.+++.++++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 377889999999999999976 56899999999754321 2346789999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 328 LL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 328 ~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEG- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCC-CCEEEeeCCCceecCCC-
Confidence 99 6789888732 66778888999999999999999 99999999999999988 68999999998654321
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...+. .
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~~~-~--------- 219 (285)
T cd05605 156 -----ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERRVK-E--------- 219 (285)
T ss_pred -----CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHHhh-h---------
Confidence 11224578999999999998899999999999999999999999998654321 1111111110 0
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~ 533 (549)
....++......+.+++..||..||.+|| ++.++++ |+||......
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~-----~~~~~~~~~~ 270 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA-----HPFFRTANFK 270 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc-----CcCccCCCHH
Confidence 00112233455678899999999999999 8999998 8999875544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=317.47 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=202.2
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++|+..+.||+|+||.||++...+++.+|+|.++......+++.+|+.++++++||||+++++++...+.++++||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 3568889999999999999998877888999999876666678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+++|.+++.. +++.....++.|++.||.|||+. +|+|+||||+||+++++ +.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCC-CCEEECCcceEEEccCCccc-
Confidence 7899999854 66888899999999999999999 99999999999999998 68999999998765421111
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
......++..|+|||++.+..++.++||||||+++|||++ |+.||....... .+. .... .. .
T Consensus 160 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~----~~~~-~~-----~--- 222 (261)
T cd05068 160 ---AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQ----QVDQ-GY-----R--- 222 (261)
T ss_pred ---ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHH----HHHc-CC-----C---
Confidence 1111223457999999998899999999999999999999 999997654221 111 1111 00 0
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..........+.+++.+|++.+|.+||++.++++.|+.
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 -MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01122334668889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=333.11 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=194.1
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
..+|.+.+.||+|+||.||+|.. .+++.+|+|+.... ....|+.+++.++||||+++++++...+..+++++++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 35799999999999999999987 45789999975432 3456999999999999999999999999999999999
Q ss_pred CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 ~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
.|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.++|+|||++.....
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~------ 209 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDV-DQVCIGDLGAAQFPVV------ 209 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEEecCcccccccc------
Confidence 9999998853 67888899999999999999999 99999999999999998 6899999999864221
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcc-cchh-hH----HHHHHHhhccccc-ccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK-ANRE-SL----VLWARSLLSSGLC-ERL 478 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~-~~~~-~l----~~~~~~~~~~~~~-~~~ 478 (549)
........||+.|+|||++.+..++.++|||||||++|||+++..|+.... .... .. ..+.......+.. ..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 112234579999999999999999999999999999999998665553221 1111 00 0111100000000 000
Q ss_pred ------------cCC--cccccC-------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 479 ------------IDP--QLNEEY-------NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 479 ------------~d~--~l~~~~-------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.+. .....+ .........+++..||+.||.+|||+.|+++ |+||++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~-----hp~f~~ 356 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN-----YPMFAQ 356 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc-----Cchhcc
Confidence 000 000000 0011234456899999999999999999999 899975
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.18 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=194.3
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhc-CCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSS-IKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~-l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+.||+|+||.||+|.+ .+++.+|+|+++... ........|..++.. ++||||+++++++.+++.++++|||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 458899999997542 223456678888875 58999999999999999999999999 7
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++..... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTD-GHIKIADFGMCKENML-----GDA 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCC-CCEEEccCCcceECCC-----CCC
Confidence 899999864 67788889999999999999999 99999999999999998 6899999999854221 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ..+.. ..+..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~---~~i~~-------~~~~~~~~- 218 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LF---QSIRM-------DNPCYPRW- 218 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HH---HHHHh-------CCCCCCcc-
Confidence 2235679999999999999999999999999999999999999997654221 11 11110 01111122
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCchhhhhhhHH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMK-TLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~~L~~~~~w~~~~~~~ 533 (549)
....+.+++..||..||.+||++. ++++ |+||+.....
T Consensus 219 ---~~~~~~~li~~~l~~~P~~R~~~~~~l~~-----h~~~~~~~~~ 257 (316)
T cd05619 219 ---LTREAKDILVKLFVREPERRLGVKGDIRQ-----HPFFREIDWS 257 (316)
T ss_pred ---CCHHHHHHHHHHhccCHhhcCCChHHHHc-----CcccCCCCHH
Confidence 234567788999999999999997 6766 7888776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=327.54 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=191.7
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhc-CCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSS-IKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~-l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++||+|+||.||+|.+ .+++.||+|+++... ...+.+..|..++.. .+||||+++++++..++.+++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 458899999997542 122345667777764 48999999999999999999999999 7
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|.+++.. ++......++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~-----~~ 151 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNG-----EG 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCC-----CC
Confidence 799988854 66778888999999999999999 99999999999999998 68999999998643221 12
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+ ..+... .+.++.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~~----~~i~~~-------~~~~~~-- 217 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LF----DSILND-------RPHFPR-- 217 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-HH----HHHHcC-------CCCCCC--
Confidence 2335679999999999999999999999999999999999999997654321 11 111110 111122
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCchhhhhhhH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMK-TLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~~L~~~~~w~~~~~~ 532 (549)
.....+.+++..||..||.+||++. ++++ |+|++....
T Consensus 218 --~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~-----h~~~~~~~~ 256 (316)
T cd05592 218 --WISKEAKDCLSKLFERDPTKRLGVDGDIRQ-----HPFFRGIDW 256 (316)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCChHHHHc-----CcccCCCCH
Confidence 2234567788999999999999875 5655 788876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=322.72 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=198.3
Q ss_pred CC-CCCceEcccCceEEEEEEe-----cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCeE
Q 008898 253 NF-SPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS--KEMY 322 (549)
Q Consensus 253 ~f-~~~~~lG~G~fg~Vy~~~~-----~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~ 322 (549)
+| ...+.||+|+||+||++.. .+++.+|+|+++.... ....+.+|+++++.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 7888999999999988642 4578999999976532 34567899999999999999999998865 3468
Q ss_pred EEEEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+++|||+ +|+|.+++.. +++..+..++.|++.||.|||++ +|+||||||+|||++++ +.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCC-CcEEEeecccccccCC
Confidence 8999999 6789999864 78888999999999999999999 99999999999999988 6899999999865443
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
..... .......++..|+|||.+.+..++.++|||||||++|||++|..|+............+..............
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 160 GHEYY--RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred cchhh--ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 21110 0111234566799999998888999999999999999999999998654322111111110000001111111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
+.......+...+..+.+++..||+.+|.+|||++++++.|+..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111223334567888999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=331.29 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=194.9
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++||+|+||.||+|.+ .+++.+|+|+++... .....+..|.+++..+ +||||+++++++..++.+++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 458899999997542 2224567888888865 7999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|..++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.++|+|||++..... ...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~-----~~~ 151 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAE-GHCKLADFGMCKEGIL-----NGV 151 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC-CCEEEeecccceeccc-----CCc
Confidence 789888854 67778888999999999999999 99999999999999998 6899999999854321 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+ ..+.... ...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~----~~i~~~~-------~~~p~~- 218 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LF----ESILHDD-------VLYPVW- 218 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HH----HHHHcCC-------CCCCCC-
Confidence 2335679999999999999899999999999999999999999998654321 11 1111111 111111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHHhcCCchhhhhhhHH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRP-------TMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RP-------s~~evl~~L~~~~~w~~~~~~~ 533 (549)
....+.+++..||..||.+|| ++.++++ |+||......
T Consensus 219 ---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~-----hp~~~~~~~~ 263 (321)
T cd05591 219 ---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ-----HPFFKEIDWV 263 (321)
T ss_pred ---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc-----CCccCCCCHH
Confidence 234567788999999999999 8888987 8898765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=326.61 Aligned_cols=265 Identities=22% Similarity=0.343 Sum_probs=201.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|...+.||+|+||.||+|.. .+++.+|+|.++.... ....+.+|+.+++.++||||+++++++..++.++++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688999999999999999976 4688999999875432 234577899999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.++|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~---- 157 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINER-GELKLADFGLARAKSVP---- 157 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEECccccceecCCC----
Confidence 99999998854 56777888999999999999999 99999999999999998 68999999998643221
Q ss_pred cCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc--c--------
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS--G-------- 473 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~-------- 473 (549)
........+|+.|+|||.+.+ ..++.++|||||||++|+|++|++||......+. +.......... .
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 158 -TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred -ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcch
Confidence 111223467999999998865 4589999999999999999999999976654222 11111100000 0
Q ss_pred -ccccccCCcccc----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 474 -LCERLIDPQLNE----EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 474 -~~~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.....-.+.... .........+.+++..||..||.+|||+.|+++ |+||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~-----h~~~~~~~ 293 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK-----HAYFRSLG 293 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc-----Chhhhhcc
Confidence 000000000000 001122345678999999999999999999998 89997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=327.99 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=193.5
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhc-CCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSS-IKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~-l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++||+|+||.||++.+ .+|+.+|+|+++... ........|..++.. ++||||+++++++.+++.+++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999987 468999999997542 223456678888875 48999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|..++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.++|+|||++..... ...
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVF-----GDN 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCC-CCEEeCccCCCeeccc-----CCC
Confidence 799988854 67778888999999999999999 99999999999999998 6899999999853221 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ...+.. ..+.+...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~---~~~~~~-------~~~~~~~~~ 219 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--L---FESIRV-------DTPHYPRWI 219 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--H---HHHHHh-------CCCCCCCCC
Confidence 2345679999999999999999999999999999999999999997654321 1 111110 111222222
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCchhhhhhhHH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMK-TLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~~L~~~~~w~~~~~~~ 533 (549)
...+.+++..||..||.+||++. ++++ |+||......
T Consensus 220 ----~~~~~~li~~~l~~dP~~R~~~~~~~~~-----h~~f~~~~~~ 257 (316)
T cd05620 220 ----TKESKDILEKLFERDPTRRLGVVGNIRG-----HPFFKTINWT 257 (316)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCChHHHHc-----CCCcCCCCHH
Confidence 34567788999999999999984 6666 7888775543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=328.46 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=196.8
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++||+|+||.||++.+ .+++.+|+|+++... .....+..|..+++.+ +||||+++++++...+.++++|||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 458899999998542 2234567888999887 6999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|..++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGIL-----GGV 151 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCC-CcEEecccCCCeecCc-----CCC
Confidence 789888853 67888899999999999999999 99999999999999998 6899999999854211 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... . ...+... ....
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~---~~~i~~~-------~~~~---- 215 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--L---FQSILED-------EVRY---- 215 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--H---HHHHHcC-------CCCC----
Confidence 2234579999999999999999999999999999999999999997554221 1 1111111 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCchhhhhhhHH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTM-----KTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~L~~~~~w~~~~~~~ 533 (549)
+......+.+++..||..||.+||++ .++++ |+|++.....
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~-----~~~~~~~~~~ 261 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG-----HPFFREIDWD 261 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc-----CCCcCCCCHH
Confidence 12234567888999999999999999 99988 8999776543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=335.99 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=200.8
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----eEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKE-----MYA 323 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~~~ 323 (549)
+|++.+.||+|+||.||++.. .+|+.||+|.+..... ....+.+|+.+++.++||||+++++++...+ .++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999986 5799999999864322 2356789999999999999999999998776 789
Q ss_pred EEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 324 IVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 324 lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
+++||+.++|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCC-CCEEeccccceeecccC
Confidence 9999999999888843 67888899999999999999999 99999999999999998 68999999998654321
Q ss_pred cccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc-------
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS------- 472 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~------- 472 (549)
. ........+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+..........
T Consensus 157 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 157 E----SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred c----cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHH
Confidence 1 1122234688999999998874 47999999999999999999999997655321 111111100000
Q ss_pred ---cc----cccccCCc-cc--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 473 ---GL----CERLIDPQ-LN--EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 473 ---~~----~~~~~d~~-l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+. ......+. .. ........+.+.+++..||..||.+|||+.++++ |+|+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~-----hp~~~~~ 294 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA-----HPYLDEG 294 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc-----CHhhCCC
Confidence 00 00000000 00 0011122456788999999999999999999998 8998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=318.82 Aligned_cols=249 Identities=18% Similarity=0.318 Sum_probs=196.5
Q ss_pred hcCCCCCceEcccCceEEEEEEec----CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~----~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|++.+.||+|+||.||+|.+. .+..+|+|.++..... ...+.+|+.+++.++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999652 3568999998765322 2467899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
||||+ +|+|.+++.. +++...+.++.||+.||.|||+. +++||||||+|||++.+ +.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~-~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCC-CcEEECCCcccccccc
Confidence 99999 6789999854 57888899999999999999999 99999999999999998 6899999998644221
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.. ........++..|+|||.+.++.++.++|||||||++|||++ |..||....... . ...+. .+.
T Consensus 160 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~---~~~~~-~~~---- 225 (266)
T cd05064 160 EA----IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--V---IKAVE-DGF---- 225 (266)
T ss_pred cc----hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--H---HHHHH-CCC----
Confidence 11 011112345678999999999999999999999999999775 999997654321 1 11111 110
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. ...+...+..+.+++..||+.+|.+||++.+|++.|.+
T Consensus 226 -~----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 -R----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -C----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0 11123345668889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.72 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=200.4
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...+.||+|+||.||++.. .+|+.+|+|+++.... ....+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688899999999999999977 5689999999985432 2345778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 327 e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence 999 7899999854 56777888999999999999999 99999999999999998 789999999986543321
Q ss_pred ccccCccccccccCCccccccccc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMM------YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...+......
T Consensus 157 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~~~~ 227 (330)
T cd05601 157 M----VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YNNIMNFQRF 227 (330)
T ss_pred c----eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HHHHHcCCCc
Confidence 1 1222457999999999987 45678999999999999999999999976543221 1111111110
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
... + . .......+.+++..|+. +|.+|||+.++++ |+||.....
T Consensus 228 ~~~--~---~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~-----h~~~~~~~~ 271 (330)
T cd05601 228 LKF--P---E--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC-----HPFFSKIDW 271 (330)
T ss_pred cCC--C---C--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC-----CCCcCCCCH
Confidence 011 0 0 11123456778889997 9999999999998 899876443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=337.52 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=196.7
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...+.||+|+||.||++.. .+|+.+|||++..... ....+.+|+++++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999976 5789999999865321 2245778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCC-CCEEEeecccccccccccc
Confidence 999 7899999854 56777788999999999999999 99999999999999988 7899999999853211000
Q ss_pred c-----------cc-------------------------------CccccccccCCccccccccccCCCCchhhHHHHHH
Q 008898 403 V-----------SE-------------------------------NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGV 440 (549)
Q Consensus 403 ~-----------~~-------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGv 440 (549)
. .. .......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 00 00011357999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHH
Q 008898 441 VLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRR---PTMKTLL 517 (549)
Q Consensus 441 il~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~evl 517 (549)
++|||++|..||....... .+. .+.... ..+.-+ .. ......+.+++..|+. +|.+| +++.+++
T Consensus 237 il~elltG~~Pf~~~~~~~-~~~----~i~~~~--~~~~~p---~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE-TYR----KIINWR--ETLYFP---DD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH-HHH----HHHccC--CccCCC---CC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 9999999999997654321 111 111100 001001 10 0122446677888987 66664 6999999
Q ss_pred HHhcCCchhhhhhh
Q 008898 518 KLFQEPDYWLKMKR 531 (549)
Q Consensus 518 ~~L~~~~~w~~~~~ 531 (549)
+ |+||+...
T Consensus 304 ~-----hp~~~~~~ 312 (377)
T cd05629 304 S-----HPFFRGVD 312 (377)
T ss_pred c-----CCCcCCCC
Confidence 8 89997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.05 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=198.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
...|.+.+.||+|+||.||++.+ .+++.||||.... ..+.+|+.+|++++|+||+++++++..++..+++|+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 45799999999999999999987 4588999996432 34678999999999999999999999999999999999
Q ss_pred CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 ~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
.|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++....... .
T Consensus 243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~---~ 315 (461)
T PHA03211 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSW---S 315 (461)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCC-CCEEEcccCCceeccccc---c
Confidence 9999998853 67889999999999999999999 99999999999999988 689999999987543321 1
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc------hhhHHHHHHHhhc-ccccccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN------RESLVLWARSLLS-SGLCERL 478 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~------~~~l~~~~~~~~~-~~~~~~~ 478 (549)
........||+.|+|||++.+..++.++|||||||+||||++|..|+...... ...+......... .......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 11123467999999999999999999999999999999999988765432211 1111111111000 0000000
Q ss_pred ----------------cCCcccc-cCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 479 ----------------IDPQLNE-EYN--REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 479 ----------------~d~~l~~-~~~--~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
..+.... .+. ......+.+++.+||+.||.+|||+.|+++ |+||..
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~-----hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR-----LPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh-----CcccCC
Confidence 0000000 000 011235778999999999999999999999 899965
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=333.92 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=200.9
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC------
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------ 319 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 319 (549)
+.++|...+.||+|+||.||++.. .+++.||||.+..... ....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999976 5688999999875432 234577899999999999999999887533
Q ss_pred CeEEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 320 EMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 320 ~~~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
..+++++++++++|.++++. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++...
T Consensus 93 ~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNED-CELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCC-CCEEEcCCccceec
Confidence 45789999999999988853 78888899999999999999999 99999999999999998 68999999998653
Q ss_pred ccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc----
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS---- 472 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~---- 472 (549)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+..+.......
T Consensus 169 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 169 DD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEV 239 (343)
T ss_pred CC--------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 32 1234578999999999876 468999999999999999999999997644221 111111110000
Q ss_pred ------cccccccC--Cccccc----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 473 ------GLCERLID--PQLNEE----YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 473 ------~~~~~~~d--~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
........ +..... ........+.+++..|+..||.+|||+.++++ |+||.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~-----hp~~~~~~~~ 307 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA-----HPYFSQYHDP 307 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc-----CcchhccCCC
Confidence 00000000 000000 00011234678999999999999999999998 8999765443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.31 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=202.0
Q ss_pred hcCCCCCceEcccCceEEEEEEec---CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
..+|.+.+.||+|+||.||++... .++.+|+|.+... ....+|+.+++.++||||+++++++.....++++|+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457999999999999999999653 3678999988643 345689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 328 LLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 328 ~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
++.++|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++.......
T Consensus 167 ~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~--- 239 (392)
T PHA03207 167 KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHP--- 239 (392)
T ss_pred hcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCC-CCEEEccCccccccCccc---
Confidence 999999998853 68888999999999999999999 99999999999999998 689999999986543321
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc--hhhHHHHHHHhhccc-cc------
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN--RESLVLWARSLLSSG-LC------ 475 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~-~~------ 475 (549)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+......+.... ..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 112223567999999999999999999999999999999999999999765432 111211111110000 00
Q ss_pred ------ccccCCcccccCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 476 ------ERLIDPQLNEEYN-------REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 476 ------~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
..+ .......+. ......+.+++++||..||++|||+.+++. |+||+..
T Consensus 320 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~-----~p~f~~~ 381 (392)
T PHA03207 320 NLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS-----LPLFTKE 381 (392)
T ss_pred hHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh-----Cchhhcc
Confidence 000 000000000 012345677889999999999999999999 8999653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=343.31 Aligned_cols=249 Identities=23% Similarity=0.296 Sum_probs=197.2
Q ss_pred CCCCCceEcccCceEEEEEEe-cC-CcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VD-GQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~-g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.|...+.||+|+||.||++.. .+ +..+|+|.+...... ...+.+|+.+++.++||||+++++++..++.+++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488889999999999999976 44 678888877554332 235678999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 330 -NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 330 -~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
+|+|.+++.+ +++.+...++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCC-CcEEEEeCcCceecCCcc
Confidence 7899988753 56677888999999999999999 99999999999999988 689999999997644321
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ....... . .++
T Consensus 224 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--~---~~~~~~~-~----~~~ 290 (478)
T PTZ00267 224 S---LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--I---MQQVLYG-K----YDP 290 (478)
T ss_pred c---cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--H---HHHHHhC-C----CCC
Confidence 1 112335679999999999999999999999999999999999999997543211 1 1111111 0 011
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
++......+.+++..||..||.+||++.+++. ++|++
T Consensus 291 -----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~-----~~~~~ 327 (478)
T PTZ00267 291 -----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH-----TEFLK 327 (478)
T ss_pred -----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh-----CHHHH
Confidence 11123345788889999999999999999987 55554
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.92 Aligned_cols=249 Identities=28% Similarity=0.330 Sum_probs=197.0
Q ss_pred HhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCC---
Q 008898 248 CHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKE--- 320 (549)
Q Consensus 248 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~--- 320 (549)
....++|.+.+.||+|+||.||++.. .+|+.||||++....... ..+.+|+.++..++|+||++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999976 579999999997654332 45678999999999999999987764322
Q ss_pred -----eEEEEEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceE
Q 008898 321 -----MYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (549)
Q Consensus 321 -----~~~lv~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~k 387 (549)
.++++|||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~-~~vk 183 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSN-GLVK 183 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCC-CCEE
Confidence 478999999 7899998853 56677888999999999999999 99999999999999998 6899
Q ss_pred EeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHH
Q 008898 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~ 467 (549)
|+|||+++...... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +..
T Consensus 184 L~DFGls~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-----~~~ 255 (496)
T PTZ00283 184 LGDFGFSKMYAATV---SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-----VMH 255 (496)
T ss_pred EEecccCeeccccc---cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----HHH
Confidence 99999986543321 1122335689999999999999999999999999999999999999997643211 111
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
..... ..++ .+......+.+++..||..||.+||++.++++
T Consensus 256 ~~~~~-----~~~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 256 KTLAG-----RYDP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHhcC-----CCCC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 11111 1111 12223456788899999999999999999997
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=328.70 Aligned_cols=247 Identities=26% Similarity=0.330 Sum_probs=192.7
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHH-HHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVE-LLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+.||+|+||.||++.+ .+|+.+|+|++..... ....+..|.. +++.++||||+++++++.+++.++++|||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999987 5799999999975321 1234555555 567899999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|..++.. +.+.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIE-----HSK 151 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCC-CcEEEeccCCCccccc-----CCC
Confidence 789988854 66777888999999999999999 99999999999999998 6899999999854221 122
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+.... ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~~-------~~~~~~- 218 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-----MYDNILNKP-------LRLKPN- 218 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-----HHHHHHcCC-------CCCCCC-
Confidence 2335679999999999999999999999999999999999999997654321 111111110 111112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH----HHHHHhcCCchhhhhhhHHH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMK----TLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~----evl~~L~~~~~w~~~~~~~~ 534 (549)
....+.+++..||+.||.+||++. ++++ |+||.......
T Consensus 219 ---~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~-----~~~~~~~~~~~ 261 (323)
T cd05575 219 ---ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKN-----HVFFSSINWDD 261 (323)
T ss_pred ---CCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc-----CCCcCCCCHHH
Confidence 244577888999999999999984 6665 78887655443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=315.99 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=199.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.+|...+.||+|+||.||+|.. .+++.+|+|.++.+.....++.+|+++++.++||||+++++++..++.++++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3578888999999999999976 45889999999866655677899999999999999999999999999999999998
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.. +++..++.++.|+++||.|||++ +++||||||+||+++++ +.++|+|||++.........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCC-CcEEeCCCccccccccceee-
Confidence 6899999853 66778889999999999999999 99999999999999988 68999999998654332111
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... + ...+.. + ..+.
T Consensus 161 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~---~~~~~~-~-----~~~~- 225 (263)
T cd05052 161 ---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V---YELLEK-G-----YRME- 225 (263)
T ss_pred ---ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H---HHHHHC-C-----CCCC-
Confidence 1112234668999999999999999999999999999998 899987543221 1 111111 1 1111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+...+..+.+++.+||..||.+|||+.++++.|+.
T Consensus 226 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 226 ---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 122234568888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=313.31 Aligned_cols=251 Identities=33% Similarity=0.522 Sum_probs=199.0
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHH---HHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~---~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
|+..+.||+|+||.||++.. .+++.+|+|++......... ..+|+.++++++||||+++++++...+.++++|+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 45678999999999999988 45779999999877644433 356999999999999999999999999999999999
Q ss_pred CC-CHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 NG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 ~g-sL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
.+ +|.+++.. +++..+..++.||++||.|||+. +|+|+||||+||+++.+ +.++|+|||.+.... ..
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~-----~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDEN-GEVKLIDFGSSVKLS-----EN 151 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTT-SEEEESSGTTTEEST-----ST
T ss_pred ccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc-ccccccccccccccc-----cc
Confidence 66 99999963 77888999999999999999999 99999999999999987 689999999986431 11
Q ss_pred CccccccccCCccccccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
........+|+.|+|||++. +..++.++||||||+++|+|++|..||...... ...................
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~------ 224 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKILKRPLPSSSQ------ 224 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHHHTHHHHHTT------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhccccccccccc------
Confidence 22333567899999999998 788999999999999999999999999876221 1111111111111000000
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
........+.+++..||..||.+||++.++++ |+||
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~-----~~~~ 260 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLK-----HPWF 260 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT-----SGGG
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhc-----CCCC
Confidence 00001267888999999999999999999999 8986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=305.79 Aligned_cols=258 Identities=25% Similarity=0.352 Sum_probs=200.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEc-----CCeEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHS-----KEMYA 323 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-----~~~~~ 323 (549)
.++|++.+.||+|||+.||++++ .++..||+|.+.+.. .+.+..++|++..++++|||++++++++.. ....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 46799999999999999999986 679999999998776 455778999999999999999999987633 33588
Q ss_pred EEEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 324 IVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
++++|. .|+|.+.++. +++.+.+.++.+|++||++||+.. .+++||||||.|||++++ +.++|.|||.+.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~-~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDS-GLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCC-CceEEEeccCcc
Confidence 888877 8999999854 677888999999999999999982 259999999999999998 689999999986
Q ss_pred cccccc----ccccCccccccccCCcccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHH
Q 008898 396 VHHQSH----QVSENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARS 468 (549)
Q Consensus 396 ~~~~~~----~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 468 (549)
...-.- ....-.....-..|..|.|||.+.- ...++++|||||||+||.|+.|..||+.......++
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl------ 251 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL------ 251 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE------
Confidence 533211 0111111123457899999999874 456899999999999999999999997544321111
Q ss_pred hhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 469 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.-....+.+.-+-.....+.+.+++++|++.||.+||++.+++..++.
T Consensus 252 ------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 252 ------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 011111122222223356788999999999999999999999998765
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=314.09 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=197.5
Q ss_pred CCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CC
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~g 331 (549)
+|+..+.||+|+||.||++.+.++..+|+|++.........+.+|+++++.++||||+++++++...+..+++|||+ ++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 57888899999999999998877788999998766656678889999999999999999999999999999999999 67
Q ss_pred CHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 332 SLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 332 sL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
+|.+++.. +++.....++.||+.||.|||+. +|+||||||+||+++.+ +.+||+|||++.........
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~---- 156 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYT---- 156 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCC-CcEEECCcccceeccccccc----
Confidence 89999854 57778899999999999999999 99999999999999998 68999999998654321111
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
......++..|+|||.+.+..++.++|||||||++|||++ |..||........ . ..... + .....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~----~~~~~-~-----~~~~~--- 222 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-V----ESVSA-G-----YRLYR--- 222 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-H----HHHHc-C-----CcCCC---
Confidence 1111234567999999999999999999999999999999 7999875443211 1 11110 1 01111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 520 (549)
+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 122345688899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=312.32 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=199.2
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|...+.||+|+||.||++.. .+++.+|+|.+...... ...+.+|++++++++||||+++++++.+++.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999976 56899999998754321 2357789999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
++|++ +++|.+++.. ++......++.|++.||.|||+. +|+|+||+|+||+++.+ +.++|+|||++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence 99999 6789998864 56677888999999999999999 99999999999999988 68999999998654321
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.. .........|+..|+|||.+.+..++.++|||||||++|||++|+.||......... . .....
T Consensus 158 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~-~~~~~-------- 222 (263)
T cd06625 158 CS--SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI----F-KIATQ-------- 222 (263)
T ss_pred cc--ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH----H-HHhcc--------
Confidence 11 111112456888999999999988999999999999999999999999754322111 0 00000
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.....++......+.+++..||..+|.+|||+.++++ |+||
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~-----~~~~ 263 (263)
T cd06625 223 -PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR-----HFFV 263 (263)
T ss_pred -CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh-----CCCC
Confidence 0111122233456778889999999999999999999 7775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.69 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=197.3
Q ss_pred cCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
.+|.+.+.||+|+||.||+|... +++.+|+|.++..... .+.+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45788889999999999999753 2478999999765433 357889999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHH-----------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc
Q 008898 324 IVYNLL-NGSLKQYLKQ-----------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~-----------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 385 (549)
++|||+ +|+|.+++.. +++.....++.|++.||.|||++ +++||||||+||+++.+ +.
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~-~~ 160 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD-LV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC-Ce
Confidence 999999 7899999853 45667788999999999999999 99999999999999998 69
Q ss_pred eEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHH
Q 008898 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVL 464 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~ 464 (549)
++|+|||++......... .......+++.|+|||++.++.++.++|||||||++|||++ |..||....... ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~ 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIE 235 (280)
T ss_pred EEECCcccceecccCcce---ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH
Confidence 999999998654322111 11123346788999999999999999999999999999998 999987554322 111
Q ss_pred HHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 465 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
. .. .+... ..+......+.+++..||..||.+||++.|+++.|+
T Consensus 236 ~---~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 C---IT-QGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H---HH-cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 11 11110 111223456788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=318.89 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=199.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|+..++||+|+||.||++.+ .+++.+|+|++...... ...+.+|+.++++++||||+++++++...+.++++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999976 57899999998754322 35688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 329 L-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 329 ~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
+ +|+|..+ ..+++.....++.|++.||.|||+. +|+|+||||+|||++.+ +.++|+|||++......
T Consensus 81 ~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~------- 148 (279)
T cd06619 81 MDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS------- 148 (279)
T ss_pred CCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-------
Confidence 9 5566544 4567778889999999999999999 99999999999999998 68999999998643221
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhH--HHHHHHhhcccccccccCCcccc
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL--VLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l--~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
......||..|+|||++.+..++.++|+|||||++|+|++|+.||.......... ..+....... ..+.+.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~- 221 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE------DPPVLP- 221 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc------CCCCCC-
Confidence 1224578999999999999899999999999999999999999997543221111 1111111100 011111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.......+.+++..|+..+|.+||+++++++ |+|+.+..
T Consensus 222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~-----~~~~~~~~ 260 (279)
T cd06619 222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMD-----HPFIVQYN 260 (279)
T ss_pred --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc-----Cccccccc
Confidence 1112345778889999999999999999998 89987554
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=317.41 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=198.1
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcC------Ce
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSK------EM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~------~~ 321 (549)
+++.|+..+.||+|+||.||+|.. .+++.+|+|++.........+..|+.+++.+ +||||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 456788889999999999999976 5688999999987666667788999999998 699999999998642 46
Q ss_pred EEEEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
++++|||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+|+||||+||+++++ +.++|+|||++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~-~~~~l~Dfg~~~ 159 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN-AEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCC-CCEEEccCCCce
Confidence 89999999 6799998864 56777888999999999999999 99999999999999998 689999999986
Q ss_pred ccccccccccCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
..... ........|++.|+|||++. +..++.++|||||||++|||++|..||............ .
T Consensus 160 ~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-----~ 229 (272)
T cd06637 160 QLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-----P 229 (272)
T ss_pred ecccc-----cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-----h
Confidence 54321 11223467899999999986 345888999999999999999999999754432211100 0
Q ss_pred cccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 471 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
... .+.. ........+.+++.+||..||.+|||+.++++ |+||
T Consensus 230 -~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~-----~~~~ 272 (272)
T cd06637 230 -RNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK-----HPFI 272 (272)
T ss_pred -cCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh-----CCCC
Confidence 000 0111 11123345788899999999999999999998 8886
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=325.94 Aligned_cols=253 Identities=19% Similarity=0.232 Sum_probs=195.7
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++||+|+||.||++.. .+++.+|+|+++.... ..+.+.+|+.++.++ +||||+++++++.+.+.+++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 5688999999985432 224477899999888 6999999999999999999999999 7
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|..++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLG-----PGD 151 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCC-CCEEEeccccceeccC-----CCC
Confidence 799888753 77888899999999999999999 99999999999999998 6899999999854221 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchh-hHHHHHHHhhcccccccccCCccccc
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE-SLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+......... ..++.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p~- 224 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIPR- 224 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCCC-
Confidence 23356799999999999999999999999999999999999999964322110 11111111111110 01111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHHhcCCchhhhhhhHHH
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPT------MKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.....+.+++..||..||.+||+ +.++++ |+||....+..
T Consensus 225 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~-----h~~f~~~~~~~ 270 (327)
T cd05617 225 ---FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS-----HTFFRSIDWDL 270 (327)
T ss_pred ---CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc-----CCCCCCCCHHH
Confidence 22345678889999999999998 467776 88988765443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=333.53 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=198.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|+..+.||+|+||.||++.. .+++.+|+|+++... .....+.+|+.++..++||||+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999987 468999999997532 12345778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.+ ++......++.|++.||.|||++ +|+||||||+|||++.+ +.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCC-CCEEEeeccCCcccccccc
Confidence 999 6799999854 67778888999999999999999 99999999999999988 7999999999864322110
Q ss_pred c------------------------------ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008898 403 V------------------------------SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452 (549)
Q Consensus 403 ~------------------------------~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~ 452 (549)
. .........+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0001122457999999999999999999999999999999999999999
Q ss_pred CCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHhcCCchhhhh
Q 008898 453 QTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT---MKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 453 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~~L~~~~~w~~~ 529 (549)
........ . ..+.... ..+.-+. ...++ ..+.+++..|+ .||.+|++ +.++++ |+||..
T Consensus 237 ~~~~~~~~-~----~~i~~~~--~~~~~p~-~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~-----hp~f~~ 298 (360)
T cd05627 237 CSETPQET-Y----RKVMNWK--ETLVFPP-EVPIS----EKAKDLILRFC-TDSENRIGSNGVEEIKS-----HPFFEG 298 (360)
T ss_pred CCCCHHHH-H----HHHHcCC--CceecCC-CCCCC----HHHHHHHHHhc-cChhhcCCCCCHHHHhc-----CCCCCC
Confidence 76543221 1 1111100 0010010 01122 34455556665 49999985 677777 899987
Q ss_pred hhHHH
Q 008898 530 KREKE 534 (549)
Q Consensus 530 ~~~~~ 534 (549)
.....
T Consensus 299 ~~~~~ 303 (360)
T cd05627 299 VDWGH 303 (360)
T ss_pred CCHHH
Confidence 65544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.01 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=198.7
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|...+.||+|+||.||++...++..+|+|.++......+.+.+|+.+++.++||||+++++++...+.++++|||+ +
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 357788899999999999998877777999999876666678999999999999999999999999989999999999 6
Q ss_pred CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 331 gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
|+|.+++.. +.+...+.++.||+.||.|||+. +++|+||||+||+++.+ +.+||+|||++........
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~---- 155 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEY---- 155 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCC-CCEEECCCccceecCCCce----
Confidence 789999854 67788899999999999999999 99999999999999988 6899999999865432211
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... . ......... +..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~---~~~~~~~~~------~~~-- 222 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--T---VEKVSQGLR------LYR-- 222 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--H---HHHHhcCCC------CCC--
Confidence 11112345678999999998889999999999999999998 999987544321 1 111111110 001
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.......+.+++..||..+|.+||++.+|++.|+
T Consensus 223 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 --PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1112456788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=315.06 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=193.6
Q ss_pred EcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCH
Q 008898 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (549)
Q Consensus 260 lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL 333 (549)
||+|+||.||++.. .+|+.+|+|.+..... ....+..|+++++.++||||+++++++..+..++++|||+ +|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 5699999999864321 1234567999999999999999999999999999999999 6789
Q ss_pred HHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 008898 334 KQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (549)
Q Consensus 334 ~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (549)
.+++.. +.+.....++.||+.||.|||+. +|+||||||+||+++.+ +.++|+|||++...... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~------~~ 150 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDG------KT 150 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCC-CCEEEeeceeeeecCCC------ce
Confidence 888743 56677788999999999999999 99999999999999998 68999999998654321 11
Q ss_pred ccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCC
Q 008898 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYN 488 (549)
Q Consensus 409 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 488 (549)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............ +.. . .
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~-----~~~-~----~ 219 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLEDE-----VKF-E----H 219 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhccc-----ccc-c----c
Confidence 2245689999999999988999999999999999999999999975433211 111111111110 000 0 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 489 REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 489 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
......+.+++..||+.||.+||++.|+++.+. .|+||+..+.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~-~h~~f~~~~~ 262 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPR-KHEFFKTINF 262 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhh-cChhhcCCCH
Confidence 123445788999999999999999966554333 3789977543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.54 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=204.5
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe-EEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEM-YAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~lv~ 326 (549)
++|...+.+|+|+||.++.+.+ .+++.+++|.+...... ......|+.++++++|||||.+.+.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5688899999999999999977 56889999999766533 3457899999999999999999999988888 99999
Q ss_pred ecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 327 NLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 327 e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
+|+ +|+|.+.+.+ +++.....++.|++.|+.|||++ .|+|||||+.|||++.+ +.++|+|||+|+...+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhcccc-CceeecchhhhhhcCCc
Confidence 999 7899999854 67788899999999999999998 99999999999999999 67899999999876553
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
. ....+.+|||.||.||++.+.+|+.|+|||||||++|||++-+++|...+... + ...+ ....
T Consensus 160 ~-----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--L---i~ki-----~~~~-- 222 (426)
T KOG0589|consen 160 D-----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--L---ILKI-----NRGL-- 222 (426)
T ss_pred h-----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH--H---HHHH-----hhcc--
Confidence 2 24557899999999999999999999999999999999999999998765322 1 1111 1111
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 519 (549)
..+.+......+..++..|++.+|..||++.+++..
T Consensus 223 ---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 ---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 223344445567778899999999999999999984
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=318.59 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=198.2
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
|+..+.||+|+||.||++.. .+++.+|+|.+...... ...+..|+.+++.++|+||+++++.+.+++.++++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67778999999999999976 56899999998754322 23467899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCc-
Confidence 9 6789988843 66677888999999999999998 99999999999999988 689999999986533211
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...... .... . ..
T Consensus 157 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~-~~~~-----~-~~- 222 (285)
T cd05630 157 -----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVER-LVKE-----V-QE- 222 (285)
T ss_pred -----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHh-hhhh-----h-hh-
Confidence 11234789999999999999999999999999999999999999986543211 000000 0000 0 00
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~ 530 (549)
.+.......+.+++..||+.||.+||| +.++++ |+||+..
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~-----h~~~~~~ 267 (285)
T cd05630 223 ---EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE-----HPLFKQI 267 (285)
T ss_pred ---hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc-----Chhhhcc
Confidence 111223345778899999999999999 899998 8999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=313.06 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=198.9
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|++.+.||+|+||.||++...++..+|+|.++......+.+.+|+.+++.++|+|++++++++.. +..+++|||+ +
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence 4688899999999999999988788889999998766667789999999999999999999998865 5578999999 6
Q ss_pred CCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
++|.+++.. +++..+..++.+++.||.|||+. +|+||||||+||+++++ +.++|+|||++........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCC-ceEEeCCceeeeeccCccc---
Confidence 799999853 67788899999999999999999 99999999999999998 6899999999865432211
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +.+. .+.... .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~----~~~~~~------~---- 221 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-EVLE----QVERGY------R---- 221 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHH----HHHcCC------C----
Confidence 11112345678999999988889999999999999999999 88898654321 1111 111100 0
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...+......+.+++.+|+..+|.+|||+.++.++|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122334568889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=330.28 Aligned_cols=245 Identities=24% Similarity=0.327 Sum_probs=194.3
Q ss_pred ceEcccCceEEEEEEe----cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 258 MLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~----~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
+.||+|+||.||++.. .+|+.+|+|+++.... ....+..|++++++++||||+++++++.+++.+++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999864 3588999999975432 2245678999999999999999999999999999999999
Q ss_pred CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 ~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++...... .
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~-----~ 152 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDH-----E 152 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCC-CcEEEeeccCCcccCCC-----C
Confidence 6899999854 67888899999999999999999 99999999999999998 68999999998643221 1
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+.... ..+
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~----~~i~~~~-------~~~--- 217 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-M----TMILKAK-------LGM--- 217 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-H----HHHHcCC-------CCC---
Confidence 223356799999999999988899999999999999999999999976543211 1 1111110 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCchhhhhhhH
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTM-----KTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~L~~~~~w~~~~~~ 532 (549)
+......+.++++.||+.||.+||++ .++++ |+||.....
T Consensus 218 -p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~-----~~~~~~~~~ 262 (318)
T cd05582 218 -PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKR-----HPFFSTIDW 262 (318)
T ss_pred -CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhC-----CCCcCCCCH
Confidence 12223457788899999999999994 55554 788876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=323.17 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=188.2
Q ss_pred ceEcccCceEEEEEEec---CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEE--cCCeEEEEEeccCCC
Q 008898 258 MLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH--SKEMYAIVYNLLNGS 332 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~lv~e~~~gs 332 (549)
..||+|+||.||+|... ++..+|+|.+..... ...+.+|+.+++.++||||+++++++. .+..++++|||++++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 57999999999999864 357899999875442 346788999999999999999999884 456789999999999
Q ss_pred HHHHHH------------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe----cCCCceEEeeeccccc
Q 008898 333 LKQYLK------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS----ENFHHPQLSDFGAAMV 396 (549)
Q Consensus 333 L~~~l~------------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~----~~~~~~kL~DFGla~~ 396 (549)
|.+++. .+++.....++.||+.||.|||+. +|+||||||+|||+. .+ +.+||+|||++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~-~~~kl~DfG~a~~ 161 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER-GRVKIADMGFARL 161 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCC-CcEEEeeccceec
Confidence 988874 255667788999999999999999 999999999999994 33 5899999999976
Q ss_pred cccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccch--------hhHHHHHH
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANR--------ESLVLWAR 467 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~--------~~l~~~~~ 467 (549)
...... .........||+.|+|||++.+. .++.++|||||||++|||+||++||.....+. ..+..+..
T Consensus 162 ~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 162 FNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred cCCCcc--cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 543211 11122345789999999998764 57999999999999999999999997543211 11111111
Q ss_pred Hhhccc--cc---------ccccC---------Cccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 468 SLLSSG--LC---------ERLID---------PQLN---EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 468 ~~~~~~--~~---------~~~~d---------~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.+.... .. ..... +.+. ..........+.+++..|+..||.+|||+.|+++ |
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~-----h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ-----D 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc-----C
Confidence 000000 00 00000 0000 0000111245778999999999999999999998 8
Q ss_pred hhh
Q 008898 525 YWL 527 (549)
Q Consensus 525 ~w~ 527 (549)
+||
T Consensus 315 p~f 317 (317)
T cd07867 315 PYF 317 (317)
T ss_pred CCC
Confidence 886
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=312.85 Aligned_cols=251 Identities=22% Similarity=0.369 Sum_probs=200.4
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|.+.+.||+|+||.||+|.. .+++.+|+|.++.... ....+.+|+.+++.++||||+++++++.+.+.+++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788999999999999999976 5789999998864321 1245788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 327 e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
||+ +|+|.+++.. ++......++.|++.||.|||++ +++|+||||+||+++.+ +.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCC-CCEEECccccceecc
Confidence 999 5789888743 45667788999999999999999 99999999999999998 689999999986643
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
... .......|++.|+|||.+.+..++.++|+||||+++|||++|+.||.........+. .......
T Consensus 158 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~---~~~~~~~----- 224 (267)
T cd08228 158 SKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC---QKIEQCD----- 224 (267)
T ss_pred chh-----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH---HHHhcCC-----
Confidence 321 112234688999999999988899999999999999999999999976543322221 1111100
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
.+ ..........+.+++.+||..+|.+||++.++++.|++.
T Consensus 225 -~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 -YP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11 111223456688899999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.10 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=196.1
Q ss_pred hcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIK-HENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~ 321 (549)
.++|.+.++||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.+++.+. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 357889999999999999999752 1347999999754322 356889999999996 9999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH-------------------------------------------------------------
Q 008898 322 YAIVYNLL-NGSLKQYLKQ------------------------------------------------------------- 339 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~------------------------------------------------------------- 339 (549)
.+++|||+ +|+|.+++.+
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999 7899988743
Q ss_pred --------------------------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec
Q 008898 340 --------------------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE 381 (549)
Q Consensus 340 --------------------------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~ 381 (549)
+++.....++.||++||.|||+. +|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 33455677999999999999999 9999999999999999
Q ss_pred CCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchh
Q 008898 382 NFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRE 460 (549)
Q Consensus 382 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~ 460 (549)
+ +.+||+|||++........ ........+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 273 ~-~~~kL~DfGla~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 273 G-KIVKICDFGLARDIMHDSN---YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred C-CEEEEEeCCcceecccccc---ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 8 6899999999865432211 112223457788999999998899999999999999999997 9999876433221
Q ss_pred hHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 461 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.. ... ..+. .. ..+...+..+.+++.+||..||.+||++.+|.+.|+.
T Consensus 349 ~~----~~~-~~~~-----~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 349 FY----NKI-KSGY-----RM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HH----HHH-hcCC-----CC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 11 111 1110 01 1122345668889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=336.31 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=206.4
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-C-----CCeeeEEEEEEcCCeEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-H-----ENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h-----~nIv~l~~~~~~~~~~~lv 325 (549)
+|.+.++||+|+||.|.+|.. .+++.||||+++....-..+...|+.||..|+ | -|+|+++++|.-.+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 678889999999999999965 77999999999976655567778999999997 4 4899999999999999999
Q ss_pred EeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC-CCceEEeeecccccccc
Q 008898 326 YNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 326 ~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~~kL~DFGla~~~~~ 399 (549)
+|++.-+|.++++. ++......++.||+.||.+||+. +|||+||||+||||.+. ...+||+|||.|.....
T Consensus 267 fELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 267 FELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred ehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 99999999999976 66778889999999999999999 99999999999999643 23799999999966443
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc------
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG------ 473 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~------ 473 (549)
.. .+.+-+..|.|||++.|.+|+.+.||||||||++||++|.+.|.+..+ .+.+....+.+....
T Consensus 344 ~v--------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne-~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 344 RV--------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE-YDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cc--------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH-HHHHHHHHHHhCCCCHHHHHh
Confidence 22 144567789999999999999999999999999999999877776654 333322222211100
Q ss_pred --ccccccCC---------------------------------ccc-------ccCCHHHHHHHHHHHHHhcccCCCCCC
Q 008898 474 --LCERLIDP---------------------------------QLN-------EEYNREEIEIVMCAARLCLLHSSSRRP 511 (549)
Q Consensus 474 --~~~~~~d~---------------------------------~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RP 511 (549)
......+. ..+ ..........+.+++++||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 00000110 000 011113346788999999999999999
Q ss_pred CHHHHHHHhcCCchhhhhhhH
Q 008898 512 TMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 512 s~~evl~~L~~~~~w~~~~~~ 532 (549)
|..+.++ |+|+.+..-
T Consensus 495 tp~qal~-----Hpfl~~~~~ 510 (586)
T KOG0667|consen 495 TPAQALN-----HPFLTGTSL 510 (586)
T ss_pred CHHHHhc-----Ccccccccc
Confidence 9999999 999985543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.15 Aligned_cols=251 Identities=21% Similarity=0.341 Sum_probs=197.2
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~ 326 (549)
+|...+.||+|+||.||++.. .+|+.||+|+++... ...+.+..|..+++.+. |++|+++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999976 568999999997542 12245678888988875 577888999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.+...++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~--- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMV--- 153 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC-CCEEEeccccccccCC---
Confidence 999 6799999854 67888999999999999999999 99999999999999998 6899999999864321
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+... ...
T Consensus 154 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~---~~i~~~-------~~~ 219 (323)
T cd05615 154 --DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LF---QSIMEH-------NVS 219 (323)
T ss_pred --CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HH---HHHHhC-------CCC
Confidence 1112234579999999999999999999999999999999999999997654321 11 111110 011
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCchhhhhhhHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTM-----KTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~L~~~~~w~~~~~~~ 533 (549)
. +......+.+++.+|+..+|.+|++. .++.+ |+||......
T Consensus 220 ~----p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~-----h~~f~~~~~~ 266 (323)
T cd05615 220 Y----PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIRE-----HAFFRRIDWD 266 (323)
T ss_pred C----CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhc-----CcccCCCCHH
Confidence 1 12223456788899999999999984 45554 7888765443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.92 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=199.4
Q ss_pred HHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 247 LCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 247 l~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
+....++|...+.||+|+||.||++.+ .+++.+|+|++.... .....+.+|+.+++.++||||+++++.+.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 334457899999999999999999987 468899999986432 122346789999999999999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++++|||+ +|+|.+++.. ++......++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCC-CCEEEEeCCceeEcC
Confidence 99999999 6899999865 55666778899999999999999 99999999999999998 799999999986543
Q ss_pred cccccccCccccccccCCccccccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGK----VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... . ...+.....
T Consensus 194 ~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~-~~~i~~~~~ 264 (371)
T cd05622 194 KEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----T-YSKIMNHKN 264 (371)
T ss_pred cCC----cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----H-HHHHHcCCC
Confidence 211 11223567999999999987543 7899999999999999999999997654321 1 111111111
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCchhhhhhh
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSR--RPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~L~~~~~w~~~~~ 531 (549)
...+. . .......+.+++..|+..++.+ ||++.++++ |+||+...
T Consensus 265 ~~~~~-----~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~-----h~~~~~~~ 311 (371)
T cd05622 265 SLTFP-----D--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR-----HLFFKNDQ 311 (371)
T ss_pred cccCC-----C--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc-----CcccCCCC
Confidence 00111 0 1123445677788899844443 789999998 78887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=317.71 Aligned_cols=249 Identities=23% Similarity=0.385 Sum_probs=195.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-----cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|+..+.||+|+||.||+|.. .++..+|+|.++..... ...+.+|+.+++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999964 24678999999754322 2467889999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHH--------------------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC
Q 008898 325 VYNLL-NGSLKQYLK--------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383 (549)
Q Consensus 325 v~e~~-~gsL~~~l~--------------------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~ 383 (549)
+|||+ +|+|.+++. .+++.....++.|++.||.|||++ +|+||||||+|||++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~- 160 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ- 160 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC-
Confidence 99999 679999984 245667788999999999999999 99999999999999988
Q ss_pred CceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhH
Q 008898 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESL 462 (549)
Q Consensus 384 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l 462 (549)
+.+||+|||++......... .......++..|+|||++.++.++.++|||||||++|||++ |..||...... ..
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~ 235 (283)
T cd05090 161 LHVKISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EV 235 (283)
T ss_pred CcEEeccccccccccCCcce---ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence 68999999998654332111 11223446778999999998889999999999999999998 88898654321 11
Q ss_pred HHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 463 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.. ... .... . ..+......+.+++..|++.||.+||++.+|++.|..
T Consensus 236 ~~---~~~-~~~~-----~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IE---MVR-KRQL-----L----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH---HHH-cCCc-----C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 111 1110 0 1112234567888899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=313.38 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=199.0
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|.+.+.||+|+||.||+|...++..+|+|.++......+.+.+|+.+++.++||||+++++++.+ +..+++|||+ +
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence 5688999999999999999987666789999998766666788999999999999999999998755 5578999999 6
Q ss_pred CCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
|+|.+++.. +++.....++.|+++||.|||+. +++|+||||+||+++++ +.++|+|||.+.........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~~-- 158 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT-- 158 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCC-CcEEeccCCceeeccccccc--
Confidence 799999964 56778899999999999999999 99999999999999998 68999999998654332211
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
......++..|+|||++.+..++.++|||||||++|||++ |..||........ . ....... .
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~----~~~~~~~----------~ 221 (262)
T cd05071 159 --ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-L----DQVERGY----------R 221 (262)
T ss_pred --cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-H----HHHhcCC----------C
Confidence 1123346778999999988899999999999999999999 7888865532211 1 1111100 0
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.....+.+..+.+++..|++.||.+||++.+++++|++
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 11123445678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.33 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=202.0
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
..+|...+.||.|+||.||+|...+++.+|+|+++.... ....+.+|+.+++.++||||+++++++...+.++++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 456888999999999999999987799999999986654 3567889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 -~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+|+|.+++.. +++.....++.||+.||.|||+. +|+|+||||+||+++++ +.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGED-LVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCC-ceEEEccccchhhcCCcc--
Confidence 6799999963 67788899999999999999999 99999999999999998 689999999986543211
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......++..|+|||.+.++.++.++||||||+++|+|++ |+.||....... .+.. .. .+
T Consensus 159 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~~----~~-~~--------- 220 (261)
T cd05148 159 ---YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VYDQ----IT-AG--------- 220 (261)
T ss_pred ---ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHH----HH-hC---------
Confidence 11113345778999999998899999999999999999998 899996544221 1111 11 00
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.....+...+..+.+++.+|++.||.+|||+.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0011122334668889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=320.75 Aligned_cols=267 Identities=22% Similarity=0.339 Sum_probs=202.5
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|...+.||+|+||.||++.. .+++.+|+|.++.... ....+.+|+.+++.++||||+++++++..++.++++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4688999999999999999977 4688999999875432 234677899999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.++|.+++.. +++.....++.||++||.|||+. +|+|+||||+|||++.+ +.++|+|||++.......
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~--- 158 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINER-GELKLADFGLARAKSIPT--- 158 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCC-CcEEECcCcchhccCCCC---
Confidence 99999998854 56777888999999999999999 99999999999999998 689999999985432211
Q ss_pred cCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc--ccccccc---
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS--SGLCERL--- 478 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~~~~~--- 478 (549)
.......+++.|+|||.+.+. .++.++|||||||++|||++|++||....... .+......... ......+
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhchhhhcc
Confidence 112234578999999988754 47899999999999999999999997654321 11111110000 0000000
Q ss_pred ------cCCcccc----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 479 ------IDPQLNE----EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 479 ------~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
-.+.... .........+.+++.+|+..||.+|||+.++++ |+||..--+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~-----h~~f~~~~~~ 295 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK-----HPYFHCLGER 295 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc-----Ccccccccch
Confidence 0011000 001122346788999999999999999999999 8999665443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=316.64 Aligned_cols=251 Identities=21% Similarity=0.364 Sum_probs=195.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
.+++|+..+.||+|+||.||+|.+. ++..+|+|.++.... ...++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999998642 256899999864332 23457899999999999999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH-------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceE
Q 008898 322 YAIVYNLL-NGSLKQYLKQ-------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~-------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~k 387 (549)
.+++|||+ +|+|.+++.. +.+.....++.|++.||.|||+. +++|+||||+||+++++ +.++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~-~~~~ 159 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED-FTVK 159 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC-CCEE
Confidence 99999998 6799999864 24456778999999999999998 99999999999999998 6899
Q ss_pred EeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHH
Q 008898 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWA 466 (549)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~ 466 (549)
|+|||++.......... ......+++.|+|||++.++.++.++|||||||++|||++ |..||....... . .
T Consensus 160 l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~---~ 231 (277)
T cd05062 160 IGDFGMTRDIYETDYYR---KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--V---L 231 (277)
T ss_pred ECCCCCccccCCcceee---cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H---H
Confidence 99999986543321111 1112345788999999998899999999999999999999 688886543321 1 1
Q ss_pred HHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 467 RSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 467 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
........ . ..+...+..+.+++.+|++.||.+|||+.++++.|+.
T Consensus 232 ~~~~~~~~-~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVMEGGL-L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHcCCc-C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111110 0 0112234568889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=322.88 Aligned_cols=250 Identities=23% Similarity=0.403 Sum_probs=192.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCc----EEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQ----VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~----~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.+|+..+.||+|+||.||+|.+ .+|. .+|+|+++.... ...++.+|+.+++.++||||++++++|.... .++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~-~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC-cee
Confidence 4699999999999999999975 3344 489999875432 2356889999999999999999999998754 556
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+++|+ +|+|.+++.. +++...+.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCC-CcEEEccccccccccC
Confidence 77777 8899999864 56777889999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.... .......++..|+|||.+.+..++.++|||||||++|||++ |..||....... +.. ... .+. ..
T Consensus 162 ~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~---~~~-~~~--~~ 230 (316)
T cd05108 162 DEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS---ILE-KGE--RL 230 (316)
T ss_pred CCcc---eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHH---HHh-CCC--CC
Confidence 2111 11112234678999999999999999999999999999998 999997543221 111 111 110 01
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.. +..+...+.+++..||..+|.+||++.+++..|....
T Consensus 231 ~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 231 PQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 1112345778889999999999999999999776443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.83 Aligned_cols=249 Identities=26% Similarity=0.303 Sum_probs=190.4
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHH-HHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVE-LLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+.||+|+||.||++.. .+|+.+|+|++.... .....+..|.. +++.++||||+++++++..++.++++|||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999977 578999999997532 12234555655 577899999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|..++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~-----~~~ 151 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIA-----QSD 151 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCC-CCEEEeecCCcccCCC-----CCC
Confidence 789888854 67778888999999999999999 99999999999999998 6899999999854221 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||........ ........ ......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-----~~~~~~~~-------~~~~~~- 218 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-----YDNILHKP-------LVLRPG- 218 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-----HHHHHcCC-------ccCCCC-
Confidence 23356799999999999999999999999999999999999999976543211 11111110 011111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
....+.++++.|+..+|.+||++++.++.+. .|+||.....
T Consensus 219 ---~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~-~h~~f~~~~~ 259 (325)
T cd05604 219 ---ASLTAWSILEELLEKDRQRRLGAKEDFLEIQ-EHPFFESLSW 259 (325)
T ss_pred ---CCHHHHHHHHHHhccCHHhcCCCCCCHHHHh-cCCCcCCCCH
Confidence 2345667889999999999998863332222 1678876443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=325.45 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=191.1
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHH-HHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVE-LLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+.||+|+||.||++.+ .+++.+|+|++..... ....+..|.. +++.++||||+++++++.+++.++++|||+ +
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 4678999999975321 1233444544 568899999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|.+++.. +.......++.||++||.|||++ +|+||||||+|||++.+ +.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~-----~~~ 151 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIE-----HNG 151 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCC-CCEEEccCCCCccccc-----CCC
Confidence 789998854 55677778999999999999999 99999999999999988 6899999999854221 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||........ ...+... . ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~-~------~~~---- 215 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNK-P------LQL---- 215 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-----HHHHHhC-C------cCC----
Confidence 23356799999999999999999999999999999999999999976543211 1111110 0 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.......+.+++..|++.||.+||++.+.+..+. .|.|+......+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~-~~~~~~~~~~~~ 261 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK-NHIFFSPINWDD 261 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh-cCcccCCCCHHH
Confidence 1223345778889999999999999874433332 256776654443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=311.61 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=199.9
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++|...+.||+|+||.||+|...+++.+|+|.+........++.+|+.+++.++|+||+++++++. .+.++++||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4578899999999999999998888999999999877766778999999999999999999999875 45688999998
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.. +++.....++.|++.||.|||+. +++|+||||+||+++++ +.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSET-LCCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCC-CCEEEccCcceeecCCCCc--
Confidence 7899998853 67778889999999999999998 99999999999999998 6899999999865442111
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+. .+ .....
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~---~~~-~~-----~~~~~ 224 (260)
T cd05067 158 --TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQ---NLE-RG-----YRMPR 224 (260)
T ss_pred --ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHH---HHH-cC-----CCCCC
Confidence 11123346778999999998889999999999999999999 999997544221 111 110 11 00111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
....+..+.+++.+|+..+|++||+++++++.|+.
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 ----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 12234568889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.16 Aligned_cols=247 Identities=26% Similarity=0.309 Sum_probs=190.7
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHH-HHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVE-LLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++||+|+||.||++.+ .+|+.+|+|++..... ....+..|.. +++.++||||+++++++.+.+.++++|||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 5689999999975321 1234555554 678899999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|..++.. +.......++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~-----~~~ 151 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVE-----PEE 151 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCC-CCEEEccCCCCccCCC-----CCC
Confidence 789888754 56777888999999999999999 99999999999999998 6899999999854221 112
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ........ . . .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~-~------~----~~ 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----MYDNILHK-P------L----QL 215 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----HHHHHhcC-C------C----CC
Confidence 2335679999999999998899999999999999999999999997654221 11111111 0 0 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH----HHHHHhcCCchhhhhhhHHH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMK----TLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~----evl~~L~~~~~w~~~~~~~~ 534 (549)
+......+.+++..||+.||.+||+.. ++++ |.|+.......
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~-----~~~~~~~~~~~ 261 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKN-----HVFFSPINWDD 261 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhC-----CCCcCCCCHHH
Confidence 122334577889999999999999764 4443 67876655443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=311.68 Aligned_cols=260 Identities=21% Similarity=0.298 Sum_probs=211.0
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...++||+|.||+|.+++. .+|+.||+|++++.-.. ......|-.+|+..+||++..|--.|+.++.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 5788999999999999999965 67999999999876432 234677999999999999999988899999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||. +|.|.-+|++ +++.....+-..|..||.|||+. +||+||||.+|+|+|.| |++||+|||+++ ..
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkD-GHIKitDFGLCK-----E~ 318 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKD-GHIKITDFGLCK-----EE 318 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccC-CceEeeecccch-----hc
Confidence 999 5678877754 67777777889999999999999 99999999999999999 899999999994 33
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........++||||.|+|||++....|+.++|+|.+||+||||++|+.||...+.+.- +.. .+ ..++ .
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-FeL---Il-----~ed~---k 386 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-FEL---IL-----MEDL---K 386 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-HHH---HH-----hhhc---c
Confidence 5556677899999999999999999999999999999999999999999987654321 110 11 1111 2
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHHHhhcc
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEELLNERR 541 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~~~~~~ 541 (549)
.+...++ ....++.-.|.+||.+|. .++||.+ |++|...++++...+...
T Consensus 387 FPr~ls~----eAktLLsGLL~kdP~kRLGgGpdDakEi~~-----h~FF~~v~W~~~~~Kki~ 441 (516)
T KOG0690|consen 387 FPRTLSP----EAKTLLSGLLKKDPKKRLGGGPDDAKEIMR-----HRFFASVDWEATYRKKIE 441 (516)
T ss_pred CCccCCH----HHHHHHHHHhhcChHhhcCCCchhHHHHHh-----hhhhccCCHHHHHHhccC
Confidence 2223333 344456788999999996 3566666 789999998888777543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=316.93 Aligned_cols=261 Identities=22% Similarity=0.304 Sum_probs=198.3
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|...+.||+|+||.||++.. .+|+.+|+|.++..... ...+.+|+.+++.++||||+++++++.+.+.+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477888999999999999987 56899999999754322 24577899999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.++|.+++.. +++.....++.||++||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~--- 153 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPV--- 153 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCC-CcEEECccchhhccCCCC---
Confidence 99999888753 67888899999999999999999 99999999999999988 689999999986543211
Q ss_pred cCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc-----ccccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG-----LCERL 478 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-----~~~~~ 478 (549)
.......+++.|+|||.+.+.. ++.++|||||||++|+|++|..|+.......+.+........... .....
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 1112346788999999987654 789999999999999999999887544332222221111100000 00000
Q ss_pred cCCc----cc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 479 IDPQ----LN-----EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 479 ~d~~----l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.+.. .. ....+.....+.+++..||..||.+|||+.++++ |+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~-----h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ-----HPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc-----CCCC
Confidence 0100 00 0111223456788999999999999999999998 8886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=355.40 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=205.0
Q ss_pred CCCCCceEcccCceEEEEEEecC--Cc----EEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHVD--GQ----VAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~~--g~----~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
+-.....||+|+||.||.|...+ |. .||||.++... ....+|.+|..+|+.++||||++++|+|.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34455679999999999997643 43 48999987653 345679999999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH----------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecc
Q 008898 325 VYNLL-NGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGl 393 (549)
++||| +|+|..||+. +...+.+.++.|||+|+.||+++ ++|||||..+|+||+.. ..+||+|||+
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~-r~VKIaDFGl 848 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDER-RVVKIADFGL 848 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeeccc-CcEEEcccch
Confidence 99999 8899999964 56778899999999999999999 99999999999999999 5899999999
Q ss_pred ccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcc
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSS 472 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 472 (549)
|+......+...+... .-...|||||.+..+.++.|+|||||||+|||++| |..||......+ .+ .....+
T Consensus 849 ArDiy~~~yyr~~~~a---~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-v~----~~~~~g 920 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEA---MLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-VL----LDVLEG 920 (1025)
T ss_pred hHhhhhchheeccCcc---ccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-HH----HHHHhC
Confidence 9966665554444331 12347999999999999999999999999999999 778876654322 22 122233
Q ss_pred cccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchh
Q 008898 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYW 526 (549)
Q Consensus 473 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w 526 (549)
+. + ..+..+++.+.+++..||+.+|++||++..|++.+...-..
T Consensus 921 gR---L-------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 921 GR---L-------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred Cc---c-------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 31 1 22456778888999999999999999999999977665533
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=318.00 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=194.8
Q ss_pred CCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
+|...+.||+|+||.||+|... +++.+|+|+++..... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667778999999999999753 2578999999755432 2457889999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHH-------------------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC
Q 008898 325 VYNLL-NGSLKQYLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384 (549)
Q Consensus 325 v~e~~-~gsL~~~l~-------------------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 384 (549)
+++|+ +++|.+++. .+++.....++.|++.||.|||+. +|+||||||+|||++++ +
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~-~ 161 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK-L 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC-C
Confidence 99998 678999884 256667788999999999999999 99999999999999988 6
Q ss_pred ceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHH
Q 008898 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLV 463 (549)
Q Consensus 385 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~ 463 (549)
.+||+|||++......... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||...... +
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~--- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-D--- 234 (283)
T ss_pred ceEecccccccccccchhe---eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-H---
Confidence 8999999998654322111 11123456789999999998899999999999999999998 88888654332 1
Q ss_pred HHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 464 LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 464 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+...+..... ..++.+++..+.+++..|++.+|.+||++.+|++.|+.
T Consensus 235 -~~~~i~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 -VIEMIRNRQV----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHcCCc----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111110 11223445668889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=309.56 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=189.5
Q ss_pred eEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCHH
Q 008898 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~ 334 (549)
.||+|+||.||+|.. .+++.+|+|.+..... ....+.+|+++++.++||||+++++++...+.++++|||+ +++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 589999999999977 5789999998864432 2356889999999999999999999999999999999998 67999
Q ss_pred HHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 008898 335 QYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (549)
Q Consensus 335 ~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (549)
+++.. +++...+.++.|+++||.|||+. +|+|+||||+|||++.+ +.++|+|||++......... ....
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~---~~~~ 154 (252)
T cd05084 82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYA---STGG 154 (252)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCC-CcEEECccccCccccccccc---ccCC
Confidence 99854 57778889999999999999999 99999999999999988 68999999998653321110 0011
Q ss_pred ccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCH
Q 008898 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNR 489 (549)
Q Consensus 411 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 489 (549)
...++..|+|||.+.++.++.++|||||||++|||++ |..||........ . ..... . .....+.
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-~----~~~~~-~---------~~~~~~~ 219 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-R----EAIEQ-G---------VRLPCPE 219 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-H----HHHHc-C---------CCCCCcc
Confidence 1123467999999999999999999999999999998 8888865433211 1 01110 0 0011122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 490 EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 490 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
..+..+.+++.+|+..+|.+|||+.++++.|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 33456888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.61 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=200.5
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
|+..+.||+|+||+||++.. .+++.+|+|.+...... ...+.+|+++++.++|+||+++++++..++.++++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778899999999999977 56899999999754322 23467899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEG-- 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCC-CCEEEecCCcceecCCC--
Confidence 9 6789888743 67788899999999999999999 99999999999999988 68999999998543221
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......|++.|+|||.+.+..++.++|+|||||++|||++|..||........ ...+........ .
T Consensus 156 ----~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~~-------~- 222 (285)
T cd05632 156 ----ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLETE-------E- 222 (285)
T ss_pred ----CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhccc-------c-
Confidence 112345789999999999988999999999999999999999999976543211 111111111100 0
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~ 533 (549)
.+.......+.+++..|+..||.+||+ +.+++. |+||+.....
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~-----~~~~~~~~~~ 270 (285)
T cd05632 223 ---VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR-----HPFFRNMNFK 270 (285)
T ss_pred ---ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc-----ChhhhcCCHH
Confidence 112223345678889999999999999 778888 8999887554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=311.82 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=197.7
Q ss_pred cCCCCCceEcccCceEEEEEEecC----CcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~----g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|...+.||+|+||.||+|.... ...+|+|.++..... ..++.+|+.+++.++||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999997632 458999998754322 34678899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|||+ +|+|.+++.. +++...+.++.|++.||.|||++ +|+|+||||+|||++++ +.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC-CCEEECccchhhccccc
Confidence 9999 6799999854 67888899999999999999998 99999999999999998 68999999999765421
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.. ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... +.. ..... ..
T Consensus 160 ~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~---~~~~~-----~~ 226 (266)
T cd05033 160 EA---TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIK---AVEDG-----YR 226 (266)
T ss_pred cc---ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHH---HHHcC-----CC
Confidence 11 111112345678999999998899999999999999999998 999986543221 111 11111 00
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+ .....+..+.+++..|++.+|++||++.+|++.|+.
T Consensus 227 ~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 227 LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 01 112334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=315.05 Aligned_cols=259 Identities=21% Similarity=0.312 Sum_probs=196.5
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|...+.||+|+||.||+|.. .++..+|+|.++.... ....+.+|+.+++.++||||+++++++.+++.++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477888999999999999987 4689999999865432 235678899999999999999999999999999999999
Q ss_pred cCCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 LNGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+.|+|.+++.. +++.....++.||++||.|||+. +|+|+||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCC-CcEEECcccceeecCCCc-
Confidence 99999988843 56777888999999999999999 99999999999999998 689999999986433211
Q ss_pred cccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc---------
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS--------- 472 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--------- 472 (549)
.......+++.|+|||.+.+. .++.++|||||||++|+|++|++||............ .......
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 ----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI-FRILGTPTEDVWPGVT 230 (285)
T ss_pred ----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HHHhCCCChhhhhcch
Confidence 111233578899999988754 4789999999999999999999999865432211111 0000000
Q ss_pred ---c---ccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 473 ---G---LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 473 ---~---~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
. ........... .........+.+++++||..||.+|||+.+|++ |+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~-----~~~~ 285 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN-----HPYF 285 (285)
T ss_pred hhHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc-----CCCC
Confidence 0 00000000000 000112345678899999999999999999998 7886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.20 Aligned_cols=242 Identities=28% Similarity=0.407 Sum_probs=196.6
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|...+.||+|+||.||++.. .+++.+++|.+.... .....+.+|+.+++.++||||+++++++.+++.++++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477888999999999999977 568999999987543 2345678899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +++|.+++.. +++...+.++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCC-CCEEEcccccceeccCcc-
Confidence 9 6799999854 45677788999999999999998 99999999999999998 689999999986544321
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||....... ... ... .+. .
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~---~~~-~~~----~--- 218 (256)
T cd08529 156 ----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LIL---KII-RGV----F--- 218 (256)
T ss_pred ----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHH---HHH-cCC----C---
Confidence 11234568899999999999999999999999999999999999997654221 111 111 010 0
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
..........+.+++.+||..+|++||++.++++
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 --PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1112233456888999999999999999999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=308.91 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=197.5
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|.....||+|+||.||++...++..+|+|.+.......+.+.+|+.+++.++|||++++++++.. +..+++|||+ +
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence 4588888999999999999988777789999987666556778899999999999999999998864 5678999999 5
Q ss_pred CCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
|+|.+++.. +++.....++.|+++||.|||+. +++|+||||+||+++++ +.++|+|||++........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCC-CeEEECCCccceEccCCcc---
Confidence 699999964 56778889999999999999999 99999999999999998 6899999999865432211
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.......++..|+|||.+.++.++.++|||||||++|||++ |..||....... ... + .... ..+
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~-~---~~~~------~~~--- 222 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-VLE-Q---VERG------YRM--- 222 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH-H---HHcC------CCC---
Confidence 11112346778999999998899999999999999999999 899987644321 111 1 1110 001
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+...+..+.+++.+||..||.+||++.+++++|+.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122345678889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=316.79 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=197.0
Q ss_pred cCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|.+.+.||+|+||.||++.. .++..+|+|.+..... ....+.+|++++++++||||+++++++...+.+++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688899999999999999964 2345789998875432 23568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH----------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceE
Q 008898 325 VYNLL-NGSLKQYLKQ----------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~k 387 (549)
+|||+ +|+|.+++.. +++...+.++.|++.||.|||+. +++||||||+|||++++ +.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~-~~~k 160 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN-LLVK 160 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC-CcEE
Confidence 99999 6899999852 67778899999999999999999 99999999999999998 6899
Q ss_pred EeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHH
Q 008898 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWA 466 (549)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~ 466 (549)
|+|||++........ ........+++.|+|||++.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 161 l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~---- 232 (288)
T cd05093 161 IGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VI---- 232 (288)
T ss_pred eccCCccccccCCce---eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HH----
Confidence 999999865432211 111123345788999999998899999999999999999998 899987654321 11
Q ss_pred HHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 467 RSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 467 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
..... +.. ...... ....+.+++.+||+.||.+|||+.++++.|+..
T Consensus 233 ~~i~~-~~~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 233 ECITQ-GRV-----LQRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHHHc-CCc-----CCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11111 111 011111 234578899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=309.30 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=202.1
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++|.+.+.||+|+||.||++...+++.+|+|.+.......+++.+|+.+++.++|+||+++++++.....++++||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4679999999999999999998877889999999877777788999999999999999999999999989999999998
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+++|.+++.. +++.....++.+++.||.|||++ +++|+||||+||+++++ +.++|+|||++.......
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~--- 157 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDE--- 157 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCC-CCEEECccccceeccchh---
Confidence 6799999853 57788899999999999999999 99999999999999998 689999999986543211
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
........++..|+|||.+.+..++.++|+|||||++|+|++ |+.||...... ..+.. ... + ...
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~----~~~-~-----~~~-- 223 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQ----VER-G-----YRM-- 223 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH----HHc-C-----CCC--
Confidence 111112234668999999998889999999999999999998 99999654322 11111 100 0 000
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+...+..+.+++.+|+..+|.+||+++++++.|+.
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111224568889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=326.36 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=193.1
Q ss_pred cCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEc-CCe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHS-KEM 321 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~-~~~ 321 (549)
++|++.+.||+|+||.||+|.. .+++.||+|+++..... ...+.+|+.+++++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4789999999999999999953 23578999998754322 24577899999999 89999999998854 467
Q ss_pred EEEEEecc-CCCHHHHHH--------------------------------------------------------------
Q 008898 322 YAIVYNLL-NGSLKQYLK-------------------------------------------------------------- 338 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~-------------------------------------------------------------- 338 (549)
++++|||+ +|+|.+++.
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88899999 678988874
Q ss_pred --HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCC
Q 008898 339 --QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416 (549)
Q Consensus 339 --~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~ 416 (549)
.+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.++|+|||++........ ........++.
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~---~~~~~~~~~~~ 239 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPD---YVRKGDARLPL 239 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCC-CcEEEeccccchhcccCcc---hhhccCCCCCc
Confidence 246677888999999999999999 99999999999999988 6899999999865432111 11122345677
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHH
Q 008898 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIV 495 (549)
Q Consensus 417 ~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 495 (549)
.|+|||++.+..++.++|||||||++|||++ |..||......+. + ...+ ..+.. +.. +......+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~---~~~~-~~~~~-----~~~----~~~~~~~~ 305 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-F---CRRL-KEGTR-----MRA----PEYATPEI 305 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-H---HHHH-hccCC-----CCC----CccCCHHH
Confidence 8999999999999999999999999999998 9999975433221 1 1111 11110 011 11223567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 496 MCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 496 ~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+++.+||+.+|++||++.+|++.|++
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.92 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=204.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
..+|...+.||+|+||.||++.. .+++.+|+|.+...... .+.+.+|+.+++.+.||||+++++++..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788999999999999999976 56899999998765433 35678899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 329 L-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 329 ~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+ +|+|.+++.. +++.+...++.|++.||.|||+. +|+|+||||+|||++.+ +.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~---- 170 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ---- 170 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCC-CCEEECccccchhccccc----
Confidence 9 6799999865 67788889999999999999999 99999999999999988 689999999886433211
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||........ +..+. .... +. .
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~----~~~~------~~--~ 236 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIA----TNGT------PE--L 236 (296)
T ss_pred -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHh----cCCC------CC--C
Confidence 112234689999999999988899999999999999999999999976543221 11110 0000 00 0
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..+......+.+++.+||..+|.+|||+.++++ ++|+....
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~-----~~~~~~~~ 277 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ-----HQFLKIAK 277 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh-----ChhhhccC
Confidence 112233456788999999999999999999998 88887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=334.29 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=197.0
Q ss_pred cCCCCCceEcccCceEEEEEEec--CC--cE-EEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV--DG--QV-AAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~--~g--~~-~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
++-...++||+|+||.||+|... ++ .. ||||..+.+. ....++++|.++|++++||||+++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34455689999999999999763 23 23 8999998533 2235789999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
++|||+| +|+|.+||+. ++..++..++.+.|.||+|||++ ++|||||-.+|+|++.+ +.+||+|||+++..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~-~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKK-GVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCC-CeEEeCccccccCC
Confidence 9999999 7899999976 66888999999999999999999 99999999999999998 46899999998654
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
.... ... ..-.-...|+|||.+..+.|+.++|||||||++||+++ |..||......+ ....+...+
T Consensus 313 ~~~~-~~~----~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-----v~~kI~~~~--- 379 (474)
T KOG0194|consen 313 SQYV-MKK----FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-----VKAKIVKNG--- 379 (474)
T ss_pred ccee-ecc----ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-----HHHHHHhcC---
Confidence 3110 000 00123468999999999999999999999999999999 788987765432 111221212
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.....+...+..+..++..||..+|++||||.++.+.|+...
T Consensus 380 ------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 380 ------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred ------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 122223355677777888999999999999999998775433
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.20 Aligned_cols=260 Identities=20% Similarity=0.250 Sum_probs=196.0
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|.+.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++..++|+||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688999999999999999987 568999999997422 12345778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 327 e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
||+ +|+|.+++.+ +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence 998 7899999864 56777888999999999999999 99999999999999988 689999999985543211
Q ss_pred ccccCccccccccCCcccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
. .......||+.|+|||++.. +.++.++|||||||++|||++|+.||........ ...+.......
T Consensus 157 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-----~~~i~~~~~~~ 227 (331)
T cd05597 157 T----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHKEHF 227 (331)
T ss_pred C----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-----HHHHHcCCCcc
Confidence 1 11123469999999999873 4578899999999999999999999976543211 11111111100
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLL--HSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~--~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
.+ +.....+ ...+.++++.|+. .++..||++.++++ |+||........
T Consensus 228 ~~--~~~~~~~----~~~~~~li~~ll~~~~~r~~r~~~~~~l~-----hp~~~~~~~~~~ 277 (331)
T cd05597 228 QF--PPDVTDV----SEEAKDLIRRLICSPETRLGRNGLQDFKD-----HPFFEGIDWDNI 277 (331)
T ss_pred cC--CCccCCC----CHHHHHHHHHHccCcccccCCCCHHHHhc-----CCCCCCCCHHHH
Confidence 11 1111112 3345555666554 44455899999999 899977654433
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=314.34 Aligned_cols=242 Identities=33% Similarity=0.522 Sum_probs=185.3
Q ss_pred CceEcccCceEEEEEEec-----CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 257 KMLIGQGGNSKVYRTNHV-----DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~-----~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.+.||.|.||.||+|.+. .+..|+||.++..... .+.+.+|++++++++||||++++|++...+.+++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999775 2568999999654322 467899999999999999999999999888899999999
Q ss_pred -CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 -~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
.|+|.+++.. +++..+..++.||++||.|||++ +++|+||+++|||++.+ +.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETT-TEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc-cccccccccccccccccccc
Confidence 5899999965 67788999999999999999999 99999999999999998 69999999998665221111
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......+...|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+.....
T Consensus 160 ---~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-----~~~~~~~~~~-------- 223 (259)
T PF07714_consen 160 ---KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-----IIEKLKQGQR-------- 223 (259)
T ss_dssp ---EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-----HHHHHHTTEE--------
T ss_pred ---cccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccccc--------
Confidence 11223346778999999999999999999999999999999 678886653221 1122211111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 520 (549)
...+..++..+.+++..||..||.+|||+.+|++.|
T Consensus 224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111222345678889999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=319.70 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=198.3
Q ss_pred cCCCCCceEcccCceEEEEEEec--------CCcEEEEEEeecCCc--CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKE 320 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 320 (549)
++|.+.+.||+|+||.||++... ++..+|+|.++.... ...++.+|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56889999999999999999652 235799999976432 234678899999999 7999999999999999
Q ss_pred eEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~ 380 (549)
.++++|||+ +|+|.+++.. +++.+.+.++.|++.||.|||++ +++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 999999999 6799999953 56677889999999999999998 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccch
Q 008898 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANR 459 (549)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~ 459 (549)
.+ +.++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 175 ~~-~~~kL~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~- 249 (307)
T cd05098 175 ED-NVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 249 (307)
T ss_pred CC-CcEEECCCcccccccccchh---hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence 88 68999999998654321111 11112234568999999998889999999999999999998 88888654321
Q ss_pred hhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 460 ESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 460 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
.+ ..... .+.. ...+......+.+++..|+..+|.+|||+.++++.|+....|..
T Consensus 250 -~~---~~~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 -EL---FKLLK-EGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred -HH---HHHHH-cCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 11 11111 1110 01122234567788999999999999999999999977666544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=340.86 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=197.8
Q ss_pred hcCCCCCceEcccCceEEEEEEecCC-cEEEEEEeecCC-cCHHHHHHHHHHHhcCC-CCCeeeEEEEE-E---c---CC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDG-QVAAVKVLKCTN-WSEEEVLREVELLSSIK-HENIVRIIGYC-H---S---KE 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g-~~~AvK~l~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~~-~---~---~~ 320 (549)
..+++++++|.+|||+.||++....+ ..||+|++-..+ ...+.+.+|+++|+.|+ |+|||.+++.. . . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34677889999999999999988655 999999886543 33466889999999997 99999999933 1 1 13
Q ss_pred eEEEEEeccC-CCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 321 MYAIVYNLLN-GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 321 ~~~lv~e~~~-gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
.++|.||||. |+|-+++.+ +++.++++|++|+++|+.+||.. ..+|||||||-+||||+.+ ++.||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~-g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSAD-GNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCC-CCEEeCccccc
Confidence 6889999995 799999953 88999999999999999999988 5579999999999999999 79999999998
Q ss_pred cccccccccccCc----cccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHH
Q 008898 395 MVHHQSHQVSENV----KPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 395 ~~~~~~~~~~~~~----~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~ 467 (549)
.-........... ......-|+.|.|||++. +.++++|+|||||||+||-|+....||+....-
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------- 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------- 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence 4321111000000 001224589999999875 667899999999999999999999999865321
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+++..+.-+..+.....|.+||+.||+.||.+||++-+++..+-.
T Consensus 265 ---------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 ---------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ---------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 1233333333346778899999999999999999999999875533
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.96 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=193.3
Q ss_pred CCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
+|...+.||+|+||.||+|... ....+++|.+...... ...+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4777889999999999999652 2357899988654322 3468889999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---------------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCC
Q 008898 325 VYNLL-NGSLKQYLKQ---------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---------------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~N 376 (549)
++||+ +|+|.+++.. +++...+.++.|++.||.|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999 6899998853 45667789999999999999999 99999999999
Q ss_pred EEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 008898 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTN 455 (549)
Q Consensus 377 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~ 455 (549)
||++++ +.++|+|||++......... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 158 ill~~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEG-RKMKISDFGLSRDVYEEDSY---VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCC-CcEEeccccccccccCccch---hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 999988 68999999998654322111 11123345678999999988889999999999999999998 99999654
Q ss_pred ccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 456 KANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 456 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.... +..+.. .+ ..... +......+.+++..|++.+|.+||++.++++.|++
T Consensus 234 ~~~~--~~~~~~----~~-----~~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 234 APER--LFNLLK----TG-----YRMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred CHHH--HHHHHh----CC-----CCCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 3221 111111 10 01111 12233567788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.62 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=198.6
Q ss_pred cCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.+|...+.||+|+||.||++... ++..+++|.++..... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35778889999999999999642 3457899988754432 3568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC
Q 008898 325 VYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 384 (549)
+|||+ +|+|.+++.. +++..++.++.||+.||.|||++ +|+||||||+|||++.+ +
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~-~ 160 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN-L 160 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC-C
Confidence 99999 7899999854 56778899999999999999999 99999999999999998 6
Q ss_pred ceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHH
Q 008898 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLV 463 (549)
Q Consensus 385 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~ 463 (549)
.++|+|||++........ ........|++.|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 161 ~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~ 235 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VI 235 (291)
T ss_pred cEEECCCCcccccCCCce---eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence 899999999865433211 111223456789999999999999999999999999999998 999987654321 11
Q ss_pred HHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 464 LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 464 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
. .. ..+.... .....+..+.+++.+||..+|.+|||+++|++.|+...
T Consensus 236 ~---~~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 236 E---CI-TQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred H---HH-hCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1 11 1111111 11223456889999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=306.09 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=201.5
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
++|+..+.||+|+||.||++... +++.+++|.++.... .+++.+|+++++.++||||+++++++.++..+++++|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 57889999999999999999875 488999999975543 567899999999999999999999999999999999999
Q ss_pred CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 ~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+++|.+++.. +++.....++.|+++||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~---- 153 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTM---- 153 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCC-CcEEEcccccchhcccCc----
Confidence 5689999853 67888899999999999999999 99999999999999998 689999999986543321
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
.......|+..|+|||++.+..++.++|||||||++|+|++|+.||........... . .....+..
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-----~------~~~~~~~~-- 219 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----I------PNKPPPTL-- 219 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-----h------ccCCCCCC--
Confidence 122234588899999999988999999999999999999999999976543221110 0 00000111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
..+......+.+++..|++.||.+|||+.++++ |+|+
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~-----~~~~ 256 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ-----HPFI 256 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc-----CCCC
Confidence 112233456788999999999999999999998 7875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=305.57 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=201.6
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...+.||+|+||.||+|... +|+.+|+|.++.... ..+.+.+|++++++++|+||+++++++..++.++++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999874 799999998864321 2356889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 327 e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
||+ +|+|.+++.. +++.....++.+++.||.|||+. +|+|+||+|+||+++.+ +.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCC-CcEEEeccceeeecc
Confidence 999 6799998853 56778889999999999999999 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....... ..+...... +.
T Consensus 158 ~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~-~~---- 224 (267)
T cd08224 158 SKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIEK-CD---- 224 (267)
T ss_pred CCC-----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH---HHHHhhhhc-CC----
Confidence 221 11224568899999999998889999999999999999999999996544221 111111110 10
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
............+.+++..|+..+|.+|||+.+|++.|++.+
T Consensus 225 ----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 ----YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001111234456788999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.18 Aligned_cols=251 Identities=26% Similarity=0.359 Sum_probs=195.5
Q ss_pred hcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
+++|.+.+.||+|+||.||+|.+. .+..+|+|.++.... ....+.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467889999999999999999774 357899998864432 234688999999999999999999999988899
Q ss_pred EEEEecc-CCCHHHHHHH----------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC--CceEEe
Q 008898 323 AIVYNLL-NGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLS 389 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~----------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~~kL~ 389 (549)
+++|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +++|+||||+||+++.+. ..++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 9999999 7899999853 56777889999999999999999 999999999999998651 258999
Q ss_pred eeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHH
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARS 468 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 468 (549)
|||++.......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||....... + ...
T Consensus 162 dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~---~~~ 233 (277)
T cd05036 162 DFGMARDIYRASYYR---KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--V---MEF 233 (277)
T ss_pred cCccccccCCcccee---cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H---HHH
Confidence 999987543221111 1112233568999999999999999999999999999997 999997654321 1 111
Q ss_pred hhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 469 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...... . ..+...+..+.+++..|++.+|.+||++.+|++.|+.
T Consensus 234 ~~~~~~------~----~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 234 VTGGGR------L----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHcCCc------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111111 0 1122234567888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.07 Aligned_cols=255 Identities=27% Similarity=0.378 Sum_probs=199.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHH-HhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVEL-LSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|++.+.||+|+||.||++.+ .+|+.||+|+++.... ....+..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 3688899999999999999987 5699999999976543 23456667665 667799999999999999999999999
Q ss_pred ccCCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 328 LLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 328 ~~~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|+.|+|.+++.. +++...+.++.||+.||.|||+++ +++||||||+||+++.+ +.+||+|||++......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCC-CCEEEeecccccccccc
Confidence 999999888853 567788899999999999999743 89999999999999998 68999999998654221
Q ss_pred cccccCccccccccCCcccccccccc----CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMY----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
.......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.......+.+.... .+
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~--- 223 (283)
T cd06617 158 ------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-----EE--- 223 (283)
T ss_pred ------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-----hc---
Confidence 11223468899999998864 4568899999999999999999999965433222221111 00
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
..+.+. .......+.+++..||..+|.+||++.++++ |+|+......
T Consensus 224 --~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~-----~~~~~~~~~~ 270 (283)
T cd06617 224 --PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ-----HPFFELHLSK 270 (283)
T ss_pred --CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc-----Cchhhhcccc
Confidence 111111 1123456788899999999999999999999 8999887644
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=307.76 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=198.1
Q ss_pred hhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
..++++.....||+|+||.||+|.. .++..+|+|.+..... ..+.+.+|+.+++.++|+||+++++++..++.+++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3456677778999999999999976 5678999998875543 3456889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH----h--chhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 327 NLL-NGSLKQYLKQ----L--KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 327 e~~-~gsL~~~l~~----~--~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
||+ +++|.+++.. + +......++.||+.||.|||+. +|+||||||+||+++.+.+.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999 6799999864 2 5566778899999999999999 9999999999999987546899999999865432
Q ss_pred ccccccCccccccccCCccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.. .......|++.|+|||++.... ++.++|+|||||++|+|++|+.||........ ..+......
T Consensus 162 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~------ 228 (268)
T cd06624 162 IN-----PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFK------ 228 (268)
T ss_pred CC-----CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhc------
Confidence 11 1122345889999999987654 78999999999999999999999965432211 111111000
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
..+ .++......+.+++.+||..+|.+|||+.++++ |+|+
T Consensus 229 -~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~-----~~~~ 268 (268)
T cd06624 229 -IHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ-----DPFL 268 (268)
T ss_pred -cCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh-----CCCC
Confidence 011 122334456788899999999999999999999 7885
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.59 Aligned_cols=260 Identities=25% Similarity=0.301 Sum_probs=193.9
Q ss_pred CCceEccc--CceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 256 PKMLIGQG--GNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 256 ~~~~lG~G--~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
..++||+| +|++||++.. .+|+.+|+|.++..... ...+.+|+.+++.++||||++++++|..++.++++|||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 7889999976 67999999999754322 235678999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 -~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecC-CcEEEcccchhhcccccccc
Confidence 6799998853 66788889999999999999999 99999999999999998 68999999865332111000
Q ss_pred --ccCccccccccCCcccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 404 --SENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 404 --~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
..........++..|+|||++.+ ..++.++|||||||++|||++|+.||.............. +......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~------~~~~~~~ 231 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN------GTVPCLL 231 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc------CCccccc
Confidence 00011122356788999999976 4589999999999999999999999975432221111100 0000000
Q ss_pred C-------------------C-----------------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 480 D-------------------P-----------------QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 480 d-------------------~-----------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
+ . .....+.......+.+++..||..||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~----- 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN----- 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc-----
Confidence 0 0 0001122233457888999999999999999999998
Q ss_pred chhhhhh
Q 008898 524 DYWLKMK 530 (549)
Q Consensus 524 ~~w~~~~ 530 (549)
|+||+..
T Consensus 307 ~p~f~~~ 313 (327)
T cd08227 307 HSFFKQI 313 (327)
T ss_pred Chhhhhc
Confidence 8999653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.96 Aligned_cols=258 Identities=22% Similarity=0.359 Sum_probs=200.2
Q ss_pred hcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
.++|++.+.||+|+||.||+|... .+..+|+|.++..... ...+.+|+.+++.++||||+++++++.+++..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 467999999999999999998643 2458999988654322 23577899999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHHh-------------chhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEE
Q 008898 323 AIVYNLL-NGSLKQYLKQL-------------KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~~-------------~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL 388 (549)
+++|||+ +|+|.+++... .+.....++.|++.||.|||++ +|+||||||+|||++++ +.++|
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~-~~~~L 160 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD-FTVKI 160 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC-CcEEE
Confidence 9999999 78999999652 2345678999999999999999 99999999999999998 68999
Q ss_pred eeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHH
Q 008898 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~ 467 (549)
+|||++.......... ......++..|+|||.+.++.++.++|+|||||++|||++ |..||......+ . ..
T Consensus 161 ~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~---~~ 232 (288)
T cd05061 161 GDFGMTRDIYETDYYR---KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--V---LK 232 (288)
T ss_pred CcCCcccccccccccc---ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--H---HH
Confidence 9999986543221111 1112345678999999998899999999999999999998 788886543221 1 11
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC-Cchhhhhh
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE-PDYWLKMK 530 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~-~~~w~~~~ 530 (549)
.....+.. ..+......+.+++..|++.||.+|||+.++++.|+. .++||+..
T Consensus 233 ~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 233 FVMDGGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 11111110 0112234678899999999999999999999999886 45777643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.40 Aligned_cols=259 Identities=27% Similarity=0.371 Sum_probs=200.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|+..+.||+|+||.||++.+ .++..+|+|.++.... ...++.+|++++++++||||+++++++.+++.++++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688999999999999999977 4688999999875432 224578999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+ +|+|.+++.. +++.....++.|+++||.|||+.+ +++|+||||+|||++.+ +.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecC-CcEEEccCCCccccccc----
Confidence 9 6799999864 567778899999999999999732 89999999999999998 68999999998543221
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc---------
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC--------- 475 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------- 475 (549)
......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....... ...+..........
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccC
Confidence 1234578999999999988889999999999999999999999996543211 11111100000000
Q ss_pred ---------------cccc---CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 476 ---------------ERLI---DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 476 ---------------~~~~---d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.... .+... .......+.+++.+||..+|.+|||+.++++ |+|+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~-----~~~~~~~ 293 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTK-----HPFIKRA 293 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhc-----Chhhhhc
Confidence 0000 00000 0113345788999999999999999999999 8999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=325.31 Aligned_cols=245 Identities=22% Similarity=0.256 Sum_probs=188.6
Q ss_pred EcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcC---CCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI---KHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 260 lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
||+|+||.||++.+ .+|+.+|+|++..... .......|..++..+ +||||+++++++.+++.++++|||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999987 5689999999965321 112345677777655 6999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|.+++.. +++.....++.||++||.|||++ +|+||||||+|||++.+ +.++|+|||++..... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~-----~~~ 151 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDAT-GHIALCDFGLSKANLT-----DNK 151 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCC-CCEEEecCCcCcCCCC-----CCC
Confidence 799888854 67788889999999999999999 99999999999999998 6899999999854222 112
Q ss_pred cccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 408 KPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....+... . ..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----~~~~i~~~-~------~~~~~- 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MYRNIAFG-K------VRFPK- 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-----HHHHHHcC-C------CCCCC-
Confidence 23356799999999998765 48999999999999999999999997654221 11111111 0 01111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHHhcCCchhhhhhhHH
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRP----TMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RP----s~~evl~~L~~~~~w~~~~~~~ 533 (549)
......+.++++.||..||.+|| ++.++++ |+|++.....
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~-----h~~~~~~~~~ 262 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE-----HPFFADIDWD 262 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc-----CccccCCCHH
Confidence 11234567788999999999998 5777776 8998765543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.52 Aligned_cols=251 Identities=23% Similarity=0.382 Sum_probs=199.8
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...+.||+|+||.||++.. .+++.+|||.+..... ...++.+|+.+++.++||||+++++++.+++.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3678888999999999999986 5799999998865322 2246788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 327 e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
||+ +++|.+++.. +++...+.++.||+.||.|||++ +++|+||||+||+++.+ +.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CCEEECcchhhhccc
Confidence 999 5689988853 56777889999999999999999 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......... ..... ..
T Consensus 158 ~~~-----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~------~~ 223 (267)
T cd08229 158 SKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIE------QC 223 (267)
T ss_pred cCC-----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH---hhhhh------cC
Confidence 221 11224568999999999998889999999999999999999999997544322111 11111 11
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
..+.. ........+.+++.+|+..||.+|||+.+|++.+.+-
T Consensus 224 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 DYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11111 1123455688889999999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=313.15 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=204.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
..+|...+.||+|+||.||++.. .+++.+|+|.+...... .+.+.+|+.+++.++||||+++++++..++.++++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999986 57999999999765433 35578899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 329 L-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 329 ~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+ +++|.+++.. +++.+...++.|++.||.|||+. +++||||||+|||++.+ +.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~---- 169 (297)
T cd06656 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ---- 169 (297)
T ss_pred cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEECcCccceEccCCc----
Confidence 9 7799999864 66778889999999999999999 99999999999999988 689999999986533221
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|..||............ ........
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------------~~~~~~~~ 235 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------ATNGTPEL 235 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------------ccCCCCCC
Confidence 1122346889999999999888999999999999999999999999765432211100 00000001
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..+......+.+++..||..+|.+||++.++++ |+|+....
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~-----~~~~~~~~ 276 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ-----HPFLKLAK 276 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc-----Cchhcccc
Confidence 112233456788899999999999999999999 89987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.39 Aligned_cols=259 Identities=26% Similarity=0.365 Sum_probs=200.2
Q ss_pred cCHHHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEE--
Q 008898 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH-- 317 (549)
Q Consensus 242 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~-- 317 (549)
+..+.+..+.++|++.+.||+|+||.||++.. .+++.+|+|+++........+..|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 33455566788999999999999999999977 5688999999876554456788899999999 6999999999873
Q ss_pred ---cCCeEEEEEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCce
Q 008898 318 ---SKEMYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386 (549)
Q Consensus 318 ---~~~~~~lv~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~ 386 (549)
.++.++++|||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++.+ +.+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~-~~~ 163 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE-GGV 163 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC-CCE
Confidence 446799999999 6789888742 55667788999999999999999 99999999999999998 689
Q ss_pred EEeeeccccccccccccccCccccccccCCcccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhh
Q 008898 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461 (549)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~ 461 (549)
+|+|||++....... .......|++.|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 164 kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~- 237 (286)
T cd06638 164 KLVDFGVSAQLTSTR-----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA- 237 (286)
T ss_pred EEccCCceeecccCC-----CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-
Confidence 999999986543211 12234468999999998753 4578999999999999999999999976543211
Q ss_pred HHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 462 LVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 462 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+ .. . .........++ ......+.+++.+||..||++|||+.++++ |.|+
T Consensus 238 ~---~~-~-~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~-----~~~~ 286 (286)
T cd06638 238 L---FK-I-PRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ-----HVFI 286 (286)
T ss_pred H---hh-c-cccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhh-----cccC
Confidence 1 10 0 00000111111 112345778899999999999999999998 6664
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=311.63 Aligned_cols=260 Identities=28% Similarity=0.388 Sum_probs=203.7
Q ss_pred cCHHHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcC
Q 008898 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (549)
Q Consensus 242 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 319 (549)
++.+++..++++|...+.||+|+||.||++.. .+++.+|+|++.........+.+|+.+++.+ +|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 44556667788999999999999999999977 5688999999976554556788899999998 799999999998643
Q ss_pred -----CeEEEEEecc-CCCHHHHHH-------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCce
Q 008898 320 -----EMYAIVYNLL-NGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386 (549)
Q Consensus 320 -----~~~~lv~e~~-~gsL~~~l~-------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~ 386 (549)
+.+++++||+ +|+|.++++ .+++.....++.|++.||.|||+. +++|+||||+||+++.+ +.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~-~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE-GGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC-CCE
Confidence 3689999999 679988874 257778889999999999999999 99999999999999988 689
Q ss_pred EEeeeccccccccccccccCccccccccCCccccccccccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhh
Q 008898 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-----KVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461 (549)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~ 461 (549)
+|+|||++........ ......|++.|+|||.+... .++.++|||||||++|||++|+.||........
T Consensus 168 kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~- 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT- 241 (291)
T ss_pred EEeecccchhcccccc-----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-
Confidence 9999999865432211 11234688999999988643 368899999999999999999999976543221
Q ss_pred HHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 462 LVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 462 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
+..+. .+....+.+ .......+.+++.+|+..+|++||++.++++ |+||+
T Consensus 242 ~~~~~-----~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~-----~~~~~ 291 (291)
T cd06639 242 LFKIP-----RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE-----HPFIK 291 (291)
T ss_pred HHHHh-----cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc-----CcccC
Confidence 11111 011111111 1223346888999999999999999999999 88874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.36 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=196.8
Q ss_pred hcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
.++|...+.||+|+||.||++... ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888999999999999999653 2468999998654322 24678899999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH-------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEE
Q 008898 323 AIVYNLL-NGSLKQYLKQ-------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~-------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL 388 (549)
+++|||+ +|+|.+++.. +.+...+.++.|++.||.|||+. +|+||||||+|||++.+ +.++|
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~-~~~kl 160 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAED-LTVKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCC-CCEEE
Confidence 9999999 6899999854 35567788999999999999999 99999999999999998 68999
Q ss_pred eeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHH
Q 008898 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~ 467 (549)
+|||++......... .......++..|+|||.+.++.++.++|||||||++|||++ |..||....... ...
T Consensus 161 ~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~--- 232 (277)
T cd05032 161 GDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLK--- 232 (277)
T ss_pred CCcccchhhccCccc---ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHH---
Confidence 999998654332211 11123456789999999998889999999999999999998 899987544321 111
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
... .+.. +.. +...+..+.+++..||..+|.+|||+.++++.|+
T Consensus 233 ~~~-~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 FVI-DGGH-----LDL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHh-cCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111 1110 111 1122557888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.95 Aligned_cols=260 Identities=20% Similarity=0.238 Sum_probs=196.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...+.||+|+||.||++.. .+++.+|+|++.+.. .....+.+|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3688899999999999999987 457899999996432 11234678999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 327 e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
||+ +|+|.+++.+ +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence 998 7899999965 56677888999999999999999 99999999999999988 689999999985432211
Q ss_pred ccccCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
.......+||+.|+|||++. .+.++.++|||||||++|||++|+.||........ ...+.....
T Consensus 157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i~~~~~-- 225 (332)
T cd05623 157 ----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHKE-- 225 (332)
T ss_pred ----cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-----HHHHhCCCc--
Confidence 11122357999999999986 34588999999999999999999999976543211 111111110
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLH--SSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
...-+.... .....+.+++++|+.. ++..||++.++++ |+||........
T Consensus 226 ~~~~p~~~~----~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~-----h~~f~~~~~~~~ 277 (332)
T cd05623 226 RFQFPAQVT----DVSEDAKDLIRRLICSREHRLGQNGIEDFKQ-----HPFFTGIDWDNI 277 (332)
T ss_pred cccCCCccc----cCCHHHHHHHHHHccChhhhcCCCCHHHHhC-----CCCcCCCCHHHH
Confidence 010111111 2234456667777654 4444789999998 899987654433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.84 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=197.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 321 (549)
.++|...+.||+|+||.||++.. .++..+|+|.++..... .+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35788999999999999999863 23558999998754322 24678999999999 79999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
.+++|||+ +|+|.+++.. +++.+...++.|++.||.|||++ +|+|+||||+|||++.+ +.++|+|||++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHG-KIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCC-CeEEECCCcccc
Confidence 99999998 6899999864 67888899999999999999999 99999999999999988 689999999986
Q ss_pred ccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
....... ........+++.|+|||.+.++.++.++|||||||++|||++ |..||........ +.... ..+.
T Consensus 190 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~----~~~~ 261 (302)
T cd05055 190 DIMNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLI----KEGY 261 (302)
T ss_pred cccCCCc---eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHH----HcCC
Confidence 5432111 011123346788999999999999999999999999999998 9999876543221 11111 1110
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+.. .......+.+++.+|+..+|++|||+.++++.|++
T Consensus 262 -----~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 -----RMAQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred -----cCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0011 11123468889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=311.69 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=200.2
Q ss_pred CHHHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEE---
Q 008898 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH--- 317 (549)
Q Consensus 243 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~--- 317 (549)
+..++....+.|+..+.||.|+||.||+|.+ .+++.+|+|++........++..|+.+++.+ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3344445567899999999999999999987 5689999999876655556788899999988 6999999999884
Q ss_pred ---cCCeEEEEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEE
Q 008898 318 ---SKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (549)
Q Consensus 318 ---~~~~~~lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL 388 (549)
..+.++++|||+ +|+|.+++.. +++.....++.||++||.|||+. +|+|+||+|+||+++++ +.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~-~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN-AEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEE
Confidence 346889999999 5689998864 45666788999999999999999 99999999999999988 68999
Q ss_pred eeeccccccccccccccCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHH
Q 008898 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLV 463 (549)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~ 463 (549)
+|||++....... .......|++.|+|||.+. ...++.++|+|||||++|||++|..||...........
T Consensus 163 ~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~ 237 (282)
T cd06636 163 VDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237 (282)
T ss_pred eeCcchhhhhccc-----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence 9999986433211 1223457899999999876 34688899999999999999999999975443211110
Q ss_pred HHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 464 LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 464 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
. .....+. .........+.+++..||..||.+||++.+|++ |+|+
T Consensus 238 -----~------~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~-----~~~~ 282 (282)
T cd06636 238 -----I------PRNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK-----HPFI 282 (282)
T ss_pred -----H------hhCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc-----CCCC
Confidence 0 0000111 111223456888999999999999999999998 7885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.19 Aligned_cols=259 Identities=20% Similarity=0.265 Sum_probs=196.8
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|.+.+.||+|+||.||++.. .+++.+|+|+++... .....+.+|+.++..++|+||+++++++.+++.++++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4788999999999999999987 468899999997532 12234678999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 327 e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
||+ +|+|.+++.. +++.....++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence 999 7899999964 46677788999999999999999 99999999999999988 689999999986543221
Q ss_pred ccccCccccccccCCcccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||........ . ..+.....
T Consensus 157 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~----~~i~~~~~-- 225 (331)
T cd05624 157 T----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-Y----GKIMNHEE-- 225 (331)
T ss_pred c----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-H----HHHHcCCC--
Confidence 1 11223579999999999875 5678999999999999999999999976543211 1 11111100
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSR--RPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.. .++.. ..+..+.+.+++.+|+..++.+ |+++.++++ |+||.......
T Consensus 226 ~~---~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~-----h~~f~~~~~~~ 276 (331)
T cd05624 226 RF---QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK-----HAFFEGIDWEN 276 (331)
T ss_pred cc---cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc-----CCCcCCCCHHH
Confidence 00 01111 1123455677778888765544 578999987 88887654433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=306.40 Aligned_cols=242 Identities=26% Similarity=0.417 Sum_probs=189.0
Q ss_pred eEcccCceEEEEEEe---cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CC
Q 008898 259 LIGQGGNSKVYRTNH---VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~---~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~g 331 (549)
.||+|+||.||+|.. .++..+|+|+++..... .+++.+|+.+++.+.||||+++++++.. +.++++|||+ +|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 489999999999954 35789999998755432 3568889999999999999999999864 5678899998 57
Q ss_pred CHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 008898 332 SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (549)
Q Consensus 332 sL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (549)
+|.+++.. +++.....++.|++.||.|||++ +|+||||||+||+++.+ +.++|+|||++.......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~--~~ 154 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYY--KA 154 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCC-CeEEECCCccccccCCCCCee--ee
Confidence 89999854 67788899999999999999999 99999999999999998 689999999986543322111 11
Q ss_pred ccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 409 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.....+++.|+|||.+....++.++|+|||||++|||++ |..||....... + ...+. .+. .+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~---~~~i~-~~~-----~~~~---- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--V---TQMIE-SGE-----RMEC---- 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--H---HHHHH-CCC-----CCCC----
Confidence 112234678999999988889999999999999999998 999997653321 1 11111 111 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+...+..+.+++..||+.||++||++.+|.+.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 12234567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.59 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=209.3
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CC
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~g 331 (549)
|.+...||+|+||.||++.| ..|+.+|+|.+..+. +..++..|+.||++++.|++|++||.+..+..+++||||| .|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 45566799999999999977 569999999987543 5678999999999999999999999999999999999999 68
Q ss_pred CHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 332 SLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 332 sL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
+..+.++ .+.+.++..++...+.||+|||.. .-||||||..|||++.+ |++||+|||.|-.. ...-.
T Consensus 114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~-G~AKLADFGVAGQL-----TDTMA 184 (502)
T KOG0574|consen 114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTD-GIAKLADFGVAGQL-----TDTMA 184 (502)
T ss_pred cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEccc-chhhhhhccccchh-----hhhHH
Confidence 9999984 378888999999999999999999 88999999999999999 79999999998432 23334
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
+..++.|||.|||||++..-+|+.++||||||+...||.-|++|+..-.+....+. +.. .|...-.-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------IPT-------~PPPTF~K 251 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------IPT-------KPPPTFKK 251 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------ccC-------CCCCCCCC
Confidence 56688999999999999999999999999999999999999999988776443221 001 11111122
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+......+.++++.||-.+|++|-|+.++++ |+|.+..
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~-----H~FiknA 289 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE-----HTFIKNA 289 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh-----hhhhcCC
Confidence 4566778899999999999999999999998 7776543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=306.38 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=199.4
Q ss_pred CCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC-------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
+|...+.||+|+||.||+|...+|+.+|+|.++..... ...+.+|+++++.++|+||+++++++.+.+.++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788899999999999998878999999998754321 13477899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
+||+ +|+|.+++.+ +++.....++.|++.||.|||+. +|+|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCC-CeEEeccchhhHhhhhcc
Confidence 9999 6799999865 57777888999999999999999 99999999999999988 689999999986542211
Q ss_pred c-cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 402 Q-VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 402 ~-~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
. ...........|++.|+|||++.+..++.++|+|||||++|+|++|..||.......... .. .. .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-~~---~~-----~~~~~ 227 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-YI---GA-----HRGLM 227 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-Hh---hh-----ccCCC
Confidence 0 011112234568999999999998889999999999999999999999997543221111 00 00 00111
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+.+... ....+.+++++||..+|.+||++.++++ |+||
T Consensus 228 ~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~-----~~~~ 265 (265)
T cd06631 228 PRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR-----HDFL 265 (265)
T ss_pred CCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc-----CCCC
Confidence 222222 3455778889999999999999999998 7875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=310.10 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=198.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+++|...+.||+|+||.||+|.. .+|+.+|+|++..... ....+.+|+.+++.++|+||+++++++..++..++++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 56899999999999999999976 5689999999865432 22467789999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.++|.+++.. +.+.....++.|++.||.|||+. +|+|+||||+|||++.+ +.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~--- 156 (291)
T cd07870 84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYL-GELKLADFGLARAKSIP--- 156 (291)
T ss_pred cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCC-CcEEEeccccccccCCC---
Confidence 999998887743 45677888999999999999999 99999999999999988 68999999998643221
Q ss_pred ccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc-----------
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS----------- 471 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~----------- 471 (549)
........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.......+.+.........
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 --SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred --CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 1112234578999999998764 57899999999999999999999998655432322221110000
Q ss_pred -ccccccccCCcccccCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 472 -SGLCERLIDPQLNEEYN-----REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 472 -~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
......+.......... ......+.+++.+|+..||.+|||+.+++. |+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~-----h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL-----HPYF 291 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc-----CCCC
Confidence 00000000000000000 011346778899999999999999999998 7886
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=308.01 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=191.3
Q ss_pred CCCCceEcccCceEEEEEEec-C---CcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe-----
Q 008898 254 FSPKMLIGQGGNSKVYRTNHV-D---GQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEM----- 321 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~-~---g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~----- 321 (549)
|.+.+.||+|+||.||+|... + +..+|+|.++..... ...+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567788999999999999763 2 368999999765433 2467899999999999999999998865543
Q ss_pred -EEEEEecc-CCCHHHHHH---------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEee
Q 008898 322 -YAIVYNLL-NGSLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (549)
Q Consensus 322 -~~lv~e~~-~gsL~~~l~---------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~D 390 (549)
.++++||+ +|+|..++. .+++.....++.|++.||.|||+. +++||||||+||+++++ +.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLRED-MTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCC-CeEEECC
Confidence 78999998 789988873 256677888999999999999999 99999999999999998 6899999
Q ss_pred eccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHh
Q 008898 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSL 469 (549)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~ 469 (549)
||++.......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+ + ....
T Consensus 157 fg~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~---~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDYYR---QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--I---YDYL 228 (273)
T ss_pred ccceeecccccccc---ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--H---HHHH
Confidence 99987544322111 1112235678999999988889999999999999999999 889886544221 1 1111
Q ss_pred hcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 470 LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 470 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..... ... +......+.+++.+|++.||.+|||+.++++.|++
T Consensus 229 ~~~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 229 RHGNR------LKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred HcCCC------CCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11110 111 22334568888899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.15 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=198.4
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----------EEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
+|.....||+|+||.||+|.. .+++.+|+|.+...... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999976 56889999988654321 1347789999999999999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
.++++||+ +++|.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++++ +.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNK-GGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCC-CCEEecccCCCccc
Confidence 99999999 6689999965 66777888999999999999999 99999999999999988 68999999998665
Q ss_pred cccccc-ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 398 HQSHQV-SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 398 ~~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
...... ..........|++.|+|||.+.+..++.++|+|||||++|+|++|..||.......... .. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~------~ 225 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-----KI------G 225 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-----HH------h
Confidence 421111 11111223568899999999998889999999999999999999999997653321110 00 0
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
....+.. +......+.+++.+||+.||.+||++.++++ |+||
T Consensus 226 ~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~-----~~~~ 267 (267)
T cd06628 226 ENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK-----HPFL 267 (267)
T ss_pred ccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh-----CCCC
Confidence 1111222 2234456788889999999999999999998 7775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=311.63 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=197.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|+..+.||+|+||.||++.. .+++.||+|.+..... ....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5788999999999999999977 4689999999875432 224567899999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.++|.+++.. +++.....++.|+++||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~---- 156 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISER-GELKLADFGLARAKSVP---- 156 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCC-CCEEECccccccccCCC----
Confidence 99999998854 56777888999999999999999 99999999999999998 68999999998543211
Q ss_pred cCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc--ccccc----
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS--GLCER---- 477 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~---- 477 (549)
........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......+.+......+... .....
T Consensus 157 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 157 -SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred -CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 111123356889999999875 4588999999999999999999999976543222221111111000 00000
Q ss_pred ---------cc-CCcccccCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 478 ---------LI-DPQLNEEYN-REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 478 ---------~~-d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.. ...+..... ......+.+++..|+..+|.+|||+.++++ |+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~-----~~~f 291 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK-----HPYF 291 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc-----CCCC
Confidence 00 000000000 001145678899999999999999999998 7886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=312.80 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=193.7
Q ss_pred cCCCCCceEcccCceEEEEEEecC---------------CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD---------------GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIG 314 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~---------------g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~ 314 (549)
++|++.+.||+|+||.||++...+ ...+|+|.++.... ....+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478899999999999999986532 23589999875432 2346889999999999999999999
Q ss_pred EEEcCCeEEEEEecc-CCCHHHHHHH---------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEE
Q 008898 315 YCHSKEMYAIVYNLL-NGSLKQYLKQ---------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNIL 378 (549)
Q Consensus 315 ~~~~~~~~~lv~e~~-~gsL~~~l~~---------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NIL 378 (549)
++...+..+++|||+ +++|.+++.. +.+...+.++.|++.||.|||+. +++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 999999999999999 6799998843 35667788999999999999999 9999999999999
Q ss_pred EecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCCcc
Q 008898 379 LSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT--GKEAIQTNK 456 (549)
Q Consensus 379 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt--G~~p~~~~~ 456 (549)
++++ +.+||+|||++........ ........+++.|+|||++.++.++.++|||||||++|+|++ |..||....
T Consensus 162 l~~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNH-YTIKIADFGMSRNLYSGDY---YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCC-CcEEecccccccccccCcc---eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9988 6899999999865432211 111122345778999999999999999999999999999988 556776543
Q ss_pred cchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 457 ANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 457 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+ ............+...... .+...+..+.+++.+|+..||.+||++.+|++.|++
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 DEQ-VIENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred hHH-HHHHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 221 1111111111011100000 111223578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.97 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=196.1
Q ss_pred hcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 321 (549)
.++|+..+.||+|+||.||++... +...+|+|.+...... ..++.+|+++++.+ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 457888999999999999999763 2368999998754322 24578899999999 79999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec
Q 008898 322 YAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE 381 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~ 381 (549)
++++|||+ +|+|.+++.. +++...+.++.|++.||.|||+. +|+||||||+|||++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 99999998 7899999853 56677889999999999999999 9999999999999998
Q ss_pred CCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchh
Q 008898 382 NFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRE 460 (549)
Q Consensus 382 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~ 460 (549)
+ +.++|+|||++.......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 168 ~-~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 168 D-HVMKIADFGLARDIHHIDYYR---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred C-CeEEeCcccccccccccccee---ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 8 689999999987544321111 1112235678999999998899999999999999999998 9999875543221
Q ss_pred hHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 461 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. ... ..+. ....+......+.+++.+|+..||.+|||+.++++.|+.
T Consensus 244 --~---~~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 244 --F---KLL-KEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred --H---HHH-HcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 1 111 1110 001122334568889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=309.77 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=189.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCc----EEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQ----VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~----~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|+..+.||+|+||.||+|.. .+++ .+++|.+..... ...++..|+.+++.+.||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~-~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA-SLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-ccEE
Confidence 4688889999999999999976 3454 477777753321 224567788899999999999999998654 4566
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
++||+ +|+|.+++.. +++.....++.||+.||.|||+. +++||||||+|||++++ +.+||+|||++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSD-SIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCC-CcEEEcCCccceeccC
Confidence 77777 7999999954 56788899999999999999999 99999999999999998 6899999999875433
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.. .........++..|+|||.+.++.++.++|||||||++|||++ |..||....... ...+ ...+. ..
T Consensus 162 ~~---~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~----~~~~~--~~ 230 (279)
T cd05111 162 DD---KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDL----LEKGE--RL 230 (279)
T ss_pred CC---cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH----HHCCC--cC
Confidence 21 1112224457788999999999999999999999999999998 999997654321 1111 11111 11
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+. .+...+..++..|+..||.+|||+.++++.|..
T Consensus 231 ~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 231 AQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1111 123446778899999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=304.62 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=198.3
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|+..+.||.|+||.||++... |+.+|+|.++......+.+.+|+.+++.++|+||+++++++...+..+++|||+ +
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 47888999999999999999764 788999999866554567889999999999999999999999899999999999 5
Q ss_pred CCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
++|.+++.. +++.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||.+.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCC-CCEEEccccccccccccc----
Confidence 799999853 67888999999999999999999 99999999999999998 689999999986542211
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
....++..|+|||.+..+.++.++||||||+++|||++ |..||....... +.. ... .+. ...
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~---~~~-~~~-----~~~-- 219 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP---HVE-KGY-----RME-- 219 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH---HHh-cCC-----CCC--
Confidence 12234567999999998889999999999999999997 999987654321 111 111 110 011
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+...+..+.+++.+|+..+|.+||++.++++.|+.
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 --APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 112234567888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=306.54 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=195.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+.+++.++||||+++++++..++.+++++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999986 5788999999975432 234577899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~---- 159 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDN-GDVKLADFGVAAKITAT---- 159 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCC-CCEEECcCccceeeccc----
Confidence 9 5789998853 57778888999999999999999 99999999999999988 68999999998654321
Q ss_pred cCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 405 ENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
........|++.|+|||.+. ...++.++|+|||||++|||++|+.||.......... . ... .....+
T Consensus 160 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~-----~~~---~~~~~~ 229 (267)
T cd06646 160 -IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-L-----MSK---SNFQPP 229 (267)
T ss_pred -ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-e-----eec---CCCCCC
Confidence 11123456889999999875 3457889999999999999999999986543221110 0 000 011111
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 519 (549)
.... .......+.++++.||..+|++|||++++++.
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1111 11234578889999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=309.12 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=188.6
Q ss_pred CCCCceEcccCceEEEEEEecC-Cc--EEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC------Ce
Q 008898 254 FSPKMLIGQGGNSKVYRTNHVD-GQ--VAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------EM 321 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~~-g~--~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------~~ 321 (549)
|.+.+.||+|+||.||+|...+ +. .+|+|.++.... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466789999999999998744 33 689998875432 235678899999999999999999987432 25
Q ss_pred EEEEEecc-CCCHHHHHHH---------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeee
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DF 391 (549)
.+++|+|+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++++ +.++|+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNEN-MNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCC-CCEEECCC
Confidence 68888998 6899988731 56777889999999999999998 99999999999999988 68999999
Q ss_pred ccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhh
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
|++.......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... . .....
T Consensus 157 g~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~---~~~~~ 228 (272)
T cd05075 157 GLSKKIYNGDYYR---QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--I---YDYLR 228 (272)
T ss_pred CcccccCccccee---cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H---HHHHH
Confidence 9987654322111 1122346778999999998899999999999999999999 788986543211 1 11111
Q ss_pred cccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 471 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..... . ........+.+++.+||..||.+|||+.+|++.|+.
T Consensus 229 ~~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 229 QGNRL------K----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred cCCCC------C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11110 0 112234557889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.42 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=194.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe--------cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH--------VDGQVAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~--------~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 319 (549)
.++|.+.+.||+|+||.||++.. .++..+|+|.++... ....++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45688889999999999999964 124579999987542 2235688999999999 799999999999999
Q ss_pred CeEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE
Q 008898 320 EMYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl 379 (549)
...+++|||+ +|+|.+++.. +++.....++.||++||.|||++ +|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 9999999999 6799999853 45566788999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccc
Q 008898 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKAN 458 (549)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~ 458 (549)
+.+ +.++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 171 ~~~-~~~kl~D~g~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 171 TEN-NVMKIADFGLARDVNNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred cCC-CcEEECCCccceecccccc---cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 988 6899999999865433211 111223346778999999998889999999999999999998 78888654321
Q ss_pred hhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 459 RESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 459 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. +...+..... . ..+......+.+++.+||..+|.+|||+.++++.|++
T Consensus 247 ~-----~~~~~~~~~~------~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 247 E-----LFKLLKEGHR------M----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred H-----HHHHHHcCCc------C----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 1 1111111110 0 1112334567888999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=360.29 Aligned_cols=260 Identities=27% Similarity=0.489 Sum_probs=216.5
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+...|...++||+|+||.||+|.. .+|..||||.++.... ....|++++++++||||++++++|.+++..++||||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 345688889999999999999987 5789999999875432 223568899999999999999999999999999999
Q ss_pred c-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 329 L-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 329 ~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
+ +|+|.++++.++|..+..++.||++||.|||..+.++|+||||||+||+++.+ +.+++. ||.+.....
T Consensus 765 ~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~-------- 834 (968)
T PLN00113 765 IEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT-------- 834 (968)
T ss_pred CCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc--------
Confidence 9 78999999999999999999999999999997666699999999999999988 466765 665432211
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc-
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE- 486 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~- 486 (549)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||............|+...........++|+.+...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 112368899999999999999999999999999999999999997655555667778877666666667777766432
Q ss_pred -CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 487 -YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 487 -~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
...++...+.+++.+||+.||++||||+++++.|+..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 3456677888999999999999999999999988754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=302.22 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=196.9
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS-KEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~lv~e 327 (549)
+|+..+.||+|+||.||++.. .+++.+|+|.+...... .+.+.+|+++++.++|+|++++++.+.. +..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478889999999999999976 45889999999754332 3457889999999999999999988764 456889999
Q ss_pred cc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 328 LL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 328 ~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|+ +++|.+++.. +++.+...++.+++.||.|||++ +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecC-CcEEEecccceEEecccC
Confidence 99 6789998854 67788899999999999999999 99999999999999988 689999999986543211
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ...... +.. +
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-----~~~~~~-~~~-----~ 220 (257)
T cd08223 157 -----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-----VYRIIE-GKL-----P 220 (257)
T ss_pred -----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHh-cCC-----C
Confidence 122345689999999999999999999999999999999999999975432211 111111 111 1
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
..+......+.+++.+|+..||.+||++.++++ |+|+
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~-----~~~~ 257 (257)
T cd08223 221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILR-----QPYI 257 (257)
T ss_pred ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhc-----CCCC
Confidence 112334456888999999999999999999998 7775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=311.07 Aligned_cols=248 Identities=24% Similarity=0.408 Sum_probs=194.5
Q ss_pred cCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.+|...+.||+|+||.||++.. .++..+|+|.++.... ....+.+|+++++.++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4677888999999999999953 2356889998875432 23568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc
Q 008898 325 VYNLL-NGSLKQYLKQ------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 385 (549)
+|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +++||||||+|||++++ +.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~-~~ 160 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG-LV 160 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC-CC
Confidence 99999 6899999853 56677889999999999999999 99999999999999988 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHH
Q 008898 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVL 464 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~ 464 (549)
++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|||++ |.+||........ .
T Consensus 161 ~kL~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~-- 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-I-- 234 (280)
T ss_pred EEECCCCceeEcCCCcee---ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-H--
Confidence 999999998654321110 11123345788999999999999999999999999999998 8999865443211 1
Q ss_pred HHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 465 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
....... .... +...+..+.+++..||..||.+||++.+|++.|+
T Consensus 235 --~~~~~~~------~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 --ECITQGR------ELER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --HHHHcCc------cCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111000 0111 1123355788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=314.56 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=191.0
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCc--EEEEEEeecCC--cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ--VAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~--~~AvK~l~~~~--~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|++.++||+|+||.||+|... ++. .+++|.++... ...+.+.+|+.+++++ +||||+++++++...+.++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 47889999999999999999764 343 47888887422 2235688899999999 799999999999999999999
Q ss_pred Eecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc
Q 008898 326 YNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 385 (549)
+||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++++ +.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~-~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN-LA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC-Ce
Confidence 9998 6899999853 45677889999999999999998 99999999999999988 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHH
Q 008898 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVL 464 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~ 464 (549)
+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||....... +
T Consensus 158 ~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~-- 227 (297)
T cd05089 158 SKIADFGLSRGEEVY------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--L-- 227 (297)
T ss_pred EEECCcCCCccccce------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H--
Confidence 999999998532110 01111223557999999998889999999999999999997 999997654322 1
Q ss_pred HHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 465 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...... + ..+.. +......+.+++..|+..+|.+|||+.++++.|+.
T Consensus 228 -~~~~~~-~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 228 -YEKLPQ-G-----YRMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred -HHHHhc-C-----CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111110 0 11111 12233567889999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=306.00 Aligned_cols=248 Identities=22% Similarity=0.361 Sum_probs=198.6
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++|...+.||+|+||.||++...++..+|+|.++......+.+.+|+.+++.++|+||+++++++.+ ..++++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 35788999999999999999987777889999987655555678899999999999999999999887 7788999999
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.. +++..+..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~- 158 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCC-CcEEECCCcceeeccCCCcc-
Confidence 6799999864 56777888999999999999998 99999999999999998 68999999998654332111
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
......++..|+|||++..+.++.++|+|||||++|+|++ |..||....... +..+. ..+. . .
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~----~~~~----~-~-- 222 (260)
T cd05073 159 ---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRAL----ERGY----R-M-- 222 (260)
T ss_pred ---cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH----hCCC----C-C--
Confidence 1112345678999999998889999999999999999999 899997653321 11111 1111 0 0
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
......+..+.+++.+|+..+|++||++.++++.|+.
T Consensus 223 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234568888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=323.16 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=203.0
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~ 326 (549)
...|++.+.||+||.++||++...+.+.||+|.+.....+ ..-+..|+..|.+|+ |.+||+||+|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3569999999999999999999888888998887654433 356889999999996 999999999999999999999
Q ss_pred eccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+-+-+|.++|++ .....+..+..||+.|+.++|.. ||||.||||.|+|+-.. .+||+|||.|.....
T Consensus 440 E~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG--~LKLIDFGIA~aI~~--- 511 (677)
T KOG0596|consen 440 ECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG--RLKLIDFGIANAIQP--- 511 (677)
T ss_pred ecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee--eEEeeeechhcccCc---
Confidence 9999999999976 22236677899999999999999 99999999999999875 799999999976554
Q ss_pred cccCccccccccCCccccccccccCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGK-----------VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS 471 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~-----------~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 471 (549)
...+......+||+.||+||.+.... .+.++||||||||||+|+.|++||..... .|++
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aK---- 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAK---- 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHH----
Confidence 33444555779999999999986332 56789999999999999999999975432 1222
Q ss_pred ccccccccCCcccccCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 472 SGLCERLIDPQLNEEYNREE-IEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 472 ~~~~~~~~d~~l~~~~~~~~-~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
+..+.||.-.-+|+.-- ...+.++++.||++||.+|||+.++|+ |+|+..
T Consensus 582 ---l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq-----hpFl~~ 632 (677)
T KOG0596|consen 582 ---LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ-----HPFLQI 632 (677)
T ss_pred ---HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc-----Cccccc
Confidence 23445553322222111 112888999999999999999999999 777654
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.79 Aligned_cols=255 Identities=26% Similarity=0.348 Sum_probs=205.7
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.|+..+.||.|+||.||+|.+ .++..+|+|+++.... ....+.+|+.+++.+.||||+++++++.+++.++++|||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 477778899999999999976 4688999999875432 2356788999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 -~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~----- 155 (277)
T cd06640 85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQ----- 155 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCC-CCEEEcccccceeccCCc-----
Confidence 6799998864 56677788999999999999999 99999999999999988 689999999986543211
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.......++..|+|||++.+..++.++|+|||||++|||++|..||......... ... .......
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~~~----------~~~~~~~ 220 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----FLI----------PKNNPPT 220 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----hhh----------hcCCCCC
Confidence 1122346888999999999888999999999999999999999999755432110 000 1111122
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
.....+..+.+++..||..+|.+||++.++++ |+|+.........
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~-----~~~~~~~~~~~~~ 265 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK-----HKFIVKNAKKTSY 265 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHh-----ChHhhhcchhhhH
Confidence 34456677889999999999999999999999 8998766654433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=309.01 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=194.4
Q ss_pred CCCCCceEcccCceEEEEEEec-CC---cEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DG---QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g---~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
+|...+.||+|+||.||+|... ++ ..+|+|.++.... ...++..|+.+++.++||||+++++++.+++.++++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 5778899999999999999763 33 3699999875422 2356889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 327 e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
||+ +|+|.+++.. +++.+.+.++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCC-CcEEECCCccccccccCc
Confidence 999 6789999854 67788899999999999999999 99999999999999988 689999999986544322
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.............+..|+|||.+.+..++.++|||||||++|||++ |..||....... ...+. ... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i---~~~------~~ 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAI---EQD------YR 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHH---HcC------Cc
Confidence 1111111111112457999999999999999999999999999886 999997554321 11111 110 00
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
-....+.+..+.+++..||..+|.+||++.+|++.|+.
T Consensus 230 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 ----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 01112334567889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=310.94 Aligned_cols=257 Identities=22% Similarity=0.340 Sum_probs=196.5
Q ss_pred hcCCCCCceEcccCceEEEEEEecC-----------------CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeee
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVD-----------------GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVR 311 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----------------g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~ 311 (549)
..+|++.+.||+|+||.||++...+ +..+|+|.+..... ..+.+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999986532 24689999875532 2356888999999999999999
Q ss_pred EEEEEEcCCeEEEEEecc-CCCHHHHHHH--------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCC
Q 008898 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLKQ--------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376 (549)
Q Consensus 312 l~~~~~~~~~~~lv~e~~-~gsL~~~l~~--------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~N 376 (549)
+++++..++.+++++|++ +++|.+++.. +++...+.++.|++.||.|||+. +|+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 999999999999999999 6789999853 46777889999999999999999 99999999999
Q ss_pred EEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCC
Q 008898 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT--GKEAIQT 454 (549)
Q Consensus 377 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt--G~~p~~~ 454 (549)
|+++.+ +.++|+|||++......... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||..
T Consensus 161 ili~~~-~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKN-YTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCC-CceEEccccceeecccCcce---eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999998 68999999998654332111 11223456789999999998889999999999999999998 6677754
Q ss_pred cccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 455 NKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 455 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..... ................. ...+...+..+.+++..|++.||.+|||+.+|++.|+.
T Consensus 237 ~~~~~--~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 237 LTDQQ--VIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred cChHH--HHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 43211 11111111111100000 01112233568899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=310.69 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=200.2
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.|+..+.||+|+||.||+|.+ .+++.+|+|.++.... ..+.+.+|+.+++.++||||+++++++..++.+++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 355667799999999999976 5688999999875432 2346789999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 -~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+++|.+++.. +++.....++.|+++||.|||+. +++|+||+|+||+++++ +.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~----- 155 (277)
T cd06642 85 GGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQ----- 155 (277)
T ss_pred CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCC-CCEEEccccccccccCcc-----
Confidence 6789988854 56778888999999999999998 99999999999999988 689999999986543211
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.......|+..|+|||++.+..++.++|+|||||++|||++|+.|+........ .. .. .. ...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~---~~-~~-----~~~~~---- 220 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LF---LI-PK-----NSPPT---- 220 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hh---hh-hc-----CCCCC----
Confidence 122234688999999999988899999999999999999999999875433211 00 00 00 01111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
........+.+++..|+..+|.+||++.++++ |+|+.....
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~-----~~~~~~~~~ 261 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK-----HKFITRYTK 261 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHH-----hHHHHHHhh
Confidence 12234456788999999999999999999999 789876553
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=302.06 Aligned_cols=240 Identities=26% Similarity=0.394 Sum_probs=191.0
Q ss_pred eEcccCceEEEEEEecCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCHHH
Q 008898 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQ 335 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~~ 335 (549)
+||+|+||.||+|...+++.+|+|.++..... ...+.+|+++++.++||||+++++++...+..+++|||+ +|+|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 68999999999998888899999998754322 245788999999999999999999999999999999999 789999
Q ss_pred HHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccccc
Q 008898 336 YLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411 (549)
Q Consensus 336 ~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 411 (549)
++.. +.+.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++......... ....
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~----~~~~ 153 (250)
T cd05085 82 FLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYS----SSGL 153 (250)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCC-CeEEECCCccceeccccccc----cCCC
Confidence 8854 56788889999999999999999 99999999999999988 68999999998643321111 1112
Q ss_pred cccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHH
Q 008898 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490 (549)
Q Consensus 412 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 490 (549)
..+++.|+|||++.++.++.++|||||||++|+|++ |..||......... .... .+. .. ..+..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-----~~~~-~~~-----~~----~~~~~ 218 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-----EQVE-KGY-----RM----SCPQK 218 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-----HHHH-cCC-----CC----CCCCC
Confidence 234667999999998899999999999999999998 99999765332211 1111 111 00 11122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 491 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.+..+.+++.+|+..+|++||++.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3456888999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=310.73 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=204.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.+|+..+.||.|+||.||++.. .+|+.+|+|.+..... ..+.+.+|+.+++.++||||+++++++...+.+++++||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999976 6789999999875443 3456788999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 -~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+++.. +++.++..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~----- 169 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQ----- 169 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEccCccchhccccc-----
Confidence 6789998865 67888999999999999999999 99999999999999988 689999999986533211
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... .. ... ....+ .
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-~~----~~~-~~~~~-------~ 236 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LI----ATN-GTPEL-------Q 236 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HH----Hhc-CCccc-------C
Confidence 11223468899999999998889999999999999999999999997665422211 10 000 00000 0
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.+......+.+++.+||..||.+||++.++++ |+|++...
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~-----~~~~~~~~ 276 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ-----HPFLKLAK 276 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh-----ChHhhhcc
Confidence 11223345778889999999999999999998 89998655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.51 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=196.0
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CCc---EEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQ---VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~---~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|...+.||+|+||.||+|... +++ .+|+|.++.... ....+..|+++++.++||||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346888899999999999999763 333 799999875432 23568889999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+|||+ +|+|.+++.. +++.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSN-LECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCC-CcEEECCCccceeccc
Confidence 99999 6789999854 57788899999999999999999 99999999999999988 6899999999865432
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.... .........++.|+|||++.+..++.++|||||||++|||++ |+.||....... +...+....
T Consensus 160 ~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----~~~~i~~~~----- 227 (268)
T cd05063 160 DPEG--TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----VMKAINDGF----- 227 (268)
T ss_pred cccc--ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHHHhcCC-----
Confidence 2111 111111223467999999998889999999999999999997 999996544321 111111110
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. .....+.+..+.+++..|+..+|.+||++.+|++.|++
T Consensus 228 ~-----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 228 R-----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred C-----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 01112334567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=311.05 Aligned_cols=250 Identities=24% Similarity=0.413 Sum_probs=196.1
Q ss_pred hcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
.++|+..+.||+|+||.||++... ++..+|+|++...... ..++.+|+.+++.++||||+++++++..++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457899999999999999999753 4678999998754322 35688899999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH-------------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCC
Q 008898 323 AIVYNLL-NGSLKQYLKQ-------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSN 376 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~-------------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~N 376 (549)
+++|||+ +|+|.+++.. +++...+.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 9999999 6799999853 45566789999999999999999 99999999999
Q ss_pred EEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 008898 377 ILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTN 455 (549)
Q Consensus 377 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~ 455 (549)
||++.+ +.++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 161 il~~~~-~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGEN-MVVKIADFGLSRNIYSADYY---KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCC-CceEECccccceecccCccc---cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998 68999999998643322111 01112234667999999998899999999999999999997 88888654
Q ss_pred ccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 456 KANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 456 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.... . ...... +... ..+...+..+.+++.+|++.+|.+|||+.|+++.|++
T Consensus 237 ~~~~--~---~~~~~~-~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEE--V---IYYVRD-GNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHH--H---HHHHhc-CCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 3221 1 111111 1100 0112234568889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=304.16 Aligned_cols=242 Identities=24% Similarity=0.390 Sum_probs=193.1
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEE-EcCCeEEEEEecc-
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYNLL- 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~-~~~~~~~lv~e~~- 329 (549)
.+|...+.||+|+||.||++.. .|..+|+|.++... ..+.+.+|+.+++.++|+|++++++++ .+++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4688889999999999999976 47789999987543 345788999999999999999999975 4566789999999
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.. +++.....++.|++.||.|||+. +++||||||+||+++++ +.+||+|||++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~---- 155 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST---- 155 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCC-CcEEecCCccceecccc----
Confidence 6799999864 56678889999999999999999 99999999999999998 68999999998543221
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... + ...+.. +. .+
T Consensus 156 ----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~---~~~~~~-~~-----~~-- 218 (256)
T cd05082 156 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--V---VPRVEK-GY-----KM-- 218 (256)
T ss_pred ----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--H---HHHHhc-CC-----CC--
Confidence 112345668999999998889999999999999999997 999986543211 1 111111 11 11
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
......+..+.+++.+|+..+|.+|||+.++++.|+.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 --DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1122334567888999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.12 Aligned_cols=257 Identities=22% Similarity=0.335 Sum_probs=207.6
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+...+.+.||+|-||.|.++....+.+||||.++..... ..+|.+|+++|.+|+||||+.|+|+|..++.+++++||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345677889999999999999877899999999876533 367999999999999999999999999999999999999
Q ss_pred -CCCHHHHHHHh-----chhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 -NGSLKQYLKQL-----KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 -~gsL~~~l~~~-----~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+|+|.+|+... .......|+.||+.||+||.+. +++||||.+.|||++.++ ++||+|||+++......+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcc-cEEecCcccccccccCCce
Confidence 89999999764 2334567999999999999999 999999999999999995 8999999999866654443
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHH--cCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI--TGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ell--tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.... ..+-..+|||||.+..++++.++|+|+|||.+||++ +...||.....+ ..+..+..+....-....
T Consensus 694 ~vqg---r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~~~~~~--- 765 (807)
T KOG1094|consen 694 RVQG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQGRQVV--- 765 (807)
T ss_pred eeec---ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCCCccee---
Confidence 3322 234467899999999999999999999999999975 578888766543 333333333322221111
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
...+..++..+.+++..||++|-.+||+++++...|+++
T Consensus 766 ---l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 ---LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 223455677888999999999999999999999888654
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.45 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=199.8
Q ss_pred cCCCCCceEcccCceEEEEEEecC-CcEEEEEEeec-CCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKC-TNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~-g~~~AvK~l~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+.|.++.-||.|+||+||++..++ +-..|.|++.. +....++++-|++||..+.||+|++|++.|.-++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 346677779999999999997644 56677888853 3344578999999999999999999999887788899999999
Q ss_pred C-CCHHHHH----HHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 N-GSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~-gsL~~~l----~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+ |-.+..+ ..++..++..+++|++.||.|||++ +|||||||..|||++-+ |.++|+|||.+.. ...
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~Tld-GdirLADFGVSAK-----n~~ 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLD-GDIRLADFGVSAK-----NKS 182 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEec-CcEeeeccccccc-----chh
Confidence 5 5566665 3478889999999999999999999 99999999999999999 7999999998732 233
Q ss_pred cCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.......+.|||+|||||+++ ..+|+.++||||||+.|.||..+.+|.....+....+- +.......++
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK------iaKSePPTLl 256 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK------IAKSEPPTLL 256 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH------HhhcCCCccc
Confidence 344556789999999999986 45799999999999999999999999876654332221 1111111111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
.+..+...+.+++..||..||..||++.++++ |+|+.
T Consensus 257 -------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~-----Hpfv~ 293 (1187)
T KOG0579|consen 257 -------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK-----HPFVQ 293 (1187)
T ss_pred -------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh-----Ccccc
Confidence 23455667788889999999999999999999 89975
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=308.23 Aligned_cols=258 Identities=27% Similarity=0.383 Sum_probs=203.1
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++|.+.+.||.|+||.||++.. .++..+|+|+++..... .+.+..|+++++.++||||+++++++..+..++++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35688889999999999999987 46899999999755432 34688899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 329 L-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 329 ~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+ +|+|.+++.. +++.....++.|++.||.|||+. +|+|+||||+||+++.+ +.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~--- 156 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKST--- 156 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCC-CCEEEccCccchhhccc---
Confidence 9 6689988854 67788899999999999999999 99999999999999998 68999999987543221
Q ss_pred ccCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
........||+.|+|||.+. ...++.++|+|||||++|+|++|+.||........ .. ..... ..
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~-~~--- 225 (280)
T cd06611 157 --LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LL----KILKS-EP--- 225 (280)
T ss_pred --ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HH----HHhcC-CC---
Confidence 11223456899999999875 34467899999999999999999999976543221 11 11111 00
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
+.+ ..+......+.+++..||..+|.+||++.++++ |+|++...+...
T Consensus 226 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~-----~~~~~~~~~~~~ 273 (280)
T cd06611 226 --PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK-----HPFVSDQSDNKA 273 (280)
T ss_pred --CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc-----ChhhcccchhHH
Confidence 111 011223345778889999999999999999999 899987754433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=308.39 Aligned_cols=254 Identities=29% Similarity=0.379 Sum_probs=205.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|+..+.||.|+||.||++.. .+++.+|+|++..... ....+.+|+.+++.++|+||+++++++.++..+++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3678888999999999999976 4689999999875532 234678899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 329 L-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 329 ~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+ +++|.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~---- 152 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTM---- 152 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC-CCEEEcccccceeecccc----
Confidence 9 6789999865 68888899999999999999998 99999999999999998 689999999986654321
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......... ... ... ..+.+..
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-----~~~-~~~-----~~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-----FLI-PKN-----NPPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-----HHh-hhc-----CCCCCcc
Confidence 1223456889999999999888999999999999999999999999765422110 000 011 1111111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
. .....+.+++..||..+|.+|||++++++ |+|+......
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~-----~~~~~~~~~~ 260 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK-----HKFIKKAKKT 260 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh-----ChhhcCCCcc
Confidence 1 13445778889999999999999999999 8999776654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.53 Aligned_cols=238 Identities=32% Similarity=0.438 Sum_probs=199.5
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
|...+-||.|+||.||-+.. .+...||||.+..+.. .-.++..|+.+|++++|||++.+-|+|-.+.+.|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55566799999999999976 6788999999975532 225799999999999999999999999999999999999
Q ss_pred cCCCHHHHH----HHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l----~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
|-|+-.+.+ +.+.+.++..|..+.+.||.|||+. +.||||||..|||+++. |.+||+|||.|....
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~------ 177 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEP-GLVKLADFGSASIMA------ 177 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCC-CeeeeccccchhhcC------
Confidence 988866666 3477788899999999999999999 99999999999999999 799999999985433
Q ss_pred cCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 405 ENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
...+++|||.|||||++. .|.|+-++||||||++..||.-.++|+...+.. ..++..+ +.-.|
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIA----------QNesP 243 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIA----------QNESP 243 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHH----------hcCCC
Confidence 345789999999999985 678999999999999999999999998655432 2232222 12223
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.+. .+++.+.++.++..||+.-|.+|||..++++
T Consensus 244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 332 5678889999999999999999999999998
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=303.16 Aligned_cols=247 Identities=22% Similarity=0.435 Sum_probs=198.0
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
.+|+..+.||+|+||.||++...++..+|+|.++.......++.+|++++++++|||++++++++.....++++|||+ +
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 367788899999999999998877889999999866666678999999999999999999999999999999999999 6
Q ss_pred CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 331 gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
|+|.+++.. +.+.....++.+++.||.|||+. +++|+||||+||+++.+ +.++|+|||++........
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~---- 155 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQY---- 155 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCC-CeEEECCCcceeecccCcc----
Confidence 789998853 56777888999999999999999 99999999999999988 6899999999864322111
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
.......++..|+|||.+.++.++.++|||||||++|||++ |..||....... ....+... .....+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~---~~~~~~~--- 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----VVETINAG---FRLYKPR--- 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHHHHhCC---CCCCCCC---
Confidence 01112235678999999998899999999999999999998 999987544211 11111111 0111111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.....+.+++.+||..+|.+|||+.++++.|.
T Consensus 225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12356888999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=305.73 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=194.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
++|...+.||+|+||.||++.. .+++.+|+|+++..... ...+.+|+.+++.++||||+++++++..++.+++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4678888899999999999976 56899999999765432 345778999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 -NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 -~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+|+|.+++.. +++.+...++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~----- 159 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDN-GHVKLADFGVSAQITAT----- 159 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEECcceeeeEccCc-----
Confidence 5789998854 67788899999999999999999 99999999999999988 68999999998654321
Q ss_pred CccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 406 NVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........|++.|+|||++. .+.++.++|+|||||++|+|++|..||....+....... ... ....+.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-----~~~----~~~~~~ 230 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----TKS----NFQPPK 230 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-----hcc----CCCCCc
Confidence 11123457899999999874 456889999999999999999999998655432211100 000 000111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
... .......+.+++..|+..+|++||++.+|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 110 0112345778899999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=309.64 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=197.2
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|+..+.||.|+||.||+|.. .+|+.+|||.++..... ...+.+|++++++++||||+++++++.+++.++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999977 56899999998754322 24688999999999999999999999999999999999
Q ss_pred cCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 329 LNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 329 ~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+.++|.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEEeeccchhhcccCc--
Confidence 98899988843 56778889999999999999999 99999999999999998 689999999986443211
Q ss_pred ccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc---------
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--------- 473 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--------- 473 (549)
.......+++.|+|||.+.+.. ++.++|||||||++|||+||+.||........ +...........
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 ---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ---cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhhhhH
Confidence 1122335788999999887654 58899999999999999999999976543222 111111100000
Q ss_pred ------ccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 474 ------LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 474 ------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.........+ ..........+.+++.+|++.||.+|||+.++++ |+||
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~-----~~~f 284 (284)
T cd07860 231 LPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA-----HPFF 284 (284)
T ss_pred HHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc-----CCCC
Confidence 0000000000 0001112345678899999999999999999998 7886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=347.08 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=196.8
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCeEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS--KEMYA 323 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~ 323 (549)
..++|.+.+.||+|+||.||++.+ .++..+|+|++...... ...+..|+.+++.|+||||++++++|.. ...++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 456899999999999999999987 45789999998754332 3468899999999999999999998843 46799
Q ss_pred EEEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCC----CCEEEecCCCCCEEEecC---------
Q 008898 324 IVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCD----PPIIHRDVKSSNILLSEN--------- 382 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~----~~iiHrDlkp~NILl~~~--------- 382 (549)
|||||+ +|+|.++|.. +++..++.|+.||+.||.|||+... ++||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999 6799998853 6778889999999999999998521 369999999999999653
Q ss_pred -------CCceEEeeeccccccccccccccCccccccccCCcccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008898 383 -------FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQ 453 (549)
Q Consensus 383 -------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~ 453 (549)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||||||||++|..||.
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIE------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccCCCCceEEccCCcccccccc------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 124899999998654321 12234579999999999864 458899999999999999999999997
Q ss_pred CcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 454 TNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 454 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
....... +...+.. + +.+.. ......+.+++..||..+|.+||++.++++ ++|++..
T Consensus 245 ~~~~~~q----li~~lk~-~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~-----h~~ik~i 301 (1021)
T PTZ00266 245 KANNFSQ----LISELKR-G-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG-----YQIIKNV 301 (1021)
T ss_pred cCCcHHH----HHHHHhc-C-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc-----cHHHhhc
Confidence 5433221 1111111 0 11110 112345778899999999999999999997 6787644
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=303.64 Aligned_cols=244 Identities=29% Similarity=0.441 Sum_probs=190.7
Q ss_pred ceEcccCceEEEEEEe-cC---CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VD---GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~---g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+.||+|+||.||+|.. .. +..+|+|.+..... ..+++.+|+.+++.+.||||+++++++.. +.++++|+|+ +
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 3699999999999965 22 36899999976554 34568899999999999999999998864 5678999998 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|.+++.. +++..+..++.|++.||.|||.. +++|+||||+|||++.+ +.++|+|||++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~--~ 153 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYY--R 153 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCC-CcEEeccccccceeecCCccc--c
Confidence 799999965 67888899999999999999999 99999999999999998 689999999987654322111 1
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .+..+.. ... .. .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~----~~~--~~-------~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLE----SGE--RL-------P 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHH----cCC--cC-------C
Confidence 1112234568999999998899999999999999999998 99999765432 1211111 110 00 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
.+...+..+.+++.+|+..+|.+||++.++++.|++.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1122345678899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=319.56 Aligned_cols=267 Identities=21% Similarity=0.272 Sum_probs=202.8
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC------
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------ 319 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 319 (549)
+.++|+..+.||+|+||.||++.. .+|+.+|+|.+..... ....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999976 5789999999864322 234577899999999999999999988543
Q ss_pred CeEEEEEeccCCCHHHHHHH-hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 320 EMYAIVYNLLNGSLKQYLKQ-LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 320 ~~~~lv~e~~~gsL~~~l~~-~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
...+++|||+.++|.+.+.. ++......++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++....
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 169 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCC-CCEEEccCccceeCC
Confidence 35799999999999988753 77778888999999999999999 99999999999999998 689999999986543
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHH----------
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARS---------- 468 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~---------- 468 (549)
.. .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ .......
T Consensus 170 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 170 TS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMS 242 (353)
T ss_pred CC------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence 21 112345688999999999999999999999999999999999999976542111 0000000
Q ss_pred --------hhccc------ccccccCC----cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 469 --------LLSSG------LCERLIDP----QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 469 --------~~~~~------~~~~~~d~----~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
..... ....+... .............+.+++.+||..||.+|||+.++++ |+|++.-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~-----~~~~~~~ 317 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ-----HPYINVW 317 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc-----ChhHhhc
Confidence 00000 00011000 0001111233556789999999999999999999998 8988743
Q ss_pred hH
Q 008898 531 RE 532 (549)
Q Consensus 531 ~~ 532 (549)
..
T Consensus 318 ~~ 319 (353)
T cd07850 318 YD 319 (353)
T ss_pred cC
Confidence 33
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.88 Aligned_cols=251 Identities=26% Similarity=0.366 Sum_probs=194.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC------HHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS------EEEVLREVELLSSIKHENIVRIIGYCHS--KEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~ 322 (549)
.+|...+.||+|+||.||++.. .++..+|+|.+...... ...+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999977 56899999998654211 2347789999999999999999998865 4678
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++++||+ +++|.+++.. +++.....++.|++.||.|||+. +|+|+||||+||+++.+ +.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSA-GNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCC-CCEEEccCCCccccc
Confidence 8999999 5789999854 56777888999999999999998 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
..... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||......... .. ... ..
T Consensus 158 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~----~~-~~~-----~~ 225 (266)
T cd06651 158 TICMS--GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI----FK-IAT-----QP 225 (266)
T ss_pred ccccc--CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH----HH-Hhc-----CC
Confidence 21111 11112346889999999999888999999999999999999999999765322111 10 100 01
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
..+.+ +......+.+++ .||..+|.+||++++|++ |+||.
T Consensus 226 ~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~-----hp~~~ 265 (266)
T cd06651 226 TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR-----HPFAQ 265 (266)
T ss_pred CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc-----Ccccc
Confidence 11222 222334455566 588899999999999998 88875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=309.19 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=196.9
Q ss_pred hcCCCCCceEcccCceEEEEEEecC-----CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVD-----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS-KEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~ 322 (549)
.++|...++||+|+||.||+|.+.+ +..+++|.++.... ....+.+|+.+++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999998754 68899998874422 23557889999999999999999998765 5678
Q ss_pred EEEEecc-CCCHHHHHHH-----------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEee
Q 008898 323 AIVYNLL-NGSLKQYLKQ-----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~-----------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~D 390 (549)
+++++|+ +|+|.+++.. +++...+.++.|++.||.|||+. +++|+||||+||+++++ +.+||+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~-~~~kl~d 160 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEE-LQVKITD 160 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCC-CcEEECC
Confidence 8899998 6899999854 56778889999999999999999 99999999999999988 6899999
Q ss_pred eccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHh
Q 008898 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSL 469 (549)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~ 469 (549)
||+++......... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||....... +.. ..
T Consensus 161 ~g~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~---~~ 232 (280)
T cd05043 161 NALSRDLFPMDYHC---LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAA---YL 232 (280)
T ss_pred CCCcccccCCceEE---eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHH---HH
Confidence 99986543221111 1112345778999999998889999999999999999999 999997653211 111 11
Q ss_pred hcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 470 LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 470 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
..... . ......+..+.+++..||..||++|||+.++++.|+..+
T Consensus 233 ~~~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 233 KDGYR------L----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HcCCC------C----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11110 0 011123456788999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.56 Aligned_cols=275 Identities=20% Similarity=0.212 Sum_probs=194.1
Q ss_pred hcCCCCCceEcccCceEEEEEEec--CCcEEEEE------------------EeecCCcCHHHHHHHHHHHhcCCCCCee
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV--DGQVAAVK------------------VLKCTNWSEEEVLREVELLSSIKHENIV 310 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~--~g~~~AvK------------------~l~~~~~~~~~~~~E~~il~~l~h~nIv 310 (549)
.++|.+.+.||+|+||+||++... ++...+.| .++........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998642 22222222 1111111234577899999999999999
Q ss_pred eEEEEEEcCCeEEEEEeccCCCHHHHHHH--------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC
Q 008898 311 RIIGYCHSKEMYAIVYNLLNGSLKQYLKQ--------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382 (549)
Q Consensus 311 ~l~~~~~~~~~~~lv~e~~~gsL~~~l~~--------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~ 382 (549)
++++++...+..+++++++.++|.+++.. ........++.||+.||.|||++ +||||||||+|||++.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 99999999999999999999999888743 12345667999999999999999 99999999999999998
Q ss_pred CCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCC-CCccc-chh
Q 008898 383 FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI-QTNKA-NRE 460 (549)
Q Consensus 383 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~-~~~~~-~~~ 460 (549)
+.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|||++|..++ ..... ...
T Consensus 304 -~~vkL~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 304 -GKIVLGDFGTAMPFEKER----EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred -CCEEEEeCCCceecCccc----ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 689999999996543321 11222467999999999999999999999999999999999987544 32221 111
Q ss_pred hHHHHHHHhhc-ccc-------cccccCCc----ccccCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 461 SLVLWARSLLS-SGL-------CERLIDPQ----LNEEYNR-----EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 461 ~l~~~~~~~~~-~~~-------~~~~~d~~----l~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
.+......+.. ... ....++.. ....... .....+.+++.+||..||.+|||+.|+++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~----- 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA----- 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh-----
Confidence 22111111100 000 00000000 0000000 11234566789999999999999999998
Q ss_pred chhhhhhhHHHHHHh
Q 008898 524 DYWLKMKREKEELLN 538 (549)
Q Consensus 524 ~~w~~~~~~~~~~~~ 538 (549)
|+||....++.....
T Consensus 454 hp~f~~~~~~~~~~~ 468 (501)
T PHA03210 454 LPLFSAEEEEEILFI 468 (501)
T ss_pred ChhhhcCCchHHHHH
Confidence 899987665554443
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.69 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=198.6
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+.|++.+.||.|+||.||+|.. .+++.+++|.+..... ....+.+|+.+++.++||||+++++++..++.++++|||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5688999999999999999987 4589999999875542 2356788999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 -NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 -~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+++|..++.+ +++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~---- 163 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKT---- 163 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCC-CCEEEccCccceecccc----
Confidence 5678777643 67888899999999999999998 99999999999999988 68999999987542221
Q ss_pred cCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
........|++.|+|||++. ...++.++|||||||++|||++|..||........ ... .....
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~----~~~~~------ 231 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLK----IAKSE------ 231 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HHH----HhcCC------
Confidence 11223456889999999985 34468899999999999999999999976543211 111 11110
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.+.. ..+......+.+++..||..+|++||++.++++ |+|+.....
T Consensus 232 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~-----~~~~~~~~~ 277 (292)
T cd06644 232 PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE-----HPFVSSVTS 277 (292)
T ss_pred CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc-----Ccccccccc
Confidence 0110 011222345778889999999999999999998 899876443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=305.50 Aligned_cols=251 Identities=29% Similarity=0.424 Sum_probs=198.6
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC------e
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKE------M 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~------~ 321 (549)
.+++|+..+.||+|+||.||+|.. .+++.+++|++.......+.+.+|+.+++++ +|+||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 467899999999999999999987 4688999999987766667789999999999 7999999999996544 5
Q ss_pred EEEEEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGl 393 (549)
++++|||+ +++|.+++.. +++.....++.|+++||.|||+. +++|+||+|+||+++.+ +.++|+|||+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~-~~~~l~d~~~ 159 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKN-AEVKLVDFGV 159 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccC-CeEEECCCcc
Confidence 89999999 5688888743 56777888999999999999999 99999999999999998 6899999999
Q ss_pred ccccccccccccCccccccccCCcccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHH
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARS 468 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 468 (549)
+....... .......|++.|+|||++.. ..++.++|||||||++|+|++|..||........ +..
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~---- 229 (275)
T cd06608 160 SAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFK---- 229 (275)
T ss_pred ceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHH----
Confidence 86543211 12234568999999998754 3467899999999999999999999975432221 111
Q ss_pred hhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 469 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.. .+. .+.. .........+.+++.+||..||.+|||+.++++ |+|+
T Consensus 230 ~~-~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~-----~~~~ 275 (275)
T cd06608 230 IP-RNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE-----HPFI 275 (275)
T ss_pred hh-ccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc-----CCCC
Confidence 10 000 1111 112234567888999999999999999999998 7884
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=311.13 Aligned_cols=256 Identities=20% Similarity=0.343 Sum_probs=194.4
Q ss_pred cCCCCCceEcccCceEEEEEEec-----------------CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-----------------DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRI 312 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-----------------~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l 312 (549)
++|++.+.||+|+||.||++... ++..+|+|+++.... ...++.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 234789999875432 23568899999999999999999
Q ss_pred EEEEEcCCeEEEEEecc-CCCHHHHHHH--------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCE
Q 008898 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQ--------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNI 377 (549)
Q Consensus 313 ~~~~~~~~~~~lv~e~~-~gsL~~~l~~--------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NI 377 (549)
++++..++..+++|||+ +|+|.+++.. +++.....++.|++.||.|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999 6799999854 33457889999999999999999 999999999999
Q ss_pred EEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCCc
Q 008898 378 LLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT--GKEAIQTN 455 (549)
Q Consensus 378 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt--G~~p~~~~ 455 (549)
|++.+ +.++|+|||++......... .......+++.|+|||...++.++.++|||||||++|||++ |..||...
T Consensus 162 li~~~-~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKN-YTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCC-CCEEeccCcccccccCCcce---eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99988 68999999998654322111 11112344678999999888899999999999999999998 67888654
Q ss_pred ccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 456 KANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 456 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...+ .............. ....+ .+..++..+.+++.+||+.||.+||++.+|++.|++
T Consensus 238 ~~~~--~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SDEQ--VIENTGEFFRDQGR-QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ChHH--HHHHHHHHHhhccc-cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 3321 11111111111000 00001 112234678889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=312.18 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=204.8
Q ss_pred CCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+|...+.||+|+||.||++... +++.+|+|.+...... ...+..|+++++.++||||+++++.+..++..+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6888899999999999999874 5899999999765432 2457889999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 328 LL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 328 ~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|+ +++|.+++.. +++.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCC-CCEEEeecchhhcccccc
Confidence 98 6799999854 56777888999999999999999 99999999999999998 689999999986443211
Q ss_pred ccc------------------------cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCccc
Q 008898 402 QVS------------------------ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (549)
Q Consensus 402 ~~~------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~ 457 (549)
... .........||..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 01112245789999999999988899999999999999999999999976543
Q ss_pred chhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHHhcCCchhhhhhhHH
Q 008898 458 NRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT----MKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 458 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~evl~~L~~~~~w~~~~~~~ 533 (549)
... + .... +..............+.+++..|+..||.+||| +.++++ |+||++....
T Consensus 238 ~~~-~---~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~-----~~~~~~~~~~ 298 (316)
T cd05574 238 DET-F---SNIL----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ-----HPFFRGVNWA 298 (316)
T ss_pred HHH-H---HHHh----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc-----CchhhcCChh
Confidence 221 1 1111 111100111114567888999999999999999 888887 8999876544
Q ss_pred HH
Q 008898 534 EE 535 (549)
Q Consensus 534 ~~ 535 (549)
.-
T Consensus 299 ~~ 300 (316)
T cd05574 299 LI 300 (316)
T ss_pred hc
Confidence 33
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=304.01 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=200.9
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
+|+..+.||+|+||.||++.. .+++.+|+|+++.... ..+.+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999976 6789999999975431 12467889999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
++||+ +++|.+++.+ +++.....++.|++.||.|||++ +++|+||+|+||+++.+...++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999 5789999865 56778888999999999999999 99999999999999877346899999998655432
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
... .........|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ ...+. ....
T Consensus 158 ~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~-~~~~--------- 225 (268)
T cd06630 158 GTG-AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIF-KIAS--------- 225 (268)
T ss_pred ccc-CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHH-HHhc---------
Confidence 111 11112245689999999999888899999999999999999999999965433211 11111 0000
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
.......+......+.+++..|+..+|.+||++.++++ |+||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~-----~~~~~ 268 (268)
T cd06630 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK-----HPVFR 268 (268)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc-----CcccC
Confidence 01112223344566788899999999999999999998 78874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=308.73 Aligned_cols=263 Identities=19% Similarity=0.251 Sum_probs=196.2
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCe-----
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIK-HENIVRIIGYCHSKEM----- 321 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~----- 321 (549)
++|+..+.||+|+||.||++.. .+|+.+|+|.++.... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688899999999999999987 5689999999865432 2356788999999995 6999999999876665
Q ss_pred EEEEEeccCCCHHHHHHH--------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecc
Q 008898 322 YAIVYNLLNGSLKQYLKQ--------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~--------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGl 393 (549)
++++|||+.++|.+++.. +++.....++.||++||.|||+. +|+||||||+||+++.+.+.++|+|||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 899999999899988843 46778889999999999999999 9999999999999998337899999999
Q ss_pred ccccccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS 472 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 472 (549)
+....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......+... ........
T Consensus 158 ~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~ 231 (295)
T cd07837 158 GRAFSIPV-----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGTP 231 (295)
T ss_pred ceecCCCc-----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHHHhCCC
Confidence 86442211 11122356889999998875 4578999999999999999999999976543222111 11111000
Q ss_pred cc--ccccc-------CCc----ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 473 GL--CERLI-------DPQ----LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 473 ~~--~~~~~-------d~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
.. ..... .+. ............+.+++..||..||.+||++.+++. |+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~-----~~~~~ 295 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT-----HPYFD 295 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc-----CCCcC
Confidence 00 00000 000 000001123456788999999999999999999999 89874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=314.56 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=193.6
Q ss_pred cCCCCCceEcccCceEEEEEEec--------CCcEEEEEEeecCCc--CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKE 320 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 320 (549)
++|.+.+.||+|+||.||++... ....+|+|.++.... ...++..|+.+++.+ +||||+++++++..++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56888999999999999999642 245789999875432 234678899999999 6999999999999989
Q ss_pred eEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~ 380 (549)
.++++|||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 999999999 6899999854 55667788999999999999999 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccch
Q 008898 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANR 459 (549)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~ 459 (549)
.+ +.+||+|||++......... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||.......
T Consensus 169 ~~-~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 169 ED-NVMKIADFGLARGVHDIDYY---KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred CC-CcEEEccccccccccccccc---cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 88 68999999998654322111 11112234567999999998899999999999999999999 888886543211
Q ss_pred hhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 460 ESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 460 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
+. .... .+.. . ..+......+.+++.+|+..+|.+|||+.++++.|++.
T Consensus 245 --~~---~~~~-~~~~-----~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 245 --LF---KLLR-EGHR-----M----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred --HH---HHHH-cCCC-----C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11 1111 1110 0 11122344677899999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=302.85 Aligned_cols=243 Identities=24% Similarity=0.322 Sum_probs=195.4
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+|+..+.||+|+||.||++.. .+++.+|+|.++... ...+.+.+|+.+++.++|+||+++++++..++.++++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477889999999999999987 468999999986433 23356788999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 -~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+|+|.+++.. ++......++.|++.||.|||+. +|+|+||||+||+++++ +.++|+|||++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~--- 153 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSP--- 153 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCC-CcEEEcccCcceeeccc---
Confidence 6789988854 56777888999999999999999 99999999999999988 68999999998654321
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ..... .+...
T Consensus 154 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~-~~~~~------- 218 (255)
T cd08219 154 --GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-----ILKVC-QGSYK------- 218 (255)
T ss_pred --ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-----HHHHh-cCCCC-------
Confidence 1122345689999999999988899999999999999999999999976543211 11111 11111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 519 (549)
..+......+.+++.+||..||.+||++.+++..
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112233457788999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=307.71 Aligned_cols=250 Identities=22% Similarity=0.388 Sum_probs=192.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCc----EEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQ----VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~----~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|...+.||+|+||.||+|.+ .+|. .||+|+++.... ....+.+|+.+++.++||||+++++++.... .++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST-VQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC-cEE
Confidence 5688899999999999999975 4454 489999875432 2356788999999999999999999997654 567
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+++++ +|+|.+++.. +++...+.++.||+.||.|||+. +|+||||||+|||++++ +.+||+|||++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSP-NHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCC-CcEEECCCCceeeccc
Confidence 78877 7899999854 57788899999999999999999 99999999999999888 6899999999876532
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+..+.. .+.
T Consensus 162 ~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~----~~~---- 228 (279)
T cd05109 162 DETE---YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLE----KGE---- 228 (279)
T ss_pred ccce---eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH----CCC----
Confidence 2111 11112235678999999998999999999999999999998 89998654321 1211111 110
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.+. ........+.+++..||..||.+||++.++++.|+...
T Consensus 229 -~~~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 -RLP----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred -cCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 000 11123446778899999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=309.19 Aligned_cols=256 Identities=29% Similarity=0.394 Sum_probs=196.9
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|...+.||+|+||.||++.+ .+++.+|+|.+..... ....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455667899999999999977 5689999999875432 2346788999999996 99999999999988999999999
Q ss_pred cCCCHHHHHH--------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 329 LNGSLKQYLK--------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 329 ~~gsL~~~l~--------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
+.++|.++.. .+++.....++.+++.||.|||+.+ +|+||||||+||+++.+ +.++|+|||++......
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccC-CcEEEeecchhHHhccC
Confidence 9887766542 2566778899999999999999732 89999999999999988 68999999998654321
Q ss_pred cccccCccccccccCCccccccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYG---KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.......|++.|+|||++.+. .++.++|||||||++|||++|+.||.......+.+ . .... +
T Consensus 162 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~-~~~~-~---- 226 (288)
T cd06616 162 ------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL---T-QVVK-G---- 226 (288)
T ss_pred ------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHH---h-hhcC-C----
Confidence 111234688999999998866 68999999999999999999999997543211111 1 1100 0
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
..+.+...........+.+++..||..+|.+|||+.+|++ |+|++....
T Consensus 227 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~-----~~~~~~~~~ 275 (288)
T cd06616 227 -DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE-----HPFIKDYEE 275 (288)
T ss_pred -CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc-----Chhhhchhh
Confidence 0111211112234556888999999999999999999999 899976543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=325.18 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=194.2
Q ss_pred cCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIK-HENIVRIIGYCHSKEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~ 322 (549)
++|.+.+.||+|+||.||+|.+. .++.||+|+++..... ...+.+|+.+|.++. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45778889999999999999753 3468999999765322 246889999999997 99999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH--------------------------------------------------------------
Q 008898 323 AIVYNLL-NGSLKQYLKQ-------------------------------------------------------------- 339 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~-------------------------------------------------------------- 339 (549)
++||||+ +|+|.+++.+
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999 7899999853
Q ss_pred ---------------------------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe
Q 008898 340 ---------------------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (549)
Q Consensus 340 ---------------------------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~ 380 (549)
+++.....++.||+.||.|||+. +|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 23345677889999999999998 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccch
Q 008898 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANR 459 (549)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~ 459 (549)
++ +.++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 274 ~~-~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 274 EG-KLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred CC-CEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 88 68999999998654321111 11123457889999999998889999999999999999998 889986543322
Q ss_pred hhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 460 ESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 460 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. + ..... .+. .+. .+......+.+++..||..+|..||++++|++.|++
T Consensus 350 ~-~---~~~~~-~~~-----~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 350 Q-F---YNAIK-RGY-----RMA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred H-H---HHHHH-cCC-----CCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 1 11111 110 011 111234568888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=304.84 Aligned_cols=253 Identities=28% Similarity=0.411 Sum_probs=202.1
Q ss_pred CCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+|+..+.||.|+||.||++.+. +++.+|+|.+..... ...++.+|+++++.++||||+++++++..++.+++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777888999999999999874 689999999876532 2356889999999999999999999999999999999999
Q ss_pred C-CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 N-GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 ~-gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
. ++|.+++.. ++......++.|+++||.|||+ . +++|+||||+||+++.+ +.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~-- 155 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSL-- 155 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCC-CCEEEeecccchhhHHHH--
Confidence 5 799999864 4667778899999999999999 7 99999999999999998 689999999985442211
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
.....|+..|+|||.+.+..++.++|||||||++|+|++|..||.......+............. .+.+
T Consensus 156 -----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~ 224 (265)
T cd06605 156 -----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------PPRL 224 (265)
T ss_pred -----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------CCCC
Confidence 11257889999999999889999999999999999999999999765322222222222221111 1111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.. ......+.+++..||..||.+|||+.+++. |+||+.+
T Consensus 225 ~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~-----~~~~~~~ 263 (265)
T cd06605 225 PS---GKFSPDFQDFVNLCLIKDPRERPSYKELLE-----HPFIKKY 263 (265)
T ss_pred Ch---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh-----Cchhhcc
Confidence 11 114455788899999999999999999998 8999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=300.17 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=197.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
++|...+.||+|+||.||++.. .+++.+++|++..... ..+.+.+|+.+++.++||||+++++++..++.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788999999999999999987 4678999999976543 3456889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 -NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 -~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+++|.+++.. ++......++.|++.||.|||+. +|+|+||+|+||+++.+ +.++|+|||++.......
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~--- 155 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTED-GDVKLADFGVSAQLTATI--- 155 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCC-CCEEECccccchhhhhhh---
Confidence 5689888843 57778888999999999999998 99999999999999988 689999999986543211
Q ss_pred cCccccccccCCccccccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYG---KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~---~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......|+..|+|||.+.+. .++.++|+|||||++|+|++|..||........... .. .. ....+
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-~~----~~----~~~~~ 224 (262)
T cd06613 156 --AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-IS----KS----NFPPP 224 (262)
T ss_pred --hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HH----hc----cCCCc
Confidence 122345688999999998876 789999999999999999999999976543222111 10 00 00001
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.+ .........+.+++.+||..+|.+|||+.+|+.
T Consensus 225 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 112334566888999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=301.64 Aligned_cols=242 Identities=26% Similarity=0.410 Sum_probs=195.9
Q ss_pred ceEcccCceEEEEEEecC----CcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~----g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+.||+|+||.||++.... +..+++|.++..... .+.+.+|+++++.++|+||+++++++..+..++++|||+ +
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999997743 789999999866543 467889999999999999999999999999999999999 7
Q ss_pred CCHHHHHHH------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 331 GSLKQYLKQ------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 331 gsL~~~l~~------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
|+|.+++.. +++.....++.|++.||.|||++ +++|+||||+||+++.+ +.++|+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGED-LVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCC-CcEEEcccccccccc
Confidence 899999864 46788899999999999999998 99999999999999998 689999999987654
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.... ........+++.|+|||.+....++.++|||||||++|||++ |..||....... + ...... +.
T Consensus 157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~---~~~~~~-~~--- 224 (262)
T cd00192 157 DDDY---YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--V---LEYLRK-GY--- 224 (262)
T ss_pred cccc---cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--H---HHHHHc-CC---
Confidence 3221 122234567889999999998899999999999999999999 699997663221 1 111111 10
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.. ..+......+.+++..|+..+|.+|||+.++++.|+
T Consensus 225 --~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --RL----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CC----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01 112222456888899999999999999999999774
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.45 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=195.6
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
|++.+.||+|+||.||++.. .++..+++|.+..... ..+.+.+|+++++.++||||+++++++..++.+++++||+ +
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 56677899999999999987 4578899999865432 2356788999999999999999999999999999999999 6
Q ss_pred CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 331 gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
|+|..++.. +++..+..++.|+++||.|||+. +|+||||||+|||++.+ +.++|+|||++...... .
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~-----~ 157 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRT-----I 157 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccC-CCEEEcccccccccccc-----c
Confidence 688887743 67788899999999999999999 99999999999999988 68999999998543221 1
Q ss_pred ccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 407 VKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......||+.|+|||++. +..++.++|||||||++|||++|++||........ ..... .. ......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~----~~-~~~~~~-- 229 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIA----KS-EPPTLA-- 229 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHh----hc-CCCCCC--
Confidence 1223456899999999984 34578899999999999999999999976543211 11110 00 000010
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.+......+.+++..||..||.+||++.++++ |+|++..
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~-----~~~~~~~ 268 (282)
T cd06643 230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ-----HPFVTVN 268 (282)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhc-----CCCEecc
Confidence 11223456788899999999999999999998 8998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=292.18 Aligned_cols=244 Identities=27% Similarity=0.373 Sum_probs=189.9
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEecc
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.+....||.|+.|.|+++.+ .+|...|||.+...... .+.+++.+.++..-+ .|+||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 34455699999999999987 56899999999765433 346778888776655 899999999999999999999998
Q ss_pred CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 ~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
..-++..+++ +++.-.-++..-+..||.||.++| +|||||+||+|||+|+. |++||||||.+-..- +
T Consensus 174 s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~-GniKlCDFGIsGrlv------d 244 (391)
T KOG0983|consen 174 STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDER-GNIKLCDFGISGRLV------D 244 (391)
T ss_pred HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccC-CCEEeecccccceee------c
Confidence 7655665543 455555678888999999999986 99999999999999999 899999999985433 2
Q ss_pred CccccccccCCcccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........|.+.|||||.+.- ..|+..+||||||+.++||.||+.||...+.+.+.+-... ++. -|.
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl---------n~e-PP~ 314 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL---------NEE-PPL 314 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH---------hcC-CCC
Confidence 333345579999999999863 4689999999999999999999999988665554332211 111 133
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
+++... ....+.+++..||++|+++||.+.++++
T Consensus 315 L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 332211 3345666778999999999999999987
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.41 Aligned_cols=261 Identities=21% Similarity=0.337 Sum_probs=200.5
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|.+.+.||+|+||.||+|.. .+|+.+|+|++..... ....+.+|+.+++.++||||+++++++..++.+++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477888999999999999987 5689999999976542 235688999999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
++++|.+++.. +++.++..++.||++||.|||+. +++|+||||+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCC--
Confidence 98899999854 67888899999999999999999 99999999999999998 6899999999865433211
Q ss_pred cCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc----------
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG---------- 473 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---------- 473 (549)
.......|+..|+|||.+.+.. ++.++|||||||++|||++|.+||...... ..+...........
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 --RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred --CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCc
Confidence 1123456899999999987554 689999999999999999998888654431 11111111100000
Q ss_pred -ccccccCCccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 474 -LCERLIDPQLN----EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 474 -~~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.......+... .....+....+.+++.+|+..+|.+|||++++++ |+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~-----h~~~ 285 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR-----HPYF 285 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh-----CcCc
Confidence 00000000000 0011123477889999999999999999999999 8887
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=300.00 Aligned_cols=242 Identities=27% Similarity=0.402 Sum_probs=191.6
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCHH
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~ 334 (549)
++||+|+||.||++...+++.+|+|.++..... ...+.+|++++++++|+||+++++++...+..+++|||+ +++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999998866999999998765432 356889999999999999999999999999999999999 67899
Q ss_pred HHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 008898 335 QYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (549)
Q Consensus 335 ~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (549)
+++.. +++.....++.+++.||.|||++ +++||||||+|||++.+ +.++|+|||++......... ....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~---~~~~ 153 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYT---VSDG 153 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCC-CcEEEeeccccccccCCcce---eccc
Confidence 99854 56677788999999999999999 99999999999999988 68999999998654321110 0111
Q ss_pred ccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCH
Q 008898 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNR 489 (549)
Q Consensus 411 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 489 (549)
...++..|+|||.+.++.++.++|+|||||++|||++ |..||........ .. ... .+ .....+.
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--~~---~~~-~~---------~~~~~~~ 218 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RE---RIE-SG---------YRMPAPQ 218 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--HH---HHh-cC---------CCCCCCc
Confidence 2234567999999998899999999999999999999 8888866543211 11 110 00 0011122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 490 EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 490 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
..+..+.+++.+|+..+|.+|||+.++++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 33457888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=303.20 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=197.9
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|+..+.||+|+||.||++... +|+.+|+|++..... ..+.+.+|+.+++.++||||+++++++..++.++++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999874 689999999865432 23457889999999999999999999999999999999
Q ss_pred ccCCC-HHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGS-LKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gs-L~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.++ |..++. .+++..+..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCC-CcEEECccccceecCCCcc-
Confidence 99654 555543 377888999999999999999998 99999999999999988 6899999999865433211
Q ss_pred ccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc-----------
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS----------- 471 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~----------- 471 (549)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......+ .+..+......
T Consensus 156 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 156 ----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred ----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhccc
Confidence 1223457889999999876 457899999999999999999999998655322 12111111100
Q ss_pred ccccccccCCcccccCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 472 SGLCERLIDPQLNEEYN-----REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 472 ~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.........+......+ ......+.+++..||..+|.+||++.++++ |+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~-----~~~f 286 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE-----HPYF 286 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc-----CCCC
Confidence 00001111111111001 122456788999999999999999999998 7876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.93 Aligned_cols=261 Identities=23% Similarity=0.280 Sum_probs=199.3
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~lv 325 (549)
++|+..+.||.|+||.||+|... +++.+|+|.++..... ...+.+|+.+++.++||||+++++++... +.++++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999874 6889999999755422 23467899999999999999999998777 899999
Q ss_pred EeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
+||+.++|.+++.. +++.....++.||+.||.|||+. +++|+||||+|||++.+ +.++|+|||++.......
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCC-CcEEEeecCceeeccCCc
Confidence 99999999988854 67888899999999999999999 99999999999999998 789999999986543321
Q ss_pred ccccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh----------
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL---------- 470 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~---------- 470 (549)
.......+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||........ +........
T Consensus 161 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 161 -----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred -----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHh
Confidence 1122345788999999987654 68999999999999999999999976543221 111000000
Q ss_pred --cc----cccccccCCcccccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 471 --SS----GLCERLIDPQLNEEYNRE-EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 471 --~~----~~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.. ..........+...++.. ..+.+.++++.||+.+|++|||+.|+++ |+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~-----~~~f 293 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK-----HPYF 293 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc-----CCCC
Confidence 00 000000011111112221 3556788999999999999999999998 7886
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=309.72 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=194.5
Q ss_pred CCCCCceEcccCceEEEEEEe-----cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSK--EMYA 323 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-----~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~ 323 (549)
.|...+.||+|+||.||++.. .++..+|+|.++.... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467888999999999999963 3578999999875432 235688999999999999999999998765 6789
Q ss_pred EEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++|||+ +++|.+++.+ +++..+..++.||+.||.|||++ +|+||||||+||+++.+ +.++|+|||++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE-HQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCC-CCEEECCCccccccc
Confidence 999999 7899999853 67888899999999999999999 99999999999999998 689999999987654
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc----------hhhHHHHHHH
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN----------RESLVLWARS 468 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~----------~~~l~~~~~~ 468 (549)
...... .......|+..|+|||.+.+..++.++|||||||++|||++++.|....... ......+...
T Consensus 161 ~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 161 TDKEYY--TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cCccce--eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 322111 1112345777899999999888999999999999999999988765332110 0001111111
Q ss_pred hhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 469 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. ..+. ...........+.+++.+|++.||.+|||+.++++.|+.
T Consensus 239 ~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 239 L-EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred H-HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 1 0000 001112234578889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=304.68 Aligned_cols=250 Identities=21% Similarity=0.337 Sum_probs=195.5
Q ss_pred cCCCCCceEcccCceEEEEEEec-C---CcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-D---GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~---g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.+|.+.+.||+|+||.||+|... + +..+|+|.++..... .+.+.+|+.+++.++||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999763 2 337999998754322 34678899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|||+ +|+|.+++.. +++.+.+.++.|++.||.|||+. +++||||||+|||++.+ +.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCC-CeEEeCCCCcccccccc
Confidence 9999 6789999864 57778899999999999999999 99999999999999988 68999999998654331
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
... ........++..|+|||.+.++.++.++|+|||||++||+++ |..||......+ ... .+.....
T Consensus 160 ~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~---~~~~~~~----- 227 (267)
T cd05066 160 PEA--AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIK---AIEEGYR----- 227 (267)
T ss_pred cce--eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHH---HHhCCCc-----
Confidence 110 011112233568999999998899999999999999999886 999997654321 111 1111100
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. ......+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 228 -~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 -L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 1112234567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=308.27 Aligned_cols=259 Identities=26% Similarity=0.356 Sum_probs=193.4
Q ss_pred cCCCCCceEcccCceEEEEEEe-----cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCeEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHS--KEMYA 323 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~ 323 (549)
++|++.+.||+|+||.||++.. .+++.+|+|.++..... .+.+.+|+++++.++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788899999999999999864 35789999998755422 3567899999999999999999998743 45789
Q ss_pred EEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+++||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++++ +.++|+|||++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESE-NRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCC-CeEEECCCccccccc
Confidence 999999 7899999853 67788899999999999999999 99999999999999998 689999999987653
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc----
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL---- 474 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---- 474 (549)
...... .......++..|+|||++.+..++.++|||||||++|||++|..|+...... +.........
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 231 (284)
T cd05081 160 QDKEYY--KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRMMGNDKQGQMI 231 (284)
T ss_pred CCCcce--eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhhcccccccccc
Confidence 321110 0111123445699999999889999999999999999999998776433211 0000000000
Q ss_pred ---cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 475 ---CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 475 ---~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+.+...............+.+++.+||..+|++|||+.+|++.|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 000011111111122334568889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=307.52 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=198.3
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|+..+.||+|+||.||++... +|+.+|+|.++.... ....+.+|+.++++++||||+++++++..++.++++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999874 789999999875422 235688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 329 L-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 329 ~-~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
+ +++|..++.. +++.....++.|++.||.|||+.+ +|+|+||||+||+++.+ +.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC-
Confidence 9 5689888854 677788999999999999999632 89999999999999997 68999999998543221
Q ss_pred ccccCccccccccCCccccccccccCC------CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGK------VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~------~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
......|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||....... ...... .
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~-~------- 221 (286)
T cd06622 157 ------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQLS-A------- 221 (286)
T ss_pred ------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHHH-H-------
Confidence 122346888999999985443 5789999999999999999999997543211 111100 0
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..+.. ....+......+.+++.+||..+|.+||++.++++ |+|+....
T Consensus 222 --~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~-----~~~~~~~~ 269 (286)
T cd06622 222 --IVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE-----HPWLVKYK 269 (286)
T ss_pred --HhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc-----Chhhhhcc
Confidence 01100 01122334566778889999999999999999998 89986654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.76 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=191.0
Q ss_pred cCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEc-CCe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHS-KEM 321 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~-~~~ 321 (549)
++|++.+.||+|+||.||+|.. .+++.||||+++..... ...+.+|+.++.++ +||||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5799999999999999999963 34789999999754322 34578899999999 68999999998854 456
Q ss_pred EEEEEecc-CCCHHHHHHH-------------------------------------------------------------
Q 008898 322 YAIVYNLL-NGSLKQYLKQ------------------------------------------------------------- 339 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~------------------------------------------------------------- 339 (549)
++++|||+ +|+|.+++..
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 88999999 7899988743
Q ss_pred ---------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 008898 340 ---------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (549)
Q Consensus 340 ---------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (549)
+++.....++.||++||.|||++ +|+||||||+|||++.+ +.++|+|||++........ .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~---~~~~~ 239 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPD---YVRKG 239 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCC-CcEEEEecccccccccCcc---hhhcC
Confidence 34556678899999999999999 99999999999999988 6899999999865422111 11112
Q ss_pred ccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCH
Q 008898 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNR 489 (549)
Q Consensus 411 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 489 (549)
...+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......... ... ..+.. ...+...
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~-~~~~~-----~~~~~~~-- 307 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----RRL-KEGTR-----MRAPDYT-- 307 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH----HHH-hccCC-----CCCCCCC--
Confidence 2345678999999998899999999999999999997 899987543322111 111 11110 1111112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 490 EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 490 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...+.+++..||+.||.+|||+.+|++.|+.
T Consensus 308 --~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 308 --TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred --CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 2347788899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.10 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=199.6
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
..|...+.||+|+||.||++.. .+|+.+|+|.+...... ..++.+|+++++.++||||++++++|..++..++++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4688889999999999999977 46899999998644321 245788999999999999999999999999999999
Q ss_pred eccCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+.|+|.+++. .+++.....++.|++.||.|||+. +|+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~--- 167 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEP-GTVKLADFGSASLVSP--- 167 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCC-CCEEEeecCcceecCC---
Confidence 999999888774 267788889999999999999999 99999999999999998 6899999999854322
Q ss_pred cccCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.....|++.|+|||++. .+.++.++||||||+++|||++|..||........ .. .... +.
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~----~~~~-~~----- 230 (307)
T cd06607 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LY----HIAQ-ND----- 230 (307)
T ss_pred ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HH----HHhc-CC-----
Confidence 12346888999999874 45688999999999999999999999875432211 10 0000 00
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.+. .........+.+++..||..+|.+||++.+|++ |+|+.....
T Consensus 231 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~-----~~~~~~~~~ 275 (307)
T cd06607 231 SPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK-----HRFVLRERP 275 (307)
T ss_pred CCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc-----ChhhcccCC
Confidence 011 112234567889999999999999999999998 789866653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.28 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=193.0
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...++||+|+||.||+|.+ .+|+.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4788999999999999999987 4689999999975422 1346889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH--------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeee
Q 008898 327 NLL-NGSLKQYLKQ--------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (549)
Q Consensus 327 e~~-~gsL~~~l~~--------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DF 391 (549)
||+ +|+|.+++.. .++...+.++.||++||.|||+. +|+||||||+|||++.+ +.++|+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~d-g~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLF-GEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCC-CCEEEEec
Confidence 999 6799998853 22345678899999999999999 99999999999999988 68999999
Q ss_pred ccccccccccc-------------cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc
Q 008898 392 GAAMVHHQSHQ-------------VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (549)
Q Consensus 392 Gla~~~~~~~~-------------~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~ 458 (549)
|++........ ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99976521110 00011122357999999999999999999999999999999999999999764322
Q ss_pred hhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHh
Q 008898 459 RESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT-MKTLLKLF 520 (549)
Q Consensus 459 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~L 520 (549)
.... .. ...++..... ..+.+..+.+++.+|+..||.+||+ ++++++.|
T Consensus 238 ki~~---~~---------~i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 238 KISY---RD---------VILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred hhhh---hh---------hccChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1100 00 0111110000 1123456778889999999999965 55555543
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=313.28 Aligned_cols=245 Identities=25% Similarity=0.400 Sum_probs=189.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCc--EEEEEEeecCC--cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQ--VAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~--~~AvK~l~~~~--~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|++.+.||+|+||.||+|.+ .++. .+|+|.++... .....+.+|++++.++ +||||+++++++..++.++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 4788899999999999999986 3454 45777765432 2234678899999999 899999999999999999999
Q ss_pred Eecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc
Q 008898 326 YNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 385 (549)
|||+ +|+|.+++.. +++...+.++.||+.||.|||++ +|+||||||+|||++.+ +.
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~-~~ 162 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN-YV 162 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC-Cc
Confidence 9999 6899999853 45677889999999999999999 99999999999999988 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHH
Q 008898 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVL 464 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~ 464 (549)
++|+|||++..... ........++..|+|||++.+..++.++|||||||++|||+| |..||....... .
T Consensus 163 ~kl~dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~-- 232 (303)
T cd05088 163 AKIADFGLSRGQEV------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L-- 232 (303)
T ss_pred EEeCccccCcccch------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--H--
Confidence 99999999843211 011111234667999999988889999999999999999998 999996543321 1
Q ss_pred HHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 465 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
..... .+. .... +......+.+++.+|++.+|.+||++.++++.|.
T Consensus 233 -~~~~~-~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 233 -YEKLP-QGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred -HHHHh-cCC-----cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111 000 0011 1112345788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=308.55 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=199.8
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|+..+.||+|+||.||++.. .+|+.+|+|++..... ..+.+.+|+++++.++||||+++++++...+.++++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4678888999999999999976 5689999998865432 245788999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+ +|+|.+++.. +++.....++.+++.||.|||+.+ +++|+||||+||+++.+ +.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~---- 157 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS---- 157 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCC-CcEEEccCCcccchhhh----
Confidence 9 6789888854 567788899999999999999742 89999999999999988 68999999987543211
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchh------hHHHHHHHhhcccccccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE------SLVLWARSLLSSGLCERL 478 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~------~l~~~~~~~~~~~~~~~~ 478 (549)
......|+..|+|||++.++.++.++|+|||||++|+|++|+.||.......+ .+..+........
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 11245789999999999888999999999999999999999999986543211 1111111111110
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.+.+. ....+..+.+++.+|+..||.+|||+.++++ +.|+..
T Consensus 230 -~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~-----~~~~~~ 271 (284)
T cd06620 230 -PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCA-----MPPFIQ 271 (284)
T ss_pred -CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhc-----Cccccc
Confidence 01111 1124456888999999999999999999998 556544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=303.19 Aligned_cols=260 Identities=26% Similarity=0.321 Sum_probs=199.7
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS--KEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~lv~ 326 (549)
++|...+.||.|++|.||++.. .+++.+|+|.+..... ....+.+|+++++.++||||++++++|.+ .+.++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3678888999999999999987 5689999999875433 23568899999999999999999998854 44789999
Q ss_pred ecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 327 e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
||+ +++|.+++.. ++......++.||+.||.|||+. +++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRK-GQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecC-CeEEEeecccccccc
Confidence 999 6789888743 56667788999999999999999 99999999999999988 689999999985432
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.. ......++..|+|||.+.+..++.++|||||||++|+|++|..||............+........ ...+
T Consensus 157 ~~-------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 228 (287)
T cd06621 157 NS-------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-NPEL 228 (287)
T ss_pred cc-------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-chhh
Confidence 21 112345788999999999899999999999999999999999999866321111111111111100 0011
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.+. . .........+.+++.+||..+|.+|||+.|+++ |+|++...
T Consensus 229 ~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~-----~~~~~~~~ 273 (287)
T cd06621 229 KDE-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE-----HPWIKAQM 273 (287)
T ss_pred ccC-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh-----Cccccccc
Confidence 000 0 001223567889999999999999999999999 89985443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=302.88 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=196.6
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-----------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-----------EEEVLREVELLSSIKHENIVRIIGYCHSKE 320 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-----------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 320 (549)
+|...+.||.|+||.||+|.. .+|+.+|+|.++..... .+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999976 56899999988642110 134678999999999999999999999999
Q ss_pred eEEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
.++++|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +++|+||+|+||+++.+ +.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDAD-GICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCC-CeEEEeecccccc
Confidence 999999999 7799999865 66777888999999999999998 99999999999999988 6899999999865
Q ss_pred cccccccccCccccccccCCccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
.... ..........|+..|+|||.+.... ++.++|+||||+++|+|++|..||........ . .. ....
T Consensus 158 ~~~~---~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~---~~-~~~~-- 227 (272)
T cd06629 158 SDDI---YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-M---FK-LGNK-- 227 (272)
T ss_pred cccc---ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-H---HH-hhcc--
Confidence 3321 1111223456889999999987654 78999999999999999999999964332111 1 11 0001
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
...+.............+.+++..|+..+|.+|||+.++++ |+|+
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~-----~~~~ 272 (272)
T cd06629 228 ---RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ-----HPFI 272 (272)
T ss_pred ---ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh-----CCCC
Confidence 01111111222234567888889999999999999999999 7775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.10 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=199.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|+..+.||+|+||.||+|.. .+|+.+|+|.+..... ....+.+|+++++.++||||+++++++..++.+++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688899999999999999987 4689999999865432 23567889999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 328 LLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 328 ~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+.++|.+++.. +++.....++.||+.||.|||++ +++|+||+|+||+++.+.+.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999899888854 34556678999999999999999 99999999999999865457899999998543221
Q ss_pred cccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc--cc-----
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS--GL----- 474 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~----- 474 (549)
........|++.|+|||.+.+. .++.++|||||||++|+|++|++||............+. ..... ..
T Consensus 157 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 ---VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR-ILGTPNEETWPGVT 232 (294)
T ss_pred ---ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCCChhhccccc
Confidence 1111234578899999988764 578999999999999999999999976543222111110 00000 00
Q ss_pred -ccccc--CCccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 475 -CERLI--DPQLN----EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 475 -~~~~~--d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
+..+. .+... ..........+.+++.+|++.+|++||++.++++ |+||....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~-----~~~~~~~~ 291 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE-----HEYFKDLG 291 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc-----CchHhHHh
Confidence 00000 00000 0011122345788899999999999999999998 89997653
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.65 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=200.7
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
+|...+.||+|+||.||+|.. .+|+.+|+|.++..... ...+..|+++++.++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999999999986 56899999999765432 24567899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||++|+|.+++.. +++.....++.||++||.|||++ +|+|+||||+|||++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPN 156 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCC-CCEEEccceeeeeccCCC
Confidence 99998899999853 67788899999999999999999 99999999999999998 789999999986543321
Q ss_pred ccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc--------
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS-------- 472 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~-------- 472 (549)
.......+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||....... .+..........
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 157 -----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred -----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhc
Confidence 11223356888999998865 457899999999999999999988876544321 111111110000
Q ss_pred cccccccCCccccc-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 473 GLCERLIDPQLNEE-----YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 473 ~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.............. ........+.+++..||+.||.+|||+.++++ |+||....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~-----~~~~~~~~ 289 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE-----HPYFSNDP 289 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh-----CccccCCC
Confidence 00000000000000 11223467889999999999999999999999 89987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=301.90 Aligned_cols=245 Identities=22% Similarity=0.311 Sum_probs=184.5
Q ss_pred eEcccCceEEEEEEec---CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCC
Q 008898 259 LIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gs 332 (549)
.||+|+||.||+|... ++..+|+|.++..... ...+.+|+.+++.++||||+++++++.+...++++|||+ +|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999753 3467999988755432 246788999999999999999999999989999999999 689
Q ss_pred HHHHHHH--------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 333 LKQYLKQ--------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 333 L~~~l~~--------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
|.+++.. .++.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCC-CcEEECCccccccccCcce--
Confidence 9999854 23445667899999999999999 99999999999999998 6899999999864322111
Q ss_pred cCccccccccCCccccccccccC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYG-------KVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~-------~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
........|++.|+|||++.+. .++.++|||||||++|||++ |+.||......+.... .. .+...
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~----~~--~~~~~ 228 (269)
T cd05087 156 -YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY----TV--REQQL 228 (269)
T ss_pred -eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH----Hh--hcccC
Confidence 1112234678899999988642 35789999999999999996 9999976543321111 11 11112
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
...++.+... ..+.+.+++..|+ .+|++|||+.+|++.|+
T Consensus 229 ~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222322222 2334666788898 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=299.41 Aligned_cols=255 Identities=29% Similarity=0.389 Sum_probs=201.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|+..+.||.|+||.||++.. .++..+|+|++..... ....+.+|+++++.++|+||+++++.+..++.+++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688999999999999999986 4688999999875432 345688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 329 L-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 329 ~-~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
+ +++|.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGED-GSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence 9 6789999854 56677888999999999999998 99999999999999998 689999999986554322
Q ss_pred ccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.... .......|++.|+|||++... .++.++|+|||||++|+|++|+.||........ + ..... . ..
T Consensus 157 ~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~---~~~~~-~------~~ 224 (267)
T cd06610 157 DRTR-KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-L---MLTLQ-N------DP 224 (267)
T ss_pred cccc-cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-H---HHHhc-C------CC
Confidence 1111 122345689999999998877 789999999999999999999999975543221 1 11110 0 01
Q ss_pred CcccccC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 481 PQLNEEY-NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 481 ~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+.+.... .......+.+++..|+..||.+||++.+|++ |+||
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~-----~p~~ 267 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK-----HKFF 267 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh-----CCCC
Confidence 1111110 1233466788999999999999999999998 7886
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.39 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=194.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---C---HHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---S---EEEVLREVELLSSIKHENIVRIIGYCHS--KEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~---~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~ 322 (549)
++|...+.||+|+||.||++.. .+|+.+|+|.+..... . .+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999976 5689999999864321 1 2357789999999999999999998865 3568
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+++|||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+|+||||+||+++.+ +.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSV-GNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCC-CCEEECcCccccccc
Confidence 8999999 6799999854 56677888999999999999999 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.... .........|+..|+|||.+.+..++.++|||||||++|||++|+.||........ . .. .... .
T Consensus 158 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~---~~-~~~~-----~ 225 (265)
T cd06652 158 TICL--SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-I---FK-IATQ-----P 225 (265)
T ss_pred cccc--cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-H---HH-HhcC-----C
Confidence 2110 11112235689999999999988899999999999999999999999975432211 1 11 1000 0
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
..+ ..+......+.++++.|+. +|.+||++++|++ |+|+
T Consensus 226 ~~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~-----~~~~ 264 (265)
T cd06652 226 TNP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR-----HTFV 264 (265)
T ss_pred CCC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc-----Cccc
Confidence 111 1233444566777888884 9999999999998 7776
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.08 Aligned_cols=241 Identities=23% Similarity=0.396 Sum_probs=187.0
Q ss_pred EcccCceEEEEEEec---CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCH
Q 008898 260 IGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (549)
Q Consensus 260 lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL 333 (549)
||+|+||.||+|.+. ++..+|+|++...... .+.+.+|+.++++++||||+++++++.. +.++++|||+ +|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999653 3567999998755322 3568899999999999999999999864 5678999999 6799
Q ss_pred HHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccc
Q 008898 334 KQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409 (549)
Q Consensus 334 ~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 409 (549)
.+++.. +++..++.++.|++.||.|||++ +++||||||+|||++.+ +.++|+|||++........... ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~--~~ 155 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYK--AR 155 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCC-CcEEeccCCccccccCCcccee--cc
Confidence 999853 67888899999999999999999 99999999999999988 6899999999864432211111 11
Q ss_pred cccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCC
Q 008898 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYN 488 (549)
Q Consensus 410 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 488 (549)
....+++.|+|||.+.+..++.++|||||||++|||++ |..||....... . ..... .+. ....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~---~~~~~-~~~---------~~~~~ 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--V---MSFIE-QGK---------RLDCP 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--H---HHHHH-CCC---------CCCCC
Confidence 12234678999999988889999999999999999996 999997654321 1 11111 111 01112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 489 REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 489 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+...+.+++..||..+|.+||++.+|.+.|+.
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 2334567789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.73 Aligned_cols=242 Identities=29% Similarity=0.475 Sum_probs=189.8
Q ss_pred eEcccCceEEEEEEecC-------CcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 259 LIGQGGNSKVYRTNHVD-------GQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~-------g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.||+|+||.||+|...+ ++.+|+|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999997532 3689999886543 23457889999999999999999999999999999999998
Q ss_pred -CCCHHHHHHH----------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC-----ceEEeeecc
Q 008898 330 -NGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH-----HPQLSDFGA 393 (549)
Q Consensus 330 -~gsL~~~l~~----------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~~kL~DFGl 393 (549)
+|+|.+++.. +++...+.++.|++.||.|||+. +++|+||||+||+++.+ + .++|+|||+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~-~~~~~~~~~l~dfg~ 157 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEK-GYDADRVVKIGDFGL 157 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecC-CCCCCcceEECCccc
Confidence 6899999853 45677888999999999999998 99999999999999987 4 799999999
Q ss_pred ccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcc
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSS 472 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 472 (549)
+.......... ......++..|+|||.+.++.++.++|||||||++|||++ |..||....... ... .....
T Consensus 158 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~---~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYR---KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQ---HVTAG 229 (269)
T ss_pred ccccccccccc---cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHH---HHhcC
Confidence 86543321111 1123345788999999999999999999999999999998 999986543221 111 11100
Q ss_pred cccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 473 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. ........+..+.+++.+||..+|.+||++.+|++.|+.
T Consensus 230 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 001122345678899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=302.65 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=194.4
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCC-CCCeeeEEEEEEcC--CeEEEEEe
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIK-HENIVRIIGYCHSK--EMYAIVYN 327 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~--~~~~lv~e 327 (549)
|...+.||+|+||.||++.. .+++.+|+|.++.... ......+|+.++.++. |+|++++++++.++ +.+++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678899999999999976 5689999999875432 2234567999999885 99999999999877 89999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.|+|.+++.. +++.....++.|++.||.|||+. +++||||+|+||+++. +.++|+|||++.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD--DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC--CCeEEEecccccccccCC--
Confidence 999999988854 67888999999999999999999 9999999999999998 589999999986543211
Q ss_pred ccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc----------
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS---------- 472 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~---------- 472 (549)
......+++.|+|||.+.. +.++.++|||||||++|||++|..||....... . ..+.......
T Consensus 154 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 ----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-Q-IAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred ----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-H-HHHHHHHcCCCCHHHHHhhc
Confidence 1123457899999997654 457899999999999999999999997654321 1 1111111100
Q ss_pred -cccccccCCccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 473 -GLCERLIDPQLN----EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 473 -~~~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
........+... ..........+.+++.+||..+|.+||++.++++ |+||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~-----~~~~ 282 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR-----HPYF 282 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh-----CCCC
Confidence 000011111100 0011234577889999999999999999999999 7886
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=308.67 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=196.5
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|+..+.||+|+||.||+|... +++.+|+|++...... .+.+.+|+++++.++||||+++++++..++.+++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999874 5899999998654322 3467889999999999999999999999999999999
Q ss_pred ccCC-CHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNG-SLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~g-sL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.+ +|.++.. .+++.....++.||+.||.|||+. +++|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCc--
Confidence 9955 5666553 367888999999999999999999 99999999999999998 689999999986543321
Q ss_pred ccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh----------cc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL----------SS 472 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~----------~~ 472 (549)
.......++..|+|||++.+. .++.++|||||||++|||++|++||....... .+........ ..
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 ---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred ---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhcc
Confidence 112234678899999998754 47889999999999999999999997554311 1111000000 00
Q ss_pred c-ccccccCCcccc-----cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 473 G-LCERLIDPQLNE-----EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 473 ~-~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
. .......+.... ...+.....+.+++..||..+|.+||++.++++ |+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~-----~~~~ 286 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH-----HEFF 286 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc-----CCCC
Confidence 0 000001111000 001123466888999999999999999999998 7886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.15 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=197.2
Q ss_pred CCCCCceEcccCceEEEEEEec---CCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSK--EMYA 323 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~ 323 (549)
.|...+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+. +.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3778889999999999999873 58899999997632 1235678899999999999999999999887 8899
Q ss_pred EEEeccCCCHHHHHH--------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec----CCCceEEeee
Q 008898 324 IVYNLLNGSLKQYLK--------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE----NFHHPQLSDF 391 (549)
Q Consensus 324 lv~e~~~gsL~~~l~--------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~----~~~~~kL~DF 391 (549)
+||||++++|.+++. .++......++.||+.||.|||+. +|+||||||+|||++. + +.+||+||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~-~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPER-GVVKIGDL 156 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCcc-ceEEECCC
Confidence 999999988888774 245667788999999999999999 9999999999999998 7 68999999
Q ss_pred ccccccccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccch--------hhH
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANR--------ESL 462 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~--------~~l 462 (549)
|++........ .........+|+.|+|||.+.+. .++.++|||||||++|+|++|++||....... ..+
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 157 GLARLFNAPLK--PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred ccccccCCCcc--cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 99865433211 11222345789999999988764 57899999999999999999999997654322 111
Q ss_pred HHHHHHhhccc-----------ccccccCCcccccCC---------H--HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 008898 463 VLWARSLLSSG-----------LCERLIDPQLNEEYN---------R--EEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520 (549)
Q Consensus 463 ~~~~~~~~~~~-----------~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 520 (549)
..+...+.... ......+......++ . .....+.+++..|+..||.+|||+.++++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~-- 312 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE-- 312 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc--
Confidence 11111110000 000000000000111 0 22345788999999999999999999998
Q ss_pred cCCchhh
Q 008898 521 QEPDYWL 527 (549)
Q Consensus 521 ~~~~~w~ 527 (549)
|+||
T Consensus 313 ---~~~f 316 (316)
T cd07842 313 ---HPYF 316 (316)
T ss_pred ---CCCC
Confidence 7886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=299.56 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=198.4
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|+..+.||+|+||.||++.. .+|+.+|+|.+..... ...++.+|+.+++.++||||+++++++...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999976 5689999999875432 235688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +++|.+++.. +++.....++.|++.||.|||++ +++|+||+|+|||++.+ +.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC-CCEEEeeccceeecCcch-
Confidence 9 6799998853 46777889999999999999998 99999999999999988 689999999986543211
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||....... . ......... +
T Consensus 156 ----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~----~~~~~~~~~------~- 219 (256)
T cd08218 156 ----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-L----VLKIIRGSY------P- 219 (256)
T ss_pred ----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-H----HHHHhcCCC------C-
Confidence 11123468899999999998889999999999999999999999997543221 1 111111110 1
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
..+......+.+++..|++.+|.+||++.+|++ |+||
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~-----~~~~ 256 (256)
T cd08218 220 ---PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE-----KNFI 256 (256)
T ss_pred ---CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh-----CcCC
Confidence 112233456888999999999999999999999 7885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.76 Aligned_cols=239 Identities=26% Similarity=0.411 Sum_probs=185.7
Q ss_pred eEcccCceEEEEEEec-CCc--EEEEEEeecCC--cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEecc-CC
Q 008898 259 LIGQGGNSKVYRTNHV-DGQ--VAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~-~g~--~~AvK~l~~~~--~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~-~g 331 (549)
+||+|+||.||+|... ++. .+++|.++... ...+.+.+|+++++++ +||||+++++++...+.++++|||+ +|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999774 444 56888887432 2335688899999999 7999999999999999999999999 78
Q ss_pred CHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeec
Q 008898 332 SLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (549)
Q Consensus 332 sL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFG 392 (549)
+|.+++.. +++.+...++.|++.||.|||+. +++||||||+|||++++ +.++|+|||
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~-~~~kl~dfg 157 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN-YVAKIADFG 157 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCC-CeEEECCCC
Confidence 99999853 46777889999999999999998 99999999999999998 689999999
Q ss_pred cccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhc
Q 008898 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLS 471 (549)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 471 (549)
++..... .........++.|+|||++.+..++.++|||||||++|||++ |..||....... . ......
T Consensus 158 l~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~---~~~~~~ 226 (270)
T cd05047 158 LSRGQEV------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L---YEKLPQ 226 (270)
T ss_pred Cccccch------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--H---HHHHhC
Confidence 9743211 011112234567999999988889999999999999999997 999996543221 1 111111
Q ss_pred ccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 472 SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 472 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+. .... .......+.+++..|+..||.+|||+.++++.|++
T Consensus 227 -~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 227 -GY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred -CC-----CCCC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 00 0011 11233457889999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=306.18 Aligned_cols=256 Identities=25% Similarity=0.345 Sum_probs=198.9
Q ss_pred cCCCCCceEcccCceEEEEEEec-----CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-----DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHS--KEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-----~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~ 322 (549)
..|...+.||+|+||.||++.+. ++..+|+|+++..... ...+.+|+++++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777889999999999999752 3689999999866553 5678999999999999999999999877 5689
Q ss_pred EEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+++|||+ +|+|.+++.. +++.....++.|++.||.|||++ +++|+||||+||+++.+ +.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESE-DLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCC-CCEEEccccccccc
Confidence 9999999 6799999954 77888899999999999999999 99999999999999998 68999999998765
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchh----------hHHHHHH
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE----------SLVLWAR 467 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~----------~l~~~~~ 467 (549)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+........ ....+..
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 160 PEDKDYY--YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccCCcce--eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 4221111 111122455679999999888999999999999999999999999865432110 0111111
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
.+. .......+..++..+.+++.+|+..+|.+|||+.+|++.|+..
T Consensus 238 ~~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLK----------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHH----------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111 1111111223346788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.46 Aligned_cols=241 Identities=27% Similarity=0.443 Sum_probs=192.1
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|.+.+.||+|+||.||++.. +++.+|+|.++... ....+.+|+.+++.++|||++++++++..+ .++++|||+ +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4588899999999999999875 67889999987543 346788999999999999999999998765 468999998 6
Q ss_pred CCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
|+|.+++.. +++.....++.|++.||.|||+. +++||||||+||+++.+ +.++|+|||++......
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSED-GVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCC-CcEEECCCccceecccc-----
Confidence 799999864 56777888999999999999998 99999999999999998 68999999998543221
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
......+..|+|||.+.++.++.++|+|||||++|||++ |+.||....... . ..... .+.. .+
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~---~~~~~-~~~~---~~---- 217 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--V---KECVE-KGYR---ME---- 217 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--H---HHHHh-CCCC---CC----
Confidence 112234567999999998899999999999999999998 999987654321 1 11111 1110 01
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.....+..+.+++..|++.+|.+||++.++++.|+.
T Consensus 218 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 --PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112234567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=302.25 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=201.6
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
-|...+.||+|+||.||+|.. .++..+|+|++..... ....+.+|+.+++.++||||+++++++..++.++++|||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788899999999999976 5688999999865432 2246788999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 -~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+++.. +++.....++.|++.|+.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~----- 155 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQ----- 155 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCC-CCEEEeecccceecccch-----
Confidence 6789998864 67788889999999999999998 99999999999999988 689999999986543211
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....... +........ .+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~------~~~---- 220 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----VLFLIPKNN------PPT---- 220 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----HHHHHhcCC------CCC----
Confidence 11223468889999999988889999999999999999999999997543211 111111110 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
........+.+++..|+..+|.+||++.++++ |+|+..+..+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~-----~~~~~~~~~~ 262 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK-----HKFIVRFAKK 262 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHh-----CHHHhhhhhc
Confidence 12233455778889999999999999999999 7898766544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=303.99 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=202.8
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...+.||+|+||.||++.. .+++.+|+|+++.... ..+.+.+|++++++++||||+++++++..++.++++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688899999999999999977 4689999999975432 2345788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. ++......++.||++||.|||+. +|+|+||+|+|||++.+ +.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--
Confidence 999 7899999854 67778888999999999999998 99999999999999998 68999999998654321
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... . +.. .. .+. ..
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~--~~~-~~-~~~------~~ 216 (290)
T cd05580 155 ------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ--I--YEK-IL-EGK------VR 216 (290)
T ss_pred ------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--H--HHH-Hh-cCC------cc
Confidence 234578999999999988889999999999999999999999997654211 1 111 11 110 11
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~ 534 (549)
+. ......+.+++..||..||.+|| +++++++ |+||.......
T Consensus 217 ~~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~-----~~~~~~~~~~~ 264 (290)
T cd05580 217 FP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN-----HPWFAGIDWIA 264 (290)
T ss_pred CC----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc-----CcccccCCHHH
Confidence 11 12245677888999999999999 8888887 88887665443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=298.22 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=194.1
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEE--cCCeEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCH--SKEMYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~lv~ 326 (549)
+|+..+.||.|+||.||++.+ .+++.+|+|+++..... .+.+..|+.+++.++||||+++++++. .+..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477888999999999999976 56889999998754433 345778999999999999999999775 345789999
Q ss_pred ecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCC--CCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 327 NLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTC--DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 327 e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
||+ +++|.+++.. +++...+.++.||+.||.|||..+ +.+++|+||+|+||+++++ +.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEeccccccc
Confidence 999 6799999854 467788899999999999999322 2299999999999999988 6899999999866
Q ss_pred cccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
...... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... .+ ..... .+.
T Consensus 160 ~~~~~~-----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~---~~~~~-~~~-- 226 (265)
T cd08217 160 LGHDSS-----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QL---ASKIK-EGK-- 226 (265)
T ss_pred ccCCcc-----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HH---HHHHh-cCC--
Confidence 543211 122456899999999999888999999999999999999999999765421 11 11111 111
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
....+......+.+++..|+..+|.+||++.+|++
T Consensus 227 -------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 -------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11223344567888999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=303.64 Aligned_cols=260 Identities=23% Similarity=0.393 Sum_probs=198.7
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+|+..+.||.|++|.||+|.. .+|..+|+|+++.... ....+.+|+.+++.++||||+++++++...+.++++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 478889999999999999987 4689999999976532 2356778999999999999999999999999999999999
Q ss_pred CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 ~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
.|+|.+++.. +++.....++.|+++||.|||+. +++|+||||+||+++++ +.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPV-- 154 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCc--
Confidence 9999998853 57788899999999999999999 99999999999999988 689999999986443211
Q ss_pred ccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc--cccccccC
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS--GLCERLID 480 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d 480 (549)
.......+++.|+|||.+.+. .++.++|||||||++|+|++|..||....... .+.......... .....+.+
T Consensus 155 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 ---NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred ---cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhc
Confidence 111234578899999988764 46899999999999999999999997654322 111111110000 00000000
Q ss_pred -----Cccc-------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 481 -----PQLN-------EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 481 -----~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.... ..+.+.....+.+++..|++.||.+||++.++++ |+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~-----~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ-----HPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc-----CCCC
Confidence 0000 0011123456788999999999999999999998 7886
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=316.34 Aligned_cols=270 Identities=23% Similarity=0.308 Sum_probs=201.2
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----Ce
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSK-----EM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~~ 321 (549)
++++|.+.+.||+|+||.||+|.+ .+|+.||+|.++.... ....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 457899999999999999999976 5689999999864322 234578899999999999999999887543 35
Q ss_pred EEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
.++++||+.++|.+++.. +++.....++.|+++||.|||+. +|+||||||+|||++.+ +.++|+|||++.....
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTN-CDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCC-CCEEECcccceeeccc
Confidence 899999999999888864 67788889999999999999999 99999999999999998 6899999999865433
Q ss_pred ccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc--cccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS--GLCE 476 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~ 476 (549)
.... ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....+...+... ....
T Consensus 159 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccc--cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHH
Confidence 2111 112234578999999998764 468999999999999999999999996543211 111111100000 0000
Q ss_pred cccCCc-----------cccc---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 477 RLIDPQ-----------LNEE---YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 477 ~~~d~~-----------l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.+.+.. .... ..+.....+.+++..||..+|.+|||+.++++ |+|++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~-----hp~~~~~~ 299 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA-----HPYLEQYH 299 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc-----CccccccC
Confidence 000000 0000 00112356788999999999999999999999 89987664
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=298.79 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=197.1
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|+..+.||+|+||.||++.. .+++.+|+|.+...... ...+.+|+.+++.++||||+++++.+..++.++++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999976 56889999998754322 34678899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +++|.+++.. +++.....++.+++.||.|||++ +++|+||+|+||+++++.+.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 9 6799999854 56777889999999999999999 99999999999999876456899999998654322
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... . ....... .. ..
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~---~~~~~~~-~~-----~~ 220 (256)
T cd08220 156 ----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--L---VLKIMSG-TF-----AP 220 (256)
T ss_pred ----ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--H---HHHHHhc-CC-----CC
Confidence 11223568899999999998889999999999999999999999997654321 1 1111111 00 01
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+ .......+.+++..||..+|.+|||+.++++ |+|+
T Consensus 221 ~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~-----~p~~ 256 (256)
T cd08220 221 I----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA-----QPIC 256 (256)
T ss_pred C----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh-----CCCC
Confidence 1 1123445778889999999999999999998 6664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=299.50 Aligned_cols=243 Identities=28% Similarity=0.431 Sum_probs=191.3
Q ss_pred ceEcccCceEEEEEEecC--Cc--EEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNHVD--GQ--VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~--g~--~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++||+|+||.||++.+.+ ++ .+|+|.+..... ..+.+.+|+.++++++||||+++++++.. ..+++++||+ +
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 358999999999997632 33 689999976554 23568899999999999999999999988 8899999999 6
Q ss_pred CCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 GSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
|+|.+++.. +++...+.++.|+++||.|||++ +++|+||||+||+++.+ +.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~- 154 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHY- 154 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecC-CEEEeccccccccccccccce-
Confidence 899999854 56778889999999999999999 99999999999999999 689999999987654322111
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.......++..|+|||++.+..++.++|||||||++|||++ |..||......+ .. ....... ...
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~----~~~~~~~--~~~------ 220 (257)
T cd05040 155 -VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-IL----KKIDKEG--ERL------ 220 (257)
T ss_pred -ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HH----HHHHhcC--CcC------
Confidence 11113457889999999998899999999999999999998 999996543322 11 1111110 011
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
..+...+..+.+++..|+..+|.+||++.++++.|.
T Consensus 221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011223456888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=303.80 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=196.9
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
|+..+.||.|++|.||+|.+ .+|..+|+|++..... ....+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778899999999999976 5799999999875432 2356788999999999999999999999999999999999
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+++|.+++.. +++.....++.|+++||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPV--- 153 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCc---
Confidence 9999999854 56788899999999999999998 99999999999999998 689999999985432211
Q ss_pred cCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc-----------
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS----------- 472 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~----------- 472 (549)
.......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||.......+... ........
T Consensus 154 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 --RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR-IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred --cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChHHhhhhhhc
Confidence 111223568899999988764 478999999999999999999999976544222111 11110000
Q ss_pred -cc---cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 473 -GL---CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 473 -~~---~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+. ......+.. ..........+.+++.+|++.||.+|||++++++ |+||
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~-----~~~~ 283 (283)
T cd07835 231 PDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ-----HPYF 283 (283)
T ss_pred hhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc-----CCCC
Confidence 00 000000000 0111122356778999999999999999999998 7886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.91 Aligned_cols=265 Identities=25% Similarity=0.346 Sum_probs=199.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~l 324 (549)
.++|++.+.||+|+||.||+|.. .+|+.||+|.++..... ...+.+|+.++++++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999987 56899999999754322 23466899999999999999999998654 57899
Q ss_pred EEeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
+|||+.++|.+++.. +++.....++.||+.||.|||+. +++||||||+||+++.+ +.++|+|||++......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CCEEECccceeeecCCc
Confidence 999999999888854 67888899999999999999999 99999999999999988 68999999998654432
Q ss_pred cccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc--ccc--
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS--GLC-- 475 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~-- 475 (549)
. .......+++.|+|||.+.+ ..++.++|||||||++|||++|++||...... +.+.......... ...
T Consensus 162 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 162 A-----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred c-----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChhhchh
Confidence 1 11122345788999999875 45789999999999999999999999765432 2221111111000 000
Q ss_pred -------ccc-cCCcccccCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 476 -------ERL-IDPQLNEEYN---REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 476 -------~~~-~d~~l~~~~~---~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
... .......... ......+.+++..|+..||++|||+.++++ |+||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~-----h~~f~~~ 296 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE-----SSYFKEK 296 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc-----ChhhccC
Confidence 000 0000000000 012455678999999999999999999998 8999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=297.31 Aligned_cols=242 Identities=22% Similarity=0.322 Sum_probs=196.0
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|+..++||.|+||.||.+.. .+++.+++|.+..... ...++.+|++++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999976 5688999999875432 235688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +|+|.+++.+ +++.+...++.|++.||.|||+. +++|+||+|+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence 9 6799999954 56778889999999999999999 99999999999999998 6899999999865433221
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
......|++.|+|||.+.+..++.++|+||||+++|||++|..||....... . ...... +.. .
T Consensus 157 -----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~----~~~~~~-~~~----~-- 219 (256)
T cd08221 157 -----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-L----VVKIVQ-GNY----T-- 219 (256)
T ss_pred -----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-H----HHHHHc-CCC----C--
Confidence 2234568999999999988889999999999999999999999997543221 1 111111 110 0
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.........+.+++..|+..+|.+||++.++++
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 111223455778889999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.70 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=199.4
Q ss_pred CCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|+..+.||+|+||.||+|.+. +++.+|+|.++.... ..+.+.+|+++++.++|+||+++++++..++.++++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6888999999999999999874 688999999875432 235688999999999999999999999999999999999
Q ss_pred cCCCHHHHH-HH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYL-KQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l-~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.+++.+.+ .+ +++.....++.||+.||.|||+. +++|+||+|+||+++++ +.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSES-GVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC-CCEEEEeeecccccCCCcc--
Confidence 976655444 32 67788899999999999999999 99999999999999998 6899999999866443221
Q ss_pred cCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc-----------c
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS-----------S 472 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~-----------~ 472 (549)
.......++..|+|||++.+. .++.++||||||+++|+|++|++||...... +.+......... .
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHhhhcccC
Confidence 122345688999999999888 7899999999999999999999999765432 111111110000 0
Q ss_pred cccc--cccCCc----ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 473 GLCE--RLIDPQ----LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 473 ~~~~--~~~d~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.... ...+.. ....++......+.++++.||..+|.+|||++++++ ++||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~-----~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ-----HPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc-----CCCC
Confidence 0000 000000 001122223567889999999999999999999998 7775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=304.52 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=205.5
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
++|...+.||+|+||.||++.. .+++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788999999999999999975 5688999999865432 3356788999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 -~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+++.+ +++..+..++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~----- 169 (293)
T cd06647 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ----- 169 (293)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCC-CCEEEccCcceecccccc-----
Confidence 6799999864 67788889999999999999999 99999999999999988 689999999886543221
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.......|++.|+|||.+.++.++.++|+|||||++|+|++|+.||........ +.. ... .+.....
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~----~~~--------~~~~~~~ 236 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL----IAT--------NGTPELQ 236 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eee----hhc--------CCCCCCC
Confidence 122234688999999999888899999999999999999999999976543211 100 000 0000011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
........+.+++..||..+|.+||++.+++. |+||+.....-
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~-----h~~~~~~~~~~ 279 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ-----HPFLKIAKPLS 279 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc-----CHHHhcCcccc
Confidence 12233456788999999999999999999998 89998776443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=299.47 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=181.1
Q ss_pred eEcccCceEEEEEEecC---CcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCC
Q 008898 259 LIGQGGNSKVYRTNHVD---GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~---g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gs 332 (549)
.||+|+||.||+|...+ ...+|+|.+...... ...+.+|+.+++.++||||+++++.+...+.++++|||+ +|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 48999999999996533 457888877644322 245788999999999999999999999999999999999 679
Q ss_pred HHHHHHHh--------chhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 333 LKQYLKQL--------KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 333 L~~~l~~~--------~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
|.+++... .+.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCC-CcEEEeccccccccccchhee
Confidence 99998542 3456678999999999999999 99999999999999998 689999999985432211111
Q ss_pred cCccccccccCCcccccccccc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMY-------GKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||....... .+. ... .. ...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~---~~~-~~-~~~ 228 (269)
T cd05042 158 ---TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLK---QVV-RE-QDI 228 (269)
T ss_pred ---ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHH---HHh-hc-cCc
Confidence 1123346778999998753 356889999999999999999 778886543321 111 111 11 111
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.+.++..... ....+.+++..|+ .||.+|||+++|+++|.
T Consensus 229 ~~~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2223322222 3344555667788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=311.93 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=193.8
Q ss_pred cCCCCCceEcccCceEEEEEEecC--------CcEEEEEEeecCCc--CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKE 320 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~--------g~~~AvK~l~~~~~--~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 320 (549)
.+|.+.+.||+|+||.||++.... +..+|+|.++.... ...++.+|+.+++++ +||||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468889999999999999996421 23689998875432 235688999999999 7999999999999989
Q ss_pred eEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~ 380 (549)
..++++||+ +|+|.+++.+ +.+.....++.||+.||.|||++ +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 999999999 6799999853 45667788999999999999999 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccch
Q 008898 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANR 459 (549)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~ 459 (549)
.+ +.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 169 ~~-~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 169 ED-NVMKIADFGLARDVHNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred CC-CcEEECCcccceeccccccc---ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 88 68999999998654332111 11122334568999999999999999999999999999998 888886543221
Q ss_pred hhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 460 ESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 460 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
+...+... .. . ..+......+.+++..|+..+|.+||++.++++.|+..
T Consensus 245 -----~~~~~~~~-~~-----~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 245 -----LFKLLKEG-HR-----M----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred -----HHHHHHcC-CC-----C----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11111111 00 0 11122345677889999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=305.73 Aligned_cols=266 Identities=24% Similarity=0.368 Sum_probs=196.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKE------ 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~------ 320 (549)
-++|...+.||+|+||.||++.. .+++.+|+|.+...... ...+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35799999999999999999987 56899999998644322 234678999999999999999999986543
Q ss_pred --eEEEEEeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 321 --MYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 321 --~~~lv~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
.++++|||+.++|.+++.. +++.+...++.||++||.|||++ +++|+||||+||+++.+ +.++|+|||++
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~-~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKD-GILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCC-CcEEECcCCCc
Confidence 4699999999999888853 67888899999999999999999 99999999999999988 68999999998
Q ss_pred cccccccccccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh--c
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL--S 471 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~--~ 471 (549)
.......... ........++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ..+........ .
T Consensus 167 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~~~~~ 244 (310)
T cd07865 167 RAFSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLCGSIT 244 (310)
T ss_pred ccccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence 7554322111 11223446788999999887654 788999999999999999999999765432 11111111000 0
Q ss_pred ccccccc-----cC-CcccccCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 472 SGLCERL-----ID-PQLNEEYNR---------EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 472 ~~~~~~~-----~d-~~l~~~~~~---------~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
....... .+ -........ .....+.+++..||..||.+|||+.++++ |+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~-----h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN-----HDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc-----CCCC
Confidence 0000000 00 000000000 01235678999999999999999999998 8886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=297.96 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=205.4
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|+..+.||+|+||.||++... +++.+++|++..... ....+.+|+.+++.++|+||+++++++...+.+++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999874 599999999876543 346788999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 329 ~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+ +++|.+++.. ++......++.|+++||.|||+ . +++|+||+|+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLD- 155 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCC-CCEEEccCccceecccCCC-
Confidence 9 5899999965 7778889999999999999999 8 99999999999999998 6899999999865433211
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCccc-chhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....+. ...... ..+.
T Consensus 156 ----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~~~------~~~~ 222 (264)
T cd06623 156 ----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAICDG------PPPS 222 (264)
T ss_pred ----cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHHhcC------CCCC
Confidence 11245688999999999988899999999999999999999999977642 111111 111110 1111
Q ss_pred ccccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 483 LNEEYNRE-EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 483 l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.+.. .+..+.+++..|+..+|.+||++.++++ ++|++..
T Consensus 223 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~-----~~~~~~~ 262 (264)
T cd06623 223 ----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ-----HPFIKKA 262 (264)
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHh-----CHHHHhc
Confidence 1222 4567888899999999999999999999 8998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=297.39 Aligned_cols=246 Identities=27% Similarity=0.346 Sum_probs=196.5
Q ss_pred CCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
+|+..+.||+|+||.||+|... ++..+++|.+..... ..+.+.+|+.+++.++|+||+++++++..++.++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999874 789999999865431 224678899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
+||+ +++|.+++.. +++.....++.||+.||.|||+. +|+|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEccCccceeccccc
Confidence 9999 5689999865 56777888999999999999999 99999999999999988 689999999986543221
Q ss_pred ccccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
......|++.|+|||.+.... ++.++|+|||||++|+|++|+.||....... ....+ ......
T Consensus 157 ------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~----~~~~~~----- 220 (258)
T cd06632 157 ------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKI----GRSKEL----- 220 (258)
T ss_pred ------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHH----HhcccC-----
Confidence 123456899999999988776 8999999999999999999999997654211 11111 110110
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+ ..+......+.+++.+||..+|.+||++.++++ |+|+
T Consensus 221 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~-----~~~~ 258 (258)
T cd06632 221 P----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE-----HPFV 258 (258)
T ss_pred C----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc-----CCCC
Confidence 1 112223455677889999999999999999998 6664
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=300.63 Aligned_cols=251 Identities=29% Similarity=0.448 Sum_probs=199.2
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCeEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIK---HENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.|+..+.||+|+||.||+|.+ .+++.+|+|.++... ....++.+|+.+++.++ |||++++++++..+..++++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778899999999999986 578999999987543 23356788999999996 999999999999999999999
Q ss_pred ecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 327 e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
||+ +++|.++++. +++.....++.|+++||.|||+. +|+|+||+|+||+++.+ +.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNS-- 155 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCC-CCEEEccCCceeecCCCc--
Confidence 999 6789998855 56777889999999999999999 99999999999999998 789999999986654322
Q ss_pred ccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......|++.|+|||.+.++ .++.++|+|||||++|+|++|..||........ .... .....+.
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----~~~~------~~~~~~~ 221 (277)
T cd06917 156 ---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MMLI------PKSKPPR 221 (277)
T ss_pred ---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----hhcc------ccCCCCC
Confidence 122345689999999988754 468999999999999999999999975433211 0000 0111111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
+... .....+.+++..||..||.+||++.++++ ++|++...
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~-----~~~~~~~~ 262 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLK-----SKWIKAHS 262 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh-----ChHhhccc
Confidence 1111 13456788889999999999999999998 89995543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.72 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=200.2
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
|.....||+|+||.||++.. .++..+|||.+...... .+.+.+|+.+++.++|+||+++++.+..++.++++|||+ +
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33345699999999999976 56889999998654322 346789999999999999999999999999999999999 5
Q ss_pred CCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 008898 331 GSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (549)
Q Consensus 331 gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (549)
++|.+++.. +++.+...++.||+.||.|||+. +|+||||||+||+++.+ +.++|+|||++...... ...
T Consensus 104 ~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~-----~~~ 174 (292)
T cd06658 104 GALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKE-----VPK 174 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCC-CCEEEccCcchhhcccc-----ccc
Confidence 688888743 67788899999999999999999 99999999999999998 68999999998543221 111
Q ss_pred ccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCC
Q 008898 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYN 488 (549)
Q Consensus 409 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 488 (549)
.....|++.|+|||.+.+..++.++|+|||||++|||++|..||........ +.... ....+.... .
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~----------~~~~~~~~~--~ 241 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MRRIR----------DNLPPRVKD--S 241 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH----------hcCCCcccc--c
Confidence 2345689999999999888899999999999999999999999975433211 11100 011111111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 489 REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 489 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
......+.+++..|+..||.+|||+.++++ |+||+.......
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~-----~~~~~~~~~~~~ 283 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQ-----HPFLKLAGPPSC 283 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh-----ChhhhccCCccc
Confidence 122345777889999999999999999998 899987655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=296.19 Aligned_cols=232 Identities=24% Similarity=0.418 Sum_probs=183.3
Q ss_pred eEcccCceEEEEEEecC-C----------cEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 259 LIGQGGNSKVYRTNHVD-G----------QVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~-g----------~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.||+|+||.||+|.+.+ + ..+++|++.........+.+|+.+++.++||||+++++++.. ...+++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEE
Confidence 58999999999998743 3 257888877655445678899999999999999999999988 77889999
Q ss_pred cc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC-------ceEEeeecccc
Q 008898 328 LL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH-------HPQLSDFGAAM 395 (549)
Q Consensus 328 ~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~~kL~DFGla~ 395 (549)
|+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ + .++|+|||++.
T Consensus 81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~-~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARY-GLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecC-ccccCCceeEEeCCCCccc
Confidence 99 7899999863 56778888999999999999998 99999999999999987 4 59999999986
Q ss_pred ccccccccccCccccccccCCccccccccccC--CCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcc
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSS 472 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 472 (549)
.... .....++..|+|||++.+. .++.++|||||||++|||++ |..||...... +.. .+.. ..
T Consensus 157 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~-~~~~---~~ 222 (259)
T cd05037 157 TVLS---------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKE-RFYQ---DQ 222 (259)
T ss_pred cccc---------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHH-HHHh---cC
Confidence 5332 1133567789999998876 78999999999999999999 57777655321 111 1111 00
Q ss_pred cccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 473 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.....+ ....+.+++..||..+|.+|||+.++++.|+
T Consensus 223 ---~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 ---HRLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---CCCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000000 0156788999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=310.01 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=206.2
Q ss_pred CceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEeccCCC
Q 008898 257 KMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGS 332 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~gs 332 (549)
.++||.|-||.||-|.+ ++|+.||||++.+-.. .+..+..|+.||+.++||.||.+...|++.+..++|||.+.|+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46799999999999987 6899999999976443 3356889999999999999999999999999999999999999
Q ss_pred HHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe--cCCCceEEeeecccccccccccccc
Q 008898 333 LKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS--ENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 333 L~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+.+.+- ++++.....+..||+.||.|||.+ +|+|+||||+|||+. ++|.++||||||+|++...
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE------ 719 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE------ 719 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch------
Confidence 877762 255555567889999999999999 999999999999996 4556899999999988554
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
......++|||.|+|||++...+|+...|+||.|||+|--|+|..||..+.+-.+++. .+. -+.-+....
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ-NAa---------FMyPp~PW~ 789 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ-NAA---------FMYPPNPWS 789 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh-ccc---------cccCCCchh
Confidence 3344578999999999999999999999999999999999999999987654322221 111 111222223
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
+++ ....++|...|+..-++|.|....+. |+|+..++.=-++++
T Consensus 790 eis----~~AidlIn~LLqVkm~kRysvdk~ls-----h~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 790 EIS----PEAIDLINNLLQVKMRKRYSVDKSLS-----HPWLQDYQTWLDLRE 833 (888)
T ss_pred hcC----HHHHHHHHHHHHHHHHHhcchHhhcc-----chhhhcchHHHHHHH
Confidence 333 34566778889999999999999998 899988887666665
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.71 Aligned_cols=272 Identities=22% Similarity=0.325 Sum_probs=202.3
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcC--CeE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSI-KHENIVRIIGYCHSK--EMY 322 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~--~~~ 322 (549)
+.++|...+.||+|+||.||+|.. .+|+.+|+|.+.... .....+.+|+.+++++ +||||++++++|... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456788999999999999999987 468899999885432 2234577899999999 999999999988643 468
Q ss_pred EEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 323 AIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 323 ~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
+++|||+.++|.+++.. +.+.....++.||+.||.|||+. +|+|+||||+||+++.+ +.++|+|||++......
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSD-CRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CcEEEeeccchhccccc
Confidence 99999999999999864 67777888999999999999999 99999999999999999 68999999998765433
Q ss_pred cccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh--c------
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL--S------ 471 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~--~------ 471 (549)
.............||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ......... .
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDIES 239 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHH
Confidence 22111122334578999999998765 4578999999999999999999999975443211 100000000 0
Q ss_pred --ccccccccC----Ccc--cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 472 --SGLCERLID----PQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 472 --~~~~~~~~d----~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
......+++ ... ...........+.+++.+|++.||.+|||+.++++ |+|+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~-----~~~~~~~~ 302 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE-----HPYVAQFH 302 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh-----Chhhhhhc
Confidence 000000000 000 00011113466888999999999999999999998 78887753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.74 Aligned_cols=270 Identities=22% Similarity=0.330 Sum_probs=213.4
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv 325 (549)
.+|....+||+|+||+|.++.. .+.+.||||+++++..- .+-.+.|-.+|... +-|+++++..+|++-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4688999999999999999976 45789999999876432 23356788888766 478999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +|+|.-.+++ +.+..+..+|..|+-||-+||++ |||+||||.+|||++.+ |++||+|||+++ .
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~e-GHiKi~DFGmcK-----E 499 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSE-GHIKIADFGMCK-----E 499 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccC-CceEeeeccccc-----c
Confidence 9999 6788888876 77788889999999999999999 99999999999999999 899999999994 3
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......+.++||||.|+|||++.+.+|+.++|+|||||+|||||.|++||+..+++ +.+.. +++.
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-elF~a-------------I~eh 565 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQA-------------IMEH 565 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH-------------HHHc
Confidence 355666778999999999999999999999999999999999999999999887643 22211 1111
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH-HHHhcCCchhhhhhhHHHHHHhhccCCCCC
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTL-LKLFQEPDYWLKMKREKEELLNERRSNGPA 546 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev-l~~L~~~~~w~~~~~~~~~~~~~~~~~~~~ 546 (549)
. -.|+.......+.+++..+...|.+|....-- -+-++.+..+..-.++..|-.+-.++++|.
T Consensus 566 n--vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk 629 (683)
T KOG0696|consen 566 N--VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPK 629 (683)
T ss_pred c--CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCc
Confidence 1 23444555566777788999999999643211 122223334445566777777777777764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.07 Aligned_cols=267 Identities=20% Similarity=0.312 Sum_probs=200.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------E 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------~ 320 (549)
.++|...+.||+|+||.||+|.. .+|+.+|+|.++.... ....+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999986 5689999999865321 234578999999999999999999988654 3
Q ss_pred eEEEEEeccCCCHHHHHH-HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 321 MYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~-~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
.++++++|+.++|..++. .+++.....++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNED-CELKILDFGLARHADA 169 (342)
T ss_pred eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEeeCCCCcCCCC
Confidence 569999999888888765 578888899999999999999999 99999999999999998 6899999999854321
Q ss_pred ccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHh---------
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL--------- 469 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~--------- 469 (549)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............+...-
T Consensus 170 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 170 --------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred --------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 1224467889999999876 4689999999999999999999999986543221111110000
Q ss_pred hcccccccccC--Cccc-ccC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 470 LSSGLCERLID--PQLN-EEY---NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 470 ~~~~~~~~~~d--~~l~-~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
........... +... ... .+.....+.+++..||..||.+||++.+++. |+||......+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~-----h~~f~~~~~~~ 307 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE-----HPYFDSFRDAD 307 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc-----Ccchhhccccc
Confidence 00000000000 0000 000 0112345778999999999999999999998 89997765433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=298.42 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=183.6
Q ss_pred ceEcccCceEEEEEEec----CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEE-cCCeEEEEEecc-
Q 008898 258 MLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCH-SKEMYAIVYNLL- 329 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~----~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~~~~~lv~e~~- 329 (549)
+.||+|+||.||+|... ++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .++..+++|+|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999753 245799998854322 2356788999999999999999999875 455688999998
Q ss_pred CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 ~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+|+|.+++.. ..+.....++.|++.||.|||+. +++||||||+|||++++ +.+||+|||++......... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~-~ 155 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYY-S 155 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCC-CcEEECCccccccccCCcce-e
Confidence 6899999864 35566778899999999999999 99999999999999998 68999999998643321110 1
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcC-CCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG-KEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
........+++.|+|||.+.+..++.++|||||||++|||++| .+||..... .+ + ........ .+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~-~---~~~~~~~~------~~~~- 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-FD-I---TVYLLQGR------RLLQ- 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-HH-H---HHHHhcCC------CCCC-
Confidence 1111233567789999999888999999999999999999995 555544322 11 1 11111110 0111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+...+..+.+++..||..+|.+||++.+|++.|+.
T Consensus 224 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 224 ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred ---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 11223568889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=300.73 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=195.7
Q ss_pred cCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
++|+....||+|+||.||++... +.+.+++|.+...... ...+.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999753 2468999988654332 356889999999999999999999999989999
Q ss_pred EEEecc-CCCHHHHHHH------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEee
Q 008898 324 IVYNLL-NGSLKQYLKQ------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~D 390 (549)
++|||+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~-~~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQ-REVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCC-CcEEEcc
Confidence 999999 5899999853 56788899999999999999999 99999999999999998 6899999
Q ss_pred eccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHh
Q 008898 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSL 469 (549)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~ 469 (549)
||++....... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 161 ~~~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~--- 231 (275)
T cd05046 161 LSLSKDVYNSE----YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRL--- 231 (275)
T ss_pred cccccccCccc----ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHH---
Confidence 99986433211 112223456778999999988889999999999999999999 78888643321 111111
Q ss_pred hcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 470 LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 470 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
..+... + ......+..+.+++.+||..+|.+||++.++++.|.
T Consensus 232 -~~~~~~-~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 -QAGKLE-L-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -HcCCcC-C-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 001100 0 011223457888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.02 Aligned_cols=259 Identities=20% Similarity=0.208 Sum_probs=185.1
Q ss_pred hcCCCCCceEcccCceEEEEEEecC----CcEEEEEEeecCCcCH--H----------HHHHHHHHHhcCCCCCeeeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWSE--E----------EVLREVELLSSIKHENIVRIIG 314 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~----g~~~AvK~l~~~~~~~--~----------~~~~E~~il~~l~h~nIv~l~~ 314 (549)
.++|.+.++||+|+||.||+|...+ +..+|+|+........ + ....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3579999999999999999998643 4567777654332211 1 1123344566778999999998
Q ss_pred EEEcCC----eEEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceE
Q 008898 315 YCHSKE----MYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (549)
Q Consensus 315 ~~~~~~----~~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~k 387 (549)
++.... ..+++++++..++.+.++. .++.....++.|++.||.|||+. +|+||||||+|||++.+ +.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~-~~~~ 166 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN-NRGY 166 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CcEE
Confidence 765443 3467777777777766654 45667788999999999999999 99999999999999988 6899
Q ss_pred Eeeeccccccccccccc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHH
Q 008898 388 LSDFGAAMVHHQSHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW 465 (549)
Q Consensus 388 L~DFGla~~~~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~ 465 (549)
|+|||+|.......... .........||+.|+|||++.+..++.++|||||||++|||++|..||.............
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999997653221110 1112233579999999999999999999999999999999999999998664322211100
Q ss_pred HHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 466 ARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 466 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
... ....+...... ....+..+.+++..|+..+|++||++.+|++.|+
T Consensus 247 ~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCD-----FIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHH-----HHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 000 01111111111 1122466888999999999999999999999764
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=300.78 Aligned_cols=259 Identities=28% Similarity=0.423 Sum_probs=207.8
Q ss_pred hhcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++.|...+.||+|+||.||++.+. ++..+++|+++........+.+|+++++.++|+|++++++++...+..++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4567888899999999999999874 688999999986654456788999999999999999999999999999999999
Q ss_pred cC-CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 329 LN-GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 329 ~~-gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+. ++|.+++.. +++..+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCC-CCEEECccchhhhhccch--
Confidence 95 799999954 57778889999999999999998 99999999999999988 689999999875443211
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|..||........ ... ..... ... .
T Consensus 171 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~~----~~~~~-~~~-----~ 236 (286)
T cd06614 171 ---SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFL----ITTKG-IPP-----L 236 (286)
T ss_pred ---hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HHH----HHhcC-CCC-----C
Confidence 112234578899999999888899999999999999999999999975543221 111 11100 000 0
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
. ........+.+++..|++.+|.+||++.++++ ++|++.....-.
T Consensus 237 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~-----~~~~~~~~~~~~ 281 (286)
T cd06614 237 K--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ-----HPFLKKACPKEE 281 (286)
T ss_pred c--chhhCCHHHHHHHHHHhccChhhCcCHHHHhh-----ChHhhccCchHh
Confidence 0 11123456888999999999999999999999 899988554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=295.83 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=199.6
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|...+.||+|+||.||++.. .+++.+++|.++..... ...+..|+.+++.++|+||+++++++...+.+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477888999999999999976 46899999999866543 45688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+ +++|.+++.. +++.....++.+++.||.|||+. +|+|+||+|+||+++++ +.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcc
Confidence 9 6789999854 67778888999999999999999 99999999999999998 689999999986654322111
Q ss_pred cCccccccccCCccccccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGK---VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
. .......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.......... . . .. .+ ..+
T Consensus 157 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~-~-~--~~-~~-----~~~ 225 (264)
T cd06626 157 G-EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM-F-H--VG-AG-----HKP 225 (264)
T ss_pred c-ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH-H-H--Hh-cC-----CCC
Confidence 1 1022356889999999998766 8899999999999999999999997543221111 0 0 00 01 111
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.++.. ......+.+++..|++.+|.+|||+.+++. |+|+
T Consensus 226 ~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~-----~~~~ 264 (264)
T cd06626 226 PIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ-----HPFV 264 (264)
T ss_pred CCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc-----CCCC
Confidence 11111 112455678889999999999999999998 7774
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=298.58 Aligned_cols=245 Identities=25% Similarity=0.337 Sum_probs=197.2
Q ss_pred EcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCH
Q 008898 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (549)
Q Consensus 260 lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL 333 (549)
||.|+||.||++.. .+++.+|+|++..... ..+.+.+|+.+++.++||||+++++++.+++.+++++||+ +|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999987 4589999999975432 2356888999999999999999999999999999999998 6899
Q ss_pred HHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 008898 334 KQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (549)
Q Consensus 334 ~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (549)
.+++.+ ++......++.||+.||.|||+. +++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~------~~~ 150 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQ------KTW 150 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCC-CCEEEeeCCcccccCccc------ccc
Confidence 999864 56778888999999999999998 99999999999999998 689999999986543321 122
Q ss_pred ccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHH
Q 008898 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490 (549)
Q Consensus 411 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 490 (549)
...|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....+.... ...... ......++..
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~ 218 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI---YNDILK---------GNGKLEFPNY 218 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH---HHHHhc---------cCCCCCCCcc
Confidence 4468899999999988889999999999999999999999997665322111 111110 0001112222
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhh
Q 008898 491 EIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 491 ~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~ 531 (549)
....+.+++..||..+|.+||+ +.|+++ |+||+...
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~-----~~~~~~~~ 259 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK-----HKWFNGFD 259 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc-----ChhhhCCC
Confidence 2567888999999999999999 899998 89998653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=302.77 Aligned_cols=257 Identities=28% Similarity=0.406 Sum_probs=198.8
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS--EEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|...+.||+|+||.||++.+. +++.+|||.++..... ...+.+|+.++..+. ||||+++++++.++..++++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 57888999999999999999885 4899999999765322 345667887776665 9999999999999999999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+.++|.+++.. +++..+..++.|++.||.|||+ . +|+||||+|+||+++.+ +.++|+|||++.......
T Consensus 95 ~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 95 LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred ccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCC-CCEEECccccchhccCCC-
Confidence 998888887754 6777888999999999999997 5 89999999999999988 689999999985433211
Q ss_pred cccCccccccccCCccccccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGK----VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~----~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.......+.+.. ..... .
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~-~--- 236 (296)
T cd06618 170 -----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK----ILQEE-P--- 236 (296)
T ss_pred -----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH----HhcCC-C---
Confidence 112335788999999987553 789999999999999999999999654332222211 11111 0
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
+.... .......+.+++.+||..||.+||++.++++ |+|+.......+
T Consensus 237 --~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~-----~~~~~~~~~~~~ 284 (296)
T cd06618 237 --PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ-----HPFIRRYETAEV 284 (296)
T ss_pred --CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhc-----ChhhhccchhHH
Confidence 00100 1123456788899999999999999999998 799877555444
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=298.06 Aligned_cols=247 Identities=27% Similarity=0.363 Sum_probs=197.9
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|...+.||+|+||.||++.. .+|..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+..++..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477889999999999999977 468899999987542 2335677999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +++|.+++.. +++.....++.|+++||.|||+. +++|+||||+||+++++...++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 9 6799998854 56788889999999999999999 999999999999999874457999999986543321
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......|++.|+|||++.+..++.++|+|||||++|||++|..||........ ....... . ..+
T Consensus 157 ----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~-~----~~~- 221 (257)
T cd08225 157 ----ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL-----VLKICQG-Y----FAP- 221 (257)
T ss_pred ----ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHhcc-c----CCC-
Confidence 111234689999999999888899999999999999999999999975543221 1111111 1 111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
........+.+++.+|+..+|++|||+.++++ |+||
T Consensus 222 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~-----~~~~ 257 (257)
T cd08225 222 ----ISPNFSRDLRSLISQLFKVSPRDRPSITSILK-----RPFL 257 (257)
T ss_pred ----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh-----CCCC
Confidence 11223346888889999999999999999998 7775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=320.10 Aligned_cols=245 Identities=25% Similarity=0.421 Sum_probs=198.9
Q ss_pred eEcccCceEEEEEEec-CCcEEEEEEeecCC-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCHHH
Q 008898 259 LIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQ 335 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~~ 335 (549)
+||+|.||+||-|+.. +...+|||.+...+ ...+.+.+|+..-++|+|.|||+++|.+.+++.+-|.||-+ +|+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999874 46688999986443 23355889999999999999999999999999999999998 889999
Q ss_pred HHHH----h--chhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccc
Q 008898 336 YLKQ----L--KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409 (549)
Q Consensus 336 ~l~~----~--~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 409 (549)
.|+. + .+..+-.+-.||++||.|||.+ .|+|||||-+|+|++.--|.+||+|||.++.... .+..+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-----inP~T 733 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-----INPCT 733 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-----CCccc
Confidence 9965 3 4456677889999999999999 9999999999999987778999999999865433 33455
Q ss_pred cccccCCccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 410 VNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 410 ~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.++.||..|||||++..| +|+.++|||||||.+.||.||++||......+... ++-|.. -..| ++
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-------FkVGmy--KvHP----~i 800 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-------FKVGMY--KVHP----PI 800 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-------hhhcce--ecCC----CC
Confidence 688999999999999866 48999999999999999999999998766544321 112211 1233 33
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
+.+.......+|.+|+.+||.+||+++++++ ++|+..
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~-----DpFlq~ 837 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ-----DPFLQH 837 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc-----Cccccc
Confidence 4555666667778999999999999999998 555543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.85 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=194.8
Q ss_pred eEccc--CceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CC
Q 008898 259 LIGQG--GNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NG 331 (549)
Q Consensus 259 ~lG~G--~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~g 331 (549)
.||+| +||.||++.+ .+|+.||+|++...... .+.+.+|+.+++.++||||++++++|..++.+++++||+ +|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999987 57999999998755433 245778999999999999999999999999999999999 57
Q ss_pred CHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc-
Q 008898 332 SLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE- 405 (549)
Q Consensus 332 sL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~- 405 (549)
+|.+++.+ +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.++++||+.+...........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCccccc
Confidence 99998865 56677778999999999999999 99999999999999988 6899999986532211110000
Q ss_pred -CccccccccCCccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh------------
Q 008898 406 -NVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL------------ 470 (549)
Q Consensus 406 -~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~------------ 470 (549)
........++..|+|||++.+. .++.++|||||||++|||++|..||..................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0001112356679999998764 4789999999999999999999999765432211111000000
Q ss_pred -------------------cccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 471 -------------------SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 471 -------------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..+......+..+...........+.++++.||..||.+|||+.++++ |+||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~-----~~~~~~~~ 315 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS-----HAFFKQVK 315 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh-----CHHHHHHH
Confidence 000000111111122223345667899999999999999999999999 89998776
Q ss_pred HH
Q 008898 532 EK 533 (549)
Q Consensus 532 ~~ 533 (549)
++
T Consensus 316 ~~ 317 (328)
T cd08226 316 EQ 317 (328)
T ss_pred Hh
Confidence 65
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=306.73 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=199.0
Q ss_pred CCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCC
Q 008898 256 PKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gs 332 (549)
....||+|+||.||++.. .+++.+|+|++..... ..+.+.+|+.+++.++||||+++++++..++.+++++||+ +++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 344699999999999976 5689999999865432 3456789999999999999999999999999999999999 678
Q ss_pred HHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 008898 333 LKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (549)
Q Consensus 333 L~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (549)
|.+++.. +++.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++...... .....
T Consensus 105 L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~-----~~~~~ 175 (297)
T cd06659 105 LTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKD-----VPKRK 175 (297)
T ss_pred HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccC-CcEEEeechhHhhcccc-----ccccc
Confidence 9888754 67888899999999999999999 99999999999999998 68999999998543221 11123
Q ss_pred ccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHH
Q 008898 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490 (549)
Q Consensus 411 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 490 (549)
...|++.|+|||++.+..++.++|||||||++|||++|..||....... .+.. +. ... .+... ....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~----~~-~~~-----~~~~~--~~~~ 242 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AMKR----LR-DSP-----PPKLK--NAHK 242 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH----Hh-ccC-----CCCcc--ccCC
Confidence 4568999999999998889999999999999999999999997544321 1111 10 000 00000 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 491 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
....+.+++..|+..+|.+||++.++++ |+|+....-.+.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~-----~~~~~~~~~~~~ 282 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD-----HPFLLQTGLPEC 282 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh-----ChhhccCCCccc
Confidence 2345778889999999999999999999 788876654333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=294.32 Aligned_cols=244 Identities=27% Similarity=0.426 Sum_probs=193.6
Q ss_pred CCCCceEcccCceEEEEEEecC-----CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 254 FSPKMLIGQGGNSKVYRTNHVD-----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~~-----g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
|.+.+.||.|+||.||++...+ +..+|+|.++.... ....+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566789999999999997743 38899999976654 3467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 327 NLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 327 e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|++ +++|.+++.. +++.....++.|++.||.|||+. +++|+||||+||+++++ +.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccC-CeEEEcccCCceecccc
Confidence 999 6799999853 67888899999999999999999 99999999999999998 68999999998665443
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
...... ...+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||....... +. ........
T Consensus 157 ~~~~~~----~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--~~---~~~~~~~~----- 222 (258)
T smart00219 157 DYYKKK----GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--VL---EYLKKGYR----- 222 (258)
T ss_pred cccccc----cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---HHHhcCCC-----
Confidence 211111 2237789999999988889999999999999999998 788886533211 11 11111110
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 520 (549)
... ....+..+.+++.+|+..||.+|||+.++++.|
T Consensus 223 -~~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -LPK----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCC----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011 112345678889999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.98 Aligned_cols=271 Identities=23% Similarity=0.318 Sum_probs=203.6
Q ss_pred CHHHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEc
Q 008898 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS 318 (549)
Q Consensus 243 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~ 318 (549)
...++-.+.++|...+.||+|+||.||++.. .+|+.||+|+++..... .+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3445566788999999999999999999976 57899999999754322 3457789999999999999999998853
Q ss_pred C------CeEEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEee
Q 008898 319 K------EMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (549)
Q Consensus 319 ~------~~~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~D 390 (549)
. ..+++++++++++|.+++.. +++..+..++.|+++||.|||+. +|+||||||+||+++.+ +.++|+|
T Consensus 88 ~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~-~~~kl~d 163 (345)
T cd07877 88 ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED-CELKILD 163 (345)
T ss_pred cccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCC-CCEEEec
Confidence 3 35788999999999888754 77888899999999999999999 99999999999999998 6899999
Q ss_pred eccccccccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHh
Q 008898 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL 469 (549)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 469 (549)
||++..... ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ +.......
T Consensus 164 fg~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~ 234 (345)
T cd07877 164 FGLARHTDD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLV 234 (345)
T ss_pred ccccccccc--------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence 999854321 1224468899999998876 4688999999999999999999999965433211 11111000
Q ss_pred hc--ccccc---------------cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 470 LS--SGLCE---------------RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 470 ~~--~~~~~---------------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.. ..... ......... ........+.+++..|+..||.+||++.+++. |+||.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~-----h~~f~~~~~ 308 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA-----HAYFAQYHD 308 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc-----ChhhhhcCC
Confidence 00 00000 000000000 00012345788999999999999999999998 899985443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.56 Aligned_cols=233 Identities=21% Similarity=0.343 Sum_probs=179.3
Q ss_pred eEcccCceEEEEEEecC-------------CcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 259 LIGQGGNSKVYRTNHVD-------------GQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~-------------g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.||+|+||.||+|...+ ...+++|++...... ...+.+|+.+++.++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999996422 235888887654322 2457788999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC------ceEEeeecc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH------HPQLSDFGA 393 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~------~~kL~DFGl 393 (549)
+|||+ +|+|..++.. +++.....++.||++||.|||+. +|+||||||+|||++.+.. .++++|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999 5788888753 67788889999999999999999 9999999999999986521 279999998
Q ss_pred ccccccccccccCccccccccCCccccccccc-cCCCCchhhHHHHHHHHHHHH-cCCCCCCCcccchhhHHHHHHHhhc
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELI-TGKEAIQTNKANRESLVLWARSLLS 471 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~ell-tG~~p~~~~~~~~~~l~~~~~~~~~ 471 (549)
+..... .....|+..|+|||.+. +..++.++|||||||++|||+ +|..|+........ . . ...
T Consensus 159 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~-~----~~~ 223 (262)
T cd05077 159 PITVLS---------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-E-R----FYE 223 (262)
T ss_pred CccccC---------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-H-H----HHh
Confidence 854321 12345788999999887 466899999999999999998 58888765432111 0 0 000
Q ss_pred ccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 008898 472 SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520 (549)
Q Consensus 472 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 520 (549)
+.. . ... .....+.+++..||+.||.+||++.+|++.|
T Consensus 224 -~~~-~-----~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 -GQC-M-----LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -cCc-c-----CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0 011 1134578899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=300.01 Aligned_cols=249 Identities=25% Similarity=0.426 Sum_probs=193.5
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCc----EEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ----VAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~----~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.+|+..+.||+|+||.||+|... +|. .+|+|.++.... ....+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46888899999999999999763 343 689998875543 23567889999999999999999999987 67888
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+|+||||+||+++.+ +.++|+|||++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~-~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCC-CeEEECCCcccccccC
Confidence 99998 7899999864 67888899999999999999998 99999999999999988 6899999999876542
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.... .......++..|+|||.+....++.++|+|||||++|||++ |+.||....... + ........ ..
T Consensus 162 ~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~---~~~~~~~~---~~ 230 (279)
T cd05057 162 DEKE---YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--I---PDLLEKGE---RL 230 (279)
T ss_pred cccc---eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--H---HHHHhCCC---CC
Confidence 2111 11112224568999999988899999999999999999998 999997654321 1 11111111 01
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
.. +..+...+.+++..||..||..||++.++++.|+..
T Consensus 231 ~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 PQ-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CC-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11 111223577888999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=299.15 Aligned_cols=260 Identities=24% Similarity=0.333 Sum_probs=197.5
Q ss_pred CCCCceEcccCceEEEEEEec-CCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeEEEEEe
Q 008898 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAIVYN 327 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~lv~e 327 (549)
|.+.+.||.|+||.||++... +|+.+|+|.+.... .....+.+|+.+++.++|||++++++++... +..+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567788999999999999874 58999999998653 2235678899999999999999999999887 89999999
Q ss_pred ccCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.++|.+++. .+++...+.++.||++||.|||+. +++|+||+|+||+++++ +.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINND-GVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCC-CCEEEccccceeeccCCCc-
Confidence 99989998884 367788899999999999999999 99999999999999998 6899999999865543221
Q ss_pred ccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc--cccccccC
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS--GLCERLID 480 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d 480 (549)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+.......... .....+.+
T Consensus 156 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 156 ---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred ---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhcccccc
Confidence 11223457889999998765 357899999999999999999999997655321 111111110000 00000000
Q ss_pred --------------CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 481 --------------PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 481 --------------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
..+...+...+...+.+++..|+..+|.+||+++++++ ++||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~-----~~~~ 287 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ-----HEYF 287 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh-----CcCC
Confidence 00001111112567888999999999999999999998 7775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=315.03 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=204.3
Q ss_pred CCCCCceEcccCceEEEEEEecC-CcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~~-g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+......||-|-||.||.|.++. .-.+|||.++.+....++|+.|..+|+.++|||+|+|+|+|..+..+||+.||| .
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 34455689999999999998744 668999999988888899999999999999999999999999999999999999 8
Q ss_pred CCHHHHHHHh-----chhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 GSLKQYLKQL-----KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 gsL~~~l~~~-----~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
|+|.+||+.. ..--.+.++.||+.|++||..+ ++|||||...|+|+.++ ..+|++|||+++.+....+...
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhcccccc-ceEEeeccchhhhhcCCceecc
Confidence 9999999763 3344678999999999999999 99999999999999999 5899999999988765433222
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.. ..-.+.|.|||.+.++.++.|+|||+|||+|||+.| |..|+..-+..+ + . .++...+.
T Consensus 424 AG----AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq--V---Y----------~LLEkgyR 484 (1157)
T KOG4278|consen 424 AG----AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V---Y----------GLLEKGYR 484 (1157)
T ss_pred cC----ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH--H---H----------HHHhcccc
Confidence 11 122567999999999999999999999999999988 777876554322 1 1 12222333
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
-..+..|+..+++|++.||+.+|.+||++.|+-+.|+.
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 33456677889999999999999999999999987754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=290.61 Aligned_cols=256 Identities=26% Similarity=0.328 Sum_probs=199.2
Q ss_pred hhcCCCCC-ceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEE----cCCeE
Q 008898 250 LTHNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH----SKEMY 322 (549)
Q Consensus 250 ~~~~f~~~-~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~----~~~~~ 322 (549)
++++|.+. ++||-|-.|+|.-+.+ .+|+++|+|++..+ ....+|++.--.. .|||||.++++|+ ....+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 46677654 4799999999999976 67999999998744 4567888865444 5999999999874 35689
Q ss_pred EEEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeeccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAA 394 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla 394 (549)
.+|||++ +|.|+..++. +++.+...|+.||+.|+.|||+. +|.||||||+|+|.+.. ...+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence 9999999 7889999864 77888889999999999999999 99999999999999643 146899999999
Q ss_pred cccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
+... ......+.+-||.|.|||++...+|+...|+||+||++|-||+|.+||.+.....-+- -.+..+..+.
T Consensus 212 K~t~------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp--gMk~rI~~gq 283 (400)
T KOG0604|consen 212 KETQ------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKRRIRTGQ 283 (400)
T ss_pred cccC------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh--hHHhHhhccC
Confidence 6532 2344557789999999999999999999999999999999999999999876421110 0111111111
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
. .+.++ -=....+...++|+.+|+.+|.+|.|+.+++. |+|+.+..
T Consensus 284 y-~FP~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~-----hpwi~~~~ 329 (400)
T KOG0604|consen 284 Y-EFPEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD-----HPWINQYE 329 (400)
T ss_pred c-cCCCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc-----Cchhcccc
Confidence 0 00111 01234567788999999999999999999998 89976543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.21 Aligned_cols=273 Identities=22% Similarity=0.291 Sum_probs=204.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEE----cCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCH----SKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~----~~~~~ 322 (549)
.++|+..+.||+|+||.||++.. .+|+.||+|++.... .....+.+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46899999999999999999976 569999999987542 22356778999999999999999998875 33578
Q ss_pred EEEEeccCCCHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 323 AIVYNLLNGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 323 ~lv~e~~~gsL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+++|||+.|+|.+++. .+++.....++.||+.||.|||+. +|+||||||+||+++.+ +.++|+|||++.....
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNED-CELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CcEEecccccceeecc
Confidence 9999999999999884 367888899999999999999999 99999999999999998 6899999999865433
Q ss_pred ccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc-------
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS------- 471 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~------- 471 (549)
.... .........|+..|+|||.+.. ..++.++|||||||++|||++|+.||....... .+..+......
T Consensus 160 ~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 160 SPTE-HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cCcC-CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhhh
Confidence 2111 1112234578999999998865 458999999999999999999999997654321 11111110000
Q ss_pred ---ccccccccC---Cccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 472 ---SGLCERLID---PQLN---EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 472 ---~~~~~~~~d---~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
........+ .... ..........+.++++.||+.+|.+||++.+++. |+|+......+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~-----~~~~~~~~~~~ 304 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ-----HPFLAQYHDPD 304 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh-----ChhhhhccCCc
Confidence 000000000 0000 0111223567889999999999999999999999 89997655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.58 Aligned_cols=246 Identities=25% Similarity=0.395 Sum_probs=200.0
Q ss_pred CCCCceEcccCceEEEEEEecC---Cc--EEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 254 FSPKMLIGQGGNSKVYRTNHVD---GQ--VAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~~---g~--~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
....++||+|-||.||+|.+.+ |. .||||..+.+. .+.+.|+.|..+|+.+.||||++|+|+|.+. ..+|||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 4455689999999999996532 33 68899998644 3457799999999999999999999999874 577889
Q ss_pred ecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 327 e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|++ -|.|.+||++ ++......+++||+.||.|||+. .++||||...|||+.+. ..+||+|||++++.....
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSP-QCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCc-ceeeecccchhhhccccc
Confidence 988 7999999976 55566677899999999999999 99999999999999988 589999999999877654
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
+.... ...-...|||||.+....++.++|||-|||.+||++. |..||+.-...+.. . -+.
T Consensus 546 yYkaS----~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------------~-~iE 606 (974)
T KOG4257|consen 546 YYKAS----RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------------G-HIE 606 (974)
T ss_pred hhhcc----ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------------E-Eec
Confidence 43332 2233568999999999999999999999999999876 99999876654321 1 111
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
..-.-+.++.++..+..++.+||+++|.+||++.+|...|.+.
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 1222344667788899999999999999999999998877553
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.42 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=191.5
Q ss_pred eEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHh---cCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLS---SIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~---~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
+||+|+||.||++.. .+++.+|+|.+...... ...+.+|..+++ ..+||||+.+++++..++.++++|||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 56899999998654321 122344544433 447999999999999999999999999
Q ss_pred CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 ~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++++ +.++|+|||++......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~------ 150 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK------ 150 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCC-CCEEEccCCcceecccc------
Confidence 6789988854 68888899999999999999999 99999999999999988 68999999998543221
Q ss_pred ccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
......||+.|+|||.+.. ..++.++|||||||++|+|++|..||......... ...... ......+
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~-------~~~~~~~-- 218 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMT-------LTVNVEL-- 218 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHh-------hcCCcCC--
Confidence 1123468999999998874 55899999999999999999999999755432111 111100 0011122
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
+......+.+++..||..||.+|| +++++++ |+||+..+....-+.
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~-----h~~~~~~~~~~~~~~ 269 (279)
T cd05633 219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE-----HVFFKGIDWQQVYLQ 269 (279)
T ss_pred --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh-----CccccCCCHhHHhcC
Confidence 223345677888999999999999 6999998 899988765554433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=300.38 Aligned_cols=261 Identities=22% Similarity=0.293 Sum_probs=197.6
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...+.||+|+||.||++.+ .+++.+|+|.++.... ....+.+|+++++.++||||+++++.+..++.++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688899999999999999987 4588999999875432 1245778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.++++. +++.....++.|++.||.|||+. +++||||||+||+++.+ +.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCC-CCEEEeeCCCccccCcCcc
Confidence 999 6799999865 56777888999999999999999 99999999999999988 6899999998853211100
Q ss_pred c----------ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc
Q 008898 403 V----------SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS 472 (549)
Q Consensus 403 ~----------~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 472 (549)
. ..........|+..|+|||.+.+..++.++|+|||||++|||++|..||....... .+ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~----~~~~~~ 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LF----GQVISD 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH----HHHHhc
Confidence 0 00011123467889999999998889999999999999999999999997543221 11 111100
Q ss_pred cccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 473 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
....+.... ..+..+.+++.+||+.||++||+..+++++|+ |+|+....
T Consensus 232 ----~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~--~~~~~~~~ 280 (305)
T cd05609 232 ----DIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ--HRFFLGLD 280 (305)
T ss_pred ----ccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHh--CccccCCC
Confidence 011111111 23445788899999999999999544444443 57764433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=303.76 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=190.5
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCc----EEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQ----VAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~----~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|+..+.||+|+||.||++.. .+|. .+|+|.+...... ..++.+|+.+++.++||||++++++|.... .++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT-IQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC-cee
Confidence 5688889999999999999976 3454 5788888754322 235788999999999999999999997654 567
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+++|+ +|+|.+++.. +++.....++.|++.||.|||+. +|+|+||||+||+++.+ +.+||+|||++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSP-NHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCC-CceEEccccccccccC
Confidence 78887 6899999854 56778889999999999999999 99999999999999988 6899999999976543
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
... ........++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....+.. .+. ..
T Consensus 162 ~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~----~~~--~~ 230 (303)
T cd05110 162 DEK---EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLE----KGE--RL 230 (303)
T ss_pred ccc---ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH----CCC--CC
Confidence 211 111123345778999999998999999999999999999997 89998654321 1111111 110 00
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. . ...+...+.+++..||..+|++||++.++++.|..
T Consensus 231 ~---~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 231 P---Q----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred C---C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 0 11123457788899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.89 Aligned_cols=265 Identities=24% Similarity=0.319 Sum_probs=200.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----Ce
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSK-----EM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~~ 321 (549)
.++|...+.||+|+||.||++.+ .+++.+|||.++... .....+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999976 568999999987532 2234677899999999999999999987643 35
Q ss_pred EEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
.++++||++++|.+++.. ++......++.|++.||.|||++ +++|+||||+||+++.+ +.++|+|||++....
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNAN-CDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC-CCEEECcCccccccC
Confidence 899999999999998854 67788899999999999999999 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc------
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS------ 471 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~------ 471 (549)
... .......|+..|+|||.+.. ..++.++|||||||++|+|++|++||....... ...........
T Consensus 160 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 160 EKG-----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDL 233 (337)
T ss_pred CCc-----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHh
Confidence 221 11224467889999998875 468999999999999999999999997643211 11111110000
Q ss_pred ----ccccc-------cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 472 ----SGLCE-------RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 472 ----~~~~~-------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..... ...++... .........+.+++++||+.+|.+|||++++++ |+|+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~-----h~~~~~~~ 298 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALA-----HPYLASLH 298 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHc-----Ccchhhhc
Confidence 00000 00000000 011123456789999999999999999999999 89997643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=318.11 Aligned_cols=247 Identities=29% Similarity=0.455 Sum_probs=192.7
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecC-----CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--eEEEEEecc
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT-----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKE--MYAIVYNLL 329 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~-----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--~~~lv~e~~ 329 (549)
.+||+|+|-+||+|.+ .+|..||--.++.+ ....+.+..|+.+|+.|+||||+++|.+|.+.. .+-++.|++
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 3599999999999976 56888875444322 222367889999999999999999999997554 588889999
Q ss_pred -CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 -NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 -~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
.|+|..|+++ ........++.||++||.|||++ +.+|||||||-+||||+.+.|.+||+|.|+|.....++
T Consensus 126 TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---- 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---- 200 (632)
T ss_pred cCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc----
Confidence 8999999976 45556678999999999999997 66999999999999999999999999999998755432
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
...++|||.|||||+.. ..|++.+||||||+.|+||+|+..||..=. +...++.-+..-.....+..+-|
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-n~AQIYKKV~SGiKP~sl~kV~d----- 270 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-NPAQIYKKVTSGIKPAALSKVKD----- 270 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-CHHHHHHHHHcCCCHHHhhccCC-----
Confidence 23478999999999776 889999999999999999999999986322 22222211111111111222222
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
..+.++|.+||.. ..+|||+.|+|+ |+||.....
T Consensus 271 -------Pevr~fIekCl~~-~~~R~sa~eLL~-----d~Ff~~d~g 304 (632)
T KOG0584|consen 271 -------PEVREFIEKCLAT-KSERLSAKELLK-----DPFFDEDGG 304 (632)
T ss_pred -------HHHHHHHHHHhcC-chhccCHHHHhh-----Chhhccccc
Confidence 3477888999999 999999999998 777766533
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.50 Aligned_cols=239 Identities=30% Similarity=0.426 Sum_probs=191.4
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.|...+.||+|+||.||++.. .++..+|+|.+...... ...+.+|+.+++.++|||++++++++.+++..+++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366778899999999999986 56899999998754321 2457889999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.|+|.+++.. +++.++..++.|++.||.|||+. +|+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEP-GQVKLADFGSASIASP---- 177 (317)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCC-CCEEEecCCCccccCC----
Confidence 999998887743 67788889999999999999999 99999999999999988 6899999998754321
Q ss_pred ccCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 404 SENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.....|++.|+|||++. .+.++.++|||||||++|||++|..||....... ....+.. ...
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~----~~~------ 241 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ----NES------ 241 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHh----ccC------
Confidence 12346889999999874 4568899999999999999999999986543211 1111111 100
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
+ ..........+.+++.+||+.+|.+||++.++++
T Consensus 242 ~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 242 P---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred C---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 0 1111233456888999999999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=290.50 Aligned_cols=250 Identities=28% Similarity=0.372 Sum_probs=203.0
Q ss_pred CCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~lv~ 326 (549)
+|...+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.++++++||||+++++.+... +.+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777889999999999999874 689999999976552 345688999999999999999999999888 8999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|++ +++|.+++.. +++..+..++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCC-CCEEEcccccEEecccccc
Confidence 999 7899999864 57888899999999999999998 99999999999999998 6899999999866544321
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
. .......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ... ....
T Consensus 157 ~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~---------~~~~ 220 (260)
T cd06606 157 G---EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL----YKI---------GSSG 220 (260)
T ss_pred c---ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH----Hhc---------cccC
Confidence 1 11234568899999999998889999999999999999999999997665211111 111 1111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
....++......+.+++.+|+..+|.+||++.++++ |+|+
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~-----~~~~ 260 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ-----HPFL 260 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh-----CCCC
Confidence 112223333567888999999999999999999999 7885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.48 Aligned_cols=271 Identities=21% Similarity=0.294 Sum_probs=201.2
Q ss_pred hcCCCC-CceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---------------HHHHHHHHHHhcCCCCCeeeEE
Q 008898 251 THNFSP-KMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---------------EEVLREVELLSSIKHENIVRII 313 (549)
Q Consensus 251 ~~~f~~-~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---------------~~~~~E~~il~~l~h~nIv~l~ 313 (549)
.++|.. .+.||.|+||.||++.. .+++.+|+|.++...... ..+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456664 57799999999999976 468999999987543221 2467899999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEee
Q 008898 314 GYCHSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (549)
Q Consensus 314 ~~~~~~~~~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~D 390 (549)
+++..++.++++|||+.|+|.+++.. ++......++.|++.||.|||+. +|+|+||+|+||+++.+ +.++|+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~-~~~kl~d 162 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSK-GICKIAD 162 (335)
T ss_pred EEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCC-CCEEECC
Confidence 99999999999999999999999854 67788889999999999999999 99999999999999988 6899999
Q ss_pred ecccccccccccc---------ccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchh
Q 008898 391 FGAAMVHHQSHQV---------SENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (549)
Q Consensus 391 FGla~~~~~~~~~---------~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~ 460 (549)
||++......... ..........+++.|+|||.+.+.. ++.++|+|||||++|||++|.+||.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 9998654421100 0111112345788999999987654 6899999999999999999999997665322
Q ss_pred hHHHHHHHhhcccc---cccc-------cCCccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 461 SLVLWARSLLSSGL---CERL-------IDPQLN---EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 461 ~l~~~~~~~~~~~~---~~~~-------~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.+............ .... ...... ..........+.+++..||..+|.+|||+.+++. |+||
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~-----~~~~ 316 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK-----HEYF 316 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc-----Cccc
Confidence 11111111110000 0000 000000 0001122456788999999999999999999998 8999
Q ss_pred hhhh
Q 008898 528 KMKR 531 (549)
Q Consensus 528 ~~~~ 531 (549)
....
T Consensus 317 ~~~~ 320 (335)
T PTZ00024 317 KSDP 320 (335)
T ss_pred CCCC
Confidence 7543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.23 Aligned_cols=245 Identities=24% Similarity=0.398 Sum_probs=191.9
Q ss_pred CCCCCceEcccCceEEEEEEecC--CcEEEEEEeecCC-----------cCHHHHHHHHHHHhc-CCCCCeeeEEEEEEc
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHVD--GQVAAVKVLKCTN-----------WSEEEVLREVELLSS-IKHENIVRIIGYCHS 318 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~~--g~~~AvK~l~~~~-----------~~~~~~~~E~~il~~-l~h~nIv~l~~~~~~ 318 (549)
+|+..+.||+|+||.||++.... ++.+|+|.+.... ....++..|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778889999999999998744 7899999886322 112346778888864 799999999999999
Q ss_pred CCeEEEEEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCCceEEe
Q 008898 319 KEMYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLS 389 (549)
Q Consensus 319 ~~~~~lv~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~~kL~ 389 (549)
++..+++|||+ +++|.+++.. +++...+.++.|++.||.|||+ . +++|+||+|+||+++.+ +.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~-~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED-DKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC-CcEEEe
Confidence 99999999999 6689888743 5667788999999999999996 5 89999999999999998 689999
Q ss_pred eeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHh
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL 469 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 469 (549)
|||++....... ......|+..|+|||.+.++.++.++|+||||+++|+|++|+.||....... .....
T Consensus 157 dfg~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-----~~~~~ 225 (269)
T cd08528 157 DFGLAKQKQPES------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-----LATKI 225 (269)
T ss_pred cccceeeccccc------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-----HHHHH
Confidence 999986543321 2234568999999999998889999999999999999999999996543221 11111
Q ss_pred hcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 470 LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 470 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
... ...+.... .....+.+++.+||..||.+||++.++...|.
T Consensus 226 ~~~-----~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEA-----VYEPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhc-----cCCcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111 11111111 22356788889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=298.37 Aligned_cols=247 Identities=26% Similarity=0.308 Sum_probs=198.8
Q ss_pred CCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+|...+.||.|+||.||++... ++..+|+|++.... ...+.+.+|++++++++||||+++++++.+++.+++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999874 68999999997543 223568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+ +++|.+++.. ++......++.||++||.|||++ +++|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCC-CCEEEeecccccccCCCc--
Confidence 99 6789999853 66778889999999999999999 99999999999999998 689999999986543221
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...+... ... .
T Consensus 155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~-~~~------~---- 217 (258)
T cd05578 155 ----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAK-QET------A---- 217 (258)
T ss_pred ----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHHH-hcc------c----
Confidence 2234568889999999998889999999999999999999999998665321 1111111 110 0
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHhcCCchhh
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTM--KTLLKLFQEPDYWL 527 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~--~evl~~L~~~~~w~ 527 (549)
....+...+..+.+++.+||..||.+||++ +++++ |+||
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~-----~~~~ 258 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN-----HPYF 258 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc-----CCCC
Confidence 011222334677888999999999999999 88776 6775
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=295.24 Aligned_cols=258 Identities=23% Similarity=0.371 Sum_probs=195.9
Q ss_pred CCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcC---HHHHHHHHHHHhcC---CCCCeeeEEEEEEcCCe-----
Q 008898 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS---EEEVLREVELLSSI---KHENIVRIIGYCHSKEM----- 321 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~----- 321 (549)
|++.+.||+|+||.||++.+. +++.+|+|+++..... ...+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567788999999999999875 5899999999754322 23466788777665 69999999999987776
Q ss_pred EEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
++++||+++++|.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~-~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSD-GQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccC-CCEEEeccCccee
Confidence 999999999899988854 67788899999999999999999 99999999999999999 7999999999865
Q ss_pred cccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
.... .......+++.|+|||.+.+..++.++|+|||||++|||++|.+||..... .+.+..+...........
T Consensus 157 ~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 157 YSFE------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred ccCC------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHh
Confidence 4322 111233578899999999998999999999999999999999999876543 222222222111111000
Q ss_pred cc---------cCCccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 477 RL---------IDPQLN---EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 477 ~~---------~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.. ...... ..........+.+++..||..||.+||++.++++ |+||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~-----~~~~ 287 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ-----HPYF 287 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc-----CcCC
Confidence 00 000000 1111233466788999999999999999999998 7885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.66 Aligned_cols=268 Identities=23% Similarity=0.315 Sum_probs=202.4
Q ss_pred HhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCeE
Q 008898 248 CHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHS-KEMY 322 (549)
Q Consensus 248 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~ 322 (549)
..++++|+..+.||.|+||.||++.. .+++.+|+|++.... .....+.+|+++++.++||||+++++++.. .+.+
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34678999999999999999999976 579999999886432 223567889999999999999999998865 5678
Q ss_pred EEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 323 AIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 323 ~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
++++||++++|.++++. ++......++.|+++||.|||+. +|+|+||+|+||+++++ +.++|+|||++.....
T Consensus 86 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 86 YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINEN-CDLKICDFGLARIQDP- 160 (328)
T ss_pred EEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCC-CCEEeCccccccccCC-
Confidence 89999999999998864 56666778999999999999999 99999999999999988 6899999999854221
Q ss_pred cccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHH-----------
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARS----------- 468 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~----------- 468 (549)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .+..+...
T Consensus 161 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 161 -------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVINT 232 (328)
T ss_pred -------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHh
Confidence 1123467889999998766 568999999999999999999999997654311 11111111
Q ss_pred hhcccccccccCCcccccCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 469 LLSSGLCERLIDPQLNEEYN-----REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 469 ~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
.........+..-......+ ......+.++++.|+..+|++|||+.+++. |+|+...+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~-----~~~~~~~~~~ 297 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA-----HPYLAPYHDP 297 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc-----CCccccccCC
Confidence 00010000000000001111 123467888999999999999999999998 8898655543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=298.21 Aligned_cols=234 Identities=21% Similarity=0.373 Sum_probs=180.5
Q ss_pred eEcccCceEEEEEEecC-C-------cEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 259 LIGQGGNSKVYRTNHVD-G-------QVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~-g-------~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.||+|+||.||+|.... + ..+|+|.+...... .+.+.+|+.+++.++||||+++++++..++..+++|||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999996532 2 34888887644322 356788999999999999999999999988999999999
Q ss_pred -CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC-------ceEEeeecccccc
Q 008898 330 -NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH-------HPQLSDFGAAMVH 397 (549)
Q Consensus 330 -~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~~kL~DFGla~~~ 397 (549)
+|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+||+++.+.. .++++|||++...
T Consensus 82 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 82 KFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred CCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 6789999854 67778888999999999999999 9999999999999987632 2699999987543
Q ss_pred ccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCC-CCCCCcccchhhHHHHHHHhhccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGK-EAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
.. .....+++.|+|||.+.+. .++.++|||||||++|||++|. .|+....... .. ... ..
T Consensus 159 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~-~~~----~~--- 220 (258)
T cd05078 159 LP---------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KL-QFY----ED--- 220 (258)
T ss_pred CC---------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HH-HHH----Hc---
Confidence 21 1234688899999999864 5799999999999999999995 5554433211 11 000 00
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
...++. .....+.+++..||+.||.+|||++++++.|+
T Consensus 221 ----~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ----RHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----cccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011111 12245788999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.91 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=192.7
Q ss_pred cCCCCCceEcccCceEEEEEEecC----CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~----g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|...+.||+|+||.||+|.+.+ ...+|+|....... ..+.+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEE
Confidence 458888999999999999997633 24789998865432 235688999999999999999999998764 46789
Q ss_pred Eecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|||+ +|+|.+++.. +++..+..++.+++.||.|||+. +++|+||||+||+++.+ +.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecC-CCeEEccCceeeecccc
Confidence 9998 6899999964 67888889999999999999998 99999999999999998 68999999998654432
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
... ......+++.|+|||.+....++.++|||||||++|||++ |..||....... .+ .. +.... .
T Consensus 161 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~-~~---~~~~~---~-- 226 (270)
T cd05056 161 SYY----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-VI-GR---IENGE---R-- 226 (270)
T ss_pred cce----ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-HH-HH---HHcCC---c--
Confidence 111 1112234568999999988889999999999999999986 999997654321 11 11 11110 0
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.. .+...+..+.+++.+|+..+|.+|||+.++++.|++
T Consensus 227 -~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 227 -LP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred -CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01 112334568888999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=293.05 Aligned_cols=245 Identities=23% Similarity=0.343 Sum_probs=181.3
Q ss_pred eEcccCceEEEEEEecCC---cEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCC
Q 008898 259 LIGQGGNSKVYRTNHVDG---QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~g---~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gs 332 (549)
.||+|+||.||++...++ ..+++|.++.... ..+.+.+|+.+++.++||||+++++.|.+....+++|||+ +|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975443 3456676654332 2357889999999999999999999999999999999999 679
Q ss_pred HHHHHHHh-------chhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 333 LKQYLKQL-------KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 333 L~~~l~~~-------~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
|.+++.+. .......++.||+.||.|||+. +++||||||+|||++.+ +.++|+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~-- 155 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYI-- 155 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCC-ccEEecccccccccCcchhh--
Confidence 99998642 3345567899999999999998 99999999999999988 68999999997543221111
Q ss_pred CccccccccCCcccccccccc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMY-------GKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.......|+..|+|||++.. ..++.++|||||||++|||++ |..||..... .+.+.. ... +....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~----~~~-~~~~~ 228 (268)
T cd05086 156 -ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNH----VIK-DQQVK 228 (268)
T ss_pred -hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH----HHh-hcccc
Confidence 11124568899999998753 245789999999999999997 4667754432 111111 111 11223
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
+.++.+...++ ..+.+++..|+ .+|.+||++++|++.|.
T Consensus 229 ~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 34444443333 34566778899 67999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=309.09 Aligned_cols=267 Identities=21% Similarity=0.323 Sum_probs=201.5
Q ss_pred hhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKE---- 320 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~---- 320 (549)
.+.++|...+.||+|+||.||++.. .+|..||||++...... ...+.+|+.+++.++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 4567899999999999999999976 57999999998643222 245778999999999999999999886543
Q ss_pred --eEEEEEeccCCCHHHHHH--HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 321 --MYAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 321 --~~~lv~e~~~gsL~~~l~--~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
.++++|++++++|.+++. .+++.....++.||++||.|||+. +|+||||||+||+++.+ +.++|+|||++..
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~-~~~kl~dfg~~~~ 167 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNED-CELKILDFGLARQ 167 (343)
T ss_pred cceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEeecccccc
Confidence 468999999889998885 477888899999999999999999 99999999999999988 6899999999864
Q ss_pred cccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHH----------H
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL----------W 465 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~----------~ 465 (549)
... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||............ +
T Consensus 168 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 168 TDS--------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccc--------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 322 1223467899999999876 45889999999999999999999999765432111110 0
Q ss_pred HHHhhccc---ccccc---cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 466 ARSLLSSG---LCERL---IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 466 ~~~~~~~~---~~~~~---~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
...+.... ....+ ....+ ..........+.+++..|+..||.+|||+.++++ |+||+.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~-----~~~~~~~~~~ 307 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA-----HPYFEEFHDP 307 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc-----CccHhhhcCc
Confidence 00000000 00000 00000 0001122345778999999999999999999998 8999876544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.57 Aligned_cols=234 Identities=22% Similarity=0.352 Sum_probs=179.9
Q ss_pred eEcccCceEEEEEEecC-------------------------CcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeE
Q 008898 259 LIGQGGNSKVYRTNHVD-------------------------GQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRI 312 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~-------------------------g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l 312 (549)
.||+|+||.||+|.... ...+++|++...... ...+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999986411 135888988654322 2457789999999999999999
Q ss_pred EEEEEcCCeEEEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC----
Q 008898 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF---- 383 (549)
Q Consensus 313 ~~~~~~~~~~~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---- 383 (549)
+++|.+++..++||||+ +|+|..++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+.
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 99999999999999999 6789888854 67788899999999999999998 999999999999997541
Q ss_pred --CceEEeeeccccccccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHH-cCCCCCCCcccch
Q 008898 384 --HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELI-TGKEAIQTNKANR 459 (549)
Q Consensus 384 --~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~ell-tG~~p~~~~~~~~ 459 (549)
..++++|||++..... .....+++.|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus 159 ~~~~~kl~d~g~~~~~~~---------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS---------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccceeeecCCcccccccc---------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 2379999998743211 112357788999998875 56899999999999999994 7999987654322
Q ss_pred hhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 460 ESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 460 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
. ..+.. . ........ ...+.+++..||..+|.+|||+.+|++.|.
T Consensus 230 ~--~~~~~----~-------~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 K--ERFYE----K-------KHRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H--HHHHH----h-------ccCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 11110 0 00111111 234778899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=292.42 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=192.6
Q ss_pred HHhhhcCCCCCceE--cccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeE
Q 008898 247 LCHLTHNFSPKMLI--GQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 247 l~~~~~~f~~~~~l--G~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 322 (549)
.....++|.+.+.+ |+|+||.||++.. .+++.+|+|.+........ |+.+...+ +||||+++++.+..++.+
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 33445667777666 9999999999976 5688999999875432221 22222222 799999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+++|||+ +|+|.+++.. +++.....++.||++||.|||+. +++||||||+||+++.+.+.++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 9999999 6899999855 68888999999999999999999 999999999999999984389999999986533
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.. ....|++.|+|||++.+..++.++|||||||++|||++|+.||............+.... ..
T Consensus 162 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~----- 225 (267)
T PHA03390 162 TP---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QK----- 225 (267)
T ss_pred CC---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cc-----
Confidence 21 134688999999999988999999999999999999999999985443321222222111 00
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhcCCchhhh
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT-MKTLLKLFQEPDYWLK 528 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~L~~~~~w~~ 528 (549)
.. .........+.+++..||+.+|.+||+ ++++++ |+||+
T Consensus 226 -~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~-----h~~~~ 266 (267)
T PHA03390 226 -KL----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK-----HPFLK 266 (267)
T ss_pred -cC----CcccccCHHHHHHHHHHhccChhhCCchHHHHhc-----CCccc
Confidence 00 111234456778889999999999995 799998 89986
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.76 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=199.9
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
|...+.||.|++|.||++.. .+|+.+++|.++..... ...+.+|+.+++.++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56677899999999999977 46899999998755433 356788999999999999999999999999999999999
Q ss_pred CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 ~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
.++|.+++.. +++..+..++.|+++||.|||+. +|+|+||||+||+++.+ +.++|+|||.+.......
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~---- 152 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTE-GVLKLADFGLARSFGSPV---- 152 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCc----
Confidence 9999888844 57788899999999999999999 99999999999999988 689999999986554322
Q ss_pred CccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc--cccccccC--
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS--GLCERLID-- 480 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d-- 480 (549)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ +.......... .....+.+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhh
Confidence 111234578899999998876 789999999999999999999999976543221 11111111000 00000000
Q ss_pred -------Cc----ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 481 -------PQ----LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 481 -------~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+. ............+.+++..||..||.+||++.+++. |+|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~-----~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA-----HPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh-----CCCC
Confidence 00 001112234567889999999999999999999998 7885
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.30 Aligned_cols=255 Identities=27% Similarity=0.386 Sum_probs=209.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
...|.+.+.||+|.|++|.++.+ .+|..||||.+.++..+. ..+.+|+++|..|+|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45688999999999999999987 569999999998765433 45789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|.+++|+.. ........++.|+..|++|||++ .|+|||||++||||+.+. ++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~--- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENM-NIKIADFGFSTFFDY--- 207 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhccccccc-ceeeeccccceeecc---
Confidence 999 8899999964 44567778999999999999999 999999999999999995 799999999876543
Q ss_pred cccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.....+++|++.|.|||++++.+| ++.+|+||+|++||-|++|..||+...-- .+-++
T Consensus 208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk------------------~Lr~r 266 (596)
T KOG0586|consen 208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK------------------ELRPR 266 (596)
T ss_pred ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc------------------cccch
Confidence 344557899999999999999988 58999999999999999999999865421 11111
Q ss_pred cccccCCH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 482 QLNEEYNR--EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 482 ~l~~~~~~--~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
.+.+.+.. -......++++++|-.+|.+|++++++.+ |+|+....+.+++..
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~-----~~W~n~~~~~~~l~p 320 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK-----DRWRNDLLEARLLAP 320 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh-----hcccchhhhhhhhhc
Confidence 12111111 11123445678899999999999999999 899988888744443
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.89 Aligned_cols=246 Identities=25% Similarity=0.318 Sum_probs=193.0
Q ss_pred EcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCH
Q 008898 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (549)
Q Consensus 260 lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL 333 (549)
||+|+||.||++.. .+|+.+|+|.+..... ....+..|+++++.++||||+++++++...+.++++|||+ +++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 5689999999865321 2334678999999999999999999999999999999999 5799
Q ss_pred HHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 008898 334 KQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (549)
Q Consensus 334 ~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (549)
.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++++ +.++|+|||++..... ...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~------~~~ 150 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDH-GNVRISDLGLAVELKG------GKK 150 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC-CCEEEccCcchhhhcc------CCc
Confidence 988843 56777888999999999999999 99999999999999998 6899999999865432 111
Q ss_pred ccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCC
Q 008898 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYN 488 (549)
Q Consensus 409 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 488 (549)
.....++..|+|||++.++.++.++|||||||++|+|++|+.||.......... ....... . . ...++
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~-----~--~----~~~~~ 218 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-ELKRRTL-----E--M----AVEYP 218 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-HHHhccc-----c--c----cccCC
Confidence 223467889999999998889999999999999999999999997654321111 1010000 0 0 01112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhH
Q 008898 489 REEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 489 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~ 532 (549)
......+.+++..||+.||.+|| ++.++++ |+|++.-+.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~-----h~~~~~~~~ 262 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE-----HPLFKDLNW 262 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh-----ChhhhcCCh
Confidence 22345677888999999999999 7777887 899976554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.37 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=200.7
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.|...+.||+|++|.||++.. .+++.+++|.++..... .+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455567899999999999976 56889999998654332 345789999999999999999999999999999999999
Q ss_pred CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 330 NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 330 ~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
+++|.+++.. +++.....++.|++.||.|||+. +|+||||+|+||+++.+ +.++|+|||++...... ..
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~-----~~ 170 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKE-----VP 170 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCC-CcEEEcccccchhhccC-----Cc
Confidence 6799999865 66778889999999999999999 99999999999999998 68999999987543221 11
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||........ ....... . .+....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-----~~~~~~~-~-----~~~~~~-- 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRDN-L-----PPKLKN-- 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-----HHHHHhc-C-----CCCCcc--
Confidence 12235689999999999988899999999999999999999999975432111 1111111 0 011110
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.......+.+++.+||..+|.+||++.++++ |+|++....
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~-----~~~~~~~~~ 277 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN-----HPFLAKAGP 277 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc-----CcccccCCC
Confidence 1123456888999999999999999999998 899876553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=303.85 Aligned_cols=267 Identities=21% Similarity=0.264 Sum_probs=197.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC-------
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSK------- 319 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------- 319 (549)
.++|...+.||+|+||.||++.. .+++.+|+|++..... ....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999987 4689999999865432 224567899999999999999999877433
Q ss_pred -CeEEEEEeccCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 320 -EMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 320 -~~~~lv~e~~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
..++++++|+.++|...+. .+++.....++.|+++||.|||+. +|+|+||||+||+++++ +.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQ-GILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CCEEECcCccc
Confidence 3579999999988888774 377888899999999999999999 99999999999999998 69999999998
Q ss_pred ccccccccccc------CccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHH
Q 008898 395 MVHHQSHQVSE------NVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 395 ~~~~~~~~~~~------~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~ 467 (549)
........... ........|++.|+|||.+.+. .++.++|||||||++|||++|++||........ ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 65433211111 1122345678999999988754 578999999999999999999999976544221 111111
Q ss_pred Hhhcc--------ccccc----ccCCcccccC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 468 SLLSS--------GLCER----LIDPQLNEEY---NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 468 ~~~~~--------~~~~~----~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
..... ..+.. .......... .......+.+++..|+..||.+|||+.+++. |+||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~-----~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE-----HPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc-----CCCC
Confidence 00000 00000 0000000000 0112256788999999999999999999998 7886
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.34 Aligned_cols=263 Identities=27% Similarity=0.372 Sum_probs=198.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKE----- 320 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 320 (549)
..++|++.+.||+|+||.||+|.+ .+|+.+|+|.++.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 456899999999999999999987 4689999999975432 2346778999999999999999999887654
Q ss_pred -----eEEEEEeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeee
Q 008898 321 -----MYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (549)
Q Consensus 321 -----~~~lv~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DF 391 (549)
.+++++||+.++|..++.. +++.....++.||+.||.|||+. +|+|+||||+||+++++ +.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~-~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNK-GQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CcEEeCcc
Confidence 7999999999888888753 67888999999999999999999 99999999999999998 68999999
Q ss_pred ccccccccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
|++........ .......+++.|+|||.+.+. .++.++|||||||++|||++|++||..... .+.+..+.....
T Consensus 161 g~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~ 235 (302)
T cd07864 161 GLARLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCG 235 (302)
T ss_pred cccccccCCcc----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhC
Confidence 99865433211 111223467889999988654 578999999999999999999999976543 222222222111
Q ss_pred cccc--ccccc--------CC------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 471 SSGL--CERLI--------DP------QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 471 ~~~~--~~~~~--------d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
.... ...+. ++ ..... ....+..+.+++..||..||.+||++.++++ |+|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~-----~~~~ 302 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN-----SPWL 302 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc-----CCCC
Confidence 1000 00000 00 00000 0112456889999999999999999999998 7775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=299.12 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=195.5
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
|...+.||+|+||.||+|.. .+|+.+++|.+...... ...+.+|+++++.++|||++++++++.+.+..+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66667899999999999976 56889999998754321 24577899999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.|+|.+++.. +++.+...++.||+.||.|||+. +++|+||+|+||+++.+ +.++|+|||++....
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~------ 172 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEP-GQVKLADFGSASKSS------ 172 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCC-CCEEEeecCCCcccC------
Confidence 99998888743 67788888999999999999999 99999999999999988 689999999874321
Q ss_pred cCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 405 ENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
......|+..|+|||++. .+.++.++|||||||++|+|++|..||.......... ...... . +
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-----~~~~~~-~-----~ 238 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQND-S-----P 238 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHHhcC-C-----C
Confidence 112456889999999984 4568899999999999999999999987654321111 111000 0 1
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.. ........+.+++.+||+.+|.+||++.+++. |+|+....
T Consensus 239 ~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~-----~~~~~~~~ 280 (313)
T cd06633 239 TL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLR-----HDFVRRDR 280 (313)
T ss_pred CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc-----CcccCCCc
Confidence 11 11122345788899999999999999999998 88986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=295.01 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=188.7
Q ss_pred CCCCceEcccCceEEEEEEec----CCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------
Q 008898 254 FSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKE------ 320 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~----~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~------ 320 (549)
|.+.+.||+|+||.||+|... +++.+|||+++..... .+++.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999642 3689999999764322 346788999999999999999999885432
Q ss_pred eEEEEEecc-CCCHHHHHH---------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEee
Q 008898 321 MYAIVYNLL-NGSLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~---------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~D 390 (549)
..+++++|+ +|+|.+++. .+++.....++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~-~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNEN-MTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCC-CCEEECc
Confidence 346778888 689988863 246677889999999999999999 99999999999999988 6899999
Q ss_pred eccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHh
Q 008898 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSL 469 (549)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~ 469 (549)
||++.......... ......+++.|++||.+....++.++|||||||++|||++ |++||...... .+.. ..
T Consensus 157 fg~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~---~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYR---QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYN---YL 228 (273)
T ss_pred ccccccccCCccee---cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHH---HH
Confidence 99986543221111 1122345678999999998889999999999999999999 88888654321 1111 11
Q ss_pred hcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 470 LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 470 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..... .. .+......+.+++..|++.+|.+||++.++++.|++
T Consensus 229 ~~~~~------~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 229 IKGNR------LK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred HcCCc------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11111 00 112234578889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=286.91 Aligned_cols=243 Identities=32% Similarity=0.447 Sum_probs=197.3
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEeccC
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN 330 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 330 (549)
+|...+.||+|+||.||++.. .+++.+++|++..... ....+.+|+++++.++|+|++++++++..++..++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 477788999999999999987 4689999999976543 44678899999999999999999999999999999999995
Q ss_pred -CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 -GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 -gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
++|.+++.. +++.....++.|+++||.|||.. +++|+||+|+||+++++ +.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccC-CeEEEeecccccccccccc---
Confidence 799999854 57888889999999999999998 99999999999999998 6899999999865443211
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........... .. ........+
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~-----~~~~~~~~~----- 219 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-IA-----TNGPPGLRN----- 219 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HH-----hcCCCCcCc-----
Confidence 2345788999999999988899999999999999999999999976543221111 00 011111111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.......+.+++..|+..||.+|||+.++++
T Consensus 220 --~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 --PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112456888999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.50 Aligned_cols=267 Identities=25% Similarity=0.305 Sum_probs=208.2
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
+.|+.-++||+||||.||-+.. .+|+.||+|.+.+... .+.-.+.|-.||.+++.++||.+--.|++.+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5688889999999999999976 6799999998864432 2334678999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 327 NLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 327 e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
..| +|+|.-+|.+ +++..+..++.+|+.||++||+. +|++||+||+|||||+. |+++|+|.|+|.....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~-GhvRISDLGLAvei~~- 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDH-GHVRISDLGLAVEIPE- 339 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccC-CCeEeeccceEEecCC-
Confidence 999 6788777744 67788889999999999999999 99999999999999999 8999999999976544
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.......+||.+|||||++.++.|+...|+|||||+||||+.|+.||....+-... ........ -|
T Consensus 340 -----g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-eEvdrr~~--------~~ 405 (591)
T KOG0986|consen 340 -----GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-EEVDRRTL--------ED 405 (591)
T ss_pred -----CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-HHHHHHHh--------cc
Confidence 23333458999999999999999999999999999999999999999876542111 01111111 11
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCchhhhhhhHHH-HHHhhccCCCC
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM-----KTLLKLFQEPDYWLKMKREKE-ELLNERRSNGP 545 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~L~~~~~w~~~~~~~~-~~~~~~~~~~~ 545 (549)
...|+....+....+.+..|..||.+|..- .++-+ |++|+..+... +.....+++-|
T Consensus 406 ---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~-----HpfFk~lnw~rleagml~PPfiP 468 (591)
T KOG0986|consen 406 ---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE-----HPFFKDLNWRRLEAGMLEPPFIP 468 (591)
T ss_pred ---hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh-----CcccccCCHhHHhccCCCCCCCC
Confidence 133445555666677788999999999754 46655 67777665443 33334444444
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=331.40 Aligned_cols=251 Identities=28% Similarity=0.419 Sum_probs=187.9
Q ss_pred HhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----
Q 008898 248 CHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSK----- 319 (549)
Q Consensus 248 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~----- 319 (549)
.+..++|+...+||+||||.||++++ -||+.||||.+.... .....+.+|+..|++|+|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34567899999999999999999987 699999999997653 2335688999999999999999976422000
Q ss_pred --------------------------------------------------------------------------------
Q 008898 320 -------------------------------------------------------------------------------- 319 (549)
Q Consensus 320 -------------------------------------------------------------------------------- 319 (549)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEeccCCC-HHHHHHH--h--chhHHHHHHHHHHHHHHHHH
Q 008898 320 ----------------------------------EMYAIVYNLLNGS-LKQYLKQ--L--KWNERMDVAIGVAKALEYLH 360 (549)
Q Consensus 320 ----------------------------------~~~~lv~e~~~gs-L~~~l~~--~--~~~~~~~i~~~i~~aL~yLH 360 (549)
..+||.||||..+ |.+++.+ + .....++++.+|++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1367889999655 4444543 2 25667899999999999999
Q ss_pred hCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc----c---------ccccccCccccccccCCccccccccccC
Q 008898 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH----Q---------SHQVSENVKPVNVVGTFGYLAPEYMMYG 427 (549)
Q Consensus 361 ~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~----~---------~~~~~~~~~~~~~~gt~~y~APE~~~~~ 427 (549)
+. |||||||||.|||++++ ..+||+|||+|.... . ..........+..+||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred hC---ceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99 99999999999999988 689999999997622 0 0111222244577999999999998755
Q ss_pred ---CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc--CCHHHHHHHHHHHHHh
Q 008898 428 ---KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE--YNREEIEIVMCAARLC 502 (549)
Q Consensus 428 ---~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~C 502 (549)
.|+.|+|+|||||||+||+. ||....+.... +..+.++.++.+ +..+....-..+|++|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i-------------L~~LR~g~iP~~~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI-------------LTNLRKGSIPEPADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH-------------HHhcccCCCCCCcccccccchHHHHHHHHH
Confidence 49999999999999999984 56554432221 122223333332 2222233345688999
Q ss_pred cccCCCCCCCHHHHHH
Q 008898 503 LLHSSSRRPTMKTLLK 518 (549)
Q Consensus 503 l~~dP~~RPs~~evl~ 518 (549)
+++||.+|||+.|+|.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999998
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=298.44 Aligned_cols=267 Identities=22% Similarity=0.276 Sum_probs=192.9
Q ss_pred eEcccCceEEEEEEecCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCHH
Q 008898 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~ 334 (549)
.+|.|+++.||++.. +++.+|+|+++.... ....+.+|+.+++.++||||+++++++.+++.++++|||+ +|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 345555555555544 689999999976532 2356889999999999999999999999999999999999 57899
Q ss_pred HHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc--ccCc
Q 008898 335 QYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV--SENV 407 (549)
Q Consensus 335 ~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~ 407 (549)
+++.. +++.....++.|+++||.|||+. +|+||||||+||+++.+ +.++|+|||.+......... ....
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecC-CceEEecCccceeecccccccccccc
Confidence 98864 56677788999999999999999 99999999999999988 68999999988644322111 1111
Q ss_pred cccccccCCcccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHh---hcccc-------c
Q 008898 408 KPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL---LSSGL-------C 475 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~---~~~~~-------~ 475 (549)
......++..|+|||++.. ..++.++|+|||||++|||++|..||.........+....... ..... .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 2234567889999999876 3588999999999999999999999986543222111110000 00000 0
Q ss_pred cc----ccCCc----ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 476 ER----LIDPQ----LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 476 ~~----~~d~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
.. ..++. ....+.......+.+++..||..||.+|||++++++ |+||+...+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~-----~p~~~~~~~~~~ 306 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN-----HSFFKQCKRRNT 306 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc-----CchHhhhcccch
Confidence 00 00010 011112233456788999999999999999999999 899987654433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.38 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=204.3
Q ss_pred CCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----eEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKE-----MYA 323 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~~~ 323 (549)
+|.+.+.||.|+||.||++... +++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++...+ .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999874 58999999987543 23356889999999999999999999987765 789
Q ss_pred EEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 324 IVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 324 lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
++|+|+.++|.+++.. +++.....++.||+.||.|||+. +|+|+||||+|||++.+ +.++|+|||++......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEcccCceEeeccc
Confidence 9999999899998854 67888899999999999999999 99999999999999999 79999999998765432
Q ss_pred cccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc--------
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS-------- 471 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~-------- 471 (549)
... ........+|+.|+|||.+.+. .++.++|+||||+++|+|++|.+||........ ..........
T Consensus 157 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 157 EDE--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccc--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCChhHhhh
Confidence 110 1112344678999999999887 789999999999999999999999976653211 1110100000
Q ss_pred --ccccccccC---Ccc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 472 --SGLCERLID---PQL---NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 472 --~~~~~~~~d---~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
.......+. ... ...........+.+++..||..+|.+|||+.++++ |+||.....+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~-----~~~~~~~~~~ 298 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA-----HPYLAQLHDP 298 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh-----CccHHhhccc
Confidence 000000000 000 00011123456788999999999999999999998 8999765554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.94 Aligned_cols=270 Identities=18% Similarity=0.238 Sum_probs=198.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC---------
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSK--------- 319 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--------- 319 (549)
..+|...+.||.|+||.||+|.. .+|+.+|+|.+..... ..+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999977 5689999999875543 235688999999999999999998766443
Q ss_pred -----CeEEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeec
Q 008898 320 -----EMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (549)
Q Consensus 320 -----~~~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFG 392 (549)
..++++|||+.++|.+++.. +++.....++.||++||.|||+. +|+||||||+||+++.+.+.++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence 36889999999999988854 67888889999999999999999 999999999999998654578999999
Q ss_pred cccccccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHH-hh
Q 008898 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARS-LL 470 (549)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~-~~ 470 (549)
++......... ........|+..|+|||.+.. ..++.++|||||||++|+|++|+.||................ ..
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 161 LARIVDPHYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cceecCCcccc--ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 98654332111 111123457889999998764 457899999999999999999999997654322211110000 00
Q ss_pred ccccc--------cccc----CCcc-cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 471 SSGLC--------ERLI----DPQL-NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 471 ~~~~~--------~~~~----d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
..... .... .+.. ...........+.+++..||..||.+|||+.++++ |+|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~-----h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM-----HPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC-----CCccccc
Confidence 00000 0000 0000 00001122345778999999999999999999998 8999743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=303.17 Aligned_cols=267 Identities=20% Similarity=0.251 Sum_probs=195.7
Q ss_pred CCCCCceEcccCceEEEEEEec-C--CcEEEEEEeecCCc---CHHHHHHHHHHHhcC-CCCCeeeEEEEEEc----CCe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-D--GQVAAVKVLKCTNW---SEEEVLREVELLSSI-KHENIVRIIGYCHS----KEM 321 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~--g~~~AvK~l~~~~~---~~~~~~~E~~il~~l-~h~nIv~l~~~~~~----~~~ 321 (549)
+|...+.||+|+||.||++... + +..+|+|.+..... ....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999763 4 78999999864321 235678899999999 59999999987532 246
Q ss_pred EEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+++++++++++|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++....
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNAD-CELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCC-CCEEeCcCCCceecc
Confidence 789999999999998853 67788899999999999999999 99999999999999998 689999999997544
Q ss_pred cccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc--cccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS--SGLC 475 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~~ 475 (549)
..... .........||+.|+|||.+.+ ..++.++|||||||++|+|++|.+||....... .+......+.. ....
T Consensus 157 ~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 157 ENPGE-NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccc-ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 32211 1112234578999999998765 468999999999999999999999997644211 11100000000 0000
Q ss_pred c---------------cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 476 E---------------RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 476 ~---------------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
. ......+. .........+.+++.+|++.||.+|||+.++++ |+|+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~-----~~~~~~~~ 299 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE-----HPYLAIWH 299 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc-----Chhhhhhc
Confidence 0 00000000 001112356788999999999999999999998 89986443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=288.55 Aligned_cols=264 Identities=28% Similarity=0.325 Sum_probs=202.0
Q ss_pred ccccCHHHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHH-HhcCCCCCeeeEEE
Q 008898 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVEL-LSSIKHENIVRIIG 314 (549)
Q Consensus 239 ~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~i-l~~l~h~nIv~l~~ 314 (549)
.-.|+.++|.. +..||.|+||.|++-.+ ..|+..|||.+..... +..++..|.+. ++.-+.||||++||
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 34455555443 34599999999999977 5699999999987654 34567888885 45557999999999
Q ss_pred EEEcCCeEEEEEeccCCCHHHHHHH--------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCce
Q 008898 315 YCHSKEMYAIVYNLLNGSLKQYLKQ--------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386 (549)
Q Consensus 315 ~~~~~~~~~lv~e~~~gsL~~~l~~--------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~ 386 (549)
.+..++..++.||+|.-||+.+.+. +++.-.-.|......||.||.+.. .|||||+||+|||++.. |.+
T Consensus 131 a~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~-G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRH-GDV 207 (361)
T ss_pred hhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecC-CCE
Confidence 9999999999999999998777632 555555667778889999999875 89999999999999999 799
Q ss_pred EEeeeccccccccccccccCccccccccCCccccccccc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHH
Q 008898 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM--YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464 (549)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~ 464 (549)
||||||.+-.. ..+...+.-+|...|||||.+. ..+|+-++||||||++|||+.||+.|+......-+++.+
T Consensus 208 KLCDFGIcGqL------v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~ 281 (361)
T KOG1006|consen 208 KLCDFGICGQL------VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ 281 (361)
T ss_pred eeecccchHhH------HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH
Confidence 99999997432 2333344557889999999986 346999999999999999999999999887664444443
Q ss_pred HHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 465 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.+ .+....+..+.- .-+....+..++..|+.+|-..||.+.++++ +++.+++..
T Consensus 282 Vv-----~gdpp~l~~~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~-----~~fyr~y~~ 335 (361)
T KOG1006|consen 282 VV-----IGDPPILLFDKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK-----FPFYRMYAV 335 (361)
T ss_pred HH-----cCCCCeecCccc----ccccCHHHHHHHHHHhhcccccCcchhhhhc-----Cchhhhhhh
Confidence 22 122222211111 1223456777889999999999999999998 577766654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=323.10 Aligned_cols=244 Identities=23% Similarity=0.398 Sum_probs=202.4
Q ss_pred CCceEcccCceEEEEEEec-C---CcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 256 PKMLIGQGGNSKVYRTNHV-D---GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~~-~---g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
++++||.|.||.||+|.++ . ...||||.+|..... ..+|+.|..||.++.||||++|.|+.......+|+.|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 5678999999999999763 2 358999999865433 357999999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 -NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 -~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|+.||++ +.+.+...+..+|+.|+.||-++ +++||||...|||++.+. ..|++|||++++..+..
T Consensus 713 ENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnL-vCKVsDFGLSRvledd~--- 785 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDP--- 785 (996)
T ss_pred hCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhheeeccce-EEEeccccceeecccCC---
Confidence 9999999975 78888899999999999999999 999999999999999995 89999999998764422
Q ss_pred cCcccccccc--CCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 405 ENVKPVNVVG--TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 405 ~~~~~~~~~g--t~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.....+.-| ..+|.|||.+.+.+++.++||||||++|||.++ |.+|+=.... ++-+ .-+..
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVI--------------kaIe~ 849 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVI--------------KAIEQ 849 (996)
T ss_pred -CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHH--------------HHHHh
Confidence 111112112 468999999999999999999999999999887 8888755443 2211 11223
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+.-+.+.+++..|.+|+..||++|-.+||.+.+|+..|++
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 33344567889999999999999999999999999998754
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=292.46 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=190.6
Q ss_pred eEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHH---HHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREV---ELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~---~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
+||+|+||.||++.+ .+++.+|+|.+...... ...+..|. ..++...||||+.+++++...+.++++|||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999977 56899999998754321 11233343 3455568999999999999999999999999
Q ss_pred CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 ~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~------ 150 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK------ 150 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCC-CCEEEccCcCccccCcc------
Confidence 6789888854 67888999999999999999999 99999999999999998 68999999998643221
Q ss_pred ccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
......|+..|+|||.+.++ .++.++|||||||++|||++|+.||........... .... ....+.+..
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--~~~~-------~~~~~~~~~ 220 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMT-------LTMAVELPD 220 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--HHHh-------hccCCCCCC
Confidence 11244789999999998754 589999999999999999999999976533211110 0000 001122222
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
. ....+.+++..|+..+|.+|| ++.++++ |+|++.......-
T Consensus 221 ~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~-----~~~~~~~~~~~~~ 267 (278)
T cd05606 221 S----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE-----HPFFRSLDWQMVF 267 (278)
T ss_pred c----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh-----CccccCCCchHhh
Confidence 2 245677888999999999999 9999998 8999776544443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=287.60 Aligned_cols=246 Identities=28% Similarity=0.412 Sum_probs=199.5
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|...+.||.|+||.||++.. .+++.+++|++..... ....+.+|+++++.++|||++++++.+..++..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 477888999999999999987 4689999999976543 335688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 329 L-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 329 ~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
+ +++|.+++.. +++.....++.+++.||.|||+. +++|+||+|+||+++++ +.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence 9 5689998854 56778899999999999999999 99999999999999988 68999999998654332
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
. .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ........ ..
T Consensus 157 ~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~-~~----- 220 (258)
T cd08215 157 V-----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LALKILKG-QY----- 220 (258)
T ss_pred c-----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-----HHHHHhcC-CC-----
Confidence 1 12234578999999999998889999999999999999999999997654221 11111111 11
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+ ..+......+.+++..||..+|++|||+.++++ ++||
T Consensus 221 ~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~-----~~~~ 258 (258)
T cd08215 221 P----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ-----SPFI 258 (258)
T ss_pred C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc-----CCCC
Confidence 1 112233456788899999999999999999998 6775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.21 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=200.8
Q ss_pred CCCCCceEcccCceEEEEEEe----cCCcEEEEEEeecCCc-----CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTNW-----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~----~~g~~~AvK~l~~~~~-----~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 322 (549)
+|+..+.||+|+||.||++.. .+|+.+|+|+++.... ..+.+.+|+.+++.+ +|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999999999975 3688999999975321 235577899999999 599999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++++||+ +|+|.+++.. +.+.....++.|+++||.|||+. +++||||+|+|||++.+ +.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCC-CCEEEeeCccceecc
Confidence 9999999 6799999864 66777788888999999999998 99999999999999998 689999999986543
Q ss_pred cccccccCccccccccCCccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
... ........|+..|+|||.+... .++.++||||||+++|+|++|..||...... .....+........
T Consensus 157 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~--- 228 (290)
T cd05613 157 EDE----VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE--- 228 (290)
T ss_pred ccc----ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccC---
Confidence 211 1112245689999999998753 4688999999999999999999999753321 11112222211110
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
+ .++......+.+++..|+..||.+|| ++.+++. |+||.....++..
T Consensus 229 ----~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~-----~~~~~~~~~~~~~ 280 (290)
T cd05613 229 ----P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK-----HPFFQKINWDDLA 280 (290)
T ss_pred ----C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc-----CcccccCCHHHHh
Confidence 1 11223345678889999999999997 8888888 8898877765543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=292.31 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=195.3
Q ss_pred CCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEecc
Q 008898 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
|.+.+.||+|+||.||+|... +++.+++|.+..... ......+|+..++.++ ||||+++++++..++..+++|||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567788999999999999874 588999999875433 2234567999999999 999999999999999999999999
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.. +++..+..++.|++.||.|||++ +++|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCC-CCEEEeecccceeccCCC---
Confidence 9999988843 57788899999999999999999 99999999999999998 689999999986543211
Q ss_pred cCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHH-----------HHHHHhhcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLV-----------LWARSLLSS 472 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~-----------~~~~~~~~~ 472 (549)
......|+..|+|||++.. ..++.++|+||||+++|||++|++||........... .|.......
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 154 ---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred ---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 1223468889999998854 4578999999999999999999999976543221100 011111111
Q ss_pred cccccccCCccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 473 GLCERLIDPQLN---EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 473 ~~~~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
............ ..........+.++++.|+..||.+|||++|++. |+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~-----~~~~ 283 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ-----HPYF 283 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh-----CCCC
Confidence 111100000000 0001111466889999999999999999999998 6775
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=327.63 Aligned_cols=273 Identities=21% Similarity=0.286 Sum_probs=210.1
Q ss_pred HHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC
Q 008898 246 ELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKE 320 (549)
Q Consensus 246 el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 320 (549)
++..-.++|.+.++||+|+||.|..+++ .+++.||+|++++- .....-|..|-+||..-+.+-|+.|.-.|++++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 4444567999999999999999999987 56999999999762 223355778999999999999999999999999
Q ss_pred eEEEEEecc-CCCHHHHHHHh---chhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 321 MYAIVYNLL-NGSLKQYLKQL---KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~~---~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
.+|+||||+ ||+|...+..+ ++..+..++..|..||.-||+. |+|||||||+|||||.+ |++||+|||.|..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~-GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKS-GHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEeccc-CcEeeccchhHHh
Confidence 999999999 88999999764 4566677888999999999999 99999999999999999 8999999999865
Q ss_pred cccccccccCccccccccCCccccccccc----c-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMM----Y-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS 471 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 471 (549)
+.. .........+|||.|++||++. + +.|+..+|+||+||++|||+.|..||.... ++.....++.
T Consensus 225 m~~----dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveTY~KIm~ 295 (1317)
T KOG0612|consen 225 MDA----DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVETYGKIMN 295 (1317)
T ss_pred cCC----CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHHHHHHhc
Confidence 543 2233445678999999999985 3 568999999999999999999999997543 3333434433
Q ss_pred ccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHhcCCchhhhhhhHHHHHHhhccCCCC
Q 008898 472 SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT---MKTLLKLFQEPDYWLKMKREKEELLNERRSNGP 545 (549)
Q Consensus 472 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~~L~~~~~w~~~~~~~~~~~~~~~~~~~ 545 (549)
-...-.+.+. -..+.+..+.+..+ --+|..|.. +.++-. |+||....+ +-..+..++..|
T Consensus 296 hk~~l~FP~~---~~VSeeakdLI~~l-----l~~~e~RLgrngiedik~-----HpFF~g~~W-~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 296 HKESLSFPDE---TDVSEEAKDLIEAL-----LCDREVRLGRNGIEDIKN-----HPFFEGIDW-DNIRESVPPVVP 358 (1317)
T ss_pred hhhhcCCCcc---cccCHHHHHHHHHH-----hcChhhhcccccHHHHHh-----CccccCCCh-hhhhhcCCCCCC
Confidence 2222222211 11333333333322 237777777 999887 899999888 555555555444
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=291.50 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=193.9
Q ss_pred EcccCceEEEEEEec-CCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCH
Q 008898 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (549)
Q Consensus 260 lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL 333 (549)
||.|+||.||++... +|+.+++|++..... ....+.+|+++++.++||||+++++.+..++.+++++|++ +++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999875 599999999975543 2346788999999999999999999999999999999999 5699
Q ss_pred HHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc---ccCc
Q 008898 334 KQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV---SENV 407 (549)
Q Consensus 334 ~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~---~~~~ 407 (549)
.+++.. +++..+..++.||++||.|||+. +++|+||+|+||+++++ +.++|+|||++......... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccc
Confidence 999865 67778889999999999999999 99999999999999998 68999999998643322110 0011
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
......+++.|+|||.+....++.++||||||+++|+|++|..||....... . ...... +.. . ....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~---~~~~~~-~~~----~--~~~~- 223 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--I---FQNILN-GKI----E--WPED- 223 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--H---HHHHhc-CCc----C--CCcc-
Confidence 2234568889999999988889999999999999999999999997654321 1 111111 000 0 0000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH---HHHHHHhcCCchhhhhh
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTM---KTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~---~evl~~L~~~~~w~~~~ 530 (549)
......+.+++..|+..+|.+|||+ .++++ |+||+..
T Consensus 224 -~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~-----~~~~~~~ 263 (265)
T cd05579 224 -VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN-----HPFFKGI 263 (265)
T ss_pred -ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc-----CccccCC
Confidence 0124667888999999999999999 66665 8898754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=293.58 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=202.0
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv 325 (549)
++|...+.||+|+||.||++.. .+|+.+|+|++.... .....+.+|.++++.+. ||||+++++++..++.++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688899999999999999977 479999999987532 22345788999999998 99999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
||++ +++|.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCC-CCEEecCCccccccCCcc
Confidence 9999 8899999965 67888999999999999999999 99999999999999988 689999999987654322
Q ss_pred ccc---------------cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHH
Q 008898 402 QVS---------------ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWA 466 (549)
Q Consensus 402 ~~~---------------~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~ 466 (549)
... .........|+..|+|||.+....++.++|+||||+++++|++|+.||........ +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~---- 231 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-F---- 231 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-H----
Confidence 110 01223355788999999999888899999999999999999999999986642111 1
Q ss_pred HHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHHhcCCchhh
Q 008898 467 RSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM----KTLLKLFQEPDYWL 527 (549)
Q Consensus 467 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~----~evl~~L~~~~~w~ 527 (549)
..... .. ..++......+.+++..||..+|.+||++ +++++ |+||
T Consensus 232 ~~~~~-------~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~-----~~~~ 280 (280)
T cd05581 232 QKILK-------LE----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA-----HPFF 280 (280)
T ss_pred HHHHh-------cC----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc-----CCCC
Confidence 01000 00 11122235568889999999999999999 99988 7775
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.55 Aligned_cols=246 Identities=24% Similarity=0.293 Sum_probs=187.2
Q ss_pred ceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH----HHHHHHHHH-HhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE----EEVLREVEL-LSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~----~~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+.||+|+||.||+|.. .+|+.+|+|+++...... ..+..|..+ ....+|+|++++++++..++.+++++||+ +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4589999999999977 568999999987543211 233445544 44568999999999999999999999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|.++++. +++.....++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~-------- 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE-------- 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC-CcEEEeecccceeccc--------
Confidence 799999864 67788889999999999999999 99999999999999988 6899999998854221
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||........ +. .... +.. ......
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~-~~~~-~~~------~~~~~~ 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV----FD-NILS-RRI------NWPEEV 216 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH----HH-HHHh-ccc------CCCCcc
Confidence 2244688999999999888899999999999999999999999976543211 11 1100 000 001111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.......+.+++..||..+|.+||++.++.+.|. |+|++..
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~--~~~~~~~ 257 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS--HPFFKSI 257 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc--ChHhhcC
Confidence 1223456888999999999999996654433322 6888654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=297.65 Aligned_cols=246 Identities=30% Similarity=0.417 Sum_probs=194.3
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.|...+.||+|+||.||+|.. .++..+|+|.+..... ...++.+|+++++.++|+|++++++++...+.+++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 466677899999999999987 4688999999864321 22457789999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.|+|.+++.. +++..+..++.|++.||.|||+. +++||||+|+||+++.+ +.++|+|||++.....
T Consensus 96 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---- 167 (308)
T ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCC-CcEEECCcccceeecC----
Confidence 999998887743 66778888999999999999999 99999999999999988 6899999999854322
Q ss_pred ccCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 404 SENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.....|++.|+|||.+. .+.++.++|||||||++|+|++|..||....... ....+.. +. .
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~-----~~-----~ 231 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ-----NE-----S 231 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhh-----cC-----C
Confidence 12346889999999975 3567889999999999999999999986543211 1111110 00 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+.. ........+.+++.+||..+|.+||++.++++ |+|+...
T Consensus 232 ~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~-----~~~~~~~ 273 (308)
T cd06634 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK-----HRFVLRE 273 (308)
T ss_pred CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhh-----Ccccccc
Confidence 111 11233456788899999999999999999998 7886544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=284.86 Aligned_cols=246 Identities=29% Similarity=0.450 Sum_probs=199.1
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|+..+.||+|+||.||++.. .+++.+++|.+..... ....+.+|++++++++|||++++++++.+++.++++|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 477889999999999999976 4688999999976653 335688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+ +++|.+++.. +++.....++.|++.||.|||+. +|+|+||+|+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~-- 154 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSK-- 154 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCC-CCEEEeccccceecCCCcc--
Confidence 9 5689998854 78888899999999999999999 99999999999999998 6899999999865543221
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
......|+..|+|||...+..++.++||||||+++|+|++|+.||........ .+... .. ..+..
T Consensus 155 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~---~~~~~---~~-----~~~~~- 219 (254)
T cd06627 155 ---DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA---LFRIV---QD-----DHPPL- 219 (254)
T ss_pred ---cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHh---cc-----CCCCC-
Confidence 12345688999999999888889999999999999999999999975542111 11111 00 01111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+......+.+++.+||..+|++|||+.+++. ++||
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~-----~~~~ 254 (254)
T cd06627 220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK-----HPWI 254 (254)
T ss_pred ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc-----CCCC
Confidence 2223456778889999999999999999997 5664
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=286.52 Aligned_cols=240 Identities=25% Similarity=0.344 Sum_probs=196.2
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|++.+.||+|+||.||++.. .+++.+|+|.+...... ...+.+|+.+++.++|+||+++++++.++..+++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477888999999999999976 57889999999764322 34577899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 329 L-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 329 ~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
+ +++|.+++.+ +++...+.++.|++.||.|||+. +++|+||+|+||+++++ +.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence 9 6789999855 67778889999999999999999 99999999999999998 68999999998664432
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||....... +.. .. ..+.
T Consensus 157 -------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~---~~-~~~~------ 217 (256)
T cd08530 157 -------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRY---KV-QRGK------ 217 (256)
T ss_pred -------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---HH-hcCC------
Confidence 1123468889999999998889999999999999999999999997654321 111 11 0111
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
...........+.+++..|+..+|.+||++.++++
T Consensus 218 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 ---YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11122344566888999999999999999999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=287.59 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=191.6
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN------WSEEEVLREVELLSSIKHENIVRIIGYCHSK--EMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~------~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~ 322 (549)
.+|+..+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999976 568999999885431 1124577899999999999999999998654 568
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++++||+ +++|.+++.. +.+.....++.|++.||.|||+. +++|+||||+||+++.+ +.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSA-GNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC-CCEEECccccccccc
Confidence 8999998 6789998864 56777888999999999999999 99999999999999988 689999999986543
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
... ..........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||........ ... ..
T Consensus 158 ~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~-------- 222 (264)
T cd06653 158 TIC--MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFK----IA-------- 222 (264)
T ss_pred ccc--ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHH----HH--------
Confidence 211 111112245689999999999988899999999999999999999999975432211 110 00
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.......++....+.+.+++..|+. +|..||+..+++.
T Consensus 223 -~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 -TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0011112233444667888899999 5799999999887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=291.73 Aligned_cols=258 Identities=25% Similarity=0.355 Sum_probs=197.4
Q ss_pred CCCCceEcccCceEEEEEEec-CCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 254 FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
|+..+.||+|+||.||+|... +++.+|+|+++... ...+.+..|+.+++.++|+|++++++++.+.+.+++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999874 59999999997653 22356788999999999999999999999999999999999
Q ss_pred CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 ~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
.++|.+++.+ +++..+..++.|++.||.|||+. +|+|+||+|+||+++++ +.++|+|||++........
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~--- 153 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLR--- 153 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCC-CCEEEecCCcccccCCCcc---
Confidence 9999999954 57788899999999999999999 99999999999999998 6899999999865432211
Q ss_pred CccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh------------c-
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL------------S- 471 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~------------~- 471 (549)
......++..|+|||.+.+. .++.++|||||||++|||++|++||........ +........ .
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHHHHhhcccc
Confidence 12233467789999998776 789999999999999999999999976543211 111000000 0
Q ss_pred --ccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 472 --SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 472 --~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
............. ...+.....+.+++..||..||.+||++.+++. |+||
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~-----~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK-----HPYF 282 (282)
T ss_pred cccccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh-----CcCC
Confidence 0000000000000 001112456889999999999999999999998 8886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.13 Aligned_cols=265 Identities=23% Similarity=0.322 Sum_probs=200.6
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe----
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEM---- 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~---- 321 (549)
+.++|...+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+.+++.++||||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467899999999999999999987 4688999999865322 22457789999999999999999987765544
Q ss_pred --EEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 322 --YAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 322 --~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+++++||++++|.+++.. +++.....++.|+++||.|||+. +|+|+||||+||+++++ +.++|+|||++...
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNED-CELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC-CCEEEccccccccc
Confidence 899999999999999854 77888899999999999999999 99999999999999998 68999999998643
Q ss_pred ccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc--ccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS--SGL 474 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~ 474 (549)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .+......... ...
T Consensus 169 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 169 DDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccc--------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHH
Confidence 221 224467889999998865 367899999999999999999999997554321 11111110000 000
Q ss_pred ccc--------ccC-------CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 475 CER--------LID-------PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 475 ~~~--------~~d-------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
... ++. +.+... .......+.+++..|+..||.+|||+.+|++ |+|+......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~-----h~~~~~~~~~ 307 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALA-----HPYLAEYHDP 307 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhc-----CCCccccCCC
Confidence 000 000 000000 0112456888999999999999999999998 8998765433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=289.14 Aligned_cols=271 Identities=22% Similarity=0.331 Sum_probs=203.0
Q ss_pred CHHHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC-cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcC
Q 008898 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIK-HENIVRIIGYCHSK 319 (549)
Q Consensus 243 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~ 319 (549)
+++++..+|++ +||+|+|+.|-.+.. .+|..||||++.+.. .....+.+|++++.+.+ |+||+.|++||+++
T Consensus 74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 35566666653 699999999998854 789999999997653 34577999999999996 99999999999999
Q ss_pred CeEEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeecc
Q 008898 320 EMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGA 393 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGl 393 (549)
..+|+|||.| +|+|..++.+ +.+.+...+..+|+.||.|||.+ ||.|||+||+|||-... ..-+|||||.+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 9999999999 7788888754 78888999999999999999999 99999999999997543 12479999988
Q ss_pred ccccccccc--cccCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccch------h
Q 008898 394 AMVHHQSHQ--VSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR------E 460 (549)
Q Consensus 394 a~~~~~~~~--~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~------~ 460 (549)
+.-...... ........+.+|+..|||||+.. ...|+.+.|.||||||||.||+|.+||.+....+ +
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 743222211 12223345789999999999864 2358999999999999999999999998754321 0
Q ss_pred ----hHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 461 ----SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 461 ----~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
.-..+.+.+.+... ++.|.. =........++++..+..|+.+|.++..++. |+|+.....+
T Consensus 306 ~Cr~CQ~~LFesIQEGkY--eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln-----hPw~~~~~~e 370 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKY--EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN-----HPWVQRCAPE 370 (463)
T ss_pred ccHHHHHHHHHHHhccCC--cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC-----Cccccccchh
Confidence 01111111111110 111110 0122345667788899999999999999998 8999876654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.37 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=196.1
Q ss_pred CceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCH
Q 008898 257 KMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL 333 (549)
...||+|+||.||++.. .+|+.+|+|.+..... ....+.+|+.+++.++|+||+++++++..++..+++|||+ +++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 45699999999999977 5789999998864332 2346788999999999999999999999999999999999 6689
Q ss_pred HHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccccc
Q 008898 334 KQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411 (549)
Q Consensus 334 ~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 411 (549)
.+++.. +++.....++.|++.||.|||+. +++|+||+|+||+++.+ +.++|+|||++....... .....
T Consensus 105 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~-----~~~~~ 175 (292)
T cd06657 105 TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEV-----PRRKS 175 (292)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-CCEEEcccccceeccccc-----ccccc
Confidence 888744 67778888999999999999999 99999999999999998 689999999875433211 11223
Q ss_pred cccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHH
Q 008898 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREE 491 (549)
Q Consensus 412 ~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 491 (549)
..|++.|+|||.+.+..++.++|+|||||++|+|++|..||....... ........ ..+.+.. ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-~~~~~~~~----------~~~~~~~--~~~~ 242 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDN----------LPPKLKN--LHKV 242 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhh----------CCcccCC--cccC
Confidence 568899999999988889999999999999999999999997543221 11111100 0011100 1112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 492 IEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 492 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
...+.+++.+||..+|.+||++.++++ |+||.....
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~-----~~~~~~~~~ 278 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK-----HPFLAKAGP 278 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc-----ChHHhccCC
Confidence 345677889999999999999999999 899877653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=289.34 Aligned_cols=245 Identities=23% Similarity=0.327 Sum_probs=191.8
Q ss_pred CCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCC------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN------WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~------~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
+|.+.+.||+|+||.||++... .+..+++|+++... ....++.+|+.+++.++||||+++++++.+.+.++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778889999999999999763 35556666665321 1223566899999999999999999999988999999
Q ss_pred Eecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 326 YNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+||+ +++|.+++.. +++.....++.|+++||.|||+. +++|+||+|+||+++++ .++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~~--~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNN--LLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeecC--CEeecccCceeec
Confidence 9999 6789888743 67788889999999999999999 99999999999999865 5999999998654
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ....... +
T Consensus 156 ~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~-~---- 220 (260)
T cd08222 156 MGSC-----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-----VVLRIVE-G---- 220 (260)
T ss_pred CCCc-----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHc-C----
Confidence 3221 12234568899999999988889999999999999999999999996443211 1111111 0
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
..+. .+......+.+++.+|+..+|++||++.++++ |+|+
T Consensus 221 -~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~-----~~~~ 260 (260)
T cd08222 221 -PTPS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR-----NPFI 260 (260)
T ss_pred -CCCC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh-----CCCC
Confidence 1111 22344557788999999999999999999999 7885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.51 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=208.8
Q ss_pred CCCCCceEcccCceEEEEEEecCCc-EEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHVDGQ-VAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~~g~-~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++....-||-||||+|=++...... .+|+|++++... ..+.+..|-.||..++.|+||++|..|.+....|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4455556999999999988764433 489999986543 23568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
.| +|.|+..|+. +.......++..+.+|++|||++ +||+|||||+|+|++.+ |.+||.|||+|+...
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~----- 571 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIG----- 571 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccC-CceEEeehhhHHHhc-----
Confidence 98 8999999964 66777788999999999999999 99999999999999999 899999999997643
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
.+.++.++||||.|.|||++.+.+.+.++|.||||+++||||+|.+||...++....- .++..- |.
T Consensus 572 -~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn-----~ILkGi------d~-- 637 (732)
T KOG0614|consen 572 -SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN-----LILKGI------DK-- 637 (732)
T ss_pred -cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH-----HHHhhh------hh--
Confidence 4556779999999999999999999999999999999999999999999877643211 111111 11
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
-.++........+++++.++.+|.+|.. +.+|-+ |.||..-+++.-...
T Consensus 638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk-----H~Wf~gfdweglr~~ 691 (732)
T KOG0614|consen 638 -IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK-----HRWFEGFDWEGLRSR 691 (732)
T ss_pred -hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh-----hhhhhcCChhhhhhc
Confidence 1223334456677888999999999987 666666 899988877665444
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=292.88 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=207.8
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-C-C----CeeeEEEEEEcCCeE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-H-E----NIVRIIGYCHSKEMY 322 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h-~----nIv~l~~~~~~~~~~ 322 (549)
++++|.+...+|+|.||+|..+.. ..+..+|||+++.-..-.+..+-|+++|+++. + | -++.+.++|+-.+..
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 377899999999999999999955 55889999999865555567788999999994 2 2 377888899999999
Q ss_pred EEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC---------------
Q 008898 323 AIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--------------- 382 (549)
Q Consensus 323 ~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--------------- 382 (549)
+||+|.++-|+++|++. ++...+..|+.|+++++.|||++ +++|-||||+|||+.+.
T Consensus 167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcccee
Confidence 99999999999999976 88889999999999999999999 99999999999998432
Q ss_pred ----CCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc
Q 008898 383 ----FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (549)
Q Consensus 383 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~ 458 (549)
...++|+|||.|+.....+ .+++.|..|.|||++++-+++.++||||+||||+|+.+|...|+... +
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h--------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-n 314 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH--------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-N 314 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc--------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-c
Confidence 1257899999997644432 46788999999999999999999999999999999999999998766 4
Q ss_pred hhhHHHHHHHhhcccccc----------------------------cccCCccc----ccCCHHHHHHHHHHHHHhcccC
Q 008898 459 RESLVLWARSLLSSGLCE----------------------------RLIDPQLN----EEYNREEIEIVMCAARLCLLHS 506 (549)
Q Consensus 459 ~~~l~~~~~~~~~~~~~~----------------------------~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~d 506 (549)
.+.+.+.... ...-... ...++..+ -.....+...+.+|++.||..|
T Consensus 315 ~EHLaMMerI-lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 315 LEHLAMMERI-LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred HHHHHHHHHh-hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 4555332222 1111000 00000000 0112244567999999999999
Q ss_pred CCCCCCHHHHHHHhcCCchhhhh
Q 008898 507 SSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 507 P~~RPs~~evl~~L~~~~~w~~~ 529 (549)
|.+|+|++|+++ |+||+.
T Consensus 394 P~~RiTl~EAL~-----HpFF~~ 411 (415)
T KOG0671|consen 394 PARRITLREALS-----HPFFAR 411 (415)
T ss_pred ccccccHHHHhc-----CHHhhc
Confidence 999999999999 899864
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=332.53 Aligned_cols=261 Identities=26% Similarity=0.312 Sum_probs=203.9
Q ss_pred HHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 247 LCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 247 l~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
+...+-+|.....||.|.||.||.|.. .+|...|+|.++-... ....+.+|..+|..++|||+|++||+=...+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 344556788889999999999999976 6799999998864432 234578999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+|.|||| +|+|.+.++. .++.....+..|+++|+.|||+. |||||||||.||+|+.+ |.+|++|||.|....
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFN-GLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecC-CcEEeecccceeEec
Confidence 9999999 8899999865 33333455778999999999999 99999999999999999 799999999997665
Q ss_pred cccccccCccccccccCCccccccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYG---KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
.... ..........||+.|||||++.+. +...+.||||+||+..||+||+.||...+.+-..... +
T Consensus 1386 ~~~~-~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~----------V 1454 (1509)
T KOG4645|consen 1386 NNAQ-TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH----------V 1454 (1509)
T ss_pred Cchh-cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH----------H
Confidence 5421 222334567899999999999854 4568999999999999999999999876543221111 1
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
...-.|.++ ......-.+++..||..||.+|.++.++++ |.+-+...
T Consensus 1455 ~~gh~Pq~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle-----~~f~~~~~ 1501 (1509)
T KOG4645|consen 1455 AAGHKPQIP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLE-----HAFGKSCT 1501 (1509)
T ss_pred hccCCCCCc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHH-----hhcccccc
Confidence 111223333 334455566779999999999999999998 55544443
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=286.26 Aligned_cols=260 Identities=24% Similarity=0.315 Sum_probs=198.4
Q ss_pred CCCCCceEcccCceEEEEEEe----cCCcEEEEEEeecCCc-----CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTNW-----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~----~~g~~~AvK~l~~~~~-----~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 322 (549)
+|...+.||+|+||.||++.. .++..+|||+++.... ..+.+.+|+.++.++ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477788999999999999864 3578899999975421 224577899999999 599999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++||||+ +|+|.+++.. +++.....++.|+++||.|||+. +++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC-CCEEEEECccccccc
Confidence 9999999 6799998853 56777888999999999999998 99999999999999998 689999999986543
Q ss_pred cccccccCccccccccCCccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
... ........|++.|+|||.+.+.. .+.++|+||||+++|||++|..||....... ....+.......
T Consensus 157 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~---- 227 (288)
T cd05583 157 AEE----EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS---- 227 (288)
T ss_pred ccc----ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc----
Confidence 321 11122356899999999987665 7889999999999999999999996443211 111111111111
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.+... ......+.+++.+||+.||.+|||++++.+.|+ |+|++.....+
T Consensus 228 ---~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~--~~~~~~~~~~~ 276 (288)
T cd05583 228 ---KPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKN--HPFFQGIDWDD 276 (288)
T ss_pred ---CCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhc--CcccccCCHHH
Confidence 11111 223345778889999999999999887776653 57887665533
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.32 Aligned_cols=240 Identities=25% Similarity=0.390 Sum_probs=194.1
Q ss_pred CceEcccCceEEEEEEec--CCc--EEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 257 KMLIGQGGNSKVYRTNHV--DGQ--VAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~--~g~--~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++||+|.||.|++|.+. +|+ .||||+++.+... ..+|.+|+.+|.+|+|+|+++|||+..+ ....+|+|++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 346999999999999773 354 6899999876543 4789999999999999999999999987 7788999999
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
.|+|.+.|.. +-......++.|||.||.||..+ ++|||||...|+||-.. ..+||||||+.+-........
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasp-rtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASP-RTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheeccc-ceeeeecccceeccCCCCcce
Confidence 7999999976 44556778999999999999999 99999999999999886 589999999987765543322
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
. ......-.+.|+|||.+....++.++|||+|||.+|||+| |..||-+-...+ +.+.+|..-
T Consensus 270 v--m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---------------IL~~iD~~e 332 (1039)
T KOG0199|consen 270 V--MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---------------ILKNIDAGE 332 (1039)
T ss_pred E--ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---------------HHHhccccc
Confidence 1 1111223568999999999999999999999999999999 688997654322 112233332
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.-.-+..+.+.+++++..||+.+|++|||+..|.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 23335677889999999999999999999999974
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.76 Aligned_cols=140 Identities=31% Similarity=0.397 Sum_probs=124.9
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|.+.+.||+|+||.||+|.+. +++.||||+++..... ...+..|+.+++.++||||+++++++...+.+++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999874 6899999999754321 246788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
||+ +|+|.+++.. +.+...+.++.||+.||.|||.. +||||||||+|||++.+ +.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 999 7899999864 56777889999999999999998 99999999999999988 689999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=296.21 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=199.6
Q ss_pred CCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcCH----HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
-|..++-||-|+||+|.+++.. +...||+|.+.+.+... ..+..|-+||.....+-||+||-.|++++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 3667778999999999999774 46799999997654322 346779999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc---ccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM---VHHQS 400 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~---~~~~~ 400 (549)
|+ +|++..+|-+ |.+.....++..+.+|+++.|.. |+|||||||+|||||.+ |++||+|||||. |..++
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccC-Cceeeeeccccccceecccc
Confidence 99 8899888855 56666777889999999999999 99999999999999999 899999999984 33333
Q ss_pred cccccCc----------------------------------cccccccCCccccccccccCCCCchhhHHHHHHHHHHHH
Q 008898 401 HQVSENV----------------------------------KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446 (549)
Q Consensus 401 ~~~~~~~----------------------------------~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ell 446 (549)
.+...+. .....+||+.|+|||++...+|+..+|+||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 2221110 112468999999999999999999999999999999999
Q ss_pred cCCCCCCCcccchh--hHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCC
Q 008898 447 TGKEAIQTNKANRE--SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMK-TLLKLFQEP 523 (549)
Q Consensus 447 tG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~~L~~~ 523 (549)
.|++||-...+... .+..| ...++-..-..++.++...+..| |...|-+.--+-. +|-.
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw----------~~~l~~~~~~~ls~e~~~li~kL---c~sad~RLGkng~d~vKa----- 927 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINW----------RNFLHIPYQGNLSKEALDLIQKL---CCSADSRLGKNGADQVKA----- 927 (1034)
T ss_pred hCCCCccCCCCCcceeeeeeh----------hhccccccccccCHHHHHHHHHH---hcChhhhhcccchhhhhc-----
Confidence 99999988776332 22222 23344444556677777666544 5544433322333 3444
Q ss_pred chhhhhhhHHH
Q 008898 524 DYWLKMKREKE 534 (549)
Q Consensus 524 ~~w~~~~~~~~ 534 (549)
|+||+......
T Consensus 928 HpfFkgIDfss 938 (1034)
T KOG0608|consen 928 HPFFKGIDFSS 938 (1034)
T ss_pred CccccccchHh
Confidence 79998877665
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=279.99 Aligned_cols=238 Identities=27% Similarity=0.346 Sum_probs=192.2
Q ss_pred EcccCceEEEEEEec-CCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCH
Q 008898 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (549)
Q Consensus 260 lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL 333 (549)
||.|+||.||++... +++.+|+|+++.... ....+..|+.+++.++||||+++++.+..++..+++||++ +++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999874 589999999876543 2346788999999999999999999999999999999999 8899
Q ss_pred HHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcccc
Q 008898 334 KQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (549)
Q Consensus 334 ~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (549)
.+++.. +++.....++.|+++||.|||+. +++|+||+|+||+++.+ +.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~-----~~~~ 151 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEG-----SRTN 151 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCC-CcEEEeecCcceecccCC-----Cccc
Confidence 999865 57788899999999999999998 99999999999999998 689999999986543321 1223
Q ss_pred ccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHH
Q 008898 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490 (549)
Q Consensus 411 ~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 490 (549)
...|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... .. ....... .. .++..
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~---~~~~~~~-------~~----~~~~~ 215 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EI---YEKILKD-------PL----RFPEF 215 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HH---HHHHhcC-------CC----CCCCC
Confidence 456888999999999888999999999999999999999999655431 11 1111110 01 11222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCH---HHHHHHhcCCchhh
Q 008898 491 EIEIVMCAARLCLLHSSSRRPTM---KTLLKLFQEPDYWL 527 (549)
Q Consensus 491 ~~~~l~~li~~Cl~~dP~~RPs~---~evl~~L~~~~~w~ 527 (549)
....+.++++.|+..||++||++ .++++ |+||
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~-----~~~f 250 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGGAEEIKA-----HPFF 250 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCcccHHHHHh-----CCCC
Confidence 24567788999999999999999 67776 6775
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.57 Aligned_cols=262 Identities=26% Similarity=0.364 Sum_probs=216.8
Q ss_pred HHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEE-----c
Q 008898 246 ELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH-----S 318 (549)
Q Consensus 246 el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~-----~ 318 (549)
.+..-++-|++...||.|.+|+||++.+ .+|+.+|+|+...+....+++..|.+||+.+ +|||++.++|++. .
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 3344467799999999999999999977 6799999999988888888999999999988 5999999999884 3
Q ss_pred CCeEEEEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeec
Q 008898 319 KEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (549)
Q Consensus 319 ~~~~~lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFG 392 (549)
++.++|||||| +||..+.++. +.|..+..|+..++.||.+||.+ .+||||||-.|||++.+ +.+||+|||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e-~~VKLvDFG 168 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTEN-AEVKLVDFG 168 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEecc-CcEEEeeee
Confidence 57899999999 6888888854 77788888999999999999999 99999999999999999 789999999
Q ss_pred cccccccccccccCccccccccCCccccccccccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHH
Q 008898 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-----KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~ 467 (549)
.+... .++.....+.+|||.|||||++... .|+..+|+||||++..||--|.+|+-+..+....+
T Consensus 169 vSaQl-----dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF----- 238 (953)
T KOG0587|consen 169 VSAQL-----DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF----- 238 (953)
T ss_pred eeeee-----ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc-----
Confidence 97443 3344556688999999999999754 47789999999999999999999998877654322
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.-..+|.....-+....+.+.++|..||..|-.+||++.++++ |++++.+.-++
T Consensus 239 --------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~-----hpFi~e~~~e~ 292 (953)
T KOG0587|consen 239 --------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK-----HPFITEQPNER 292 (953)
T ss_pred --------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc-----CCcccccccHH
Confidence 1112232223335677888999999999999999999999998 78876444333
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.59 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=193.7
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------eEEE
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKE------MYAI 324 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~------~~~l 324 (549)
|...+.||+||||.||+|++ .+|+.+|||.++... ...+...+|+++|++|+|+|||+++++=++.. .-.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44556799999999999986 679999999997643 34466889999999999999999998765443 5678
Q ss_pred EEecc-CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC-C--ceEEeeeccc
Q 008898 325 VYNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF-H--HPQLSDFGAA 394 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~--~~kL~DFGla 394 (549)
+|||| +|||...|++ +++.+.+.+..++..||.|||++ +|+||||||.||++-... | .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 89999 8899999964 88899999999999999999999 999999999999985321 2 3489999999
Q ss_pred cccccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccch-hhHHHHHHHhhcc
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANR-ESLVLWARSLLSS 472 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~-~~l~~~~~~~~~~ 472 (549)
+... ++.....++||+.|++||.+.. +.|+..+|.|||||++|+..||..||....... ..-.+|.......
T Consensus 172 rel~------d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 172 RELD------DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred ccCC------CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 7643 4446678899999999999984 789999999999999999999999997654432 2223444443333
Q ss_pred cccccccCCcc------------cccCCHHHHHHHHHHHHHhcccCCCCCC
Q 008898 473 GLCERLIDPQL------------NEEYNREEIEIVMCAARLCLLHSSSRRP 511 (549)
Q Consensus 473 ~~~~~~~d~~l------------~~~~~~~~~~~l~~li~~Cl~~dP~~RP 511 (549)
.-+.-..++.. +...+......+...+..++..+|++|-
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 22221111111 2233445667777888889999999998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.89 Aligned_cols=240 Identities=24% Similarity=0.323 Sum_probs=191.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++.|.....+|.|+|+.|-.+.+ .+++.+++|++.... .+..+|+.++... +||||+++.+.+.++...++|||.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 56788888899999999999876 568999999997652 3445677666655 799999999999999999999999
Q ss_pred cCC-CHHHHHHHhc--hhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe-cCCCceEEeeeccccccccccccc
Q 008898 329 LNG-SLKQYLKQLK--WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~g-sL~~~l~~~~--~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.| -|.+.+.... ..++..++.+|+.|+.|||++ |||||||||+|||++ +. ++++|+|||.+......
T Consensus 398 l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~-g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSA-GHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCC-CcEEEEEechhhhCchh----
Confidence 954 4555553322 246667999999999999998 999999999999995 55 79999999998654432
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
..+.+-|..|.|||++...+|++++||||||++||+||+|+.||.......+ + ... + ..
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-i---~~~-i------------~~ 528 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-I---HTR-I------------QM 528 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-H---HHh-h------------cC
Confidence 3355778899999999999999999999999999999999999987654311 1 111 1 11
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+.++....+...+|++.||+.||.+||+|.++.. |+|+
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~-----h~w~ 566 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA-----HPWF 566 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhcc-----Ccch
Confidence 2222334456777889999999999999999998 8999
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=276.95 Aligned_cols=262 Identities=22% Similarity=0.283 Sum_probs=193.4
Q ss_pred cCCCCCceEcccCceEEEEEEec---C--CcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV---D--GQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS-KEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~---~--g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~ 322 (549)
..|+....||+|.||.||++... + .+.+|+|.++..... .....+|+..++.++|||++.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46888899999999999999432 2 237999999765321 2457899999999999999999998866 7899
Q ss_pred EEEEeccCCCHHHHHH--------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC---CCceEEeee
Q 008898 323 AIVYNLLNGSLKQYLK--------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN---FHHPQLSDF 391 (549)
Q Consensus 323 ~lv~e~~~gsL~~~l~--------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~~kL~DF 391 (549)
++++||...+|.+.++ .++......++.||+.|+.|||++ -|+||||||.|||+..+ .|.+||+||
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999999999999984 256667788999999999999999 89999999999999755 358999999
Q ss_pred ccccccccccccccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchh-----hHHHH
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRE-----SLVLW 465 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~-----~l~~~ 465 (549)
|+|+.+...-. .-.....++-|+.|.|||.+.|.. |+.++||||+|||+.||++-.+.|......-. ...+.
T Consensus 181 GlaR~~~~plk--pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 181 GLARLFNNPLK--PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cHHHHhhcccc--ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99987765322 222233567799999999999765 89999999999999999999988876543111 01111
Q ss_pred HHHhhcccccc--cccCCcccccC------------CH----HH-------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 466 ARSLLSSGLCE--RLIDPQLNEEY------------NR----EE-------IEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 466 ~~~~~~~~~~~--~~~d~~l~~~~------------~~----~~-------~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.+....-|... .+.+-....++ ++ .. ...-.+++.++|..||.+|.|+++.++
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 11111111111 11111000111 00 00 122667889999999999999999998
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=275.18 Aligned_cols=224 Identities=23% Similarity=0.196 Sum_probs=176.5
Q ss_pred cCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCHHHHHHH-
Q 008898 263 GGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ- 339 (549)
Q Consensus 263 G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~~~l~~- 339 (549)
|.||.||++.+ .+++.+|+|.++... ...+|...+....||||+++++++...+.++++|||+ +|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 89999999977 678999999997543 2334555555667999999999999999999999999 6799998854
Q ss_pred --hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCc
Q 008898 340 --LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417 (549)
Q Consensus 340 --~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~ 417 (549)
+++.....++.|+++||.|||+. +|+||||||+||+++.+ +.++|+|||.+...... .....++..
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--------~~~~~~~~~ 147 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--------CDGEAVENM 147 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC-CCEEEecccchhccccc--------cccCCcCcc
Confidence 67788899999999999999999 99999999999999998 68999999987443221 123346778
Q ss_pred cccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHH
Q 008898 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMC 497 (549)
Q Consensus 418 y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 497 (549)
|+|||.+.+..++.++|+||+||++|||++|..|+....... .......++.. ....+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------~~~~~~~~~~~----~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------NTHTTLNIPEW----VSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------ccccccCCccc----CCHHHHH
Confidence 999999988889999999999999999999998875322110 00000111122 2345777
Q ss_pred HHHHhcccCCCCCCCH-----HHHHHHhcCCchhh
Q 008898 498 AARLCLLHSSSRRPTM-----KTLLKLFQEPDYWL 527 (549)
Q Consensus 498 li~~Cl~~dP~~RPs~-----~evl~~L~~~~~w~ 527 (549)
++.+|++.||.+||++ .++++ |+||
T Consensus 208 li~~~l~~dp~~R~~~~~~~~~~~~~-----h~~~ 237 (237)
T cd05576 208 LLQQLLQFNPTERLGAGVAGVEDIKS-----HPFF 237 (237)
T ss_pred HHHHHccCCHHHhcCCCccchHHHHc-----CCCC
Confidence 8899999999999996 77776 7775
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=252.52 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=201.7
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+|...+.||+|.||+||+++. .+++.||+|.++.++.+ .....+|+.+|+.++|+||++++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455667899999999999976 56899999999876543 35789999999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
|..+|..|... +.......++.|++.||.++|++ ++.|||+||.|.|++.+ |++||+|||+|+-+.-.-
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~n-gelkladfglarafgipv--- 155 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPV--- 155 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccC-CcEEecccchhhhcCCce---
Confidence 99999999865 55667778999999999999999 99999999999999999 899999999996543211
Q ss_pred cCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc-----ccccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG-----LCERL 478 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-----~~~~~ 478 (549)
......+-|..|.+|.++.+.+ |+...|+||-|||+.|+.....|.-...+.++++......+.... .+..+
T Consensus 156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 1112234588999999998776 799999999999999998855554444444444444333332111 12344
Q ss_pred cCCcccccCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 479 IDPQLNEEYNR---------EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 479 ~d~~l~~~~~~---------~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
.|-.....|+. ..-..=.++++..+.-+|.+|.+++..++ |++|.
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq-----hpyf~ 287 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ-----HPYFS 287 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc-----Ccccc
Confidence 44443333332 22233456778889999999999999998 66654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=275.76 Aligned_cols=268 Identities=24% Similarity=0.372 Sum_probs=200.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEc--------C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHS--------K 319 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~--------~ 319 (549)
+.|....+||+|.||.||+++. ++|+.||+|.+-.++. -.....+|+.+|..|+|+|++.++.+|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3456667899999999999976 5688889887643221 13567899999999999999999988843 2
Q ss_pred CeEEEEEeccCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 320 EMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 320 ~~~~lv~e~~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
..+++|+.+|..+|...|. +++..++.+++.++.+||.|+|.+ .|+|||+||.|+||+.+ |.+||+|||+++
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~d-gilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKD-GILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCC-ceEEeecccccc
Confidence 3699999999988888873 588899999999999999999999 99999999999999999 799999999998
Q ss_pred ccccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc--
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS-- 472 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~-- 472 (549)
.+..+....... .++.+-|..|.+||.+.+. .|+++.|||..|||+.||++|.+-++.+.+.+. +.. ...+...
T Consensus 173 ~fs~~~n~~kpr-ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq-l~~-Is~LcGs~t 249 (376)
T KOG0669|consen 173 AFSTSKNVVKPR-YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ-LHL-ISQLCGSIT 249 (376)
T ss_pred ceecccccCCCC-cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH-HHH-HHHHhccCC
Confidence 777665444333 4455669999999998865 699999999999999999999999988765321 111 1111111
Q ss_pred --ccc--------ccccCCcccccCCHHH---H------HHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 473 --GLC--------ERLIDPQLNEEYNREE---I------EIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 473 --~~~--------~~~~d~~l~~~~~~~~---~------~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
-+. ..+--+.++....... . +..++++..++..||.+||.+++++. |.||....
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln-----h~~F~kdp 322 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN-----HDFFWKDP 322 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc-----hhhhhcCC
Confidence 000 0000000111100111 1 24567889999999999999999998 77775443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=270.44 Aligned_cols=195 Identities=23% Similarity=0.346 Sum_probs=170.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|....+||+|+|++|..+++ ++.+.||+|++++.-. +.+-+..|-.+..+. +||++|-|..+|+++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 35799999999999999999987 6689999999986422 223356777777655 79999999999999999999
Q ss_pred EEecc-CCCHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|.||. +|+|.-+++ +++++.+..+...|+-||.|||+. |||+||||.+|+|+|.. |++||+|+|+++
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldae-ghikltdygmck----- 399 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAE-GHIKLTDYGMCK----- 399 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccC-Cceeecccchhh-----
Confidence 99999 667765553 478888888999999999999999 99999999999999999 899999999994
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~ 454 (549)
........+.++||||.|.|||++.+..|...+|+|+|||+|+||+.|+.||+-
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 345566777899999999999999999999999999999999999999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=303.45 Aligned_cols=260 Identities=19% Similarity=0.254 Sum_probs=170.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cC----CcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEE------EEcC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VD----GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGY------CHSK 319 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~----g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~------~~~~ 319 (549)
.++|...+.||+|+||.||+|.+ .+ +..+|+|.++..... +....| .++...+.++..++.. +..+
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 56899999999999999999987 45 789999988643221 111111 1222223333222211 2456
Q ss_pred CeEEEEEecc-CCCHHHHHHHhc-----------------------hhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCC
Q 008898 320 EMYAIVYNLL-NGSLKQYLKQLK-----------------------WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSS 375 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~~~~-----------------------~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~ 375 (549)
..++++++|+ +|+|.+++.... ......++.||+.||.|||+. +|+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHH
Confidence 7899999999 678998885421 122446899999999999999 9999999999
Q ss_pred CEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccC----------------------CCCchh
Q 008898 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG----------------------KVDEKI 433 (549)
Q Consensus 376 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~~~k~ 433 (549)
|||++.+.+.+||+|||+|....... ........||+.|+|||.+... .++.++
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGI----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccccccc----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 99999754689999999996543221 1223356889999999966432 234567
Q ss_pred hHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc----cccccCCccccc----C--CHHHHHHHHHHHHHhc
Q 008898 434 DVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL----CERLIDPQLNEE----Y--NREEIEIVMCAARLCL 503 (549)
Q Consensus 434 DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----~~~~~d~~l~~~----~--~~~~~~~l~~li~~Cl 503 (549)
|||||||+||||+++..++... +..+...+...+. ......+..... + .........+++..||
T Consensus 361 DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999977664322 1111111111100 000111110000 0 0001123457999999
Q ss_pred ccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 504 LHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 504 ~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..||.+|||+.++++ |+||....
T Consensus 435 ~~dP~kR~ta~e~L~-----Hpff~~~~ 457 (566)
T PLN03225 435 RFKGRQRISAKAALA-----HPYFDREG 457 (566)
T ss_pred cCCcccCCCHHHHhC-----CcCcCCCC
Confidence 999999999999999 89986544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=281.80 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=194.7
Q ss_pred CCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHh--cCCCCCeeeEEEEEEcCC----eEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLS--SIKHENIVRIIGYCHSKE----MYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~--~l~h~nIv~l~~~~~~~~----~~~lv~ 326 (549)
......+||+|.||.||+|.+ +++.||||++.... .+.+..|-+|.+ .++|+||+++++.-.... .++||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345567899999999999987 45999999997432 356777877776 458999999999876555 899999
Q ss_pred ecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhC------CCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 327 NLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHT------CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 327 e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~------~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+|. .|+|.+||+. .+|.+..+++.-|++||+|||+. ++.+|+|||||+.||||..| ....|+|||+|..+
T Consensus 288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFGLALRL 366 (534)
T ss_pred eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccceeEEe
Confidence 998 8999999976 89999999999999999999975 35689999999999999999 68999999999877
Q ss_pred ccccccccCccccccccCCccccccccccCC-CC-----chhhHHHHHHHHHHHHcCCCCCCC------------cccch
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VD-----EKIDVYSYGVVLLELITGKEAIQT------------NKANR 459 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~-----~k~DvwSlGvil~elltG~~p~~~------------~~~~~ 459 (549)
.... ........+||.+|||||++.+.- +. .+.||||+|.+||||++....++. .-...
T Consensus 367 ~p~~---~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 367 EPGK---PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred cCCC---CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 6432 223334578999999999887542 22 369999999999999997644431 00011
Q ss_pred hhHHHHHHHhhcccccccccCCcccccC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 460 ESLVLWARSLLSSGLCERLIDPQLNEEY-NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 460 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
..+..........+. .|.++..+ ....+..+.+.+..||..||+-|.|+.=+.+++.+..
T Consensus 444 Pt~e~mq~~VV~kK~-----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQ-----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCHHHHHHHHHhhcc-----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 112222222222211 22222211 2245678899999999999999999998888765543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=257.72 Aligned_cols=270 Identities=23% Similarity=0.354 Sum_probs=217.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcC--CeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSK--EMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~--~~~~lv~ 326 (549)
.++|++.+.+|+|.|+.||.|.. .+.++++||++++-. .+.+.+|+.||+.|. ||||++|+++..+. ....+++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 46788999999999999999976 668899999998543 467899999999997 99999999988654 5778899
Q ss_pred ecc-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 327 NLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 327 e~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
|++ +-+.......++...+..++.+++.||.|||++ ||.|||+||.|+++|.....++|+|+|+|.+.......+
T Consensus 115 E~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn- 190 (338)
T KOG0668|consen 115 EYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN- 190 (338)
T ss_pred hhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceee-
Confidence 999 556777777888889999999999999999999 999999999999999877789999999998766543322
Q ss_pred CccccccccCCccccccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc------ccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC------ERL 478 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------~~~ 478 (549)
-.+.+..|--||.+. ...|+...|+|||||+|..|+..+.||-....+.++++..++.+.-+... .--
T Consensus 191 -----VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 191 -----VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred -----eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 234566788999876 45689999999999999999999999998888888888887766543211 111
Q ss_pred cCCcccc---cCC------------H-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 479 IDPQLNE---EYN------------R-EEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 479 ~d~~l~~---~~~------------~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
+||.+.. .++ . -......+++...|+.|-++|||++|... |+||....+.+..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~-----HpyF~~~~~~~~~ 334 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA-----HPYFAPVREAESS 334 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc-----CchHHHHHHHhhc
Confidence 2332211 000 0 11245778889999999999999999998 9999888776654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=272.15 Aligned_cols=282 Identities=25% Similarity=0.392 Sum_probs=213.3
Q ss_pred HHHHhhcCCccccCHHHHHhhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhc--CCCC
Q 008898 230 LAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSS--IKHE 307 (549)
Q Consensus 230 ~~~~~~~~~~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~--l~h~ 307 (549)
+..++..++..-+..-....+..+....+.||+|.||.||+|.+ .|..||||++... ++....+|.+|.+. |+|+
T Consensus 189 l~~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHE 265 (513)
T KOG2052|consen 189 LDDLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHE 265 (513)
T ss_pred HHhhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc--chhhhhhHHHHHHHHHhccc
Confidence 33444455555555555556677788889999999999999998 4788999999744 35668888888874 5999
Q ss_pred CeeeEEEEEEcCC----eEEEEEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhC-----CCCCEEEecCCCC
Q 008898 308 NIVRIIGYCHSKE----MYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHT-----CDPPIIHRDVKSS 375 (549)
Q Consensus 308 nIv~l~~~~~~~~----~~~lv~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~-----~~~~iiHrDlkp~ 375 (549)
||+.+++.-..++ .++||.+|- .|||++||.+ ++....++++.-+|.||.+||.. .++.|.|||||+.
T Consensus 266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 9999998765443 688999888 8999999976 66677899999999999999963 4567999999999
Q ss_pred CEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCC----C-C-chhhHHHHHHHHHHHHcC-
Q 008898 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK----V-D-EKIDVYSYGVVLLELITG- 448 (549)
Q Consensus 376 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~-~-~k~DvwSlGvil~elltG- 448 (549)
|||+..+ +..-|+|+|+|..+.... ..-.......+||-+|||||++...- + + ..+||||||.++||+...
T Consensus 346 NILVKkn-~~C~IADLGLAv~h~~~t-~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc 423 (513)
T KOG2052|consen 346 NILVKKN-GTCCIADLGLAVRHDSDT-DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC 423 (513)
T ss_pred cEEEccC-CcEEEeeceeeEEecccC-CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence 9999999 789999999997665543 23334556779999999999986431 1 1 358999999999999752
Q ss_pred ---------CCCCCCcccchhhHHHHHHHhhcccccccccCCccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 449 ---------KEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN-EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 449 ---------~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
+.||.+--+.+.++....+.. .-+-+-|.++ ...+.+....|.++++.||..+|.-|-|+=-|-+
T Consensus 424 ~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV-----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 424 ESGGIVEEYQLPYYDVVPSDPSFEEMRKVV-----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred hcCCEehhhcCCcccCCCCCCCHHHHhcce-----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 377776666555554433222 2222233332 3345677889999999999999999999887777
Q ss_pred Hhc
Q 008898 519 LFQ 521 (549)
Q Consensus 519 ~L~ 521 (549)
.|.
T Consensus 499 tl~ 501 (513)
T KOG2052|consen 499 TLA 501 (513)
T ss_pred HHH
Confidence 553
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=277.01 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=198.5
Q ss_pred HhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH--------HHHHHHHHHHhcCCCCCeeeEEEEEE-
Q 008898 248 CHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE--------EEVLREVELLSSIKHENIVRIIGYCH- 317 (549)
Q Consensus 248 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~--------~~~~~E~~il~~l~h~nIv~l~~~~~- 317 (549)
..+.++|-.+.+||+|||+.||++.. ...+.+|||+-....... +...+|..|-+.|.||.||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34556777888999999999999966 557899999864332111 34678999999999999999999985
Q ss_pred cCCeEEEEEeccCC-CHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeee
Q 008898 318 SKEMYAIVYNLLNG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDF 391 (549)
Q Consensus 318 ~~~~~~lv~e~~~g-sL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DF 391 (549)
+.+.++-|.|||.| +|+-||++ +++.+...|+.||..||.||.+. ..+|||-||||.||||.+. .|.+||+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 66789999999965 68888865 77888999999999999999988 5699999999999999542 368999999
Q ss_pred cccccccccccccc--CccccccccCCccccccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHH
Q 008898 392 GAAMVHHQSHQVSE--NVKPVNVVGTFGYLAPEYMMYG----KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW 465 (549)
Q Consensus 392 Gla~~~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~ 465 (549)
|+++++....+... -..+....||..|++||.|.-+ +.+.|+||||+|||+|..+.|+.||..+...++.+..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe- 696 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE- 696 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh-
Confidence 99998876443322 2234467899999999998755 3688999999999999999999999877654443321
Q ss_pred HHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 466 ARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 466 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
..++....+.--.. +........+|++||++--++|....++..
T Consensus 697 -NTIlkAtEVqFP~K--------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 -NTILKATEVQFPPK--------PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -hchhcceeccCCCC--------CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111111111111 112234566789999999999998887765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=299.76 Aligned_cols=249 Identities=25% Similarity=0.442 Sum_probs=194.9
Q ss_pred cCCCCCceEcccCceEEEEEEec----C----CcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV----D----GQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSKE 320 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~----~----g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 320 (549)
++..+.+.||+|.||.|++|... . ...||||.++..... .+.+..|+++|+.+ +|+||+.++|+|.+.+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455568999999999999532 1 357999999865543 45688999999988 5999999999999999
Q ss_pred eEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~ 380 (549)
.++++.||+ .|+|.+|++. +...+.+.++.|||.|++||++. ++|||||..+|||++
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence 999999999 8999999953 44567789999999999999999 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCcccccccc--CCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCccc
Q 008898 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG--TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKA 457 (549)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~ 457 (549)
.+ ..+||+|||+|+............ -.| ...|||||.+....|+.++|||||||+||||+| |..|+..-..
T Consensus 453 ~~-~~~kIaDFGlar~~~~~~~y~~~~----~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 453 KN-KVIKIADFGLARDHYNKDYYRTKS----SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred CC-CEEEEccccceeccCCCCceEecC----CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 99 589999999997654433222111 112 335999999999999999999999999999999 6777765221
Q ss_pred chhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 458 NRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 458 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. ..+.. ...+|.. ...+..+...+.++++.||+.+|.+||++.++.+.|+.
T Consensus 528 ~-~~l~~----~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 528 T-EELLE----FLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred H-HHHHH----HHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 2 12211 2222221 12233445677888999999999999999999998877
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=244.58 Aligned_cols=200 Identities=24% Similarity=0.359 Sum_probs=166.4
Q ss_pred CCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--cCHHHHHHHHHHHh-cCCCCCeeeEEEEEEcCCeEEEEEeccCC
Q 008898 256 PKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLS-SIKHENIVRIIGYCHSKEMYAIVYNLLNG 331 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--~~~~~~~~E~~il~-~l~h~nIv~l~~~~~~~~~~~lv~e~~~g 331 (549)
....||+|+||.|=+-++ .+|...|+|.+...- ...++.++|+++.. ....|++|.+||........++.||.|.-
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 344599999999988877 679999999997553 33456788998755 45799999999998888999999999999
Q ss_pred CHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 332 SLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 332 sL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
||+.|.++ .++.-.-+|+.-+.+||.|||++. .|||||+||+|||++.+ |++|+||||.+-+..+
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~d----- 201 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYD-GQVKICDFGISGYLVD----- 201 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccC-CcEEEcccccceeehh-----
Confidence 99988754 566777889999999999999985 89999999999999999 8999999999855333
Q ss_pred cCccccccccCCcccccccccc----CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHH
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMY----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL 464 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~ 464 (549)
+...+...|.-.|||||.+.. ..|+-++||||||+.+.||.+++.|++......+.+.+
T Consensus 202 -SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 202 -SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred -hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 223333568889999998863 36999999999999999999999999988776555543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=257.25 Aligned_cols=237 Identities=32% Similarity=0.424 Sum_probs=189.4
Q ss_pred CceEEEEEEec-CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEeccCC-CHHHHHHH
Q 008898 264 GNSKVYRTNHV-DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQ 339 (549)
Q Consensus 264 ~fg~Vy~~~~~-~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~g-sL~~~l~~ 339 (549)
+||.||++... +|+.+|+|++...... .+.+.+|++.++.++|+||+++++++......++++|++.+ +|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999875 5899999999765432 46788999999999999999999999998999999999955 99999865
Q ss_pred ---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCC
Q 008898 340 ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416 (549)
Q Consensus 340 ---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~ 416 (549)
+++.....++.+++.++.|||+. +++|+||+|+||+++.+ +.++|+|||.+....... ......++.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~------~~~~~~~~~ 150 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDED-GHVKLADFGLARQLDPGG------LLTTFVGTP 150 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCC-CcEEEccccceeeecccc------ccccccCCc
Confidence 57788889999999999999999 99999999999999998 689999999986544321 223456888
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHH
Q 008898 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVM 496 (549)
Q Consensus 417 ~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 496 (549)
.|++||.+.+..++.++||||||+++|+|++|..||........ ... ....... . . ..........+.
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~---~~~~~~~-~----~---~~~~~~~~~~~~ 218 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFK---KIGKPKP-P----F---PPPEWKISPEAK 218 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHH---HHhccCC-C----C---ccccccCCHHHH
Confidence 99999999988899999999999999999999999976322211 111 1110000 0 0 000000345678
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 497 CAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 497 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+++.+|+..+|.+||++.++++ ++|+
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~-----~~~~ 244 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ-----HPFF 244 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh-----CCCC
Confidence 8899999999999999999998 6775
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=289.75 Aligned_cols=244 Identities=25% Similarity=0.405 Sum_probs=192.9
Q ss_pred CCCCceEcccCceEEEEEEe-cCC----cEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDG----QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g----~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
....++||.|+||+||+|.+ ..| -+||+|++..... ...+++.|+-+|.+|.|||+++|+++|.... +.||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 55677899999999999976 344 3789999865443 3578999999999999999999999998765 77888
Q ss_pred ecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 327 NLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 327 e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
+|+ .|.|.+|++. +.....+.+..|||+||.|||.. .++||||-.+|||+... .++|++|||+|+......
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCC-CeEEEEecchhhccCccc
Confidence 888 7899999964 66677889999999999999988 99999999999999887 589999999998765422
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.........-.+.|||-|.+....|+.++|||||||.+||++| |..|++....+. .. .+++.+.
T Consensus 853 ---~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~-dlle~ge------ 917 (1177)
T KOG1025|consen 853 ---KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----IP-DLLEKGE------ 917 (1177)
T ss_pred ---ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----hh-HHHhccc------
Confidence 1112222223568999999999999999999999999999998 889987654322 11 1111211
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 520 (549)
.-..++-+...+..++.+||..|+..||+++++...+
T Consensus 918 ---RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 918 ---RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred ---cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 1223445566677888999999999999999987644
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=282.00 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=177.1
Q ss_pred hcCCCCCceEcccCceEEEEEEe-----------------cCCcEEEEEEeecCCcC-H--------------HHHHHHH
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-----------------VDGQVAAVKVLKCTNWS-E--------------EEVLREV 298 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-----------------~~g~~~AvK~l~~~~~~-~--------------~~~~~E~ 298 (549)
.++|.+.++||+|+||.||+|.. .+++.||||.++..... . +....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999853 23568999998754321 1 1233467
Q ss_pred HHHhcCCCCCe-----eeEEEEEEc--------CCeEEEEEecc-CCCHHHHHHH-------------------------
Q 008898 299 ELLSSIKHENI-----VRIIGYCHS--------KEMYAIVYNLL-NGSLKQYLKQ------------------------- 339 (549)
Q Consensus 299 ~il~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~-~gsL~~~l~~------------------------- 339 (549)
.++.+++|.++ ++++++|.. .+..++||||+ +|+|.+++..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 667777743 35689999999 7889888742
Q ss_pred --hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCc
Q 008898 340 --LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417 (549)
Q Consensus 340 --~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~ 417 (549)
+.+..+..++.|+++||.|||+. +|+||||||+|||++.+ +.+||+|||++........ .......+|+.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~----~~~~~g~~tp~ 375 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGIN----FNPLYGMLDPR 375 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCC-CcEEEEeCcCccccccCCc----cCccccCCCcc
Confidence 13445677899999999999999 99999999999999998 6899999999865432211 11112235889
Q ss_pred cccccccccCC--------------------C--CchhhHHHHHHHHHHHHcCCC-CCCCcccch-------hhHHHHHH
Q 008898 418 YLAPEYMMYGK--------------------V--DEKIDVYSYGVVLLELITGKE-AIQTNKANR-------ESLVLWAR 467 (549)
Q Consensus 418 y~APE~~~~~~--------------------~--~~k~DvwSlGvil~elltG~~-p~~~~~~~~-------~~l~~~~~ 467 (549)
|+|||.+.... | ..+.||||+||++|+|++|.. |+....... ..+..|..
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 99999876432 1 234799999999999999975 664322111 11112211
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHhcCCchhhhh
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSS---SRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPs~~evl~~L~~~~~w~~~ 529 (549)
... ...+-.. .........+++..||..+| .+|+|+.++++ |+||..
T Consensus 456 ~~~------~~~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~-----Hp~f~~ 505 (507)
T PLN03224 456 YKG------QKYDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS-----HRFFLP 505 (507)
T ss_pred hcc------cCCCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC-----CCCcCC
Confidence 100 0011111 11223556777788888765 78999999999 999954
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=288.22 Aligned_cols=242 Identities=26% Similarity=0.359 Sum_probs=190.3
Q ss_pred CCCCceEcccCceE-EEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 008898 254 FSPKMLIGQGGNSK-VYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLLNG 331 (549)
Q Consensus 254 f~~~~~lG~G~fg~-Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~g 331 (549)
|...+++|.|+.|+ ||+|.. +|+.||||++-.+. ..-+.+|+..|+.- +|||||++|+.-.+....||..|+|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 55667899999985 699987 68899999886432 23467999999877 599999999999999999999999999
Q ss_pred CHHHHHHH--hch-----hHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec---C-CCceEEeeeccccccccc
Q 008898 332 SLKQYLKQ--LKW-----NERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---N-FHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 332 sL~~~l~~--~~~-----~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~-~~~~kL~DFGla~~~~~~ 400 (549)
+|.++++. ... ...+.+..|+++||++||+. +||||||||.||||+. + ...++|+|||+++.....
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 99999976 111 23466889999999999999 9999999999999986 2 136789999999876654
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcC-CCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG-KEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
...- ....+..||-+|+|||++....-+.++|||||||++|+.++| .+||......+.++.. ....+..+
T Consensus 665 ~sS~--~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~------~~~~L~~L- 735 (903)
T KOG1027|consen 665 KSSF--SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT------GNYTLVHL- 735 (903)
T ss_pred cchh--hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc------Cccceeee-
Confidence 3222 235577899999999999998888999999999999999997 8999877655433211 01001111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
... .++ ...+||..|+.++|..||++.+|+.
T Consensus 736 -----~~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 -----EPL-PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----ccC-chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 111 6778999999999999999999997
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=260.78 Aligned_cols=257 Identities=21% Similarity=0.266 Sum_probs=196.4
Q ss_pred HHHhhhcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEE
Q 008898 246 ELCHLTHNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCH 317 (549)
Q Consensus 246 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~ 317 (549)
++..-..+++...++-+|.||+||+|.+. +.+.+.+|.++..... ...+..|.-.+..++|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34444567888889999999999999543 3456667777643322 234678999999999999999999985
Q ss_pred c-CCeEEEEEecc-CCCHHHHHHH-----------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC
Q 008898 318 S-KEMYAIVYNLL-NGSLKQYLKQ-----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384 (549)
Q Consensus 318 ~-~~~~~lv~e~~-~gsL~~~l~~-----------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 384 (549)
+ ...-++++.++ -|+|..||.. .+..+...++.|++.|++|||+. +|||.||..+|++||+..
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L- 433 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL- 433 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe-
Confidence 4 45666667777 5899999962 44566778999999999999999 999999999999999994
Q ss_pred ceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHH
Q 008898 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLV 463 (549)
Q Consensus 385 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~ 463 (549)
++||+|-.+++..-+.++---+ .+......||+||.+.+..|+.++|+|||||+||||+| |+.|+..-++...
T Consensus 434 qVkltDsaLSRDLFP~DYhcLG---DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--- 507 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLG---DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--- 507 (563)
T ss_pred eEEeccchhccccCcccccccC---CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH---
Confidence 8999999998766554332111 11223557999999999999999999999999999998 8888876654321
Q ss_pred HHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 464 LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 464 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.-.+.+|. +-..+.++++.+..++..||+..|++||+++++..-|.+-|
T Consensus 508 ---~~ylkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 508 ---EHYLKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ---HHHHhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11222221 22235567888899999999999999999999998876533
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=258.12 Aligned_cols=267 Identities=23% Similarity=0.356 Sum_probs=200.0
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-----C---CCeeeEEEEEE----c
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----H---ENIVRIIGYCH----S 318 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-----h---~nIv~l~~~~~----~ 318 (549)
.+|...++||.|-|++||++.. .+.+.||+|+.+....-.+..+.||.+|+++. | .+||+|++.|. .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 6788999999999999999976 56789999999977655677889999999883 2 47999999985 4
Q ss_pred CCeEEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC---------
Q 008898 319 KEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH--------- 384 (549)
Q Consensus 319 ~~~~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------- 384 (549)
+.+.++|+|+++.+|..+++. ++......|+.||+.||.|||..| ||||-||||+|||+..+..
T Consensus 158 G~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~a 235 (590)
T KOG1290|consen 158 GQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAREA 235 (590)
T ss_pred CcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhhh
Confidence 568999999999999999965 777888999999999999999997 9999999999999943200
Q ss_pred --------------------------------------------------------------------------------
Q 008898 385 -------------------------------------------------------------------------------- 384 (549)
Q Consensus 385 -------------------------------------------------------------------------------- 384 (549)
T Consensus 236 ~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~ 315 (590)
T KOG1290|consen 236 GEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNEST 315 (590)
T ss_pred ccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccc
Confidence
Q ss_pred ----------------------------------------------------------------------------ceEE
Q 008898 385 ----------------------------------------------------------------------------HPQL 388 (549)
Q Consensus 385 ----------------------------------------------------------------------------~~kL 388 (549)
.+||
T Consensus 316 v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKI 395 (590)
T KOG1290|consen 316 VERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKI 395 (590)
T ss_pred hhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEE
Confidence 0122
Q ss_pred eeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCccc-----chhhHH
Q 008898 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-----NRESLV 463 (549)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~-----~~~~l~ 463 (549)
+|||-|.|.... .+.-+-|..|.|||++.+.+|+..+||||++|+++||.||...|+.... +.+.+.
T Consensus 396 aDlGNACW~~kh--------FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 396 ADLGNACWVHKH--------FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred eeccchhhhhhh--------hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 222222221110 0122457889999999999999999999999999999999999875332 233333
Q ss_pred HHHHHhh-------cccc-cccccCC----------c-------cc--ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 008898 464 LWARSLL-------SSGL-CERLIDP----------Q-------LN--EEYNREEIEIVMCAARLCLLHSSSRRPTMKTL 516 (549)
Q Consensus 464 ~~~~~~~-------~~~~-~~~~~d~----------~-------l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 516 (549)
...+.+. ..|. -.++.+. . +. -.++.++...+.+++.-||..+|++|||+.++
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 3332221 1111 1111111 0 11 23466788889999999999999999999999
Q ss_pred HHHhcCCchhhhhhhHH
Q 008898 517 LKLFQEPDYWLKMKREK 533 (549)
Q Consensus 517 l~~L~~~~~w~~~~~~~ 533 (549)
++ |+|+......
T Consensus 548 l~-----hPwLn~~~~~ 559 (590)
T KOG1290|consen 548 LK-----HPWLNPVAGP 559 (590)
T ss_pred hc-----CccccCCCCC
Confidence 99 9999855543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-31 Score=267.08 Aligned_cols=270 Identities=24% Similarity=0.310 Sum_probs=205.0
Q ss_pred CHHHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC------CCCeeeEEEE
Q 008898 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK------HENIVRIIGY 315 (549)
Q Consensus 243 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~------h~nIv~l~~~ 315 (549)
.+.--..+..+|.+....|+|-|+.|.+|.. ..|+.||||+|.....-.+.=+.|++||++|+ --|+++|+..
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3333344567888888999999999999976 45889999999865543345568999999996 2478999999
Q ss_pred EEcCCeEEEEEeccCCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEe
Q 008898 316 CHSKEMYAIVYNLLNGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389 (549)
Q Consensus 316 ~~~~~~~~lv~e~~~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~ 389 (549)
|...+++|+|+|.+.-+|.+.|+. +.......++.|+.-||..|... +|+|.||||+|||+++....+|||
T Consensus 503 F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence 999999999999999999999987 44556778999999999999998 999999999999999887789999
Q ss_pred eeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHH--
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR-- 467 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~-- 467 (549)
|||.|.......- +...-+..|.|||++.|-.|+...|+||.||.||||.||+-.|.+...++.. ..++.
T Consensus 580 DfGSA~~~~enei-------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML-rl~me~K 651 (752)
T KOG0670|consen 580 DFGSASFASENEI-------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML-RLFMELK 651 (752)
T ss_pred cCccccccccccc-------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH-HHHHHhc
Confidence 9999966443211 1112234699999999999999999999999999999999999887755432 11111
Q ss_pred -----Hhhcccc-cc--------------------------cccCC------ccc--ccCCH---HHHHHHHHHHHHhcc
Q 008898 468 -----SLLSSGL-CE--------------------------RLIDP------QLN--EEYNR---EEIEIVMCAARLCLL 504 (549)
Q Consensus 468 -----~~~~~~~-~~--------------------------~~~d~------~l~--~~~~~---~~~~~l~~li~~Cl~ 504 (549)
.++..+. .. ..+.| .+. ..++. .....+.+|+..||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 1111110 00 01111 000 11222 334567889999999
Q ss_pred cCCCCCCCHHHHHHHhcCCchhhh
Q 008898 505 HSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 505 ~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
.||++|.|..+.|+ |+||.
T Consensus 732 LdP~KRit~nqAL~-----HpFi~ 750 (752)
T KOG0670|consen 732 LDPEKRITVNQALK-----HPFIT 750 (752)
T ss_pred cChhhcCCHHHHhc-----CCccc
Confidence 99999999999998 77764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=253.85 Aligned_cols=278 Identities=23% Similarity=0.325 Sum_probs=211.0
Q ss_pred HHHhhhcCCCCCceEcccCceEEEEEEe-c---CCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCC
Q 008898 246 ELCHLTHNFSPKMLIGQGGNSKVYRTNH-V---DGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKE 320 (549)
Q Consensus 246 el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~---~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~ 320 (549)
.+..+.+.|..+++||+|.|+.||++.. . ..+.+|+|.+.... ....+..|+++|..+. +.||+++.+++..++
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445667899999999999999999955 2 46799999987543 3467899999999995 999999999999999
Q ss_pred eEEEEEecc-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 321 MYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
...+|++|+ ..+..+++..++..++..++..+..||.++|.+ |||||||||+|+|.+...+.-.|.|||+|.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999 567899999999999999999999999999999 9999999999999998877788999999973111
Q ss_pred cc------c---------------------------------cccCccccccccCCcccccccccc-CCCCchhhHHHHH
Q 008898 400 SH------Q---------------------------------VSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYG 439 (549)
Q Consensus 400 ~~------~---------------------------------~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlG 439 (549)
.. . ...........||++|.|||++.. ..-+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 000011124679999999999874 4578999999999
Q ss_pred HHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc---------c--ccc---------------ccC-Ccccc-------
Q 008898 440 VVLLELITGKEAIQTNKANRESLVLWARSLLSSG---------L--CER---------------LID-PQLNE------- 485 (549)
Q Consensus 440 vil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---------~--~~~---------------~~d-~~l~~------- 485 (549)
||++-+++++.||-....+-+.+.+.+....... . +.+ -++ ..+..
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999999776655554444332221111 1 000 000 00000
Q ss_pred --cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 486 --EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 486 --~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
....-.+..+++++.+|+..||.+|.|+++.|+ |++|....+
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk-----HpFF~~~~~ 389 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALK-----HPFFDEADR 389 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhc-----CcCCcchhh
Confidence 001112237889999999999999999999999 888875443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=261.92 Aligned_cols=191 Identities=23% Similarity=0.402 Sum_probs=165.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHH---------HHHHHHHHHhcCC---CCCeeeEEEEEEc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEE---------EVLREVELLSSIK---HENIVRIIGYCHS 318 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~---------~~~~E~~il~~l~---h~nIv~l~~~~~~ 318 (549)
.+|...+.+|+|+||.|++|.+ .+...|+||.+.++..-.+ .+-.|+.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4588889999999999999987 4567899999987653322 2456999999997 9999999999999
Q ss_pred CCeEEEEEeccC-C-CHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecc
Q 008898 319 KEMYAIVYNLLN-G-SLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (549)
Q Consensus 319 ~~~~~lv~e~~~-g-sL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGl 393 (549)
++.|||++|.-+ | +|++++. ++.+.+...|+.||+.|+++||.. +|||||||-+|+.++.+ |.+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~-g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSN-GFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecC-CeEEEeeccc
Confidence 999999999873 3 7999995 488889999999999999999999 99999999999999999 8999999999
Q ss_pred ccccccccccccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCC
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQ 453 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~ 453 (549)
|.+.. +.....++||..|.|||++.|.+| +..-|||++|++||-++....||.
T Consensus 717 aa~~k-------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTK-------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhc-------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 86533 334457899999999999999988 567899999999999999888875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=244.64 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=194.7
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEc------CCe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHS------KEM 321 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~~~ 321 (549)
.+|...+.+|.|.- .|..+.. ..++.+|+|.+.... ...+...+|...+..++|+||++++.+|.- -..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777778899988 5555533 568899999875332 223567899999999999999999998842 347
Q ss_pred EEEEEeccCCCHHHHHH-HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 322 YAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~-~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
+|+|||+|.++|.+.+. +++-.....+++|+++|++|||+. +|+||||||+||++..+ ..+||.|||+|+.....
T Consensus 96 ~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSD-CTLKILDFGLARTEDTD 171 (369)
T ss_pred HHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecch-hheeeccchhhcccCcc
Confidence 89999999999998875 355666778999999999999999 99999999999999999 58999999999643322
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc-----
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC----- 475 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~----- 475 (549)
...+..+.|..|.|||++.+..|.+.+||||+||++.||++|.-.|.+.. .+.+|.+.....|..
T Consensus 172 ------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d----~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 172 ------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD----HIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred ------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch----HHHHHHHHHHHhcCCCHHHH
Confidence 34456678999999999999889999999999999999999998887432 233333332222211
Q ss_pred -----------------------ccccCCcccc--cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 476 -----------------------ERLIDPQLNE--EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 476 -----------------------~~~~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
..+.|..... ..+.-......+++.+||-.||++|.+++++|+ |++++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~-----HPY~~ 314 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR-----HPYIK 314 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc-----CCeee
Confidence 0111111111 011123355778889999999999999999999 77665
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=247.70 Aligned_cols=263 Identities=23% Similarity=0.341 Sum_probs=191.2
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----eE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKE-----MY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~~ 322 (549)
.+.++.+.||-|+||.||.+.+ .+|+.+|+|.+..-. .+.+.+.+|+.+|..++|.|++..+++.+-.. .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3567888999999999999976 789999999886432 23467899999999999999999887664432 46
Q ss_pred EEEEeccCCCHHHHH---HHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 323 AIVYNLLNGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 323 ~lv~e~~~gsL~~~l---~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
|++.|++..+|...+ +.++.....-+.+||++||.|||+. +|.||||||.|.|+++|. .+||||||+|+....
T Consensus 133 YV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCc-eEEecccccccccch
Confidence 677788888888887 3477777888999999999999999 999999999999999994 899999999976543
Q ss_pred ccccccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc------
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS------ 472 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~------ 472 (549)
.. ....+..+-|-.|.|||+++|.. |+.++||||.|||+.||+..+-.|+...+.+ .+.+....+.-.
T Consensus 209 d~----~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq-QL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 209 RD----RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE-QLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred hh----hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH-HHHHHHHHhCCCcHHHHH
Confidence 21 11122334578999999999864 8999999999999999999998888766522 222221111100
Q ss_pred ----cccc-----cccCCcccccC---C-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 473 ----GLCE-----RLIDPQLNEEY---N-REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 473 ----~~~~-----~~~d~~l~~~~---~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
|... ....|.+.--| + ...-...+.+...++..||+.|.+..+.+..+..+
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 0000 00111111000 1 11123345567789999999999999988755433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=226.90 Aligned_cols=204 Identities=36% Similarity=0.571 Sum_probs=177.2
Q ss_pred EcccCceEEEEEEec-CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEeccC-CCHHH
Q 008898 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQ 335 (549)
Q Consensus 260 lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~-gsL~~ 335 (549)
||+|++|.||++... +++.+++|++...... ...+.+|+.+++.+.|++++++++++......++++|++. ++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999874 4899999999866542 4678899999999999999999999999899999999996 89999
Q ss_pred HHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec-CCCceEEeeeccccccccccccccCcccc
Q 008898 336 YLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVHHQSHQVSENVKPV 410 (549)
Q Consensus 336 ~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 410 (549)
++.. +++..+..++.+++.+|.|||+. +++|+||+|.||+++. + +.++|+|||.+........ ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~-----~~~ 151 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKS-----LLK 151 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcc-----hhh
Confidence 9864 57788899999999999999999 9999999999999998 6 6899999999865443211 122
Q ss_pred ccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCH
Q 008898 411 NVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNR 489 (549)
Q Consensus 411 ~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 489 (549)
...+...|++||.+... .++.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 34578899999998877 788999999999999999
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008898 490 EEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519 (549)
Q Consensus 490 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 519 (549)
..+.+++..|+..+|.+||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 457788899999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-29 Score=235.40 Aligned_cols=251 Identities=20% Similarity=0.299 Sum_probs=190.8
Q ss_pred hhhcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEE-EEEcCCeEEEE
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIG-YCHSKEMYAIV 325 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~-~~~~~~~~~lv 325 (549)
.+.+.|.+.+.||+|.||++.+++|. +...+++|.+........+|.+|...--.| .|.||+.-|+ .|++.+.|+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34567899999999999999999984 477899999988777888999998865555 4899998775 56788899999
Q ss_pred Eecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE-ecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL-SENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl-~~~~~~~kL~DFGla~~~~~~~ 401 (549)
+||+ .|+|...+.. +.+.....++.|++.|+.|+|++ +++|||||.+|||| +.|+..+||||||+......
T Consensus 101 qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-- 175 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-- 175 (378)
T ss_pred eccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence 9999 7999988854 55666678999999999999999 99999999999998 56667899999999743222
Q ss_pred ccccCccccccccCCcccccccccc---CC--CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMY---GK--VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~---~~--~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
.......+..|.|||.... +. .++.+|+|.||+++|.+|||..||+.....+.....|.........
T Consensus 176 ------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 176 ------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred ------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 2222334567999997653 22 4788999999999999999999999655555555555554433221
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.-|.....+ .+.++.+.++-+.++|.+|=-+.+..+
T Consensus 248 --~~P~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 248 --ALPKKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred --cCchhhccc----CHHHHHHHHHhcCCcccccchhHHHHH
Confidence 112222222 345566778899999999954444443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=261.83 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=200.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++|.....+|.|.||.|||+++ ..++..|+|+++..... ..-+..|+-+++..+||||+.++|.+-..+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46789999999999999999977 67999999999976533 34567899999999999999999999999999999999
Q ss_pred c-CCCHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 L-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~-~gsL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
| +|+|.+... .+++.++..++...++||.|||+. +=+|||||-.|||+++. |.+||+|||.+... ..
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~-gDvklaDfgvsaqi-----ta 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDE-GDVKLADFGVSAQI-----TA 164 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---Ccccccccccceeeccc-CceeecccCchhhh-----hh
Confidence 9 568877653 377778888999999999999999 99999999999999999 79999999987322 23
Q ss_pred cCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 405 ENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.-.+...+.||+.|||||+.. .+.|+..+|||++|+...|+---++|.....+.+..+.+ .+ ...+|
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-Tk---------S~~qp 234 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-TK---------SGFQP 234 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-hc---------cCCCC
Confidence 334556789999999999864 567999999999999999998888887776665543322 11 11122
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.-.. -.....+.+-++++.|+..+|.+|||++.+++
T Consensus 235 p~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Cccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 12344567888899999999999999998887
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=278.87 Aligned_cols=203 Identities=18% Similarity=0.214 Sum_probs=143.6
Q ss_pred cCCC-CCeeeEEEEE-------EcCCeEEEEEeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEe
Q 008898 303 SIKH-ENIVRIIGYC-------HSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370 (549)
Q Consensus 303 ~l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHr 370 (549)
.++| +||.+++++| ...+.+++++|+++++|.+++.. +++.+.+.++.||++||.|||++ +|+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 4455 5778888877 33457888899999999999953 77888999999999999999999 99999
Q ss_pred cCCCCCEEEecC------------------CCceEEeeeccccccccccc-----c------ccCccccccccCCccccc
Q 008898 371 DVKSSNILLSEN------------------FHHPQLSDFGAAMVHHQSHQ-----V------SENVKPVNVVGTFGYLAP 421 (549)
Q Consensus 371 Dlkp~NILl~~~------------------~~~~kL~DFGla~~~~~~~~-----~------~~~~~~~~~~gt~~y~AP 421 (549)
||||+||||+.. .+.+|++|||+++....... . ..........||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999643 13456666666543211000 0 000011224689999999
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHH
Q 008898 422 EYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARL 501 (549)
Q Consensus 422 E~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~ 501 (549)
|++.+..|+.++|||||||+||||++|.+|+..... ....+... ...+... ........++..
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~---------~~~~~~~-----~~~~~~~~~~~~ 247 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHR---------VLPPQIL-----LNWPKEASFCLW 247 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHh---------hcChhhh-----hcCHHHHHHHHH
Confidence 999999999999999999999999999888653221 11111110 1111110 112234567788
Q ss_pred hcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 502 CLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 502 Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
||.++|.+||++.++++ |+|+...
T Consensus 248 ~L~~~P~~Rps~~eil~-----h~~~~~~ 271 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQ-----SEFINEP 271 (793)
T ss_pred hCCCChhhCcChHHHhh-----chhhhhh
Confidence 99999999999999998 8998653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=223.56 Aligned_cols=193 Identities=37% Similarity=0.514 Sum_probs=165.6
Q ss_pred CCCCceEcccCceEEEEEEecC-CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEeccC
Q 008898 254 FSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLN 330 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~~-g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 330 (549)
|...+.||.|++|.||++.+.+ ++.+|+|.+..... ..+.+.+|++.++.++|+|++++++++...+..++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567789999999999998854 88999999986554 34678899999999999999999999999899999999995
Q ss_pred C-CHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 G-SLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 g-sL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+ +|.+++.. +++.....++.+++.++.|||+. +++|+||+|.||+++.+ +.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~---- 152 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDL---- 152 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcc----
Confidence 5 99999865 67777889999999999999999 99999999999999998 689999999986654321
Q ss_pred CccccccccCCcccccccc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008898 406 NVKPVNVVGTFGYLAPEYM-MYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~-~~~~~~~k~DvwSlGvil~elltG~~p~~~ 454 (549)
........++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0122345678899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=209.76 Aligned_cols=165 Identities=22% Similarity=0.235 Sum_probs=124.3
Q ss_pred CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 331 gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
|+|.+++.. +++.+++.++.||+.||.|||+. + ||+|||++.+ +.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~-~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWD-GLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCc-cceee--ccceEeeccc------
Confidence 789999863 78899999999999999999998 5 9999999998 68888 9998654321
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
...||+.|||||++.+..++.++|||||||++|||++|+.||.........+..+....... ++.. ..
T Consensus 63 ----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~ 130 (176)
T smart00750 63 ----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD-------DPRD-RS 130 (176)
T ss_pred ----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC-------Cccc-cc
Confidence 12589999999999999999999999999999999999999976543222222222211110 0000 01
Q ss_pred CCHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 487 YNREEIE--IVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 487 ~~~~~~~--~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
....... .+.+++..||..+|.+||++.++++ |.|+...
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~-----~~~~~~~ 171 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLA-----HCRALFA 171 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHH-----HHHHHHH
Confidence 1122222 5889999999999999999999999 5565543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-23 Score=212.83 Aligned_cols=256 Identities=21% Similarity=0.228 Sum_probs=190.0
Q ss_pred CCCCCceEcccCceEEEEEEecC--CcEEEEEEeecCCcC-HHHHHHHHHHHhcCCC----CCeeeEEEEE-EcCCeEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHVD--GQVAAVKVLKCTNWS-EEEVLREVELLSSIKH----ENIVRIIGYC-HSKEMYAI 324 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~~--g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h----~nIv~l~~~~-~~~~~~~l 324 (549)
+|.+.+.||+|+||.||.+.... ...+|+|+....... ...+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999998744 358899988754322 1267789999888863 6889999888 57888999
Q ss_pred EEeccCCCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC----CceEEeeecccc
Q 008898 325 VYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF----HHPQLSDFGAAM 395 (549)
Q Consensus 325 v~e~~~gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~~kL~DFGla~ 395 (549)
||+.++.+|.++.. +++..+.+.++.|++.+|++||+. |++||||||+|+++.... ..+.|.|||+|+
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 99999999999883 477888999999999999999999 999999999999997542 358999999997
Q ss_pred ccc--ccccc--ccC-ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh
Q 008898 396 VHH--QSHQV--SEN-VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 396 ~~~--~~~~~--~~~-~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
... ..... ... .....+.||..|.++....+...+.+-|+||++.++.||+.|..||........ ........
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~- 253 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP- 253 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh-
Confidence 322 11111 111 112356799999999999999999999999999999999999999976553221 11111111
Q ss_pred cccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 471 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
....... +....+..+.++...+-..+...+|....+...|++
T Consensus 254 ----~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 254 ----RKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred ----hhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 0011110 111223344445555666899999999999887644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=238.47 Aligned_cols=262 Identities=21% Similarity=0.249 Sum_probs=196.3
Q ss_pred CCCceEcccCceEEEEEEe-cCCcEEEEEEeec---CCcCHH----HHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 255 SPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKC---TNWSEE----EVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 255 ~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~---~~~~~~----~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
....++|.|++|.|+.... .....++.|.... ...... .+..|..+-..++|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999998877754 3444455554331 111111 2556888888999999988877776666666669
Q ss_pred eccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 327 NLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 327 e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
||+.++|..++.. +...++..++.|++.|+.|||.. ||.|||+|++|++++.+ +.+||+|||.+.++......
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecC-CceEEeecCcceeeccCcch
Confidence 9997799999855 77788888999999999999999 99999999999999999 69999999999776543221
Q ss_pred ccCccccccccCCccccccccccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDE-KIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~-k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......++|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......+..+. .. ......-...
T Consensus 477 -~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----~~---~~~~~~~~~~ 548 (601)
T KOG0590|consen 477 -NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----TN---NYSDQRNIFE 548 (601)
T ss_pred -hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----hh---cccccccccc
Confidence 124455789999999999999999975 68999999999999999999987766544320 00 0011111111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
-........+.....++..||+.||.+|.|+.+|++ .+|++....+
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~-----d~W~~~i~~c 594 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN-----DEWIRSIECC 594 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh-----ChHhhhcceE
Confidence 112234466777888999999999999999999999 7999876543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-22 Score=198.74 Aligned_cols=254 Identities=29% Similarity=0.406 Sum_probs=190.2
Q ss_pred CCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCC-CeeeEEEEEEcCCeEEEEEec
Q 008898 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHE-NIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~-nIv~l~~~~~~~~~~~lv~e~ 328 (549)
|.....||.|+||.||++... ..+++|.+...... ...+.+|+.+++.+.|+ +++++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566778999999999999876 78899999765432 45688999999999988 799999999877778999999
Q ss_pred c-CCCHHHHHH------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 329 L-NGSLKQYLK------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 329 ~-~gsL~~~l~------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
+ ++++.+++. .+.......++.|++.++.|+|+. +++|||+||+||+++.....++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9 567887775 366677888999999999999999 999999999999999883269999999987443322
Q ss_pred ccccC-ccccccccCCcccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcccc---hhhHHHHHHHhhcccc
Q 008898 402 QVSEN-VKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKAN---RESLVLWARSLLSSGL 474 (549)
Q Consensus 402 ~~~~~-~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~ 474 (549)
..... .......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... ...... +.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~----~~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI----ILELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH----HHhcCC
Confidence 11111 13456789999999999987 57889999999999999999999997665531 111111 111110
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
. .................+.+++..|+..+|..|.+..+...
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 233 P--SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred c--ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 0 00000000000222356778889999999999999998776
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=215.29 Aligned_cols=167 Identities=18% Similarity=0.182 Sum_probs=127.0
Q ss_pred hhhcCCCCCceEcccCceEEEEEEec--CCcEEEEEEeecCC------cCHHHHHHHHHHHhcCCCCCeee-EEEEEEcC
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNHV--DGQVAAVKVLKCTN------WSEEEVLREVELLSSIKHENIVR-IIGYCHSK 319 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~g~~~AvK~l~~~~------~~~~~~~~E~~il~~l~h~nIv~-l~~~~~~~ 319 (549)
.+.++|...+.||+|+||+||+|.+. +++.+|||++.... .....+.+|+++|+.++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34578999999999999999999763 57888999875321 11345889999999999999985 4432
Q ss_pred CeEEEEEecc-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecC-CCCCEEEecCCCceEEeeecccccc
Q 008898 320 EMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV-KSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+..+++|||+ +++|.. +... ....++.++++||.|||+. ||+|||| ||+|||++.+ +.++|+|||+|...
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~~---~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARPH---GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPD-GEAAVIDFQLASVF 162 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCcc---chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCC-CCEEEEECccceec
Confidence 4579999999 556752 2211 1256788999999999999 9999999 9999999887 68999999999866
Q ss_pred cccccccc---CccccccccCCccccccccccC
Q 008898 398 HQSHQVSE---NVKPVNVVGTFGYLAPEYMMYG 427 (549)
Q Consensus 398 ~~~~~~~~---~~~~~~~~gt~~y~APE~~~~~ 427 (549)
........ .....+..+++.|+|||.+...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 54321111 1122467899999999998643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=187.64 Aligned_cols=258 Identities=21% Similarity=0.235 Sum_probs=188.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-ENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
...|...+.||.|+||.+|.|.. .+|..||||+-.... ...++..|..+.+.|++ ..|..+..|..+...-.+||++
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 45799999999999999999977 679999999865432 33567889999999975 6777888888899999999999
Q ss_pred cCCCHHHHH----HHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeeccccccccccc
Q 008898 329 LNGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~~gsL~~~l----~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla~~~~~~~~ 402 (549)
++.+|++.+ +.++..+.+.++-|++.-++|+|.. ++|||||||+|+|..-+ ...+.|+|||+|+.......
T Consensus 93 LGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 93 LGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred cCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 999988877 4578888899999999999999999 99999999999998643 23578999999976544321
Q ss_pred cc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 403 VS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 403 ~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.. .........||..|.+--...+..-+..-|+-|+|.+|..+.-|..||++...... .+-.+.+.+.. ..-. -
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk--~QKyEkI~EkK-~s~~-i 245 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK--KQKYEKISEKK-MSTP-I 245 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH--HHHHHHHHHhh-cCCC-H
Confidence 11 11122356899999988877777788999999999999999999999998765221 01111111110 0000 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 520 (549)
..+-..++. .+.-.+..|-..--++-|...-+-+++
T Consensus 246 e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 246 EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 111223333 344445678777777778766554443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=192.05 Aligned_cols=201 Identities=18% Similarity=0.263 Sum_probs=167.4
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEeccC
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLLN 330 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 330 (549)
.|.+.+.||+|+||..+.|.. -+++.||||.-.. .....++..|....+.|. .++|...|-|-.++-.-.+|+|+++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLG 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLG 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhC
Confidence 699999999999999999965 7899999996542 223356788998888885 6899988888888888999999999
Q ss_pred CCHHHHH----HHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC----CCceEEeeeccccccccccc
Q 008898 331 GSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN----FHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 331 gsL~~~l----~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~~kL~DFGla~~~~~~~~ 402 (549)
.||++.+ ++++..+...+|.|++.-++|+|++ .+|+|||||+|+||... ...+.++|||+|+.......
T Consensus 108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 9988877 4688899999999999999999999 99999999999999632 23578999999976544321
Q ss_pred cc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCccc
Q 008898 403 VS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (549)
Q Consensus 403 ~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~ 457 (549)
.. .-.......||.+||+--..++.+-+..-|+-|||=++..+|-|..||+....
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 11 11122356799999999999999999999999999999999999999998765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-22 Score=216.42 Aligned_cols=251 Identities=20% Similarity=0.210 Sum_probs=177.0
Q ss_pred CCCCCceEcccCceEEEEEEecCCcEEEEEEeecCC--cCHHHH---HHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN--WSEEEV---LREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~--~~~~~~---~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+|...+.||.+.|=+|.++++..|. ++||++-+.. .+...+ .+|++ ...++|||++++.-+..++.-.|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667788999999999999988887 8899985443 233333 44555 566789999999888888888889999
Q ss_pred ccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc-ccc
Q 008898 328 LLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS-HQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~-~~~ 403 (549)
|...+|++.+.. +...+..-|+.|++.||..+|.. ||+|+|||.+||||+.- ..+.|+||..-+...-. +..
T Consensus 102 yvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeee-chhhhhcccccCCccCCCCCc
Confidence 999999999965 44556677999999999999999 99999999999999988 58999999765332111 100
Q ss_pred ccC-ccccccccCCccccccccccC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhh
Q 008898 404 SEN-VKPVNVVGTFGYLAPEYMMYG----------K-VDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 404 ~~~-~~~~~~~gt~~y~APE~~~~~----------~-~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
.+. ....+-..-.+|+|||.|... . .+++.||||+||+++||++ |++||.-. ++..+. -.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr--~~ 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYR--SG 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHh--cc
Confidence 000 001111223479999988642 1 5678999999999999988 68887421 111110 00
Q ss_pred cccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 471 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.....+..+... +-..+..++..|++.||.+|.++++.|+.-.+.-
T Consensus 251 ~~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 251 NADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred CccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 000111110000 0124677889999999999999999999766654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6e-22 Score=208.46 Aligned_cols=226 Identities=24% Similarity=0.294 Sum_probs=176.2
Q ss_pred EcccCceEEEEEEe----cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 260 IGQGGNSKVYRTNH----VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 260 lG~G~fg~Vy~~~~----~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+|+|+||+|+++.. ..|..+|+|++++..... .....|..++...+ ||+++++.-.++.+...++++++. +
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999998732 347899999987643221 24556888888887 999999999999999999999999 5
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|.|...+.. +.+.....+...++-|++.+|+. +|+|||+|++||+++.+ |++++.|||+++..-...
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~------ 151 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEK------ 151 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeeccc-CccccCCchhhhHhHhhh------
Confidence 688877754 44455556677888999999999 99999999999999999 899999999986543211
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
..|||..|||||++. .+..++|+||||++++||+||-.||.... ...+. . .....
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~---------~~~Il---------~--~~~~~ 206 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT---------MKRIL---------K--AELEM 206 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH---------HHHHh---------h--hccCC
Confidence 118999999999988 67889999999999999999999998611 11111 1 11234
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHh
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTM--KTLLKLF 520 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~--~evl~~L 520 (549)
+.........+++.++..+|.+|.-. ..+.+.+
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 56667778888899999999999866 3444443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=175.85 Aligned_cols=191 Identities=14% Similarity=0.144 Sum_probs=141.7
Q ss_pred CCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHH-----HHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEe
Q 008898 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEE-----EVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~-----~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+.....|++|+||+||.+.. ++.+++.+.+..+.+... -+.+|+++|++|. |+++.+++++ +..+++|+
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999998765 778888888876665433 4678999999995 5889999886 34689999
Q ss_pred ccCC-CHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecC-CCCCEEEecCCCceEEeeecccccccccccc--
Q 008898 328 LLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV-KSSNILLSENFHHPQLSDFGAAMVHHQSHQV-- 403 (549)
Q Consensus 328 ~~~g-sL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~~kL~DFGla~~~~~~~~~-- 403 (549)
|+.| +|.+.+.. ....++.|++.+|.++|+. ||+|||| ||+|||++.+ +.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~----~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 79 YLAGAAMYQRPPR----GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eecCccHHhhhhh----hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchHHH
Confidence 9855 67654322 2245778999999999999 9999999 7999999988 68999999999754432210
Q ss_pred --c-cC---ccccccccCCccccccccccC-CCC-chhhHHHHHHHHHHHHcCCCCCCCccc
Q 008898 404 --S-EN---VKPVNVVGTFGYLAPEYMMYG-KVD-EKIDVYSYGVVLLELITGKEAIQTNKA 457 (549)
Q Consensus 404 --~-~~---~~~~~~~gt~~y~APE~~~~~-~~~-~k~DvwSlGvil~elltG~~p~~~~~~ 457 (549)
. .. ........++.|++|+...-- ..+ ...++++.|+.+|.++|++.+.-.+.+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 00 000112367888888764422 333 578999999999999999988765544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-21 Score=183.94 Aligned_cols=170 Identities=16% Similarity=0.200 Sum_probs=130.9
Q ss_pred hhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHH----------HHHHHHHHhcCCCCCeeeEEEEEEc
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE----------VLREVELLSSIKHENIVRIIGYCHS 318 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~----------~~~E~~il~~l~h~nIv~l~~~~~~ 318 (549)
.+.++|+..++||.|+||.||+... +++.+|+|++.......+. +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3467899999999999999999765 5778999999754433222 5789999999999999999887653
Q ss_pred C--------CeEEEEEeccCC-CHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEe
Q 008898 319 K--------EMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389 (549)
Q Consensus 319 ~--------~~~~lv~e~~~g-sL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~ 389 (549)
. ...+++|||+.| +|.++.. .+. ....+++.+|..||.. |++|||+||+||+++++ + ++|+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~-g-i~li 176 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN-G-LRII 176 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC-C-EEEE
Confidence 2 358899999966 7877632 221 3456999999999999 99999999999999988 6 9999
Q ss_pred eeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHH
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ell 446 (549)
|||........ .. ...+++...|+.++|+|+||+.+..+.
T Consensus 177 Dfg~~~~~~e~-------~a----------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQR-------KA----------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccch-------hh----------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99987432111 00 011355566778999999999887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-19 Score=179.45 Aligned_cols=225 Identities=18% Similarity=0.235 Sum_probs=143.8
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCC-----------CCeeeEEE---
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKH-----------ENIVRIIG--- 314 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h-----------~nIv~l~~--- 314 (549)
+.....||.|+|+.||.+.+ .+|+.+|+|++...... .+++.+|.-....+.+ ..++++--
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 34566899999999999988 56999999998644322 2445555544444322 12222110
Q ss_pred -----EEEcC---C-----eEEEEEeccCCCHHHHHHH----------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEec
Q 008898 315 -----YCHSK---E-----MYAIVYNLLNGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371 (549)
Q Consensus 315 -----~~~~~---~-----~~~lv~e~~~gsL~~~l~~----------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrD 371 (549)
++... + .++++|+-+.++|.+++.- .....++.+..|+++.+++||+. |++|+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 12211 1 3467888888999888743 22334456678999999999999 999999
Q ss_pred CCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccC--------CCCchhhHHHHHHHHH
Q 008898 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG--------KVDEKIDVYSYGVVLL 443 (549)
Q Consensus 372 lkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~~~k~DvwSlGvil~ 443 (549)
|+|+|++++.+ |.+.|+||+......... .....+..|.+||..... .++.+.|.|+||+++|
T Consensus 171 i~~~nfll~~~-G~v~Lg~F~~~~r~g~~~--------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 171 IKPENFLLDQD-GGVFLGDFSSLVRAGTRY--------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp -SGGGEEE-TT-S-EEE--GGGEEETTEEE--------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred cceeeEEEcCC-CCEEEcChHHHeecCcee--------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999 799999998764433211 112335679999976432 4788999999999999
Q ss_pred HHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCC
Q 008898 444 ELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRR 510 (549)
Q Consensus 444 elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 510 (549)
.|.||+.||.......... ..+ .... +.++.+..+|..+|++||.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~------------------~~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPE------------------WDF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSG------------------GGG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCcccccc------------------ccc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999998664422100 011 2223 778899999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-21 Score=181.11 Aligned_cols=234 Identities=18% Similarity=0.342 Sum_probs=178.0
Q ss_pred eEcccCceEEEEEEecCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCHH
Q 008898 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~ 334 (549)
+|.+...|..|+|++. |..+++|+++..... ..+|..|.-.|+-+.||||++++|.|.....+.++..|| .|+|+
T Consensus 197 kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 4778888999999985 445667888655433 357889999999999999999999999999999999999 79999
Q ss_pred HHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEE-EecCCCCCEEEecCCCceEEe--eeccccccccccccccC
Q 008898 335 QYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPII-HRDVKSSNILLSENFHHPQLS--DFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 335 ~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~ii-HrDlkp~NILl~~~~~~~kL~--DFGla~~~~~~~~~~~~ 406 (549)
..+.. .+..+..+++.+|+.|+.|||+.. ++| ---|.+..+++|++. ..+|. |--++ ...
T Consensus 276 nvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedl-tarismad~kfs--------fqe- 343 (448)
T KOG0195|consen 276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDL-TARISMADTKFS--------FQE- 343 (448)
T ss_pred HHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchh-hhheecccceee--------eec-
Confidence 99964 456788899999999999999983 444 446889999999984 56653 43222 111
Q ss_pred ccccccccCCccccccccccCCCC---chhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVD---EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~---~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
....-.|.||+||.+...+-+ .++|+|||++++|||.|..-||....+..-.. ++.-+.+
T Consensus 344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------------kialegl 406 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------------KIALEGL 406 (448)
T ss_pred ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------------hhhhccc
Confidence 122346789999999866543 57999999999999999999998776532111 1111223
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...+++.....+..++.-|+..||.+||.+..|+-+|++
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 334445555678888899999999999999999888764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-20 Score=172.93 Aligned_cols=133 Identities=17% Similarity=0.217 Sum_probs=101.5
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcCH---------------------------HHHHHHHHHHhcCCCCCe
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---------------------------EEVLREVELLSSIKHENI 309 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~---------------------------~~~~~E~~il~~l~h~nI 309 (549)
...||+|+||.||+|...+|+.||||+++...... .....|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999988789999999997642210 112349999999987776
Q ss_pred eeEEEEEEcCCeEEEEEeccCCC-HHHH-HH--HhchhHHHHHHHHHHHHHHHH-HhCCCCCEEEecCCCCCEEEecCCC
Q 008898 310 VRIIGYCHSKEMYAIVYNLLNGS-LKQY-LK--QLKWNERMDVAIGVAKALEYL-HHTCDPPIIHRDVKSSNILLSENFH 384 (549)
Q Consensus 310 v~l~~~~~~~~~~~lv~e~~~gs-L~~~-l~--~~~~~~~~~i~~~i~~aL~yL-H~~~~~~iiHrDlkp~NILl~~~~~ 384 (549)
.....+... ..++||||++|+ +... +. .++......++.|++.+|.|| |+. +|+||||||+|||+++ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~--~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD--G 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC--C
Confidence 433332222 237999999654 4333 22 366777889999999999999 688 9999999999999985 4
Q ss_pred ceEEeeeccccc
Q 008898 385 HPQLSDFGAAMV 396 (549)
Q Consensus 385 ~~kL~DFGla~~ 396 (549)
.++|+|||+|..
T Consensus 155 ~v~LiDFG~a~~ 166 (190)
T cd05147 155 KLYIIDVSQSVE 166 (190)
T ss_pred cEEEEEcccccc
Confidence 799999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.1e-19 Score=167.52 Aligned_cols=134 Identities=22% Similarity=0.253 Sum_probs=103.8
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcC---------------------------HHHHHHHHHHHhcCCCCCe
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---------------------------EEEVLREVELLSSIKHENI 309 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---------------------------~~~~~~E~~il~~l~h~nI 309 (549)
...||+|+||.||+|.+.+|+.||||+++..... ...+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4579999999999998778999999999765211 0113578899999999987
Q ss_pred eeEEEEEEcCCeEEEEEeccCCC-H-HHHHHH--hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCC
Q 008898 310 VRIIGYCHSKEMYAIVYNLLNGS-L-KQYLKQ--LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFH 384 (549)
Q Consensus 310 v~l~~~~~~~~~~~lv~e~~~gs-L-~~~l~~--~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~ 384 (549)
.....+.... .++||||++|. + ...+.. ++..+...++.|++.++.+||+ . ||+||||||+|||++ + +
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~-~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D-G 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C-C
Confidence 5443333322 37999999664 3 333433 4556778899999999999999 8 999999999999999 5 5
Q ss_pred ceEEeeecccccc
Q 008898 385 HPQLSDFGAAMVH 397 (549)
Q Consensus 385 ~~kL~DFGla~~~ 397 (549)
.++|+|||+|...
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 8999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-19 Score=169.14 Aligned_cols=136 Identities=21% Similarity=0.330 Sum_probs=104.2
Q ss_pred CCCCceEcccCceEEEEEEecCCcEEEEEEeecCC-cCHHHHHHHHHHHhcC-----CCCCeeeEEEEEEcCC---e-EE
Q 008898 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-WSEEEVLREVELLSSI-----KHENIVRIIGYCHSKE---M-YA 323 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l-----~h~nIv~l~~~~~~~~---~-~~ 323 (549)
.....+||+|+||.||. ...++.. +||++.... ...+.+.+|+.+++.+ .||||++++|+++++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 2234444 699887543 2346789999999999 5799999999998874 3 44
Q ss_pred EEEeccC---CCHHHHHHHhchhHHHHHHHHHHHHH-HHHHhCCCCCEEEecCCCCCEEEecC---CCceEEeeeccc
Q 008898 324 IVYNLLN---GSLKQYLKQLKWNERMDVAIGVAKAL-EYLHHTCDPPIIHRDVKSSNILLSEN---FHHPQLSDFGAA 394 (549)
Q Consensus 324 lv~e~~~---gsL~~~l~~~~~~~~~~i~~~i~~aL-~yLH~~~~~~iiHrDlkp~NILl~~~---~~~~kL~DFGla 394 (549)
+++||.+ |+|.+++++....+...++.+++.++ +|||++ +|+||||||+|||++.. ...++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7899954 79999997643333345677888777 999999 99999999999999742 237999995433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=182.38 Aligned_cols=213 Identities=20% Similarity=0.323 Sum_probs=156.8
Q ss_pred HhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCE-EEecCCC
Q 008898 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPI-IHRDVKS 374 (549)
Q Consensus 301 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~i-iHrDlkp 374 (549)
|+.+.|.|+.+++|.+.++...+++.+|| .|+|.+.+.. +++.....+..+|+.||.|||+. +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 46789999999999999999999999999 8999999954 66777788899999999999988 55 9999999
Q ss_pred CCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCC-------CCchhhHHHHHHHHHHHHc
Q 008898 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-------VDEKIDVYSYGVVLLELIT 447 (549)
Q Consensus 375 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-------~~~k~DvwSlGvil~ellt 447 (549)
.|++++..+ .+||+|||+....... ..........-..-|.|||.+.+.. .+.+.||||||++++|+++
T Consensus 78 ~nClvd~~w-~lklt~~Gl~~~~~~~---~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 78 SNCLVDSRW-VLKLTDFGLNSLLEET---AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred ccceeeeeE-EEEechhhhccccccc---ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 999999996 8999999997654320 0001111112345699999987642 4667999999999999999
Q ss_pred CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCch
Q 008898 448 GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDY 525 (549)
Q Consensus 448 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 525 (549)
...||......... ...+..+.. ......-|.+... .+..+.+..++..||..+|..||++..+-..++..+.
T Consensus 154 r~~~~~~~~~~~~~-~eii~~~~~--~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDP-DEIILRVKK--GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccCccccccccCCh-HHHHHHHHh--cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99999875442221 111112221 1111122222211 1444568889999999999999999999887776553
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=171.24 Aligned_cols=196 Identities=22% Similarity=0.256 Sum_probs=135.8
Q ss_pred CCCCeeeEEEEEEc---------------------------CCeEEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHH
Q 008898 305 KHENIVRIIGYCHS---------------------------KEMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKA 355 (549)
Q Consensus 305 ~h~nIv~l~~~~~~---------------------------~~~~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~a 355 (549)
.|||||+++++|.+ +..+|+||.-...+|.+|+-. .+.....-++.|+++|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEa 353 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEA 353 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHH
Confidence 59999999876632 247899998888999999954 4555666788999999
Q ss_pred HHHHHhCCCCCEEEecCCCCCEEEe--cC-CCceEEeeeccccccccc-cccccCccccccccCCccccccccccCC---
Q 008898 356 LEYLHHTCDPPIIHRDVKSSNILLS--EN-FHHPQLSDFGAAMVHHQS-HQVSENVKPVNVVGTFGYLAPEYMMYGK--- 428 (549)
Q Consensus 356 L~yLH~~~~~~iiHrDlkp~NILl~--~~-~~~~kL~DFGla~~~~~~-~~~~~~~~~~~~~gt~~y~APE~~~~~~--- 428 (549)
+.|||++ ||.|||+|++|||+. +| ...+.|+|||++---... -...-.......-|....||||++...+
T Consensus 354 v~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 354 VTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999 999999999999984 33 124578999987322211 0111112223445788899999986432
Q ss_pred --C-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhccc
Q 008898 429 --V-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLH 505 (549)
Q Consensus 429 --~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~ 505 (549)
. -.|+|.|+.|.+.||++....||....+..-.. ...++---|.+ +..++..+.+++...|++
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~----------r~Yqe~qLPal----p~~vpp~~rqlV~~lL~r 496 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT----------RTYQESQLPAL----PSRVPPVARQLVFDLLKR 496 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheech----------hhhhhhhCCCC----cccCChHHHHHHHHHhcC
Confidence 1 258999999999999999999998743311111 11111111223 333445567777889999
Q ss_pred CCCCCCCHHHHH
Q 008898 506 SSSRRPTMKTLL 517 (549)
Q Consensus 506 dP~~RPs~~evl 517 (549)
||.+|++..=..
T Consensus 497 ~pskRvsp~iAA 508 (598)
T KOG4158|consen 497 DPSKRVSPNIAA 508 (598)
T ss_pred CccccCCccHHH
Confidence 999999976443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=192.55 Aligned_cols=194 Identities=23% Similarity=0.228 Sum_probs=152.2
Q ss_pred hhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCeEEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK---HENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~lv~ 326 (549)
-.+.|.+.+.||+|+||+||+|...+|+.+|+|+-+.....+-.+ =.+++.+|+ -+.|..+...+.-.+.-++++
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI--~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI--CLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee--hHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 346788889999999999999998889999999987665332222 223334444 233444444445557778889
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec------CCCceEEeeeccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE------NFHHPQLSDFGAAMV 396 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~------~~~~~kL~DFGla~~ 396 (549)
+|. .|+|.+++.. +++.-.+.+..||+..++.||.. +|||+||||+|+||.. +..-++|+|||.+..
T Consensus 774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 998 7999999953 67777888999999999999999 9999999999999942 223589999999865
Q ss_pred cccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEA 451 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p 451 (549)
+.- ..++.+....++|-.+-.+|+..|..++..+|.|.|+-+++-||.|+..
T Consensus 851 m~l---fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 851 MKL---FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeE---cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 433 3444566678899999999999999999999999999999999999643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.5e-19 Score=193.96 Aligned_cols=220 Identities=24% Similarity=0.324 Sum_probs=148.9
Q ss_pred hhcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
..++|..+++|..|+||.||.++|+ +.+.+|+|+ ++.+ .+.+- |+.....|+++ ++.
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~----lilRn--ilt~a~npfvv--------gDc------- 138 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN----LILRN--ILTFAGNPFVV--------GDC------- 138 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccc----hhhhc--cccccCCccee--------chh-------
Confidence 3568999999999999999999885 467888854 3222 11111 44444555555 000
Q ss_pred cCCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc-------
Q 008898 329 LNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH------- 401 (549)
Q Consensus 329 ~~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~------- 401 (549)
.+|...+..++ .+++.+++|||+. +|+|||+||+|.+|+.- |++|++|||+.+......
T Consensus 139 --~tllk~~g~lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 139 --ATLLKNIGPLP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred --hhhcccCCCCc--------chhhHHhHhhccC---CeecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhhhc
Confidence 11221111121 1237899999999 99999999999999998 899999999985422210
Q ss_pred ---ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 402 ---QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 402 ---~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
..........++|||.|.|||++.-.+|...+|||++|+|+||++-|..||..+.++. .+-.++.. ... +
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~visd---~i~---w 277 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISD---DIE---W 277 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhhhhhh---hcc---c
Confidence 1122223346799999999999999999999999999999999999999998876542 22111111 111 1
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
+. . +........+++...|+.+|..|--...-++
T Consensus 278 --pE---~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 278 --PE---E-DEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred --cc---c-CcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 11 1 2223345677889999999999975554443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.4e-17 Score=155.34 Aligned_cols=132 Identities=25% Similarity=0.372 Sum_probs=110.2
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcC---------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+.||+|++|.||+|.+ +|..+++|+....... ...+.+|+.++..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 6778999987543211 13467899999999999988777777677788899999
Q ss_pred c-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 329 L-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 329 ~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
+ +++|.+++..... ....++.+++.+|.+||+. +++|+|++|.|||++ + +.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 9 5689999876555 7788999999999999999 999999999999999 4 5799999998743
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=151.78 Aligned_cols=135 Identities=21% Similarity=0.218 Sum_probs=104.9
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC-----------------------HHHHHHHHHHHhcCCCC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-----------------------EEEVLREVELLSSIKHE 307 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~-----------------------~~~~~~E~~il~~l~h~ 307 (549)
..-|...+.||+|+||.||++...+|+.+|||++...... ......|..++..+.|+
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 3347778899999999999998888999999997653311 11256788899988877
Q ss_pred --CeeeEEEEEEcCCeEEEEEeccC-CCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC
Q 008898 308 --NIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384 (549)
Q Consensus 308 --nIv~l~~~~~~~~~~~lv~e~~~-gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 384 (549)
.+...++. ...+++|||+. ++|.+.... .....++.+++.++.++|+. +|+|+||||+||+++++ +
T Consensus 94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~-~ 162 (198)
T cd05144 94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD-E 162 (198)
T ss_pred CCCCCceeec----CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC-C
Confidence 44444442 34588999995 466654321 34567889999999999998 99999999999999987 6
Q ss_pred ceEEeeeccccc
Q 008898 385 HPQLSDFGAAMV 396 (549)
Q Consensus 385 ~~kL~DFGla~~ 396 (549)
.++|+|||++..
T Consensus 163 ~~~liDfg~~~~ 174 (198)
T cd05144 163 KIYIIDWPQMVS 174 (198)
T ss_pred cEEEEECCcccc
Confidence 899999999843
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=156.76 Aligned_cols=135 Identities=17% Similarity=0.226 Sum_probs=103.1
Q ss_pred CCCCCceEcccCceEEEEEE--ecCCcEEEEEEeecCCcC-------------------------HHHHHHHHHHHhcCC
Q 008898 253 NFSPKMLIGQGGNSKVYRTN--HVDGQVAAVKVLKCTNWS-------------------------EEEVLREVELLSSIK 305 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~--~~~g~~~AvK~l~~~~~~-------------------------~~~~~~E~~il~~l~ 305 (549)
-|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ...+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37788899999999999998 468999999999754210 012457999999997
Q ss_pred CC--CeeeEEEEEEcCCeEEEEEeccCC-CHHHHH-HH--hchhHHHHHHHHHHHHHHHHHhCCCCC-EEEecCCCCCEE
Q 008898 306 HE--NIVRIIGYCHSKEMYAIVYNLLNG-SLKQYL-KQ--LKWNERMDVAIGVAKALEYLHHTCDPP-IIHRDVKSSNIL 378 (549)
Q Consensus 306 h~--nIv~l~~~~~~~~~~~lv~e~~~g-sL~~~l-~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~-iiHrDlkp~NIL 378 (549)
+. .+.+++++ ...++||||++| +|.... .. ....+...++.||+.+|.+||+. + |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence 53 34444543 234799999966 555443 22 33344568999999999999999 9 999999999999
Q ss_pred EecCCCceEEeeeccccc
Q 008898 379 LSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 379 l~~~~~~~kL~DFGla~~ 396 (549)
++ + +.++|+|||.|..
T Consensus 182 i~-~-~~i~LiDFg~a~~ 197 (237)
T smart00090 182 VH-D-GKVVIIDVSQSVE 197 (237)
T ss_pred EE-C-CCEEEEEChhhhc
Confidence 99 5 5899999999843
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.3e-16 Score=148.68 Aligned_cols=128 Identities=23% Similarity=0.339 Sum_probs=101.5
Q ss_pred eEcccCceEEEEEEecCCcEEEEEEeecCCc--C-------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW--S-------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~--~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+||+|+||.||++.. +|..+++|....... . ...+.+|+++++.+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 678899998653221 1 134668999999999887654444455566678999999
Q ss_pred -CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 330 -NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 330 -~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
+++|.+++..... .++.+++.+|.+||+. +++|+|++|.||+++ + +.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 5688887754322 7899999999999999 999999999999999 4 5899999999854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-17 Score=173.32 Aligned_cols=171 Identities=26% Similarity=0.445 Sum_probs=121.6
Q ss_pred eEEEEEecc-CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecc
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGl 393 (549)
.++|.|++| .++|.++|.. .++...+.++.|++.|++| + +.+|+|+||.||++..+ ..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d-~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDD-DQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccc-hhhhhhhhhh
Confidence 588999999 6899999953 5667788899999999999 5 89999999999999988 5899999999
Q ss_pred ccccccccc-cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhc
Q 008898 394 AMVHHQSHQ-VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLS 471 (549)
Q Consensus 394 a~~~~~~~~-~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 471 (549)
..-...... .......+...||..||+||.+.+..|+.++||||||+||+||+. =..+++.... + ...+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----~-----~d~r 473 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT----L-----TDIR 473 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----h-----hhhh
Confidence 855433220 111223446689999999999999999999999999999999986 2222221110 0 1111
Q ss_pred ccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 008898 472 SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTL 516 (549)
Q Consensus 472 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 516 (549)
+ ..++|.....++. =..++.+++...|.+||++.+.
T Consensus 474 ~----g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 D----GIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred c----CCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 1 1122222222211 2345688999999999955443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.5e-16 Score=171.79 Aligned_cols=134 Identities=23% Similarity=0.330 Sum_probs=106.4
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEe-ecC-Cc-------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVL-KCT-NW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l-~~~-~~-------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
..|...++||+|+||.||++.+.+.. +++|+. ... .. ..+.+.+|+++++.++|++++....++...+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44567889999999999999875443 344432 211 11 123577899999999999998887777777778
Q ss_pred EEEEecc-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
+++|||+ +++|.+++. ....++.+++++|.|||+. +++||||||+|||++ + +.++|+|||++..
T Consensus 412 ~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl~-~-~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIVR-D-DRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEEE-C-CcEEEEeCccccc
Confidence 8999999 668988875 3567899999999999999 999999999999995 4 4799999999854
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-15 Score=143.57 Aligned_cols=131 Identities=20% Similarity=0.293 Sum_probs=94.2
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHH-------------------------HHHHHHHHhcCCCCC--e
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE-------------------------VLREVELLSSIKHEN--I 309 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~-------------------------~~~E~~il~~l~h~n--I 309 (549)
.+.||+|+||.||++...+|+.||||+++........ ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4579999999999998878999999998754322111 124555565554332 4
Q ss_pred eeEEEEEEcCCeEEEEEeccCC-CH-HHHHHHhch-hHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCCc
Q 008898 310 VRIIGYCHSKEMYAIVYNLLNG-SL-KQYLKQLKW-NERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHH 385 (549)
Q Consensus 310 v~l~~~~~~~~~~~lv~e~~~g-sL-~~~l~~~~~-~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~ 385 (549)
.+.+++ ...+++|||+.| ++ ...+..... .+...++.+++.++.++|. . +|+|+||||+||+++ + +.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~-~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D-GK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C-Cc
Confidence 444443 235899999965 21 112222222 6677899999999999999 7 999999999999999 5 58
Q ss_pred eEEeeeccccc
Q 008898 386 PQLSDFGAAMV 396 (549)
Q Consensus 386 ~kL~DFGla~~ 396 (549)
++|+|||.+..
T Consensus 153 ~~liDfg~a~~ 163 (187)
T cd05119 153 VYIIDVPQAVE 163 (187)
T ss_pred EEEEECccccc
Confidence 99999999843
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.7e-15 Score=132.38 Aligned_cols=134 Identities=20% Similarity=0.247 Sum_probs=110.7
Q ss_pred CCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCC--CCeeeEEEEEEcCCeEEEEEeccCC-C
Q 008898 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH--ENIVRIIGYCHSKEMYAIVYNLLNG-S 332 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~g-s 332 (549)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.+.| .++++++++....+..++++||+.| .
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 35679999999999998744 7899999875543 4678899999999976 5899999998888889999999965 4
Q ss_pred HHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 333 LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 333 L~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
+..+ +......++.+++++|.+||.....+++|+|++|+||+++++ +.+++.|||.+..
T Consensus 80 ~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred cccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence 5433 445566788999999999998755579999999999999986 6899999998843
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-16 Score=173.36 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=188.7
Q ss_pred CCCCCceEcccCceEEEEEEec--CCcEEEEEEeecCCcC---HHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV--DGQVAAVKVLKCTNWS---EEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~--~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.|...+-||+|+|+.|-..... ....+|+|.+...... ...+..|..+-..+. |+|++.+++.....+.+++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4666667999999999887552 3456677766544322 234456888888887 999999999999999999999
Q ss_pred ecc-CCCHHHHH-H----HhchhHHHHHHHHHHHHHHHHH-hCCCCCEEEecCCCCCEEEecCCC-ceEEeeeccccccc
Q 008898 327 NLL-NGSLKQYL-K----QLKWNERMDVAIGVAKALEYLH-HTCDPPIIHRDVKSSNILLSENFH-HPQLSDFGAAMVHH 398 (549)
Q Consensus 327 e~~-~gsL~~~l-~----~~~~~~~~~i~~~i~~aL~yLH-~~~~~~iiHrDlkp~NILl~~~~~-~~kL~DFGla~~~~ 398 (549)
++. +|++.+.+ . .......-.++.|+..++.|+| .. ++.||||||+|.+++.. + .++++|||+|....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDES-GSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccC-CCcccCCCchhhcccc
Confidence 998 56777766 2 2445566778999999999999 77 99999999999999998 6 79999999997665
Q ss_pred cccccccCcccccccc-CCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 399 QSHQVSENVKPVNVVG-TFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~g-t~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
... .........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|++...........|.... +..
T Consensus 177 ~~~--g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~- 250 (601)
T KOG0590|consen 177 NKN--GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRF- 250 (601)
T ss_pred ccC--CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccc-
Confidence 421 12233345678 99999999988754 46889999999999999999999987765443332222211 000
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
..... ........+++.+++..+|..|.+.+++-. ++|+..
T Consensus 251 ---~~~~~----~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~-----d~~~~~ 291 (601)
T KOG0590|consen 251 ---TQLPW----NSISDQAHDLLHKILKENPSNRLSIEELKL-----DNWLSS 291 (601)
T ss_pred ---ccCcc----ccCChhhhhcccccccCCchhccccccccc-----cccccc
Confidence 01111 122234556667888899999999999987 789887
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.2e-14 Score=139.08 Aligned_cols=133 Identities=17% Similarity=0.279 Sum_probs=100.8
Q ss_pred CceEc-ccCceEEEEEEecCCcEEEEEEeecCC--------------cCHHHHHHHHHHHhcCCCCCe--eeEEEEEEcC
Q 008898 257 KMLIG-QGGNSKVYRTNHVDGQVAAVKVLKCTN--------------WSEEEVLREVELLSSIKHENI--VRIIGYCHSK 319 (549)
Q Consensus 257 ~~~lG-~G~fg~Vy~~~~~~g~~~AvK~l~~~~--------------~~~~~~~~E~~il~~l~h~nI--v~l~~~~~~~ 319 (549)
...|| .||.|+||.+... +..++||.+.... .....+.+|+.++..|.|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999998774 6778898875321 112457789999999998775 6677665332
Q ss_pred -Ce---EEEEEeccCC--CHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecc
Q 008898 320 -EM---YAIVYNLLNG--SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (549)
Q Consensus 320 -~~---~~lv~e~~~g--sL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGl 393 (549)
.. .++++|++.| +|.+++....... ..+.+|+.+|.+||+. ||+||||||.|||++.+ +.++|+|||.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~--~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~-~~v~LIDfg~ 188 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSE--EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPD-GKFWLIDFDR 188 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCH--HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC-CCEEEEECCC
Confidence 22 2489999954 7988886543222 3467899999999999 99999999999999987 5899999998
Q ss_pred ccc
Q 008898 394 AMV 396 (549)
Q Consensus 394 a~~ 396 (549)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.8e-13 Score=141.52 Aligned_cols=249 Identities=24% Similarity=0.245 Sum_probs=180.5
Q ss_pred hcCCCCCceEcc--cCceEEEEEEe---cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQ--GGNSKVYRTNH---VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIK-HENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~--G~fg~Vy~~~~---~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~ 321 (549)
...|.+...+|. |.+|.||.+.. .++..+|+|.-+.... ....-.+|+.....++ |+|.++.+..+++.+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345777888999 99999999854 4688999997432221 1223456777666664 9999999999999999
Q ss_pred EEEEEeccCCCHHHHHHH----hchhHHHHHHHHHHH----HHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecc
Q 008898 322 YAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAK----ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~----aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGl 393 (549)
+++..|+++.+|..+... ++....+....+... ||..+|+. +++|-|+||.||+...+....+++|||+
T Consensus 193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 999999999999888743 555667778888888 99999999 9999999999999998855789999999
Q ss_pred ccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG 473 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 473 (549)
....................|...|++||... +-++.+.|+|++|.++.+-.+|..+........ |..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~------ 337 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQ------ 337 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC-----ccc------
Confidence 87655543222222223336778899999654 678899999999999999999988776553321 110
Q ss_pred ccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 474 LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 474 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
..... +...+...-...+...+..|++.+|..|++.+.+..
T Consensus 338 -~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00111 111111111223334778899999999999887665
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.9e-12 Score=132.71 Aligned_cols=138 Identities=20% Similarity=0.173 Sum_probs=93.2
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcCH-----------------------------------------HHHH
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE-----------------------------------------EEVL 295 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~-----------------------------------------~~~~ 295 (549)
.+.||.|++|.||+|...+|+.||||+.+...... -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986532100 0133
Q ss_pred HHHHHHhcC----CCCCeeeEEEEE-EcCCeEEEEEecc-CCCHHHHHHHh-chhHHHHHHHHHHH-HHHHHHhCCCCCE
Q 008898 296 REVELLSSI----KHENIVRIIGYC-HSKEMYAIVYNLL-NGSLKQYLKQL-KWNERMDVAIGVAK-ALEYLHHTCDPPI 367 (549)
Q Consensus 296 ~E~~il~~l----~h~nIv~l~~~~-~~~~~~~lv~e~~-~gsL~~~l~~~-~~~~~~~i~~~i~~-aL~yLH~~~~~~i 367 (549)
+|...+.++ +|.+-+.+-.++ ......+++|||+ +++|.++.... .......++..++. .+..+|.. |+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~---g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRD---GF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhC---Cc
Confidence 344444433 232223322222 2234568999999 45777765321 11134456666666 46788888 99
Q ss_pred EEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 368 iHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+|+|++|.||+++.+ +.++|+|||++....
T Consensus 279 ~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 999999999999888 689999999985543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.5e-11 Score=125.44 Aligned_cols=166 Identities=21% Similarity=0.279 Sum_probs=126.7
Q ss_pred EecCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEeccCCCHHHHHHHhchhHHHHHHH
Q 008898 272 NHVDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI 350 (549)
Q Consensus 272 ~~~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~gsL~~~l~~~~~~~~~~i~~ 350 (549)
...++.++.|...+.+... ...+.+-++.|+.++||||+++++.+++++.+|+|.|-+. .|..+++++.......-+.
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~-Pl~~~lk~l~~~~v~~Gl~ 111 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR-PLETVLKELGKEEVCLGLF 111 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc-cHHHHHHHhHHHHHHHHHH
Confidence 3457888899888766542 2346677889999999999999999999999999999875 4677787877777777899
Q ss_pred HHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCC
Q 008898 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430 (549)
Q Consensus 351 ~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 430 (549)
||+.||.|||..| +++|++|.-+.|+++.. |+-||++|.++........ ......---.|..|+.+....
T Consensus 112 qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~-----~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 112 QILAALSFLNDDC--NLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNA-----PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHhccC--CeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCc-----ccccchhhhcccChhhcCccc--
Confidence 9999999999665 99999999999999999 7999999998743222111 001111122456666444222
Q ss_pred chhhHHHHHHHHHHHHcC
Q 008898 431 EKIDVYSYGVVLLELITG 448 (549)
Q Consensus 431 ~k~DvwSlGvil~elltG 448 (549)
...|.|-|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.9e-11 Score=113.23 Aligned_cols=128 Identities=20% Similarity=0.123 Sum_probs=92.4
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCee-eEEEEEEcCCeEEEEEeccCC-CHHH
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV-RIIGYCHSKEMYAIVYNLLNG-SLKQ 335 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv-~l~~~~~~~~~~~lv~e~~~g-sL~~ 335 (549)
+.|+.|.++.||++... ++.+++|+..........+..|+.+++.+.+.+++ +++.+.. ...+++||++.| ++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence 46889999999999864 77899998765432234567899999988655544 4555443 234789999965 4443
Q ss_pred HHHHhchhHHHHHHHHHHHHHHHHHhCC--CCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 336 YLKQLKWNERMDVAIGVAKALEYLHHTC--DPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 336 ~l~~~~~~~~~~i~~~i~~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
. .......+.+++++|..||+.. ..+++|+|++|.||+++. +.++++|||.+.
T Consensus 81 ~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~--~~~~liDf~~a~ 135 (170)
T cd05151 81 E-----DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD--GRLWLIDWEYAG 135 (170)
T ss_pred c-----cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC--CeEEEEeccccc
Confidence 2 1112345678999999999982 123599999999999994 479999999873
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-11 Score=121.87 Aligned_cols=197 Identities=24% Similarity=0.344 Sum_probs=127.3
Q ss_pred HhcCCCCCeeeEEEEEEcC-----CeEEEEEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCE
Q 008898 301 LSSIKHENIVRIIGYCHSK-----EMYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPI 367 (549)
Q Consensus 301 l~~l~h~nIv~l~~~~~~~-----~~~~lv~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~i 367 (549)
|-++.|.||+++..|+.+. ....++.||+ .|+|..+|++ +......+++.||..||.|||+. +..|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 4455799999998888543 3566777888 8999999976 33334457899999999999987 6799
Q ss_pred EEecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc
Q 008898 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447 (549)
Q Consensus 368 iHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt 447 (549)
||+++..+-|++..+ |-+|++---.. ....+.............|-++|.|||.=.....+.++|||+||+..+||..
T Consensus 200 ihgnlTc~tifiq~n-gLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHN-GLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccCCcchhheeecCC-ceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999988 66665421111 1111111111111112346788999998666677889999999999999988
Q ss_pred CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 448 GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 448 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
|.---.......+.-+..+..++ .+-++ .-..+++.|+...|..||+|++++-
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~------~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVII------GLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhhhee------eccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 75332211111000000011110 11111 1123557899999999999999876
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.6e-10 Score=103.17 Aligned_cols=120 Identities=23% Similarity=0.272 Sum_probs=97.9
Q ss_pred EEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCccc--------c------------chHHHHHHhhhccCce
Q 008898 24 TVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD--------L------------NTFHIHEDLCKSKKVD 83 (549)
Q Consensus 24 ~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~--------~------------~~~~~~~~~c~~k~~~ 83 (549)
+|||++|.+..|+.+|.||+......|+.|++|||.++..... . +.+..+...|...+++
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 80 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQ 80 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 4899999999999999999998888999999999985532110 0 1125556678888899
Q ss_pred EEEEEEecCcchhhHHHHHhhhcccEEEEecccCC----CC-chhHHHHHhhhCCCCcEEEEecc
Q 008898 84 FLVKVCIGDSYITELSNQVRISYATILALGCSLSG----LK-DSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 84 ~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~----~~-~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
++..+..|.+...+|+++|+...|+.||+|++.+. .- .+.|+.++.+++++.|.|+.|.+
T Consensus 81 ~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~ 145 (146)
T cd01989 81 CEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSK 145 (146)
T ss_pred EEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEeC
Confidence 99999988777889999999999999999998661 11 12399999999999999999976
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.3e-11 Score=130.48 Aligned_cols=143 Identities=15% Similarity=0.155 Sum_probs=87.4
Q ss_pred hcCCCCCceEcccCceEEEEEEecC-CcEEEEEEeecCCc---------------------------CH--------H--
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNW---------------------------SE--------E-- 292 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~-g~~~AvK~l~~~~~---------------------------~~--------~-- 292 (549)
..+|+. +.||.|++|.||+|.+.+ |+.||||+.++.-. .. +
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999876 99999999975410 00 1
Q ss_pred ----HHHHHHHHHhcC----CCCCeeeEEEEEE-cCCeEEEEEeccC-CCHHHH--HHHhchhHHHHHHHHHHH-HHHHH
Q 008898 293 ----EVLREVELLSSI----KHENIVRIIGYCH-SKEMYAIVYNLLN-GSLKQY--LKQLKWNERMDVAIGVAK-ALEYL 359 (549)
Q Consensus 293 ----~~~~E~~il~~l----~h~nIv~l~~~~~-~~~~~~lv~e~~~-gsL~~~--l~~~~~~~~~~i~~~i~~-aL~yL 359 (549)
++.+|..-+.++ .+.+.+.+-.++. -....++||||+. +.+.++ +..... ....++...++ -+..+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHHH
Confidence 123344333333 2333333323222 2356789999995 577664 222111 11122222211 12233
Q ss_pred HhCCCCCEEEecCCCCCEEEecCCC----ceEEeeecccccccc
Q 008898 360 HHTCDPPIIHRDVKSSNILLSENFH----HPQLSDFGAAMVHHQ 399 (549)
Q Consensus 360 H~~~~~~iiHrDlkp~NILl~~~~~----~~kL~DFGla~~~~~ 399 (549)
+.. |++|+|+||.||+++.+ + .+++.|||++.....
T Consensus 277 f~~---GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 FRD---GFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhC---CeeeCCCChHHeEEecC-CCCCCeEEEEecceEEECCH
Confidence 445 99999999999999987 5 799999999865443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.9e-11 Score=127.20 Aligned_cols=243 Identities=21% Similarity=0.143 Sum_probs=168.6
Q ss_pred HHhhhcCCCCCceEcccCceEEEEEEe--cCCcEEEEEEeecCCcCH-HH--HHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 008898 247 LCHLTHNFSPKMLIGQGGNSKVYRTNH--VDGQVAAVKVLKCTNWSE-EE--VLREVELLSSI-KHENIVRIIGYCHSKE 320 (549)
Q Consensus 247 l~~~~~~f~~~~~lG~G~fg~Vy~~~~--~~g~~~AvK~l~~~~~~~-~~--~~~E~~il~~l-~h~nIv~l~~~~~~~~ 320 (549)
......+|.....||.|.|+.|+.... .++..|++|.+...-... .+ -..|+-+...+ .|.+++.++..|...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 444566799999999999999999854 467899999886543222 22 34566666665 4888898888777777
Q ss_pred eEEEEEecc-CCCHHHHH---HHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 321 MYAIVYNLL-NGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l---~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
..++-.||+ ++++.... ..+.....+.+..|++.++.++|++ .++|+|+||+||++..+.+..+++|||.+..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 778999999 55544333 3367778889999999999999999 9999999999999988645778999998742
Q ss_pred cccccccccCccccccccCCccc--cccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYL--APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
..-. .....++-.++ +|+......+..+.|++|||.-+.|.++|...-..... |..
T Consensus 417 ~~~~--------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------~~~------- 474 (524)
T KOG0601|consen 417 LAFS--------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------SLT------- 474 (524)
T ss_pred ccee--------cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------cee-------
Confidence 1111 11222333444 44444456788999999999999999988655433221 110
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 519 (549)
+..-.-+.. +.. ...+..+.+.++..++..||.+.++...
T Consensus 475 i~~~~~p~~----~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 475 IRSGDTPNL----PGL-KLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred eecccccCC----Cch-HHhhhhhhhhhcCCccccchhhhhhccc
Confidence 001111111 111 2455667788999999999999887663
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=7e-10 Score=105.05 Aligned_cols=130 Identities=18% Similarity=0.211 Sum_probs=93.4
Q ss_pred ceEcccCceEEEEEEecC-------CcEEEEEEeecCCc----------------------CHH-H----HHHHHHHHhc
Q 008898 258 MLIGQGGNSKVYRTNHVD-------GQVAAVKVLKCTNW----------------------SEE-E----VLREVELLSS 303 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~-------g~~~AvK~l~~~~~----------------------~~~-~----~~~E~~il~~ 303 (549)
..||.|--+.||.|...+ +..+|||+.+.+.. +.. . ..+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 47999999853210 111 1 2379999998
Q ss_pred CCC--CCeeeEEEEEEcCCeEEEEEeccCCC-H-HHHHHH--hchhHHHHHHHHHHHHHHHH-HhCCCCCEEEecCCCCC
Q 008898 304 IKH--ENIVRIIGYCHSKEMYAIVYNLLNGS-L-KQYLKQ--LKWNERMDVAIGVAKALEYL-HHTCDPPIIHRDVKSSN 376 (549)
Q Consensus 304 l~h--~nIv~l~~~~~~~~~~~lv~e~~~gs-L-~~~l~~--~~~~~~~~i~~~i~~aL~yL-H~~~~~~iiHrDlkp~N 376 (549)
+.. -++...+++ ..-++||||++|+ + ...++. ++..+...+..+++.+|..| |.. +|||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 853 456666654 4567899999763 2 112222 22334556788999999998 778 99999999999
Q ss_pred EEEecCCCceEEeeeccccc
Q 008898 377 ILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 377 ILl~~~~~~~kL~DFGla~~ 396 (549)
||++++ .+.|+|||.|..
T Consensus 156 IL~~~~--~v~iIDF~qav~ 173 (197)
T cd05146 156 MLWHDG--KVWFIDVSQSVE 173 (197)
T ss_pred EEEECC--cEEEEECCCcee
Confidence 999864 699999998843
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-09 Score=100.12 Aligned_cols=128 Identities=29% Similarity=0.374 Sum_probs=94.9
Q ss_pred eEcccCceEEEEEEecCCcEEEEEEe-ecCCcC--------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 259 LIGQGGNSKVYRTNHVDGQVAAVKVL-KCTNWS--------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~g~~~AvK~l-~~~~~~--------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
++++|+-+.+|.+.+.+ ..+++|.- ++.-.. .....+|..++.++.--.|.--+=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 57899999999997643 34666653 222111 134677999999886544444444555667788999999
Q ss_pred CCC-HHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 330 NGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 330 ~gs-L~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
.|. |.+++... ...++..+-.-+.-||.. ||+|+||.++||++..+ .+.++|||++.+
T Consensus 82 ~G~~lkd~l~~~----~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 886 55577554 356777888888999999 99999999999999987 499999999843
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.1e-11 Score=135.41 Aligned_cols=267 Identities=21% Similarity=0.227 Sum_probs=172.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.+.|.+.+-+-.|.|+.++.+.. ..|...+.|+......- .+....+-.++-...||.++...--+......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 35666777788999999998765 33555566655433211 12222333333334456666544444456778899
Q ss_pred Eecc-CCCHHHHHHHhc---hhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc-
Q 008898 326 YNLL-NGSLKQYLKQLK---WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS- 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~~~---~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~- 400 (549)
++|. +|+|...|.... ..........+..+++|||.. .++|+|++|.|++...+ ++.+++|||......-.
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhccc-CCcccCcccccccccccc
Confidence 9998 567877775432 333444566788899999998 89999999999999999 78999999843211100
Q ss_pred ---c--------------------cccc--CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Q 008898 401 ---H--------------------QVSE--NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (549)
Q Consensus 401 ---~--------------------~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~ 455 (549)
. .... ........||+.|.|||...+......+|+|++|++++|.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 0000 01223568999999999999999999999999999999999999999877
Q ss_pred ccchhhHHHHHHHhhcccccccccCCccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 456 KANRESLVLWARSLLSSGLCERLIDPQLN-EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 456 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
...+.. ..+..-... ..-..+......+++...+..+|.+|-.+.--.+ ..-|++|....+..
T Consensus 1039 tpq~~f--------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e--~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1039 TPQQIF--------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE--VKGHPFFQDVDWEN 1102 (1205)
T ss_pred chhhhh--------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccc--cccCCccCCCCccc
Confidence 654321 111111111 1112233455667777888999999988872222 12255555555444
Q ss_pred HHH
Q 008898 535 ELL 537 (549)
Q Consensus 535 ~~~ 537 (549)
..+
T Consensus 1103 l~~ 1105 (1205)
T KOG0606|consen 1103 LAL 1105 (1205)
T ss_pred ccc
Confidence 333
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-09 Score=105.49 Aligned_cols=138 Identities=20% Similarity=0.302 Sum_probs=99.5
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCC--CCeeeEEEEEEcCC---eEEEEEeccC
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKH--ENIVRIIGYCHSKE---MYAIVYNLLN 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~---~~~lv~e~~~ 330 (549)
+.||.|.++.||++...+|+.+++|+...... ....+..|.++++.+.+ .++.+++.+...+. ..+++|+++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999886678999999765433 34578899999999975 44677787776542 6689999996
Q ss_pred C-CHHHHH--HHhchhHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 008898 331 G-SLKQYL--KQLKWNERMDVAIGVAKALEYLHHT--------------------------------------------- 362 (549)
Q Consensus 331 g-sL~~~l--~~~~~~~~~~i~~~i~~aL~yLH~~--------------------------------------------- 362 (549)
| ++.+.+ ..++......++.+++++|.+||+.
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW 163 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence 5 454433 1234444555666666666666642
Q ss_pred --------CCCCEEEecCCCCCEEEecC-CCceEEeeecccc
Q 008898 363 --------CDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAM 395 (549)
Q Consensus 363 --------~~~~iiHrDlkp~NILl~~~-~~~~kL~DFGla~ 395 (549)
....++|+|+.|.||+++.+ .+.+.|+||+.+.
T Consensus 164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 12468999999999999983 2467899999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=6.4e-09 Score=95.31 Aligned_cols=137 Identities=25% Similarity=0.307 Sum_probs=99.9
Q ss_pred CCceEcccCceEEEEEEecCCcEEEEEEeecCC-c--------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-W--------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~-~--------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
...+|-+|+-++|+++.. .|+.+.||.-.... . ......+|+.+|.++.--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999987 57777777542211 1 1245678999998876434333333445556667889
Q ss_pred eccCC--CHHHHHHHh----chhH-HHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCce--EEeeeccccc
Q 008898 327 NLLNG--SLKQYLKQL----KWNE-RMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP--QLSDFGAAMV 396 (549)
Q Consensus 327 e~~~g--sL~~~l~~~----~~~~-~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~--kL~DFGla~~ 396 (549)
||+.| ++.+|+... .... ...++..|-+.+.-||.+ +|||+||..+||++.++.... .++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988 788888542 1222 257888999999999999 999999999999998764443 7999999743
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.2e-08 Score=94.37 Aligned_cols=121 Identities=25% Similarity=0.336 Sum_probs=81.7
Q ss_pred EEEEEEecCCcEEEEEEeecCCcC---------------------------HHHHHHHHHHHhcCCCC--CeeeEEEEEE
Q 008898 267 KVYRTNHVDGQVAAVKVLKCTNWS---------------------------EEEVLREVELLSSIKHE--NIVRIIGYCH 317 (549)
Q Consensus 267 ~Vy~~~~~~g~~~AvK~l~~~~~~---------------------------~~~~~~E~~il~~l~h~--nIv~l~~~~~ 317 (549)
.||.|...+|..+|||+.+..... .....+|.+.|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489998888999999998542110 12356799999999765 456666553
Q ss_pred cCCeEEEEEeccC--CCHHHHHHHhc--hhHHHHHHHHHHHHHHH-HHhCCCCCEEEecCCCCCEEEecCCCceEEeeec
Q 008898 318 SKEMYAIVYNLLN--GSLKQYLKQLK--WNERMDVAIGVAKALEY-LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (549)
Q Consensus 318 ~~~~~~lv~e~~~--gsL~~~l~~~~--~~~~~~i~~~i~~aL~y-LH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFG 392 (549)
..+|||||++ |.....+.... ......++.+++..+.. +|.. ||+|+||.+.|||++++ .+.++|||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT--CEEE--GT
T ss_pred ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc--eEEEEecC
Confidence 3479999997 75334444433 45566778888886665 5677 99999999999999987 69999999
Q ss_pred cccc
Q 008898 393 AAMV 396 (549)
Q Consensus 393 la~~ 396 (549)
.+..
T Consensus 152 qav~ 155 (188)
T PF01163_consen 152 QAVD 155 (188)
T ss_dssp TEEE
T ss_pred ccee
Confidence 8843
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.9e-08 Score=84.39 Aligned_cols=117 Identities=15% Similarity=0.223 Sum_probs=88.1
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcccc-------ch-H--------HHHHHhhhccCceEEE
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL-------NT-F--------HIHEDLCKSKKVDFLV 86 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~~-------~~-~--------~~~~~~c~~k~~~~~~ 86 (549)
++|||++|.+..++.++.||+....+.|+.|++|||......... .. . ......+...+.....
T Consensus 3 ~~Ilv~~d~~~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (140)
T PF00582_consen 3 KRILVAIDGSEESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAAEDEESEEEAEEEEQARQAEAEEAEAEGGIVIE 82 (140)
T ss_dssp SEEEEEESSSHHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSEEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccccccccccccchhhhhhhHHHHHHhhhccceeE
Confidence 699999999999999999999999999999999999965442111 00 0 0001234455555555
Q ss_pred EEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEe
Q 008898 87 KVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 87 ~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
.+..+.+..+.++++++...++.||+|.+.. +.-.+.++.++++++| |-|+.|
T Consensus 83 ~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~--~pVlvv 139 (140)
T PF00582_consen 83 VVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAP--CPVLVV 139 (140)
T ss_dssp EEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTS--SEEEEE
T ss_pred EEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCC--CCEEEe
Confidence 5555668888999999999999999999985 2122349999999999 877665
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.9e-07 Score=93.15 Aligned_cols=253 Identities=17% Similarity=0.204 Sum_probs=153.0
Q ss_pred CCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeee--------EEEEEEcCCeEEEE
Q 008898 255 SPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVR--------IIGYCHSKEMYAIV 325 (549)
Q Consensus 255 ~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~--------l~~~~~~~~~~~lv 325 (549)
.....||+|+-+.+|-.....+ .+.|+....... .....+..|... .||-+.. |+|- ......-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa--~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPA--AQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhhc--hhheeecCCCch--HHHHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence 3456799999999997533222 244666433211 111223334333 4554332 1111 122336677
Q ss_pred EeccCC--CHHHHHH---------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 326 YNLLNG--SLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 326 ~e~~~g--sL~~~l~---------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
|..+.| ....+++ ...|...++++..++.+..-||+. |.+-+|+.++|+|++++ +.+.|.|-..-
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~-~~V~LVdsDsf 164 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDD-SKVVLVDSDSF 164 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecC-ceEEEEcccce
Confidence 777755 3444442 267888999999999999999999 99999999999999999 68888875433
Q ss_pred cccccccccccCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcC-CCCCCCcccc---hhhHH-H
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITG-KEAIQTNKAN---RESLV-L 464 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG-~~p~~~~~~~---~~~l~-~ 464 (549)
.... .+......+|...|.+||... +-.-+...|.|.|||+++++|.| ++||.+-... ..-+. .
T Consensus 165 qi~~------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 165 QINA------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred eecc------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 2221 122334568999999999765 33457789999999999999887 9999764321 11111 1
Q ss_pred HHHHhhcc-cccccccCCcccccCCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHhcC
Q 008898 465 WARSLLSS-GLCERLIDPQLNEEYNREEIEIVMCAARLCLLH--SSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 465 ~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPs~~evl~~L~~ 522 (549)
.+...+-. .....-..+......-...+..+.-+...|+.. ++.-|||++-.+.-|..
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 11111100 000011111111111123345566677788876 46799999988776644
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.1e-07 Score=90.83 Aligned_cols=134 Identities=17% Similarity=0.140 Sum_probs=94.4
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcC------------HHHHHHHHHHHhcCCCCC--eeeEEEEEEc-----
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS------------EEEVLREVELLSSIKHEN--IVRIIGYCHS----- 318 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~------------~~~~~~E~~il~~l~h~n--Iv~l~~~~~~----- 318 (549)
+++-......|++... +|+.+.||......+. ...+.+|...+..|...+ ....+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455555556777655 6788999977543311 124778988887774322 3344444432
Q ss_pred CCeEEEEEeccCC--CHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC------CCc
Q 008898 319 KEMYAIVYNLLNG--SLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN------FHH 385 (549)
Q Consensus 319 ~~~~~lv~e~~~g--sL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~------~~~ 385 (549)
...-++|+|++.| +|.+++.. ........++.+++..+.-||.. ||+|+|+++.|||++.+ ...
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 2356789999977 68888753 23345667899999999999999 99999999999999851 247
Q ss_pred eEEeeecccc
Q 008898 386 PQLSDFGAAM 395 (549)
Q Consensus 386 ~kL~DFGla~ 395 (549)
+.|+||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 8999999874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.2e-09 Score=111.65 Aligned_cols=154 Identities=21% Similarity=0.327 Sum_probs=105.4
Q ss_pred HHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc----ccCccccccccCCcccccccccc
Q 008898 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV----SENVKPVNVVGTFGYLAPEYMMY 426 (549)
Q Consensus 351 ~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~----~~~~~~~~~~gt~~y~APE~~~~ 426 (549)
+++.||.|+|... ++||++|.|++|.++.+ +..||+.|+++......... .+.....-..-...|.|||++.+
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4559999999886 99999999999999999 78999999988654442110 11111111223568999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCC-CCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhccc
Q 008898 427 GKVDEKIDVYSYGVVLLELITGKEA-IQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLH 505 (549)
Q Consensus 427 ~~~~~k~DvwSlGvil~elltG~~p-~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~ 505 (549)
...+.++|+||+||++|.+..|..+ +........ . ......+..-...++.+.+..+.+-+.+++..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--~----------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--Y----------SFSRNLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch--h----------hhhhcccccccccccccCcHHHHHHHHHHhcC
Confidence 8889999999999999999955444 443322110 0 01111112222234455666777777899999
Q ss_pred CCCCCCCHHHHHHH
Q 008898 506 SSSRRPTMKTLLKL 519 (549)
Q Consensus 506 dP~~RPs~~evl~~ 519 (549)
++.-||++.++...
T Consensus 252 ~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 252 DSAVRPTLDLLLSI 265 (700)
T ss_pred CcccCcchhhhhcc
Confidence 99999988887653
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.3e-07 Score=79.55 Aligned_cols=115 Identities=13% Similarity=0.122 Sum_probs=87.5
Q ss_pred EEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcc-c---cchHHHHHHhhhccCceEEEEEEecCcchhhHH
Q 008898 24 TVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL-D---LNTFHIHEDLCKSKKVDFLVKVCIGDSYITELS 99 (549)
Q Consensus 24 ~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~-~---~~~~~~~~~~c~~k~~~~~~~v~~g~~~~~~l~ 99 (549)
+|||++|.+..++++|.||.....+.|..+.+|||..+.... . .+.+..+..+++..+++ ..+..+.++..+|+
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~I~ 78 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKAPWYVVYVETPRLNRLSEAERRRLAEALRLAEELGAE--VVTLPGDDVAEAIV 78 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCCCEEEEEEecCccccCCHHHHHHHHHHHHHHHHcCCE--EEEEeCCcHHHHHH
Confidence 599999999999999999999988999999999999654321 1 13335556667665654 34556667889999
Q ss_pred HHHhhhcccEEEEecccCC----CCchhHHHHHhhhCCCCcEEEEe
Q 008898 100 NQVRISYATILALGCSLSG----LKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 100 ~e~k~~~~~~lvlg~~~~~----~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
++|+...++.||+|.+... .-.+.++.+.+.++ +.|.|+.+
T Consensus 79 ~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 79 EFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred HHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhC-CCCeEEEe
Confidence 9999999999999999661 11123888888888 55877654
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.6e-07 Score=90.13 Aligned_cols=130 Identities=24% Similarity=0.300 Sum_probs=93.6
Q ss_pred CCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC-----------------------HHHHHHHHHHHhcCCCC--Ce
Q 008898 255 SPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-----------------------EEEVLREVELLSSIKHE--NI 309 (549)
Q Consensus 255 ~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~-----------------------~~~~~~E~~il~~l~h~--nI 309 (549)
.+...||.|--|.||.|....|.++|||.=+....+ .....+|.++|..|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 355679999999999999989999999964321111 12356899999999755 56
Q ss_pred eeEEEEEEcCCeEEEEEeccCCC-HHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEE
Q 008898 310 VRIIGYCHSKEMYAIVYNLLNGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (549)
Q Consensus 310 v~l~~~~~~~~~~~lv~e~~~gs-L~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL 388 (549)
.+-+++ +...++||++.|- |... + ++....-.++..|++-+.-+-.. ||||+|+.+-||++++| |.+.+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~-r-~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d-g~~~v 243 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRL-R-LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED-GDIVV 243 (304)
T ss_pred CCcccc----ccceeeeehcccceeecc-c-CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC-CCEEE
Confidence 655554 6778999999874 3221 1 12333444555555555555566 99999999999999999 68999
Q ss_pred eeeccc
Q 008898 389 SDFGAA 394 (549)
Q Consensus 389 ~DFGla 394 (549)
+||--+
T Consensus 244 IDwPQ~ 249 (304)
T COG0478 244 IDWPQA 249 (304)
T ss_pred EeCccc
Confidence 999765
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.8e-06 Score=88.10 Aligned_cols=160 Identities=20% Similarity=0.255 Sum_probs=117.8
Q ss_pred eEEEEEEe-cCCcEEEEEEeecCC-cCHHHHHHHHHHHhcCCCCCeeeEEEEEE----cCCeEEEEEeccC--CCHHHHH
Q 008898 266 SKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCH----SKEMYAIVYNLLN--GSLKQYL 337 (549)
Q Consensus 266 g~Vy~~~~-~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~----~~~~~~lv~e~~~--gsL~~~l 337 (549)
.+.|++.. .||..|++|++.-.. ........-+++.+++.|+|+|++..++. .+..+++||+|.. ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899965 789999999994322 12223445688999999999999988775 4568999999984 5777765
Q ss_pred H------------------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 338 K------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 338 ~------------------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
- ..++...|.++.|+..||.++|+. |+.-+-|.|.+|+++.+. .++|+..|...+...
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE 445 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence 1 144567889999999999999999 999999999999999884 677766665433211
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEA 451 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p 451 (549)
.. .+| +.. -.+-|.=.||.+++.|.||..-
T Consensus 446 d~-----------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP-----------------TEP--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC-----------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 00 011 111 1457889999999999999543
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.4e-06 Score=78.30 Aligned_cols=116 Identities=12% Similarity=0.115 Sum_probs=86.3
Q ss_pred cEEEEEEecChh--hHHHHHHHHHHhcCCCCeEEEEEeeccCCcc--------cc---------chHHHHHHhhhcc---
Q 008898 23 RTVIFGLKSDHY--SREILLQLLTVIAKPGDNVLAVHVEEQNDTL--------DL---------NTFHIHEDLCKSK--- 80 (549)
Q Consensus 23 ~~~~v~~~~~~~--~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~--------~~---------~~~~~~~~~c~~k--- 80 (549)
++|||++|.+.+ ++.++.||+....+.|..|.+|||..+.... .. .....++.+++..
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLGLAYSAELPAMDDLKAEAKSQLEEIIKKFKLP 82 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccccccccccchHHHHHHHHHHHHHHHHHHHhCCC
Confidence 589999999997 6899999999888899999999998542110 00 1113455666543
Q ss_pred CceEEEEEEecCcchhhHHHHHhhhcccEEEEecccCCC---CchhHHHHHhhhCCCCcEEEEe
Q 008898 81 KVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGL---KDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 81 ~~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~~---~~~~v~~~c~~~~~~~c~v~~v 141 (549)
.+.++..+..|.+ ...|++.|+...++.||+|.++... -.+.++.++.++++ |-|+.|
T Consensus 83 ~~~~~~~v~~G~p-~~~I~~~a~~~~~DLIV~Gs~~~~~~~~llGS~a~~vl~~a~--cpVlvV 143 (144)
T PRK15005 83 TDRVHVHVEEGSP-KDRILELAKKIPADMIIIASHRPDITTYLLGSNAAAVVRHAE--CSVLVV 143 (144)
T ss_pred CCceEEEEeCCCH-HHHHHHHHHHcCCCEEEEeCCCCCchheeecchHHHHHHhCC--CCEEEe
Confidence 4567888888966 5689999999999999999875411 11238899998888 877765
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.3e-06 Score=78.52 Aligned_cols=115 Identities=14% Similarity=0.159 Sum_probs=83.8
Q ss_pred cEEEEEEecC--hhhHHHHHHHHHHhcCCCCeEEEEEeeccCCccc-----c--chH---------HHHHHhhhc---cC
Q 008898 23 RTVIFGLKSD--HYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD-----L--NTF---------HIHEDLCKS---KK 81 (549)
Q Consensus 23 ~~~~v~~~~~--~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~-----~--~~~---------~~~~~~c~~---k~ 81 (549)
++|||++|.+ ..|..+|.||+.. |+.+..|.+|||..+..... . ..+ ..++.+++. .+
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~l-a~~~~~l~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 81 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFL-AQDDGVIHLLHVLPGSASLSLHRFAADVRRFEEHLQHEAEERLQTMVSHFTIDP 81 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHH-HhcCCeEEEEEEecCcccccccccccchhhHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 6899999998 4899999999965 66678999999986532110 0 111 334555543 34
Q ss_pred ceEEEEEEecCcchhhHHHHHhhhcccEEEEecccCCC---CchhHHHHHhhhCCCCcEEEEe
Q 008898 82 VDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGL---KDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 82 ~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~~---~~~~v~~~c~~~~~~~c~v~~v 141 (549)
++++..+..|.+ ...|++.|+...|+.||+|++.+.. -.+.++.+..++++ |-|+.|
T Consensus 82 ~~v~~~v~~G~~-~~~I~~~a~~~~~DLIVmG~~g~~~~~~llGS~a~~v~~~a~--~pVLvV 141 (142)
T PRK15456 82 SRIKQHVRFGSV-RDEVNELAEELGADVVVIGSRNPSISTHLLGSNASSVIRHAN--LPVLVV 141 (142)
T ss_pred cceEEEEcCCCh-HHHHHHHHhhcCCCEEEEcCCCCCccceecCccHHHHHHcCC--CCEEEe
Confidence 567777888855 5679999999999999999986521 11238889998888 888765
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.1e-06 Score=79.22 Aligned_cols=117 Identities=13% Similarity=0.180 Sum_probs=86.0
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccC-Cc------ccc---------chHHHHHHhhhccCceEE
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQN-DT------LDL---------NTFHIHEDLCKSKKVDFL 85 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~-~~------~~~---------~~~~~~~~~c~~k~~~~~ 85 (549)
-++|||++|.|..|+.+|.||+.-....|..|++|||..+. .. ... +....++.++...++++.
T Consensus 3 ~~~ILvavD~S~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 82 (144)
T PRK15118 3 YKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHVDVNYSDLYTGLIDVNLGDMQKRISEETHHALTELSTNAGYPIT 82 (144)
T ss_pred ceEEEEEccCChhHHHHHHHHHHHHHhhCCEEEEEEEccChhhhhhhhhhcchHHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 36899999999999999999999776778899999994221 10 000 001334666666677764
Q ss_pred EEE-EecCcchhhHHHHHhhhcccEEEEecccC--CCCchhHHHHHhhhCCCCcEEEEec
Q 008898 86 VKV-CIGDSYITELSNQVRISYATILALGCSLS--GLKDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 86 ~~v-~~g~~~~~~l~~e~k~~~~~~lvlg~~~~--~~~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
..+ ..|.+ ..+|+++|+...++.||+|.+.. +.-.| ++.+..++++ |-|+.|-
T Consensus 83 ~~~~~~G~p-~~~I~~~a~~~~~DLIV~Gs~~~~~~~lgS-va~~v~~~a~--~pVLvv~ 138 (144)
T PRK15118 83 ETLSGSGDL-GQVLVDAIKKYDMDLVVCGHHQDFWSKLMS-SARQLINTVH--VDMLIVP 138 (144)
T ss_pred EEEEEecCH-HHHHHHHHHHhCCCEEEEeCcccHHHHHHH-HHHHHHhhCC--CCEEEec
Confidence 444 46765 66899999999999999999954 11124 9999999999 8888774
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.1e-06 Score=72.80 Aligned_cols=113 Identities=17% Similarity=0.215 Sum_probs=86.7
Q ss_pred EEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCccc------c-----chHHHHHHhhhccCceEEEEEEecC
Q 008898 24 TVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD------L-----NTFHIHEDLCKSKKVDFLVKVCIGD 92 (549)
Q Consensus 24 ~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~------~-----~~~~~~~~~c~~k~~~~~~~v~~g~ 92 (549)
+|+|+++.+..++.++.||+...-+.+..|.+|||..+..... . +.+..+...|...++++...+..|.
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 80 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAELLEEEARALLEALREALAEAGVKVETVVLEGD 80 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcchhHHHHHHHHHHHHHHHHHHHHhcCCCceEEEEecCC
Confidence 4899999999999999999999999999999999986543310 1 2235556667778999999999888
Q ss_pred cchhhHHHHHhhhcccEEEEecccCCC----CchhHHHHHhhhCCCCcEEE
Q 008898 93 SYITELSNQVRISYATILALGCSLSGL----KDSEVLTRCLRALPPACTIL 139 (549)
Q Consensus 93 ~~~~~l~~e~k~~~~~~lvlg~~~~~~----~~~~v~~~c~~~~~~~c~v~ 139 (549)
+ .++|+++++...++.||+|.+.... ..+.++.+-++..+ |.++
T Consensus 81 ~-~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~~~~~~ll~~~~--~pvl 128 (130)
T cd00293 81 P-AEAILEAAEELGADLIVMGSRGRSGLRRLLLGSVAERVLRHAP--CPVL 128 (130)
T ss_pred C-HHHHHHHHHHcCCCEEEEcCCCCCccceeeeccHHHHHHhCCC--CCEE
Confidence 7 7899999999999999999886621 11225666665544 5554
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.5e-06 Score=75.94 Aligned_cols=115 Identities=9% Similarity=0.111 Sum_probs=83.5
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCc-------ccc----chH-----HHHHHhhhc-cCceEE
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT-------LDL----NTF-----HIHEDLCKS-KKVDFL 85 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~-------~~~----~~~-----~~~~~~c~~-k~~~~~ 85 (549)
++|||++|.+..|+.+|.||+...-+.|-.|++|||..+... ... ... ..++.+.+. ....++
T Consensus 4 k~ILvavD~S~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 83 (142)
T PRK09982 4 KHIGVAISGNEEDALLVNKALELARHNDAHLTLIHIDDGLSELYPGIYFPATEDILQLLKNKSDNKLYKLTKNIQWPKTK 83 (142)
T ss_pred eEEEEEecCCcchHHHHHHHHHHHHHhCCeEEEEEEccCcchhchhhhccchHHHHHHHHHHHHHHHHHHHHhcCCCcce
Confidence 689999999999999999999988899999999999853210 000 000 223333332 245677
Q ss_pred EEEEecCcchhhHHHHHhhhcccEEEEecccCC--CCchhHHHHHhhhCCCCcEEEEe
Q 008898 86 VKVCIGDSYITELSNQVRISYATILALGCSLSG--LKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 86 ~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~--~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
..+..|.+ ...|++.|+...|+.||+|..++. ...+ ++.+..++++ |-|+.|
T Consensus 84 ~~v~~G~p-~~~I~~~A~~~~aDLIVmG~~~~~~~~~~~-va~~V~~~s~--~pVLvv 137 (142)
T PRK09982 84 LRIERGEM-PETLLEIMQKEQCDLLVCGHHHSFINRLMP-AYRGMINKMS--ADLLIV 137 (142)
T ss_pred EEEEecCH-HHHHHHHHHHcCCCEEEEeCChhHHHHHHH-HHHHHHhcCC--CCEEEe
Confidence 78888865 668999999999999999976331 1114 8888888877 777766
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.7e-06 Score=80.84 Aligned_cols=103 Identities=22% Similarity=0.287 Sum_probs=78.4
Q ss_pred HHHHHHHHHHHhcCCC--CCeeeEEEEEEcC----CeEEEEEeccCC--CHHHHHHH---hchhHHHHHHHHHHHHHHHH
Q 008898 291 EEEVLREVELLSSIKH--ENIVRIIGYCHSK----EMYAIVYNLLNG--SLKQYLKQ---LKWNERMDVAIGVAKALEYL 359 (549)
Q Consensus 291 ~~~~~~E~~il~~l~h--~nIv~l~~~~~~~----~~~~lv~e~~~g--sL~~~l~~---~~~~~~~~i~~~i~~aL~yL 359 (549)
.....+|...+..|.. -.+...+++.+.. ...++++|++.| +|.+++.. .+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3457788887777753 2344555655442 245788999866 69999876 45566778999999999999
Q ss_pred HhCCCCCEEEecCCCCCEEEecCC--CceEEeeeccccc
Q 008898 360 HHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAAMV 396 (549)
Q Consensus 360 H~~~~~~iiHrDlkp~NILl~~~~--~~~kL~DFGla~~ 396 (549)
|.. ||+|+|+++.|||++.+. ..+.|+||+-+..
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 999999999999999872 1688999997743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.2e-06 Score=80.44 Aligned_cols=131 Identities=15% Similarity=0.240 Sum_probs=84.2
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC--eeeEEEEEEcCCeEEEEEeccCCC--H
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVRIIGYCHSKEMYAIVYNLLNGS--L 333 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~gs--L 333 (549)
..||+|..+.||+. .|..+++|.... ......+.+|.++++.+..-. +.+.+++....+.+.++|+++.|. +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 245677888764 334566889999999886433 467788887788888999999773 2
Q ss_pred HHHHHHhchhHHHHHHHH--------------------------------------HHH-HHHHHHhCC-CCCEEEecCC
Q 008898 334 KQYLKQLKWNERMDVAIG--------------------------------------VAK-ALEYLHHTC-DPPIIHRDVK 373 (549)
Q Consensus 334 ~~~l~~~~~~~~~~i~~~--------------------------------------i~~-aL~yLH~~~-~~~iiHrDlk 373 (549)
...+.. .......++.. +.+ ...+|.... ...++|+|+.
T Consensus 83 ~~~~~~-~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISD-NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcC-CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211100 00000001111 111 122332221 2357899999
Q ss_pred CCCEEEecCCCceEEeeecccc
Q 008898 374 SSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 374 p~NILl~~~~~~~kL~DFGla~ 395 (549)
|.||+++++ + +.++||+.+.
T Consensus 162 ~~Nii~~~~-~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGK-G-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCC-C-cEEEechhcC
Confidence 999999987 5 8999999873
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.1e-06 Score=77.84 Aligned_cols=130 Identities=17% Similarity=0.232 Sum_probs=95.4
Q ss_pred EcccCceEEEEEEecCCcEEEEEEeec----C---CcCHHHHHHHHHHHhcCCCC--CeeeEEEEEE-c----CCeEEEE
Q 008898 260 IGQGGNSKVYRTNHVDGQVAAVKVLKC----T---NWSEEEVLREVELLSSIKHE--NIVRIIGYCH-S----KEMYAIV 325 (549)
Q Consensus 260 lG~G~fg~Vy~~~~~~g~~~AvK~l~~----~---~~~~~~~~~E~~il~~l~h~--nIv~l~~~~~-~----~~~~~lv 325 (549)
-|+||-+-|++... +|+.+-+|.-.. + ......|.+|...|..|..- .+.+.. ++. . ...-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 47899999999776 344688887641 1 22456789999999888532 244444 332 1 1246788
Q ss_pred EeccCC--CHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc--eEEeeecccc
Q 008898 326 YNLLNG--SLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH--PQLSDFGAAM 395 (549)
Q Consensus 326 ~e~~~g--sL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~--~kL~DFGla~ 395 (549)
.|-++| +|.+++.. .+...+..+..+++.++.-||.. |+.|+|+.+.|||++.+ +. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 887864 79999855 24455678999999999999999 99999999999999855 35 8999998653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.7e-05 Score=75.53 Aligned_cols=131 Identities=25% Similarity=0.411 Sum_probs=95.9
Q ss_pred CCceEcccCceEEEEEEecCCcEEEEEEeecCC-----------------cCHHHHHHHHHHHhcCC------CCCeeeE
Q 008898 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-----------------WSEEEVLREVELLSSIK------HENIVRI 312 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~-----------------~~~~~~~~E~~il~~l~------h~nIv~l 312 (549)
...+||+|+.-.||. |.+.....||+..... ....+..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345799999999995 5556667889987655 12355677777665555 7899999
Q ss_pred EEEEEcCCeEEEEEecc---CC----CHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC-C
Q 008898 313 IGYCHSKEMYAIVYNLL---NG----SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF-H 384 (549)
Q Consensus 313 ~~~~~~~~~~~lv~e~~---~g----sL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~ 384 (549)
+|+.+++....+|+|.+ +| +|.++++.-.... .+...+-+-..||-.. +|+.+|++|.||++.... +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~--~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE--ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH--HHHHHHHHHHHHHHHc---CCeecCCCcccEEEEecCCC
Confidence 99999999999999987 34 5888886543333 4444555667788888 999999999999996442 1
Q ss_pred --ceEEee-ecc
Q 008898 385 --HPQLSD-FGA 393 (549)
Q Consensus 385 --~~kL~D-FGl 393 (549)
.+.|+| ||-
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 466777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.9e-05 Score=69.53 Aligned_cols=116 Identities=14% Similarity=0.210 Sum_probs=89.6
Q ss_pred EEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCccc------c-----chHHHHHHhhhccCceEEEEEEecC
Q 008898 24 TVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD------L-----NTFHIHEDLCKSKKVDFLVKVCIGD 92 (549)
Q Consensus 24 ~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~------~-----~~~~~~~~~c~~k~~~~~~~v~~g~ 92 (549)
+|||+++.+..+..+|.||..-.-+.+=.|+++||..+..... . ..+..+..++...+++++..+..+.
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 80 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQNGEIIPLNVIEVPNHSSPSQLEVNVQRARKLLRQAERIAASLGVPVHTIIRIDH 80 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCcchhHHHHHHHHHHHHHHHHHhhhcCCceEEEEEecC
Confidence 5999999999999999999998888888999999996543221 0 2225556677777888887776655
Q ss_pred cchhhHHHHHhhhcccEEEEecccCCCC----chhHHHHHhhhCCCCcEEEEe
Q 008898 93 SYITELSNQVRISYATILALGCSLSGLK----DSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 93 ~~~~~l~~e~k~~~~~~lvlg~~~~~~~----~~~v~~~c~~~~~~~c~v~~v 141 (549)
+....|++.|+...++.||+|....... .+.++.+..++++ |.|+.+
T Consensus 81 ~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~--~pvlvv 131 (132)
T cd01988 81 DIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAP--CDVAVV 131 (132)
T ss_pred CHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCC--CCEEEe
Confidence 6778899999999999999999976221 1237888888888 877655
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-05 Score=71.74 Aligned_cols=116 Identities=7% Similarity=0.149 Sum_probs=85.9
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcc-cc-----chH---------HHHHHhhhccCceEE-
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL-DL-----NTF---------HIHEDLCKSKKVDFL- 85 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~-~~-----~~~---------~~~~~~c~~k~~~~~- 85 (549)
-++|||++|.|..+..+|.+|+.-..+-|..|.+||+....... .. +.+ ..++.++..-+++..
T Consensus 3 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (142)
T PRK10116 3 YSNILVAVAVTPESQQLLAKAVSIARPVNGKISLITLASDPEMYNQFAAPMLEDLRSVMQEETQSFLDKLIQDADYPIEK 82 (142)
T ss_pred CceEEEEccCCcchHHHHHHHHHHHHHhCCEEEEEEEccCcccchhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCeEE
Confidence 36999999999999999999999877778899999997443211 00 011 234555665566554
Q ss_pred EEEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEec
Q 008898 86 VKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 86 ~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
..+..|.+ ..++++.|+...++.||+|++.. +. .+ ++.+++++++ |-|+.|-
T Consensus 83 ~~~~~G~~-~~~I~~~a~~~~~DLiV~g~~~~~~~~~~-~s-~a~~v~~~~~--~pVLvv~ 138 (142)
T PRK10116 83 TFIAYGEL-SEHILEVCRKHHFDLVICGNHNHSFFSRA-SC-SAKRVIASSE--VDVLLVP 138 (142)
T ss_pred EEEecCCH-HHHHHHHHHHhCCCEEEEcCCcchHHHHH-HH-HHHHHHhcCC--CCEEEEe
Confidence 44456766 56899999999999999999966 21 24 8889999988 8887774
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.6e-07 Score=100.46 Aligned_cols=179 Identities=21% Similarity=0.207 Sum_probs=130.5
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCeEEEEEeccCCC--H
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN-IVRIIGYCHSKEMYAIVYNLLNGS--L 333 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~gs--L 333 (549)
..-+++|+++++||.+....+....+.+... ....-++++|.+++||| .+..++-++.++..++.++++.+. -
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 3447899999999987644454556665433 34556899999999999 777777778888999999998432 1
Q ss_pred HHHH--H--HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccc
Q 008898 334 KQYL--K--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409 (549)
Q Consensus 334 ~~~l--~--~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 409 (549)
..-. . .+..-+...+...-.+++.|||+. .=+|+| ||+..+. ..++.||+.+.-... ....
T Consensus 323 ~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~------~~~~ 387 (829)
T KOG0576|consen 323 ALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSEE--EVKLLDFAVPPQLTR------TMKP 387 (829)
T ss_pred cccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----ccccccc--ccccccccCCcccCc------cccc
Confidence 1111 1 122223334455567789999977 558888 8888876 589999998754332 2245
Q ss_pred cccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008898 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (549)
Q Consensus 410 ~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~ 454 (549)
.+..+|+.++|||+...+.+..+.|.|++|+-..+|--|-+|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 677899999999999999999999999999987788777777544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.5e-05 Score=73.80 Aligned_cols=134 Identities=19% Similarity=0.215 Sum_probs=87.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHH----------HHHHHHHHhcCC---CCCeeeEEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE----------VLREVELLSSIK---HENIVRIIGYC 316 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~----------~~~E~~il~~l~---h~nIv~l~~~~ 316 (549)
+..+|...+++-......|.+-.. +|+.+.+|..+....-.+. ..+++..+..+. -.....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788888888877777777654 6788999988654322221 223333333332 22222322222
Q ss_pred -----EcCCeEEEEEeccCC-CHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEee
Q 008898 317 -----HSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (549)
Q Consensus 317 -----~~~~~~~lv~e~~~g-sL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~D 390 (549)
.-...++++|||+.| .|.++.. +.. .++..+.+++.-||+. |+.|+|..|.|++++++ .+++.|
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~--~i~iID 177 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN--GIRIID 177 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC--cEEEEE
Confidence 223467789999977 4555431 211 2445677889999999 99999999999999977 499999
Q ss_pred eccc
Q 008898 391 FGAA 394 (549)
Q Consensus 391 FGla 394 (549)
|+..
T Consensus 178 ~~~k 181 (229)
T PF06176_consen 178 TQGK 181 (229)
T ss_pred Cccc
Confidence 9865
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.3e-05 Score=74.85 Aligned_cols=145 Identities=21% Similarity=0.278 Sum_probs=96.9
Q ss_pred cCHHHHHhhhcCCCCCceEc---ccCceEEEEEEecCCcEEEEEEeecCCcCH--------------------HH-----
Q 008898 242 FTSQELCHLTHNFSPKMLIG---QGGNSKVYRTNHVDGQVAAVKVLKCTNWSE--------------------EE----- 293 (549)
Q Consensus 242 ~~~~el~~~~~~f~~~~~lG---~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~--------------------~~----- 293 (549)
.+...+..+.+...+..+.| .|--+.||+|...++..+|+|+.+...... .+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45556666677777766655 455668999988889999999987542211 11
Q ss_pred HHHHHHHHhcCC--CCCeeeEEEEEEcCCeEEEEEeccCCC------HHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCC
Q 008898 294 VLREVELLSSIK--HENIVRIIGYCHSKEMYAIVYNLLNGS------LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDP 365 (549)
Q Consensus 294 ~~~E~~il~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~gs------L~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~ 365 (549)
..+|..-|+++. +-.+.+-+++. .-.|+|||++.. |.+.- +...+...+..++++.+.-|-..+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~--~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP--LELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCC--cCchhHHHHHHHHHHHHHHHHHhc--
Confidence 345777777663 33444445443 347899999543 33221 122245556677777777776632
Q ss_pred CEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 366 ~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
+++|+||..-|||+.+ +.+.++|||-|..
T Consensus 187 ~LVHgDLSEyNiL~~~--~~p~iID~~QaV~ 215 (268)
T COG1718 187 GLVHGDLSEYNILVHD--GEPYIIDVSQAVT 215 (268)
T ss_pred CcccccchhhheEEEC--CeEEEEECccccc
Confidence 9999999999999994 4799999998854
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.1e-05 Score=72.81 Aligned_cols=136 Identities=20% Similarity=0.225 Sum_probs=79.8
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCC--CeeeEEEEEE---cCCeEEEEEeccCCC
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE--NIVRIIGYCH---SKEMYAIVYNLLNGS 332 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~~~---~~~~~~lv~e~~~gs 332 (549)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.+.. .....+++|+++.|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468999999999998866 58999987654 3456788899998888533 3556666443 334578899999663
Q ss_pred -HHH----------------HHHH---h-------chhH---------HH-----H-------HHHHHHH-HHHHHHhC-
Q 008898 333 -LKQ----------------YLKQ---L-------KWNE---------RM-----D-------VAIGVAK-ALEYLHHT- 362 (549)
Q Consensus 333 -L~~----------------~l~~---~-------~~~~---------~~-----~-------i~~~i~~-aL~yLH~~- 362 (549)
+.. .+.. . .... .. . ....+.+ .+..++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 444 1110 0 0000 00 0 0112222 33444431
Q ss_pred ---CCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 363 ---CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 363 ---~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
....++|+|+.|.|||++++.+.+-|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 234799999999999999332455799999873
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=5e-05 Score=82.29 Aligned_cols=134 Identities=22% Similarity=0.245 Sum_probs=84.0
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcC---------------------------H----H----------HHHH
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---------------------------E----E----------EVLR 296 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---------------------------~----~----------~~~~ 296 (549)
..|+.++-|.||+|...+|+.||||+..+.-.. . + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 579999999999999999999999998653110 0 0 1233
Q ss_pred HHHHHhcC----C-CCCeeeEEE-EEEcCCeEEEEEeccCC-CHHHH--HHHhchhHHHHHHHHHHHH-HHHHHhCCCCC
Q 008898 297 EVELLSSI----K-HENIVRIIG-YCHSKEMYAIVYNLLNG-SLKQY--LKQLKWNERMDVAIGVAKA-LEYLHHTCDPP 366 (549)
Q Consensus 297 E~~il~~l----~-h~nIv~l~~-~~~~~~~~~lv~e~~~g-sL~~~--l~~~~~~~~~~i~~~i~~a-L~yLH~~~~~~ 366 (549)
|..-+.++ + .|++ .+=. |++-...-.++|||+.| .+.+. ++.-... ...++..++++ +..+-.. |
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d-~k~ia~~~~~~f~~q~~~d---g 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID-RKELAELLVRAFLRQLLRD---G 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC-HHHHHHHHHHHHHHHHHhc---C
Confidence 44433333 2 2332 2222 22334567899999987 46555 3331111 22233333332 2233334 9
Q ss_pred EEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 367 iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
++|.|..|.||+++.+ +.+-+.|||+....
T Consensus 286 ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l 315 (517)
T COG0661 286 FFHADPHPGNILVRSD-GRIVLLDFGIVGRL 315 (517)
T ss_pred ccccCCCccceEEecC-CcEEEEcCcceecC
Confidence 9999999999999999 78999999997543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=71.01 Aligned_cols=69 Identities=19% Similarity=0.241 Sum_probs=49.2
Q ss_pred EcccCc-eEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEeccCC
Q 008898 260 IGQGGN-SKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLLNG 331 (549)
Q Consensus 260 lG~G~f-g~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~g 331 (549)
|-.|.+ ..||+.... +..+.+|+..... ..++.+|+++++.+. +--+.+++++...++..+++|+++.|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 344555 789998764 4678888876443 345778999988884 34456778877766678899999966
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00011 Score=67.50 Aligned_cols=127 Identities=18% Similarity=0.206 Sum_probs=85.9
Q ss_pred CCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeee-EEEEEEcCCeEEEEEeccCC-CH
Q 008898 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR-IIGYCHSKEMYAIVYNLLNG-SL 333 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~-l~~~~~~~~~~~lv~e~~~g-sL 333 (549)
..+.||+|.+|.||+|.+. |..+|+|+-+.+ .....+..|.++|..++.-++.+ +|.|-.+ ++.|||+.| .|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcch
Confidence 3456999999999999885 447888876543 34567889999999998766654 4444322 344999977 67
Q ss_pred HHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCC-CCCEEEecCCCceEEeeeccccc
Q 008898 334 KQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVK-SSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 334 ~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlk-p~NILl~~~~~~~kL~DFGla~~ 396 (549)
.+.-...+ .+-...++++-.-|-.. ||-|..|. |...+|..+ +.+.|+||..|..
T Consensus 100 ~~~~~~~~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGGD----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhccc----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 66543222 22234455554455566 89999987 544444444 3799999998853
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.81 E-value=8.1e-05 Score=70.42 Aligned_cols=96 Identities=27% Similarity=0.425 Sum_probs=77.9
Q ss_pred HHHHHHhcCCC-CCeeeEEEEEEcCCeEEEEEeccC-CCH-------HHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCC
Q 008898 296 REVELLSSIKH-ENIVRIIGYCHSKEMYAIVYNLLN-GSL-------KQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366 (549)
Q Consensus 296 ~E~~il~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~-gsL-------~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~ 366 (549)
.|.-+++.+.+ +++.+++|+| +.++ +.|+.+ +++ .+++ ..+|..+.++|.++++.+.+|++.....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C---G~~~-v~E~~~~~~~~~~~~~l~~~~-~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC---GRFY-VVEYVGAGSLYGIYRPLSQFL-QSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC---CCEE-EEEeecCcccccccccccccc-ccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47888888876 6999999999 4444 556664 544 3443 5789999999999999999999976667
Q ss_pred EEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 367 iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+...|++|+|+-++++ +.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence 9999999999999988 68999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00023 Score=72.46 Aligned_cols=119 Identities=9% Similarity=0.089 Sum_probs=84.2
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCc--cc---c------------chHHHHHHh---hhccCc
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT--LD---L------------NTFHIHEDL---CKSKKV 82 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~--~~---~------------~~~~~~~~~---c~~k~~ 82 (549)
++|||++|.+..+..+|.||+.-..+-|..|++|||..+... .. . +....++.+ ++..++
T Consensus 4 ~~ILv~~D~s~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 83 (305)
T PRK11175 4 QNILVVIDPNQDDQPALRRAVYLAQRNGGKITAFLPIYDFSYEMTTLLSPDEREAMRQGVISQRTAWIREQAKPYLDAGI 83 (305)
T ss_pred ceEEEEcCCCccccHHHHHHHHHHHhcCCCEEEEEeccCchhhhhcccchhHHHHHHHHHHHHHHHHHHHHHHHHhhcCC
Confidence 579999999999999999999976677889999999743211 00 0 001122333 345578
Q ss_pred eEEEEEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEecc
Q 008898 83 DFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 83 ~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
.++..|.++......+++.|+...++.||+|.... +...+.+..+.+++++ |-|+.|..
T Consensus 84 ~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~--~pvlvv~~ 146 (305)
T PRK11175 84 PIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCP--CPVLMVKD 146 (305)
T ss_pred ceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCC--CCEEEecc
Confidence 88888876335566899999999999999998754 1111127777888877 88887753
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00024 Score=82.34 Aligned_cols=141 Identities=13% Similarity=0.232 Sum_probs=89.4
Q ss_pred CceEcccCceEEEEEEecCC---cEEEEEEeecCC--cCHHHHHHHHHHHhcCC-CCCe--eeEEEEEEcC---CeEEEE
Q 008898 257 KMLIGQGGNSKVYRTNHVDG---QVAAVKVLKCTN--WSEEEVLREVELLSSIK-HENI--VRIIGYCHSK---EMYAIV 325 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g---~~~AvK~l~~~~--~~~~~~~~E~~il~~l~-h~nI--v~l~~~~~~~---~~~~lv 325 (549)
...++.|.+..+|+....++ ..+++|+..... .....+.+|..+|+.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45689999999999876543 467777765432 22356889999999995 6654 7788888664 357899
Q ss_pred EeccCCCH-HH--------------------HHH---Hhchh----------------HHHHH---------------HH
Q 008898 326 YNLLNGSL-KQ--------------------YLK---QLKWN----------------ERMDV---------------AI 350 (549)
Q Consensus 326 ~e~~~gsL-~~--------------------~l~---~~~~~----------------~~~~i---------------~~ 350 (549)
||++.|.. .+ .+. ..++. +...+ ..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99997642 10 110 01100 00000 01
Q ss_pred HHHHHHHHHHhCCC--------CCEEEecCCCCCEEEecCCCc-eEEeeecccccc
Q 008898 351 GVAKALEYLHHTCD--------PPIIHRDVKSSNILLSENFHH-PQLSDFGAAMVH 397 (549)
Q Consensus 351 ~i~~aL~yLH~~~~--------~~iiHrDlkp~NILl~~~~~~-~kL~DFGla~~~ 397 (549)
.+...+.+|..+.. ..+||+|+++.|||++.+.+. .-|.||+++.+-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344667755422 259999999999999864233 468999988653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00033 Score=68.62 Aligned_cols=69 Identities=19% Similarity=0.264 Sum_probs=42.8
Q ss_pred ceEcccCce-EEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCC---CeeeEEEEEEcC---CeEEEEEeccC
Q 008898 258 MLIGQGGNS-KVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE---NIVRIIGYCHSK---EMYAIVYNLLN 330 (549)
Q Consensus 258 ~~lG~G~fg-~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~---nIv~l~~~~~~~---~~~~lv~e~~~ 330 (549)
..|+.||.. .||+. +..+++|..+. ......+.+|.+++..+... .+..+++..... ...+++|+++.
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457777776 58975 23567786553 33445788999999887532 234444444322 23477899986
Q ss_pred C
Q 008898 331 G 331 (549)
Q Consensus 331 g 331 (549)
|
T Consensus 78 G 78 (235)
T cd05155 78 G 78 (235)
T ss_pred C
Confidence 5
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00061 Score=73.80 Aligned_cols=132 Identities=19% Similarity=0.228 Sum_probs=80.7
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcCH----------------------------H----------HHHHHHH
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE----------------------------E----------EVLREVE 299 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~----------------------------~----------~~~~E~~ 299 (549)
+.||.-+.|.||+++..+|+.||||+-++.-... + +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4689999999999999999999999975431100 0 1223332
Q ss_pred ----HHhcCCCCC------eeeEEEEEEcCCeEEEEEeccCC----CHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCC
Q 008898 300 ----LLSSIKHEN------IVRIIGYCHSKEMYAIVYNLLNG----SLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTC 363 (549)
Q Consensus 300 ----il~~l~h~n------Iv~l~~~~~~~~~~~lv~e~~~g----sL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~ 363 (549)
+.+.+.|-+ |.++|- .-.....|+|||++| +| +++.. .+... ++..+.++ |++..-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl-~~i~~~gi~~~~---i~~~l~~~--~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDL-DAIDKRGISPHD---ILNKLVEA--YLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCH-HHHHHcCCCHHH---HHHHHHHH--HHHHHH
Confidence 223334544 333332 223467899999976 34 33433 33333 33333332 222222
Q ss_pred CCCEEEecCCCCCEEEecC---CCceEEeeecccccc
Q 008898 364 DPPIIHRDVKSSNILLSEN---FHHPQLSDFGAAMVH 397 (549)
Q Consensus 364 ~~~iiHrDlkp~NILl~~~---~~~~kL~DFGla~~~ 397 (549)
..|++|+|=.|.||++..+ ...+.+-|||+....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 2299999999999999942 357899999997543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00095 Score=63.31 Aligned_cols=124 Identities=23% Similarity=0.391 Sum_probs=87.1
Q ss_pred cCCCCCceEcccCc-eEEEEEEecCCcEEEEEEeec---CC-------cC------------HHHHHHHHHHHhcCC---
Q 008898 252 HNFSPKMLIGQGGN-SKVYRTNHVDGQVAAVKVLKC---TN-------WS------------EEEVLREVELLSSIK--- 305 (549)
Q Consensus 252 ~~f~~~~~lG~G~f-g~Vy~~~~~~g~~~AvK~l~~---~~-------~~------------~~~~~~E~~il~~l~--- 305 (549)
.+++..+.||.|.- |.||+++. +|+.||+|+++. .. .. ...|..|-....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 57888899999999 99999987 678999999432 00 00 023667777766664
Q ss_pred CCCe--eeEEEEEEcC------------------CeEEEEEeccCCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCC
Q 008898 306 HENI--VRIIGYCHSK------------------EMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDP 365 (549)
Q Consensus 306 h~nI--v~l~~~~~~~------------------~~~~lv~e~~~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~ 365 (549)
+.++ ++.+||..-. ..+.||.||....- .....-+.+|.+-|..+|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~~~~~~dl~~~~k~--- 183 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDIPQMLRDLKILHKL--- 183 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHHHHHHHHHHHHHHC---
Confidence 5566 8888887211 24677888774322 11122345677778889998
Q ss_pred CEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 366 PIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 366 ~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
||+-+|+++.|.. .-+|+|||.+
T Consensus 184 gI~~~Dv~~~ny~------~G~lvDfs~~ 206 (207)
T PF13095_consen 184 GIVPRDVKPRNYR------GGKLVDFSSS 206 (207)
T ss_pred CeeeccCcccccc------CCEEEecccC
Confidence 9999999999986 2499999964
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0026 Score=65.25 Aligned_cols=134 Identities=16% Similarity=0.247 Sum_probs=74.6
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC--eeeEEE------EEEcCCeEEEEEecc
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVRIIG------YCHSKEMYAIVYNLL 329 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~------~~~~~~~~~lv~e~~ 329 (549)
+.|+.|....+|+....+| .+++|+.. ....+.+..|..++..|.... +.+.+. +...++..+++++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 3466777788999876555 68889875 223455556666666653211 233332 122345678899998
Q ss_pred CCC-H-----------HHHHHH-------hc----------h-hHHHH------------HH-HHHHHHHHHHHhC----
Q 008898 330 NGS-L-----------KQYLKQ-------LK----------W-NERMD------------VA-IGVAKALEYLHHT---- 362 (549)
Q Consensus 330 ~gs-L-----------~~~l~~-------~~----------~-~~~~~------------i~-~~i~~aL~yLH~~---- 362 (549)
.|. + -+.+-+ +. | ..... .. ..+...+..+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 663 1 111110 10 1 11110 01 1111222333211
Q ss_pred CCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 363 ~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
...++||+|+.|.||+++.+ ...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGD-RLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence 24589999999999999976 344799999873
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0013 Score=64.25 Aligned_cols=70 Identities=11% Similarity=0.202 Sum_probs=45.4
Q ss_pred ceEcccCceEEEEEEecC--CcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCeEEEEEeccCC
Q 008898 258 MLIGQGGNSKVYRTNHVD--GQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN-IVRIIGYCHSKEMYAIVYNLLNG 331 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~--g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~g 331 (549)
+.|..|-...+|+....+ ++.+++|+........-+..+|+.+++.+.... ..++++.+. + .++|||+.|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence 457778888999987654 678889977543322223457888888885333 344554443 2 378999865
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0018 Score=65.86 Aligned_cols=73 Identities=11% Similarity=0.066 Sum_probs=53.9
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCC---CCeeeEEEEEEc---CCeEEEEEeccC
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH---ENIVRIIGYCHS---KEMYAIVYNLLN 330 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h---~nIv~l~~~~~~---~~~~~lv~e~~~ 330 (549)
.+.||.|..+.||+....++ .+.+|..+. ......+..|...|+.|.. -.+.+++++|.. .+..++|||++.
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 44699999999999876555 466777543 2234678899999998853 367788888754 356899999986
Q ss_pred C
Q 008898 331 G 331 (549)
Q Consensus 331 g 331 (549)
|
T Consensus 97 G 97 (297)
T PRK10593 97 G 97 (297)
T ss_pred C
Confidence 5
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00062 Score=68.99 Aligned_cols=135 Identities=19% Similarity=0.204 Sum_probs=81.3
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC--eeeEEE------EEEcCCeEEEEEec
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVRIIG------YCHSKEMYAIVYNL 328 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~------~~~~~~~~~lv~e~ 328 (549)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.. +.+++. +...++..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 345777877899998654 44688898764 34466778888888775322 444443 12334567889999
Q ss_pred cCCC-HH-----------HHHHH-------h----------chhHHH----------HHHHHHHHHHHHHHh----CCCC
Q 008898 329 LNGS-LK-----------QYLKQ-------L----------KWNERM----------DVAIGVAKALEYLHH----TCDP 365 (549)
Q Consensus 329 ~~gs-L~-----------~~l~~-------~----------~~~~~~----------~i~~~i~~aL~yLH~----~~~~ 365 (549)
+.|. +. +.+.+ + .|.... .....+..++.++.+ ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 8662 11 11100 0 111100 011123344555553 1234
Q ss_pred CEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 366 ~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
+++|+|+.|.||+++++ +.+-|.||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 79999999999999987 456799999873
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0024 Score=64.91 Aligned_cols=119 Identities=11% Similarity=0.081 Sum_probs=83.5
Q ss_pred CCcEEEEEEecChhh-------HHHHHHHHHHhcCC-CCeEEEEEeeccCCcc--------ccc---------hHHHHHH
Q 008898 21 KKRTVIFGLKSDHYS-------REILLQLLTVIAKP-GDNVLAVHVEEQNDTL--------DLN---------TFHIHED 75 (549)
Q Consensus 21 ~~~~~~v~~~~~~~~-------~~~l~wa~~~~~~~-~d~v~~~hv~~~~~~~--------~~~---------~~~~~~~ 75 (549)
..++|||++|.+.++ ..+|.+|+.-...- +-.|.+|||....... ... ....++.
T Consensus 151 ~~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (305)
T PRK11175 151 EGGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAIELPEFDPSVYNDAIRGQHLLAMKA 230 (305)
T ss_pred CCCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccccccccchhhHHHHHHHHHHHHHHH
Confidence 457999999998753 67999999776665 7889999997432110 000 1134556
Q ss_pred hhhccCceE-EEEEEecCcchhhHHHHHhhhcccEEEEecccCC----CCchhHHHHHhhhCCCCcEEEEec
Q 008898 76 LCKSKKVDF-LVKVCIGDSYITELSNQVRISYATILALGCSLSG----LKDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 76 ~c~~k~~~~-~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~----~~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
+.+..+++. ...+..|. ....|.+.|+...|+.||+|...++ .-.+.++++.+++++ |-|+.|.
T Consensus 231 ~~~~~~~~~~~~~v~~G~-~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~--~pVLvv~ 299 (305)
T PRK11175 231 LRQKFGIDEEQTHVEEGL-PEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLN--CDLLAIK 299 (305)
T ss_pred HHHHhCCChhheeeccCC-HHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCC--CCEEEEc
Confidence 666666654 34456675 4668999999999999999997551 111238999999998 9998884
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0075 Score=63.61 Aligned_cols=72 Identities=21% Similarity=0.239 Sum_probs=51.4
Q ss_pred ceEcccCceEEEEEEecCC-cEEEEEEeec------C--CcCHHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCeEEEE
Q 008898 258 MLIGQGGNSKVYRTNHVDG-QVAAVKVLKC------T--NWSEEEVLREVELLSSIK---HENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g-~~~AvK~l~~------~--~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~lv 325 (549)
+.||.|.+..||++...+| +.++||.-.. . ....+....|.+.|+.+. ..++.+++.+.. +..+++
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4689999999999988776 5899998531 1 123456677888888763 345777777743 557889
Q ss_pred EeccCC
Q 008898 326 YNLLNG 331 (549)
Q Consensus 326 ~e~~~g 331 (549)
||++.+
T Consensus 110 ME~L~~ 115 (401)
T PRK09550 110 MEDLSD 115 (401)
T ss_pred EecCCC
Confidence 999843
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0015 Score=64.74 Aligned_cols=129 Identities=15% Similarity=0.155 Sum_probs=73.0
Q ss_pred EcccCceEEEEEEecCCcEEEEEEeecCCcCH-HHHHHHHHHHhcCCCCCe-eeEEEEEEcCCeEEEEEeccCCC-HHH-
Q 008898 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYNLLNGS-LKQ- 335 (549)
Q Consensus 260 lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~-~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~gs-L~~- 335 (549)
+..|-.+.+|+.. .+++.+++|+........ -+..+|..+++.+....+ .+++..+. -+++|+|+.|. +..
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4567778899887 457788888765432221 235678999988864333 33444432 25789998662 221
Q ss_pred -------------HHHH---h-------chhHH-HHHHHH---------HHHHHHHHHhC-----CCCCEEEecCCCCCE
Q 008898 336 -------------YLKQ---L-------KWNER-MDVAIG---------VAKALEYLHHT-----CDPPIIHRDVKSSNI 377 (549)
Q Consensus 336 -------------~l~~---~-------~~~~~-~~i~~~---------i~~aL~yLH~~-----~~~~iiHrDlkp~NI 377 (549)
.+.+ . ..... ..+..+ +...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1111 0 00111 011111 11112222111 123589999999999
Q ss_pred EEecCCCceEEeeecccc
Q 008898 378 LLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 378 Ll~~~~~~~kL~DFGla~ 395 (549)
+++++ + +.|+||..|.
T Consensus 159 l~~~~-~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQ-G-LKLIDWEYAS 174 (256)
T ss_pred EEeCC-C-CEEEeccccC
Confidence 99987 4 7999999873
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.01 Score=60.61 Aligned_cols=135 Identities=18% Similarity=0.204 Sum_probs=79.7
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC--eeeEEEE------EEcCCeEEEEEec
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVRIIGY------CHSKEMYAIVYNL 328 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~~------~~~~~~~~lv~e~ 328 (549)
.+.++.|....+|+....+| .+++|+.... ...+++..|.+++..|.... +.+++.. ...++..++++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 34577777789999876545 5778877542 23456667788887774222 3444331 1224567889999
Q ss_pred cCCC------HHH------HHHH-------h-----------chhHHH------------HHHHHHHHHHHHHHh----C
Q 008898 329 LNGS------LKQ------YLKQ-------L-----------KWNERM------------DVAIGVAKALEYLHH----T 362 (549)
Q Consensus 329 ~~gs------L~~------~l~~-------~-----------~~~~~~------------~i~~~i~~aL~yLH~----~ 362 (549)
+.|. ..+ .+.+ + .|.... .....+...++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 8652 111 1100 1 010000 011123345555543 2
Q ss_pred CCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 363 ~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
...+++|+|+.+.||+++++ +...|+||+.+
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~ 215 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGD-SVKGVIDFYFA 215 (307)
T ss_pred CCCccCCCCCCcCcEEEECC-ceEEEeecccc
Confidence 24589999999999999988 55689999987
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0038 Score=64.74 Aligned_cols=95 Identities=9% Similarity=0.006 Sum_probs=70.6
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCC--CCeEEEEEeeccCCcccc---------chHHHHHHhhhc------cCceE
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKP--GDNVLAVHVEEQNDTLDL---------NTFHIHEDLCKS------KKVDF 84 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~--~d~v~~~hv~~~~~~~~~---------~~~~~~~~~c~~------k~~~~ 84 (549)
-++|||.+|.|..|+.++.+|+.-.-.. |..|.+|||......... +.+...+..... .++.+
T Consensus 5 ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~~~~~~~~~eelle~~~~~~~~~l~~~~~gV~v 84 (357)
T PRK12652 5 ANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPEGQDELAAAEELLERVEVWATEDLGDDASSVTI 84 (357)
T ss_pred cCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccchhHHHHHHHHHHHHHHHHHHHhhhcccCCCce
Confidence 4689999999999999999999977664 589999999854221110 111222333322 47888
Q ss_pred EEEEEe--------cCcchhhHHHHHhhhcccEEEEecccC
Q 008898 85 LVKVCI--------GDSYITELSNQVRISYATILALGCSLS 117 (549)
Q Consensus 85 ~~~v~~--------g~~~~~~l~~e~k~~~~~~lvlg~~~~ 117 (549)
+..+.. | +...++++.|+..+++.||+|-..+
T Consensus 85 e~~vv~~~~~~~~~G-~pae~Iv~~Aee~~aDLIVm~~~~~ 124 (357)
T PRK12652 85 ETALLGTDEYLFGPG-DYAEVLIAYAEEHGIDRVVLDPEYN 124 (357)
T ss_pred EEEEEeccccccCCC-CHHHHHHHHHHHcCCCEEEECCCCC
Confidence 888876 5 4567899999999999999999877
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0018 Score=74.60 Aligned_cols=190 Identities=20% Similarity=0.231 Sum_probs=120.3
Q ss_pred HHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE----eccC-CCHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCC
Q 008898 294 VLREVELLSSIKHENIVRIIGYCHSKEMYAIVY----NLLN-GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDP 365 (549)
Q Consensus 294 ~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~----e~~~-gsL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~ 365 (549)
...|++.+..+.|+|+..++.|..+....-+++ +++. -++...++ ..+....+.+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 345677788889999999998886554333333 3442 24544443 366677778889999999999998
Q ss_pred CEEEecCCCC---CEEEecCCCceEEe--eeccccccccccccccCccccccccCCccccccccccCCCCc--hhhHHHH
Q 008898 366 PIIHRDVKSS---NILLSENFHHPQLS--DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE--KIDVYSY 438 (549)
Q Consensus 366 ~iiHrDlkp~---NILl~~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~--k~DvwSl 438 (549)
...|.-+..+ +--.+.+ +...++ ||+.......... .....-+..|.|||......++. ..|+|.+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEK------SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred ccceeEEecccccccccCcc-ceeecchhhhcccccCCCccc------chhhcCccccccccccccccchhhhhhHHHHH
Confidence 5555544444 3333334 344555 7776644333221 11223455678888777666554 4799999
Q ss_pred HHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 439 GVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 439 Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
|..+..+..|..+-....... .+++.. ....+.++...|+..++++|++..+++.
T Consensus 379 gll~~~~~~~~~i~~~~~~~~-----------------~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVPV-----------------SLLDVL--------STSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHHhhhhhcCcccccccchh-----------------hhhccc--------cchhhhhhhhhhcchhhhhccchhhhhh
Confidence 999999998866543221110 111111 1113556678899999999999999998
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.014 Score=52.19 Aligned_cols=119 Identities=16% Similarity=0.255 Sum_probs=90.2
Q ss_pred CcEEEEEEe-cChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcccc----------------------chHHHHHHhhh
Q 008898 22 KRTVIFGLK-SDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL----------------------NTFHIHEDLCK 78 (549)
Q Consensus 22 ~~~~~v~~~-~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~~----------------------~~~~~~~~~c~ 78 (549)
.++|++++| .+..++.++.+|+......+..+.++||......... ......+..-.
T Consensus 5 ~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (154)
T COG0589 5 YKKILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEEELEEEAEELLAEAKALAE 84 (154)
T ss_pred cceEEEEeCCCCHHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccchhhhhHHHHHHHHHHHHHHHHHHHH
Confidence 469999999 8889999999999999999999999999855442111 11133344444
Q ss_pred ccCce-EEEEEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEec
Q 008898 79 SKKVD-FLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 79 ~k~~~-~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
..++. .+..+..|.+....+.+.|....|+.||+|.... +.-.+.+.++.+++++ |.|+.+.
T Consensus 85 ~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGsvs~~v~~~~~--~pVlvv~ 151 (154)
T COG0589 85 AAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGSVAEKVLRHAP--CPVLVVR 151 (154)
T ss_pred HcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeehhHHHHHhcCC--CCEEEEc
Confidence 45666 4788899999888899999999999999999755 2112348899988888 8777664
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0014 Score=65.82 Aligned_cols=143 Identities=18% Similarity=0.238 Sum_probs=95.9
Q ss_pred ccCHHHHHhhhcC---CCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC-----------------------HHHH
Q 008898 241 RFTSQELCHLTHN---FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-----------------------EEEV 294 (549)
Q Consensus 241 ~~~~~el~~~~~~---f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~-----------------------~~~~ 294 (549)
-+++-.|..+.++ ++.++.||-|--+.+|.+-..+|+..++|.-.....+ .-..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 3455556555554 5678889999999999999888999999864321111 0124
Q ss_pred HHHHHHHhcCC-CCC-eeeEEEEEEcCCeEEEEEeccCC-CHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEec
Q 008898 295 LREVELLSSIK-HEN-IVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371 (549)
Q Consensus 295 ~~E~~il~~l~-h~n-Iv~l~~~~~~~~~~~lv~e~~~g-sL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrD 371 (549)
.+|...|+.|. |.+ +.+.+++ +..++||+++.| .|.+.-.-. ....+...+...+.-|-.. |+||+|
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~---d~~~ly~~lm~~Iv~la~~---GlIHgD 227 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE---DPPTLYDDLMGLIVRLANH---GLIHGD 227 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC---ChHHHHHHHHHHHHHHHHc---Cceecc
Confidence 57888888885 322 3333333 567889999865 454332222 2223344455555566666 999999
Q ss_pred CCCCCEEEecCCCceEEeeeccc
Q 008898 372 VKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 372 lkp~NILl~~~~~~~kL~DFGla 394 (549)
..-=||+++++ +.++++||--+
T Consensus 228 FNEFNimv~dd-~~i~vIDFPQm 249 (465)
T KOG2268|consen 228 FNEFNIMVKDD-DKIVVIDFPQM 249 (465)
T ss_pred cchheeEEecC-CCEEEeechHh
Confidence 99999999988 57999999754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0077 Score=61.21 Aligned_cols=69 Identities=14% Similarity=0.204 Sum_probs=44.7
Q ss_pred eEcccCceEEEEEEecC-------CcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCe-eeEEEEEEcCCeEEEEEeccC
Q 008898 259 LIGQGGNSKVYRTNHVD-------GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYNLLN 330 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~-------g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~ 330 (549)
.|..|-...+|+....+ ++.+++|+.........+..+|..++..+....+ .++++++.. .++++|+.
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 45566667899987654 5789999976544333456788888888854333 345555532 24678775
Q ss_pred C
Q 008898 331 G 331 (549)
Q Consensus 331 g 331 (549)
|
T Consensus 81 G 81 (302)
T cd05156 81 S 81 (302)
T ss_pred C
Confidence 4
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.0092 Score=63.54 Aligned_cols=166 Identities=20% Similarity=0.205 Sum_probs=97.6
Q ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEEc-CCeEEEEEeccCCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEe
Q 008898 292 EEVLREVELLSSIKHENIVRIIGYCHS-KEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370 (549)
Q Consensus 292 ~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~lv~e~~~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHr 370 (549)
.++.--..+++.+.|+|...++.+... .....+|+|+++-+|++++.... ... +. ++ .+ ++.|-
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~-l~~---~s----~~----~~---~~~~~ 91 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN-LKD---ES----LL----AH---GVLHL 91 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc-cch---hh----hc----cc---cccee
Confidence 456667888999999999999988753 34688899999999999986533 111 11 11 11 44443
Q ss_pred cCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCC
Q 008898 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450 (549)
Q Consensus 371 Dlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~ 450 (549)
| ..+.+| -++.. . ....| +|+|||++|.++.|+.-|..
T Consensus 92 -----~--------~~~~td-~~~t~------~------~~~~~----------------pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 92 -----N--------IIYITD-HFLTK------Y------PSPIG----------------PKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred -----h--------hhhccc-ccccc------C------CCCCC----------------cchhhhhHHHHHHHHHHhhH
Confidence 1 233444 11100 0 01111 49999999999999999987
Q ss_pred CCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 451 AIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 451 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
.+..... .+.++...+....+.....+.- ...+.-++.+.+.++...|+-..|..||...++.+
T Consensus 130 l~~~~~~-s~~l~~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 130 LEAELTE-SEYLEILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHH-HHHHHHHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 7655432 2222222222211111111100 01222345567788889999999999997666544
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.017 Score=59.22 Aligned_cols=133 Identities=18% Similarity=0.244 Sum_probs=89.0
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcC----------------------HH-----HHHHHHHHHhcCCCCCee
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS----------------------EE-----EVLREVELLSSIKHENIV 310 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~----------------------~~-----~~~~E~~il~~l~h~nIv 310 (549)
.+|..|--+.||.+...+|..+|||+++.+-.. +. -...|+.-|.+|+.-.|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 467788889999999999999999998643110 11 134577777777543322
Q ss_pred eEEEEEEcCCeEEEEEeccCCC--HHHHHH--HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCce
Q 008898 311 RIIGYCHSKEMYAIVYNLLNGS--LKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386 (549)
Q Consensus 311 ~l~~~~~~~~~~~lv~e~~~gs--L~~~l~--~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~ 386 (549)
----+.. ....|||+|++++ -.-.|+ .++...+..+-.+++.-+.-|-+.| ++||.||.=-|+|+.+. .+
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~LyhdG--~l 303 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHDG--KL 303 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEECC--EE
Confidence 1000011 2457899999643 111222 2444556666677777788777766 99999999999999875 79
Q ss_pred EEeeeccccc
Q 008898 387 QLSDFGAAMV 396 (549)
Q Consensus 387 kL~DFGla~~ 396 (549)
.++|.+-+..
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999987643
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.033 Score=65.39 Aligned_cols=112 Identities=14% Similarity=0.066 Sum_probs=84.4
Q ss_pred CCcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCc--cccchHHHHHHhhhccCceEEEEEEecCcchhhH
Q 008898 21 KKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT--LDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITEL 98 (549)
Q Consensus 21 ~~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~--~~~~~~~~~~~~c~~k~~~~~~~v~~g~~~~~~l 98 (549)
.+.+|||+|+-+.++..++.+|..-..+=|-...+|||.++... ...+.-...+++.-+++.+-++.+..|.++..+|
T Consensus 249 ~~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~~~~~~~~~~l~~~~~lA~~lGa~~~~~~~~dva~~i 328 (895)
T PRK10490 249 TRDAILLCIGHNTGSEKLVRTAARLAARLGSVWHAVYVETPRLHRLPEKKRRAILSALRLAQELGAETATLSDPAEEKAV 328 (895)
T ss_pred cCCeEEEEECCCcchHHHHHHHHHHHHhcCCCEEEEEEecCCcCcCCHHHHHHHHHHHHHHHHcCCEEEEEeCCCHHHHH
Confidence 34589999999999999999999988888889999999866432 1111112224444445556667788999999999
Q ss_pred HHHHhhhcccEEEEecccCCCC---chhHHHHHhhhCC
Q 008898 99 SNQVRISYATILALGCSLSGLK---DSEVLTRCLRALP 133 (549)
Q Consensus 99 ~~e~k~~~~~~lvlg~~~~~~~---~~~v~~~c~~~~~ 133 (549)
++-|+..+|+.||+|.+.++.+ .| ++..-.+.++
T Consensus 329 ~~~A~~~~vt~IViG~s~~~~~~~~~s-~~~~l~r~~~ 365 (895)
T PRK10490 329 LRYAREHNLGKIIIGRRASRRWWRRES-FADRLARLGP 365 (895)
T ss_pred HHHHHHhCCCEEEECCCCCCCCccCCC-HHHHHHHhCC
Confidence 9999999999999999977322 24 7777776655
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.05 Score=54.74 Aligned_cols=45 Identities=16% Similarity=0.144 Sum_probs=30.8
Q ss_pred EcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC
Q 008898 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK 305 (549)
Q Consensus 260 lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~ 305 (549)
.++|-...||.....+|+.+++|.-+. ......+.+|.++|+.+.
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRR-PDVSERAAAEKRVLALVR 63 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHH
Confidence 345555667766555688898887652 223456788999998885
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.057 Score=56.17 Aligned_cols=133 Identities=14% Similarity=0.211 Sum_probs=74.6
Q ss_pred eEcccCceEEEEEEecC-----CcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCee-eEEEEEEcCCeEEEEEeccCC-
Q 008898 259 LIGQGGNSKVYRTNHVD-----GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV-RIIGYCHSKEMYAIVYNLLNG- 331 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~-----g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv-~l~~~~~~~~~~~lv~e~~~g- 331 (549)
.|-.|-...+|+....+ ++.+++|+........-+...|..+++.+..-++. ++++++..+ .+++|+.|
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 45557788999986432 36888998765432222336788888888644443 455655332 46777754
Q ss_pred CHHH-------HH-------HH---hc---------hhHHHHHHH-----------------HHHHHHHHHHh-----CC
Q 008898 332 SLKQ-------YL-------KQ---LK---------WNERMDVAI-----------------GVAKALEYLHH-----TC 363 (549)
Q Consensus 332 sL~~-------~l-------~~---~~---------~~~~~~i~~-----------------~i~~aL~yLH~-----~~ 363 (549)
+|.. .+ .+ .+ +.+...+.. .+...+..|.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 2211 11 11 00 111111110 11112222221 22
Q ss_pred CCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 364 ~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
...++|+|+++.|||++++.+.+.++||..|.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 33689999999999998743579999999873
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.46 Score=48.94 Aligned_cols=69 Identities=17% Similarity=0.361 Sum_probs=45.4
Q ss_pred cCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC--eee-E--EE--EEEcCCeEEEEEeccCC
Q 008898 263 GGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVR-I--IG--YCHSKEMYAIVYNLLNG 331 (549)
Q Consensus 263 G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n--Iv~-l--~~--~~~~~~~~~lv~e~~~g 331 (549)
+.-..||+....+|..+++|+.........++..|++.+..|.... ++. + -| +...++..+.+++++.|
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 4456799988777888999998765566777888888887764211 221 1 11 22334567778888755
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.082 Score=54.63 Aligned_cols=69 Identities=10% Similarity=0.169 Sum_probs=41.8
Q ss_pred eEcccCceEEEEEEecC----CcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCee-eEEEEEEcCCeEEEEEeccCC
Q 008898 259 LIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV-RIIGYCHSKEMYAIVYNLLNG 331 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~~----g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv-~l~~~~~~~~~~~lv~e~~~g 331 (549)
.|..|=...+|+....+ +..+++|+........-+-.+|..+++.+..-++. ++++++. +. ++.+|+.|
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 35457777899886432 24788898754322222345788888888654443 4566553 22 46777755
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.2 Score=50.83 Aligned_cols=28 Identities=32% Similarity=0.423 Sum_probs=24.8
Q ss_pred CCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 365 ~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
.+++|+|+.+.||+++.+ .+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~~--~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN--EVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeCC--cEEEEECccc
Confidence 489999999999999874 5899999976
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 549 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 9e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 9e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 549 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-102 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 9e-97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-88 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-69 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-54 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 7e-53 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-52 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-52 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 7e-51 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-48 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-48 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-47 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-47 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-46 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-46 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-46 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-46 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-45 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 8e-40 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-37 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-36 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-35 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-33 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-32 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-32 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 8e-32 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-31 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-31 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 9e-31 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-30 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-30 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-30 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-30 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-29 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-29 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-29 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 6e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-29 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-28 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-27 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-27 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-27 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-27 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-27 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 5e-27 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 6e-27 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 6e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 8e-27 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-26 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-26 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-26 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-26 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-26 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 6e-26 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-26 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-25 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-25 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-25 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-25 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-25 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-25 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-25 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-25 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-25 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-25 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-25 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-25 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-25 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 7e-25 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 8e-25 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-24 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-24 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-24 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-24 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-24 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-24 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-24 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-24 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-24 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-24 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-24 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 9e-24 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-24 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-23 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-23 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-23 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-23 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-23 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-23 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-23 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-23 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-23 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-23 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-23 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-23 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-23 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-07 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-23 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-23 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 6e-23 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 8e-23 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-23 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 9e-23 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-22 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-22 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-22 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-22 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-22 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-22 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-22 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-22 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-22 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-22 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-22 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-22 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 6e-22 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 6e-22 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-22 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 8e-22 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 9e-22 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-21 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-21 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-21 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-21 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-21 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-20 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-20 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-20 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-20 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-20 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-20 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-20 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-20 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 8e-20 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 9e-20 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-19 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-19 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-19 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-19 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-19 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-19 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-19 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-19 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-19 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-19 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-19 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-19 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 6e-19 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 7e-19 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 7e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 8e-19 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-18 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-18 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-18 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-18 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-18 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-18 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 4e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-18 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 7e-18 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 9e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-17 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-17 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-17 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-17 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-17 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-17 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-17 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 6e-17 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 7e-17 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 9e-17 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-16 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-16 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-16 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-16 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-16 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-16 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-16 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-16 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-16 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 5e-16 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-16 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-16 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-16 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-15 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-15 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-15 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-15 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 6e-15 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-14 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-14 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-14 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-14 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-14 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 5e-14 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 9e-14 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-13 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-13 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-12 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-12 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-12 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-12 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-12 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 6e-12 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 7e-12 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-11 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-11 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-11 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-11 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-11 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 9e-11 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-05 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 6e-10 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 7e-10 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 7e-10 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-09 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-09 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-08 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-09 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-08 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-08 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 8e-07 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-05 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-102
Identities = 115/292 (39%), Positives = 159/292 (54%), Gaps = 22/292 (7%)
Query: 237 GSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW--SEEEV 294
G +RF+ +EL + NFS K ++G+GG KVY+ DG + AVK LK E +
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 295 LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL-------KQLKWNERM 346
EVE++S H N++R+ G+C + +VY + NGS+ L L W +R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 347 DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVS 404
+A+G A+ L YLH CDP IIHRDVK++NILL E F + DFG A M + +H V+
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTH-VT 192
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES--- 461
V GT G++APEY+ GK EK DV+ YGV+LLELITG+ A + +
Sbjct: 193 -----TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 462 LVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM 513
L+ W + LL E L+D L Y EE+E ++ A LC S RP M
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 9e-97
Identities = 106/291 (36%), Positives = 154/291 (52%), Gaps = 23/291 (7%)
Query: 236 EGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-SEEEV 294
S R +L T+NF K LIG G KVY+ DG A+K + EE
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 295 LREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL-------KQLKWNERM 346
E+E LS +H ++V +IG+C + ++Y + NG+LK++L + W +R+
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 347 DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG---AAMVHHQSHQV 403
++ IG A+ L YLH IIHRDVKS NILL ENF P+++DFG Q+H +
Sbjct: 143 EICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV-PKITDFGISKKGTELDQTH-L 197
Query: 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE-SL 462
S VK GT GY+ PEY + G++ EK DVYS+GVVL E++ + AI + +L
Sbjct: 198 STVVK-----GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM 513
WA ++G E+++DP L ++ E + A CL SS RP+M
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 2e-88
Identities = 89/309 (28%), Positives = 155/309 (50%), Gaps = 36/309 (11%)
Query: 228 EKLAVLEAEGSSRRFTSQELCHLTHNFSPKM------LIGQGGNSKVYRTNHVDGQVAAV 281
E ++ ++ F+ EL ++T+NF + +G+GG VY+ +V+ AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK-GYVNNTTVAV 59
Query: 282 KVLKCTNWS-----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQ 335
K L +++ +E+++++ +HEN+V ++G+ + +VY + NGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 336 YL------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
L L W+ R +A G A + +LH + IHRD+KS+NILL E F ++S
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFT-AKIS 175
Query: 390 DFGAA---MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446
DFG A Q+ ++ + VGT Y+APE + G++ K D+YS+GVVLLE+I
Sbjct: 176 DFGLARASEKFAQTV-MTSRI-----VGTTAYMAPEALR-GEITPKSDIYSFGVVLLEII 228
Query: 447 TGKEAIQTNKANRESLVLWARSLLSS-GLCERLIDPQLNEEYNREEIEIVMCAARLCLLH 505
TG A+ ++ + L+ + E ID ++ + + +E + A CL
Sbjct: 229 TGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHE 286
Query: 506 SSSRRPTMK 514
++RP +K
Sbjct: 287 KKNKRPDIK 295
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-69
Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 31/311 (9%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLRE 297
S ++ L + + +G V++ + AVK+ + + E
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYE 68
Query: 298 VELLSSIKHENIVRIIGYC----HSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAI 350
V L +KHENI++ IG ++ GSL +LK + WNE +A
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAE 128
Query: 351 GVAKALEYLHH-------TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403
+A+ L YLH P I HRD+KS N+LL N ++DFG A+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSA 187
Query: 404 SENVKPVNVVGTFGYLAPEYMMYG-----KVDEKIDVYSYGVVLLELITGKEAIQT---- 454
+ VGT Y+APE + +ID+Y+ G+VL EL + A
Sbjct: 188 GDT---HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 455 NKANRESLVLWARSL--LSSGLCERLIDPQLNEEYNREEIEIVMCA-ARLCLLHSSSRRP 511
E + SL + + + P L + + + ++C C H + R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 512 TMKTLLKLFQE 522
+ + + +
Sbjct: 305 SAGCVGERITQ 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-54
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 19/198 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G+G V + + A+K ++ + + + E+ LS + H NIV++ G C +
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 320 EMYAIVYNLL-NGSLKQYL------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+V GSL L M + ++ + YLH +IHRD+
Sbjct: 74 --VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
K N+LL ++ DFG A N G+ ++APE EK
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTACDIQTHM--------TNNKGSAAWMAPEVFEGSNYSEK 183
Query: 433 IDVYSYGVVLLELITGKE 450
DV+S+G++L E+IT ++
Sbjct: 184 CDVFSWGIILWEVITRRK 201
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 7e-53
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE-----EEVLREVELLSSIKHENIVRIIG 314
IG GG KVYR G AVK + + E V +E +L + +KH NI+ + G
Sbjct: 15 IGIGGFGKVYR-AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 315 YCHSKEMYAIV--YNLLNGSLKQYL--KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
C + +V + G L + L K++ + ++ A+ +A+ + YLH PIIHR
Sbjct: 74 VCLKEPNLCLVMEF-ARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 371 DVKSSNILLSENFHHPQ-------LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
D+KSSNIL+ + + ++DFG A H++ ++S G + ++APE
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-------AGAYAWMAPEV 185
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKE 450
+ + DV+SYGV+L EL+TG+
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC 316
IG G V+R G AVK+L ++ E LREV ++ ++H NIV +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 317 HSKEMYAIV--YNLLNGSLKQYL------KQLKWNERMDVAIGVAKALEYLHHTCDPPII 368
+IV Y L GSL + L +QL R+ +A VAK + YLH +PPI+
Sbjct: 104 TQPPNLSIVTEY-LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HR++KS N+L+ + + ++ DFG + + + S++ GT ++APE +
Sbjct: 162 HRNLKSPNLLVDKKYT-VKVCDFGLSRLKASTFLSSKSA-----AGTPEWMAPEVLRDEP 215
Query: 429 VDEKIDVYSYGVVLLELITGKE 450
+EK DVYS+GV+L EL T ++
Sbjct: 216 SNEKSDVYSFGVILWELATLQQ 237
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 4e-52
Identities = 69/317 (21%), Positives = 121/317 (38%), Gaps = 40/317 (12%)
Query: 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVE-- 299
+ E N LIG+G VY+ + D + AVKV N + + E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIY 59
Query: 300 LLSSIKHENIVRIIGYC-----HSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIG 351
+ ++H+NI R I + Y +V NGSL +YL W +A
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHS 119
Query: 352 VAKALEYLH------HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV-- 403
V + L YLH P I HRD+ S N+L+ + +SDFG +M + V
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRP 178
Query: 404 -SENVKPVNVVGTFGYLAPEYMM-------YGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
E+ ++ VGT Y+APE + +++D+Y+ G++ E+ +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 456 KANRESLVLWARSLLSSGLCERLID--------PQLNEEYNREEIEI-VMCA-ARLCLLH 505
++ E + + + + E + P+ E + + + + C
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 506 SSSRRPTMKTLLKLFQE 522
+ R T + + E
Sbjct: 299 DAEARLTAQXAEERMAE 315
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-51
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--------EEVLREVELLSSIKHENIV 310
IG+GG V++ D V A+K L + +E REV ++S++ H NIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 311 RIIGYCHSKEMYAIVYNLL-NGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDP 365
++ G +V + G L L +KW+ ++ + + +A +EY+ + +P
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNP 143
Query: 366 PIIHRDVKSSNILLSENFHHPQ----LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
PI+HRD++S NI L + ++DFG + S ++G F ++AP
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--------VSGLLGNFQWMAP 195
Query: 422 EYMMY--GKVDEKIDVYSYGVVLLELITGKE 450
E + EK D YS+ ++L ++TG+
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 39/206 (18%), Positives = 84/206 (40%), Gaps = 29/206 (14%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC 316
+ + + ++++ G VKVLK +WS + E L H N++ ++G C
Sbjct: 18 LNENHSGELWK-GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 317 HS--KEMYAIV--YNLLNGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
S ++ + + GSL L + ++ + A+ +A+ + +LH T +P I
Sbjct: 77 QSPPAPHPTLITHW-MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLI 134
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-- 425
+ S ++++ E+ ++S + ++APE +
Sbjct: 135 PRHALNSRSVMIDEDM-TARISMADVKFSFQSP----------GRMYAPAWVAPEALQKK 183
Query: 426 -YGKVDEKIDVYSYGVVLLELITGKE 450
D++S+ V+L EL+T +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREV 209
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-48
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 24/208 (11%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC 316
IG+G +VY G+VA ++++ +E + REV +HEN+V +G C
Sbjct: 41 IGKGRFGQVYHGRW-HGEVA-IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 317 HSKEMYAIVYNLL-NGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
S AI+ +L +L + L N+ +A + K + YLH I+H+D
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKD 155
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-- 429
+KS N+ ++DFG + K G +LAPE +
Sbjct: 156 LKSKNVFYDNG--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 430 -------DEKIDVYSYGVVLLELITGKE 450
+ DV++ G + EL +
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREW 241
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-47
Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 33/295 (11%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-- 316
IG+G +V+ G+ AVKV T + E+ ++HENI+ I
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 317 --HSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLH-----HTCDPP 366
S ++ + NGSL YLK L + +A L +LH P
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
I HRD+KS NIL+ +N ++D G A+ ++ P VGT Y+ PE ++
Sbjct: 163 IAHRDLKSKNILVKKNG-TCCIADLGLAVKFISDTN-EVDIPPNTRVGTKRYMPPE-VLD 219
Query: 427 GKV-------DEKIDVYSYGVVLLELITGKEAIQTNKANR---ESLVLWARSL--LSSGL 474
+ D+YS+G++L E+ + + + LV S + +
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279
Query: 475 CERLIDPQLNEEYNREEIEIVMCA-ARLCLLHSSSRRPTM----KTLLKLFQEPD 524
C + + P ++ +E M C H+ + R T KTL K+ + D
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-47
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVL-KCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G+G + + H G+V +K L + ++ L+EV+++ ++H N+++ IG +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 318 SKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+ + + G+L+ +K Q W++R+ A +A + YLH IIHRD+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN---------VVGTFGYLAPEY 423
S N L+ EN + ++DFG A + E ++ + VVG ++APE
Sbjct: 135 NSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEA 451
+ DEK+DV+S+G+VL E+I A
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 65/288 (22%), Positives = 119/288 (41%), Gaps = 27/288 (9%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-- 316
+G+G +V+R + G+ AVK+ + E+ ++HENI+ I
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 317 --HSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLH-----HTCDPP 366
HS ++ + GSL YL+ L + + + +A L +LH P
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA 133
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE---- 422
I HRD+KS NIL+ +N ++D G A++H QS +V VGT Y+APE
Sbjct: 134 IAHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTN-QLDVGNNPRVGTKRYMAPEVLDE 191
Query: 423 --YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR---ESLVLWARSL--LSSGLC 475
+ +++D++++G+VL E+ + + + +V S + +C
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVC 251
Query: 476 ERLIDPQLNEEYNREEIEIVMCA-ARLCLLHSSSRRPTMKTLLKLFQE 522
P + + + + + C + S R T + K +
Sbjct: 252 VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 33/299 (11%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS 318
IG+G +V+R G+ AVK+ E+ ++HENI+ I +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 319 KEMYAIVYNLL-----NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLH-----HTCDPP 366
L+ +GSL YL + + + +A+ A L +LH P
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE---- 422
I HRD+KS NIL+ +N ++D G A+ H + + + P + VGT Y+APE
Sbjct: 168 IAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEVLDD 225
Query: 423 --YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR---ESLVLWARSL--LSSGLC 475
M + + ++ D+Y+ G+V E+ ++ + LV S+ + +C
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 285
Query: 476 ERLIDPQLNEEYNREEIEIVMCA-ARLCLLHSSSRRPTM----KTLLKLFQEPDYWLKM 529
E+ + P + + E VM R C + + R T KTL +L Q+ +KM
Sbjct: 286 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG--IKM 342
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-46
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEE---EVLREVELLSSIKHENIVRIIGYC 316
IG G VY+ G VA VK+L T + + EV +L +H NI+ +GY
Sbjct: 32 IGSGSFGTVYK-GKWHGDVA-VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 317 HSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
+ AIV SL +L + + + +D+A A+ ++YLH IIHRD
Sbjct: 90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRD 145
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY---GK 428
+KS+NI L E+ ++ DFG A + + + G+ ++APE +
Sbjct: 146 LKSNNIFLHEDNT-VKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQDSNP 201
Query: 429 VDEKIDVYSYGVVLLELITGKE 450
+ DVY++G+VL EL+TG+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQL 223
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-40
Identities = 73/284 (25%), Positives = 118/284 (41%), Gaps = 58/284 (20%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLR---EVELLSSIKHENIVRIIG 314
IG+G VY+ + A L+ ++ E R E E+L ++H NIVR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 315 YCHSKEMYAIVYNLL-----NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPP 366
S L+ +G+LK YLK+ +K + K L++LH T PP
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPP 151
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
IIHRD+K NI ++ ++ D G A + S + V+GT ++APE M
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-------VIGTPEFMAPE-MYE 203
Query: 427 GKVDEKIDVYSYGVVLLELITGK------------EAIQTNKANRESLVLWARSLLSSGL 474
K DE +DVY++G+ +LE+ T + T+ S
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF------------ 251
Query: 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+++ P++ +E IE C+ + R ++K LL
Sbjct: 252 -DKVAIPEV-----KEIIE-------GCIRQNKDERYSIKDLLN 282
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENI 309
++ +G+GG S V + DG A+K + C EE RE ++ H NI
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 310 VRIIGYCH-SKEMYAIVYNLL----NGSLKQYLKQLKWNER-------MDVAIGVAKALE 357
+R++ YC + + LL G+L +++LK + + +G+ + LE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG----AAMVHHQSHQVSENVKPVNVV 413
+H HRD+K +NILL + P L D G A + S Q
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 414 GTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL 469
T Y APE + + +DE+ DV+S G VL ++ G+ +S+ L
Sbjct: 205 CTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258
Query: 470 LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ +L PQ + ++ +++ + +RP + LL
Sbjct: 259 ---AVQNQLSIPQ-SPRHSSALWQLL----NSMMTVDPHQRPHIPLLLS 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 77/322 (23%), Positives = 136/322 (42%), Gaps = 54/322 (16%)
Query: 251 THNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI 309
+F ++GQG +V + N +D + A+K ++ T +L EV LL+S+ H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 310 VRIIGYCHSKEMYAIVYNLL--------------NGSLKQYLKQLKWNERMDVAIG---- 351
VR + + + NG+L + N++ D
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ +AL Y+H IIHRD+K NI + E+ + ++ DFG A H+S + +
Sbjct: 125 ILEALSYIH---SQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 412 ---------VVGTFGYLAPEYMMYGKV--DEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
+GT Y+A E ++ G +EKID+YS G++ E+I R
Sbjct: 181 PGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYPFS----TGMERV 235
Query: 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520
+++ L S P ++ + E +I+ RL + H ++RP +TLL
Sbjct: 236 NIL----KKLRSV--SIEFPPDFDDNKMKVEKKII----RLLIDHDPNKRPGARTLLN-- 283
Query: 521 QEPDYWLKMKREKEELLNERRS 542
WL +K + E + +S
Sbjct: 284 ---SGWLPVKHQDEVIKEALKS 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 65/317 (20%), Positives = 124/317 (39%), Gaps = 54/317 (17%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENI 309
+F P +G+GG V+ N VD A+K ++ N + E+V+REV+ L+ ++H I
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 310 VRIIGY---------CHSKEMYAIVYNLL----NGSLKQYLKQLKWNERMDVAIG----- 351
VR +Y + +LK ++ E + ++
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 352 -VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-------MVHHQSHQV 403
+A+A+E+LH ++HRD+K SNI + + ++ DFG +
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLV 463
+ VGT Y++PE + K+D++S G++L EL+ + +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------PFSTQME- 232
Query: 464 LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523
R + + P L + E +V + L S RP +++
Sbjct: 233 ---RVRTLTDVRNLKF-PPLFTQKYPCEYVMV----QDMLSPSPMERPEAINIIEN---- 280
Query: 524 DYWLKMKREKEELLNER 540
+ + + +L +R
Sbjct: 281 AVFEDLDFPGKTVLRQR 297
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 61/290 (21%), Positives = 120/290 (41%), Gaps = 34/290 (11%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRII 313
IG+G S+VYR +DG A+K ++ + + + ++E++LL + H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNER-------MDVAIGVAKALEYLHHTCDP 365
IV L G L + +K K +R + + ALE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
++HRD+K +N+ ++ +L D G S+ ++VGT Y++PE +
Sbjct: 156 RVMHRDIKPANVFITAT-GVVKLGDLGLG-----RFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 426 YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485
+ K D++S G +L E+ + +K N SL + + P ++
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--------KIEQCDYPPLPSD 261
Query: 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535
Y+ E ++V +C+ +RP + + + + E
Sbjct: 262 HYSEELRQLV----NMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 66/307 (21%), Positives = 127/307 (41%), Gaps = 62/307 (20%)
Query: 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+F LIG GG +V++ H +DG+ +K +K N E+ REV+ L+ + H NIV
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVH 68
Query: 312 IIGYCHSKEMYAIVYNLL-----------------NGSLKQYLKQLKWN-----ERMDVA 349
G + + G+L+Q++++ + +++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ K ++Y+H +I+RD+K SNI L + ++ DFG + + K
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTS------LKNDGKR 178
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARS 468
GT Y++PE + +++D+Y+ G++L EL+ A +T+K
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------------ 226
Query: 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528
L D +++ ++++E ++ + L RP +L+ K
Sbjct: 227 -----FFTDLRDGIISDIFDKKEKTLL----QKLLSKKPEDRPNTSEILRT----LTVWK 273
Query: 529 MKREKEE 535
EK E
Sbjct: 274 KSPEKNE 280
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 64/280 (22%), Positives = 109/280 (38%), Gaps = 43/280 (15%)
Query: 259 LIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHENIVRIIG 314
IG G + + DG++ K L + +E E ++ EV LL +KH NIVR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 315 YCHSKE--MYAIVYNLL-NGSLKQYLKQLKWNER-------MDVAIGVAKALEYLH--HT 362
+ IV G L + + + + V + AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
++HRD+K +N+ L + +L DFG A + + ++ VGT Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAK-----TFVGTPYYMSPE 186
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID-- 480
M +EK D++S G +L EL A S L ++ +
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFT------------AFSQKE--LAGKIREGK 232
Query: 481 -PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKL 519
++ Y+ E EI+ L RP+++ +L+
Sbjct: 233 FRRIPYRYSDELNEII----TRMLNLKDYHRPSVEEILEN 268
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVL----REVELLSSIKHENIVRII 313
+G GG S VY + + A+K + +EE L REV S + H+NIV +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 314 GYCHSKEMYAIVYNLLNG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
+ Y +V + G +L +Y++ L + ++ + +++ H I+H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVH 134
Query: 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
RD+K NIL+ N ++ DFG A ++ N V+GT Y +PE
Sbjct: 135 RDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNH----VLGTVQYFSPEQAKGEAT 189
Query: 430 DEKIDVYSYGVVLLELITGK 449
DE D+YS G+VL E++ G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 64/315 (20%), Positives = 112/315 (35%), Gaps = 45/315 (14%)
Query: 223 KRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAV 281
R++ + E S S+ +F +G G +V++ + DG++ AV
Sbjct: 28 PRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87
Query: 282 KVLKCTNWSEEEV---LREVELLSSI-KHENIVRIIG-YCHSKEMYAIVYNLLNGSLKQY 336
K ++ L EV + +H VR+ + +Y + L SL+Q+
Sbjct: 88 KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY-LQTELCGPSLQQH 146
Query: 337 LKQLKWNERM------DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390
+ W + AL +LH ++H DVK +NI L +L D
Sbjct: 147 CE--AWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPR-GRCKLGD 200
Query: 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
FG + ++ G Y+APE + G DV+S G+ +LE+ E
Sbjct: 201 FGLLV------ELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNME 253
Query: 451 AIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRR 510
L L + + P+ + E ++ + L R
Sbjct: 254 -------------LPHGGEGWQQLRQGYLPPEFTAGLSSELRSVL----VMMLEPDPKLR 296
Query: 511 PTMKTLLKL--FQEP 523
T + LL L ++P
Sbjct: 297 ATAEALLALPVLRQP 311
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 71/276 (25%), Positives = 126/276 (45%), Gaps = 34/276 (12%)
Query: 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHEN 308
+ IG+G K DG+ +K + + S +E REV +L+++KH N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 309 IVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKW-----NERMDVAIGVAKALEYLHHT 362
IV+ IV + G L + + K ++ +D + + AL+++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH-- 142
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
D I+HRD+KS NI L+++ QL DFG A V + + +++ +GT YL+PE
Sbjct: 143 -DRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELAR-----ACIGTPYYLSPE 195
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482
+ K D+++ G VL EL T K A + + ++LVL + SG P
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--SMKNLVL----KIISGSF-----PP 244
Query: 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
++ Y+ + +V + RP++ ++L+
Sbjct: 245 VSLHYSYDLRSLV----SQLFKRNPRDRPSVNSILE 276
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 51/201 (25%), Positives = 79/201 (39%), Gaps = 19/201 (9%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVL-----REVELLSSIKHENIVRI 312
L+G+GG VY ++ A+K++ S + V RE ++ ++V I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 313 IGYCHSKEMYAIVYNLLNG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPII 368
+ + L+NG L L++ L + + + AL+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GAT 156
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRDVK NIL+S + L DFG A VGT Y+APE
Sbjct: 157 HRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGN----TVGTLYYMAPERFSESH 211
Query: 429 VDEKIDVYSYGVVLLELITGK 449
+ D+Y+ VL E +TG
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKH--ENIVRII 313
IG GG+SKV++ + Q+ A+K + + E+ L+ ++ + I+R+
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
Y + + +V N L +LK+ + ER + +A+ +H I+H
Sbjct: 76 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHS 132
Query: 371 DVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPE------ 422
D+K +N L+ + +L DFG A M + V + + VGT Y+ PE
Sbjct: 133 DLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKD-----SQVGTVNYMPPEAIKDMS 185
Query: 423 -----YMMYGKVDEKIDVYSYGVVLLELITGK 449
K+ K DV+S G +L + GK
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKH--ENIVRII 313
IG GG+SKV++ + Q+ A+K + + E+ L+ ++ + I+R+
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
Y + + +V N L +LK+ + ER + +A+ +H I+H
Sbjct: 95 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHS 151
Query: 371 DVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPE------ 422
D+K +N L+ + +L DFG A M + V + + VGT Y+ PE
Sbjct: 152 DLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKD-----SQVGTVNYMPPEAIKDMS 204
Query: 423 -----YMMYGKVDEKIDVYSYGVVLLELITGK 449
K+ K DV+S G +L + GK
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 260 IGQGGNS--KVYRTNHVD-GQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRII 313
IG+G V + G+ V+ + C+N + E+ + H NIV
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 314 G-YCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAIG-----VAKALEYLHHTCDPP 366
+ E++ +V + + GS K + + ++AI V KAL+Y+HH
Sbjct: 93 ATFIADNELW-VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---G 148
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFG--AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
+HR VK+S+IL+S + LS +M+ H Q + P V +L+PE +
Sbjct: 149 YVHRSVKASHILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 425 MYGKV--DEKIDVYSYGVVLLELITGK 449
D K D+YS G+ EL G
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN-WSEEEVLREVELLSSIK-HENIVRIIGY 315
++ +GG + VY V G+ A+K L +++EV + + H NIV+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 316 C--------HSKEMYAIVYNLLNGSLKQYLKQLKWNERM------DVAIGVAKALEYLHH 361
+ + ++ L G L ++LK+++ + + +A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV-------G 414
PPIIHRD+K N+LLS +L DFG+A S + + +V
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 415 TFGYLAPEYM--MYGK--VDEKIDVYSYGVVLLELITGK 449
T Y PE + +Y + EK D+++ G +L L +
Sbjct: 213 TPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 8e-30
Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 42/228 (18%)
Query: 248 CHLTHNFSPKM--------------LIGQGGNSKVYRTNH--VDGQVAAVKVLKCTNWSE 291
C ++F P++ I GG +Y V+G+ +K L +
Sbjct: 62 CGSPYSFLPQLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DA 120
Query: 292 EEV---LREVELLSSIKHENIVRIIGY-----CHSKEMYAIVYNLLNG-SLKQYLKQ-LK 341
E + E + L+ + H +IV+I + H + IV + G SLK+ Q L
Sbjct: 121 EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP 180
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
E + + + AL YLH +++ D+K NI+L+E +L D GA +
Sbjct: 181 VAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFG 235
Query: 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+ GT G+ APE + D+Y+ G L L
Sbjct: 236 Y---------LYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDL 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKH--ENIVRII 313
IG GG+SKV++ + Q+ A+K + + E+ L+ ++ + I+R+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
Y + + +V N L +LK+ + ER + +A+ +H I+H
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHS 179
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE-------- 422
D+K +N L+ + +L DFG A +Q + +V + VG Y+ PE
Sbjct: 180 DLKPANFLIVDG--MLKLIDFGIA---NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 423 ---YMMYGKVDEKIDVYSYGVVLLELITGK 449
K+ K DV+S G +L + GK
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 63/284 (22%), Positives = 107/284 (37%), Gaps = 38/284 (13%)
Query: 172 SKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLA 231
S + GQ + L K+ ++ S+ + D + E ++ +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY---------- 51
Query: 232 VLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWS 290
E T Q +G+G +V+R + G AVK ++ +
Sbjct: 52 --EYREEVHWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR 97
Query: 291 EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV--YNLLNGSLKQYLKQLKWNERMDV 348
EE+ + + IV + G I L GSL Q +KQ+
Sbjct: 98 VEEL----VACAGLSSPRIVPLYGAVREGPWVNIFMEL-LEGGSLGQLIKQMGCLPEDRA 152
Query: 349 AIGVA---KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405
+ + LEYLH I+H DVK+ N+LLS + L DFG A+
Sbjct: 153 LYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209
Query: 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+ + GT ++APE +M D K+D++S ++L ++ G
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLS-SIKHENIVR 311
+F PK ++G G + D + AVK + REV+LL S +H N++R
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIR 82
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK----ALEYLHHTCDPPI 367
++ I L +L++Y++Q + I + + L +LH I
Sbjct: 83 YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---I 139
Query: 368 IHRDVKSSNILLSENFHHPQ----LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
+HRD+K NIL+S H + +SDFG V GT G++APE
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG--VPGTEGWIAPEM 197
Query: 424 M---MYGKVDEKIDVYSYGVVLLELITG 448
+ +D++S G V +I+
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVL----REVELLSSIKHENIVRI- 312
++G GG S+V+ + D + AVKVL+ + RE + +++ H IV +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 313 -IG--YCHSKEMYAIVYNLLNG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDP 365
G + + IV ++G +L+ + + ++V +AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--- 135
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV----NVVGTFGYLAP 421
IIHRDVK +NI++S + ++ DFG A ++++ V V+GT YL+P
Sbjct: 136 GIIHRDVKPANIMISAT-NAVKVMDFGIARA------IADSGNSVTQTAAVIGTAQYLSP 188
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELITGK 449
E VD + DVYS G VL E++TG+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 56/278 (20%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIG-Y 315
IG+G +V++ +V A+K++ + E++ +E+ +LS + + G Y
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVK 373
+++ I+ L GS L+ +E I + K L+YLH IHRD+K
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIK 146
Query: 374 SSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEYMMYGKVDEK 432
++N+LLSE+ +L+DFG + Q+++ N VGT ++APE + D K
Sbjct: 147 AANVLLSEH-GEVKLADFGV------AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199
Query: 433 IDVYSYGVVLLELITGK------------EAIQTNKANRESLVLWARSLLSSGLCERLID 480
D++S G+ +EL G+ I N
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP----------------------- 236
Query: 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
P L Y++ E V CL S RPT K LLK
Sbjct: 237 PTLEGNYSKPLKEFV----EACLNKEPSFRPTAKELLK 270
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 63/272 (23%), Positives = 124/272 (45%), Gaps = 47/272 (17%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQY 336
A+K L+ + + +E+L E +++S+ + ++ R++G C + + ++ L+ G L Y
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY 106
Query: 337 LK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392
++ + ++ + +AK + YL ++HRD+ + N+L+ H +++DFG
Sbjct: 107 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTP-QHVKITDFG 162
Query: 393 AA--MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-G 448
A + + +E K P+ ++A E +++ + DV+SYGV + EL+T G
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIK------WMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 449 KEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL--NEEYNREEIEIVMCAARLCLLHS 506
+ E S+L G ERL P + + Y +M R C +
Sbjct: 217 SKPYD-GIPASE-----ISSILEKG--ERLPQPPICTIDVYM------IM---RKCWMID 259
Query: 507 SSRRPTMKTLLKLFQEPDYWLKMKREKEELLN 538
+ RP + L+ F KM R+ + L
Sbjct: 260 ADSRPKFRELIIEFS------KMARDPQRYLV 285
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 47/263 (17%), Positives = 82/263 (31%), Gaps = 34/263 (12%)
Query: 251 THNFSPKMLIGQGGNSKVYRTNHVD------GQVAAVKVLKCTN-WSEEEVLREVELLSS 303
+ L+G+G ++VY D Q +KV K N W + +E L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 304 IKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKW--------NERMDVAIGVAK 354
++ + +V L + G+L + K + A+ +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHP----------QLSDFGAAMVHHQSHQVS 404
+E +H D IIH D+K N +L F L D G ++
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI---DMKLFP 237
Query: 405 ENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLV 463
+ T G+ E M+ K + +ID + + ++ G N+
Sbjct: 238 KGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296
Query: 464 LWARSLLSSGLCERLIDPQLNEE 486
R L + LN
Sbjct: 297 GLFRRLPHLDMWNEFFHVMLNIP 319
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 41/281 (14%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+GQG +V+ A+K LK S E L+E +++ ++HE +V++ +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y + + GSL +LK L+ + +D+A +A + Y+ +HRD+++
Sbjct: 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRA 308
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+ EN +++DFG A ++ + + K P+ + APE +YG+ K
Sbjct: 309 ANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGRFTIK 361
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL--NEEYNRE 490
DV+S+G++L EL T NRE + G R+ P ++
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERG--YRMPCPPECPESLHD-- 412
Query: 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ------EPDY 525
+M C RPT + L + EP Y
Sbjct: 413 ----LM---CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 35/264 (13%)
Query: 268 VYRTNHVDGQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325
R ++ VA VK + T + + L+E +L H NIVR+IG C K+ IV
Sbjct: 134 RLRADNT--LVA-VKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190
Query: 326 YNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380
L+ G +L+ +L+ + + A +EYL IHRD+ + N L++
Sbjct: 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVT 247
Query: 381 ENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYG 439
E + ++SDFG + + S ++ V V T APE + YG+ + DV+S+G
Sbjct: 248 EK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGRYSSESDVWSFG 302
Query: 440 VVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCA 498
++L E + G N +N++ R + G RL P+L + + +M
Sbjct: 303 ILLWETFSLGASPYP-NLSNQQ-----TREFVEKG--GRLPCPELCP----DAVFRLM-- 348
Query: 499 ARLCLLHSSSRRPTMKTLLKLFQE 522
C + +RP+ T+ + Q
Sbjct: 349 -EQCWAYEPGQRPSFSTIYQELQS 371
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 41/281 (14%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+GQG +V+ A+K LK S E L+E +++ ++HE +V++ +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 320 EMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y + + GSL +LK L+ + +D+A +A + Y+ +HRD+++
Sbjct: 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRA 391
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+ EN +++DFG A ++ + + K P+ + APE +YG+ K
Sbjct: 392 ANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGRFTIK 444
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL--NEEYNRE 490
DV+S+G++L EL T NRE + G R+ P ++
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERG--YRMPCPPECPESLHD-- 495
Query: 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ------EPDY 525
+M C RPT + L + EP Y
Sbjct: 496 ----LM---CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 52/288 (18%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENIVRIIG-Y 315
IG G + V + A+K L+ S +E+L+E++ +S H NIV +
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 316 CHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAI-----------GVAKALEYLHHTC 363
E++ +V LL+ GS+ +K + + V + LEYLH
Sbjct: 83 VVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
IHRDVK+ NILL E+ Q++DFG + ++ N VGT ++APE
Sbjct: 141 --GQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 424 MMYGKV-DEKIDVYSYGVVLLELITGKE------------AIQTNKANRESLVLWARSLL 470
M + D K D++S+G+ +EL TG N
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS----------- 246
Query: 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
L + D ++ ++Y + +++ LCL +RPT LL+
Sbjct: 247 ---LETGVQDKEMLKKYGKSFRKMI----SLCLQKDPEKRPTAAELLR 287
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 76/299 (25%), Positives = 128/299 (42%), Gaps = 47/299 (15%)
Query: 260 IGQGGNSKVYR--TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC- 316
+G G +VY VA VK LK EE L+E ++ IKH N+V+++G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVA-VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 317 HSKEMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
Y I + G+L YL+ ++ + +A ++ A+EYL IHR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRN 343
Query: 372 VKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKV 429
+ + N L+ EN H +++DFG + ++ ++ K P+ + APE + Y K
Sbjct: 344 LAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKF 396
Query: 430 DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL--NEEY 487
K DV+++GV+L E+ T + + LL R+ P+ + Y
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKD--YRMERPEGCPEKVY 449
Query: 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLL----KLFQEPDYWLKMKREKEELLNERRS 542
+M R C + S RP+ + +FQE E E+ L +R +
Sbjct: 450 E------LM---RACWQWNPSDRPSFAEIHQAFETMFQESSI----SDEVEKELGKRGT 495
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 34/207 (16%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G VY + A+KVL E ++ REVE+ S ++H NI+R+
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 314 GYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERMDVAIG------VAKALEYLHHTC 363
GY H VY +L G++ + L++L + D +A AL Y H
Sbjct: 76 GYFHDATR---VYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR 129
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
+IHRD+K N+LL +++DFG + VH + + + ++ GT YL PE
Sbjct: 130 ---VIHRDIKPENLLLGSA-GELKIADFGWS-VH------APSSRRTDLCGTLDYLPPE- 177
Query: 424 MMYGKV-DEKIDVYSYGVVLLELITGK 449
M+ G++ DEK+D++S GV+ E + GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 50/292 (17%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV G+ AVK LK ++ +E+E+L ++ HENIV+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 313 IGYCHSKE---MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDP 365
G C + I+ L +GSLK+YL ++ +++ A+ + K ++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH---QVSENVK-PVNVVGTFGYLAP 421
+HRD+ + N+L+ H ++ DFG V ++ PV + AP
Sbjct: 146 QYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------WYAP 198
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLW--------ARSLLSS 472
E +M K DV+S+GV L EL+T + + + L
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258
Query: 473 GLCERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
G +RL P +E Y +M R C S R + + L++ F+
Sbjct: 259 G--KRLPCPPNCPDEVYQ------LM---RKCWEFQPSNRTSFQNLIEGFEA 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 56/299 (18%), Positives = 104/299 (34%), Gaps = 51/299 (17%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSI-KHENIVRII 313
IG G V++ +DG + A+K K + LREV + + +H ++VR
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 314 G-YCHSKEMYAIVYNLLN-GSLKQYLKQLKWNER-------MDVAIGVAKALEYLHHTCD 364
+ M I N GSL + + D+ + V + L Y+H
Sbjct: 78 SAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ---------VSENVKPVNVVGT 415
++H D+K SNI +S S+ G + V+ P G
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGD 193
Query: 416 FGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474
+LA E + K D+++ + ++ + + W + G
Sbjct: 194 SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-------QWHE--IRQGR 244
Query: 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533
P++ + ++E E++ ++ + RRP+ L+K L K
Sbjct: 245 L-----PRIPQVLSQEFTELL----KVMIHPDPERRPSAMALVKH---S--VLLSASRK 289
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 20/222 (9%)
Query: 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEE 293
+ F + + HL+ + +G G +V + V A+K++ + S +
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 294 VLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKW-NERM--DVA 349
+L EV +L + H NI+++ + K Y +V G L + NE +
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENV 407
V + YLH I+HRD+K N+LL + DFG + V ++ E
Sbjct: 143 KQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE-- 197
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+GT Y+APE ++ K DEK DV+S GV+L L+ G
Sbjct: 198 ----RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 50/291 (17%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV TN G++ AVK LK +E+++L ++ HE+I++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 313 IGYCHSKE---MYAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKALEYLH-HTCDPP 366
G C + ++ + GSL+ YL + + + A + + + YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHY--- 155
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSH-QVSENVK-PVNVVGTFGYLAPE 422
IHRD+ + N+LL + ++ DFG A + + +V E+ PV + APE
Sbjct: 156 -IHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF------WYAPE 207
Query: 423 YMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESL--------VLWARSLLSSG 473
+ K DV+S+GV L EL+T + E + VL LL G
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267
Query: 474 LCERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
ERL P E Y+ +M + C +S RPT + L+ + +
Sbjct: 268 --ERLPRPDKCPAEVYH------LM---KNCWETEASFRPTFENLIPILKT 307
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+GG +K + + D +V A K++ E++ E+ + S+ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 314 GYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERM--DVA----IGVAKALEYLHHTC 363
G+ + V+ +L SL + K+ K + A + +YLH
Sbjct: 108 GFFEDNDF---VFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
+IHRD+K N+ L+E+ ++ DFG A V + + + GT Y+APE
Sbjct: 162 ---VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGE------RKKVLCGTPNYIAPE 211
Query: 423 YMMYGKV-DEKIDVYSYGVVLLELITGK 449
++ K ++DV+S G ++ L+ GK
Sbjct: 212 -VLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 49/195 (25%), Positives = 100/195 (51%), Gaps = 17/195 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ + AVK +K + S E L E ++ +++H+ +V++ +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 320 EMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y I + GSL +LK + + +D + +A+ + ++ IHRD+++
Sbjct: 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRA 312
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+S + +++DFG A ++ + E K P+ + APE + +G K
Sbjct: 313 ANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFGSFTIK 365
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G++L+E++T
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 71/278 (25%), Positives = 118/278 (42%), Gaps = 43/278 (15%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
+KV++ S + V + + S+ H +IVR++G C + + L GSL ++
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHV 105
Query: 338 K----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393
+ L ++ + +AK + YL ++HR++ + N+LL Q++DFG
Sbjct: 106 RQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSP-SQVQVADFGV 161
Query: 394 A--MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
A + + K P+ ++A E + +GK + DV+SYGV + EL+T
Sbjct: 162 ADLLPPDDKQLLYSEAKTPIK------WMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215
Query: 451 AIQTNKANRESLVLWARSLLSSGLCERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSS 508
E V LL G ERL PQ+ + Y VM C + +
Sbjct: 216 EPYAGLRLAE--VP---DLLEKG--ERLAQPQICTIDVYM------VM---VKCWMIDEN 259
Query: 509 RRPTMKTLLKLFQEPDYWLKMKREKEELLNERRSNGPA 546
RPT K L F +M R+ L +R +GP
Sbjct: 260 IRPTFKELANEFT------RMARDPPRYLVIKRESGPG 291
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+GG +K + + D +V A K++ E++ E+ + S+ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 314 GYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERM--DVA----IGVAKALEYLHHTC 363
G+ + V+ +L SL + K+ K + A + +YLH
Sbjct: 82 GFFEDNDF---VFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
+IHRD+K N+ L+E+ ++ DFG A V + + + GT Y+APE
Sbjct: 136 ---VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGE------RKKVLCGTPNYIAPE 185
Query: 423 YMMYGKV-DEKIDVYSYGVVLLELITGK 449
++ K ++DV+S G ++ L+ GK
Sbjct: 186 -VLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 24/282 (8%), Positives = 62/282 (21%), Gaps = 56/282 (19%)
Query: 211 IAQETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR 270
I + + + A + + + S L + G S V+
Sbjct: 22 IGYCREEALKEPAAMVEAVTATVWPQNAETTVDS-LLSQGERKLKLVEPLRVGDRSVVFL 80
Query: 271 -TNHVDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCH-------- 317
+ + A+KV + E + + + E+
Sbjct: 81 VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140
Query: 318 ------------------SKEMYAIVYNLLNGSLKQYLKQLK----------WNERMDVA 349
+ Y ++ + L+ L +
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ + L ++H N+ + + L D A +
Sbjct: 201 AQLIRLAANLQSKG---LVHGHFTPDNLFIMPD-GRLMLGDVSAL--------WKVGTRG 248
Query: 410 VNVVGTFGYLAPEYMM--YGKVDEKIDVYSYGVVLLELITGK 449
Y E++ ++ + G+ + +
Sbjct: 249 PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 61/285 (21%), Positives = 126/285 (44%), Gaps = 41/285 (14%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL 337
A+K L+ + + +E+L E +++S+ + ++ R++G C + + I + G L Y+
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV 107
Query: 338 K----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393
+ + ++ + +AK + YL ++HRD+ + N+L+ H +++DFG
Sbjct: 108 REHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTP-QHVKITDFGL 163
Query: 394 A--MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE 450
A + + +E K P+ ++A E +++ + DV+SYGV + EL+T
Sbjct: 164 AKLLGAEEKEYHAEGGKVPIK------WMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 451 AIQTNKANRESLVLWARSLLSSGLCERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSS 508
E S+L G ERL P + + Y +M C + +
Sbjct: 218 KPYDGIPASE-----ISSILEKG--ERLPQPPICTIDVYM------IM---VKCWMIDAD 261
Query: 509 RRPTMKTLL----KLFQEPDYWLKMKREKEELLNERRSNGPAETL 549
RP + L+ K+ ++P +L ++ ++ L + L
Sbjct: 262 SRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRAL 306
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRIIG 314
+G+G +V + + GQ AVKV+ +E +LREV+LL + H NI+++
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 315 YCHSKEMYAIVYNLLNG-SLKQYLKQLKW-NERM--DVAIGVAKALEYLHHTCDPPIIHR 370
+ K + +V + G L + K +E + V + Y+H I+HR
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHR 150
Query: 371 DVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
D+K N+LL + DFG + S ++ + +GT Y+APE +++G
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD------KIGTAYYIAPE-VLHGT 203
Query: 429 VDEKIDVYSYGVVLLELITG 448
DEK DV+S GV+L L++G
Sbjct: 204 YDEKCDVWSTGVILYILLSG 223
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIGYC 316
++G+G VY + + A+K + + + + E+ L +KH+NIV+ +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 317 HSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVA---KALEYLHHTCDPPII 368
I + GSL L+ LK NE+ + + L+YLH I+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQILEGLKYLHDNQ---IV 144
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+K N+L++ ++SDFG + N GT Y+APE + G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 429 V--DEKIDVYSYGVVLLELITGK 449
+ D++S G ++E+ TGK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G +V + + + Q AVKV+ N +LREVELL + H NI+++
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 316 CHSKEMYAIVYNLLNG-SLKQYLKQLKW-NERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
+ IV L G L + + K +E + V + Y+H I+HRD
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRD 146
Query: 372 VKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
+K NILL + DFG + Q+ ++ + +GT Y+APE ++ G
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD------RIGTAYYIAPE-VLRGTY 199
Query: 430 DEKIDVYSYGVVLLELITG 448
DEK DV+S GV+L L++G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 66/274 (24%), Positives = 115/274 (41%), Gaps = 39/274 (14%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG G V+ ++ A+K ++ SEE+ + E E++ + H +V++ G C +
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 320 EMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDV 372
+V + +G L YL+ + + + V + + YL +IHRD+
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDL 130
Query: 373 KSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVD 430
+ N L+ EN ++SDFG V + S K PV + +PE + +
Sbjct: 131 AARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPEVFSFSRYS 183
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL--NEEYN 488
K DV+S+GV++ E+ + + N++N E +S+G RL P+L Y
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDISTG--FRLYKPRLASTHVYQ 236
Query: 489 REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
+M C RP LL+ E
Sbjct: 237 ------IM---NHCWRERPEDRPAFSRLLRQLAE 261
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 52/229 (22%), Positives = 87/229 (37%), Gaps = 36/229 (15%)
Query: 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLS-SIKHEN 308
L + + ++G G + V G+ AVK + + L E++LL+ S H N
Sbjct: 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPN 70
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG----------VAKALEY 358
++R + I L N +L+ ++ ++ +A + +
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQ------------LSDFGAAMVHHQSHQVSEN 406
LH IIHRD+K NIL+S + +SDFG S Q S
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC-KKLDSGQSSFR 186
Query: 407 VKPVNVVGTFGYLAPE-------YMMYGKVDEKIDVYSYGVVLLELITG 448
N GT G+ APE ++ ID++S G V +++
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 76/293 (25%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK-CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G V G+V AVK L+ T + RE+E+L S++H+NIV+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 314 GYCHSKE---MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLH-HTCDP 365
G C+S + I+ L GSL+ YL+ ++ + + + K +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-- 135
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ---VSENVK-PVNVVGTFGYLAP 421
IHRD+ + NIL+ + ++ DFG V Q + V E + P+ + AP
Sbjct: 136 --IHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF------WYAP 186
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR----------SLLS 471
E + K DV+S+GVVL EL T E ++ A ++ + LL
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 472 SGLCERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
+ RL P +E Y +M C ++ ++RP+ + L +
Sbjct: 247 NN--GRLPRPDGCPDEIYM------IM---TECWNNNVNQRPSFRDLALRVDQ 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 36/208 (17%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G VY + A+KVL E ++ RE+E+ S ++H NI+R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 314 GYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERMDVAIG------VAKALEYLHHTC 363
Y H ++ +Y +L G L + L++ R D +A AL Y H
Sbjct: 81 NYFHDRKR---IYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK 134
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
+IHRD+K N+L+ +++DFG + + GT YL PE
Sbjct: 135 ---VIHRDIKPENLLMGYK-GELKIADFGWSVHAPSLRRRTM--------CGTLDYLPPE 182
Query: 423 YMMYGKV-DEKIDVYSYGVVLLELITGK 449
M+ GK DEK+D++ GV+ E + G
Sbjct: 183 -MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 56/195 (28%), Positives = 102/195 (52%), Gaps = 17/195 (8%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G +V+ + AVK LK + S + L E L+ ++H+ +VR+ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 320 EMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
+Y I + NGSL +LK +L N+ +D+A +A+ + ++ IHRD+++
Sbjct: 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRA 137
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEK 432
+NIL+S+ +++DFG A ++ + E K P+ + APE + YG K
Sbjct: 138 ANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPEAINYGTFTIK 190
Query: 433 IDVYSYGVVLLELIT 447
DV+S+G++L E++T
Sbjct: 191 SDVWSFGILLTEIVT 205
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 32/214 (14%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE--VLREVELLSSIKHENIVRIIGY 315
++GQG + V+R H G + A+KV ++ +RE E+L + H+NIV++
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 316 --CHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM--DVAIG----VAKALEYLHHTCDPP 366
+ ++ GSL L++ + + V + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 367 IIHRDVKSSNILLSENFHHPQ---LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE- 422
I+HR++K NI+ L+DFGAA ++ ++ + V++ GT YL P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA------RELEDDEQFVSLYGTEEYLHPDM 186
Query: 423 -------YMMYGKVDEKIDVYSYGVVLLELITGK 449
K +D++S GV TG
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 66/292 (22%), Positives = 115/292 (39%), Gaps = 51/292 (17%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK-CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G V G + AVK L+ + + RE+++L ++ + IV+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 314 GYCHSKE---MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLH-HTCDP 365
G + + ++ L +G L+ +L+ +L + + + + K +EYL C
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC-- 148
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH---QVSENVK-PVNVVGTFGYLAP 421
+HRD+ + NIL+ H +++DFG A + V E + P+ + AP
Sbjct: 149 --VHRDLAARNILVESE-AHVKIADFGLAKLLPLDKDYYVVREPGQSPIF------WYAP 199
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELIT-------GKEAIQTNKANRESLVLWAR--SLLSS 472
E + + DV+S+GVVL EL T + +R LL
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 473 GLCERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
G +RL P E + +M +LC S RP+ L
Sbjct: 260 G--QRLPAPPACPAEVHE------LM---KLCWAPSPQDRPSFSALGPQLDM 300
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 73/305 (23%), Positives = 129/305 (42%), Gaps = 43/305 (14%)
Query: 228 EKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKC 286
++ L G + +L +L +G G +V++ G V AVK ++
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENLG-------EMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 287 TNWSEE--EVLREVE-LLSSIKHENIVRIIG-YCHSKEMYAIVYNLLNGSLKQYLKQLK- 341
+ EE +L +++ +L S IV+ G + + +++ I L+ ++ K+++
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF-IAMELMGTCAEKLKKRMQG 119
Query: 342 -WNERM--DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398
ER+ + + + KAL YL +IHRDVK SNILL E +L DFG
Sbjct: 120 PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDER-GQIKLCDFGI----- 171
Query: 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-----DEKIDVYSYGVVLLELITGKEAIQ 453
S ++ ++ G Y+APE + D + DV+S G+ L+EL TG+ +
Sbjct: 172 -SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230
Query: 454 TNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM 513
K + E L + + L ++ + V + CL +RP
Sbjct: 231 NCKTDFEVL-----TKVLQEEPPLLPGH---MGFSGDFQSFV----KDCLTKDHRKRPKY 278
Query: 514 KTLLK 518
LL+
Sbjct: 279 NKLLE 283
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWS--------------EEEVLREVELLSSI 304
+G G +V A+KV+K + + EE+ E+ LL S+
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 305 KHENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLH 360
H NI+++ K+ + +V G +Q + + K++E ++ + + YLH
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
I+HRD+K NILL + DFG S S++ K + +GT Y
Sbjct: 164 KHN---IVHRDIKPENILLENKNSLLNIKIVDFGL------SSFFSKDYKLRDRLGTAYY 214
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
+APE ++ K +EK DV+S GV++ L+ G
Sbjct: 215 IAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 52/206 (25%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
F +G+G VY+ H + GQ+ A+K + + +E+++E+ ++ ++V+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVK 88
Query: 312 IIG-YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCD 364
G Y + +++ ++ GS+ ++ N+ + + K LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM-- 144
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEY 423
IHRD+K+ NILL+ H +L+DFG + Q+++ + N V+GT ++APE
Sbjct: 145 -RKIHRDIKAGNILLNTE-GHAKLADFGV------AGQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGK 449
+ + D++S G+ +E+ GK
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK-CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G V G+V AVK L+ T + RE+E+L S++H+NIV+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 314 GYCHSKE---MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPP 366
G C+S + I+ L GSL+ YL+ ++ + + + K +EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ---VSENVK-PVNVVGTFGYLAPE 422
IHRD+ + NIL+ + ++ DFG V Q + V E + P+ + APE
Sbjct: 166 YIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF------WYAPE 218
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR----------SLLSS 472
+ K DV+S+GVVL EL T E ++ A ++ + LL +
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278
Query: 473 GLCERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
RL P +E Y +M C ++ ++RP+ + L +
Sbjct: 279 N--GRLPRPDGCPDEIYM------IM---TECWNNNVNQRPSFRDLALRVDQ 319
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 58/196 (29%), Positives = 104/196 (53%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVL-REVELLSSIKHENIVRIIG-YC 316
IG+G V G+ AVK++ E+L EV ++ +H N+V + Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
+E++ ++ L G+L + Q++ NE + V +AL YLH +IHRD+KS
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKS 169
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKI 433
+ILL+ + +LSDFG Q+S++V K ++VGT ++APE + ++
Sbjct: 170 DSILLTLD-GRVKLSDFGF------CAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEV 222
Query: 434 DVYSYGVVLLELITGK 449
D++S G++++E++ G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRIIG-YC 316
IGQG + VY V GQ A++ + ++E ++ E+ ++ K+ NIV + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKS 374
E++ ++ L GSL + + +E A+ +ALE+LH +IHRD+KS
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKS 144
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENV-KPVNVVGTFGYLAPEYMMYGKVDEKI 433
NILL + +L+DFG Q++ K +VGT ++APE + K+
Sbjct: 145 DNILLGMD-GSVKLTDFGFCA------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 434 DVYSYGVVLLELITGK 449
D++S G++ +E+I G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHENIVRII 313
L+G+G + VYR + G A+K++ + V EV++ +KH +I+ +
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 314 GYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERMDVAIG----VAKALEYLHHTCDP 365
Y VY +L NG + +YLK + A + + YLH
Sbjct: 78 NYFEDSNY---VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+HRD+ SN+LL+ N + +++DFG A + + K + GT Y++PE +
Sbjct: 133 -ILHRDLTLSNLLLTRN-MNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPE-IA 184
Query: 426 YGKV-DEKIDVYSYGVVLLELITGK 449
+ DV+S G + L+ G+
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 66/275 (24%), Positives = 119/275 (43%), Gaps = 39/275 (14%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE--EVLREVE-LLSSIKHENIVRIIGY 315
+G+G V + HV GQ+ AVK ++ T S+E +L +++ + ++ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQL-KWNERMD------VAIGVAKALEYLHHTCDPPII 368
+ I L++ SL ++ KQ+ + + +A+ + KALE+LH +I
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VI 132
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE----YM 424
HRDVK SN+L++ ++ DFG S + ++V G Y+APE +
Sbjct: 133 HRDVKPSNVLINAL-GQVKMCDFGI------SGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 425 MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484
K D++S G+ ++EL + + + L PQL
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP----------SPQLP 235
Query: 485 EE-YNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ ++ E ++ CL +S RPT L++
Sbjct: 236 ADKFSAEFVDFT----SQCLKKNSKERPTYPELMQ 266
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE--EVLREVE-LLSSIKHENIVRIIGY 315
IG+G V + H GQ+ AVK ++ T +E ++L +++ ++ S IV+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 316 CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD--------VAIGVAKALEYLHHTCDPPI 367
+ I L++ S ++ K + + + KAL +L + I
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKI 147
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
IHRD+K SNILL + + +L DFG + S Q+ +++ G Y+APE +
Sbjct: 148 IHRDIKPSNILLDRS-GNIKLCDFG---I---SGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 428 KV----DEKIDVYSYGVVLLELITGK 449
D + DV+S G+ L EL TG+
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 76/299 (25%), Positives = 130/299 (43%), Gaps = 47/299 (15%)
Query: 260 IGQGGNSKVYR--TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G G +VY VA VK LK EE L+E ++ IKH N+V+++G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVA-VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 318 SKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
+ + I+ + G+L YL++ + + +A ++ A+EYL IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 372 VKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKV 429
+ + N L+ EN H +++DFG + ++ ++ K P+ + APE + Y K
Sbjct: 137 LAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKF 189
Query: 430 DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL--NEEY 487
K DV+++GV+L E+ T + + LL R+ P+ + Y
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKD--YRMERPEGCPEKVY 242
Query: 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLL----KLFQEPDYWLKMKREKEELLNERRS 542
+M R C + S RP+ + +FQE E E+ L +R +
Sbjct: 243 E------LM---RACWQWNPSDRPSFAEIHQAFETMFQESSI----SDEVEKELGKRGT 288
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 47/295 (15%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEE--EVLREVELLSSIKHENIVRIIG-Y 315
+G G V++ +H G V A K++ +++RE+++L IV G +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 316 CHSKEMYAIVYNLLN-GSLKQYLKQLK-WNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
E+ I ++ GSL Q LK+ E++ V+I V K L YL I+HRD
Sbjct: 101 YSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRD 157
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
VK SNIL++ +L DFG S Q+ +++ V GT Y++PE +
Sbjct: 158 VKPSNILVNSR-GEIKLCDFGV------SGQLIDSMANSFV-GTRSYMSPERLQGTHYSV 209
Query: 432 KIDVYSYGVVLLELITGK--------EAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483
+ D++S G+ L+E+ G+ + ++ + L +
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269
Query: 484 NEEYNREEIEIVMCAA--------------------RLCLLHSSSRRPTMKTLLK 518
+ E++ CL+ + + R +K L+
Sbjct: 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 50/197 (25%), Positives = 97/197 (49%), Gaps = 21/197 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G V A+K++K + SE+E + E +++ ++ HE +V++ G C +
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 320 EMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDV 372
I+ + NG L YL+ + + + +++ V +A+EYL +HRD+
Sbjct: 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDL 146
Query: 373 KSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVD 430
+ N L+++ ++SDFG + V + S K PV + PE +MY K
Sbjct: 147 AARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFS 199
Query: 431 EKIDVYSYGVVLLELIT 447
K D++++GV++ E+ +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 21/197 (10%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
+G G V AVK++K + SE+E +E + + + H +V+ G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 320 EMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDV 372
IV + NG L YL+ L+ ++ +++ V + + +L H IHRD+
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ-----FIHRDL 130
Query: 373 KSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVD 430
+ N L+ + ++SDFG V + S K PV + APE Y K
Sbjct: 131 AARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------WSAPEVFHYFKYS 183
Query: 431 EKIDVYSYGVVLLELIT 447
K DV+++G+++ E+ +
Sbjct: 184 SKSDVWAFGILMWEVFS 200
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 257 KMLIGQGGNSKVYR--TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+ +G G V + Q+ A+KVLK EE++RE +++ + + IVR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCD 364
+IG C ++ + +V + G L ++L ++ + ++ V+ ++YL +
Sbjct: 75 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH---QVSENVK-PVNVVGTFGYLA 420
+HRD+ + N+LL H+ ++SDFG + K P+ + A
Sbjct: 131 --FVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYA 181
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELIT 447
PE + + K + DV+SYGV + E ++
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 56/293 (19%), Positives = 108/293 (36%), Gaps = 57/293 (19%)
Query: 260 IGQGGNSKVYR--------TNHVDGQVAAVKVLK-CTNWSEEEVLREVELLSSIKHENIV 310
+GQG +K+++ + +KVL E ++S + H+++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 311 RIIGYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTC 363
G C + +V + GSL YLK + +++VA +A A+ +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133
Query: 364 DPPIIHRDVKSSNILLSENFHHPQ-------LSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
+IH +V + NILL LSD G ++ + E +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-------- 182
Query: 417 GYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475
++ PE + K + D +S+G L E+ +G + + ++
Sbjct: 183 -WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----KLQFYEDR-- 234
Query: 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTL---LKLFQEPDY 525
+L P+ E N ++ C+ + RP+ + + L PD
Sbjct: 235 HQLPAPKAAELAN------LI---NNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 65/258 (25%), Positives = 101/258 (39%), Gaps = 41/258 (15%)
Query: 280 AVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLK 334
AVK LK S+ ++ +REV + S+ H N++R+ G + M +V L GSL
Sbjct: 50 AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLL 108
Query: 335 QYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390
L+ A+ VA+ + YL IHRD+ + N+LL+ ++ D
Sbjct: 109 DRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATR-DLVKIGD 164
Query: 391 FGAA---MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELI 446
FG + + + E+ K P + APE + D + +GV L E+
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFA------WCAPESLKTRTFSHASDTWMFGVTLWEMF 218
Query: 447 TGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL--NEEYNREEIEIVMCAARLCLL 504
T + + +L + G ERL P+ + YN VM C
Sbjct: 219 TYGQEPWIGLNGSQ--IL--HKIDKEG--ERLPRPEDCPQDIYN------VMVQ---CWA 263
Query: 505 HSSSRRPTMKTLLKLFQE 522
H RPT L E
Sbjct: 264 HKPEDRPTFVALRDFLLE 281
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 32/214 (14%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE--VLREVELLSSIKHENIVRIIGY 315
++GQG + V+R H G + A+KV ++ +RE E+L + H+NIV++
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 316 --CHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM--DVAIG----VAKALEYLHHTCDPP 366
+ ++ GSL L++ + + V + +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 367 IIHRDVKSSNILLSENFHHPQ---LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE- 422
I+HR++K NI+ L+DFGAA Q + GT YL P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS------LYGTEEYLHPDM 186
Query: 423 -------YMMYGKVDEKIDVYSYGVVLLELITGK 449
K +D++S GV TG
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 20/193 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G +V + + + Q AVKV+ N +LREVELL + H NI+++
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 316 CHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
+ IV L G + +K+ +++E + V + Y+H I+HRD
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRD 146
Query: 372 VKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
+K NILL + DFG + Q+ ++ + +GT Y+APE ++ G
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD------RIGTAYYIAPE-VLRGTY 199
Query: 430 DEKIDVYSYGVVL 442
DEK DV+S GV+L
Sbjct: 200 DEKCDVWSAGVIL 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
+G+G +VY TNH ++ AVK K CT ++E+ + E ++ ++ H +IV++I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPP 366
G + + I+ L G L YL+ LK + ++ + KA+ YL +
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN----- 133
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYM 424
+HRD+ NIL++ +L DFG + + + + + + P+ +++PE +
Sbjct: 134 CVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIK------WMSPESI 186
Query: 425 MYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483
+ + DV+ + V + E+++ GK+ N++ V+ +L G +RL P L
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQPFF-WLENKD--VI---GVLEKG--DRLPKPDL 238
Query: 484 --NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
Y +M C + S RP L+ +
Sbjct: 239 CPPVLYT------LM---TRCWDYDPSDRPRFTELVCSLSD 270
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 60/292 (20%), Positives = 109/292 (37%), Gaps = 56/292 (19%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLKCTNWSEEEV---LREVELLSSIKHENIVRI 312
+G+G V V AVK+LK + ++ LRE + H ++ ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 313 IGYC-------HSKEMYAIVYNLLNGSLKQYLKQLKWNER---------MDVAIGVAKAL 356
+G I+ + +G L +L + E + + +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 357 EYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQS-HQVSENVK-PVN 411
EYL + IHRD+ + N +L+E+ ++DFG + ++ ++ K PV
Sbjct: 151 EYLSSRN-----FIHRDLAARNCMLAEDMT-VCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLL 470
+LA E + DV+++GV + E++T G+ N E + L
Sbjct: 205 ------WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA-GIENAEIY-----NYL 252
Query: 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
G RL P EE+ +M C +RP+ L +
Sbjct: 253 IGG--NRLKQP----PECMEEVYDLM---YQCWSADPKQRPSFTCLRMELEN 295
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 45/223 (20%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLK------------------CTNWSEEEVLREVELL 301
+ QG +K+ D + A+K + ++ E++++
Sbjct: 39 LNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 302 SSIKHENIVRIIGYCHS-KEMYAIVYNLLNGSLKQYL---KQLKWNERMDVAIGVAK--- 354
+ IK+E + G + E+Y I + N S+ ++ L N + I V K
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 355 -----ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+ Y+H+ + I HRDVK SNIL+ +N +LSDFG + + + K
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKN-GRVKLSDFGES-------EYMVDKKI 207
Query: 410 VNVVGTFGYLAPEYMMYGK---VDEKIDVYSYGVVLLELITGK 449
GT+ ++ PE + K+D++S G+ L +
Sbjct: 208 KGSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 67/282 (23%), Positives = 120/282 (42%), Gaps = 45/282 (15%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
IG+G VY + ++ A+K L E LRE L+ + H N++ +I
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 314 GYCHSKE--MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDP 365
G E + ++ + +G L Q+++ + + + VA+ +EYL
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---- 144
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQ---SHQVSENVK-PVNVVGTFGYLA 420
+HRD+ + N +L E+F +++DFG A + + S Q + + PV + A
Sbjct: 145 -FVHRDLAARNCMLDESFT-VKVADFGLARDILDREYYSVQQHRHARLPVK------WTA 196
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480
E + + K DV+S+GV+L EL+T + + L+ G RL
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT-----HFLAQG--RRLPQ 249
Query: 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
P EY + + VM + C + RPT + L+ ++
Sbjct: 250 P----EYCPDSLYQVM---QQCWEADPAVRPTFRVLVGEVEQ 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 23/202 (11%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL--KCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
+G G V+ G +K + + E++ E+E+L S+ H NI++I
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 317 HSKEMYAIVYNLLNGS------LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPII 368
IV G + + +E ++ + AL Y H ++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 369 HRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
H+D+K NIL + H + DFG + + N GT Y+APE +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGL------AELFKSDEHSTNAAGTALYMAPE-VFK 199
Query: 427 GKVDEKIDVYSYGVVLLELITG 448
V K D++S GVV+ L+TG
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTG 221
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 52/196 (26%), Positives = 100/196 (51%), Gaps = 23/196 (11%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG+G V ++ +VA VK +K + + L E +++ ++H N+V+++G +
Sbjct: 201 IGKGEFGDVMLGDYRGNKVA-VKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 320 E--MYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+ +Y + + GSL YL+ L + + ++ V +A+EYL +HRD+
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDL 315
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
+ N+L+SE+ + ++SDFG ++ + K PV + APE + K
Sbjct: 316 AARNVLVSED-NVAKVSDFGLT---KEASSTQDTGKLPVK------WTAPEALREKKFST 365
Query: 432 KIDVYSYGVVLLELIT 447
K DV+S+G++L E+ +
Sbjct: 366 KSDVWSFGILLWEIYS 381
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH 317
+G G +VY+ HV GQ+AA+KV+ T EEE+ +E+ +L H NI G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG-AF 90
Query: 318 SKEMYAIVYNLL--------NGSLKQYLKQLKWNERMDVAIG-----VAKALEYLHHTCD 364
K+ + + L GS+ +K K N + I + + L +LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEY 423
+IHRD+K N+LL+EN +L DFG S Q+ V N +GT ++APE
Sbjct: 150 --VIHRDIKGQNVLLTENA-EVKLVDFGV------SAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 424 MMYGKV-----DEKIDVYSYGVVLLELITGK 449
+ + D K D++S G+ +E+ G
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 30/238 (12%), Positives = 73/238 (30%), Gaps = 55/238 (23%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLRE----VELLSSIKHE--- 307
++GQ T+ G+ V V + + + ++E + LL IK++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 308 ----------NIVRIIGYCHSKE-----------MYAIVYNLLNGSLKQYLKQLK----- 341
++V+ +Y + +L+ + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 342 -----WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396
+ R+ + + V + L LHH ++H ++ +I+L + L+ F +
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR-GGVFLTGFEHLVR 260
Query: 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGK 449
S A + + + D ++ G+ + +
Sbjct: 261 DGASAVSPIGR----GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 47/201 (23%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
IG+G V++ + + +A A+K K ++ E+ L+E + H +IV++I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYL-HHTCDPPII 368
G ++ I+ G L+ +L+ L + A ++ AL YL +
Sbjct: 83 GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF----V 138
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMY 426
HRD+ + N+L+S N +L DFG + + ++ + K P+ ++APE + +
Sbjct: 139 HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAPESINF 191
Query: 427 GKVDEKIDVYSYGVVLLELIT 447
+ DV+ +GV + E++
Sbjct: 192 RRFTSASDVWMFGVCMWEILM 212
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 68/258 (26%), Positives = 105/258 (40%), Gaps = 35/258 (13%)
Query: 212 AQETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKML------IGQGGN 265
+P + + + A G + ++ L P+ L IG G
Sbjct: 8 HHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSF 67
Query: 266 SKVYRTNHVD-GQVAAVKVLKCTNWSEEE----VLREVELLSSIKHENIVRIIG-YCHSK 319
VY V +V A+K + + E +++EV L ++H N ++ G Y
Sbjct: 68 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 320 EMYAIVYNLLNGSLKQYLKQLK--WNERMDVAI--GVAKALEYLHHTCDPPIIHRDVKSS 375
+ +V GS L+ K E A+ G + L YLH +IHRDVK+
Sbjct: 128 TAW-LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAG 183
Query: 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEYMMYGKV---DE 431
NILLSE +L DFG + + P N VGT ++APE ++ D
Sbjct: 184 NILLSEP-GLVKLGDFG----------SASIMAPANSFVGTPYWMAPEVILAMDEGQYDG 232
Query: 432 KIDVYSYGVVLLELITGK 449
K+DV+S G+ +EL K
Sbjct: 233 KVDVWSLGITCIELAERK 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL--KCTNWSEEEVLREVELLSSIKHENIVRII--- 313
+G GG V R + G+ A+K + + + E E++++ + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 314 ---GYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERM--DVAIGV----AKALEYLHHTC 363
++ + G L++YL Q + + + + AL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 364 DPPIIHRDVKSSNILLSENFHHPQ--LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
IIHRD+K NI+L + D G A Q +E VGT YLAP
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE------FVGTLQYLAP 192
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELITGK 449
E + K +D +S+G + E ITG
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 4e-23
Identities = 49/289 (16%), Positives = 99/289 (34%), Gaps = 38/289 (13%)
Query: 247 LCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH 306
L L H + +D + S + + +
Sbjct: 58 LAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDP 117
Query: 307 ENIVRIIGYCHSKEMYAIVYNLL----NGSLKQYLKQLKWNERMDVAIG------VAKAL 356
+ +G +Y + +LK ++ + E + + +A+A+
Sbjct: 118 FSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAV 177
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV---- 412
E+LH ++HRD+K SNI + + ++ DFG Q + + P+
Sbjct: 178 EFLHSKG---LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233
Query: 413 ---VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL 469
VGT Y++PE + K+D++S G++L EL+ R
Sbjct: 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------------ERVR 281
Query: 470 LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ + + P L + +E +V + L S + RP +++
Sbjct: 282 IITDVRNLKF-PLLFTQKYPQEHMMV----QDMLSPSPTERPEATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 22/73 (30%), Positives = 34/73 (46%), Gaps = 3/73 (4%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKV--LKCTNWSEEEVLREVELLSSIKHENI 309
+F P +G+GG V+ N VD A+K L + E+V+REV+ L+ ++H I
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 310 VRIIGYCHSKEMY 322
VR
Sbjct: 67 VRYFNAWLETPPE 79
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 52/193 (26%), Positives = 97/193 (50%), Gaps = 27/193 (13%)
Query: 268 VYRTNHVDGQVAAVKVLK---CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324
Y+ V VA VK+LK ++E+L E ++ + + IVR+IG C ++ +
Sbjct: 37 YYQMKKVVKTVA-VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM-L 94
Query: 325 VYNLL-NGSLKQYL---KQLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSSNIL 378
V + G L +YL + +K +++ V+ ++YL + +HRD+ + N+L
Sbjct: 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVL 149
Query: 379 LSENFHHPQLSDFGAA--MVHHQSH-QVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKID 434
L H+ ++SDFG + + +++ + + K PV + APE + Y K K D
Sbjct: 150 LVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVK------WYAPECINYYKFSSKSD 202
Query: 435 VYSYGVVLLELIT 447
V+S+GV++ E +
Sbjct: 203 VWSFGVLMWEAFS 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 18/192 (9%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVL-KCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
++G G S+V+ + G++ A+K + K + + + E+ +L IKHENIV +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 317 HSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDV 372
S Y +V L++G + L++ + E+ V V A++YLH + I+HRD+
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDL 132
Query: 373 KSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
K N+L + ++ +DFG + Q+ +S GT GY+APE +
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLS-KMEQNGIMST------ACGTPGYVAPEVLAQKPYS 185
Query: 431 EKIDVYSYGVVL 442
+ +D +S GV+
Sbjct: 186 KAVDCWSIGVIT 197
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 63/316 (19%), Positives = 124/316 (39%), Gaps = 32/316 (10%)
Query: 148 LVQRQGTSQQGSTNVLLKSSLSSSSKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDV 207
LV+ G L ++ +SS+ + T +LT P +
Sbjct: 235 LVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTP 294
Query: 208 GVCIAQETVQ-VPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNS 266
+ P + +FE E ++ + L + +G G
Sbjct: 295 EPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI----ADIELGCGNFG 350
Query: 267 KVYR--TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321
V + Q+ A+KVLK EE++RE +++ + + IVR+IG C ++ +
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL 410
Query: 322 YAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSS 375
++ G L ++L ++ + ++ V+ ++YL + +HR++ +
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAAR 465
Query: 376 NILLSENFHHPQLSDFGAAMVHHQSHQV---SENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
N+LL H+ ++SDFG + K P+ + APE + + K
Sbjct: 466 NVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYAPECINFRKFSS 518
Query: 432 KIDVYSYGVVLLELIT 447
+ DV+SYGV + E ++
Sbjct: 519 RSDVWSYGVTMWEALS 534
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-23
Identities = 52/197 (26%), Positives = 101/197 (51%), Gaps = 25/197 (12%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG+G V ++ +VA VK +K + + L E +++ ++H N+V+++G +
Sbjct: 29 IGKGEFGDVMLGDYRGNKVA-VKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 320 E--MYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYL-HHTCDPPIIHRD 371
+ +Y + + GSL YL+ L + + ++ V +A+EYL + +HRD
Sbjct: 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHRD 142
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMYGKVD 430
+ + N+L+SE+ + ++SDFG ++ + K PV + APE + K
Sbjct: 143 LAARNVLVSED-NVAKVSDFGLT---KEASSTQDTGKLPVK------WTAPEALREKKFS 192
Query: 431 EKIDVYSYGVVLLELIT 447
K DV+S+G++L E+ +
Sbjct: 193 TKSDVWSFGILLWEIYS 209
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 8e-23
Identities = 63/281 (22%), Positives = 111/281 (39%), Gaps = 43/281 (15%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
IG+G VY + A VK L + L E ++ H N++ +
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 313 IGYCHSKE--MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPP 366
+G C E ++ + +G L+ +++ + + + VAK ++YL
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKK 148
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK----PVNVVGTFGYLAP 421
+HRD+ + N +L E F +++DFG A ++ + + N PV ++A
Sbjct: 149 FVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLPVK------WMAL 201
Query: 422 EYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481
E + K K DV+S+GV+L EL+T + + L G RL+ P
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLLQG--RRLLQP 254
Query: 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
EY + + VM C + RP+ L+
Sbjct: 255 ----EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 288
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 57/292 (19%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLKCTNWSEEEV---LREVELLSSIKHENIVR 311
+G+G V + +VA VK +K N S+ E+ L E + H N++R
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVA-VKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 312 IIGYCHSKEMYAIVYNLL------NGSLKQYLK---------QLKWNERMDVAIGVAKAL 356
++G C I ++ G L YL + + + +A +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 357 EYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK-PVN 411
EYL + +HRD+ + N +L ++ ++DFG + + ++ K PV
Sbjct: 161 EYLSNRN-----FLHRDLAARNCMLRDDMT-VCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 412 VVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLL 470
++A E + K DV+++GV + E+ T G N E + L
Sbjct: 215 ------WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP-GVQNHE--MY---DYL 262
Query: 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
G RL P E +E+ +M C RPT L ++
Sbjct: 263 LHG--HRLKQP----EDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQLEK 305
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 9e-23
Identities = 30/244 (12%), Positives = 76/244 (31%), Gaps = 66/244 (27%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLRE----------------- 297
++GQ T+ G+ V V + + + ++E
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 298 ---------VELLSSIKHENIVRIIGYCHSKEM--YAIVYNLLNGSLKQYLKQLK----- 341
+L+ + + ++R+ + +Y + +L+ + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 342 -----WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396
+ R+ + + V + L LHH ++H ++ +I+L + L+ F +
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR-GGVFLTGFEHLV- 254
Query: 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----------GKVDEKIDVYSYGVVLLEL 445
+ V + G+ PE + D ++ G+V+ +
Sbjct: 255 --------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 446 ITGK 449
Sbjct: 307 WCAD 310
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 48/216 (22%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 237 GSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEE 292
G F + N+ K +G+G S V R + G A K++ K + +
Sbjct: 14 GRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ 73
Query: 293 EVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DV 348
++ RE + ++H NIVR+ + + +V++L+ G + + + ++E
Sbjct: 74 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC 133
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSEN 406
+ +++ Y H I+HR++K N+LL+ + +DFG + +V+++
Sbjct: 134 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL------AIEVNDS 184
Query: 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVL 442
GT GYL+PE + + +D+++ GV+L
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 46/203 (22%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 250 LTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLREVELLSSIK 305
+ N+ K +G+G S V R + G A K++ K + +++ RE + ++
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 306 HENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHH 361
H NIVR+ + + +V++L+ G + + + ++E + +++ Y H
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH- 122
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
I+HR++K N+LL+ + +DFG + +V+++ GT GYL
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGL------AIEVNDSEAWHGFAGTPGYL 174
Query: 420 APEYMMYGKVDEKIDVYSYGVVL 442
+PE + + +D+++ GV+L
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVIL 197
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 54/203 (26%), Positives = 107/203 (52%), Gaps = 23/203 (11%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIG-YC 316
+G G KVY+ + + G +AA KV++ + E E+ + E+E+L++ H IV+++G Y
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLK--WNERMDVAI--GVAKALEYLHHTCDPPIIHRDV 372
H +++ ++ G++ + +L E + + +AL +LH IIHRD+
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDL 143
Query: 373 KSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN-VVGTFGYLAPEYMMYGKV-- 429
K+ N+L++ +L+DFG S + + ++ + +GT ++APE +M +
Sbjct: 144 KAGNVLMTLE-GDIRLADFGV------SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 430 ---DEKIDVYSYGVVLLELITGK 449
D K D++S G+ L+E+ +
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIE 219
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 76/302 (25%), Positives = 116/302 (38%), Gaps = 67/302 (22%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G G +VY + + AVK L C+ E + L E ++S H+NIVR
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 312 IIGYCHSKE-MYAIVYNLLNGSLKQYL----------KQLKWNERMDVAIGVAKALEYL- 359
IG + ++ + G LK +L L + + VA +A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 360 -HHTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAA-MVHHQSHQVSENVKPVNVVGT 415
+H IHRD+ + N LL+ DFG A ++ S+ G
Sbjct: 158 ENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY---------RKGG 203
Query: 416 FGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSL 469
L PE M G K D +S+GV+L E+ + G +K+N+E VL
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQE--VL---EF 257
Query: 470 LSSGLCERLIDPQ--LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLL----KLFQEP 523
++SG R+ P+ Y +M C H RP +L Q+P
Sbjct: 258 VTSG--GRMDPPKNCPGPVYR------IM---TQCWQHQPEDRPNFAIILERIEYCTQDP 306
Query: 524 DY 525
D
Sbjct: 307 DV 308
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 47/201 (23%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
IG+G V++ + + +A A+K K ++ E+ L+E + H +IV++I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLH-HTCDPPII 368
G ++ I+ G L+ +L+ L + A ++ AL YL +
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF----V 513
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVK-PVNVVGTFGYLAPEYMMY 426
HRD+ + N+L+S N +L DFG + + ++ + K P+ ++APE + +
Sbjct: 514 HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAPESINF 566
Query: 427 GKVDEKIDVYSYGVVLLELIT 447
+ DV+ +GV + E++
Sbjct: 567 RRFTSASDVWMFGVCMWEILM 587
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 250 LTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLK------CTNWSEEEVLREVELLS 302
+ +IG+G S V R N GQ AVK++ S E++ RE +
Sbjct: 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 303 SIKHENIVRIIGYCHSKEMYAIVYNLLNGS------LKQYLKQLKWNERM--DVAIGVAK 354
+KH +IV ++ S M +V+ ++G+ +K+ ++E + + +
Sbjct: 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILL-SENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNV 412
AL Y H D IIHRDVK +LL S+ P +L FG A+ +S V+
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG-----GR 193
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVL 442
VGT ++APE + + +DV+ GV+L
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 44/193 (22%), Positives = 89/193 (46%), Gaps = 18/193 (9%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G S V R + GQ A ++ K + +++ RE + +KH NIVR+
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 316 CHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRD 371
+ + ++++L+ G + + + ++E + +A+ + H ++HR+
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRN 135
Query: 372 VKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
+K N+LL+ + +DFG A+ Q GT GYL+PE +
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF-----GFAGTPGYLSPEVLRKDPY 190
Query: 430 DEKIDVYSYGVVL 442
+ +D+++ GV+L
Sbjct: 191 GKPVDLWACGVIL 203
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 49/284 (17%)
Query: 260 IGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
IG+G VY + A VK L + L E ++ H N++ +
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 313 IGYCHSKE--MYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCD 364
+G C E ++ + +G L+ +++ + + + VAK +++L
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--- 212
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPVNVVGTFGYL---- 419
+HRD+ + N +L E F +++DFG A ++ + N T L
Sbjct: 213 --FVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHN-------KTGAKLPVKW 262
Query: 420 -APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478
A E + K K DV+S+GV+L EL+T + + L G RL
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-----VYLLQG--RRL 315
Query: 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
+ P EY + + VM C + RP+ L+
Sbjct: 316 LQP----EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 352
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 17/191 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G+G S VYR + A+KVLK ++ V E+ +L + H NI+++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 318 SKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVK 373
+ ++V L+ G + +++ ++ER D + +A+ YLH I+HRD+K
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLK 175
Query: 374 SSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
N+L + L +DFG S V V V GT GY APE +
Sbjct: 176 PENLLYATPAPDAPLKIADFGL------SKIVEHQVLMKTVCGTPGYCAPEILRGCAYGP 229
Query: 432 KIDVYSYGVVL 442
++D++S G++
Sbjct: 230 EVDMWSVGIIT 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 42/191 (21%), Positives = 75/191 (39%), Gaps = 18/191 (9%)
Query: 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRIIGYCH 317
IG+G +V A K + + + +E+E++ S+ H NI+R+
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 318 SKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVK 373
+V L G ++ + + + E + V A+ Y H + HRD+K
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLK 133
Query: 374 SSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
N L + L DFG A + VGT Y++P+ ++ G
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT------KVGTPYYVSPQ-VLEGLYGP 186
Query: 432 KIDVYSYGVVL 442
+ D +S GV++
Sbjct: 187 ECDEWSAGVMM 197
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 72/300 (24%), Positives = 131/300 (43%), Gaps = 68/300 (22%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK-CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV+ N + AVK LK T + ++ RE ELL++++HE+IV+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 313 IGYCHSKE-MYAIVYNLLNGSLKQYLK-------------------QLKWNERMDVAIGV 352
G C + + + + +G L ++L+ +L ++ + +A +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 353 AKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK 408
A + YL H +HRD+ + N L+ N ++ DFG + + ++V +
Sbjct: 143 ASGMVYLASQH-----FVHRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 409 -PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQ--TNKANRESLVL 464
P+ ++ PE +MY K + DV+S+GV+L E+ T GK Q +N E V+
Sbjct: 197 LPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGK---QPWFQLSNTE--VI 245
Query: 465 WARSLLSSGLCERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
++ G L P++ E Y+ VM C +R +K + K+
Sbjct: 246 ---ECITQG--RVLERPRVCPKEVYD------VM---LGCWQREPQQRLNIKEIYKILHA 291
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 64/270 (23%), Positives = 115/270 (42%), Gaps = 53/270 (19%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK +E ++ E++++S + +HENIV ++G C H + I G L
Sbjct: 80 AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 336 YLK-----------------QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSSN 376
+L+ + + + VA+ + +L + IHRDV + N
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARN 194
Query: 377 ILLSENFHHPQLSDFGAA-MVHHQSH-QVSENVK-PVNVVGTFGYLAPEYMMYGKVDEKI 433
+LL+ H ++ DFG A + + S+ V N + PV ++APE + +
Sbjct: 195 VLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFDCVYTVQS 247
Query: 434 DVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEI 492
DV+SYG++L E+ + G N + L+ G ++ P + + I
Sbjct: 248 DVWSYGILLWEIFSLGLNPYPGILVNSKFY-----KLVKDG--YQMAQP----AFAPKNI 296
Query: 493 EIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
+M + C + RPT + + QE
Sbjct: 297 YSIM---QACWALEPTHRPTFQQICSFLQE 323
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 74/302 (24%), Positives = 114/302 (37%), Gaps = 67/302 (22%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G G +VY + + AVK L C+ E + L E ++S H+NIVR
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 312 IIGYCHSKE-MYAIVYNLLNGSLKQYL----------KQLKWNERMDVAIGVAKALEYL- 359
IG + ++ + G LK +L L + + VA +A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 360 -HHTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAA-MVHHQSHQVSENVKPVNVVGT 415
+H IHRD+ + N LL+ DFG A ++ + G
Sbjct: 199 ENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK---------GG 244
Query: 416 FGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSL 469
L PE M G K D +S+GV+L E+ + G +K+N+E L
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVL-----EF 298
Query: 470 LSSGLCERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLL----KLFQEP 523
++SG R+ P+ Y +M C H RP +L Q+P
Sbjct: 299 VTSG--GRMDPPKNCPGPVYR------IM---TQCWQHQPEDRPNFAIILERIEYCTQDP 347
Query: 524 DY 525
D
Sbjct: 348 DV 349
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 68/289 (23%), Positives = 119/289 (41%), Gaps = 51/289 (17%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
+G G +V +++ A+K LK T + L E ++ H NI+R+
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYL--HHTCDPP 366
G + IV + NGSL +L+ Q + + + G+A ++YL
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG----- 167
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMV---HHQSHQVSENVK-PVNVVGTFGYLAPE 422
+HRD+ + NIL++ N ++SDFG V ++ + K P+ + +PE
Sbjct: 168 YVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR------WTSPE 220
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482
+ Y K DV+SYG+VL E+++ E +N++ V+ + G RL P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VI---KAVDEG--YRLPPPM 273
Query: 483 L--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLL----KLFQEPDY 525
Y +M C + RP + ++ KL + P
Sbjct: 274 DCPAALYQ------LM---LDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
IG G +VY+ + + VA +K LK T + L E ++ H NI+R
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVA-IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPP 366
+ G + I+ + NG+L ++L+ + + + + G+A ++YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--- 167
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAA---MVHHQSHQVSENVK-PVNVVGTFGYLAPE 422
+HRD+ + NIL++ N ++SDFG + ++ + K P+ + APE
Sbjct: 168 YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR------WTAPE 220
Query: 423 YMMYGKVDEKIDVYSYGVVLLELIT 447
+ Y K DV+S+G+V+ E++T
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 257 KMLIGQGGNSKVYR-TNHVDGQVAAVKVL-KCTNWSEEEVLREVELLSSIK-HENIVRII 313
+ ++G+G +++V N + Q AVK++ K V REVE+L + H N++ +I
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 314 GYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIH 369
+ ++ + +V+ + G L K+ +NE V VA AL++LH + I H
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAH 134
Query: 370 RDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPV--NVVGTFGYLAPE--- 422
RD+K NIL + DF + S P G+ Y+APE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 423 --YMMYGKVDEKIDVYSYGVVL 442
D++ D++S GV+L
Sbjct: 195 AFSEEASIYDKRCDLWSLGVIL 216
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 59/289 (20%), Positives = 117/289 (40%), Gaps = 51/289 (17%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+GQG VY A+K + + E L E ++ ++VR
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 312 IIGYCHSKE-MYAIVYNLLNGSLKQYL-------------KQLKWNERMDVAIGVAKALE 357
++G + I+ + G LK YL ++ + +A +A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSH--QVSENVKPVNVVG 414
YL+ +HRD+ + N +++E+F ++ DFG ++ + + + + PV
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 205
Query: 415 TFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSG 473
+++PE + G DV+S+GVVL E+ T ++ Q +N + VL + G
Sbjct: 206 ---WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQ--VL---RFVMEG 256
Query: 474 LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
L P + + + +M R+C ++ RP+ ++ +E
Sbjct: 257 --GLLDKP----DNCPDMLFELM---RMCWQYNPKMRPSFLEIISSIKE 296
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVE-LLSSIKH 306
T + K IG G S R + AVK++ + S+ + E+E LL +H
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQH 75
Query: 307 ENIVRIIGYCHSKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHT 362
NI+ + + +V L+ G L + L+Q ++ER V + K +EYLH
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH-- 133
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQ---LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
++HRD+K SNIL + +P+ + DFG A +EN + T ++
Sbjct: 134 -AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-----AENGLLMTPCYTANFV 187
Query: 420 APEYMMYGKVDEKIDVYSYGVVL 442
APE + D D++S GV+L
Sbjct: 188 APEVLERQGYDAACDIWSLGVLL 210
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIV 310
++ +G+G S+V+ ++ + VK+LK ++++ RE+++L +++ NI+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNII 94
Query: 311 R---IIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI---GVAKALEYLHHTCD 364
I+ S+ + ++ N KQ + L D+ + KAL+Y H
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL---TDYDIRFYMYEILKALDYCHSMG- 150
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE-- 422
I+HRDVK N+++ +L D+G A +H + + V + + PE
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR------VASRYFKGPELL 202
Query: 423 --YMMYGKVDEKIDVYSYGVVLLELITGKEAI 452
Y MY D +D++S G +L +I KE
Sbjct: 203 VDYQMY---DYSLDMWSLGCMLASMIFRKEPF 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 20/192 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCH 317
+G+G S + + Q AVK++ E +E+ L + H NIV++ H
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 318 SKEMYAIVYNLLNGS--LKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVK 373
+ +V LLNG ++ K+ ++E + + A+ ++H D ++HRD+K
Sbjct: 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLK 133
Query: 374 SSNILLSENFHHPQL--SDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
N+L ++ + ++ DFG A + + + T Y APE + D
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT------PCFTLHYAAPELLNQNGYD 187
Query: 431 EKIDVYSYGVVL 442
E D++S GV+L
Sbjct: 188 ESCDLWSLGVIL 199
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 25/203 (12%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA-AVKVLK--CTNWSEEEVLREVELLSSIKHENIVRII 313
IG G + +V V A+K LK T + L E ++ H NI+R+
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 314 GYCHSKEMYAIVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPII 368
G + IV + NGSL +L+ Q + + + GV + YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAA---MVHHQSHQVSENVK-PVNVVGTFGYLAPEYM 424
HRD+ + N+L+ N ++SDFG + + + K P+ + APE +
Sbjct: 174 HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR------WTAPEAI 226
Query: 425 MYGKVDEKIDVYSYGVVLLELIT 447
+ DV+S+GVV+ E++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 69/300 (23%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK-CTNWSEEEVLREVELLSSIKHENIVRI 312
+G+G KV+ N + Q AVK LK + + ++ RE ELL+ ++H++IVR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 313 IGYCHSKE-MYAIVYNLLNGSLKQYL------------------KQLKWNERMDVAIGVA 353
G C + + + +G L ++L L + + VA VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 354 KALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPV 410
+ YL H +HRD+ + N L+ + ++ DFG + ++ +
Sbjct: 169 AGMVYLAGLH-----FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYY-------- 214
Query: 411 NVVGTFGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQ--TNKANRESL 462
VG L PE ++Y K + DV+S+GVVL E+ T GK Q +N E
Sbjct: 215 -RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK---QPWYQLSNTE-- 268
Query: 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
+ ++ G L P E+ +M R C +R ++K + Q
Sbjct: 269 AI---DCITQG--RELERP----RACPPEVYAIM---RGCWQREPQQRHSIKDVHARLQA 316
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 41/200 (20%), Positives = 80/200 (40%), Gaps = 24/200 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS 318
+G+G V+R + K +K + V +E+ +L+ +H NI+ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 319 KEMYAIVYNLLNG-----SLKQYLKQLKWNERMDVAIGVAK----ALEYLHHTCDPPIIH 369
E +++ ++G + + NER + AL++LH I H
Sbjct: 73 MEELVMIFEFISGLDIFERINT--SAFELNERE--IVSYVHQVCEALQFLH---SHNIGH 125
Query: 370 RDVKSSNILLSENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
D++ NI+ ++ +FG Q+ Q+ + Y APE +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFG------QARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 429 VDEKIDVYSYGVVLLELITG 448
V D++S G ++ L++G
Sbjct: 180 VSTATDMWSLGTLVYVLLSG 199
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVL---KCTNWSEEE------VLREVELLSSIKHENI 309
+G G +V + A++++ K S E V E+E+L + H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 310 VRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHTCDP 365
++I + +++ Y IV L+ G L + + E + A++YLH +
Sbjct: 203 IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---EN 258
Query: 366 PIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE- 422
IIHRD+K N+LLS + +DFG + + + E + GT YLAPE
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI------LGETSLMRTLCGTPTYLAPEV 312
Query: 423 --YMMYGKVDEKIDVYSYGVVLLELITG 448
+ + +D +S GV+L ++G
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 45/221 (20%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G+ KVY+ G+ A+K LK EE E L + ++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 312 IIGYCHSKE-MYAIVYNLLNGSLKQYLK-------------------QLKWNERMDVAIG 351
++G + + I +G L ++L L+ + + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 352 VAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSH-QVSENV 407
+A +EYL HH ++H+D+ + N+L+ + + ++SD G V+ + ++ N
Sbjct: 137 IAAGMEYLSSHH-----VVHKDLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNS 190
Query: 408 K-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT 447
P+ ++APE +MYGK D++SYGVVL E+ +
Sbjct: 191 LLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 54/228 (23%), Positives = 101/228 (44%), Gaps = 31/228 (13%)
Query: 240 RRFTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV 294
F S E+ + + IG G V + + + A+K K + + +
Sbjct: 9 NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQT 66
Query: 295 -----LREVELLSSIKHENIVRII-------GYCHSKEMYAIVYNLLNGSLKQYLKQLKW 342
RE+ L+ + H+NI+ ++ +++Y IV L++ +L Q ++
Sbjct: 67 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELD 125
Query: 343 NERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
+ERM + + +++LH IIHRD+K SNI++ + ++ DFG A S
Sbjct: 126 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSF 181
Query: 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
++ V T Y APE ++ E +D++S G ++ E+I G
Sbjct: 182 MMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 24/198 (12%), Positives = 55/198 (27%), Gaps = 43/198 (21%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRII 313
G + ++ + + A+ + +E L LS I + R++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 314 GYCHSKEMYAIVYNLLNG-SLKQYLKQ-LKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
H++ +V + G SL++ + +A A + H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSI 154
Query: 372 VKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
S + +S + G V+ + +
Sbjct: 155 DHPSRVRVSID---------GDV-----------------VLAYPATMPD-------ANP 181
Query: 432 KIDVYSYGVVLLELITGK 449
+ D+ G L L+ +
Sbjct: 182 QDDIRGIGASLYALLVNR 199
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 70/300 (23%), Positives = 121/300 (40%), Gaps = 63/300 (21%)
Query: 260 IGQGGNSKVYR---TNHVDGQVA---AVKVLK--CTNWSEEEVLREVELLSSI-KHENIV 310
+G G KV + A AVK+LK E ++ E+++LS + H NIV
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 311 RIIGYC-HSKEMYAIVYNLLNGSLKQYLK---------------------QLKWNERMDV 348
++G C I G L +L+ L + +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 349 AIGVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSH-QVS 404
+ VAK + +L + IHRD+ + NILL+ ++ DFG A + + S+ V
Sbjct: 151 SYQVAKGMAFLASKN-----CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVK 204
Query: 405 ENVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESL 462
N + PV ++APE + + DV+SYG+ L EL + G + +
Sbjct: 205 GNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
++ G R++ P E+ E+ +M + C +RPT K +++L ++
Sbjct: 259 -----KMIKEG--FRMLSP----EHAPAEMYDIM---KTCWDADPLKRPTFKQIVQLIEK 304
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 55/255 (21%), Positives = 82/255 (32%), Gaps = 58/255 (22%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLK------CTNWSEEEVLREVELL 301
L + K IGQG V + + A+K++ E + EV L+
Sbjct: 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 302 SSIKHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAIG--------- 351
+ H NI R+ ++ +V L + G L L + A+
Sbjct: 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 352 ----------------------------------VAKALEYLHHTCDPPIIHRDVKSSNI 377
+ AL YLH + I HRD+K N
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENF 199
Query: 378 LLSENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG--KVDEKID 434
L S N +L DFG + E GT ++APE + K D
Sbjct: 200 LFSTNKSFEIKLVDFGLS-KEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 435 VYSYGVVLLELITGK 449
+S GV+L L+ G
Sbjct: 259 AWSAGVLLHLLLMGA 273
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 66/315 (20%), Positives = 120/315 (38%), Gaps = 75/315 (23%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVAAVKVL---KCTNWSEEE----VLREVELL----SSIKH 306
L+G+GG V+ + + D A+KV+ + WS EV LL + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 307 ENIVRIIGYCHSKEMYAIV--YNLLNGSLKQYLKQLKWNERM--DVAIG----VAKALEY 358
++R++ + ++E + +V L L Y+ + + + V A+++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQH 154
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFG 417
H ++HRD+K NIL+ +L DFG A++H + + GT
Sbjct: 155 CHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--------DGTRV 203
Query: 418 YLAPEYMMYGKVD-EKIDVYSYGVVLLELITGK------EAIQTNKANRESLVLWARSLL 470
Y PE++ + V+S G++L +++ G + I + L + +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAE-------LHFPAHV 256
Query: 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530
S C LI R CL S RP+++ +L D W++
Sbjct: 257 SPD-CCALI--------------------RRCLAPKPSSRPSLEEILL-----DPWMQTP 290
Query: 531 REKEELLNERRSNGP 545
E L + P
Sbjct: 291 AEDVPLNPSKGGPAP 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 70/299 (23%), Positives = 116/299 (38%), Gaps = 62/299 (20%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSI-KHENIV 310
+G+G +V + AVK+LK T+ ++ E+++L I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 311 RIIGYC--HSKEMYAIVYNLLNGSLKQYLK-------------------QLKWNERMDVA 349
++G C + IV G+L YL+ L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 350 IGVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSH-QVSE 405
VAK +E+L IHRD+ + NILLSE ++ DFG A ++
Sbjct: 155 FQVAKGMEFLASRK-----CIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKG 208
Query: 406 NVK-PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLV 463
+ + P+ ++APE + + DV+S+GV+L E+ + G K + E
Sbjct: 209 DARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC- 261
Query: 464 LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
L G R+ P +Y E+ M C S+RPT L++
Sbjct: 262 ----RRLKEG--TRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 307
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 8e-20
Identities = 53/230 (23%), Positives = 102/230 (44%), Gaps = 31/230 (13%)
Query: 238 SSRRFTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEE 292
+F S E+ + + IG G V + V + A+K K + +
Sbjct: 44 VDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQN 101
Query: 293 EV-----LREVELLSSIKHENIVRII-------GYCHSKEMYAIVYNLLNGSLKQYLKQL 340
+ RE+ L+ + H+NI+ ++ +++Y +V L++ +L Q ++
Sbjct: 102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY-LVMELMDANLCQVIQME 160
Query: 341 KWNERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399
+ERM + + +++LH IIHRD+K SNI++ + ++ DFG A
Sbjct: 161 LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGT 216
Query: 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
S ++ V T Y APE ++ E +D++S G ++ E++ K
Sbjct: 217 SFMMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 38/211 (18%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK-------CTNWSEEEVLREVELLSSIKHENIVR 311
+G G + V + G A K +K S EE+ REV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 312 IIGYCHSKEMYAIVYNLLNG-------SLKQYLKQLKWNERMDVAIGVAK----ALEYLH 360
+ ++ ++ L++G + K+ L +E A K + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESL-----SEEE--ATSFIKQILDGVNYLH 132
Query: 361 HTCDPPIIHRDVKSSNILL-SENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
I H D+K NI+L +N P + DFG +H++ + V+ N+ GT
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL------AHEIEDGVEFKNIFGTPE 183
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
++APE + Y + + D++S GV+ L++G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 56/272 (20%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T +++ E+E++ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKS 374
YL+ Q+ + + + +A+ +EYL IHRD+ +
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAA 185
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSH-QVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
N+L++EN + +++DFG A +++ + + + N + PV ++APE +
Sbjct: 186 RNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTH 238
Query: 432 KIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490
+ DV+S+GV++ E+ T G E LL G R+ P
Sbjct: 239 QSDVWSFGVLMWEIFTLGGSPYPG-IPVEELF-----KLLKEG--HRMDKP----ANCTN 286
Query: 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
E+ ++M R C S+RPT K L++
Sbjct: 287 ELYMMM---RDCWHAVPSQRPTFKQLVEDLDR 315
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 63/315 (20%), Positives = 117/315 (37%), Gaps = 73/315 (23%)
Query: 259 LIGQGGNSKVYRTNHV-DGQVAAVKVL---KCTNWSE----EEVLREVELLSSIKHE--N 308
L+G GG VY V D A+K + + ++W E V EV LL +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 309 IVRIIGYCHSKEMYAIV--YNLLNGSLKQYLKQLKWNERM--DVAIG----VAKALEYLH 360
++R++ + + + ++ L ++ + + ++A V +A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH 166
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH-QVSENVKPVNVVGTFGYL 419
+ ++HRD+K NIL+ N +L DFG+ + + GT Y
Sbjct: 167 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--------DGTRVYS 215
Query: 420 APEYMMYGKVD-EKIDVYSYGVVLLELITGK------EAIQTNKANRESLVLWARSLLSS 472
PE++ Y + V+S G++L +++ G E I + ++ R +SS
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ-------VFFRQRVSS 268
Query: 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532
C+ LI R CL S RPT + + W++
Sbjct: 269 E-CQHLI--------------------RWCLALRPSDRPTFEEIQN-----HPWMQDVLL 302
Query: 533 KEELLNERRSNGPAE 547
+E +
Sbjct: 303 PQETAEIHLHSLSPG 317
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 38/199 (19%), Positives = 80/199 (40%), Gaps = 21/199 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIGYCH 317
+G G V+R G+V K + + V E+ +++ + H ++ +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 318 SKEMYAIVYNLLNGS-LKQYL--KQLKWNERMDVAIGVAK----ALEYLHHTCDPPIIHR 370
K ++ L+G L + + K +E I + L+++H + I+H
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEA--EVINYMRQACEGLKHMH---EHSIVHL 173
Query: 371 DVKSSNILLSENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
D+K NI+ ++ DFG + +++ + T + APE + V
Sbjct: 174 DIKPENIMCETKKASSVKIIDFG------LATKLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 430 DEKIDVYSYGVVLLELITG 448
D+++ GV+ L++G
Sbjct: 228 GFYTDMWAIGVLGYVLLSG 246
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 56/272 (20%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T +++ E+E++ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 336 YL-------------------KQLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKS 374
YL +Q+ + + + +A+ +EYL IHRD+ +
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAA 231
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSH-QVSENVK-PVNVVGTFGYLAPEYMMYGKVDE 431
N+L++EN + +++DFG A +++ + + + N + PV ++APE +
Sbjct: 232 RNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTH 284
Query: 432 KIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490
+ DV+S+GV++ E+ T G E LL G R+ P
Sbjct: 285 QSDVWSFGVLMWEIFTLGGSPYPG-IPVEELF-----KLLKEG--HRMDKP----ANCTN 332
Query: 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
E+ ++M R C S+RPT K L++
Sbjct: 333 ELYMMM---RDCWHAVPSQRPTFKQLVEDLDR 361
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 67/310 (21%), Positives = 121/310 (39%), Gaps = 79/310 (25%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
IG+G +V++ + + AVK+LK + + + RE L++ + NIV+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 312 IIGYC-HSKEMYAIVYNLLNGSLKQYL---------------------------KQLKWN 343
++G C K M + + G L ++L L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 344 ERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQS 400
E++ +A VA + YL +HRD+ + N L+ EN +++DFG + ++
Sbjct: 175 EQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSAD 228
Query: 401 HQVSENVKPVNVVGTFGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQ- 453
+ + PE + Y + + DV++YGVVL E+ + G Q
Sbjct: 229 YY---------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL---QP 276
Query: 454 -TNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT 512
A+ E V+ + G L P E E+ +M RLC + RP+
Sbjct: 277 YYGMAHEE--VI---YYVRDG--NILACP----ENCPLELYNLM---RLCWSKLPADRPS 322
Query: 513 MKTLLKLFQE 522
++ ++ Q
Sbjct: 323 FCSIHRILQR 332
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 65/298 (21%), Positives = 123/298 (41%), Gaps = 39/298 (13%)
Query: 166 SSLSSSSKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRK 225
+ ++ P R+ +++ S + + + E++ +
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 226 IFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL 284
L +++ F + + PK +IG+G +S V R + G AVK++
Sbjct: 76 SMGPEDELPDWAAAKEFYQK--------YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 285 K---------CTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL-NGSL 333
+ E RE +L + H +I+ +I S +V++L+ G L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 334 KQYL-KQLKWNERM--DVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390
YL +++ +E+ + + +A+ +LH I+HRD+K NILL +N +LSD
Sbjct: 188 FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM-QIRLSD 243
Query: 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE------YMMYGKVDEKIDVYSYGVVL 442
FG S + K + GT GYLAPE + +++D+++ GV+L
Sbjct: 244 FG------FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 48/216 (22%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-------EEVLREVELLSSIKHENIVR 311
+G G + V + G A K +K EE+ REV +L + H NI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 312 IIGYCHSKEMYAIVYNLLNG----------------SLKQYLKQLKWNERMDVAIGVAKA 355
+ ++ ++ L++G ++KQ +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------------ILDG 127
Query: 356 LEYLHHTCDPPIIHRDVKSSNILL-SENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNV 412
+ YLH I H D+K NI+L +N P + DFG +H++ + V+ N+
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL------AHEIEDGVEFKNI 178
Query: 413 VGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
GT ++APE + Y + + D++S GV+ L++G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 2e-19
Identities = 44/199 (22%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKHENIVRIIGYCH 317
+G G V+R T G A K + + S+ E V +E++ +S ++H +V +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 318 SKEMYAIVYNLLNGS-LKQYL--KQLKWNERMDVAIGVAK----ALEYLHHTCDPPIIHR 370
++Y ++G L + + + K +E A+ + L ++H + +H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMH---ENNYVHL 279
Query: 371 DVKSSNILL-SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV 429
D+K NI+ ++ + +L DFG + + GT + APE V
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFG------LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333
Query: 430 DEKIDVYSYGVVLLELITG 448
D++S GV+ L++G
Sbjct: 334 GYYTDMWSVGVLSYILLSG 352
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 29/202 (14%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVL---KCTNWSEEE------VLREVELLSSIKHENI 309
+G G +V + A+K++ K S E V E+E+L + H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 310 VRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQL-KWNERM--DVAIGVAKALEYLHHTCDP 365
++I + +++ Y IV L+ G L + + E + A++YLH
Sbjct: 78 IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG-- 134
Query: 366 PIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE- 422
IIHRD+K N+LLS + +DFG + + ++ + + GT YLAPE
Sbjct: 135 -IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT------LCGTPTYLAPEV 187
Query: 423 --YMMYGKVDEKIDVYSYGVVL 442
+ + +D +S GV+L
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVIL 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 38/211 (18%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKC-------TNWSEEEVLREVELLSSIKHENIVR 311
+G G + V + G A K +K S E++ REV +L I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 312 IIGYCHSKEMYAIVYNLLNG-------SLKQYLKQLKWNERMDVAIGVAK----ALEYLH 360
+ +K ++ L+ G + K+ L E A K + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESL-----TEEE--ATEFLKQILNGVYYLH 131
Query: 361 HTCDPPIIHRDVKSSNILL-SENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
I H D+K NI+L N P++ DFG +H++ + N+ GT
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL------AHKIDFGNEFKNIFGTPE 182
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
++APE + Y + + D++S GV+ L++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 28/200 (14%)
Query: 257 KMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELL-SSIKHENIVRIIG 314
K ++G G N KV + GQ A+K+L + +EV+ + +IV I+
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKARQEVDHHWQASGGPHIVCILD 89
Query: 315 YC----HSKEMYAIVYNLLN-GSLKQYL---KQLKWNERM--DVAIGVAKALEYLHHTCD 364
H K I+ + G L + + ER ++ + A+++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN- 148
Query: 365 PPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
I HRDVK N+L + L +DFG A + + T Y+APE
Sbjct: 149 --IAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQT------PCYTPYYVAPE 199
Query: 423 YMMYGKVDEKIDVYSYGVVL 442
+ K D+ D++S GV++
Sbjct: 200 VLGPEKYDKSCDMWSLGVIM 219
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 38/211 (18%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK-------CTNWSEEEVLREVELLSSIKHENIVR 311
+G G + V + G+ A K +K S EE+ REV +L I+H NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 312 IIGYCHSKEMYAIVYNLLNG-------SLKQYLKQLKWNERMDVAIGVAK----ALEYLH 360
+ +K ++ L++G + K+ L E A K + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESL-----TED--EATQFLKQILDGVHYLH 125
Query: 361 HTCDPPIIHRDVKSSNILL-SENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
I H D+K NI+L +N +P++ DFG +H++ + N+ GT
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI------AHKIEAGNEFKNIFGTPE 176
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
++APE + Y + + D++S GV+ L++G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 59/293 (20%), Positives = 113/293 (38%), Gaps = 28/293 (9%)
Query: 169 SSSSKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFE 228
SS + + ++ S S S + ++ A T ++P KR
Sbjct: 7 HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVW----SNADLTERMPVKSKRTSAL 62
Query: 229 KLAVLEAEG-SSRRFTSQELCHLTH--NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL 284
+ + R + + + S ++G G +V++ G A K++
Sbjct: 63 AVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII 122
Query: 285 KCTNWSE-EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNGS-LKQYL--KQL 340
K + EEV E+ +++ + H N++++ SK +V ++G L + +
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY 182
Query: 341 KWNERMDVAIGVAK----ALEYLHHTCDPPIIHRDVKSSNILL-SENFHHPQLSDFGAAM 395
E I K + ++H I+H D+K NIL + + ++ DFG
Sbjct: 183 NLTELD--TILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFG--- 234
Query: 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
+ + K GT +LAPE + Y V D++S GV+ L++G
Sbjct: 235 ---LARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 62/279 (22%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK + E ++ E+++++ + HENIV ++G C S +Y I G L
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 336 YLK--------------------------QLKWNERMDVAIGVAKALEYL--HHTCDPPI 367
YL+ L + + + A VAK +E+L
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----C 193
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSH-QVSENVK-PVNVVGTFGYLAPEYM 424
+HRD+ + N+L++ ++ DFG A + S+ V N + PV ++APE +
Sbjct: 194 VHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESL 246
Query: 425 MYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483
G K DV+SYG++L E+ + G + L+ +G ++ P
Sbjct: 247 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY-----KLIQNG--FKMDQP-- 297
Query: 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
Y EEI I+M + C S +RP+ L
Sbjct: 298 --FYATEEIYIIM---QSCWAFDSRKRPSFPNLTSFLGC 331
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 62/308 (20%), Positives = 117/308 (37%), Gaps = 75/308 (24%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVR 311
+G+G KV + AVK+LK + ++L E +L + H ++++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 312 IIGYC-HSKEMYAIVYNLLNGSLKQYL---------------------------KQLKWN 343
+ G C + IV GSL+ +L + L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 344 ERMDVAIGVAKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQS 400
+ + A +++ ++YL ++HRD+ + NIL++E ++SDFG + V+ +
Sbjct: 151 DLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEG-RKMKISDFGLSRDVYEED 204
Query: 401 HQVSENVKPVNVVGTFGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQT 454
V + G + A E + + DV+S+GV+L E++T G
Sbjct: 205 ---------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 455 NKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMK 514
+LL +G R+ P + EE+ +M C +RP
Sbjct: 256 -IPPERLF-----NLLKTG--HRMERP----DNCSEEMYRLM---LQCWKQEPDKRPVFA 300
Query: 515 TLLKLFQE 522
+ K ++
Sbjct: 301 DISKDLEK 308
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWS----------EEEVLRE 297
N+ PK ++G+G +S V R + + AVK++ T E L+E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 298 VELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL-KQLKWNERM--DVAIGV 352
V++L + H NI+++ + + +V++L+ G L YL +++ +E+ + +
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
+ + LH I+HRD+K NILL ++ + +L+DFG S Q+ K V
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDM-NIKLTDFG------FSCQLDPGEKLREV 183
Query: 413 VGTFGYLAPE------YMMYGKVDEKIDVYSYGVVL 442
GT YLAPE + +++D++S GV++
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 50/229 (21%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 240 RRFTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV 294
+ F Q++ L + +G G V + G+ A+K K + + E+
Sbjct: 8 KGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEI 65
Query: 295 -----LREVELLSSIKHENIVRII-------GYCHSKEMYAIVYNLLNGSLKQYLKQLKW 342
RE+ LL ++HEN++ ++ + + Y +V + L++ +
Sbjct: 66 FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY-LVMPFMQTDLQKIMGLKFS 124
Query: 343 NERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
E++ + + K L+Y+H ++HRD+K N+ ++E+ ++ DFG A H
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDC-ELKILDFGLA--RHADA 178
Query: 402 QVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
+++ V T Y APE ++ + ++ +D++S G ++ E++TGK
Sbjct: 179 EMTGY------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS 318
IG G V++ V+ +VA KVL+ + RE++++ +KH N+V + + +S
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQ----DKRFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 319 KEMYA------IVYNLLNGSLKQYLKQL-KWNERMDVAIG------VAKALEYLHHTCDP 365
+V + ++ + + K + M + + + ++L Y+H
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-- 161
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP-VNVVGTFGYLAPEYM 424
I HRD+K N+LL +L DFG+A ++ +P V+ + + Y APE +
Sbjct: 162 -ICHRDIKPQNLLLDPPSGVLKLIDFGSA-------KILIAGEPNVSYICSRYYRAPELI 213
Query: 425 M----YGKVDEKIDVYSYGVVLLELITGK 449
Y ID++S G V+ EL+ G+
Sbjct: 214 FGATNYTT---NIDIWSTGCVMAELMQGQ 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH 317
+G G N KV + N + A+K+L+ + REVEL + +IVRI+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 318 ----SKEMYAIVYNLLNG----------SLKQYLKQLKWNERM--DVAIGVAKALEYLHH 361
++ IV L+G + + ER ++ + +A++YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF------TEREASEIMKSIGEAIQYLH- 178
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
I HRDVK N+L + + L +DFG A + ++ T Y+
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT------PCYTPYYV 230
Query: 420 APEYMMYGKVDEKIDVYSYGVVL 442
APE + K D+ D++S GV++
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIM 253
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 38/210 (18%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKH-ENIVRIIG 314
+G+G + V + + GQ A K LK E+L E+ +L K ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 315 YCHSKEMYAIVYNLLNG----------SLKQYLKQLKWNERMDVAIGVAK----ALEYLH 360
+ ++ G + +E I + K + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMV------SEND--VIRLIKQILEGVYYLH 148
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
I+H D+K NILLS + + DFG S ++ + ++GT Y
Sbjct: 149 ---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM------SRKIGHACELREIMGTPEY 199
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITG 448
LAPE + Y + D+++ G++ L+T
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 50/222 (22%)
Query: 259 LIGQGGNSKVYR---TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRI 312
+IG+G +V + AA+K +K + + E+E+L + H NI+ +
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 313 IGYC-HSKEMYAIVYNLLNGSLKQYL-------------------KQLKWNERMDVAIGV 352
+G C H +Y + +G+L +L L + + A V
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 353 AKALEYL--HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
A+ ++YL IHRD+ + NIL+ EN + +++DFG + + V
Sbjct: 152 ARGMDYLSQKQ-----FIHRDLAARNILVGEN-YVAKIADFGLS-----------RGQEV 194
Query: 411 NVVGTFGYL-----APEYMMYGKVDEKIDVYSYGVVLLELIT 447
V T G L A E + Y DV+SYGV+L E+++
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 44/212 (20%), Positives = 87/212 (41%), Gaps = 40/212 (18%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
+G+G +VY+ + V + A+K ++ + EEE +REV LL ++H NI+ +
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA---KALEYLHHTCDPPIIHR 370
H +++ LK+Y+ + + + + + H +HR
Sbjct: 100 SVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHR 156
Query: 371 DVKSSNILLSENFHHPQ----LSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAP 421
D+K N+LLS + + DFG A + +H++ + T Y P
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI---I-------TLWYRPP 206
Query: 422 EYMM----YGKVDEKIDVYSYGVVLLELITGK 449
E ++ Y +D++S + E++
Sbjct: 207 EILLGSRHYS---TSVDIWSIACIWAEMLMKT 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 251 THNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVK-VLKCTNWSEEEVLREVELLSSIKHEN 308
+++ +IG G VY+ D G++ A+K VL+ + RE++++ + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCN 108
Query: 309 IVRIIGYCHSK-----EMY-AIVYNLLNGSLKQYLKQL-KWNERMDVAIG------VAKA 355
IVR+ + +S E+Y +V + + ++ + + + + + V + ++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L Y+H I HRD+K N+LL + +L DFG+A Q+ V+ + +
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQLVRGEPNVSYICS 219
Query: 416 FGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y APE + Y IDV+S G VL EL+ G+
Sbjct: 220 RYYRAPELIFGATDYTS---SIDVWSAGCVLAELLLGQ 254
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 45/231 (19%), Positives = 94/231 (40%), Gaps = 40/231 (17%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----------H 306
+G G S V+ + V+ A+K+++ E E++LL +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 307 ENIVRIIGY-CHSKEMYA---IVYNLLNGSLKQYLKQLKWNERM-------DVAIGVAKA 355
+I++++ + H +V+ +L +L +K K+ R ++ +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLG 143
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ-----LSDFGAAMVHHQSHQVSENVKPV 410
L+Y+H C IIH D+K N+L+ ++D G A + + +
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--------T 193
Query: 411 NVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461
N + T Y +PE ++ D++S ++ ELITG + ++ + +
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 41/210 (19%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRIIG 314
+G+G VY+ G++ A+K ++ E+E +RE+ LL + H NIV +I
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDA--EDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA----------KALEYLHHTCD 364
HS+ +V+ + LK+ L + + + + + + H
Sbjct: 87 VIHSERCLTLVFEFMEKDLKKVL------DENKTGLQDSQIKIYLYQLLRGVAHCHQHR- 139
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV-NVVGTFGYLAPEY 423
I+HRD+K N+L++ + +L+DFG A V+ + V T Y AP+
Sbjct: 140 --ILHRDLKPQNLLINSD-GALKLADFGLA------RAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 424 MM----YGKVDEKIDVYSYGVVLLELITGK 449
+M Y +D++S G + E+ITGK
Sbjct: 191 LMGSKKYS---TSVDIWSIGCIFAEMITGK 217
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 46/199 (23%)
Query: 280 AVKVLK--CTNWSEEEVLREVELLSSI-KHENIVRIIGYC-HSKEMYAIVYNLLNGSLKQ 335
AVK+LK T +++ E+E++ I KH+NI+ ++G C +Y IV G+L++
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 336 YLK-------------------QLKWNERMDVAIGVAKALEYL--HHTCDPPIIHRDVKS 374
YL+ QL + + A VA+ +EYL IHRD+ +
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAA 219
Query: 375 SNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPVNVVGTFGYL-----APEYMMYGK 428
N+L++E+ + +++DFG A +HH T G L APE +
Sbjct: 220 RNVLVTED-NVMKIADFGLARDIHHID---------YYKKTTNGRLPVKWMAPEALFDRI 269
Query: 429 VDEKIDVYSYGVVLLELIT 447
+ DV+S+GV+L E+ T
Sbjct: 270 YTHQSDVWSFGVLLWEIFT 288
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 260 IGQGGNSKVYRTNHVD---GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC 316
+G+G VY+ D + A+K ++ T S RE+ LL +KH N++ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS-ACREIALLRELKHPNVISLQKVF 87
Query: 317 HSKEMYAI--VYNLLNGSLKQYLKQLKWNERMDVAIGVA------------KALEYLHHT 362
S + +++ L +K + ++ + + + YLH
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 363 CDPPIIHRDVKSSNILLSENFHHP---QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
++HRD+K +NIL+ +++D G A + + + ++ PV VV TF Y
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV-VV-TFWYR 202
Query: 420 APEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
APE ++ Y K ID+++ G + EL+T +
Sbjct: 203 APELLLGARHYTK---AIDIWAIGCIFAELLTSE 233
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 45/222 (20%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVK-VLKCTNWSEEEVLREVELLSSIKH 306
F + + GQG V G A+K V++ + E L+ ++ L+ + H
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHH 78
Query: 307 ENIVRIIGYCHS------KEMY-AIVYNLLNGSLKQYLKQL-KWNERMDVAIG------V 352
NIV++ Y ++ +++Y +V + +L + + + + +
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA-MVHHQSHQVSENVKPVN 411
+++ LH + HRD+K N+L++E +L DFG+A + V+
Sbjct: 139 IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY------ 191
Query: 412 VVGTFGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
+ + Y APE + Y +D++S G + E++ G+
Sbjct: 192 -ICSRYYRAPELIFGNQHYTT---AVDIWSVGCIFAEMMLGE 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 33/206 (16%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRIIG 314
IG+G VY+ + G+ A+K ++ E+E +RE+ +L +KH NIV++
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAI------GVAKALEYLHHTCDPPII 368
H+K+ +V+ L+ LK+ L ++ + + Y H ++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV-NVVGTFGYLAPEYMM-- 425
HRD+K N+L++ +++DFG A V+ + + T Y AP+ +M
Sbjct: 123 HRDLKPQNLLINRE-GELKIADFGLA------RAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 426 --YGKVDEKIDVYSYGVVLLELITGK 449
Y ID++S G + E++ G
Sbjct: 176 KKYS---TTIDIWSVGCIFAEMVNGT 198
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 66/271 (24%), Positives = 111/271 (40%), Gaps = 25/271 (9%)
Query: 193 PSSSTSSTTRQESDVGVCIAQETVQ-VPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLT 251
T+ T R E + QE + E + F ++ E +T
Sbjct: 123 RQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVT 182
Query: 252 -HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIK 305
+ F ++G+GG +V G++ A K L+ E L E ++L +
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 306 HENIVRIIGYC-HSKEMYAIVYNLLN-GSLKQYLKQLKWNE-RMDVAI----GVAKALEY 358
+V + Y +K+ +V L+N G LK ++ + A+ + LE
Sbjct: 243 SRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH I++RD+K NILL ++ H ++SD G A+ V E VGT GY
Sbjct: 302 LH---RERIVYRDLKPENILLDDH-GHIRISDLGLAV------HVPEGQTIKGRVGTVGY 351
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+APE + + D ++ G +L E+I G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 56/273 (20%), Positives = 114/273 (41%), Gaps = 26/273 (9%)
Query: 193 PSSSTSSTTRQESDVGVCIAQETVQ-VPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLT 251
+ R + G + Q ++ V + + F++ ++ E +
Sbjct: 124 SFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMG 183
Query: 252 -HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIK 305
F ++G+GG +V+ G++ A K L + + E ++L+ +
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 306 HENIVRIIGYC-HSKEMYAIVYNLLN-GSLKQYLKQLKWNER---MDVAI----GVAKAL 356
IV + Y +K +V ++N G ++ ++ + + AI + L
Sbjct: 244 SRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
E+LH II+RD+K N+LL ++ + ++SD G A+ + K GT
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDD-GNVRISDLGLAV-----ELKAGQTKTKGYAGTP 353
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
G++APE ++ + D +D ++ GV L E+I +
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 49/216 (22%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE------VLREVELLSSIKHENIVRI 312
+G+G + VY+ + Q+ A+K +K + SE + LRE++LL + H NI+ +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA----------KALEYLHHT 362
+ K ++V++ + L+ + + + + + + LEYLH
Sbjct: 78 LDAFGHKSNISLVFDFMETDLEVII------KDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFG 417
I+HRD+K +N+LL EN +L+DFG A +HQV V T
Sbjct: 132 W---ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQV---V-------TRW 177
Query: 418 YLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y APE + YG +D+++ G +L EL+
Sbjct: 178 YRAPELLFGARMYG---VGVDMWAVGCILAELLLRV 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 41/210 (19%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIKHENIVRIIG 314
+G+G + VY+ + + + A+K ++ + EE +REV LL +KH NIV +
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVA------IGVAKALEYLHHTCDPPII 368
H+++ +V+ L+ LKQYL +++ + + L Y H ++
Sbjct: 68 IIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VL 122
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAPEY 423
HRD+K N+L++E +L+DFG A ++V V T Y P+
Sbjct: 123 HRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEV---V-------TLWYRPPDI 171
Query: 424 MM----YGKVDEKIDVYSYGVVLLELITGK 449
++ Y +ID++ G + E+ TG+
Sbjct: 172 LLGSTDYS---TQIDMWGVGCIFYEMATGR 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 4e-17
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
IG+G V++ N ++ A+K ++ + ++E LRE+ LL +KH+NIVR+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEYLHHTCDPPI 367
HS + +V+ + LK+Y N +D I + K L + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGYLAPE 422
+HRD+K N+L++ N +L++FG A V S +V T Y P+
Sbjct: 123 LHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVV----------TLWYRPPD 171
Query: 423 YMM----YGKVDEKIDVYSYGVVLLELITGKEAI 452
+ Y ID++S G + EL +
Sbjct: 172 VLFGAKLYS---TSIDMWSAGCIFAELANAGRPL 202
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 36/210 (17%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV----LREVELLSSIKHENIVRIIG 314
+G G + VY+ N G A+K +K + EE +RE+ L+ +KHENIVR+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA----------KALEYLHHTCD 364
H++ +V+ ++ LK+Y+ + + + L + H
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGN-TPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV-NVVGTFGYLAPEY 423
I+HRD+K N+L+++ +L DFG A V + V T Y AP+
Sbjct: 129 --ILHRDLKPQNLLINKR-GQLKLGDFGLA------RAFGIPVNTFSSEVVTLWYRAPDV 179
Query: 424 MM----YGKVDEKIDVYSYGVVLLELITGK 449
+M Y ID++S G +L E+ITGK
Sbjct: 180 LMGSRTYS---TSIDIWSCGCILAEMITGK 206
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE------NIVR 311
+IG+G +V + +H Q A+K+++ + E+ +L ++ + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPP 366
++ + + + LL+ +L + +K+ A + + L+ LH
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNR 220
Query: 367 IIHRDVKSSNILLSENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
IIH D+K NILL + ++ DFG++ HQ + + Y APE ++
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--------YTYIQSRFYRAPEVIL 272
Query: 426 YGKVDEKIDVYSYGVVLLELITGK 449
+ ID++S G +L EL+TG
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE 307
+ LIG+G +V + + V+ + A+K++K + EV LL +
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH 110
Query: 308 ------NIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKAL 356
IV + + + +V+ +L+ +L L+ + N A + AL
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHP-QLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
+L + IIH D+K NILL ++ DFG++ Q + +
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--------YQYIQS 221
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y +PE ++ D ID++S G +L+E+ TG+
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 44/218 (20%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEE-----VLREVELLSSIKHENIVRII 313
IGQG +V++ H GQ A+K + N E+E LRE+++L +KHEN+V +I
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLI 82
Query: 314 GYCHSKEMYA--------IVYNLLNGSLKQYLKQLKWNERMDVAIGVA----------KA 355
C +K +V++ L L + V ++
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLL------SNVLVKFTLSEIKRVMQMLLNG 136
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L Y+H I+HRD+K++N+L++ + +L+DFG A + N VV T
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVV-T 191
Query: 416 FGYLAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
Y PE ++ YG ID++ G ++ E+ T
Sbjct: 192 LWYRPPELLLGERDYG---PPIDLWGAGCIMAEMWTRS 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK---CTNWSEEE-VLREVELLSSIKHE 307
+F IG+G KV D ++ A+K + C +E V +E++++ ++H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 308 NIVRIIGYCHSKE-MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK--------ALEY 358
+V + +E M+ +V LL G L+ +L+Q N K AL+Y
Sbjct: 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ---NVHFK--EETVKLFICELVMALDY 130
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
L + IIHRD+K NILL E+ H ++DF A + + + GT Y
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEH-GHVHITDFNIAA------MLPRETQITTMAGTKPY 180
Query: 419 LAPEYMM------YGKVDEKIDVYSYGVVLLELITGK 449
+APE Y +D +S GV EL+ G+
Sbjct: 181 MAPEMFSSRKGAGYSFA---VDWWSLGVTAYELLRGR 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 27/203 (13%)
Query: 260 IGQGGNSKVYRTNHVD-GQVAAVKVL---KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
IG+G +KV H+ G+ A+K++ + S +++ REV ++ + H NIV++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 316 CHSKEMYAIVYNLL-NGSLKQYLKQLKWNERM--DVAIG----VAKALEYLHHTCDPPII 368
+++ ++ G + YL + RM A + A++Y H I+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+K+ N+LL + + +++DFG + ++ G Y APE + GK
Sbjct: 137 HRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDA------FCGAPPYAAPE-LFQGK 188
Query: 429 VDE--KIDVYSYGVVLLELITGK 449
+ ++DV+S GV+L L++G
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGS 211
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 51/241 (21%), Positives = 91/241 (37%), Gaps = 35/241 (14%)
Query: 233 LEAEGSSRRFT-SQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE 291
++A+G + EL + ++ + I G V +G A+K + T
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG 61
Query: 292 EE------------VLREVELLSSIKHENIVRII------GYCHSKEMYAIVYNLLNGSL 333
VLRE+ LL+ H NI+ + ++Y +V L+ L
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLY-LVTELMRTDL 120
Query: 334 KQYLKQLKW---NERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389
Q + + + + + + L LH ++HRD+ NILL++N +
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLH-EAG--VVHRDLHPGNILLADNN-DITIC 176
Query: 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITG 448
DF A + V Y APE +M + + +D++S G V+ E+
Sbjct: 177 DFNLAREDTADANKTHY------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 449 K 449
K
Sbjct: 231 K 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSS 303
+ ++ IG+G V ++++ A+K K + + + LRE+++L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLREIKILLR 81
Query: 304 IKHENIVRII------GYCHSKEMYAIVYNLLNGSLKQYLK-QLKWNERMDVAI-GVAKA 355
+HENI+ I K++Y IV +L+ L + LK Q N+ + + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVY-IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L+Y+H + + ++HRD+K SN+LL+ ++ DFG A V T
Sbjct: 141 LKYIH-SAN--VLHRDLKPSNLLLNTTC-DLKICDFGLA--RVADPDHDHTGFLTEYVAT 194
Query: 416 FGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
Y APE M+ + ID++S G +L E+++ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 48/209 (22%), Positives = 90/209 (43%), Gaps = 34/209 (16%)
Query: 260 IGQGGNSKVYRTNHV-DGQVAAVKV-----LKCTNWSEEEVL----REVELLSSIKHENI 309
+G G V+ + VK + W E+ L E+ +LS ++H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 310 VRIIGYCHSKEMYAIV--YNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEYLHH 361
++++ ++ + +V + L ++ + + R+D + + A+ YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
IIHRD+K NI+++E+F +L DFG+A + GT Y AP
Sbjct: 149 KD---IIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFY------TFCGTIEYCAP 198
Query: 422 EYMMYGK--VDEKIDVYSYGVVLLELITG 448
E ++ G +++++S GV L L+
Sbjct: 199 E-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK----CTNWSEEEVLREVELLSSIKHE 307
+F ++G+G S V + + A+K+L+ V RE +++S + H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 308 NIVRIIGYCHSKE-MYAIVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEYLH 360
V++ E +Y + NG L +Y++++ D + ALEYLH
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH 147
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
IIHRD+K NILL+E+ H Q++DFG A S+ + + VGT Y++
Sbjct: 148 GK---GIIHRDLKPENILLNEDM-HIQITDFGTA---KVLSPESKQARANSFVGTAQYVS 200
Query: 421 PEYMM---YGKVDEKIDVYSYGVVLLELITGK 449
PE + K D+++ G ++ +L+ G
Sbjct: 201 PELLTEKSACKS---SDLWALGCIIYQLVAGL 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 59/228 (25%), Positives = 108/228 (47%), Gaps = 35/228 (15%)
Query: 242 FTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-- 294
F QEL + + +G G V + G AVK K + + +
Sbjct: 15 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA 72
Query: 295 ---LREVELLSSIKHENIVRII-------GYCHSKEMYAIVYNLLNGSLKQYLK-QLKWN 343
RE+ LL +KHEN++ ++ ++Y +V +L+ L +K Q +
Sbjct: 73 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-LVTHLMGADLNNIVKCQKLTD 131
Query: 344 ERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402
+ + I + + L+Y+H + D IIHRD+K SN+ ++E+ ++ DFG A H + +
Sbjct: 132 DHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDC-ELKILDFGLA--RHTADE 185
Query: 403 VSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
++ V T Y APE M+ + ++ +D++S G ++ EL+TG+
Sbjct: 186 MTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 53/232 (22%), Positives = 101/232 (43%), Gaps = 35/232 (15%)
Query: 238 SSRRFTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEE 292
+ F QE+ + + +G G V + G A+K K +
Sbjct: 7 ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQS 64
Query: 293 EV-----LREVELLSSIKHENIVRII-------GYCHSKEMYAIVYNLLNGSLKQYLK-Q 339
E+ RE+ LL ++HEN++ ++ + Y +V + L + +K +
Sbjct: 65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY-LVMPFMGTDLGKLMKHE 123
Query: 340 LKWNERMDVAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398
+R+ + + K L Y+H IIHRD+K N+ ++E+ ++ DFG A
Sbjct: 124 KLGEDRIQFLVYQMLKGLRYIH-AAG--IIHRDLKPGNLAVNEDC-ELKILDFGLA--RQ 177
Query: 399 QSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
+++ V T Y APE ++ + + + +D++S G ++ E+ITGK
Sbjct: 178 ADSEMTGY------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 42/211 (19%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-----LREVELLSSIKHENIVRII 313
IG+G V++ N GQ+ A+K K ++ V LRE+ +L +KH N+V ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIK--KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEYLHHTCDPPI 367
K +V+ + ++ L + + + +A+ + H
Sbjct: 69 EVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAA-----MVHHQSHQVSENVKPVNVVGTFGYLAPE 422
IHRDVK NIL++++ +L DFG A + +V+ T Y +PE
Sbjct: 124 IHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVA----------TRWYRSPE 172
Query: 423 YMM----YGKVDEKIDVYSYGVVLLELITGK 449
++ YG +DV++ G V EL++G
Sbjct: 173 LLVGDTQYGP---PVDVWAIGCVFAELLSGV 200
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSS 303
+++ +F K L+G+G V T+ G++ A+K K + + LRE+++L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KIEPFDKPLFALRTLREIKILKH 65
Query: 304 IKHENIVRII------GYCHSKEMYAIVYNLLNGSLKQYLK-QLKWNERMDVAI-GVAKA 355
KHENI+ I + + E+Y I+ L+ L + + Q+ ++ + I +A
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVY-IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV--- 412
++ LH + +IHRD+K SN+L++ N ++ DFG A + +S +
Sbjct: 125 VKVLH-GSN--VIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 413 --VGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
V T Y APE M+ K +DV+S G +L EL +
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 50/215 (23%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-----LREVELLSSIKHENIVRII 313
+G+G V + N G++ A+K ++ ++++ +RE++LL ++HEN+V ++
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA----------KALEYLHHTC 363
C K+ + +V+ ++ ++ L E + + + H
Sbjct: 91 EVCKKKKRWYLVFEFVDHTILDDL------ELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAM-----VHHQSHQVSENVKPVNVVGTFGY 418
IIHRD+K NIL+S++ +L DFG A +V+ T Y
Sbjct: 145 ---IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVA----------TRWY 190
Query: 419 LAPEYMM----YGKVDEKIDVYSYGVVLLELITGK 449
APE ++ YGK +DV++ G ++ E+ G+
Sbjct: 191 RAPELLVGDVKYGK---AVDVWAIGCLVTEMFMGE 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 7e-16
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 36/213 (16%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE--------VLREVELL---SSIKHE 307
IG G VY+ + G A+K ++ N +REV LL + +H
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPN--GGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 308 NIVRIIGYCHSKEMYA-----IVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKAL 356
N+VR++ C + +V+ ++ L+ YL + + + L
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP-PPGLPAETIKDLMRQFLRGL 133
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
++LH C I+HRD+K NIL++ +L+DFG A S + VV T
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSG-GTVKLADFGLA------RIYSYQMALTPVVVTL 183
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y APE ++ +D++S G + E+ K
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLK-----CTNWSEEEVLREVELLSSIKHENIVR- 311
L+G+G KV + AVK+LK E V +E++LL ++H+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 312 --IIGYCHSKEMYAIVYNLLNGSLKQ---YLKQLKWNERMDVAIG----VAKALEYLHHT 362
++ ++MY +V +++ + + ++ A G + LEYLH
Sbjct: 72 VDVLYNEEKQKMY-MVMEYCVCGMQEMLDSVPEKRFPV--CQAHGYFCQLIDGLEYLHSQ 128
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
I+H+D+K N+LL+ ++S G A H + + G+ + PE
Sbjct: 129 G---IVHKDIKPGNLLLTTG-GTLKISALGVA---EALHPFAADDTCRTSQGSPAFQPPE 181
Query: 423 YMMYGKVDE--KIDVYSYGVVLLELITGK 449
K+D++S GV L + TG
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 53/243 (21%), Positives = 86/243 (35%), Gaps = 77/243 (31%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVL---------------------------KCTNWS 290
IG+G V N D A+KVL
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 291 EEEVLREVELLSSIKHENIVR---------------IIGYCHSKEMYAIVYNLLNGSLK- 334
E+V +E+ +L + H N+V+ + + + + L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSE 136
Query: 335 ----QYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390
Y + L K +EYLH+ IIHRD+K SN+L+ E+ H +++D
Sbjct: 137 DQARFYFQDL------------IKGIEYLHYQK---IIHRDIKPSNLLVGED-GHIKIAD 180
Query: 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE----KIDVYSYGVVLLELI 446
FG + S + N VGT ++APE + +DV++ GV L +
Sbjct: 181 FGVSNEFKGSDALLS-----NTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFV 234
Query: 447 TGK 449
G+
Sbjct: 235 FGQ 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 46/213 (21%), Positives = 88/213 (41%), Gaps = 45/213 (21%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVL--KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G +V + + AVK++ K E + +E+ + + HEN+V+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 316 CHSKEMYAIV-----------YNLLNGSLKQ-----YLKQLKWNERMDVAIGVAKALEYL 359
+ + + + + + QL + + YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---------MA---GVVYL 121
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG--AAMVHHQSHQVSENVKPVNVVGTFG 417
H I HRD+K N+LL E + ++SDFG ++ ++ + GT
Sbjct: 122 HGIG---ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLN-----KMCGTLP 172
Query: 418 YLAPEYMMYGK--VDEKIDVYSYGVVLLELITG 448
Y+APE ++ + E +DV+S G+VL ++ G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 260 IGQGGNSKVY--RTNHVDGQVAAVKVLKCTNWSEEE-----VLREVELL---SSIKHENI 309
IG+G KV+ R G+ A+K ++ EE +REV +L + +H N+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 310 VRIIGYCHSKEMYA-----IVYNLLNGSLKQYLKQLKWNERMDVAIG------VAKALEY 358
VR+ C +V+ ++ L YL ++ + + + L++
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDF 135
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
LH ++HRD+K NIL++ + +L+DFG A S + +VV T Y
Sbjct: 136 LHSHR---VVHRDLKPQNILVTSS-GQIKLADFGLA------RIYSFQMALTSVVVTLWY 185
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
APE ++ +D++S G + E+ K
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 55/206 (26%), Positives = 82/206 (39%), Gaps = 34/206 (16%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
IG G ++ AVK ++ +E V RE+ S++H NIVR
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 318 SKEMYAIV--YNLLNGSLKQYLKQLKWNERM--DVA-------IGVAKALEYLHHTCDPP 366
+ AI+ Y G L + + R D A + + Y H
Sbjct: 87 TPTHLAIIMEY-ASGGELYERICN---AGRFSEDEARFFFQQLLS---GVSYCHSMQ--- 136
Query: 367 IIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
I HRD+K N LL + P+L DFG + Q P + VGT Y+APE +
Sbjct: 137 ICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ------PKSTVGTPAYIAPE-V 188
Query: 425 MYGK--VDEKIDVYSYGVVLLELITG 448
+ + + DV+S GV L ++ G
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 46/213 (21%), Positives = 88/213 (41%), Gaps = 45/213 (21%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVL--KCTNWSEEEVLREVELLSSIKHENIVRIIGY 315
+G+G +V + + AVK++ K E + +E+ + + HEN+V+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 316 CHSKEMYAIV-----------YNLLNGSLKQ-----YLKQLKWNERMDVAIGVAKALEYL 359
+ + + + + + QL + + YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---------MA---GVVYL 121
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG--AAMVHHQSHQVSENVKPVNVVGTFG 417
H I HRD+K N+LL E + ++SDFG ++ ++ + GT
Sbjct: 122 HGIG---ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLN-----KMCGTLP 172
Query: 418 YLAPEYMMYGK--VDEKIDVYSYGVVLLELITG 448
Y+APE ++ + E +DV+S G+VL ++ G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 8e-15
Identities = 70/256 (27%), Positives = 123/256 (48%), Gaps = 34/256 (13%)
Query: 213 QETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQEL-CHLT-HNFSPKMLIGQGGNSKVYR 270
++ ++++ +F+K + ++ + EL HLT ++FS +IG+GG +VY
Sbjct: 148 PYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG 207
Query: 271 TNHVD-GQVAAVKVLK-----------CTNWSEEEVLREVELLSSIKHENIVRIIGYCHS 318
D G++ A+K L +E +L L+S+ IV + H+
Sbjct: 208 CRKADTGKMYAMKCLDKKRIKMKQGETLAL-NERIML---SLVSTGDCPFIVCMSYAFHT 263
Query: 319 KEMYAIVYNLLN-GSLKQYLKQL-KWNERMDV--AIGVAKALEYLHHTCDPPIIHRDVKS 374
+ + + +L+N G L +L Q ++E A + LE++H + +++RD+K
Sbjct: 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKP 320
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKI 433
+NILL E+ H ++SD G A S+ KP VGT GY+APE + G D
Sbjct: 321 ANILLDEH-GHVRISDLGLAC------DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 434 DVYSYGVVLLELITGK 449
D +S G +L +L+ G
Sbjct: 373 DWFSLGCMLFKLLRGH 388
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 59/285 (20%), Positives = 110/285 (38%), Gaps = 42/285 (14%)
Query: 184 RQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFEKLAVLEAEGSSRRFT 243
++ L P S +S D + + + P K K + + + + +
Sbjct: 7 EKMDNLLRDPKSEVNSDCL--LDGLDALVYD-LDFPALRKNKNIDNF-LSRYKDTINKIR 62
Query: 244 SQELCHLTHNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR------ 296
+ ++ +IG+G +V H +V A+K+L + E+++
Sbjct: 63 DLRMK--AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-----KFEMIKRSDSAF 115
Query: 297 ---EVELLSSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDV--AI 350
E ++++ +V++ +V + G L + E+
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 175
Query: 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPV 410
V AL+ +H IHRDVK N+LL ++ H +L+DFG M ++ V +
Sbjct: 176 EVVLALDAIHSMG---FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDT--- 228
Query: 411 NVVGTFGYLAPE-------YMMYGKVDEKIDVYSYGVVLLELITG 448
VGT Y++PE YG+ D +S GV L E++ G
Sbjct: 229 -AVGTPDYISPEVLKSQGGDGYYGRE---CDWWSVGVFLYEMLVG 269
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 57/259 (22%), Positives = 97/259 (37%), Gaps = 64/259 (24%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-----LREVELLS 302
H+ N+ K LIG+G VY + + A+K K E+ + LRE+ +L+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILN 80
Query: 303 SIKHENIVRII------GYCHSKEMYAIVYNLLNGSLKQYLK---------------QLK 341
+K + I+R+ E+Y IV + + LK+ K L
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELY-IVLEIADSDLKKLFKTPIFLTEEHIKTILYNL- 138
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
++H IIHRD+K +N LL+++ ++ DFG A +
Sbjct: 139 -----------LLGENFIH-ESG--IIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEK 183
Query: 402 QVSENVKPVNV-----------------VGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLL 443
+ V T Y APE ++ + ID++S G +
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 444 ELITGKEAIQTNKANRESL 462
EL+ ++ + NR L
Sbjct: 244 ELLNMLQSHINDPTNRFPL 262
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRII 313
+G+G KV H Q A+K + + V RE+ L ++H +I+++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK------ALEYLHHTCDPPI 367
+ +V G L Y+ + +RM G A+EY H I
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---I 129
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
+HRD+K N+LL +N + +++DFG + + + + G+ Y APE ++ G
Sbjct: 130 VHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLK------TSCGSPNYAAPE-VING 181
Query: 428 KVDE--KIDVYSYGVVLLELITGK 449
K+ ++DV+S G+VL ++ G+
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 46/224 (20%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSI 304
L + +G GGN V+ ++ + A+K K + LRE++++ +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--KIVLTDPQSVKHALREIKIIRRL 65
Query: 305 KHENIVRII---------------GYCHSKEMYAIVYNLLNGSLKQYLK--QLKWNERMD 347
H+NIV++ +Y IV + L L+ L E
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY-IVQEYMETDLANVLEQGPLL-EEHAR 123
Query: 348 VAI-GVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406
+ + + + L+Y+H + + ++HRD+K +N+ ++ ++ DFG A + S
Sbjct: 124 LFMYQLLRGLKYIH-SAN--VLHRDLKPANLFINTEDLVLKIGDFGLARI--MDPHYSHK 178
Query: 407 VKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK 449
+ T Y +P ++ + ID+++ G + E++TGK
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 49/267 (18%), Positives = 98/267 (36%), Gaps = 75/267 (28%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-----LREVELLS 302
+ + + LIG G V + ++ +V A+K K E+ + LRE+ +L+
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILN 107
Query: 303 SIKHENIVRIIGYCHS------KEMYAIVYNLLNGSLKQYLK---------------QLK 341
+ H+++V+++ E+Y +V + + K+ + L
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELY-VVLEIADSDFKKLFRTPVYLTELHIKTLLYNL- 165
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
++Y+H + I+HRD+K +N L++++ ++ DFG A
Sbjct: 166 -----------LVGVKYVH-SAG--ILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPE 210
Query: 402 QVSENVKPVNVVGTFG----------------------YLAPEYMM----YGKVDEKIDV 435
+ + Y APE ++ Y + IDV
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE---AIDV 267
Query: 436 YSYGVVLLELITGKEAIQTNKANRESL 462
+S G + EL+ + A+R L
Sbjct: 268 WSIGCIFAELLNMIKENVAYHADRGPL 294
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 47/216 (21%), Positives = 92/216 (42%), Gaps = 50/216 (23%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVL----REVELLSSIKHENIVR-- 311
+G G KV H G AVK+L +V+ RE++ L +H +I++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 312 -----------IIGYCHSKEMYAIVYNLLNGSLK-----QYLKQLKWNERMDVAIGVAKA 355
++ Y E++ Y +G ++ + +Q+ A
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFD--YICKHGRVEEMEARRLFQQI------------LSA 123
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
++Y H ++HRD+K N+LL + + +++DFG + + + G+
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLR------TSCGS 173
Query: 416 FGYLAPEYMMYGKVDE--KIDVYSYGVVLLELITGK 449
Y APE ++ G++ ++D++S GV+L L+ G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 46/236 (19%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE 307
L + F +G G +V + + + AVKV++ E ++L I+++
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND 91
Query: 308 -----NIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALE 357
NIV+ G + +++ L SL + + + + I + KAL
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLS------------------------DFGA 393
YL + H D+K NILL + + L DFG
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
A H +++ T Y APE ++ D D++S+G VL EL TG
Sbjct: 209 ATFKSDYH--------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 8e-13
Identities = 48/203 (23%), Positives = 78/203 (38%), Gaps = 60/203 (29%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCH 317
+G G N KV + N + A+K+L+ + REVEL + +IVRI+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYE 81
Query: 318 ----SKEMYAIVYNLLNG----------SLKQYLKQLKWNERM--DVAIGVAKALEYLHH 361
++ IV L+G + + ER ++ + +A++YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF------TEREASEIMKSIGEAIQYLH- 134
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQL--SDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
I HRDVK N+L + + L +DFG
Sbjct: 135 --SINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------------F 166
Query: 420 APEYMMYGKVDEKIDVYSYGVVL 442
A E K D+ D++S GV++
Sbjct: 167 AKE-TTGEKYDKSCDMWSLGVIM 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 39/219 (17%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVL-KCTNWSEEEV---LREVELLSSIKHE 307
+F +IG+G +V + +V A+K+L K E E ++L + +
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 308 NIVRIIGYC--HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAK--------ALE 357
I + Y +Y ++ + G L L K+ +R+ +A+ A++
Sbjct: 135 WITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS--KFEDRLPEE--MARFYLAEMVIAID 189
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
+H +HRD+K NIL+ N H +L+DFG+ + + V +V VGT
Sbjct: 190 SVHQLH---YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSV----AVGTPD 241
Query: 418 YLAPE--------YMMYGKVDEKIDVYSYGVVLLELITG 448
Y++PE YG D +S GV + E++ G
Sbjct: 242 YISPEILQAMEGGKGRYGPE---CDWWSLGVCMYEMLYG 277
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 51/226 (22%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK-----------CTNWSEEEVLREVEL 300
+F +IG+G S+V GQV A+K++ C E +VL
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF-REERDVL----- 115
Query: 301 LSSIKHENIVRIIGYC--HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIG------V 352
+ I ++ + +Y ++ + G L L K+ ER+ + +
Sbjct: 116 -VNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS--KFGERIPAEMARFYLAEI 171
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
A++ +H +HRD+K NILL H +L+DFG+ + V V
Sbjct: 172 VMAIDSVHRLG---YVHRDIKPDNILLDRC-GHIRLADFGSCLKLRADGTVRSLV----A 223
Query: 413 VGTFGYLAPE----------YMMYGKVDEKIDVYSYGVVLLELITG 448
VGT YL+PE YG D ++ GV E+ G
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPE---CDWWALGVFAYEMFYG 266
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 37/214 (17%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLK---CTNWSEEE-VLREVELLSSIKH 306
F +G G +V H + G A+K+L + E L E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 307 ENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKALEYLHHT 362
+V++ +V + G + +L + +++E A + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV-----GTFG 417
+I+RD+K N+L+ + + Q++DFG A K V GT
Sbjct: 161 D---LIYRDLKPENLLIDQQ-GYIQVTDFGFA-------------KRVKGRTWTLCGTPE 203
Query: 418 YLAPEYMM---YGKVDEKIDVYSYGVVLLELITG 448
LAPE ++ Y K +D ++ GV++ E+ G
Sbjct: 204 ALAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 48/216 (22%), Positives = 90/216 (41%), Gaps = 50/216 (23%)
Query: 259 LIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVL----REVELLSSIKHENIVR-- 311
+G G KV H G AVK+L +V+ RE++ L +H +I++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 312 -----------IIGYCHSKEMYAIVYNLLNGSLK-----QYLKQLKWNERMDVAIGVAKA 355
++ Y E++ Y NG L + +Q+
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFD--YICKNGRLDEKESRRLFQQI------------LSG 128
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
++Y H ++HRD+K N+LL + + +++DFG + + + G+
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLR------TSCGS 178
Query: 416 FGYLAPEYMMYGKVDE--KIDVYSYGVVLLELITGK 449
Y APE ++ G++ ++D++S GV+L L+ G
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 56/242 (23%), Positives = 104/242 (42%), Gaps = 60/242 (24%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEV-----LREVELLS 302
H+ + +G+G V++ + G+V AVK K + + RE+ +L+
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILT 63
Query: 303 SIK-HENIVRIIGYCHS---KEMYAIVYNLLNGSLKQYLK--------------QLKWNE 344
+ HENIV ++ + +++Y +V++ + L ++ QL
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVY-LVFDYMETDLHAVIRANILEPVHKQYVVYQL---- 118
Query: 345 RMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404
K ++YL H+ ++HRD+K SNILL+ H +++DFG + +V+
Sbjct: 119 --------IKVIKYL-HSGG--LLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVT 166
Query: 405 ENVKPVNVVGTFG----------------YLAPEYMM-YGKVDEKIDVYSYGVVLLELIT 447
N+ T Y APE ++ K + ID++S G +L E++
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 448 GK 449
GK
Sbjct: 227 GK 228
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 49/235 (20%), Positives = 91/235 (38%), Gaps = 48/235 (20%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR--TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH 306
L+ + +G+G KV + G+ AVK++K + E E+++L +
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNT 70
Query: 307 E------NIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM--------DVAIGV 352
V+++ + IV+ LL S ++K+ N + +A +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKE---NGFLPFRLDHIRKMAYQI 127
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS------------------DFGAA 394
K++ +LH + H D+K NIL ++ + + DFG+A
Sbjct: 128 CKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
+ H +V T Y APE ++ + DV+S G +L+E G
Sbjct: 185 TYDDEHH--------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 49/232 (21%), Positives = 85/232 (36%), Gaps = 42/232 (18%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQ-VAAVKVLKCTNWSEEEVLREVELLSSIKH 306
L + +G+G KV +H G+ A+K+++ E E+ +L IK
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKE 75
Query: 307 E------NIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKA 355
+ V + + + I + LL + ++LK+ +A + A
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ------------------LSDFGAAMVH 397
L +LH + H D+K NIL + ++DFG+A
Sbjct: 136 LRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
H+ H +V T Y PE ++ + DV+S G +L E G
Sbjct: 193 HEHH--------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 49/248 (19%), Positives = 94/248 (37%), Gaps = 67/248 (27%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+S +G G V ++ G+ A+K K RE++++ + H NI++
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQ-DPRYKNRELDIMKVLDHVNIIK 64
Query: 312 IIGYCHSKEMYA--------------------------------------IVYNLLNGSL 333
++ Y ++ ++ + +L
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 334 KQYLKQ-LKWNERMDVAIG------VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386
+ LK ++ + + + + +A+ ++H I HRD+K N+L++ +
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTL 181
Query: 387 QLSDFGAAMVHHQSHQ-VSENVKPVNVVGTFGYLAPEYMM----YGKVDEKIDVYSYGVV 441
+L DFG+A S V+ + + Y APE M+ Y ID++S G V
Sbjct: 182 KLCDFGSAKKLIPSEPSVAY-------ICSRFYRAPELMLGATEYTP---SIDLWSIGCV 231
Query: 442 LLELITGK 449
ELI GK
Sbjct: 232 FGELILGK 239
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 59/225 (26%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR--EVE-------LL 301
+F +G G +V+ G+ A+KVLK +E V+R +VE +L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-----KEIVVRLKQVEHTNDERLML 60
Query: 302 SSIKHENIVRIIGYCHSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDVAIGVAK----- 354
S + H I+R+ G + ++ + + G L L K ++ VAK
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP------VAKFYAAE 114
Query: 355 ---ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
ALEYLH D II+RD+K NILL +N H +++DFG A K V
Sbjct: 115 VCLALEYLHS-KD--IIYRDLKPENILLDKN-GHIKITDFGFA-------------KYVP 157
Query: 412 VV-----GTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITG 448
V GT Y+APE + Y K ID +S+G+++ E++ G
Sbjct: 158 DVTYTLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAG 199
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 68/377 (18%), Positives = 112/377 (29%), Gaps = 133/377 (35%)
Query: 260 IGQGGNSKVY--RTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK--------HENI 309
+G G S V+ VA +KV+K E L E+ LL S++ E +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVA-MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 310 VRIIGY--------CHSKEMYAIVYNLLNGSLKQYLKQLKWNERM-------DVAIGVAK 354
V+++ H +V+ +L L +++ K N + + V +
Sbjct: 104 VQLLDDFKISGVNGTH----ICMVFEVLGHHLLKWII--KSNYQGLPLPCVKKIIQQVLQ 157
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSEN-------------------------------- 382
L+YLH C IIH D+K NILLS N
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 383 ----------------FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
+++D G A H+ + T Y + E ++
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT--------EDIQTRQYRSLEVLIG 267
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES-----------------LVLWARSL 469
+ D++S + EL TG + + + L
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327
Query: 470 LSS------------------GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRP 511
S GL E L++ E+++EE L +R
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVE---KYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 512 TMKTLLKLFQEPDYWLK 528
T L+ WL
Sbjct: 385 TAAECLR-----HPWLN 396
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVL-KCTNWSEEEV---LREVELLSSIKHE 307
F L+G+G KV G+ A+K+L K +++EV L E +L + +H
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 308 NIVRIIGYC-HSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKALEYLHHT 362
+ + Y + + V NG L +L ++ ++E + AL+YLH
Sbjct: 209 FLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF----GY 418
+ +++RD+K N++L ++ H +++DFG E +K + TF Y
Sbjct: 268 KN--VVYRDLKLENLMLDKD-GHIKITDFGLC---------KEGIKDGATMKTFCGTPEY 315
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
LAPE + +D + GVV+ E++ G+
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 253 NFSPKMLIGQGGNSKVY----RTNHVDGQVAAVKVLK---CTNWSEEEVLREVELLSSIK 305
F ++GQG KV+ + Q+ A+KVLK E ++L +
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 306 HENIVRIIGYC---HSKEMYAIVYNLLN-GSLKQYL-KQLKWNERMDV--AIGVAKALEY 358
H IV++ Y K +Y ++ + L G L L K++ + E +A AL++
Sbjct: 85 HPFIVKLH-YAFQTEGK-LY-LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF-G 417
LH II+RD+K NILL E H +L+DFG + E++ +F G
Sbjct: 142 LH---SLGIIYRDLKPENILLDEE-GHIKLTDFGLS---------KESIDHEKKAYSFCG 188
Query: 418 ---YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y+APE + + D +S+GV++ E++TG
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 66/304 (21%), Positives = 120/304 (39%), Gaps = 52/304 (17%)
Query: 169 SSSSKYPAFGQPATTRQLQKSLTAPSSSTSSTTRQESDVGVCIAQETVQVPESIKRKIFE 228
S K G Q + + E + Q ++ + K
Sbjct: 265 SELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTAN 324
Query: 229 KLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCT 287
++ + G+ R +F+ M++G+G KV + ++ AVK+LK
Sbjct: 325 TISKFDNNGNRDRMKLT-------DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-- 375
Query: 288 NWSEEEVLR--EVE--------LLSSIKHENIVRIIGYC-HSKEMYAIVYNLLNG-SLKQ 335
++ V++ +VE L K + ++ C + + V +NG L
Sbjct: 376 ---KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMY 431
Query: 336 YL-KQLKWNERMDV--AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392
++ + ++ E V A +A L +L II+RD+K N++L H +++DFG
Sbjct: 432 HIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE-GHIKIADFG 487
Query: 393 AAMVHHQSHQVSENVKPVNVVGTF-G---YLAPE---YMMYGKVDEKIDVYSYGVVLLEL 445
EN+ TF G Y+APE Y YGK +D +++GV+L E+
Sbjct: 488 MCK---------ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEM 535
Query: 446 ITGK 449
+ G+
Sbjct: 536 LAGQ 539
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 30/226 (13%)
Query: 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLH 360
L SI G+ K + + L Y L + + VAK +E+L
Sbjct: 153 LDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL--YKDFLTLEHLICYSFQVAKGMEFL- 209
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA--MVHHQSHQVSENVK-PVNVVGTFG 417
IHRD+ + NILLSE + ++ DFG A + + + + P+
Sbjct: 210 --ASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLK------ 260
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCE 476
++APE + + DV+S+GV+L E+ + G K + E L G
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRLKEG--T 313
Query: 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
R+ P +Y E+ M C S+RPT L++
Sbjct: 314 RMRAP----DYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 28/136 (20%), Positives = 52/136 (38%), Gaps = 15/136 (11%)
Query: 260 IGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSI-KHENIV 310
+G+G +V + AVK+LK T+ ++ E+++L I H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 311 RIIGYC--HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPII 368
++G C + IV G+L YL ++R + K + I
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 369 HRDVKSSNILLSENFH 384
D+K ++ +
Sbjct: 146 PVDLKRRLDSITSSQS 161
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVL-KCTNWSEEEV---LREVELLSSIKHE 307
+F L+G+G KV G+ A+K+L K +++EV + E +L + +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 308 NIVRIIGYC-HSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKALEYLHHT 362
+ + Y + + V NG L +L ++ + E + ALEYLH
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF-G---Y 418
+++RD+K N++L ++ H +++DFG E + + TF G Y
Sbjct: 123 -SRDVVYRDIKLENLMLDKD-GHIKITDFGLC---------KEGISDGATMKTFCGTPEY 171
Query: 419 LAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
LAPE + +D + GVV+ E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 7e-10
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 44/221 (19%)
Query: 253 NFSPKMLIGQGGNSKVY----RTNHVDGQVAAVKVLK----CTNWSEEE-VLREVELLSS 303
F ++G+GG KV+ T G++ A+KVLK N + E +L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 304 IKHENIVRIIGYC---HSKEMYAIVYNLLN-GSLKQYLKQLKWNERM---DVA---IG-V 352
+KH IV +I Y K +Y ++ L+ G L L++ E + D A + +
Sbjct: 78 VKHPFIVDLI-YAFQTGGK-LY-LILEYLSGGELFMQLER----EGIFMEDTACFYLAEI 130
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNV 412
+ AL +LH II+RD+K NI+L+ H +L+DFG E++ V
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQ-GHVKLTDFGLC---------KESIHDGTV 177
Query: 413 VGTF-G---YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
TF G Y+APE +M + +D +S G ++ +++TG
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 35/105 (33%), Positives = 51/105 (48%), Gaps = 23/105 (21%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
+ AL +LH D II+RD+K N+LL H +L+DFG E +
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHE-GHCKLADFGMCK---------EGICNGV 179
Query: 412 VVGTF-G---YLAPE---YMMYGKVDEKIDVYSYGVVLLELITGK 449
TF G Y+APE M+YG +D ++ GV+L E++ G
Sbjct: 180 TTATFCGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGH 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 39/217 (17%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVL--REVE--------LL 301
+F +IG+G KV H AVKVL+ ++ +L +E + LL
Sbjct: 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ-----KKAILKKKEEKHIMSERNVLL 93
Query: 302 SSIKHENIVRIIGYC-HSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKAL 356
++KH +V + + + + V + +NG L +L ++ + E A +A AL
Sbjct: 94 KNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 152
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
YLH I++RD+K NILL H L+DFG EN++ + TF
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQ-GHIVLTDFGLC---------KENIEHNSTTSTF 199
Query: 417 -G---YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
G YLAPE + D +D + G VL E++ G
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 23/102 (22%)
Query: 355 ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG 414
AL YLH + II+RD+K N+LL H +L+D+G E ++P +
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCK---------EGLRPGDTTS 168
Query: 415 TF-G---YLAPE---YMMYGKVDEKIDVYSYGVVLLELITGK 449
TF G Y+APE YG +D ++ GV++ E++ G+
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 45/219 (20%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR--EVE--------LL 301
+F ++G+G KV+ Q A+K LK ++ VL +VE L
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-----KDVVLMDDDVECTMVEKRVLS 72
Query: 302 SSIKHENIVRIIGYC-HSKEMYAIVYNLLN-GSLKQYLKQL-KWNERMDV--AIGVAKAL 356
+ +H + + +KE V LN G L +++ K++ A + L
Sbjct: 73 LAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
++LH I++RD+K NILL ++ H +++DFG EN+ TF
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKD-GHIKIADFGMCK---------ENMLGDAKTNTF 178
Query: 417 -G---YLAPE---YMMYGKVDEKIDVYSYGVVLLELITG 448
G Y+APE Y +D +S+GV+L E++ G
Sbjct: 179 CGTPDYIAPEILLGQKYNHS---VDWWSFGVLLYEMLIG 214
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 45/220 (20%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLR--EVE--------LL 301
+F+ M++G+G KV + ++ AVK+LK ++ V++ +VE L
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-----KDVVIQDDDVECTMVEKRVLA 75
Query: 302 SSIKHENIVRIIGYC-HSKEMYAIVYNLLNG-SLKQYL-KQLKWNERMDV--AIGVAKAL 356
K + ++ C + + V +NG L ++ + ++ E V A +A L
Sbjct: 76 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
+L II+RD+K N++L H +++DFG EN+ TF
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSE-GHIKIADFGMCK---------ENIWDGVTTKTF 181
Query: 417 -G---YLAPE---YMMYGKVDEKIDVYSYGVVLLELITGK 449
G Y+APE Y YGK +D +++GV+L E++ G+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQ 218
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 3e-09
Identities = 83/577 (14%), Positives = 173/577 (29%), Gaps = 162/577 (28%)
Query: 1 MVGKLSIEKNFFSVLRTRTLKKRTVIFG----LKSDHYSR-EILLQLLTVI--AKPGDNV 53
++ + E+ S++ +++R ++ + SR + L+L + +P NV
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153
Query: 54 ------------LAVHVEEQNDTLDLNTFHIH-----EDLCKSKKVDFLVKVC--IGDSY 94
+A+ V F I ++ L K+ I ++
Sbjct: 154 LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 95 ITELSNQVRISYATILALGCSLSGLKDSEVLTRCLRALPPACTILVMDN----------- 143
+ + I I ++ L L S+ CL LV+ N
Sbjct: 214 TSRSDHSSNIKL-RIHSIQAELRRLLKSKPYENCL---------LVLLNVQNAKAWNAFN 263
Query: 144 LG-RILVQRQGTSQQGSTNVL---LKSSLSSSSKYPAFGQPATTRQLQKSLTAPSSSTSS 199
L +IL+ T + T+ L + +S L K L
Sbjct: 264 LSCKILLT---TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320
Query: 200 TTRQESDVGVCIAQETVQVP----ESIKRKIFEKLA-VLEAEGSSRRFTSQELCHLTHNF 254
+ + I E+++ ++ K +KL ++E+ S E +
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES--SLNVLEPAEYRKMFDRL 378
Query: 255 S--PKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI 312
S P ++ + +L W + +V + +
Sbjct: 379 SVFPP-------SAHI-----------PTILL-SLIWFDVIK-SDVMV-----------V 407
Query: 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRD- 371
+ H +L+ K+ + + LE + +HR
Sbjct: 408 VNKLHKY-------SLVEKQPKESTISI-----PSI------YLELKVKLENEYALHRSI 449
Query: 372 VKSSNILL---SENFHHPQLSD-FGAAMVHH-----QSHQVSENVKPVNVVGTFGYLAPE 422
V NI S++ P L F + + HH +++ F +
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTL----------FRMV--- 496
Query: 423 YMMYGKVDEKI--DVYSYGV------VLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474
++ + +++KI D ++ L +L K I N E LV
Sbjct: 497 FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV----------- 545
Query: 475 CERLID--PQLNEE-YNREEIEIVMCAARLCLLHSSS 508
++D P++ E + +++ R+ L+
Sbjct: 546 -NAILDFLPKIEENLICSKYTDLL----RIALMAEDE 577
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 6e-08
Identities = 61/411 (14%), Positives = 118/411 (28%), Gaps = 111/411 (27%)
Query: 201 TRQESDVGVCIAQETVQVPESIKR--KIFEKLAVLEAEGSS--RRFTSQELCHLTHNF-- 254
+++E D + +++ ++F L ++ ++F + L + + F
Sbjct: 47 SKEEID-------HIIMSKDAVSGTLRLFW---TLLSKQEEMVQKFVEEVL-RINYKFLM 95
Query: 255 SP--KMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN 308
SP +++Y D QV K + L+ + L ++
Sbjct: 96 SPIKTEQRQPSMMTRMYIEQRDRLYNDNQV----FAKYNVSRLQPYLKLRQALLELRPAK 151
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYL-----KQLKWNERMDVAI------------G 351
V I G + GS K ++ K +MD I
Sbjct: 152 NVLIDG------V--------LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET 197
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
V + L+ L + DP R SSNI L + +L + + V NV+
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK 257
Query: 412 VVGTFG----------------YLAPEYMMYGKVDEKIDVYS--YGVVLLELITG----- 448
F +L+ + +D + LL
Sbjct: 258 AWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 449 --KEAIQTNKANRESLVLWARSLLSSGLCERLID-PQLNEEYNREEIEIVMCAARLCL-- 503
+E + TN S + E + D + + + + L
Sbjct: 318 LPREVLTTN------------PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365
Query: 504 LHSSSRRPTMKTLLKLFQE----PD-----YWLKMK-REKEELLNE--RRS 542
L + R L +F P W + + ++N+ + S
Sbjct: 366 LEPAEYRKMFDR-LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 23/105 (21%)
Query: 352 VAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVN 411
++ AL YLH + II+RD+K N+LL H +L+D+G E ++P +
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCK---------EGLRPGD 208
Query: 412 VVGTF-G---YLAPE---YMMYGKVDEKIDVYSYGVVLLELITGK 449
TF G Y+APE YG +D ++ GV++ E++ G+
Sbjct: 209 TTSTFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGR 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 48/207 (23%), Positives = 78/207 (37%), Gaps = 28/207 (13%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIKH-ENIVRIIGYC 316
IG G +Y T+ G+ A+K+ ++ L E ++ ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPPIIHR 370
+ +V LL SL+ + + +A + +EY+H IHR
Sbjct: 75 AEGDYNVMVMELLGPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHR 129
Query: 371 DVKSSNILLS--ENFHHPQLSDFGAAM--VHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
DVK N L+ + + + DFG A ++HQ + N+ GT Y A
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINTHL 188
Query: 427 GKV----DEKIDVYSYGVVLLELITGK 449
G D D+ S G VL+ G
Sbjct: 189 GIEQSRRD---DLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 29/151 (19%), Positives = 55/151 (36%), Gaps = 26/151 (17%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLK-----CTNWSEEEVLREVELLSSIKHENIVRII 313
IG G ++ N + A+K+ E +++ + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-----SGDGIPQVY 71
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPPI 367
+ + A+V LL SL+ + +AI + +EY+H +
Sbjct: 72 YFGPCGKYNAMVLELLGPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---L 126
Query: 368 IHRDVKSSNILL----SENFHHPQLSDFGAA 394
I+RDVK N L+ ++ + DF A
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 42/206 (20%), Positives = 80/206 (38%), Gaps = 26/206 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVL-REVELLSSIK-HENIVRIIGYC 316
IG G ++Y TN + A+K+ ++ L E ++ ++ I + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWNERMDV------AIGVAKALEYLHHTCDPPIIHR 370
+ +V +LL SL+ + ++ + A + +E++H +HR
Sbjct: 73 VEGDYNVLVMDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 371 DVKSSNILL--SENFHHPQLSDFGAAM--VHHQSHQVSENVKPVNVVGTFGYL---APEY 423
D+K N L+ + + DFG A +HQ + N+ GT Y
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG 187
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGK 449
+ + D D+ S G VL+ + G
Sbjct: 188 IEQSRRD---DLESLGYVLMYFLRGS 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 28/147 (19%), Positives = 56/147 (38%), Gaps = 18/147 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-ENIVRIIGYCH 317
IG+G ++ TN ++ Q A+K + ++ E + I + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 318 SKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGVAKALEYLHHTCDPPIIHRD 371
+V +LL SL+ L + A + ++ +H +++RD
Sbjct: 77 EGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 131
Query: 372 VKSSNILL----SENFHHPQLSDFGAA 394
+K N L+ S+N + + DFG
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 64/233 (27%)
Query: 253 NFSPKMLIGQGGNSKVY----RTNHVDGQVAAVKVLK------------CTNWSEEEVLR 296
NF ++G G KV+ + H G++ A+KVLK T +E +VL
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR-TERQVLE 113
Query: 297 EVELLSSIKHENIVRIIGYC---HSKEMYAIVYNLLN-GSLKQYL-KQLKWNERMDVAIG 351
+ + +V + Y +K ++ ++ + +N G L +L ++ ++ E
Sbjct: 114 HIR-----QSPFLVTLH-YAFQTETK-LH-LILDYINGGELFTHLSQRERFTEHE----- 160
Query: 352 VAK--------ALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403
+ ALE+LH II+RD+K NILL N H L+DFG +
Sbjct: 161 -VQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN-GHVVLTDFGLS--------- 206
Query: 404 SENVKPVNVV-----GTFGYLAPEYMMYGKV--DEKIDVYSYGVVLLELITGK 449
E V GT Y+AP+ + G D+ +D +S GV++ EL+TG
Sbjct: 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 30/163 (18%), Positives = 54/163 (33%), Gaps = 33/163 (20%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELL---------------S 302
IG GG +Y + A V+K + E++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 303 SIKHENIVRIIGY----CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD------VAIGV 352
+ + I G + +V L L++ N + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG---QNGTFKKSTVLQLGIRM 160
Query: 353 AKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDFGAA 394
LEY+H +H D+K++N+LL +N L+D+G +
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 3e-06
Identities = 41/271 (15%), Positives = 70/271 (25%), Gaps = 71/271 (26%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTN---------------WSEEEVLREVELLSSI 304
IG+G +V++T VA +K++ E + +E+ LLS
Sbjct: 28 IGEGVFGEVFQTIADHTPVA-IKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 305 ---KHENIVRIIGYCHSKEMYA-------IVYNLLNGSLKQYL----------------- 337
+ E + + + Y YN GS
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 338 ---------KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388
K + + +L + HRD+ N+LL +
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLH 204
Query: 389 SDFGAAMVHHQSHQV---------SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYG 439
S + S + VV + + G D + D+Y
Sbjct: 205 YTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT-GDGDYQFDIYRLM 263
Query: 440 VVLLELITGKEAIQTNKANRESLVLWARSLL 470
G+ +N VLW L
Sbjct: 264 KKENNNRWGEYHPYSN-------VLWLHYLT 287
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 29/165 (17%), Positives = 56/165 (33%), Gaps = 36/165 (21%)
Query: 260 IGQGG---------NSKVYRTNHVDGQVAAVKV------LKCTNWSEEEVLREVEL---- 300
+ S + + Q ++K+ L + + +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 301 -LSSIKHENIVRIIGY-CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMD--------VAI 350
L S I +G+ H + +V L SL+ L + + VA
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALD---VSPKHVLSERSVLQVAC 166
Query: 351 GVAKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDFGAA 394
+ ALE+LH +H +V + NI + E+ L+ +G A
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 32/166 (19%), Positives = 64/166 (38%), Gaps = 36/166 (21%)
Query: 259 LIGQGGNSKVY------RTNHVDGQVAAVKVLKCTN------------WSEEEVLREVEL 300
IGQGG +Y + VKV N ++ E +++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 301 LSSIKHENIVRIIGY----CHSKEMYAIVYNLLNGSLKQYLKQLKWNER-------MDVA 349
+K+ + + G + K ++ + L++ + N + + ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYE---ANAKRFSRKTVLQLS 158
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDFGAA 394
+ + LEY+H +H D+K+SN+LL+ +N L D+G A
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 549 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 98.81 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 98.81 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 98.79 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 98.71 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 98.7 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 98.66 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 98.66 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 98.64 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 98.62 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 98.61 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 98.59 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 98.56 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 98.49 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.39 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 98.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.23 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 98.19 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 98.16 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 98.05 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.98 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 97.92 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 97.91 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 97.87 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.81 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 97.77 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.77 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 97.72 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.17 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.15 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.85 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.44 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.34 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.32 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.0 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.67 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.58 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.27 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.14 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=439.30 Aligned_cols=259 Identities=23% Similarity=0.366 Sum_probs=211.8
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+.|+..+.||+|+||+||+|.+ .+|+.||||+++.... ..+.+.+|+.+|+.++|||||+++++|.+++.+||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4688899999999999999987 5799999999975432 3456889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 -~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+++.. +++.+...++.||+.||.|||++ +||||||||+||||+.+ +.+||+|||+|+..... .
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~-----~ 224 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKE-----V 224 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECCSS-----S
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCC-CCEEEecCcCceecCCC-----C
Confidence 6799999965 78888999999999999999999 99999999999999999 79999999999764332 2
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
....+.+||+.|||||++.+..|+.++|||||||++|||++|++||....... .+.. +. .+ ..+.+.
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~----i~-~~-----~~~~~~-- 291 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKM----IR-DN-----LPPRLK-- 291 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH----HH-HS-----SCCCCS--
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHH----HH-cC-----CCCCCC--
Confidence 23446799999999999999999999999999999999999999997654321 1111 11 11 111111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHH
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELL 537 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~ 537 (549)
........+.+++..||..||.+|||+.|+++ |+||+.......+.
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~-----Hp~~~~~~~p~~l~ 337 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK-----HPFLAKAGPPASIV 337 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT-----CGGGGGCCCGGGTG
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc-----CHhhcCCCCCcccC
Confidence 11122345778889999999999999999998 99998765444333
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=436.04 Aligned_cols=260 Identities=22% Similarity=0.330 Sum_probs=211.6
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||++++. ....+.+.+|+++|+.++|||||++++++++++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999987 67999999999753 233467899999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++++ +++.+...++.||+.||.|||++ +||||||||+|||++.+ +++||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~-- 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNED-MHIQITDFGTAKVLSPE-- 185 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-SCEEECCCTTCEECCTT--
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCC-CCEEEEEcCCceecCCC--
Confidence 999 6799999965 77888999999999999999999 99999999999999999 79999999999765432
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|++||....... .+ ..+... +..
T Consensus 186 -~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~----~~i~~~-------~~~ 252 (311)
T 4aw0_A 186 -SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IF----AKIIKL-------EYD 252 (311)
T ss_dssp -TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----HHHHHT-------CCC
T ss_pred -CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH----HHHHcC-------CCC
Confidence 22234457799999999999999999999999999999999999999997654321 11 111111 112
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc-CCchhhhhhhHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ-EPDYWLKMKREKE 534 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~-~~~~w~~~~~~~~ 534 (549)
++..++ ..+.+++..||..||.+|||+.|++..-. ..|+||+..++..
T Consensus 253 ~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 253 FPEKFF----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp CCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred CCcccC----HHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 223333 35678889999999999999998632100 1389998876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=441.57 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=201.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||+++..... .+.+.+|+.+|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999987 57999999999866433 3568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 328 LL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 328 ~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|+ +|+|.+++.. +++.+...++.||+.||.|||++ +||||||||+||||+.+ +.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTT-CCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCC-CCEEEcccccceeecCC-
Confidence 99 6899999954 46677889999999999999999 99999999999999998 79999999999764331
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.....+.+||+.|||||++.+..|+.++|||||||+||||++|++||....... .+ ..+.... . +
T Consensus 179 ----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~----~~i~~~~-~-----~ 243 (350)
T 4b9d_A 179 ----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LV----LKIISGS-F-----P 243 (350)
T ss_dssp ----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH----HHHHHTC-C-----C
T ss_pred ----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HH----HHHHcCC-C-----C
Confidence 112346789999999999999999999999999999999999999998654322 11 1111111 0 1
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.....+ ...+.+++..||..||.+|||+.|+++ |+|+...
T Consensus 244 ~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~-----hp~~~~~ 283 (350)
T 4b9d_A 244 PVSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILE-----KGFIAKR 283 (350)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT-----SHHHHTT
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc-----CHHhhcC
Confidence 122223 345778889999999999999999998 8998654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=429.29 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=196.8
Q ss_pred CCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEc----CCeEEEEE
Q 008898 255 SPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS----KEMYAIVY 326 (549)
Q Consensus 255 ~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~~~lv~ 326 (549)
...+.||+|+||+||+|.+ .+++.||+|++...... .+.+.+|+.+|++|+|||||+++++|.+ ++.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4566799999999999987 56899999999755433 3568899999999999999999999864 45689999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCC--EEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
||+ +|+|.+++.+ +++.....++.||+.||.|||++ + ||||||||+||||+...+.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 999 6899999965 67888899999999999999998 6 999999999999985337899999999965322
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
....+.+||+.|||||++. ++|+.++|||||||+||||+||+.||......... ...+... . ..
T Consensus 185 ------~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~----~~~i~~~-~----~~ 248 (290)
T 3fpq_A 185 ------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----YRRVTSG-V----KP 248 (290)
T ss_dssp ------TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH----HHHHTTT-C----CC
T ss_pred ------CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH----HHHHHcC-C----CC
Confidence 2334678999999999886 46999999999999999999999999754432211 1111111 1 01
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+...... ...+.+++..||..||.+|||+.++++ |+||+.+
T Consensus 249 ~~~~~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~-----Hp~~~~~ 289 (290)
T 3fpq_A 249 ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN-----HAFFQEE 289 (290)
T ss_dssp GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGC--
T ss_pred CCCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc-----CccccCC
Confidence 1111222 234778889999999999999999998 9999754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=437.87 Aligned_cols=260 Identities=24% Similarity=0.276 Sum_probs=206.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
+.|...+.||+|+||.||+|.+ .+|+.||||+++.... ..+|+.+|+.++|||||++++++.+++.+||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 4577888999999999999987 5699999999986543 247999999999999999999999999999999999
Q ss_pred CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 ~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+++++ +++.+...++.||+.||.|||++ +||||||||+||||+.+..++||+|||+|+...........
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 6899999965 78889999999999999999999 99999999999999988336999999999876543222222
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.....++||+.|||||++.+..|+.++|||||||+||||++|++||........ +.... ... .....
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~----~~~--------~~~~~ 277 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIA----SEP--------PPIRE 277 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHH----HSC--------CGGGG
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHH----cCC--------CCchh
Confidence 233457899999999999999999999999999999999999999986554321 11111 110 00011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC--------Cchhhhhhh
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE--------PDYWLKMKR 531 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~--------~~~w~~~~~ 531 (549)
++......+.+++..||..||.+|||+.|+++.|.. .|+|+....
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 223344567788899999999999999999887642 468876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=423.90 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=194.4
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||++++... ....+.+|+.+|+.++||||+++++++.+++.+++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999987 5799999999975432 2356889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 327 NLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 327 e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
||++|+|.+++.+ +++.+...++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~---- 164 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTD---- 164 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT-CCEEECCSSCC---------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCC-CCEEEeecCCCeecCC----
Confidence 9999999999964 78889999999999999999999 99999999999999998 7999999999965432
Q ss_pred ccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.....+.+||+.|||||++.+..| +.++|||||||++|||++|+.||...... + + ...+... . ..
T Consensus 165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~-~---~~~i~~~-~------~~ 230 (275)
T 3hyh_A 165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-V-L---FKNISNG-V------YT 230 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H-H---HHHHHHT-C------CC
T ss_pred --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-H-H---HHHHHcC-C------CC
Confidence 223346789999999999998886 58999999999999999999999765321 1 1 1111111 1 11
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
++..++ ..+.+++.+||+.||.+|||+.|+++ |+||+.
T Consensus 231 ~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~-----hpw~k~ 268 (275)
T 3hyh_A 231 LPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ-----DDWFKV 268 (275)
T ss_dssp CCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH-----CHHHHT
T ss_pred CCCCCC----HHHHHHHHHHccCChhHCcCHHHHHc-----Cccccc
Confidence 222233 45677889999999999999999999 999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=444.59 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=211.7
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+.|+..+.||+|+||.||+|.+ .+|+.||||+++.... ..+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5689999999999999999987 5799999999976543 3456889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 -~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.++++. +++.++..++.||+.||.|||++ +||||||||+||||+.+ +.+||+|||+|+..... .
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~-----~ 301 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKE-----V 301 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTT-CCEEECCCTTCEECCSS-----C
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCC-CCEEEecCccceECCCC-----C
Confidence 6799999965 78888999999999999999999 99999999999999999 79999999999764332 2
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
....+.+||+.|||||++.+..|+.++|||||||++|||++|++||....... .+.. +. .+ ..+.+.
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~----i~-~~-----~~~~~~-- 368 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKM----IR-DN-----LPPRLK-- 368 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH----HH-HS-----CCCCCS--
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHH----HH-cC-----CCCCCc--
Confidence 23456799999999999999999999999999999999999999997654321 1111 11 11 111111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
........+.+++..||..||.+|||+.|+++ |+||+.......+
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~-----Hp~~~~~~~p~~l 413 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK-----HPFLAKAGPPASI 413 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT-----CGGGGGCCCGGGT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc-----CHHhcCCCCCccc
Confidence 01122345677889999999999999999998 9999876544433
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=433.80 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=201.9
Q ss_pred cCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|.+.+.||+|+||+||+|.+. ++..||||+++.... ..+++.+|+++|++++|||||+++|+|.+++.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46888899999999999999763 478999999976543 24578999999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH----------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceE
Q 008898 325 VYNLL-NGSLKQYLKQ----------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~k 387 (549)
||||+ +|+|.++|.. +++.+++.++.||+.||.|||++ +||||||||+||||+.+ +.+|
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~-~~~K 168 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN-LLVK 168 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC-CcEE
Confidence 99999 7899999953 67889999999999999999999 99999999999999999 6899
Q ss_pred EeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHH
Q 008898 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWA 466 (549)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~ 466 (549)
|+|||+|+........ .......||+.|||||++.++.|+.++|||||||+||||+| |+.||......+ +.
T Consensus 169 i~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~--- 240 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VI--- 240 (299)
T ss_dssp ECCCSCHHHHTGGGCE---EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH---
T ss_pred ECCcccceecCCCCce---eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH---
Confidence 9999999765432211 12234579999999999999999999999999999999999 899998754322 11
Q ss_pred HHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 467 RSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 467 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+. .+.. + ..+..++..+.+++..||+.||.+|||+++|++.|+.
T Consensus 241 ~~i~-~~~~-----~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 241 ECIT-QGRV-----L----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHH-HTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH-cCCC-----C----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111 1111 1 1122344567889999999999999999999887653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=432.88 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=202.9
Q ss_pred CCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
+++..+.||+|+||+||+|.+ .+++.||||+++... ...++|.+|+.++++++|||||+++|+|.+++.+++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 456677899999999999975 246899999997543 234779999999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC
Q 008898 325 VYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH 384 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 384 (549)
||||+ +|+|.++|.. +++.+++.++.||+.||.|||++ +||||||||+||||+++ +
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~-~ 182 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK-L 182 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-G
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC-C
Confidence 99999 7899999942 67888999999999999999999 99999999999999999 6
Q ss_pred ceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHH
Q 008898 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLV 463 (549)
Q Consensus 385 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~ 463 (549)
.+||+|||+|+....... .......+||+.|||||++.++.|+.++|||||||+||||+| |+.||......+ +.
T Consensus 183 ~~Ki~DFGlar~~~~~~~---~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~ 257 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADY---YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VV 257 (308)
T ss_dssp CEEECCSCCBCGGGGGGC---BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HH
T ss_pred CEEECCcccceeccCCCc---eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence 899999999976543221 122345689999999999999999999999999999999998 899997654321 21
Q ss_pred HHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 464 LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 464 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+.. +.. .+.+.+++..+.+++..||+.||.+||||++|++.|+.
T Consensus 258 ---~~i~~-~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 258 ---EMIRN-RQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp ---HHHHT-TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---HHHHc-CCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111 111 11233455678889999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=434.73 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=196.8
Q ss_pred cCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|...+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777889999999999999753 478999999976543 23578999999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc
Q 008898 325 VYNLL-NGSLKQYLKQ------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 385 (549)
||||+ +|+|.+++.. +++.+++.++.||+.||.|||++ +||||||||+||||+++ +.
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~-~~ 196 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG-LV 196 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT-TE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC-Cc
Confidence 99999 7899999853 67888999999999999999999 99999999999999999 69
Q ss_pred eEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHH
Q 008898 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVL 464 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~ 464 (549)
+||+|||+|+....... .......+||+.|||||++.+..|+.++|||||||+||||+| |+.||......+ +.
T Consensus 197 ~Ki~DFGla~~~~~~~~---~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~- 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AI- 270 (329)
T ss_dssp EEECCCC-------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HH-
T ss_pred EEEcccccceeccCCCc---ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HH-
Confidence 99999999976543221 122235679999999999999999999999999999999999 899998654322 11
Q ss_pred HHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 465 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+.. +. .+.. +..++..+.+++..||+.||.+|||+.||++.|+.
T Consensus 271 --~~i~~-g~-----~~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 271 --DCITQ-GR-----ELER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp --HHHHH-TC-----CCCC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred --HHHHc-CC-----CCCC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 11111 11 1111 22334567888999999999999999999997754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=426.55 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=196.6
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|...+.||+|+||+||+|.+.+ .+|||+++..... .+.|.+|+.+|++++|||||+++|+|.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567888999999999999998643 5899999765433 3568899999999999999999999865 568899999
Q ss_pred c-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 329 L-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 329 ~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+ +|+|.+++.. +++.++..++.||+.||.|||++ +||||||||+||||+++ +.+||+|||+|+.....
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~--- 185 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRW--- 185 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETT-EEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCC-CcEEEeeccCceecccC---
Confidence 9 7899999953 78899999999999999999999 99999999999999999 69999999999765432
Q ss_pred ccCccccccccCCcccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||........ +... ... ....
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~----~~~----~~~~ 256 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFM----VGR----GYAS 256 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHH----HHT----TCCC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHH----Hhc----CCCC
Confidence 12223346789999999999864 4689999999999999999999999976543221 1111 111 1112
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
|.+ .....+++..+.+++..||+.||.+|||+.+|++.|+.
T Consensus 257 p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 257 PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 221 12233445678889999999999999999999987754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=426.71 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=202.2
Q ss_pred cCCCCCceEcccCceEEEEEEec----CCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~----~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|++.+.||+|+||+||+|.+. +++.||||+++.... ....+.+|+.+|++++|||||++++++++++.+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999762 478999999975432 23467889999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
||||+ +|+|.+++.+ +++.+...++.||+.||.|||++ +||||||||+|||++.+ +++||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTT-SCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCC-CCEEecccccceeccCC
Confidence 99999 6899999965 77888999999999999999999 99999999999999999 79999999999754321
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||....... .+ ..+... .
T Consensus 180 -----~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~----~~i~~~-------~ 242 (304)
T 3ubd_A 180 -----EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TM----TMILKA-------K 242 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----HHHHHC-------C
T ss_pred -----CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HH----HHHHcC-------C
Confidence 223346789999999999999999999999999999999999999998654322 11 111111 1
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHHHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
...+..++ ..+.+++..||..||.+||| ++|+++ |+||+..++..-
T Consensus 243 ~~~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~-----Hp~f~~idw~~l 293 (304)
T 3ubd_A 243 LGMPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR-----HSFFSTIDWNKL 293 (304)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT-----SGGGTTCCHHHH
T ss_pred CCCCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc-----CccccCCCHHHH
Confidence 11222333 45677889999999999998 578887 999998765543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=415.05 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=199.1
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----eEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE----MYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----~~~lv~e 327 (549)
.+|...+.||+|+||+||+|.+ +|+.||||+++...........|+.++.+++||||++++++|.+++ .++||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 3567788999999999999987 6899999999765432223345666667899999999999997653 6899999
Q ss_pred cc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhC-----CCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 328 LL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHT-----CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 328 ~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
|+ +|+|.++++. +++..+..++.|++.||.|||+. +.++||||||||+||||+.+ +.+||+|||+|+....
T Consensus 82 y~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEEET
T ss_pred CCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCCCCccccC
Confidence 99 7899999975 78889999999999999999976 34589999999999999999 6899999999976544
Q ss_pred ccccccCccccccccCCccccccccccC------CCCchhhHHHHHHHHHHHHcCCCCCCCcccc----------hhhHH
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYG------KVDEKIDVYSYGVVLLELITGKEAIQTNKAN----------RESLV 463 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvil~elltG~~p~~~~~~~----------~~~l~ 463 (549)
.... ........+||+.|||||++.+. .++.++|||||||+||||+||.+|+...... .....
T Consensus 161 ~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 161 ATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTE-ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCc-eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 3211 12223356899999999998754 3678999999999999999998877543221 11122
Q ss_pred HHHHHhhcccccccccCCcccccC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 464 LWARSLLSSGLCERLIDPQLNEEY-NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 464 ~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+.... .....+|.++..+ +.+.+..+.+++..||+.||.+||||.+|++.|++
T Consensus 240 ~~~~~~-----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 240 EMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHH-----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHH-----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 222221 1222334443322 34667889999999999999999999999998854
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=413.97 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=188.5
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--------
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKE-------- 320 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-------- 320 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||+++..... .+.+.+|+.+|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4689999999999999999987 57999999999765432 356889999999999999999999986543
Q ss_pred ----eEEEEEecc-CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEe
Q 008898 321 ----MYAIVYNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389 (549)
Q Consensus 321 ----~~~lv~e~~-~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~ 389 (549)
.++++|||+ +|+|.+++.. ..+...+.++.||++||.|||++ +||||||||+|||++.+ +.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~-~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD-DVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCC-CcEEEc
Confidence 378999999 7899999964 23344678999999999999999 99999999999999998 799999
Q ss_pred eeccccccccccccc-------cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhH
Q 008898 390 DFGAAMVHHQSHQVS-------ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462 (549)
Q Consensus 390 DFGla~~~~~~~~~~-------~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l 462 (549)
|||+|+......... ......+.+||+.|||||++.+..|+.++|||||||++|||++ ||...... .
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---V 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---H
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---H
Confidence 999997655432111 1122345689999999999999999999999999999999996 77543221 1
Q ss_pred HHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 463 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
..+. ... +...+. ..........+++..||+.||.+|||+.++++ |+||+....+
T Consensus 235 ~~~~-~~~---------~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~-----h~~~~~~~~p 289 (299)
T 4g31_A 235 RTLT-DVR---------NLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE-----NAVFEDLDFP 289 (299)
T ss_dssp HHHH-HHH---------TTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT-----SGGGCCC---
T ss_pred HHHH-HHh---------cCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc-----CHhhCCCCCC
Confidence 1111 110 011111 11222334567899999999999999999998 8999876544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=418.33 Aligned_cols=274 Identities=24% Similarity=0.271 Sum_probs=210.2
Q ss_pred HhhhcCCCCCceEcccCceEEEEEEec----CCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeE
Q 008898 248 CHLTHNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 248 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~----~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 322 (549)
..+.++|++.+.||+|+||+||+|.+. +++.||+|.+.... ....+.+|+++|+.+ +||||+++++++.+++.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 346788999999999999999999752 47899999987543 346788999999988 699999999999999999
Q ss_pred EEEEecc-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
++||||+ +|+|.++++.+++.+...++.||+.||.|||++ |||||||||+|||++.+.+.+||+|||+|+......
T Consensus 96 ~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999 689999999999999999999999999999999 999999999999999876799999999997544321
Q ss_pred cc-----------------------ccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCccc
Q 008898 402 QV-----------------------SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (549)
Q Consensus 402 ~~-----------------------~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~ 457 (549)
.. .......+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 10 111223456899999999999876 489999999999999999999999976655
Q ss_pred chhhHHHHHHHhhccc-----------ccc-------------------cccCCcccc---------cCCHHHHHHHHHH
Q 008898 458 NRESLVLWARSLLSSG-----------LCE-------------------RLIDPQLNE---------EYNREEIEIVMCA 498 (549)
Q Consensus 458 ~~~~l~~~~~~~~~~~-----------~~~-------------------~~~d~~l~~---------~~~~~~~~~l~~l 498 (549)
+.+.+........... ... ....|.... .......+...++
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 4444433322111000 000 000000000 0001122456788
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 499 ARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 499 i~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+.+||..||.+|||++|+++ |+||+..
T Consensus 333 l~~lL~~dP~~R~ta~eaL~-----Hp~f~~i 359 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALL-----HPFFKDM 359 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHT-----SGGGTTC
T ss_pred HHHHCcCChhHCcCHHHHhc-----CcccCCC
Confidence 99999999999999999999 9999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=421.44 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=201.3
Q ss_pred hcCCCCCceEcccCceEEEEEEecC------CcEEEEEEeecCCcC--HHHHHHHHHHHhcCCC-CCeeeEEEEEEc-CC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVD------GQVAAVKVLKCTNWS--EEEVLREVELLSSIKH-ENIVRIIGYCHS-KE 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~------g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h-~nIv~l~~~~~~-~~ 320 (549)
.++|++.+.||+|+||+||+|.+.. ++.||||.++..... .+.+.+|+.+|+++.| ||||+++|+|.+ ++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 4678899999999999999997632 368999999765432 3568899999999965 999999999965 46
Q ss_pred eEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~ 380 (549)
.+++||||| +|+|.++|+. +++.++..++.||++||.|||++ +||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence 789999999 7899999964 57788899999999999999999 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccch
Q 008898 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANR 459 (549)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~ 459 (549)
++ +.+||+|||+|+...... ......+.+||+.|||||++.++.|+.++|||||||+||||+| |+.||.......
T Consensus 220 ~~-~~vKi~DFGlar~~~~~~---~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 220 EK-NVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp GG-GCEEECCCGGGSCTTTCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred CC-CCEEECcchhhhhcccCC---CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99 689999999997654321 1223345689999999999999999999999999999999998 999998755433
Q ss_pred hhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 460 ESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 460 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
..... + ..+. .+..+. .++..+.+++..||+.||.+|||+.+|++.|+
T Consensus 296 ~~~~~----i-~~g~-----~~~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 296 EFCRR----L-KEGT-----RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp HHHHH----H-HHTC-----CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHH----H-HcCC-----CCCCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 22111 1 1111 111222 23345778889999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=422.69 Aligned_cols=271 Identities=23% Similarity=0.289 Sum_probs=207.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEc------CC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHS------KE 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~------~~ 320 (549)
.++|++.+.||+|+||+||+|.+ .+|+.||||+++...... +.+.+|+.+|+.|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46799999999999999999987 679999999997654332 457899999999999999999998753 36
Q ss_pred eEEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 321 MYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
.+|+||||++|+|.+++.. +++..+..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+..
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNEN-CELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-CCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCC-CCEEEeecceeeec
Confidence 7899999999999999953 78889999999999999999999 99999999999999998 79999999999765
Q ss_pred ccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc--
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL-- 474 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-- 474 (549)
.... ........+.+||+.|||||++.+. .|+.++||||+||++|||++|++||...... +.+............
T Consensus 209 ~~~~-~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 209 CTSP-AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp --------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred ccCc-cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHH
Confidence 4322 1122334567999999999998875 4699999999999999999999999876532 222222221111000
Q ss_pred ccc-----------ccCCcccc---cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 475 CER-----------LIDPQLNE---EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 475 ~~~-----------~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
... ...+.... ...+.....+.+++.+||..||.+|||+.|+++ |+||+....
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~-----Hp~f~~~~~ 353 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR-----HPFLAKYHD 353 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT-----SGGGTTTCC
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc-----CHhhCcCCC
Confidence 000 00000000 000112345678899999999999999999998 999987544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=419.80 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=208.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHH---HHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLRE---VELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E---~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
++|.+.++||+|+||+||+|.+ .+|+.||||++++.. .....+.+| +.+++.++|||||+++++|++.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999987 569999999997532 222334444 66777889999999999999999999
Q ss_pred EEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 324 IVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+||||+ +|+|.+++.+ +++.....++.||+.||.|||++ +||||||||+||||+.+ |++||+|||+|+....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~-G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEH-GHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCC-CCEEecccceeeecCC
Confidence 999999 7899999965 78888999999999999999999 99999999999999999 7999999999976432
Q ss_pred ccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
....+.+||+.|||||++.. ..|+.++|||||||+||||++|++||......... ........
T Consensus 345 -------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~~i~~------- 408 (689)
T 3v5w_A 345 -------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT------- 408 (689)
T ss_dssp -------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHHHHHH-------
T ss_pred -------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhhcC-------
Confidence 22346799999999999975 57999999999999999999999999765432211 11111111
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
....++..++ ..+.+++..||..||.+|++ +.||++ |+||+..++..-..+
T Consensus 409 ~~~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~-----HpfF~~idW~~l~~~ 464 (689)
T 3v5w_A 409 MAVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE-----SPFFRSLDWQMVFLQ 464 (689)
T ss_dssp CCCCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT-----SGGGTTCCHHHHHTT
T ss_pred CCCCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc-----CccccCCCHHHHHcC
Confidence 0112223333 45677889999999999998 789988 999999988776544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=417.35 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=208.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++|.+.+.||+|+||.||+|.+ .+|+.||+|+++..... .+.+.+|+.+|+.|+||||+++++++.+++.++++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999987 57999999999765533 35688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC-CCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +|+|.+++. .+++.+...++.||+.||.|||++ +|+||||||+|||++.+ .+.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--- 309 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 309 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC---
Confidence 9 679999984 378888999999999999999999 99999999999999854 36899999999976543
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......+||+.|||||++.+..|+.++|||||||+||||++|++||....... .+. .+.... ....+.
T Consensus 310 ---~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~----~i~~~~---~~~~~~ 378 (573)
T 3uto_A 310 ---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLR----NVKSCD---WNMDDS 378 (573)
T ss_dssp ---TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH----HHHTTC---CCCCSG
T ss_pred ---CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHH----HHHhCC---CCCCcc
Confidence 233446789999999999999999999999999999999999999998654322 111 111110 001111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
....++ ..+.+++..||..||.+|||+.|+++ |+||+..
T Consensus 379 ~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~-----Hpw~~~~ 417 (573)
T 3uto_A 379 AFSGIS----EDGKDFIRKLLLADPNTRMTIHQALE-----HPWLTPG 417 (573)
T ss_dssp GGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH-----STTTSCC
T ss_pred cccCCC----HHHHHHHHHHccCChhHCcCHHHHhc-----CcCcCCC
Confidence 122233 45677889999999999999999999 8998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=380.73 Aligned_cols=282 Identities=39% Similarity=0.669 Sum_probs=244.0
Q ss_pred CccccCHHHHHhhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEE
Q 008898 238 SSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGY 315 (549)
Q Consensus 238 ~~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~ 315 (549)
....|+..++....++|...+.||+|+||.||+|...+|+.||||+++.... ....+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4567899999999999999999999999999999888899999999975432 22368899999999999999999999
Q ss_pred EEcCCeEEEEEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceE
Q 008898 316 CHSKEMYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (549)
Q Consensus 316 ~~~~~~~~lv~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~k 387 (549)
+.+.+..+++|||+ +|+|.+++.. +++..+..++.|++.||.|||+.+..+|+||||||+|||++.+ +.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~k 174 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAV 174 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEE
Confidence 99999999999999 6799999964 7788899999999999999999877799999999999999998 6899
Q ss_pred EeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcc---cchhhHHH
Q 008898 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK---ANRESLVL 464 (549)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~---~~~~~l~~ 464 (549)
|+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ........
T Consensus 175 l~Dfg~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 175 VGDFGLAKLMDYKD----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp ECCCSSCEECCSSS----SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred eccCccccccCccc----ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 99999997654321 122334569999999999999999999999999999999999999996322 23334566
Q ss_pred HHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 465 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
|............+.+..+...+.......+.+++..||+.||.+|||+.+|++.|++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 777777777788888888888899999999999999999999999999999999998765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=376.53 Aligned_cols=274 Identities=36% Similarity=0.606 Sum_probs=232.9
Q ss_pred cCHHHHHhhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC
Q 008898 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKE 320 (549)
Q Consensus 242 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 320 (549)
++..++..++++|...+.||+|+||.||+|.+.+|+.+|+|++..... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 344455667889999999999999999999988899999999876543 3467889999999999999999999999999
Q ss_pred eEEEEEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeec
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFG 392 (549)
.++++|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDEN-FVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTT-CCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCC-CCEEEeecc
Confidence 999999999 6799998842 67888999999999999999999 99999999999999998 689999999
Q ss_pred cccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCccc-chhhHHHHHHHhhc
Q 008898 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA-NRESLVLWARSLLS 471 (549)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~-~~~~l~~~~~~~~~ 471 (549)
++....... .........||+.|+|||++.++.++.++|||||||++|||++|+.||..... .......|......
T Consensus 185 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 185 ISKKGTELD---QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp TCEECSSSS---CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ccccccccc---ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 986543211 11222345689999999999999999999999999999999999999986554 33345556655566
Q ss_pred ccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 472 SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 472 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+.....+++.+......+....+.+++..||..||.+|||+.++++.|+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 666777888888888889999999999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=361.04 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=209.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++|...+.||+|+||.||+|.+ .+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++..++.+++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999986 679999999997544 3356688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 329 L-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 329 ~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~----- 169 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE----- 169 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECCST-----
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCC-CCEEEeeCCCceecCCc-----
Confidence 9 7899999976 77888899999999999999999 99999999999999998 68999999998654432
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..... + ... ...
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~----~-~~~---~~~-- 238 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATN----G-TPE---LQN-- 238 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHH----C-SCC---CSC--
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhC----C-CCC---CCC--
Confidence 122345679999999999999999999999999999999999999997655422211 11100 0 000 111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
+......+.+++..||..||.+|||+.++++ |+|++...
T Consensus 239 --~~~~~~~~~~li~~~l~~dp~~Rps~~ell~-----h~~~~~~~ 277 (297)
T 3fxz_A 239 --PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ-----HQFLKIAK 277 (297)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT-----CGGGGGCC
T ss_pred --ccccCHHHHHHHHHHccCChhHCcCHHHHhh-----ChhhcccC
Confidence 1223355778899999999999999999998 89997543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=366.64 Aligned_cols=267 Identities=21% Similarity=0.314 Sum_probs=206.8
Q ss_pred hhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
+.++|+..+.||+|+||.||+|.+.+|+.+|+|+++..... ...+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35689999999999999999999888999999999754322 356889999999999999999999999999999999
Q ss_pred eccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+.|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~-- 172 (311)
T 3niz_A 99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSD-GALKLADFGLARAFGIP-- 172 (311)
T ss_dssp ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEETTSC--
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCC-CCEEEccCcCceecCCC--
Confidence 9999999998854 67788899999999999999999 99999999999999998 68999999999654321
Q ss_pred cccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc--cc---
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL--CE--- 476 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~~--- 476 (549)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +............ ..
T Consensus 173 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 ---VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp ---CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGT
T ss_pred ---cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhh
Confidence 112234578999999999876 4689999999999999999999999986654322 2222221111100 00
Q ss_pred ----------cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 477 ----------RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 477 ----------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
...+..............+.+++..||..||.+|||+.++++ |+||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----hp~f~~~~ 308 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN-----HPYFKDLD 308 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT-----SGGGTTSC
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc-----CcccccCC
Confidence 000000000011112345778999999999999999999998 99998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=367.20 Aligned_cols=256 Identities=20% Similarity=0.288 Sum_probs=210.8
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...+.||+|+||+||++.+ .+|+.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5789999999999999999987 46999999999753 233467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||++.....
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~--- 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS--- 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC---
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCC-CCEEEeeccchhhccc---
Confidence 999 6799999864 67888899999999999999999 99999999999999998 7999999999864322
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ...+... ...
T Consensus 158 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~---~~~i~~~-------~~~ 223 (337)
T 1o6l_A 158 --DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--L---FELILME-------EIR 223 (337)
T ss_dssp --TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHHC-------CCC
T ss_pred --CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--H---HHHHHcC-------CCC
Confidence 2223446789999999999999999999999999999999999999997654321 1 1111111 011
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEELL 537 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~~ 537 (549)
++.. ....+.+++..||..||.+|| ++.++++ |+||+...+.....
T Consensus 224 ~p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~-----h~~f~~~~~~~~~~ 274 (337)
T 1o6l_A 224 FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME-----HRFFLSINWQDVVQ 274 (337)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT-----SGGGTTCCHHHHHT
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc-----CCCcCCCCHHHHHh
Confidence 2222 234577888999999999999 8999998 99998877665543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=370.76 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=210.0
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
+.++|.+.+.||+|+||.||++.+ .+|+.+|+|+++.... ..+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 457899999999999999999987 5699999999976432 24678999999999999999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC---ceEEeeeccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH---HPQLSDFGAA 394 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~~kL~DFGla 394 (549)
+++||||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+.. .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999 7899999954 78889999999999999999999 9999999999999987732 7999999999
Q ss_pred cccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+. .+.....
T Consensus 167 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~----~i~~~~~ 235 (361)
T 2yab_A 167 HEIEDG------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA----NITAVSY 235 (361)
T ss_dssp EECCTT------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH----HHHTTCC
T ss_pred eEcCCC------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHH----HHHhcCC
Confidence 664332 22345679999999999999999999999999999999999999997654321 111 1111100
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
-.++.... .....+.+++..||..||.+|||+.++++ |+|+.......
T Consensus 236 ---~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~-----hp~~~~~~~~~ 283 (361)
T 2yab_A 236 ---DFDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR-----HPWITPVDTQQ 283 (361)
T ss_dssp ---CCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT-----STTTSCSSHHH
T ss_pred ---CCCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc-----CcCcCCCchhh
Confidence 00111111 12345778899999999999999999998 99998655443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=367.16 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=207.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.++|...+.||+|+||.||+|.+ .+|+.||||++...... .+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999988 67999999999765433 345789999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~--- 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTV--- 166 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECSTTCCGGGSS---
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCC-CCEEEeeccCceecCC---
Confidence 999 7799999854 77888899999999999999999 99999999999999998 6899999999865432
Q ss_pred cccCccccccccCCccccccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVD-EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~-~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... + ........ .
T Consensus 167 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~---~~~i~~~~-------~ 231 (328)
T 3fe3_A 167 ---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--L---RERVLRGK-------Y 231 (328)
T ss_dssp ---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHHCC-------C
T ss_pred ---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--H---HHHHHhCC-------C
Confidence 2233466899999999999988875 89999999999999999999997654321 1 11111110 1
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
..+... ...+.+++..||..||.+|||+.++++ |+|+.....
T Consensus 232 ~~p~~~----s~~~~~li~~~L~~dP~~R~t~~eil~-----h~~~~~~~~ 273 (328)
T 3fe3_A 232 RIPFYM----STDCENLLKRFLVLNPIKRGTLEQIMK-----DRWINAGHE 273 (328)
T ss_dssp CCCTTS----CHHHHHHHHHHCCSSTTTSCCHHHHTT-----CTTTTTTCT
T ss_pred CCCCCC----CHHHHHHHHHHCCCChhHCcCHHHHhc-----CHhhcCCCc
Confidence 111222 345677889999999999999999998 899976543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=356.97 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=208.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|+..+.||+|+||.||+|.+ .+|+.||+|+++..... ...+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688999999999999999987 56899999999755432 3568899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~--- 154 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIP--- 154 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECCSC---
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEeecccceecCCc---
Confidence 999998888753 77888999999999999999999 99999999999999998 68999999999654321
Q ss_pred ccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc-----ccc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL-----CER 477 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----~~~ 477 (549)
........||+.|+|||++.+.. ++.++|||||||++|||++|..||.......+.+............ ...
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 12223457899999999998766 7999999999999999999988875554444433333322211110 000
Q ss_pred ccCC---------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 478 LIDP---------QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 478 ~~d~---------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..+. .............+.+++..||+.||.+|||+.|+++ |+||....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~-----hp~f~~~~ 290 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ-----HPYFSDFC 290 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGTTC-
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc-----CcccccCC
Confidence 0000 0001111233456778899999999999999999999 99998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=358.31 Aligned_cols=264 Identities=23% Similarity=0.356 Sum_probs=203.7
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|...+.||+|+||.||+|.+.+|+.+|+|+++..... ...+.+|+.+++.++||||+++++++.+++.++++||+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468889999999999999999888999999999755432 36788999999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~---- 153 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINRE-GELKIADFGLARAFGIP---- 153 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC-----
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CCEEEeECccccccCcc----
Confidence 99999999864 67788899999999999999999 99999999999999998 68999999998654321
Q ss_pred cCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc-----ccc-
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL-----CER- 477 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----~~~- 477 (549)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+............ ...
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred -ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhcc
Confidence 1122345789999999998764 58999999999999999999999998654322 22222211111000 000
Q ss_pred -ccCCcc-------cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 478 -LIDPQL-------NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 478 -~~d~~l-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
..++.. ...+.......+.+++..||..||.+|||+.++++ |+||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-----hp~f~~~ 287 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE-----HAYFKEN 287 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SGGGGC-
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc-----Ccchhhc
Confidence 001110 01111223456778999999999999999999998 8999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=365.52 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=208.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+.++|.+.+.||+|+||.||++.+ .+++.+|+|+++........+.+|+.+++.++||||+++++++.+.+.++++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 457899999999999999999987 5689999999987665566788999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec--CCCceEEeeecccccccccc
Q 008898 329 L-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE--NFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 329 ~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~~kL~DFGla~~~~~~~ 401 (549)
+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++. + +.+||+|||++......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~-~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRS-STIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSC-CCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCC-CCEEEEECCCCeECCCC-
Confidence 9 5799999953 67888999999999999999999 9999999999999986 4 68999999999764332
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+. .+..... ..++
T Consensus 158 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~----~i~~~~~---~~~~ 224 (321)
T 1tki_A 158 -----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIE----NIMNAEY---TFDE 224 (321)
T ss_dssp -----CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHH----HHHHTCC---CCCH
T ss_pred -----CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHH----HHHcCCC---CCCh
Confidence 22345679999999999998889999999999999999999999997654321 111 1111100 0000
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.... .....+.+++..||..||.+|||+.++++ |+|++...
T Consensus 225 ~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~-----hp~~~~~~ 265 (321)
T 1tki_A 225 EAFK----EISIEAMDFVDRLLVKERKSRMTASEALQ-----HPWLKQKI 265 (321)
T ss_dssp HHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH-----SHHHHSCG
T ss_pred hhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc-----ChhhccCc
Confidence 0011 12346778899999999999999999999 99997653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=362.40 Aligned_cols=257 Identities=24% Similarity=0.371 Sum_probs=208.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
.++|...+.||+|+||.||++.+ .+|+.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45789999999999999999987 5699999999975432 356789999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC----ceEEeeeccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH----HPQLSDFGAA 394 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~----~~kL~DFGla 394 (549)
++||||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ + .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR-NVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCS-SSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecC-CCCCCCEEEEECCCC
Confidence 9999999 6799999954 78889999999999999999999 99999999999999877 4 7999999999
Q ss_pred cccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+......
T Consensus 166 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~------ 232 (326)
T 2y0a_A 166 HKIDFG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAV------ 232 (326)
T ss_dssp EECCTT------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHT------
T ss_pred eECCCC------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHhc------
Confidence 764322 12235679999999999999999999999999999999999999997654321 11111100
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.......+.......+.+++..||..||.+|||+.++++ |+||+......
T Consensus 233 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-----hp~~~~~~~~~ 282 (326)
T 2y0a_A 233 -----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ-----HPWIKPKDTQQ 282 (326)
T ss_dssp -----CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH-----STTTSCCSHHH
T ss_pred -----CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc-----CCCccCCcchh
Confidence 000111111122345778899999999999999999999 89998765544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=352.62 Aligned_cols=274 Identities=32% Similarity=0.545 Sum_probs=222.8
Q ss_pred CccccCHHHHHhhhcCCCCC------ceEcccCceEEEEEEecCCcEEEEEEeecCC-----cCHHHHHHHHHHHhcCCC
Q 008898 238 SSRRFTSQELCHLTHNFSPK------MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-----WSEEEVLREVELLSSIKH 306 (549)
Q Consensus 238 ~~~~~~~~el~~~~~~f~~~------~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~-----~~~~~~~~E~~il~~l~h 306 (549)
....|++.++..++++|... +.||+|+||.||+|.. +++.+|+|++.... ...+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999988 8999999999999986 68899999986432 123568899999999999
Q ss_pred CCeeeEEEEEEcCCeEEEEEecc-CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE
Q 008898 307 ENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (549)
Q Consensus 307 ~nIv~l~~~~~~~~~~~lv~e~~-~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl 379 (549)
|||+++++++.+.+.++++|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 99999999999999999999999 7899999963 67788899999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccch
Q 008898 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR 459 (549)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~ 459 (549)
+.+ +.++|+|||++....... .........||+.|+|||.+.+ .++.++|||||||++|+|++|.+||.......
T Consensus 167 ~~~-~~~kl~Dfg~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 167 DEA-FTAKISDFGLARASEKFA---QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp CTT-CCEEECCCTTCEECCSCS---SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred cCC-CcEEEeeccccccccccc---ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 998 689999999986543321 1112234579999999998764 58999999999999999999999998655432
Q ss_pred hhHHHHHHHhh-cccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 460 ESLVLWARSLL-SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 460 ~~l~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. +..+..... ....+...+++.+ ..........+.+++..||..||.+|||+.++++.|++
T Consensus 242 ~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 242 L-LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp B-TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred H-HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1 222222222 2223344444444 33467778889999999999999999999999998864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=370.92 Aligned_cols=272 Identities=24% Similarity=0.310 Sum_probs=212.5
Q ss_pred ccccCHHHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-----CCCeeeE
Q 008898 239 SRRFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----HENIVRI 312 (549)
Q Consensus 239 ~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-----h~nIv~l 312 (549)
...++.++...+.++|.+.+.||+|+||.||+|.+ .+++.||||+++........+..|+.+++.+. ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34456666667788999999999999999999987 56899999999865544566788999999986 9999999
Q ss_pred EEEEEcCCeEEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec------
Q 008898 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE------ 381 (549)
Q Consensus 313 ~~~~~~~~~~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~------ 381 (549)
++++...+.+++|||+++|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred cceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence 999999999999999999999999965 67788899999999999999999 9999999999999975
Q ss_pred -------------------CCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHH
Q 008898 382 -------------------NFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVL 442 (549)
Q Consensus 382 -------------------~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil 442 (549)
+ +.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~-~~~kl~DFG~a~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKS-TGIKLIDFGCATFKSD--------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp EEEEECTTTCCEEEEEEESC-CCEEECCCTTCEETTS--------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccchhcccccccccccccCC-CCEEEEeccCceecCC--------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 4 6899999999965332 12355799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCcccchhhHHHHHHHhhc-----------ccccccccCCcc----cccC-CH---------------HH
Q 008898 443 LELITGKEAIQTNKANRESLVLWARSLLS-----------SGLCERLIDPQL----NEEY-NR---------------EE 491 (549)
Q Consensus 443 ~elltG~~p~~~~~~~~~~l~~~~~~~~~-----------~~~~~~~~d~~l----~~~~-~~---------------~~ 491 (549)
|||++|+.||....... .+......... ...........+ +... .. ..
T Consensus 250 ~ell~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (360)
T 3llt_A 250 AELYTGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328 (360)
T ss_dssp HHHHHSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred HHHHHCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence 99999999998654322 11111111000 000000000000 0000 00 01
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 492 IEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 492 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
.+.+.+++..||+.||.+|||+.++++ |+||+
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~-----hp~f~ 360 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLK-----HKFLE 360 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTT-----SGGGC
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhc-----CcccC
Confidence 156778999999999999999999998 89985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=369.43 Aligned_cols=256 Identities=22% Similarity=0.281 Sum_probs=204.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|+..+.||+|+||.||++.+ .+|+.||||+++... ...+.+.+|..+++.+ +||||+++++++.+.+.+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 36799999999999999999987 568999999997542 2335678899999988 79999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
||||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||+|+....
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCC-CCEEEccccceeeccc-
Confidence 99999 6799999864 77888899999999999999999 99999999999999999 7999999999864221
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+ ..+... .
T Consensus 177 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~----~~i~~~----~--- 240 (353)
T 3txo_A 177 ----NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LF----EAILND----E--- 240 (353)
T ss_dssp -------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----HHHHHC----C---
T ss_pred ----CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HH----HHHHcC----C---
Confidence 2233446789999999999999899999999999999999999999997654322 11 111111 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhcCCchhhhhhhHHHHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM------KTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
...+.. ....+.+++..||..||.+||++ .++++ |+||+...+....
T Consensus 241 ~~~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~-----hp~f~~~~w~~l~ 293 (353)
T 3txo_A 241 VVYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR-----HPFFKEIDWAQLN 293 (353)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT-----SGGGTTCCHHHHH
T ss_pred CCCCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh-----CCcccCCCHHHHh
Confidence 111122 23457778899999999999998 88888 9999987765543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=357.88 Aligned_cols=266 Identities=24% Similarity=0.345 Sum_probs=202.6
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC------cCHHHHHHHHHHHhcCC---CCCeeeEEEEEEcC
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN------WSEEEVLREVELLSSIK---HENIVRIIGYCHSK 319 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~------~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~ 319 (549)
+.++|++.+.||+|+||.||+|.+ .+|+.||+|+++... .....+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 367899999999999999999987 678999999997432 12356778888877764 99999999999765
Q ss_pred C-----eEEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEe
Q 008898 320 E-----MYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389 (549)
Q Consensus 320 ~-----~~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~ 389 (549)
. .++++||+++|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~-~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG-GTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTT-SCEEEC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCC-CCEEEe
Confidence 5 5899999999999999965 67888999999999999999999 99999999999999998 689999
Q ss_pred eeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHh
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL 469 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 469 (549)
|||++..... ........||+.|+|||++.+..++.++|||||||++|||++|++||....... .+.......
T Consensus 163 Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~ 235 (308)
T 3g33_A 163 DFGLARIYSY------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLI 235 (308)
T ss_dssp SCSCTTTSTT------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHH
T ss_pred eCccccccCC------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 9999865432 222345689999999999999999999999999999999999999998765432 222222211
Q ss_pred hccccccccc----------CCc---ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 470 LSSGLCERLI----------DPQ---LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 470 ~~~~~~~~~~----------d~~---l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.... ...+. .+. .......+....+.+++..||..||.+|||+.++++ |+||+....
T Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~-----h~~~~~~~~ 305 (308)
T 3g33_A 236 GLPP-EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ-----HSYLHKDEG 305 (308)
T ss_dssp CCCC-TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT-----STTC-----
T ss_pred CCCC-hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc-----CccccCCCC
Confidence 1100 00000 000 000011123456788999999999999999999999 999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=364.38 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=205.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|.+.+.||+|+||.||+|.+ .+|+.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999987 679999999997432 2235688999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 326 YNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 326 ~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|||++|+|.+++.. +++.+...++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~-- 161 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDG-- 161 (336)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTS--
T ss_pred EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCC-CCEEEEEeccceeccCC--
Confidence 99999999998854 78888999999999999999999 99999999999999998 68999999998654332
Q ss_pred cccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+...
T Consensus 162 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------------~~~i~~~ 223 (336)
T 3h4j_B 162 ----NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------------FKKVNSC 223 (336)
T ss_dssp ----BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--------------BCCCCSS
T ss_pred ----cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--------------HHHHHcC
Confidence 22345689999999999988776 7899999999999999999999976543210 0111100
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
. ...+......+.+++..||..||.+|||+.++++ |+||+..
T Consensus 224 ~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~-----hp~~~~~ 265 (336)
T 3h4j_B 224 V--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR-----DPWFNVN 265 (336)
T ss_dssp C--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT-----CHHHHTT
T ss_pred C--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh-----ChhhccC
Confidence 0 0112223345778899999999999999999998 8999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=358.91 Aligned_cols=266 Identities=24% Similarity=0.351 Sum_probs=211.9
Q ss_pred ccCHHHHHhhhcC----------CCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCC
Q 008898 241 RFTSQELCHLTHN----------FSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHEN 308 (549)
Q Consensus 241 ~~~~~el~~~~~~----------f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~n 308 (549)
.++.+++..+++. |...+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.+++.++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3555555555443 666778999999999999875 799999999976543 3467889999999999999
Q ss_pred eeeEEEEEEcCCeEEEEEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc
Q 008898 309 IVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (549)
Q Consensus 309 Iv~l~~~~~~~~~~~lv~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 385 (549)
|+++++++...+.++++|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~-~~ 179 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD-GR 179 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC-Cc
Confidence 999999999999999999999 7799999864 78888999999999999999999 99999999999999988 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHH
Q 008898 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW 465 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~ 465 (549)
+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 180 ~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-~--- 250 (321)
T 2c30_A 180 VKLSDFGFCAQISKDV-----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-M--- 250 (321)
T ss_dssp EEECCCTTCEECCSSS-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H---
T ss_pred EEEeeeeeeeecccCc-----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H---
Confidence 9999999986543321 122356799999999999999999999999999999999999999976543221 1
Q ss_pred HHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 466 ARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 466 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
..+.. ...+.+.. .......+.+++..||..||.+|||+.++++ |+|+......
T Consensus 251 -~~~~~------~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~-----hp~~~~~~~~ 304 (321)
T 2c30_A 251 -KRLRD------SPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD-----HPFLLQTGLP 304 (321)
T ss_dssp -HHHHH------SSCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT-----SGGGGGCCCG
T ss_pred -HHHhc------CCCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc-----ChhhccCCCc
Confidence 11111 01111110 1122345778889999999999999999998 8999765433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=362.70 Aligned_cols=246 Identities=23% Similarity=0.236 Sum_probs=195.5
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcCH---HHHHHHHHHHhc-CCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSE---EEVLREVELLSS-IKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~---~~~~~E~~il~~-l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|+..+.||+|+||.||+|.+. +|+.||||++....... .....|+..+.. .+||||++++++|.+++.+++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 467999999999999999999884 79999999987554332 234555555554 4899999999999999999999
Q ss_pred EeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||++|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGG-GCEEECCCTTCEECC---
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCC-CCEEEccceeeeecccC-
Confidence 99999999999865 78889999999999999999999 99999999999999998 68999999998654332
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......||+.|+|||++.+ .++.++|||||||++|||++|..|+...... . .+. .+
T Consensus 211 -----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~-~~~-~~-------- 267 (311)
T 3p1a_A 211 -----GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-------Q-QLR-QG-------- 267 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-------H-HHT-TT--------
T ss_pred -----CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------H-HHh-cc--------
Confidence 12234569999999998875 7999999999999999999997776543211 1 011 11
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.....+.......+.+++..||..||.+|||+.++++ |+||+.
T Consensus 268 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~-----hp~~~~ 310 (311)
T 3p1a_A 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA-----LPVLRQ 310 (311)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT-----SGGGSC
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh-----CccccC
Confidence 1111111123456788899999999999999999999 899964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=367.56 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=201.2
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCC--CCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKH--ENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~lv 325 (549)
.++|.+.+.||+|+||.||++...+++.||||+++...... +.+.+|+.+++.++| |||+++++++.+++.+++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45799999999999999999998889999999998654433 457899999999976 9999999999999999999
Q ss_pred EeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 326 YNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 326 ~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+.+|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||+++ +.+||+|||++.......
T Consensus 88 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~~--~~~kl~DFG~a~~~~~~~- 161 (343)
T 3dbq_A 88 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDT- 161 (343)
T ss_dssp ECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET--TEEEECCCSSSCCC-----
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEEC--CcEEEeecccccccCccc-
Confidence 99889999999965 67888999999999999999999 9999999999999985 479999999997654321
Q ss_pred cccCccccccccCCcccccccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMY-----------GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS 471 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 471 (549)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+..
T Consensus 162 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------- 232 (343)
T 3dbq_A 162 --TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA------- 232 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH-------
T ss_pred --ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH-------
Confidence 1112335679999999999865 67899999999999999999999999764332211111
Q ss_pred ccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 472 SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 472 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.+++.....++......+.+++..||..||.+|||+.++++ |+|+..+.
T Consensus 233 ------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~-----hp~~~~~~ 281 (343)
T 3dbq_A 233 ------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA-----HPYVQIQT 281 (343)
T ss_dssp ------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SHHHHSCC
T ss_pred ------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh-----CccccccC
Confidence 11111111222222346778899999999999999999998 89997543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=370.42 Aligned_cols=260 Identities=18% Similarity=0.242 Sum_probs=207.5
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|...++||+|+||+||++.+ .+++.||+|++++.... ...+.+|..++.++ +||||+++++++.+.+.+++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 5799999999999999999987 46889999999865322 23478899999876 899999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +|+|..++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||+|+...
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~-g~ikL~DFGla~~~~--- 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL--- 204 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCCC---
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCC-CCEEEeecceeeecc---
Confidence 9999 6799999864 78888999999999999999999 99999999999999999 799999999996422
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccch----hhHHHHHHHhhccccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR----ESLVLWARSLLSSGLCER 477 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~----~~l~~~~~~~~~~~~~~~ 477 (549)
.......+.+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........+...
T Consensus 205 --~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----- 277 (396)
T 4dc2_A 205 --RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----- 277 (396)
T ss_dssp --CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-----
T ss_pred --cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-----
Confidence 12233456789999999999999999999999999999999999999996432211 0111111111111
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhcCCchhhhhhhHHHHH
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM------KTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
...++.. ....+.++++.||..||.+||++ .++++ |+||+...+....
T Consensus 278 --~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~-----Hpff~~i~w~~l~ 331 (396)
T 4dc2_A 278 --QIRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG-----HPFFRNVDWDMME 331 (396)
T ss_dssp --CCCCCTT----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH-----STTTTTCCHHHHH
T ss_pred --ccCCCCc----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc-----CccccCCCHHHHH
Confidence 1112222 23457788899999999999995 68888 9999887765543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=358.26 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=209.2
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|...+.||+|+||.||++.. .+|+.||+|+++... ...+.+.+|..+++.++||||+++++++.+.+.++++|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5789999999999999999987 569999999997542 23456788999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTT-SCEEECCCSSCEECSS---
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCC-CCEEEeecCcceecCC---
Confidence 999 6799999965 67888889999999999999999 99999999999999998 7999999999965432
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.... ..
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~----~~i~~~~-------~~ 221 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-Y----EKILNAE-------LR 221 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H----HHHHHCC-------CC
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-H----HHHHhCC-------CC
Confidence 22356899999999999999999999999999999999999999976543211 1 1111110 11
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEELL 537 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~~ 537 (549)
++..+ ...+.+++..||..||.+|| ++.++++ |+||+...+.....
T Consensus 222 ~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~-----hp~f~~~~~~~~~~ 272 (318)
T 1fot_A 222 FPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN-----HPWFKEVVWEKLLS 272 (318)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT-----SGGGSSCCHHHHHT
T ss_pred CCCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc-----CccccCCCHHHHHh
Confidence 12222 34577888999999999999 8999998 99998776655443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=357.42 Aligned_cols=269 Identities=25% Similarity=0.384 Sum_probs=194.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|...+.||+|+||.||+|.+ .+|+.||+|+++.... ....+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45799999999999999999987 5689999999975432 33678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH---------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 328 LLNGSLKQYLKQ---------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 328 ~~~gsL~~~l~~---------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
|+.|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKR-GQLKLGDFGLARAFG 159 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCSSCEETT
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCC-CCEEECcCccceecC
Confidence 999999999853 56777888999999999999999 99999999999999998 689999999996543
Q ss_pred cccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--cc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--LC 475 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~ 475 (549)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+........... ..
T Consensus 160 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPV-----NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCC-----CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTC
T ss_pred CCc-----ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHh
Confidence 211 122345789999999999864 6899999999999999999999999866532 22222222111000 00
Q ss_pred ---ccc--cCCcc------------cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 476 ---ERL--IDPQL------------NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 476 ---~~~--~d~~l------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
..+ ..+.. ...........+.+++..||..||.+|||+.++++ |+||.......
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~-----hp~f~~~~~~~ 304 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH-----HPWFAEYYHHA 304 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT-----SGGGGGGCC--
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC-----Chhhhcccchh
Confidence 000 00000 00001112346788999999999999999999998 99998776543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=367.29 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=201.7
Q ss_pred hcCCCCCceEcccCceEEEEEEec--------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEcC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 319 (549)
.++|.+.+.||+|+||.||+|.+. ++..||||+++..... .+.+.+|+.+++.+ +||||++++++|.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357889999999999999999752 3568999999765432 35688999999999 899999999999999
Q ss_pred CeEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE
Q 008898 320 EMYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl 379 (549)
+.+++||||+ +|+|.+++.. +++.+++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 9999999999 6799999964 46778889999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccc
Q 008898 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKAN 458 (549)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~ 458 (549)
+.+ +.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 237 ~~~-~~~kl~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 237 TEN-NVMKIADFGLARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp CTT-CCEEECCCSSCEETTCCCT---TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCC-CCEEEccccCCcccCcccc---eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 998 6899999999976543221 112234567889999999999999999999999999999999 99999765432
Q ss_pred hhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 459 RESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 459 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. +.. .+. .+. .+. .+..+...+.+++..||..||.+|||+.++++.|+.
T Consensus 313 ~--~~~---~~~-~~~-----~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 313 E--LFK---LLK-EGH-----RMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp G--HHH---HHH-TTC-----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H--HHH---HHh-cCC-----CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 2 111 111 111 111 122334567888999999999999999999998864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=362.99 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=205.1
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
+.++|++.+.||+|+||.||++.+ .+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 356899999999999999999987 4799999999975432 2356889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~- 159 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN- 159 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCTTCEECEETT-
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCC-CCEEEEEeeccceeccCC-
Confidence 999 569998885 377888999999999999999999 99999999999999998 689999999997543221
Q ss_pred cccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............|..... ...
T Consensus 160 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------~~~- 229 (323)
T 3tki_A 160 --RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------YLN- 229 (323)
T ss_dssp --EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-------TST-
T ss_pred --cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-------cCC-
Confidence 1122235689999999999988776 78999999999999999999999876544333322221110 000
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.... ....+.+++..||..||.+|||+.|+++ |+||...
T Consensus 230 -~~~~----~~~~~~~li~~~L~~dP~~R~t~~eil~-----h~~~~~~ 268 (323)
T 3tki_A 230 -PWKK----IDSAPLALLHKILVENPSARITIPDIKK-----DRWYNKP 268 (323)
T ss_dssp -TGGG----SCHHHHHHHHHHSCSSTTTSCCHHHHTT-----CTTTTCC
T ss_pred -cccc----CCHHHHHHHHHHccCChhhCcCHHHHhh-----Chhhccc
Confidence 0112 2345677889999999999999999998 8998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=365.28 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=209.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|...+.||+|+||.||+|.+ .+|+.||+|+++.. ......+..|..++..+ +||||+++++++.+.+.+++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 46899999999999999999987 56899999999754 23345678899999876 89999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
||||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||++.....
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD-GHIKIADFGMCKENML- 170 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCC-
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCC-CCEEEeEChhhhhccc-
Confidence 99999 6799999965 77888999999999999999999 99999999999999998 7999999999864322
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+ ..+... .
T Consensus 171 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~----~~i~~~-------~ 234 (345)
T 1xjd_A 171 ----GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-LF----HSIRMD-------N 234 (345)
T ss_dssp ----TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----HHHHHC-------C
T ss_pred ----CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-HH----HHHHhC-------C
Confidence 1223446789999999999999999999999999999999999999997654321 11 111111 1
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCchhhhhhhHHHHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMK-TLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~~L~~~~~w~~~~~~~~~~ 536 (549)
+..+..+ ...+.+++..||..||.+||++. ++++ |+||+...+....
T Consensus 235 ~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~~-----hp~f~~~~w~~l~ 282 (345)
T 1xjd_A 235 PFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ-----HPLFREINWEELE 282 (345)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG-----SGGGTTCCHHHHH
T ss_pred CCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHHc-----CccccCCCHHHHh
Confidence 1122222 34577888999999999999998 8877 8999887665443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=353.79 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=203.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++|...+.||+|+||.||++.+ .+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35788999999999999999987 568999999886543 2345688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 329 L-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 329 ~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+ +|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTT-SCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCC-CCEEEeecccceeccccccc
Confidence 9 6799999965 77888999999999999999999 99999999999999998 68999999999765432211
Q ss_pred cc---------CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 404 SE---------NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 404 ~~---------~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
.. ........||+.|+|||++.+..++.++|||||||++|||++|..|+............ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------~ 235 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------N 235 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---------C
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---------h
Confidence 11 11122568999999999999999999999999999999999999998764432211100 0
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.....+... +...+..+.+++..||+.||.+|||+.++++.|+...
T Consensus 236 ~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 236 VRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000001111 1122345778899999999999999999999887654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=371.14 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=200.4
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCC--CCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIK--HENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~--h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.+|.+.+.||+|+||.||++.+.+++.||||++...... .+.+.+|+.+|+.+. ||||+++++++..++.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458999999999999999999877999999999765433 356789999999996 599999999999999999999
Q ss_pred eccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 327 NLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 327 e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+.+|+|.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||+++ +.+||+|||++.......
T Consensus 136 E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~~-- 208 (390)
T 2zmd_A 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDT-- 208 (390)
T ss_dssp ECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEESS--SCEEECCCSSSCCC------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEEC--CeEEEEecCccccccCCC--
Confidence 9878999999965 66778889999999999999999 9999999999999964 579999999997643321
Q ss_pred ccCccccccccCCcccccccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMY-----------GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS 472 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 472 (549)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+.. .
T Consensus 209 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~----~--- 280 (390)
T 2zmd_A 209 -TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA----I--- 280 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH----H---
T ss_pred -ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH----H---
Confidence 1112335679999999999875 46899999999999999999999999765432221111 1
Q ss_pred cccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 473 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
+++.....++......+.+++..||..||.+|||+.++++ |+|+..+..
T Consensus 281 ------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~-----hp~~~~~~~ 329 (390)
T 2zmd_A 281 ------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA-----HPYVQIQTH 329 (390)
T ss_dssp ------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SHHHHSCC-
T ss_pred ------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh-----CcCccccCc
Confidence 1111111111112346778899999999999999999998 899976543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=362.45 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=203.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN------WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~------~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++... ...+.+.+|+.+++.++||||+++++++.+++.++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45789999999999999999987 569999999996421 23567899999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC--CceEEeeecc
Q 008898 324 IVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGA 393 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~~kL~DFGl 393 (549)
+||||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+. ..+||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999 5799888743 57778889999999999999999 999999999999998652 2499999999
Q ss_pred ccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG 473 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 473 (549)
+....... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .... .+....
T Consensus 180 a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~----~i~~~~ 248 (351)
T 3c0i_A 180 AIQLGESG-----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFE----GIIKGK 248 (351)
T ss_dssp CEECCTTS-----CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHH----HHHHTC
T ss_pred eeEecCCC-----eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHH----HHHcCC
Confidence 96654321 122355799999999999999999999999999999999999999976432 1111 111110
Q ss_pred ccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 474 LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 474 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
. ...+..... ....+.+++..||..||.+|||+.++++ |+|++...
T Consensus 249 ~---~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~-----hp~~~~~~ 294 (351)
T 3c0i_A 249 Y---KMNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN-----HPWLKERD 294 (351)
T ss_dssp C---CCCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SHHHHTHH
T ss_pred C---CCCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc-----ChhhcCCc
Confidence 0 000000111 2346778899999999999999999998 89997643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=361.08 Aligned_cols=253 Identities=19% Similarity=0.260 Sum_probs=210.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|...+.||+|+||.||++.+ .+|+.||+|+++... ...+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 35799999999999999999987 469999999997542 2346788999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECSS--
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCC-CCEEEcccccceeccC--
Confidence 9999 7899999965 67888899999999999999999 99999999999999998 7999999999965432
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...+... . .
T Consensus 194 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~----~~~i~~~-~------~ 255 (350)
T 1rdq_E 194 ------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-I----YEKIVSG-K------V 255 (350)
T ss_dssp ------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H----HHHHHHC-C------C
T ss_pred ------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-H----HHHHHcC-C------C
Confidence 1235689999999999999999999999999999999999999997654321 1 1111111 0 1
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHHHHH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
.++.. ....+.+++..||..||.+||+ +.+|++ |+||....+....
T Consensus 256 ~~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~-----h~~f~~~~w~~~~ 306 (350)
T 1rdq_E 256 RFPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN-----HKWFATTDWIAIY 306 (350)
T ss_dssp CCCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT-----SGGGTTCCHHHHH
T ss_pred CCCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh-----CcCcCCCCHHHHh
Confidence 11222 2345778889999999999998 999998 8999887766544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=365.26 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=196.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.++|...+.||+|+||.||++.+ .+++.||+|++.......+.+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 46799999999999999999988 47999999999877666678899999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC-CceEEeeeccccccccccccc
Q 008898 330 -NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF-HHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 -~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+. +.+||+|||++.....
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~----- 170 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL----- 170 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc-----
Confidence 7799999854 77888999999999999999999 999999999999998762 2499999999863221
Q ss_pred cCccccccccCCccccccccccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEK-IDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k-~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............ ......... ..
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-~~~~~~~~~-------~~ 241 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT-IQRILSVKY-------SI 241 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH-HHHHHTTCC-------CC
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH-HHHHhcCCC-------CC
Confidence 122234579999999999998888655 89999999999999999999865543222111 111111100 00
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.. .......+.+++..||..||.+|||+.++++ |+||..
T Consensus 242 ~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~-----hp~f~~ 280 (361)
T 3uc3_A 242 PD--DIRISPECCHLISRIFVADPATRISIPEIKT-----HSWFLK 280 (361)
T ss_dssp CT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT-----SHHHHT
T ss_pred CC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHh-----Ccchhc
Confidence 00 0112345778899999999999999999999 899854
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=357.78 Aligned_cols=247 Identities=29% Similarity=0.431 Sum_probs=194.0
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|.+.+.||+|+||.||+|.. +|+.+|||++....... +.+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46788999999999999999976 68899999997655433 467899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCC--EEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 328 LL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 328 ~~-~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
|+ +|+|.+++.. +++..++.++.||+.||.|||+. + |+||||||+|||++.+ +.+||+|||++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKA 190 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTT-CCEEECCCC------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCC-CcEEECCCCCCcccc
Confidence 99 6799999953 77788899999999999999999 8 9999999999999998 689999999986533
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... . .
T Consensus 191 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~~--~------~ 255 (309)
T 3p86_A 191 ST-----FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVGF--K------C 255 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHH--S------C
T ss_pred cc-----ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh--c------C
Confidence 21 1223356799999999999999999999999999999999999999986543221 111100 0 0
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
........ ....+.+++..||..||.+|||+.++++.|+
T Consensus 256 ~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~ 294 (309)
T 3p86_A 256 KRLEIPRN----LNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294 (309)
T ss_dssp CCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11112222 3345778899999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=349.92 Aligned_cols=248 Identities=21% Similarity=0.394 Sum_probs=205.9
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|...+.||+|+||.||++.+.+++.+|+|++.......+++.+|+.++++++||||+++++++.+++.++++|||+ +
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 578889999999999999999988899999999987777788999999999999999999999999999999999999 6
Q ss_pred CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 331 gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++........
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~---- 161 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQY---- 161 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHH----
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCC-CCEEecccccccccccccc----
Confidence 799999964 67888899999999999999999 99999999999999988 6899999999975443211
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
.......||+.|+|||.+.+..++.++|||||||++|+|++ |+.||....... .. ..+... ..+....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-~~----~~~~~~------~~~~~~~ 230 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VV----EDISTG------FRLYKPR 230 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HH----HHHHTT------CCCCCCT
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-HH----HHHhcC------ccCCCCC
Confidence 12224457889999999999999999999999999999999 999997654322 11 111111 0111111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. ....+.+++..||+.||.+|||+.++++.|++
T Consensus 231 ~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 231 L----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp T----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 1 23457788899999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=370.84 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=205.6
Q ss_pred hhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.+.++|...+.||+|+||.||+|.+ .+|+.+|+|++...... .+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3467899999999999999999977 57999999999765432 3457899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeeccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHH 398 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla~~~~ 398 (549)
||||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||++....
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999 6799998854 77888899999999999999999 99999999999999842 2579999999996543
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|.+||....... .+.. +.. +.. ..
T Consensus 165 ~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~----i~~-~~~-~~ 232 (444)
T 3soa_A 165 GE-----QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQ----IKA-GAY-DF 232 (444)
T ss_dssp TT-----CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH----HHH-TCC-CC
T ss_pred CC-----CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHH----HHh-CCC-CC
Confidence 32 122235689999999999999999999999999999999999999997654321 1111 111 100 00
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..+ . .......+.+++..||..||.+|||+.++++ |+|+....
T Consensus 233 ~~~-~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~-----hp~~~~~~ 275 (444)
T 3soa_A 233 PSP-E----WDTVTPEAKDLINKMLTINPSKRITAAEALK-----HPWISHRS 275 (444)
T ss_dssp CTT-T----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH-----SCTTHHHH
T ss_pred Ccc-c----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc-----CccccCCc
Confidence 111 1 1122345778889999999999999999999 99997543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=346.53 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=207.7
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++|...+.||+|+||.||++...++..+|+|+++......+++.+|+.+++.++||||+++++++.+++.++++|||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 4678999999999999999999888889999999887777788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 ~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+|+|.+++.. +++..++.++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++........
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~--- 159 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQY--- 159 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTT-CCEEECCTTCEEECCTTCE---
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCC-CCEEEccCccceecchhhh---
Confidence 6789999854 67888999999999999999999 99999999999999998 6899999999976543221
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.......||+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......... ...... .. ...
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-----~~~~~~---~~---~~~ 227 (268)
T 3sxs_A 160 -VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-----KVSQGH---RL---YRP 227 (268)
T ss_dssp -EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-----HHHTTC---CC---CCC
T ss_pred -hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-----HHHcCC---CC---CCC
Confidence 11223456788999999999899999999999999999999 999997654322111 111110 11 111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.. ....+.+++..||..||.+|||+.++++.|+...
T Consensus 228 ~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HL----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TT----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred Cc----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11 2345778899999999999999999999887654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=358.07 Aligned_cols=259 Identities=19% Similarity=0.250 Sum_probs=206.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|...+.||+|+||.||++.+ .+++.||+|+++..... ...+.+|..+++.+ +||||+++++++.+.+.+++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5789999999999999999987 46899999999865322 24577899999987 899999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCGGGCBCSCC--
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCC-CCEEEEeccccccccC--
Confidence 9999 6799999864 77888899999999999999999 99999999999999998 7999999999864322
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccch----hhHHHHHHHhhccccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR----ESLVLWARSLLSSGLCER 477 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~----~~l~~~~~~~~~~~~~~~ 477 (549)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........+...
T Consensus 163 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~----- 234 (345)
T 3a8x_A 163 ---PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----- 234 (345)
T ss_dssp ---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-----
T ss_pred ---CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-----
Confidence 1223446789999999999999999999999999999999999999997532111 1111111111111
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhcCCchhhhhhhHHHH
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM------KTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~~L~~~~~w~~~~~~~~~ 535 (549)
...++.. ....+.+++..||..||.+||++ .++++ |+||+...+...
T Consensus 235 --~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~-----hp~f~~~~w~~~ 287 (345)
T 3a8x_A 235 --QIRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG-----HPFFRNVDWDMM 287 (345)
T ss_dssp --CCCCCTT----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT-----SGGGTTCCHHHH
T ss_pred --CCCCCCC----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc-----CCccCCCCHHHH
Confidence 0112222 23457788899999999999995 67877 899987765543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.33 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=208.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|.+.+.||+|+||.||++.+ .+++.||+|+++... .....+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5799999999999999999987 568999999997532 23467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~--- 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPR--- 167 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECCT---
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCC-CCEEEeccceeeeccC---
Confidence 999 7799999964 67888899999999999999999 99999999999999998 7999999999976432
Q ss_pred cccCccccccccCCcccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 168 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~~~~~~~~------- 235 (384)
T 4fr4_A 168 ---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK--EIVHTFETT------- 235 (384)
T ss_dssp ---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH--HHHHHHHHC-------
T ss_pred ---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH--HHHHHHhhc-------
Confidence 223346789999999999874 45899999999999999999999999755432211 111111100
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhcCCchhhhhhhHHHHHH
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT-MKTLLKLFQEPDYWLKMKREKEELL 537 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~L~~~~~w~~~~~~~~~~~ 537 (549)
.... +......+.+++..||..||.+||+ +.++++ |+||....+.....
T Consensus 236 ~~~~----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~-----hp~f~~~~w~~~~~ 285 (384)
T 4fr4_A 236 VVTY----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN-----FPYMNDINWDAVFQ 285 (384)
T ss_dssp CCCC----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT-----SGGGTTCCHHHHHT
T ss_pred ccCC----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc-----ChhhhcCCHHHHHh
Confidence 0111 2223356788889999999999998 888877 89998887765543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=361.45 Aligned_cols=256 Identities=20% Similarity=0.308 Sum_probs=208.8
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCC----cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|...+.||+|+||.||++.+. +|+.||+|+++... ...+.+..|..++..+ +||||+++++++.+.+.+++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 367999999999999999999884 58899999997542 3346688999999988 79999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
||||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||++.....
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCC-
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCC-CcEEEEeCCccccccc-
Confidence 99999 6799999964 77888999999999999999999 99999999999999998 7999999999864221
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+... .
T Consensus 174 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~----~~i~~~-------~ 237 (353)
T 2i0e_A 174 ----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LF----QSIMEH-------N 237 (353)
T ss_dssp ----TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----HHHHHC-------C
T ss_pred ----CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HH----HHHHhC-------C
Confidence 2223446789999999999999999999999999999999999999997654321 11 111111 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHHHHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
..++. .....+.+++..||..||.+||+ +.++++ |+||+...+....
T Consensus 238 ~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~-----h~~f~~~~w~~l~ 289 (353)
T 2i0e_A 238 VAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE-----HAFFRYIDWEKLE 289 (353)
T ss_dssp CCCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT-----SGGGTTCCHHHHH
T ss_pred CCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc-----CccccCCCHHHHH
Confidence 11122 23345778889999999999995 588887 8999877665543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=372.97 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=209.6
Q ss_pred HHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC
Q 008898 245 QELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSK 319 (549)
Q Consensus 245 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 319 (549)
.++....++|...+.||+|+||.||++.+ .+++.||+|+++... .....+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34555678899999999999999999987 468999999997532 1224578999999999999999999999999
Q ss_pred CeEEEEEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 320 EMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
+.+++||||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||+|..
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~-g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS-GHLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCC-CCEEEeccceeEe
Confidence 9999999999 7799999975 67777889999999999999999 99999999999999999 7999999999965
Q ss_pred cccccccccCccccccccCCccccccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK----VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS 472 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 472 (549)
..... .....+.+||+.|+|||++.+.. ++.++|||||||++|||++|++||........ . ..+...
T Consensus 218 ~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~----~~i~~~ 288 (410)
T 3v8s_A 218 MNKEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-Y----SKIMNH 288 (410)
T ss_dssp CCTTS----EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H----HHHHTH
T ss_pred eccCC----cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-H----HHHHhc
Confidence 43321 11233668999999999998765 88999999999999999999999986543221 1 111111
Q ss_pred cccccccCCcccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCchhhhhhhH
Q 008898 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSR--RPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 473 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.. .+.-|. ...+ ...+.+++..||..+|.+ ||++.+|++ |+||+...+
T Consensus 289 ~~--~~~~p~-~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~-----Hp~f~~~~w 338 (410)
T 3v8s_A 289 KN--SLTFPD-DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKR-----HLFFKNDQW 338 (410)
T ss_dssp HH--HCCCCT-TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHT-----SGGGCCSSC
T ss_pred cc--cccCCC-cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhc-----CccccCCCH
Confidence 10 000010 0112 345777889999999988 999999999 999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=378.00 Aligned_cols=268 Identities=20% Similarity=0.257 Sum_probs=211.3
Q ss_pred CHHHHHhhhcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEE
Q 008898 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCH 317 (549)
Q Consensus 243 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~ 317 (549)
...++....++|...++||+|+||+||++.+. +++.||+|+++.... ....+.+|..++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455566789999999999999999999884 588999999975321 1234788999999999999999999999
Q ss_pred cCCeEEEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeec
Q 008898 318 SKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (549)
Q Consensus 318 ~~~~~~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFG 392 (549)
+++.+++||||+ +|+|.+++.. +++.....++.||+.||.|||+. +||||||||+|||++.+ +.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~-g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMN-GHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCC-CCEEEcchh
Confidence 999999999999 7899999964 67888899999999999999999 99999999999999998 799999999
Q ss_pred cccccccccccccCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHH
Q 008898 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~ 467 (549)
+|+...... .......+||+.|+|||++. .+.++.++|||||||++|||++|+.||........ ..
T Consensus 221 la~~~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~---- 291 (437)
T 4aw2_A 221 SCLKLMEDG----TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YG---- 291 (437)
T ss_dssp TCEECCTTS----CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH----
T ss_pred hhhhcccCC----CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HH----
Confidence 996543321 11223468999999999987 45689999999999999999999999986543221 11
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSR--RPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.+.... ..+.-|.....++ ..+.++++.||..+|.+ ||++.++++ |+||+...+..
T Consensus 292 ~i~~~~--~~~~~p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~-----Hpff~~i~w~~ 349 (437)
T 4aw2_A 292 KIMNHK--ERFQFPTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKK-----HPFFSGIDWDN 349 (437)
T ss_dssp HHHTHH--HHCCCCSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHT-----SGGGTTCCTTT
T ss_pred hhhhcc--ccccCCcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhC-----CCccCCCCHHH
Confidence 111110 0111111112223 45667788999888888 999999998 99998776544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.09 Aligned_cols=255 Identities=23% Similarity=0.354 Sum_probs=205.1
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
+.++|...+.||+|+||.||+|.+ .+|+.+|+|+++...... +.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356799999999999999999987 568999999998654432 4578999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC--CceEEeeecccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~~kL~DFGla~~~~~ 399 (549)
|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+. +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999 6799998854 67888999999999999999999 999999999999998652 3599999999865432
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
. .......||+.|+|||++.+..++.++|||||||++|+|++|.+||....... .. ..+.. +.. ...
T Consensus 184 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~----~~i~~-~~~-~~~ 250 (362)
T 2bdw_A 184 S------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LY----AQIKA-GAY-DYP 250 (362)
T ss_dssp C------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----HHHHH-TCC-CCC
T ss_pred C------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HH----HHHHh-CCC-CCC
Confidence 2 22335689999999999999999999999999999999999999997654321 11 11111 100 000
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
..... .....+.+++..||..||.+|||+.++++ |+|+...
T Consensus 251 -~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~-----hp~~~~~ 291 (362)
T 2bdw_A 251 -SPEWD----TVTPEAKSLIDSMLTVNPKKRITADQALK-----VPWICNR 291 (362)
T ss_dssp -TTGGG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTT-----SHHHHTH
T ss_pred -ccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHhc-----CcccCCC
Confidence 00111 22345778889999999999999999998 8998653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=360.22 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=205.0
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----eEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE----MYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----~~~lv~ 326 (549)
.++|+..+.||+|+||.||+|.+. ++.||||+++..........+|+.+++.++||||+++++++.... .+++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 467999999999999999999874 789999999866555556677999999999999999999997643 479999
Q ss_pred ecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhC-------CCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 327 NLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHT-------CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 327 e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~-------~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
||+ +|+|.++++. +++..+..++.||+.||.|||+. +..+|+||||||+|||++.+ +.+||+|||++..
T Consensus 102 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~kL~DFg~a~~ 180 (322)
T 3soc_A 102 AFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALK 180 (322)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC-CeEEEccCCcccc
Confidence 999 6799999975 78888999999999999999976 23489999999999999998 6899999999976
Q ss_pred cccccccccCccccccccCCccccccccccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCcccchh-----------
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-----KVDEKIDVYSYGVVLLELITGKEAIQTNKANRE----------- 460 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~----------- 460 (549)
...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 181 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 181 FEAGKS---AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp ECTTSC---CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred cccccC---ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 544221 1223346799999999999863 456789999999999999999999976543111
Q ss_pred hHHHHHHHhhcccccccccCCccccc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 461 SLVLWARSLLSSGLCERLIDPQLNEE-YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 461 ~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
....+...... ....+.+... ........+.+++..||+.||.+|||+.++++.|+..
T Consensus 258 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 258 SLEDMQEVVVH-----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CHHHHHHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhhhhhhhc-----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111111 1112222211 1234567799999999999999999999999988654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.56 Aligned_cols=267 Identities=22% Similarity=0.317 Sum_probs=210.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEc--CCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHS--KEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~--~~~~~lv~ 326 (549)
.++|.+.+.||+|+||.||+|.+ .+++.||+|+++.. ..+.+.+|+.+++.+. ||||+++++++.+ ....+++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 36799999999999999999987 67899999999744 3577899999999997 9999999999987 67889999
Q ss_pred ecc-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 327 NLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 327 e~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
||+ +++|.++++.++......++.||+.||.|||+. +|+||||||+|||++.+...+||+|||++.......
T Consensus 113 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---- 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---- 185 (330)
T ss_dssp ECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC----
T ss_pred eccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC----
Confidence 999 678999999999999999999999999999999 999999999999999774489999999997544321
Q ss_pred CccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc------c
Q 008898 406 NVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER------L 478 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~------~ 478 (549)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......+.+............... .
T Consensus 186 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2234578999999999887 668999999999999999999999997655444444333222211110000 0
Q ss_pred cCC----------------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 479 IDP----------------QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 479 ~d~----------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
.++ .............+.+++..||..||.+|||+.++++ |+||+...+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~-----hp~f~~~~~~ 329 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME-----HPYFYTVVKD 329 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT-----SGGGTTCC--
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc-----CccHhhhccC
Confidence 000 0001111113456788899999999999999999999 9999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=356.50 Aligned_cols=257 Identities=23% Similarity=0.327 Sum_probs=200.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe----cCCcEEEEEEeecCCc-----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTNW-----SEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~----~~g~~~AvK~l~~~~~-----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
.++|...+.||+|+||.||++.. .+|+.+|+|+++.... ....+.+|+.+++.++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35799999999999999999987 4689999999976431 23457789999999999999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+++||||+ +|+|.+++.. +.+.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQ-GHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT-SCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCC-CcEEEEeCCccccc
Confidence 99999999 6799999865 67778889999999999999999 99999999999999998 69999999998643
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+ ..+...
T Consensus 172 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~----~~i~~~----- 236 (327)
T 3a62_A 172 IHD-----GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TI----DKILKC----- 236 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH----HHHHHT-----
T ss_pred ccC-----CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HH----HHHHhC-----
Confidence 221 122335689999999999999999999999999999999999999997654321 11 111111
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHHH
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEELL 537 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~~ 537 (549)
...++. .....+.+++..||..||.+|| ++.++++ |+||+.....+...
T Consensus 237 --~~~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~-----hp~f~~~~~~~~~~ 290 (327)
T 3a62_A 237 --KLNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA-----HPFFRHINWEELLA 290 (327)
T ss_dssp --CCCCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH-----SGGGSSCCHHHHHT
T ss_pred --CCCCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc-----CCcccCCCHHHHhh
Confidence 011112 2234577888999999999999 7889999 89998776655443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=356.39 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=196.2
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-------
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKE------- 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~------- 320 (549)
.++|++.+.||+|+||.||+|.+. +|+.||||+++.... ..+.+.+|+.+++.++||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999884 799999999975442 3467899999999999999999999885543
Q ss_pred --------------------------------------------------eEEEEEecc-CCCHHHHHHH------hchh
Q 008898 321 --------------------------------------------------MYAIVYNLL-NGSLKQYLKQ------LKWN 343 (549)
Q Consensus 321 --------------------------------------------------~~~lv~e~~-~gsL~~~l~~------~~~~ 343 (549)
.++++|||+ +|+|.+++.. ..+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 389999999 6799999965 3344
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc-------CccccccccCC
Q 008898 344 ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE-------NVKPVNVVGTF 416 (549)
Q Consensus 344 ~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~~~~gt~ 416 (549)
.++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++........... ........||+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 5788999999999999999 99999999999999988 6899999999976544321111 12233567999
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHH
Q 008898 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVM 496 (549)
Q Consensus 417 ~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 496 (549)
.|+|||++.+..++.++|||||||++|||++|..|+..... . ..... ....+ .........+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~----~---~~~~~------~~~~~----~~~~~~~~~~~ 303 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR----I---ITDVR------NLKFP----LLFTQKYPQEH 303 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH----H---HHHHH------TTCCC----HHHHHHCHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH----H---HHHhh------ccCCC----cccccCChhHH
Confidence 99999999999999999999999999999999776532111 0 00000 00001 11123334567
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 497 CAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 497 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
+++..||+.||.+|||+.++++ |+||+.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~-----~~~f~~ 331 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE-----NAIFEN 331 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH-----STTCCC
T ss_pred HHHHHHccCCCCcCCCHHHHhh-----chhhhc
Confidence 8999999999999999999999 899864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=352.36 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=203.0
Q ss_pred hhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhc--CCCCCeeeEEEEEEc----CCeEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSS--IKHENIVRIIGYCHS----KEMYA 323 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~~~~~----~~~~~ 323 (549)
+.++|...+.||+|+||.||+|.+ +|+.||||++.... ...+.+|.+++.. ++||||+++++++.. ...++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 457899999999999999999987 78999999997543 3556667777665 899999999998643 35689
Q ss_pred EEEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHH--------hCCCCCEEEecCCCCCEEEecCCCceEEeeec
Q 008898 324 IVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLH--------HTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFG 392 (549)
++|||+ +|+|.++++. +++...+.++.||+.||.||| +. +|+||||||+|||++.+ +.+||+|||
T Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~-~~~kl~Dfg 158 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKN-GQCCIADLG 158 (301)
T ss_dssp EEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTT-SCEEECCCT
T ss_pred EehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCC-CCEEEeeCC
Confidence 999999 6799999964 778888999999999999999 77 99999999999999998 689999999
Q ss_pred cccccccccccccCccccccccCCccccccccccC------CCCchhhHHHHHHHHHHHHcC----------CCCCCCcc
Q 008898 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG------KVDEKIDVYSYGVVLLELITG----------KEAIQTNK 456 (549)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~k~DvwSlGvil~elltG----------~~p~~~~~ 456 (549)
++.......... ........||+.|+|||++.+. .++.++|||||||++|||++| ..||....
T Consensus 159 ~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 159 LAVMHSQSTNQL-DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TCEEEETTTTEE-ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred Ceeecccccccc-cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 997654332111 1122345799999999999876 455799999999999999999 88887654
Q ss_pred cchhhHHHHHHHhhcccccccccCCccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 457 ANRESLVLWARSLLSSGLCERLIDPQLN-EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 457 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.................. .+.+. ..+.......+.+++..||+.||.+|||+.+|++.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CSSCCHHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 433333333322222211 11111 22334567889999999999999999999999998875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=351.72 Aligned_cols=277 Identities=23% Similarity=0.316 Sum_probs=200.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.++|...+.||+|+||.||+|.+ .+|+.+|+|++...... .+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 35789999999999999999987 45999999998765433 245778999999999999999999999999999999
Q ss_pred eccCC-CHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLLNG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~~g-sL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+.| +|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCcc-
Confidence 99954 57777653 77888999999999999999999 99999999999999998 689999999996644221
Q ss_pred cccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc----------
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS---------- 471 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~---------- 471 (549)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.........
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 157 ----DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHH
T ss_pred ----cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhcccccccccccc
Confidence 12234578999999999876 5689999999999999999999999987654322 1111111100
Q ss_pred -cccccc--ccCCccccc---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHhhccC
Q 008898 472 -SGLCER--LIDPQLNEE---YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLNERRS 542 (549)
Q Consensus 472 -~~~~~~--~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~~~~~ 542 (549)
...... +.++..... ........+.+++..||..||.+|||++++++ |+||+...+.++..+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----hp~f~~~~~~~~~~~~~~~ 303 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH-----HPYFENIREIEDLAKEHDK 303 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT-----SGGGTTCC-----------
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc-----ChHHHhccCHHHHHHhhcc
Confidence 000000 111110000 00123345788999999999999999999999 9999998888776655443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=362.37 Aligned_cols=272 Identities=23% Similarity=0.271 Sum_probs=205.6
Q ss_pred hcCCCCCceEccc--CceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQG--GNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G--~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|++.+.||+| +||.||++.+ .+|+.||||+++...... +.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 9999999988 479999999998654333 457789999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
||||+ +|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~-~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVD-GKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC-CCEEEcccccceeec
Confidence 99999 6899999854 67788899999999999999999 99999999999999988 699999999885443
Q ss_pred cccc--cccCccccccccCCcccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 399 QSHQ--VSENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 399 ~~~~--~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
.... ...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............+.........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 2111 111122234579999999999987 579999999999999999999999997654433221111100000000
Q ss_pred ---------------------cccccC---C------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 475 ---------------------CERLID---P------QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 475 ---------------------~~~~~d---~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
...... + .....+.......+.+++..||..||.+|||+.++++ |
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~-----h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN-----H 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT-----S
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc-----C
Confidence 000000 0 0000122233456888999999999999999999998 8
Q ss_pred hhhhhhh
Q 008898 525 YWLKMKR 531 (549)
Q Consensus 525 ~w~~~~~ 531 (549)
+||+...
T Consensus 335 p~f~~~~ 341 (389)
T 3gni_B 335 SFFKQIK 341 (389)
T ss_dssp GGGGGC-
T ss_pred HHHHHHh
Confidence 9998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=354.90 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=195.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---------------------------HHHHHHHHHHHh
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---------------------------EEEVLREVELLS 302 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---------------------------~~~~~~E~~il~ 302 (549)
.++|...+.||+|+||.||+|.+ .+++.||||++...... .+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35799999999999999999987 56899999999754311 245789999999
Q ss_pred cCCCCCeeeEEEEEEc--CCeEEEEEecc-CCCHHHHHH--HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCE
Q 008898 303 SIKHENIVRIIGYCHS--KEMYAIVYNLL-NGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNI 377 (549)
Q Consensus 303 ~l~h~nIv~l~~~~~~--~~~~~lv~e~~-~gsL~~~l~--~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NI 377 (549)
.++||||+++++++.+ .+.++++|||+ +|+|.+++. .+++.....++.||+.||.|||+. +|+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 9999999999999986 67899999999 567877653 377888999999999999999999 999999999999
Q ss_pred EEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCC
Q 008898 378 LLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK---VDEKIDVYSYGVVLLELITGKEAIQT 454 (549)
Q Consensus 378 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~~ 454 (549)
|++.+ +.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 169 l~~~~-~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 169 LVGED-GHIKIADFGVSNEFKGSD-----ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp EECTT-SCEEECCCTTCEECSSSS-----CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EECCC-CCEEEecCCCcccccccc-----ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99998 689999999986544321 1223457999999999998765 37899999999999999999999976
Q ss_pred cccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 455 NKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 455 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
..... +...+... . ...+ ... .....+.+++..||..||.+|||+.++++ |+||.
T Consensus 243 ~~~~~-----~~~~~~~~-~---~~~~-~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~-----hp~~~ 297 (298)
T 2zv2_A 243 ERIMC-----LHSKIKSQ-A---LEFP-DQP----DIAEDLKDLITRMLDKNPESRIVVPEIKL-----HPWVT 297 (298)
T ss_dssp SSHHH-----HHHHHHHC-C---CCCC-SSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT-----CHHHH
T ss_pred ccHHH-----HHHHHhcc-c---CCCC-Ccc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc-----Ccccc
Confidence 53211 11111111 0 0001 011 22345778889999999999999999998 89985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=367.59 Aligned_cols=272 Identities=22% Similarity=0.330 Sum_probs=195.8
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCC-CCCeeeEEEEEEcCC--eE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIK-HENIVRIIGYCHSKE--MY 322 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~--~~ 322 (549)
+.++|...+.||+|+||.||+|.+ .+|+.||||++...... ...+.+|+.+++.+. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999987 57999999998654322 345778999999997 999999999997544 79
Q ss_pred EEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 323 AIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 323 ~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
++||||+.|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 87 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 87 YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEESSSC
T ss_pred EEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCC-CCEEecCCccccccccc
Confidence 99999999999999965 67778888999999999999999 99999999999999999 68999999999765331
Q ss_pred ccc----------------ccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHH
Q 008898 401 HQV----------------SENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLV 463 (549)
Q Consensus 401 ~~~----------------~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~ 463 (549)
... .........+||+.|+|||++.+ ..++.++|||||||++|||++|++||....... .+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~ 241 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN-QLE 241 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 111 11122345689999999999986 678999999999999999999999998765322 222
Q ss_pred HHHHHhhccc--ccccccC------------------CcccccC------------CHHHHHHHHHHHHHhcccCCCCCC
Q 008898 464 LWARSLLSSG--LCERLID------------------PQLNEEY------------NREEIEIVMCAARLCLLHSSSRRP 511 (549)
Q Consensus 464 ~~~~~~~~~~--~~~~~~d------------------~~l~~~~------------~~~~~~~l~~li~~Cl~~dP~~RP 511 (549)
.....+.... ....+.. ......+ .......+.+++..||..||.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 1111110000 0000000 0000000 001234578899999999999999
Q ss_pred CHHHHHHHhcCCchhhhhhh
Q 008898 512 TMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 512 s~~evl~~L~~~~~w~~~~~ 531 (549)
|+.++++ |+|+....
T Consensus 322 t~~e~l~-----Hp~~~~~~ 336 (388)
T 3oz6_A 322 SANDALK-----HPFVSIFH 336 (388)
T ss_dssp CHHHHTT-----STTTTTTC
T ss_pred CHHHHhC-----CHHHHHhc
Confidence 9999998 89986544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=349.57 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=206.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--eEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKE--MYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--~~~lv 325 (549)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++... ...+.+.+|+.+++.++||||+++++++...+ .+++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 46799999999999999999987 459999999997543 23467889999999999999999999997655 78999
Q ss_pred Eecc-CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE----ecCCCceEEeeeccc
Q 008898 326 YNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL----SENFHHPQLSDFGAA 394 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~~kL~DFGla 394 (549)
|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||+ +.+ +.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSC-EEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCC-ceEEEccCCCc
Confidence 9999 6899999965 78888999999999999999999 99999999999998 555 57999999999
Q ss_pred cccccccccccCccccccccCCccccccccc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHH
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMM--------YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWA 466 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~ 466 (549)
...... .......||+.|+|||++. +..++.++|||||||++|||++|+.||..............
T Consensus 164 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 164 RELEDD------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp EECCTT------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred eecCCC------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 764332 2223457999999999986 57789999999999999999999999975543222222222
Q ss_pred HHhhcc--cccccc-----------cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 467 RSLLSS--GLCERL-----------IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 467 ~~~~~~--~~~~~~-----------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...... .....+ -+......+.......+.+++..||+.||.+|||+.|+++...+
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 211111 000000 01112234567888899999999999999999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=373.42 Aligned_cols=269 Identities=20% Similarity=0.255 Sum_probs=204.1
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK------E 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~------~ 320 (549)
.++|+..+.||+|+||.||+|.+ .+|+.||||++...... ...+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 56899999999999999999987 56899999999754322 35678999999999999999999999654 4
Q ss_pred eEEEEEeccCCCHHHHHH-HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 321 MYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~-~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
.+++||||+.|+|.+.+. .+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+|.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCCCCC-----
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCC-CCEEEEEEEeeeecCC
Confidence 679999999998888774 378888899999999999999999 99999999999999998 6899999999965432
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc------
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG------ 473 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~------ 473 (549)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... .+......+....
T Consensus 217 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 217 ------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp ------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHTT
T ss_pred ------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHH
Confidence 222345689999999999999999999999999999999999999998654321 1221111111000
Q ss_pred ---ccc---------------cccCCccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 474 ---LCE---------------RLIDPQLN---EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 474 ---~~~---------------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
... ......+. ..........+.+++.+||..||.+|||+.|+++ |+||.....
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~-----Hp~~~~~~~ 364 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ-----HPYINVWYD 364 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT-----STTTGGGCC
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc-----ChhhhhccC
Confidence 000 00000000 0001122567889999999999999999999999 999986554
Q ss_pred HHH
Q 008898 533 KEE 535 (549)
Q Consensus 533 ~~~ 535 (549)
..+
T Consensus 365 ~~~ 367 (464)
T 3ttj_A 365 PAE 367 (464)
T ss_dssp HHH
T ss_pred ccc
Confidence 443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.17 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=192.1
Q ss_pred hhcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+.++|...+.||+|+||.||+|.+. +++.||||+++... ..+.+.+|+.+++.++||||+++++++.+.+.++++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4578999999999999999999884 58899999998543 345678899999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec---CCCceEEeeecccccccccc
Q 008898 329 L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---NFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 329 ~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~~kL~DFGla~~~~~~~ 401 (549)
+ +|+|.+++.. +++.+...++.||+.||.|||+. +|+||||||+|||++. + +.+||+|||++......
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~-~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPD-APLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTT-CCEEECCCC---------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCC-CCEEEccCccccccCcc-
Confidence 9 6799999854 67888999999999999999999 9999999999999975 5 68999999998654321
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.........+.. +..... .
T Consensus 205 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----i~~~~~--~---- 269 (349)
T 2w4o_A 205 -----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR----ILNCEY--Y---- 269 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH----HHTTCC--C----
T ss_pred -----cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH----HHhCCC--c----
Confidence 1223567999999999999999999999999999999999999999765443222111 111110 0
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
............+.+++..||..||.+|||+.++++ |+|+...
T Consensus 270 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-----hp~~~~~ 312 (349)
T 2w4o_A 270 -FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ-----HPWVTGK 312 (349)
T ss_dssp -CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH-----STTTTST
T ss_pred -cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc-----CcccCCC
Confidence 011111223456778899999999999999999999 8998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=351.77 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=209.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
.++|.+.+.||+|+||.||++.+ .+|+.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999987 4689999999975432 356789999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC---ceEEeeecccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH---HPQLSDFGAAM 395 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~~kL~DFGla~ 395 (549)
+++|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+.. .++|+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 9999999 6799999965 67888999999999999999999 9999999999999988732 69999999986
Q ss_pred ccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+.. +....
T Consensus 168 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~----i~~~~-- 234 (321)
T 2a2a_A 168 EIEDG------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLAN----ITSVS-- 234 (321)
T ss_dssp ECCTT------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHH----HHTTC--
T ss_pred ecCcc------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHHH----HHhcc--
Confidence 54332 12235579999999999999999999999999999999999999997654321 1111 11000
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
...++.... .....+.+++..||..||.+|||+.++++ |+|+.....+...
T Consensus 235 -~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~-----hp~~~~~~~~~~~ 285 (321)
T 2a2a_A 235 -YDFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR-----HPWITPVDNQQAM 285 (321)
T ss_dssp -CCCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH-----STTTSCSSHHHHH
T ss_pred -cccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc-----CccccCCCccccc
Confidence 000111111 12345788899999999999999999999 8999865544433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=349.61 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=201.2
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
+.++|.+.+.||+|+||.||++.+ .+++.+|+|++...... .+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 356899999999999999999987 56899999998654322 2467899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
+|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCCSSSTTC---
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CCEEEEeCCCccccccc
Confidence 99999 6699999965 67888999999999999999999 99999999999999998 68999999999654332
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
. ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......... ...... .
T Consensus 165 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-----~~~~~~------~ 229 (294)
T 4eqm_A 165 S----LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-----KHIQDS------V 229 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-----HHHSSC------C
T ss_pred c----ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHhhcc------C
Confidence 1 112234579999999999999999999999999999999999999998765422211 111110 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRP-TMKTLLKLFQEP 523 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~ 523 (549)
+........+.+..+.+++.+|+..||.+|| ++.++.+.|+..
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 1111122233456688889999999999999 899998877653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.07 Aligned_cols=252 Identities=26% Similarity=0.344 Sum_probs=191.8
Q ss_pred hcCCCCC-ceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHH-hcCCCCCeeeEEEEEEc----CCeEE
Q 008898 251 THNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELL-SSIKHENIVRIIGYCHS----KEMYA 323 (549)
Q Consensus 251 ~~~f~~~-~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il-~~l~h~nIv~l~~~~~~----~~~~~ 323 (549)
.++|... ++||+|+||.||++.+ .+|+.||||+++.. ..+.+|+.++ +..+||||+++++++.. .+.++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 3466665 6899999999999987 56899999999743 4677889887 45689999999998865 66799
Q ss_pred EEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec---CCCceEEeeeccc
Q 008898 324 IVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---NFHHPQLSDFGAA 394 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~~kL~DFGla 394 (549)
+||||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++. + +.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~-~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPN-AILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTT-CCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCC-ccEEEEecccc
Confidence 999999 6799999954 78889999999999999999999 9999999999999987 5 68999999999
Q ss_pred cccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .+. .+.
T Consensus 212 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~i~-~~~ 283 (400)
T 1nxk_A 212 KETTS------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-RIR-MGQ 283 (400)
T ss_dssp EECC-----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH-HHH-HTC
T ss_pred cccCC------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH-HHH-cCc
Confidence 65432 1223456899999999999999999999999999999999999999976543211000000 000 000
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
. ....+ . .......+.+++..||..||.+|||+.++++ |+|+..
T Consensus 284 ~-~~~~~-~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~-----hp~~~~ 327 (400)
T 1nxk_A 284 Y-EFPNP-E----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN-----HPWIMQ 327 (400)
T ss_dssp C-CCCTT-T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH-----SHHHHT
T ss_pred c-cCCCc-c----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc-----CccccC
Confidence 0 00000 0 1122345778899999999999999999999 899864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=357.90 Aligned_cols=251 Identities=21% Similarity=0.339 Sum_probs=199.6
Q ss_pred hcCCCCCceEcccCceEEEEEEec----CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~----~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|.+.+.||+|+||.||+|.+. .+..||||+++.... ..+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357889999999999999999873 345699999976432 23568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
||||+ +|+|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCC-CCEEECCCCccccccc
Confidence 99999 679999995 377888999999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||........ . ......
T Consensus 204 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~----~~~~~~------ 270 (325)
T 3kul_A 204 DPD--AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-I----SSVEEG------ 270 (325)
T ss_dssp -----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-H----HHHHTT------
T ss_pred Ccc--ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-H----HHHHcC------
Confidence 211 1112223456888999999999999999999999999999999 9999976543221 1 111111
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
... ..+...+..+.+++..||..||.+|||+.+|++.|+.
T Consensus 271 ~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 271 YRL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 011 1122334567888999999999999999999998854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.51 Aligned_cols=257 Identities=19% Similarity=0.264 Sum_probs=201.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|...+.||+|+||.||++.+ .+|+.||||+++... .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35799999999999999999987 569999999997532 2234577899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|||+ +|+|.+++.. +++.....++.||+.||.|||+ . +|+||||||+|||++.+ +.+||+|||+|.....
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIK- 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCC-CCEEEccCCCceeccC-
Confidence 9999 6799999864 6788889999999999999998 7 99999999999999998 6999999999864322
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+... .
T Consensus 302 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~----~~i~~~-------~ 365 (446)
T 4ejn_A 302 ----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-F----ELILME-------E 365 (446)
T ss_dssp ---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H----HHHHHC-------C
T ss_pred ----CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-H----HHHHhC-------C
Confidence 12233457899999999999999999999999999999999999999976543221 1 111111 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEELL 537 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~~ 537 (549)
..++.. ....+.+++..||..||.+|| ++.++++ |+||.....+....
T Consensus 366 ~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~-----hp~f~~~~~~~~~~ 418 (446)
T 4ejn_A 366 IRFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ-----HRFFAGIVWQHVYE 418 (446)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT-----SGGGTTCCHHHHHT
T ss_pred CCCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh-----CccccCCCHHHHhh
Confidence 111222 234577888999999999999 9999999 99999877665443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=348.67 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=203.4
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++|...+.||+|+||.||++.+.++..+|+|+++......+++.+|+.+++.++||||+++++++.+.+.++++|||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 3578889999999999999999888889999999987777788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 330 NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 330 ~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
+|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~--- 175 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEY--- 175 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTT-SCEEECSTTGGGGBCCHHH---
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCC-CCEEEcccccccccccccc---
Confidence 7899999954 77888999999999999999999 99999999999999998 6899999999975543211
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.......||+.|+|||++.+..++.++|||||||++|+|++ |+.||........ . ..+... ......
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-~----~~~~~~------~~~~~~ 243 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-A----EHIAQG------LRLYRP 243 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-H----HHHHTT------CCCCCC
T ss_pred -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-H----HHHhcc------cCCCCC
Confidence 11223457888999999999999999999999999999998 9999976553221 1 111111 111111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. .....+.+++..||+.||.+|||+.++++.|++
T Consensus 244 ~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 244 H----LASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp T----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred C----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1 123467788999999999999999999997753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=359.39 Aligned_cols=269 Identities=22% Similarity=0.325 Sum_probs=201.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH--HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|...+.||+|+||.||+|.. .+++.||+|+++...... ..+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4688999999999999999987 478999999997543221 1355799999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~---- 153 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINER-GELKLADFGLARAKSIP---- 153 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTT-CCEEECSSSEEECC-------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCC-CCEEEccCcccccccCC----
Confidence 99999999865 67788899999999999999999 99999999999999998 68999999998653321
Q ss_pred cCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--cccccc--
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--LCERLI-- 479 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~~~-- 479 (549)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+........... ......
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcc
Confidence 122234578999999999886 568999999999999999999999998765322 2222222111100 000000
Q ss_pred -------CCccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 480 -------DPQLN----EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 480 -------d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
.+... ..........+.+++..||..||.+|||+.|+++ |+||....+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~-----hp~f~~~~~~~~ 293 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK-----HPFFLSLGERIH 293 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT-----SGGGGGGCSTTS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc-----Chhhhhcccccc
Confidence 00000 0001112345778999999999999999999999 999987665433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=344.08 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=208.5
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
+.++|...+.||+|+||.||+|.+ .+|+.+|+|++....... +.+.+|+.+++.++||||+++++++.+++..+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 467899999999999999999987 568999999997654332 4577899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC--CceEEeeecccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~~kL~DFGla~~~~~ 399 (549)
|||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++.+. +.+||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999 6689888854 67888999999999999999999 999999999999998652 2499999999865433
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
. .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... .... .... .. ...
T Consensus 161 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~----~~~~-~~-~~~ 227 (284)
T 3kk8_A 161 S------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQ----IKAG-AY-DYP 227 (284)
T ss_dssp S------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH----HHHT-CC-CCC
T ss_pred C------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHH----HHhc-cc-cCC
Confidence 2 22234679999999999999999999999999999999999999997654322 1111 1100 00 001
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
.+ . .......+.+++..||+.||.+|||+.++++ |+|+....+....
T Consensus 228 ~~-~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~-----h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 228 SP-E----WDTVTPEAKSLIDSMLTVNPKKRITADQALK-----VPWICNRERVASA 274 (284)
T ss_dssp TT-T----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT-----SHHHHSCCCGGGS
T ss_pred ch-h----hcccCHHHHHHHHHHcccChhhCCCHHHHhc-----CccccCChhHHhH
Confidence 11 0 1122345778889999999999999999999 8999876554443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=354.98 Aligned_cols=264 Identities=23% Similarity=0.286 Sum_probs=203.3
Q ss_pred HHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC------CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC
Q 008898 247 LCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT------NWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319 (549)
Q Consensus 247 l~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~------~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 319 (549)
+..+.++|...+.||+|+||.||+|.+ .+++.+|+|++... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345567899999999999999999987 56889999999643 22346788999999999999999999999999
Q ss_pred CeEEEEEecc-CCCHHHHHH-------------------------------------------HhchhHHHHHHHHHHHH
Q 008898 320 EMYAIVYNLL-NGSLKQYLK-------------------------------------------QLKWNERMDVAIGVAKA 355 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~-------------------------------------------~~~~~~~~~i~~~i~~a 355 (549)
+.+++||||+ +|+|.+++. .+++.....++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999 789999884 13456677899999999
Q ss_pred HHHHHhCCCCCEEEecCCCCCEEEecCC-CceEEeeeccccccccccccccCccccccccCCcccccccccc--CCCCch
Q 008898 356 LEYLHHTCDPPIIHRDVKSSNILLSENF-HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY--GKVDEK 432 (549)
Q Consensus 356 L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k 432 (549)
|.|||+. +|+||||||+|||++.+. ..+||+|||++........ ..........||+.|+|||++.+ ..++.+
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-GEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC-C--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCc-cccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999 999999999999998662 2799999999975433211 11112345679999999999875 678999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 008898 433 IDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT 512 (549)
Q Consensus 433 ~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 512 (549)
+|||||||++|||++|+.||........ ... ...... ....+ ........+.+++..||..||.+|||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~-~~~----~~~~~~--~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQ----VLNKKL--CFENP-----NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH----HHHCCC--CTTSG-----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHH-HHH----HHhccc--ccCCc-----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999976654321 111 111110 00001 01112346778889999999999999
Q ss_pred HHHHHHHhcCCchhhhhhh
Q 008898 513 MKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 513 ~~evl~~L~~~~~w~~~~~ 531 (549)
+.++++ |+||+...
T Consensus 325 ~~~~l~-----hp~~~~~~ 338 (345)
T 3hko_A 325 AMRALQ-----HPWISQFS 338 (345)
T ss_dssp HHHHHH-----SHHHHTTS
T ss_pred HHHHhc-----ChhhccCh
Confidence 999999 99997654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=368.72 Aligned_cols=263 Identities=21% Similarity=0.333 Sum_probs=205.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC------CCCCeeeEEEEEEcCCeEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI------KHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l------~h~nIv~l~~~~~~~~~~~ 323 (549)
..+|.+.+.||+|+||.||+|.+ .+++.||||+++........+.+|+.+++.+ +|+||+++++++...+.++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 46799999999999999999977 5689999999986654456677888888776 5789999999999999999
Q ss_pred EEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc--eEEeeeccccc
Q 008898 324 IVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH--PQLSDFGAAMV 396 (549)
Q Consensus 324 lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~--~kL~DFGla~~ 396 (549)
++||++.|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +. +||+|||++..
T Consensus 176 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQ-GRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESST-TSCCEEECCCTTCEE
T ss_pred EEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccC-CCcceEEeeccccee
Confidence 9999999999999964 67788899999999999999999 99999999999999988 45 99999999854
Q ss_pred cccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc----
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS---- 472 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~---- 472 (549)
... .....+||+.|+|||++.+..++.++|||||||++|||++|++||...... +.+..+.......
T Consensus 252 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~-~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 252 EHQ--------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG-DQLACMIELLGMPSQKL 322 (429)
T ss_dssp TTC--------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHH
T ss_pred cCC--------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHH
Confidence 322 223568999999999999999999999999999999999999999876542 2222222211100
Q ss_pred ----cccccccCCc--------------------------------cccc----CCHHHHHHHHHHHHHhcccCCCCCCC
Q 008898 473 ----GLCERLIDPQ--------------------------------LNEE----YNREEIEIVMCAARLCLLHSSSRRPT 512 (549)
Q Consensus 473 ----~~~~~~~d~~--------------------------------l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs 512 (549)
.....+++.. .... ........+.+++..||..||.+|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 0000000000 0000 00011355788999999999999999
Q ss_pred HHHHHHHhcCCchhhhhhh
Q 008898 513 MKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 513 ~~evl~~L~~~~~w~~~~~ 531 (549)
+.|+++ |+||+...
T Consensus 403 a~e~L~-----Hpw~~~~~ 416 (429)
T 3kvw_A 403 PGQALR-----HPWLRRRL 416 (429)
T ss_dssp HHHHHT-----STTTC---
T ss_pred HHHHhC-----ChhhccCC
Confidence 999999 99998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=368.79 Aligned_cols=272 Identities=20% Similarity=0.298 Sum_probs=190.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEE-----cCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCH-----SKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~-----~~~~ 321 (549)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++...... .+.+.+|+.+|+.++||||+++++++. ..+.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999977 57899999999754332 356889999999999999999999984 3357
Q ss_pred EEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+++|||+++|+|.+++.. +++..+..++.||+.||.|||+. +||||||||+||||+.+ +.+||+|||+|+...
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQD-CSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-CCEEECCCTTCBCTT
T ss_pred EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCC-CCEeecccccchhcc
Confidence 999999999999999965 77888999999999999999999 99999999999999999 699999999997654
Q ss_pred ccccccc----------------------CccccccccCCccccccccc-cCCCCchhhHHHHHHHHHHHHc--------
Q 008898 399 QSHQVSE----------------------NVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELIT-------- 447 (549)
Q Consensus 399 ~~~~~~~----------------------~~~~~~~~gt~~y~APE~~~-~~~~~~k~DvwSlGvil~ellt-------- 447 (549)
....... .......+||+.|+|||++. +..|+.++|||||||+||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 3211100 11234568999999999864 5679999999999999999999
Q ss_pred ---CCCCCCCcccc-------------------hhhHHHHHHHhhccc--cc------------ccc---cCCcccccCC
Q 008898 448 ---GKEAIQTNKAN-------------------RESLVLWARSLLSSG--LC------------ERL---IDPQLNEEYN 488 (549)
Q Consensus 448 ---G~~p~~~~~~~-------------------~~~l~~~~~~~~~~~--~~------------~~~---~d~~l~~~~~ 488 (549)
|+++|...... .+.+......+.... .+ ..+ ....+.. ..
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 366 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE-RF 366 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG-GS
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH-HC
Confidence 66666443210 111111111110000 00 000 0000000 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 489 REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 489 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
+.....+.+++..||..||.+|||+.|+++ |+||+....
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~-----Hp~f~~~~~ 405 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLA-----HPFFKEVRI 405 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH-----SGGGTTTCC
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhc-----CHhhhhcCC
Confidence 122455778999999999999999999999 999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=359.45 Aligned_cols=257 Identities=22% Similarity=0.294 Sum_probs=199.8
Q ss_pred CCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCC
Q 008898 256 PKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gs 332 (549)
..+.||+|+||.||+|.. .+|+.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+.+++||||+ +|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356899999999999987 5699999999986542 3467889999999999999999999999999999999999 679
Q ss_pred HHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec-CCCceEEeeeccccccccccccccCc
Q 008898 333 LKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 333 L~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++. +.+.+||+|||++...... .
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~------~ 243 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR------E 243 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT------C
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc------c
Confidence 9888843 67788889999999999999999 9999999999999953 2258999999999764332 1
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+..+... .. . ..+.....
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~----~~--~-~~~~~~~~- 314 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILAC----RW--D-LEDEEFQD- 314 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHT----CC--C-SCSGGGTT-
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc----cC--C-CChhhhcc-
Confidence 2234579999999999998899999999999999999999999997654321 12111111 00 0 01111112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
....+.+++..||..||.+|||+.++++ |+||........+..
T Consensus 315 ---~~~~~~~li~~~L~~dp~~Rps~~e~l~-----hp~~~~~~~~~~~~~ 357 (373)
T 2x4f_A 315 ---ISEEAKEFISKLLIKEKSWRISASEALK-----HPWLSDHKLHSRLSA 357 (373)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHHHHH-----SHHHHCHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCChhhCCCHHHHhc-----CcCcCCCchhhhhhh
Confidence 2346778889999999999999999999 899987765544433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=370.60 Aligned_cols=266 Identities=21% Similarity=0.247 Sum_probs=208.8
Q ss_pred CHHHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEE
Q 008898 243 TSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCH 317 (549)
Q Consensus 243 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~ 317 (549)
...+.....++|...+.||+|+||.||++.+ .+|+.||+|++++... ....+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3445555678999999999999999999987 5799999999975321 1234788999999999999999999999
Q ss_pred cCCeEEEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeec
Q 008898 318 SKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (549)
Q Consensus 318 ~~~~~~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFG 392 (549)
+.+.+++||||+ +|+|.+++.+ +++.....++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~-g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRC-GHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCC-CCEEEeech
Confidence 999999999999 7899999964 67778889999999999999999 99999999999999998 799999999
Q ss_pred cccccccccccccCccccccccCCccccccccc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHH
Q 008898 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-------YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW 465 (549)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~ 465 (549)
++....... .......+||+.|+|||++. ...++.++|||||||++|||++|+.||........ ..
T Consensus 208 la~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~-- 280 (412)
T 2vd5_A 208 SCLKLRADG----TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YG-- 280 (412)
T ss_dssp TCEECCTTS----CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH--
T ss_pred hheeccCCC----ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HH--
Confidence 996543321 11223568999999999987 35689999999999999999999999976543221 11
Q ss_pred HHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHhcCCchhhhhhhHH
Q 008898 466 ARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRR---PTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 466 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~evl~~L~~~~~w~~~~~~~ 533 (549)
.+.... ..+..|..... ....+.++++.||. +|.+| |++.++++ |+||+...+.
T Consensus 281 --~i~~~~--~~~~~p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~-----Hpff~~i~w~ 337 (412)
T 2vd5_A 281 --KIVHYK--EHLSLPLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRT-----HPFFFGLDWD 337 (412)
T ss_dssp --HHHTHH--HHCCCC----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT-----SGGGTTCCST
T ss_pred --HHHhcc--cCcCCCccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc-----CCCcCCCCHH
Confidence 111100 00111111122 23457788899999 99998 69999998 9999876554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=375.64 Aligned_cols=259 Identities=23% Similarity=0.288 Sum_probs=211.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|...++||+|+||.||++.+ .+|+.||+|++.... .....+.+|+.+|+.++||||+++++++.+++.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999987 579999999997532 2345688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 326 YNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
|||+ +|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||+|.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~-g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH-GHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCC-CCeEEEecccceeccc
Confidence 9999 7899999864 77888899999999999999999 99999999999999998 7999999999976433
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+...
T Consensus 339 ~------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~-~i~~~i~~~------- 404 (576)
T 2acx_A 339 G------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKEV------- 404 (576)
T ss_dssp T------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH-HHHHHHHHC-------
T ss_pred C------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH-HHHHHhhcc-------
Confidence 2 22335689999999999999899999999999999999999999998754321111 111111100
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
...+ +......+.+++..||..||.+|| ++.++++ |+||+...+..-.
T Consensus 405 ~~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~-----HpfF~~i~w~~l~ 457 (576)
T 2acx_A 405 PEEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE-----HPLFKKLNFKRLG 457 (576)
T ss_dssp CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT-----SGGGTTCCHHHHH
T ss_pred cccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh-----ChhhccCCHHHHh
Confidence 1111 122334677888999999999999 7899998 9999987765443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=357.12 Aligned_cols=266 Identities=17% Similarity=0.254 Sum_probs=198.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.++|...+.||+|+||.||++.+ .+++.||||+++..... ...+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 45799999999999999999986 57899999999755432 245778999999999999999999999999999999
Q ss_pred eccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC----CCceEEeeecccccccc
Q 008898 327 NLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN----FHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 327 e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~~kL~DFGla~~~~~ 399 (549)
||+.|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||++.....
T Consensus 113 e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 113 EYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp ECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 9999999999965 67888899999999999999999 99999999999999533 14599999999965432
Q ss_pred ccccccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc--c-
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL--C- 475 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~- 475 (549)
. ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .+............ .
T Consensus 190 ~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 190 P-----IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp ---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTST
T ss_pred c-----ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhhhh
Confidence 1 11223457899999999998754 8999999999999999999999998765432 22222221110000 0
Q ss_pred -----ccc-------cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 476 -----ERL-------IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 476 -----~~~-------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
..+ ....+...........+.+++..||..||.+|||+.++++ |+||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~-----hp~f~~~ 325 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE-----HPYFSHN 325 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT-----SGGGSSS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC-----CcccCCC
Confidence 000 0000000000112356788999999999999999999999 9999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=360.39 Aligned_cols=253 Identities=18% Similarity=0.229 Sum_probs=205.1
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++|.+.+.||+|+||.||+|.+ .+|+.+|+|++..... ....+.+|+.+|+.++||||+++++++.+.+.+++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999987 5689999999976542 335688999999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC-CCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +|+|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 204 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 204 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence 9 679999985 367888999999999999999999 99999999999999743 257999999999764331
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......||+.|+|||++.+..++.++|||||||++|||++|..||....... .+.. +.... ...++.
T Consensus 205 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~----i~~~~---~~~~~~ 272 (387)
T 1kob_A 205 ----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQN----VKRCD---WEFDED 272 (387)
T ss_dssp ----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHH----HHHCC---CCCCSS
T ss_pred ----cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHH----HHhCC---CCCCcc
Confidence 12234579999999999999999999999999999999999999998654321 1111 11100 001111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.... ....+.+++..||..||.+|||+.++++ |+|++.
T Consensus 273 ~~~~----~s~~~~~li~~~L~~dP~~Rpt~~ell~-----hp~~~~ 310 (387)
T 1kob_A 273 AFSS----VSPEAKDFIKNLLQKEPRKRLTVHDALE-----HPWLKG 310 (387)
T ss_dssp TTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHT-----STTTSS
T ss_pred cccc----CCHHHHHHHHHHcCCChhHCcCHHHHhh-----CccccC
Confidence 1122 2345778889999999999999999998 888864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=360.36 Aligned_cols=260 Identities=24% Similarity=0.310 Sum_probs=199.6
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHH-HhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVEL-LSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|...+.||+|+||.||++.+ .+++.||+|++++.... ...+.+|..+ ++.++||||+++++++.+.+.+++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 5799999999999999999987 46889999999765422 2446677776 5778999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +|+|.+++.. +.+.....++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCCCBCGGGBC--
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCC-CCEEEeeCcccccccc--
Confidence 9999 6799999865 67788888999999999999999 99999999999999998 7999999999864322
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
........+||+.|+|||++.+..++.++|||||||++|||++|..||....... .. ..+... . .
T Consensus 192 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~----~~i~~~-~------~ 256 (373)
T 2r5t_A 192 ---HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MY----DNILNK-P------L 256 (373)
T ss_dssp ---CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HH----HHHHHS-C------C
T ss_pred ---CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HH----HHHHhc-c------c
Confidence 1223446789999999999999999999999999999999999999997654321 11 111111 0 1
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELL 537 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~ 537 (549)
.+...+ ...+.+++..||..||.+||++.+.++.+. .|+||+...+.+-..
T Consensus 257 ~~~~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~i~-~h~~f~~~~w~~l~~ 307 (373)
T 2r5t_A 257 QLKPNI----TNSARHLLEGLLQKDRTKRLGAKDDFMEIK-SHVFFSLINWDDLIN 307 (373)
T ss_dssp CCCSSS----CHHHHHHHHHHTCSSGGGSTTTTTTHHHHH-TSGGGTTCCHHHHHT
T ss_pred CCCCCC----CHHHHHHHHHHcccCHHhCCCCCCCHHHHh-CCccccCCCHHHHHh
Confidence 111222 345778889999999999999853222221 278998877665443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=358.01 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=201.8
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+.++|...+.||+|+||.||++.+ .+|+.||+|+++.... ...+|++++.++ +||||+++++++.+++.+++|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456799999999999999999987 5689999999986543 245688888877 79999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC---ceEEeeeccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH---HPQLSDFGAAMVHHQS 400 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~~kL~DFGla~~~~~~ 400 (549)
|+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||+.++.+ .+||+|||++......
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99 6799999854 67888999999999999999999 9999999999999854422 4999999999754332
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||....... ...+...+... ..
T Consensus 174 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~~-~~----- 240 (342)
T 2qr7_A 174 -----NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILARIGSG-KF----- 240 (342)
T ss_dssp -----TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHHHHHC-CC-----
T ss_pred -----CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHHHccC-Cc-----
Confidence 122345689999999999998889999999999999999999999997643211 11111111111 10
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.+...+.......+.+++..||..||.+|||+.++++ |+|+..
T Consensus 241 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~-----hp~~~~ 283 (342)
T 2qr7_A 241 -SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR-----HPWIVH 283 (342)
T ss_dssp -CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT-----SHHHHT
T ss_pred -ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc-----CCeecC
Confidence 1111111223456778889999999999999999998 899854
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.69 Aligned_cols=250 Identities=23% Similarity=0.377 Sum_probs=204.9
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++|...+.||+|+||.||+|.+.++..||||+++......+.+.+|+.+|+.++||||+++++++. .+.+++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 4578889999999999999999988899999999887777788999999999999999999999987 56788999999
Q ss_pred CCCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++. .+++...+.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++........
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~~- 340 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYT- 340 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCHHHH-
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCCcee-
Confidence 789999995 366778889999999999999999 99999999999999998 68999999999765432111
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
......+|+.|+|||++.++.++.++|||||||++|||++ |+.||....... .. . .+.. +. ..
T Consensus 341 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-~~-~---~i~~-~~--~~----- 404 (454)
T 1qcf_A 341 ---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VI-R---ALER-GY--RM----- 404 (454)
T ss_dssp ---TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HH-H---HHHH-TC--CC-----
T ss_pred ---ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-HH-H---HHHc-CC--CC-----
Confidence 1123346789999999999999999999999999999999 999997654321 11 1 1111 10 00
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
..+..++..+.+++..||..||.+|||+.+|++.|+...
T Consensus 405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 112233456888899999999999999999999997653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=359.73 Aligned_cols=266 Identities=20% Similarity=0.250 Sum_probs=202.5
Q ss_pred hhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEc---------
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS--------- 318 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--------- 318 (549)
...++|...+.||+|+||.||+|.+ .+|+.||||++..+.. ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 3467899999999999999999987 6799999999975532 23479999999999999999999843
Q ss_pred -----------------------------CCeEEEEEeccCCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhC
Q 008898 319 -----------------------------KEMYAIVYNLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHT 362 (549)
Q Consensus 319 -----------------------------~~~~~lv~e~~~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~ 362 (549)
+..+++||||+.|+|.+.+.. +++..+..++.||+.||.|||+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 334889999999998888753 67788899999999999999999
Q ss_pred CCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCC-CCchhhHHHHHHH
Q 008898 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVV 441 (549)
Q Consensus 363 ~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvi 441 (549)
+|+||||||+|||++.+.+.+||+|||+|...... .......||+.|+|||.+.+.. ++.++|||||||+
T Consensus 161 ---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 161 ---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp ---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred ---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999999854378999999999754332 2223457899999999988754 8999999999999
Q ss_pred HHHHHcCCCCCCCcccchhhHHHHHHHhhccc--------------ccccccCCcccccCCHHHHHHHHHHHHHhcccCC
Q 008898 442 LLELITGKEAIQTNKANRESLVLWARSLLSSG--------------LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSS 507 (549)
Q Consensus 442 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--------------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP 507 (549)
+|||++|+.||......+ .+........... ....+........++......+.+++..||..||
T Consensus 232 l~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999998765322 2222222111100 0000001111111222334568889999999999
Q ss_pred CCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 508 SRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 508 ~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.+|||+.|+++ |+||+....
T Consensus 311 ~~R~t~~e~l~-----hp~f~~~~~ 330 (383)
T 3eb0_A 311 DLRINPYEAMA-----HPFFDHLRN 330 (383)
T ss_dssp GGSCCHHHHHT-----SGGGHHHHH
T ss_pred hhCCCHHHHhc-----CHHHHHHHh
Confidence 99999999999 999986543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=361.40 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=202.8
Q ss_pred HHHHhhhcCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEE
Q 008898 245 QELCHLTHNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGY 315 (549)
Q Consensus 245 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~ 315 (549)
.+.....++|.+.+.||+|+||.||+|.+ .+++.||||+++..... .+.+.+|+.+++++ +||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 33444567899999999999999999973 34689999999765432 24688999999999 79999999999
Q ss_pred EEcCC-eEEEEEecc-CCCHHHHHHH------------------------------------------------------
Q 008898 316 CHSKE-MYAIVYNLL-NGSLKQYLKQ------------------------------------------------------ 339 (549)
Q Consensus 316 ~~~~~-~~~lv~e~~-~gsL~~~l~~------------------------------------------------------ 339 (549)
+.+.+ .++++|||+ +|+|.+++..
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 97754 489999999 6799999854
Q ss_pred ---------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 340 ---------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 340 ---------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~--- 247 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP--- 247 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCT---
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCC-CcEEEEeccceeeecccc---
Confidence 66778889999999999999999 99999999999999988 689999999997543321
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||.............. .+. ....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-----~~~-----~~~~ 317 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-----EGT-----RMRA 317 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH-----HTC-----CCCC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH-----cCC-----CCCC
Confidence 1122335578999999999999999999999999999999998 9999987654332221111 110 1111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
... ....+.+++..||+.||.+|||+.++++.|+.
T Consensus 318 ~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 318 PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 122 23457788899999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=351.80 Aligned_cols=258 Identities=18% Similarity=0.208 Sum_probs=203.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++|...+.||+|+||.||+|.+ .+|+.||||++..... ...+.+|+.+++.+ +||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 56899999999999999999987 6799999999975432 34688999999999 999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc-----eEEeeecccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH-----PQLSDFGAAMVHHQ 399 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~-----~kL~DFGla~~~~~ 399 (549)
++|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +. +||+|||++.....
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEESBC
T ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccC-CCCCCceEEEEEcccceeeec
Confidence 99999999963 78888999999999999999999 99999999999999987 45 99999999976543
Q ss_pred ccccc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 400 SHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 400 ~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.....
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~i~~~~~--- 237 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQKIGDTKR--- 237 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHHHHHHHH---
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHHHHhhhc---
Confidence 22111 11123467899999999999999999999999999999999999999987543211 111111100000
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+ ........+ .+.+++..||..||.+||++.+|.+.|++
T Consensus 238 -~~~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 238 -ATP--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp -HSC--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred -cCC--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000 000001122 68889999999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.83 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=201.0
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|...+.||+|+||.||+|.+. +++.||||+++..... ...+.+|+.+|+.++||||+++++++..++.+++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888999999999999999884 7899999999754322 2357889999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 328 LL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 328 ~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCC-CcEEECcCCCceecCCCce
Confidence 99 6899999954 67788899999999999999999 99999999999999988 6899999999865432211
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.. ......+++.|+|||.+.++.++.++|||||||++|||++ |..||....... ... ....... .
T Consensus 269 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~---~~~~~~~------~ 334 (377)
T 3cbl_A 269 AA---SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TRE---FVEKGGR------L 334 (377)
T ss_dssp EC---CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHH---HHHTTCC------C
T ss_pred ee---cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH---HHHcCCC------C
Confidence 11 1112235778999999999999999999999999999998 999997654321 111 1111110 1
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
..+..++..+.+++..||+.||.+|||+.+|++.|+..
T Consensus 335 ----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 335 ----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11222345678889999999999999999999988653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=349.69 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=202.1
Q ss_pred hcCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
.++|.+.+.||+|+||.||++.+ .+++.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+++.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788999999999999999975 2357999999975432 235688999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH---------------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCC
Q 008898 323 AIVYNLL-NGSLKQYLKQ---------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---------------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp 374 (549)
+++|||+ +|+|.+++.. +++..++.++.||++||.|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 9999999 6899999965 66778899999999999999999 999999999
Q ss_pred CCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 008898 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQ 453 (549)
Q Consensus 375 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~ 453 (549)
+|||++.+ +.+||+|||++......... .......||+.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 179 ~NIli~~~-~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 179 RNILVAEG-RKMKISDFGLSRDVYEEDSY---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGEEEETT-TEEEECCCTTCEECTTTSCE---ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred heEEEcCC-CCEEEccccccccccccccc---eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999998 68999999998755432211 12234467889999999999999999999999999999999 999997
Q ss_pred CcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 454 TNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 454 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...... +.... . .+. .+.. +......+.+++..||..||.+|||+.++++.|+.
T Consensus 255 ~~~~~~--~~~~~---~-~~~-----~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 255 GIPPER--LFNLL---K-TGH-----RMER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp TCCGGG--HHHHH---H-TTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHH--HHHHh---h-cCC-----cCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 665422 11111 1 110 1111 22234567888999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.96 Aligned_cols=258 Identities=16% Similarity=0.172 Sum_probs=205.4
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+.++|.+.+.||+|+||.||+|.+ .+|+.||+|++.... ....+.+|+.+++.+ +|+|++++++++.++..++++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 356799999999999999999987 679999999987543 234678899999999 79999999999999999999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc-----eEEeeeccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH-----PQLSDFGAAMVHH 398 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~-----~kL~DFGla~~~~ 398 (549)
|++|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +. +||+|||++....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~-~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRP-NSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCS-SSTTTTCEEECCCTTCEESB
T ss_pred ecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccC-CCCCCCeEEEEECccccccc
Confidence 999999999973 78888999999999999999999 99999999999999876 34 9999999997654
Q ss_pred cccccc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccch-h-hHHHHHHHhhcccc
Q 008898 399 QSHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR-E-SLVLWARSLLSSGL 474 (549)
Q Consensus 399 ~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~-~-~l~~~~~~~~~~~~ 474 (549)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||....... . .+........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-Ccc
Confidence 422111 1122345679999999999999999999999999999999999999998754321 1 1111111100 000
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
... + ....+..+.+++..||..||.+|||+.+|++.|++
T Consensus 242 ~~~-----~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 242 LRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHH-----H----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 000 0 11224567888999999999999999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=352.59 Aligned_cols=265 Identities=24% Similarity=0.311 Sum_probs=201.4
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS------EEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
..++|...+.||+|+||.||+|.+ .+|+.||+|+++..... ...+.+|+.+++.++||||+++++++.+.+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 356899999999999999999987 46899999999754321 13578999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 323 AIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 323 ~lv~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+++|||+.|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECCCGGGSTTT
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCC-CCEEEEecccceecc
Confidence 99999999999999854 67888999999999999999999 99999999999999998 689999999996543
Q ss_pred cccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|.+||....... .+.......... ....
T Consensus 164 ~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~-~~~~ 236 (346)
T 1ua2_A 164 SP-----NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTP-TEEQ 236 (346)
T ss_dssp SC-----CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCC-CTTT
T ss_pred CC-----cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCC-Chhh
Confidence 21 1223356799999999998764 48999999999999999999999997765322 222222211110 0000
Q ss_pred cc------CC---cccccCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 478 LI------DP---QLNEEYN-----REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 478 ~~------d~---~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+. +. ......+ ......+.+++..||..||.+|||+.++++ |+||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----h~~f~~~ 298 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK-----MKYFSNR 298 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT-----SGGGTSS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc-----ChhhhcC
Confidence 00 00 0000001 223467888999999999999999999999 8998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=355.93 Aligned_cols=246 Identities=30% Similarity=0.423 Sum_probs=200.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
+.|...+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999987 67999999999765322 245789999999999999999999999999999999
Q ss_pred eccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+.|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCC-CCEEEeeccCceecCC---
Confidence 9999999888843 67888899999999999999999 99999999999999998 6999999999865432
Q ss_pred cccCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.....||+.|+|||++. .+.++.++|||||||++|||++|+.||........ +.. .....
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~----~~~~~------ 269 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYH----IAQNE------ 269 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH----HHHSC------
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHH----HHhcC------
Confidence 12457999999999985 56789999999999999999999999976543221 111 11111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.+... .......+.+++..||..||.+|||+.++++ |+|+..
T Consensus 270 ~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~-----h~~~~~ 311 (348)
T 1u5q_A 270 SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK-----HRFVLR 311 (348)
T ss_dssp CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT-----CHHHHS
T ss_pred CCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhh-----Chhhhc
Confidence 11111 1122345778889999999999999999998 888754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=352.84 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=181.5
Q ss_pred CceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEecc-CCCH
Q 008898 257 KMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLL-NGSL 333 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~-~gsL 333 (549)
.+.||+|+||.||++.+ .+|+.||||++... ....+.+|+.+++.+. ||||+++++++.+++.+++||||+ +|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 47899999999999987 56899999999754 3467789999999997 999999999999999999999999 6799
Q ss_pred HHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC--CceEEeeeccccccccccccccCcc
Q 008898 334 KQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAAMVHHQSHQVSENVK 408 (549)
Q Consensus 334 ~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~~kL~DFGla~~~~~~~~~~~~~~ 408 (549)
.+++.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+. ..+||+|||++...... ...
T Consensus 94 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-----~~~ 165 (325)
T 3kn6_A 94 FERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-----NQP 165 (325)
T ss_dssp HHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-----CCc
Confidence 999965 68888999999999999999999 999999999999998652 17999999999654332 122
Q ss_pred ccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccch--hhHHHHHHHhhcccccccccCCccccc
Q 008898 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR--ESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 409 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .........+..... .....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-------~~~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-------SFEGE 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-------CCCSH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-------CCCcc
Confidence 335678999999999999999999999999999999999999997654311 111111112111110 00111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
........+.+++..||..||.+|||+.++++ |+|+...
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~-----h~w~~~~ 277 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY-----NEWLQDG 277 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT-----CGGGCTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc-----ChhhccC
Confidence 11123456788899999999999999999998 8999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=363.51 Aligned_cols=250 Identities=26% Similarity=0.343 Sum_probs=198.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
.++|...+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35788899999999999999974 3467899999975432 234688999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH----------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC--CceEEe
Q 008898 323 AIVYNLL-NGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLS 389 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~----------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~~kL~ 389 (549)
++||||+ +|+|.+++.. +++..++.++.||+.||.|||++ +|+||||||+|||++.+. ..+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999 6799999964 66778899999999999999999 999999999999998541 259999
Q ss_pred eeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHH
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARS 468 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 468 (549)
|||++........ ........||+.|+|||++.+..++.++|||||||++|||++ |..||....... + ...
T Consensus 227 DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~---~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--V---LEF 298 (367)
T ss_dssp CCHHHHHHHHHSS---CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H---HHH
T ss_pred CCccccccccccc---cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--H---HHH
Confidence 9999975433211 122234568999999999999999999999999999999998 999997654321 1 111
Q ss_pred hhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 469 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
+..... ... +...+..+.+++..||+.||.+|||+.+|++.|+
T Consensus 299 i~~~~~------~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 299 VTSGGR------MDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp HHTTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHcCCC------CCC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 111110 111 1223445788899999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=355.67 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=202.3
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---------SEEEVLREVELLSSIKHENIVRIIGYCHSK 319 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 319 (549)
+.++|...+.||+|+||.||+|.+ .+++.||||+++.... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356799999999999999999986 6789999999986532 123467899999999999999999999999
Q ss_pred CeEEEEEecc-CC-CHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 320 EMYAIVYNLL-NG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 320 ~~~~lv~e~~-~g-sL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
+.++++||++ .| +|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED-FTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-SCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC-CcEEEeecccc
Confidence 9999999988 55 89999964 77888999999999999999999 99999999999999998 68999999999
Q ss_pred cccccccccccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG 473 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 473 (549)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......
T Consensus 178 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------- 237 (335)
T 3dls_A 178 AYLERG------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------- 237 (335)
T ss_dssp EECCTT------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------
T ss_pred eECCCC------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------
Confidence 664332 22335679999999999998887 889999999999999999999997533210
Q ss_pred ccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 474 LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 474 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
..... .+.. ....+.+++..||..||.+|||+.++++ |+|++.
T Consensus 238 --~~~~~--~~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~-----hp~~~~ 280 (335)
T 3dls_A 238 --EAAIH--PPYL----VSKELMSLVSGLLQPVPERRTTLEKLVT-----DPWVTQ 280 (335)
T ss_dssp --TTCCC--CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHH-----CTTTTC
T ss_pred --hhccC--CCcc----cCHHHHHHHHHHccCChhhCcCHHHHhc-----CccccC
Confidence 00011 1111 2345778889999999999999999999 899865
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.06 Aligned_cols=267 Identities=22% Similarity=0.312 Sum_probs=201.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKE------ 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~------ 320 (549)
.++|...+.||+|+||.||+|.+ .+++.||||++...... ...+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999987 56899999999764332 245789999999999999999999997654
Q ss_pred eEEEEEeccCCCHHHHHH-HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 321 MYAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~-~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
.+++||||+.|+|.+++. .+++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECCCCC------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCC-CCEEEEEeeccccccc
Confidence 789999999999998885 377888899999999999999999 99999999999999998 6899999999865432
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc-----
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL----- 474 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----- 474 (549)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.......+.
T Consensus 180 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 180 S------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ----WNKVIEQLGTPCPEF 249 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHC-CCCCCHHH
T ss_pred c------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCCHHH
Confidence 1 122356799999999999999999999999999999999999999986543211 1111110000
Q ss_pred ----------------------cccccCCcc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 475 ----------------------CERLIDPQL---NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 475 ----------------------~~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
......... ...........+.+++..||..||.+|||+.++++ |+||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~-----hp~~~~ 324 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ-----HPYINV 324 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH-----SHHHHT
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC-----Ccchhh
Confidence 000000000 00011233567899999999999999999999999 999987
Q ss_pred hhHHHHH
Q 008898 530 KREKEEL 536 (549)
Q Consensus 530 ~~~~~~~ 536 (549)
.....+.
T Consensus 325 ~~~~~~~ 331 (371)
T 2xrw_A 325 WYDPSEA 331 (371)
T ss_dssp TCCHHHH
T ss_pred hcCcccc
Confidence 6555443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=357.20 Aligned_cols=264 Identities=16% Similarity=0.180 Sum_probs=200.9
Q ss_pred hcCCCCCceEcccCceEEEEEEecC------CcEEEEEEeecCCcCH------------HHHHHHHHHHhcCCCCCeeeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVD------GQVAAVKVLKCTNWSE------------EEVLREVELLSSIKHENIVRI 312 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~------g~~~AvK~l~~~~~~~------------~~~~~E~~il~~l~h~nIv~l 312 (549)
.++|.+.+.||+|+||.||+|.+.+ ++.||||++....... ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999998744 4789999987654211 123456667788899999999
Q ss_pred EEEEEcC----CeEEEEEeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe--cC
Q 008898 313 IGYCHSK----EMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS--EN 382 (549)
Q Consensus 313 ~~~~~~~----~~~~lv~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~--~~ 382 (549)
++++... ...++||||++|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence 9998654 56899999998899999954 68889999999999999999999 999999999999999 66
Q ss_pred CCceEEeeeccccccccccccc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchh
Q 008898 383 FHHPQLSDFGAAMVHHQSHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (549)
Q Consensus 383 ~~~~kL~DFGla~~~~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~ 460 (549)
+.+||+|||++.......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 191 -~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 191 -DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp -TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred -CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 689999999997654432111 11222456799999999999999999999999999999999999999986543322
Q ss_pred hHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 461 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
.. .+..... ...+..++++.+.. ...+..+.+++..||..||.+||++.+|++.|+..
T Consensus 270 ~~-~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 270 YV-RDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HH-HHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HH-HHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 22 1111111 11122222222211 12235677888999999999999999999988653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=344.06 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=197.1
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|...+.||+|+||.||++.. .++..+|+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 45789999999999999999987 568999999997643 345778999999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeecccccc
Q 008898 328 LL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVH 397 (549)
Q Consensus 328 ~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla~~~ 397 (549)
|+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99 6699998842 67788899999999999999999 99999999999999532 257999999999654
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
... .......||+.|+|||++. +.++.++|||||||++|||++|+.||........ ...... ....
T Consensus 178 ~~~------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~--~~~~--- 243 (285)
T 3is5_A 178 KSD------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATY--KEPN--- 243 (285)
T ss_dssp ---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH--CCCC---
T ss_pred CCc------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--Hhhhcc--CCcc---
Confidence 331 2223557999999999875 5789999999999999999999999976543221 111100 0000
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.......+ ...+.+++..||..||.+|||+.++++ |+||+.
T Consensus 244 --~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~-----hp~f~~ 284 (285)
T 3is5_A 244 --YAVECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH-----HEWFKQ 284 (285)
T ss_dssp --CCC--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT-----SGGGGC
T ss_pred --cccccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc-----CHHhhc
Confidence 00000112 345678889999999999999999998 899975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=358.01 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=207.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC--------CCCeeeEEEEEE----
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK--------HENIVRIIGYCH---- 317 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~--------h~nIv~l~~~~~---- 317 (549)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++......+.+.+|+.+++.+. |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 56899999999999999999987 56899999999866545567889999999885 788999999987
Q ss_pred cCCeEEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC---------
Q 008898 318 SKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--------- 383 (549)
Q Consensus 318 ~~~~~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--------- 383 (549)
....+++||||++|+|.+++.. +++..+..++.||+.||.|||+++ +|+||||||+|||++.+.
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhh
Confidence 5678999999999998888743 678889999999999999999853 899999999999998662
Q ss_pred ---------------------------------------CceEEeeeccccccccccccccCccccccccCCcccccccc
Q 008898 384 ---------------------------------------HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424 (549)
Q Consensus 384 ---------------------------------------~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~ 424 (549)
..+||+|||++...... .....||+.|+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------SCSCCSCGGGCCHHHH
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------CccCCCCCcccCChhh
Confidence 16999999999654321 2345799999999999
Q ss_pred ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccch-----hhHHHHHHHhhcc------------------cccccccCC
Q 008898 425 MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR-----ESLVLWARSLLSS------------------GLCERLIDP 481 (549)
Q Consensus 425 ~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~-----~~l~~~~~~~~~~------------------~~~~~~~d~ 481 (549)
.+..++.++|||||||++|||++|+.||....... ..+.......... +....+.+.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999997654321 1111111111000 000000000
Q ss_pred cc---------cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 482 QL---------NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 482 ~l---------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.. ...++......+.+++..||..||.+|||+.++++ |+||++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-----hp~~~~ 397 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR-----HPWLNS 397 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT-----SGGGGC
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh-----CccccC
Confidence 00 01235677788999999999999999999999999 999963
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=373.16 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=207.2
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.++|...+.||+|+||.||+|.+. ++..||||+++......+.+.+|+.+|++++||||++++++|...+.+++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 356888899999999999999885 4889999999877767788999999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 -~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+|+|.+++.. +++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCE-
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCC-CcEEEeecccceeccCCce-
Confidence 6899999964 67778889999999999999999 99999999999999988 6899999999976543211
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......+|+.|+|||++.++.++.++|||||||+||||++ |..||....... +... +. .+
T Consensus 374 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~---~~-~~--------- 435 (495)
T 1opk_A 374 ---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL---LE-KD--------- 435 (495)
T ss_dssp ---ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH---HH-TT---------
T ss_pred ---eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHH---HH-cC---------
Confidence 11223456789999999999999999999999999999999 999997654322 1111 11 11
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.....+..++..+.+++..||+.||.+|||+.+|++.|+..-
T Consensus 436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111112233456788899999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.77 Aligned_cols=268 Identities=27% Similarity=0.393 Sum_probs=186.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|...+.||+|+||.||++.+ .+++.||||++.... ...+.+.+|+.+++.++||||+++++++...+.++++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 46899999999999999999986 468999999986543 233567899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH-----------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 328 LL-NGSLKQYLKQ-----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 328 ~~-~gsL~~~l~~-----------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
|+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~ 169 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGED-GSVQIADFGVSA 169 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT-CCEEECCCHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCC-CCEEEEeccchh
Confidence 99 6799999864 67888999999999999999999 99999999999999998 689999999987
Q ss_pred ccccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
..................||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~ 247 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQNDPPSL 247 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HTSSCCCT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hccCCCcc
Confidence 6543322222223345679999999999876 56899999999999999999999999876543321110 00000000
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
.....++.....+ ...+.+++..||..||.+|||+.++++ |+||.....+
T Consensus 248 ~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~-----h~~~~~~~~~ 297 (303)
T 2vwi_A 248 ETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR-----HKFFQKAKNK 297 (303)
T ss_dssp TC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT-----STTC------
T ss_pred ccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh-----ChhhhcCCCC
Confidence 1111112222223 345778889999999999999999998 8999866544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=356.77 Aligned_cols=278 Identities=19% Similarity=0.239 Sum_probs=207.0
Q ss_pred HHHHHhhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC------------HHHHHHHHHHHhcCCCCCeee
Q 008898 244 SQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS------------EEEVLREVELLSSIKHENIVR 311 (549)
Q Consensus 244 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~------------~~~~~~E~~il~~l~h~nIv~ 311 (549)
..++..+.++|...+.||+|+||.||+|.+.+|+.||||++...... .+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999998643211 256889999999999999999
Q ss_pred EEEEEE-----cCCeEEEEEeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC
Q 008898 312 IIGYCH-----SKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN 382 (549)
Q Consensus 312 l~~~~~-----~~~~~~lv~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~ 382 (549)
+++++. ....+++||||+.|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADN 170 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred eeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCC
Confidence 999984 3347899999999999999854 67888999999999999999999 99999999999999988
Q ss_pred CCceEEeeeccccccccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhh
Q 008898 383 FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461 (549)
Q Consensus 383 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~ 461 (549)
+.+||+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .
T Consensus 171 -~~~kl~Dfg~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~ 242 (362)
T 3pg1_A 171 -NDITICDFNLAREDTA------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-Q 242 (362)
T ss_dssp -CCEEECCTTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H
T ss_pred -CCEEEEecCccccccc------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 6899999999864322 122234578999999999887 678999999999999999999999998754322 1
Q ss_pred HHHHHHHhhccc----------ccccccCC-------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 462 LVLWARSLLSSG----------LCERLIDP-------QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 462 l~~~~~~~~~~~----------~~~~~~d~-------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
+........... ........ .............+.+++..||..||.+|||+.++++ |
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR-----H 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT-----S
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc-----C
Confidence 111111111000 00000000 0001111122355788999999999999999999998 9
Q ss_pred hhhhhhhHHHHHH
Q 008898 525 YWLKMKREKEELL 537 (549)
Q Consensus 525 ~w~~~~~~~~~~~ 537 (549)
+||+......+..
T Consensus 318 p~f~~~~~~~~~~ 330 (362)
T 3pg1_A 318 PYFESLFDPLDLT 330 (362)
T ss_dssp GGGTTTCCGGGGT
T ss_pred chhhhccCccccc
Confidence 9998776544443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.69 Aligned_cols=247 Identities=16% Similarity=0.197 Sum_probs=194.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHH---HHhcCCCCCeeeEE-------EE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVE---LLSSIKHENIVRII-------GY 315 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~---il~~l~h~nIv~l~-------~~ 315 (549)
.++|...+.||+|+||.||+|.+ .+|+.||||+++... ...+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999986 569999999997432 22366889994 55566899999998 66
Q ss_pred EEcCC-----------------eEEEEEeccCCCHHHHHHH---hc-------hhHHHHHHHHHHHHHHHHHhCCCCCEE
Q 008898 316 CHSKE-----------------MYAIVYNLLNGSLKQYLKQ---LK-------WNERMDVAIGVAKALEYLHHTCDPPII 368 (549)
Q Consensus 316 ~~~~~-----------------~~~lv~e~~~gsL~~~l~~---~~-------~~~~~~i~~~i~~aL~yLH~~~~~~ii 368 (549)
+.+.+ ..+++|||++|+|.+++.. ++ +..++.++.||+.||.|||+. +|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 66553 3889999999999999964 33 467778999999999999999 999
Q ss_pred EecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccC-----------CCCchhhHHH
Q 008898 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-----------KVDEKIDVYS 437 (549)
Q Consensus 369 HrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~~~k~DvwS 437 (549)
||||||+|||++.+ +.+||+|||+|..... .....+| +.|+|||++.+. .++.++||||
T Consensus 229 HrDikp~NIll~~~-~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 229 HTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp CSCCCGGGEEECTT-CCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred cCCCCHHHEEEcCC-CCEEEEechhheecCC--------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 99999999999998 6999999999864221 2335578 999999999887 8999999999
Q ss_pred HHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 008898 438 YGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLL 517 (549)
Q Consensus 438 lGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 517 (549)
|||++|||++|+.||........ ...+... ...+ ...+.+++..||..||.+|||+.+++
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~--------------~~~~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGG--------------SEWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHHHHHHHSSCCC------CC--------------SGGGGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccc--------------hhhhhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 99999999999999975442110 0111110 0122 34577888999999999999999999
Q ss_pred HHhcCCchhhhhhhHHHH
Q 008898 518 KLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 518 ~~L~~~~~w~~~~~~~~~ 535 (549)
+ |+||+...+...
T Consensus 359 ~-----hp~f~~~~~~~~ 371 (377)
T 3byv_A 359 E-----TPEYEQLRTELS 371 (377)
T ss_dssp T-----SHHHHHHHHHHH
T ss_pred h-----ChHHHHHHHHHH
Confidence 9 899987665543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=341.25 Aligned_cols=249 Identities=26% Similarity=0.427 Sum_probs=201.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|.+.+.||+|+||.||++.+ .+++.+|+|++.... .....+.+|+.+++.++||||+++++++.+.+.++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46799999999999999999987 557899999996532 2235688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSA-GELKIADFGWSVHAPS-- 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTT-SCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCC-CCEEEEeccccccCCc--
Confidence 9999 5689999865 67788899999999999999999 99999999999999998 6899999999854322
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.......||+.|+|||.+.+..++.++||||||+++|+|++|..||........ .. .+.. ...
T Consensus 162 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~-------~~~ 224 (279)
T 3fdn_A 162 -----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YK----RISR-------VEF 224 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH----HHHH-------TCC
T ss_pred -----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HH----HHHh-------CCC
Confidence 122345799999999999999999999999999999999999999976543211 11 1100 011
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.... .....+.+++..||..||.+|||+.++++ |+|+....
T Consensus 225 ~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~-----h~~~~~~~ 265 (279)
T 3fdn_A 225 TFPD----FVTEGARDLISRLLKHNPSQRPMLREVLE-----HPWITANS 265 (279)
T ss_dssp CCCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHHH-----CHHHHHHC
T ss_pred CCCC----cCCHHHHHHHHHHhccChhhCCCHHHHhh-----CccccCCc
Confidence 1112 22345778889999999999999999999 99997654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=352.89 Aligned_cols=249 Identities=21% Similarity=0.390 Sum_probs=191.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCc----EEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQ----VAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~----~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
.++|...+.||+|+||.||+|.+ .+++ ++|+|.++... .....+.+|+.+++.++||||++++++|.+++. +
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-Q 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSE-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe-E
Confidence 35799999999999999999986 3454 35788775432 334678999999999999999999999988764 4
Q ss_pred EEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++++++ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET-TEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCC-CCEEEccCcceeEcc
Confidence 556665 8899999965 67888999999999999999999 99999999999999998 689999999997654
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +..... ...
T Consensus 169 ~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~---~~~---- 236 (327)
T 3poz_A 169 AEE---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILE---KGE---- 236 (327)
T ss_dssp TTC---C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHH---TTC----
T ss_pred CCc---ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHH---cCC----
Confidence 322 1122234457889999999999999999999999999999999 999997654422 111111 110
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
....+......+.+++..||..||.+|||+.++++.|+.
T Consensus 237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 011122234467788999999999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=358.89 Aligned_cols=261 Identities=10% Similarity=0.019 Sum_probs=188.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHH---HHHhcCCCCCeeeEE-------EEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREV---ELLSSIKHENIVRII-------GYC 316 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~---~il~~l~h~nIv~l~-------~~~ 316 (549)
.+|...+.||+|+||.||+|.+ .+|+.||||+++..... .+.+.+|+ .+|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 4588899999999999999987 57999999999875532 24466774 45555 799988855 444
Q ss_pred EcC-----------------CeEEEEEeccCCCHHHHHHH----hchhHH------HHHHHHHHHHHHHHHhCCCCCEEE
Q 008898 317 HSK-----------------EMYAIVYNLLNGSLKQYLKQ----LKWNER------MDVAIGVAKALEYLHHTCDPPIIH 369 (549)
Q Consensus 317 ~~~-----------------~~~~lv~e~~~gsL~~~l~~----~~~~~~------~~i~~~i~~aL~yLH~~~~~~iiH 369 (549)
... ..+++||||+.|+|.+++.. +.+..+ ..++.||+.||.|||++ +|+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 332 34899999999999999965 344445 67789999999999999 9999
Q ss_pred ecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCcccccccccc--CCCCchhhHHHHHHHHHHHHc
Q 008898 370 RDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELIT 447 (549)
Q Consensus 370 rDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~ellt 447 (549)
|||||+|||++.+ +.+||+|||+|..... ......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 218 rDikp~NIll~~~-~~~kL~DFG~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 218 GHFTPDNLFIMPD-GRLMLGDVSALWKVGT--------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TTCSGGGEEECTT-SCEEECCGGGEEETTC--------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CcCCHHHEEECCC-CCEEEEecceeeecCC--------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999998 6899999999965432 1114467799999999987 679999999999999999999
Q ss_pred CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 448 GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 448 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
|+.||.......... .........................+.+++..||..||.+|||+.++++ |+||
T Consensus 289 g~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-----hp~f 356 (371)
T 3q60_A 289 LFLPFGLVTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME-----TPEF 356 (371)
T ss_dssp SSCSTTBCCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT-----SHHH
T ss_pred CCCCCCCcCcccccc-------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc-----CHHH
Confidence 999998764321100 0000000000111111111233456788899999999999999999998 9999
Q ss_pred hhhhHHHHHH
Q 008898 528 KMKREKEELL 537 (549)
Q Consensus 528 ~~~~~~~~~~ 537 (549)
+...++....
T Consensus 357 ~~~~~~~~~~ 366 (371)
T 3q60_A 357 LQLQNEISSS 366 (371)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHhhh
Confidence 8877665543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=364.03 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=200.2
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEc------CCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS------KEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~~~~~l 324 (549)
.+|...+.||+|+||.||+|.+ .+|+.||||++.... ....+|+++|+.++||||++++++|.. ...+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4688899999999999999988 469999999997543 223479999999999999999998843 124678
Q ss_pred EEeccCCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 325 VYNLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 325 v~e~~~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
||||+.++|.+.+.. +++.....++.||+.||.|||+. +|+||||||+|||++.+.+.+||+|||+++..
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999999988877743 66777889999999999999999 99999999999999976567899999999754
Q ss_pred ccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc----
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS---- 472 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~---- 472 (549)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+..+...+...
T Consensus 208 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 208 VRG------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CTT------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHH
T ss_pred ccC------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 321 122345789999999998765 7899999999999999999999999876532 2233222221100
Q ss_pred -----cccccccCCccc-----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 473 -----GLCERLIDPQLN-----EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 473 -----~~~~~~~d~~l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.....+..+.+. ..+.......+.+++.+||..||.+|||+.++++ |+||....
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~-----hp~f~~~~ 344 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA-----HSFFDELR 344 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC-----CHhhcccc
Confidence 000111111110 0112233456888999999999999999999998 89997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=354.16 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=202.9
Q ss_pred hhcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
..++|...+.||+|+||.||+|.+. +++.+|+|+++..... .+.+.+|+.+++.++||||+++++++.+++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3578999999999999999999874 3489999999765322 3568899999999999999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH---------------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCC
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVK 373 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---------------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlk 373 (549)
++++|||+ +|+|.+++.. +++.+++.++.||++||.|||+. +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999999 6799999964 56677889999999999999999 99999999
Q ss_pred CCCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 008898 374 SSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAI 452 (549)
Q Consensus 374 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~ 452 (549)
|+|||++.+ +.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 202 p~NIl~~~~-~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 202 TRNCLVGEN-MVVKIADFGLSRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp GGGEEECGG-GCEEECCCSCHHHHTGGGC---BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cceEEECCC-CeEEEeecCCCcccccCcc---ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999998 6899999999865443221 112234568999999999999999999999999999999999 99999
Q ss_pred CCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 453 QTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 453 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
....... + ...+.. +.. +.. +...+..+.+++..||..||.+|||+.++++.|++..
T Consensus 278 ~~~~~~~--~---~~~~~~-~~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 278 YGMAHEE--V---IYYVRD-GNI-----LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTSCHHH--H---HHHHHT-TCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCChHH--H---HHHHhC-CCc-----CCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 7654321 1 111111 111 111 1223456788899999999999999999999887644
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=338.32 Aligned_cols=254 Identities=20% Similarity=0.256 Sum_probs=203.8
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+.++|...+.||+|+||.||+|.+ .++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+++.++++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 456799999999999999999987 457899999997543 345778999999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE---ecCCCceEEeeeccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~~kL~DFGla~~~~~~ 400 (549)
|+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||+ +.+ +.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTT
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCc
Confidence 99 6799998854 67888999999999999999999 99999999999999 566 68999999998654332
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... ...... .. . .
T Consensus 163 ------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~----~~-~---~-- 224 (277)
T 3f3z_A 163 ------KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIR----EG-T---F-- 224 (277)
T ss_dssp ------SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH----HC-C---C--
T ss_pred ------cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHH----hC-C---C--
Confidence 22234579999999998765 49999999999999999999999997654322 111111 00 0 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.............+.+++..||+.||.+|||+.++++ |+||+...
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~-----h~~~~~~~ 269 (277)
T 3f3z_A 225 -TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE-----HEWFEKQL 269 (277)
T ss_dssp -CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT-----SHHHHHHH
T ss_pred -CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc-----CHHHhccc
Confidence 0000000012356788899999999999999999998 89997643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=360.24 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=191.6
Q ss_pred hcCCCCCceEcccCceEEEEEEec----CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~----~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|.+.+.||+|+||.||+|.+. ++..+|||+++.... ..+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999764 477899999976432 23568899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
||||+ +|+|.+++.. +++.+++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSN-LVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCC-CCEEECcCcccccccc
Confidence 99999 7899999964 67888999999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +. ..+.. +
T Consensus 200 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~---~~i~~-~----- 266 (373)
T 2qol_A 200 DPEA--AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VI---KAVDE-G----- 266 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HH---HHHHT-T-----
T ss_pred CCcc--ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---HHHHc-C-----
Confidence 2111 111122345788999999999999999999999999999998 999997654321 11 11111 1
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
.....+...+..+.+++..||+.||.+||++.+|++.|+..
T Consensus 267 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 ----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 00111223446688899999999999999999999988653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=361.26 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=202.8
Q ss_pred hcCCCCCceEcccCceEEEEEEec--------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEcC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 319 (549)
.++|.+.+.||+|+||.||+|... ++..+|||+++..... ...+.+|+++++.+ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457889999999999999999752 2358999999765432 25688999999999 899999999999999
Q ss_pred CeEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE
Q 008898 320 EMYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl 379 (549)
+.+++||||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 9999999999 6799999965 67788999999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccc
Q 008898 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKAN 458 (549)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~ 458 (549)
+.+ +.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 225 ~~~-~~~kL~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 225 TED-NVMKIADFGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp CTT-CCEEECSCSCCCCSSCCCT---TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCC-CcEEEcccCcccccccccc---cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 998 6899999999976543221 122234567889999999999999999999999999999999 99999765432
Q ss_pred hhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 459 RESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 459 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
. + ...+.... .+.... .....+.+++..||+.||.+|||+.+|++.|+..-
T Consensus 301 ~--~---~~~~~~~~------~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 301 E--L---FKLLKEGH------RMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp H--H---HHHHHTTC------CCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--H---HHHHHcCC------CCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1 11111111 111112 23346778889999999999999999999886654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=339.37 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=204.3
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc-------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~-------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
.++|...+.||+|+||.||++.+. +|+.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 457889999999999999999884 699999999975432 356789999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC---CceEEeeecccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF---HHPQLSDFGAAM 395 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~~kL~DFGla~ 395 (549)
+++|||+ +++|.+++.. +++.....++.||+.||.|||+. +|+||||||+||+++.+. ..++|+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999 6899999964 78888999999999999999999 999999999999998762 179999999986
Q ss_pred ccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .+.. +...
T Consensus 161 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~----~~~~--- 226 (283)
T 3bhy_A 161 KIEAG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTN----ISAV--- 226 (283)
T ss_dssp ECC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH----HHTT---
T ss_pred eccCC------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHH----hHhc---
Confidence 54322 12234579999999999999999999999999999999999999997654321 1111 1000
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
...............+.+++..||..||.+|||+.++++ |+|++....
T Consensus 227 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~-----h~~~~~~~~ 274 (283)
T 3bhy_A 227 ----NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE-----HSWIKAIRR 274 (283)
T ss_dssp ----CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH-----CHHHHHHHH
T ss_pred ----ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh-----CHHHHHHHH
Confidence 000000001122356788899999999999999999999 899986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=355.70 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=199.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKE------ 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~------ 320 (549)
.++|...+.||+|+||.||+|.+ .+|+.||||++...... .+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999987 57999999999654333 346789999999999999999999997653
Q ss_pred eEEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 321 MYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
.+++||||++++|.++++. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNED-CELKILDFGLARQAD 179 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCC-CCEEEEeeecccccc
Confidence 4699999999999999965 67788889999999999999999 99999999999999998 689999999996543
Q ss_pred cccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--c-
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--L- 474 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~- 474 (549)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+........... .
T Consensus 180 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 180 S--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp S--------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHH
T ss_pred c--------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence 2 1234578999999999887 679999999999999999999999998654321 1211111110000 0
Q ss_pred --------------cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 475 --------------CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 475 --------------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
........+ ..........+.+++.+||..||.+|||+.++++ |+||......+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~-----hp~f~~~~~~~ 318 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA-----HPYFESLHDTE 318 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH-----SGGGTTTC---
T ss_pred HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc-----ChHHHhhcCCc
Confidence 000000011 1111223456788899999999999999999999 89998765443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.33 Aligned_cols=270 Identities=23% Similarity=0.339 Sum_probs=205.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEc--------
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHS-------- 318 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~-------- 318 (549)
.++|...+.||+|+||.||+|.+ .+|+.||+|++..... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999987 6799999999865432 23568899999999999999999999876
Q ss_pred CCeEEEEEeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 319 KEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 319 ~~~~~lv~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
.+.+++||||+.|+|.+.+.. +++.++..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRD-GVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCC-CCEEEccchhc
Confidence 457899999999999888854 78888999999999999999999 99999999999999998 68999999999
Q ss_pred cccccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc-
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS- 472 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~- 472 (549)
........ ..........||+.|+|||++.+ ..++.++|||||||++|||++|++||....... .+..........
T Consensus 172 ~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 172 RAFSLAKN-SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSIT 249 (351)
T ss_dssp EECCCCSS-SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred cccccccc-ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence 76543221 12223345678999999999876 458999999999999999999999998765322 222211111100
Q ss_pred -cccccccCCc--------ccccCC-HHH------HHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 473 -GLCERLIDPQ--------LNEEYN-REE------IEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 473 -~~~~~~~d~~--------l~~~~~-~~~------~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.......+.. ...... .+. ...+.+++..||..||.+|||+.++++ |+||....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~-----hp~f~~~~ 319 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN-----HDFFWSDP 319 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGGSSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC-----CCCcCCCC
Confidence 0000000000 000000 011 245778999999999999999999999 99997543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=343.58 Aligned_cols=272 Identities=24% Similarity=0.329 Sum_probs=204.5
Q ss_pred ccCHHHHHhhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcC--CCCCeeeEEEEEEc
Q 008898 241 RFTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI--KHENIVRIIGYCHS 318 (549)
Q Consensus 241 ~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l--~h~nIv~l~~~~~~ 318 (549)
.........+.++|.+.+.||+|+||.||+|.+. |+.||||++.... .....+|.+++..+ +||||+++++++..
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 3444444556788999999999999999999874 8999999997543 34455666666554 89999999999987
Q ss_pred C----CeEEEEEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCC-----CCCEEEecCCCCCEEEecCCCce
Q 008898 319 K----EMYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTC-----DPPIIHRDVKSSNILLSENFHHP 386 (549)
Q Consensus 319 ~----~~~~lv~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~~ 386 (549)
. ..++++|||+ +|+|.++++. +++..++.++.|++.||.|||+.+ .++|+||||||+|||++.+ +.+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~ 181 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTC 181 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCE
Confidence 7 7899999999 6799999975 778888999999999999999752 3489999999999999998 689
Q ss_pred EEeeeccccccccccccccCccccccccCCccccccccccCCCCch------hhHHHHHHHHHHHHcC----------CC
Q 008898 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK------IDVYSYGVVLLELITG----------KE 450 (549)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k------~DvwSlGvil~elltG----------~~ 450 (549)
||+|||++......... .........||+.|+|||++.+..++.+ +|||||||++|||++| ..
T Consensus 182 kl~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNE-VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EECCCTTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeCCCceeecccccc-ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 99999999654432211 1112235579999999999987766654 9999999999999999 66
Q ss_pred CCCCcccchhhHHHHHHHhhcccccccccCCcccccC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 451 AIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY-NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 451 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
||............+....... ...+.....+ ...+...+.+++..||+.||.+|||+.++++.|+.
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIK-----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHHHhhh-----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 7665443332222222222111 1122222211 23677889999999999999999999999998864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=353.14 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=201.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 321 (549)
.++|...+.||+|+||.||+|.+ .++..+|+|+++... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46788999999999999999975 245689999997543 2336788999999999 89999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH--------------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCC
Q 008898 322 YAIVYNLL-NGSLKQYLKQ--------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~--------------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp 374 (549)
++++|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 99999999 6799999954 46778899999999999999999 999999999
Q ss_pred CCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 008898 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQ 453 (549)
Q Consensus 375 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~ 453 (549)
+|||++.+ +.+||+|||++....... .........||+.|+|||.+.++.++.++|||||||++|||++ |..||.
T Consensus 201 ~NIll~~~-~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 201 RNVLVTHG-KVVKICDFGLARDIMSDS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp GGEEEETT-TEEEECCCGGGSCGGGCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred hhEEEcCC-CcEEeCCCccCcccccCc---cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999998 689999999997554321 1122234567889999999999999999999999999999998 999997
Q ss_pred CcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 454 TNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 454 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
....... +.... ..+ ..+.. +......+.+++..||..||.+|||+.++++.|+.
T Consensus 277 ~~~~~~~-~~~~~----~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 277 GIPVDAN-FYKLI----QNG-----FKMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp TCCCSHH-HHHHH----HTT-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCcHHH-HHHHH----hcC-----CCCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 7654322 11111 111 11111 12234567888999999999999999999997753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=339.66 Aligned_cols=248 Identities=22% Similarity=0.392 Sum_probs=204.9
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|...+.||+|+||.||++.+.+++.+|+|+++......+.+.+|+.+++.++||||+++++++.+++.++++|||+ +
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 578889999999999999999888899999999987777788999999999999999999999999999999999999 6
Q ss_pred CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 331 gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++........
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~---- 159 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQY---- 159 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHH----
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCC-CCEEEcccccccccccccc----
Confidence 799999964 67888899999999999999999 99999999999999988 6899999999865433211
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
.......||+.|+|||++.+..++.++||||||+++|+|++ |+.||....... . ...+... .....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~---~~~i~~~------~~~~~-- 226 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--V---VEDISTG------FRLYK-- 226 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---HHHHHTT------CCCCC--
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--H---HHHHhcC------CcCCC--
Confidence 11223457889999999999999999999999999999999 899997654321 1 1111111 00111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+......+.+++..||..||.+|||+.++++.|++
T Consensus 227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 227 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11223467788999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=354.62 Aligned_cols=272 Identities=22% Similarity=0.276 Sum_probs=207.7
Q ss_pred hhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----C
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSK-----E 320 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~ 320 (549)
.+.++|...+.||+|+||.||++.+ .+++.||||++...... ...+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3456899999999999999999987 56889999999754322 25688999999999999999999999654 4
Q ss_pred eEEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 321 MYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
.++++||+++|+|.++++. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 104 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 104 DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTT-CDLKICDFGLARVAD 179 (364)
T ss_dssp CEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred eEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCC-CCEEEEeCcceEecC
Confidence 7899999999999999965 67888899999999999999999 99999999999999998 689999999997654
Q ss_pred cccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--cc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--LC 475 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~ 475 (549)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +........... ..
T Consensus 180 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDL 256 (364)
T ss_dssp GGGCB--CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSCCHHHH
T ss_pred CCCCc--cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence 32211 112235689999999998764 4589999999999999999999999977654322 211111111000 00
Q ss_pred ------------ccccCCcc--cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 476 ------------ERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 476 ------------~~~~d~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.....+.. ...........+.+++..||..||.+|||+.++++ |+||+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~-----hp~~~~~~~ 322 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA-----HPYLEQYYD 322 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SGGGTTTCC
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc-----CcchhhccC
Confidence 00000000 00001112345788999999999999999999998 999987643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=342.37 Aligned_cols=246 Identities=25% Similarity=0.452 Sum_probs=197.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC--H------HHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--E------EEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~--~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
.++|...+.||+|+||.||+|.+ .+++.+|+|++...... . +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46799999999999999999987 57999999998654322 1 56889999999999999999999997665
Q ss_pred EEEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCC--EEEecCCCCCEEEecCCCc-----eEEe
Q 008898 322 YAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHH-----PQLS 389 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~-----~kL~ 389 (549)
+++|||+ +|+|.+++.. +++.....++.|++.||.|||+. + |+||||||+|||++.+ +. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~-~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSL-DENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCC-CTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEecc-CCCCceeEEeC
Confidence 6899999 5899988843 67888999999999999999999 8 9999999999999876 44 9999
Q ss_pred eeccccccccccccccCccccccccCCccccccccc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHH
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM--YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~ 467 (549)
|||++..... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..............
T Consensus 172 Dfg~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~- 242 (287)
T 4f0f_A 172 DFGLSQQSVH--------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI- 242 (287)
T ss_dssp CCTTCBCCSS--------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH-
T ss_pred CCCccccccc--------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH-
Confidence 9999853222 233567999999999984 45578999999999999999999999987654432221111
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
... ...+.. +......+.+++..||+.||.+|||+.++++.|++
T Consensus 243 --~~~-----~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 --REE-----GLRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp --HHS-----CCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred --hcc-----CCCCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111 111222 22334567888999999999999999999998875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=369.28 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=209.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|...++||+|+||.||++.+ .+|+.||+|+++... .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 36788999999999999999988 469999999997542 2345688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 326 YNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
|||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +++||+|||++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~-g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDD-GNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCC-CCEEEeecceeeec
Confidence 9999 6799999864 66778889999999999999999 99999999999999998 79999999999764
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+...+....
T Consensus 340 ~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~~~~~~i~~~~---- 409 (543)
T 3c4z_A 340 KAGQ-----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRVLEQA---- 409 (543)
T ss_dssp CTTC-----CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-HHHHHHHHHCC----
T ss_pred cCCC-----cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-HHHHHHHhhcc----
Confidence 3321 1223468999999999999999999999999999999999999999875432111 11111111110
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCchhhhhhhHHHHH
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM-----KTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
... +......+.+++..||..||.+||++ .+|++ |+||+...+..-.
T Consensus 410 ---~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~-----Hpff~~i~w~~l~ 461 (543)
T 3c4z_A 410 ---VTY----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT-----HPLFRDISWRQLE 461 (543)
T ss_dssp ---CCC----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT-----SGGGTTCCHHHHH
T ss_pred ---cCC----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc-----CccccCCCHHHHH
Confidence 111 22234567778899999999999975 77887 8999987665443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=354.61 Aligned_cols=271 Identities=18% Similarity=0.212 Sum_probs=196.5
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-------e
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE-------M 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-------~ 321 (549)
..++|.+.+.||+|+||.||+|.+ .+|+.||||++...........+|+..++.++||||+++++++...+ .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 356899999999999999999987 56899999999766555556778888899999999999999986533 3
Q ss_pred EEEEEeccCCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHH--hCCCCCEEEecCCCCCEEEecCCCceEEeeec
Q 008898 322 YAIVYNLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLH--HTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH--~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFG 392 (549)
++++|||+.|+|.+.+.. +++.....++.|++.||.||| +. +|+||||||+|||++...+.+||+|||
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 889999999998776642 566778889999999999999 77 999999999999999733799999999
Q ss_pred cccccccccccccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc
Q 008898 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS 471 (549)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 471 (549)
++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .+..+......
T Consensus 178 ~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~ 250 (360)
T 3e3p_A 178 SAKKLSPS------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVLGC 250 (360)
T ss_dssp TCBCCCTT------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCC
T ss_pred CceecCCC------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHcCC
Confidence 99654432 2223557899999999987655 8999999999999999999999998765322 22222221110
Q ss_pred cc-cc----------ccccCC------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 472 SG-LC----------ERLIDP------QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 472 ~~-~~----------~~~~d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.. .. ....+. .............+.+++..||..||.+|||+.++++ |+||+......
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-----hp~f~~~~~~~ 325 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC-----HPYFDELHDPA 325 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT-----SGGGGGGGCTT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc-----CccccccCCcc
Confidence 00 00 000000 0001111224567889999999999999999999998 99998876544
Q ss_pred H
Q 008898 535 E 535 (549)
Q Consensus 535 ~ 535 (549)
.
T Consensus 326 ~ 326 (360)
T 3e3p_A 326 T 326 (360)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=349.29 Aligned_cols=273 Identities=23% Similarity=0.373 Sum_probs=205.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.++|...+.||+|+||.||++.+ .+|+.||+|++....... +.+.+|+.+++.++||||+++++++.+.+.++++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 35789999999999999999987 458999999997654332 44778999999999999999999999999999999
Q ss_pred eccCC-CHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLLNG-SLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~~g-sL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+.| +|.+++. .+++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCC-CcEEEEeCCCceeecCC--
Confidence 99965 4555543 377888999999999999999999 99999999999999998 68999999998654332
Q ss_pred cccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh-----------
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL----------- 470 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~----------- 470 (549)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ +........
T Consensus 178 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 178 ---GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHH
T ss_pred ---ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhh
Confidence 1122345789999999999875 689999999999999999999999987654322 111111100
Q ss_pred cccccccccCCcccccC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 471 SSGLCERLIDPQLNEEY-----NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 471 ~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
..........+...... .......+.+++..||..||.+|||+.++++ |+||......+...+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~-----hp~f~~~~~~~~~~~ 321 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH-----HDFFQMDGFAERFSQ 321 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG-----SHHHHGGGHHHHHHH
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc-----CchhccCChhhhhhH
Confidence 00011111111111111 1123467888999999999999999999999 999987765554443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=346.16 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=206.4
Q ss_pred hhcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
..++|...+.||+|+||.||+|.+. ++..+|+|+++......+.+.+|+.+++.++||||+++++++.+++.++++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 3567899999999999999999874 588999999987766667899999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+||+++.+ +.++|+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~- 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT- 165 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSS-
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCC-CCEEEccCccceeccCCc-
Confidence 9 5799999965 67788899999999999999999 99999999999999988 689999999997654321
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
........||+.|+|||.+.+..++.++||||||+++|+|++ |..||....... .... +.. ....
T Consensus 166 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~---~~~------~~~~ 231 (288)
T 3kfa_A 166 ---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL---LEK------DYRM 231 (288)
T ss_dssp ---SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH---HHT------TCCC
T ss_pred ---cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH---Hhc------cCCC
Confidence 122234467889999999999999999999999999999999 999997654332 1111 110 0111
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.. +...+..+.+++..||..||.+|||+.++++.|+.
T Consensus 232 ~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 232 ER----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 11 22234567888999999999999999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.99 Aligned_cols=275 Identities=22% Similarity=0.300 Sum_probs=200.9
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----C
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK-----E 320 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~ 320 (549)
+.++|.+.+.||+|+||.||+|.+ .+|+.||||+++..... .+.+.+|+.+|+.++||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 356899999999999999999987 56899999999754332 35688999999999999999999999765 5
Q ss_pred eEEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 321 MYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
.+++||||++|+|.++++. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~-~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQD-CSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred eEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCC-CCEEEccCCCcccc
Confidence 7999999999999999975 78889999999999999999999 99999999999999999 68999999999765
Q ss_pred ccccccc-----------------cCccccccccCCcccccccc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCC-----
Q 008898 398 HQSHQVS-----------------ENVKPVNVVGTFGYLAPEYM-MYGKVDEKIDVYSYGVVLLELITGKEAIQT----- 454 (549)
Q Consensus 398 ~~~~~~~-----------------~~~~~~~~~gt~~y~APE~~-~~~~~~~k~DvwSlGvil~elltG~~p~~~----- 454 (549)
....... ........+||+.|+|||++ ....++.++|||||||++|||++|..||..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 4322110 00123567899999999986 456699999999999999999985444432
Q ss_pred ------ccc----------------chhhHHHHHHHhhccc----------cccccc---CCccc---ccCCHHHHHHHH
Q 008898 455 ------NKA----------------NRESLVLWARSLLSSG----------LCERLI---DPQLN---EEYNREEIEIVM 496 (549)
Q Consensus 455 ------~~~----------------~~~~l~~~~~~~~~~~----------~~~~~~---d~~l~---~~~~~~~~~~l~ 496 (549)
... ....+......+.... .....+ ..... ..........+.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 210 0111111111110000 000000 00000 000011235677
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 497 CAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 497 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
+++..||..||.+|||+.++++ |+||+.....
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~-----Hp~f~~~~~~ 371 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALD-----HPYLKDVRKK 371 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHT-----CGGGTTTCCT
T ss_pred HHHHHHhcCCcccCCCHHHHhc-----ChhhhhccCc
Confidence 8899999999999999999999 9999876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=350.97 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=202.6
Q ss_pred cCHHHHHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEc-
Q 008898 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHS- 318 (549)
Q Consensus 242 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~- 318 (549)
++..++....++|.+.+.||+|+||.||+|.+ .+|+.+|+|++.........+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34444555678899999999999999999987 5799999999987766678899999999998 79999999999976
Q ss_pred -----CCeEEEEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceE
Q 008898 319 -----KEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQ 387 (549)
Q Consensus 319 -----~~~~~lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~k 387 (549)
.+.++++|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+|+||||+|||++.+ +.++
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~-~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN-AEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT-CCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCC-CCEE
Confidence 56899999999 4599999964 56777889999999999999999 99999999999999988 6899
Q ss_pred EeeeccccccccccccccCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhH
Q 008898 388 LSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462 (549)
Q Consensus 388 L~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l 462 (549)
|+|||++...... ........||+.|+|||++. +..++.++|||||||++|+|++|..||........ +
T Consensus 170 l~Dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~ 243 (326)
T 2x7f_A 170 LVDFGVSAQLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-L 243 (326)
T ss_dssp ECCCTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H
T ss_pred EeeCcCceecCcC-----ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-H
Confidence 9999998654321 11223457999999999987 56689999999999999999999999976543221 1
Q ss_pred HHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 463 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.. ... .. .+... .......+.+++..||..||.+|||+.++++ |+||+....
T Consensus 244 ~~----~~~-~~-----~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~-----hp~~~~~~~ 295 (326)
T 2x7f_A 244 FL----IPR-NP-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK-----HPFIRDQPN 295 (326)
T ss_dssp HH----HHH-SC-----CCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT-----SHHHHCCTT
T ss_pred HH----hhc-Cc-----cccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh-----ChHHhhCcc
Confidence 11 100 00 01110 1112346778889999999999999999998 889876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=341.00 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=191.1
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCc-----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~-----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|...+.||+|+||.||++.+. |+.+|||+++.... ..+.+.+|+.+++.++||||+++++++.+++.++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357889999999999999999874 88999999875432 235688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHH--HhchhHHHHHHHHHHHHHHHHHhCCCCC---EEEecCCCCCEEEecC-------CCceEEeeec
Q 008898 326 YNLL-NGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPP---IIHRDVKSSNILLSEN-------FHHPQLSDFG 392 (549)
Q Consensus 326 ~e~~-~gsL~~~l~--~~~~~~~~~i~~~i~~aL~yLH~~~~~~---iiHrDlkp~NILl~~~-------~~~~kL~DFG 392 (549)
|||+ +|+|.+++. .+++.....++.|++.||.|||+. + |+||||||+|||++.+ .+.++|+|||
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999 678999984 477888899999999999999999 7 9999999999999862 2579999999
Q ss_pred cccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc
Q 008898 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS 472 (549)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 472 (549)
++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .....
T Consensus 162 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~ 229 (271)
T 3dtc_A 162 LAREWHRT-------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-----GVAMN 229 (271)
T ss_dssp C--------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-----HHHTS
T ss_pred cccccccc-------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----hhhcC
Confidence 98654321 1124579999999999999999999999999999999999999998654322111 11111
Q ss_pred cccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 473 GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 473 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
......+......+.+++..||+.||.+|||+.++++.|+.
T Consensus 230 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 ---------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ---------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11111222334568889999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=345.89 Aligned_cols=266 Identities=23% Similarity=0.336 Sum_probs=208.0
Q ss_pred hhcCCCCCceEcccCceEEEEEEe--cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCC------CeeeEEEEEEcCCe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH--VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE------NIVRIIGYCHSKEM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~--~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~------nIv~l~~~~~~~~~ 321 (549)
+.++|.+.+.||+|+||.||++.. .+++.||||+++......+.+.+|+.+++.++|+ +++++++++..++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 356899999999999999999976 3688999999986554456788999999988765 49999999999999
Q ss_pred EEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--------------
Q 008898 322 YAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-------------- 382 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-------------- 382 (549)
+++||||++++|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 999999999999999964 45778899999999999999999 99999999999999873
Q ss_pred ----CCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc
Q 008898 383 ----FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN 458 (549)
Q Consensus 383 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~ 458 (549)
.+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE--------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS--------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccCCCceEeeCcccccCcc--------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 15799999999865332 123457999999999999999999999999999999999999999865432
Q ss_pred hhhHHHHHHHhhccc--cc-----c---------------------cccCCc-ccccCCHHHHHHHHHHHHHhcccCCCC
Q 008898 459 RESLVLWARSLLSSG--LC-----E---------------------RLIDPQ-LNEEYNREEIEIVMCAARLCLLHSSSR 509 (549)
Q Consensus 459 ~~~l~~~~~~~~~~~--~~-----~---------------------~~~d~~-l~~~~~~~~~~~l~~li~~Cl~~dP~~ 509 (549)
. .+........... .. . ....+. ............+.+++..||..||.+
T Consensus 241 ~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 241 E-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp H-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred H-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 2 1211111110000 00 0 000000 001112345678899999999999999
Q ss_pred CCCHHHHHHHhcCCchhhhhhhH
Q 008898 510 RPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 510 RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
|||+.++++ |+||+...+
T Consensus 320 Rpt~~ell~-----hp~f~~~~~ 337 (339)
T 1z57_A 320 RITLREALK-----HPFFDLLKK 337 (339)
T ss_dssp SCCHHHHTT-----SGGGGGGGC
T ss_pred ccCHHHHhc-----CHHHHHHhc
Confidence 999999999 899986543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=343.04 Aligned_cols=254 Identities=25% Similarity=0.332 Sum_probs=190.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH--HH-HHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE--EE-VLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~--~~-~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.++|++.+.||+|+||.||++.+ .+|+.||+|+++...... .. +.++...++.++||||+++++++.+++.++++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999987 579999999997653322 22 344555688899999999999999999999999
Q ss_pred eccCCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 327 NLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 327 e~~~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
||+.|+|.+++.. +++..+..++.||+.||.|||+.+ +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 86 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTT-CCEEBCCC--------
T ss_pred ehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCC-CCEEEeecCCcccccc
Confidence 9999999888753 678888999999999999999842 89999999999999998 6899999999865433
Q ss_pred ccccccCccccccccCCcccccccc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYM----MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
. .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.........+...... .
T Consensus 163 ~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~-- 230 (290)
T 3fme_A 163 D------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE----P-- 230 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS----C--
T ss_pred c------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc----C--
Confidence 2 122334799999999996 45678999999999999999999999997644333222221111 0
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.+.. ........+.+++..||+.||.+|||+.++++ |+||....
T Consensus 231 ----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~-----hp~f~~~~ 274 (290)
T 3fme_A 231 ----SPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ-----HPFFTLHE 274 (290)
T ss_dssp ----CCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT-----SHHHHHHH
T ss_pred ----CCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh-----CcccccCc
Confidence 0111 11122345778889999999999999999998 99997654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=349.02 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=197.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-----cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHS--KEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~ 322 (549)
.++|++.+.||+|+||.||++.+ .+++.||||++...... .+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999973 36889999999765432 3568899999999999999999999854 3568
Q ss_pred EEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
++||||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENE-NRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCC-CeEEEccCcccccc
Confidence 9999999 7799999965 77888899999999999999999 99999999999999998 68999999999765
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhh-----------HHHHH
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES-----------LVLWA 466 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-----------l~~~~ 466 (549)
...... ........||+.|+|||.+.+..++.++|||||||++|||++|..|+......... .....
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 165 PQDKEF--FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cCCcce--eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 432211 11222345778899999999999999999999999999999999998654321100 00001
Q ss_pred HHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 467 RSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 467 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
... ........+..++..+.+++..||..||.+|||+.++++.|+.
T Consensus 243 ~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 243 ELL----------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHH----------HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHH----------hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111 0111111223344668889999999999999999999998864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=342.69 Aligned_cols=266 Identities=27% Similarity=0.454 Sum_probs=201.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEc----------
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS---------- 318 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~---------- 318 (549)
+.++|+..+.||+|+||.||+|.+ .+|+.+|+|+++......+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356799999999999999999987 579999999997655445678899999999999999999998854
Q ss_pred ---CCeEEEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEee
Q 008898 319 ---KEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (549)
Q Consensus 319 ---~~~~~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~D 390 (549)
.+.++++|||+ +|+|.+++.. +++...+.++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~-~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDES-RNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCC-CCEEEee
Confidence 45789999999 6799999964 56677889999999999999999 99999999999999998 6899999
Q ss_pred ecccccccccccc---------ccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchh
Q 008898 391 FGAAMVHHQSHQV---------SENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (549)
Q Consensus 391 FGla~~~~~~~~~---------~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~ 460 (549)
||++......... ..........||+.|+|||++.+. .++.++|||||||++|||++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9998765432100 011223456799999999999865 68999999999999999998 5543222111
Q ss_pred hHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 461 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
.. ..+.. .....+..++......+.+++..||..||.+|||+.++++ |+|+......+...+
T Consensus 237 ~~----~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~-----h~~~~~~~~~~~~~~ 298 (303)
T 1zy4_A 237 IL----KKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN-----SGWLPVKHQDEVIKE 298 (303)
T ss_dssp HH----HHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH-----SSCSCCCCHHHHHHH
T ss_pred HH----Hhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC-----CCCcCCCChHHHHHH
Confidence 11 11111 1112223334444566788999999999999999999999 999987766655443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=341.33 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=203.2
Q ss_pred hhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
..++|...+.||+|+||.||+|...+++.+|+|+++......+.+.+|+++++.++||||+++++++.. +..+++|||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 356788999999999999999998888899999998777677889999999999999999999999875 4578999999
Q ss_pred -CCCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 -NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 -~gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+|+|.+++. .+++.....++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCC-CCEEECCCcccccccCccc-
Confidence 789999984 377888999999999999999999 99999999999999988 6899999999976543221
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......+|+.|+|||.+.++.++.++|||||||++|||++ |+.||....... +. ..+... ....
T Consensus 165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~---~~~~~~------~~~~ 230 (279)
T 1qpc_A 165 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VI---QNLERG------YRMV 230 (279)
T ss_dssp ---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH---HHHHTT------CCCC
T ss_pred ---ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HH---HHHhcc------cCCC
Confidence 11223457889999999998899999999999999999999 999997654321 11 111111 0111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. +......+.+++..|+..||.+|||+.++++.|+.
T Consensus 231 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 231 R----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 1 12233567888999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=366.93 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=204.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++... .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35789999999999999999988 479999999997542 2235688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTT-CCEEECCCSSCEECCTT-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecC-CCeEEEeccchhhcccc-
Confidence 9999 7799999853 78888999999999999999999 99999999999999998 68999999999764332
Q ss_pred ccccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... . ...+... . .
T Consensus 170 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~----~~~i~~~-~---~-- 233 (476)
T 2y94_A 170 -----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-L----FKKICDG-I---F-- 233 (476)
T ss_dssp -----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-H----HHHHHTT-C---C--
T ss_pred -----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-H----HHHHhcC-C---c--
Confidence 22345689999999999998776 789999999999999999999998654321 1 1111111 0 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
..+..+ ...+.+++..||..||.+|||+.++++ |+||+.
T Consensus 234 -~~p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~-----hp~~~~ 272 (476)
T 2y94_A 234 -YTPQYL----NPSVISLLKHMLQVDPMKRATIKDIRE-----HEWFKQ 272 (476)
T ss_dssp -CCCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHT-----CHHHHT
T ss_pred -CCCccC----CHHHHHHHHHHcCCCchhCcCHHHHHh-----CHHhhh
Confidence 111122 345778889999999999999999998 899865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=363.43 Aligned_cols=243 Identities=24% Similarity=0.371 Sum_probs=198.1
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-eEEEEEecc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE-MYAIVYNLL 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-~~~lv~e~~ 329 (549)
.++|...+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|++++||||+++++++.+.+ .+++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 356888899999999999999874 7899999998654 4578999999999999999999999987654 799999999
Q ss_pred -CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 -~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+|+|.+++.. +++...+.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT-SCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCC-CCEEEeeCCCccccccc---
Confidence 6799999965 46778899999999999999999 99999999999999998 68999999998643221
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+. . . .+. .+. ..
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-~-~---~i~-~~~-----~~- 405 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-V-P---RVE-KGY-----KM- 405 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-H-H---HHH-TTC-----CC-
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-H-H---HHH-cCC-----CC-
Confidence 122357889999999999999999999999999999998 9999976543221 1 1 111 111 11
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+..++..+.+++..||..||.+|||+.++++.|+.
T Consensus 406 ---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 406 ---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1122344567888999999999999999999998864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=349.23 Aligned_cols=269 Identities=24% Similarity=0.339 Sum_probs=203.4
Q ss_pred cCHHHHHhhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCC--CCCeeeEEEEE
Q 008898 242 FTSQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIK--HENIVRIIGYC 316 (549)
Q Consensus 242 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~--h~nIv~l~~~~ 316 (549)
+.++.+....++|.+.+.||+|+||.||++.+.+++.+|+|++...... .+.+.+|+.+++.+. ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3344444456789999999999999999999888999999999765433 356789999999997 59999999999
Q ss_pred EcCCeEEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecc
Q 008898 317 HSKEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGA 393 (549)
Q Consensus 317 ~~~~~~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGl 393 (549)
.+++.++++||+.+|+|.+++.. +++..+..++.||++||.|||+. +|+||||||+|||+++ +.+||+|||+
T Consensus 98 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~--~~~kL~Dfg~ 172 (313)
T 3cek_A 98 ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD--GMLKLIDFGI 172 (313)
T ss_dssp ECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET--TEEEECCCSS
T ss_pred ecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC--CeEEEeeccc
Confidence 99999999999889999999965 67788899999999999999999 9999999999999975 4899999999
Q ss_pred ccccccccccccCccccccccCCcccccccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhH
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-----------GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL 462 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l 462 (549)
+....... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+
T Consensus 173 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 173 ANQMQPDT---TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp SCC-----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred cccccCcc---ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 86543321 1112234579999999999875 468899999999999999999999997654322221
Q ss_pred HHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 463 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
.. . .++.....++......+.+++..||..||.+|||+.++++ |+|+..+......
T Consensus 250 ~~----~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~-----h~~~~~~~~~~~~ 305 (313)
T 3cek_A 250 HA----I---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA-----HPYVQIQTHPVNQ 305 (313)
T ss_dssp HH----H---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SHHHHCC------
T ss_pred HH----H---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc-----CccccCCCCchhh
Confidence 11 1 1111111111122356778889999999999999999999 8999876654433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=340.61 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=183.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|.+.+.||+|+||.||+|.. .+|+.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.++++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35789999999999999999987 579999999997532 2235688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTT-CCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC-CCEEEEeecceeeccCC
Confidence 9999 6699999965 67888999999999999999999 99999999999999998 68999999998654321
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ + .... ..+
T Consensus 166 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~----~~~~-------~~~ 228 (278)
T 3cok_A 166 H-----EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-L----NKVV-------LAD 228 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC-------SSC
T ss_pred C-----CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-H----HHHh-------hcc
Confidence 1 122345799999999999988999999999999999999999999976543211 0 0000 001
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
...+.. ....+.+++..||..||.+|||+.++++ |+||....
T Consensus 229 ~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~-----h~~~~~~~ 270 (278)
T 3cok_A 229 YEMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLD-----HPFMSRNS 270 (278)
T ss_dssp CCCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT-----STTTC---
T ss_pred cCCccc----cCHHHHHHHHHHcccCHhhCCCHHHHhc-----CccccCCC
Confidence 111222 2345778899999999999999999998 89997644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=351.45 Aligned_cols=267 Identities=24% Similarity=0.325 Sum_probs=202.2
Q ss_pred cCC-CCCceEcccCceEEEEEEe-----cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCe
Q 008898 252 HNF-SPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS--KEM 321 (549)
Q Consensus 252 ~~f-~~~~~lG~G~fg~Vy~~~~-----~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~ 321 (549)
++| ...+.||+|+||.||++.+ .+++.||||+++.... ..+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 8899999999999998854 2588999999986542 23568899999999999999999999976 468
Q ss_pred EEEEEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++++|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDND-RLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCC-CCEEECCcccccccc
Confidence 89999999 6799999965 77888999999999999999999 99999999999999998 689999999997654
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............+.............
T Consensus 186 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 186 EGHEY--YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp TTCSE--EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccc--cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 32211 1122345688899999999999999999999999999999999999976432211110000000000001111
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
++.......+...+..+.+++..||..||.+|||+.++++.|+...
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111112223334467888999999999999999999999886544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=348.63 Aligned_cols=267 Identities=21% Similarity=0.311 Sum_probs=196.9
Q ss_pred hcCCCCC-ceEcccCceEEEEEEe-cCCcEEEEEEeecCC-cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~-~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.+.|.+. ++||+|+||.||+|.+ .+++.||||+++... .....+.+|+.++.++ +||||+++++++.+++.+++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4567774 7899999999999986 579999999997654 3356789999999985 7999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC--ceEEeeeccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH--HPQLSDFGAAMVHHQS 400 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~~kL~DFGla~~~~~~ 400 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+.. .+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 999 6899999964 67888899999999999999999 9999999999999987621 3899999998654321
Q ss_pred ccc--ccCccccccccCCcccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchh----------hHH
Q 008898 401 HQV--SENVKPVNVVGTFGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE----------SLV 463 (549)
Q Consensus 401 ~~~--~~~~~~~~~~gt~~y~APE~~~~-----~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~----------~l~ 463 (549)
... .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 111 11112234579999999999875 4588999999999999999999999976543210 000
Q ss_pred HHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 464 LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 464 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.....+... . . .............+.+++..||..||.+|||+.++++ |+||.....
T Consensus 248 ~~~~~i~~~-~---~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~-----hp~~~~~~~ 304 (316)
T 2ac3_A 248 MLFESIQEG-K---Y---EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ-----HPWVQGCAP 304 (316)
T ss_dssp HHHHHHHHC-C---C---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH-----STTCC----
T ss_pred HHHHHHhcc-C---c---ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc-----ChhhcCCCC
Confidence 111111110 0 0 0000000112356788999999999999999999999 999986543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=347.48 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=202.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 321 (549)
.++|...+.||+|+||.||+|.. .+++.+|+|+++.... ..+.+.+|+.+++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788999999999999999974 3468999999986543 235688999999999 89999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH---------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl 379 (549)
++++|||+ +|+|.+++.. +++...+.++.||+.||.|||+. +|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 99999999 5699999964 57788899999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccc
Q 008898 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKAN 458 (549)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~ 458 (549)
+.+ +.+||+|||++........ ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 179 ~~~-~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 179 THG-RITKICDFGLARDIKNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp ETT-TEEEECCCGGGSCTTSCTT---SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cCC-CCEEEcccccccccccccc---ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 998 6899999999976543221 112234567889999999999999999999999999999999 99999766543
Q ss_pred hhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 459 RESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 459 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...... ... + ..+.. +...+..+.+++..||..||.+|||+.++++.|++
T Consensus 255 ~~~~~~-~~~----~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 255 SKFYKM-IKE----G-----FRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHHH-HHH----T-----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHH-hcc----C-----CCCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 221111 111 1 11111 12233567888999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=366.80 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=200.4
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++|...+.||+|+||.||+|.+.++..||||+++......+.+.+|+.+|++++||||+++++++.+ +.+++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 35688889999999999999999878889999998776677889999999999999999999999976 6788999999
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++........
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~-- 335 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY-- 335 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEEECCCCTTC---------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCC-CCEEECCCccceecCCCce--
Confidence 6799999953 67888999999999999999999 99999999999999988 6899999999976443211
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
.......+|+.|+|||.+.++.++.++|||||||++|||++ |+.||....... .+ ..+.. +.
T Consensus 336 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~----~~i~~-~~--------- 398 (452)
T 1fmk_A 336 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VL----DQVER-GY--------- 398 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HH----HHHHT-TC---------
T ss_pred --ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-HH----HHHHc-CC---------
Confidence 11223457889999999999999999999999999999999 999997654321 11 11111 10
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
....+..++..+.+++..||..||.+|||+.+|++.|+...
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 01112234556888999999999999999999999887643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=350.22 Aligned_cols=260 Identities=20% Similarity=0.286 Sum_probs=187.9
Q ss_pred hhhcCCCCCceEcccCceEEEEEEecC-Cc---EEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNHVD-GQ---VAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~-g~---~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
...++|...+.||+|+||.||+|.+.. +. .+|||+++... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999997643 32 79999997643 234568899999999999999999999987665
Q ss_pred E------EEEEecc-CCCHHHHHHH---------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc
Q 008898 322 Y------AIVYNLL-NGSLKQYLKQ---------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (549)
Q Consensus 322 ~------~lv~e~~-~gsL~~~l~~---------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 385 (549)
. +++|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~-~~ 175 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED-MT 175 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-SC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC-CC
Confidence 5 8999999 6799999843 67788899999999999999999 99999999999999998 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHH
Q 008898 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVL 464 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~ 464 (549)
+||+|||++......... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||........ .
T Consensus 176 ~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~-- 249 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYY---RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-Y-- 249 (323)
T ss_dssp EEECCCCC--------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-H--
T ss_pred EEEeeccccccccccccc---cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-H--
Confidence 999999999765432211 11223457889999999999999999999999999999999 9999986554321 1
Q ss_pred HHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC--chhhhhh
Q 008898 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP--DYWLKMK 530 (549)
Q Consensus 465 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~--~~w~~~~ 530 (549)
........ . ..+......+.+++..||..||.+|||+.++++.|++. |+|+...
T Consensus 250 --~~~~~~~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 250 --NYLIGGNR------L----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp --HHHHTTCC------C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred --HHHhcCCC------C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 11111110 1 11222345678899999999999999999999988874 4776554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=350.55 Aligned_cols=266 Identities=22% Similarity=0.294 Sum_probs=204.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-----cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEE--cCCeEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCH--SKEMYA 323 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~ 323 (549)
++|...+.||+|+||.||++.+ .+++.||||++...... .+.+.+|+.+++.++||||+++++++. +.+.++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788999999999999999983 46889999999765432 345889999999999999999999886 556799
Q ss_pred EEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESE-AHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET-TEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCC-CCEEEcccccceecc
Confidence 999999 7899999965 67888999999999999999999 99999999999999998 689999999997654
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............+.............
T Consensus 179 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 179 LDKDY--YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp TTCSE--EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cCCcc--ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 32211 1122345688899999999999999999999999999999999999875433210000000000000000111
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
+........+......+.+++..||..||.+|||+.++++.|+..
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111222333456688899999999999999999999988765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=353.12 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=207.9
Q ss_pred cCCCCCceEcccCceEEEEEEe----cCCcEEEEEEeecCC-----cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~----~~g~~~AvK~l~~~~-----~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 321 (549)
++|...+.||+|+||.||++.. .+|+.||||+++... ...+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999987 368999999986432 2235577899999999 69999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+++||||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN-GHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC-CcEEEeeCCCCeec
Confidence 99999999 6799999964 67888899999999999999999 99999999999999998 68999999998654
Q ss_pred ccccccccCccccccccCCccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
.... .......+||+.|+|||++.++ .++.++|||||||++|||++|+.||........ ...+.......
T Consensus 210 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~--- 281 (355)
T 1vzo_A 210 VADE----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKS--- 281 (355)
T ss_dssp CGGG----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHC---
T ss_pred ccCC----CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhcc---
Confidence 3211 1223356799999999999863 478999999999999999999999976543221 11111111111
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
.+.. +......+.+++..||..||.+|| ++.++++ |+||....+.+...+
T Consensus 282 ----~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~-----h~~f~~~~~~~l~~~ 336 (355)
T 1vzo_A 282 ----EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE-----HLFFQKINWDDLAAK 336 (355)
T ss_dssp ----CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT-----SGGGTTCCHHHHHTT
T ss_pred ----CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc-----CcchhcCChhHhhhc
Confidence 1111 223345677889999999999999 9999998 899988776655544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=337.91 Aligned_cols=247 Identities=21% Similarity=0.280 Sum_probs=196.9
Q ss_pred hhcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCC---cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN---WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 324 (549)
+.++|.+.+.||+|+||.||+|.+. +++.+|+|+++... .....+.+|+.++..+ +||||+++++++.+++.+++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999874 79999999998543 2345688899999999 89999999999999999999
Q ss_pred EEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--------------
Q 008898 325 VYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-------------- 382 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-------------- 382 (549)
+|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999 6699999964 57888999999999999999999 99999999999999843
Q ss_pred ----CCceEEeeeccccccccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCccc
Q 008898 383 ----FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (549)
Q Consensus 383 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~ 457 (549)
...++|+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP---------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS---------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred ccCCceEEEEcccccccccCCc---------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 136899999998654321 123589999999999876 567899999999999999999987754321
Q ss_pred chhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 458 NRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 458 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
... +. .+. .+.+...+ ...+.+++..||..||.+|||+.++++ |+||....
T Consensus 237 ----~~~----~~-~~~-----~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~-----h~~~~~~~ 287 (289)
T 1x8b_A 237 ----WHE----IR-QGR-----LPRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK-----HSVLLSAS 287 (289)
T ss_dssp ----HHH----HH-TTC-----CCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT-----CTTC----
T ss_pred ----HHH----HH-cCC-----CCCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh-----ChHhhhhc
Confidence 111 10 111 12222223 345778889999999999999999999 89998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=379.70 Aligned_cols=256 Identities=20% Similarity=0.307 Sum_probs=210.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|.+.++||+|+||.||++.+ .+++.||||+++.. ....+.+..|..++..+ +||||+++++++.+.+.+++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 46799999999999999999987 56889999999753 22345678899999988 79999999999999999999
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
||||+ +|+|.+++.. +++..+..++.||+.||.|||+. +||||||||+||||+.+ +++||+|||+|+....
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~- 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIW- 494 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSS-SCEEECCCTTCEECCC-
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCC-CcEEEeecceeecccc-
Confidence 99999 6799999965 78888999999999999999999 99999999999999999 7999999999964322
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
........+||+.|+|||++.+..|+.++|||||||+||||++|+.||....... . ...+....
T Consensus 495 ----~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~----~~~i~~~~------- 558 (674)
T 3pfq_A 495 ----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-L----FQSIMEHN------- 558 (674)
T ss_dssp ----TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H----HHHHHSSC-------
T ss_pred ----CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-H----HHHHHhCC-------
Confidence 2223456789999999999999999999999999999999999999998654321 1 11121111
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCchhhhhhhHHHHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM-----KTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
..+ +......+.++++.||..||.+||++ ++|++ |+||+...+..-.
T Consensus 559 ~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~-----h~ff~~i~w~~l~ 610 (674)
T 3pfq_A 559 VAY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE-----HAFFRYIDWEKLE 610 (674)
T ss_dssp CCC----CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS-----SGGGSSCCHHHHT
T ss_pred CCC----CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc-----CccccCCCHHHHH
Confidence 111 22234567788899999999999998 88887 8999887665543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.16 Aligned_cols=266 Identities=20% Similarity=0.285 Sum_probs=187.9
Q ss_pred cCCCC-CceEcccCceEEEEEEec---CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEE--cCCeEEEE
Q 008898 252 HNFSP-KMLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH--SKEMYAIV 325 (549)
Q Consensus 252 ~~f~~-~~~lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~lv 325 (549)
+.|.. .++||+|+||.||+|.+. +++.||+|++..... ...+.+|+.+|+.++||||+++++++. .+..+++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 44555 458999999999999864 578999999975543 357889999999999999999999994 47789999
Q ss_pred EeccCCCHHHHHH------------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE----ecCCCceEEe
Q 008898 326 YNLLNGSLKQYLK------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL----SENFHHPQLS 389 (549)
Q Consensus 326 ~e~~~gsL~~~l~------------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~~kL~ 389 (549)
|||+.|+|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||+ +.+ +.+||+
T Consensus 99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~-~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER-GRVKIA 174 (405)
T ss_dssp EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTT-TCEEEC
T ss_pred EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCC-CcEEEE
Confidence 9999999998885 267778899999999999999999 99999999999999 455 689999
Q ss_pred eeccccccccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccc--------hh
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKAN--------RE 460 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~--------~~ 460 (549)
|||+|....... .........+||+.|+|||++.+. .++.++|||||||++|||++|++||...... .+
T Consensus 175 Dfg~a~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 175 DMGFARLFNSPL--KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp CTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred ECCCceecCCCC--cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999997654321 111223456899999999999874 4899999999999999999999999765431 12
Q ss_pred hHHHHHHHhhcccc--ccccc------------CCcccccCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 008898 461 SLVLWARSLLSSGL--CERLI------------DPQLNEEYN---------REEIEIVMCAARLCLLHSSSRRPTMKTLL 517 (549)
Q Consensus 461 ~l~~~~~~~~~~~~--~~~~~------------d~~l~~~~~---------~~~~~~l~~li~~Cl~~dP~~RPs~~evl 517 (549)
.+......+..... ...+. ......... ......+.+++..||..||.+|||+.+++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 22222211110000 00000 000000000 00134577899999999999999999999
Q ss_pred HHhcCCchhhhh
Q 008898 518 KLFQEPDYWLKM 529 (549)
Q Consensus 518 ~~L~~~~~w~~~ 529 (549)
+ |+||..
T Consensus 333 ~-----hp~f~~ 339 (405)
T 3rgf_A 333 Q-----DPYFLE 339 (405)
T ss_dssp T-----SGGGTS
T ss_pred c-----Chhhcc
Confidence 9 999965
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.95 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=207.3
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
+.++|.+.+.||+|+||.||+|.+ .+++.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 346799999999999999999987 4789999999975432 2467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+|+||||+||+++.+ +.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~- 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN- 159 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCTTCEECEETT-
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccC-CCEEEeeCCCccccCCCc-
Confidence 999 5699988853 67888999999999999999999 99999999999999998 689999999986543221
Q ss_pred cccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
.........||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||............|.... .. .
T Consensus 160 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~------~ 228 (276)
T 2yex_A 160 --RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---TY------L 228 (276)
T ss_dssp --EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC---TT------S
T ss_pred --chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc---cc------c
Confidence 1112235679999999999987775 7899999999999999999999987654333332222110 00 0
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
..... ....+.+++..||..||.+|||+.++++ |+||.....
T Consensus 229 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~-----~~~~~~~~~ 270 (276)
T 2yex_A 229 NPWKK----IDSAPLALLHKILVENPSARITIPDIKK-----DRWYNKPLK 270 (276)
T ss_dssp TTGGG----SCHHHHHHHHHHSCSSTTTSCCHHHHTT-----CTTTTCCCC
T ss_pred Cchhh----cCHHHHHHHHHHCCCCchhCCCHHHHhc-----CccccChhh
Confidence 01112 2345678899999999999999999998 899976543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=351.95 Aligned_cols=269 Identities=22% Similarity=0.253 Sum_probs=206.3
Q ss_pred hhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CC-----CeeeEEEEEEcCCe
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HE-----NIVRIIGYCHSKEM 321 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~-----nIv~l~~~~~~~~~ 321 (549)
.+.++|.+.+.||+|+||.||+|.+ .+++.||||+++........+..|+.+++.+. |+ +|+++++++...+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4567899999999999999999987 56889999999865444566778999888875 44 49999999999999
Q ss_pred EEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec-CCCceEEeeecccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAM 395 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~~kL~DFGla~ 395 (549)
+++||||++|+|.+++.. +++.....++.||+.||.|||+. +.+|+||||||+|||++. +.+.+||+|||++.
T Consensus 131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999999999999999964 57788899999999999999952 239999999999999964 22579999999996
Q ss_pred ccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG-- 473 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-- 473 (549)
.... ......||+.|+|||++.+..++.++|||||||++|||++|++||....... .+...........
T Consensus 210 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 210 QLGQ--------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD-QMNKIVEVLGIPPAH 280 (382)
T ss_dssp ETTC--------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHH
T ss_pred eccc--------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence 5432 1234679999999999999999999999999999999999999998765322 2222111110000
Q ss_pred ----------ccccccCCc-------------------------------------ccccCCHHHHHHHHHHHHHhcccC
Q 008898 474 ----------LCERLIDPQ-------------------------------------LNEEYNREEIEIVMCAARLCLLHS 506 (549)
Q Consensus 474 ----------~~~~~~d~~-------------------------------------l~~~~~~~~~~~l~~li~~Cl~~d 506 (549)
....+.+.. -...........+.+++..||..|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 000000000 001112334467899999999999
Q ss_pred CCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 507 SSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 507 P~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
|.+|||+.++++ |+||+....
T Consensus 361 P~~Rpta~e~L~-----hp~f~~~~~ 381 (382)
T 2vx3_A 361 PKTRIQPYYALQ-----HSFFKKTAD 381 (382)
T ss_dssp TTTSCCHHHHTT-----SGGGCC---
T ss_pred hhhCCCHHHHhc-----CcccccCCC
Confidence 999999999999 999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=338.03 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=196.9
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEc----CCeEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS----KEMYAI 324 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~~~l 324 (549)
.|...+.||+|+||.||+|.+ .++..+|+|++...... .+.+.+|+.+++.++||||+++++++.. +..+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 467788899999999999987 56889999999765433 3457899999999999999999998864 467899
Q ss_pred EEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCC--EEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
||||+ +|+|.+++.. +++.....++.||+.||.|||+. + |+||||||+|||++.+.+.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999 6799999965 67788899999999999999998 7 99999999999998433789999999985432
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
. .......||+.|+|||++. +.++.++|||||||++|+|++|+.||.......... ........
T Consensus 184 ~-------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~~---- 247 (290)
T 1t4h_A 184 A-------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY----RRVTSGVK---- 247 (290)
T ss_dssp T-------TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH----HHHTTTCC----
T ss_pred c-------cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH----HHHhccCC----
Confidence 2 1223457999999999876 569999999999999999999999997654322211 11111100
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
....... ....+.+++..||..||.+|||+.++++ |+||+..
T Consensus 248 -~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~-----h~~f~~~ 289 (290)
T 1t4h_A 248 -PASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN-----HAFFQEE 289 (290)
T ss_dssp -CGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGC--
T ss_pred -ccccCCC----CCHHHHHHHHHHccCChhhCCCHHHHhh-----CcccccC
Confidence 0111111 2245788899999999999999999999 8999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.18 Aligned_cols=263 Identities=20% Similarity=0.261 Sum_probs=198.7
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------eEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE------MYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~------~~~l 324 (549)
..+|...++||+|+||.||+|.+.++..+|+|.+..... ...+|+.+++.++||||+++++++.... .+++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 356899999999999999999987766788888864432 2237999999999999999999985433 3889
Q ss_pred EEeccCCCHHHHHH-------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 325 VYNLLNGSLKQYLK-------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 325 v~e~~~gsL~~~l~-------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
||||+.+++.+.+. .+++.....++.||+.||.|||+. +|+||||||+|||++.+.+.+||+|||+|...
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 99999888776653 266778889999999999999999 99999999999999943379999999999764
Q ss_pred ccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc----
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS---- 472 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~---- 472 (549)
... .......||+.|+|||++.+. .++.++|||||||++|||++|++||...... +.+......+...
T Consensus 193 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 193 IAG------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CTT------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHH
T ss_pred cCC------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 322 122355789999999998765 5899999999999999999999999876532 2222222211100
Q ss_pred ------cc----cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 473 ------GL----CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 473 ------~~----~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.. ........+...+.......+.+++..||..||.+|||+.++++ |+||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~-----hp~f~~~~ 329 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC-----HPFFDELR 329 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT-----SGGGSTTT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc-----Chhhhhhc
Confidence 00 00000000111122223457888999999999999999999998 89997644
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=363.71 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=196.2
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---------HHHHHHHHHHHhcCCCCCeeeEEEEEEcC
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---------EEEVLREVELLSSIKHENIVRIIGYCHSK 319 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---------~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 319 (549)
+.++|...+.||+|+||.||+|.+ .+++.||||++...... ...+.+|+.+|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 467899999999999999999987 56899999999754211 1247899999999999999999999865
Q ss_pred CeEEEEEecc-CCCHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC--CceEEeeecc
Q 008898 320 EMYAIVYNLL-NGSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGA 393 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~~kL~DFGl 393 (549)
+.+++||||+ +|+|.+++. .+++.....++.||+.||.|||+. +|+||||||+|||++.+. ..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 4578999999 679988874 378888999999999999999999 999999999999997541 3599999999
Q ss_pred ccccccccccccCccccccccCCcccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
+..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..............
T Consensus 289 a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---- 358 (419)
T 3i6u_A 289 SKILGE------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---- 358 (419)
T ss_dssp TTSCC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH----
T ss_pred ceecCC------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh----
Confidence 976432 122335689999999999863 5688999999999999999999999976543222111110
Q ss_pred cccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 471 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
.+... ..+.... .....+.+++..||..||.+|||+.++++ |+||........
T Consensus 359 -~~~~~--~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~-----hp~~~~~~~~~~ 411 (419)
T 3i6u_A 359 -SGKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR-----HPWLQDEDMKRK 411 (419)
T ss_dssp -TTCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH-----SGGGCCHHHHHH
T ss_pred -cCCCC--CCchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC-----CcccCChhHHHH
Confidence 01000 0000001 12356788899999999999999999999 999977655443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=357.07 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=205.3
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE---
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMY--- 322 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~--- 322 (549)
+.++|...+.||+|+||.||+|.+ .+|+.||||+++..... ...+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 356899999999999999999987 56999999999765433 35678999999999999999999999877654
Q ss_pred ---EEEEeccCCCHHHHHH-HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 323 ---AIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 323 ---~lv~e~~~gsL~~~l~-~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+++|||+.|+|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 120 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNED-CELKILDFGLARHAD 195 (371)
T ss_dssp CCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECSTTCC----
T ss_pred eeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCC-CCEEEEecCcccccc
Confidence 9999999999998885 378889999999999999999999 99999999999999998 689999999986433
Q ss_pred cccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--cc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--LC 475 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~ 475 (549)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+........... ..
T Consensus 196 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 196 A--------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFV 266 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHH
T ss_pred c--------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHH
Confidence 2 2234578999999999887 678999999999999999999999998654322 1211111110000 00
Q ss_pred ------------ccccCCcc--cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 476 ------------ERLIDPQL--NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 476 ------------~~~~d~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
..+..... ...........+.+++..||..||.+|||+.++++ |+||.....+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----hp~f~~~~~~~~ 335 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT-----HPFFEPFRDPEE 335 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT-----SGGGTTTCCGGG
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc-----CcccccCCCccc
Confidence 00000000 00001122456788999999999999999999998 999987654443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=348.66 Aligned_cols=268 Identities=22% Similarity=0.363 Sum_probs=207.1
Q ss_pred hhhcCCCCCceEcccCceEEEEEEe--cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcC---CCCCeeeEEEEEE---
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNH--VDGQVAAVKVLKCTNWS---EEEVLREVELLSSI---KHENIVRIIGYCH--- 317 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~--~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l---~h~nIv~l~~~~~--- 317 (549)
.+.++|.+.+.||+|+||.||++.+ .+|+.||+|+++..... ...+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4567899999999999999999987 46889999999754321 23566788777766 8999999999987
Q ss_pred --cCCeEEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEee
Q 008898 318 --SKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (549)
Q Consensus 318 --~~~~~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~D 390 (549)
....++++|||+.|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~-~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS-GQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECS
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCC-CCEEEec
Confidence 5678999999999999999965 67888899999999999999999 99999999999999998 6899999
Q ss_pred eccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh
Q 008898 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+........
T Consensus 164 fg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGG------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred CcccccccCC------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcC
Confidence 9998654321 12335678999999999999999999999999999999999999998765322 1222221111
Q ss_pred cccc---cccc------c---CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 471 SSGL---CERL------I---DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 471 ~~~~---~~~~------~---d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.... .... . .......+.......+.+++..||..||.+|||+.++++ |+||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-----hp~~~~~~~ 305 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS-----HPYFQDLER 305 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT-----SGGGTTCCC
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc-----Cccccccch
Confidence 0000 0000 0 000011122233456788999999999999999999998 899976553
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=345.39 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=198.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-----cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSK--EMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~ 322 (549)
+.|+..+.||+|+||.||++.+ .+++.||+|+++... .....+.+|+.+++.++||||+++++++... +.+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999983 468999999997543 2346788999999999999999999999876 678
Q ss_pred EEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+++|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE-HQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCC-CCEEECcccccccc
Confidence 9999999 6799999943 67888999999999999999999 99999999999999998 69999999999765
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc----------hhhHHHHHH
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN----------RESLVLWAR 467 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~----------~~~l~~~~~ 467 (549)
...... ........||..|+|||.+.+..++.++|||||||++|+|++|..|+...... ......+..
T Consensus 177 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 177 ETDKEY--YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp CTTCCE--EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cCCCcc--eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 443211 11223456888999999999999999999999999999999999987543211 111111111
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.... ......+......+.+++..||..||.+|||+.++++.|+.
T Consensus 255 ~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 255 TLKE----------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHT----------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhc----------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111 11111222334568889999999999999999999998853
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=363.07 Aligned_cols=256 Identities=26% Similarity=0.355 Sum_probs=201.1
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.++|...+.||+|+||.||+|.+ .++..+|+|+++... .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45689999999999999999987 468999999997543 23467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeeccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla~~~~~~ 400 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||++......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999 6799888854 67788899999999999999999 99999999999999764 245999999998764432
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
......+||+.|+|||++. +.++.++|||||||++|+|++|.+||....... .+.... .... ..+
T Consensus 193 ------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~----~~~~---~~~ 257 (494)
T 3lij_A 193 ------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKVE----KGKY---TFD 257 (494)
T ss_dssp ------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH----HTCC---CCC
T ss_pred ------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH----hCCC---CCC
Confidence 2233567999999999876 579999999999999999999999998654321 111111 1100 001
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
...... ....+.+++..||..||.+|||+.++++ |+|++.....
T Consensus 258 ~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~-----hp~~~~~~~~ 301 (494)
T 3lij_A 258 SPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALE-----HPWIKEMCSK 301 (494)
T ss_dssp SGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT-----CHHHHHHHHH
T ss_pred chhccc----CCHHHHHHHHHHCCCChhhCccHHHHhc-----CcccccCccc
Confidence 111112 2345778889999999999999999998 9999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=365.39 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=201.2
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--------------cCHHHHHHHHHHHhcCCCCCeeeEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--------------WSEEEVLREVELLSSIKHENIVRIIG 314 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--------------~~~~~~~~E~~il~~l~h~nIv~l~~ 314 (549)
+.++|.+.+.||+|+||.||+|.+ .+++.+|+|+++... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999987 568899999997543 22356889999999999999999999
Q ss_pred EEEcCCeEEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC--ceEE
Q 008898 315 YCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH--HPQL 388 (549)
Q Consensus 315 ~~~~~~~~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~~kL 388 (549)
++.+++.+++||||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+.. .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEE
Confidence 999999999999999 6799998854 77888999999999999999999 9999999999999987622 6899
Q ss_pred eeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHH
Q 008898 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARS 468 (549)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 468 (549)
+|||++...... ......+||+.|+|||++. +.++.++|||||||++|+|++|.+||....... .+. .
T Consensus 191 ~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~----~ 258 (504)
T 3q5i_A 191 VDFGLSSFFSKD------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-IIK----K 258 (504)
T ss_dssp CCCTTCEECCTT------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH----H
T ss_pred EECCCCEEcCCC------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHH----H
Confidence 999999764332 2233567999999999876 579999999999999999999999998654321 111 1
Q ss_pred hhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 469 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+..... ..+...... ....+.+++..||..||.+|||+.++++ |+|++..
T Consensus 259 i~~~~~---~~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~-----h~~~~~~ 308 (504)
T 3q5i_A 259 VEKGKY---YFDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN-----SRWIKKY 308 (504)
T ss_dssp HHHCCC---CCCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SHHHHHT
T ss_pred HHcCCC---CCCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc-----CHhhhhc
Confidence 111100 000000011 2345778899999999999999999998 8999654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=348.05 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=195.8
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKE---- 320 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~---- 320 (549)
+.++|.+.+.||+|+||.||++.+ .+++.||||+++..... ...+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 357899999999999999999987 67899999999765322 245789999999999999999999986544
Q ss_pred eEEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
..++||||+ +|+|.+++.. +++.+...++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISAT-NAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETT-SCEEECCCSCC--
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCC-CCEEEeeccCccc
Confidence 359999999 6799999964 67888999999999999999999 99999999999999998 6899999999976
Q ss_pred cccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .......
T Consensus 166 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-----~~~~~~~-- 236 (311)
T 3ork_A 166 IADSGN--SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-----QHVREDP-- 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----HHHHCCC--
T ss_pred cccccc--ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHhcCCC--
Confidence 543211 1122234679999999999999999999999999999999999999997655422111 1111100
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.............+.+++..||+.||.+||+..+++. +.|++..
T Consensus 237 -----~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~-----~~l~~~~ 280 (311)
T 3ork_A 237 -----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR-----ADLVRVH 280 (311)
T ss_dssp -----CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH-----HHHHHHH
T ss_pred -----CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH-----HHHHHHh
Confidence 0000001122355778889999999999999888887 6777643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.36 Aligned_cols=262 Identities=21% Similarity=0.330 Sum_probs=207.5
Q ss_pred HHHhhhcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEE
Q 008898 246 ELCHLTHNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCH 317 (549)
Q Consensus 246 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~ 317 (549)
+.....++|...+.||+|+||.||+|.+. +++.+|+|++...... ...+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999653 3678999999754432 245889999999999999999999999
Q ss_pred cCCeEEEEEecc-CCCHHHHHHH-------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC
Q 008898 318 SKEMYAIVYNLL-NGSLKQYLKQ-------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383 (549)
Q Consensus 318 ~~~~~~lv~e~~-~gsL~~~l~~-------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~ 383 (549)
+++.++++|||+ +|+|.+++.. +++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~- 174 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED- 174 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT-
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC-
Confidence 999999999999 6799999964 26678889999999999999999 99999999999999998
Q ss_pred CceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhH
Q 008898 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESL 462 (549)
Q Consensus 384 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l 462 (549)
+.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||....... .
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~ 249 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--V 249 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--H
T ss_pred CeEEECcCcccccccccccc---ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--H
Confidence 68999999998654432211 12224467899999999999999999999999999999999 899997654321 1
Q ss_pred HHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc-hhhhh
Q 008898 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD-YWLKM 529 (549)
Q Consensus 463 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~-~w~~~ 529 (549)
......... +. .+...+..+.+++..||..||.+|||+.++++.|++.- +|++.
T Consensus 250 ---~~~~~~~~~------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~ 304 (322)
T 1p4o_A 250 ---LRFVMEGGL------LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304 (322)
T ss_dssp ---HHHHHTTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred ---HHHHHcCCc------CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcc
Confidence 111111110 01 11223456788899999999999999999999998753 55543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=336.00 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=203.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|.+.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++.++||||+++++++.+.+.++++|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5789999999999999999987 468899999996532 23467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYK-GELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECSSS--
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCC-CCEEEecccccccCccc--
Confidence 999 5699999865 67888899999999999999999 99999999999999988 68999999998543321
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
......||+.|+|||.+.+..++.++||||||+++|+|++|..||........ . ..+... +..
T Consensus 168 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~----~~~~~~-------~~~ 230 (284)
T 2vgo_A 168 -----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-H----RRIVNV-------DLK 230 (284)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H----HHHHTT-------CCC
T ss_pred -----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-H----HHHhcc-------ccC
Confidence 22345799999999999999999999999999999999999999976543211 1 111110 111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+... ....+.+++..||..||.+|||+.++++ |+||+..
T Consensus 231 ~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~-----h~~~~~~ 269 (284)
T 2vgo_A 231 FPPF----LSDGSKDLISKLLRYHPPQRLPLKGVME-----HPWVKAN 269 (284)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHT-----CHHHHHH
T ss_pred CCCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhh-----CHHHHhh
Confidence 2222 2345778899999999999999999998 8999743
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=345.40 Aligned_cols=273 Identities=22% Similarity=0.310 Sum_probs=209.8
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCC-cEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC------eeeEEEEEEcCCe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDG-QVAAVKVLKCTNWSEEEVLREVELLSSIKHEN------IVRIIGYCHSKEM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g-~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n------Iv~l~~~~~~~~~ 321 (549)
+.++|.+.+.||+|+||.||+|.. .++ +.||+|+++......+.+.+|+.+++.++|++ ++.+++++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 357899999999999999999987 344 78999999865544567888999999987665 8999999999999
Q ss_pred EEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE-----------------
Q 008898 322 YAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL----------------- 379 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl----------------- 379 (549)
++++|||++|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||+
T Consensus 97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 999999999999888854 67788899999999999999999 99999999999999
Q ss_pred --ecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCccc
Q 008898 380 --SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (549)
Q Consensus 380 --~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~ 457 (549)
+.+ +.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 174 ~~~~~-~~~kl~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 174 KSVKN-TSIRVADFGSATFDHE--------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp EEESC-CCEEECCCTTCEETTS--------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCC-CcEEEeecCccccccc--------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 455 6899999999865322 12345799999999999999999999999999999999999999986553
Q ss_pred chhhHHHHHHHhhcc--ccc------ccccC--------------------C-cccccCCHHHHHHHHHHHHHhcccCCC
Q 008898 458 NRESLVLWARSLLSS--GLC------ERLID--------------------P-QLNEEYNREEIEIVMCAARLCLLHSSS 508 (549)
Q Consensus 458 ~~~~l~~~~~~~~~~--~~~------~~~~d--------------------~-~l~~~~~~~~~~~l~~li~~Cl~~dP~ 508 (549)
.. .+.......... ... ..... + .............+.+++..||..||.
T Consensus 245 ~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 245 RE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 22 121111111000 000 00000 0 000011233456788999999999999
Q ss_pred CCCCHHHHHHHhcCCchhhhhhhHHHHHHhhc
Q 008898 509 RRPTMKTLLKLFQEPDYWLKMKREKEELLNER 540 (549)
Q Consensus 509 ~RPs~~evl~~L~~~~~w~~~~~~~~~~~~~~ 540 (549)
+|||+.++++ |+||.....++...+..
T Consensus 324 ~Rpt~~e~l~-----hp~f~~~~~~~~~~~~~ 350 (355)
T 2eu9_A 324 QRITLAEALL-----HPFFAGLTPEERSFHTS 350 (355)
T ss_dssp TSCCHHHHTT-----SGGGGGCCHHHHC----
T ss_pred hCcCHHHHhc-----ChhhcCCChhhcccccc
Confidence 9999999998 99999877666554433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=365.44 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=205.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|...+.||+|+||.||++.+ .+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45799999999999999999987 479999999996542 3456789999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe---cCCCceEEeeeccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS---ENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~~kL~DFGla~~~~ 398 (549)
|||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++ .+ +.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~-~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKD-ANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTT-CCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCC-CcEEEEeeeeeEEcc
Confidence 9999 7899998853 78888999999999999999999 999999999999994 44 689999999986543
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||....... .+.. +..... .
T Consensus 181 ~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~----i~~~~~-~-- 245 (484)
T 3nyv_A 181 AS------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKK----VEKGKY-T-- 245 (484)
T ss_dssp CC------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH----HHHCCC-C--
T ss_pred cc------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHH----HHcCCC-C--
Confidence 32 22345679999999998875 79999999999999999999999998654321 1111 111100 0
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
...... ......+.+++..||..||.+|||+.++++ |+|++....
T Consensus 246 ~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~-----h~~~~~~~~ 290 (484)
T 3nyv_A 246 FELPQW----KKVSESAKDLIRKMLTYVPSMRISARDALD-----HEWIQTYTK 290 (484)
T ss_dssp CCSGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT-----SHHHHHHTC
T ss_pred CCCccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh-----Chhhccccc
Confidence 000011 122345778899999999999999999998 899976543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=348.21 Aligned_cols=265 Identities=17% Similarity=0.189 Sum_probs=198.7
Q ss_pred hcCCCCCceEcccCceEEEEEEec----CCcEEEEEEeecCCcC------------HHHHHHHHHHHhcCCCCCeeeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWS------------EEEVLREVELLSSIKHENIVRIIG 314 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~----~g~~~AvK~l~~~~~~------------~~~~~~E~~il~~l~h~nIv~l~~ 314 (549)
.++|.+.+.||+|+||.||+|... ++..+|+|++...... ...+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357899999999999999999874 5789999999765321 123667889999999999999999
Q ss_pred EEEc----CCeEEEEEeccCCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC--c
Q 008898 315 YCHS----KEMYAIVYNLLNGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH--H 385 (549)
Q Consensus 315 ~~~~----~~~~~lv~e~~~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~ 385 (549)
++.. ...++++|||++|+|.+++.. +++.+++.++.||+.||.|||+. +|+||||||+|||++.+ + .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~-~~~~ 191 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK-NPDQ 191 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS-STTS
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC-CCCc
Confidence 9977 789999999998899999853 78889999999999999999999 99999999999999977 4 8
Q ss_pred eEEeeeccccccccccccc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHH
Q 008898 386 PQLSDFGAAMVHHQSHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLV 463 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~ 463 (549)
+||+|||++.......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999997654322111 11222456899999999999999999999999999999999999999975433322222
Q ss_pred HHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 464 LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 464 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
....... ......+. .... ....+..+.+++..||..||.+|||+.+|++.|+...
T Consensus 272 ~~~~~~~-~~~~~~~~-~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 272 TAKTNLL-DELPQSVL-KWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHH-HTTTHHHH-HHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHhhc-ccccHHHH-hhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2111111 00000000 0000 0023346888889999999999999999999998755
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=361.88 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=201.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC---CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT---NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.++|.+.+.||+|+||.||++.+ .+++.||||++... ......+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 46799999999999999999987 57999999999643 334567899999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeeccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla~~~~~~ 400 (549)
||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||++......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999 6799888853 77888999999999999999999 99999999999999632 247999999998654332
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||....... .+.. +..... . .+
T Consensus 178 ------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~----i~~~~~-~--~~ 242 (486)
T 3mwu_A 178 ------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKR----VETGKY-A--FD 242 (486)
T ss_dssp ----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH----HHHTCC-C--SC
T ss_pred ------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH----HHhCCC-C--CC
Confidence 22335579999999998875 69999999999999999999999997654321 1111 111100 0 00
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
...... ....+.+++..||..||.+|||+.++++ |+|++..
T Consensus 243 ~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~~~l~-----hp~~~~~ 283 (486)
T 3mwu_A 243 LPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE-----HPWIQKY 283 (486)
T ss_dssp SGGGGG----SCHHHHHHHHHHTCSSTTTSCCHHHHHH-----CHHHHHT
T ss_pred CcccCC----CCHHHHHHHHHHcCCChhhCcCHHHHhc-----CHhhccC
Confidence 011112 2345778889999999999999999999 8999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=351.95 Aligned_cols=266 Identities=25% Similarity=0.357 Sum_probs=204.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|...+.||+|+||.||++.+ .+++.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 45799999999999999999987 4689999999986532 23568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+ +|+|.+++.. +++.....++.|++.||.|||+.+ +|+||||||+|||++.+ +.++|+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCC-CCEEEEECCCCcccccc---
Confidence 99 6699999965 677888999999999999999832 89999999999999998 68999999998543221
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcc-----------
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSS----------- 472 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~----------- 472 (549)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .......
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF-GCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHH-C-----------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-cccccccCCCCCCCcccC
Confidence 123457999999999999999999999999999999999999999865432211100 0000000
Q ss_pred ------------------cccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 473 ------------------GLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 473 ------------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.....+................+.+++..||..||.+|||+.++++ |+||+....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----hp~~~~~~~ 333 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV-----HAFIKRSDA 333 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT-----SHHHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh-----ChHhhcchH
Confidence 0000000000000111112346788899999999999999999998 999977553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=337.26 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=201.3
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC-----cCHHHHHHHHHHHhcCCCCCeeeEEEEE--EcCCe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSIKHENIVRIIGYC--HSKEM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~-----~~~~~~~~E~~il~~l~h~nIv~l~~~~--~~~~~ 321 (549)
+.++|.+.+.||+|+||.||++.+ .+++.+|+|+++... .....+.+|+.+++.++||||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999987 568999999997532 2346688999999999999999999998 45568
Q ss_pred EEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
++++|||+.++|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++..
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTG-GTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCC-CcEEeeccccccc
Confidence 999999998888888854 67788899999999999999999 99999999999999998 6899999999866
Q ss_pred cccccccccCccccccccCCccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
.... ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... . ...+... .
T Consensus 159 ~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~----~~~i~~~-~ 229 (305)
T 2wtk_C 159 LHPF---AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-L----FENIGKG-S 229 (305)
T ss_dssp CCTT---CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H----HHHHHHC-C
T ss_pred cCcc---ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-H----HHHHhcC-C
Confidence 4331 1122233557999999999988654 3789999999999999999999997654221 1 1111111 0
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
..+... ....+.+++..||..||.+|||+.++++ |+|++....
T Consensus 230 ------~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~-----~~~~~~~~~ 272 (305)
T 2wtk_C 230 ------YAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ-----HSWFRKKHP 272 (305)
T ss_dssp ------CCCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHH-----SHHHHSCCC
T ss_pred ------CCCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhc-----CcccccCCC
Confidence 111122 2345778889999999999999999999 899976554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=335.64 Aligned_cols=243 Identities=18% Similarity=0.345 Sum_probs=196.8
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK--EMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~lv~ 326 (549)
++|...+.||+|+||.||+|.+ +++.+|+|+++..... .+.+.+|+.++++++||||+++++++.+. +.++++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5788999999999999999987 4889999999865433 34688999999999999999999999876 7889999
Q ss_pred ecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCC--EEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 327 NLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 327 e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
||+ +|+|.+++.. +++..++.++.||+.||.|||+. + |+||||||+|||++.+ +.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDED-MTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCC-cceeEEeccceeeec
Confidence 999 5799999964 67888999999999999999998 8 9999999999999988 689999998863311
Q ss_pred cccccccCccccccccCCccccccccccCCCCc---hhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE---KIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~---k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
.....||+.|+|||.+.+..++. ++|||||||++|||++|+.||.......... .....
T Consensus 165 ----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~~~~--- 226 (271)
T 3kmu_A 165 ----------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-----KVALE--- 226 (271)
T ss_dssp ----------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-----HHHHS---
T ss_pred ----------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-----HHHhc---
Confidence 12346899999999998765544 8999999999999999999997654322111 11111
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
...+.... .....+.+++..||..||.+|||+.++++.|+..
T Consensus 227 --~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 227 --GLRPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp --CCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11122222 2344578888999999999999999999988653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=333.56 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=199.5
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
++|....+||+|+||.||+|.+ .+++.||+|.++.... ..+.+.+|+.+++.++||||+++++++.+.+.++++|||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3566667999999999999987 5688999999976543 3467889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 330 -NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 330 -~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
+|+|.+++.. +.+.....++.||+.||.|||+. +|+|+||||+|||++.+.+.++|+|||++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 176 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-- 176 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence 6799999965 34666788999999999999999 99999999999999983378999999998654321
Q ss_pred cccCccccccccCCccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~--~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
........||+.|+|||++.++. ++.++|||||||++|+|++|+.||........... ..... ...
T Consensus 177 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~-------~~~ 244 (295)
T 2clq_A 177 ---NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--KVGMF-------KVH 244 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--HHHHH-------CCC
T ss_pred ---CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--hhccc-------ccc
Confidence 11223457999999999987654 88999999999999999999999975443222111 11110 111
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
+.+... ....+.+++..||..||.+|||+.++++ |+|++....
T Consensus 245 ~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~-----~~~~~~~~~ 287 (295)
T 2clq_A 245 PEIPES----MSAEAKAFILKCFEPDPDKRACANDLLV-----DEFLKVSSK 287 (295)
T ss_dssp CCCCTT----SCHHHHHHHHHTTCSSTTTSCCHHHHHT-----SGGGCC---
T ss_pred cccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc-----Chhhhhccc
Confidence 222222 3345778889999999999999999998 899976553
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=347.14 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=205.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|...+.||+|+||.||++.+ .+++.+|+|++..... ..+.+.+|+.+++.++||||+++++++.+.+.++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35788999999999999999987 4588999999975432 235678899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +++|.+++.. +++.+...++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~- 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYD- 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT-CCEEECCCTTCEECCST-
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCC-CCEEEeeccCceecccC-
Confidence 9999 5799998864 67888999999999999999999 99999999999999998 68999999998654321
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ... .... ..
T Consensus 195 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~----~~~~-------~~ 258 (335)
T 2owb_A 195 ----GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLR----IKKN-------EY 258 (335)
T ss_dssp ----TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH----HHHT-------CC
T ss_pred ----cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHH----HhcC-------CC
Confidence 1122346799999999999999999999999999999999999999976543221 111 1100 01
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.+...+ ...+.+++..||..||.+|||+.++++ |+||....
T Consensus 259 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~-----~~~~~~~~ 299 (335)
T 2owb_A 259 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLN-----DEFFTSGY 299 (335)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG-----SHHHHTSC
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc-----CccccCCC
Confidence 111222 345777889999999999999999998 89987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.58 Aligned_cols=255 Identities=28% Similarity=0.435 Sum_probs=203.3
Q ss_pred HHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---------HHHHHHHHHHHhcC-CCCCeeeEEEE
Q 008898 247 LCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---------EEEVLREVELLSSI-KHENIVRIIGY 315 (549)
Q Consensus 247 l~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---------~~~~~~E~~il~~l-~h~nIv~l~~~ 315 (549)
...+.++|.+.+.||+|+||.||+|.+ .+|+.||||++...... .+.+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 344567899999999999999999988 47999999999765321 23567899999999 79999999999
Q ss_pred EEcCCeEEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeee
Q 008898 316 CHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (549)
Q Consensus 316 ~~~~~~~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DF 391 (549)
+...+.+++||||+ +|+|.+++.. +++.....++.||+.||.|||+. ||+|+||||+|||++.+ +.++|+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~-~~ikl~Df 244 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDN-MQIRLSDF 244 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC-CCEEEEec
Confidence 99999999999999 5699999864 67888899999999999999999 99999999999999998 68999999
Q ss_pred ccccccccccccccCccccccccCCcccccccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHH
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY------GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW 465 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~ 465 (549)
|++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+...
T Consensus 245 G~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~i 317 (365)
T 2y7j_A 245 GFSCHLEPG------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-MLRMI 317 (365)
T ss_dssp TTCEECCTT------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH
T ss_pred CcccccCCC------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-HHHHH
Confidence 998654432 22335689999999999863 358899999999999999999999997653211 11111
Q ss_pred HHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 466 ARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 466 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
.. +... ...+ ... .....+.+++..||..||.+|||+.++++ |+||+
T Consensus 318 ~~-----~~~~-~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~-----hp~f~ 364 (365)
T 2y7j_A 318 ME-----GQYQ-FSSP-EWD----DRSSTVKDLISRLLQVDPEARLTAEQALQ-----HPFFE 364 (365)
T ss_dssp HH-----TCCC-CCHH-HHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH-----SGGGC
T ss_pred Hh-----CCCC-CCCc-ccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc-----CcccC
Confidence 10 0000 0000 001 11345778899999999999999999999 89986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=353.06 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=206.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--eEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKE--MYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--~~~lv 325 (549)
.++|.+.++||+|+||.||+|.+ .+|+.||||+++... ...+.+.+|+++++.++||||+++++++...+ .+++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 46799999999999999999987 459999999997543 23467889999999999999999999997655 78999
Q ss_pred Eecc-CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE----ecCCCceEEeeeccc
Q 008898 326 YNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL----SENFHHPQLSDFGAA 394 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~~kL~DFGla 394 (549)
|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||+ +.+ +.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSC-EEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCc-eeEEEecCCCc
Confidence 9999 6799999954 77888999999999999999999 99999999999999 555 57999999999
Q ss_pred cccccccccccCccccccccCCcccccccccc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHH
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY--------GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWA 466 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~ 466 (549)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 164 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 164 RELEDD------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp EECCCG------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred eEccCC------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 764432 12234579999999999875 5678899999999999999999999976543222222222
Q ss_pred HHhhccc--ccc---c-------c-cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 467 RSLLSSG--LCE---R-------L-IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 467 ~~~~~~~--~~~---~-------~-~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
....... ... . + .+......+.......+.+++..||+.||.+||++.++++.++.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 2221110 000 0 0 01112234567888899999999999999999999999887754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=346.35 Aligned_cols=272 Identities=25% Similarity=0.346 Sum_probs=205.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----Ce
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSK-----EM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~~ 321 (549)
+.++|...+.||+|+||.||+|.+ .+|+.||||+++..... ...+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 457899999999999999999987 46899999999754322 34578999999999999999999988654 68
Q ss_pred EEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
++++||++.|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSN-CDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT-CCEEECCCTTCEECC-
T ss_pred EEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCC-CcEEEEeccccccccc
Confidence 999999999999999865 77888999999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccc-----cCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc
Q 008898 400 SHQVS-----ENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG 473 (549)
Q Consensus 400 ~~~~~-----~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 473 (549)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 243 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGTPH 243 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCc
Confidence 21111 1112234679999999998765 6789999999999999999999999987653221 111111111000
Q ss_pred ---ccc------------cc---cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 474 ---LCE------------RL---IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 474 ---~~~------------~~---~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
... .+ ....+ ..........+.+++..||..||.+|||+.++++ |+||.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----hp~~~~~~~ 314 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE-----HPYLQTYHD 314 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGTTTCC
T ss_pred hhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc-----CccccccCC
Confidence 000 00 00000 0001123456778999999999999999999999 899987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=338.22 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=202.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
+.++|...+.||+|+||.||++.+ .+|+.+|+|+++.... ....+.+|+.+++.++||||+++++++.+.+.++++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 456799999999999999999987 4799999999986543 33568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE---ecCCCceEEeeeccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~~kL~DFGla~~~~~~ 400 (549)
|+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+||++ +.+ +.++|+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN- 161 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC-
Confidence 99 6799999854 67788899999999999999999 99999999999999 555 6899999999854322
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... +.. +.. .
T Consensus 162 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~----i~~-~~~-~--- 225 (304)
T 2jam_A 162 ------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEK----IKE-GYY-E--- 225 (304)
T ss_dssp ------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH----HHH-CCC-C---
T ss_pred ------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHH----HHc-CCC-C---
Confidence 12234579999999999999999999999999999999999999997654321 1111 111 100 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
............+.+++..||..||.+|||+.++++ |+|+...
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~-----h~~~~~~ 268 (304)
T 2jam_A 226 --FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS-----HPWIDGN 268 (304)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT-----SHHHHSS
T ss_pred --CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc-----CccccCC
Confidence 011111223456788899999999999999999998 8998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.45 Aligned_cols=258 Identities=20% Similarity=0.303 Sum_probs=203.4
Q ss_pred HHhhhcCCCCC-ceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCC
Q 008898 247 LCHLTHNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIK-HENIVRIIGYCHSKE 320 (549)
Q Consensus 247 l~~~~~~f~~~-~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~ 320 (549)
...+.+.|... +.||+|+||.||+|.. .+|+.||+|+++... .....+.+|+.+++.+. ||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34456677777 8899999999999987 469999999997543 23567889999999995 699999999999999
Q ss_pred eEEEEEecc-CCCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec---CCCceEEeee
Q 008898 321 MYAIVYNLL-NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---NFHHPQLSDF 391 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~~kL~DF 391 (549)
.+++||||+ +|+|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++. + +.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~-~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPL-GDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTB-CCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCC-CcEEEeeC
Confidence 999999999 568988873 378888999999999999999999 9999999999999987 4 68999999
Q ss_pred ccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS 471 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 471 (549)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......
T Consensus 179 g~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~--- 248 (327)
T 3lm5_A 179 GMSRKIGHA------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQV--- 248 (327)
T ss_dssp GGCEEC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHT---
T ss_pred ccccccCCc------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhc---
Confidence 999764332 122345799999999999999999999999999999999999999976543221 1111100
Q ss_pred ccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 472 SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 472 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
. ..............+.+++..||..||.+|||+.++++ |+||+...
T Consensus 249 ~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~-----h~~~~~~~ 295 (327)
T 3lm5_A 249 N--------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS-----HSWLQQWD 295 (327)
T ss_dssp C--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT-----CGGGCCCC
T ss_pred c--------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC-----CHhhcccc
Confidence 0 01111111223456778899999999999999999998 89987643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=340.66 Aligned_cols=267 Identities=24% Similarity=0.365 Sum_probs=209.2
Q ss_pred HHHHHhhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhc--CCCCCeeeEEEEEEcCC-
Q 008898 244 SQELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSS--IKHENIVRIIGYCHSKE- 320 (549)
Q Consensus 244 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~~~~~~~- 320 (549)
......+.++|...+.||+|+||.||++.+ +|+.||||+++.. ....+.+|.+++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 333345567899999999999999999987 5899999999754 34667889998887 78999999999998776
Q ss_pred ---eEEEEEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHH--------hCCCCCEEEecCCCCCEEEecCCCce
Q 008898 321 ---MYAIVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLH--------HTCDPPIIHRDVKSSNILLSENFHHP 386 (549)
Q Consensus 321 ---~~~lv~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~~ 386 (549)
.++++|||+ +|+|.+++.. +++..++.++.|++.||.||| +. +|+||||||+|||++.+ +.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~-~~~ 186 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN-GTC 186 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT-SCE
T ss_pred ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC-CCE
Confidence 899999999 5699999976 778889999999999999999 66 99999999999999998 689
Q ss_pred EEeeeccccccccccccccCccccccccCCccccccccccCC------CCchhhHHHHHHHHHHHHcC----------CC
Q 008898 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK------VDEKIDVYSYGVVLLELITG----------KE 450 (549)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~------~~~k~DvwSlGvil~elltG----------~~ 450 (549)
||+|||++.......... ........||+.|+|||++.+.. ++.++|||||||++|||++| ..
T Consensus 187 kL~Dfg~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EECCCTTCEEEETTTTEE-EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEECCCceecccccccc-ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999996654322111 11223557999999999988652 34789999999999999999 77
Q ss_pred CCCCcccchhhHHHHHHHhhcccccccccCCccccc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 451 AIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE-YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 451 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
||............+....... ...+.+... ...+....+.+++..||..||.+|||+.+|++.|+..
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTS-----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCcCcccHHHHHHHHHHH-----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 8876544333333333332221 122222222 2346778899999999999999999999999988654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=337.96 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=188.0
Q ss_pred hcCCCCCceEcccCceEEEEEEecC----CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~----g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|.+.+.||+|+||.||+|.+.. +..+|+|+++.... ..+.+.+|+.+++.++||||+++++++. ++.+++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678899999999999999997632 45799999875432 2356889999999999999999999985 456789
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+|||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCC-CCEEECccccccccCc
Confidence 99999 5699999963 67888899999999999999999 99999999999999988 6899999999976543
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||........ . . .+....
T Consensus 169 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-~-~---~i~~~~----- 234 (281)
T 1mp8_A 169 STY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-I-G---RIENGE----- 234 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-H-H---HHHTTC-----
T ss_pred ccc----cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-H-H---HHHcCC-----
Confidence 211 11223457889999999999999999999999999999997 9999986544321 1 1 111110
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
... .+...+..+.+++..||..||.+|||+.++++.|+.
T Consensus 235 -~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 235 -RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp -CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 011 122334567788999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=339.52 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=205.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.+.|...+.||+|+||.||+|.. .+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++.++++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35688899999999999999986 568999999997653 334678999999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 328 LL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 328 ~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
|+ +|+|.+++.. +++.....++.||+.||.|||+. +|+|+||||+||+++.+ +.++|+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~--- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQ--- 173 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECBTTB---
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCC-CCEEEeecccceecCccc---
Confidence 99 5699999864 67888899999999999999999 99999999999999998 689999999986543321
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ... .. .+ ..+.+.
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~---~~-~~-----~~~~~~ 240 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LFL---IP-KN-----NPPTLE 240 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH---HH-HS-----CCCCCC
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--HHH---hh-cC-----CCCCCc
Confidence 122355799999999999999999999999999999999999999976543221 111 10 11 111222
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
..+ ...+.+++..||..||.+|||+.++++ |+|+...
T Consensus 241 ~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~-----~~~~~~~ 277 (303)
T 3a7i_A 241 GNY----SKPLKEFVEACLNKEPSFRPTAKELLK-----HKFILRN 277 (303)
T ss_dssp SSC----CHHHHHHHHHHCCSSGGGSCCHHHHTT-----CHHHHHH
T ss_pred ccc----CHHHHHHHHHHcCCChhhCcCHHHHhh-----ChhhhcC
Confidence 223 345778889999999999999999998 8888443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=336.05 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=205.1
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|...+.||+|+||.||++.+. +++.+|+|++..... ..+.+.+|+.+++.++||||+++++++.+++.++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457889999999999999999874 588999999975432 235678899999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +++|.+++.. +++.+...++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~- 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYD- 168 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEECCST-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCC-CCEEEEeccCceecccC-
Confidence 9999 5799998864 67888999999999999999999 99999999999999998 68999999998654321
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
........||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .. ..... ..
T Consensus 169 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~----~~~~~-------~~ 232 (294)
T 2rku_A 169 ----GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YL----RIKKN-------EY 232 (294)
T ss_dssp ----TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH----HHHTT-------CC
T ss_pred ----ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH----HHhhc-------cC
Confidence 1122345799999999999998999999999999999999999999976543221 11 11110 01
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.+...+ ...+.+++..||..||.+|||+.++++ |+||....
T Consensus 233 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~-----~~~~~~~~ 273 (294)
T 2rku_A 233 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLN-----DEFFTSGY 273 (294)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG-----SHHHHTSC
T ss_pred CCcccc----CHHHHHHHHHHcccChhhCcCHHHHhh-----ChheecCC
Confidence 111222 345778889999999999999999998 89997543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=346.79 Aligned_cols=251 Identities=22% Similarity=0.391 Sum_probs=190.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcE----EEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQV----AAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~----~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
.++|...+.||+|+||.||+|.+ .+++. +|+|.+.... .....+.+|+.+++.++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 36799999999999999999986 44553 5777765432 34577899999999999999999999998876 45
Q ss_pred EEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++++++ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET-TEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCC-CCEEEccCcceeEcc
Confidence 555555 8899999965 67888899999999999999999 99999999999999998 689999999997654
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
... .........||+.|+|||.+.+..++.++|||||||++|||++ |..||....... +... +....
T Consensus 169 ~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~---~~~~~---- 236 (327)
T 3lzb_A 169 AEE---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI---LEKGE---- 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH---HHTTC----
T ss_pred Ccc---ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHH---HHcCC----
Confidence 321 1112223457889999999999999999999999999999999 999998764432 1111 11110
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.. ..+......+.+++..||..||.+|||+.++++.|+...
T Consensus 237 --~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 --RL----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01 111223345778899999999999999999999887543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=346.71 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=200.3
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CC-----cEEEEEEeecCCc--CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DG-----QVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g-----~~~AvK~l~~~~~--~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 321 (549)
.++|...+.||+|+||.||+|.+. ++ ..+|+|+++.... ..+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 467889999999999999999863 23 4899999976542 235688999999999 89999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH-----------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC
Q 008898 322 YAIVYNLL-NGSLKQYLKQ-----------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~-----------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~ 383 (549)
++++|||+ +|+|.+++.. +++...+.++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~- 200 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG- 200 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG-
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC-
Confidence 99999999 5699999854 36678889999999999999999 99999999999999998
Q ss_pred CceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhH
Q 008898 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESL 462 (549)
Q Consensus 384 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l 462 (549)
+.+||+|||++....... .........||+.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GEEEBCCCGGGCCGGGCT---TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CeEEECcccccccccccc---ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 689999999997543321 1112234567889999999999999999999999999999998 999997654432211
Q ss_pred HHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 463 VLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 463 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..... + ..... +...+..+.+++..||..||.+|||+.++++.|+.
T Consensus 278 -~~~~~----~-----~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 278 -KLVKD----G-----YQMAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp -HHHHH----T-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHhc----C-----CCCCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 11111 1 01111 11123567888999999999999999999997754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.26 Aligned_cols=258 Identities=23% Similarity=0.303 Sum_probs=196.0
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEeccC
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLLN 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 330 (549)
+.|...++||+|+||+||.+...+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.+++.++++|||++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 4455678899999999987766789999999997543 35678999999876 89999999999999999999999999
Q ss_pred CCHHHHHHHh----------chhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC------------CCceEE
Q 008898 331 GSLKQYLKQL----------KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN------------FHHPQL 388 (549)
Q Consensus 331 gsL~~~l~~~----------~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~------------~~~~kL 388 (549)
|+|.+++... .+...+.++.||+.||.|||+. +|+||||||+|||++.+ ...+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 9999999642 2234567999999999999999 99999999999999753 137999
Q ss_pred eeeccccccccccccccCccccccccCCcccccccccc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchh
Q 008898 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-------GKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRE 460 (549)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~ 460 (549)
+|||++......... .........||+.|+|||++.+ ..++.++|||||||++|||++ |+.||........
T Consensus 170 ~DFG~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 170 SDFGLCKKLDSGQSS-FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp CCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred cccccceecCCCCcc-ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 999999765432211 1112235679999999999976 568999999999999999999 9999976543221
Q ss_pred hHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 461 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.. ..... ..+.............+.+++..||..||.+|||+.++++ |+||....
T Consensus 249 ~i---~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~-----hp~f~~~~ 303 (434)
T 2rio_A 249 NI---IRGIF--------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR-----HPLFWPKS 303 (434)
T ss_dssp HH---HHTCC--------CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT-----SGGGSCHH
T ss_pred HH---hcCCC--------CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh-----CCccCCcH
Confidence 11 11100 0111122224566778999999999999999999999998 89996543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=336.80 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=190.2
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|...+.||+|+||.||+|... ..+|+|+++...... +.+.+|+.+++.++||||+++++++. .+.++++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 467999999999999999999763 359999997655433 45789999999999999999999764 456889999
Q ss_pred cc-CCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 328 LL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 328 ~~-~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+ +|+|.+++. .+++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-- 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRW-- 173 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT-TEEEECCCC----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC-CCEEEccceeccccccc--
Confidence 99 579999983 377888999999999999999999 99999999999999998 69999999998654321
Q ss_pred cccCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
..........||+.|+|||++. +..++.++|||||||++|+|++|+.||............ ... +..
T Consensus 174 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~----~~~---- 243 (289)
T 3og7_A 174 -SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM-VGR----GSL---- 243 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH-HHH----TSC----
T ss_pred -cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH-hcc----ccc----
Confidence 1122233567999999999986 667899999999999999999999999876543322211 111 111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
.+.+ .......+..+.+++..||..||.+|||+.++++.|+..
T Consensus 244 ~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 244 SPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp CCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred Ccch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111 111223346688899999999999999999999988653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=340.28 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=193.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|.+.+.||+|+||.||+|.. .+|+.+|+|+++.... ....+.+|+.+++.++||||+++++++..++.++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35689999999999999999987 5799999999975332 235678999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 326 YNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
|||+ +|+|.+++.. +++...+.++.||+.||.|||+. +|+|+||||+|||++.+ +.++|+|||++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT-GVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCC-CCEEEEeccceeee
Confidence 9999 5699999864 67788899999999999999999 99999999999999988 68999999998654
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........+ .........
T Consensus 187 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~--- 255 (310)
T 2wqm_A 187 SSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIEQCDY--- 255 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH---HHHHHTTCS---
T ss_pred cCCC-----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH---HHHhhcccC---
Confidence 3321 12234578999999999999999999999999999999999999997654332222 111111110
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+... .......+.+++..||..||.+|||+.++++.|++.+...
T Consensus 256 ---~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 256 ---PPLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp ---CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1111 1122346778889999999999999999999887766443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.07 Aligned_cols=260 Identities=20% Similarity=0.243 Sum_probs=198.1
Q ss_pred hhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEE-EcCCeEEEEE
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVY 326 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~-~~~~~~~lv~ 326 (549)
.+.++|...+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+.+++.++|++++..+.++ ..++..+++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 3467899999999999999999987 6789999998765432 24578899999999988877766655 6778899999
Q ss_pred eccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE---ecCCCceEEeeecccccccc
Q 008898 327 NLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 327 e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~~kL~DFGla~~~~~ 399 (549)
||++|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||+ +.+ +.+||+|||++.....
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBC
T ss_pred EccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCC-CeEEEecCccceeccC
Confidence 9999999999963 78889999999999999999999 99999999999999 566 6899999999976544
Q ss_pred ccccc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccch--hhHHHHHHHhhccccc
Q 008898 400 SHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR--ESLVLWARSLLSSGLC 475 (549)
Q Consensus 400 ~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~ 475 (549)
..... .........||+.|+|||.+.+..++.++|||||||++|+|++|+.||....... ............. ..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hh
Confidence 32111 1122335689999999999999999999999999999999999999998654321 1111111111000 00
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
+.... ..+..+.+++..||+.||.+|||+.++++.|+..
T Consensus 240 -----~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 240 -----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -----HHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -----hhhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00001 1235688889999999999999999999987653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.65 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=204.7
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++|...+.||+|+||.||+|.+.++..||||+++......+.+.+|+.+|+.++||||+++++++.+ +.+++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 45688889999999999999999888889999998777677889999999999999999999999976 6788999999
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.. +++.+++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++........
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~-- 418 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY-- 418 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCHHH--
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCC-CcEEEcccccceecCCCce--
Confidence 6799999953 67888999999999999999999 99999999999999988 6899999999976433211
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
.......+|..|+|||++.++.++.++|||||||+||||++ |+.||....... .+ ..+.. +.
T Consensus 419 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-~~----~~i~~-~~--------- 481 (535)
T 2h8h_A 419 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VL----DQVER-GY--------- 481 (535)
T ss_dssp --HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-HH----HHHHT-TC---------
T ss_pred --ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HH----HHHHc-CC---------
Confidence 11123456789999999999999999999999999999999 999997654321 11 11111 10
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
....+..+...+.+++..||..||.+|||+.+|++.|+...
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 01112233456788899999999999999999999997754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=346.56 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=200.5
Q ss_pred hcCCCCCceEcccCceEEEEEEec--------CCcEEEEEEeecCCc--CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNW--SEEEVLREVELLSSI-KHENIVRIIGYCHSK 319 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 319 (549)
.++|...+.||+|+||.||+|.+. ++..||+|+++.... ....+.+|+.+++.+ +||||+++++++..+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467899999999999999999763 467899999976542 235688999999999 899999999999999
Q ss_pred CeEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE
Q 008898 320 EMYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL 379 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl 379 (549)
+.+++||||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999 6799999964 56778899999999999999999 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccc
Q 008898 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKAN 458 (549)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~ 458 (549)
+.+ +.+||+|||++......... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 191 ~~~-~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 191 TEN-NVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp CTT-CCEEECCCTTCEECTTTSSE---ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCC-CCEEEccccccccccccccc---cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 988 68999999999765432211 11223457889999999998899999999999999999999 99999765432
Q ss_pred hhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 459 RESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 459 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
. +. ..+.. +. .+.. +......+.+++..||..||.+|||+.++++.|+..
T Consensus 267 ~--~~---~~~~~-~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 E--LF---KLLKE-GH-----RMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp H--HH---HHHHH-TC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H--HH---HHHhc-CC-----CCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 11 11111 10 1111 122335677888999999999999999999988654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=343.81 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=198.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---------SEEEVLREVELLSSIKHENIVRIIGYCHSK 319 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 319 (549)
+.++|.+.+.||+|+||.||+|.+ .+++.||||++..... ....+.+|+.+++.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 356799999999999999999987 5689999999965421 123478899999999999999999999776
Q ss_pred CeEEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC--CceEEeeecc
Q 008898 320 EMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGA 393 (549)
Q Consensus 320 ~~~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~~kL~DFGl 393 (549)
+ ++++|||+ +|+|.+++.. +++.....++.||+.||.|||++ +|+||||||+|||++.+. ..+||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 88999999 5699998843 67788899999999999999999 999999999999998752 2499999999
Q ss_pred ccccccccccccCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
+...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||...............
T Consensus 164 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--- 234 (322)
T 2ycf_A 164 SKILGET------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS--- 234 (322)
T ss_dssp CEECCCC------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---
T ss_pred ceecccc------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---
Confidence 8654321 1223457999999999974 467899999999999999999999999765433221111111
Q ss_pred cccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 471 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
+... ..+.... .....+.+++..||..||.+|||+.++++ |+|+.....
T Consensus 235 --~~~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~-----h~~~~~~~~ 283 (322)
T 2ycf_A 235 --GKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR-----HPWLQDEDM 283 (322)
T ss_dssp --TCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT-----SGGGCCHHH
T ss_pred --Cccc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh-----CcCcCCHHH
Confidence 1000 0001111 12356788899999999999999999998 899876553
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=335.46 Aligned_cols=245 Identities=21% Similarity=0.339 Sum_probs=195.3
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CC-------cEEEEEEeecCC-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DG-------QVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g-------~~~AvK~l~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
.++|...+.||+|+||.||+|.+. ++ ..+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457889999999999999999763 34 479999997544 334678899999999999999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc--------eEE
Q 008898 322 YAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH--------PQL 388 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~--------~kL 388 (549)
.+++|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~-~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIRE-EDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEEC-CBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecC-Ccccccccceeee
Confidence 99999999 5799999965 67788899999999999999999 99999999999999988 45 999
Q ss_pred eeeccccccccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHH
Q 008898 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~ 467 (549)
+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+............+.
T Consensus 163 ~Dfg~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~- 232 (289)
T 4fvq_A 163 SDPGISITVLP---------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE- 232 (289)
T ss_dssp CCCCSCTTTSC---------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-
T ss_pred ccCcccccccC---------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-
Confidence 99999854322 123468999999999987 6789999999999999999996555443332222111111
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
.. ..+.... ...+.+++..||+.||.+|||+.++++.|+..-
T Consensus 233 ---~~--------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 233 ---DR--------HQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp ---TT--------CCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred ---cc--------CCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 00 0111111 234778889999999999999999999887654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=333.22 Aligned_cols=258 Identities=20% Similarity=0.260 Sum_probs=201.9
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEE-EcCCeEEEEEe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAIVYN 327 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~-~~~~~~~lv~e 327 (549)
+.++|...+.||+|+||.||+|.+ .+|+.||+|++..... ...+.+|+.+++.++|++++..+.++ ..++..+++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 467899999999999999999987 6799999999875542 35688999999999988877666555 67788899999
Q ss_pred ccCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe---cCCCceEEeeeccccccccc
Q 008898 328 LLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS---ENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 328 ~~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~~kL~DFGla~~~~~~ 400 (549)
|++|+|.+++. .+++..+..++.||+.||.|||++ +|+||||||+|||++ .+ +.+||+|||++......
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGT-TCEEECCCTTCEECBCT
T ss_pred ecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCC-CeEEEeeCCCccccccc
Confidence 99999999996 377888999999999999999999 999999999999995 55 68999999999765443
Q ss_pred cccc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc--hhhHHHHHHHhhcccccc
Q 008898 401 HQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN--RESLVLWARSLLSSGLCE 476 (549)
Q Consensus 401 ~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~~ 476 (549)
.... .........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...+........... .
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-I- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-H-
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-h-
Confidence 2111 011234568999999999999999999999999999999999999999864431 112211111111000 0
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+.+.. ..+..+.+++..||+.||.+|||+.+|++.|+.
T Consensus 240 ----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 240 ----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp ----HHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred ----HHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 00111 123457888999999999999999999998864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=343.23 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=203.0
Q ss_pred HHHHhhhcCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEE
Q 008898 245 QELCHLTHNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGY 315 (549)
Q Consensus 245 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~ 315 (549)
.+.....++|.+.+.||+|+||.||+|.+ .+++.+|||+++..... ...+.+|+.+++.+ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33444567899999999999999999974 34689999999765432 24688999999999 79999999999
Q ss_pred EEcCC-eEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCC
Q 008898 316 CHSKE-MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374 (549)
Q Consensus 316 ~~~~~-~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp 374 (549)
+...+ .++++|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCcc
Confidence 87654 589999999 5699999964 67788899999999999999999 999999999
Q ss_pred CCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 008898 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQ 453 (549)
Q Consensus 375 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~ 453 (549)
+|||++.+ +.+||+|||++....... .........||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 177 ~Nil~~~~-~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 177 RNILLSEK-NVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp GGEEECGG-GCEEECCCGGGSCTTTCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceEEECCC-CCEEECCCccccccccCc---cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999988 689999999996543321 1122334568899999999999999999999999999999998 999997
Q ss_pred CcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 454 TNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 454 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.............. +. ....... ....+.+++..||+.||.+|||+.++++.|+.
T Consensus 253 ~~~~~~~~~~~~~~-----~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 253 GVKIDEEFCRRLKE-----GT-----RMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp TCCCSHHHHHHHHH-----TC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccchhHHHHHHhcc-----Cc-----cCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 66543322211111 10 0111112 23457788899999999999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.51 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=205.0
Q ss_pred hhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----------CHHHHHHHHHHHhcCC-CCCeeeEEEEE
Q 008898 249 HLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----------SEEEVLREVELLSSIK-HENIVRIIGYC 316 (549)
Q Consensus 249 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----------~~~~~~~E~~il~~l~-h~nIv~l~~~~ 316 (549)
.+.++|...+.||+|+||.||+|.+ .+|+.||||+++.... ..+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3457899999999999999999987 5689999999976531 1245778999999995 99999999999
Q ss_pred EcCCeEEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeec
Q 008898 317 HSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFG 392 (549)
Q Consensus 317 ~~~~~~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFG 392 (549)
..++.++++|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+|+||||+||+++.+ +.++|+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD-MNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC-CcEEEeccc
Confidence 9999999999999 5799999964 67888999999999999999999 99999999999999998 689999999
Q ss_pred cccccccccccccCccccccccCCccccccccc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHH
Q 008898 393 AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM------YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWA 466 (549)
Q Consensus 393 la~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~ 466 (549)
++...... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||....... ...
T Consensus 170 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~--- 239 (298)
T 1phk_A 170 FSCQLDPG------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLR--- 239 (298)
T ss_dssp TCEECCTT------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH---
T ss_pred chhhcCCC------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HHH---
Confidence 98654332 2233457999999999885 4568899999999999999999999997654321 111
Q ss_pred HHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 467 RSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 467 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
.+.... . ....+ ........+.+++..||..||.+|||+.++++ |+||+....
T Consensus 240 -~~~~~~-~-~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~-----h~~~~~~~~ 292 (298)
T 1phk_A 240 -MIMSGN-Y-QFGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA-----HPFFQQYVV 292 (298)
T ss_dssp -HHHHTC-C-CCCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT-----SGGGCTTC-
T ss_pred -HHhcCC-c-ccCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh-----ChHhhhccc
Confidence 111110 0 00001 11223456788899999999999999999998 899986654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.60 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=200.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.++|...+.||+|+||.||+|.+ .+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+.++++|||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 46799999999999999999987 459999999998654 3467899999999999999999999999999999999999
Q ss_pred C-CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 N-GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~-gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
. |+|.+++.. +++.....++.||+.||.|||+. +|+|+||||+||+++.+ +.++|+|||++.......
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~--- 179 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTM--- 179 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECBTTB---
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCC-CCEEEeecccchhhhhhc---
Confidence 4 599999862 77888999999999999999999 99999999999999998 689999999986543321
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.......||+.|+|||.+.+..++.++|||||||++|+|++|..||.......... . . ......... .
T Consensus 180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~----~-~~~~~~~~~---~- 247 (314)
T 3com_A 180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-M----I-PTNPPPTFR---K- 247 (314)
T ss_dssp --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-H----H-HHSCCCCCS---S-
T ss_pred --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-H----H-hcCCCcccC---C-
Confidence 12234579999999999999999999999999999999999999997654322111 0 0 001000110 1
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+......+.+++..||..||.+|||+.++++ |+|+...
T Consensus 248 ---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~-----~~~~~~~ 285 (314)
T 3com_A 248 ---PELWSDNFTDFVKQCLVKSPEQRATATQLLQ-----HPFVRSA 285 (314)
T ss_dssp ---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT-----SHHHHTC
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHHh-----CHHHhcC
Confidence 1122346778899999999999999999998 8898654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.66 Aligned_cols=273 Identities=26% Similarity=0.387 Sum_probs=197.4
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHH--HhcCCCCCeeeEEEEEE-----cCCeEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVEL--LSSIKHENIVRIIGYCH-----SKEMYA 323 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~i--l~~l~h~nIv~l~~~~~-----~~~~~~ 323 (549)
.++|...+.||+|+||.||+|.. +++.||||+++.... ..+..|.++ +..++||||+++++++. ....++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 35799999999999999999976 689999999975543 344444444 55689999999998553 234688
Q ss_pred EEEecc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCC------CCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 324 IVYNLL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTC------DPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~------~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
+||||+ +|+|.+++.. .++.....++.||+.||.|||+.+ ..+|+||||||+|||++.+ +.+||+|||++
T Consensus 89 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kL~DFG~a 167 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLS 167 (336)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-SCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-CcEEEeeccce
Confidence 999999 7799999965 567778899999999999999763 2389999999999999998 68999999999
Q ss_pred ccccccccc---ccCccccccccCCcccccccccc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhh---
Q 008898 395 MVHHQSHQV---SENVKPVNVVGTFGYLAPEYMMY-------GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES--- 461 (549)
Q Consensus 395 ~~~~~~~~~---~~~~~~~~~~gt~~y~APE~~~~-------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~--- 461 (549)
......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||.......+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 765432211 11222335579999999999986 35677999999999999999998777543321110
Q ss_pred ----------HHHHHHHhhcccccccccCCcccccC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc-hhhh
Q 008898 462 ----------LVLWARSLLSSGLCERLIDPQLNEEY--NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD-YWLK 528 (549)
Q Consensus 462 ----------l~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~-~w~~ 528 (549)
...+........ ..+.+.... .......+.+++..||..||.+|||+.++++.|++.- .|.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred hhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 001111111111 111111111 2345677999999999999999999999999988754 6665
Q ss_pred hhhH
Q 008898 529 MKRE 532 (549)
Q Consensus 529 ~~~~ 532 (549)
....
T Consensus 323 ~~~~ 326 (336)
T 3g2f_A 323 NKSV 326 (336)
T ss_dssp ----
T ss_pred cccC
Confidence 5443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=341.76 Aligned_cols=272 Identities=19% Similarity=0.263 Sum_probs=199.4
Q ss_pred hhcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEE----------
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCH---------- 317 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~---------- 317 (549)
+.++|...+.||+|+||.||+|.+. +|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3568999999999999999999884 589999999976542 2356889999999999999999999873
Q ss_pred ----cCCeEEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeee
Q 008898 318 ----SKEMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (549)
Q Consensus 318 ----~~~~~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DF 391 (549)
+.+.++++|||+.|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+.+.+||+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 4478999999999999999965 67788889999999999999999 99999999999999855368999999
Q ss_pred ccccccccccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
|++........ .........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+........
T Consensus 166 g~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~ 242 (320)
T 2i6l_A 166 GLARIMDPHYS--HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILESIP 242 (320)
T ss_dssp TTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHSC
T ss_pred ccccccCCCcc--cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 99976543211 1122234568999999998875 678999999999999999999999998765321 1111111110
Q ss_pred c--cccccc------------ccCCcc-cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 471 S--SGLCER------------LIDPQL-NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 471 ~--~~~~~~------------~~d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
. .....+ ...+.. ...........+.+++..||..||.+|||+.++++ |+||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----hp~~~~~~~ 314 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS-----HPYMSIYSF 314 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT-----SHHHHTTCC
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC-----CcccccccC
Confidence 0 000000 000000 00001123456788999999999999999999998 999986543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=339.92 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=195.3
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|...+.||+|+||.||++.+ .++.+|+|++.... ..+.+.+|+.++++++||||+++++++.+ ..++||||+ +
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT-HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh-HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 4688899999999999999987 47889999987433 34678899999999999999999998874 478999999 6
Q ss_pred CCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 331 GSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 331 gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
|+|.+++.. +.+...+.++.||++||.|||+.+.++|+||||||+|||++.+...+||+|||++.....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~----- 158 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----- 158 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-----
Confidence 799999964 456778899999999999999943349999999999999998833479999999854322
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+... . + ..+...
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~--~-~-----~~~~~~ 226 (307)
T 2eva_A 159 ---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-MWAVH--N-G-----TRPPLI 226 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH-HHHHH--T-T-----CCCCCB
T ss_pred ---ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH-HHHHh--c-C-----CCCCcc
Confidence 1123469999999999999999999999999999999999999997654322111 11111 1 1 111112
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
.. .+..+.+++..||..||.+|||+.++++.|+....++..
T Consensus 227 ~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 227 KN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred cc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 22 234577889999999999999999999999877665543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.97 Aligned_cols=264 Identities=24% Similarity=0.345 Sum_probs=188.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSK------E 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~------~ 320 (549)
.++|...+.||+|+||.||+|.+ .+|+.||||++...... ...+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999986 57999999999754332 35678999999999999999999998654 5
Q ss_pred eEEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 321 MYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
.+++++|+++++|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED-CELKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECC--------
T ss_pred eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCC-CCEEEeecccccccc
Confidence 6899999999999988864 77888899999999999999999 99999999999999998 689999999986533
Q ss_pred cccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--cc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--LC 475 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~ 475 (549)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+........... ..
T Consensus 184 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 184 D--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred c--------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 2 1234579999999999887 67899999999999999999999999765532 22222221111100 00
Q ss_pred ccc--------cC--Cccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 476 ERL--------ID--PQLN----EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 476 ~~~--------~d--~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
..+ +. +... ..........+.+++.+||..||.+|||+.++++ |+||.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~-----hp~~~~~~~ 320 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA-----HAYFAQYHD 320 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGTTTCC
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc-----ChhhhhccC
Confidence 000 00 0000 0000112345788999999999999999999998 899976543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.73 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=192.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcE----EEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQV----AAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~----~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
.++|...+.||+|+||.||+|.+ .+++. +|+|.+.... .....+.+|+.+++.++||||+++++++.+ +.++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 35788999999999999999986 44543 7788775432 222457789999999999999999999875 5577
Q ss_pred EEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 324 IVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
++|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSP-SQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSS-SCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCC-CeEEECCCCcccccC
Confidence 888888 6899999853 67888999999999999999999 99999999999999988 689999999997654
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
... .........||+.|+|||++.++.++.++|||||||++|||++ |+.||....... +... +.... .
T Consensus 167 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~---~~~~~---~ 235 (325)
T 3kex_A 167 PDD---KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDL---LEKGE---R 235 (325)
T ss_dssp CCT---TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHH---HHTTC---B
T ss_pred ccc---ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHH---HHcCC---C
Confidence 322 1122335568889999999999999999999999999999999 999998654322 1111 11110 0
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
... +......+.+++..||..||.+|||+.++++.|+.
T Consensus 236 ~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~ 273 (325)
T 3kex_A 236 LAQ-------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 273 (325)
T ss_dssp CCC-------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHH
T ss_pred CCC-------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 001 11122346778899999999999999999998864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=336.94 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=198.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEE--cCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCH--SKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~l 324 (549)
.++|...+.||+|+||.||++.. .+|+.+|+|++...... .+.+.+|+.+++.++||||+++++++. .++.+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46799999999999999999987 47899999999865433 345789999999999999999999874 4678999
Q ss_pred EEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCC-----EEEecCCCCCEEEecCCCceEEeee
Q 008898 325 VYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPP-----IIHRDVKSSNILLSENFHHPQLSDF 391 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~-----iiHrDlkp~NILl~~~~~~~kL~DF 391 (549)
+|||+ +|+|.+++.. +++...+.++.||+.||.|||+. + |+||||||+|||++.+ +.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~-~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSS-SCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCC-CCEEEecC
Confidence 99999 5699999954 77888999999999999999999 7 9999999999999988 68999999
Q ss_pred ccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS 471 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 471 (549)
|++...... ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... + ...+.
T Consensus 161 g~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~---~~~i~- 229 (279)
T 2w5a_A 161 GLARILNHD-----TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--L---AGKIR- 229 (279)
T ss_dssp CHHHHC--------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHH-
T ss_pred chheeeccc-----cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--H---HHHHh-
Confidence 998654321 111234578999999999999999999999999999999999999997654321 1 11111
Q ss_pred ccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 472 SGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 472 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
.+.. +.+.. .....+.+++..||..||.+|||+.+|++ +.|+.
T Consensus 230 ~~~~-----~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~-----~~~~~ 272 (279)
T 2w5a_A 230 EGKF-----RRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILE-----NPLIL 272 (279)
T ss_dssp HTCC-----CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT-----STTCC
T ss_pred hccc-----ccCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHh-----Chhhh
Confidence 1111 11112 23356788889999999999999999999 55654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=346.08 Aligned_cols=257 Identities=16% Similarity=0.193 Sum_probs=201.1
Q ss_pred cCCCCCceEcccCceEEEEEEec---------CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeee-----------
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV---------DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR----------- 311 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~---------~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~----------- 311 (549)
++|.+.+.||+|+||.||+|.+. +++.||+|++... +.+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 57999999999999999999875 3789999999754 46789999999999999987
Q ss_pred ----EEEEEEc-CCeEEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec
Q 008898 312 ----IIGYCHS-KEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE 381 (549)
Q Consensus 312 ----l~~~~~~-~~~~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~ 381 (549)
+++++.. ++.+++||||++|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred CccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 5677765 788999999998899999964 67888999999999999999999 9999999999999998
Q ss_pred CCC--ceEEeeeccccccccccccc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCccc
Q 008898 382 NFH--HPQLSDFGAAMVHHQSHQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKA 457 (549)
Q Consensus 382 ~~~--~~kL~DFGla~~~~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~ 457 (549)
+ + .+||+|||++.......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 195 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 195 E-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp T-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred C-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 8 5 79999999997654322111 11122345899999999999999999999999999999999999999987654
Q ss_pred chhhHHHHHHHhhcccccccccCCccc-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 458 NRESLVLWARSLLSSGLCERLIDPQLN-EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 458 ~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
....+......... ....+.+.... ..+ ...+.+++..||..||.+|||+.+|++.|++
T Consensus 274 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 274 NTEDIMKQKQKFVD--KPGPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp CHHHHHHHHHHHHH--SCCCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CHHHHHHHHHhccC--ChhhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 33333322222111 11111111111 112 3557788899999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=330.82 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=195.8
Q ss_pred hcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|.+.+.||+|+||.||+|.+. +|+.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999874 79999999997532 2345788999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
||++ +++|.+++.. +++.....++.||+.||.|||+. +|+|+||||+|||++.+ +.++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCC-CCEEEeecccccccCCC-
Confidence 9999 6799999964 67888899999999999999999 99999999999999998 68999999998654332
Q ss_pred ccccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... + ...+.. +.
T Consensus 165 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~---~~~~~~-~~------ 227 (276)
T 2h6d_A 165 -----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--L---FKKIRG-GV------ 227 (276)
T ss_dssp -----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHH-CC------
T ss_pred -----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--H---HHHhhc-Cc------
Confidence 12234578999999999987765 689999999999999999999997653221 1 111111 10
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
...... ....+.+++..||..||.+|||+.++++ |+||+..
T Consensus 228 ~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~-----h~~~~~~ 268 (276)
T 2h6d_A 228 FYIPEY----LNRSVATLLMHMLQVDPLKRATIKDIRE-----HEWFKQD 268 (276)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH-----SHHHHTT
T ss_pred ccCchh----cCHHHHHHHHHHccCChhhCCCHHHHHh-----ChhhccC
Confidence 011122 2345778899999999999999999999 8999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=347.94 Aligned_cols=265 Identities=20% Similarity=0.301 Sum_probs=203.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe-----
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEM----- 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~----- 321 (549)
.++|...+.||+|+||.||+|.+ .+|+.||||++...... ...+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999999987 56999999999764433 2467899999999999999999999977653
Q ss_pred -EEEEEeccCCCHHHHHH-HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 322 -YAIVYNLLNGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 322 -~~lv~e~~~gsL~~~l~-~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
++++|||+.|+|.+++. .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNED-CELKILDFGLARHADA 178 (353)
T ss_dssp CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTT-CCEEECSTTCTTC---
T ss_pred eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCC-CcEEEeecccccCCCC
Confidence 59999999999988874 478888999999999999999999 99999999999999998 6899999999865322
Q ss_pred ccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--c--
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--L-- 474 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~-- 474 (549)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+........... .
T Consensus 179 --------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 179 --------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHT
T ss_pred --------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 1234578999999999887 678999999999999999999999998755322 1211111110000 0
Q ss_pred ----------cccc---cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHH
Q 008898 475 ----------CERL---IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 475 ----------~~~~---~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~ 534 (549)
...+ ..+.+ ..........+.+++..||..||.+|||+.++++ |+||......+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~-----hp~f~~~~~~~ 316 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT-----HPFFEPFRDPE 316 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT-----SGGGTTTCCGG
T ss_pred HHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc-----CcchhhccCcc
Confidence 0000 00001 1111233456788899999999999999999998 99998765443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=333.75 Aligned_cols=243 Identities=24% Similarity=0.377 Sum_probs=191.1
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCeEEEEEecc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS-KEMYAIVYNLL 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~lv~e~~ 329 (549)
.++|...+.||+|+||.||++.+ +|+.+|+|+++... ..+.+.+|+.+++.++||||+++++++.+ ++.++++|||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 35789999999999999999987 58899999997543 45678999999999999999999998754 45789999999
Q ss_pred -CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 -~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+||+++.+ +.++|+|||++......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-SCEEECCCCC----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCC-CcEEEeecccccccccc---
Confidence 4599999954 57778899999999999999999 99999999999999988 68999999998643321
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||....... .. .... .+ ..+.
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~---~~~~-~~-----~~~~ 234 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV---PRVE-KG-----YKMD 234 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HH---HHHT-TT-----CCCC
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---HHHh-cC-----CCCC
Confidence 123357889999999999999999999999999999998 999997654322 11 1111 11 1111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. +...+..+.+++..||..||.+|||+.++++.|+.
T Consensus 235 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 235 A----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 1 22234567888899999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=335.07 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=197.3
Q ss_pred cCCCCCc-eEcccCceEEEEEEec---CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKM-LIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~-~lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|.+.. .||+|+||.||+|.+. ++..+|+|+++.... ..+.+.+|+.+++.++||||+++++++. .+.++++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence 4566665 8999999999999753 578899999986532 2356889999999999999999999994 4568999
Q ss_pred Eecc-CCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
||++ +|+|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEET-TEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCC-CCEEECcccceeeeccC
Confidence 9999 569999984 378889999999999999999999 99999999999999998 68999999999765432
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +.. .+.. +.
T Consensus 164 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~---~i~~-~~----- 230 (287)
T 1u59_A 164 DSYY--TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMA---FIEQ-GK----- 230 (287)
T ss_dssp SCEE--CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHH---HHHT-TC-----
T ss_pred ccee--eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHH---HHhc-CC-----
Confidence 2111 11223457899999999998899999999999999999998 999997654322 111 1111 10
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+. ++...+..+.+++..||..||.+||++.++++.|+.
T Consensus 231 ~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 231 RME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred cCC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 122334568888999999999999999999997754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=344.05 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=182.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCC-CCCeeeEEEEEE--------cC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIK-HENIVRIIGYCH--------SK 319 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~-h~nIv~l~~~~~--------~~ 319 (549)
..+|...+.||+|+||.||++.+ .+|+.||+|++...... ...+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35789999999999999999987 57899999998655432 356789999999996 999999999983 44
Q ss_pred CeEEEEEeccCCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCC--EEEecCCCCCEEEecCCCceEEeee
Q 008898 320 EMYAIVYNLLNGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDF 391 (549)
Q Consensus 320 ~~~~lv~e~~~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~~kL~DF 391 (549)
..++++|||++|+|.+++.. +++..++.++.||+.||.|||+. + |+||||||+|||++.+ +.+||+||
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~-~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQ-GTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTT-SCEEBCCC
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCC-CCEEEecC
Confidence 56899999999999999865 78888999999999999999998 8 9999999999999998 68999999
Q ss_pred cccccccccccccc-------CccccccccCCcccccccc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhh
Q 008898 392 GAAMVHHQSHQVSE-------NVKPVNVVGTFGYLAPEYM---MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461 (549)
Q Consensus 392 Gla~~~~~~~~~~~-------~~~~~~~~gt~~y~APE~~---~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~ 461 (549)
|++........... ........||+.|+|||++ .+..++.++|||||||++|+|++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 99976543221110 0111245699999999998 566789999999999999999999999975432110
Q ss_pred HHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCc
Q 008898 462 LVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPD 524 (549)
Q Consensus 462 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 524 (549)
. .. ........ .....+.+++..||+.||.+|||+.++++.|+...
T Consensus 262 ----~----~~-----~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 ----V----NG-----KYSIPPHD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -----------------CCCCTTC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----h----cC-----cccCCccc----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 00 00000011 11234678899999999999999999999886544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=337.65 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=200.1
Q ss_pred hhcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCC-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
..++|++.+.||+|+||.||+|.+. +++.+|+|++.... ...+.+.+|+.+++.++||||+++++++..++.++++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3568999999999999999999884 68999999987543 345678899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 328 LL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 328 ~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT-SCEEECCCHHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCC-CCEEEEECCCCcccccc--
Confidence 99 5689988854 67888999999999999999999 99999999999999988 68999999987532211
Q ss_pred cccCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
........||+.|+|||++. +..++.++|||||||++|+|++|..||........ ..... .... ..
T Consensus 171 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~~~~-~~ 241 (302)
T 2j7t_A 171 ---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIA----KSDP-PT 241 (302)
T ss_dssp ---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHH----HSCC-CC
T ss_pred ---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHh----ccCC-cc
Confidence 11122457899999999984 66789999999999999999999999976543221 11111 1100 00
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
. .. +......+.+++..||..||.+|||+.++++ |+|+.....
T Consensus 242 ~---~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~-----h~~~~~~~~ 284 (302)
T 2j7t_A 242 L---LT----PSKWSVEFRDFLKIALDKNPETRPSAAQLLE-----HPFVSSITS 284 (302)
T ss_dssp C---SS----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT-----STTTTTCCC
T ss_pred c---CC----ccccCHHHHHHHHHHcccChhhCCCHHHHhc-----ChHHhhhcc
Confidence 0 01 1222345778899999999999999999998 899876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=336.06 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=195.1
Q ss_pred hcCCCCCc-eEcccCceEEEEEEe---cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 251 THNFSPKM-LIGQGGNSKVYRTNH---VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 251 ~~~f~~~~-~lG~G~fg~Vy~~~~---~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
.++|.+.+ .||+|+||.||+|.. .+++.+|||+++..... .+.+.+|+.+++.++||||+++++++ ..+.++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999954 34789999999755322 35688999999999999999999999 556788
Q ss_pred EEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 324 IVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
++||++ +|+|.+++.. +++...+.++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET-TEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCC-CcEEEccCCcceeecc
Confidence 999999 5799999965 77888999999999999999999 99999999999999998 6899999999876543
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
..... .......||+.|+|||.+.+..++.++||||||+++|+|++ |+.||....... +.. .+.. +.
T Consensus 170 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~---~~~~-~~---- 237 (291)
T 1xbb_A 170 DENYY--KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTA---MLEK-GE---- 237 (291)
T ss_dssp TCSEE--EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH---HHHT-TC----
T ss_pred CCCcc--cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH---HHHc-CC----
Confidence 22111 11123356789999999998889999999999999999999 999998654322 111 1111 11
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+. .+...+..+.+++..||..||.+|||+.++++.|+.
T Consensus 238 -~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 238 -RMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp -CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 122334568888999999999999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=342.38 Aligned_cols=243 Identities=16% Similarity=0.186 Sum_probs=196.3
Q ss_pred hhcCCCCCceEcccCceEEEEEE------ecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC---CCCeeeEEEEEEcCC
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTN------HVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK---HENIVRIIGYCHSKE 320 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~------~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~ 320 (549)
..++|.+.+.||+|+||.||+|. ..+++.||+|+++.. ...++.+|+.+++.++ |+||+++++++..++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 35678999999999999999993 356899999999754 3567888888888887 999999999999999
Q ss_pred eEEEEEecc-CCCHHHHHHH--------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec----------
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ--------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---------- 381 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~--------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~---------- 381 (549)
..++||||+ +|+|.+++.. +++..++.++.||+.||.|||+. +||||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 999999999 6899999963 77888999999999999999999 9999999999999988
Q ss_pred -CCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchh
Q 008898 382 -NFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (549)
Q Consensus 382 -~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~ 460 (549)
+ +.+||+|||+|...... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 218 ~~-~~~kl~DFG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 218 LS-AGLALIDLGQSIDMKLF---PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp -C-TTEEECCCTTCEEGGGS---CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred cc-CCEEEeeCchhhhhhcc---CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 6 68999999999654321 122233456899999999999999999999999999999999999999965433210
Q ss_pred hHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhc
Q 008898 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRR-PTMKTLLKLFQ 521 (549)
Q Consensus 461 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-Ps~~evl~~L~ 521 (549)
. +...+..... .+.+.+++..|+..+|.+| |++.++.+.|+
T Consensus 294 -------------~----~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 294 -------------K----PEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp -------------E----ECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred -------------e----echhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 0 1111111111 3456677889999999999 57787777664
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.02 Aligned_cols=239 Identities=25% Similarity=0.453 Sum_probs=195.4
Q ss_pred hhcCCCCCceEcccCceEEEEEEec-CCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEc----------
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS---------- 318 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~---------- 318 (549)
+..+|...+.||+|+||.||++.+. +|+.+|+|+++... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 3567999999999999999999884 79999999998654 457789999999999999999998854
Q ss_pred ------CCeEEEEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCce
Q 008898 319 ------KEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHP 386 (549)
Q Consensus 319 ------~~~~~lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~ 386 (549)
...++++|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+|+||||+|||++.+ +.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT-KQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET-TEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC-CCE
Confidence 45689999999 5699999954 56778899999999999999999 99999999999999998 689
Q ss_pred EEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHH
Q 008898 387 QLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWA 466 (549)
Q Consensus 387 kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~ 466 (549)
+|+|||++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|..|+..... +.
T Consensus 162 kl~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------~~ 228 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-------FF 228 (284)
T ss_dssp EECCCTTCEESSCCS------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-------HH
T ss_pred EECcchhheeccccc------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-------HH
Confidence 999999986544321 22345799999999999999999999999999999999999998753211 01
Q ss_pred HHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 467 RSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 467 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
..+ .+..+...++ ..+.+++..||..||.+|||+.++++.|.
T Consensus 229 ~~~---------~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 229 TDL---------RDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp HHH---------HTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHh---------hcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111 1111222233 34677889999999999999999999763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=341.72 Aligned_cols=261 Identities=24% Similarity=0.343 Sum_probs=199.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEE----cCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCH----SKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~----~~~~~~l 324 (549)
.++|...+.||+|+||.||++.. .+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++. ....+++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45799999999999999999987 6799999999875442 3456889999999999999999999986 3458899
Q ss_pred EEecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 325 VYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
+|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.++|+|||++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDE-GQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-SCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCC-CCEEEEecCcchh
Confidence 99999 5699999965 67888999999999999999999 99999999999999988 6899999999865
Q ss_pred cccccccc----cCccccccccCCccccccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHh
Q 008898 397 HHQSHQVS----ENVKPVNVVGTFGYLAPEYMMYGK---VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL 469 (549)
Q Consensus 397 ~~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~---~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 469 (549)
........ .........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.........+.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-- 261 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-- 261 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--
Confidence 43211000 001112346799999999987654 689999999999999999999999653222211111110
Q ss_pred hcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 470 LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 470 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
. .. .. .........+.+++..||..||.+|||+.++++.|+...+...
T Consensus 262 -~-----~~-~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 262 -N-----QL-SI----PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp -C-----C---C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred -c-----cC-CC----CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 0 00 00 1112223568888999999999999999999999877654433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=339.89 Aligned_cols=246 Identities=24% Similarity=0.388 Sum_probs=194.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEE--EEEEeecCC--cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVA--AVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~--AvK~l~~~~--~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|...+.||+|+||.||++.+ .+|..+ |+|.++... ...+.+.+|+.+++++ +||||+++++++.+.+.++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5789999999999999999976 456644 999987532 2335688999999999 899999999999999999999
Q ss_pred Eecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc
Q 008898 326 YNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 385 (549)
|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~-~~ 180 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN-YV 180 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG-GC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC-Ce
Confidence 9999 6799999953 56778899999999999999999 99999999999999988 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHH
Q 008898 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVL 464 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~ 464 (549)
+||+|||++..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 181 ~kL~Dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----- 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEV------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 249 (327)
T ss_dssp EEECCTTCEESSCE------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----
T ss_pred EEEcccCcCccccc------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----
Confidence 99999999864222 111223457889999999998889999999999999999998 999997654321
Q ss_pred HHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 465 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
....+.. + ..... +......+.+++..||..||.+|||+.++++.|+.
T Consensus 250 ~~~~~~~-~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 250 LYEKLPQ-G-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HHHHGGG-T-----CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhhc-C-----CCCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1111111 1 11111 12233567888999999999999999999997754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.43 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=194.2
Q ss_pred CCCCCceEcccCceEEEEEEec-CC---cEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE-EEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV-DG---QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMY-AIV 325 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~-~g---~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~-~lv 325 (549)
.|...++||+|+||.||+|.+. ++ ..+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999753 33 3799999975432 235688999999999999999999999766554 888
Q ss_pred Eecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|+|+ +|+|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDES-FTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-CCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC-CcEEeCcCCCcccccCC
Confidence 9988 7899999964 67788899999999999999999 99999999999999998 68999999999754432
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
.. ..........||+.|+|||.+.+..++.++|||||||++|+|++|..|+.......+ +...... .. .
T Consensus 178 ~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~---~~------~ 246 (298)
T 3pls_A 178 EY-YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQ---GR------R 246 (298)
T ss_dssp GG-GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHT---TC------C
T ss_pred cc-cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhc---CC------C
Confidence 21 122233355788999999999999999999999999999999996555543332222 1111111 00 0
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
... +......+.+++..||..||.+|||+.++++.|++
T Consensus 247 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 247 LPQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111 12223567888999999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.83 Aligned_cols=250 Identities=22% Similarity=0.363 Sum_probs=193.0
Q ss_pred cCCCCCceEcccCceEEEEEEecC-----CcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD-----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~-----g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|...+.||+|+||.||+|.... +..+|+|+++..... ...+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778999999999999997632 246999999754322 3468899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
||||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCC-CcEEECCCCcchhhcc
Confidence 99999 5699999964 67888999999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... + ...+.....
T Consensus 200 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~---~~~~~~~~~---- 268 (333)
T 1mqb_A 200 DPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--V---MKAINDGFR---- 268 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---HHHHHTTCC----
T ss_pred cccc--ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--H---HHHHHCCCc----
Confidence 2111 111223356889999999999999999999999999999999 999997654321 1 111111100
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. ..+......+.+++..||..||.+||++.++++.|+.
T Consensus 269 --~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 269 --L----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp --C----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --C----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 1122334567888999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=347.70 Aligned_cols=269 Identities=20% Similarity=0.321 Sum_probs=206.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-----------CCCeeeEEEEEEc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----------HENIVRIIGYCHS 318 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-----------h~nIv~l~~~~~~ 318 (549)
.++|.+.+.||+|+||.||+|.+ .+++.||||++.......+.+.+|+.+++.+. ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 35799999999999999999987 67899999999866555567889999999886 8999999999875
Q ss_pred CC----eEEEEEeccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC-----CC
Q 008898 319 KE----MYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-----FH 384 (549)
Q Consensus 319 ~~----~~~lv~e~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~ 384 (549)
.+ .++++||+++++|.+++.. +++..+..++.||+.||.|||+.+ +|+||||||+|||++.+ .+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcc
Confidence 44 7899999999999999965 677888999999999999999843 89999999999999633 13
Q ss_pred ceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc-----h
Q 008898 385 HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN-----R 459 (549)
Q Consensus 385 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~-----~ 459 (549)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 176 ~~kl~Dfg~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 176 QIKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp EEEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred eEEEcccccccccCC--------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 799999999965432 122457899999999999999999999999999999999999999865421 1
Q ss_pred hhHHHHHHHhhc------------------ccccccccCCc---------ccccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 008898 460 ESLVLWARSLLS------------------SGLCERLIDPQ---------LNEEYNREEIEIVMCAARLCLLHSSSRRPT 512 (549)
Q Consensus 460 ~~l~~~~~~~~~------------------~~~~~~~~d~~---------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 512 (549)
..+......+.. .+....+.... ....++......+.+++..||..||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111111100 00000000000 011345677888999999999999999999
Q ss_pred HHHHHHHhcCCchhhhhhhHHH
Q 008898 513 MKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 513 ~~evl~~L~~~~~w~~~~~~~~ 534 (549)
+.++++ |+||+.....+
T Consensus 328 ~~ell~-----hp~f~~~~~~~ 344 (373)
T 1q8y_A 328 AGGLVN-----HPWLKDTLGME 344 (373)
T ss_dssp HHHHHT-----CGGGTTCTTCT
T ss_pred HHHHhh-----ChhhhcccCcc
Confidence 999999 99998765443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=337.91 Aligned_cols=257 Identities=28% Similarity=0.378 Sum_probs=181.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC--HHHHHHHHH-HHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVE-LLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~--~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.++|...+.||+|+||.||++.+ .+|+.||||+++..... ...+..|+. +++.++||||+++++++.+++.++++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 35788999999999999999987 57999999999765422 234556666 778889999999999999999999999
Q ss_pred eccCCCHHHHHHH--------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 327 NLLNGSLKQYLKQ--------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 327 e~~~gsL~~~l~~--------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
||+.|+|.+++.. +++.....++.|++.||.|||+.. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRS-GNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETT-TEEEECCCSSSCC--
T ss_pred eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCC-CCEEEccCCCceecc
Confidence 9999999888752 567788899999999999999842 89999999999999998 699999999986543
Q ss_pred cccccccCccccccccCCcccccccc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYM----MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
.. .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.......+.+ ...
T Consensus 178 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~----- 242 (327)
T 3aln_A 178 DS------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL----TQV----- 242 (327)
T ss_dssp ----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCC-----
T ss_pred cc------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH----HHH-----
Confidence 21 122234799999999998 45678999999999999999999999997643221111 000
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.....+.+...........+.+++..||..||.+|||+.++++ |+|+....
T Consensus 243 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~-----hp~~~~~~ 293 (327)
T 3aln_A 243 -VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK-----HPFILMYE 293 (327)
T ss_dssp -CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT-----SHHHHHHH
T ss_pred -hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh-----ChHHHHhH
Confidence 0001111111111223456788889999999999999999998 89987654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=341.72 Aligned_cols=255 Identities=21% Similarity=0.354 Sum_probs=205.4
Q ss_pred HHhhhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-------HHHHHHHHHHHhcCC--CCCeeeEEEEE
Q 008898 247 LCHLTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-------EEEVLREVELLSSIK--HENIVRIIGYC 316 (549)
Q Consensus 247 l~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-------~~~~~~E~~il~~l~--h~nIv~l~~~~ 316 (549)
...+.++|...+.||+|+||.||+|.+ .+++.||||+++..... ...+.+|+.+++.+. ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344567899999999999999999986 57899999999765322 234678999999996 59999999999
Q ss_pred EcCCeEEEEEeccC--CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeee
Q 008898 317 HSKEMYAIVYNLLN--GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (549)
Q Consensus 317 ~~~~~~~lv~e~~~--gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DF 391 (549)
...+.+++++|++. ++|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+.+.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999999995 789999864 67788899999999999999999 99999999999999944378999999
Q ss_pred ccccccccccccccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
|++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .
T Consensus 195 g~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----------~ 256 (320)
T 3a99_A 195 GSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----------I 256 (320)
T ss_dssp TTCEECCSS-------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----------H
T ss_pred ccccccccc-------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-----------h
Confidence 998654321 2234579999999999987776 68899999999999999999999653210 0
Q ss_pred cccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHHHh
Q 008898 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLN 538 (549)
Q Consensus 471 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~~~ 538 (549)
.. . ......+ ...+.+++..||..||.+|||+.++++ |+||......++..+
T Consensus 257 ~~----~---~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~-----hp~~~~~~~~~~~~~ 308 (320)
T 3a99_A 257 RG----Q---VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN-----HPWMQDVLLPQETAE 308 (320)
T ss_dssp HC----C---CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT-----SGGGSSCCCHHHHHH
T ss_pred cc----c---ccccccC----CHHHHHHHHHHccCChhhCcCHHHHhc-----CHhhcCccCcccccc
Confidence 00 0 0111222 345778889999999999999999998 899987765555444
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=330.65 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=194.4
Q ss_pred hcCCCCCceEcccCceEEEEEEecC----CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~----g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|...+.||+|+||.||+|.+.+ +..+|+|+++.... ..+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4678999999999999999997532 34699999976532 235688999999999999999999998765 4678
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+||++ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASP-ECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEET-TEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCC-CcEEeCccCCCccccc
Confidence 89998 6799999954 67788899999999999999999 99999999999999998 6899999999876443
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||........ . .... ...
T Consensus 166 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-~-~~~~---~~~----- 231 (281)
T 3cc6_A 166 EDY----YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-I-GVLE---KGD----- 231 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-H-HHHH---HTC-----
T ss_pred ccc----cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-H-HHHh---cCC-----
Confidence 211 11234457889999999999999999999999999999998 9999976543221 1 1111 000
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.... +......+.+++..||..||.+|||+.++++.|+.
T Consensus 232 -~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 232 -RLPK----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp -CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 0111 11223557888999999999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=333.48 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=193.7
Q ss_pred cCCCCCceEcccCceEEEEEEecC----CcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEE-EcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYC-HSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~----g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~-~~~~~~~l 324 (549)
.+|...+.||+|+||.||+|...+ +..+|+|.++.... ..+.+.+|+.++++++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468888999999999999997632 23689999875432 235688999999999999999999986 45668899
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+|||+ +|+|.+++.. +++.....++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK-FTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-CCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCC-CCEEECcccccccccc
Confidence 99999 5699999964 67788899999999999999999 99999999999999998 6899999999976543
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.... .........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||....... ..... ....
T Consensus 181 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~----~~~~----- 249 (298)
T 3f66_A 181 KEYY-SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYL----LQGR----- 249 (298)
T ss_dssp GGGC-BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-HHHHH----HTTC-----
T ss_pred cchh-ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHH----hcCC-----
Confidence 2211 1222335568899999999999999999999999999999999 555665443322 11111 1100
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
...... ..+..+.+++..||..||.+|||+.++++.|+..
T Consensus 250 -~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 -RLLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp -CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011111 1234578889999999999999999999988653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.09 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=194.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
.++|...+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45799999999999999999973 357899999996443 2235688999999999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH----------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEe
Q 008898 323 AIVYNLL-NGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLS 389 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~----------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~ 389 (549)
+++|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ ...++|+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999 7799999964 56678899999999999999999 99999999999999843 1369999
Q ss_pred eeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHH
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARS 468 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 468 (549)
|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++ |..||....... +. ..
T Consensus 186 Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~---~~ 257 (327)
T 2yfx_A 186 DFGMARDIYRASY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VL---EF 257 (327)
T ss_dssp CCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH---HH
T ss_pred ccccccccccccc---cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HH---HH
Confidence 9999865433211 112234568999999999999999999999999999999998 999997654321 11 11
Q ss_pred hhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 469 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
...... +.. +......+.+++..||..||.+|||+.++++.|+
T Consensus 258 ~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 258 VTSGGR------MDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp HHTTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhcCCC------CCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 111110 111 1223356788899999999999999999999664
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=344.52 Aligned_cols=262 Identities=22% Similarity=0.321 Sum_probs=205.9
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCH------------------HHHHHHHHHHhcCCCCCeeeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE------------------EEVLREVELLSSIKHENIVRI 312 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~------------------~~~~~E~~il~~l~h~nIv~l 312 (549)
.++|.+.+.||+|+||.||+|.+ +|+.||+|++....... +.+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 99999999997542211 778999999999999999999
Q ss_pred EEEEEcCCeEEEEEecc-CCCHHHH------HH-----HhchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEE
Q 008898 313 IGYCHSKEMYAIVYNLL-NGSLKQY------LK-----QLKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILL 379 (549)
Q Consensus 313 ~~~~~~~~~~~lv~e~~-~gsL~~~------l~-----~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl 379 (549)
++++.+.+.+++||||+ +|+|.++ +. .+++..+..++.||+.||.|||+ . +|+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 99999999999999999 5599888 43 36788899999999999999999 8 99999999999999
Q ss_pred ecCCCceEEeeeccccccccccccccCccccccccCCccccccccccC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCccc
Q 008898 380 SENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDE-KIDVYSYGVVLLELITGKEAIQTNKA 457 (549)
Q Consensus 380 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~-k~DvwSlGvil~elltG~~p~~~~~~ 457 (549)
+.+ +.++|+|||++...... ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||.....
T Consensus 186 ~~~-~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 186 DKN-GRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp CTT-SCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred cCC-CcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 998 68999999998654322 23355799999999999887 6766 99999999999999999999987654
Q ss_pred chhhHHHHHHHhhcccc-cc----cccCCccc---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 458 NRESLVLWARSLLSSGL-CE----RLIDPQLN---EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 458 ~~~~l~~~~~~~~~~~~-~~----~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
..+.... +..... .. ....+... ..........+.+++..||..||.+|||+.++++ |+||..
T Consensus 258 ~~~~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~-----hp~f~~ 328 (348)
T 2pml_X 258 LVELFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK-----HEWLAD 328 (348)
T ss_dssp SHHHHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT-----SGGGTT
T ss_pred HHHHHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc-----CccccC
Confidence 3222211 111100 00 00000000 0001233456788999999999999999999999 899976
Q ss_pred hhHH
Q 008898 530 KREK 533 (549)
Q Consensus 530 ~~~~ 533 (549)
....
T Consensus 329 ~~~~ 332 (348)
T 2pml_X 329 TNIE 332 (348)
T ss_dssp CCHH
T ss_pred CCHH
Confidence 5543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=337.32 Aligned_cols=250 Identities=21% Similarity=0.314 Sum_probs=188.8
Q ss_pred hcCCCCCceEcccCceEEEEEEec----CCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCC---
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV----DGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKE--- 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~----~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~--- 320 (549)
.++|...+.||+|+||.||+|... +++.+|+|+++...... +.+.+|+.+++.++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 567889999999999999999653 34589999997654333 45889999999999999999999997654
Q ss_pred --eEEEEEecc-CCCHHHHHH---------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEE
Q 008898 321 --MYAIVYNLL-NGSLKQYLK---------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQL 388 (549)
Q Consensus 321 --~~~lv~e~~-~gsL~~~l~---------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL 388 (549)
..+++|||+ +|+|.+++. .+++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~-~~~kl 188 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD-MTVCV 188 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT-SCEEE
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC-CcEEE
Confidence 358999999 679999983 267888999999999999999999 99999999999999998 68999
Q ss_pred eeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHH
Q 008898 389 SDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWAR 467 (549)
Q Consensus 389 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~ 467 (549)
+|||++......... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||........ . .
T Consensus 189 ~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~-~--- 260 (313)
T 3brb_A 189 ADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-Y-D--- 260 (313)
T ss_dssp CSCSCC-------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-H-H---
T ss_pred eecCcceeccccccc---CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-H-H---
Confidence 999998654432111 12223457889999999999999999999999999999999 8899876543221 1 1
Q ss_pred HhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 468 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...... .+.. +......+.+++..||..||.+|||+.++++.|+.
T Consensus 261 ~~~~~~------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 261 YLLHGH------RLKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp HHHTTC------CCCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHcCC------CCCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111110 1111 12233567888999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=333.64 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=193.1
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|...+.||+|+||.||++.+ .+++.||+|+++..... .+.+.+|+.+++.++||||+++++++..++.++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 36799999999999999999987 46899999999754322 25678999999999999999999999999999999
Q ss_pred EeccC-CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLLN-GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~~-gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+. ++|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSAD-DFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCC-CCEEEecCccCccccccc
Confidence 99995 599999965 67888999999999999999999 99999999999999988 689999999986543321
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+ ...+..... .
T Consensus 189 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~---~~~~~~~~~-----~- 253 (309)
T 2h34_A 189 ----LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VM---GAHINQAIP-----R- 253 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HH---HHHHHSCCC-----C-
T ss_pred ----cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HH---HHHhccCCC-----C-
Confidence 11223457999999999999999999999999999999999999999765432 11 111111100 0
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRP-TMKTLLKLFQEP 523 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~ 523 (549)
........+..+.+++..||..||.+|| ++.++++.|+..
T Consensus 254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 1111223344577889999999999999 999999987643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=330.81 Aligned_cols=255 Identities=26% Similarity=0.375 Sum_probs=202.9
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN---WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
+.++|.+.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++++++||||+++++++.+.+.++++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 456799999999999999999987 478999999997543 3456788999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC--CceEEeeecccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF--HHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~~kL~DFGla~~~~~ 399 (549)
||++ +++|.+++.. +++.....++.||+.||.|||+. +|+|+||||+||+++.+. ..+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999 6799888853 67888999999999999999999 999999999999997642 3699999999865432
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
. .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||....... .. ..+..... . .
T Consensus 177 ~------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~----~~~~~~~~-~--~ 241 (287)
T 2wei_A 177 N------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-IL----KRVETGKY-A--F 241 (287)
T ss_dssp C------SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----HHHHHCCC-C--C
T ss_pred C------CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HH----HHHHcCCC-C--C
Confidence 2 12234468999999998875 58999999999999999999999997654321 11 11111110 0 0
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
+...... ....+.+++..||..||.+|||+.++++ |+||+...
T Consensus 242 ~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~-----hp~~~~~~ 284 (287)
T 2wei_A 242 DLPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE-----HPWIQKYS 284 (287)
T ss_dssp CSGGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH-----SHHHHHHC
T ss_pred Cchhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc-----CHHHhccc
Confidence 0000112 2345778889999999999999999999 89997653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=365.97 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=190.7
Q ss_pred eEcccCceEEEEEEec---CCcEEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-CCC
Q 008898 259 LIGQGGNSKVYRTNHV---DGQVAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGS 332 (549)
Q Consensus 259 ~lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~gs 332 (549)
.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.+|+.++||||++++++|.. +.+++||||+ +|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999763 46689999997643 345789999999999999999999999976 5689999999 779
Q ss_pred HHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcc
Q 008898 333 LKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408 (549)
Q Consensus 333 L~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~ 408 (549)
|.+++. .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++........ ...
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~~~~~~--~~~ 495 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNR-HYAKISDFGLSKALGADDSY--YTA 495 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECCCSTTTTCC----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCC-CcEEEeeccCcccccCCCce--eee
Confidence 999994 378889999999999999999999 99999999999999998 69999999999765332111 111
Q ss_pred ccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccC
Q 008898 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487 (549)
Q Consensus 409 ~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 487 (549)
.....+|+.|+|||++.++.++.++|||||||+||||++ |+.||....... +.. .+.. +. ....
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~---~i~~-~~---------~~~~ 560 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMA---FIEQ-GK---------RMEC 560 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHH---HHHT-TC---------CCCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH---HHHc-CC---------CCCC
Confidence 123346789999999999999999999999999999998 999998755322 111 1111 11 0112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 488 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+..++..+.+++..||..||.+||++.+|++.|+.
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 22344668889999999999999999999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=348.56 Aligned_cols=259 Identities=19% Similarity=0.249 Sum_probs=202.9
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCeEEEEEe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-ENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~lv~e 327 (549)
+.++|.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+|+++++.+.| +++..+..++.+.+..++|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 357899999999999999999987 6799999999875442 2458899999999987 556666677788889999999
Q ss_pred ccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEE---ecCCCceEEeeeccccccccc
Q 008898 328 LLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILL---SENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 328 ~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~~kL~DFGla~~~~~~ 400 (549)
|++|+|.+++.. +++..++.++.||+.||.|||++ +||||||||+|||| +.+ +.+||+|||++......
T Consensus 84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGT-TCEEECCCTTCEECBCT
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCC-CeEEEEeCCcceeccCC
Confidence 999999999963 78889999999999999999999 99999999999999 455 68999999999765442
Q ss_pred cccc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccch--hhHHHHHHHhhcccccc
Q 008898 401 HQVS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR--ESLVLWARSLLSSGLCE 476 (549)
Q Consensus 401 ~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~ 476 (549)
.... .........||+.|+|||++.+..++.++|||||||+||||++|+.||....... ..+..+..... .....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-ATSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-HSCHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-cccHH
Confidence 2111 1112236689999999999999999999999999999999999999998754421 11111111110 00001
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
.+ ... .+..+.+++..||..||.+||++.+|+++|++.
T Consensus 239 ~l-----~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 239 AL-----CRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH-----HTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HH-----hcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 10 111 235678889999999999999999999988765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.79 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=186.1
Q ss_pred CCCCCceEcccCceEEEEEEec--CC--cEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEE-cCCeEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHV--DG--QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCH-SKEMYAIV 325 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~--~g--~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~~~~~lv 325 (549)
.|...+.||+|+||.||+|... ++ ..+|+|.++.... ..+.+.+|+.++++++||||+++++++. .++..+++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999763 22 4689999875432 2356889999999999999999999875 45678899
Q ss_pred Eecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCC-CCEEEeecccccccccc
Confidence 9999 6799999964 66788899999999999999999 99999999999999998 68999999999754332
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
... .........||+.|+|||.+.+..++.++|||||||++|||++ |.+||......+. . . ...... ...
T Consensus 246 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-~-~---~~~~~~---~~~ 316 (373)
T 3c1x_A 246 EFD-SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-T-V---YLLQGR---RLL 316 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-H-H---HHHTTC---CCC
T ss_pred ccc-cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-H-H---HHHcCC---CCC
Confidence 211 1112234567889999999999999999999999999999999 6777765543221 1 1 111111 111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
. +...+..+.+++..||..||.+|||+.++++.|+..
T Consensus 317 ---~----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 317 ---Q----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ---C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 112335678889999999999999999999988653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=366.39 Aligned_cols=243 Identities=24% Similarity=0.384 Sum_probs=191.1
Q ss_pred ceEcccCceEEEEEEe---cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNH---VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~---~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+.||+|+||.||+|.+ .+++.||||+++.... ..+++.+|+.+|+.++||||+++++++.. +.+++||||+ +
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999954 3467999999976433 24679999999999999999999999975 4578999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|.+++.. +++..+..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+++........ ..
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~--~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY--YK 527 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCC-CCEEEEEcCCccccccCccc--cc
Confidence 799999964 77888999999999999999999 99999999999999998 68999999999765432211 11
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +. ..+. .+. .. .
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~---~~i~-~~~-----~~----~ 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT---AMLE-KGE-----RM----G 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH---HHHH-TTC-----CC----C
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---HHHH-cCC-----CC----C
Confidence 2223457889999999999999999999999999999998 999997654322 11 1111 111 11 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+..++..+.+++..||..||.+|||+.+|++.|+.
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 122344668888999999999999999999998864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=348.42 Aligned_cols=256 Identities=24% Similarity=0.333 Sum_probs=193.9
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEEeccC
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVYNLLN 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 330 (549)
.+|...++||+|+||.||.....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.+.+.++++||+++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 46888999999999997665566899999999975432 2356899999999 79999999999999999999999999
Q ss_pred CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC----CCceEEeeeccccccccccc
Q 008898 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN----FHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 331 gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~~kL~DFGla~~~~~~~~ 402 (549)
|+|.+++.. ........++.||+.||.|||+. +|+||||||+|||++.+ ...+||+|||+|........
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 999999965 33456788999999999999999 99999999999999532 12578999999976543211
Q ss_pred cccCccccccccCCccccccccc---cCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMM---YGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~---~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
.........||+.|+|||++. +..++.++|||||||++|||++ |..||.......... ....... ..
T Consensus 179 --~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~------~~~~~~~-~~ 249 (432)
T 3p23_A 179 --SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI------LLGACSL-DC 249 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH------HTTCCCC-TT
T ss_pred --ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH------HhccCCc-cc
Confidence 112234567999999999997 4567889999999999999999 899996543322111 1111100 00
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
. .........+.+++..||..||.+|||+.++++ |+||.....
T Consensus 250 ~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~-----hp~f~~~~~ 292 (432)
T 3p23_A 250 L------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK-----HPFFWSLEK 292 (432)
T ss_dssp S------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT-----STTTCCHHH
T ss_pred c------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh-----CccccChHH
Confidence 0 111234455788999999999999999999998 899976544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.20 Aligned_cols=249 Identities=23% Similarity=0.386 Sum_probs=191.3
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-------HHHHHHHHHHHhcC----CCCCeeeEEEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-------EEEVLREVELLSSI----KHENIVRIIGYCH 317 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-------~~~~~~E~~il~~l----~h~nIv~l~~~~~ 317 (549)
+.++|.+.+.||+|+||.||+|.+ .+++.||+|+++..... ...+.+|+.+++++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 356899999999999999999987 56899999999755422 12355799999888 8999999999999
Q ss_pred cCCeEEEEEec-c-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe-cCCCceEEeee
Q 008898 318 SKEMYAIVYNL-L-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS-ENFHHPQLSDF 391 (549)
Q Consensus 318 ~~~~~~lv~e~-~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~~kL~DF 391 (549)
..+.+++++|+ + +++|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++ .+ +.++|+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~-~~~kl~df 184 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRR-GCAKLIDF 184 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTT-TEEEECCC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCC-CeEEEEEc
Confidence 88999999998 4 6799999964 67888999999999999999999 999999999999999 55 78999999
Q ss_pred ccccccccccccccCccccccccCCccccccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD-EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 470 (549)
|++...... ......||+.|+|||++.+..+. .++|||||||++|||++|+.||...... ..
T Consensus 185 g~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~--- 247 (312)
T 2iwi_A 185 GSGALLHDE-------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------LE--- 247 (312)
T ss_dssp SSCEECCSS-------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HH---
T ss_pred chhhhcccC-------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-------hh---
Confidence 998664432 22345799999999999877764 5899999999999999999999653210 00
Q ss_pred cccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 471 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
. ...+... ....+.+++..||..||.+|||+.++++ |+|+....+....
T Consensus 248 --~------~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~-----~~~~~~~~~~~~~ 296 (312)
T 2iwi_A 248 --A------ELHFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILL-----DPWMQTPAEDVPL 296 (312)
T ss_dssp --T------CCCCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHH-----STTTCC-------
T ss_pred --h------ccCCccc----CCHHHHHHHHHHccCChhhCcCHHHHhc-----ChhhcCchhcccc
Confidence 0 0011122 2345778889999999999999999999 8999877654433
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=336.38 Aligned_cols=253 Identities=25% Similarity=0.319 Sum_probs=173.5
Q ss_pred hcCCCCC-ceEcccCceEEEEEEec-CCcEEEEEEeecCCcCHHHHHHHH-HHHhcCCCCCeeeEEEEEEc----CCeEE
Q 008898 251 THNFSPK-MLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTNWSEEEVLREV-ELLSSIKHENIVRIIGYCHS----KEMYA 323 (549)
Q Consensus 251 ~~~f~~~-~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~~~~~~~~~E~-~il~~l~h~nIv~l~~~~~~----~~~~~ 323 (549)
.++|.+. ++||+|+||.||+|.+. +|+.||||++.... ...+|+ ..++.+.||||+++++++.. +..++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 5678885 47999999999999874 69999999997542 223333 34677899999999999865 45689
Q ss_pred EEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeecccc
Q 008898 324 IVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAM 395 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla~ 395 (549)
+||||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ .+.+||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999 5699999964 67888999999999999999999 99999999999999763 2459999999986
Q ss_pred ccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .... ..
T Consensus 180 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~-~~--- 247 (336)
T 3fhr_A 180 ETTQ-------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-KRRI-RL--- 247 (336)
T ss_dssp EC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred eccc-------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH-HHhh-hc---
Confidence 5332 1223457899999999998888999999999999999999999999765432210000 0000 00
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.. ..............+.+++..||..||.+|||+.++++ |+||...
T Consensus 248 ~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----hp~~~~~ 294 (336)
T 3fhr_A 248 GQ---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN-----HPWINQS 294 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH-----SHHHHTG
T ss_pred cc---cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc-----Ccccccc
Confidence 00 00111111223456778889999999999999999999 8998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=329.83 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=188.5
Q ss_pred hcCCCCCceEcccCceEEEEEEec--CCc--EEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV--DGQ--VAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~--~g~--~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 322 (549)
.++|...+.||+|+||.||+|.+. +++ .+|+|+++... ...+.+.+|+.+++.++||||+++++++.+++ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357899999999999999999752 333 68999987543 22356889999999999999999999998765 7
Q ss_pred EEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
++++|++ +|+|.+++.. +++.....++.||+.||.|||+. +|+|+||||+|||++.+ +.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATR-DLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET-TEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCC-CCEEEccccccccc
Confidence 7889998 6899999854 67788899999999999999999 99999999999999998 68999999998765
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... . .........
T Consensus 172 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~---~~~~~~~~~-- 242 (291)
T 1u46_A 172 PQNDDH--YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--I---LHKIDKEGE-- 242 (291)
T ss_dssp CC-CCE--EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---HHHHHTSCC--
T ss_pred cccccc--hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--H---HHHHHccCC--
Confidence 432211 112224467889999999998889999999999999999999 999997654321 1 111111110
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.. ......+..+.+++..||..||.+|||+.++++.|++
T Consensus 243 ---~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 281 (291)
T 1u46_A 243 ---RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 281 (291)
T ss_dssp ---CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CC----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 01 1112234567888999999999999999999997754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=336.70 Aligned_cols=257 Identities=25% Similarity=0.349 Sum_probs=199.1
Q ss_pred hcCCCCCceEcccCceEEEEEEe-----cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-----VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSK--EMY 322 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~ 322 (549)
.++|.+.+.||+|+||.||++.. .+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999973 4689999999976543 235688999999999999999999998654 378
Q ss_pred EEEEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 323 AIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
+++|||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENE-NRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET-TEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCC-CcEEEecCcchhhc
Confidence 9999999 6799999964 67888899999999999999999 99999999999999998 68999999999765
Q ss_pred ccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccch----------hhHH-HHH
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR----------ESLV-LWA 466 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~----------~~l~-~~~ 466 (549)
....... .......+|..|+|||.+.+..++.++|||||||++|||++|..|+....... .... .+.
T Consensus 196 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 196 PQDKEYY--KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CSSCSEE--ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccccccc--ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 4322111 11123457788999999999899999999999999999999999986532110 0000 001
Q ss_pred HHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 467 RSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 467 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
..+ ........+...+..+.+++..||..||.+|||+.++++.|+..
T Consensus 274 ~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 274 ELL----------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHH----------HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHh----------hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 00001111223345688899999999999999999999987653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=328.46 Aligned_cols=254 Identities=26% Similarity=0.334 Sum_probs=183.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH--HH-HHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE--EE-VLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~--~~-~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.++|...+.||+|+||.||+|.+ .+|+.||||++....... .+ +.++..+++.++||||+++++++.+++.++++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 35788899999999999999987 479999999998654332 22 334455788889999999999999999999999
Q ss_pred eccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 327 NLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 327 e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
||+++.+..+... +++.....++.||+.||.|||+ . +|+|+||||+|||++.+ +.+||+|||++......
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDER-GQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTT-SCEEECCCTTC-------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCC-CCEEEEECCCchhccCC-
Confidence 9997666666643 6778888999999999999998 6 89999999999999998 68999999998654321
Q ss_pred ccccCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.......+.+... . ...
T Consensus 179 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~-~~~--- 246 (318)
T 2dyl_A 179 -----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV---L-QEE--- 246 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH---H-HSC---
T ss_pred -----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH---h-ccC---
Confidence 1223457999999999984 4568899999999999999999999997644332222111 1 110
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.+.+.. .......+.+++..||..||.+|||+.++++ |+|++...
T Consensus 247 ---~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~-----h~~~~~~~ 291 (318)
T 2dyl_A 247 ---PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE-----HSFIKRYE 291 (318)
T ss_dssp ---CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT-----SHHHHHHH
T ss_pred ---CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh-----CHHHHhcc
Confidence 011110 0112345778889999999999999999998 89987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=336.64 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=194.6
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|...+.||+|+||.||+|...+ .+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+.++++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4679999999999999999998743 489999875432 22457789999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 328 LL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 328 ~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||+++ +.++|+|||++........
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~~--~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC----CCEECCCSCCC-------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEeC--CCEEEeecCCccccccccc
Confidence 99 5799999964 67888999999999999999999 9999999999999984 4899999999865433222
Q ss_pred cccCccccccccCCcccccccccc---------CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMY---------GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG 473 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~---------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 473 (549)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ . ..... +
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~----~~~~~-~ 258 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-I----WQMGT-G 258 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-H----HHHHT-T
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H----HHhcc-C
Confidence 222233345579999999999874 3578999999999999999999999976543221 1 11111 1
Q ss_pred ccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCch
Q 008898 474 LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDY 525 (549)
Q Consensus 474 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 525 (549)
. .+.... ......+.+++..||..||.+|||+.++++.|+....
T Consensus 259 ~-----~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 259 M-----KPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp C-----CCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred C-----CCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1 111110 0122347788899999999999999999999988763
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.39 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=194.8
Q ss_pred hcCCCCCceEcccCceEEEEEEecC----CcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~----g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
.++|...+.||+|+||.||+|.+.. +..+|+|.++..... .+.+.+|+.+++.++||||+++++++.+ +.+++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 4678889999999999999997632 467999998754322 3568899999999999999999999854 56889
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
||||+ +|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~-~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCC-CCEEEEecCCCeecCC
Confidence 99999 6899999963 67788889999999999999999 99999999999999998 6999999999976543
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
... .......||+.|+|||++.+..++.++|||||||++|||++ |..||....... ... .+....
T Consensus 544 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~---~i~~~~----- 609 (656)
T 2j0j_A 544 STY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG---RIENGE----- 609 (656)
T ss_dssp --------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH---HHHHTC-----
T ss_pred Ccc----eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHH---HHHcCC-----
Confidence 211 12223457889999999999999999999999999999997 999997654322 111 111110
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+. .+...+..+.+++..||..||.+|||+.++++.|+.
T Consensus 610 -~~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 610 -RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp -CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011 122334567888999999999999999999998754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=331.32 Aligned_cols=248 Identities=16% Similarity=0.165 Sum_probs=188.6
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHHHHHHHhcCCC-CCee----------e---
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLREVELLSSIKH-ENIV----------R--- 311 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h-~nIv----------~--- 311 (549)
..+|...++||+|+||.||+|.+ .+|+.||||+++.... ..+.+.+|+.+++.+.| +|.. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577788999999999999986 5799999999974322 23678899999999987 2211 1
Q ss_pred --------EEEEEEc-----CCeEEEEEeccCCCHHHHHHH----------hchhHHHHHHHHHHHHHHHHHhCCCCCEE
Q 008898 312 --------IIGYCHS-----KEMYAIVYNLLNGSLKQYLKQ----------LKWNERMDVAIGVAKALEYLHHTCDPPII 368 (549)
Q Consensus 312 --------l~~~~~~-----~~~~~lv~e~~~gsL~~~l~~----------~~~~~~~~i~~~i~~aL~yLH~~~~~~ii 368 (549)
++.++.. ...++++|+++.|+|.++++. +++..++.++.||+.||.|||++ +||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1111111 235788899999999999842 56677888999999999999999 999
Q ss_pred EecCCCCCEEEecCCCceEEeeeccccccccccccccCccccccccCCcccccccc----------ccCCCCchhhHHHH
Q 008898 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM----------MYGKVDEKIDVYSY 438 (549)
Q Consensus 369 HrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~~~k~DvwSl 438 (549)
||||||+|||++.+ +.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 234 HrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 234 HTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CSCCCGGGEEECTT-CCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred cCCcccceEEEecC-CeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999999999999 68999999998654321 335578 999999999 55568899999999
Q ss_pred HHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 008898 439 GVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518 (549)
Q Consensus 439 Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 518 (549)
||++|||++|+.||........ ........ ..+ ++.+.+++..||..||.+|||+.++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~--------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG--------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC--------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhhh--------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999999976543210 01111100 112 356888899999999999999999998
Q ss_pred HhcCCchhhhhhhHHHHH
Q 008898 519 LFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 519 ~L~~~~~w~~~~~~~~~~ 536 (549)
|+||+...+....
T Consensus 364 -----~~~~~~~~~~~~~ 376 (413)
T 3dzo_A 364 -----TPEYEQLRTELSA 376 (413)
T ss_dssp -----SHHHHHHHHHHHH
T ss_pred -----CHHHHHHHHHHHH
Confidence 8999876655443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.97 Aligned_cols=262 Identities=24% Similarity=0.275 Sum_probs=201.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEc------CCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS------KEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~~~~ 322 (549)
++|.+.+.||+|+||.||++.+ .+|+.||||+++.... ..+.+.+|+.+++.++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999987 5689999999875432 23568899999999999999999998755 6788
Q ss_pred EEEEecc-CCCHHHHHHH------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC--ceEEeeecc
Q 008898 323 AIVYNLL-NGSLKQYLKQ------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH--HPQLSDFGA 393 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~~kL~DFGl 393 (549)
++||||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+.. .++|+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999 7899999964 67788999999999999999999 9999999999999997621 389999999
Q ss_pred ccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc
Q 008898 394 AMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG 473 (549)
Q Consensus 394 a~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 473 (549)
+...... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||...... ..|........
T Consensus 171 a~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~ 240 (676)
T 3qa8_A 171 AKELDQG------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKS 240 (676)
T ss_dssp CCBTTSC------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC---
T ss_pred ccccccc------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhccc
Confidence 9764332 2223567999999999999999999999999999999999999999764321 11111111110
Q ss_pred ccccc------------cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 474 LCERL------------IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 474 ~~~~~------------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
..... ................+.+++..||..||.+|||+.++++ |+||....
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~-----hp~F~~l~ 305 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN-----VGCFQALD 305 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC-----CTTHHHHH
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc-----CHHHHHHH
Confidence 00000 0001122344557788999999999999999999999987 89987643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=309.82 Aligned_cols=229 Identities=28% Similarity=0.390 Sum_probs=179.5
Q ss_pred hcCCCCC-ceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHH-hcCCCCCeeeEEEEEEc----CCeEE
Q 008898 251 THNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELL-SSIKHENIVRIIGYCHS----KEMYA 323 (549)
Q Consensus 251 ~~~f~~~-~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il-~~l~h~nIv~l~~~~~~----~~~~~ 323 (549)
.++|... ++||+|+||.||++.+ .+++.||+|+++.. ..+.+|+.++ +.++||||+++++++.. +..++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3567776 7899999999999987 67899999999743 5677899988 66799999999999876 67899
Q ss_pred EEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec---CCCceEEeeeccc
Q 008898 324 IVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE---NFHHPQLSDFGAA 394 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~~kL~DFGla 394 (549)
++|||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++. + +.++|+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~-~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPN-AILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTT-CCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCC-CcEEEeccccc
Confidence 999999 5699999965 67888999999999999999999 9999999999999997 5 68999999998
Q ss_pred cccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
... .+..++.++|||||||++|||++|+.||........ ....
T Consensus 168 ~~~---------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~~~ 210 (299)
T 3m2w_A 168 KET---------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SPGM 210 (299)
T ss_dssp EEC---------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCS
T ss_pred ccc---------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hHHH
Confidence 432 124577899999999999999999999976543210 0000
Q ss_pred cccccCCcccccCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 475 CERLIDPQLNEEYN----REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 475 ~~~~~d~~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
......... .++ ......+.+++..||..||.+|||+.++++ |+|+....
T Consensus 211 ~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~-----hp~~~~~~ 264 (299)
T 3m2w_A 211 KTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN-----HPWIMQST 264 (299)
T ss_dssp CCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SHHHHTGG
T ss_pred HHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc-----Chhhcccc
Confidence 011110100 111 123456788899999999999999999998 89986543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=307.20 Aligned_cols=227 Identities=14% Similarity=0.132 Sum_probs=179.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH----HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++....... +.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 45799999999999999999987 458999999998654332 5688999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH-hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ-LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~-~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|||+ +++|.++++. ....+...++.||+.||.|||+. +|+||||||+|||++.+ +.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~-g~~kl~~~~----------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSID-GDVVLAYPA----------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETT-SCEEECSCC-----------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCC-CCEEEEecc-----------
Confidence 9999 5799999965 34456788999999999999999 99999999999999998 689987543
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
|++| ++.++|||||||++|||++|+.||.......... ........ .+..
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-------~~~~~~~~--~~~~ 224 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-------PAERDTAG--QPIE 224 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-------ECCBCTTS--CBCC
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-------HHHHHhcc--CCCC
Confidence 3333 6899999999999999999999998755321000 00000000 0000
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
........+..+.+++.+||+.||.+| |+.++++.|+..
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 011122334568889999999999999 999999987553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=323.28 Aligned_cols=244 Identities=16% Similarity=0.130 Sum_probs=185.1
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCc---------CHHHHHHHHHHHhcCC---------CCCeeeE
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW---------SEEEVLREVELLSSIK---------HENIVRI 312 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~---------~~~~~~~E~~il~~l~---------h~nIv~l 312 (549)
.++|...+.||+|+||.||+|.+ +|+.||||+++.... ..+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999987 789999999976532 2367889999988885 7777777
Q ss_pred EEEEE------------------------------cCCeEEEEEecc-CCCHHHHH--HHhchhHHHHHHHHHHHHHHHH
Q 008898 313 IGYCH------------------------------SKEMYAIVYNLL-NGSLKQYL--KQLKWNERMDVAIGVAKALEYL 359 (549)
Q Consensus 313 ~~~~~------------------------------~~~~~~lv~e~~-~gsL~~~l--~~~~~~~~~~i~~~i~~aL~yL 359 (549)
.+++. ..+.+++||||+ +|++.+.+ ..+++..+..++.||+.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 76542 268899999999 66554444 2367888999999999999999
Q ss_pred H-hCCCCCEEEecCCCCCEEEecCCC--------------------ceEEeeeccccccccccccccCccccccccCCcc
Q 008898 360 H-HTCDPPIIHRDVKSSNILLSENFH--------------------HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418 (549)
Q Consensus 360 H-~~~~~~iiHrDlkp~NILl~~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y 418 (549)
| +. +|+||||||+|||++.+ + .+||+|||+|+.... ...+||+.|
T Consensus 178 H~~~---~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----------~~~~gt~~y 243 (336)
T 2vuw_A 178 EASL---RFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----------GIVVFCDVS 243 (336)
T ss_dssp HHHH---CCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----------TEEECCCCT
T ss_pred HHhC---CEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCC----------CcEEEeecc
Confidence 9 88 99999999999999987 4 799999999975432 134799999
Q ss_pred ccccccccCCCCchhhHHHHHHH-HHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHH
Q 008898 419 LAPEYMMYGKVDEKIDVYSYGVV-LLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMC 497 (549)
Q Consensus 419 ~APE~~~~~~~~~k~DvwSlGvi-l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 497 (549)
+|||++.+.. +.++||||||++ .+++++|..||....... .....+.... .................+.+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~----~~~~~~~~~~----~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH----YLTDKMLKQM----TFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH----HHHHHHHHTC----CCSSCCCSHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh----HHHHhhhhhh----ccCcccchhhhhhcCHHHHH
Confidence 9999998666 899999998777 788999999984321000 0011111000 01111112223456788999
Q ss_pred HHHHhcccCCCCCCCHHHHH-HHhcCCchhhh
Q 008898 498 AARLCLLHSSSRRPTMKTLL-KLFQEPDYWLK 528 (549)
Q Consensus 498 li~~Cl~~dP~~RPs~~evl-~~L~~~~~w~~ 528 (549)
++..||..| |+.+++ + |+||+
T Consensus 315 li~~~L~~d-----sa~e~l~~-----Hp~f~ 336 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLLCQ-----HSLFK 336 (336)
T ss_dssp HHHHGGGSS-----SHHHHHHH-----CGGGC
T ss_pred HHHHHhccC-----CHHHHHhc-----CCCcC
Confidence 999999977 999999 8 89984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=343.43 Aligned_cols=240 Identities=23% Similarity=0.279 Sum_probs=189.9
Q ss_pred hcCCCCCceEcccCceEEEEEEec--CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe-----
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV--DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEM----- 321 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~--~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~----- 321 (549)
.++|.+.+.||+|+||.||++.+. +|+.||||++..... ....+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999874 689999999875432 23457899999999999999999999976554
Q ss_pred EEEEEecc-CCCHHHHHH-HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 322 YAIVYNLL-NGSLKQYLK-QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~-~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+++||||+ +++|.+++. .+++.+++.++.||+.||.|||++ +||||||||+|||++.+ .+||+|||++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE--QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS--CEEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC--cEEEEecccchhccc
Confidence 79999999 568888775 488889999999999999999999 99999999999999986 799999999865432
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
. ....||+.|+|||++.++ ++.++|||||||++|+|++|.+||....... +.
T Consensus 234 ~---------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------~~ 285 (681)
T 2pzi_A 234 F---------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------LP 285 (681)
T ss_dssp C---------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------CC
T ss_pred C---------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc------------------cc
Confidence 1 345799999999998765 4899999999999999999998886532110 00
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
...........+.+++.+||..||.+||+..+.+. +.|+....+
T Consensus 286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~-----~~l~~~~~~ 329 (681)
T 2pzi_A 286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS-----AQLTGVLRE 329 (681)
T ss_dssp ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHH-----HHHHHHHHH
T ss_pred ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHH-----HHHHHHHHH
Confidence 00001123356888999999999999997666555 456554443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=286.59 Aligned_cols=183 Identities=17% Similarity=0.131 Sum_probs=129.4
Q ss_pred EcccCceEEEEEEe-cCCcEEEEEEeecCCc-----------CHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEEE
Q 008898 260 IGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-----------SEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 260 lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-----------~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
.+.|++|.+..+.. -.|+.+|+|++..... ..+++.+|+++|+++ +|+||+++++++++++.+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56677776666533 4588999999975421 124588999999999 7999999999999999999999
Q ss_pred ecc-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 327 NLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 327 e~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
||+ +|+|.+++.+........|+.||+.||.|||++ |||||||||+|||++.+ +.+||+|||+|+.... .
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~-----~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQ-----D 392 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTT-SCEEECCCTTEESCC-------
T ss_pred ecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHC---CceeccCchHhEEECCC-CCEEEeecccCeeCCC-----C
Confidence 999 669999998755555567999999999999999 99999999999999999 7999999999965433 2
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAI 452 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~ 452 (549)
.....+.+||+.|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 223456789999999998875 5678899999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=253.72 Aligned_cols=187 Identities=17% Similarity=0.209 Sum_probs=142.8
Q ss_pred CCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC---------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 255 SPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 255 ~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
...++||+|+||.||++.. .++.+++|........ .+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 5778899987543211 23478999999999999999665555566778999
Q ss_pred Eecc-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 326 YNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
|||+ +|+|.+++.. ...++.||++||.|||++ +|+||||||+|||++. .+||+|||+|+.........
T Consensus 418 mE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHH
T ss_pred EECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC---eEEEEECccCEECCCccccc
Confidence 9999 5899999876 668999999999999999 9999999999999998 69999999997654321100
Q ss_pred c--CccccccccCCcccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008898 405 E--NVKPVNVVGTFGYLAPEYMMY--GKVDEKIDVYSYGVVLLELITGKEAIQ 453 (549)
Q Consensus 405 ~--~~~~~~~~gt~~y~APE~~~~--~~~~~k~DvwSlGvil~elltG~~p~~ 453 (549)
. .......+||+.|||||++.. ..|+..+|+|+..+-.++.+.++.++.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 0 001236789999999999986 668889999999999888888777653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-23 Score=207.77 Aligned_cols=144 Identities=17% Similarity=0.149 Sum_probs=115.7
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCc-------------------CHHHHHHHHHHHhcCCCCCeee
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW-------------------SEEEVLREVELLSSIKHENIVR 311 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~-------------------~~~~~~~E~~il~~l~h~nIv~ 311 (549)
...|...+.||+|+||.||+|.+.+|+.+|+|+++.... ....+.+|+.+++.++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 344666799999999999999887799999999964321 2345789999999999 4 56
Q ss_pred EEEEEEcCCeEEEEEecc-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEee
Q 008898 312 IIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSD 390 (549)
Q Consensus 312 l~~~~~~~~~~~lv~e~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~D 390 (549)
+.+++.. +..++||||+ +|+|.+ + .......++.||+.||.|||+. +|+||||||+|||++ + +.++|+|
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l---~~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~-~~vkl~D 235 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-V---RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E-EGIWIID 235 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-C---CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T-TEEEECC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-c---chhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C-CcEEEEE
Confidence 6665544 5568999999 558887 3 3355667999999999999999 999999999999999 6 7999999
Q ss_pred eccccccccccccccCccccccccCCccccccccc
Q 008898 391 FGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425 (549)
Q Consensus 391 FGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~ 425 (549)
||+|. .+..|+|||++.
T Consensus 236 FG~a~------------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSV------------------EVGEEGWREILE 252 (282)
T ss_dssp CTTCE------------------ETTSTTHHHHHH
T ss_pred CCCCe------------------ECCCCCHHHHHH
Confidence 99983 244589999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.1e-20 Score=182.00 Aligned_cols=133 Identities=18% Similarity=0.243 Sum_probs=106.7
Q ss_pred CCCCceEcccCceEEEEEEe-cCCcE--EEEEEeecCCcC-------------------------HHHHHHHHHHHhcCC
Q 008898 254 FSPKMLIGQGGNSKVYRTNH-VDGQV--AAVKVLKCTNWS-------------------------EEEVLREVELLSSIK 305 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~-~~g~~--~AvK~l~~~~~~-------------------------~~~~~~E~~il~~l~ 305 (549)
|...+.||+|+||.||+|.+ .+|+. +|||+++..... ...+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999987 78988 999997643211 125778999999998
Q ss_pred CCCe--eeEEEEEEcCCeEEEEEeccC--C----CHHHHHHHhchhHHHHHHHHHHHHHHHHH-hCCCCCEEEecCCCCC
Q 008898 306 HENI--VRIIGYCHSKEMYAIVYNLLN--G----SLKQYLKQLKWNERMDVAIGVAKALEYLH-HTCDPPIIHRDVKSSN 376 (549)
Q Consensus 306 h~nI--v~l~~~~~~~~~~~lv~e~~~--g----sL~~~l~~~~~~~~~~i~~~i~~aL~yLH-~~~~~~iiHrDlkp~N 376 (549)
|+++ ..++.+ +..++||||++ | +|.++....++.....++.|++.||.||| +. +|+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHH
Confidence 8754 344443 35689999994 4 68777655556678899999999999999 88 99999999999
Q ss_pred EEEecCCCceEEeeeccccc
Q 008898 377 ILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 377 ILl~~~~~~~kL~DFGla~~ 396 (549)
||++. .++|+|||+|..
T Consensus 202 ILl~~---~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID---KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS---SEEECCCTTCEE
T ss_pred EEEcC---cEEEEECccccc
Confidence 99987 699999999854
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=6.8e-16 Score=159.83 Aligned_cols=131 Identities=20% Similarity=0.296 Sum_probs=96.7
Q ss_pred CCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC---------------HHH--------HHHHHHHHhcCCCCCee
Q 008898 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS---------------EEE--------VLREVELLSSIKHENIV 310 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~---------------~~~--------~~~E~~il~~l~h~nIv 310 (549)
|++...||.|+||.||+|...+|+.+|||+++..... ... ..+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 8889999999999999999888999999998642111 011 23567777777554432
Q ss_pred --eEEEEEEcCCeEEEEEeccCC-CHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC---
Q 008898 311 --RIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH--- 384 (549)
Q Consensus 311 --~l~~~~~~~~~~~lv~e~~~g-sL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--- 384 (549)
..+++ . ..+|||||++| +|.++. .......++.||+.+|.|||+. |||||||||.|||++++ +
T Consensus 177 vp~p~~~--~--~~~LVME~i~G~~L~~l~---~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d-gd~~ 245 (397)
T 4gyi_A 177 VPEPIAQ--S--RHTIVMSLVDALPMRQVS---SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE-KDAE 245 (397)
T ss_dssp CCCEEEE--E--TTEEEEECCSCEEGGGCC---CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE-ECSS
T ss_pred CCeeeec--c--CceEEEEecCCccHhhhc---ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC-CCcc
Confidence 22222 1 23699999965 554332 2344567889999999999999 99999999999999877 4
Q ss_pred -------ceEEeeecccc
Q 008898 385 -------HPQLSDFGAAM 395 (549)
Q Consensus 385 -------~~kL~DFGla~ 395 (549)
.+.|+||+-+.
T Consensus 246 d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CTTSEEEEEEECCCTTCE
T ss_pred cccccccceEEEEeCCcc
Confidence 27899999774
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=5.2e-11 Score=116.89 Aligned_cols=141 Identities=12% Similarity=0.139 Sum_probs=108.8
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCC-cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
...|.....+|.|+++.||++... ++.+++|+..... .....+.+|+.+++.+. +..+.++++++...+..+++||+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 346777778888999999999753 6789999987521 22346889999999885 67788899999888899999999
Q ss_pred cCC-CHHHHHHHhchhHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 008898 329 LNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTC-------------------------------------------- 363 (549)
Q Consensus 329 ~~g-sL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~-------------------------------------------- 363 (549)
+.| +|.+.+. +......++.+++++|..||+..
T Consensus 92 i~G~~l~~~~~--~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 92 ADGVLCSEEYE--DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp CSSEEHHHHCC--TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred cCCeehhhccC--CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 966 6765421 22344578889999999999820
Q ss_pred ------------CCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 364 ------------DPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 364 ------------~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
...++|+|++|.|||++++ +.+.|+||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhcc
Confidence 1359999999999999875 445699999873
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=4e-11 Score=116.90 Aligned_cols=135 Identities=16% Similarity=0.116 Sum_probs=96.8
Q ss_pred CCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC--eeeEEEEEEcCCeEEEEEeccC
Q 008898 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVRIIGYCHSKEMYAIVYNLLN 330 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~ 330 (549)
++....+.+.|..+.||++...+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..+++||++.
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 34433333455669999998777888999997644 2345778999999886544 5568888888888999999996
Q ss_pred C-CHHHHHHHhchhHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 008898 331 G-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTC---------------------------------------------- 363 (549)
Q Consensus 331 g-sL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~---------------------------------------------- 363 (549)
| +|. . .......++.++++.|..||+..
T Consensus 99 G~~l~--~---~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 99 GQDLL--S---SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp SEETT--T---SCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred CcccC--c---CcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 6 553 1 11223356777788888888652
Q ss_pred ---------CCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 364 ---------DPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 364 ---------~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
...++|+|++|.|||++++ +.+.|+|||.+.
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~ 213 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLG 213 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhcc
Confidence 1129999999999999876 455699999873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=1.5e-09 Score=111.65 Aligned_cols=140 Identities=14% Similarity=0.223 Sum_probs=102.0
Q ss_pred CCceEcccCceEEEEEEecCCcEEEEEEee--cCC--cCHHHHHHHHHHHhcCC--CCCeeeEEEEEEcC---CeEEEEE
Q 008898 256 PKMLIGQGGNSKVYRTNHVDGQVAAVKVLK--CTN--WSEEEVLREVELLSSIK--HENIVRIIGYCHSK---EMYAIVY 326 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~--~~~--~~~~~~~~E~~il~~l~--h~nIv~l~~~~~~~---~~~~lv~ 326 (549)
..+.|+.|.++.||+.... +..+++|+.. ... .....+.+|..+++.|. +..+.+++.++.+. +..+++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3456899999999998765 4678888776 332 22356788999999887 45678899988766 4588999
Q ss_pred eccCCC-HH-HHHHHhchhHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 008898 327 NLLNGS-LK-QYLKQLKWNERMDVAIGVAKALEYLHHTC----------------------------------------- 363 (549)
Q Consensus 327 e~~~gs-L~-~~l~~~~~~~~~~i~~~i~~aL~yLH~~~----------------------------------------- 363 (549)
|++.|. +. ..+..++..+...++.+++.+|..||+..
T Consensus 121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 999763 42 23334566677788899999999999731
Q ss_pred --------------CCCEEEecCCCCCEEEecCCCc-eEEeeeccccc
Q 008898 364 --------------DPPIIHRDVKSSNILLSENFHH-PQLSDFGAAMV 396 (549)
Q Consensus 364 --------------~~~iiHrDlkp~NILl~~~~~~-~kL~DFGla~~ 396 (549)
...++|+|++|.|||++.+... +.|.||+.+.+
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 2479999999999999976322 58999999865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=3.1e-09 Score=106.74 Aligned_cols=183 Identities=21% Similarity=0.275 Sum_probs=118.6
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCC--eeeEEEEEEcCC---eEEEEEeccC
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HEN--IVRIIGYCHSKE---MYAIVYNLLN 330 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~n--Iv~l~~~~~~~~---~~~lv~e~~~ 330 (549)
.+.++.|.+..||+.. ..+++|+.... .....+.+|..+|+.+. +.. +.+++.+....+ .-|+||+++.
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999863 45888886432 23456889999998873 322 344555543333 3478899997
Q ss_pred C-CHHH-HHHHhchhHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 008898 331 G-SLKQ-YLKQLKWNERMDVAIGVAKALEYLHHTC--------------------------------------------- 363 (549)
Q Consensus 331 g-sL~~-~l~~~~~~~~~~i~~~i~~aL~yLH~~~--------------------------------------------- 363 (549)
| +|.+ ....++..++..++.+++..|..||+..
T Consensus 100 G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 100 GVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp CEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred CeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 6 4543 3345666677778888888888888621
Q ss_pred ----------CCCEEEecCCCCCEEEecC-CCceEEeeeccccccccccccccCccccccccCCcc---ccccccc----
Q 008898 364 ----------DPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY---LAPEYMM---- 425 (549)
Q Consensus 364 ----------~~~iiHrDlkp~NILl~~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y---~APE~~~---- 425 (549)
...++|+|++|.||+++++ .+.+.|+||+.+....... .......+ ..|+...
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---------Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---------DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---------HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---------HHHHHHhhccccCHHHHHHHHH
Confidence 1358999999999999984 2467899999886533211 00111111 2222211
Q ss_pred -cCCC---------CchhhHHHHHHHHHHHHcCCCCCC
Q 008898 426 -YGKV---------DEKIDVYSYGVVLLELITGKEAIQ 453 (549)
Q Consensus 426 -~~~~---------~~k~DvwSlGvil~elltG~~p~~ 453 (549)
++.. ..-.+.|++|.++|.+.+|+.+|.
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1111 123689999999999999988864
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=98.81 E-value=2.2e-08 Score=87.85 Aligned_cols=113 Identities=12% Similarity=0.188 Sum_probs=90.6
Q ss_pred cEEEEEEecChhhHHHHHHHHHHh-cCCCCeEEEEEeeccCCccc---------------c---chHHHHHHhhhccCce
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVI-AKPGDNVLAVHVEEQNDTLD---------------L---NTFHIHEDLCKSKKVD 83 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~-~~~~d~v~~~hv~~~~~~~~---------------~---~~~~~~~~~c~~k~~~ 83 (549)
++|||++|.+..|..+|.||+.-. .+.|..|++|||..+..... . +.+..+...+...+++
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 81 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVLAAYDEIEMKEEEKAKLLTQKFSTFFTEKGIN 81 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccccCcHHHHHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 689999999999999999999999 89999999999996544210 1 2235667777788999
Q ss_pred EEEEEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEe
Q 008898 84 FLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 84 ~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
++..+..|. ....|+++|+ .++.||+|.+.. +.-.+ ++.+++++++ |-|+.|
T Consensus 82 ~~~~v~~g~-~~~~I~~~a~--~~dliV~G~~~~~~~~~~~Gs-~~~~vl~~~~--~pVlvv 137 (138)
T 3idf_A 82 PFVVIKEGE-PVEMVLEEAK--DYNLLIIGSSENSFLNKIFAS-HQDDFIQKAP--IPVLIV 137 (138)
T ss_dssp CEEEEEESC-HHHHHHHHHT--TCSEEEEECCTTSTTSSCCCC-TTCHHHHHCS--SCEEEE
T ss_pred eEEEEecCC-hHHHHHHHHh--cCCEEEEeCCCcchHHHHhCc-HHHHHHhcCC--CCEEEe
Confidence 999999995 5678999999 999999998855 21233 8888888887 777665
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=98.81 E-value=1.5e-08 Score=89.82 Aligned_cols=116 Identities=13% Similarity=0.092 Sum_probs=91.8
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCC-----------cc----cc-------chHHHHHHhhhcc
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQND-----------TL----DL-------NTFHIHEDLCKSK 80 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~-----------~~----~~-------~~~~~~~~~c~~k 80 (549)
++|||++|.+..|+.+|.||+.-..+.|..|++|||..+.. .. .. +.+..+...+...
T Consensus 3 ~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (147)
T 3hgm_A 3 NRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRATEL 82 (147)
T ss_dssp SEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHHHhc
Confidence 68999999999999999999998888999999999985432 00 00 2236667778888
Q ss_pred CceE---EEEEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEe
Q 008898 81 KVDF---LVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 81 ~~~~---~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
++++ +..+..|. ....|+++|+...++.||+|.+.+ +.-.+.++.+++++++ |-|+.|
T Consensus 83 g~~~~~~~~~~~~g~-~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 83 GVPADKVRAFVKGGR-PSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp TCCGGGEEEEEEESC-HHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCS--SCEEEC
T ss_pred CCCccceEEEEecCC-HHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCC--CCEEEC
Confidence 8888 88889985 567899999999999999998865 1112338999999988 777654
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=98.79 E-value=6.4e-08 Score=85.66 Aligned_cols=117 Identities=9% Similarity=0.214 Sum_probs=92.9
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcccc------------------chHHHHHHhhhccCc-
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL------------------NTFHIHEDLCKSKKV- 82 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~~------------------~~~~~~~~~c~~k~~- 82 (549)
-++|||++|.+..|+.+|.||+.-..+.|..|++|||..+...... +.+..+...+...++
T Consensus 5 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 84 (146)
T 3s3t_A 5 YTNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVLSELLDAEAAHAKDAMRQRQQFVATTSAP 84 (146)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHHHHHHHHHHHHHHHHHHHHHHHHTTSSCC
T ss_pred cceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccHHHHHHHHHHHHHHHHHHHHHHHhcCCc
Confidence 4699999999999999999999988888999999999865432110 223556667777788
Q ss_pred eEEEEEEecCcchhhHHH-HHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEe
Q 008898 83 DFLVKVCIGDSYITELSN-QVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 83 ~~~~~v~~g~~~~~~l~~-e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
+++..+..|. ....|++ .|+...++.||+|.+.. +.-.+.++.+++++++ |-|+.|
T Consensus 85 ~~~~~~~~g~-~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV 145 (146)
T 3s3t_A 85 NLKTEISYGI-PKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAP--CNVIVI 145 (146)
T ss_dssp CCEEEEEEEC-HHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCS--SEEEEE
T ss_pred ceEEEEecCC-hHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCC--CCEEEe
Confidence 9999999995 5668999 99999999999998855 1112238999999988 888765
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.71 E-value=9.9e-08 Score=86.73 Aligned_cols=121 Identities=13% Similarity=0.135 Sum_probs=91.6
Q ss_pred eecCCCcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEE--EeeccCCc-c----------c-c-----chHHHHHHhh
Q 008898 17 TRTLKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAV--HVEEQNDT-L----------D-L-----NTFHIHEDLC 77 (549)
Q Consensus 17 ~~~~~~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~--hv~~~~~~-~----------~-~-----~~~~~~~~~c 77 (549)
.-....++|||++|.+..|..+|.||+.-.. .|..|++| ||..+... . . . +.+..+...+
T Consensus 12 ~~~~~~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 90 (163)
T 1tq8_A 12 MSLSAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERA 90 (163)
T ss_dssp -CCCCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHH
T ss_pred cccccCCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccccccccccHHHHHHHHHHHHHHHHHHHHHH
Confidence 3344567999999999999999999999888 99999999 88743221 0 0 0 2235556667
Q ss_pred hccCce-EEEEEEecCcchhhHHHHHhhhcccEEEEecccCCC-----CchhHHHHHhhhCCCCcEEEEec
Q 008898 78 KSKKVD-FLVKVCIGDSYITELSNQVRISYATILALGCSLSGL-----KDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 78 ~~k~~~-~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~~-----~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
...+++ ++..+..|. ....|++.|+...++.||+|.+.... -.+ ++.+++++++ |-|+.|.
T Consensus 91 ~~~gv~~v~~~v~~G~-~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGS-va~~vl~~a~--~PVlvV~ 157 (163)
T 1tq8_A 91 HNAGAKNVEERPIVGA-PVDALVNLADEEKADLLVVGNVGLSTIAGRLLGS-VPANVSRRAK--VDVLIVH 157 (163)
T ss_dssp HTTTCCEEEEEEECSS-HHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBB-HHHHHHHHTT--CEEEEEC
T ss_pred HHcCCCeEEEEEecCC-HHHHHHHHHHhcCCCEEEECCCCCCcccceeecc-HHHHHHHhCC--CCEEEEe
Confidence 777888 888888885 47789999999999999999985521 123 8899999888 9998885
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.70 E-value=1.8e-07 Score=84.47 Aligned_cols=118 Identities=12% Similarity=0.128 Sum_probs=91.4
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccC-----C---c--------cc-------c---------ch
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQN-----D---T--------LD-------L---------NT 69 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~-----~---~--------~~-------~---------~~ 69 (549)
-++|||++|.+..|..+|.||+....+.|..|++|||..+. . . .. . +.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (162)
T 1mjh_A 5 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 84 (162)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHHH
Confidence 46899999999999999999999888889999999998543 1 1 11 0 11
Q ss_pred HHHHHHhhhccCceEEEEEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEec
Q 008898 70 FHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 70 ~~~~~~~c~~k~~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
+..+...+...+++++..+..|. ....|++.|+...++.||+|.+.. +.-.+.++.+++++++ |-|+.|.
T Consensus 85 l~~~~~~~~~~g~~~~~~v~~G~-~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~--~pVlvv~ 158 (162)
T 1mjh_A 85 MENIKKELEDVGFKVKDIIVVGI-PHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVK 158 (162)
T ss_dssp HHHHHHHHHHTTCEEEEEEEEEC-HHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEEC
T ss_pred HHHHHHHHHHcCCceEEEEcCCC-HHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCC--CCEEEEe
Confidence 24445556677899998888884 577899999999999999998855 1112339999999987 8888774
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=8.8e-08 Score=84.41 Aligned_cols=116 Identities=10% Similarity=0.098 Sum_probs=89.8
Q ss_pred cEEEEEEecChh--hHHHHHHHHHHhcCCCCeEEEEEeeccCCcc-----------c-c-----chHHHHHHhhhccC--
Q 008898 23 RTVIFGLKSDHY--SREILLQLLTVIAKPGDNVLAVHVEEQNDTL-----------D-L-----NTFHIHEDLCKSKK-- 81 (549)
Q Consensus 23 ~~~~v~~~~~~~--~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~-----------~-~-----~~~~~~~~~c~~k~-- 81 (549)
++|||++|.+.. |+.+|.||+.-..+.|..|++|||..+.... . . .....++.+++..+
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 81 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAYTAELPGMDELREGSETQLKEIAKKFSIP 81 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHHTTSCCC
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccccccccccchhhhHHHHHHHHHHHHHHHHHHcCCC
Confidence 789999999999 9999999999888899999999998653211 0 0 22255677777764
Q ss_pred -ceEEEEEEecCcchhhHHHHHhhhcccEEEEecccCC---CCchhHHHHHhhhCCCCcEEEEe
Q 008898 82 -VDFLVKVCIGDSYITELSNQVRISYATILALGCSLSG---LKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 82 -~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~---~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
+.++..+..| +....|+++|+...++.||+|.+... .-.+.++.+++++++ |-|+.|
T Consensus 82 ~~~v~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~v~~~~~--~pVlvv 142 (143)
T 3fdx_A 82 EDRMHFHVAEG-SPKDKILALAKSLPADLVIIASHRPDITTYLLGSNAAAVVRHAE--CSVLVV 142 (143)
T ss_dssp GGGEEEEEEES-CHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSCHHHHHHHHHCS--SEEEEE
T ss_pred CCceEEEEEec-ChHHHHHHHHHHhCCCEEEEeCCCCCCeeeeeccHHHHHHHhCC--CCEEEe
Confidence 4578888899 55778999999999999999998541 112238999999888 888765
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=1.2e-07 Score=85.47 Aligned_cols=118 Identities=8% Similarity=-0.008 Sum_probs=90.7
Q ss_pred CCcEEEEEEec-ChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcccc-------chHHHHHHhhhccCceEEEEE--Ee
Q 008898 21 KKRTVIFGLKS-DHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL-------NTFHIHEDLCKSKKVDFLVKV--CI 90 (549)
Q Consensus 21 ~~~~~~v~~~~-~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~~-------~~~~~~~~~c~~k~~~~~~~v--~~ 90 (549)
--++|||++|. +..|..+|.||+.-..+.|..|++|||..+.+.... +.+..+...+...++++++.+ ..
T Consensus 23 m~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~v~~ 102 (155)
T 3dlo_A 23 IYMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGRTKDEDIIEAKETLSWAVSIIRKEGAEGEEHLLVRG 102 (155)
T ss_dssp CCCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTTSCHHHHHHHHHHHHHHHHHHHHTTCCEEEEEEESS
T ss_pred ccCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCcccHHHHHHHHHHHHHHHHHHHhcCCCceEEEEecC
Confidence 34699999999 999999999999988888999999999865432211 223555667777788888765 33
Q ss_pred cCcchhhHHHHHhhhcccEEEEecccCCC----CchhHHHHHhhhCCCCcEEEEe
Q 008898 91 GDSYITELSNQVRISYATILALGCSLSGL----KDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 91 g~~~~~~l~~e~k~~~~~~lvlg~~~~~~----~~~~v~~~c~~~~~~~c~v~~v 141 (549)
| +...+|++.|+...|+.||+|.+.... -.+.++.+.+++++ |-|+.|
T Consensus 103 G-~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~--~PVLvV 154 (155)
T 3dlo_A 103 K-EPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKAN--KPVICI 154 (155)
T ss_dssp S-CHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCS--SCEEEE
T ss_pred C-CHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCC--CCEEEe
Confidence 5 557789999999999999999875511 11238899998888 777665
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=98.64 E-value=2.3e-07 Score=84.52 Aligned_cols=119 Identities=13% Similarity=0.083 Sum_probs=91.3
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCc------c------------cc---------chHHHHH
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT------L------------DL---------NTFHIHE 74 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~------~------------~~---------~~~~~~~ 74 (549)
-++|||++|.+..|+.+|.||+....+.|..|++|||..+... . .. +.+..+.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 84 (170)
T 2dum_A 5 FRKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQEKA 84 (170)
T ss_dssp CSEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC------------CCTTSHHHHHHHHHHHHHHHH
T ss_pred cceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 3689999999999999999999988889999999999854321 0 00 1124445
Q ss_pred HhhhccCceEEE--EEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEecc
Q 008898 75 DLCKSKKVDFLV--KVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 75 ~~c~~k~~~~~~--~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
..+...+++++. .+..|. ....|++.|+...++.||+|.+.. +.-.+.++.+++++++ |-|+.|..
T Consensus 85 ~~~~~~g~~~~~~~~~~~g~-~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~PVlvv~~ 156 (170)
T 2dum_A 85 EEVKRAFRAKNVRTIIRFGI-PWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTK--KPVLIIKE 156 (170)
T ss_dssp HHHHHHTTCSEEEEEEEEEC-HHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCS--SCEEEECC
T ss_pred HHHHHcCCceeeeeEEecCC-hHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCC--CCEEEEcc
Confidence 555566888887 888885 567899999999999999999855 1112239999999988 88888853
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=98.62 E-value=1.4e-07 Score=82.57 Aligned_cols=116 Identities=15% Similarity=0.150 Sum_probs=88.0
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCc--c-----cc------chHHHHHHhhhccCc-eEEEEE
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT--L-----DL------NTFHIHEDLCKSKKV-DFLVKV 88 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~--~-----~~------~~~~~~~~~c~~k~~-~~~~~v 88 (549)
++|||++|.+..|..+|.||+....+.|..|++|||..+... . .. ..-..++.+++..++ +++..+
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~g~~~~~~~~ 82 (137)
T 2z08_A 3 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEEARALTGVPKEDALL 82 (137)
T ss_dssp SEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC--------------CHHHHHHHHHHHHHHHHHCCCGGGEEE
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCCCccccccchHHHHHHHHHHHHHHHHHHHHHcCCCccEEEE
Confidence 689999999999999999999988888999999999864220 0 00 111445666666777 777888
Q ss_pred EecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEe
Q 008898 89 CIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 89 ~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
..|. ....|++.|+...++.||+|.+.. +.-.+.++.++.++++ |-|+.|
T Consensus 83 ~~g~-~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv 136 (137)
T 2z08_A 83 LEGV-PAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 136 (137)
T ss_dssp EESS-HHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCS--SCEEEE
T ss_pred EecC-HHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCC--CCEEEe
Confidence 8885 577899999999999999998864 1112338999998887 777665
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=98.61 E-value=3.4e-07 Score=82.08 Aligned_cols=117 Identities=15% Similarity=0.124 Sum_probs=90.8
Q ss_pred CCcEEEEEEe--cChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCccc----------------cchHHHHHHhhhccCc
Q 008898 21 KKRTVIFGLK--SDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD----------------LNTFHIHEDLCKSKKV 82 (549)
Q Consensus 21 ~~~~~~v~~~--~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~----------------~~~~~~~~~~c~~k~~ 82 (549)
.-++|||++| .+..|+.+|.||+.-..+.|..|++|||..+..... .+.+..+...+...++
T Consensus 14 ~~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 93 (156)
T 3fg9_A 14 VYRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIFDSLTPSKIQAKRKHVEDVVAEYVQLAEQRGV 93 (156)
T ss_dssp CCC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred cCceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccccCCHHHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 3479999999 999999999999998888899999999986543110 0223555666777788
Q ss_pred -eEEEEEEe-cCcchhhHHHH-HhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEe
Q 008898 83 -DFLVKVCI-GDSYITELSNQ-VRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 83 -~~~~~v~~-g~~~~~~l~~e-~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
.++..+.. |. ....|++. |+...++.||+|.+.. +.-.+ ++.+++++++ |-|+.|
T Consensus 94 ~~~~~~v~~~g~-~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~Gs-~~~~vl~~a~--~PVlvV 155 (156)
T 3fg9_A 94 NQVEPLVYEGGD-VDDVILEQVIPEFKPDLLVTGADTEFPHSKIAGA-IGPRLARKAP--ISVIVV 155 (156)
T ss_dssp SSEEEEEEECSC-HHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCSC-HHHHHHHHCS--SEEEEE
T ss_pred CceEEEEEeCCC-HHHHHHHHHHHhcCCCEEEECCCCCCccceeecc-hHHHHHHhCC--CCEEEe
Confidence 58999998 74 56789999 9999999999998855 22223 8899999988 888765
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.59 E-value=3.1e-07 Score=84.09 Aligned_cols=119 Identities=14% Similarity=0.256 Sum_probs=88.7
Q ss_pred CcEEEEEEecCh---------hhHHHHHHHHHHhcCC---CCeEEEEEeeccCCc-c-------c-c-------------
Q 008898 22 KRTVIFGLKSDH---------YSREILLQLLTVIAKP---GDNVLAVHVEEQNDT-L-------D-L------------- 67 (549)
Q Consensus 22 ~~~~~v~~~~~~---------~~~~~l~wa~~~~~~~---~d~v~~~hv~~~~~~-~-------~-~------------- 67 (549)
-++|||++|.+. .|+.+|.||+..+++. |..|++|||..+... . . .
T Consensus 5 ~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (175)
T 2gm3_A 5 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAK 84 (175)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHH
T ss_pred ccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHHHH
Confidence 369999999999 9999999999988774 789999999743210 0 0 0
Q ss_pred --chHHHHHHhhhccCceEEEEEEecCcchhhHHHHHhhhcccEEEEecccCC----CCchhHHHHHhhhCCCCcEEEEe
Q 008898 68 --NTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSG----LKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 68 --~~~~~~~~~c~~k~~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~----~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
+.+..+...+...++.++..|..|. ....|++.|+...++.||+|.+... .-.+.++.+++++++ |-|+.|
T Consensus 85 ~~~~l~~~~~~~~~~g~~~~~~v~~G~-~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~~a~--~pVlvv 161 (175)
T 2gm3_A 85 GLHLLEFFVNKCHEIGVGCEAWIKTGD-PKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTI 161 (175)
T ss_dssp HHHHHHHHHHHHHHHTCEEEEEEEESC-HHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEEE
T ss_pred HHHHHHHHHHHHHHCCCceEEEEecCC-HHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHhCCC--CCEEEE
Confidence 1123444556667899988888995 5778999999999999999988551 112238999999988 888888
Q ss_pred cc
Q 008898 142 DN 143 (549)
Q Consensus 142 ~~ 143 (549)
..
T Consensus 162 ~~ 163 (175)
T 2gm3_A 162 KR 163 (175)
T ss_dssp EC
T ss_pred cC
Confidence 53
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=2.9e-07 Score=81.80 Aligned_cols=118 Identities=8% Similarity=0.109 Sum_probs=88.9
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCc-------------ccc------chHHHHHHhhhccCc
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT-------------LDL------NTFHIHEDLCKSKKV 82 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~-------------~~~------~~~~~~~~~c~~k~~ 82 (549)
-++|||++|.+..|+.+|.||+.-..+.|..|++|||..+... ... +.-..++.+++..++
T Consensus 6 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 85 (150)
T 3tnj_A 6 YHHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLDVEKQKLSQIGNTLGI 85 (150)
T ss_dssp CSEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSSCCCHHHHHHHHHHHHHHHHHHHTC
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 4699999999999999999999988888999999999854321 000 112556777777777
Q ss_pred e-EEEEEEecCcchhhHHHHHhhhcccEEEEecccCCC---CchhHHHHHhhhCCCCcEEEEec
Q 008898 83 D-FLVKVCIGDSYITELSNQVRISYATILALGCSLSGL---KDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 83 ~-~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~~---~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
+ ++..+..|.+ ...|+++|+...++.||+|.+.... -.+.++.+++++++ |-|+.|.
T Consensus 86 ~~~~~~~~~g~~-~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~ 146 (150)
T 3tnj_A 86 DPAHRWLVWGEP-REEIIRIAEQENVDLIVVGSHGRHGLALLLGSTANSVLHYAK--CDVLAVR 146 (150)
T ss_dssp CGGGEEEEESCH-HHHHHHHHHHTTCSEEEEEEC--------CCCHHHHHHHHCS--SEEEEEE
T ss_pred CcceEEEecCCH-HHHHHHHHHHcCCCEEEEecCCCCCcCeEecchHHHHHHhCC--CCEEEEe
Confidence 7 5777888854 6789999999999999999885421 11238899999888 9888774
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.49 E-value=9.4e-07 Score=77.57 Aligned_cols=117 Identities=15% Similarity=0.148 Sum_probs=89.5
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeecc-CC-cc--------------ccchHHHHHHhhhccCceE-E
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQ-ND-TL--------------DLNTFHIHEDLCKSKKVDF-L 85 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~-~~-~~--------------~~~~~~~~~~~c~~k~~~~-~ 85 (549)
++|||++|.+..|+.+|.||+.-..+.|..|++|||... +. .. ..+....++.+++..++++ .
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (141)
T 1jmv_A 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPISE 82 (141)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCCCC
T ss_pred ceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhccccccchHHHHHHHHHHHHHHHHHHHHHcCCCceE
Confidence 689999999999999999999988888999999999832 21 00 0112255677777777776 5
Q ss_pred EEEEecCcchhhHHHHHhhhcccEEEEecccCCCC--chhHHHHHhhhCCCCcEEEEecc
Q 008898 86 VKVCIGDSYITELSNQVRISYATILALGCSLSGLK--DSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 86 ~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~~~--~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
..+..|. ....|++.|+...++.||+|.+ .... .+.++.+++++++ |-|+.|..
T Consensus 83 ~~~~~g~-~~~~I~~~a~~~~~dliV~G~~-~~~~~~lgs~~~~vl~~~~--~pVlvv~~ 138 (141)
T 1jmv_A 83 KLSGSGD-LGQVLSDAIEQYDVDLLVTGHH-QDFWSKLMSSTRQVMNTIK--IDMLVVPL 138 (141)
T ss_dssp EEEEEEC-HHHHHHHHHHHTTCCEEEEEEC-CCCHHHHHHHHHHHHTTCC--SEEEEEEC
T ss_pred EEEecCC-HHHHHHHHHHhcCCCEEEEeCC-CchhhhhcchHHHHHhcCC--CCEEEeeC
Confidence 6667775 4678999999999999999998 5211 1238999998888 98888753
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.35 E-value=1.5e-06 Score=75.97 Aligned_cols=111 Identities=14% Similarity=0.076 Sum_probs=82.3
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEee-cc-C--------Ccc-cc--------chHHHHHHh--h--h
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVE-EQ-N--------DTL-DL--------NTFHIHEDL--C--K 78 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~-~~-~--------~~~-~~--------~~~~~~~~~--c--~ 78 (549)
-++|||++|.+..|+.+|.||+.-..+.|..|++|||. .. + ... .. ..-..++.+ | .
T Consensus 4 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 83 (138)
T 1q77_A 4 MKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREVWEKLTG 83 (138)
T ss_dssp CEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred ccEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccccCCCCChHHHHHHHHHHHHHHHHHHHHhhc
Confidence 36899999999999999999999888889999999998 52 1 001 00 001222333 2 2
Q ss_pred ccCceEEEEEEecCcchhhHHHHHhhhcccEEEEecccCCCCchhHHHHHhhhCCCCcEEEEe
Q 008898 79 SKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 79 ~k~~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
..+ +++..+..|. ....|++.|+...++.||+|.+.. + ++.+++++++ |-|+.|
T Consensus 84 ~~~-~~~~~~~~g~-~~~~I~~~a~~~~~dliV~G~~g~----s-v~~~vl~~a~--~PVlvv 137 (138)
T 1q77_A 84 STE-IPGVEYRIGP-LSEEVKKFVEGKGYELVVWACYPS----A-YLCKVIDGLN--LASLIV 137 (138)
T ss_dssp CCC-CCCEEEECSC-HHHHHHHHHTTSCCSEEEECSCCG----G-GTHHHHHHSS--SEEEEC
T ss_pred cCC-cceEEEEcCC-HHHHHHHHHHhcCCCEEEEeCCCC----c-hHHHHHHhCC--CceEee
Confidence 334 5666777785 566899999999999999998844 5 8888888888 877765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=8.1e-06 Score=79.82 Aligned_cols=132 Identities=17% Similarity=0.151 Sum_probs=93.0
Q ss_pred EcccCce-EEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEeccCC-CHHH
Q 008898 260 IGQGGNS-KVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNLLNG-SLKQ 335 (549)
Q Consensus 260 lG~G~fg-~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~g-sL~~ 335 (549)
+..|..| .||+... .++..+++|+-... ...++.+|..+|+.+. +--+.++++++.+++..+++|+++.| ++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4445554 6898765 35678899986533 3456788999998875 33467788999988999999999976 5655
Q ss_pred HHHHhchhHHHHHHHHHHHHHHHHHhCCC---------------------------------------------------
Q 008898 336 YLKQLKWNERMDVAIGVAKALEYLHHTCD--------------------------------------------------- 364 (549)
Q Consensus 336 ~l~~~~~~~~~~i~~~i~~aL~yLH~~~~--------------------------------------------------- 364 (549)
.... .......+..+++..|.-||....
T Consensus 110 ~~~~-~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 188 (272)
T 4gkh_A 110 VLEE-YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLP 188 (272)
T ss_dssp HHHH-CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCC
T ss_pred cccC-CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccc
Confidence 5432 223344556666677777765310
Q ss_pred ----CCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 365 ----PPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 365 ----~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
..++|+|+.+.|||++++ +.+-|+||+.+.
T Consensus 189 ~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~ 222 (272)
T 4gkh_A 189 FSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVG 222 (272)
T ss_dssp CCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred ccCCcEEEcCCCCCCeEEEECC-eEEEEEECcccc
Confidence 128999999999999976 555699999873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=5.2e-06 Score=83.28 Aligned_cols=135 Identities=19% Similarity=0.225 Sum_probs=86.6
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCC---CeeeEEEEEE-cCCeEEEEEeccCC-
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE---NIVRIIGYCH-SKEMYAIVYNLLNG- 331 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~---nIv~l~~~~~-~~~~~~lv~e~~~g- 331 (549)
...++.|....||+. |..+++|+.. .......+.+|..+|+.|.+. .+.+.+.++. ..+..+++|+++.|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456888888999987 5668888743 222335688999999998752 3556666664 44567799999976
Q ss_pred CHHHH-HHHhchhHHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 008898 332 SLKQY-LKQLKWNERMDVAIGVAKALEYLHHT------------------------------------------------ 362 (549)
Q Consensus 332 sL~~~-l~~~~~~~~~~i~~~i~~aL~yLH~~------------------------------------------------ 362 (549)
+|.+. +..++..+...++.++++.|..||+.
T Consensus 99 ~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 99 ILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp ECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred ECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 34431 22222233333333444444333332
Q ss_pred ---------CCCCEEEecCCCCCEEEec---CCCceEEeeeccccc
Q 008898 363 ---------CDPPIIHRDVKSSNILLSE---NFHHPQLSDFGAAMV 396 (549)
Q Consensus 363 ---------~~~~iiHrDlkp~NILl~~---~~~~~kL~DFGla~~ 396 (549)
....++|+|++|.|||++. +.....|+||+.+.+
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2236799999999999987 323347999998754
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=98.19 E-value=9.4e-06 Score=80.50 Aligned_cols=117 Identities=9% Similarity=0.059 Sum_probs=92.5
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCccccchHHHHHHhhhccCceEEEEEEecCcchhhHHHH
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQ 101 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~~~~~~~~~~~c~~k~~~~~~~v~~g~~~~~~l~~e 101 (549)
-++|||++|.+..+..+|.||+.-..+-|-.|++|||..+ ......+..+...+...+++++..+..+.+....|+++
T Consensus 7 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~g~~~~~i~~~ 84 (290)
T 3mt0_A 7 IRSILVVIEPDQLEGLALKRAQLIAGVTQSHLHLLVCEKR--RDHSAALNDLAQELREEGYSVSTNQAWKDSLHQTIIAE 84 (290)
T ss_dssp CCEEEEECCSSCSCCHHHHHHHHHHHHHCCEEEEEEECSS--SCCHHHHHHHHHHHHHTTCCEEEEEECSSSHHHHHHHH
T ss_pred hceEEEEeCCCccchHHHHHHHHHHHhcCCeEEEEEeeCc--HHHHHHHHHHHHHHhhCCCeEEEEEEeCCCHHHHHHHH
Confidence 3699999999999999999999998889999999999864 11123334445556678899999998766667789999
Q ss_pred HhhhcccEEEEecccCC----CCchhHHHHHhhhCCCCcEEEEec
Q 008898 102 VRISYATILALGCSLSG----LKDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 102 ~k~~~~~~lvlg~~~~~----~~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
|+...++.||+|.+... .-.+.++.+.+++++ |-|+.|.
T Consensus 85 a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~--~PVlvv~ 127 (290)
T 3mt0_A 85 QQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAP--CPVLMTK 127 (290)
T ss_dssp HHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCS--SCEEEEC
T ss_pred HHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCC--CCEEEec
Confidence 99999999999988551 112238888888887 8787775
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=98.16 E-value=7e-06 Score=81.59 Aligned_cols=119 Identities=16% Similarity=0.218 Sum_probs=95.6
Q ss_pred CCCcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCccccchHHHHHHhhhccCceEEEEEEecCcchhhHH
Q 008898 20 LKKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELS 99 (549)
Q Consensus 20 ~~~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~~~~~~~~~~~c~~k~~~~~~~v~~g~~~~~~l~ 99 (549)
...++|+|++|.+..+..+|.||+.-....|..|.+|||..+.. ....+..+...++..+++++..+..| +...+|+
T Consensus 168 ~~~~~Ilv~~d~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~--~~~~l~~~~~~l~~~~~~~~~~~~~g-~~~~~I~ 244 (294)
T 3loq_A 168 SLFDRVLVAYDFSKWADRALEYAKFVVKKTGGELHIIHVSEDGD--KTADLRVMEEVIGAEGIEVHVHIESG-TPHKAIL 244 (294)
T ss_dssp CTTSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEECSSSC--CHHHHHHHHHHHHHTTCCEEEEEECS-CHHHHHH
T ss_pred ccCCEEEEEECCCHHHHHHHHHHHHHhhhcCCEEEEEEEccCch--HHHHHHHHHHHHHHcCCcEEEEEecC-CHHHHHH
Confidence 45679999999999999999999998878899999999986543 33444566777777889999888888 6678999
Q ss_pred HHHhhhcccEEEEecccCCCC----chhHHHHHhhhCCCCcEEEEecc
Q 008898 100 NQVRISYATILALGCSLSGLK----DSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 100 ~e~k~~~~~~lvlg~~~~~~~----~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
+.|+...++.||+|...+... .+.++++.+.+++ |-|+.|..
T Consensus 245 ~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pvLvv~~ 290 (294)
T 3loq_A 245 AKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSP--VPVFVCKR 290 (294)
T ss_dssp HHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCS--SCEEEECS
T ss_pred HHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCC--CCEEEECC
Confidence 999999999999999865211 1237888888887 88877743
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.3e-05 Score=79.47 Aligned_cols=122 Identities=7% Similarity=0.028 Sum_probs=91.6
Q ss_pred cCCCcEEEEEEecChh-------hHHHHHHHHHHhcCCCCeEEEEEeeccCCcc------cc------chHHHHHHhhhc
Q 008898 19 TLKKRTVIFGLKSDHY-------SREILLQLLTVIAKPGDNVLAVHVEEQNDTL------DL------NTFHIHEDLCKS 79 (549)
Q Consensus 19 ~~~~~~~~v~~~~~~~-------~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~------~~------~~~~~~~~~c~~ 79 (549)
....++|+|++|.+.. |..+|.||+.-....|..|.+|||..+.... .. .....++.+++.
T Consensus 131 ~~~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 210 (290)
T 3mt0_A 131 PWTGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSADPTFQLSETIEARYREACRTFQAE 210 (290)
T ss_dssp CSTTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC---------CHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCccccccCchhHHHHHHHHHHHHHHHHHHHH
Confidence 3367899999999998 9999999999988899999999998643311 00 112445556666
Q ss_pred cCce-EEEEEEecCcchhhHHHHHhhhcccEEEEecccCC----CCchhHHHHHhhhCCCCcEEEEecc
Q 008898 80 KKVD-FLVKVCIGDSYITELSNQVRISYATILALGCSLSG----LKDSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 80 k~~~-~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~----~~~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
.+++ +...+..| +...+|++.|+...++.||+|.+.+. .-.+.++.+.+.+++ |-|+.|..
T Consensus 211 ~g~~~~~~~v~~g-~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~ 276 (290)
T 3mt0_A 211 YGFSDEQLHIEEG-PADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLE--SDVLVLKP 276 (290)
T ss_dssp HTCCTTTEEEEES-CHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCS--SEEEEECC
T ss_pred cCCCcceEEEecc-CHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCC--CCEEEECC
Confidence 6773 56777888 56778999999999999999988551 112239999999888 98988853
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=2e-05 Score=78.88 Aligned_cols=118 Identities=12% Similarity=0.143 Sum_probs=88.7
Q ss_pred CCcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcc------c--c---------chHHHHHHhhhcc---
Q 008898 21 KKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL------D--L---------NTFHIHEDLCKSK--- 80 (549)
Q Consensus 21 ~~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~------~--~---------~~~~~~~~~c~~k--- 80 (549)
..++|||++|.+..+..+|.||+.-..+.|..|++|||..+.... . . +.+..+...+...
T Consensus 18 ~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 97 (309)
T 3cis_A 18 SSLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVATWLEVPLPPGVLRWQQDHGRHLIDDALKVVEQASLR 97 (309)
T ss_dssp CTTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECCCCCCCTTCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred CCCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEecCcccccccCCCCchhhHHHHHHHHHHHHHHHHHHHHhccc
Confidence 347999999999999999999999988899999999998532110 0 0 1124444555544
Q ss_pred --CceEEEEEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEecc
Q 008898 81 --KVDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 81 --~~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
+++++..+..|. ....|++.|+ .++.||+|.+.. +.-.+.++.+++++++ |-|+.|..
T Consensus 98 ~~~~~~~~~~~~g~-~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~ 161 (309)
T 3cis_A 98 AGPPTVHSEIVPAA-AVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAH--CPVVIIHD 161 (309)
T ss_dssp SCCSCEEEEEESSC-HHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHCS--SCEEEECT
T ss_pred CCCceEEEEEecCC-HHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhCC--CCEEEEcC
Confidence 888998888885 5668999997 899999998854 1112238899998887 88888854
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=5.4e-05 Score=75.67 Aligned_cols=117 Identities=13% Similarity=0.123 Sum_probs=86.5
Q ss_pred CCcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcc-----c---c-----chH-HHHHHhhhc-cCceEE
Q 008898 21 KKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL-----D---L-----NTF-HIHEDLCKS-KKVDFL 85 (549)
Q Consensus 21 ~~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~-----~---~-----~~~-~~~~~~c~~-k~~~~~ 85 (549)
..++|+|++|.+..+..+|.||+......|..|.+|||..+.... . . +.+ ...+.+++. .++.++
T Consensus 170 ~~~~Ilv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 249 (309)
T 3cis_A 170 QQAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVSEWPGIDWPATQSMAEQVLAERLAGWQERYPNVAIT 249 (309)
T ss_dssp CCCCEEEECCSSHHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCTTCSSCCHHHHHHHHHHHHHHHHTTHHHHCTTSCEE
T ss_pred CCCeEEEEeCCChHHHHHHHHHHHHHHhcCCEEEEEEEeecccccCCCcccHHHHHHHHHHHHHHHHHHHHhhCCCCcEE
Confidence 457999999999999999999999888889999999998543211 0 0 111 112223332 478888
Q ss_pred EEEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEec
Q 008898 86 VKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 86 ~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
..+..| +...+|++.|+ .|+.||+|.+.+ +.-.+.++.+.+++++ |-|+.|.
T Consensus 250 ~~~~~g-~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~--~pVlvv~ 305 (309)
T 3cis_A 250 RVVVRD-QPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLAR--TPVIVAR 305 (309)
T ss_dssp EEEESS-CHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCS--SCEEEEC
T ss_pred EEEEcC-CHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCC--CCEEEeC
Confidence 888888 45778999998 899999999865 1112239999998888 8887774
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=2.9e-05 Score=75.84 Aligned_cols=116 Identities=14% Similarity=0.047 Sum_probs=88.0
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCc--------c----c--------c--------chHHHHH
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT--------L----D--------L--------NTFHIHE 74 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~--------~----~--------~--------~~~~~~~ 74 (549)
++|||++|.+..|..+|.||+.-..+.|..|++|||..+... . . . +.+..+.
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 80 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERVR 80 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 479999999999999999999988888999999999843210 0 0 0 1224555
Q ss_pred HhhhccCceEEEEEEecCcchhhHHHHHhhhcccEEEEecccCC-C----CchhHHHHHhhhCCCCcEEEEecc
Q 008898 75 DLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLSG-L----KDSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 75 ~~c~~k~~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~-~----~~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
..+...+++++..+..|.+ ...|++. ...++.||+|.+... . -.+.++.+++++++ |-|+.|..
T Consensus 81 ~~~~~~g~~~~~~~~~g~~-~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~--~PVlvv~~ 149 (268)
T 3ab8_A 81 QSALAAGVAVEAVLEEGVP-HEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASP--VPVLLAPG 149 (268)
T ss_dssp HHHHHTTCCEEEEEEEECH-HHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCS--SCEEEECS
T ss_pred HHHHhCCCCeEEEEecCCH-HHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCC--CCEEEECC
Confidence 6677788999998888865 5578877 889999999987432 1 12338999999988 88888753
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=6.8e-05 Score=75.11 Aligned_cols=119 Identities=9% Similarity=0.075 Sum_probs=89.5
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCC--ccc------c------------chHHHHHHhhhccC
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQND--TLD------L------------NTFHIHEDLCKSKK 81 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~--~~~------~------------~~~~~~~~~c~~k~ 81 (549)
-++|||++|.+..+..+|.||+.-..+.|-.|++|||..+.. ... . ..+..+...+...+
T Consensus 7 ~k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 86 (319)
T 3olq_A 7 YQNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQKTAWIKQQARYYLEAG 86 (319)
T ss_dssp SCEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhhccccChhhHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 369999999999999999999999888999999999974211 000 0 11234445566779
Q ss_pred ceEEEEEE-ecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEecc
Q 008898 82 VDFLVKVC-IGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 82 ~~~~~~v~-~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
+.++..+. .|. ....|+++|+...++.||+|.+.. +.-.+.++.+.+++++ |-|+.|..
T Consensus 87 v~~~~~~~~~g~-~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~ 150 (319)
T 3olq_A 87 IQIDIKVIWHNR-PYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCP--APVWMVKD 150 (319)
T ss_dssp CCEEEEEEECSC-HHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCS--SCEEEEES
T ss_pred CeEEEEEEecCC-hHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCC--CCEEEecC
Confidence 99999998 564 566899999999999999999865 1112237888888887 87877753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=3.7e-05 Score=79.77 Aligned_cols=73 Identities=16% Similarity=0.069 Sum_probs=48.0
Q ss_pred CceEcccCceEEEEEEec-CCcEEEEEEeecCC--------cCHHHHHHHHHHHhcCCC--C-CeeeEEEEEEcCCeEEE
Q 008898 257 KMLIGQGGNSKVYRTNHV-DGQVAAVKVLKCTN--------WSEEEVLREVELLSSIKH--E-NIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~~--------~~~~~~~~E~~il~~l~h--~-nIv~l~~~~~~~~~~~l 324 (549)
.+.||.|.++.||++... +++.+++|...... ...+.+..|.++++.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 457899999999999653 46889999865321 122456789888887742 3 344566543 344678
Q ss_pred EEeccCC
Q 008898 325 VYNLLNG 331 (549)
Q Consensus 325 v~e~~~g 331 (549)
+||++.|
T Consensus 113 vmE~l~g 119 (397)
T 2olc_A 113 VMEDLSH 119 (397)
T ss_dssp EECCCTT
T ss_pred EEEeCCC
Confidence 9999965
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00016 Score=72.85 Aligned_cols=132 Identities=18% Similarity=0.279 Sum_probs=75.7
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-----CCCeeeEE-E--EEEcCCeEEEEEecc
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----HENIVRII-G--YCHSKEMYAIVYNLL 329 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-----h~nIv~l~-~--~~~~~~~~~lv~e~~ 329 (549)
..|+.|..+.||+....+| .+++|+.... ...+..|..+++.|. .|.++... | +....+..+++|+++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3466677899999977555 4889988752 344555666666553 23333310 1 123456788999999
Q ss_pred CCC-H-----------HHHHHH-------h--c-----------hhHH-------------------------------H
Q 008898 330 NGS-L-----------KQYLKQ-------L--K-----------WNER-------------------------------M 346 (549)
Q Consensus 330 ~gs-L-----------~~~l~~-------~--~-----------~~~~-------------------------------~ 346 (549)
.|. + -+.+.+ + + |... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 662 1 111111 1 0 1100 0
Q ss_pred HHHHHHHHHHHHHHh----------CCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 347 DVAIGVAKALEYLHH----------TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 347 ~i~~~i~~aL~yLH~----------~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
.+...+..++.+|+. .....++|+|+.+.|||++.+ +.+.|+||+.+
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a 250 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhc
Confidence 011123445667763 123489999999999999866 57999999987
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=97.77 E-value=1.5e-05 Score=79.09 Aligned_cols=117 Identities=11% Similarity=0.047 Sum_probs=89.0
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcc-------cc-----------chHHHHHHhhhccCce
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTL-------DL-----------NTFHIHEDLCKSKKVD 83 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~-------~~-----------~~~~~~~~~c~~k~~~ 83 (549)
-++|||++|.+..|..+|.||+.-..+-|..|++|||....... .. +.+..+...+...+++
T Consensus 22 ~~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 101 (294)
T 3loq_A 22 SNAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDIDHYIDEMSEKAEEVLPEVAQKIEAAGIK 101 (294)
T ss_dssp TCEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCTTHHHHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred hccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 36999999999999999999999888889999999998544310 00 2235566777788999
Q ss_pred EEE-EEE-ecCcchhhHHHHHhhhcccEEEEecccCCCC----chhHHHHHhhhCCCCcEEEEecc
Q 008898 84 FLV-KVC-IGDSYITELSNQVRISYATILALGCSLSGLK----DSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 84 ~~~-~v~-~g~~~~~~l~~e~k~~~~~~lvlg~~~~~~~----~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
++. .+. .|.. ...| .|+...++.||+|.+..... .+.++.+++++++ |-|+.|..
T Consensus 102 ~~~~~v~~~g~~-~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~ 162 (294)
T 3loq_A 102 AEVIKPFPAGDP-VVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSK--VPVYIFKH 162 (294)
T ss_dssp EEECSSCCEECH-HHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCS--SCEEEECC
T ss_pred cceeEeeccCCh-hHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCC--CCEEEecC
Confidence 988 787 7866 4456 89999999999998755210 1127888888888 88887753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=1.3e-05 Score=81.73 Aligned_cols=74 Identities=9% Similarity=0.036 Sum_probs=51.9
Q ss_pred ceE-cccCceEEEEEEec-------CCcEEEEEEeecCC---c-CHHHHHHHHHHHhcCCC---CCeeeEEEEEEcC---
Q 008898 258 MLI-GQGGNSKVYRTNHV-------DGQVAAVKVLKCTN---W-SEEEVLREVELLSSIKH---ENIVRIIGYCHSK--- 319 (549)
Q Consensus 258 ~~l-G~G~fg~Vy~~~~~-------~g~~~AvK~l~~~~---~-~~~~~~~E~~il~~l~h---~nIv~l~~~~~~~--- 319 (549)
+.| +.|....+|+.... +++.+++|+..... . ....+.+|..+++.|.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88888999998654 26788899765432 1 12457789988888742 3567788887655
Q ss_pred CeEEEEEeccCC
Q 008898 320 EMYAIVYNLLNG 331 (549)
Q Consensus 320 ~~~~lv~e~~~g 331 (549)
+..+++||++.|
T Consensus 106 g~~~~v~e~l~G 117 (357)
T 3ats_A 106 GTPFFLMDYVEG 117 (357)
T ss_dssp SSCEEEEECCCC
T ss_pred CCceEEEEecCC
Confidence 346789999965
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=9.1e-05 Score=74.16 Aligned_cols=121 Identities=9% Similarity=0.046 Sum_probs=89.6
Q ss_pred CCCcEEEEEEecCh-------hhHHHHHHHHHHhcCC--CCeEEEEEeeccCCccc------c-----------chHHHH
Q 008898 20 LKKRTVIFGLKSDH-------YSREILLQLLTVIAKP--GDNVLAVHVEEQNDTLD------L-----------NTFHIH 73 (549)
Q Consensus 20 ~~~~~~~v~~~~~~-------~~~~~l~wa~~~~~~~--~d~v~~~hv~~~~~~~~------~-----------~~~~~~ 73 (549)
...++|+|++|.+. .|..+|.||+.-...- |..|.+|||..+..... . .....+
T Consensus 154 ~~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (319)
T 3olq_A 154 PEYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIAIELPDFDPNLYNNALRGQHLIAM 233 (319)
T ss_dssp CTTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCCTTCTTCCHHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhhccCCcccHHHHHHHHHHHHHHHH
Confidence 34689999999999 4699999998866655 99999999985543210 0 112455
Q ss_pred HHhhhccCc-eEEEEEEecCcchhhHHHHHhhhcccEEEEecccCCCCc----hhHHHHHhhhCCCCcEEEEecc
Q 008898 74 EDLCKSKKV-DFLVKVCIGDSYITELSNQVRISYATILALGCSLSGLKD----SEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 74 ~~~c~~k~~-~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~~~~----~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
+.+++..++ .+...|..|.+ ..+|++.|+...++.||+|...+.... +.++++.+.+++ |-|+.|..
T Consensus 234 ~~~~~~~~~~~~~~~v~~g~~-~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~ 305 (319)
T 3olq_A 234 KELRQKFSIPEEKTHVKEGLP-EQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHIK--CDLLAIKP 305 (319)
T ss_dssp HHHHHHTTCCGGGEEEEESCH-HHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTCC--SEEEEECC
T ss_pred HHHHHHhCCCcccEEEecCCc-HHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhCC--CCEEEECC
Confidence 666666665 35566778855 789999999999999999997552211 248899998888 99988854
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00014 Score=70.98 Aligned_cols=115 Identities=18% Similarity=0.132 Sum_probs=85.6
Q ss_pred CCcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCccccchHHHHHHhhhccCceEEEEEEecCcchhhHHH
Q 008898 21 KKRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDLNTFHIHEDLCKSKKVDFLVKVCIGDSYITELSN 100 (549)
Q Consensus 21 ~~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~~~~~~~~~~~c~~k~~~~~~~v~~g~~~~~~l~~ 100 (549)
..++|+|++|.+..+..+|.||..-....|..|.+|||..+.+ .....+..+.......+++++..+..| +...+|++
T Consensus 153 ~~~~ilv~~d~s~~~~~al~~a~~la~~~~a~l~ll~v~~~~~-~~~~~l~~~~~~l~~~~~~~~~~~~~g-~~~~~i~~ 230 (268)
T 3ab8_A 153 ELEGALLGYDASESAVRALHALAPLARALGLGVRVVSVHEDPA-RAEAWALEAEAYLRDHGVEASALVLGG-DAADHLLR 230 (268)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHHHHHHTCCEEEEEECSSHH-HHHHHHHHHHHHHHHTTCCEEEEEECS-CHHHHHHH
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHhhhcCCCEEEEEEEcCcHH-HHHHHHHHHHHHHHHcCCceEEEEeCC-ChHHHHHH
Confidence 5579999999999999999999887777888999999985431 111233445566666788888888887 55778999
Q ss_pred HHhhhcccEEEEecccCCCCchhHHHHHhhhCCCCcEEEEe
Q 008898 101 QVRISYATILALGCSLSGLKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 101 e~k~~~~~~lvlg~~~~~~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
.|+.. +.||+|....+.-.+.++.+.+.+++ |-|+.+
T Consensus 231 ~a~~~--dliV~G~~~~~~~~Gs~~~~vl~~~~--~pvlvv 267 (268)
T 3ab8_A 231 LQGPG--DLLALGAPVRRLVFGSTAERVIRNAQ--GPVLTA 267 (268)
T ss_dssp HCCTT--EEEEEECCCSCCSSCCHHHHHHHHCS--SCEEEE
T ss_pred HHHhC--CEEEECCcccccEeccHHHHHHhcCC--CCEEEe
Confidence 99988 99999992222222238888888877 766654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.001 Score=69.46 Aligned_cols=77 Identities=12% Similarity=0.183 Sum_probs=47.6
Q ss_pred CCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCcccccccc--CCccccccccccCC---CCchhhHHHH
Q 008898 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVG--TFGYLAPEYMMYGK---VDEKIDVYSY 438 (549)
Q Consensus 364 ~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~---~~~k~DvwSl 438 (549)
...++|+|++|.|||++.+ + +.|+||+.+.+........ ...+ ...|++|+...... -....++.+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G~p~~Dla------~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYGPMGFDIG------AYLGNLILAFFAQDGHATQENDRKEYKQWILRT 302 (420)
T ss_dssp CCEEECSCCSGGGEEECSS-C-EEECCCTTCEEECHHHHHH------HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCC-C-CEEEeCcccccCchHHHHH------HHHHHHHHHHHhcccccccccchHHHHHHHHHH
Confidence 3489999999999999987 4 9999999886543211000 0011 13466666554211 1223455577
Q ss_pred HHHHHHHHcC
Q 008898 439 GVVLLELITG 448 (549)
Q Consensus 439 Gvil~elltG 448 (549)
...+|+.+++
T Consensus 303 ~~~~~~~y~~ 312 (420)
T 2pyw_A 303 IEQTWNLFNK 312 (420)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 7778877765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0029 Score=63.35 Aligned_cols=73 Identities=15% Similarity=0.375 Sum_probs=50.2
Q ss_pred ceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCC--CeeeEEEE-----EEcCCeEEEEEeccC
Q 008898 258 MLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHE--NIVRIIGY-----CHSKEMYAIVYNLLN 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~-----~~~~~~~~lv~e~~~ 330 (549)
..++ |....||+....+|+.+++|+..........+..|..+++.|... .+.+++.. ...++..+++|+++.
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4577 888899998776777899999875545567788888888877422 23334332 122456678999997
Q ss_pred C
Q 008898 331 G 331 (549)
Q Consensus 331 g 331 (549)
|
T Consensus 111 G 111 (328)
T 1zyl_A 111 G 111 (328)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0022 Score=64.31 Aligned_cols=72 Identities=18% Similarity=0.185 Sum_probs=57.2
Q ss_pred CceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCeEEEEEeccCC
Q 008898 257 KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK---HENIVRIIGYCHSKEMYAIVYNLLNG 331 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~g 331 (549)
...|+.|.+..+|+... +++.+++|+.... ....+..|...|+.|. ...+.+++.++...+..+++||++.|
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 45689999999999875 5678889987643 2456788999888874 35678888888888889999999965
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00075 Score=67.48 Aligned_cols=151 Identities=16% Similarity=0.207 Sum_probs=83.3
Q ss_pred cCHHHHHhhhcCCCC-----CceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC--eeeEEE
Q 008898 242 FTSQELCHLTHNFSP-----KMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN--IVRIIG 314 (549)
Q Consensus 242 ~~~~el~~~~~~f~~-----~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~ 314 (549)
++.+++..+-..|.. .+.|+.|....+|+....+| .+++|+.... ...+.+..|..+++.|.... +.+++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 344445444455554 23467788899999977555 5789988652 12345667888777664212 233331
Q ss_pred E------EEcCCeEEEEEeccCCC-H-----H------HHHHH-------h-----------chhHHHH-----------
Q 008898 315 Y------CHSKEMYAIVYNLLNGS-L-----K------QYLKQ-------L-----------KWNERMD----------- 347 (549)
Q Consensus 315 ~------~~~~~~~~lv~e~~~gs-L-----~------~~l~~-------~-----------~~~~~~~----------- 347 (549)
. ....+..+++++++.|. + . +.+.+ + .|...+.
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 12235678899998662 1 1 11110 0 1111000
Q ss_pred -HHHHHHHHHHHHHhC----CCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 348 -VAIGVAKALEYLHHT----CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 348 -i~~~i~~aL~yLH~~----~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
+...+.+.+.+++.. ....++|+|+.+.|||++++ +.+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhcc
Confidence 011244456666542 13479999999999999987 444799999873
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0014 Score=65.09 Aligned_cols=71 Identities=7% Similarity=0.008 Sum_probs=43.7
Q ss_pred CCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCe-eeEEEEEEcCCeEEEEEecc-CC
Q 008898 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYNLL-NG 331 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lv~e~~-~g 331 (549)
+.-.+.|+.|....+|+. +.+++|+.........+..+|..+++.+....+ .++++++.+ .-+++++|+ +|
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g 92 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGA 92 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCC
Confidence 444678999999999998 457888876432111223568877776642222 455655432 335778998 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0082 Score=60.24 Aligned_cols=134 Identities=13% Similarity=0.152 Sum_probs=68.9
Q ss_pred eEcccCceE-EEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCC--CCeeeEEEEEEcCCeEEEEEeccCC-CHH
Q 008898 259 LIGQGGNSK-VYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH--ENIVRIIGYCHSKEMYAIVYNLLNG-SLK 334 (549)
Q Consensus 259 ~lG~G~fg~-Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~g-sL~ 334 (549)
.|+.|+... +|+....+|+.+++|...... ...+..|+.+++.+.. -.+.+++.+..+.+ +++||.++| .+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence 465555554 667765446777777654332 1234567777766642 23556676644433 578888865 454
Q ss_pred HHHHHhc---------------------------hhHH--H-------H-H------------HHHHHHHHHHHHh---C
Q 008898 335 QYLKQLK---------------------------WNER--M-------D-V------------AIGVAKALEYLHH---T 362 (549)
Q Consensus 335 ~~l~~~~---------------------------~~~~--~-------~-i------------~~~i~~aL~yLH~---~ 362 (549)
+++...+ +... . . + ...+...+..|.. .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 4332110 0000 0 0 0 0011112222211 1
Q ss_pred CCCCEEEecCCCCCEEEecC---CCceEEeeeccccc
Q 008898 363 CDPPIIHRDVKSSNILLSEN---FHHPQLSDFGAAMV 396 (549)
Q Consensus 363 ~~~~iiHrDlkp~NILl~~~---~~~~kL~DFGla~~ 396 (549)
....++|+|+.+.|||++.+ .+.+.|+||+.+.+
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23479999999999999863 13689999998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0049 Score=64.58 Aligned_cols=70 Identities=9% Similarity=0.140 Sum_probs=48.2
Q ss_pred CceEcccCceEEEEEEecC--------CcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCe-eeEEEEEEcCCeEEEEEe
Q 008898 257 KMLIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~--------g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lv~e 327 (549)
.+.|+.|....+|++...+ ++.+++|+.... ...+.+..|..+++.|...++ .++++.+.+ .++++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3468888889999998643 578999987432 222566789999888853333 567776542 27889
Q ss_pred ccCC
Q 008898 328 LLNG 331 (549)
Q Consensus 328 ~~~g 331 (549)
|+.|
T Consensus 153 ~l~G 156 (429)
T 1nw1_A 153 YIPS 156 (429)
T ss_dssp CCCE
T ss_pred EeCC
Confidence 8865
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0043 Score=63.93 Aligned_cols=134 Identities=13% Similarity=0.162 Sum_probs=76.0
Q ss_pred ceEcccCceEEEEEEec--------CCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEec
Q 008898 258 MLIGQGGNSKVYRTNHV--------DGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~--------~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+.|..|-...+|++... +++.+++|+............+|..+++.|. +.-..++++++.+ .++|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45667778889998764 2578999986432234466778999998875 3333567777643 288999
Q ss_pred cCCC-H-----------HHH---HHH---h----------chhHHHHHHHHH-------------------HHHHHHHH-
Q 008898 329 LNGS-L-----------KQY---LKQ---L----------KWNERMDVAIGV-------------------AKALEYLH- 360 (549)
Q Consensus 329 ~~gs-L-----------~~~---l~~---~----------~~~~~~~i~~~i-------------------~~aL~yLH- 360 (549)
+.|. | ... |.+ . -+.+...+..++ ...+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 8651 1 111 111 0 112222222222 11233332
Q ss_pred ---hC-CCCCEEEecCCCCCEEEecC---CCceEEeeecccc
Q 008898 361 ---HT-CDPPIIHRDVKSSNILLSEN---FHHPQLSDFGAAM 395 (549)
Q Consensus 361 ---~~-~~~~iiHrDlkp~NILl~~~---~~~~kL~DFGla~ 395 (549)
.. ....++|+|+.+.|||++.+ .+.+.|+||..|.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 12368999999999999875 2478999999873
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.34 E-value=0.017 Score=61.06 Aligned_cols=71 Identities=11% Similarity=0.126 Sum_probs=45.8
Q ss_pred CceEcccCceEEEEEEecC-CcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCe-eeEEEEEEcCCeEEEEEeccCC
Q 008898 257 KMLIGQGGNSKVYRTNHVD-GQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI-VRIIGYCHSKEMYAIVYNLLNG 331 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~-g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~g 331 (549)
.+.|+.|-...+|++...+ +..+++|+........-+..+|..+++.|...++ .++++++. +. ++|+|+.|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCC
Confidence 3468888889999998754 5788899874322111123578999988865444 56777763 22 48999865
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.011 Score=57.90 Aligned_cols=73 Identities=15% Similarity=0.145 Sum_probs=51.5
Q ss_pred CCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCC---CCeeeEEEEEEcCCeEEEEEecc
Q 008898 254 FSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKH---ENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 254 f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h---~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
......+|.|..+.||+....||+.+.+|+....... ...+..|...|+.|.. -.+.+++++. .-+++||++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 4445679999999999999999999999987544322 3457789999888742 2344555543 236778887
Q ss_pred C
Q 008898 330 N 330 (549)
Q Consensus 330 ~ 330 (549)
.
T Consensus 93 ~ 93 (288)
T 3f7w_A 93 D 93 (288)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0065 Score=61.99 Aligned_cols=70 Identities=9% Similarity=0.094 Sum_probs=41.4
Q ss_pred ceEcccCceEEEEEEecC---------CcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCeEEEEEe
Q 008898 258 MLIGQGGNSKVYRTNHVD---------GQVAAVKVLKCTNWSEEEVLREVELLSSIKHEN-IVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~---------g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~lv~e 327 (549)
..|+.|....+|+....+ ++.+++|+.........+...|..+++.+...+ +.++++.. .+ +++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEEE
Confidence 457788888999987643 268888887543221112457888888775333 34666554 22 57899
Q ss_pred ccCC
Q 008898 328 LLNG 331 (549)
Q Consensus 328 ~~~g 331 (549)
++.|
T Consensus 115 ~i~G 118 (369)
T 3c5i_A 115 WLYG 118 (369)
T ss_dssp CCCS
T ss_pred EecC
Confidence 9866
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.75 E-value=0.043 Score=51.57 Aligned_cols=98 Identities=16% Similarity=0.139 Sum_probs=61.2
Q ss_pred CHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 332 SLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 332 sL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
+|.+.|+. ++++++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+ |.+-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~d-G~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRD-GAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETT-SCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecC-Cceeccc-cccc------------
Confidence 69999964 7889999999999999877622111 1 123345688899888 6665543 1110
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEA 451 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p 451 (549)
.....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122467888663 3456888999999999998864433
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.67 E-value=0.025 Score=57.14 Aligned_cols=31 Identities=19% Similarity=0.422 Sum_probs=26.8
Q ss_pred CCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 365 ~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
..++|+|+.+.||+++++ +.+.|+||+.+.+
T Consensus 206 ~~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-ESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGG-GCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCC-CeEEEEECCCCee
Confidence 379999999999999876 5789999988754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.58 E-value=0.41 Score=49.76 Aligned_cols=70 Identities=11% Similarity=0.088 Sum_probs=44.7
Q ss_pred ceEcccCceEEEEEEecC--------CcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEec
Q 008898 258 MLIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~--------g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+.|..|-...+|+....+ ++.+++++........-+..+|..+++.+. +.-..++++.+. + +++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEEEE
Confidence 457778888999987653 578999986433211223457888888775 323445665442 2 678999
Q ss_pred cCC
Q 008898 329 LNG 331 (549)
Q Consensus 329 ~~g 331 (549)
+.|
T Consensus 152 I~G 154 (424)
T 3mes_A 152 IDG 154 (424)
T ss_dssp CCS
T ss_pred eCC
Confidence 866
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.27 E-value=0.2 Score=46.81 Aligned_cols=117 Identities=12% Similarity=0.186 Sum_probs=83.9
Q ss_pred CCCCeeeEEEEEEcCCeEEEEEeccC-CCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCC
Q 008898 305 KHENIVRIIGYCHSKEMYAIVYNLLN-GSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENF 383 (549)
Q Consensus 305 ~h~nIv~l~~~~~~~~~~~lv~e~~~-gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~ 383 (549)
.||+.++. .+-.+.+.+.+.++... +.=+..++..+...+++++.+|+....+++.. +|--|.|+||+++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~- 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRD- 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTT-
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCC-
Confidence 68888876 56677778887777663 32233377888899999999999988776644 788999999999999
Q ss_pred CceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Q 008898 384 HHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455 (549)
Q Consensus 384 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~ 455 (549)
+.+++.-.|+-.. ++|. .++..-=.-.+=|++..+++++..|+..
T Consensus 116 ~~p~i~~RGik~~----------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 116 GLPIAKTRGLQNV----------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp SCEEESCCEETTT----------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred CCEEEEEccCccC----------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 6899988886411 1221 1122222345788899999999888654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.14 E-value=1 Score=42.13 Aligned_cols=115 Identities=14% Similarity=0.110 Sum_probs=80.8
Q ss_pred CCCCeeeEEEEEEcCCeEEEEEecc-CCCHHHHHHHhchhHHHHHHHHHHHHHH-HHHhCCCCCEEEecCCCCCEEEecC
Q 008898 305 KHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALE-YLHHTCDPPIIHRDVKSSNILLSEN 382 (549)
Q Consensus 305 ~h~nIv~l~~~~~~~~~~~lv~e~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~-yLH~~~~~~iiHrDlkp~NILl~~~ 382 (549)
.||++ --.+-.+++.+.+.++.. ++.=...++.++..++++++.+|+.... +++ .-+|--|.|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCC
Confidence 57777 334447778888888776 4433446688999999999999988776 555 44788999999999999
Q ss_pred CCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008898 383 FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT 454 (549)
Q Consensus 383 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~ 454 (549)
+.+++.-.|+-. -++|.-+ +..-=.-.+=|++..++.++..|+.
T Consensus 121 -~~p~i~hRGi~~----------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 121 -LEPFFLHVGVKE----------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp -CCEEESCCEETT----------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred -CcEEEEEcCCcc----------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 689998888631 2333221 1111133577888889888877743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 549 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-55 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-17 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 7e-55
Identities = 67/277 (24%), Positives = 121/277 (43%), Gaps = 27/277 (9%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+G G +V+ + AVK LK + S + L E L+ ++H+ +VR
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPP 366
+ + +Y I + NGSL +LK +L N+ +D+A +A+ + ++
Sbjct: 73 LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
IHRD++++NIL+S+ +++DFG A + +E + APE + Y
Sbjct: 130 YIHRDLRAANILVSDTLSC-KIADFGLARLIED----NEYTAREGAKFPIKWTAPEAINY 184
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486
G K DV+S+G++L E++T N E + R R++ P +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------GYRMVRP---DN 234
Query: 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523
E +++ RLC RPT L + ++
Sbjct: 235 CPEELYQLM----RLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 9e-54
Identities = 71/275 (25%), Positives = 121/275 (44%), Gaps = 31/275 (11%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEV---LREVELLSSIKHENIVRIIGY 315
IG G VY+ G VA VK+L T + +++ EV +L +H NI+ +GY
Sbjct: 15 RIGSGSFGTVYKGKW-HGDVA-VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 316 CHSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
+ ++ IV SL +L + + +D+A A+ ++YLH IIHR
Sbjct: 73 STAPQLA-IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHR 128
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY---G 427
D+KS+NI L E+ ++ DFG A V + S + + + G+ ++APE +
Sbjct: 129 DLKSNNIFLHEDL-TVKIGDFGLATVKSRW---SGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 428 KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487
+ DVY++G+VL EL+TG+ + + + R LS L ++
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL------SKVRSNC 238
Query: 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
+ ++ CL RP +L +
Sbjct: 239 PKAMKRLMA----ECLKKKRDERPLFPQILASIEL 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-52
Identities = 63/277 (22%), Positives = 116/277 (41%), Gaps = 27/277 (9%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+ ++ +GQG +V+ A+K LK S E L+E +++ ++HE +V+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCDPP 366
+ + +Y + + GSL +L K L+ + +D+A +A + Y+
Sbjct: 77 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
+HRD++++NIL+ EN +++DFG A + + + + APE +Y
Sbjct: 134 YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQ----GAKFPIKWTAPEAALY 188
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486
G+ K DV+S+G++L EL T NRE L R E
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----------RMPCPPE 238
Query: 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523
+++ C RPT + L ++
Sbjct: 239 CPESLHDLMC----QCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-52
Identities = 56/272 (20%), Positives = 112/272 (41%), Gaps = 21/272 (7%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI 312
+ IG G V+ ++ A+K ++ SEE+ + E E++ + H +V++
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 313 IGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAK-ALEYLHHTCDPPIIHR 370
G C + +V+ + +G L YL+ + + +G+ E + + + +IHR
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+ + N L+ EN ++SDFG + + + +PE + +
Sbjct: 126 DLAARNCLVGENQ-VIKVSDFG----MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490
K DV+S+GV++ E+ + + N++N E + + RL P+L + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------RLYKPRLASTHVYQ 233
Query: 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
+ C RP LL+ E
Sbjct: 234 IM-------NHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-51
Identities = 69/301 (22%), Positives = 116/301 (38%), Gaps = 45/301 (14%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKC--TNWSEEEVLREVELLSSIKHENI 309
+F +G G V++ ++ G V A K++ +++RE+++L I
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDP 365
V G +S +I + GSL Q LK+ + V+I V K L YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK- 125
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+HRDVK SNIL++ +L DFG + S S VGT Y++PE +
Sbjct: 126 -IMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF-------VGTRSYMSPERLQ 176
Query: 426 YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVL--------------------- 464
+ D++S G+ L+E+ G+ I A L+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 465 ---WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAAR----LCLLHSSSRRPTMKTLL 517
+ L+D +NE + + + CL+ + + R +K L+
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 518 K 518
Sbjct: 297 V 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-51
Identities = 66/287 (22%), Positives = 119/287 (41%), Gaps = 27/287 (9%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSK 319
IG+G +V+R G+ AVK+ E+ ++HENI+ I +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 320 -----EMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTC-----DPPI 367
+++ + +GSL YL + + + +A+ A L +LH P I
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY---- 423
HRD+KS NIL+ +N ++D G V H S + ++ P + VGT Y+APE
Sbjct: 130 AHRDLKSKNILVKKNG-TCCIADLG-LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 424 --MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANR-----ESLVLWARSLLSSGLCE 476
M + + ++ D+Y+ G+V E+ ++ + + + +CE
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 477 RLIDPQLNEEYNREEIEIVMCA-ARLCLLHSSSRRPTMKTLLKLFQE 522
+ + P + + E VM R C + + R T + K +
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 8e-51
Identities = 64/275 (23%), Positives = 119/275 (43%), Gaps = 27/275 (9%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI 312
+ + +G G V A+K++K + SE+E + E +++ ++ HE +V++
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 313 IGYCHSKEMYAIVYNLL-NGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
G C + I+ + NG L YL + + + +++ V +A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
+HRD+ + N L+++ ++SDFG + E V + PE +MY
Sbjct: 122 LHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 428 KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487
K K D++++GV++ E+ + + N E+ A+ L RL P L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-------RLYRPHLAS-- 227
Query: 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
E++ +M C + RPT K LL +
Sbjct: 228 --EKVYTIM---YSCWHEKADERPTFKILLSNILD 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 9e-50
Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 34/271 (12%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGY 315
IG+G VY+ + A L+ ++ + E E+L ++H NIVR
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 316 CHS----KEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPI 367
S K+ +V L+ +G+LK YLK+ +K + K L++LH PPI
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPI 135
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
IHRD+K NI ++ ++ D G A + S + V+GT ++APE
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-------VIGTPEFMAPEMYE-E 187
Query: 428 KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487
K DE +DVY++G+ +LE+ T + ++ ++ + R+ +
Sbjct: 188 KYDESVDVYAFGMCMLEMATSE-------------YPYSECQNAAQIYRRVTSGVKPASF 234
Query: 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
++ I V C+ + R ++K LL
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 4e-49
Identities = 57/301 (18%), Positives = 109/301 (36%), Gaps = 38/301 (12%)
Query: 242 FTSQELCHLTHNFSPKM---------LIGQGGNSKVYRTNHV----DGQVAAVKVLK--C 286
FT ++ F+ ++ +IG G +V + A+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 287 TNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL----KQLK 341
T + L E ++ H N++ + G I+ + NGSL +L Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
+ + + G+A ++YL +HRD+ + NIL++ N ++SDFG +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDT 182
Query: 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461
+ + APE + Y K DV+SYG+V+ E+++ E + N++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 462 LVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
+ I+ + + C + RP ++
Sbjct: 243 I--------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 522 E 522
+
Sbjct: 289 K 289
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-47
Identities = 66/275 (24%), Positives = 119/275 (43%), Gaps = 36/275 (13%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHE 307
+F +G+G VY + A+KVL E ++ REVE+ S ++H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 308 NIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTC 363
NI+R+ GY H ++ G++ + L++ +A AL Y H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH--- 123
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
+IHRD+K N+LL +++DFG ++ S + + + GT YL PE
Sbjct: 124 SKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTT-------LCGTLDYLPPEM 175
Query: 424 MMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483
+ DEK+D++S GV+ E + GK + N +E+ +R ++
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRISR-----------VEFTF 223
Query: 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ +++ L H+ S+RP ++ +L+
Sbjct: 224 PDFVTEGARDLI----SRLLKHNPSQRPMLREVLE 254
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-47
Identities = 56/277 (20%), Positives = 109/277 (39%), Gaps = 35/277 (12%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRI 312
IG+G V ++ G AVK +K + + L E +++ ++H N+V++
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQL 65
Query: 313 IGYC-HSKEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDP 365
+G K IV + GSL YL+ L + + ++ V +A+EYL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
+HRD+ + N+L+SE+ ++SDFG + + APE +
Sbjct: 123 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQD--------TGKLPVKWTAPEALR 173
Query: 426 YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485
K K DV+S+G++L E+ + ++ + + +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------KMDAPD 223
Query: 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
E++ + C ++ RP+ L + +
Sbjct: 224 GCPPAVYEVM----KNCWHLDAAMRPSFLQLREQLEH 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-47
Identities = 62/282 (21%), Positives = 106/282 (37%), Gaps = 37/282 (13%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE---VLREVELLSSIKHEN 308
++ IG G + + DG++ K L + +E E ++ EV LL +KH N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 309 IVRIIGYCHSKE--MYAIVYNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEY 358
IVR + IV G L + + L + V + AL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 359 LH--HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
H ++HRD+K +N+ L + +L DFG A + + ++ T
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVG-----TP 178
Query: 417 GYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476
Y++PE M +EK D++S G +L EL S A +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-----FSQKELAGKIREGKF-- 231
Query: 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
++ Y+ E EI+ L RP+++ +L+
Sbjct: 232 ----RRIPYRYSDELNEIITR----MLNLKDYHRPSVEEILE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (415), Expect = 4e-47
Identities = 67/295 (22%), Positives = 119/295 (40%), Gaps = 32/295 (10%)
Query: 252 HNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV 310
+ + K +G G +VY AVK LK EE L+E ++ IKH N+V
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 311 RIIGYCHSKEMYAIVYNLL-NGSLKQYL-----KQLKWNERMDVAIGVAKALEYLHHTCD 364
+++G C + + I+ + G+L YL +++ + +A ++ A+EYL
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--- 133
Query: 365 PPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
IHRD+ + N L+ EN +++DFG + + + + APE +
Sbjct: 134 KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAH----AGAKFPIKWTAPESL 188
Query: 425 MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484
Y K K DV+++GV+L E+ T + + L++
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--------------ELLEKDYR 234
Query: 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLNE 539
E E V R C + S RP+ + + F+ + +E+ E
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET---MFQESSISDEVEKE 286
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 5e-47
Identities = 57/284 (20%), Positives = 110/284 (38%), Gaps = 29/284 (10%)
Query: 260 IGQGGNSKVYRTNHV---DGQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRIIG 314
+G G V + + A+KVLK EE++RE +++ + + IVR+IG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 315 YCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
C ++ + ++ G L ++L + + ++ V+ ++YL +HR
Sbjct: 77 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHR 133
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+ + N+LL + ++SDFG + S + APE + + K
Sbjct: 134 DLAARNVLLVNRH-YAKISDFGLSKALGADD--SYYTARSAGKWPLKWYAPECINFRKFS 190
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490
+ DV+SYGV + E ++ + E + + + E E
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----------RMECPPECPPE 240
Query: 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534
++ C ++ RP T+ + + Y L K E
Sbjct: 241 LYALM----SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-46
Identities = 56/284 (19%), Positives = 109/284 (38%), Gaps = 31/284 (10%)
Query: 260 IGQGGNSKVYRTNHVD---GQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRII 313
+G G V + + + AVK+LK +E+L E ++ + + IVR+I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 314 GYCHSKEMYAIVYNLLNGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
G C ++ ++ G L +YL + +K +++ V+ ++YL +HR
Sbjct: 75 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHR 131
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
D+ + N+LL H+ ++SDFG + + + + APE + Y K
Sbjct: 132 DLAARNVLLVTQ-HYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490
K DV+S+GV++ E + + E + + RE
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----------RMGCPAGCPRE 238
Query: 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKE 534
+++ LC + RP + + + + E
Sbjct: 239 MYDLM----NLCWTYDVENRPGFAAVELRLRNY--YYDVVNEGH 276
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-46
Identities = 57/281 (20%), Positives = 114/281 (40%), Gaps = 30/281 (10%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENI 309
++ +G+G +V N V + AVK++ + E + +E+ + + HEN+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 310 VRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDP 365
V+ G+ + + G L ++ + + + + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I HRD+K N+LL E + ++SDFG A V + + + GT Y+APE +
Sbjct: 124 -ITHRDIKPENLLLDERD-NLKISDFGLATVFRYN---NRERLLNKMCGTLPYVAPELLK 178
Query: 426 YGKVD-EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484
+ E +DV+S G+VL ++ G+ + + W E+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---------KEKKTYLNPW 229
Query: 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK--LFQEP 523
++ + + ++ L+ + S R T+ + K + +P
Sbjct: 230 KKIDSAPLALL----HKILVENPSARITIPDIKKDRWYNKP 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-45
Identities = 72/313 (23%), Positives = 133/313 (42%), Gaps = 47/313 (15%)
Query: 249 HLTHNFSPK------MLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-EEVLREVEL 300
H+T + +P+ +G G KVY+ N +AA KV+ + E E+ + E+++
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDI 62
Query: 301 LSSIKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL----KQLKWNERMDVAIGVAKA 355
L+S H NIV+++ + + I+ G++ + + L ++ V A
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L YLH D IIHRD+K+ NIL + + +L+DFG + + ++ Q + + +GT
Sbjct: 123 LNYLH---DNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRD-----SFIGT 173
Query: 416 FGYLAPEYMMY-----GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470
++APE +M D K DV+S G+ L+E+ + R +L
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---------VL 224
Query: 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530
++ + + + CL + R T LL+ ++ +
Sbjct: 225 LKIAKSEPPTLAQPSRWSSNFKDFL----KKCLEKNVDARWTTSQLLQ-----HPFVTVD 275
Query: 531 REK--EELLNERR 541
K EL+ E +
Sbjct: 276 SNKPIRELIAEAK 288
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 2e-45
Identities = 76/297 (25%), Positives = 123/297 (41%), Gaps = 44/297 (14%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSSIKHENIVRIIG 314
IG G VY + + +V A+K + + E +++EV L ++H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 315 YCHSKEMYAIVYNLLNGSL----KQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHR 370
+ +V GS + + K L+ E V G + L YLH +IHR
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHR 139
Query: 371 DVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY---MMYG 427
DVK+ NILLSE +L DFG+A + ++ VGT ++APE M G
Sbjct: 140 DVKAGNILLSEPG-LVKLGDFGSASIMAPANS---------FVGTPYWMAPEVILAMDEG 189
Query: 428 KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487
+ D K+DV+S G+ +EL K + N +L A++ P L +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQN----------ESPALQSGH 238
Query: 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLL-----KLFQEPDYWLKMKREKEELLNE 539
E + CL RPT + LL + P + + + ++ + E
Sbjct: 239 WSEYFRNFV---DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE 292
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-44
Identities = 52/283 (18%), Positives = 105/283 (37%), Gaps = 32/283 (11%)
Query: 252 HNFSPKMLIGQGGNSKVYR-----TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSI 304
+ + +IG G +VY+ ++ A+K LK T + L E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 305 KHENIVRIIGYCHSKEMYAIVYNLLNGSLKQYL-----KQLKWNERMDVAIGVAKALEYL 359
H NI+R+ G + I+ + + + + + G+A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM--- 123
Query: 360 HHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
+ + +HRD+ + NIL++ N ++SDFG + V + + +
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTT--SGGKIPIRWT 180
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479
APE + Y K DV+S+G+V+ E++T E +N E + + I
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM--------------KAI 226
Query: 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
+ + + C +RRP ++ + +
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-44
Identities = 69/284 (24%), Positives = 121/284 (42%), Gaps = 34/284 (11%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-VLREVELLSSIKHENIVRIIGYC 316
IGQG + VY + GQ A++ + ++E ++ E+ ++ K+ NIV +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 317 HSKEMYAIVYNLL-NGSLKQYLKQLKWNE--RMDVAIGVAKALEYLHHTCDPPIIHRDVK 373
+ +V L GSL + + +E V +ALE+LH +IHRD+K
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIK 143
Query: 374 SSNILLSENFHHPQLSDFG-AAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEK 432
S NILL + +L+DFG A + + + S +VGT ++APE + K
Sbjct: 144 SDNILLGMD-GSVKLTDFGFCAQITPEQSKRS------TMVGTPYWMAPEVVTRKAYGPK 196
Query: 433 IDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEI 492
+D++S G++ +E+I G+ R L + Q E+ +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLR---------ALYLIATNGTPELQNPEKLSAIFR 247
Query: 493 EIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEEL 536
+ + CL +R + K LL+ +LK+ + L
Sbjct: 248 DFL----NRCLDMDVEKRGSAKELLQ-----HQFLKIAKPLSSL 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (394), Expect = 2e-43
Identities = 55/278 (19%), Positives = 107/278 (38%), Gaps = 29/278 (10%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-EEVLREVELLSSIKH 306
H+ ++ +G G V+R T G A K + + S+ E V +E++ +S ++H
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 82
Query: 307 ENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYL----KQLKWNERMDVAIGVAKALEYLHH 361
+V + ++Y + G L + + ++ +E ++ V K L ++H
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 362 TCDPPIIHRDVKSSNILLSENFH-HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
+H D+K NI+ + +L DFG + GT + A
Sbjct: 143 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLT------AHLDPKQSVKVTTGTAEFAA 193
Query: 421 PEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480
PE V D++S GV+ L++G N + + +S C+ +D
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKS------CDWNMD 245
Query: 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ + + + R LL + R T+ L+
Sbjct: 246 DSAFSGISEDGKDFI----RKLLLADPNTRMTIHQALE 279
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 3e-43
Identities = 60/307 (19%), Positives = 120/307 (39%), Gaps = 57/307 (18%)
Query: 252 HNFSPKMLIGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSS 303
+N IG+G +V++ + + AVK+LK + + + RE L++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 304 IKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ----------------------- 339
+ NIV+++G C + +++ + G L ++L+
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 340 ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395
L E++ +A VA + YL +HRD+ + N L+ EN +++DFG +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMV-VKIADFGLSR 188
Query: 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTN 455
+ + + N ++ PE + Y + + DV++YGVVL E+ +
Sbjct: 189 NIYSADYYKADG---NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 456 KANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKT 515
A+ E + + E E ++ RLC + RP+ +
Sbjct: 246 MAHEEVIYYVRDGNI----------LACPENCPLELYNLM----RLCWSKLPADRPSFCS 291
Query: 516 LLKLFQE 522
+ ++ Q
Sbjct: 292 IHRILQR 298
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-43
Identities = 61/285 (21%), Positives = 108/285 (37%), Gaps = 33/285 (11%)
Query: 250 LTHNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLK--CTNWSEEEVLREVELLSS 303
L +F+ +IG+G VY +D AVK L + L E ++
Sbjct: 27 LIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 304 IKHENIVRIIGYC--HSKEMYAIVYNLLNGSLKQYL----KQLKWNERMDVAIGVAKALE 357
H N++ ++G C ++ + +G L+ ++ + + + VAK +
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM- 143
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
+HRD+ + N +L E +++DFG A + S + K
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNK-TGAKLPVK 199
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCER 477
++A E + K K DV+S+GV+L EL+T + + LL R
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQG---RR 252
Query: 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
L+ P EY + + VM C + RP+ L+
Sbjct: 253 LLQP----EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-42
Identities = 54/299 (18%), Positives = 119/299 (39%), Gaps = 36/299 (12%)
Query: 254 FSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVL------KCTNWSEEEVLREVELLSSIKH 306
F ++G G VY+ +G+ + V + + +E+L E +++S+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 307 ENIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLK----WNERMDVAIGVAKALEYLHHT 362
++ R++G C + + I + G L Y+++ K ++ + +AK + YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 129
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
++HRD+ + N+L+ H +++DFG A + + ++A E
Sbjct: 130 --RRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWMALE 183
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482
+++ + DV+SYGV + EL+T E +++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKG 229
Query: 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLL----KLFQEPDYWLKMKREKEELL 537
V C + + RP + L+ K+ ++P +L ++ ++ L
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-42
Identities = 60/314 (19%), Positives = 117/314 (37%), Gaps = 56/314 (17%)
Query: 252 HNFSPKMLIGQGGNSKVYRTNHVDG---QVAAVKVLK--CTNWSEEEVLREVELLSSI-K 305
++ + +IG+G +V + AA+K +K + + E+E+L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 306 HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ-------------------LKWNER 345
H NI+ ++G C + + +G+L +L++ L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 346 MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405
+ A VA+ ++YL IHRD+ + NIL+ EN + +++DFG +
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQE------V 179
Query: 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLW 465
VK ++A E + Y DV+SYGV+L E+++ E
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239
Query: 466 ARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDY 525
+ + + E +++ R C RP+ +L
Sbjct: 240 PQGY----------RLEKPLNCDDEVYDLM----RQCWREKPYERPSFAQILVSLN---- 281
Query: 526 WLKMKREKEELLNE 539
+M E++ +N
Sbjct: 282 --RMLEERKTYVNT 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 7e-42
Identities = 61/302 (20%), Positives = 105/302 (34%), Gaps = 51/302 (16%)
Query: 252 HNFSPKMLIGQGGNSKVYR------TNHVDGQVAAVKVLKCTN--WSEEEVLREVELLSS 303
+ S +G G KV AVK+LK + E ++ E+++LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 304 IK-HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---------------------L 340
+ H NIV ++G C ++ G L +L++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 341 KWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400
+ + + VAK + +L IHRD+ + NILL+ + DFG A
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITK-ICDFGLARDIKND 198
Query: 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460
S V N ++APE + + DV+SYG+ L EL + +
Sbjct: 199 ---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLF 520
++I + + C +RPT K +++L
Sbjct: 256 KF-------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 521 QE 522
++
Sbjct: 303 EK 304
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-42
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSSIKHE 307
+F ++G+G S V + A+K+L+ + +E V RE +++S + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 308 NIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366
V++ E + NG L +Y++++ + A+ + L +
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
IIHRD+K NILL+E+ H Q++DFG A V S+ + + VGT Y++PE +
Sbjct: 129 IIHRDLKPENILLNEDM-HIQITDFGTAKVLSPE---SKQARANSFVGTAQYVSPELLTE 184
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
+ D+++ G ++ +L+ G
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGL 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (382), Expect = 1e-41
Identities = 51/294 (17%), Positives = 107/294 (36%), Gaps = 30/294 (10%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYC 316
+G G V+R G+V K + + V E+ +++ + H ++ +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 317 HSKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRD 371
K ++ L G L + + E ++ + L+++H + I+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 372 VKSSNILLSENFH-HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVD 430
+K NI+ ++ DFG A +++ + T + APE + V
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLA------TKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 431 EKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNRE 490
D+++ GV+ L++G + + E+L R C+ D + E
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKR-------CDWEFDEDAFSSVSPE 258
Query: 491 EIEIVMCAARLCLLHSSSRRPTMKTLLKL-FQEPDYWLKMKREKEELLNERRSN 543
+ + + L +R T+ L+ + + D+ R N+ R
Sbjct: 259 AKDFI----KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 2e-41
Identities = 57/275 (20%), Positives = 101/275 (36%), Gaps = 22/275 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
IG G +Y T+ G+ A+K+ ++ E ++ ++ + I +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 318 S-KEMYAIVYNLLNGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+ + +V LL SL+ ++ + +A + +EY+H IHRDV
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDV 129
Query: 373 KSSNIL--LSENFHHPQLSDFGAAMVHH--QSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
K N L L + + + DFG A + ++HQ + N+ GT Y + + +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189
Query: 429 VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYN 488
+ D+ S G VL+ G Q KA + S L + Y
Sbjct: 190 QSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEKKMSTPIEVLCKGYP 245
Query: 489 REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523
E + C +P L +LF+
Sbjct: 246 SEFATYL----NFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 63/302 (20%), Positives = 108/302 (35%), Gaps = 56/302 (18%)
Query: 253 NFSPKMLIGQGGNSKVYRTNHVD------GQVAAVKVLKCTNWSEE--EVLREVELLSSI 304
N ++G G KV AVK+LK S E ++ E+++++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 305 -KHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ----------------------- 339
HENIV ++G C +++ G L YL+
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 340 ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396
L + + + A VAK +E+L +HRD+ + N+L++ ++ DFG A
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKV-VKICDFGLA-- 211
Query: 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNK 456
S V N ++APE + G K DV+SYG++L E+ +
Sbjct: 212 -RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 457 ANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTL 516
+ +LI + E + + C S +RP+ L
Sbjct: 271 PVDANF-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 517 LK 518
Sbjct: 318 TS 319
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-41
Identities = 59/275 (21%), Positives = 96/275 (34%), Gaps = 31/275 (11%)
Query: 260 IGQGGNSKVYR----TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVR 311
+G G V R AVK LK S+ ++ +REV + S+ H N++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYL----KQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
+ G + M + GSL L A+ VA+ + YL
Sbjct: 76 LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRF 132
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
IHRD+ + N+LL+ ++ DFG Q+ V + F + APE +
Sbjct: 133 IHRDLAARNLLLATRD-LVKIGDFGLMRALPQND--DHYVMQEHRKVPFAWCAPESLKTR 189
Query: 428 KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEY 487
D + +GV L E+ T + + L + E+
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---------LPRPEDC 240
Query: 488 NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
++ +++ C H RPT L E
Sbjct: 241 PQDIYNVMV----QCWAHKPEDRPTFVALRDFLLE 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 54/282 (19%), Positives = 103/282 (36%), Gaps = 33/282 (11%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G+G V+R + K +K + V +E+ +L+ +H NI+ +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 318 SKEMYAIVYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
S E +++ + + + + L E + V +AL++LH I H D+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128
Query: 373 KSSNILLSENFH-HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDE 431
+ NI+ ++ +FG A + Y APE + V
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR------LLFTAPEYYAPEVHQHDVVST 182
Query: 432 KIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREE 491
D++S G ++ L++G N++ + E D + +E + E
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAET-NQQIIENIMN-------AEYTFDEEAFKEISIEA 234
Query: 492 IEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533
++ V L+ R T L+ WLK K E+
Sbjct: 235 MDFV----DRLLVKERKSRMTASEALQ-----HPWLKQKIER 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (365), Expect = 1e-39
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHE 307
+F +G G +V+ + +G+ A+KVLK E E +LS + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 308 NIVRIIGYCHSKEMYAIVYNLLNGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366
I+R+ G + ++ + + G L L++ + A+ L +
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
II+RD+K NILL +N H +++DFG A + GT Y+APE +
Sbjct: 125 IIYRDLKPENILLDKNG-HIKITDFGFAKYVPDVTY--------TLCGTPDYIAPEVVST 175
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
++ ID +S+G+++ E++ G
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-39
Identities = 53/274 (19%), Positives = 101/274 (36%), Gaps = 32/274 (11%)
Query: 259 LIGQGGNSKVYRTNHVD----GQVAAVKVLK--CTNWSEEEVLREVELLSSIKHENIVRI 312
IG+G V++ ++ A+K K ++ E+ L+E + H +IV++
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 313 IGYCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPII 368
IG ++ I+ G L+ +L+ L + A ++ AL YL +
Sbjct: 74 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+ + N+L+S N +L DFG + + + S K ++APE + + +
Sbjct: 131 HRDIAARNVLVSSND-CVKLGDFGLS----RYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 429 VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYN 488
DV+ +GV + E++ N + + +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----------RLPMPPNCP 235
Query: 489 REEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
++ C + SRRP L
Sbjct: 236 PTLYSLM----TKCWAYDPSRRPRFTELKAQLST 265
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (360), Expect = 5e-39
Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 35/300 (11%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSSIK 305
+ + + ++G G S+V + ++ A+K + E + E+ +L IK
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 306 HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHH 361
H NIV + S ++ L+ G L + + + + V A++YLH
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 362 TCDPPIIHRDVKSSNILLSENFH--HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYL 419
I+HRD+K N+L +SDFG + + +S GT GY+
Sbjct: 126 LG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS------TACGTPGYV 176
Query: 420 APEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479
APE + + +D +S GV+ L+ G E+ +L E
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILK---AEYEF 228
Query: 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEELLNE 539
D ++ + + + R + +R T + L+ W+ ++ +++
Sbjct: 229 DSPYWDDISDSAKDFI----RHLMEKDPEKRFTCEQALQ-----HPWIAGDTALDKNIHQ 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 55/293 (18%), Positives = 109/293 (37%), Gaps = 43/293 (14%)
Query: 252 HNFSPKMLIGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSS 303
+ +GQG VY A+K + + E L E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 304 IKHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ-------------LKWNERMDVA 349
++VR++G + ++ L+ G LK YL+ ++ + +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 350 IGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKP 409
+A + YL+ +HRD+ + N +++E+F ++ DFG + ++ K
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT-VKIGDFG---MTRDIYETDYYRKG 192
Query: 410 VNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSL 469
+ +++PE + G DV+S+GVVL E+ T E +N + L
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252
Query: 470 LSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
L + E+ R+C ++ RP+ ++ +E
Sbjct: 253 L----------LDKPDNCPDMLFEL----MRMCWQYNPKMRPSFLEIISSIKE 291
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-38
Identities = 63/296 (21%), Positives = 126/296 (42%), Gaps = 39/296 (13%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLK----CTNWSEEEVLREVELLS-SIKH 306
+F ++G+G KV+ Q A+K LK + E + E +LS + +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 307 ENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHT 362
+ + +KE V L G L +++ + A + L++LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 363 CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE 422
I++RD+K NILL ++ H +++DFG + + K GT Y+APE
Sbjct: 123 G---IVYRDLKLDNILLDKDGHI-KIADFGMC-----KENMLGDAKTNTFCGTPDYIAPE 173
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482
++ K + +D +S+GV+L E++ G+ + E L R +P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMD----------NPF 221
Query: 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK---LFQEPDYWLKMKREKEE 535
+E ++++ + +R ++ ++ LF+E + W +++R++ +
Sbjct: 222 YPRWLEKEAKDLLVK----LFVREPEKRLGVRGDIRQHPLFREIN-WEELERKEID 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (350), Expect = 5e-38
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 249 HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSS 303
HL+ + ++G GG S+V+ + + AVKVL+ + RE + ++
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 304 IKHENIVRIIGYCHSKE----MYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKA 355
+ H IV + ++ + IV + +L+ + + ++V +A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 356 LEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGT 415
L + IIHRDVK +NI++S + ++ DFG A S + + V+GT
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSG--NSVTQTAAVIGT 177
Query: 416 FGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
YL+PE VD + DVYS G VL E++TG+
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (351), Expect = 5e-38
Identities = 44/276 (15%), Positives = 88/276 (31%), Gaps = 24/276 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-ENIVRIIGYC 316
IG+G ++ TN ++ Q A+K + ++ E + I + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDV 372
+V +LL SL+ L A + ++ +H +++RD+
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDI 127
Query: 373 KSSNILLSENFHHPQ----LSDFGAA--MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
K N L+ + DFG + Q + N+ GT Y++ +
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486
+ + D+ + G V + + G Q KA + +L
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK----QSTPLRELCAG 243
Query: 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
+ E + + + P L LF +
Sbjct: 244 FPEEFYKYM----HYARNLAFDATPDYDYLQGLFSK 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 136 bits (344), Expect = 4e-37
Identities = 68/294 (23%), Positives = 127/294 (43%), Gaps = 46/294 (15%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE----------EEVLREVELL 301
N+ PK ++G+G +S V R + + AVK++ T E L+EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 302 SSIK-HENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKAL 356
+ H NI+++ + + +V++L+ G L YL + L E + + + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 357 EYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTF 416
LH I+HRD+K NILL ++ + +L+DFG + ++ V GT
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLR------EVCGTP 173
Query: 417 GYLAPEYMM------YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL 470
YLAPE + + +++D++S GV++ L+ G +L R ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-----RKQMLMLRMIM 228
Query: 471 SSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK--LFQE 522
S ++Y+ ++V L+ +R T + L FQ+
Sbjct: 229 S---GNYQFGSPEWDDYSDTVKDLV----SRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 58/290 (20%), Positives = 118/290 (40%), Gaps = 35/290 (12%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTN-------WSEEEVLREVELLSSIKHENIV 310
+G G + V + G A K +K S E++ REV +L I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 311 RIIGYCHSKEMYAIVYNLLNGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIH 369
+ +K ++ L+ G L +L + + + + + L +++ I H
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 370 RDVKSSNILLSEN---FHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
D+K NI+L + ++ DFG A H++ + N+ GT ++APE + Y
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLA------HKIDFGNEFKNIFGTPEFVAPEIVNY 190
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486
+ + D++S GV+ L++G + +E+L + + +
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANVSA-------VNYEFEDEYFSN 242
Query: 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEEL 536
+ + + R L+ +R T++ L+ W+K K ++ L
Sbjct: 243 TSALAKDFI----RRLLVKDPKKRMTIQDSLQ-----HPWIKPKDTQQAL 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 6e-37
Identities = 55/276 (19%), Positives = 104/276 (37%), Gaps = 48/276 (17%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE-------EEVLREVELLSSIK--HEN 308
L+G GG VY D A+K ++ S+ V EV LL +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 309 IVRIIGYCHSKEMYAIVYNLLNG--SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTC 363
++R++ + + + ++ L ++ + L+ V +A+ +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEY 423
+ ++HRD+K NIL+ N +L DFG+ + + GT Y PE+
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVYSPPEW 180
Query: 424 MMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482
+ Y + V+S G++L +++ G + ++ V + + + S C+ LI
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV--SSECQHLI--- 235
Query: 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
R CL S RPT + +
Sbjct: 236 -----------------RWCLALRPSDRPTFEEIQN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 8e-37
Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 33/284 (11%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE------EEVLREVELLSSIKHENIVR 311
+G+G + VY+ + Q+ A+K +K + SE LRE++LL + H NI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 312 IIGYCHSKEMYAIVYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPI 367
++ K ++V++ + L+ +K L + + + LEYLH I
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---I 121
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
+HRD+K +N+LL EN +L+DFG A ++ + V T Y APE +
Sbjct: 122 LHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNR-----AYTHQVVTRWYRAPELLFGA 175
Query: 428 KV-DEKIDVYSYGVVLLELITGK------------EAIQTNKANRESLVLWARSLLSSGL 474
++ +D+++ G +L EL+ I L +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK 518
+ + ++ + L + R T LK
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 62/295 (21%), Positives = 109/295 (36%), Gaps = 52/295 (17%)
Query: 259 LIGQGGNSKVYRTNHV--------DGQVAAVKVLK--CTNWSEEEVLREVELLSSI-KHE 307
+G+G +V + AVK+LK T +++ E+E++ I KH+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 308 NIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLK-------------------QLKWNERMD 347
NI+ ++G C ++ G+L++YL+ QL + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 348 VAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407
A VA+ +EYL IHRD+ + N+L++E+ A +HH +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWAR 467
++APE + + DV+S+GV+L E+ T + E L
Sbjct: 197 GR----LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252
Query: 468 SLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522
E ++ R C S+RPT K L++
Sbjct: 253 GHR----------MDKPSNCTNELYMMM----RDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-36
Identities = 58/289 (20%), Positives = 113/289 (39%), Gaps = 32/289 (11%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHEN 308
NF IG+G VY+ N + G+V A+K ++ +E +RE+ LL + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 309 IVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTC 363
IV+++ H++ +V+ L+ LK+++ + + + L + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 364 DPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPE- 422
++HRD+K N+L++ +L+DFG A + + V T Y APE
Sbjct: 123 ---VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR-----TYTHEVVTLWYRAPEI 173
Query: 423 YMMYGKVDEKIDVYSYGVVLLELITGK------EAIQTNKANRESLVLWARSLLSSGLCE 476
+ +D++S G + E++T + I +L +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 477 RLIDPQLNEEYNREEIEIVMCAA-------RLCLLHSSSRRPTMKTLLK 518
P + ++ ++V L + ++R + K L
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-36
Identities = 62/318 (19%), Positives = 118/318 (37%), Gaps = 45/318 (14%)
Query: 247 LCHLTHNFSPKMLIGQGGNSKVYRTNHV--DGQVAAVKVLKCTNWSE---EEVLREVEL- 300
LC + IG+G KV++ + G+ A+K ++ E +REV +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 301 --LSSIKHENIVRIIGYCHSKE-----MYAIVYNLLNGSLKQYLKQ-----LKWNERMDV 348
L + +H N+VR+ C +V+ ++ L YL + + D+
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 349 AIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVK 408
+ + L++LH ++HRD+K NIL++ + A + Q S
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---- 174
Query: 409 PVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQT-----------NKA 457
VV T Y APE ++ +D++S G + E+ K + +
Sbjct: 175 ---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
Query: 458 NRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLL 517
W R + Q E++ + E+ CL + ++R + + L
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
Query: 518 KLFQEPDYWLK-MKREKE 534
+ + ++R KE
Sbjct: 292 S-----HPYFQDLERCKE 304
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (339), Expect = 1e-35
Identities = 63/274 (22%), Positives = 115/274 (41%), Gaps = 37/274 (13%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE-------VLREVELLSSI 304
+FS +IG+GG +VY G++ A+K L ++ + L+S+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 305 KHENIVRIIGYCHSKEMYAIVYNLL-NGSLKQYLKQLK---WNERMDVAIGVAKALEYLH 360
IV + H+ + + + +L+ G L +L Q + A + LE++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 361 HTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLA 420
+ +++RD+K +NILL E+ H ++SD G A + KP VGT GY+A
Sbjct: 125 N---RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-------KPHASVGTHGYMA 173
Query: 421 PEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479
PE + G D D +S G +L +L+ G + +K + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------LTM 224
Query: 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM 513
+L + ++ E ++ L +RR
Sbjct: 225 AVELPDSFSPELRSLL----EGLLQRDVNRRLGC 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 1e-35
Identities = 63/301 (20%), Positives = 112/301 (37%), Gaps = 50/301 (16%)
Query: 252 HNFSPKMLIGQGGNSKVYR------TNHVDGQVAAVKVLK--CTNWSEEEVLREVELLSS 303
+G+G +V + AVK+LK T+ ++ E+++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 304 IKHE-NIVRIIGYCHSKE--MYAIVYNLLNGSLKQYLKQ-------------------LK 341
I H N+V ++G C + IV G+L YL+ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 342 WNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401
+ + VAK +E+L IHRD+ + NILLSE ++ DFG A +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNV-VKICDFGLA---RDIY 185
Query: 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES 461
+ + V+ + ++APE + + DV+S+GV+L E+ + +
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG----VK 241
Query: 462 LVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521
+ L G + + E + ++ C S+RPT L++
Sbjct: 242 IDEEFCRRLKEG-----TRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLG 292
Query: 522 E 522
Sbjct: 293 N 293
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (331), Expect = 8e-35
Identities = 58/294 (19%), Positives = 115/294 (39%), Gaps = 39/294 (13%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIV 310
++ +G+G S+V+ N + + VK+LK ++++ RE+++L +++ NI+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNII 93
Query: 311 RIIGYCH---SKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
+ S+ + ++ N KQ + L + + KAL+Y H I
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---I 150
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-Y 426
+HRDVK N+++ +L D+G A + V + + PE ++ Y
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLA------EFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 427 GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486
D +D++S G +L +I KE N + LV A+ L + L + + + +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 487 YNREEIEIVMCAARL----------------------CLLHSSSRRPTMKTLLK 518
+I R L + R T + ++
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 41/203 (20%), Positives = 87/203 (42%), Gaps = 12/203 (5%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEE----VLREVELLSSIKHE 307
+F L+G+G KV G+ A+K+L+ ++ + E +L + +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 308 NIVRIIGYCHSKE-MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPP 366
+ + + + + ++ G L +L + + A+ + L +
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 367 IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY 426
+++RD+K N++L ++ H +++DFG +S+ GT YLAPE +
Sbjct: 126 VVYRDIKLENLMLDKDG-HIKITDFGLC-----KEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 427 GKVDEKIDVYSYGVVLLELITGK 449
+D + GVV+ E++ G+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 130 bits (326), Expect = 1e-34
Identities = 62/287 (21%), Positives = 121/287 (42%), Gaps = 34/287 (11%)
Query: 260 IGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYC 316
IG+G VY+ + G+ A+K ++ E +RE+ +L +KH NIV++
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 317 HSKEMYAIVYNLLNGSLKQYLKQLKWN-ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSS 375
H+K+ +V+ L+ LK+ L + E + + + L + + D ++HRD+K
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM-YGKVDEKID 434
N+L++ +++DFG A + K + + T Y AP+ +M K ID
Sbjct: 130 NLLINREGEL-KIADFGLARAFGIPVR-----KYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 435 VYSYGVVLLELITG-----------------KEAIQTNKANRESLVLWARSLLSSGLCER 477
++S G + E++ G + N N ++ + + + E
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLK--LFQE 522
L + + I+++ L ++R T K L+ F+E
Sbjct: 244 LPWESFLKGLDESGIDLL----SKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGY 315
IG+G V ++V+ A+K + + LRE+++L +HENI+ I
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 316 CHS-----KEMYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPII 368
+ + +V +L+ L + LK L + + + L+Y+H ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 131
Query: 369 HRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGK 428
HRD+K SN+LL+ ++ DFG A V H V T Y APE M+ K
Sbjct: 132 HRDLKPSNLLLNTT-CDLKICDFGLARVADPDH--DHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 429 VD-EKIDVYSYGVVLLELITGK 449
+ ID++S G +L E+++ +
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNR 210
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 67/308 (21%), Positives = 125/308 (40%), Gaps = 44/308 (14%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSI-KHENIVRIIGYC 316
++G G N KV + N + A+K+L+ + REVEL + +IVRI+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 317 HS----KEMYAIVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPP 366
+ ++ IV L G L ++ E ++ + +A++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 367 IIHRDVKSSNILLSENFH--HPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYM 424
I HRDVK N+L + +L+DFG + + + + T Y+APE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFG------FAKETTSHNSLTTPCYTPYYVAPEVL 185
Query: 425 MYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484
K D+ D++S GV++ L+ G +N S + R + +++
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLL---------KLFQEPDYWLKMKREKEE 535
EE ++ R L ++R T+ + K+ Q P + ++ +E +E
Sbjct: 246 EEV----KMLI----RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 536 LLNERRSN 543
+ +
Sbjct: 298 RWEDVKEE 305
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-34
Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 253 NFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVR 311
+++ +IG G VY+ G++ A+K + + RE++++ + H NIVR
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKLDHCNIVR 77
Query: 312 IIGYCHS------KEMYAIVYNLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEY 358
+ + +S + +V + + ++ + + L + ++L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 359 LHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGY 418
+H I HRD+K N+LL + +L DFG+A Q+ V+ + + Y
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQLVRGEPNVSYICSRYY 188
Query: 419 LAP-EYMMYGKVDEKIDVYSYGVVLLELITGK 449
AP IDV+S G VL EL+ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-33
Identities = 62/302 (20%), Positives = 121/302 (40%), Gaps = 32/302 (10%)
Query: 247 LCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EEVLREVELLS 302
C + IGQG +V++ + GQ A+K + N E LRE+++L
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 303 SIKHENIVRIIGYCHSKE---------MYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVA 353
+KHEN+V +I C +K +Y + + L ++ +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124
Query: 354 KALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVV 413
L L++ I+HRD+K++N+L++ + +L+DFG A + S+ + N V
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKN-SQPNRYTNRV 182
Query: 414 GTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRE-SLVLWARSLLS 471
T Y PE ++ + ID++ G ++ E+ T +Q N + +L+ ++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 472 SGLCERLIDPQLNEEYNREEIEIVMCAARL---------------CLLHSSSRRPTMKTL 516
+ + + +L E+ + + RL L+ ++R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 517 LK 518
L
Sbjct: 303 LN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-32
Identities = 54/278 (19%), Positives = 103/278 (37%), Gaps = 24/278 (8%)
Query: 260 IGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGY 315
IG+G V++ N ++ A+K ++ + E LRE+ LL +KH+NIVR+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 316 CHSKEMYAIVY-NLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKS 374
HS + +V+ K + + V + + L+ L ++HRD+K
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129
Query: 375 SNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKID 434
N+L++ N +L++FG A + VV + ID
Sbjct: 130 QNLLINRNGEL-KLANFGLARAFGIPVRCYSAE----VVTLWYRPPDVLFGAKLYSTSID 184
Query: 435 VYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS---------SGLCERLIDPQLNE 485
++S G + EL + + L R L + + L + P
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 486 EYNREEIEIVMCAA-----RLCLLHSSSRRPTMKTLLK 518
+ + + A + L + +R + + L+
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-30
Identities = 57/327 (17%), Positives = 113/327 (34%), Gaps = 43/327 (13%)
Query: 236 EGSSRRFTSQELCHLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE--- 291
G R+ ++ + + +G G V + G A+K L SE
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61
Query: 292 EEVLREVELLSSIKHENIVRIIGYCHSKEM------YAIVYNLLNGSLKQYLKQ--LKWN 343
+ RE+ LL ++HEN++ ++ E + +V + L + +K L +
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 121
Query: 344 ERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403
+ + K L Y+H IIHRD+K N+ ++E+ L A +
Sbjct: 122 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG- 177
Query: 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK------EAIQTNKA 457
VV + + + + + +D++S G ++ E+ITGK + + K
Sbjct: 178 -------YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230
Query: 458 NRESLV-----LWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAA----RLCLLHSSS 508
+ R P+L ++ + A L+ +
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 509 RRPTMKTLLKLFQEPDYWLKMKREKEE 535
+R T L + + + E+
Sbjct: 291 QRVTAGEALA-----HPYFESLHDTED 312
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (296), Expect = 6e-30
Identities = 49/251 (19%), Positives = 94/251 (37%), Gaps = 25/251 (9%)
Query: 208 GVCIAQETVQVPESIKRKIFEKLAVLEAEGSSRRFTSQELCHLTHNFSPKMLIGQGGNSK 267
G A + ES+K + + + + + +L F +G G +
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGR 56
Query: 268 VYR-TNHVDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMY 322
V + G A+K+L + E L E +L ++ +V++
Sbjct: 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 323 AIVYNL-LNGSLKQYL---KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNIL 378
+V G + +L + A + EYLH +I+RD+K N+L
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLL 173
Query: 379 LSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSY 438
+ + + Q++DFG A + GT LAPE ++ ++ +D ++
Sbjct: 174 IDQQ-GYIQVTDFGFAKRVKGRTW--------TLCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 439 GVVLLELITGK 449
GV++ E+ G
Sbjct: 225 GVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-29
Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 30/274 (10%)
Query: 253 NFSPKMLIGQGGNSKVYR----TNHVDGQVAAVKVLKCTNWSE-----EEVLREVELLSS 303
NF ++G G KV+ + H G++ A+KVLK + E E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 304 IKHE-NIVRIIGYCHSKEMYAIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHH 361
I+ +V + ++ ++ + +NG L +L Q + +V I V + + L H
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 362 TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAP 421
II+RD+K NILL N H L+DFG + + + GT Y+AP
Sbjct: 145 LHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADE----TERAYDFCGTIEYMAP 199
Query: 422 EYMMYGK--VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479
+ + G D+ +D +S GV++ EL+TG + + S +R +L S
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG-EKNSQAEISRRILKS------- 251
Query: 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTM 513
+P +E + +++ + L+ +R
Sbjct: 252 EPPYPQEMSALAKDLI----QRLLMKDPKKRLGC 281
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 6e-27
Identities = 69/326 (21%), Positives = 119/326 (36%), Gaps = 49/326 (15%)
Query: 242 FTSQELC----HLTHNFSPKMLIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EE 293
F QEL + + +G G V + G AVK L S +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 294 VLREVELLSSIKHENIVRIIGYCHSKE------MYAIVYNLLNGSLKQYLKQ--LKWNER 345
RE+ LL +KHEN++ ++ +V +L+ L +K L +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 346 MDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405
+ + + L+Y+H IIHRD+K SN+ ++E+ L DFG A
Sbjct: 124 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL-DFGLARHTDDEMT--- 176
Query: 406 NVKPVNVVGTFGYLAPEYMM-YGKVDEKIDVYSYGVVLLELITGK------------EAI 452
V T Y APE M+ + ++ +D++S G ++ EL+TG+ + I
Sbjct: 177 -----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231
Query: 453 QTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARL---CLLHSSSR 509
+ +L S S+ + + + I A L L+ S +
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
Query: 510 RPTMKTLLKLFQEPDYWLKMKREKEE 535
R T L + + ++
Sbjct: 292 RITAAQALA-----HAYFAQYHDPDD 312
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 9e-27
Identities = 46/202 (22%), Positives = 87/202 (43%), Gaps = 21/202 (10%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIG 314
IG G V + V + A+K L ++ + RE+ L+ + H+NI+ ++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 315 YCHSK------EMYAIVYNLLNGS-LKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPI 367
+ + +V L++ + + +L + + +++LH I
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---I 140
Query: 368 IHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG 427
IHRD+K SNI++ + L DFG A S ++ V T Y APE ++
Sbjct: 141 IHRDLKPSNIVVKSDCTLKIL-DFGLARTAGTSFMMT------PYVVTRYYRAPEVILGM 193
Query: 428 KVDEKIDVYSYGVVLLELITGK 449
E +D++S G ++ E++ K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 1e-26
Identities = 39/212 (18%), Positives = 75/212 (35%), Gaps = 26/212 (12%)
Query: 259 LIGQGGNSKVYR-TNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCH 317
+G G S V+ + V+ A+K+++ E E++LL + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 318 SK--------------------EMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALE 357
+ + NLL K + + ++ + L+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 358 YLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFG 417
Y+H C IIH D+K N+L+ L + + + N + T
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIK---IADLGNACWYDEHYTNSIQTRE 194
Query: 418 YLAPEYMMYGKVDEKIDVYSYGVVLLELITGK 449
Y +PE ++ D++S ++ ELITG
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.3 bits (192), Expect = 2e-17
Identities = 30/200 (15%), Positives = 67/200 (33%), Gaps = 29/200 (14%)
Query: 259 LIGQGGNSKVYRTNHVDGQVAAVKVLK-----------CTNWSEEEVLREVELLSSIKHE 307
L+G+G S V+ VK K ++ + + +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 308 NIVRIIGYCHSKEMYAIVYNLLNGSLKQYLKQLKWNERM--DVAIGVAKALEYLHHTCDP 365
+ ++ G K +YA N + L + + +V + + + +H
Sbjct: 67 ALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG-- 123
Query: 366 PIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMM 425
I+H D+ N+L+SE + DF ++ + + V + T+
Sbjct: 124 -IVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITY--------- 171
Query: 426 YGKV-DEKIDVYSYGVVLLE 444
+ + + D+ S +L+
Sbjct: 172 FSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 549 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.23 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.03 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 98.99 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 98.84 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 98.72 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 98.32 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.2 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.71 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=421.20 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=205.2
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|++.+.||+|+||+||+|.+ .+|+.||||+++.... ..+.+.+|+.+|++++||||+++++++.+++.+++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46799999999999999999987 5799999999976532 23568899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+ +|+|.+++.. +++.++..++.||+.||.|||++ +|+||||||+|||++++ +.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT-CCEEECCCTTCEECEETT--
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCC-CCEEEccchhheeeccCC--
Confidence 99 5799999843 78888999999999999999999 99999999999999998 689999999997654322
Q ss_pred ccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........+||+.|||||++.+..+ +.++|||||||++|||++|++||............+.. ... ...
T Consensus 158 -~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~----~~~-----~~~ 227 (271)
T d1nvra_ 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKT-----YLN 227 (271)
T ss_dssp -EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT----TCT-----TST
T ss_pred -ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc----CCC-----CCC
Confidence 1122345789999999999998876 57899999999999999999999766543322221111 000 001
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
....+ ...+.+++.+||..||.+|||++|+++ |+||+.
T Consensus 228 ~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~-----hpwf~~ 265 (271)
T d1nvra_ 228 PWKKI----DSAPLALLHKILVENPSARITIPDIKK-----DRWYNK 265 (271)
T ss_dssp TGGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT-----CTTTTC
T ss_pred ccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc-----CHhhCc
Confidence 11122 345667889999999999999999998 999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=415.84 Aligned_cols=253 Identities=28% Similarity=0.405 Sum_probs=209.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
++|+..+.||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|+.+|+.++||||+++++++.+++.+++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999987 679999999997554 34567899999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 330 -NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 330 -~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
+|+|.+++.. +++.+...++.||+.||.|||++ |||||||||+|||++.+ +.+||+|||+|...... .
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~-----~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE-----Q 170 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECCST-----T
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCC-CcEeeccchhheeeccc-----c
Confidence 6799998865 77888999999999999999999 99999999999999998 79999999999765332 2
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
......+||+.|+|||++.++.|+.++|||||||++|||++|+.||........ +.... ..+ ......+.
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~----~~~----~~~~~~~~- 240 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIA----TNG----TPELQNPE- 240 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHH----HHC----SCCCSSGG-
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHH----hCC----CCCCCCcc-
Confidence 233456899999999999999999999999999999999999999976543221 11111 111 01111112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.....+.+++..||..||.+|||+.|+++ |+||+...
T Consensus 241 ---~~s~~~~~li~~~L~~dP~~R~s~~eil~-----Hp~~~~~~ 277 (293)
T d1yhwa1 241 ---KLSAIFRDFLNRCLDMDVEKRGSAKELLQ-----HQFLKIAK 277 (293)
T ss_dssp ---GSCHHHHHHHHHHTCSSTTTSCCHHHHTT-----CGGGGGCC
T ss_pred ---cCCHHHHHHHHHHccCChhHCcCHHHHhc-----CHhhCCCC
Confidence 23345778889999999999999999998 89997543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=411.10 Aligned_cols=246 Identities=26% Similarity=0.432 Sum_probs=205.8
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|++.+.||+|+||+||+|.+ .+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4689999999999999999988 56899999999643 233467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||++||.|||++ +|+||||||+|||++.+ +.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSA-GELKIADFGWSVHAPS--- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEECCCCSCSCCCC---
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCC-CCEeecccceeeecCC---
Confidence 999 6799999864 78888999999999999999999 99999999999999998 6899999999965432
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.......||+.|||||++.+..|+.++|||||||++|||++|+.||....... .+ ..+... +..
T Consensus 159 ----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~----~~i~~~-------~~~ 222 (263)
T d2j4za1 159 ----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TY----KRISRV-------EFT 222 (263)
T ss_dssp ----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH----HHHHTT-------CCC
T ss_pred ----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HH----HHHHcC-------CCC
Confidence 22345689999999999999999999999999999999999999997654321 11 111111 111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
++.. ..+.+.+++..||..||.+|||++|+++ |+||..
T Consensus 223 ~p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~-----hp~~~~ 260 (263)
T d2j4za1 223 FPDF----VTEGARDLISRLLKHNPSQRPMLREVLE-----HPWITA 260 (263)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT-----CHHHHH
T ss_pred CCcc----CCHHHHHHHHHHccCCHhHCcCHHHHHc-----CcCcCC
Confidence 2222 3345778889999999999999999998 999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=412.18 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=191.5
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEc--CCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHS--KEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~lv 325 (549)
++|++.+.||+|+||+||+|.+ .+|+.||+|+++...... +.+.+|+.+|++++||||+++++++.+ ++.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999987 579999999997665433 457899999999999999999998854 5678999
Q ss_pred Eecc-CCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCC--CCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 326 YNLL-NGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTC--DPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
|||+ +|+|.+++.+ +++..++.++.||+.||.|||+.. ..+||||||||+|||++.+ +.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeecccee
Confidence 9999 6799999853 678889999999999999999872 1249999999999999998 789999999997
Q ss_pred ccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
..... .......+||+.|||||++.+..|+.++|||||||++|||++|++||......+ + ...+. .+..
T Consensus 163 ~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~---~~~i~-~~~~ 231 (269)
T d2java1 163 ILNHD-----TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--L---AGKIR-EGKF 231 (269)
T ss_dssp HC----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H---HHHHH-HTCC
T ss_pred ecccC-----CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--H---HHHHH-cCCC
Confidence 65432 122345789999999999999999999999999999999999999997654321 1 11111 1111
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhh
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWL 527 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~ 527 (549)
+.++..+ .+.+.+++.+||..||.+|||+.|+++ |+|+
T Consensus 232 -----~~~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~-----hp~i 269 (269)
T d2java1 232 -----RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE-----NPLI 269 (269)
T ss_dssp -----CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT-----STTC
T ss_pred -----CCCCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh-----CCcC
Confidence 1122233 345778889999999999999999998 8884
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=423.11 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=205.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|++.+.||+|+||+||+|.+ .+|+.||+|+++.... ....+.+|+.+|+.++||||++++++|.+++.+++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999987 5799999999976532 24578899999999999999999999999999999999
Q ss_pred cc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 328 LL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 328 ~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+ +|+|.+++.+ +++..+..++.||+.||.|||+ + +|+||||||+|||++.+ +.+||+|||+|......
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH--
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCC-CCEEEeeCCCccccCCC--
Confidence 99 5799999964 7888899999999999999996 5 89999999999999998 69999999999754331
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc--------
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL-------- 474 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-------- 474 (549)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||......................
T Consensus 159 -----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 159 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp -----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred -----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2235689999999999999999999999999999999999999997654332211100000000000
Q ss_pred --------------------cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 475 --------------------CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 475 --------------------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.........+..........+.+++..||..||.+|||++|+++ |+||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~-----Hpf~~~~~ 305 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV-----HAFIKRSD 305 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SHHHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh-----CHhhCcCC
Confidence 00000000000000011245778889999999999999999999 99997544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=406.60 Aligned_cols=245 Identities=27% Similarity=0.417 Sum_probs=195.5
Q ss_pred CCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEc----CCeEEEEE
Q 008898 255 SPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHS----KEMYAIVY 326 (549)
Q Consensus 255 ~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~~~lv~ 326 (549)
+..+.||+|+||+||+|.+ .+++.||+|.+...... .+.+.+|+++|++++||||+++++++.+ +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4556799999999999987 56889999999765433 3457899999999999999999999864 45789999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCC--EEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPP--IIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~--iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
||+ +|+|.+++.+ +++..+..++.||+.||.|||++ + |+||||||+|||++++.+.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 999 6799999965 67788899999999999999998 6 999999999999975336899999999965322
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
......+||+.|||||++.+ +|+.++|||||||++|||++|+.||.......... ..+.. +. ..
T Consensus 168 ------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~----~~i~~-~~----~~ 231 (270)
T d1t4ha_ 168 ------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY----RRVTS-GV----KP 231 (270)
T ss_dssp ------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH----HHHTT-TC----CC
T ss_pred ------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH----HHHHc-CC----CC
Confidence 22346789999999998864 69999999999999999999999997554322211 11111 11 11
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
+...... ...+.+++..||+.||.+|||+.|+++ |+||+
T Consensus 232 ~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~-----Hp~fk 270 (270)
T d1t4ha_ 232 ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN-----HAFFQ 270 (270)
T ss_dssp GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGC
T ss_pred cccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC-----CcccC
Confidence 1112222 234678899999999999999999999 89985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=408.92 Aligned_cols=249 Identities=23% Similarity=0.409 Sum_probs=196.1
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|+..+.||+|+||.||+|.+.+++.||||+++......+++.+|+.++++++||||++++|+|..++.+++||||+ +
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 468889999999999999999988899999999887777889999999999999999999999999999999999999 7
Q ss_pred CCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 331 GSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 331 gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
|+|.+++.. +++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~---- 156 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQY---- 156 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGG-GCEEECSCC--------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCC-CCeEecccchheeccCCCc----
Confidence 899999854 67888899999999999999999 99999999999999999 6899999999976543221
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
.......||+.|+|||++.++.|+.++|||||||++|||+|+..|+.......+.+.. +.. + .....
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~----i~~-~--~~~~~------ 223 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----IST-G--FRLYK------ 223 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH----HHH-T--CCCCC------
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH----HHh-c--CCCCC------
Confidence 1223457899999999999999999999999999999999964444333322222211 111 1 01111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+..+...+.+++..||+.||.+|||+++|++.|++
T Consensus 224 -p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 224 -PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 12223567889999999999999999999998864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=409.35 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=204.3
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN-WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
+.|++.+.||+|+||.||+|.+ .+|+.||||+++... ...+.+.+|+++|++++||||+++++++.+++.+++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688899999999999999987 579999999997643 33467889999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 -NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 -~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.+ +++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|.......
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~~--- 164 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI--- 164 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECHHHH---
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCC-CCEEEEechhhhccCCCc---
Confidence 6799998743 67888999999999999999999 99999999999999998 689999999986543221
Q ss_pred cCccccccccCCccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMM-----YGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
....+.+||+.|+|||++. +..|+.++|||||||++|||++|+.||......+. +.... .. ....+
T Consensus 165 --~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~----~~-~~~~~- 235 (288)
T d2jfla1 165 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIA----KS-EPPTL- 235 (288)
T ss_dssp --HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHH----HS-CCCCC-
T ss_pred --ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHH----cC-CCCCC-
Confidence 1223568999999999984 45689999999999999999999999987654321 11111 11 10011
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
..+......+.+++..||+.||.+|||+.|+++ |+|+..
T Consensus 236 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~-----hp~~~~ 274 (288)
T d2jfla1 236 ------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ-----HPFVTV 274 (288)
T ss_dssp ------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT-----SGGGCC
T ss_pred ------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc-----CcccCC
Confidence 111223346778889999999999999999998 899964
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-51 Score=413.49 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=206.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 329 (549)
.++|...+.||+|+||.||+|.+ .+|+.||||+++.+....+++.+|+.+|++++||||++++++|.+++.++++|||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 35788889999999999999987 46899999999887777788999999999999999999999999999999999999
Q ss_pred -CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 330 -NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 330 -~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
+|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+||||+.+ +.+||+|||+|+......
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~-- 169 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT-- 169 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSS--
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCC-CcEEEccccceeecCCCC--
Confidence 6899999854 67788899999999999999999 99999999999999999 689999999997654322
Q ss_pred ccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
........||+.|+|||++.++.|+.++|||||||++|||++|..|+........ +.. .+ ..+ ..+
T Consensus 170 --~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~---~i-~~~-----~~~-- 235 (287)
T d1opja_ 170 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYE---LL-EKD-----YRM-- 235 (287)
T ss_dssp --SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH---HH-HTT-----CCC--
T ss_pred --ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHH---HH-hcC-----CCC--
Confidence 1122345689999999999999999999999999999999998777654433222 111 11 111 111
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
..+...++.+.+++..||..||.+|||+.+|++.|+.
T Consensus 236 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 236 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272 (287)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1222334567889999999999999999999997753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=405.80 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=202.6
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL- 329 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~- 329 (549)
.++|+..+.||+|+||.||+|.+.+++.||||+++......+.+.+|+.++++++||||++++|++.+ +.+++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 35688889999999999999999888999999998877777889999999999999999999998865 4568899999
Q ss_pred CCCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++. .+++..++.++.||++||.|||++ +|+||||||+||||+++ +.+||+|||+|+.......
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~-- 164 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY-- 164 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE--
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecc-cceeeccccceEEccCCcc--
Confidence 789998772 378899999999999999999999 99999999999999999 6899999999976544221
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.......||+.|||||++.++.++.++|||||||++|||+||..|+.......+.+.. +.. ...+..+
T Consensus 165 --~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~----i~~------~~~~~~p 232 (272)
T d1qpca_ 165 --TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LER------GYRMVRP 232 (272)
T ss_dssp --ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHT------TCCCCCC
T ss_pred --ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH----HHh------cCCCCCc
Confidence 1223457899999999999999999999999999999999976665444333222211 111 1111122
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
. ..++.+.+++..||+.||.+|||+++|++.|+
T Consensus 233 ~----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 233 D----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 2 23446788899999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-51 Score=413.18 Aligned_cols=251 Identities=21% Similarity=0.345 Sum_probs=189.4
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCc---EEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ---VAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~---~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|+..++||+|+||+||+|.+. +|+ .+|||.+...... .+.+.+|+.+|++++||||++++|+|.+++.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45677789999999999999873 333 6889988654322 35689999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|||+ +|+|.+++.. +++.+++.++.||++||.|||++ +|+||||||+||||+.+ +.+||+|||+|+.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCC---------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCC-CcEEECCcccceEccCC
Confidence 9999 6799998854 68889999999999999999999 99999999999999999 68999999999776543
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.............||+.|||||.+.++.++.++|||||||++|||+| |++||......+ +. ..+....
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~---~~i~~~~------ 250 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VI---NAIEQDY------ 250 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH---HHHHTTC------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HH---HHHHcCC------
Confidence 33333333334568999999999999999999999999999999998 899997654321 11 1111111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
....+.+.+..+.+++..||+.||.+|||+.+|++.|+
T Consensus 251 ----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 251 ----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11122334566888999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=405.50 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=195.7
Q ss_pred hcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.++|...+.||+|+||.||+|.+. ..||||+++.... ..+.+.+|+.+|++++||||+++++++.+ +.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367999999999999999999764 3599999975432 23578899999999999999999999865 56789999
Q ss_pred cc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 328 LL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 328 ~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+ +|+|.+++.. +++..+..++.||++||.|||++ +||||||||+|||++.+ +.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~~- 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWS- 158 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT-SSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCC-CCEEEccccceeeccccC-
Confidence 99 5899999953 78889999999999999999999 99999999999999999 689999999997654321
Q ss_pred cccCccccccccCCcccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.........||+.|||||++.+ +.|+.++|||||||+||||+||+.||.............. .+ ..
T Consensus 159 --~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~-----~~----~~ 227 (276)
T d1uwha_ 159 --GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----RG----YL 227 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH-----HT----SC
T ss_pred --CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh-----cC----CC
Confidence 2223345689999999999864 3589999999999999999999999986554322111111 11 11
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.|.+ ......+++.+.+++..||+.||.+|||+++|++.|+
T Consensus 228 ~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 228 SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1111 1223334567888999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=408.17 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=205.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||+++.. ....+.+.+|+++|++++||||+++++++.+++.+++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999987 57999999999743 223467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.|++.||.|||++ +||||||||+|||++++ +.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~- 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNED-MHIQITDFGTAKVLSPES- 162 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCC-ceEEecccccceecccCC-
Confidence 999 6799998864 78888999999999999999999 99999999999999998 689999999997654321
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... + ...+... ...
T Consensus 163 --~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~---~~~i~~~-------~~~ 228 (288)
T d1uu3a_ 163 --KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--I---FQKIIKL-------EYD 228 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHTT-------CCC
T ss_pred --cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--H---HHHHHcC-------CCC
Confidence 2223345689999999999999999999999999999999999999998654321 1 1111111 111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc-CCchhhhhhhH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ-EPDYWLKMKRE 532 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~-~~~~w~~~~~~ 532 (549)
++..+ ...+.+++..||..||.+|||++|+++... ..|+||+...+
T Consensus 229 ~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 229 FPEKF----FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp CCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 22233 345678899999999999999998643211 13789977654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=399.49 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=208.5
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|+..+.||+|+||+||+|.+.+++.||||+++......+++.+|+.++++++||||++++|+|.+++.+++||||+ +
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 579999999999999999999988899999999988778889999999999999999999999999999999999999 6
Q ss_pred CCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 331 GSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 331 gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
|+|.+++. .+.+..+..++.||++||.|||++ +|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~---- 155 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEY---- 155 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSC----
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCC-CcEEECcchhheeccCCCc----
Confidence 88999874 367788999999999999999999 99999999999999998 6899999999976543221
Q ss_pred ccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
.......||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+ .. ..+.. +. ...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-~~----~~i~~-~~--~~~------ 221 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TA----EHIAQ-GL--RLY------ 221 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HH----HHHHT-TC--CCC------
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-HH----HHHHh-CC--CCC------
Confidence 12234579999999999999999999999999999999998 899997665322 11 11111 11 111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+...+..+.+++..||+.||.+|||+++|++.|.+
T Consensus 222 -~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 -RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122234568889999999999999999999998864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-51 Score=412.21 Aligned_cols=253 Identities=22% Similarity=0.344 Sum_probs=192.3
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
+.+.|++.+.||+|+||+||+|.+ .+|+.||||++..... ....+.+|+.+|+.++||||+++++++.+++.+++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456799999999999999999987 5699999999975532 2345778999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec--CCCceEEeeeccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE--NFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~~kL~DFGla~~~~~~ 400 (549)
||+ +|+|.+++.. +++.+...++.||+.||.|||++ +|+||||||+|||+.. +.+.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999 5899999964 78889999999999999999999 9999999999999953 2268999999999754332
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||....... + ...+....
T Consensus 164 ------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~---~~~i~~~~------- 225 (307)
T d1a06a_ 164 ------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--L---FEQILKAE------- 225 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H---HHHHHTTC-------
T ss_pred ------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--H---HHHHhccC-------
Confidence 22345689999999999999999999999999999999999999997654322 1 11111111
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
..............+.+++..||..||.+|||+.|+++ |+||+
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~-----hp~~~ 268 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ-----HPWIA 268 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH-----STTTT
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc-----CHhhC
Confidence 01111112233456778889999999999999999999 89986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=405.07 Aligned_cols=260 Identities=23% Similarity=0.367 Sum_probs=207.7
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-------CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-------SEEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
+.++|++.+.||+|+||+||+|.+ .+|+.||||++++... ..+.+.+|+.+|++++||||+++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 356799999999999999999987 5799999999975421 24678999999999999999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCC---ceEEeeeccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFH---HPQLSDFGAA 394 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~~kL~DFGla 394 (549)
+++||||+ +|+|.+++.. +++.....++.||+.||.|||+. +|+||||||+|||++.+.. .+||+|||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999 6799999954 78888999999999999999999 9999999999999987621 5899999999
Q ss_pred cccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
...... ....+..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+. .+....
T Consensus 165 ~~~~~~------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~----~i~~~~- 232 (293)
T d1jksa_ 165 HKIDFG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA----NVSAVN- 232 (293)
T ss_dssp EECTTS------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH----HHHTTC-
T ss_pred hhcCCC------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHH----HHHhcC-
Confidence 764432 22345679999999999999999999999999999999999999998654322 111 111110
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHH
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
..............+.++++.||..||.+|||+.++++ |+||+...+++-
T Consensus 233 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~-----hp~~~~~~~~~~ 282 (293)
T d1jksa_ 233 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ-----HPWIKPKDTQQA 282 (293)
T ss_dssp ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH-----STTTCC------
T ss_pred ------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc-----CcccCCCChhHh
Confidence 01111111122345778899999999999999999999 999987665443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-50 Score=409.01 Aligned_cols=245 Identities=29% Similarity=0.398 Sum_probs=199.0
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH----HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE----EEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
.|+..+.||+|+||.||+|.+ .+|+.||||+++...... +.+.+|+.+|++++||||+++++++.+++.+++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488899999999999999987 578999999997654332 457899999999999999999999999999999999
Q ss_pred ccC-CCHHHHHH---HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLN-GSLKQYLK---QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~-gsL~~~l~---~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
|+. |+|..++. .+++.++..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCC-CCEEEeecccccccCC----
Confidence 994 56665553 378889999999999999999999 99999999999999998 6999999999965332
Q ss_pred ccCccccccccCCcccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccC
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMY---GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLID 480 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~---~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 480 (549)
....+||+.|||||++.+ +.|+.++|||||||++|||++|+.||........ + .... .. . .
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~---~~i~-~~-~-----~ 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-L---YHIA-QN-E-----S 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H---HHHH-HS-C-----C
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-H---HHHH-hC-C-----C
Confidence 224579999999999864 4689999999999999999999999976543221 1 1111 11 0 1
Q ss_pred CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 481 PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 481 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
+.+. +....+.+.+++..||..||.+|||+.++++ |+|+..
T Consensus 232 ~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~-----Hp~~~~ 272 (309)
T d1u5ra_ 232 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK-----HRFVLR 272 (309)
T ss_dssp CCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT-----CHHHHS
T ss_pred CCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh-----CHHhcC
Confidence 1111 1122346778889999999999999999998 889864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=406.46 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=211.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||++++. ....+.+.+|+.+|+.++||||+++++++.+++.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999987 67999999999753 223467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||+|||++ +||||||||+|||++.+ +.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~--- 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS--- 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC---
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCC-CCEEEeeccccccccc---
Confidence 999 7899999865 67778889999999999999999 99999999999999999 7999999999965432
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||....... + ...... + ...
T Consensus 158 --~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~---~~~i~~-~------~~~ 223 (337)
T d1o6la_ 158 --DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--L---FELILM-E------EIR 223 (337)
T ss_dssp --TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHH-C------CCC
T ss_pred --CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--H---HHHHhc-C------CCC
Confidence 2223446789999999999999999999999999999999999999998765322 1 111111 1 112
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHHHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
++..++. .+.+++..||+.||.+||+ +.++++ |+||+..+..+..
T Consensus 224 ~p~~~s~----~~~dli~~~L~~dP~~R~~~~~~~~~eil~-----Hp~f~~i~~~~l~ 273 (337)
T d1o6la_ 224 FPRTLSP----EAKSLLAGLLKKDPKQRLGGGPSDAKEVME-----HRFFLSINWQDVV 273 (337)
T ss_dssp CCTTSCH----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT-----SGGGTTCCHHHHH
T ss_pred CCccCCH----HHHHHHHhhccCCchhhcccccccHHHHHc-----CcccccCCHHHHH
Confidence 2233343 4677889999999999995 889988 9999887655443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-49 Score=409.89 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=207.0
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
-++|++.+.||+|+||.||+|.+ .+|+.||||++...... .+.+.+|+.+|++++||||+++++++.+++.+++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 36899999999999999999987 57999999999765433 35678999999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC-CCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +|+|.+++. .+++.++..++.||+.||.|||++ +||||||||+|||++.+ .+.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--- 178 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 178 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc---
Confidence 9 689999983 278899999999999999999999 99999999999999642 26899999999976433
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
.....+..||+.|||||++.+..|+.++|||||||++|||++|+.||...... +.+.. +.... ....+.
T Consensus 179 ---~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~----i~~~~---~~~~~~ 247 (350)
T d1koaa2 179 ---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRN----VKSCD---WNMDDS 247 (350)
T ss_dssp ---TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH----HHHTC---CCSCCG
T ss_pred ---ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHH----HHhCC---CCCCcc
Confidence 22334678999999999999999999999999999999999999999765432 21211 11110 001111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
....+ .+.+.+++..||..||.+|||+.|+++ |+||...
T Consensus 248 ~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~-----hp~~~~~ 286 (350)
T d1koaa2 248 AFSGI----SEDGKDFIRKLLLADPNTRMTIHQALE-----HPWLTPG 286 (350)
T ss_dssp GGGGC----CHHHHHHHHHHCCSSGGGSCCHHHHHH-----STTTSCT
T ss_pred cccCC----CHHHHHHHHHHccCChhHCcCHHHHhc-----CcccCCC
Confidence 11222 345678889999999999999999999 8898643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-49 Score=409.10 Aligned_cols=253 Identities=19% Similarity=0.248 Sum_probs=205.9
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW-SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++|++.+.||+|+||.||+|.+ .+|+.||||+++.... ....+.+|+.+|++++||||+++++++.+++.+++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999987 5799999999976543 234678899999999999999999999999999999999
Q ss_pred c-CCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEec-CCCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSE-NFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +|+|.+++. .+++.+...++.||+.||.|||++ |||||||||+||||+. +.+.+||+|||+|.....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~--- 181 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 181 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC---
Confidence 9 689998874 378889999999999999999999 9999999999999973 236899999999976543
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........||+.|+|||++.+..|+.++|||||||++|||+||+.||....... .+. .+... +..
T Consensus 182 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~----~i~~~-------~~~ 246 (352)
T d1koba_ 182 ---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQ----NVKRC-------DWE 246 (352)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH----HHHHC-------CCC
T ss_pred ---CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHH----HHHhC-------CCC
Confidence 223346689999999999999999999999999999999999999997654322 111 11110 011
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
............+.+++..||..||.+|||+.|+++ |+||+.
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~-----Hp~~~~ 288 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE-----HPWLKG 288 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT-----STTTSS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc-----CHhhCC
Confidence 111111223345678889999999999999999998 888853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=408.65 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=200.4
Q ss_pred cCCCCCceEcccCceEEEEEEecC-C-----cEEEEEEeecCC--cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD-G-----QVAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~-g-----~~~AvK~l~~~~--~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 322 (549)
++|.+.+.||+|+||+||+|.+.. + ..||+|.+.... .....+.+|+.+|+++ +|||||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568889999999999999997632 2 379999986443 2335688999999988 899999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH--------------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCC
Q 008898 323 AIVYNLL-NGSLKQYLKQ--------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSS 375 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~--------------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~ 375 (549)
++||||+ +|+|.+++.. +++..++.++.||++||.|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 9999999 7899999853 57788899999999999999999 9999999999
Q ss_pred CEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 008898 376 NILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQT 454 (549)
Q Consensus 376 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~ 454 (549)
|||++.+ +.+||+|||+|+...... ......+..||+.|||||++.++.|+.++|||||||++|||+| |++||..
T Consensus 194 Nill~~~-~~~Kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 194 NVLVTHG-KVVKICDFGLARDIMSDS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp GEEEETT-TEEEECCCGGGSCGGGCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccccccC-CeEEEeeccccccccCCC---ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999 699999999997654422 1222335678999999999999999999999999999999998 8999976
Q ss_pred cccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 455 NKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 455 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
...... +.... ..+ ..+ ..+...++.+.+++..||+.||.+|||++||++.|.
T Consensus 270 ~~~~~~-~~~~~----~~~-----~~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDAN-FYKLI----QNG-----FKM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSHH-HHHHH----HTT-----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHH-HHHHH----hcC-----CCC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 554332 21111 111 111 122233456888999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=397.19 Aligned_cols=242 Identities=24% Similarity=0.384 Sum_probs=190.9
Q ss_pred ceEcccCceEEEEEEec---CCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 258 MLIGQGGNSKVYRTNHV---DGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
+.||+|+||.||+|.+. .++.||||+++..... .+.+.+|+.+|++++||||++++++|.++ .+++||||+ +
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999753 3568999999754322 35689999999999999999999999764 578999999 6
Q ss_pred CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccCc
Q 008898 331 GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSENV 407 (549)
Q Consensus 331 gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~ 407 (549)
|+|.+++.+ +++..++.++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+........ ..
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~--~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY--YK 165 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSE--EE
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhccccc-Ccccccchhhhhhccccccc--cc
Confidence 799999965 78889999999999999999999 99999999999999998 69999999999765432211 11
Q ss_pred cccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCccccc
Q 008898 408 KPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNEE 486 (549)
Q Consensus 408 ~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 486 (549)
......||+.|||||.+.++.++.++|||||||++|||+| |+.||......+ + ...+. .+. .+..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~---~~~i~-~~~-----~~~~--- 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--V---TAMLE-KGE-----RMGC--- 231 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H---HHHHH-TTC-----CCCC---
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--H---HHHHH-cCC-----CCCC---
Confidence 2234578999999999999999999999999999999998 899998654321 1 11111 111 1111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 487 YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 487 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
+..++..+.+++..||+.||.+|||+.+|++.|+
T Consensus 232 -p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 232 -PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp -CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred -CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 2233456778899999999999999999998874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-49 Score=401.86 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=207.2
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||+++.. ....+.+.+|+.+|+.++||||+++++++.+++.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4699999999999999999987 56999999999743 223467889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|..++.. +++.....++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTT-SCEEECCCSSCEECSS---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCC-CCEEEecCccceEecc---
Confidence 999 6788888854 56777788999999999999999 99999999999999998 7999999999976433
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||........ ...+... ...
T Consensus 157 -----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~i~~~-------~~~ 219 (316)
T d1fota_ 157 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNA-------ELR 219 (316)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHC-------CCC
T ss_pred -----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-----HHHHHcC-------CCC
Confidence 22356899999999999999999999999999999999999999976543221 1111111 111
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKE 534 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~ 534 (549)
.+..++ ..+.+++.+||..||.+|| |++++++ |+||+...++.
T Consensus 220 ~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~-----Hp~f~~i~~~~ 267 (316)
T d1fota_ 220 FPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN-----HPWFKEVVWEK 267 (316)
T ss_dssp CCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT-----SGGGSSCCHHH
T ss_pred CCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc-----CcccccCCHHH
Confidence 222233 4577788999999999996 9999998 99998876654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=397.30 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=192.8
Q ss_pred cCCCCCceEcccCceEEEEEEecC-C----cEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD-G----QVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~-g----~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
+.|+..++||+|+||.||+|.+.+ + ..||||+++..... ..++.+|+.++++++||||++++|++.+.+.+++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 468889999999999999997643 2 47999999754432 3468899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 325 VYNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 325 v~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+|||+ +|++.+++.. +++.++..++.||+.||.|||++ +|+||||||+||||+.+ +.+||+|||+|+....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN-LVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCCCC------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCC-CeEEEcccchhhcccC
Confidence 99999 6678887743 78888999999999999999999 99999999999999999 6999999999976543
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
.... ........||+.|||||++.++.++.++|||||||++|||++|..|+.......+.+. .+. .+
T Consensus 163 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~----~i~-~~------ 229 (283)
T d1mqba_ 163 DPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----AIN-DG------ 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHH-TT------
T ss_pred CCcc--ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH----HHh-cc------
Confidence 2211 1122345689999999999999999999999999999999997666654433322211 111 11
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.....+.+++..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 230 ---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 230 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268 (283)
T ss_dssp ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ---CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence 111223334567888999999999999999999999775
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=397.29 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=198.3
Q ss_pred cCCCCCce-EcccCceEEEEEEec---CCcEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKML-IGQGGNSKVYRTNHV---DGQVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~-lG~G~fg~Vy~~~~~---~g~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|...+. ||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+++|++++||||++++|+|.+ +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999653 355899999975432 23568899999999999999999999976 457899
Q ss_pred Eecc-CCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|||+ +|+|.+++. .+++..+..++.||++||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEET-TEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccC-Cceeeccchhhhccccc
Confidence 9999 679999983 378889999999999999999999 99999999999999998 69999999999776543
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ +. ..+. .+.
T Consensus 163 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~---~~i~-~~~----- 229 (285)
T d1u59a_ 163 DSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM---AFIE-QGK----- 229 (285)
T ss_dssp SCE--ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HH---HHHH-TTC-----
T ss_pred ccc--cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HH---HHHH-cCC-----
Confidence 211 122234578999999999999999999999999999999998 899998654321 11 1111 111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.+.. +...+..+.+++..||+.||.+|||+.+|++.|+
T Consensus 230 ~~~~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 230 RMEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp CCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1112 2233456788999999999999999999999885
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-49 Score=403.50 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=209.1
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCC----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTN----WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVY 326 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~ 326 (549)
++|++.+.||+|+||.||+|.+ .+|+.||||+++... ...+.+.+|+.+|+.++||||+++++++.+.+.++++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999987 579999999997432 23466889999999999999999999999999999999
Q ss_pred ecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 327 NLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 327 e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
||+ +|+|.+++.. +++.....++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-SCEEECCCTTCEECSS---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCC-CCEEeeeceeeeeccc---
Confidence 999 7899998854 78888999999999999999999 99999999999999998 7999999999976432
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
...+..||+.|||||++.+..|+.++|||||||++|||++|+.||....... .+ ..+... .+.
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~----~~i~~~-------~~~ 256 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IY----EKIVSG-------KVR 256 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----HHHHHC-------CCC
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-HH----HHHhcC-------CCC
Confidence 2235689999999999999999999999999999999999999997654321 11 111111 011
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
.+..+ ...+.++++.||..||.+|+ |++++++ |+||+..++....
T Consensus 257 ~p~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~-----Hp~f~~~~~~~~~ 306 (350)
T d1rdqe_ 257 FPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN-----HKWFATTDWIAIY 306 (350)
T ss_dssp CCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT-----SGGGTTCCHHHHH
T ss_pred CCccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc-----CccccCCCHHHHH
Confidence 12223 34567788999999999994 9999998 9999887665543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=395.22 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=199.0
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEecc-C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNLL-N 330 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~-~ 330 (549)
++|++.+.||+|+||.||+|.+.+++.||||+++......+.+.+|+.++++++||||++++++|.++ .+++||||+ +
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecC-CeEEEEEecCC
Confidence 46889999999999999999998888899999988777778899999999999999999999999654 577899999 7
Q ss_pred CCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccccc
Q 008898 331 GSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSE 405 (549)
Q Consensus 331 gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~ 405 (549)
|+|..++. .+++.+++.++.||+.||.|||++ +|+||||||+||||+.+ +.+||+|||+|+......
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~---- 167 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE---- 167 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG-GCEEECCCCTTC----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCC-CcEEEcccchhhhccCCC----
Confidence 88988873 278999999999999999999999 99999999999999998 689999999997654322
Q ss_pred CccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCcccc
Q 008898 406 NVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLNE 485 (549)
Q Consensus 406 ~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 485 (549)
........||+.|+|||++..+.++.++|||||||++|||++|..|+.......+.+.... . + ..+.
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~----~-~-----~~~~--- 234 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----R-G-----YRMP--- 234 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----T-T-----CCCC---
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH----h-c-----CCCC---
Confidence 1222345799999999999999999999999999999999997777655544333222211 1 1 1111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 486 EYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 486 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+...++.+.+++.+||+.||.+|||+++|+++|+.
T Consensus 235 -~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 235 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 222334568889999999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=400.53 Aligned_cols=255 Identities=20% Similarity=0.267 Sum_probs=208.1
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+.++|.+.+.||+|+||.||+|.+ .+|+.||||+++........+.+|+++|+.++||||+++++++.+++.+++||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 457899999999999999999987 5689999999987765566788999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC-CCceEEeeeccccccccccc
Q 008898 329 L-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN-FHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~~kL~DFGla~~~~~~~~ 402 (549)
+ +|+|.+++.. +++.+...++.||++||.|||++ +|+||||||+|||++.+ ...+||+|||++.....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--- 156 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--- 156 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc---
Confidence 9 5799999953 67888999999999999999999 99999999999999854 24789999999865432
Q ss_pred cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCc
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQ 482 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 482 (549)
........||+.|+|||.+.+..|+.++|||||||++|+|++|..||....... .+ ..+..... ..+..
T Consensus 157 ---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~----~~i~~~~~---~~~~~ 225 (321)
T d1tkia_ 157 ---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-II----ENIMNAEY---TFDEE 225 (321)
T ss_dssp ---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH----HHHHHTCC---CCCHH
T ss_pred ---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HH----HHHHhCCC---CCChh
Confidence 223345679999999999999999999999999999999999999998765322 11 11111100 00000
Q ss_pred ccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 483 LNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 483 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.... ....+.+++..||..||.+|||+.|+++ |+||+..
T Consensus 226 ~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~-----hp~~~~~ 264 (321)
T d1tkia_ 226 AFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ-----HPWLKQK 264 (321)
T ss_dssp HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH-----SHHHHSC
T ss_pred hccC----CCHHHHHHHHHHccCChhHCcCHHHHhc-----CHhhccC
Confidence 1111 2345678899999999999999999998 8998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-48 Score=388.76 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=205.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----------HHHHHHHHHHHhcCC-CCCeeeEEEEEEc
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----------EEEVLREVELLSSIK-HENIVRIIGYCHS 318 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----------~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 318 (549)
.++|++.+.||+|+||+||+|.+ .+|+.||||+++..... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999987 57999999999765321 134788999999997 9999999999999
Q ss_pred CCeEEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccc
Q 008898 319 KEMYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAA 394 (549)
Q Consensus 319 ~~~~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla 394 (549)
++.+++||||+ +|+|.++++. +++..+..++.||++||.|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~-~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD-MNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCC-CCeEEccchhe
Confidence 99999999999 6799999954 78889999999999999999999 99999999999999998 68999999999
Q ss_pred cccccccccccCccccccccCCcccccccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHH
Q 008898 395 MVHHQSHQVSENVKPVNVVGTFGYLAPEYMMY------GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARS 468 (549)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 468 (549)
...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....
T Consensus 158 ~~~~~~------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~---- 226 (277)
T d1phka_ 158 CQLDPG------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRM---- 226 (277)
T ss_dssp EECCTT------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH----
T ss_pred eEccCC------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHH----
Confidence 765432 22345689999999999863 347889999999999999999999998765322 1111
Q ss_pred hhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 469 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
+... .. .. ....... ..+.+.+++.+||..||.+|||+.|+++ |+||+..
T Consensus 227 i~~~-~~-~~-~~~~~~~----~s~~~~~li~~~L~~~p~~R~s~~eil~-----h~~~~~~ 276 (277)
T d1phka_ 227 IMSG-NY-QF-GSPEWDD----YSDTVKDLVSRFLVVQPQKRYTAEEALA-----HPFFQQY 276 (277)
T ss_dssp HHHT-CC-CC-CTTTGGG----SCHHHHHHHHHHCCSSGGGSCCHHHHTT-----SGGGCTT
T ss_pred HHhC-CC-CC-CCccccc----CCHHHHHHHHHHccCChhHCcCHHHHHc-----CHHHHHh
Confidence 1111 10 01 1111122 3345778889999999999999999998 9999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-48 Score=401.17 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=205.0
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc----CHHHHHH---HHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW----SEEEVLR---EVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~----~~~~~~~---E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
++|++.++||+|+||.||+|.+ .+|+.||||++..... ....+.+ |+.+++.++||||+++++++.+++.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999987 5699999999964321 2223444 467788889999999999999999999
Q ss_pred EEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 324 IVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
+||||+ +|+|.+++.. +++..+..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEH-GHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-SCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCC-CcEEEeeeceeeecCC
Confidence 999999 6899999965 67788899999999999999999 99999999999999998 7999999999975433
Q ss_pred ccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccc
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERL 478 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 478 (549)
. .....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||......... ....... .
T Consensus 160 ~-------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~-------~ 223 (364)
T d1omwa3 160 K-------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTL-------T 223 (364)
T ss_dssp S-------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSS-------S
T ss_pred C-------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcc-------c
Confidence 2 2335689999999999975 46899999999999999999999999865442211 1111110 0
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCchhhhhhhHHHHHH
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPT-----MKTLLKLFQEPDYWLKMKREKEELL 537 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~~~~w~~~~~~~~~~~ 537 (549)
..+..+..++ ..+.+++..||..||.+||| ++++++ |+||+...+.....
T Consensus 224 ~~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~-----Hp~f~~i~~~~~~~ 278 (364)
T d1omwa3 224 MAVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE-----SPFFRSLDWQMVFL 278 (364)
T ss_dssp CCCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT-----SGGGTTCCHHHHHT
T ss_pred CCCCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc-----CccccCCCHHHHhc
Confidence 1112222333 45678889999999999999 689998 99998876655444
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=396.87 Aligned_cols=249 Identities=22% Similarity=0.376 Sum_probs=193.5
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCc----EEEEEEeecCC--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQ----VAAVKVLKCTN--WSEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAI 324 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~----~~AvK~l~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 324 (549)
++|+..++||+|+||+||+|.+ .+|+ +||+|.++... ...+++.+|+.++++++||||++++|+|.+++.+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 4699999999999999999987 3454 68888886432 345679999999999999999999999998777666
Q ss_pred EEeccCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 325 VYNLLNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 325 v~e~~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
++++.+|+|.+++.. +++..++.++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~-~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET-TEEEECCCSHHHHTTTT
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCC-CCeEeeccccceecccc
Confidence 666668999888854 77888999999999999999999 99999999999999999 69999999999765432
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
. .........||+.|+|||++.++.|+.++|||||||++|||+| |.+||....... +.... ..+.
T Consensus 165 ~---~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i----~~~~----- 230 (317)
T d1xkka_ 165 E---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL----EKGE----- 230 (317)
T ss_dssp C---C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHH----HHTC-----
T ss_pred c---ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCC-----
Confidence 2 1222334578999999999999999999999999999999998 788887654322 11111 1111
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+ ..+..++..+.+++.+||..||.+|||+.+|++.|..
T Consensus 231 ~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 231 RL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 01 1122334567889999999999999999999987654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=391.68 Aligned_cols=249 Identities=21% Similarity=0.374 Sum_probs=202.5
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC-------HHHHHHHHHHHhcCC--CCCeeeEEEEEEcCC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS-------EEEVLREVELLSSIK--HENIVRIIGYCHSKE 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~-------~~~~~~E~~il~~l~--h~nIv~l~~~~~~~~ 320 (549)
.++|++.++||+|+||.||+|.+ .+|+.||||+++..... ...+.+|+.+|++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 56899999999999999999987 57999999999754321 123668999999986 899999999999999
Q ss_pred eEEEEEeccC--CCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 321 MYAIVYNLLN--GSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 321 ~~~lv~e~~~--gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
.+++|||++. +++.+++.. +++.+...++.||++||.|||++ +|+||||||+|||++.+.+.+||+|||+|.
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 9999999994 478888754 78888999999999999999999 999999999999999765689999999996
Q ss_pred ccccccccccCccccccccCCccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKV-DEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL 474 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 474 (549)
.... ....+..||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... . ...
T Consensus 160 ~~~~-------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i-------~~~-- 219 (273)
T d1xwsa_ 160 LLKD-------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----I-------IRG-- 219 (273)
T ss_dssp ECCS-------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----H-------HHC--
T ss_pred eccc-------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----H-------hhc--
Confidence 5432 22345689999999999988776 5779999999999999999999975321 0 000
Q ss_pred cccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHHHHH
Q 008898 475 CERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREKEEL 536 (549)
Q Consensus 475 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~~~~ 536 (549)
.......++ ..+.+++.+||..||.+|||++|+++ |+||+....+++.
T Consensus 220 -----~~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~-----hp~~~~~~~p~e~ 267 (273)
T d1xwsa_ 220 -----QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN-----HPWMQDVLLPQET 267 (273)
T ss_dssp -----CCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT-----SGGGSSCCCHHHH
T ss_pred -----ccCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc-----CHhhCCCCCCCCc
Confidence 011122233 45677889999999999999999998 8999875444433
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=395.63 Aligned_cols=252 Identities=25% Similarity=0.306 Sum_probs=198.5
Q ss_pred hcCCCCC-ceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHh-cCCCCCeeeEEEEEEc----CCeEE
Q 008898 251 THNFSPK-MLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLS-SIKHENIVRIIGYCHS----KEMYA 323 (549)
Q Consensus 251 ~~~f~~~-~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~-~l~h~nIv~l~~~~~~----~~~~~ 323 (549)
.++|.+. ++||+|+||.||+|.+ .+|+.||||+++.. ..+.+|+.++. .++||||++++++|++ +..++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4678876 4699999999999987 67999999999743 56778999865 4589999999999865 46799
Q ss_pred EEEecc-CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeecccc
Q 008898 324 IVYNLL-NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAM 395 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla~ 395 (549)
+||||+ +|+|.+++.+ +++.+...++.||+.||.|||++ +|+||||||+|||++.+ .+.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence 999999 5799999964 78889999999999999999999 99999999999999853 2579999999997
Q ss_pred ccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
..... ......+||+.|||||++.+..|+.++|||||||+||+|+||+.||........ ...+... . ..
T Consensus 163 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~~~-i---~~ 231 (335)
T d2ozaa1 163 ETTSH------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTR-I---RM 231 (335)
T ss_dssp ECCCC------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------C-C---CS
T ss_pred eccCC------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHHHH-H---hc
Confidence 64432 223456899999999999999999999999999999999999999976543211 0000000 0 00
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhh
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLK 528 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~ 528 (549)
. ...++..........+.++++.||..||.+|||+.++++ |+||.
T Consensus 232 ~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~-----hp~~~ 276 (335)
T d2ozaa1 232 G---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN-----HPWIM 276 (335)
T ss_dssp C---SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH-----SHHHH
T ss_pred C---CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc-----CHHhh
Confidence 0 011111112234567888999999999999999999998 78874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=394.53 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=205.4
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecC----CcCHHHHHHHHHHHh-cCCCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCT----NWSEEEVLREVELLS-SIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~----~~~~~~~~~E~~il~-~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++++ ....+.+..|..++. .++||||+++++++.+++.+++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5789999999999999999987 57999999999753 233456777777765 78999999999999999999999
Q ss_pred Eecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSH 401 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~ 401 (549)
|||+ +|+|.+++.. +++.+...++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG- 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCC-Cceeccccchhhhcccc-
Confidence 9999 6799999954 67788899999999999999999 99999999999999998 79999999999654322
Q ss_pred ccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCC
Q 008898 402 QVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDP 481 (549)
Q Consensus 402 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 481 (549)
........||+.|+|||++.+..|+.++|||||||++|||++|+.||....... + +. .+.. + .+
T Consensus 157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~--~~-~i~~-~------~~ 220 (320)
T d1xjda_ 157 ----DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--L--FH-SIRM-D------NP 220 (320)
T ss_dssp ----TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H--HH-HHHH-C------CC
T ss_pred ----cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--H--HH-HHHc-C------CC
Confidence 223345689999999999999999999999999999999999999998654322 1 11 1111 1 12
Q ss_pred cccccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCchhhhhhhHH
Q 008898 482 QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMK-TLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 482 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~~L~~~~~w~~~~~~~ 533 (549)
..+..+ ...+.+++++||..||.+|||+. ++++ |+||+..+..
T Consensus 221 ~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~-----hpff~~~~~~ 264 (320)
T d1xjda_ 221 FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ-----HPLFREINWE 264 (320)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG-----SGGGTTCCHH
T ss_pred CCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh-----CchhccCCHH
Confidence 222223 34577888999999999999996 7877 8999875443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-48 Score=393.37 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=202.6
Q ss_pred hhcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCe
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 321 (549)
-.++|+..+.||+|+||+||+|.+. +++.||||+++..... .+++.+|+.+|++++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3578999999999999999999763 3578999999765432 3568999999999999999999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH---------------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCC
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---------------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVK 373 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---------------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlk 373 (549)
.+++||++ +|+|.+++.. +++..++.++.||+.||+|||++ +|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 99999999 7899999853 56778899999999999999999 99999999
Q ss_pred CCCEEEecCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCC-CCC
Q 008898 374 SSNILLSENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK-EAI 452 (549)
Q Consensus 374 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~-~p~ 452 (549)
|+|||++.+ +.+||+|||+|+...... ......+..||+.|+|||.+.+..|+.++|||||||++|||++|. +||
T Consensus 168 p~NILld~~-~~~Kl~DFGls~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 168 TRNCLVGEN-MVVKIADFGLSRNIYSAD---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp GGGEEECGG-GCEEECCCSCHHHHTGGG---CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ccceEECCC-CcEEEccchhheeccCCc---cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999 689999999997554321 222334567899999999999999999999999999999999996 566
Q ss_pred CCcccchhhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 453 QTNKANRESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 453 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
..... .+.+ ..+. .+.. +.. +...+..+.+++..||+.||.+||||.+|+++|++.
T Consensus 244 ~~~~~-~e~~----~~v~-~~~~-----~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAH-EEVI----YYVR-DGNI-----LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCH-HHHH----HHHH-TTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCH-HHHH----HHHH-cCCC-----CCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 65433 2211 1111 1111 111 223334678899999999999999999999988753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=387.86 Aligned_cols=260 Identities=24% Similarity=0.305 Sum_probs=196.7
Q ss_pred CCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC------HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 256 PKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS------EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 256 ~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
..++||+|+||+||+|.+ .+|+.||||+++..... ...+.+|+.+|++++||||+++++++.+++.+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 356899999999999987 56999999999754322 13578999999999999999999999999999999999
Q ss_pred cCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.|++...+. .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~---- 153 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSP---- 153 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSC----
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCC-CccccccCccccccCCC----
Confidence 9776655553 377788999999999999999999 99999999999999998 68999999999654432
Q ss_pred cCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--ccc---cc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--LCE---RL 478 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~---~~ 478 (549)
.......+||+.|+|||++..+ .|+.++|||||||++|||++|.+||...... +.+....+...... ... ..
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 154 -NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred -cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCCCChhhccchhcc
Confidence 2223356899999999998755 5799999999999999999999999766532 22222222111000 000 00
Q ss_pred cCCc---ccccC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 479 IDPQ---LNEEY-----NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 479 ~d~~---l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
.... ..... .....+.+.+++..||..||.+|||++|+++ |+||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~-----Hp~f~~~ 286 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK-----MKYFSNR 286 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT-----SGGGTSS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC-----CHhhCCC
Confidence 0000 00000 0112356788899999999999999999998 9999754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=387.68 Aligned_cols=264 Identities=22% Similarity=0.345 Sum_probs=203.9
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||+++.... ..+.+.+|+++|++++||||+++++++.+++.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999987 6799999999975432 24678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccc
Q 008898 328 LLNGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 328 ~~~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~ 402 (549)
|+.|++.+++.. +++..+..++.||+.||.|||++ +||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCC--
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeeccc-CcceeccCCcceeccCC--
Confidence 998887777632 78889999999999999999999 99999999999999988 68999999999765432
Q ss_pred cccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--cc---c
Q 008898 403 VSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--LC---E 476 (549)
Q Consensus 403 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~---~ 476 (549)
........||+.|+|||.+.... ++.++|||||||++|+|++|+.||....... .+........... .. .
T Consensus 156 ---~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp ---SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGG
T ss_pred ---cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccc
Confidence 22334568999999999887766 4789999999999999999999998654322 2211111111000 00 0
Q ss_pred cccC--Cccccc-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 477 RLID--PQLNEE-------YNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 477 ~~~d--~~l~~~-------~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
...+ ...... ........+.+++++||..||.+|||+.|+++ |+||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~-----H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA-----HPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC-----CHhhccC
Confidence 0000 000000 00112246778899999999999999999998 9999654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=383.18 Aligned_cols=242 Identities=24% Similarity=0.374 Sum_probs=191.5
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCeEEEEEecc-
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS-KEMYAIVYNLL- 329 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~lv~e~~- 329 (549)
++|+..+.||+|+||.||+|.+ .|..||||+++.+. ..+.+.+|++++++++||||++++|+|.+ ++.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 4678889999999999999988 57889999997654 45779999999999999999999999854 56789999999
Q ss_pred CCCHHHHHHH-----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 NGSLKQYLKQ-----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 ~gsL~~~l~~-----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-SCEEECCCCC-----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCC-CCEeecccccceecCC-----
Confidence 7899999843 68889999999999999999999 99999999999999999 6899999999865332
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhcccccccccCCcc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQL 483 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 483 (549)
......+|+.|+|||++.++.++.++|||||||++|||+| |++||......+ +..+ +. .+ ..+..
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~---i~-~~-----~~~~~ 221 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPR---VE-KG-----YKMDA 221 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHH---HT-TT-----CCCCC
T ss_pred ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHH---HH-cC-----CCCCC
Confidence 2234568999999999999999999999999999999998 677776654332 2111 11 11 11222
Q ss_pred cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 484 NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 484 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+......+.+++.+||..||.+|||+.+|++.|+.
T Consensus 222 ----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 222 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 22334567889999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-47 Score=382.98 Aligned_cols=253 Identities=24% Similarity=0.298 Sum_probs=193.2
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC----HHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS----EEEVLREVELLSSIKHENIVRIIGYCHSKE---- 320 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~---- 320 (549)
+.++|++.+.||+|+||.||+|.+ .+|+.||||+++..... ...+.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 457899999999999999999987 67999999999765322 245789999999999999999999986543
Q ss_pred eEEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccc
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMV 396 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~ 396 (549)
.+++||||+ +|+|.+++.. +++.+...++.||+.||.|||++ +|+||||||+|||++.+ +..+|+|||.+..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISAT-NAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT-SCEEECCCTTCEE
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCcc-ccceeehhhhhhh
Confidence 489999999 5789988854 78888999999999999999999 99999999999999998 6899999999865
Q ss_pred cccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc
Q 008898 397 HHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE 476 (549)
Q Consensus 397 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 476 (549)
..... .........+||+.|+|||++.+..++.++|||||||++|||+||++||........ + . .....+.
T Consensus 161 ~~~~~--~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~---~-~~~~~~~-- 231 (277)
T d1o6ya_ 161 IADSG--NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-A---Y-QHVREDP-- 231 (277)
T ss_dssp CC------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H---H-HHHHCCC--
T ss_pred hcccc--ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-H---H-HHHhcCC--
Confidence 43322 122234467899999999999999999999999999999999999999976543221 1 1 1111111
Q ss_pred cccCCcccccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHh
Q 008898 477 RLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRP-TMKTLLKLF 520 (549)
Q Consensus 477 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L 520 (549)
..........++.+.+++.+||..||.+|| |++++++.|
T Consensus 232 -----~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 232 -----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp -----CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred -----CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 111111222345677888999999999999 899988743
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-47 Score=383.38 Aligned_cols=263 Identities=23% Similarity=0.348 Sum_probs=202.4
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEec
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
++|...+.||+|+||+||+|.+.+|+.||||+++.... ..+.+.+|+.+|++++||||+++++++..++.++++|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57889999999999999999998999999999976532 246789999999999999999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+.|++...+.. +++.....++.||+.||+|||+. +||||||||+|||++.+ +.+||+|||+|......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~---- 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINRE-GELKIADFGLARAFGIP---- 153 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCC-CCEEecccccceecccC----
Confidence 98776666633 78889999999999999999999 99999999999999999 69999999999664332
Q ss_pred cCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc--c---ccc-
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--L---CER- 477 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~---~~~- 477 (549)
........|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+. +........... . ...
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGS
T ss_pred -ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhh
Confidence 1223345789999999998765 468999999999999999999999976543222 221111111100 0 000
Q ss_pred --------ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 478 --------LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 478 --------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
...+.............+.+++++||..||.+|||++|+++ |+||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~-----Hp~f~~ 286 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE-----HAYFKE 286 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT-----SGGGGC
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc-----CcccCc
Confidence 00000011111223356778899999999999999999998 999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=382.24 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=187.4
Q ss_pred cCCCCCceEcccCceEEEEEEecC----CcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD----GQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~----g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|+..+.||+|+||.||+|.+.. +..+|||.++..... .+.+.+|+.+|++++||||+++++++.+ +.+++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 578899999999999999997632 357889988644322 3568899999999999999999999964 668899
Q ss_pred Eecc-CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccc
Q 008898 326 YNLL-NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~ 400 (549)
|||+ +|+|.+++.. +++..++.++.||++||.|||++ +||||||||+||+++.+ +.+||+|||+|+.....
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET-TEEEECC----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCC-CcEEEccchhheeccCC
Confidence 9999 6789888743 67888999999999999999999 99999999999999998 69999999999765432
Q ss_pred cccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccccc
Q 008898 401 HQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCERLI 479 (549)
Q Consensus 401 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 479 (549)
. ........||+.|+|||++.++.++.++|||||||++|||++ |.+||......+ +.. .+.. +.
T Consensus 162 ~----~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~---~i~~-~~----- 226 (273)
T d1mp8a_ 162 T----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG---RIEN-GE----- 226 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH---HHHT-TC-----
T ss_pred c----ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHH---HHHc-CC-----
Confidence 1 122334578999999999999999999999999999999998 899997665432 111 1111 11
Q ss_pred CCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 480 DPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 480 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
.+. .+...++.+.+++..||..||.+|||+.+|++.|+
T Consensus 227 ~~~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 227 RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 111 12233456888999999999999999999999775
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=387.92 Aligned_cols=265 Identities=22% Similarity=0.363 Sum_probs=200.5
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cC-CcEEEEEEeecCCc---CHHHHHHHHHHHhcC---CCCCeeeEEEEEEc---
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VD-GQVAAVKVLKCTNW---SEEEVLREVELLSSI---KHENIVRIIGYCHS--- 318 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~-g~~~AvK~l~~~~~---~~~~~~~E~~il~~l---~h~nIv~l~~~~~~--- 318 (549)
..++|++.+.||+|+||+||+|.+ .+ ++.||||+++.... ....+.+|+.+|+.| +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 357899999999999999999987 44 67899999965432 223566788877665 79999999998852
Q ss_pred --CCeEEEEEeccCCCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeee
Q 008898 319 --KEMYAIVYNLLNGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDF 391 (549)
Q Consensus 319 --~~~~~lv~e~~~gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DF 391 (549)
...++++||++.|++..+.. .+++.....++.||+.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~-~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS-GQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECSC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCC-CCeeecch
Confidence 35789999999777655543 267788889999999999999999 99999999999999998 68999999
Q ss_pred ccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc
Q 008898 392 GAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS 471 (549)
Q Consensus 392 Gla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 471 (549)
|++..... ........||+.|+|||++.+..|+.++|||||||++|||++|++||...... +.+.........
T Consensus 161 g~~~~~~~------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSF------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCG------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCC
T ss_pred hhhhhhcc------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCC
Confidence 99865332 22334668999999999999999999999999999999999999999866532 222222221111
Q ss_pred ccccc---------c---ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhh
Q 008898 472 SGLCE---------R---LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 472 ~~~~~---------~---~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~ 530 (549)
..... . ...+.....+.....+.+.+++.+||..||.+|||+.|+++ |+||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~-----Hpff~~i 299 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS-----HPYFQDL 299 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT-----SGGGTTC
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc-----ChhhcCc
Confidence 10000 0 00000011122223456778899999999999999999999 9999754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=387.20 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=197.2
Q ss_pred cCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----eEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHSKE----MYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----~~~lv~e 327 (549)
.+|...+.||+|+||.||+|.+ +|+.||||+++.+.........|+..+..++||||++++++|.+.+ .+++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4567778999999999999986 6889999999755432222334555556789999999999997543 6899999
Q ss_pred cc-CCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhC-----CCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 328 LL-NGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHT-----CDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 328 ~~-~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
|+ +|+|.+++++ +++..++.++.|++.||.|||+. ++++||||||||+||||+.+ +.+||+|||++.....
T Consensus 82 y~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEEET
T ss_pred cccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecCccccccC
Confidence 99 7899999975 78889999999999999999973 23599999999999999999 6999999999976544
Q ss_pred ccccccCccccccccCCccccccccccCC------CCchhhHHHHHHHHHHHHcCCCCCCCcccchh----------hHH
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGK------VDEKIDVYSYGVVLLELITGKEAIQTNKANRE----------SLV 463 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~------~~~k~DvwSlGvil~elltG~~p~~~~~~~~~----------~l~ 463 (549)
... ..........||+.|+|||++.+.. ++.++|||||||+||||+||..|+......+. ...
T Consensus 161 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 161 ATD-TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTT-EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCc-ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 321 1122334578999999999987542 67799999999999999999988754332111 111
Q ss_pred HHHHHhhcccccccccCCcccccC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 464 LWARSLLSSGLCERLIDPQLNEEY-NREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 464 ~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
...... .....+|.++..+ +.+....+.+++..||+.||.+|||+.||++.|+
T Consensus 240 ~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 240 EMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp HHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 111111 1122233333322 3456677899999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=381.99 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=188.1
Q ss_pred cCCCCCceEcccCceEEEEEEec--CC--cEEEEEEeecCCc----CHHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV--DG--QVAAVKVLKCTNW----SEEEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~--~g--~~~AvK~l~~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
++|+..+.||+|+||.||+|.+. ++ ..||||+++.... ..+++.+|+.+|++++||||++++|+|.++ .++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 46888999999999999999752 23 3789999875422 235689999999999999999999999764 567
Q ss_pred EEEecc-CCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 324 IVYNLL-NGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
+||||+ +|+|.+++. .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATR-DLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccc-cceeeccchhhhhcc
Confidence 889998 788888773 378889999999999999999999 99999999999999999 589999999997654
Q ss_pred cccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccchhhHHHHHHHhhccccccc
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANRESLVLWARSLLSSGLCER 477 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 477 (549)
.... .........||+.|+|||.+.+..++.++|||||||++|||+| |++||....... . ...+...+.
T Consensus 163 ~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~---~~~i~~~~~--- 232 (273)
T d1u46a_ 163 QNDD--HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--I---LHKIDKEGE--- 232 (273)
T ss_dssp C-CC--EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---HHHHHTSCC---
T ss_pred cCCC--cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--H---HHHHHhCCC---
Confidence 4321 1122334568889999999999999999999999999999998 899997654322 1 111212211
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+.. +...+..+.+++..||..||.+|||+.+|++.|++
T Consensus 233 --~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 --RLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111 22233467889999999999999999999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=385.02 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=189.2
Q ss_pred hcCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEc-CC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHS-KE 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~-~~ 320 (549)
.++|+..+.||+|+||.||+|.+. +++.||||+++..... .+.+.+|..++.++ +|+||+.+++++.+ ++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357899999999999999999753 3468999999754322 34577788877766 68999999998865 45
Q ss_pred eEEEEEecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe
Q 008898 321 MYAIVYNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~ 380 (549)
.++++|||+ +|+|.+++.. +++.++..++.||+.||.|||++ +||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 789999999 7899999853 56788899999999999999999 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCC-CCCCCcccch
Q 008898 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK-EAIQTNKANR 459 (549)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~-~p~~~~~~~~ 459 (549)
.+ +.+||+|||+|+..... ..........||+.|+|||++.++.++.++|||||||++|||+||. +||.......
T Consensus 169 ~~-~~~Kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 169 EK-NVVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp GG-GCEEECC------CCSC---TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CC-CcEEEccCcchhhcccc---ccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 98 68999999999764432 2222334568999999999999999999999999999999999975 5676544332
Q ss_pred hhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 460 ESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 460 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
. +.... ..+. .+..+.. .+..+.+++.+||..||.+|||+.+|++.|+.
T Consensus 245 ~-~~~~~----~~~~-----~~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 245 E-FCRRL----KEGT-----RMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp H-HHHHH----HHTC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H-HHHHH----hcCC-----CCCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2 21111 1111 1122222 33457788999999999999999999998753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=383.83 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=200.6
Q ss_pred cCCCCCceEcccCceEEEEEEe------cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH------VDGQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSKEMY 322 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~------~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 322 (549)
++|+..+.||+|+||.||+|.+ .+++.||||+++..... ...+.+|+.+++.+ +||||++++++|.+++.+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788889999999999999975 24679999999865432 34688999999999 699999999999999999
Q ss_pred EEEEecc-CCCHHHHHHH---------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe
Q 008898 323 AIVYNLL-NGSLKQYLKQ---------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (549)
Q Consensus 323 ~lv~e~~-~gsL~~~l~~---------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~ 380 (549)
+++|||+ +|+|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 9999999 7899999853 56778899999999999999999 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchh
Q 008898 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRE 460 (549)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~ 460 (549)
.+ +.+||+|||+++...... .........||+.|+|||++.++.++.++|||||||++|||+|+..|+.......+
T Consensus 180 ~~-~~~ki~DfG~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 180 HG-RITKICDFGLARDIKNDS---NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp TT-TEEEECCCGGGSCTTSCT---TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cc-CcccccccchheeccCCC---cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 98 699999999997654422 22233456899999999999999999999999999999999995544443333333
Q ss_pred hHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 461 SLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 461 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
.+...... + ..+.. +...+..+.+++.+||+.||.+|||+.+|++.|++
T Consensus 256 ~~~~~i~~----~-----~~~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 256 KFYKMIKE----G-----FRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHHH----T-----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhc----C-----CCCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 22222211 1 11111 22234568889999999999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=381.62 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=204.7
Q ss_pred cCCCCCceEcccCceEEEEEEec------CCcEEEEEEeecCCcCH--HHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV------DGQVAAVKVLKCTNWSE--EEVLREVELLSSIKHENIVRIIGYCHSKEMYA 323 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~~AvK~l~~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 323 (549)
++|...+.||+|+||.||+|.+. ++..||||+++...... ..+.+|+.++++++||||++++++|..++.++
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 57888899999999999999753 35789999997544322 35789999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHH-------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEe
Q 008898 324 IVYNLL-NGSLKQYLKQ-------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLS 389 (549)
Q Consensus 324 lv~e~~-~gsL~~~l~~-------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~ 389 (549)
+||||+ +|+|.+++.. +++..+..++.|+++||.|||++ +|+||||||+|||++.+ +.+||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~-~~~Kl~ 175 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED-FTVKIG 175 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT-CCEEEC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC-ceEEEe
Confidence 999999 7899999843 35677889999999999999999 99999999999999999 689999
Q ss_pred eeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCC-CCCCCcccchhhHHHHHHH
Q 008898 390 DFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGK-EAIQTNKANRESLVLWARS 468 (549)
Q Consensus 390 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~-~p~~~~~~~~~~l~~~~~~ 468 (549)
|||+|+....... ........||+.|+|||.+.++.++.++|||||||++|||+||. +||..... .+.+ ..
T Consensus 176 DFGla~~~~~~~~---~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-~~~~----~~ 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVL----RF 247 (308)
T ss_dssp CTTCCCGGGGGGC---EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-HHHH----HH
T ss_pred ecccceeccCCcc---eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-HHHH----HH
Confidence 9999976544322 22234457899999999999999999999999999999999985 66655432 2212 11
Q ss_pred hhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC-chhhh
Q 008898 469 LLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP-DYWLK 528 (549)
Q Consensus 469 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~-~~w~~ 528 (549)
+..... +. .+..++..+.+++.+||+.||.+|||+++|++.|++. +++|+
T Consensus 248 i~~~~~------~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 248 VMEGGL------LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp HHTTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HHhCCC------CC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 111111 11 1222345688899999999999999999999999885 46664
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-47 Score=381.86 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=193.7
Q ss_pred cCCCCCceEcccCceEEEEEEec-CCc--EEEEEEeecCC--cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCeEEEE
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHV-DGQ--VAAVKVLKCTN--WSEEEVLREVELLSSI-KHENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~--~~AvK~l~~~~--~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv 325 (549)
++|++.++||+|+||.||+|.+. +|. .||||.++... ...+.+.+|+++|+++ +||||++++++|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888999999999999999874 454 46788775432 2335689999999998 799999999999999999999
Q ss_pred Eecc-CCCHHHHHHH-------------------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCc
Q 008898 326 YNLL-NGSLKQYLKQ-------------------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHH 385 (549)
Q Consensus 326 ~e~~-~gsL~~~l~~-------------------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 385 (549)
|||+ +|+|.+++.. +++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~-~~ 165 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN-YV 165 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG-GC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC-Cc
Confidence 9999 7899999842 57788999999999999999999 99999999999999999 68
Q ss_pred eEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCC-CCCCcccchhhHHH
Q 008898 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKE-AIQTNKANRESLVL 464 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~-p~~~~~~~~~~l~~ 464 (549)
+||+|||+|+..... .......||+.|+|||.+.++.++.++|||||||++|||++|.. ||..... .+ +
T Consensus 166 ~kl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-~~-~-- 235 (309)
T d1fvra_ 166 AKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AE-L-- 235 (309)
T ss_dssp EEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HH-H--
T ss_pred eEEcccccccccccc------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-HH-H--
Confidence 999999998654321 12234568999999999999999999999999999999999765 5654432 11 1
Q ss_pred HHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 465 WARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 465 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
...+.. + ..+.. +...++.+.+++.+||..||++||||++|++.|++
T Consensus 236 -~~~i~~-~-----~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 236 -YEKLPQ-G-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp -HHHGGG-T-----CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHh-c-----CCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111 1 11112 22334568888999999999999999999997743
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=385.64 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=199.6
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCeeeEEEEEEc------CCeEEEE
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIVRIIGYCHS------KEMYAIV 325 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~~~~~lv 325 (549)
+|...++||+|+||+||+|.+ .+|+.||||+++.+.. ...+|+.+|++++||||++++++|.. ...+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 588889999999999999988 5699999999976542 23479999999999999999999843 2357899
Q ss_pred EeccCCCHHHHHHH-------hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 326 YNLLNGSLKQYLKQ-------LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 326 ~e~~~gsL~~~l~~-------~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
|||++|++.+.+.. +++..+..++.||+.||+|||++ +|+||||||+|||++.+...+||+|||++....
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99998876666532 77888899999999999999998 999999999999999874589999999987643
Q ss_pred cccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhc------
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLS------ 471 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~------ 471 (549)
.. ....+.+||+.|+|||.+.+ ..|+.++|||||||++|||++|++||...... +.+......+..
T Consensus 175 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 175 RG------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp TT------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred CC------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhh
Confidence 32 22335689999999998875 46899999999999999999999999766532 222222111100
Q ss_pred ----cc----ccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 472 ----SG----LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 472 ----~~----~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
.. .....................+.+++.+||..||.+|||+.|+++ |+||+.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~-----Hp~f~~~~~~ 312 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA-----HSFFDELRDP 312 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGGGGGCT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc-----CHhhccccCC
Confidence 00 000000000111112223445778899999999999999999998 9999765443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=382.18 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=196.1
Q ss_pred cCCCCCceEcccCceEEEEEEecC--------CcEEEEEEeecCCcC--HHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNWS--EEEVLREVELLSSI-KHENIVRIIGYCHSKE 320 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~~~--------g~~~AvK~l~~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 320 (549)
++|.+.+.||+|+||.||+|.... +..||||+++.+... ..++.+|...+.++ +||||++++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578889999999999999997532 247999999765432 35678899988887 7999999999999999
Q ss_pred eEEEEEecc-CCCHHHHHH-------------------HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEe
Q 008898 321 MYAIVYNLL-NGSLKQYLK-------------------QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLS 380 (549)
Q Consensus 321 ~~~lv~e~~-~gsL~~~l~-------------------~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~ 380 (549)
.+++||||+ +|+|.+++. .+++.+++.++.||+.||+|||+. +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 999999999 789999994 257888999999999999999999 999999999999999
Q ss_pred cCCCceEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCcccch
Q 008898 381 ENFHHPQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELIT-GKEAIQTNKANR 459 (549)
Q Consensus 381 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~ellt-G~~p~~~~~~~~ 459 (549)
.+ +.+||+|||++....... .........||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.......
T Consensus 170 ~~-~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 170 ED-NVMKIADFGLARDIHHID---YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp TT-CCEEECSTTCCCCGGGCC---TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred CC-CCeEeccchhhccccccc---cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 99 689999999997655422 2223345678999999999999999999999999999999998 688886554321
Q ss_pred hhHHHHHHHhhcccccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 460 ESLVLWARSLLSSGLCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 460 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+.. .+ ..+ ..+..+.. .++.+.+++.+||+.||.+|||+.||++.|++
T Consensus 246 --~~~---~i-~~~-----~~~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 246 --LFK---LL-KEG-----HRMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp --HHH---HH-HTT-----CCCCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHH---HH-HcC-----CCCCCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111 11 111 11122222 33467889999999999999999999998854
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=376.20 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=193.2
Q ss_pred CceEcccCceEEEEEEecC--C--cEEEEEEeecCCc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCeEEEEEecc
Q 008898 257 KMLIGQGGNSKVYRTNHVD--G--QVAAVKVLKCTNW--SEEEVLREVELLSSIKHENIVRIIGYCHS-KEMYAIVYNLL 329 (549)
Q Consensus 257 ~~~lG~G~fg~Vy~~~~~~--g--~~~AvK~l~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~lv~e~~ 329 (549)
.++||+|+||+||+|.+.+ + ..||||.++.... ..+++.+|+++|++++||||++++|++.+ +..+++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998743 2 2689999975332 23568999999999999999999999865 56899999999
Q ss_pred -CCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccc
Q 008898 330 -NGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVS 404 (549)
Q Consensus 330 -~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~ 404 (549)
+|+|.+++.. ..+..++.++.|++.||.|||+. +|+||||||+|||++++ +.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCC-
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCC-CCEEEecccchhhccccccc-
Confidence 6889998863 55677889999999999999999 99999999999999998 68999999999765543222
Q ss_pred cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccccccCCccc
Q 008898 405 ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCERLIDPQLN 484 (549)
Q Consensus 405 ~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 484 (549)
.........||+.|+|||.+..+.++.++||||||+++|||+||..||.......+. ...+.... ....
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~----~~~i~~g~---~~~~---- 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----TVYLLQGR---RLLQ---- 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C----HHHHHTTC---CCCC----
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH----HHHHHcCC---CCCC----
Confidence 222233457899999999999999999999999999999999988888654432221 11111111 1111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 008898 485 EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEP 523 (549)
Q Consensus 485 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 523 (549)
+...++.+.+++..||..||.+||||.||++.|+..
T Consensus 256 ---p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 256 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122345678899999999999999999999987544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.7e-46 Score=380.55 Aligned_cols=264 Identities=21% Similarity=0.288 Sum_probs=205.6
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEc--CCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHS--KEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~--~~~~~lv~e 327 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||+++... .+.+.+|+.+|+.++ ||||+++++++.. ...+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5799999999999999999987 679999999997543 567889999999995 9999999999874 457999999
Q ss_pred cc-CCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccccccccccC
Q 008898 328 LL-NGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQVSEN 406 (549)
Q Consensus 328 ~~-~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~ 406 (549)
|+ +|+|..+.+.+++.++..++.||+.||.|||++ +|+||||||+|||++.+.+.+||+|||+|......
T Consensus 113 ~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~------ 183 (328)
T d3bqca1 113 HVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG------ 183 (328)
T ss_dssp CCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT------
T ss_pred ecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC------
Confidence 99 578888888899999999999999999999999 99999999999999976457999999999764432
Q ss_pred ccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh------------ccc
Q 008898 407 VKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL------------SSG 473 (549)
Q Consensus 407 ~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~------------~~~ 473 (549)
......+||+.|+|||.+.+.. ++.++||||+||++|||++|+.||................+. ...
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 2234567999999999988654 799999999999999999999999876553332222111110 000
Q ss_pred --ccccccCC--------cccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 474 --LCERLIDP--------QLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 474 --~~~~~~d~--------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
........ .............+.+++++||..||.+|||++|+++ |+||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~-----Hp~F~~v~ 326 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME-----HPYFYTVV 326 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGTTSC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc-----CcccCCCC
Confidence 00000000 0000011122345678899999999999999999998 99998653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=381.76 Aligned_cols=265 Identities=22% Similarity=0.299 Sum_probs=199.2
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHSKE----- 320 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 320 (549)
+.++|+..+.||+|+||+||+|.+ .+|+.||||+++...... +.+.+|+.+|+.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357899999999999999999987 569999999997654332 45789999999999999999999997654
Q ss_pred -eEEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 321 -MYAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 321 -~~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
.+++||||++++|..+++. +++.....++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|...
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNED-CELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred ceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccc-cccccccccceecc
Confidence 5799999998888888864 88888999999999999999999 99999999999999999 68999999999654
Q ss_pred ccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc---
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG--- 473 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--- 473 (549)
.. ......||+.|+|||.+.+. .++.++||||+||++|||++|++||....... .+...........
T Consensus 172 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 172 DS--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CS--------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHH
T ss_pred CC--------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCcHHH
Confidence 32 22356799999999998865 46899999999999999999999997764322 1111111110000
Q ss_pred --------------ccccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 474 --------------LCERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 474 --------------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
.........+ ..........+.+++..||..||.+|||+.|+++ |+||+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~-----Hp~f~~~~~~ 310 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA-----HPYFESLHDT 310 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH-----SGGGTTTC--
T ss_pred HhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc-----ChhhCcCCCc
Confidence 0000000000 1111122345678889999999999999999999 9999875533
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=380.75 Aligned_cols=272 Identities=22% Similarity=0.291 Sum_probs=202.2
Q ss_pred hhcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC--HHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----Ce
Q 008898 250 LTHNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS--EEEVLREVELLSSIKHENIVRIIGYCHSK-----EM 321 (549)
Q Consensus 250 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~~ 321 (549)
++++|+..+.||+|+||+||+|.+ .+|+.||||+++..... .+.+.+|+.+|++++||||+++++++... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 456799999999999999999976 67999999999755422 35688999999999999999999998654 34
Q ss_pred EEEEEeccCCCHHHHHHH--hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 322 YAIVYNLLNGSLKQYLKQ--LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 322 ~~lv~e~~~gsL~~~l~~--~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
++++|++++|+|.+++.. +++..+..++.||++||+|||++ +||||||||+|||++.+ +.+||+|||+|.....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTT-CDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-CCEEECCCTTCEECCG
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCC-CCEEEcccCceeeccC
Confidence 778888889999999964 78888899999999999999999 99999999999999998 6999999999976544
Q ss_pred ccccccCccccccccCCcccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccccc--
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMY-GKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLCE-- 476 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-- 476 (549)
... ........+||+.|+|||++.. ..++.++||||+||++|||++|+.||.......... .............
T Consensus 162 ~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 162 DHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN-HILGILGSPSQEDLN 238 (345)
T ss_dssp GGC--BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCHHHHH
T ss_pred CCc--cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH-HHhhhccCCChhhhh
Confidence 321 1222345689999999999854 567899999999999999999999997654322111 1111110000000
Q ss_pred ----------cccCCccc----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhHH
Q 008898 477 ----------RLIDPQLN----EEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKREK 533 (549)
Q Consensus 477 ----------~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~~ 533 (549)
....+... ..........+.+++..||..||.+|||+.++++ |+||+.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~-----hpf~~~~~~~ 304 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA-----HPYLEQYYDP 304 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT-----SGGGTTTCCG
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc-----CHhhccCCCC
Confidence 00000000 0000111235778899999999999999999998 8998755443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=373.49 Aligned_cols=267 Identities=24% Similarity=0.335 Sum_probs=197.6
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCc---CHHHHHHHHHHHhcCCCCCeeeEEEEEEc--------C
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNW---SEEEVLREVELLSSIKHENIVRIIGYCHS--------K 319 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~--------~ 319 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||++..... ....+.+|+.+|+.++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6799999999999999999987 6799999999865432 34678899999999999999999998854 3
Q ss_pred CeEEEEEeccCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 320 EMYAIVYNLLNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 320 ~~~~lv~e~~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
+.++++||++.+.+..... .++......++.||++||.|||++ +|+||||||+|||++.+ +.+||+|||++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~-~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRD-GVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCC-CcEEeeecceee
Confidence 4689999999776665542 366778889999999999999999 99999999999999999 689999999997
Q ss_pred ccccccccccCccccccccCCccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc-
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLAPEYMMYG-KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG- 473 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~- 473 (549)
....... .........+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+.+...........
T Consensus 166 ~~~~~~~-~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 166 AFSLAKN-SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLCGSITP 243 (318)
T ss_dssp ECCC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCT
T ss_pred ecccccc-cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHHHHHhcCCCCh
Confidence 6543221 122233456899999999998865 689999999999999999999999976543 222222222211110
Q ss_pred -ccccccCC--------cccccCCH-H------HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 474 -LCERLIDP--------QLNEEYNR-E------EIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 474 -~~~~~~d~--------~l~~~~~~-~------~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
........ ........ + ....+.+++.+||..||++|||++|+++ |+||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~-----Hpff~~ 310 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN-----HDFFWS 310 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH-----SGGGSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc-----Chhhcc
Confidence 00000000 00000000 0 1234567899999999999999999999 999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=363.25 Aligned_cols=264 Identities=21% Similarity=0.258 Sum_probs=202.7
Q ss_pred cCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcC---HHHHHHHHHHHhcCCCCCeeeEEEEEEcCCeEEEEEe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWS---EEEVLREVELLSSIKHENIVRIIGYCHSKEMYAIVYN 327 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e 327 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||+++..... ...+.+|+.+|+.++||||+++++++.+.+.++++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4789999999999999999987 67899999999765432 3568899999999999999999999999999999999
Q ss_pred ccCC-CHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccccccc
Q 008898 328 LLNG-SLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQSHQV 403 (549)
Q Consensus 328 ~~~g-sL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~~~~~ 403 (549)
++.| +|..++.. +++..+..++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||.|.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~-- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCC--
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccC-CceeeeecchhhcccCCC--
Confidence 9955 55555533 67788889999999999999999 99999999999999988 689999999997654322
Q ss_pred ccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhcccc-----ccc
Q 008898 404 SENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGL-----CER 477 (549)
Q Consensus 404 ~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----~~~ 477 (549)
.......+++.|+|||.+.... ++.++|||||||++|||++|+.||.......+.+............ ...
T Consensus 156 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 ---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 1222345788999999988665 6899999999999999999999986554433333222221111000 000
Q ss_pred ccC---------CcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhh
Q 008898 478 LID---------PQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKM 529 (549)
Q Consensus 478 ~~d---------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~ 529 (549)
..+ ..............+.+++.+||..||.+|||++|+++ |+||..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~-----Hp~f~~ 288 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ-----HPYFSD 288 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT-----SGGGSS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc-----ChhhcC
Confidence 000 00011111223345778889999999999999999999 899964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=370.99 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=204.2
Q ss_pred cCCCCCceEcccCceEEEEEEe----cCCcEEEEEEeecCC-----cCHHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCe
Q 008898 252 HNFSPKMLIGQGGNSKVYRTNH----VDGQVAAVKVLKCTN-----WSEEEVLREVELLSSIKH-ENIVRIIGYCHSKEM 321 (549)
Q Consensus 252 ~~f~~~~~lG~G~fg~Vy~~~~----~~g~~~AvK~l~~~~-----~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~ 321 (549)
++|++.+.||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|+++|++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999975 248899999986432 233567899999999966 899999999999999
Q ss_pred EEEEEecc-CCCHHHHHHH---hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccc
Q 008898 322 YAIVYNLL-NGSLKQYLKQ---LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVH 397 (549)
Q Consensus 322 ~~lv~e~~-~gsL~~~l~~---~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~ 397 (549)
++++|||+ +|+|.+++.. +.......++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN-GHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCC-CCEEEeeccchhhh
Confidence 99999999 6899999865 55677888999999999999999 99999999999999998 78999999999765
Q ss_pred ccccccccCccccccccCCccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccccc
Q 008898 398 HQSHQVSENVKPVNVVGTFGYLAPEYMMYG--KVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSGLC 475 (549)
Q Consensus 398 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 475 (549)
.... .....+..||+.|+|||.+.+. .++.++|||||||+||||++|+.||................. ..
T Consensus 180 ~~~~----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-~~--- 251 (322)
T d1vzoa_ 180 VADE----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KS--- 251 (322)
T ss_dssp CGGG----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HC---
T ss_pred cccc----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-cC---
Confidence 4321 2223456899999999999765 468899999999999999999999987654332222111111 00
Q ss_pred ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCchhhhhhhHHHH
Q 008898 476 ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRP-----TMKTLLKLFQEPDYWLKMKREKEE 535 (549)
Q Consensus 476 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~~~~w~~~~~~~~~ 535 (549)
.+.. +......+.+++..||.+||.+|| |++|+++ |+||+..+...-
T Consensus 252 ----~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~-----Hpff~~i~~~~l 303 (322)
T d1vzoa_ 252 ----EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE-----HLFFQKINWDDL 303 (322)
T ss_dssp ----CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT-----SGGGTTCCHHHH
T ss_pred ----CCCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc-----CHhhcCCCHHHH
Confidence 1111 223345677788999999999999 4789987 999988655433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-44 Score=361.38 Aligned_cols=258 Identities=19% Similarity=0.204 Sum_probs=197.7
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCee-eEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENIV-RIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nIv-~l~~~~~~~~~~~lv~e~ 328 (549)
.++|++.+.||+|+||.||+|.+ .+|+.||||++..... ..++..|+++++.++|+|++ .+..++.+++.+++||||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46799999999999999999987 5689999999875432 34578999999999876655 455666788899999999
Q ss_pred cCCCHHHHHH----HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC--CCceEEeeeccccccccccc
Q 008898 329 LNGSLKQYLK----QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN--FHHPQLSDFGAAMVHHQSHQ 402 (549)
Q Consensus 329 ~~gsL~~~l~----~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~~kL~DFGla~~~~~~~~ 402 (549)
++|+|.+.+. .+++..+..++.|++.||+|||++ +||||||||+|||++.. ...++|+|||+|+.......
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 9999888774 378889999999999999999999 99999999999998632 24699999999987654322
Q ss_pred cc--cCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhH--HHHHHHhhcccccccc
Q 008898 403 VS--ENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESL--VLWARSLLSSGLCERL 478 (549)
Q Consensus 403 ~~--~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l--~~~~~~~~~~~~~~~~ 478 (549)
.. .........||+.|||||.+.+..++.++|||||||++|||++|+.||.......... ..+...... ...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~--- 237 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI--- 237 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH---
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CCh---
Confidence 11 1223346789999999999999999999999999999999999999997655432211 111111000 000
Q ss_pred cCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 008898 479 IDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQE 522 (549)
Q Consensus 479 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 522 (549)
+.+.. ..+..+.+++..|++.||.+||++.++.++|+.
T Consensus 238 --~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 --EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp --HHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred --hHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 01111 223457788899999999999999999888763
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=372.44 Aligned_cols=266 Identities=20% Similarity=0.249 Sum_probs=197.8
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEE------cCC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCH------SKE 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~------~~~ 320 (549)
.++|++.+.||+|+||+||+|.+ .+|+.||||+++...... ..+.+|+.+|++++||||++++++|. ..+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36799999999999999999987 579999999998654433 35789999999999999999999985 346
Q ss_pred eEEEEEeccCCCHHHHH-HHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccccccc
Q 008898 321 MYAIVYNLLNGSLKQYL-KQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHHQ 399 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l-~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~~ 399 (549)
.+++||||+.|++.+.+ ..+++..+..++.||+.||.|||++ ||+||||||+|||++.+ +.++++|||++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~-~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT-CCEEECCCCC------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccc-cceeeechhhhhcccc
Confidence 89999999988766655 4588889999999999999999999 99999999999999998 6899999999865433
Q ss_pred ccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhh---------
Q 008898 400 SHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLL--------- 470 (549)
Q Consensus 400 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~--------- 470 (549)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........
T Consensus 172 ------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 172 ------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTT
T ss_pred ------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHH
Confidence 233345679999999999999999999999999999999999999997654321 1111111000
Q ss_pred ----------ccccc-----ccccCCcc---cccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhhH
Q 008898 471 ----------SSGLC-----ERLIDPQL---NEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKRE 532 (549)
Q Consensus 471 ----------~~~~~-----~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~~ 532 (549)
..... ........ ...........+.++++.||..||++|||++|+++ |+||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~-----Hpw~~~~~~ 319 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ-----HPYINVWYD 319 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT-----STTTGGGCC
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc-----CcccCCCCC
Confidence 00000 00000000 01112334567889999999999999999999999 999987543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-44 Score=360.50 Aligned_cols=258 Identities=16% Similarity=0.156 Sum_probs=202.3
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCeEEEEEec
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH-ENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++... ....+.+|+++++.+.| +|++.+++++.++...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 46799999999999999999987 568999999986543 23457789999999975 8999999999999999999999
Q ss_pred cCCCHHHHHHH----hchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecC----CCceEEeeeccccccccc
Q 008898 329 LNGSLKQYLKQ----LKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSEN----FHHPQLSDFGAAMVHHQS 400 (549)
Q Consensus 329 ~~gsL~~~l~~----~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~~kL~DFGla~~~~~~ 400 (549)
++|+|.+++.. ++......++.|++.||+|||++ |||||||||+|||++.+ .+.+||+|||+|+.....
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred cCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 99999999854 67788889999999999999999 99999999999999742 257999999999876543
Q ss_pred cc--cccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccchhh-HHHHHHHhhccccccc
Q 008898 401 HQ--VSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKANRES-LVLWARSLLSSGLCER 477 (549)
Q Consensus 401 ~~--~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~ 477 (549)
.. ..........+||+.|||||++.+..++.++|||||||++|||++|..||......... ...............+
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 21 11222344678999999999999999999999999999999999999999865442211 1110101000001111
Q ss_pred ccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 008898 478 LIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQ 521 (549)
Q Consensus 478 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 521 (549)
+... .++.+.+++..|++.+|.+||+++.+.++|+
T Consensus 240 -----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 240 -----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp -----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred -----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 1112 2345777889999999999999999888664
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=372.60 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=197.4
Q ss_pred hcCCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCH---HHHHHHHHHHhcCCCCCeeeEEEEEEc------CC
Q 008898 251 THNFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSE---EEVLREVELLSSIKHENIVRIIGYCHS------KE 320 (549)
Q Consensus 251 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~------~~ 320 (549)
.++|++.+.||+|+||+||+|.+ .+|+.||||+++...... +.+.+|+.+|+.++||||+++++++.. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999987 679999999997654333 457899999999999999999999853 33
Q ss_pred eEEEEEeccCCCHHHHHH--HhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeeccccccc
Q 008898 321 MYAIVYNLLNGSLKQYLK--QLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAMVHH 398 (549)
Q Consensus 321 ~~~lv~e~~~gsL~~~l~--~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~~~~ 398 (549)
.+++++++.+|+|.+++. .+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+|++|||+|....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED-CELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT-CCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccc-ccccccccchhcccC
Confidence 567777777899999985 378888999999999999999999 99999999999999999 789999999985433
Q ss_pred cccccccCccccccccCCccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcccchhhHHHHHHHhhccc-cc-
Q 008898 399 QSHQVSENVKPVNVVGTFGYLAPEYMMYGK-VDEKIDVYSYGVVLLELITGKEAIQTNKANRESLVLWARSLLSSG-LC- 475 (549)
Q Consensus 399 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~k~DvwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-~~- 475 (549)
. ...+..||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||........ ............ ..
T Consensus 173 ~--------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 173 D--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELL 243 (348)
T ss_dssp G--------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHH
T ss_pred c--------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHh
Confidence 2 234567999999999877664 68999999999999999999999976643221 111111111000 00
Q ss_pred ---------------ccccCCcccccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCchhhhhhh
Q 008898 476 ---------------ERLIDPQLNEEYNREEIEIVMCAARLCLLHSSSRRPTMKTLLKLFQEPDYWLKMKR 531 (549)
Q Consensus 476 ---------------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~w~~~~~ 531 (549)
.......+.. ........+.+++.+||..||.+|||+.|+++ |+||.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~-----Hp~f~~~~ 308 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA-----HAYFAQYH 308 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT-----SGGGTTTC
T ss_pred hhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc-----CHhhCCCC
Confidence 0000000000 00112345678899999999999999999998 89998643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-40 Score=342.02 Aligned_cols=262 Identities=19% Similarity=0.260 Sum_probs=192.1
Q ss_pred CCCCCceEcccCceEEEEEEe-cCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC-----------CCCeeeEEEEEEc--
Q 008898 253 NFSPKMLIGQGGNSKVYRTNH-VDGQVAAVKVLKCTNWSEEEVLREVELLSSIK-----------HENIVRIIGYCHS-- 318 (549)
Q Consensus 253 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-----------h~nIv~l~~~~~~-- 318 (549)
+|++.+.||+|+||+||+|.+ .+|+.||||+++.+....+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 599999999999999999987 67999999999876555567788999988875 5789999988753
Q ss_pred CCeEEEEEecc--CCCHHHHHH-----HhchhHHHHHHHHHHHHHHHHHh-CCCCCEEEecCCCCCEEEecCCC-----c
Q 008898 319 KEMYAIVYNLL--NGSLKQYLK-----QLKWNERMDVAIGVAKALEYLHH-TCDPPIIHRDVKSSNILLSENFH-----H 385 (549)
Q Consensus 319 ~~~~~lv~e~~--~gsL~~~l~-----~~~~~~~~~i~~~i~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~-----~ 385 (549)
....+++++++ .++...... .+.+..+..++.||+.||.|||+ . +|+||||||+|||++.+.. .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccce
Confidence 34555555555 344444432 26667788999999999999998 5 9999999999999986521 3
Q ss_pred eEEeeeccccccccccccccCccccccccCCccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCcccc-----hh
Q 008898 386 PQLSDFGAAMVHHQSHQVSENVKPVNVVGTFGYLAPEYMMYGKVDEKIDVYSYGVVLLELITGKEAIQTNKAN-----RE 460 (549)
Q Consensus 386 ~kL~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~k~DvwSlGvil~elltG~~p~~~~~~~-----~~ 460 (549)
++++|||.+..... .....+||+.|+|||++.+..++.++||||+||++++|++|+.||...... .+
T Consensus 171 ~kl~dfg~s~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 171 IKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred eeEeeccccccccc--------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 89999999865432 223567999999999999999999999999999999999999999754321 11
Q ss_pred hHHHHHHHhhcc-----------------cccccccCCc----------ccccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 008898 461 SLVLWARSLLSS-----------------GLCERLIDPQ----------LNEEYNREEIEIVMCAARLCLLHSSSRRPTM 513 (549)
Q Consensus 461 ~l~~~~~~~~~~-----------------~~~~~~~d~~----------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 513 (549)
.+......+... ......+... ............+.+++.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 111111111000 0000000000 0122345677889999999999999999999
Q ss_pred HHHHHHhcCCchhhhhh
Q 008898 514 KTLLKLFQEPDYWLKMK 530 (549)
Q Consensus 514 ~evl~~L~~~~~w~~~~ 530 (549)
+|+++ |+||+..
T Consensus 323 ~e~L~-----Hp~f~~~ 334 (362)
T d1q8ya_ 323 GGLVN-----HPWLKDT 334 (362)
T ss_dssp HHHHT-----CGGGTTC
T ss_pred HHHhc-----CcccCCC
Confidence 99998 9999844
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.7e-23 Score=195.25 Aligned_cols=161 Identities=17% Similarity=0.171 Sum_probs=119.2
Q ss_pred CCCceEcccCceEEEEEEecCCcEEEEEEeecCCcC-------------------HHHHHHHHHHHhcCCCCCeeeEEEE
Q 008898 255 SPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTNWS-------------------EEEVLREVELLSSIKHENIVRIIGY 315 (549)
Q Consensus 255 ~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~-------------------~~~~~~E~~il~~l~h~nIv~l~~~ 315 (549)
.+.+.||+|+||.||+|...+|+.||||+++..... .....+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356789999999999999888999999987642111 1224568889999999999988866
Q ss_pred EEcCCeEEEEEeccCCCHHHHHHHhchhHHHHHHHHHHHHHHHHHhCCCCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 316 CHSKEMYAIVYNLLNGSLKQYLKQLKWNERMDVAIGVAKALEYLHHTCDPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 316 ~~~~~~~~lv~e~~~gsL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
.. .+++||++.+... ..++......++.|+++||.|||++ +|+||||||+|||++++ .++|+|||+|.
T Consensus 83 ~~----~~lvme~~~~~~~---~~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~--~~~liDFG~a~ 150 (191)
T d1zara2 83 EG----NAVLMELIDAKEL---YRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE--GIWIIDFPQSV 150 (191)
T ss_dssp ET----TEEEEECCCCEEG---GGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT--EEEECCCTTCE
T ss_pred cC----CEEEEEeeccccc---cchhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC--CEEEEECCCcc
Confidence 42 3689999976422 3456667778999999999999999 99999999999999976 58999999985
Q ss_pred ccccccccccCccccccccCCcccc------ccccccCCCCchhhHHHHHHH
Q 008898 396 VHHQSHQVSENVKPVNVVGTFGYLA------PEYMMYGKVDEKIDVYSYGVV 441 (549)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~gt~~y~A------PE~~~~~~~~~k~DvwSlGvi 441 (549)
....... ..|+. .+.+ ...|+.++|+||+.--
T Consensus 151 ~~~~~~~-------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 151 EVGEEGW-------------REILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp ETTSTTH-------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred cCCCCCc-------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 4321110 01111 1212 3567889999997543
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.23 E-value=3e-11 Score=108.94 Aligned_cols=118 Identities=14% Similarity=0.248 Sum_probs=92.2
Q ss_pred cEEEEEEecCh---------hhHHHHHHHHHHhcCCCCe---EEEEEeeccCCcc---------c--------c------
Q 008898 23 RTVIFGLKSDH---------YSREILLQLLTVIAKPGDN---VLAVHVEEQNDTL---------D--------L------ 67 (549)
Q Consensus 23 ~~~~v~~~~~~---------~~~~~l~wa~~~~~~~~d~---v~~~hv~~~~~~~---------~--------~------ 67 (549)
++|||+||-+. .|+.||.||+.++.+.||. |+++||....... . .
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAKG 81 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHHH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 68999999664 8999999999999999995 9999998543210 0 0
Q ss_pred -chHHHHHHhhhccCceEEEEEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEec
Q 008898 68 -NTFHIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 68 -~~~~~~~~~c~~k~~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
+.+..+...|..++++++..|..|.. ...|+++|+...++.||+|.+.. +.-.+.++.||+++++ |-|++|.
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~v~~G~~-~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~~~--cpVlvV~ 158 (171)
T d2gm3a1 82 LHLLEFFVNKCHEIGVGCEAWIKTGDP-KDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTIK 158 (171)
T ss_dssp HHHHHHHHHHHHHHTCEEEEEEEESCH-HHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEEEE
T ss_pred HHHHHHHHHHHHhcCCceEEEEEeCCh-HHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhCCC--CCEEEEe
Confidence 12266788999999999999999965 66899999999999999998865 2112239999999998 9998885
Q ss_pred c
Q 008898 143 N 143 (549)
Q Consensus 143 ~ 143 (549)
.
T Consensus 159 ~ 159 (171)
T d2gm3a1 159 R 159 (171)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.03 E-value=4.8e-10 Score=96.41 Aligned_cols=116 Identities=15% Similarity=0.138 Sum_probs=88.6
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcccc-------------chHHHHHHhhhccCceEEEEE-
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL-------------NTFHIHEDLCKSKKVDFLVKV- 88 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~~-------------~~~~~~~~~c~~k~~~~~~~v- 88 (549)
++|||++|.+..|+.+++||+....+.|+.|+++||..+...... +....++.+++..++...-.+
T Consensus 2 k~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 81 (135)
T d2z3va1 2 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEEARALTGVPKEDALL 81 (135)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTCCTTHHHHHHHHHHHHHHHHHHHHHHHHCCCGGGEEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCccccccchhHHHHHHHHHHHHHHHHHHHHhcCCCeEEEEE
Confidence 689999999999999999999999999999999999864331111 112556667776655544333
Q ss_pred EecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEe
Q 008898 89 CIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVM 141 (549)
Q Consensus 89 ~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v 141 (549)
..| +...+|++.|+...++.||+|.+.+ +.-.+.++.+|+++++ |-|+.|
T Consensus 82 ~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 82 LEG-VPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp EES-CHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCS--SCEEEE
T ss_pred EcC-ChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCC--CCEEeC
Confidence 455 5577999999999999999998865 2222349999999998 877765
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=98.99 E-value=2.1e-09 Score=95.10 Aligned_cols=118 Identities=10% Similarity=0.130 Sum_probs=94.0
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCccc----------------c----------------chH
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLD----------------L----------------NTF 70 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~----------------~----------------~~~ 70 (549)
|+|||++|.+..|+.+|+||+...-..|..|.+|||..+..... . +.+
T Consensus 4 ~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 83 (160)
T d1mjha_ 4 KKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNKM 83 (160)
T ss_dssp CEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHHHH
Confidence 79999999999999999999999999999999999974432100 0 112
Q ss_pred HHHHHhhhccCceEEEEEEecCcchhhHHHHHhhhcccEEEEecccC----CCCchhHHHHHhhhCCCCcEEEEecc
Q 008898 71 HIHEDLCKSKKVDFLVKVCIGDSYITELSNQVRISYATILALGCSLS----GLKDSEVLTRCLRALPPACTILVMDN 143 (549)
Q Consensus 71 ~~~~~~c~~k~~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~----~~~~~~v~~~c~~~~~~~c~v~~v~~ 143 (549)
..+..-|...++.++..+..| ....+|++.|+...++.||+|.+.. +.-.+.++.+++++++ |-|+.|..
T Consensus 84 ~~~~~~~~~~gv~~~~~~~~G-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~--~pVlvV~~ 157 (160)
T d1mjha_ 84 ENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKR 157 (160)
T ss_dssp HHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECC
T ss_pred HHHHHHHHhcCCeEEEEEEec-cHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCC--CCEEEEcC
Confidence 445666788899999999999 4577899999999999999998755 2222349999999998 98888753
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=98.84 E-value=4.8e-09 Score=90.41 Aligned_cols=118 Identities=14% Similarity=0.130 Sum_probs=89.5
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCcccc----------------chHHHHHHhhhccCceEEE
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDTLDL----------------NTFHIHEDLCKSKKVDFLV 86 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~~~~----------------~~~~~~~~~c~~k~~~~~~ 86 (549)
++|||++|.+..|+.+|.||+...-+.|+.|.++||..+...... .....++.++...+.....
T Consensus 3 k~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (140)
T d1jmva_ 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPISE 82 (140)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCCCC
T ss_pred CeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccccchHHHHHHHHHHHHHHHHHHHHhcCCceEE
Confidence 689999999999999999999999999999999999854431000 1114456666666666555
Q ss_pred EEEecCcchhhHHHHHhhhcccEEEEecccCCC-CchhHHHHHhhhCCCCcEEEEec
Q 008898 87 KVCIGDSYITELSNQVRISYATILALGCSLSGL-KDSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 87 ~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~~-~~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
.+..+.+....|++.|+...++.||+|.+.+.. ..+.++.+++++++ |-|+.|-
T Consensus 83 ~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~lgs~~~~li~~~~--~pVliVp 137 (140)
T d1jmva_ 83 KLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSKLMSSTRQVMNTIK--IDMLVVP 137 (140)
T ss_dssp EEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHHHHHHHHHHHTTCC--SEEEEEE
T ss_pred EEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCCcccHHHHHHhccC--CCEEEEe
Confidence 555555678899999999999999999764411 12248899999988 8888773
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.72 E-value=4.1e-08 Score=85.10 Aligned_cols=117 Identities=13% Similarity=0.132 Sum_probs=85.8
Q ss_pred CcEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccC-Cc------------------cccchHHHHHHhhhccCc
Q 008898 22 KRTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQN-DT------------------LDLNTFHIHEDLCKSKKV 82 (549)
Q Consensus 22 ~~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~-~~------------------~~~~~~~~~~~~c~~k~~ 82 (549)
-|+|||++|.+..|+.+|.||+.. |++++.++.+|+..+. .. .....+..++.+|...++
T Consensus 5 yk~ILv~vD~s~~s~~al~~A~~l-a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 83 (147)
T d1tq8a_ 5 YKTVVVGTDGSDSSMRAVDRAAQI-AGADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNAGA 83 (147)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHH-HTTTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTTTC
T ss_pred CCEEEEEECCCHHHHHHHHHHHHH-HhcCCCEEEEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 379999999999999999999975 5666666666654221 10 000233667788888777
Q ss_pred e-EEEEEEecCcchhhHHHHHhhhcccEEEEecccCCC-C---chhHHHHHhhhCCCCcEEEEec
Q 008898 83 D-FLVKVCIGDSYITELSNQVRISYATILALGCSLSGL-K---DSEVLTRCLRALPPACTILVMD 142 (549)
Q Consensus 83 ~-~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~~~~-~---~~~v~~~c~~~~~~~c~v~~v~ 142 (549)
. ++..+..|.. ...|+++|+...++.||+|.+.... . .+.+..+++++++ |-|+.|.
T Consensus 84 ~~~~~~~~~G~~-~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~--~pVlvV~ 145 (147)
T d1tq8a_ 84 KNVEERPIVGAP-VDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVH 145 (147)
T ss_dssp CEEEEEEECSSH-HHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEEC
T ss_pred CcEEEEEEecCh-HHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCC--CCEEEEe
Confidence 5 7888888865 6689999999999999999985511 0 1127889999988 9888875
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=98.32 E-value=8.7e-07 Score=75.35 Aligned_cols=93 Identities=11% Similarity=-0.016 Sum_probs=72.7
Q ss_pred cEEEEEEecChhhHHHHHHHHHHhcCCCCeEEEEEeeccCCc----------ccc---------chHHHHHHhhh---cc
Q 008898 23 RTVIFGLKSDHYSREILLQLLTVIAKPGDNVLAVHVEEQNDT----------LDL---------NTFHIHEDLCK---SK 80 (549)
Q Consensus 23 ~~~~v~~~~~~~~~~~l~wa~~~~~~~~d~v~~~hv~~~~~~----------~~~---------~~~~~~~~~c~---~k 80 (549)
|+|||++|.+..|+.||.||+.-.-+-|..|.++||..+... ... .....++.+|+ ..
T Consensus 5 k~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~l~~~~~~~~~~ 84 (138)
T d1q77a_ 5 KVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREVWEKLTGS 84 (138)
T ss_dssp EEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred CEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccchhhhhhhhhhhhccccchhhccccccc
Confidence 799999999999999999999999999999999999843210 000 11133444444 34
Q ss_pred CceEEEEEEecCcchhhHHHHHhhhcccEEEEeccc
Q 008898 81 KVDFLVKVCIGDSYITELSNQVRISYATILALGCSL 116 (549)
Q Consensus 81 ~~~~~~~v~~g~~~~~~l~~e~k~~~~~~lvlg~~~ 116 (549)
.+.++..|..|.+ ...+.+.|+...++.||+|++-
T Consensus 85 ~~~~~~~v~~G~~-~~~I~~~a~~~~~DLIV~Gs~g 119 (138)
T d1q77a_ 85 TEIPGVEYRIGPL-SEEVKKFVEGKGYELVVWACYP 119 (138)
T ss_dssp CCCCCEEEECSCH-HHHHHHHHTTSCCSEEEECSCC
T ss_pred ceeEEEeeecchh-HHHHHHhhhhccCCEEEEecCC
Confidence 6778888889865 6679999999999999999873
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.20 E-value=3.7e-06 Score=79.53 Aligned_cols=147 Identities=14% Similarity=0.165 Sum_probs=94.2
Q ss_pred HHHHhhhcCCCCCceEcccCceEEEEEEecCCcEEEEEEeecCC-cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeE
Q 008898 245 QELCHLTHNFSPKMLIGQGGNSKVYRTNHVDGQVAAVKVLKCTN-WSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMY 322 (549)
Q Consensus 245 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~~AvK~l~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~ 322 (549)
.++...-+.|+..+..+-++.+.||+... +++.+.+|+..... .....+.+|..++..+. +--+.+++.+...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 34555556666555544444578999864 56667788775432 23345778888887764 33466788888888889
Q ss_pred EEEEeccCC-CHHHHHHHhchhHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 008898 323 AIVYNLLNG-SLKQYLKQLKWNERMDVAIGVAKALEYLHHTC-------------------------------------- 363 (549)
Q Consensus 323 ~lv~e~~~g-sL~~~l~~~~~~~~~~i~~~i~~aL~yLH~~~-------------------------------------- 363 (549)
+++|+++.| ++.+... .......++.++++.+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~--~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYE--DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EEEEECCSSEEHHHHTT--TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEEEEeccccccccccc--ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999999966 4433221 11122233444555555555321
Q ss_pred ------------------CCCEEEecCCCCCEEEecCCCceEEeeecccc
Q 008898 364 ------------------DPPIIHRDVKSSNILLSENFHHPQLSDFGAAM 395 (549)
Q Consensus 364 ------------------~~~iiHrDlkp~NILl~~~~~~~kL~DFGla~ 395 (549)
...++|+|+.|.|||++++ +.+-|.||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhcc
Confidence 0138999999999999976 445699999873
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=4.8e-05 Score=71.11 Aligned_cols=70 Identities=16% Similarity=0.091 Sum_probs=51.1
Q ss_pred EcccCc-eEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCC--CCeeeEEEEEEcCCeEEEEEeccCC
Q 008898 260 IGQGGN-SKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKH--ENIVRIIGYCHSKEMYAIVYNLLNG 331 (549)
Q Consensus 260 lG~G~f-g~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~g 331 (549)
+..|.. +.||+....++..+.+|...... ...+..|...++.+.. -.+.+++.+..+++..+++|+++.|
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 445554 67999988778888999876443 2346778888876643 3356778888888889999999965
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.15 E-value=0.00094 Score=66.73 Aligned_cols=72 Identities=17% Similarity=0.085 Sum_probs=46.2
Q ss_pred ceEcccCceEEEEEEec-CCcEEEEEEeecC------C--cCHHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCeEEEE
Q 008898 258 MLIGQGGNSKVYRTNHV-DGQVAAVKVLKCT------N--WSEEEVLREVELLSSIK---HENIVRIIGYCHSKEMYAIV 325 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~-~g~~~AvK~l~~~------~--~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~lv 325 (549)
+.||.|....||+.... +++.++||.-... . ........|.+.|+.+. ...+.+++.+. .+..+++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 35899999999999764 4678899975321 1 12344567888887663 23455666554 3455788
Q ss_pred EeccCC
Q 008898 326 YNLLNG 331 (549)
Q Consensus 326 ~e~~~g 331 (549)
||++.|
T Consensus 110 mE~L~~ 115 (392)
T d2pula1 110 MEDLSH 115 (392)
T ss_dssp ECCCTT
T ss_pred EeccCC
Confidence 999854
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.10 E-value=0.00073 Score=65.66 Aligned_cols=67 Identities=16% Similarity=0.400 Sum_probs=48.9
Q ss_pred ceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCCCCCe--eeEE-----EEEEcCCeEEEEEeccCC
Q 008898 265 NSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIKHENI--VRII-----GYCHSKEMYAIVYNLLNG 331 (549)
Q Consensus 265 fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~h~nI--v~l~-----~~~~~~~~~~lv~e~~~g 331 (549)
--.||++...+|..+++|+......+.+++..|...+..|....+ +..+ ..+..++..+.+++++.|
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999998899999999998877788889999998887742221 1111 133456678888888865
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.45 E-value=0.006 Score=58.34 Aligned_cols=62 Identities=10% Similarity=0.163 Sum_probs=39.6
Q ss_pred cCHHHHHhhhcCCCCCceE-----cccCceEEEEEEecCCcEEEEEEeecCCcCHHHHHHHHHHHhcCC
Q 008898 242 FTSQELCHLTHNFSPKMLI-----GQGGNSKVYRTNHVDGQVAAVKVLKCTNWSEEEVLREVELLSSIK 305 (549)
Q Consensus 242 ~~~~el~~~~~~f~~~~~l-----G~G~fg~Vy~~~~~~g~~~AvK~l~~~~~~~~~~~~E~~il~~l~ 305 (549)
++.+|+..+..+|...++. ..|---+.|+....+|+ +++|+.... .+.+++..|++++..|.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhh
Confidence 4667788888888876553 35555778998876654 889988643 23345666777777764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.71 E-value=0.019 Score=56.82 Aligned_cols=69 Identities=9% Similarity=0.104 Sum_probs=47.4
Q ss_pred ceEcccCceEEEEEEecC--------CcEEEEEEeecCCcCHHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCeEEEEEec
Q 008898 258 MLIGQGGNSKVYRTNHVD--------GQVAAVKVLKCTNWSEEEVLREVELLSSIK-HENIVRIIGYCHSKEMYAIVYNL 328 (549)
Q Consensus 258 ~~lG~G~fg~Vy~~~~~~--------g~~~AvK~l~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 328 (549)
+.|+.|-.-.+|++...+ .+.+.+++.- ......+..+|..+++.+. +.-..++++++.+ .+||+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 468888888999997643 3467777665 3334456678999998885 4334577887743 577888
Q ss_pred cCC
Q 008898 329 LNG 331 (549)
Q Consensus 329 ~~g 331 (549)
+.|
T Consensus 123 i~g 125 (395)
T d1nw1a_ 123 IPS 125 (395)
T ss_dssp CCE
T ss_pred ecc
Confidence 865
|